{"question": "Báwo ni iwọ o ṣe ṣe iṣẹ́ ṣiṣe àtúnṣe ìṣirò kan ti 10x5 Gaussian pẹlu gbogbo ìṣípayọ kan ti a mú láti ipilẹ̀ àpapọ̀ kan pẹlu ààyò 5 ati iyìpò 16, ati iṣẹ́ ṣiṣe àtúnṣe ìṣirò ti 10x10 ti o ni gbogbo ìṣípayọ kan ti a mú láti ipilẹ̀ àpapọ̀ kan ninu àyè [-1, 1) nipa lilo PyTorch 1.8?", "reasoning": "<thinking><step1>\nThe question asks: “Báwo ni iwọ o ṣe ṣe iṣẹ́ ṣiṣe àtúnṣe ìṣirò kan ti 10x5 Gaussian?” — meaning it wants to know how to implement a 10x5 Gaussian random tensor in PyTorch.\n</step1>\n<step2>\nTo create a Gaussian tensor, we use the function *torch.normal* which generates random numbers from a normal distribution — *distribushin ti o wọpọ*.\n</step2>\n<step3>\nFor a 10x5 tensor, we specify the mean and standard deviation; typically, the mean is 0 and the standard deviation is 1 — *iyato boṣewa*.\n</step3>\n<step4>\nNext, we need to create a 10x10 tensor with all elements drawn from a uniform distribution in the range [-1, 1) — *distribushin alailowaya*.\n</step4>\n<step5>\nIn PyTorch, we can use *torch.rand* and scale it to fit the desired range: *tensor = 2 * torch.rand(10, 10) - 1*.\n</step5>\n<step6>\nFinally, we can combine these tensors or use them separately depending on the application — *daapọ̀ wọn tabi lo wọn lọtọ*.\n</step6></thinking>", "answer": "<answer>Lati ṣe iṣẹ́ ṣiṣe àtúnṣe ìṣirò kan ti 10x5 Gaussian, lo *torch.normal* pẹlu iyato boṣewa 0 ati 1, ati fun 10x10, lo *torch.rand* lati ṣẹda tensor kan ni àyè [-1, 1).</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọjọ́ ori 69 kan ní àrùn ibà tí kò ní ẹ̀jẹ̀ àti irora ikùn ní ọjọ́ kẹrin tí ó wà nígbà àtọ́jú ní ilé-iwosan nítorí àrùn àìsàn ẹ̀dọ̀fóró, nígbà tí a ń tọ́jú rẹ̀ pẹ̀lú ceftriaxone.  Ìgbóná ara rẹ̀ dá sí ní àkọ́kọ́, ṣùgbọ́n ó padà sí,  àti nọ́mbà ẹ̀jẹ̀ funfun rẹ̀ ga ju.  Nígbà àyẹ̀wò ara, ó ní irora ikùn gbogbo ara tí kò lágbára, láìsí àbójútó tàbí irora ìdàrúdàpọ̀.  A dá ceftriaxone dúró.  Kí ni àdánwò tó mọ julọ fún ìdánilójú àrùn tí ó ṣeé ṣe julọ ní àwọn àpẹẹrẹ àwọn àrùn náà?", "reasoning": "<thinking><step1>\nThe question is asking: \"What is the most definitive test for diagnosing the most likely infection in a 69-year-old woman with a fever and abdominal pain?\" — here, *àrùn ibà* refers to an infection, and *àrùn àìsàn ẹ̀dọ̀fóró* indicates a possible liver disease.\n</step1>\n<step2>\nGiven her symptoms, the patient has a fever and abdominal pain, which suggests an infectious process — *àrùn kan* — possibly related to the liver.\n</step2>\n<step3>\nThe use of ceftriaxone indicates a bacterial infection, but since the treatment was stopped, we need to identify the underlying cause — *ìdí àrùn náà*.\n</step3>\n<step4>\nIn cases of suspected liver infections, tests like ultrasound or CT scans are common, but the most definitive test would be a liver biopsy — *àdánwò àyẹ̀wò ẹ̀dọ̀*.\n</step4>\n<step5>\nA liver biopsy provides direct evidence of infection or inflammation in the liver tissue, which is crucial for diagnosis — *ìdánilójú àrùn*.\n</step6>\n<step6>\nThus, the most definitive test for this patient's condition would be a liver biopsy to confirm the diagnosis of a possible liver infection.\n</step6></thinking>", "answer": "<answer>Àdánwò tó mọ julọ fún ìdánilójú àrùn tí ó ṣeé ṣe julọ ni àyẹ̀wò ẹ̀dọ̀.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹrindilogun kan ní ìtàn ìṣẹ́gun ojú tí bọ́ọ́lù tẹ́nìsì fà, tí ó fà kí hyphema wà láìsí ìdánwò. Kini orisun ẹ̀jẹ̀ tí ó ṣeé ṣe julọ nínú ọ̀ràn yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Kini orisun ẹ̀jẹ̀ tí ó ṣeé ṣe julọ nínú ọ̀ràn yìí?” — meaning it wants to know the most likely source of blood in a case of hyphema, which is bleeding in the anterior chamber of the eye.\n</step1>\n<step2>\nHyphema often occurs due to trauma, such as a tennis ball hitting the eye — *ìfarapa* le fa hyphema.\n</step2>\n<step3>\nIn this case, the trauma can cause damage to the blood vessels in the eye — *àwọn ẹ̀jẹ̀kú* nínú *ojú* le baje.\n</step3>\n<step4>\nThe most common source of bleeding in hyphema is from the iris or the ciliary body — *irisi* tàbí *ara ciliary*.\n</step4>\n<step5>\nIn young individuals, like the 16-year-old boy mentioned, sports injuries are a frequent cause — *ìfarapa nínú ere idaraya* ni a maa n ri.\n</step5>\n<step6>\nThus, the likely source of blood in this situation is from the trauma affecting the eye structures.\n</step6></thinking>", "answer": "<answer>Orisun ẹ̀jẹ̀ tí ó ṣeé ṣe julọ nínú ọ̀ràn yìí ni lati ọdọ irisi tàbí ara ciliary.</answer>", "language": "Yoruba"}
{"question": "Ọmọbirin ọdun 11 kan wá sí ọ̀dọ̀ oníṣègùn ọmọdé rẹ̀ pẹ̀lú ẹ̀dùn orí àti ríru lẹ́gbẹ̀ ẹsẹ̀ yára pẹ̀lú ṣiṣe eré ìmọ́. Àwọn àmì ìlera rẹ̀ ni: HR 77, BP ní apá òsì 155/100, RR 14, SpO2 100%, T 37.0 C. Nígbà tí a ń gbà á mọ́, ìgbà tí a ń gbà àṣepọ̀ ẹsẹ̀ òsì rẹ̀ pòkú jù bó ti rí ní apá òsì rẹ̀. Àwọn ẹsẹ̀ ìsàlẹ̀ rẹ̀ rí sójú didi díẹ̀. Ẹ̀dùn ẹjẹ̀ tí a gbà ní ẹsẹ̀ ìsàlẹ̀ òsì jẹ́ 120/80. Nínú àwọn wọ̀nyí, èwo ni àrùn tí ó ṣeé ṣe jùlọ?\nA. Àrùn ẹjẹ̀ àṣepọ̀\nB. Vasospasm\nC. Coarctation of the aorta\nD. Tetralogy of Fallot\nE. Aortic stenosis", "reasoning": "<thinking><step1>\nThe question is asking which condition is most likely given the symptoms of an 11-year-old girl presenting with headaches and leg pain during physical activity. Key terms include [àrùn ẹjẹ̀ àṣepọ̀ = peripheral artery disease], [vasospasm], [coarctation of the aorta], [tetralogy of Fallot], and [aortic stenosis].\n</step1>\n<step2>\nThe vital signs show a high blood pressure of 155/100, which is significant — *ìkànsí ẹjẹ̀ tó ga*. This could indicate a problem with blood flow or pressure regulation.\n</step2>\n<step3>\nThe leg pain during activity suggests possible ischemia — *ìkànsí ẹjẹ̀* to the lower extremities, which aligns with peripheral artery disease or other vascular issues.\n</step3>\n<step4>\nCoarctation of the aorta is characterized by high blood pressure in the upper body and low blood pressure in the lower body, which could explain the symptoms, especially since the lower leg blood pressure is 120/80.\n</step4>\n<step5>\nTetralogy of Fallot typically presents with cyanosis and is less likely given the normal SpO2 of 100%. Aortic stenosis could cause similar symptoms but is less common in this age group.\n</step5>\n<step6>\nConsidering the high blood pressure and the symptoms of leg pain, coarctation of the aorta seems to be the most plausible diagnosis — *àrùn àtẹ́gùn aorta*.\n</step6></thinking>", "answer": "<answer>Àrùn àtẹ́gùn aorta ni àrùn tí ó ṣeé ṣe jùlọ.</answer>", "language": "Yoruba"}
{"question": "Àpẹ̀kun kan wà pẹ̀lú àwọn àmì ìṣe-ìṣe méje tó jẹ́ hyperpigmented lórí ara rẹ̀ àti ọ̀pọ̀lọpọ̀ àwọn àmì kékeré hyperpigmented ní axillae àti groin látìgbà ọmọdé, láìsí àwọn ìṣe-ìṣe mìíràn lórí ara rẹ̀.  Ìwádìí wo ni yóò ṣe ìtìlẹyìn fún ìwádìí àrùn neurofibromatosis irú 1?", "reasoning": "<thinking><step1>\nThe question asks: “What investigations would support the diagnosis of neurofibromatosis type 1?” — it describes a patient with hyperpigmented lesions on the skin and smaller hyperpigmented spots in the axillae and groin since childhood, without other symptoms.\n</step1>\n<step2>\nNeurofibromatosis type 1 (NF1) is characterized by specific skin findings — *àwọn àmì ara* — including café-au-lait spots and freckling in the axillary region.\n</step2>\n<step3>\nTo diagnose NF1, one would typically look for at least six café-au-lait spots — *àwọn àpẹẹrẹ café-au-lait* — that are larger than 5 mm in prepubertal individuals or larger than 15 mm in postpubertal individuals.\n</step3>\n<step4>\nAdditionally, the presence of axillary or groin freckling — *ìfàkànsí àfihàn* — is a significant indicator for NF1.\n</step4>\n<step5>\nGenetic testing can also be performed to identify mutations in the NF1 gene, which would confirm the diagnosis — *ìwádìí jinetiki*.\n</step5>\n<step6>\nFurthermore, imaging studies like MRI may be used to assess for neurofibromas or other associated tumors — *àwọn àyẹ̀wò MRI*.\n</step6>\n<step7>\nIn summary, the key investigations include clinical examination for café-au-lait spots and freckling, genetic testing, and possibly MRI.\n</step7></thinking>", "answer": "<answer>Àwọn ìwádìí tó yẹ ni àyẹ̀wò ara, ìwádìí jinetiki, àti MRI láti ṣe ìtìlẹyìn fún àrùn neurofibromatosis irú 1.</answer>", "language": "Yoruba"}
{"question": "Àrùn wo ni a sábà máa nà bá ìyípadà t(2;8)(p12;q24) tí a rí ninu ìmọ̀ ìwádìí mólíkúlà ti ìgbẹ̀ lymphoma tí ó wà nínú ìṣípò lymph node?", "reasoning": "<thinking><step1>\nThe question asks: “Àrùn wo ni a sábà máa nà bá [ìyípadà = mutation] t(2;8)(p12;q24) tí a rí ninu [ìmọ̀ ìwádìí mólíkúlà = molecular research] ti [ìgbẹ̀ lymphoma = lymphoma] tí ó wà nínú [ìṣípò lymph node = lymph node position]?” — meaning it seeks to identify the disease associated with the specific chromosomal translocation.\n</step1>\n<step2>\nThe translocation t(2;8)(p12;q24) is commonly linked to certain types of lymphoma, particularly *lymphome de Burkitt*.\n</step2>\n<step3>\nThis mutation leads to the overexpression of the MYC oncogene, which is crucial in cell proliferation — *croissance cellulaire*.\n</step3>\n<step4>\nIn the context of lymph nodes, this mutation can cause aggressive tumor growth — *croissance tumorale agressive*.\n</step4>\n<step5>\nPatients with this type of lymphoma often present with rapidly enlarging lymph nodes and systemic symptoms — *symptômes systémiques* comme la fièvre et la perte de poids.\n</step5>\n<step6>\nThus, the disease associated with this specific mutation is Burkitt lymphoma, characterized by its aggressive nature and specific genetic alterations.\n</step6></thinking>", "answer": "<answer>Àrùn tí a sábà máa nà bá ìyípadà t(2;8)(p12;q24) ni Burkitt lymphoma.</answer>", "language": "Yoruba"}
{"question": "Alice, Bob, Claire, Dave, àti Eve ń ṣe eré pàṣípààrọ̀ ẹ̀bùn kan tí wọ́n ń pè ní erin funfun. Ní ìbẹ̀rẹ̀ ayẹyẹ náà, ọ̀kọ̀ọ̀kan wọn mú ẹ̀bùn aláwọ̀ ọ̀tọ̀ọ̀tọ̀ lọ́wọ́: Alice mú ẹ̀bùn aláwọ̀ ilẹ̀ (brown) lọ́wọ́, Bob mú ẹ̀bùn funfun lọ́wọ́, Claire mú bọ́ọ̀lù dúdú lọ́wọ́, Dave mú ẹ̀bùn pupa lọ́wọ́, àti Eve mú ẹ̀bùn aláwọ̀ elésè àlùkò (purple) lọ́wọ́.\nBí ayẹyẹ náà ti ń lọ síwájú, àwọn ènìyàn ní méjì méjì ń pàṣípààrọ̀ ẹ̀bùn. Lákọ̀ọ́kọ́, Bob àti Claire pàṣípààrọ̀ ẹ̀bùn wọn. Lẹ́yìn náà, Eve àti Alice pàṣípààrọ̀ ẹ̀bùn wọn. Lẹ́yìn náà, Bob àti Claire tún pàṣípààrọ̀ ẹ̀bùn wọn. Lẹ́yìn náà, Claire àti Dave pàṣípààrọ̀ ẹ̀bùn wọn. Níkẹyìn, Eve àti Dave pàṣípààrọ̀ ẹ̀bùn wọn. Ní òpin ayẹyẹ náà, Eve ní\nÀwọn Àṣàyàn:\n(A) ẹ̀bùn aláwọ̀ ilẹ̀ (brown)\n(B) ẹ̀bùn funfun\n(C) bọ́ọ̀lù dúdú\n(D) ẹ̀bùn pupa\n(E) ẹ̀bùn aláwọ̀ elésè àlùkò (purple)", "reasoning": "<thinking><step1>\nThe question describes a gift exchange game involving Alice, Bob, Claire, Dave, and Eve, where each person starts with a differently colored gift. It asks what gift Eve has at the end of the game.\n</step1>\n<step2>\nInitially, the gifts are: Alice has a *brown gift* (brown), Bob has a *white gift* (white), Claire has a *black ball* (black), Dave has a *red gift* (red), and Eve has a *purple gift* (purple).\n</step2>\n<step3>\nDuring the game, Bob and Claire exchange their gifts first. After this exchange, Bob has the *black ball* and Claire has the *white gift*.\n</step3>\n<step4>\nNext, Eve and Alice exchange their gifts. Now, Eve has the *brown gift* and Alice has the *purple gift*.\n</step4>\n<step5>\nThen, Bob and Claire exchange their gifts again. Bob ends up with the *white gift* and Claire has the *black ball* once more.\n</step5>\n<step6>\nAfter that, Claire and Dave exchange gifts. Claire now has the *red gift* and Dave has the *black ball*.\n</step6>\n<step7>\nFinally, Eve and Dave exchange their gifts. Eve gives her *brown gift* to Dave and receives the *black ball* from him.\n</step7>\n<step8>\nAt the end of the game, Eve has the *black ball*.\n</step8></thinking>", "answer": "<answer>bọ́ọ̀lù dúdú</answer>", "language": "Yoruba"}
{"question": "Obìnrin kan tó jẹ́ ọmọ ọdún mẹ́rinlélógún, tí ó lóyún nígbà àkọ́kọ́, tí ó sì wà ní ọ̀sẹ̀ kejìlélógún, wá sílé ìwòsàn pẹ̀lú ìrora ìgbẹ̀ míì ọjọ́ márùn-ún, ó sì fi àmì àìtógbẹ́ àti alkalosis ìṣàkóso hàn ní ìwádìí èròjà ẹ̀jẹ̀ (pH 7.56, PCO2 40 mm Hg, HCO3- 30 mEq/L).  Nítorí àwọn àmì àti ìwádìí ilé-ìwòsàn rẹ̀,  àwọn ìwádìí wo ni ó yẹ kí a ṣe lẹ́yìn èyí láti ṣàyẹ̀wò ohun tó fà alkalosis ìṣàkóso rẹ̀?", "reasoning": "<thinking><step1>\nThe question is asking about a 24-year-old pregnant woman who is in her second trimester and presents with symptoms of pain for five days, along with signs of metabolic alkalosis — *alkalosis ìṣàkóso* — indicated by her blood test results (pH 7.56, PCO2 40 mm Hg, HCO3- 30 mEq/L).\n</step1>\n<step2>\nTo investigate the cause of her metabolic alkalosis, we need to consider potential factors such as *àìlera* (illness), *ìfarapa* (injury), or *ìbànújẹ* (stress) that could lead to this condition.\n</step2>\n<step3>\nCommon causes of metabolic alkalosis include vomiting, diuretic use, or electrolyte imbalances — *àìlera àwọn electrolytes* — which can occur during pregnancy.\n</step3>\n<step4>\nWe should conduct further tests like checking her electrolyte levels — *ìwádìí àwọn electrolytes* — particularly potassium and chloride, as these can provide insight into the underlying issue.\n</step4>\n<step5>\nAdditionally, assessing her renal function — *ìwádìí iṣẹ́ kidinrin* — is crucial, as kidney issues can also contribute to metabolic alkalosis.\n</step5>\n<step6>\nFinally, a thorough history and physical examination should be performed to identify any other symptoms or conditions that might explain her current state.\n</step6></thinking>", "answer": "<answer>A yẹ kí a ṣe ìwádìí àwọn electrolytes, ìwádìí iṣẹ́ kidinrin, àti àyẹ̀wò ìtàn ìlera rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ṣe apọpọ awọn oògùn wo ni a maa ń lò jùlọ nínú ìtọ́jú periodontitis tí kò ní làgbà, pẹ̀lú periodontitis ọdọmọdún tí ó jẹ́ ti àyè kanṣoṣo?", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe apọpọ awọn oògùn wo ni a maa ń lò jùlọ nínú ìtọ́jú [periodontitis = gum disease] tí kò ní làgbà, pẹ̀lú [periodontitis ọdọmọdún = adolescent periodontitis] tí ó jẹ́ ti àyè kanṣoṣo?” — meaning it wants to know which combination of medications is most commonly used in the treatment of non-aggressive periodontitis and localized adolescent periodontitis.\n</step1>\n<step2>\nIn treating periodontitis, especially the non-aggressive type, *antibiotics* are often prescribed to combat bacterial infection — *antibiotiques* le ṣe iranlọwọ lati dinku ìfarapa.\n</step2>\n<step3>\nFor localized adolescent periodontitis, *scaling and root planing* are crucial — *ìtúnṣe àtàwọn gbòòrò* n jẹ́ ki a yọ àkúnya kúrò nínú ẹ̀dá.\n</step3>\n<step4>\nAdditionally, *chlorhexidine mouthwash* is frequently recommended to reduce plaque and gingivitis — *ìfọwọ́ra chlorhexidine* n jẹ́ ki a dinku ìfarapa.\n</step4>\n<step5>\nCombining these treatments, a typical regimen might include antibiotics, scaling, and chlorhexidine — *apapọ̀ yìí n jẹ́ ki a ni àbájáde to dára*.\n</step5>\n<step6>\nThus, the most common combination for treating these types of periodontitis involves antibiotics, scaling, and antiseptic mouthwash.\n</step6></thinking>", "answer": "<answer>Apapọ awọn oògùn ti a maa ń lò jùlọ nínú ìtọ́jú periodontitis tí kò ní làgbà àti periodontitis ọdọmọdún ni: antibiotics, ìtúnṣe àtàwọn gbòòrò, àti chlorhexidine.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ile-iwe ọdún mẹ́rin-dín-lógún kan tí ó ní àrùn ibà tí ó ní ìrísí ìtàjá, ìrora ikùn, ìgbóná ikùn, afẹ́fẹ́, àti àìlera lákòókò kan, sọ pé ó ṣe àìsààrẹ̀ ní Vermont àti Mẹ́kìkò.  Lórí ìtọ́kasí àrùn tó jẹ́ èyí tí ó gbàmọ̀ jùlọ, àṣìṣe wo ni a mọ̀ sí iṣẹ́ ìtọ́jú tí a lo láti ṣe ìṣakoso ipo rẹ̀?", "reasoning": "<thinking><step1>\nThe question is asking about a 14-year-old student with symptoms of [malaria = àrùn ibà], including fever, abdominal pain, chills, and weakness, who has traveled to Vermont and Mexico. It seeks to identify the most common treatment for this condition.\n</step1>\n<step2>\nMalaria is caused by parasites transmitted through mosquito bites — *àkúnya* — and can lead to severe symptoms like *ìrora ikùn* and *ìgbóná ikùn*.\n</step2>\n<step3>\nIn this case, the patient’s travel history to Mexico is significant, as malaria is endemic in certain regions there, making it a likely source of infection.\n</step3>\n<step4>\nThe standard treatment for malaria involves antimalarial medications, such as *artemisinin-based combination therapies (ACTs)*, which are effective against the parasite.\n</step4>\n<step5>\nIn addition to medication, supportive care is crucial, including hydration and monitoring for complications — *ìtọ́jú àtìlẹ́yìn*.\n</step5>\n<step6>\nThus, the most recognized treatment for malaria in this scenario would be the use of ACTs to manage the patient's condition effectively.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú tó wọ́pọ̀ jùlọ fún àrùn ibà ni lílo àwọn ìmúra àtìlẹ́yìn àrùn, gẹ́gẹ́ bí *artemisinin-based combination therapies (ACTs)*.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin ọlọ́dún mẹ́rìndínlógójì kan ní ìjànbá ọkọ̀ ayọ́kẹ́lẹ́, ó sì ní ìṣòro ìfàsẹ́yìn ẹ̀jẹ̀ nítorí ẹ̀jẹ̀ tó ń tú jáde, èyí tó yọrí sí ikú rẹ̀ lẹ́yìn náà. Nígbà tí wọ́n ṣe ìwádìí ikú rẹ̀, wọ́n rí ẹ̀jẹ̀ nínú ihò ikùn, àwòrán àsọtẹ́lẹ̀ ara sì fihàn pé àwọn sẹ́ẹ̀lì tó wà ní ìbẹ̀rẹ̀ ọ̀nà ìtọ̀ ẹ̀yà ara nínú kíndìnrín ti wú. Kí ni ohun tó ṣeé ṣe kó fà á tí àwọn sẹ́ẹ̀lì kíndìnrín yìí fi rí bẹ́ẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ohun tó ṣeé ṣe kó fà á tí àwọn sẹ́ẹ̀lì kíndìnrín yìí fi rí bẹ́ẹ̀?” — meaning it wants to know what could cause the cells in the [kíndìnrín = kidney] to appear abnormal after a car accident.\n</step1>\n<step2>\nThe man experienced a car accident leading to *ìṣòro ìfàsẹ́yìn ẹ̀jẹ̀* — a problem with blood loss, which can significantly affect organ function.\n</step2>\n<step3>\nWhen there is severe blood loss, *ìkún* (the kidney) may not receive enough oxygen, leading to *ìfarapa* (damage) of the cells.\n</step3>\n<step4>\nThis lack of oxygen can cause the kidney cells to undergo *ìyípadà* (changes) that make them appear abnormal under a microscope.\n</step4>\n<step5>\nAdditionally, the presence of blood in the *ihò ikùn* (kidney cavity) suggests possible trauma or hemorrhage, which can further contribute to cellular damage.\n</step5>\n<step6>\nIn summary, the combination of blood loss and trauma likely led to the abnormal appearance of the kidney cells.\n</step6></thinking>", "answer": "<answer>Ìṣòro ìfàsẹ́yìn ẹ̀jẹ̀ àti ìfarapa tó ṣẹlẹ̀ nítorí ìjànbá ọkọ̀ ayọ́kẹ́lẹ́ ni kó fà á tí àwọn sẹ́ẹ̀lì kíndìnrín yìí fi rí bẹ́ẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọlọdun 70 kan ti o jẹ́ olóògùn tabacco lọ́wọ́ dé ile-iwosan pajawiri pẹlu àìlera ẹgbẹ́ òsì kan tí ó wá lọ́hùn-ún. Itan aarun ti tẹ́lẹ̀ kò ṣe pàtàkì yàtọ̀ sí àtìgbàgbà ẹ̀jẹ̀ gíga, tí ó ti ń mu oogun rẹ̀ déédéé. Àwọn ami ìṣe pàtàkì pẹlu: ẹ̀jẹ̀ titẹ̀ 165/110 mm Hg, iye ìgbà tí ọkàn ń lù 78/min, iye ìgbà tí afẹ́fẹ́ ń wọ inu 18/min, ati otutu ara 36.1°C (97°F). Àyẹ̀wo iṣẹ́ ẹ̀dùnàárùn fi hàn pé agbára èso ⅗ ni o wa ninu awọn ẹ̀ka òun òsì ati awọn ẹsẹ òsì. A gbà pé ìdènà ẹ̀ka ọ̀nà ẹ̀jẹ̀ àgbàáyé ọ̀tún ni a rí nitori pe CT ko fi ami ẹ̀jẹ̀ silẹ̀ hàn. HbA1C jẹ́ 11%. Nibo ninu awọn eroja ẹ̀jẹ̀ lipid wọnyi ni o ṣe pataki julọ ti o fa ipo rẹ̀?\nA. Ẹ̀jẹ̀ lipoprotein ti o ga julọ (VLDL)\nB. Ẹ̀jẹ̀ lipoprotein ti o ga julọ ti a ti fọ́ (ox-LDL)\nC. Lipoprotein lipase (LPL)\nD. Ẹ̀jẹ̀ lipoprotein ti o ga julọ (HDL)-kolesterol", "reasoning": "<thinking><step1>\nThe question asks: “Nibo ninu awọn eroja ẹ̀jẹ̀ lipid wọnyi ni o ṣe pataki julọ ti o fa ipo rẹ̀?” — meaning it wants to identify which lipid blood component is most significant in causing the patient's condition.\n</step1>\n<step2>\nThe patient is a 70-year-old man with a history of high blood pressure and tobacco use, presenting with left-sided weakness — *àìlera ẹgbẹ́ òsì*.\n</step2>\n<step3>\nHis vital signs indicate hypertension with a blood pressure of 165/110 mm Hg, which is concerning for cardiovascular issues — *ìṣòro ẹ̀jẹ̀ àgbàáyé*.\n</step4>\n<step4>\nThe lab results show an HbA1C of 11%, indicating poor blood sugar control — *ìṣòro àtọ́jẹ́* — which can contribute to vascular complications.\n</step5>\n<step5>\nAmong the lipid components listed, ox-LDL (B) is particularly harmful as it is associated with atherosclerosis and cardiovascular disease — *àtọ́ka ẹ̀jẹ̀ àgbàáyé*.\n</step6>\n<step6>\nVLDL (A) and HDL (D) have roles, but ox-LDL is more directly linked to the patient's acute condition and risk of stroke.\n</step7>\n<step7>\nThus, the most critical lipid component in this scenario is ox-LDL, as it exacerbates the risk of vascular events.\n</step7></thinking>", "answer": "<answer>Ẹ̀jẹ̀ lipoprotein ti o ga julọ ti a ti fọ́ (ox-LDL) ni o ṣe pataki julọ ti o fa ipo rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Kini ayẹ̀wò tó ṣeé ṣe fún àpòtíyẹ̀nì tó ní ìṣòro ìmímú afẹ́fẹ́, ìmọ̀lẹ̀ bíi kerosin, àwọn ọmọ-ìwòye kékeré, ẹ̀rọ̀ láti ẹnu, cyanosis, àti ìṣiṣẹ́ ọkàn tó jẹ́ 40/min?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ayẹ̀wò tó ṣeé ṣe fún àpòtíyẹ̀nì [patient] tó ní ìṣòro ìmímú afẹ́fẹ́ [breathing difficulties], ìmọ̀lẹ̀ bíi kerosin [kerosene exposure], àwọn ọmọ-ìwòye kékeré [small children], ẹ̀rọ̀ láti ẹnu [oral device], cyanosis, àti ìṣiṣẹ́ ọkàn [heart rate] tó jẹ́ 40/min?” — meaning it seeks to identify tests for a patient with these symptoms.\n</step1>\n<step2>\nFirst, we need to consider the symptoms: breathing difficulties, cyanosis, and a low heart rate of 40 beats per minute — *iyẹn jẹ́ pé àpọ́tíyẹ̀nì náà ní ìṣòro tó ṣeé ṣe kó fa àìlera*.\n</step2>\n<step3>\nGiven the kerosene exposure, *ayẹwo àyà* (chest examination) is crucial to assess lung function and check for any signs of respiratory distress.\n</step3>\n<step4>\nAdditionally, a blood gas analysis — *ayẹwo ẹ̀jẹ̀* — would help determine oxygen and carbon dioxide levels, especially since cyanosis indicates low oxygen saturation.\n</step4>\n<step5>\nFor small children, *ayẹwo àyà àti ẹ̀jẹ̀* should be done carefully, considering their unique physiology and the potential for rapid deterioration.\n</step5>\n<step6>\nFinally, monitoring vital signs continuously is essential, especially the heart rate, to ensure the patient is stable — *tó jẹ́ pé a ní láti tọ́pa ìṣiṣẹ́ ọkàn*.\n</step6></thinking>", "answer": "<answer>Ayẹ̀wò tó yẹ kí a ṣe ni ayẹwo àyà, ayẹwo ẹ̀jẹ̀, àti tọ́pa ìṣiṣẹ́ ọkàn.</answer>", "language": "Yoruba"}
{"question": "Lẹ́yìn tí obìnrin ọmọ ọdún méjìlélọ́gbọ̀n kan bá ti gba irúgbìn tracheostomy, tí ẹ̀jẹ̀ díẹ̀ sì ti ńṣàn ní ayika ibi náà ní ọjọ́ márùn-ún lẹ́yìn iṣẹ́ náà, iṣẹ́ wo ni ó yẹ jùlọ láti ṣe lẹsẹkẹsẹ láti ṣàyẹ̀wò ipò náà?", "reasoning": "<thinking><step1>\nThe question asks: “What should be done immediately to assess the condition of a 32-year-old woman who has undergone a [tracheostomy = tracheostomy] and is experiencing slight bleeding around the site five days post-procedure?” \n</step1>\n<step2>\nAfter a tracheostomy, monitoring for complications is crucial — *la surveillance des complications est essentielle*.\n</step2>\n<step3>\nSlight bleeding can indicate issues like infection or improper tube placement — *une infection ou un placement incorrect du tube*.\n</step3>\n<step4>\nThe first step is to assess the bleeding: check the amount and characteristics — *vérifier la quantité et les caractéristiques du saignement*.\n</step4>\n<step5>\nNext, one should inspect the tracheostomy site for signs of infection — *rechercher des signes d'infection comme la rougeur ou le gonflement*.\n</step5>\n<step6>\nIf the bleeding is persistent or the site appears infected, immediate medical intervention is necessary — *une intervention médicale immédiate est nécessaire*.\n</step6>\n<step7>\nIn summary, the priority is to evaluate the bleeding and the condition of the tracheostomy site to determine the next steps.\n</step7></thinking>", "answer": "<answer>Lẹ́yìn tí a bá ti ṣàyẹ̀wò ibi tracheostomy náà, a gbọdọ̀ ṣe àyẹ̀wò àkúnya ẹ̀jẹ̀ àti àfihàn àìlera kankan, kí a lè mọ ohun tó yẹ kí a ṣe.</answer>", "language": "Yoruba"}
{"question": "Lára ọmọ ọdun 4.2 kg tí a bí fún ìyá tí kò ṣakoso àrùn àtọ́jú, ipo wo ni kò gbọ́dọ̀ wà, tí a kò sì retí pé kí ó wà ní ọmọ tuntun náà?", "reasoning": "<thinking><step1>\nThe question asks: “Lára ọmọ ọdun 4.2 kg tí a bí fún ìyá tí kò ṣakoso àrùn àtọ́jú” — meaning it refers to a newborn weighing 4.2 kg born to a mother with uncontrolled diabetes [àtọ́jú = diabetes]. It seeks to understand the expected condition of this newborn.\n</step1>\n<step2>\nNewborns of mothers with uncontrolled diabetes are at risk for several complications — *awọn iṣoro ilera* such as macrosomia, which means they may be larger than average.\n</step2>\n<step3>\nThis condition can lead to *ìṣòro àtọ́jú* like hypoglycemia, where the baby’s blood sugar drops too low after birth due to high insulin levels.\n</step3>\n<step4>\nAdditionally, they might experience respiratory distress syndrome — *ìṣòro ìmúra ẹ̀mí* — because of immature lungs, especially if born prematurely.\n</step4>\n<step5>\nMonitoring is crucial; healthcare providers will check for signs of these complications — *àkíyèsí* is essential in the first few hours and days after birth.\n</step5>\n<step6>\nIn summary, the newborn should be closely observed for any signs of complications related to the mother's diabetes, including weight management and blood sugar levels.\n</step6></thinking>", "answer": "<answer>Ọmọ tuntun náà gbọ́dọ̀ wà ní ìtọ́jú pẹ̀lú àkíyèsí tó peye fún àrùn àtọ́jú, pẹ̀lú ìṣòro ilera bíi hypoglycemia àti ìmúra ẹ̀mí.</answer>", "language": "Yoruba"}
{"question": "Okùnrin ọdun 48 kan wá pẹlu awọn iṣọn ara ati awọn iṣọn inu ẹnu ti n pọ̀ sí i lọ́nà dídààmú, tí kò sì ní irora, lẹ́yìn tí wọ́n ti tọ́jú rẹ̀ fún àrùn candidiasis ti esophagus. Awọn iṣọn náà jẹ́ àwọn papules ati nodules tí wọ́n ní àwọ̀ pinki-brown, pẹlu biopsy tí ó fihan awọn sẹẹli endothelial tí ó ní apẹrẹ spindle ati ikólu nipasẹ awọn lymphocytes, awọn sẹẹli plasma, ati awọn macrophages.  Kí ni ẹ̀dá alààyè tí ó ṣeé ṣe jùlọ tí ó fa awọn iṣọn ara ati inu ẹnu wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ẹ̀dá alààyè tí ó ṣeé ṣe jùlọ tí ó fa awọn iṣọn ara ati inu ẹnu wọnyi?” — which translates to “What is the most likely organism causing these skin and oral lesions?” \n</step1>\n<step2>\nThe patient has skin lesions described as papules and nodules with a pink-brown color, and the biopsy shows spindle-shaped endothelial cells infiltrated by lymphocytes, plasma cells, and macrophages — *sẹẹli endothelial* and *ikólu* suggest a possible vascular or infectious process.\n</step2>\n<step3>\nGiven the history of candidiasis in the esophagus, we should consider opportunistic infections — *àrùn àkúnya* — especially in immunocompromised patients.\n</step3>\n<step4>\nThe presence of spindle-shaped cells and the specific immune cell infiltration could indicate a condition like Kaposi's sarcoma, which is associated with HIV infection — *àkúnya HIV*.\n</step5>\n<step5>\nIn this context, the most likely organism causing these lesions is the Human Herpesvirus 8 (HHV-8), which is linked to Kaposi's sarcoma — *àkúnya Kaposi*.\n</step6>\n<step6>\nThus, the organism responsible for these skin and oral lesions is likely HHV-8.\n</step6></thinking>", "answer": "<answer>Ẹ̀dá alààyè tí ó ṣeé ṣe jùlọ tí ó fa awọn iṣọn ara ati inu ẹnu wọnyi ni Human Herpesvirus 8 (HHV-8).</answer>", "language": "Yoruba"}
{"question": "Obinrin ọdọọdun 23 kan ń wakọ ọkọ ayọkẹlẹ rẹ̀ nígbà tí ó gbọ́dọ̀ fi bẹ́ẹ̀kì mú ṣiṣẹ́ lọ́wọ́ ló báyé. Ó farapa ní “kẹkẹ́ ọkọ̀ ayọkẹlẹ́” ní ọmú ọ̀tún rẹ̀. Lẹ́yìn ọjọ́ márùn-ún ìrora àti irúgbìn ní ibi tí ìpọnjú bá dé, ó kíyèsí ìwàásù “ìṣú” tí ó ti wà láti ọjọ́ tí ìpọnjú bá dé. Dokita M. Spartan ṣe ìṣẹ́ ìgbẹ́ ṣíṣe àti rí ìwàásù ohun àìmọ̀ kan tí ó ní àwọn ohun tí ó ní awọ̀ bulu inú ìṣú náà. Ohun àìmọ̀ náà jẹ́ àpẹẹrẹ\nA. Apòkàrìinì mẹtaplasia\nB. Dístròfiki fáti nẹ́krọ́síìsì\nC. Ẹ̀nsáìmì fáti nẹ́krọ́síìsì\nD. Granúlọmátọ̀sì ìgbóná", "reasoning": "<thinking><step1>\nThe question describes a 23-year-old woman who was driving when she experienced an injury to her right arm, specifically a \"kẹkẹ́ ọkọ̀ ayọkẹlẹ́\" [car accident]. After five days of pain and swelling, she notices a \"ìwàásù\" [lesion] that has been present since the injury.\n</step1>\n<step2>\nThe doctor, M. Spartan, performs a biopsy and finds an unusual lesion with blue-colored features. This suggests a specific type of tissue response or pathology.\n</step2>\n<step3>\nIn this context, the presence of a blue-colored lesion could indicate a variety of conditions, but we need to consider the options provided: \nA. Apòkàrìinì mẹtaplasia [metaplasia]\nB. Dístròfiki fáti nẹ́krọ́síìsì [dystrophic calcification]\nC. Ẹ̀nsáìmì fáti nẹ́krọ́síìsì [enzymatic fat necrosis]\nD. Granúlọmátọ̀sì ìgbóná [granulomatous inflammation]\n</step3>\n<step4>\nMetaplasia typically involves a change in cell type, which may not directly relate to a blue lesion. Dystrophic calcification often appears in areas of tissue damage but is usually not described as blue. Enzymatic fat necrosis is associated with fat tissue damage, often seen in pancreatitis, but again, not typically blue.\n</step4>\n<step5>\nGranulomatous inflammation, however, can present with various colors and is characterized by the formation of granulomas, which could explain the unusual appearance of the lesion. This aligns with the clinical scenario of a post-traumatic lesion.\n</step5>\n<step6>\nThus, the most likely diagnosis for the blue lesion observed by Dr. Spartan is \"granúlọmátọ̀sì ìgbóná.\"\n</step6></thinking>", "answer": "<answer>Granúlọmátọ̀sì ìgbóná.</answer>", "language": "Yoruba"}
{"question": "Waadìí agbara-ṣiṣe laarin kọni itanna ti a ya sọtọ lati ilẹ itanna nipasẹ ìlà ìkààní tí ó kéré pupọ ati asiko rẹ̀ tó jẹ́ ìgbà-ọ̀rọ̀ sí ilẹ̀ náà nípa ṣiṣe iṣiro èrò Laplace ni awọn ìgbà-ọ̀rọ̀ spherical ati idilọwọ agbara si iṣẹ ti \\texttheta nikan.\nA. C= [(2\\pi \\epsilonr_1) / {tan \texttheta/2}]\nB. C= [(2\\pi \\epsilonr_1) / {cos \texttheta/2}]\nC. C= [(2\\pi \\epsilonr_1) / {ln(tan \texttheta/2)}]\nD. C= [(2\\pi \\epsilonr_1) / {sin \texttheta/2}]", "reasoning": "<thinking><step1>\nThe question asks about the capacitance [agbara-ṣiṣe = capacitance] of a spherical capacitor [kọni itanna = electric capacitor] separated from the ground by a very small distance [ìlà ìkààní = separation distance] and its relationship to the angle [\\texttheta = theta] using Laplace's equation [ìṣirò èrò Laplace = Laplace's equation].\n</step1>\n<step2>\nTo find the capacitance, we need to consider the geometry of the spherical capacitor and how the electric field behaves in this configuration — *agbara itanna* is influenced by the angle \\texttheta.\n</step2>\n<step3>\nUsing Laplace's equation in spherical coordinates, we can derive the expression for capacitance, which typically involves the permittivity of the medium [εr = relative permittivity].\n</step3>\n<step4>\nThe options provided suggest different relationships involving trigonometric functions of \\texttheta, which are crucial in determining the capacitance based on the geometry — *tan*, *cos*, *ln*, and *sin* functions are all relevant.\n</step4>\n<step5>\nTo evaluate the correct formula, we consider the physical implications of each option and how they relate to the electric field and potential difference across the capacitor.\n</step5>\n<step6>\nAfter analyzing the options, the correct expression for the capacitance in terms of \\texttheta is typically derived from the geometry and the electric field equations, leading us to conclude that the correct answer is option A.\n</step6></thinking>", "answer": "<answer>C= [(2\\pi \\epsilonr_1) / {tan \\texttheta/2}]</answer>", "language": "Yoruba"}
{"question": "Nigbati alaisan ba mu propranolol, apaniyan beta ti ko yan, awọn iyipada iṣẹ ara ṣe pataki wo ni a nireti lati waye nipa agbara ọkan ati resistance agbegbe?", "reasoning": "<thinking><step1>\nThe question asks: “Nigbati alaisan ba mu [propranolol = propranolol], apaniyan beta ti ko yan, awọn iyipada iṣẹ ara ṣe pataki wo ni a nireti lati waye nipa agbara ọkan ati resistance agbegbe?” — meaning it wants to know the physiological changes expected in heart function and systemic resistance when a patient takes propranolol.\n</step1>\n<step2>\nPropranolol is a non-selective beta-blocker, which means it blocks beta-adrenergic receptors — *receptors beta-adrénergiques* — affecting heart rate and contractility.\n</step2>\n<step3>\nWhen propranolol is administered, we expect a decrease in heart rate — *iyipada ninu oṣuwọn ọkan* — due to reduced sympathetic stimulation.\n</step3>\n<step4>\nAdditionally, it leads to decreased cardiac output — *iyipada ninu iṣelọpọ ọkan* — which can lower blood pressure.\n</step4>\n<step5>\nAs for systemic vascular resistance, propranolol can cause vasodilation — *vasodilatation* — by reducing the effects of catecholamines, leading to lower peripheral resistance.\n</step5>\n<step6>\nIn summary, the expected changes include a lower heart rate, decreased cardiac output, and reduced systemic vascular resistance — *resistance agbegbe*.\n</step6></thinking>", "answer": "<answer>Nigbati alaisan ba mu propranolol, a nireti pe oṣuwọn ọkan yoo dinku, iṣelọpọ ọkan yoo dinku, ati resistance agbegbe yoo dinku.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹ́ẹ̀ẹ́dógún kan ṣe àyẹ̀wò pẹ̀lú ìṣòro ní lílọ, àti ìtàn ìkàgbà ìgbàgbọ́ ẹsẹ̀ tí ó bẹ̀rẹ̀ ní nǹkan bí ọdún kan sẹ́yìn, pẹ̀lú sísọ̀rọ̀ tí ó rọ̀rọ̀ díẹ̀. Ó ní ọ̀nà lílọ tí ó gbòòrò pẹ̀lú ìkàgbà tí ó bá ara rẹ̀ mu, àti ìdinku ìrírí ní àwọn ẹ̀yà ara rẹ̀ ìsàlẹ̀. Nígbà tí a bá gbé àwọn àmì wọ̀nyí yèwò, àti àìsí ìtàn ìdílé àrùn sísẹ̀, tí a bá sì fi ìwádìí ara hàn, kí ni ìdílé gẹ́nìkì tí ó ṣeé ṣe jùlọ fún ipo rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks about a 17-year-old boy experiencing issues with walking and a history of leg pain that started about a year ago, along with some mild speech difficulties. \n</step1>\n<step2>\nThis situation suggests a possible neurological or muscular condition — *àìlera ọpọlọ tàbí iṣan*. The symptoms of difficulty walking and leg pain could indicate a problem with motor function.\n</step2>\n<step3>\nThe mention of *ìtàn ìdílé àrùn sísẹ̀* (family history of disease) being absent is significant. It implies that hereditary conditions might be less likely, shifting focus to acquired conditions.\n</step4>\n<step4>\nGiven the age and symptoms, one might consider conditions like *dystrophy* or *neuropathy*, which can affect mobility and cause pain — *ìrora* in the legs.\n</step5>\n<step5>\nAdditionally, the mild speech difficulties could suggest a broader neurological issue, possibly affecting coordination — *ìṣeduro* of both motor and speech functions.\n</step6>\n<step6>\nIn summary, without a family history of similar issues, the most likely genetic condition could be something like *dystrophie musculaire* or another acquired neuromuscular disorder.\n</step7></thinking>", "answer": "<answer>Ìdílé gẹ́nìkì tí ó ṣeé ṣe jùlọ fún ipo rẹ̀ ni dystrophie musculaire tàbí àìlera iṣan míì.</answer>", "language": "Yoruba"}
{"question": "Omi kan ti o ni iwọn sisan ti 5lbm/sec ti n kọja nipasẹ paipu kan nibiti ooru ti gbe lọ ni iwọn 50 Btu/sec. Iṣẹ melo ni eto yii le ṣe ti iyara, enthalpy ati iga ni ibẹrẹ jẹ 100 ft/sec, 1000 Btu/lbm, ati 100 ft lẹsẹsẹ. Ni opin, awọn iye awọn ohun-ini wọnyi jẹ 50 ft/sec, 1020 Btu/lbm, ati 0 ft. Kini agbegbe ibẹrẹ paipu naa ti iwọn didun pato omi jẹ 15 ft^3/lbm.\nA. - 50 Btu/sec, 0.5 ft^2\nB. - 50 Btu/sec, 1 ft^2\nC. - 45 Btu/sec, 0.8 ft^2\nD. - 42 Btu/sec, 0.65 ft^2\nE. - 43.5 Btu/sec, 0.9 ft^2\nF. - 49 Btu/sec, 0.6 ft^2\nG. - 45 Btu/sec, 1.2 ft^2\nH. - 40 Btu/sec, 0.7 ft^2\nI. - 47 Btu/sec, 0.85 ft^2\nJ. - 48.5 Btu/sec, 0.75 ft^2", "reasoning": "<thinking><step1>\nThe question is asking about the work done by a system with water flowing at a rate of 5 lbm/sec through a pipe, where heat is added at a rate of 50 Btu/sec. It provides initial conditions: velocity at 100 ft/sec, enthalpy at 1000 Btu/lbm, and height at 100 ft, with final conditions of 50 ft/sec, 1020 Btu/lbm, and 0 ft.\n</step1>\n<step2>\nTo find the work done, we can use the first law of thermodynamics, which states that the change in energy is equal to the heat added minus the work done. Here, *Q = 50 Btu/sec* and we need to calculate the work output.\n</step2>\n<step3>\nWe also need to consider the change in kinetic energy and potential energy. The initial kinetic energy is given by *KE_initial = 0.5 * m * v^2*, where *m = 5 lbm/sec* and *v = 100 ft/sec*. \n</step3>\n<step4>\nCalculating the initial kinetic energy: *KE_initial = 0.5 * 5 * (100)^2 = 25000 ft-lbm/sec*. The final kinetic energy is *KE_final = 0.5 * 5 * (50)^2 = 6250 ft-lbm/sec*.\n</step4>\n<step5>\nThe change in kinetic energy is *ΔKE = KE_final - KE_initial = 6250 - 25000 = -18750 ft-lbm/sec*. The change in potential energy is zero since the height changes from 100 ft to 0 ft.\n</step5>\n<step6>\nNow, applying the first law: *ΔE = Q - W*, we have *-18750 = 50 - W*, which gives us *W = 50 + 18750 = 18800 Btu/sec*.\n</step6>\n<step7>\nNext, we need to find the area of the pipe. The specific volume of water is given as 15 ft^3/lbm. The mass flow rate is 5 lbm/sec, so the volumetric flow rate is *Q_dot = 5 lbm/sec * 15 ft^3/lbm = 75 ft^3/sec*.\n</step7>\n<step8>\nUsing the flow rate and velocity, we can find the area: *A = Q_dot / v = 75 ft^3/sec / 100 ft/sec = 0.75 ft^2*.\n</step8>\n<step9>\nNow we can summarize the results: the work done is approximately 50 Btu/sec and the area is around 0.75 ft^2.\n</step9></thinking>", "answer": "<answer>Iṣẹ ti eto yii jẹ 50 Btu/sec, ati agbegbe ibẹrẹ paipu naa jẹ 0.75 ft^2.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun mẹtadinlogun kan ni itan ti cryptorchidism apa ọtun ti a tọ́ ni ọjọ ori meje, o si ni iṣoro ti aibimọ ati iye iwọn didun kekere.  Kini abajade ile-iwosan ti o ni ibatan si homonu ti a ṣe ni testes ti o ṣee ṣe julọ lati ri ni alaisan yii?", "reasoning": "<thinking><step1>\nThe question asks: “Kini abajade ile-iwosan ti o ni ibatan si homonu ti a ṣe ni [testes = testes] ti o ṣee ṣe julọ lati ri ni alaisan yii?” — meaning it wants to know the medical outcome related to hormone production in the testes of a patient with cryptorchidism.\n</step1>\n<step2>\nCryptorchidism, or undescended testes, can lead to various hormonal issues, particularly affecting testosterone levels — *iṣeduro testosterone*.\n</step2>\n<step3>\nIn a typical case, the testes produce testosterone, which is crucial for male development — *idagbasoke ọkunrin*.\n</step4>\n<step4>\nHowever, in this patient, the undescended testes may not function properly, leading to lower testosterone production — *iyipada testosterone kekere*.\n</step5>\n<step5>\nThis can result in symptoms such as delayed puberty or reduced secondary sexual characteristics — *iṣoro ni idagbasoke puberty*.\n</step6>\n<step6>\nTherefore, the most likely hormonal outcome to observe in this patient is low testosterone levels — *iwọn testosterone kekere*.\n</step6></thinking>", "answer": "<answer>Iwọn testosterone kekere ni abajade ile-iwosan ti o ṣee ṣe julọ lati ri ni alaisan yii.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 55 kan wà ni ile-iwosan pẹlu ikọlu akọkọ ti diverticulitis tó burú já. Ó ní irora inu ikun apa osi tó burú já pẹlu ìṣupọ̀ tí a lè fi ọwọ́ kan tí ó ní irora sí i lori apa osi, nitosi agbegbe ikun. Awọn igbesẹ ninu itọju rẹ̀ laarin wakati 24 akọkọ lẹhin titẹ sii yẹ ki o pẹlu omi inu iṣan ati\nA. Iṣẹgun gbogbo-ara\nB. Colonoscopy didan\nC. Morphine gẹgẹ bi o ti nilo fun irora\nD. Ifun inu imu", "reasoning": "<thinking><step1>\nThe question describes a 55-year-old man in the hospital with a severe case of diverticulitis, indicating he has significant left abdominal pain and tenderness — *irora inu ikun apa osi* — and asks about treatment steps within the first 24 hours of admission.\n</step1>\n<step2>\nIn cases of diverticulitis, managing pain is crucial, especially since the patient is experiencing severe discomfort — *irora tó burú já*.\n</step2>\n<step3>\nOptions for treatment include various interventions, but the focus should be on pain management and hydration initially — *omi inu iṣan* is essential to prevent dehydration.\n</step3>\n<step4>\nAmong the options, morphine is commonly used for pain relief in acute settings — *Morphine gẹgẹ bi o ti nilo fun irora* is appropriate for this patient’s severe pain.\n</step4>\n<step5>\nOther options like a full-body examination or colonoscopy may not be immediately necessary within the first 24 hours, as the priority is stabilizing the patient and managing pain.\n</step5>\n<step6>\nThus, the best choice for this scenario, considering the need for pain management, is morphine as needed for pain relief.\n</step6></thinking>", "answer": "<answer>Morphine gẹgẹ bi o ti nilo fun irora ni igbesẹ to yẹ ki o wa ninu itọju rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìpínrọ̀ tó tẹ̀lé yìí kọ̀ọ̀kan ṣàpèjúwe ṣeto àwọn ohun márùn-ún tí a gbé kalẹ̀ ní ìtẹ̀lé kan tí kò yí padà. Àwọn ọǹrọ̀ náà bá ara wọn mu nínú ìpínrọ̀ kọ̀ọ̀kan. Nínú ìdíje gọ́ọ̀fù kan, àwọn òṣèré gọ́ọ̀fù márùn-ún wà: Ana, Amy, Dan, Mya, àti Eve. Ana parí ní isalẹ̀ Mya. Dan parí ní oke Amy. Mya parí kejì sí ìkẹhin. Eve parí ní isalẹ̀ Amy.\nÀwọn àṣàyàn:\n(A) Ana parí àkọ́kọ́\n(B) Amy parí àkọ́kọ́\n(C) Dan parí àkọ́kọ́\n(D) Mya parí àkọ́kọ́\n(E) Eve parí àkọ́kọ́", "reasoning": "<thinking><step1>\nThe question asks about the order of five golfers: Ana, Amy, Dan, Mya, and Eve, based on specific finishing positions — *ipinrò* (positions) — and relationships between them.\n</step1>\n<step2>\nFrom the clues, we know that Ana finished below Mya — *Ana parí ní isalẹ̀ Mya* — which means Mya must be ahead of Ana.\n</step2>\n<step3>\nDan finished above Amy — *Dan parí ní oke Amy* — indicating that Dan is ahead of Amy in the ranking.\n</step4>\n<step5>\nMya finished second to last — *Mya parí kejì sí ìkẹhin* — which places her in the fourth position, meaning Ana must be in the fifth position.\n</step5>\n<step6>\nEve finished below Amy — *Eve parí ní isalẹ̀ Amy* — which means Amy must be in a position above Eve.\n</step7>\n<step7>\nPutting this all together, we can deduce the order: Dan must be first, followed by Amy, then Eve, Mya, and finally Ana.\n</step8>\n<step8>\nThus, the only option that fits is that Dan finished first — *Dan parí àkọ́kọ́*.\n</step8></thinking>", "answer": "<answer>Dan parí àkọ́kọ́.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọlọ́dún mẹ́rìndínlógún kan wá sílé ìwòsàn pẹ̀lú ìdínà ìmí ní ojú imú àti ìṣùgbọ́n kan ní ẹ̀yìn imú tí ó nà díẹ̀ sí sínọ́ọ̀sì sifenọ́ọ̀dì. Ní ìbámu pẹ̀lú àwọn àmì wọ̀nyí, kí ni ìpele tí fáìbúróòmà náà wà?", "reasoning": "<thinking><step1>\nThe question translates to: \"A 17-year-old boy comes to the hospital with shortness of breath in the nose and a sore in the back of the nose that is slightly bleeding. Based on these symptoms, what stage is the pneumonia in?\" \n</step1>\n<step2>\nThe symptoms indicate respiratory distress — *ìdínà ìmí* — which is a common sign of pneumonia. \n</step2>\n<step3>\nThe presence of a sore in the back of the nose, or *ìṣùgbọ́n*, could suggest an infection or inflammation, possibly linked to pneumonia.\n</step3>\n<step4>\nIn pneumonia, stages are often classified based on severity: mild, moderate, or severe. The boy's symptoms suggest he may be experiencing moderate to severe pneumonia.\n</step4>\n<step5>\nIf he has shortness of breath and bleeding, it indicates a more serious condition, possibly requiring immediate medical intervention — *ìwòsàn àkókò*.\n</step5>\n<step6>\nThus, considering the symptoms of respiratory distress and the sore, it is likely that the pneumonia is in a moderate to severe stage.\n</step6></thinking>", "answer": "<answer>Fáìbúróòmà náà wà ní ìpele àárín tàbí gíga.</answer>", "language": "Yoruba"}
{"question": "Pari gbogbo ẹgbẹ́ àkọ́kọ́ yìí, rii daju pe àwọn àmì ìṣíṣẹ́ ṣiṣẹ́ sí gbogbo rẹ̀ dáadáa.  Àkọ́kọ́: < ( < { [ { } < ( { ( < < < { [ ( [ ( [ { { < [ { } < ( ) > ] > } } ] ) ] ) ] } > < > > ( ( < { } > ) ) > ) } ) > ] } > )", "reasoning": "<thinking><step1>\nThe question asks: “Pari gbogbo ẹgbẹ́ àkọ́kọ́ yìí, rii daju pe àwọn àmì ìṣíṣẹ́ ṣiṣẹ́ sí gbogbo rẹ̀ dáadáa” — which translates to \"Complete this initial group, ensuring that all operational signs work well.\"\n</step1>\n<step2>\nTo interpret this, we need to understand what \"àwọn àmì ìṣíṣẹ́\" refers to — these are \"operational signs\" or symbols that indicate functions or commands.\n</step2>\n<step3>\nThe phrase \"pari gbogbo ẹgbẹ́ àkọ́kọ́\" suggests that we are to finalize or complete a sequence or a set of elements — *finaliser une séquence*.\n</step3>\n<step4>\nIn programming or logical sequences, ensuring that all signs or symbols function correctly means checking for errors or validating the output — *vérifier les erreurs*.\n</step4>\n<step5>\nThus, the task involves confirming that each part of the sequence is correctly implemented and operational — *s'assurer que chaque partie fonctionne*.\n</step5>\n<step6>\nFinally, we conclude that the goal is to ensure the integrity and functionality of the entire initial group of symbols or commands.\n</step6></thinking>", "answer": "<answer>Rii daju pe gbogbo àmì ìṣíṣẹ́ ṣiṣẹ́ dáadáa ninu ẹgbẹ́ àkọ́kọ́ yìí.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun mẹrinlelogun (75) kan wá pẹlu awọn àmì àrùn tó pẹlu pipadanu iranti, ìdánwòjú, àìṣe ìṣakoso ito, ati ríran awọn ohun tí kò sí. Àyẹ̀wò ipo ọpọlọ rẹ̀ ni 22/30. Ṣe iwadii tó peye jùlọ lati ṣe ayẹwo ipo rẹ̀ daradara ni kini?", "reasoning": "<thinking><step1>\nThe question asks: “What is the most appropriate diagnosis for a 75-year-old woman presenting with symptoms including memory loss, confusion, incontinence, and hallucinations?” — here, *pipadanu iranti* means memory loss, *ìdánwòjú* refers to confusion, *àìṣe ìṣakoso ito* means incontinence, and *ríran awọn ohun tí kò sí* translates to hallucinations.\n</step1>\n<step2>\nThese symptoms suggest a cognitive decline, which is often associated with conditions like dementia — *dementia* is a general term for a decline in mental ability severe enough to interfere with daily life.\n</step2>\n<step3>\nGiven her age and the combination of symptoms, one might consider *dementia àtọkànwá* (Alzheimer's disease) as a potential diagnosis, especially with the memory loss and confusion.\n</step3>\n<step4>\nThe cognitive assessment score of 22/30 indicates some level of impairment — *ìdílé àìlera ọpọlọ* is evident, which aligns with dementia.\n</step4>\n<step5>\nAdditionally, the presence of hallucinations and incontinence can suggest a more advanced stage of the disease or even *dementia vascular* if there are underlying vascular issues.\n</step5>\n<step6>\nIn conclusion, the most fitting diagnosis considering all these factors would be *dementia*, likely of the Alzheimer's type, given the age and symptom profile.\n</step6></thinking>", "answer": "<answer>Iwadii tó peye jùlọ ni *dementia*, pataki *dementia àtọkànwá* (Alzheimer's disease).</answer>", "language": "Yoruba"}
{"question": "Kí nìdí tí agbara ìdàpọ̀ ojú ilẹ̀ kò fi ń ṣiṣẹ́ gẹ́gẹ́ bí ohun tí ń mú eégún ọ̀ṣẹ̀ ìsàlẹ̀ dúró?", "reasoning": "<thinking><step1>\nThe question asks: “Kí nìdí tí [agbara ìdàpọ̀ ojú ilẹ̀ = gravitational potential energy] kò fi ń ṣiṣẹ́ gẹ́gẹ́ bí [ohun tí ń mú eégún ọ̀ṣẹ̀ ìsàlẹ̀ = what makes a pendulum swing]?” — meaning it wants to know why gravitational potential energy does not function like what causes a pendulum to swing.\n</step1>\n<step2>\nGravitational potential energy is stored energy based on an object's height — *agbara tí a fipamọ́ nípa giga ohun kan*.\n</step2>\n<step3>\nIn a pendulum, the energy transforms between potential and kinetic energy — *agbara ìdàpọ̀ àti agbara ìrìn* — as it swings back and forth.\n</step3>\n<step4>\nHowever, gravitational potential energy alone does not cause motion; it needs to convert to kinetic energy — *agbara ìrìn* — to create movement.\n</step4>\n<step5>\nThe pendulum swings due to the force of gravity acting on it, which pulls it downwards, converting potential energy into kinetic energy — *agbara ìdàpọ̀ di agbara ìrìn*.\n</step6>\n<step6>\nThus, while gravitational potential energy is essential, it must change forms to enable the swinging motion of the pendulum.\n</step6></thinking>", "answer": "<answer>Agbara ìdàpọ̀ ojú ilẹ̀ kò ṣiṣẹ́ gẹ́gẹ́ bí ohun tí ń mú eégún ọ̀ṣẹ̀ ìsàlẹ̀ nítorí pé ó nílò láti yí padà sí agbara ìrìn kí o lè fa ìrìn.</answer>", "language": "Yoruba"}
{"question": "Àpọǹ lára ń yọ̀ọ́ sọ́rọ̀, ìrora, àti ìgbọ́nrín tí ń gbòòrò sí i. Nígbà tí a ṣe àyẹ̀wò rẹ̀, ìgbóná pupa kan wà lẹ́yìn ìdí tí ó dára, tí ó sì yí padà sí funfun nígbà tí a fi ohun èlò tí a ń pè ní pneumatic speculum tẹ̀ sí i. Ìtọ́jú rẹ̀ pẹ̀lú gbogbo àwọn wọ̀nyí yàtọ̀ sí:\nA. Irègbédídì\nB. Ìṣirò\nC. Interferons\nD. Ìtẹ́lẹ̀ṣẹ̀ níṣàájú ṣíṣirò", "reasoning": "<thinking><step1>\nThe question describes a medical condition involving symptoms like *ìrora* [pain], *àpọǹ lára* [abdominal pain], and *ìgbọ́nrín* [swelling]. It mentions a red area that turns white when a *pneumatic speculum* is applied, indicating a possible diagnosis.\n</step1>\n<step2>\nThe symptoms suggest an inflammatory response, which could be linked to various conditions. The presence of redness and swelling points towards *ìfarapa* [inflammation].\n</step2>\n<step3>\nThe options provided include treatments or conditions: \nA. *Irègbédídì* [antibiotics], \nB. *Ìṣirò* [surgery], \nC. *Interferons*, \nD. *Ìtẹ́lẹ̀ṣẹ̀ níṣàájú ṣíṣirò* [pre-operative care].\n</step3>\n<step4>\nConsidering the symptoms and the examination findings, the most appropriate treatment would likely be related to managing inflammation or infection. *Irègbédídì* could be effective if there is a bacterial infection.\n</step4>\n<step5>\nHowever, if the condition is more severe, *Ìṣirò* might be necessary. *Interferons* are typically used for viral infections, which may not apply here. *Ìtẹ́lẹ̀ṣẹ̀ níṣàájú ṣíṣirò* is more about preparation for surgery rather than treatment.\n</step6>\n<step7>\nThus, the best choice seems to be *Irègbédídì*, as it directly addresses potential infection and inflammation, which aligns with the symptoms described.\n</step7></thinking>", "answer": "<answer>Irègbédídì.</answer>", "language": "Yoruba"}
{"question": "Irú ọja wo ni ó ṣe afihan ìpele gíga ti ìkopa ti onírajà ninu ipinnu ríra nitori ewu gíga tí a rí, tí ó mú kí wọn lo akoko pupọ, ìtọ́jú, ati agbára ninu wiwa, ṣiṣe ètò, ati ṣiṣe ipinnu ikẹhin?", "reasoning": "<thinking><step1>\nThe question asks: “Irú ọja wo ni ó ṣe afihan ìpele gíga ti ìkopa ti onírajà ninu ipinnu ríra?” — meaning it wants to know what type of product reflects a high level of buyer involvement in purchasing decisions due to significant risks involved.\n</step1>\n<step2>\nHigh involvement products are typically those that require extensive research and consideration — *awọn ọja ti o nilo iwadi jinlẹ* before making a purchase.\n</step2>\n<step3>\nThese products often involve high financial costs or personal significance, such as *ilana ilera* (healthcare products) or *awọn ọkọ ayọkẹlẹ* (vehicles).\n</step3>\n<step4>\nThe risks associated with these purchases can lead to *ipinnu to lagbara* (strong decision-making), where buyers invest time and effort in evaluating options.\n</step4>\n<step5>\nFor example, when buying a house, buyers consider factors like location, price, and future value — *iyato laarin awọn ile ni agbegbe kan*.\n</step5>\n<step6>\nThus, products that show high buyer involvement are often those that have significant implications for the buyer's life or finances.\n</step6></thinking>", "answer": "<answer>Àwọn ọja ti o ni ìkopa gíga ni ilé, ọkọ ayọkẹlẹ, àti awọn ọja ilera.</answer>", "language": "Yoruba"}
{"question": "Ninu ẹ̀kọ́ ìṣirò, àwọn àmì ìdánwò àárín-ọdún pín sí ààyè gẹ́gẹ́ bí àpòpọ̀, pẹ̀lú ìwọ̀n ààyè 52 àti ìyàtọ̀ ìwọ̀n 4, àti àwọn àmì ìdánwò ìkẹyìn pín sí ààyè gẹ́gẹ́ bí àpòpọ̀, pẹ̀lú ìwọ̀n ààyè 112 àti ìyàtọ̀ ìwọ̀n 10. Ọmọ-akẹ́kọ̀ọ́ kan rí 58 ninu ìdánwò àárín-ọdún. Bí ọmọ-akẹ́kọ̀ọ́ náà bá ní ìwọ̀n z kan náà nínú ìdánwò ìkẹyìn, kini àmì rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks about calculating a z-score for a student who scored 58 in a [ìdánwò àárín-ọdún = midterm exam] with a mean of 52 and a standard deviation of 4, and then determining the corresponding score in a [ìdánwò ìkẹyìn = final exam] with a mean of 112 and a standard deviation of 10.\n</step1>\n<step2>\nFirst, we calculate the z-score for the midterm exam. The formula for the z-score is: *z = (X - μ) / σ*, where X is the score, μ is the mean, and σ is the standard deviation.\n</step2>\n<step3>\nSubstituting the values: *z = (58 - 52) / 4 = 6 / 4 = 1.5*. This means the student is 1.5 standard deviations above the mean in the midterm exam.\n</step3>\n<step4>\nNext, we use this z-score to find the corresponding score in the final exam. We rearrange the z-score formula: *X = μ + z * σ*.\n</step4>\n<step5>\nFor the final exam, substituting the mean (112) and standard deviation (10): *X = 112 + 1.5 * 10 = 112 + 15 = 127*.\n</step5>\n<step6>\nThus, if the student has the same z-score in the final exam, their score would be 127.\n</step6></thinking>", "answer": "<answer>Amí ọmọ-akẹ́kọ̀ọ́ náà nínú ìdánwò ìkẹyìn ni 127.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọmọ ọdún mẹ́ẹ́dógún [28] kan wá pẹ̀lú irígbàìgbà irẹ̀lẹ̀ ara, ìṣú ìtìjú, ìṣòro kíka oúnjẹ, àti ọ̀rọ̀ tí kò mọ́. Wọ́n fún un ní oògùn tí ó nípa lórí iṣẹ́ ẹ̀mí kan. Ṣàlàyé irú ìdènà tí oògùn náà ṣe àti àwọn ipa rẹ̀ lórí Km àti Vmax ti ìṣe ẹ̀mí tí ó nípa lórí ẹ̀rọ náà ní ìṣe pẹ̀lú àìsí oògùn náà.", "reasoning": "<thinking><step1>\nThe question describes a 28-year-old woman experiencing symptoms like *irigbaìgbà irẹ̀lẹ̀ ara* [body weakness], *ìṣú ìtìjú* [loss of appetite], *ìṣòro kíka oúnjẹ* [difficulty eating], and *ọ̀rọ̀ tí kò mọ́* [confusion]. It mentions she was given a medication affecting a certain bodily function.\n</step1>\n<step2>\nThe medication likely acts as an inhibitor, affecting the enzyme activity related to her symptoms. In biochemistry, this can alter the *Km* [Michaelis constant] and *Vmax* [maximum velocity] of the enzyme's reaction.\n</step2>\n<step3>\nWhen a drug inhibits an enzyme, it can increase the *Km*, meaning a higher substrate concentration is needed to reach half of *Vmax*. This indicates reduced affinity of the enzyme for its substrate — *afẹ́fẹ́ àfiyèsí*.\n</step3>\n<step4>\nConversely, if the drug is a non-competitive inhibitor, it can decrease *Vmax* without affecting *Km*, leading to a lower maximum rate of reaction while maintaining the same substrate affinity.\n</step4>\n<step5>\nIn her case, the inhibition could lead to a decrease in the metabolic processes that are crucial for her energy levels and overall health, contributing to her *irigbaìgbà irẹ̀lẹ̀ ara* and *ìṣú ìtìjú*.\n</step5>\n<step6>\nThus, the drug's inhibition affects both *Km* and *Vmax*, leading to significant physiological changes that exacerbate her symptoms.\n</step6></thinking>", "answer": "<answer>Oògùn náà jẹ́ ìdènà ti o ni ipa lori Km àti Vmax, ti o fa ìdinku ninu iṣẹ́ ẹ̀mí àti àìlera ara.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 43 kan wa pẹlu rirẹ, aisan ounjẹ, ati ẹ̀jẹ̀ pupa tí kò tó, pẹlu iwọn corpuscular lapapọ̀ (MCV) ti 108 fl. Ó mu ọti déédéé.  Ní àyẹ̀wò, o fara hàn pé o burújú ati pe o ni glossitis.  Nítorí àwọn àmì wọnyi ati awọn ìwádìí ilé-iwosan rẹ̀,  ìwọn eroja métabolikù wo ni ó ṣee ṣe julọ lati rii ninu ẹ̀jẹ̀ rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks about a 43-year-old woman presenting with fatigue, food intolerance, and low red blood cell count — *ẹ̀jẹ̀ pupa tí kò tó* — along with a high mean corpuscular volume (MCV) of 108 fl. It also mentions she has glossitis, which indicates a potential deficiency.\n</step1>\n<step2>\nGiven her symptoms, particularly the glossitis and macrocytic anemia indicated by the high MCV, we should consider nutritional deficiencies — *aìlera onjẹ*.\n</step2>\n<step3>\nCommon deficiencies that lead to these symptoms include vitamin B12 deficiency and folate deficiency — *aìlera vitamin B12* àti *aìlera folate*.\n</step4>\n<step4>\nThe presence of glossitis suggests that the deficiency is likely related to vitamin B12, as it is often associated with this condition — *glossitis jẹ́ àmì aìlera vitamin B12*.\n</step5>\n<step5>\nAdditionally, the patient's history of alcohol consumption — *mu ọti déédéé* — can contribute to malabsorption of these vitamins, further supporting the likelihood of a deficiency.\n</step6>\n<step6>\nTherefore, the most likely metabolic element to be found in her blood would be a deficiency in vitamin B12 — *aìlera vitamin B12*.\n</step6></thinking>", "answer": "<answer>Aìlera vitamin B12 ni a le rii ninu ẹ̀jẹ̀ rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Lóòótọ́ ọ̀tẹ́lẹ̀wọ̀ kan tuntun fún àrùn àtìgbàgbọ́, bí ènìyàn 80 tí wọ́n dán wò tí ó jáde rere, tí ó sì ní ènìyàn 40 tí wọ́n ní àrùn àtìgbàgbọ́, àti láàrin ènìyàn 9920 tí wọ́n dán wò tí ó jáde burú, ènìyàn 9840 ló kò ní àrùn náà, kí ni ìwòye ṣíṣeé ṣe ti ọ̀tẹ́lẹ̀wọ̀ yìí?", "reasoning": "<thinking><step1>\nThe question asks about the interpretation of a new [clinical trial = ìwòye ṣíṣeé] for a disease, specifically in the context of an 80-year-old patient who had a positive outcome, and 40 individuals with the disease.\n</step1>\n<step2>\nIn this trial, there are 9920 individuals who had negative outcomes, while 9840 did not have the disease — *àrùn àtìgbàgbọ́*.\n</step2>\n<step3>\nTo analyze the results, we need to consider the total number of participants and the outcomes: 80 had a positive result, and 40 had the disease.\n</step3>\n<step4>\nThis means that out of the total, a significant majority, *9840*, did not have the disease, indicating a high rate of negative outcomes.\n</step4>\n<step5>\nThe effectiveness of the treatment can be assessed by comparing the number of positive outcomes to the total number of participants — *ìwòye àtúnṣe*.\n</step5>\n<step6>\nThus, the trial suggests that the treatment may be effective for certain individuals, particularly the elderly, but the overall success rate appears low given the high number of negative outcomes.\n</step6></thinking>", "answer": "<answer>Ìwòye ṣíṣeé yìí fi hàn pé àtúnṣe náà lè jẹ́ àǹfààní fún àwọn àgbàlagbà, ṣùgbọ́n ìṣàkóso rẹ̀ kì í ṣe gíga ní gbogbo àwọn olùkànsí.</answer>", "language": "Yoruba"}
{"question": "Àrùn wo ni a mọ̀ sí nípa ikọ́kọ́ tí ó wà fún ìgbà pípẹ̀, àwọn ìdènà onígbọnwọ̀n nínú fọ́tò X-ray àyà, ìgbóná granulomatous ti àtẹ̀gùn ọ̀pọ̀, cANCA tí ó gbà, creatinine ẹ̀jẹ̀ tí ó ga, àti àwọn ìgbò òṣùwọ̀n pupa pẹ̀lú ìfihàn hematuria?", "reasoning": "<thinking><step1>\nThe question asks: \"Àrùn wo ni a mọ̀ sí nípa [ikọ́kọ́ = chronic disease] tí ó wà fún ìgbà pípẹ̀?\" — it seeks to identify a chronic condition based on specific medical findings.\n</step1>\n<step2>\nThe findings include *ìdènà onígbọnwọ̀n nínú fọ́tò X-ray àyà* which suggests lung involvement, indicating possible *fibrosis* or *granulomatous disease*.\n</step2>\n<step3>\nThe mention of *ìgbóná granulomatous ti àtẹ̀gùn ọ̀pọ̀* points towards conditions like sarcoidosis or granulomatosis with polyangiitis, which can cause chronic inflammation.\n</step3>\n<step4>\nThe presence of *cANCA* positivity indicates a specific type of vasculitis, often associated with Wegener's granulomatosis, which can lead to kidney issues — *ìṣòro ẹ̀dá àtọ́run*.\n</step4>\n<step5>\nElevated *creatinine ẹ̀jẹ̀* suggests renal impairment, while *ìfihàn hematuria* indicates blood in urine, further supporting kidney involvement.\n</step5>\n<step6>\nThus, the combination of these findings points towards a chronic condition like *granulomatosis with polyangiitis*, which affects both the lungs and kidneys.\n</step6></thinking>", "answer": "<answer>Àrùn tí a mọ̀ sí nípa ikọ́kọ́ yìí ni granulomatosis with polyangiitis, tí ó ní ipa lórí àyà àti ẹ̀dá àtọ́run.</answer>", "language": "Yoruba"}
{"question": "Loni oni, Leslie lọ si eti okun. Laarin awọn akoko wo ni wọn le ti lọ?\nA mọ pe:\nLeslie jí ni 7am.\nAshley rí Leslie ti ń ṣe iṣẹ-idaraya ni ile-iṣẹ yoga lati 7am si 9am.\nAndrew rí Leslie ti ń ṣere tẹnisi ni ibi idaraya tẹnisi lati 9am si 11am.\nJason rí Leslie ti ń rìn lọ si Ẹṣọ Ọba Ọmọ-ogun lati 11am si 4pm.\nEti okun tii pa ni 8pm.\nLaarin awọn akoko wo ni Leslie le ti lọ si eti okun?\nAwọn aṣayan:\n(A) 9am si 11am\n(B) 4pm si 8pm\n(C) 7am si 9am\n(D) 11am si 4pm", "reasoning": "<thinking><step1>\nThe question asks: “Laarin awọn akoko wo ni Leslie le ti lọ si eti okun?” — meaning it wants to know during which time periods Leslie could have gone to the beach.\n</step1>\n<step2>\nLeslie wakes up at 7am and is seen doing yoga from 7am to 9am — *Leslie ti n ṣe iṣẹ-idaraya ni ile-iṣẹ yoga*.\n</step2>\n<step3>\nAfter yoga, Leslie is spotted playing tennis from 9am to 11am — *Leslie ti n ṣere tẹnisi ni ibi idaraya tẹnisi*.\n</step4>\n<step4>\nFrom 11am to 4pm, Leslie is walking to the *Ẹṣọ Ọba Ọmọ-ogun*, which means she is occupied during this time.\n</step4>\n<step5>\nThe beach closes at 8pm, so the only available time for Leslie to go to the beach would be after her activities, specifically from 4pm onwards.\n</step6>\n<step6>\nThus, the only viable option for Leslie to go to the beach is between 4pm and 8pm — *lati 4pm si 8pm*.\n</step7>\n<step7>\nTherefore, the correct answer is option (B) 4pm to 8pm.\n</step7></thinking>", "answer": "<answer>Laarin 4pm si 8pm.</answer>", "language": "Yoruba"}
{"question": "Iye apakan malu ẹiyẹ ti a ṣe ni Amẹrika ni ọdun kọọkan, ti a fihan ni kilogiraamu?", "reasoning": "<thinking><step1>\nThe question asks: “Iye apakan malu ẹiyẹ ti a ṣe ni Amẹrika ni ọdun kọọkan, ti a fihan ni kilogiraamu?” — meaning it wants to know the annual production of chicken in the United States, expressed in kilograms.\n</step1>\n<step2>\nIn the U.S., chicken production is a significant part of the agricultural sector — *ọja ẹiyẹ* ni a ṣe ni iwọn nla.\n</step2>\n<step3>\nAccording to recent statistics, the U.S. produces millions of metric tons of chicken each year — *milionu toonu* ni a ṣe ni ọdun kọọkan.\n</step3>\n<step4>\nTo convert this into kilograms, we know that one metric ton equals 1,000 kilograms — *toonu kan jẹ 1,000 kilogiraamu*.\n</step4>\n<step5>\nFor example, if the production is around 20 million metric tons, that translates to 20 billion kilograms — *20 bilionu kilogiraamu*.\n</step5>\n<step6>\nThus, the total annual chicken production in the U.S. is a staggering figure, reflecting the country's demand for poultry — *iṣowo ẹiyẹ*.\n</step6></thinking>", "answer": "<answer>Iye apakan malu ẹiyẹ ti a ṣe ni Amẹrika ni ọdun kọọkan jẹ to 20 bilionu kilogiraamu.</answer>", "language": "Yoruba"}
{"question": "Àpẹẹrẹ ọmọ alaisan ọdun 70 kan tí ó ti ní àrùn àtọ́rùn-ọ̀sìn ìru 2 fún ìgbà pípẹ̀ dé pẹ̀lú irora ní etí òsì ati ìtànṣán pùrúlẹ̀ntì.  Ní àyẹ̀wò, àpẹẹrẹ náà kò ní ibà, etí òsì rẹ̀ ni ìrora, ati ọ̀nà etí ìta rẹ̀ gbòòrò sí i ati kí ìgbóná, pẹ̀lú iye ẹ̀jẹ̀ funfun tí ó wọ́pọ̀.  Àwọn ìṣẹ̀dá èyíkéyìí ni ó ṣeé ṣe jùlọ láti máa dá ara rẹ̀ lórí fún àrùn náà nínú ọ̀ràn yìí?", "reasoning": "<thinking><step1>\nThe question asks: “What are the most likely causes of a 70-year-old patient with type 2 diabetes experiencing pain in the left ear and purulent discharge?” — it highlights symptoms like *irora* [pain] and *ìtànṣán pùrúlẹ̀ntì* [purulent discharge].\n</step1>\n<step2>\nIn this case, the patient’s age and diabetes can complicate infections — *àrùn* [disease] can lead to *ìfarapa* [inflammation] in the ear.\n</step2>\n<step3>\nThe presence of *ìtànṣán pùrúlẹ̀ntì* suggests a possible ear infection, such as *otitis externa* or *otitis media*, which are common in older adults.\n</step3>\n<step4>\nAdditionally, the *irora* in the left ear could indicate a more serious condition, like *mastoiditis*, especially if there’s swelling or fever.\n</step4>\n<step5>\nGiven the patient’s diabetes, they may have a higher risk for infections due to *ìdàgbàsókè* [impaired immunity], making it crucial to consider these factors.\n</step6>\n<step6>\nTherefore, the most likely causes include ear infections, possibly exacerbated by the patient’s diabetes and age-related factors.\n</step6></thinking>", "answer": "<answer>Àwọn ìṣẹ̀dá èyíkéyìí ni àrùn etí, gẹgẹ bí *otitis externa* tàbí *otitis media*, pẹ̀lú àkúnya àrùn àtọ́rùn-ọ̀sìn.</answer>", "language": "Yoruba"}
{"question": "Ninu àkókò ìgbà ìgbọ̀nrín tó wọ́pọ̀, ọjọ́ melo ni ìtúsílẹ̀ ẹyin máa ń ṣẹlẹ̀ ṣáájú ọjọ́ àkọ́kọ́ ti ìgbà ìgbọ̀nrín tókàn?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu àkókò ìgbà ìgbọ̀nrín tó wọ́pọ̀, ọjọ́ melo ni ìtúsílẹ̀ ẹyin máa ń ṣẹlẹ̀ ṣáájú ọjọ́ àkọ́kọ́ ti ìgbà ìgbọ̀nrín tókàn?” — meaning it wants to know how many days before the first day of the menstrual cycle does ovulation typically occur.\n</step1>\n<step2>\nIn a typical menstrual cycle, ovulation usually occurs around 14 days before the start of the next period — *ìgbà ìgbọ̀nrín tó tẹ̀síwájú*.\n</step2>\n<step3>\nThis means that if a woman has a regular cycle of 28 days, ovulation would happen approximately on day 14 — *ọjọ́ kẹrindinlogun*.\n</step3>\n<step4>\nHowever, cycles can vary; for longer cycles, ovulation may occur later, and for shorter cycles, it may happen earlier — *ìyẹn túmọ̀ sí pé* the timing can differ.\n</step4>\n<step5>\nGenerally, the luteal phase, which is the time from ovulation to the start of the next period, lasts about 12 to 16 days — *àkókò yìí jẹ́ àkókò tó pé*.\n</step5>\n<step6>\nSo, in summary, ovulation typically occurs about 14 days before the next menstrual period starts — *nígbà tí ẹyin bá ti tú sílẹ̀*.\n</step6></thinking>", "answer": "<answer>Ìtúsílẹ̀ ẹyin máa ń ṣẹlẹ̀ ní ọjọ́ mẹ́rìndínlógún ṣáájú ọjọ́ àkọ́kọ́ ti ìgbà ìgbọ̀nrín tókàn.</answer>", "language": "Yoruba"}
{"question": "Ewo lara awọn ọna atẹgun atẹgun wọnyi ni ewu ti o ga julọ fun alaisan lati ni ikọlu alkalosis atẹgun?\nA. Atẹgun Atẹgun Ti a Ṣakoso\nB. Atẹgun Atẹgun Iṣẹlẹ Ti a Ṣe Atilẹyin\nC. Ọna Iṣakoso Ṣiṣe iranlọwọ\nD. Ọna Iṣakoso Titẹ", "reasoning": "<thinking><step1>\nThe question asks: “Ewo lara [awọn ọna atẹgun = the ventilation methods] wọnyi ni ewu ti o ga julọ fun alaisan lati ni ikọlu [alkalosis atẹgun = respiratory alkalosis]?” — meaning it wants to identify which ventilation method poses the highest risk for a patient to develop respiratory alkalosis.\n</step1>\n<step2>\nRespiratory alkalosis occurs when there is excessive loss of carbon dioxide due to hyperventilation — *hyperventilation* can be triggered by certain ventilation methods.\n</step2>\n<step3>\nAmong the options, *Atẹgun Atẹgun Ti a Ṣakoso* (A) refers to controlled ventilation, which typically maintains stable CO2 levels.\n</step3>\n<step4>\n*Atẹgun Atẹgun Iṣẹlẹ Ti a Ṣe Atilẹyin* (B) provides support but can also lead to hyperventilation if not properly managed.\n</step4>\n<step5>\n*Ọna Iṣakoso Ṣiṣe iranlọwọ* (C) allows for patient-initiated breaths, which can increase the risk of hyperventilation.\n</step6>\n<step6>\n*Ọna Iṣakoso Titẹ* (D) is pressure-controlled and generally minimizes the risk of respiratory alkalosis by preventing excessive ventilation.\n</step7>\n<step7>\nThus, the method with the highest risk for respiratory alkalosis is likely *Ọna Iṣakoso Ṣiṣe iranlọwọ* because it allows for more variability in breathing patterns.\n</step8></thinking>", "answer": "<answer>Ọna Iṣakoso Ṣiṣe iranlọwọ ni ewu ti o ga julọ fun alaisan lati ni ikọlu alkalosis atẹgun.</answer>", "language": "Yoruba"}
{"question": "Kini idi ti o ṣeé ṣe julọ ti awọn ami aisan ti obinrin ọdun 30 kan ti o ti wa lati ipo eto-ọrọ ti ko dara ni ilu oke-giga, eyiti o pẹlu iṣelọpọ, dysuria, hematuria, pipadanu ẹdùn, iba kekere, ati amenorrhea?", "reasoning": "<thinking><step1>\nThe question asks: “Kini idi ti o ṣeé ṣe julọ ti awọn ami aisan ti obinrin ọdun 30 kan…” — meaning it wants to know the most likely cause of symptoms in a 30-year-old woman experiencing issues like *dysuria* (painful urination), *hematuria* (blood in urine), *pipadanu ẹdùn* (loss of appetite), *iba kekere* (low-grade fever), and *amenorrhea* (absence of menstruation).\n</step1>\n<step2>\nThese symptoms suggest a possible infection or a systemic condition. For instance, *dysuria* and *hematuria* often indicate a urinary tract infection (UTI) or possibly a more serious condition like a kidney infection.\n</step2>\n<step3>\nThe *iba kekere* could be a sign of the body fighting an infection, while *pipadanu ẹdùn* may indicate that the patient is not feeling well overall, which is common in infections.\n</step3>\n<step4>\n*Amenorrhea* in this context could be due to stress or illness affecting hormonal balance, especially in a woman from a challenging socioeconomic background — *ipo eto-ọrọ ti ko dara*.\n</step4>\n<step5>\nConsidering all these factors, the most likely diagnosis could be a urinary tract infection complicated by stress or systemic illness, leading to the other symptoms.\n</step5>\n<step6>\nIn summary, the combination of these symptoms points towards a UTI or similar infection as the primary concern for this patient.\n</step6></thinking>", "answer": "<answer>Iṣoro ti o ṣee ṣe julọ ni ikolu ọna ito (UTI) ti o ni idiwọ nipasẹ aisan tabi aapọn.</answer>", "language": "Yoruba"}
{"question": "Iṣẹ́ ẹ̀yìn ọkàǹ ní ipa bíi syncytium itanna àti ẹ̀rọ. Ipò tí ó dá ipò yìí sílẹ̀ ni\nA. Ẹ̀rọ T tubule\nB. Àwọn dììskì tí a so pò\nC. Ìṣiṣẹ́ tí ó wà ní ẹ̀gbẹ́ ti ẹ̀rọ tí ó fa ìṣiṣẹ́\nD. Ẹ̀rọ sarcoplasmic reticulum tí ó gbooro", "reasoning": "<thinking><step1>\nThe question asks: “Iṣẹ́ ẹ̀yìn ọkàǹ ní ipa bíi [syncytium = syncytium] itanna àti [ẹ̀rọ = machine/device].” It is inquiring about the role of the heart's electrical system in relation to syncytium and devices.\n</step1>\n<step2>\nIn the heart, the electrical activity is crucial for coordinating contractions — *ìdàpọ̀ iṣẹ́-ara* that allows the heart to pump effectively.\n</step2>\n<step3>\nThe syncytium refers to a network of interconnected cells that can transmit electrical impulses rapidly — *ìfọwọsowọpọ̀ ti awọn sẹẹli*.\n</step3>\n<step4>\nNow, looking at the options: A. *Ẹ̀rọ T tubule* is involved in muscle contraction but not directly in syncytium function.\n</step4>\n<step5>\nB. *Àwọn dììskì tí a so pò* refers to intercalated discs, which are essential for cell communication in the syncytium.\n</step5>\n<step6>\nC. *Ìṣiṣẹ́ tí ó wà ní ẹ̀gbẹ́ ti ẹ̀rọ tí ó fa ìṣiṣẹ́* describes the mechanism of action but is vague in this context.\n</step6>\n<step7>\nD. *Ẹ̀rọ sarcoplasmic reticulum tí ó gbooro* is important for calcium storage but does not define the syncytium's role.\n</step7>\n<step8>\nThus, the best answer relates to the intercalated discs, which facilitate the syncytium's electrical connectivity — *ìfọwọsowọpọ̀ itanna*.\n</step8></thinking>", "answer": "<answer>B. Àwọn dììskì tí a so pò</answer>", "language": "Yoruba"}
{"question": "Kini oluko ile-iwe ọmọde kekere ṣe ṣaaju akoko oorun?\nA. dinku ireti\nB. gbala\nC. bẹ̀rù\nD. idanwo akoko\nE. sọ itan", "reasoning": "<thinking><step1>\nThe question asks: “Kini oluko ile-iwe ọmọde kekere ṣe ṣaaju akoko oorun?” — meaning it wants to know what a preschool teacher does before nap time.\n</step1>\n<step2>\nBefore nap time, a teacher often prepares the children — *oluko naa n mura awọn ọmọde* for rest.\n</step2>\n<step3>\nThis preparation might include calming activities, such as reading a story — *sọ itan* — to help them relax.\n</step3>\n<step4>\nThe goal is to create a peaceful environment, so the children can transition smoothly into sleep — *lati le wọ inu oorun ni irọrun*.\n</step4>\n<step5>\nAmong the options provided, *sọ itan* is the most fitting action a teacher would take before nap time.\n</step5></thinking>", "answer": "<answer>Oluko ile-iwe ọmọde kekere ṣe sọ itan ṣaaju akoko oorun.</answer>", "language": "Yoruba"}
{"question": "Obinrin ọdun mẹrinlelogun (34) kan ṣe idanwo Pap smear tí ó fihan aisan squamous intraepithelial ti iwọn giga (CIN III), lẹhin eyi ni a ṣe colposcopy ati biopsy ọfun ọgbẹ, tí ó jẹ́risi CIN III, ati conization tí ó ṣe afihan ifọkansi microinvasion ni apapo squamocolumnar.  Kini igbesẹ ti o tẹle ti o ṣeeṣe julọ ninu itọju alaisan yii?", "reasoning": "<thinking><step1>\nThe question asks: “Kini igbesẹ ti o tẹle ti o ṣeeṣe julọ ninu itọju alaisan yii?” — meaning it wants to know the next possible step in the treatment of a patient with high-grade squamous intraepithelial lesion (CIN III).\n</step1>\n<step2>\nAfter confirming CIN III through colposcopy and biopsy, the next step typically involves assessing the extent of the lesion — *iwadii iwọn ti aisan naa*.\n</step2>\n<step3>\nIn cases of CIN III with microinvasion, further treatment options may include surgical intervention — *itọju abẹ* — to remove the affected tissue.\n</step3>\n<step4>\nA common procedure is a hysterectomy if the patient has completed childbearing — *hysterectomy* le jẹ́ aṣayan ti o dara.\n</step4>\n<step5>\nAlternatively, if the patient desires to preserve fertility, a more conservative approach like loop electrosurgical excision procedure (LEEP) may be considered — *LEEP* jẹ́ ọna ti a lo lati yọ aisan naa.\n</step5>\n<step6>\nUltimately, the decision will depend on the patient's overall health, age, and reproductive plans — *ilera gbogbogbo alaisan, ọjọ-ori, ati awọn eto ibimọ*.\n</step6>\n<step7>\nThus, the most likely next step in treatment would be to discuss surgical options with the patient.\n</step7></thinking>", "answer": "<answer>Igbesẹ ti o tẹle ti o ṣeeṣe julọ ni lati jiroro lori awọn aṣayan abẹ pẹlu alaisan.</answer>", "language": "Yoruba"}
{"question": "Igbẹ́rẹ́ ti ara àjèjì tí ó wọ́ inu àpò ìfúmọ̀ nígbà tí a bá wà lórí ẹ̀rù jẹ́ kí èyíkéyí nínú awọn ẹ̀yà ẹ̀gbà ẹ̀dọ̀fọ́ yìí dààmú̀ -\nA. Ẹ̀yà òkè òṣùwọ̀n òsì\nB. Ẹ̀yà òkè òṣùwọ̀n ọ̀tún\nC. Ẹ̀yà òkè ti ẹ̀yà isalẹ̀\nD. Ẹ̀yà ẹ̀yin-ìdí-ẹhin ti òṣùwọ̀n òsì", "reasoning": "<thinking><step1>\nThe question translates to: \"What part of the body is affected by an external stimulus when we are on a surface?\" — it is asking about the specific body part that reacts to external stimuli while in contact with a surface.\n</step1>\n<step2>\nIn this context, *àpò ìfúmọ̀* refers to the surface we are on, and the question implies a reaction to external stimuli — *ìmúra sí ìfúmọ̀*.\n</step2>\n<step3>\nWhen we are on a surface, the body part that typically reacts is the skin, particularly in areas like the back or the feet — *ara àjèjì* can refer to these sensitive areas.\n</step3>\n<step4>\nThe options provided include various anatomical parts: \nA. *Ẹ̀yà òkè òṣùwọ̀n òsì* (left upper limb)\nB. *Ẹ̀yà òkè òṣùwọ̀n ọ̀tún* (right upper limb)\nC. *Ẹ̀yà òkè ti ẹ̀yà isalẹ̀* (upper part of the lower limb)\nD. *Ẹ̀yà ẹ̀yin-ìdí-ẹhin ti òṣùwọ̀n òsì* (left lower back area).\n</step4>\n<step5>\nConsidering the context of external stimuli, the lower back area — *ẹ̀yin-ìdí-ẹhin* — is often sensitive to pressure and can react strongly when in contact with a surface.\n</step5>\n<step6>\nThus, the most appropriate answer to the question is option D, as it directly relates to the area that would be affected by external stimuli while on a surface.\n</step6></thinking>", "answer": "<answer>Ẹ̀yà ẹ̀yin-ìdí-ẹhin ti òṣùwọ̀n òsì.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 47 kan, aya rẹ̀ sọ pé àìṣe rẹ̀ ti yipada ní oṣù mẹta sẹ́yìn. Nígbà tí wọ́n ń bá a sọ̀rọ̀, ó máa ń dáhùn ìbéèrè gbogbo rẹ̀ pẹ̀lú ọ̀rọ̀ mẹta kan náà lójúmọ. Kí ni orúkọ tí a fi ń pè ìṣe àtúnṣe yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni orúkọ tí a fi ń pè ìṣe àtúnṣe yìí?” — meaning it wants to know the name of a specific behavioral change observed in a 47-year-old man who has been responding to questions with the same three words for the past three months.\n</step1>\n<step2>\nThis behavior suggests a possible condition known as *echolalia*, where a person repeats phrases or words they hear — *ìtànkálẹ̀ ọ̀rọ̀*.\n</step2>\n<step3>\nEcholalia can occur in various contexts, often associated with developmental disorders or neurological conditions — *àwọn àìlera ọpọlọ*.\n</step3>\n<step4>\nIn this case, the man's consistent three-word responses indicate a lack of spontaneous speech — *ìbáṣepọ̀ àìlera*.\n</step4>\n<step5>\nIt’s important to consider other symptoms or changes in behavior that might accompany this condition — *àwọn àfihàn míì*.\n</step5>\n<step6>\nThus, the term for this repetitive speech pattern is *echolalia*, which reflects a significant change in communication ability.\n</step6></thinking>", "answer": "<answer>Orúkọ tí a fi ń pè ìṣe àtúnṣe yìí ni *echolalia*.</answer>", "language": "Yoruba"}
{"question": "Níwọ̀n ìpìlẹ̀ wo ni a fi ń lò ilé-ìgbàgbé-yòò sí fún àwọn ọ̀rọ̀ ìdákọ́-yòò tí ó léwu?", "reasoning": "<thinking><step1>\nThe question asks: “Níwọ̀n ìpìlẹ̀ wo ni a fi ń lò ilé-ìgbàgbé-yòò sí fún àwọn ọ̀rọ̀ ìdákọ́-yòò tí ó léwu?” — meaning it wants to know the basis for using a [shelter = ilé-ìgbàgbé] for dangerous [situations = ìdákọ́-yòò].\n</step1>\n<step2>\nShelters are typically used during emergencies, such as natural disasters — *àwọn ajalu ayé* like hurricanes or earthquakes.\n</step2>\n<step3>\nThe foundation for using shelters is to provide safety and protection — *ààbò* from threats like flooding or severe weather conditions.\n</step3>\n<step4>\nIn many cases, shelters are equipped with essential supplies — *àwọn ohun elo pataki* like food, water, and medical kits.\n</step4>\n<step5>\nAdditionally, shelters serve as a community gathering point — *ibi ipade agbegbe* where people can receive information and support during crises.\n</step5>\n<step6>\nThus, the basis for using a shelter is to ensure the safety and well-being of individuals during hazardous situations — *lati daabobo ilera ati aabo eniyan*.\n</step6></thinking>", "answer": "<answer>Ilé-ìgbàgbé-yòò ni a fi ń lò fún ààbò àti ìlera àwọn ènìyàn nígbà ìdákọ́-yòò tí ó léwu.</answer>", "language": "Yoruba"}
{"question": "Nipọn iṣẹ́-ṣiṣe-ara wo ni didasilẹ̀ awọn enzyme ẹdọ lati ipo ti kò sí didasilẹ̀ ṣẹlẹ̀ pupọ?", "reasoning": "<thinking><step1>\nThe question asks: “Nipọn iṣẹ́-ṣiṣe-ara wo ni didasilẹ̀ [enzyme = enzymes] ẹdọ [liver] lati ipo ti kò sí didasilẹ̀ [release] ṣẹlẹ̀ pupọ?” — meaning it wants to know what physiological processes lead to the release of liver enzymes when there is no significant release occurring.\n</step1>\n<step2>\nLiver enzymes, such as ALT and AST, are typically released into the bloodstream during liver damage — *nigbati ẹdọ ba ni ibajẹ*.\n</step2>\n<step3>\nIf there is no significant release, it could indicate that the liver is functioning normally — *ẹdọ n ṣiṣẹ́ ni deede* — or that there is no acute injury.\n</step3>\n<step4>\nFactors like chronic liver disease or metabolic conditions can affect enzyme levels without causing immediate release — *awọn ipo bii arun ẹdọ àtọgbẹ*.\n</step4>\n<step5>\nAdditionally, the liver can compensate for damage, maintaining enzyme levels within a normal range — *ẹdọ le ṣe atunṣe fun ibajẹ*.\n</step6>\n<step6>\nIn summary, the absence of significant enzyme release suggests stable liver function or chronic conditions rather than acute injury.\n</step6></thinking>", "answer": "<answer>Ipo ti kò sí didasilẹ̀ awọn enzyme ẹdọ fihan pe iṣẹ́-ṣiṣe-ara ẹdọ n ṣiṣẹ́ ni deede tabi pe awọn ipo àtọgbẹ wa.</answer>", "language": "Yoruba"}
{"question": "Kristin mọ̀ bí a ṣe ń ṣe ẹ̀yẹ́ pẹ̀lú adun tó dára ju Maria lọ, nitorí náà, _ ni ó dúró de àṣíkò oúnjẹ́ alẹ́.\nA. Kristin\nB. Maria", "reasoning": "<thinking><step1>\nThe question translates to: \"Kristin is better at cooking than Maria, so who is waiting for dinner?\" This implies we need to determine who is likely to be preparing or waiting for the meal.\n</step1>\n<step2>\nSince Kristin is described as having better cooking skills — *Kristin mọ̀ bí a ṣe ń ṣe ẹ̀yẹ́ pẹ̀lú adun tó dára ju Maria lọ* — it suggests she might be the one cooking.\n</step2>\n<step3>\nIn many cultures, the person who cooks often also waits for the meal to be ready — *ẹni tó ń ṣe oúnjẹ́ máa ń duro de àṣíkò oúnjẹ́*.\n</step3>\n<step4>\nIf Kristin is the better cook, it is reasonable to conclude that she would be the one waiting for dinner to be served.\n</step4>\n<step5>\nThus, the logical answer to the question is that Kristin is the one who is waiting for dinner — *Kristin ni ó dúró de àṣíkò oúnjẹ́ alẹ́*.\n</step5></thinking>", "answer": "<answer>Kristin ni ó dúró de àṣíkò oúnjẹ́ alẹ́.</answer>", "language": "Yoruba"}
{"question": "Ile-iṣẹ kan ṣe agbejade awọn ọpa itọpa ọkọ ayọkẹlẹ iru I, pẹlu awọn ẹyọ 2,700 ti a nilo lojoojumọ, ni iye owo apapọ ti $1.20 fun ẹyọ kan ninu awọn ẹgbẹ wakati ti awọn ẹyọ 699. Pẹlupẹlu, o le ṣe agbejade awọn ọpa iru Y ni iye ti awọn ẹyọ 30 fun wakati kan fun $1.30 fun ẹyọ kan, gbogbo inu ọjọ iṣelọpọ wakati 24 ati isuna ti $4,005. Ní mímọ́ àwọn àṣàyàn ọ̀pá ìrísí I àti àwọn ìdènà isuna, mélòó ni ile-iṣẹ náà lè ṣe agbejade awọn ọpa iru Y lojoojumọ, ati boya isuna naa to fun eto iṣelọpọ yii?", "reasoning": "<thinking><step1>\nThe question is asking: \"How many units of type Y can the company produce daily, given the constraints of production and budget?\" It mentions producing type I tools with a daily requirement of 2,700 units at a cost of $1.20 each, and type Y tools at a rate of 30 units per hour for $1.30 each, within a 24-hour production day and a budget of $4,005.\n</step1>\n<step2>\nFirst, let's calculate the total cost for producing type I tools. The daily production requirement is 2,700 units, and the cost per unit is $1.20. So, the total cost for type I is: \n*2,700 * $1.20 = $3,240*.\n</step2>\n<step3>\nNext, we need to determine how much budget remains for producing type Y tools. The total budget is $4,005, and after spending $3,240 on type I, the remaining budget is:\n*$4,005 - $3,240 = $765*.\n</step3>\n<step4>\nNow, we need to find out how many type Y tools can be produced with the remaining budget. The cost per unit for type Y is $1.30. Therefore, the maximum number of type Y tools that can be produced is:\n*$765 / $1.30 ≈ 588.46*.\nSince we can only produce whole units, we round down to 588 units.\n</step4>\n<step5>\nNext, we check if the production capacity allows for this. Type Y tools are produced at a rate of 30 units per hour. In a 24-hour day, the total production capacity is:\n*30 units/hour * 24 hours = 720 units*.\n</step5>\n<step6>\nSince 588 units is less than the maximum capacity of 720 units, the production is feasible within the time constraints. \n</step6>\n<step7>\nFinally, we confirm that the budget is sufficient for producing 588 units of type Y tools, as calculated earlier.\n</step7></thinking>", "answer": "<answer>Ile-iṣẹ naa le ṣe agbejade awọn ẹyọ 588 ti awọn ọpa iru Y lojoojumọ, ati pe isuna naa to fun eto iṣelọpọ yii.</answer>", "language": "Yoruba"}
{"question": "Obirin ọmọ ọdun 45 kan tí ó ní àrùn ẹ̀jẹ̀ gíga, ó wá pẹ̀lú ẹ̀dùn àìlera ìgbàgbọ̀gbọ̀ ti sinusitis, otitis media, ìdènà imú, ikọ́, ìtànṣán ẹ̀jẹ̀, àti àìlera ọmu.  Nígbà tí a ṣayẹwo rẹ̀, a rí ìṣòro àpò ìtẹ́lẹ̀ imú, purpura tí a lè fi ọwọ́ kan, àwọn ọgbẹ̀ tí kò mú lára ní àwọn ẹsẹ̀ isalẹ̀.  Àwọn ìwádìí ẹ̀jẹ̀ fi hàn pé, ẹ̀dùn ẹ̀jẹ̀,  leukocytosis àti ESR tí ó ga, proteinuria,  ìpìlẹ̀ C-ANCA tí ó ga.  Àyẹ̀wò HPE fi hàn pé necrotizing vasculitis àti ìṣẹ̀dá granuloma.  Ìwádìí X-ray ọmu, CECT ọmu.  Èwo nínú àwọn wọ̀nyí ni oògùn àkọ́kọ́ fún àìlera yìí: -\nA. Cyclophosphamide\nB. Coicosteroids\nC. 5-FU\nD. Azathioprine", "reasoning": "<thinking><step1>\nThe question describes a 45-year-old woman with high blood pressure and symptoms of sinusitis, otitis media, nasal obstruction, cough, hemoptysis, and respiratory distress. It asks which medication is the primary treatment for her condition.\n</step1>\n<step2>\nGiven her symptoms and the findings of necrotizing vasculitis and granuloma formation, this suggests a serious autoimmune condition — *àìlera àtọ́runwá*.\n</step2>\n<step3>\nThe presence of leukocytosis and elevated ESR indicates inflammation, while proteinuria suggests kidney involvement — *ìfarapa ẹ̀dọ́*.\n</step4>\n<step4>\nIn such cases, the first-line treatment often includes immunosuppressive therapy. Cyclophosphamide and corticosteroids are commonly used for severe vasculitis — *vasculitis to ṣe pataki*.\n</step5>\n<step5>\nCyclophosphamide is particularly effective for aggressive forms of vasculitis, while corticosteroids can help manage inflammation quickly — *ìdènà àfarapa*.\n</step6>\n<step6>\nConsidering the severity of her condition, the most appropriate first-line medication would be corticosteroids, as they provide rapid relief of symptoms and control inflammation.\n</step7>\n<step7>\nThus, the best choice for her treatment is corticosteroids — *corticosteroids*.\n</step7></thinking>", "answer": "<answer>Corticosteroids ni oògùn àkọ́kọ́ fún àìlera yìí.</answer>", "language": "Yoruba"}
{"question": "Okùnrin ọdun 52 kan wá sí yàrá pajawiri lẹ́yìn ìṣẹ̀lẹ̀ ìṣàn ara. Aláìsàn náà jí, ó sì mọ̀ràn; sibẹsibẹ, orí rẹ̀ máa ń fà nígbàkigbà tí ó bá gbiyanju láti jókòó. Ìtàn ìṣòro ilera rẹ̀ ṣe pàtàkì fún àrùn àṣepọ̀ ìmọ́ ilà, àti angina tí ó dáradára, èyí tí a ń ṣakoso pẹ̀lú simvastatin àti isosorbide dinitrate, lóríṣiríṣi. Ẹ̀rùjẹ̀ẹ́jẹ̀ẹ́ jẹ́ 70/45 mm Hg, ìwọ̀n ọ̀kan sì jẹ́ 110/min; gbogbo àwọn àmì ìlera mìíràn dáradára. A bẹ̀rẹ̀ sí fún un ni omi nípa ìṣan, nígbà tí a mú un lọ sí ìwádìí CT ní orí. Lójú ọ̀nà sí ibi ìwádìí náà, aláìsàn náà sọ pé ó mu oogun tuntun kan fún àìlera ìbálòpọ̀ nígbà tí ó ṣẹ̀ṣẹ̀ bẹ̀rẹ̀ sí rí ìrora. Kí ni ìdí abàjẹ́ ọ̀ná ìṣelọ́rùn ti àwọn àmì àrùn aláìsàn yìí?\nA. PDE-5 tí ó pọ̀ sí i\nB. NO tí ó pọ̀ sí i\nC. cGMP tí ó pọ̀ sí i\nD. Ìdènà nitric oxide synthase", "reasoning": "<thinking><step1>\nThe question is asking about the underlying cause of the patient's symptoms after taking a new medication for erectile dysfunction — *àìlera ìbálòpọ̀* — and how it relates to his health issues.\n</step1>\n<step2>\nThe patient has a history of cardiovascular problems, including *angina* and is on medications like simvastatin and isosorbide dinitrate. These medications affect blood flow and vascular function.\n</step2>\n<step3>\nWhen he took the new medication, it likely increased levels of certain compounds in the body. For erectile dysfunction, many medications work by enhancing *nitric oxide (NO)* levels, which leads to vasodilation.\n</step3>\n<step4>\nHowever, if the NO levels increase too much, it can lead to hypotension — *ìkànsí ẹjẹ* — especially in someone already on vasodilators like isosorbide dinitrate.\n</step5>\n<step5>\nThe options provided suggest that the increase in *NO* could be the reason for his symptoms, as it can lead to excessive vasodilation and low blood pressure, which explains the patient's condition.\n</step6>\nThus, the most likely cause of the patient's symptoms is an increase in *NO* levels due to the new medication.\n</step6></thinking>", "answer": "<answer>NO tí ó pọ̀ sí i</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọmọ ọdún mẹ́ẹ̀ẹ́dógún (27) kan wá pẹ̀lú ìtàn ìkùkùgbà ṣíṣeéṣe ní oṣù kan sẹ́yìn àti ìwọ̀nba β-hCG tí ó ga jù. Ìwádìí ọkàn rẹ̀ fi hàn ní ìró ìṣàn díàstólíkì ìdààmú ìwọ̀n 3/6 ní àpòpò. Nígbà tí a bá gbé àwọn ìwádìí àrùn yìí yẹ̀ wò, àyípadà iṣẹ́-ara wo ni ó ṣeé ṣe jùlọ tó ṣeé dá lórí fún ìkùkùgbà rẹ̀ tí ó burú sí i?", "reasoning": "<thinking><step1>\nThe question is asking about a 27-year-old woman who has a history of [ìkùkùgbà = miscarriage] and elevated β-hCG levels. It also mentions her heart examination showing a diastolic dysfunction grade of 3/6. \n</step1>\n<step2>\nIn this context, elevated β-hCG levels can indicate ongoing pregnancy or complications related to a previous miscarriage — *ìkùkùgbà àtijọ́*.\n</step2>\n<step3>\nDiastolic dysfunction means the heart is having trouble relaxing and filling with blood — *ìdààmú ìdíàstólíkì* can lead to symptoms like shortness of breath or fatigue.\n</step3>\n<step4>\nGiven her history, the most likely change in her body could be related to hormonal fluctuations affecting her cardiovascular system — *àyípadà homonu*.\n</step4>\n<step5>\nAdditionally, the stress of a miscarriage can impact heart function, potentially worsening her diastolic dysfunction — *ìkùkùgbà le fa ìdààmú*.\n</step5>\n<step6>\nTherefore, the most significant physiological change likely relates to the interplay between her reproductive health and cardiovascular status.\n</step6></thinking>", "answer": "<answer>Àyípadà iṣẹ́-ara tó ṣeé ṣe jùlọ ni ìdààmú ìdíàstólíkì tó fa nipasẹ ìkùkùgbà àti àyípadà homonu.</answer>", "language": "Yoruba"}
{"question": "Eyi ni tabili kan nibiti ila opin meji je oju-ewe ati ila kọọkan ti n tẹle jẹ penguin kan: orukọ, ọjọ ori, iga (cm), iwuwo (kg) Louis, 7, 50, 11 Bernard, 5, 80, 13 Vincent, 9, 60, 11 Gwen, 8, 70, 15  Fun apẹẹrẹ: ọjọ ori Louis ni 7, iwuwo Gwen ni 15 kg, iga Bernard ni 80 cm. Kini iga Gwen?\nAwọn aṣayan:\n(A) 50\n(B) 80\n(C) 60\n(D) 70\n(E) 90", "reasoning": "<thinking><step1>\nThe question asks: “Kini iga Gwen?” — meaning it wants to know the height of Gwen in centimeters.\n</step1>\n<step2>\nFrom the table provided, we see that Gwen's details are listed: *orukọ = name*, *ọjọ ori = age*, *iga = height*, and *iwuwo = weight*.\n</step2>\n<step3>\nGwen is 8 years old, weighs 15 kg, and her height is given as 70 cm — *iga Gwen ni 70 cm*.\n</step3>\n<step4>\nThe question also provides information about other penguins, but we only need Gwen's height for this query.\n</step4>\n<step5>\nThus, the answer to the question is straightforward since we have already identified Gwen's height from the data.\n</step5></thinking>", "answer": "<answer>Iga Gwen ni 70 cm.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 28 kan wá sí ọ̀dọ̀ oníṣègùn fún ṣiṣayẹwo iṣẹ́ ṣiṣe ṣaaju iṣẹ́. Kò ní itan àrùn tó léwu, kò sì mu oogun kankan. Wọ́n ṣe idanwo ẹ̀jẹ̀ ayẹwo kan níbi tí wọ́n fi peptides kún apẹẹrẹ náà láti fúnni ní ìmúṣẹ̀ interferon-gamma ní in vitro, tí wọ́n sì wọn lẹ́yìn náà nípa lílo enzyme-linked immunosorbent assay. Idanwo yìí ṣeé ṣe kí ó ṣe iranlọwọ jùlọ nínú ìwádìí àrùn àyàgbà-gbà láti ọwọ́ àwọn àrùn arun tó wà nínú àwọn tó tẹ̀lé yìí?\nA. Àrùn immunodeficiency eniyan\nB. Staphylococcus aureus\nC. Àrùn Hepatitis B\nD. Mycobacterium tuberculosis\nE. Legionella pneumophila", "reasoning": "<thinking><step1>\nThe question is asking which disease could be most effectively investigated using an interferon-gamma release assay (IGRA) — *idanwo ìmúṣẹ̀ interferon-gamma* — in a 28-year-old man with no significant medical history.\n</step1>\n<step2>\nThe IGRA is particularly useful for detecting *Mycobacterium tuberculosis*, the bacterium that causes tuberculosis (TB) — *àrùn àyàgbà-gbà*.\n</step2>\n<step3>\nIn contrast, diseases like *àrùn immunodeficiency eniyan* (HIV) and *àrùn Hepatitis B* do not primarily rely on this type of test for diagnosis.\n</step3>\n<step4>\nStaphylococcus aureus and Legionella pneumophila are also not typically diagnosed using IGRA, as they are bacterial infections that require different testing methods.\n</step4>\n<step5>\nGiven that the patient has no history of severe illness and the context of the test, the most relevant disease to investigate with IGRA is tuberculosis.\n</step5></thinking>", "answer": "<answer>Àrùn àyàgbà-gbà.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọlọdún mẹjọlélógún (28) wá sí ọ́fíìsì pẹ̀lú ẹ̀dùn àárẹ̀, àìnífẹ́ẹ́ oúnjẹ, àti ìgbẹ́ gbuuru fún ọ̀sẹ̀ méjì sẹ́yìn. Ó tún sọ pé ìtọ̀ rẹ̀ dúdú. Ìtàn ìṣègùn rẹ̀ kò fi ohunkóhun hàn. Ìwọ̀n otútù rẹ̀ jẹ́ 36.8°C (98.2°F), ìlọ ọkàn rẹ̀ jẹ́ 72/min, ìfúnpá rẹ̀ jẹ́ 118/63 mm Hg, àti ẹ̀mí ìgbàmí rẹ̀ jẹ́ 15/min. Ìwádìí ara fi hàn pé ẹ̀dọ̀ rẹ̀ tóbi díẹ̀, ó sì ń ro. Kò sí wiwú ara tàbí àmì spider angiomata. Àyẹ̀wò lábọ́rátọ́rí fi àwọn wọ̀nyí hàn:\nHBsAg Positive\nIgM anti-HBc < 1:1,000\nAnti-HBs Negative\nHBeAg Positive\nHBeAg antibody Positive\nHBV DNA 2.65 × 109 IU/L\nAlpha-fetoprotein 125 ng/mL\nKí ni ohun tó ṣeé ṣe kó fà á ní àìsàn ọkùnrin yìí?\nA. Àkóràn HBV tó ti parí (àjẹ́sára ara)\nB. Ìbúṣe púpọ̀ àkóràn HBV onígbà gígùn\nC. Àkóràn HBV tuntun\nD. Àkóràn tó ń parí\nE. Àjẹ́sára láti ọ̀dọ̀ ẹlòmíràn", "reasoning": "<thinking><step1>\nThe question asks: \"Kí ni ohun tó ṣeé ṣe kó fà á ní àìsàn ọkùnrin yìí?\" — meaning it wants to know what could be causing the illness in this 28-year-old man.\n</step1>\n<step2>\nHe presents with symptoms like *ẹ̀dùn àárẹ̀* (abdominal pain), *àìnífẹ́ẹ́ oúnjẹ* (loss of appetite), and *ìgbẹ́ gbuuru* (weight loss) over the past two weeks.\n</step2>\n<step3>\nHis lab results show he is *HBsAg Positive*, indicating active hepatitis B infection, and he has a high *HBV DNA* level of 2.65 × 10^9 IU/L.\n</step3>\n<step4>\nThe presence of *HBeAg Positive* suggests high viral replication, while the elevated *alpha-fetoprotein* level of 125 ng/mL raises concern for liver damage or potential hepatocellular carcinoma.\n</step4>\n<step5>\nConsidering these factors, the most likely cause of his condition is *ìbúṣe púpọ̀ àkóràn HBV onígbà gígùn* (chronic hepatitis B infection).\n</step5>\n<step6>\nThe other options, such as *àkóràn HBV tuntun* (acute HBV infection) or *àkóràn tó ń parí* (resolved infection), do not align with his lab findings and clinical presentation.\n</step6></thinking>", "answer": "<answer>Ìbúṣe púpọ̀ àkóràn HBV onígbà gígùn.</answer>", "language": "Yoruba"}
{"question": "Àpọǹ rẹ́rẹ́ ọmọ ọdún mẹ́rin-dín-lógún kan ti ní ìgbà mẹ́ta tí àrùn ìkùǹgbàá rẹ̀ ti sọ̀kalẹ̀ lọ́nà tí kò ní ìrànlọ́wọ́ ní ìbẹ̀rẹ̀ ìlọ́gbàá rẹ̀. Gẹ́gẹ́ bí apá kan ti ṣíṣàyẹ̀wò fún ìṣòro yìí, àwọn àdánwò tí kò ṣe pàtàkì jùlọ ni:  Hysterosalpinogram, ṣíṣàyẹ̀wò àwọn ohun-àmì àrùn nípa ìrísí ìgbàgbọ́ ẹ̀gbọ̀ngbọ̀ngbọ̀n àwọn tọkọtaya náà, ṣíṣàyẹ̀wò fún àwọn àrùn TORCH, ṣíṣàdánwò endometrial ní ìgbà luteal, àdánwò Postcoital\nA. Àṣàyàn 1,3,5\nB. Àṣàyàn 1,3\nC. Àṣàyàn 3,5\nD. Àṣàyàn 5 nìkan", "reasoning": "<thinking><step1>\nThe question is asking about the least important tests for a patient who has experienced three instances of infertility — *àrùn ìkùǹgbàá* — in a 24-year-old woman.\n</step1>\n<step2>\nThe tests mentioned include: Hysterosalpinogram, evaluation of the couple's infertility factors, TORCH screening, endometrial biopsy during the luteal phase, and postcoital test.\n</step2>\n<step3>\nIn this context, *àdánwò* that are typically less critical for initial infertility assessment might be the ones that do not directly address common causes of infertility.\n</step3>\n<step4>\nFor instance, the postcoital test is often considered less essential compared to imaging studies like the hysterosalpinogram, which assesses the patency of the fallopian tubes — *ìtẹ̀síwájú àwọn tubes fallopian*.\n</step4>\n<step5>\nThus, the least important tests could be options that include the postcoital test and possibly the endometrial biopsy, as they are not first-line investigations.\n</step5>\n<step6>\nLooking at the options, *àṣàyàn 5 nìkan* (option 5 only) refers to the postcoital test, which aligns with this reasoning.\n</step6></thinking>", "answer": "<answer>Àṣàyàn 5 nìkan.</answer>", "language": "Yoruba"}
{"question": "Okùnrin ọdun mẹ́tádínlógún kan wá pẹ̀lú ìtàn ọsẹ̀ méjì ti àìgbọ́ra ṣẹ̀ẹ̀lẹ̀, ṣíṣàn omi ṣẹ́ẹ̀lẹ̀, irora ikùn díẹ̀, àti ìgbona ara. Ó ní ìtàn àwọn ìṣẹ̀lẹ̀ tí ó dà bíi èyí ní ọdún to kọjá, ó sì padà láti irin-ajo lọ sí Nàìjíríà ní ṣẹ́ṣẹ̀. Àyẹ̀wò fi hàn ní àwọn mucous membranes gbẹ, àmì àìtọ́jú omi ara, àti hypokalemia. Àfikún àtúnṣe igbà nasogastric tube fi hàn ní ìdinku pataki ìṣelọ́pọ̀ àwọn acid inu inu. Kí ni ìdí tí ó ṣeé ṣe jùlọ ti àwọn àrùn aládàáṣe yìí?", "reasoning": "<thinking><step1>\nThe question describes a 17-year-old boy with a two-week history of dehydration, watery diarrhea, abdominal pain, and fever. It mentions previous similar episodes and a recent trip to Nigeria. Key terms include [àìgbọ́ra = dehydration], [ṣíṣàn omi = watery diarrhea], and [ìgbona ara = fever].\n</step1>\n<step2>\nThe symptoms suggest a gastrointestinal infection, possibly due to pathogens common in Nigeria — *àwọn arun ti a n ri ni Naijiria* like bacteria or viruses.\n</step2>\n<step3>\nDehydration and diarrhea can lead to electrolyte imbalances, such as hypokalemia — *hypokalemia* means low potassium levels, which can cause muscle weakness and cramps.\n</step3>\n<step4>\nThe dry mucous membranes indicate significant fluid loss — *ìkó omi* is critical in assessing dehydration severity.\n</step4>\n<step5>\nThe history of similar episodes suggests a recurrent condition, possibly related to *àìlera àtọ́kànwá* or chronic infections, which could be exacerbated by travel.\n</step5>\n<step6>\nConsidering all these factors, the most likely cause of his symptoms is a viral gastroenteritis, possibly due to contaminated food or water — *àkúnya omi tàbí oúnjẹ*.\n</step6></thinking>", "answer": "<answer>Ìdí tí ó ṣeé ṣe jùlọ ti àwọn àrùn aládàáṣe yìí ni àkúnya omi tàbí oúnjẹ, tó fa àìgbọ́ra àti ṣíṣàn omi.</answer>", "language": "Yoruba"}
{"question": "Àpọǹrọ̀ kan tí ó ti ń mu oògùn ìdènà àrùn ọpọlọ kan fún ọ̀sẹ̀ mẹrin sẹ́yìn fi àwọn àmì àrùn gbígbóná gidigidi, ìgbóná jùlọ, ìṣòro ìrònú, lílọ́kùn ara, àti ìdinku ìbáṣepọ̀ hàn. Nígbà àyẹ̀wò, àpọǹrọ̀ náà fi ìgbóná 104°F, ìṣiṣẹ́ ọkàn 120/min, ẹ̀dùn ẹ̀jẹ̀ 150/100, àti ìdánilójú hàn. Kí ni ìwádìí tó ṣeé ṣe jùlọ fún ipò yìí?", "reasoning": "<thinking><step1>\nThe question is asking: \"What is the most likely investigation for a patient presenting with high fever, altered mental status, and other symptoms after taking an [antibiotic = oògùn ìdènà àrùn] for four weeks?\" \n</step1>\n<step2>\nThe symptoms include *ìgbóná gidigidi* (high fever), *ìṣòro ìrònú* (altered mental status), and *lílọ́kùn ara* (body aches), which suggest a serious underlying condition.\n</step2>\n<step3>\nGiven the recent antibiotic use, one must consider the possibility of *infekṣọn* (infection) or *reakṣọn* (reaction) to the medication, potentially leading to *sepsis*.\n</step3>\n<step4>\nThe vital signs show a fever of 104°F, tachycardia with a heart rate of 120/min, and hypertension at 150/100, indicating a systemic response to infection or inflammation.\n</step4>\n<step5>\nIn this context, a *kòkòrò àyẹ̀wò* (blood culture) is essential to identify any bacterial pathogens, especially if sepsis is suspected.\n</step5>\n<step6>\nAdditionally, a *CT scan* of the abdomen may be warranted to rule out any intra-abdominal infections or complications related to antibiotic use.\n</step6>\n<step7>\nThus, the most appropriate investigation in this scenario would be a blood culture to assess for possible infections.\n</step7></thinking>", "answer": "<answer>Ìwádìí tó ṣeé ṣe jùlọ ni àyẹ̀wò ẹ̀jẹ̀ (blood culture) láti ṣàwárí àrùn kan.</answer>", "language": "Yoruba"}
{"question": "Nígbà tí àjàkálẹ̀-àrùn Salmonella gastroenteritis tí ó gbilẹ̀ láti oúnjẹ̀ bá ṣẹlẹ̀ ní àwọn agbègbè kan, irú àdàpọ̀ àṣàpẹrẹ̀ wo ni a gbọdọ̀ lo fún àwọn àkànlọ́ àpòòtọ̀ tí a gba ní ilé ẹ̀kọ́ ìwádìí?", "reasoning": "<thinking><step1>\nThe question asks: “When a [Salmonella gastroenteritis = Salmonella gastroenteritis] outbreak occurs from food in certain areas, what type of [preventive measures = àdàpọ̀ àṣàpẹrẹ̀] should we implement for the [research samples = àkànlọ́ àpòòtọ̀] collected in the laboratory?”\n</step1>\n<step2>\nFirst, it’s important to understand that Salmonella gastroenteritis is caused by consuming contaminated food — *oúnjẹ̀ tó ní àrùn*.\n</step2>\n<step3>\nPreventive measures include proper handling and storage of food samples — *ìtọ́jú to peye* — to avoid further contamination.\n</step3>\n<step4>\nIn the lab, we should ensure that samples are kept at safe temperatures — *ìtọ́jú ìtura* — to inhibit bacterial growth.\n</step4>\n<step5>\nAdditionally, using sterile equipment and practicing good hygiene is crucial — *ìmọ̀ràn àtọ́kànwá* — to prevent cross-contamination.\n</step5>\n<step6>\nFinally, it’s essential to document all procedures and findings meticulously — *ìkọ̀wé gbogbo ìlànà àti àbájáde* — for accurate research outcomes.\n</step6></thinking>", "answer": "<answer>A gbọdọ̀ lo àdàpọ̀ àṣàpẹrẹ̀ tó dá lórí ìtọ́jú oúnjẹ̀, ìtọ́jú ìtura, àti ìmọ̀ràn àtọ́kànwá fún àkànlọ́ àpòòtọ̀.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 42 kan ni a mu wá sí ẹka pajawiri nipasẹ ọmọbinrin rẹ̀. Ó sọ pé baba rẹ̀ ti mu ọti lile gidigidi fún ọdun 16 sẹyin, ṣugbọn ó dẹkun ọjọ́ mẹrin sẹyin lẹhin tí ó pinnu lati dẹkun mimu ọti lori ọjọ́ibi rẹ̀. Ó tún sọ pé ó ti ń sọ̀rọ̀ nípa rírí awọn ọmọ ẹlẹ́dẹ̀ tí ń sáré ní yàrá rẹ̀ láti òwúrọ̀ yìí, bí ó tilẹ̀ jẹ́ pé kò sí ọmọ ẹlẹ́dẹ̀ kan síbẹ̀. Kò sí itan-àkọ́kọ́ ti àìsàn eyikeyi tí a mọ̀ tàbí lílo ohun míì. Ní àyẹ̀wò ara, otutu rẹ̀ jẹ́ 38.4ºC (101.2ºF), ìṣiṣẹ́ ọkàn rẹ̀ jẹ́ 116/min, ẹ̀rù jẹ́ 160/94 mm Hg, ati ìṣiṣẹ́ ẹ̀dùn jẹ́ 22/min. Ó binu gidigidi, kò sì mọ̀ orukọ rẹ̀, akoko, tàbí ibi tí ó wà. Ní àyẹ̀wò ara, ìgbona ara púpọ̀ ati awọn iwariri wà. Ẹ̀yà wo ni ó ṣàpẹẹrẹ daradara julọ si ọ̀nà àìsàn tí ó fa ipo rẹ̀?\nA. Iṣiṣẹ́ GABA tí ó pọ̀ sí i\nB. Iṣiṣẹ́ awọn ongbẹ NMDA tí ó pọ̀ sí i\nC. Idinku iṣiṣẹ́ norepinephrine tí ó pọ̀ sí i\nD. Idinku iṣiṣẹ́ glutamate tí ó pọ̀ sí i", "reasoning": "<thinking><step1>\nThe question asks: \"Which mechanism best explains the condition of a 42-year-old man who was brought to the emergency department?\" It mentions symptoms like confusion, high temperature, and hallucinations — *iwariri*.\n</step1>\n<step2>\nThe patient has a history of heavy alcohol use, which can lead to withdrawal symptoms after cessation — *àìlera mimu ọti*.\n</step2>\n<step3>\nGiven that he has confusion and hallucinations, this suggests a possible alcohol withdrawal delirium — *delirium tremens*.\n</step4>\n<step4>\nIn alcohol withdrawal, neurotransmitter systems are affected, particularly GABA and glutamate. Increased glutamate activity can lead to excitotoxicity — *iṣẹ́ glutamate*.\n</step5>\n<step5>\nAmong the options, increased glutamate activity (D) is most relevant, as it correlates with the symptoms of agitation and confusion seen in withdrawal.\n</step6>\nThus, the mechanism that best explains his condition is related to increased glutamate activity.\n</step6></thinking>", "answer": "<answer>Idinku iṣiṣẹ́ glutamate tí ó pọ̀ sí i.</answer>", "language": "Yoruba"}
{"question": "Kí ni àpẹẹrẹ ìfìwéránṣẹ́ méjì-nínú-ọ̀kan níbi tí ọ̀rọ̀ ènìyàn ti tako ohùn tàbí ìṣesí ara wọn?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àpẹẹrẹ [ìfìwéránṣẹ́ méjì-nínú-ọ̀kan = double entendre] níbi tí ọ̀rọ̀ ènìyàn [tako = oppose] ohùn tàbí [ìṣesí ara = body language] wọn?” — meaning it seeks examples of double entendres where people oppose their words or body language.\n</step1>\n<step2>\nA double entendre is a phrase that has two meanings, one of which is often risqué or ironic — *àpẹẹrẹ kan ni pé, ẹni le sọ pé “Mo fẹ́ràn rẹ, ṣugbọn…”* which can imply affection but also a hidden agenda.\n</step2>\n<step3>\nIn communication, when someone says one thing but their body language suggests the opposite — *nígbà tí ohùn wọn sọ pé “Mo wà pẹ̀lú rẹ,” ṣugbọn ìṣesí ara wọn fihan pé wọn kò nífẹ̀ẹ́*.\n</step3>\n<step4>\nFor instance, a person might smile while saying they are happy, yet their crossed arms indicate discomfort — *àpẹẹrẹ yìí fihan ìfìwéránṣẹ́ méjì-nínú-ọ̀kan*.\n</step4>\n<step5>\nAnother example could be someone saying, “I’m fine,” while avoiding eye contact — *ìfìwéránṣẹ́ yìí jẹ́ àpẹẹrẹ ti ìtànkálẹ̀ àìlera*.\n</step5>\n<step6>\nThus, double entendres can reveal contradictions between verbal and non-verbal cues, highlighting the complexity of human communication.\n</step6></thinking>", "answer": "<answer>Àpẹẹrẹ ìfìwéránṣẹ́ méjì-nínú-ọ̀kan ni ẹni tó sọ pé “Mo fẹ́ràn rẹ,” ṣugbọn ìṣesí ara wọn fihan pé wọn kò nífẹ̀ẹ́.</answer>", "language": "Yoruba"}
{"question": "Nigba ayẹwo ara ti akọni agbara ọkunrin ọlọdun mẹrindilogun ti o ni tendinopathy ti ori gigun ti biceps ti a fihan pẹlu rediogirafi, nibo ni irora maa n ni rilara nigba ti ejika ba n ṣiṣẹ agbara?", "reasoning": "<thinking><step1>\nThe question asks: “Nigba ayẹwo ara ti akọni agbara ọkunrin ọlọdun mẹrindilogun ti o ni [tendinopathy = tendinopathy] ti ori gigun ti [biceps = biceps] ti a fihan pẹlu [rediogirafi = radiography], nibo ni irora maa n ni rilara?” — meaning it wants to know where pain is felt during strength testing of the shoulder in a 14-year-old male with biceps tendinopathy shown on radiography.\n</step1>\n<step2>\nIn tendinopathy, the tendon becomes inflamed or degenerated — *tendon naa n ni irora* and may cause pain during movement.\n</step2>\n<step3>\nWhen testing strength in the shoulder, the biceps tendon is particularly stressed — *tendon biceps naa n ṣiṣẹ* to lift the arm.\n</step3>\n<step4>\nPain is typically felt in the front of the shoulder — *ni iwaju ejika*, where the biceps tendon attaches to the shoulder joint.\n</step4>\n<step5>\nThis pain can be exacerbated by activities that involve lifting or pulling — *ninu awọn iṣẹ ti o ni lifting tabi pulling*.\n</step5>\n<step6>\nTherefore, during strength testing, the patient will likely report pain in the anterior shoulder region — *ni agbegbe iwaju ejika*.\n</step6></thinking>", "answer": "<answer>Irora maa n ni rilara ni agbegbe iwaju ejika nigba ti ejika ba n ṣiṣẹ agbara.</answer>", "language": "Yoruba"}
{"question": "Positron tí o rìn lọra pupọ kan ṣe ibaraẹnisọrọ pẹlu electron tí ó dúró.  Ewo ninu awọn ọrọ atẹle ṣapejuwe abajade ti o ṣeeṣe ti iṣe yii daradara ati idi ti yoo ṣẹlẹ?\nA. Itọju agbara gbigbe sọ pe iṣe naa le ja si awọn onigun mẹta ti o jọra ti n gbe ni awọn itọsọna oriṣiriṣi.\nB. Itọju iwọn apẹrẹ fihan pe ti eyikeyi patikulu tuntun ba ṣẹda ninu iṣe naa, o gbọdọ ni iwọn gbogbo ti o jẹ iwọntunwọnsi ti awọn iwọn electron ati positron.\nC. Itọju agbara gbigbe fihan pe awọn onigun meji ti o jọra ti o n gbe kuro ni awọn itọsọna ti o yato si le ṣẹda.\nD. Itọju iwọn apẹrẹ fihan pe iṣe naa ko le ṣẹlẹ nitori awọn iwọn electron ati positron yatọ pupọ.\nE. Itọju agbara fihan pe iṣe naa yoo ja si positron naa ni gbigba agbara gbigbe ati electron naa yoo maa dúró.\nF. Itọju agbara ina fihan pe iṣe naa yoo ṣẹda patikulu tuntun kan pẹlu agbara ina rere.\nG. Itọju iwọn apẹrẹ fihan pe iṣe naa yoo ja si ṣiṣẹda patikulu tuntun kan pẹlu iwọn ti o tobi ju awọn iwọn electron ati positron.\nH. Itọju agbara ina fihan pe gbogbo awọn patikulu tuntun ti a ṣẹda ninu iṣe naa kii yoo ni agbara ina.\nI. Itọju agbara fihan pe positron antimatter le run sinu agbara, o fi electron ti o dúró silẹ.\nJ. Itọju agbara fihan pe iṣe naa yoo ja si ṣiṣẹda onigun kan.", "reasoning": "<thinking><step1>\nThe question asks about the interaction between a positron and a stationary electron, specifically which statement describes the possible outcome of this interaction well and why it would occur.\n</step1>\n<step2>\nIn particle physics, when a positron interacts with an electron, they can annihilate each other — *aniyàn* — resulting in energy release, typically in the form of photons.\n</step2>\n<step3>\nThe relevant principle here is conservation of energy and momentum — *itọju agbara ati iwọn*. This means that the total energy before and after the interaction must remain constant.\n</step4>\n<step4>\nAmong the options, statement I mentions that positron antimatter can annihilate into energy, leaving the stationary electron — *electron ti o dúró* — which aligns with the principles of particle interactions.\n</step5>\n<step5>\nThis annihilation process is a fundamental aspect of how matter and antimatter interact, leading to the creation of energy in the form of gamma rays.\n</step6>\n<step6>\nThus, the correct answer is that the interaction results in the positron annihilating into energy, leaving the electron unchanged.\n</step6></thinking>", "answer": "<answer>Itọju agbara fihan pe positron antimatter le run sinu agbara, o fi electron ti o dúró silẹ.</answer>", "language": "Yoruba"}
{"question": "Àpèjúwe àwọn ìwádìí ìwádìí Spitz ní ọdún 1945 lórí ipa àìní ìrírí àwọn ìmọ̀ràn àti àwọn ènìyàn ní ọmọdé. Ìpinnu wo ni Spitz dé nípa ipa rẹ̀ lórí idagbasoke déédéé?", "reasoning": "<thinking><step1>\nThe question asks: “Àpèjúwe àwọn ìwádìí [Spitz studies] ní ọdún 1945 lórí ipa [impact] àìní ìrírí [lack of experience] àwọn ìmọ̀ràn [caregivers] àti àwọn ènìyàn [people] ní ọmọdé [children].” It seeks to summarize Spitz's findings on the effects of caregiver absence on child development.\n</step1>\n<step2>\nSpitz conducted research showing that children who lacked consistent caregivers experienced significant emotional and developmental delays — *àìlera ẹdá àti ìdàgbàsókè*.\n</step2>\n<step3>\nHe observed that these children often displayed signs of distress, such as withdrawal and failure to thrive — *ìfarapa, ìkópa, àti àìlera* in their social interactions.\n</step3>\n<step4>\nSpitz concluded that the absence of nurturing relationships leads to *ìdàgbàsókè àìlera* and can severely impact a child's emotional health.\n</step4>\n<step5>\nHis work emphasized the importance of stable attachments, suggesting that *ìbáṣepọ̀ tó dára* with caregivers is crucial for healthy development.\n</step5>\n<step6>\nThus, Spitz's findings highlight that a lack of caregiver presence can lead to long-term negative effects on a child's growth and emotional well-being — *ìlera ọpọlọ*.\n</step6></thinking>", "answer": "<answer>Ìwádìí Spitz fi hàn pé àìní ìrírí àwọn ìmọ̀ràn nípa àìlera ẹdá àti ìdàgbàsókè àwọn ọmọdé, tó sì ní ipa tó lágbára lórí ìlera wọn.</answer>", "language": "Yoruba"}
{"question": "Lẹhin ibajẹ egungun apá ọwọ́ (humerus), ewo ni o ṣe pataki julọ ninu sisọda egungun tuntun ti yoo sopọ awọn ẹya meji naa papọ?\nA. Egungun cancellous\nB. Cailage\nC. Egungun Compact\nD. Periosteum", "reasoning": "<thinking><step1>\nThe question asks: “Lẹhin ibajẹ egungun apá ọwọ́ (humerus), ewo ni o ṣe pataki julọ ninu sisọda egungun tuntun ti yoo sopọ awọn ẹya meji naa papọ?” — meaning it wants to know which structure is most important in healing a fractured humerus.\n</step1>\n<step2>\nWhen a bone like the humerus is fractured, the body initiates a healing process that involves several key components — *awọn eroja pataki*.\n</step2>\n<step3>\nOne crucial aspect of bone healing is the formation of new bone tissue, which can involve different types of bone — *egungun*.\n</step3>\n<step4>\nCancellous bone, or *egungun cancellous*, is known for its spongy structure and is important in the healing process due to its ability to support new blood vessel growth — *ilọsiwaju awọn ẹjẹ tuntun*.\n</step4>\n<step5>\nCompact bone, or *egungun compact*, provides strength but is less involved in the initial healing phase compared to cancellous bone.\n</step5>\n<step6>\nThe periosteum, or *periosteum*, is a layer that covers the bone and plays a role in healing by providing a source of cells for new bone formation — *ilana fun formation egungun tuntun*.\n</step6>\n<step7>\nHowever, the most critical component in the early stages of healing is the cancellous bone, as it facilitates the connection between the fractured ends — *sopọ awọn ẹya meji naa papọ*.\n</step7></thinking>", "answer": "<answer>Egungun cancellous ni o ṣe pataki julọ ninu sisọda egungun tuntun ti yoo sopọ awọn ẹya meji naa papọ.</answer>", "language": "Yoruba"}
{"question": "Ṣe apejuwe iyoku ti jara naa, rii daju pe awon awo igbẹkẹle ti wa ni pipade daradara.  Input: ( ) ( [ [ ] ] ) ( { [ { < { ( ) < [ [ < > { [ ( < ( < [ { < < ( [ ( ) ] [ ( < ( { [ ] } ) > ) ] [ < > ] ) > [ { ( < > ) } ] > } ] > ) > ) ] } ] ] > { } [ [ ] ] { } } > ( ( < > ) ) } ] }", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe apejuwe iyoku ti jara naa, rii daju pe awon awo igbẹkẹle ti wa ni pipade daradara?” — which translates to \"Describe the remaining part of the jar, ensuring that the reliable covers are properly closed.\"\n</step1>\n<step2>\nTo address this, we first need to understand what is meant by \"iyoku ti jara naa\" — the remaining part of the jar. This implies we are discussing the contents or the state of the jar.\n</step2>\n<step3>\nNext, \"awon awo igbẹkẹle\" refers to the reliable covers or lids. It is crucial that these lids are securely closed to prevent any spillage or contamination — *ki o ma ba a ti wa ni idibajẹ*.\n</step3>\n<step4>\nIn practical terms, we should check that the lids are tightly sealed — *ri daju pe awon awo naa ti wa ni pipade daradara* — to maintain the integrity of the contents.\n</step4>\n<step5>\nIf the jar contains liquids, for example, it is essential to ensure that there are no leaks — *ki o ma si awọn ikoko ti o le fa idibajẹ*.\n</step5>\n<step6>\nThus, the description of the remaining part of the jar should emphasize the importance of the covers being properly closed to ensure safety and preservation.\n</step6></thinking>", "answer": "<answer>Iyoku ti jara naa gbọdọ jẹ ki awon awo igbẹkẹle ti wa ni pipade daradara lati daabobo akoonu rẹ.</answer>", "language": "Yoruba"}
{"question": "Àpọnà kan farahàn pẹ̀lú ìṣẹ̀lẹ̀ sí ìyàtọ̀ ìwọ̀n ojú mejeeji, àìfarabalẹ̀ sí ooru àti ìṣẹ̀lẹ̀ ọkàn títì; àyẹ̀wò tó bá yẹ̀ julọ níbí yóò jẹ́:\nA. Àrùn Hashimoto ti àyà\nB. Àrùn àyà\nC. Ìṣòro àyà gbogbo\nD. Àrùn Reidel ti àyà", "reasoning": "<thinking><step1>\nThe question translates to: \"A condition characterized by both bilateral eye symptoms, insensitivity to heat, and persistent heart events; the most appropriate examination here would be:\" — it is asking for a diagnosis based on specific symptoms.\n</step1>\n<step2>\nThe symptoms include *ìṣẹ̀lẹ̀ sí ìyàtọ̀ ìwọ̀n ojú mejeeji* (bilateral eye symptoms) and *àìfarabalẹ̀ sí ooru* (insensitivity to heat), which suggests a systemic issue rather than a localized one.\n</step2>\n<step3>\nThe mention of *ìṣẹ̀lẹ̀ ọkàn títì* (persistent heart events) indicates a potential autoimmune or endocrine disorder affecting multiple systems.\n</step3>\n<step4>\nAmong the options, *Àrùn Hashimoto ti àyà* (Hashimoto's disease) is an autoimmune condition that can lead to hypothyroidism, which may explain the heat insensitivity and heart issues.\n</step5>\n<step5>\nIn contrast, *Àrùn àyà* (liver disease) and *Ìṣòro àyà gbogbo* (general heart problems) do not directly correlate with the eye symptoms and heat insensitivity as clearly as Hashimoto's.\n</step6>\n<step6>\n*Àrùn Reidel ti àyà* (Reidel's disease) is less common and typically presents with different symptoms, making it a less likely candidate.\n</step7>\n<step7>\nThus, the most fitting diagnosis considering all symptoms is *Àrùn Hashimoto ti àyà*.\n</step7></thinking>", "answer": "<answer>Àrùn Hashimoto ti àyà.</answer>", "language": "Yoruba"}
{"question": "Ní ọ̀ràn ọmọbìnrin ọdún márùn-ún kan tí ó ní E. coli pyelonephritis tí ó ṣì ní iba lẹ́yìn ọjọ́ mẹ́rin ti ìtọ́jú onígbàgbọ́ pẹ̀lú oògùn aró, àti fíìmù tí ó fi hàn àyè tí ó dàbí ẹ̀gbà kan nínú kídínì rẹ̀ pẹ̀lú ìyípadà kékeré nínú ìfàámọ̀, ṣùgbọ́n kò sí àpòòtọ̀, ìgbésẹ̀ ìtọ́jú wo ni ó yẹ?", "reasoning": "<thinking><step1>\nThe question asks: “What treatment steps should be taken for a [omọbìnrin = girl] aged five who has E. coli [pyelonephritis = pyelonephritis] and still has fever after four days of faith-based treatment with herbal medicine, and shows a film that resembles a [ẹ̀gbà = abscess] in her kidney with slight changes in her [ìfàámọ̀ = urinalysis], but no [àpòòtọ̀ = obstruction]?” \n</step1>\n<step2>\nFirst, it's important to recognize that E. coli pyelonephritis can lead to serious complications if not treated properly — *pyelonephritis E. coli le fa awọn iṣoro to ṣe pataki ti a ko ba tọju rẹ daradara*.\n</step2>\n<step3>\nSince the girl has had a fever for four days, this indicates that the infection may not be resolving — *ìbànújẹ́ náà le jẹ́ pé àìlera naa kò tii parí*.\n</step4>\n<step4>\nThe presence of an abscess-like structure in the kidney suggests that there may be a need for further intervention, possibly surgical — *ìfarapa le jẹ́ dandan, boya iṣẹ́ abẹ́*.\n</step5>\n<step5>\nAdditionally, the slight changes in urinalysis could indicate ongoing infection or inflammation, necessitating a reevaluation of her treatment — *ìfàámọ̀ rẹ̀ le fihan pé àìlera naa ṣi wa, ti o nilo ayẹwo tuntun*.\n</step6>\n<step6>\nTherefore, the appropriate treatment steps would include hospitalization for intravenous antibiotics and possibly imaging studies to assess the abscess — *ìtọ́jú ni ile-iwosan pẹlu awọn oògùn amúnibẹ́rẹ́ ati awọn iwadii aworan lati ṣe ayẹwo ẹ̀gbà*.\n</step7>\n<step7>\nIn summary, immediate medical intervention is crucial to prevent further complications — *ìtọ́jú iṣoogun lẹsẹkẹsẹ jẹ́ pataki lati yago fun awọn iṣoro siwaju*.\n</step8></thinking>", "answer": "<answer>Ìtọ́jú to yẹ ni lati gbe ọmọbìnrin naa lọ sí ile-iwosan fun ìtọ́jú amúnibẹ́rẹ́, pẹlu ayẹwo aworan lati ṣe ayẹwo ẹ̀gbà.</answer>", "language": "Yoruba"}
{"question": "Kini àyẹ̀wò fun aláìsàn kan tí ìwádìí manometry esophageal fi hàn pé ó ní panesophageal pressurization àti agbara ìdènà ìkẹhin tí ó ju 450mm Hg lọ ní ara rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Kini àyẹ̀wò fun aláìsàn kan tí ìwádìí [manometry esophageal = esophageal manometry] fi hàn pé ó ní [panesophageal pressurization = panesophageal pressurization] àti [agbara ìdènà ìkẹhin = lower esophageal sphincter pressure] tí ó ju 450mm Hg lọ ní ara rẹ̀?” — meaning it wants to know the implications of esophageal manometry findings showing high pressure.\n</step1>\n<step2>\nEsophageal manometry measures the pressure and pattern of muscle contractions in the esophagus — *ó ṣe pataki fun ìtẹ́numọ̀ àìlera* like dysphagia or gastroesophageal reflux disease (GERD).\n</step2>\n<step3>\nA high panesophageal pressurization indicates increased pressure throughout the esophagus, which can lead to *ìṣòro ìjẹun* or swallowing difficulties.\n</step3>\n<step4>\nThe lower esophageal sphincter pressure being over 450 mm Hg suggests a potential *ìdènà* or obstruction, which may cause reflux or other complications.\n</step4>\n<step5>\nIn clinical terms, this could be associated with conditions like achalasia or other motility disorders — *àìlera ìmúra*.\n</step5>\n<step6>\nThus, the findings suggest significant esophageal dysfunction that may require further evaluation or treatment — *ìwádìí àtúnṣe*.\n</step6></thinking>", "answer": "<answer>Àyẹ̀wò yìí fihan pé aláìsàn náà ní ìṣòro ìmúra esophagus, tí ó lè fa dysphagia tàbí reflux gastroesophageal.</answer>", "language": "Yoruba"}
{"question": "Ni irú ipò alaisan tí ó ṣe akiyesi pé òun ní ìṣoro ìmu ọtí, ṣugbọn kò ní ìfẹ́ lati ṣe ohunkóhun nípa rẹ̀, ìpele iyipada wo ni ipò yìí ṣe afihan julọ ninu àpòtí ìyípadà ihuwasi transtheoretical?", "reasoning": "<thinking><step1>\nThe question asks: “Ni irú ipò alaisan tí ó ṣe akiyesi pé òun ní ìṣoro ìmu ọtí, ṣugbọn kò ní ìfẹ́ lati ṣe ohunkóhun nípa rẹ̀?” — meaning it wants to know what stage of the transtheoretical model of behavior change applies to someone who recognizes they have a drinking problem but is not motivated to take action.\n</step1>\n<step2>\nIn the transtheoretical model, there are several stages, including precontemplation, contemplation, preparation, action, and maintenance. Here, the individual is aware of their issue — *ní ìmọ̀ nípa iṣoro wọn* — but lacks the desire to change.\n</step2>\n<step3>\nThis lack of motivation indicates that they are not yet ready to take action, which aligns with the precontemplation stage — *ipò àkọ́kọ́*.\n</step3>\n<step4>\nIn this stage, individuals may deny the problem or feel ambivalent about change — *kò ní ìfẹ́ lati yipada* — even when they recognize the issue.\n</step5>\n<step5>\nThus, the person is stuck in a mindset where they acknowledge the drinking problem but do not see the need for immediate action — *kò ní ìfẹ́ lati ṣe ohunkóhun*.\n</step6>\n<step6>\nTherefore, the most representative stage for this situation is precontemplation.\n</step6></thinking>", "answer": "<answer>Ipò alaisan yìí ṣe afihan ipò àkọ́kọ́ ninu àpòtí ìyípadà ihuwasi transtheoretical.</answer>", "language": "Yoruba"}
{"question": "Ninu ipo aisan ti a mọ̀ sí Hirschsprung, irú iru ara sẹẹli afọwọṣe wo ni kò sí, tí ó sì ń fa kí àpòòpò yípo?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu ipo aisan ti a mọ̀ sí [Hirschsprung = Hirschsprung disease], irú iru ara sẹẹli [afọwọṣe = cells] wo ni kò sí, tí ó sì ń fa kí àpòòpò yípo?” — meaning it wants to know what type of cells are absent in Hirschsprung disease and how this leads to bowel obstruction.\n</step1>\n<step2>\nHirschsprung disease is characterized by the absence of *les cellules ganglionnaires* in the colon, which are essential for bowel motility.\n</step2>\n<step3>\nThese ganglion cells, or *cellules nerveuses*, are responsible for coordinating the contractions of the intestines — *les contractions intestinales*.\n</step3>\n<step4>\nWithout these cells, the affected segment of the colon cannot relax, leading to a condition called *obstruction intestinale*.\n</step4>\n<step5>\nThis results in a buildup of stool, causing *une distension abdominale* and discomfort.\n</step5>\n<step6>\nIn summary, the absence of ganglion cells in Hirschsprung disease leads to severe bowel obstruction due to the lack of proper nerve signaling.\n</step6></thinking>", "answer": "<answer>Ninu ipo aisan ti a mọ̀ sí Hirschsprung, ara sẹẹli afọwọṣe ti kò sí ni *cellules ganglionnaires*, tí ó ń fa kí àpòòpò yípo.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọmọ ọdun mejileladojeeni (72) ni a ti ṣe ayẹwo àrùn jẹjẹrẹ ẹ̀dọ̀fóró kékeré tí kò tíì tàn káàkiri, tí a ṣe àfihàn rẹ̀ pẹ̀lú èèmọ̀ 2.5 cm ní ìsàlẹ̀ ẹ̀dọ̀fóró ọ̀tún, àti pé ó ti kan àwọn èèmọ̀ omi ara tí ó wà ní ẹ̀gbẹ́ kan náà, ṣùgbọ́n kò tíì tàn dé àwọn ẹ̀yà ara jíjìnnà réré.  Aláìsàn náà yẹ fún ìtọ́jú líle koko nítorí kò sí ohun tí ó lè dí ìtọ́jú pẹ̀lú èròjà kemika tàbí ìtànṣán dúró, àti pé ipò ìlera rẹ̀ dára.  Nítorí àwọn nǹkan wọ̀nyí, kí ni ìtọ́jú tó yẹ jùlọ fún aláìsàn yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ìtọ́jú tó yẹ jùlọ fún aláìsàn yìí?” — meaning it wants to know the most appropriate treatment for a 72-year-old man diagnosed with a small liver tumor [àrùn jẹjẹrẹ ẹ̀dọ̀fóró kékeré].\n</step1>\n<step2>\nThe tumor is 2.5 cm in size and located in the right lobe of the liver [ìsàlẹ̀ ẹ̀dọ̀fóró ọ̀tún], which indicates it is still localized and has not spread to distant organs.\n</step2>\n<step3>\nGiven that the patient is suitable for aggressive treatment [ìtọ́jú líle koko], options like surgery or localized therapies should be considered first.\n</step3>\n<step4>\nSurgical resection [ìyapa] could be an option if the tumor is operable and the patient's overall health is good, as stated in the question.\n</step4>\n<step5>\nIf surgery is not feasible, other treatments like radiofrequency ablation [ìtànṣán dúró] or transarterial chemoembolization might be appropriate.\n</step5>\n<step6>\nSince the patient has no significant comorbidities and his health status is good, aggressive treatment is warranted to ensure the best outcome.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú tó yẹ jùlọ fún aláìsàn yìí ni ìyapa tàbí ìtànṣán dúró.</answer>", "language": "Yoruba"}
{"question": "Kini àìsàn tí ó wọ́pọ̀ jùlọ tó máa ń fa ìṣẹ̀dá ìgbẹ́ ìka ọwọ́ ní ọkùnrin ọdún méjìlélógójì kan?", "reasoning": "<thinking><step1>\nThe question asks: “Kini àìsàn tí ó wọ́pọ̀ jùlọ tó máa ń fa ìṣẹ̀dá ìgbẹ́ ìka ọwọ́ ní ọkùnrin ọdún méjìlélógójì kan?” — meaning it wants to know what the most common disease that causes hand tremors in a 50-year-old man is.\n</step1>\n<step2>\nIn English, hand tremors can be caused by various conditions, but one of the most prevalent is *Parkinson's disease* — *àìsàn Parkinson*.\n</step2>\n<step3>\nParkinson's disease is a neurodegenerative disorder that affects movement — *àìsàn ti n fa ìyípadà ninu ìmúlò*.\n</step3>\n<step4>\nSymptoms include resting tremors, stiffness, and bradykinesia — *ìkànsí, ìdàgbàsókè, àti ìdàgbàsókè tó lọra*.\n</step4>\n<step5>\nIn men around the age of 50, the onset of Parkinson's can lead to noticeable hand tremors — *ìgbẹ́ ìka ọwọ́* that may worsen over time.\n</step5>\n<step6>\nOther conditions like essential tremor or thyroid issues exist, but Parkinson's is the most common in this demographic.\n</step6></thinking>", "answer": "<answer>Àìsàn Parkinson ni àìsàn tí ó wọ́pọ̀ jùlọ tó máa ń fa ìgbẹ́ ìka ọwọ́ ní ọkùnrin ọdún méjìlélógójì kan.</answer>", "language": "Yoruba"}
{"question": "Da ṣiṣẹ́ ṣiṣe gbigba glucose sinu inu inu inu, kini ọ̀rọ̀ òtítọ́ kan nipa iye glucose ti o wa ni ominira laarin lumen inu ati awọn sẹẹli inu?", "reasoning": "<thinking><step1>\nThe question asks: “Da ṣiṣẹ́ ṣiṣe gbigba glucose sinu inu inu inu” — which translates to “How does glucose absorption occur in the intestines?” It specifically inquires about the concentration of glucose in the lumen and within the cells.\n</step1>\n<step2>\nGlucose absorption primarily occurs in the small intestine — *inu kekere*. The epithelial cells lining the intestine facilitate this process.\n</step2>\n<step3>\nIn the lumen, glucose concentration is influenced by dietary intake and the rate of absorption — *iyipada ti o wa ni inu* versus *iyipada ti o wa ninu awọn sẹẹli*.\n</step3>\n<step4>\nTransport proteins, such as SGLT1, help move glucose from the lumen into the cells — *sẹẹli*. This process is driven by sodium gradients.\n</step4>\n<step5>\nOnce inside the cells, glucose can be used for energy or stored as glycogen — *glicojeni*. The balance between glucose in the lumen and inside the cells is crucial for maintaining homeostasis.\n</step5>\n<step6>\nTherefore, the concentration of glucose in the lumen is typically higher immediately after a meal, while inside the cells, it varies based on metabolic needs — *a nilo agbara*.\n</step6></thinking>", "answer": "<answer>Iye glucose ni lumen jẹ giga lẹhin ounje, ṣugbọn o yatọ ni awọn sẹẹli da lori awọn aini agbara.</answer>", "language": "Yoruba"}
{"question": "Labẹ ipo wo tí ó ní í ṣe pẹ̀lú ọtí mímu ni a ka ẹnìkan sí ẹni tí ó ṣeé gbẹ̀sẹ̀ lé lórí ìwà ọ̀daràn rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Labẹ ipo wo tí ó ní í ṣe pẹ̀lú [ọtí mímu = drinking alcohol] ni a ka ẹnìkan sí [eni tí ó ṣeé gbẹ̀sẹ̀ lé lórí ìwà ọ̀daràn rẹ̀ = someone who is responsible for their criminal behavior]?” — meaning it wants to know under what circumstances a person is considered responsible for their actions when influenced by alcohol.\n</step1>\n<step2>\nWhen discussing responsibility, we must consider the concept of *ìmúlò ọtí* — how alcohol affects judgment and behavior.\n</step2>\n<step3>\nIn legal terms, if someone is intoxicated, *ti ẹnìkan bá ti mu ọtí tó pọ̀*, it may impair their ability to make rational decisions.\n</step3>\n<step4>\nHowever, the law often holds individuals accountable regardless of intoxication, unless they can prove that their judgment was severely compromised — *ti wọn bá le fi hàn pé ìmúlò ọtí ti fa àìlera*.\n</step4>\n<step5>\nFor example, if a person commits a crime while under the influence, *bí ẹnìkan bá ṣe ẹṣẹ nígbà tí ó ti mu ọtí*, they may still face charges unless they can demonstrate a lack of intent due to intoxication.\n</step5>\n<step6>\nThus, the context of the crime and the level of intoxication are crucial in determining responsibility — *ìpinnu yìí dá lórí ipo ẹṣẹ àti ìmúlò ọtí*.\n</step6></thinking>", "answer": "<answer>Labẹ ipo ti ọtí mímu, ẹnìkan le jẹ́ ẹni tí ó ṣeé gbẹ̀sẹ̀ lé lórí ìwà ọ̀daràn rẹ̀, ayafi ti wọn bá le fi hàn pé ìmúlò ọtí ti fa àìlera.</answer>", "language": "Yoruba"}
{"question": "Nigbati a bá ń bẹ̀rẹ̀ sí í lo oogun warfarin ní ẹnu, ìṣòro ẹ̀jẹ̀ wo ni ó yára kùnà jùlọ nínú ẹ̀jẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Nigbati a bá ń bẹ̀rẹ̀ sí í lo [oogun warfarin = warfarin medication] ní ẹnu, ìṣòro ẹ̀jẹ̀ wo ni ó yára kùnà jùlọ nínú ẹ̀jẹ̀?” — meaning it wants to know what blood issue is most likely to occur when starting warfarin.\n</step1>\n<step2>\nWarfarin is an anticoagulant, which means it prevents blood clotting — *o n dènà ìkó ẹ̀jẹ̀*.\n</step2>\n<step3>\nWhen starting warfarin, the most common issue is bleeding — *ìfarapa* or excessive bleeding due to its blood-thinning effects.\n</step3>\n<step4>\nPatients may experience symptoms like easy bruising — *ìfarapa rọrùn* — or prolonged bleeding from cuts.\n</step4>\n<step5>\nMonitoring is crucial; healthcare providers often check INR levels — *ìwọn INR* — to ensure the blood is not too thin.\n</step5>\n<step6>\nIf the INR is too high, the risk of bleeding increases significantly — *ìkànsí ìfarapa*.\n</step6>\n<step7>\nThus, the primary concern when starting warfarin is the risk of bleeding complications — *ìṣòro ìfarapa*.\n</step7></thinking>", "answer": "<answer>Ìṣòro ẹ̀jẹ̀ tó yára kùnà jùlọ nígbà tí a bá ń bẹ̀rẹ̀ sí í lo warfarin ni ìfarapa.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mẹtadinlogun kan wá pẹlu pipadanu irun ti n pọ si, ti a ṣe apejuwe nipasẹ pipadanu irun ti ko ni igbona, ti o tan kaakiri ori, pẹlu iyọkuro bitemporal.  Pẹlu awọn ami aisan wọnyi ni lokan, oogun wo ni a gbọdọ fun lati toju ipo yii daradara?", "reasoning": "<thinking><step1>\nThe question asks: “What medication should be given to a 19-year-old man experiencing progressive hair loss, described as non-scarring hair loss, diffusely affecting the scalp with bitemporal recession?” — this indicates a concern for a specific type of hair loss.\n</step1>\n<step2>\nThe description suggests *alopecia androgenetica* or male pattern baldness, which is common in young men and characterized by thinning hair and receding hairline — *iyọkuro bitemporal*.\n</step2>\n<step3>\nIn such cases, medications like minoxidil are often recommended; it helps to stimulate hair growth — *o n mu ki irun dagba*.\n</step4>\n<step4>\nAnother option is finasteride, which works by inhibiting the hormone responsible for hair loss — *o n dènà homonu ti o fa pipadanu irun*.\n</step5>\n<step5>\nIt's important to consider the patient's age and potential side effects of these medications, but both are commonly used for treating this condition effectively.\n</step6>\n<step6>\nThus, for this 19-year-old man, *minoxidil* or *finasteride* would be appropriate treatments to manage his hair loss condition.\n</step6></thinking>", "answer": "<answer>Minoxidil tabi finasteride ni a gbọdọ fun lati toju ipo pipadanu irun yii.</answer>", "language": "Yoruba"}
{"question": "Da awọn aworan microscopi ti a pese, kini ayẹwo ikẹhin ni?", "reasoning": "<thinking><step1>\nThe question asks: “Da awọn aworan microscopi ti a pese, kini ayẹwo ikẹhin ni?” — which translates to “From the provided microscopic images, what is the final diagnosis?”\n</step1>\n<step2>\nTo determine the final diagnosis, we first need to analyze the microscopic images — *awọn aworan microscopi* — for any abnormalities or specific characteristics.\n</step2>\n<step3>\nCommon findings in such images might include *ìfarapa* (damage), *ìkànsí* (inflammation), or signs of infection — *àpẹẹrẹ, àkópọ̀ àkóràn*.\n</step3>\n<step4>\nNext, we compare these findings with known conditions — for instance, if we see *àkópọ̀ àkóràn*, it might suggest a bacterial infection.\n</step4>\n<step5>\nFinally, we synthesize all the information from the images and any clinical data available to arrive at a conclusion — *ayẹwo ikẹhin*.\n</step6>\n<step6>\nThus, the final diagnosis will depend on the specific findings observed in the microscopic images.\n</step6></thinking>", "answer": "<answer>Ayẹwo ikẹhin yoo dale lori awọn àwòrán microscopi ti a pese, ti o le fihan ìfarapa tabi àkópọ̀ àkóràn.</answer>", "language": "Yoruba"}
{"question": "Bakteria wo ni o maa n fa arun ọkan ti o ni ibatan si valve ti a fi sii ni igba diẹ lẹhin abẹrẹ (laarin osu meji)?", "reasoning": "<thinking><step1>\nThe question asks: “Bakteria wo ni o maa n fa arun ọkan ti o ni ibatan si valve ti a fi sii ni igba diẹ lẹhin abẹrẹ (laarin osu meji)?” — meaning it wants to know which bacteria can cause heart infections related to a valve placed shortly after an injection (within two months).\n</step1>\n<step2>\nInfections related to heart valves are often due to *bakteria* that enter the bloodstream — *sangre* — especially after medical procedures.\n</step2>\n<step3>\nCommon bacteria include *Staphylococcus aureus* and *Streptococcus viridans*, which can lead to *endocarditis* — an infection of the heart lining.\n</step3>\n<step4>\nThese bacteria can colonize the artificial valve, leading to serious complications — *iṣoro to ṣe pataki* if not treated promptly.\n</step5>\n<step5>\nRisk factors include poor dental hygiene or skin infections, which can introduce bacteria into the bloodstream — *bakteria le wọ inu ẹjẹ*.\n</step6>\n<step6>\nThus, the primary bacteria responsible for heart infections after valve placement are typically *Staphylococcus aureus* and *Streptococcus viridans*.\n</step6></thinking>", "answer": "<answer>Bakteria ti o maa n fa arun ọkan ni *Staphylococcus aureus* ati *Streptococcus viridans*.</answer>", "language": "Yoruba"}
{"question": "Alaisan kan wa pelu awon aisan inu, wiwu inu, ati irora inu.  MRI fihan pe awon eegun inu obinrin mejeeji ni kokoro pelu titan kaakiri si egungun inu ibadi ati egbo inu. Lati inu awon nnkan ti a ri yii, kini ipo ti kokoro inu obinrin yii wa?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ipo ti kokoro inu obinrin yii wa?” — meaning it wants to know the condition of the woman's internal organs based on the MRI findings.\n</step1>\n<step2>\nThe MRI shows that both ovaries have *kokoro* (infection) with *titan kaakiri* (widespread inflammation) affecting the pelvic area — *egungun inu ibadi* and *egbo inu* (internal organs).\n</step2>\n<step3>\nThis suggests a serious condition, possibly *apakan* (abscess) or *iyapa* (cyst) due to the inflammation.\n</step3>\n<step4>\nThe symptoms mentioned, like *wiwu inu* (abdominal pain) and *irora inu* (internal pain), indicate that the infection is causing significant discomfort.\n</step4>\n<step5>\nIn English, we would say that the presence of widespread inflammation and infection in the ovaries suggests a severe underlying issue that needs immediate attention.\n</step5>\n<step6>\nThus, the condition of the woman's internal organs is critical, indicating a possible *kokoro inu* that requires urgent medical intervention.\n</step6></thinking>", "answer": "<answer>Ipo ti kokoro inu obinrin yii wa ni pataki, ti o fihan pe o ni kokoro ati titan kaakiri ti o nilo itọju lẹsẹkẹsẹ.</answer>", "language": "Yoruba"}
{"question": "Ṣe ìṣirò agbára ìfàsẹ́yìn (drag force) tó ń ṣiṣẹ́ lórí pálíìbù (plate) dídán tí ìwọ̀n rẹ̀ jẹ́ 0.75 ft × 7 ft nígbà tí wọ́n bá fà á ní gígùn rẹ̀ lórí ojú omi tó dúró jẹ́ẹ́ pẹ̀lú ìyára (velocity) ti 25 ft/s. Fún omi \\rho (ìwúwo-inú-ìwọ̀n) = 62.4 lb/ft^3, ѵ (viscosity ìṣàn-kìnnìún) = 1.08 × 10^-5 ft^2/s.\nA. 6.9 lb_f\nB. 14.2 lb_f\nC. 11.3 lb_f\nD. 12.4 lb_f\nE. 10.5lb_f\nF. 8.27lb_f\nG. 5.6 lb_f\nH. 4.8 lb_f\nI. 9.1lb_f\nJ. 7.3lb_f", "reasoning": "<thinking><step1>\nThe question asks for the calculation of the drag force [ìṣirò agbára ìfàsẹ́yìn] acting on a plate [pálíìbù] with dimensions 0.75 ft × 7 ft when it is pulled through still water at a velocity [ìyára] of 25 ft/s.\n</step1>\n<step2>\nTo find the drag force, we can use the drag equation: *F_d = \\frac{1}{2} \\cdot C_d \\cdot \\rho \\cdot A \\cdot v^2*, where *C_d* is the drag coefficient, *ρ* is the fluid density, *A* is the reference area, and *v* is the velocity.\n</step2>\n<step3>\nAssuming a typical drag coefficient [C_d] for a flat plate is around 1.98, we first calculate the area [A] of the plate: *A = 0.75 ft × 7 ft = 5.25 ft²*.\n</step3>\n<step4>\nNext, we substitute the values into the drag equation: *F_d = \\frac{1}{2} \\cdot 1.98 \\cdot 62.4 lb/ft³ \\cdot 5.25 ft² \\cdot (25 ft/s)^2*.\n</step4>\n<step5>\nCalculating this gives us: *F_d = 0.5 × 1.98 × 62.4 × 5.25 × 625 = 11.3 lb_f*.\n</step5>\n<step6>\nThus, the drag force acting on the plate is approximately 11.3 lb_f.\n</step6></thinking>", "answer": "<answer>Ìṣirò agbára ìfàsẹ́yìn tó ń ṣiṣẹ́ lórí pálíìbù náà jẹ́ 11.3 lb_f.</answer>", "language": "Yoruba"}
{"question": "Tani yoo ṣeé ṣe lati ṣe ipinnu irora ti a ni nigba ibalopọ gẹgẹbi ijiya nitori ẹkọ iṣe wọn?", "reasoning": "<thinking><step1>\nThe question asks: “Tani yoo ṣeé ṣe lati ṣe ipinnu irora ti a ni nigba ibalopọ gẹgẹbi ijiya nitori ẹkọ iṣe wọn?” — meaning it wants to know who can help determine pain experienced during intercourse as a result of their training.\n</step1>\n<step2>\nPain during intercourse, or *irora nigba ibalopọ*, can be caused by various factors, including physical or psychological issues — *awọn iṣoro ti ara tabi ti ọkan*.\n</step2>\n<step3>\nA healthcare professional, such as a gynecologist or a sex therapist, is typically the best person to evaluate this pain — *dokita obinrin tabi onimọran ibalopọ*.\n</step4>\n<step4>\nThey can conduct a thorough examination and ask about the patient's history — *iwadii jinlẹ* — to identify the root cause of the pain.\n</step5>\n<step5>\nAdditionally, they may suggest treatments or therapies to alleviate the discomfort — *itọju tabi awọn ọna abuja*.\n</step6>\n<step6>\nIn summary, a qualified healthcare provider is essential for addressing *irora ibalopọ* effectively.\n</step6></thinking>", "answer": "<answer>Dokita obinrin tabi onimọran ibalopọ ni ẹni ti o le ṣe ipinnu irora ti a ni nigba ibalopọ.</answer>", "language": "Yoruba"}
{"question": "Ṣàbẹ̀wò bí àwọn ọ̀rọ̀-ìṣirò tí ó wà nínú Z[x] ṣe ń mú ìwòye Eisenstein ṣẹ̀ fún àìlọ́ṣẹ̀ lórí Q. x^2 - 12\nA. Bẹ́ẹ̀ni, pẹ̀lú p=4.\nB. Rárá, nítorí pé àwọn ọ̀rọ̀-ìṣirò náà ṣẹ̀ṣẹ̀ jáde.\nC. Bẹ́ẹ̀ni, pẹ̀lú p=1.\nD. Rárá, nítorí pé àwọn ọ̀rọ̀-ìṣirò náà kò mú ìwòye Eisenstein ṣẹ̀.\nE. Rárá.\nF. Bẹ́ẹ̀ni, pẹ̀lú p=12.\nG. Bẹ́ẹ̀ni, pẹ̀lú p=3.\nH. Bẹ́ẹ̀ni, pẹ̀lú p=5.\nI. Bẹ́ẹ̀ni, pẹ̀lú p=6.\nJ. Bẹ́ẹ̀ni, pẹ̀lú p=2.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣàbẹ̀wò bí àwọn ọ̀rọ̀-ìṣirò tí ó wà nínú Z[x] ṣe ń mú ìwòye Eisenstein ṣẹ̀ fún àìlọ́ṣẹ̀ lórí Q. x^2 - 12” — meaning it wants to know if the polynomial x^2 - 12 satisfies Eisenstein's criterion for irreducibility over the rationals [Q].\n</step1>\n<step2>\nEisenstein's criterion states that a polynomial is irreducible over Q if there exists a prime number p such that the coefficients of the polynomial meet specific conditions — *p* divides all coefficients except the leading one, and *p²* does not divide the constant term.\n</step2>\n<step3>\nFor the polynomial x^2 - 12, the coefficients are 1 (leading) and -12 (constant). We need to check various primes to see if they satisfy the criterion.\n</step3>\n<step4>\nIf we take p = 2, it divides -12 but not 1, and since 2² = 4 does not divide -12, this satisfies Eisenstein's criterion — *ìwòye Eisenstein*.\n</step5>\n<step5>\nHowever, we also need to check other primes like p = 3. Here, 3 divides -12 but not 1, and 3² = 9 does not divide -12, which also satisfies the criterion.\n</step6>\n<step6>\nThus, we can conclude that the polynomial x^2 - 12 is irreducible over Q, and we have found valid primes such as 2 and 3 that work.\n</step7>\n<step7>\nThe options provided include various primes, and since we found that p = 2 and p = 3 both satisfy the conditions, we can select the appropriate answers.\n</step8>\n<step8>\nThe correct answer is that the polynomial satisfies Eisenstein's criterion with p = 2 or p = 3.\n</step8></thinking>", "answer": "<answer>Bẹ́ẹ̀ni, pẹ̀lú p=2 àti p=3.</answer>", "language": "Yoruba"}
{"question": "Èlémenti ọ̀nà SVG yii <path d=\"M 98.96,92.35 L 44.27,28.27\"/> ṣe àtẹ̀jáde\nÀwọn àṣàyàn:\n(A) yíká\n(B) ọ̀nà méje-kùnrin\n(C) ọ̀nà mẹ́fà-kùnrin\n(D) afẹ́fẹ́\n(E) làìpì\n(F) ọ̀nà mẹ́jọ-kùnrin\n(G) ọ̀nà márùn-ún-kùnrin\n(H) àyàká\n(I) apá kan\n(J) kòtò", "reasoning": "<thinking><step1>\nThe question asks: “Èlémenti ọ̀nà SVG yii <path d=\"M 98.96,92.35 L 44.27,28.27\"/> ṣe àtẹ̀jáde?” — which translates to “What does this SVG path element represent?” \n</step1>\n<step2>\nThe SVG path command \"M\" indicates a move to a specific point, while \"L\" indicates a line to another point — *M* n tọka si ibi kan, *L* n tọka si ila kan.\n</step2>\n<step3>\nIn this case, the path starts at coordinates (98.96, 92.35) and draws a line to (44.27, 28.27) — *iyẹn ni pe, o n fa ila kan lati ibi kan si omiiran*.\n</step3>\n<step4>\nThis creates a straight line segment, which can be described as a geometric shape — *a ṣe apejuwe rẹ gẹgẹ bi apẹrẹ oníṣòwò*.\n</step5>\n<step5>\nAmong the options provided, the most fitting description for a straight line is \"ọ̀nà méje-kùnrin\" — which means \"seven-sided path\" but in this context, it refers to a simple line.\n</step5>\n<step6>\nThus, the SVG path represents a linear element, which can be interpreted as a basic geometric line.\n</step6></thinking>", "answer": "<answer>Ọ̀nà mẹ́fà-kùnrin.</answer>", "language": "Yoruba"}
{"question": "Ninu obinrin ọdun mẹtadinlogun kan ti a ń ṣayẹwo fun ailagbara lati lóyún, hysterosalpingography fihan irisi “bii ilẹkẹ” ti igbọn fallopian ati ikun ti ampulla. Kini idi ti o ṣeeṣe julọ fun awọn abajade wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “Kini idi ti o ṣeeṣe julọ fun awọn abajade wọnyi?” — meaning it wants to know the most likely reason for the findings in a 19-year-old woman undergoing hysterosalpingography (HSG) that shows a “bii ilẹkẹ” [like a butterfly] appearance of the fallopian tubes and ampulla.\n</step1>\n<step2>\nThe “bii ilẹkẹ” appearance typically indicates that the fallopian tubes are patent, meaning they are open and not blocked — *ti ko ni idiwọ*.\n</step2>\n<step3>\nIn a young woman, this finding could suggest that there are no structural abnormalities, which is a positive sign for fertility — *aami rere fun ibimọ*.\n</step3>\n<step4>\nHowever, it could also indicate conditions like *endometriosis* or *adhesions* that might not be visible on HSG but can affect fertility.\n</step4>\n<step5>\nAdditionally, the ampulla is the site where fertilization usually occurs, so its normal appearance is crucial for conception — *ibẹrẹ ibimọ*.\n</step6>\n<step6>\nThus, the most likely reason for these findings is that the fallopian tubes are functioning properly, allowing for the possibility of pregnancy — *iyẹn ni pe awọn igbọn fallopian n ṣiṣẹ daradara*.\n</step6></thinking>", "answer": "<answer>Idi ti o ṣeeṣe julọ fun awọn abajade wọnyi ni pe awọn igbọn fallopian n ṣiṣẹ daradara, ti o funni ni anfani fun ibimọ.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 45 kan ti a ti yọ́ ìṣẹ̀dá arun kúrò ní apá parietal ọpọlọ rẹ̀ ní ọdún 2 sẹ́yìn, nísinsìnyí ó ń ṣe àrùn orí, ògbólógbòó, àti ìdinku ìṣe-ọkàn. Nínú ipò iṣẹ́-ògùṣọ̀ yìí, ṣe àyẹ̀wò fíìmù ìbẹ̀rẹ̀ wo ni ó yẹ jùlọ láti ṣe?", "reasoning": "<thinking><step1>\nThe question asks: “Obirin ọdun 45 kan ti a ti yọ́ ìṣẹ̀dá arun kúrò ní apá parietal ọpọlọ rẹ̀ ní ọdún 2 sẹ́yìn” — meaning a 45-year-old woman who had a [tumor = ìṣẹ̀dá arun] removed from her parietal lobe two years ago is now experiencing headaches, dizziness, and cognitive decline.\n</step1>\n<step2>\nIn this context, the symptoms suggest possible complications or recurrence of the tumor — *àìlera* or *ìyípadà* in her condition.\n</step2>\n<step3>\nThe most relevant imaging study to evaluate her current state would be an MRI — *ìmúlẹ̀ àwòrán MRI* — as it provides detailed images of the brain.\n</step3>\n<step4>\nAn MRI can help identify any new lesions or changes in the brain structure — *àwọn ayipada ninu ìkànsí ọpọlọ* that could explain her symptoms.\n</step4>\n<step5>\nAdditionally, it is important to assess for any signs of increased intracranial pressure — *ìkànsí àtẹ́gùn* — which could also contribute to her headaches and dizziness.\n</step5>\n<step6>\nThus, an MRI is the most appropriate initial imaging study to conduct in this case.\n</step6></thinking>", "answer": "<answer>Ìmúlẹ̀ àwòrán MRI ni fíìmù ìbẹ̀rẹ̀ tó yẹ jùlọ láti ṣe.</answer>", "language": "Yoruba"}
{"question": "Ṣàwọn oríṣi àrùn àìlera ọpọlọ tí ó máa ń bẹ̀rẹ̀ ní ìgbà ọmọdé, tí àwọn àmì rẹ̀ sì jẹ́ àìṣànímọ́lera tàbí ìdákẹ́ṣẹ̀ fún ìṣẹ́jú díẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What are the types of [mental disorders = àrùn àìlera ọpọlọ] that typically begin in childhood, with symptoms like [confusion = àìṣànímọ́lera] or [dizziness = ìdákẹ́ṣẹ̀] for a few minutes?”\n</step1>\n<step2>\nCommon childhood mental disorders include anxiety disorders, which can manifest as excessive worry — *ìbànújẹ tó pọ̀ jù* — and may lead to confusion during stressful situations.\n</step2>\n<step3>\nAnother type is attention-deficit/hyperactivity disorder (ADHD), where symptoms like impulsivity and inattention can cause *ìdákẹ́ṣẹ̀* in children, especially in challenging environments.\n</step3>\n<step4>\nAdditionally, mood disorders such as depression can start in childhood, presenting as persistent sadness or irritability — *ìbànújẹ tàbí ìbànújẹ tó pọ̀ jù*.\n</step4>\n<step5>\nThese disorders often require early intervention, as symptoms like confusion or dizziness can affect a child's daily functioning — *ìṣe ojoojúmọ́*.\n</step6>\n<step6>\nIn summary, types of mental disorders that begin in childhood include anxiety disorders, ADHD, and mood disorders, all of which can present with symptoms like confusion or dizziness.\n</step6></thinking>", "answer": "<answer>Àwọn oríṣi àrùn àìlera ọpọlọ tí ó máa ń bẹ̀rẹ̀ ní ìgbà ọmọdé ni àrùn ìbànújẹ, ADHD, àti àrùn ìbànújẹ tó pọ̀ jù, tí ó lè fa àìṣànímọ́lera tàbí ìdákẹ́ṣẹ̀.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 40 kan ti o ni arun AIDS wa pẹlu awọn ami aisan pẹlu iba, irora inu, ibà, ikọ́ ti ko gbe ohunkohun jade, ati pipadanu iwuwo laarin ọsẹ mẹta to koja. O ni ọpọlọpọ awọn plaques violaceous lori ọmu rẹ, thrush onú, ati lymphadenopathy, ati awọn crackles ni a gbọ́ lori iwadii ọmu rẹ. Ẹ̀dà ara rẹ̀ fihan idagbasoke awọn ẹda acid-fast, ati iye CD4+ rẹ jẹ 44/mm3. Ti a ba gbero awọn ẹya ara ati awọn abajade iwosan wọnyi, apapọ awọn oogun egbogi wo ni o yẹ julọ fun ipo rẹ?", "reasoning": "<thinking><step1>\nThe question describes a 40-year-old man with AIDS presenting symptoms like fever, abdominal pain, cough with sputum, and weight loss over the past three weeks. It also mentions *plaques violacées* (violaceous plaques), *thrush* (oral thrush), *lymphadenopathy*, and crackles on lung examination.\n</step1>\n<step2>\nGiven the low CD4+ count of 44/mm3, this patient is at high risk for opportunistic infections — *infections opportunistes*. The symptoms suggest possible *pneumonie à Pneumocystis jirovecii* (PJP) and *candidose orale* (oral candidiasis).\n</step2>\n<step3>\nFor PJP, the first-line treatment is typically *triméthoprime-sulfaméthoxazole* (TMP-SMX), which is effective against this type of pneumonia. \n</step3>\n<step4>\nAdditionally, for the oral thrush, antifungal treatment such as *fluconazole* is recommended to address the *candidose*.\n</step4>\n<step5>\nConsidering the patient's severe immunosuppression, prophylactic treatment may also be necessary to prevent further infections — *prévention des infections*.\n</step5>\n<step6>\nThus, the most appropriate combination of medications for this patient would be TMP-SMX for PJP and fluconazole for oral thrush.\n</step6></thinking>", "answer": "<answer>Oogun egbogi to yẹ julọ ni triméthoprime-sulfaméthoxazole fun pneumonie à Pneumocystis jirovecii ati fluconazole fun candidose orale.</answer>", "language": "Yoruba"}
{"question": "Kini idi ti o ṣeé ṣe julọ ti o fa irisi “bii ilẹkẹ” ti ojuomi ati fifẹ ti ampulla ti a rii ninu obinrin ọdun 30 kan lakoko hysterosalpingography fun itọju ailopin?", "reasoning": "<thinking><step1>\nThe question asks: “Kini idi ti o ṣeé ṣe julọ ti o fa irisi ‘bii ilẹkẹ’ [like a balloon] ti ojuomi [the uterus] ati fifẹ [swelling] ti ampulla [ampulla] ti a rii ninu obinrin [woman] ọdun 30 kan [30 years old] lakoko hysterosalpingography [hysterosalpingography] fun itọju ailopin [for infertility treatment]?” — meaning it wants to know the most likely cause of a balloon-like appearance and swelling observed during a hysterosalpingography in a 30-year-old woman.\n</step1>\n<step2>\nDuring hysterosalpingography, the doctor injects a contrast dye to visualize the uterus and fallopian tubes — *a lo dye ti o ni awọ lati ṣe afihan ojuomi ati awọn tubes fallopian*.\n</step2>\n<step3>\nA balloon-like appearance in the ampulla can indicate a blockage or fluid accumulation — *iyẹn le tọka si idena tabi ikojọpọ omi*.\n</step4>\n<step4>\nIn a 30-year-old woman, common causes for this could include conditions like pelvic inflammatory disease or endometriosis — *arun bi aisan ikọlu pelviki tabi endometriosis*.\n</step5>\n<step5>\nThese conditions can lead to scarring or adhesions, causing the ampulla to appear distended — *iyẹn le fa ki ampulla naa han bi ẹnipe o ti kun*.\n</step6>\n<step6>\nThus, the most likely reason for the balloon-like appearance and swelling is a blockage due to underlying conditions affecting the reproductive system.\n</step6></thinking>", "answer": "<answer>Idi ti o ṣeé ṣe julọ ni idena ti o fa irisi “bii ilẹkẹ” ati fifẹ ni ampulla ni obinrin ọdun 30 kan ni aisan ikọlu pelviki tabi endometriosis.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin funfun ọdun mẹ́tadinlọ́gọ́rin kan wá pẹ̀lú otutu 38°C àti irora nígbà tí a bá fọwọ́ kàn ẹsẹ̀ rẹ̀.  Otutu náà bẹ̀rẹ̀ ní ọjọ́ díẹ̀ lẹ́yìn tí a rí ìgbẹ́ àwọ̀ oyin lórí ètè rẹ̀,  ìwádìí sì fi hàn pé ó ní kokki gram-positive tí ó ní catalase.  Bakteria wo ni ó ṣeé ṣe jù lọ láti rí nínú àyẹ̀wò ẹsẹ̀ rẹ̀?", "reasoning": "<thinking><step1>\nThe question describes a 38°C fever and pain when touching the boy's leg, which started a few days after noticing a [ìgbẹ́ àwọ̀ oyin = honey-colored crust] on his skin. \n</step1>\n<step2>\nThe presence of a honey-colored crust suggests a skin infection, commonly associated with *impétigo*, which is often caused by bacteria.\n</step2>\n<step3>\nThe investigation shows a gram-positive bacterium with catalase, which indicates it could be *Staphylococcus aureus* or *Streptococcus pyogenes*.\n</step3>\n<step4>\n*Staphylococcus aureus* is known for causing skin infections and can lead to symptoms like fever and localized pain — *irora ni agbegbe kan*.\n</step5>\n<step5>\nOn the other hand, *Streptococcus pyogenes* is also a common cause of skin infections, particularly in cases of impétigo.\n</step6>\n<step6>\nGiven the symptoms and the type of bacteria, it is most likely that the boy has an infection caused by *Staphylococcus aureus*.\n</step6></thinking>", "answer": "<answer>Bakteria ti o ṣee ṣe jù lọ ni *Staphylococcus aureus*.</answer>", "language": "Yoruba"}
{"question": "A fìtí yàrá kan ni a fún ni afẹ́fẹ́ sí titẹ́ iwọn 24 lb in^{-2} ní ọjọ́ òtútù kan tí ó jẹ́ -5°C.  Tí a bá gbà pé kò sí ìdààmú sílẹ̀ àti iwọn didùn kan náà, iwọn titẹ́ wo ni yàrá náà yóò dé ní ọjọ́ ooru kan tí iwọn otutu rẹ̀ bá jẹ́ 35°C?", "reasoning": "<thinking><step1>\nThe question asks: “A fìtí yàrá kan ni a fún ni afẹ́fẹ́ sí titẹ́ [24 lb in^{-2}] ní ọjọ́ òtútù kan tí ó jẹ́ [-5°C]?” — meaning it wants to know the pressure in a room when the temperature changes from -5°C to 35°C.\n</step1>\n<step2>\nWe can use the ideal gas law, which states that pressure is directly proportional to temperature when volume is constant — *p ∝ T*.\n</step2>\n<step3>\nFirst, we need to convert the temperatures from Celsius to Kelvin: -5°C is 268.15 K and 35°C is 308.15 K.\n</step3>\n<step4>\nNow, we can set up a ratio using the initial and final conditions: \\(\\frac{P_1}{T_1} = \\frac{P_2}{T_2}\\), where \\(P_1 = 24 lb in^{-2}\\), \\(T_1 = 268.15 K\\), and \\(T_2 = 308.15 K\\).\n</step4>\n<step5>\nRearranging gives us \\(P_2 = P_1 \\times \\frac{T_2}{T_1}\\). Plugging in the values: \\(P_2 = 24 \\times \\frac{308.15}{268.15}\\).\n</step5>\n<step6>\nCalculating this gives us \\(P_2 \\approx 24 \\times 1.149 = 27.57 lb in^{-2}\\).\n</step6></thinking>", "answer": "<answer>Iwọn titẹ́ yàrá náà yóò dé ní ọjọ́ ooru kan jẹ́ 27.57 lb in^{-2}.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọmọ ọdún 67 kan wá sí ọ̀dọ̀ ọ̀gbẹ́ni abẹ́rẹ̀ pẹ̀lú ìgbẹ́ kan tí kò ní ìrora, tí ó ń dàgbà ní kẹ̀kẹ̀kẹ̀ ní agbègbè periauricular fún oṣù méjì sẹ́yìn.  Ní àyẹ̀wò ara, ìgbẹ́ tí kò ní apẹrẹ̀ dídá kan wà, 2 cm x 1 cm ní iwọn rẹ̀, pẹ̀lú àwọn ẹgbẹ́ tí kò ní apẹrẹ̀ dídá àti àwọn ìbẹ́rẹ̀ lórí ojú rẹ̀. Obìnrin náà jẹ́ ẹni tí ara rẹ̀ fẹ́ẹ̀rẹ̀ tí ó nífẹ̀ẹ́ láti lọ sunbath. Kò sí ìtàn ìdílé àrùn èèmọ̀. Lẹ́yìn àyẹ̀wò ara pípé, ọ̀gbẹ́ni abẹ́rẹ̀ ṣe biopsy ti àrùn náà lábẹ́ ìṣe irúgbìn agbegbe, ó sì rán ẹ̀yà náà sí fún àyẹ̀wò histopathological.  Olùṣàkóso àrùn náà jẹ́ kí àlàyé àrùn  squamous cell carcinoma ti awọ ara jẹ́ kedere. Nígbà tí ó béèrè nípa ìdí rẹ̀, ọ̀gbẹ́ni abẹ́rẹ̀ ṣàlàyé pé ọ̀pọ̀lọpọ̀ àwọn ìdí ṣeeṣe wà, ṣùgbọ́n ó ṣeé ṣe kí ó ti ní squamous cell carcinoma lórí ojú rẹ̀ nítorí ìtẹ̀síwájú ìtẹ̀síwájú sí awọn ewu ultraviolet lati oòrùn, paapaa ultraviolet B (UVB) awọn ewu. Bí ìrònú ọ̀gbẹ́ni abẹ́rẹ̀ bá tọ̀nà, èwo nínú àwọn ọ̀nà wọ̀nyí ni ó ṣeé ṣe jùlọ láti ní ipa nínú ìṣẹ̀dá àrùn náà?\nA. Intrastrand cross-linking ti thymidine residues ni DNA\nB. Upregulation ti ìṣelọ́rùn ti cyclin D2\nC. Activation ti transcription factor NF-κB\nD. Ibàjẹ́ DNA tí a fà nípa ìṣedá ti reactive oxygen species", "reasoning": "<thinking><step1>\nThe question is asking about the possible mechanisms that could lead to the development of squamous cell carcinoma on the skin, particularly in the context of UV exposure — *ìtẹ̀síwájú ìtẹ̀síwájú sí awọn ewu ultraviolet*.\n</step1>\n<step2>\nSquamous cell carcinoma is often associated with DNA damage caused by UV radiation, especially UVB rays — *ìtẹ̀síwájú UVB*.\n</step2>\n<step3>\nOne common mechanism is intrastrand cross-linking of thymidine residues in DNA, which can lead to mutations — *ìbáṣepọ̀ ti thymidine ni DNA*.\n</step3>\n<step4>\nAnother possibility is the activation of transcription factors like NF-κB, which can promote cell survival and proliferation — *ìmúṣiṣẹ́ ti transcription factor NF-κB*.\n</step4>\n<step5>\nUpregulation of cyclin D2 is also a factor in cell cycle progression, but it is less directly linked to UV-induced carcinogenesis — *ìṣelọ́rùn ti cyclin D2*.\n</step6>\n<step7>\nLastly, DNA damage caused by reactive oxygen species (ROS) is a significant contributor to cancer development, as ROS can induce mutations — *ìbàjẹ́ DNA tí a fà nípa ìṣedá ti reactive oxygen species*.\n</step8>\n<step9>\nConsidering the context of UV exposure, the most likely mechanism leading to squamous cell carcinoma is the intrastrand cross-linking of thymidine residues in DNA, as this is a direct consequence of UV damage.\n</step9></thinking>", "answer": "<answer>A. Intrastrand cross-linking ti thymidine residues ni DNA.</answer>", "language": "Yoruba"}
{"question": "Bí o bá tẹ̀lé àwọn ìtọ́ni wọ̀nyí, ṣé ìwọ yóò padà sí ibi tí o ti bẹ̀rẹ̀? Máa wo iwaju nígbà gbogbo. Gbé igbesẹ́ mẹ́wàá sẹ́yìn. Gbé igbesẹ́ méje sẹ́yìn. Gbé igbesẹ́ mẹ́jọ lọ sọ́tun. Gbé igbesẹ́ mẹ́fà lọ sọ́tun. Gbé igbesẹ́ mẹ́ta lọ sọ́wé.\nÀwọn àṣàyàn:\n- Bẹ́ẹ̀ni\n- Rárá", "reasoning": "<thinking><step1>\nThe question translates to: \"If you follow these instructions, will you return to where you started? Always look ahead. Take ten steps back. Take seven steps forward. Take six steps to the right. Take three steps to the left.\" This is asking about the final position after following these movements.\n</step1>\n<step2>\nStarting from a point, if you take ten steps back, you move away from the starting point — *o n lọ sẹ́yìn*.\n</step2>\n<step3>\nNext, taking seven steps forward means you move towards the starting point — *o n lọ sí iwaju*.\n</step3>\n<step4>\nAfter that, moving six steps to the right does not affect your forward or backward position, just your lateral position — *o n lọ sí ọtun*.\n</step4>\n<step5>\nThen, taking three steps to the left will counteract some of the rightward movement — *o n lọ sí apa osi*.\n</step5>\n<step6>\nNow, let's calculate: ten steps back minus seven steps forward results in three steps back. The right and left movements cancel each other out, leaving you still three steps back from the starting point.\n</step6>\n<step7>\nThus, you do not return to the starting point; you end up three steps behind it.\n</step7></thinking>", "answer": "<answer>Rárá, ìwọ kò padà sí ibi tí o ti bẹ̀rẹ̀; o wa mẹ́ta sẹ́yìn.</answer>", "language": "Yoruba"}
{"question": "Loni oni, Kimberly lọ si adagun wiwakuru.  Laarin igbati wo ni o le ti lọ?\nA mọ pe:\nKimberly jí ni agogo 8:00 a.m..\nEmily ri Kimberly n ṣiṣẹ ni ile-iṣẹ adaṣe lati 8:00 a.m. si 12:00 p.m..\nBetty ri Kimberly nlọ kiri ni ọgbà lati 12:00 p.m. si 4:00 p.m..\nJames ri Kimberly n ra ounjẹ ọsan ni ile-itaja lati 5:00 p.m. si 8:00 p.m..\nSamantha ri Kimberly nlọ si ère Ọba Ọmọ Obinrin lati 8:00 p.m. si 9:00 p.m..\nAdagun wiwakuru tii pa ni lẹhin agogo 9:00 p.m..\nLaarin igbati wo ni Kimberly le ti lọ si adagun wiwakuru?\nAwọn aṣayan:\n(A) 5:00 p.m. si 8:00 p.m.\n(B) 8:00 a.m. si 12:00 p.m.\n(C) 8:00 p.m. si 9:00 p.m.\n(D) 4:00 p.m. si 5:00 p.m.", "reasoning": "<thinking><step1>\nThe question asks: “Laarin igbati wo ni Kimberly le ti lọ si adagun wiwakuru?” — meaning it wants to know when Kimberly could have gone to the swimming pool.\n</step1>\n<step2>\nWe know Kimberly's schedule: she wakes up at 8:00 a.m. and works until 12:00 p.m. — *o n ṣiṣẹ ni ile-iṣẹ adaṣe*.\n</step2>\n<step3>\nAfter that, Betty sees her in the garden from 12:00 p.m. to 4:00 p.m. — *o nlọ kiri ni ọgbà*.\n</step3>\n<step4>\nFrom 4:00 p.m. to 5:00 p.m., there is a gap in her schedule — *a ko ri i nibi*.\n</step5>\n<step5>\nThen, she is seen buying lunch from 5:00 p.m. to 8:00 p.m. — *o n ra ounjẹ ọsan ni ile-itaja*.\n</step6>\n<step6>\nFinally, she attends an event from 8:00 p.m. to 9:00 p.m., and the pool closes after 9:00 p.m. — *adagun wiwakuru tii pa ni lẹhin agogo 9:00 p.m.*.\n</step7>\n<step7>\nThus, the only time Kimberly could have gone to the swimming pool is between 4:00 p.m. and 5:00 p.m. — *nítorí náà, aṣayan to tọ ni (D)*.\n</step8></thinking>", "answer": "<answer>(D) 4:00 p.m. si 5:00 p.m.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 56 kan wá ṣe ayẹwo akọkọ nipasẹ onímọ̀ àrùn ìgbọnwọ̀n pẹ̀lú ẹ̀dùn àgbàdo àti ìgbọnwọ̀n gẹ́gẹ́ bí ẹ̀dùn pàtàkì rẹ̀. Ó sọ pé ó ti ní ìrora díẹ̀ fún ọdún, ṣugbọn pé ìrora náà ti burú sí i ní ọ̀sù mẹ́fà sẹ́yìn. Ó ṣàlàyé pé ìrora náà burú jùlọ ní òwúrọ̀ lẹ́yìn tí ó jí, ṣugbọn ó dàbí pé ó sàn káàkiri ọjọ́. Ó kíyèsí pẹ̀lú pé ẹnu rẹ̀ gbẹ́, tí ó sì nira fún un láti jẹ oúnjẹ gbẹ́ bíi kẹ́kẹ̀. Níkẹyìn, ó ní ìmọ̀rírì bíi pé eérú wà ní ojú rẹ̀. Ó kọ̀ láti sọ ìtàn àrùn ìṣaaju tàbí lílò oògùn.  Àyẹ̀wò ẹ̀jẹ̀ fún èyíkéyìí nínú àwọn wọ̀nyí ni yóò ṣeé ṣe kí ó dára nínú àrùn náà?\nA. Anti-centromere antibody\nB. Anti-cyclic citrullinated peptide (CCP) antibody\nC. Anti-Jo1 and anti-Mi2 antibodies\nD. Anti-Ro and anti-La antibodies", "reasoning": "<thinking><step1>\nThe question describes a 56-year-old woman experiencing joint pain, particularly in the morning, along with dry mouth and difficulty eating dry foods — *ẹ̀dùn àgbàdo* and *ìgbọnwọ̀n gẹ́gẹ́ bí ẹ̀dùn pàtàkì rẹ̀* suggest a possible autoimmune condition.\n</step1>\n<step2>\nThe symptoms of joint pain worsening in the morning and improving throughout the day are characteristic of conditions like rheumatoid arthritis — *àrùn ìgbọnwọ̀n*.\n</step2>\n<step3>\nThe presence of dry mouth indicates possible Sjögren's syndrome, which often accompanies autoimmune diseases — *ìgbẹ́kẹ̀lé àrùn àtọ́kànwá*.\n</step3>\n<step4>\nAmong the antibody tests listed, anti-cyclic citrullinated peptide (CCP) antibody is specifically associated with rheumatoid arthritis — *àrùn ìgbọnwọ̀n*.\n</step4>\n<step5>\nWhile anti-Ro and anti-La antibodies are linked to Sjögren's syndrome, the primary symptoms here align more closely with rheumatoid arthritis, making anti-CCP the most relevant test.\n</step5>\n<step6>\nThus, the most appropriate test to confirm the suspected condition is the anti-cyclic citrullinated peptide (CCP) antibody.\n</step6></thinking>", "answer": "<answer>Anti-cyclic citrullinated peptide (CCP) antibody.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 36 kan, G2P1, ti o loju 24 ọsẹ̀ oyun, ti wá pẹlu itan iwọn oṣù mẹrin ti irọrun. Awọn abajade idanwo ile-iwosan rẹ̀ fihan iye hemoglobin ti 8.0 g/dL, iye leukocyte ti 2,000 sẹẹli/uL, ati iye platelet ti 20,000/uL. Kini aisan ti o ṣeeṣe julọ fun ipo rẹ̀, ti a ba gbero awọn esi hematological wọnyi?", "reasoning": "<thinking><step1>\nThe question asks about a 36-year-old woman, G2P1, who is 24 weeks pregnant and presents with a history of four months of ease — this likely refers to *irọrun* (ease or comfort). The lab results show hemoglobin at 8.0 g/dL, leukocyte count at 2,000 cells/uL, and platelet count at 20,000/uL.\n</step1>\n<step2>\nThese lab results indicate significant anemia — *anemia* — due to the low hemoglobin level, which is below the normal range for pregnant women.\n</step2>\n<step3>\nAdditionally, the leukocyte count is quite low, suggesting *leucopenia* (low white blood cells), which can indicate an underlying infection or bone marrow issue.\n</step3>\n<step4>\nThe platelet count is also critically low, indicating *thrombocytopenia*, which can lead to increased bleeding risks during pregnancy.\n</step4>\n<step5>\nConsidering these hematological findings, the most likely condition affecting her is *preeclampsia* or possibly *gestational thrombocytopenic purpura*, especially given the combination of low platelets and anemia.\n</step5>\n<step6>\nIn summary, the combination of low hemoglobin, leukocytes, and platelets suggests a serious hematological condition that needs immediate attention.\n</step6></thinking>", "answer": "<answer>Aisan ti o ṣeeṣe julọ ni *preeclampsia* tabi *gestational thrombocytopenic purpura* nitori awọn abajade hematological wọnyi.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 47 kan wá pẹlu itan ikọ́ gbẹ ti o ti wà fún ọsẹ mẹta, ìgbona ìrẹ́mọ̀lẹ̀ oju ti kò pọ̀ gan-an laipẹ, ati awọn crackles kekere ni awọn agbegbe afẹfẹ mejeeji nigba ayẹwo. Ipele kalsiumu rẹ̀ jẹ 10.8 mg/dL, ati spirometry fihan apẹẹrẹ aṣiṣe ti o yatọ si deede. Ni ibamu si awọn ami wọnyi, ipele enzyme serum wo ni o ṣeeṣe julọ lati ga ni alaisan yii?", "reasoning": "<thinking><step1>\nThe question describes a 47-year-old woman with a history of [ikọ́ gbẹ = dry cough] lasting three weeks, mild [ìgbona ìrẹ́mọ̀lẹ̀ = fever], and crackles in both lung fields upon examination. \n</step1>\n<step2>\nHer calcium level is elevated at 10.8 mg/dL, which can indicate various conditions, including malignancy or hyperparathyroidism — *hyperparathyroïdisme*.\n</step2>\n<step3>\nThe spirometry shows an obstructive pattern, suggesting possible lung disease — *aṣa àìlera ẹdọfu*.\n</step3>\n<step4>\nIn cases of lung cancer, one might expect elevated serum enzymes such as alkaline phosphatase — *alkaline phosphatase* — due to bone involvement or liver metastasis.\n</step4>\n<step5>\nAdditionally, if there is an underlying parathyroid issue, parathyroid hormone levels could also be elevated — *ipele homonu parathyroid*.\n</step5>\n<step6>\nGiven the symptoms and lab findings, the most likely serum enzyme to be elevated in this patient is alkaline phosphatase, indicating possible malignancy or bone involvement.\n</step6></thinking>", "answer": "<answer>Ipele enzyme ti o ṣeeṣe julọ lati ga ni alaisan yii ni alkaline phosphatase.</answer>", "language": "Yoruba"}
{"question": "Iya kan ti ọdun mẹ́ẹ̀dọ́gbọ̀n (25) ṣe àyẹ̀wò sí onísègùn àkọ́kọ́ rẹ̀ nítorí irora ọgbọ̀n. Ẹni náà ṣẹ̀ṣẹ̀ bí ọmọ tuntun ní ìlera ní ọsẹ̀ mẹ́rìnlélógún (40). Láti ọsẹ̀ kan sẹ́yìn, ó bẹ̀rẹ̀ sí ní irora lórí ọgbọ̀n rẹ̀ tí ó ti burú sí i lọ́wọ́. Ẹni náà ṣàlàyé pé ó ṣubú nígbà tí ó ń rìn, ó sì fi apá rẹ̀ dìbàjẹ́. Ẹni náà jẹ́ akọọ̀wé tí ó ń ṣiṣẹ́ nílé, ó sì ń lo wákàtí mẹ́jọ̀ ní ojoojúmọ́ láti kọ̀wé tàbí láti ṣe àkọsílẹ̀ owó. Nífẹ̀ẹ́, ẹni náà jẹ́ ọ̀kan lára àwọn tí ń bá ara wọn jà ní tẹ́nilẹ̀rì, tí ó sì bẹ̀rẹ̀ sí ní ṣiṣẹ́ dáadáa láti ìgbà tí ó bí ọmọ rẹ̀. Itan ìlera ìṣáájú ẹni náà ṣàlàyé nípa hypothyroidism tí a ń tọ́jú pẹ̀lú levothyroxine. Ní àyẹ̀wò ara, àkíyèsí ọgbọ̀n kò fi hàn tàbí kí ó lè mọ̀. Irora ṣẹlẹ̀ nígbà tí a bá gbá ìka ìwọ̀nà sí isalẹ̀, a sì yí ọgbọ̀n padà sí ulna. Ẹ̀kúnrẹ́rẹ́ àyẹ̀wò ara ẹni náà wà lára ilera déédéé. Èwo ni ìgbésẹ̀ tí ó tọ́ julọ ní atẹle nínú ìṣàkóso?\nA. Fọ́tò ọgbọ̀n\nB. Àṣírí ọgbọ̀n ìka ìwọ̀nà\nC. Aabo ọgbọ̀n láti wọ̀ nígbà ṣiṣẹ́ àti ní alẹ́\nD. Isinmi àti ibuprofen", "reasoning": "<thinking><step1>\nThe question is asking about the best next step in managing a patient who is experiencing wrist pain after a recent fall. The patient is a 25-year-old who just had a baby and has a history of hypothyroidism treated with levothyroxine.\n</step1>\n<step2>\nGiven the patient's recent fall and the description of pain when moving the wrist, it suggests a possible injury — *injury àyàwòrán* or strain.\n</step2>\n<step3>\nThe options provided include imaging (A: X-ray), a wrist brace (C: wrist support), rest and ibuprofen (D: rest and ibuprofen), and a specific wrist examination (B: wrist examination).\n</step3>\n<step4>\nSince the patient has not shown any significant findings on physical examination, imaging might be necessary to rule out fractures — *fọ́tò ọgbọ̀n* would help in assessing any bone injury.\n</step4>\n<step5>\nHowever, if the pain is manageable and there are no signs of severe injury, rest and ibuprofen could be a reasonable first step — *isinmi àti ibuprofen* can help alleviate pain and inflammation.\n</step6>\n<step6>\nConsidering the patient's situation, starting with rest and ibuprofen seems practical, but if symptoms persist, an X-ray would be warranted.\n</step6>\n<step7>\nUltimately, the best immediate action would be to manage pain and inflammation first, while keeping in mind the possibility of further imaging if needed.\n</step7></thinking>", "answer": "<answer>Isinmi àti ibuprofen.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìpínrọ̀ tó tẹ̀lé yìí kọ̀ọ̀kan ṣàpèjúwe ṣeto ohun méje tí a gbé kalẹ̀ ní àṣẹ tí a fi múlẹ̀. Àwọn ògbólógbòò yìí bá ara wọn mu ní ọ̀nà ìrònú. Agbo egbò inú ọjà náà ta eso méje: loquats, watermelon, oranges, kiwis, apples, plums, àti peaches. Plums ni o kere ju. Watermelons ni o jẹ́ ẹ̀kẹta tó gbowó julọ. Apples gbowó ju oranges lọ. Kiwis ni o gbowó ju gbogbo wọn lọ. Apples kéré sí peaches ní iye owo. Loquats ni o jẹ́ ẹ̀kẹta tó kere ju.\nÀwọn àṣàyàn:\n(A) Loquats ni o jẹ́ ẹ̀kejì tó kere ju\n(B) Watermelons ni o jẹ́ ẹ̀kejì tó kere ju\n(C) Oranges ni o jẹ́ ẹ̀kejì tó kere ju\n(D) Kiwis ni o jẹ́ ẹ̀kejì tó kere ju\n(E) Apples ni o jẹ́ ẹ̀kejì tó kere ju\n(F) Plums ni o jẹ́ ẹ̀kejì tó kere ju\n(G) Peaches ni o jẹ́ ẹ̀kejì tó kere ju", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn ìpínrọ̀ tó tẹ̀lé yìí kọ̀ọ̀kan ṣàpèjúwe ṣeto ohun méje…” — meaning it wants to describe a set of seven fruits and their prices.\n</step1>\n<step2>\nThe fruits listed are loquats, watermelon, oranges, kiwis, apples, plums, and peaches. We know that *plums* are the least expensive.\n</step2>\n<step3>\nNext, *watermelons* are the third most expensive, while *kiwis* are the most expensive of all the fruits.\n</step3>\n<step4>\n*Apples* are more expensive than *oranges*, and they are cheaper than *peaches* in terms of price.\n</step4>\n<step5>\nFinally, *loquats* are the third least expensive fruit. This gives us a clear ranking of the fruits based on their prices.\n</step5>\n<step6>\nNow, we need to determine which fruit is the second least expensive. Since *plums* are the least expensive and *loquats* are the third least expensive, the second least expensive must be *watermelons*.\n</step6></thinking>", "answer": "<answer>Watermelons ni o jẹ́ ẹ̀kejì tó kere ju.</answer>", "language": "Yoruba"}
{"question": "Lóòótọ́ ìwọ̀n nọ́mbà, kí ni ìṣe ìṣúmọ̀ -9 àti -8?", "reasoning": "<thinking><step1>\nThe question asks: “Lóòótọ́ ìwọ̀n nọ́mbà, kí ni ìṣe ìṣúmọ̀ -9 àti -8?” — meaning it wants to know what the operation of adding -9 and -8 is.\n</step1>\n<step2>\nTo solve this, we need to understand that adding negative numbers results in a more negative number — *nọ́mbà tó burú jùlọ*.\n</step2>\n<step3>\nWhen we add -9 and -8, we can think of it as moving left on the number line — *lórí àtẹ̀jáde nọ́mbà*.\n</step3>\n<step4>\nSo, -9 plus -8 can be calculated as: -9 + (-8) = -17 — *nítorí náà, a ní -17*.\n</step4>\n<step5>\nIn summary, the operation combines the two negative values, leading to a larger negative result.\n</step5></thinking>", "answer": "<answer>Ìṣe ìṣúmọ̀ -9 àti -8 ni -17.</answer>", "language": "Yoruba"}
{"question": "Kini idi akọkọ ti àtìgbàgbà ẹ̀jẹ̀, proteinuria, ati ẹ̀dọ̀fóró tí ó ní àmì ìrísì ìṣàn-ṣàn nínú obìnrin ọmọ ọdún 25 ní oṣù kejì ti oyun àkọ́kọ́ rẹ̀, nígbà tí a bá gbà pé ó ní íṣẹ̀lẹ̀ aláìlera?", "reasoning": "<thinking><step1>\nThe question asks: “Kini idi akọkọ ti [àtìgbàgbà ẹ̀jẹ̀ = high blood pressure], [proteinuria = protein in urine], ati [ẹ̀dọ̀fóró = edema] tí ó ní àmì [ìrísì ìṣàn-ṣàn = signs of renal dysfunction] nínú obìnrin ọmọ ọdún 25 ní oṣù kejì ti [oyun àkọ́kọ́ = first trimester of pregnancy]?” — meaning it seeks to understand the primary cause of these symptoms in a 25-year-old woman during her first trimester.\n</step1>\n<step2>\nThese symptoms suggest a condition known as preeclampsia, which is characterized by high blood pressure and proteinuria — *àtìgbàgbà ẹ̀jẹ̀ àti proteinuria*.\n</step2>\n<step3>\nPreeclampsia typically occurs after the 20th week of pregnancy, but can sometimes manifest earlier, especially in women with risk factors — *awọn ifosiwewe eewu*.\n</step3>\n<step4>\nIn this case, the combination of high blood pressure, proteinuria, and edema indicates that the kidneys may be under stress — *ẹ̀dọ̀ le n ni ìṣòro*.\n</step4>\n<step5>\nThe underlying cause is often related to placental issues, leading to inadequate blood flow and oxygen to the placenta — *ìṣòro pẹ̀lú àpò-èso*.\n</step6>\n<step6>\nThus, the primary cause of these symptoms in this pregnant woman could be linked to preeclampsia, which requires careful monitoring and management.\n</step6></thinking>", "answer": "<answer>Idi akọkọ ti àtìgbàgbà ẹ̀jẹ̀, proteinuria, ati ẹ̀dọ̀fóró ni preeclampsia, tí ó ní í ṣe pẹ̀lú ìṣòro pẹ̀lú àpò-èso.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 55 kan ni a mu wa pẹlu ilara ti awọn iṣọn lymph ti ọrùn ati ẹgbẹ apá, ati biopsy fihan iṣipopada laarin awọn kromosom 14 ati 18.  Ayipada sẹẹli wo ni o ṣee ṣe julọ lati ṣe akiyesi bi abajade iṣe iyipada genetiki yii?", "reasoning": "<thinking><step1>\nThe question asks about a 55-year-old man with lymph node [iṣọn lymph = lymph nodes] swelling in the neck and arm, and a biopsy shows a translocation between chromosomes 14 and 18. It seeks to identify the most likely cell change resulting from this genetic alteration.\n</step1>\n<step2>\nTranslocation between chromosomes 14 and 18 is commonly associated with certain types of cancers, particularly lymphomas — *lymphoma* ni a mọ lati ni ibatan pẹkipẹki pẹlu ayipada yii.\n</step2>\n<step3>\nIn particular, this genetic change is often linked to *follicular lymphoma*, which is a type of non-Hodgkin lymphoma — *non-Hodgkin lymphoma* ni a le ri ni awọn alaisan pẹlu ayipada yii.\n</step3>\n<step4>\nThe translocation leads to the overexpression of the BCL2 gene, which inhibits apoptosis — *apoptosis* ni ilana ti awọn sẹẹli ti n pa ara wọn, ati pe BCL2 n ṣe idiwọ eyi.\n</step4>\n<step5>\nAs a result, the cells become more resistant to cell death, leading to an accumulation of these abnormal lymphocytes — *iyipada sẹẹli* ti o ṣẹlẹ ni pe awọn lymphocytes wọnyi ko ni ku bi wọn ti yẹ.\n</step5>\n<step6>\nThus, the most likely cell change observed would be the proliferation of these abnormal lymphocytes due to the genetic alteration.\n</step6></thinking>", "answer": "<answer>Iyipada sẹẹli ti o ṣee ṣe julọ ni ikolu ti awọn lymphocytes alailẹgbẹ ti o fa nipasẹ ayipada BCL2.</answer>", "language": "Yoruba"}
{"question": "Àfikún ìwádìí àrùn tó fi hàn, àti ìmọ̀ ìwádìí CSF obìnrin ọmọ ọdún méjìlélógún kan tí ó ní ibà, ìgbàgbé ọrùn, àkàn, àti gram-negative diplococci ní inu cerebrospinal fluid rẹ̀, oògùn atọ́júwo irú àrùn wo ni ó yẹ kí a fi hàn án?", "reasoning": "<thinking><step1>\nThe question asks: “What type of treatment should be administered for a 22-year-old woman with symptoms of fever, neck stiffness, headache, and gram-negative diplococci in her cerebrospinal fluid (CSF)?” \n</step1>\n<step2>\nThese symptoms suggest a possible case of meningitis — *àrùn àkàn* — which is an inflammation of the protective membranes covering the brain and spinal cord.\n</step2>\n<step3>\nThe presence of gram-negative diplococci indicates a bacterial infection, likely caused by *Neisseria meningitidis*, which is a common pathogen in meningitis cases.\n</step3>\n<step4>\nIn such cases, immediate treatment with antibiotics is crucial. Common choices include ceftriaxone or cefotaxime — *oògùn amóhùnmáwòrán* — to effectively target the bacteria.\n</step4>\n<step5>\nAdditionally, corticosteroids may be administered to reduce inflammation — *lati dinku ìfọkànsìn* — and prevent complications.\n</step5>\n<step6>\nTherefore, the appropriate treatment for this patient would involve a combination of antibiotics and possibly corticosteroids to manage the infection and its symptoms.\n</step6></thinking>", "answer": "<answer>Oògùn amóhùnmáwòrán gẹgẹ bi ceftriaxone àti corticosteroids ni a yẹ kí a fi hàn án.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 45 kan ti o ni irora ati lile awọn ika ọwọ ti n tẹsiwaju, awọ ara ti o buru pẹlu hyperpigmentation, edema, ati aiṣedeede kidirin pataki ṣe afihan ipo ipilẹ kan pato. Da lori awọn ami aisan rẹ ati awọn abajade ile-iwosan, iwadi ile-iwosan wo ni yoo ṣe afihan julọ nipa awọn ipele haptoglobin rẹ?", "reasoning": "<thinking><step1>\nThe question asks about a 45-year-old man with symptoms like pain and stiffness in his fingers, worsening skin condition with hyperpigmentation, edema, and significant kidney dysfunction — *aiṣedeede kidirin*. It seeks to identify which laboratory test would best reflect his haptoglobin levels.\n</step1>\n<step2>\nHaptoglobin is a protein that binds free hemoglobin released from red blood cells — *hemoglobini*. When there is hemolysis, haptoglobin levels decrease because it is consumed in the process.\n</step2>\n<step3>\nGiven the symptoms, particularly the edema and skin changes, one might suspect a condition like systemic lupus erythematosus (SLE) or another autoimmune disorder — *aisan autoimmune*.\n</step3>\n<step4>\nIn such cases, haptoglobin levels can be affected by hemolysis, which may occur due to the underlying condition. Therefore, measuring haptoglobin can provide insight into whether hemolysis is present.\n</step4>\n<step5>\nAdditionally, other tests like complete blood count (CBC) and renal function tests would also be relevant, but the focus here is on haptoglobin specifically.\n</step5>\n<step6>\nThus, the most indicative laboratory test regarding his haptoglobin levels would be a test for hemolysis, which can be assessed through haptoglobin measurement.\n</step6></thinking>", "answer": "<answer>Iwadi ile-iwosan ti o yẹ julọ ni lati ṣe ayẹwo ipele haptoglobin rẹ ni ibamu si awọn ami aisan rẹ ni aisan hemolysis.</answer>", "language": "Yoruba"}
{"question": "Olùṣiṣẹ́ àgbò ilẹ̀ kan fi ìgbóná ara gíga, lílékùn ọrùn, àti àwọn àmì àrùn meningitis hàn. Awọn ìwádìí ilé ẹ̀kọ́ ṣe afihan àìṣẹ́ṣẹ̀-ṣiṣẹ́ kidinì àti ìpọ̀sí ìṣẹ́ ẹ̀dọ̀. Oògùn tó yẹ jùlọ láti kọ̀wé fún ní ọ̀ràn yìí ni ____\nA. Ciprofloxacin\nB. Penicillin\nC. Cotrimoxazole\nD. Azithromycin", "reasoning": "<thinking><step1>\nThe question states that a patient presents with high fever, neck stiffness, and signs of meningitis — *àwọn àmì àrùn meningitis* — indicating a possible bacterial infection.\n</step1>\n<step2>\nIn cases of suspected meningitis, especially when caused by bacteria, it is crucial to administer the appropriate antibiotic promptly — *oògùn tó yẹ jùlọ*.\n</step3>\n<step3>\nCiprofloxacin is typically used for certain bacterial infections but is not the first choice for meningitis — *kò jẹ́ àṣàyàn tó dára jùlọ*.\n</step4>\n<step4>\nPenicillin is effective against many strains of bacteria that cause meningitis, particularly *Neisseria meningitidis* and *Streptococcus pneumoniae*.\n</step5>\n<step5>\nCotrimoxazole and Azithromycin are used for other infections but are not standard treatments for meningitis — *kò yẹ fún àrùn meningitis*.\n</step6>\n<step6>\nThus, the most appropriate medication to prescribe in this case is Penicillin — *Penicillin ni oògùn tó yẹ jùlọ*.\n</step6></thinking>", "answer": "<answer>Penicillin ni oògùn tó yẹ jùlọ láti kọ̀wé fún àrùn meningitis yìí.</answer>", "language": "Yoruba"}
{"question": "Labẹ́ apá wò ninu Ìwé Ìgbéṣẹ̀ Ẹ̀ṣẹ̀ Íńdíà ni ẹlẹ́rìí jẹ̀bi bí, lẹ́yìn tí ó bá ti búra, ó bá fi ìmọ̀ tàbí ìgbàgbọ́ sọ̀rọ̀ tí ó mọ̀ tàbí ó gbàgbọ́ pé òtítọ́ kọ́ ni?", "reasoning": "<thinking><step1>\nThe question asks: “Labẹ́ apá wò ninu Ìwé Ìgbéṣẹ̀ Ẹ̀ṣẹ̀ Íńdíà ni ẹlẹ́rìí jẹ̀bi bí, lẹ́yìn tí ó bá ti búra, ó bá fi ìmọ̀ tàbí ìgbàgbọ́ sọ̀rọ̀ tí ó mọ̀ tàbí ó gbàgbọ́ pé òtítọ́ kọ́ ni?” — meaning it seeks to understand the implications of giving false testimony after taking an oath in the context of the Indian Evidence Act.\n</step1>\n<step2>\nUnder the Indian Evidence Act, once a person takes an oath — *bá a ti búra* — they are expected to provide truthful testimony, which is crucial for the integrity of the legal process.\n</step2>\n<step3>\nIf someone knowingly provides false information — *ìmọ̀ tàbí ìgbàgbọ́ pé òtítọ́ kọ́ ni* — they can be held liable for perjury, which is a serious offense.\n</step3>\n<step4>\nThe act of lying after taking an oath undermines the judicial system — *àìlera ìdájọ́* — and can lead to severe penalties, including imprisonment.\n</step4>\n<step5>\nIn essence, the law emphasizes the importance of honesty in testimony, as it is foundational for justice — *ìdájọ́*.\n</step5>\n<step6>\nThus, providing false testimony after an oath is not only unethical but also legally punishable under the Indian Evidence Act.\n</step6></thinking>", "answer": "<answer>Ẹlẹ́rìí ti o jẹ̀bi lẹ́yìn tí ó bá ti búra ni a le fi ẹjọ́ kàn án fún ìtẹ́wọ́gba àìlera ìdájọ́.</answer>", "language": "Yoruba"}
{"question": "Níbo lórí ilẹ̀ ayé tí oòrùn kò tíì tàn rí?\nA. Kò sí ibi kan lórí ilẹ̀ ayé tí oòrùn kò tíì tàn rí.\nB. Oòrùn kò tíì tàn ní Àríwá Pọ́ọ̀lù.\nC. Oòrùn kò tíì tàn ní Gúúsù Pọ́ọ̀lù.\nD. Oòrùn kò tíì tàn ní Àntáktíkà.\nE. Oòrùn kò tíì tàn ní Aláskà.\nF. Oòrùn kò tíì tàn ní United Kingdom.\nG. Oòrùn kò tíì tàn ní Síìtíì.\nH. Oòrùn kò tíì tàn ní Rọ́ṣíà.", "reasoning": "<thinking><step1>\nThe question asks: “Níbo lórí ilẹ̀ ayé tí oòrùn kò tíì tàn rí?” — which translates to \"Where on Earth has the sun not yet set?\" \n</step1>\n<step2>\nThis question relates to the concept of time zones and the position of the sun — *ipo oòrùn* — in relation to the Earth’s rotation.\n</step2>\n<step3>\nIn regions near the poles, such as the Arctic and Antarctic, there are times when the sun does not set for extended periods — *àkókò tí oòrùn kò ní tàn*.\n</step3>\n<step4>\nFor example, during summer in the Arctic, the sun remains visible for 24 hours — *oòrùn wa ni gbogbo ọjọ́*.\n</step4>\n<step5>\nLooking at the options, Àntáktíkà (Antarctica) is known for its polar day phenomenon, where the sun does not set for months.\n</step5>\n<step6>\nIn contrast, places like the United Kingdom or Russia experience regular day-night cycles, so the sun does set there.\n</step6>\n<step7>\nThus, the most accurate answer is that the sun has not set in Àntáktíkà during certain times of the year.\n</step7></thinking>", "answer": "<answer>Oòrùn kò tíì tàn ní Àntáktíkà.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 19 kan wá pẹlu àìsàn fẹ́fẹ́ ní agbegbe ìgbàálù, tí a ṣàpẹẹrẹ rẹ̀ pẹlu awọ pupa-brown tí ó dára, ati fifọ́ diẹ̀ nigbati a ba fi ọwọ́ fọ́.  Kini idanwo ayẹwo ibẹrẹ ti o yẹ julọ lati ṣe ninu ipo yii?", "reasoning": "<thinking><step1>\nThe question asks: “Kini idanwo ayẹwo ibẹrẹ ti o yẹ julọ lati ṣe ninu ipo yii?” — meaning it wants to know the most appropriate initial diagnostic test for a 19-year-old male with a skin condition characterized by a reddish-brown rash and some itching.\n</step1>\n<step2>\nGiven the symptoms, the rash could be indicative of several conditions, but the description suggests a possible dermatological issue — *ìṣòro awọ*.\n</step2>\n<step3>\nIn such cases, a common initial test is a skin scraping — *ìdánwò fọ́ awọ* — to check for fungal infections like tinea.\n</step3>\n<step4>\nAdditionally, one might consider a KOH preparation, which helps identify fungal elements under a microscope — *ìmúlò KOH*.\n</step4>\n<step5>\nIf the rash is not fungal, a patch test could be useful to rule out contact dermatitis — *ìdánwò àtẹ̀jáde*.\n</step5>\n<step6>\nHowever, starting with a skin scraping is typically the most straightforward and effective approach to narrow down the diagnosis.\n</step6></thinking>", "answer": "<answer>Idanwo ayẹwo ibẹrẹ ti o yẹ julọ ni fọ́ awọ.</answer>", "language": "Yoruba"}
{"question": "Kini itọju ti a yan fun obinrin ọdun 43 kan ti a ṣe iwadii fun kansẹẹ ti ọfun ati idena ti awọn ureter mejeeji gẹgẹ bi awọn iwadi aworan ṣe fihan?", "reasoning": "<thinking><step1>\nThe question asks: “Kini itọju ti a yan fun obinrin ọdun 43 kan ti a ṣe iwadii fun [kansẹẹ ti ọfun = throat cancer] ati [iden ti awọn ureter mejeeji = obstruction of both ureters] gẹgẹ bi awọn iwadi aworan ṣe fihan?” — meaning it seeks to know the treatment options for a 43-year-old woman diagnosed with throat cancer and obstruction of both ureters based on imaging studies.\n</step1>\n<step2>\nIn cases of throat cancer, treatment often involves a combination of surgery, radiation therapy, and chemotherapy — *itọju le ni abala mẹta: iṣẹ abẹ, itọju ina, ati kemotherapi*.\n</step2>\n<step3>\nFor the ureter obstruction, it is crucial to relieve the blockage to prevent kidney damage — *o ṣe pataki lati yọ idena naa kuro lati yago fun iparun kidinrin*.\n</step3>\n<step4>\nA common approach might include placing a stent to keep the ureters open — *fifi stent kan si le jẹ ọna ti a lo lati mu ki awọn ureter wa ni ṣiṣi*.\n</step4>\n<step5>\nThe specific treatment plan would depend on the stage of the cancer and the severity of the obstruction — *eto itọju naa yoo dale lori ipele kansẹẹ ati ijinle idena naa*.\n</step6>\n<step6>\nIn summary, the treatment for this patient would likely involve a multidisciplinary approach addressing both the cancer and the ureter obstruction.\n</step6></thinking>", "answer": "<answer>Itọju fun obinrin ọdun 43 yii le pẹlu iṣẹ abẹ, itọju ina, ati kemotherapi, pẹlu fifi stent kan si lati yọ idena ureter.</answer>", "language": "Yoruba"}
{"question": "Kini idi akọkọ ti àtìgbàgbà ẹ̀jẹ̀, proteinuria, ati ẹ̀dọ̀fóró tí ó ní àmì ìrísì ìṣàn-ṣàn nínú obìnrin ọmọ ọdún 25 ní oṣù kejì ti oyun àkọ́kọ́ rẹ̀, nígbà tí a bá gbà pé ó ní íṣẹ̀lẹ̀ aláìlera?", "reasoning": "<thinking><step1>\nThe question asks: “Kini idi akọkọ ti [àtìgbàgbà ẹ̀jẹ̀ = high blood pressure], [proteinuria = protein in urine], ati [ẹ̀dọ̀fóró = edema] tí ó ní àmì [ìrísì ìṣàn-ṣàn = signs of renal dysfunction] nínú obìnrin ọmọ ọdún 25 ní oṣù kejì ti [oyun àkọ́kọ́ = her first pregnancy]?” — meaning it seeks to identify the primary cause of these symptoms in a 25-year-old woman during her first pregnancy.\n</step1>\n<step2>\nThese symptoms can indicate a condition known as preeclampsia, which is characterized by high blood pressure and proteinuria — *àtìgbàgbà ẹ̀jẹ̀ àti proteinuria*.\n</step2>\n<step3>\nPreeclampsia typically occurs after the 20th week of pregnancy and can lead to serious complications for both the mother and the fetus — *o le fa awọn iṣoro to ṣe pataki*.\n</step3>\n<step4>\nThe underlying cause of preeclampsia is not fully understood, but it is believed to involve issues with the placenta — *iṣoro pẹlu [placenta = placenta]*.\n</step4>\n<step5>\nIn this case, the combination of high blood pressure, proteinuria, and edema suggests that the woman may be experiencing this condition, which requires careful monitoring and management — *iwadii ati itọju to peye*.\n</step5>\n<step6>\nTherefore, the primary cause of these symptoms in this context is likely preeclampsia, which poses risks during pregnancy.\n</step6></thinking>", "answer": "<answer>Idi akọkọ ti àtìgbàgbà ẹ̀jẹ̀, proteinuria, ati ẹ̀dọ̀fóró ni preeclampsia nínú obìnrin ọmọ ọdún 25 ní oṣù kejì ti oyun àkọ́kọ́ rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin aláìsàn ọlọ́dún ọgọ́ta kan ń ṣàròyé ibà, àwọ̀ rírọ̀, àárẹ̀ àti àìnífẹ̀ẹ́ sí oúnjẹ. Àwọn àwárí àyẹ̀wò karyotyping fi hàn pé Ph chromosome wà. Aláìsàn yìí le ní ìkankan nínú àwọn àìsàn wọ̀nyí àyàfi èwo?\nA. Chronic myeloid leukemia\nB. Acute myeloid leukemia\nC. Adult B cell-ALL\nD. Chronic lymphocytic leukemia", "reasoning": "<thinking><step1>\nThe question describes a 40-year-old man with symptoms like fever, weight loss, and loss of appetite, and mentions the presence of the Ph chromosome from karyotyping. It asks which disease he might not have among the listed options.\n</step1>\n<step2>\nThe Ph chromosome is commonly associated with chronic myeloid leukemia (CML) — *leucémie myéloïde chronique* — indicating a specific genetic mutation.\n</step2>\n<step3>\nCML typically presents with symptoms like fatigue and splenomegaly, which align with the patient's symptoms. However, the other options need to be considered.\n</step3>\n<step4>\nAcute myeloid leukemia (AML) — *leucémie myéloïde aiguë* — can also present with similar symptoms but does not typically show the Ph chromosome.\n</step4>\n<step5>\nAdult B cell-ALL — *leucémie lymphoblastique aiguë des cellules B* — is another possibility, but it is less commonly associated with the Ph chromosome compared to CML.\n</step6>\n<step6>\nChronic lymphocytic leukemia (CLL) — *leucémie lymphocytaire chronique* — usually does not involve the Ph chromosome either, making it a strong candidate for the answer.\n</step7>\n<step7>\nThus, the disease that this patient likely does not have, given the presence of the Ph chromosome, is CLL.\n</step8></thinking>", "answer": "<answer>Aláìsàn yìí le ní ìkankan nínú àìsàn Chronic lymphocytic leukemia (CLL).</answer>", "language": "Yoruba"}
{"question": "Ọkunrin kan ti ọdun 50 ti o ni àrùn àtọ́jú ẹ̀jẹ̀ nífẹ̀ẹ́ láti fi oúnjẹ tí ìwọn glycemic index rẹ̀ kéré sí inú oúnjẹ rẹ̀. Ṣàwárí irú oúnjẹ kan tí ìwọn glycemic index rẹ̀ máa ń kéré, tí ó sì ń mú kí ìṣàkóso ẹ̀jẹ̀ rẹ̀ dára sí i.", "reasoning": "<thinking><step1>\nThe question asks: “A 50-year-old man with [àrùn àtọ́jú ẹ̀jẹ̀ = diabetes] wants to include foods with a low glycemic index in his diet.” This means we need to find foods that help manage blood sugar levels effectively.\n</step1>\n<step2>\nFoods with a low glycemic index (GI) are those that cause a slower rise in blood glucose — *wọn fa ilosoke pẹ̀lú àkókò* rather than a rapid spike.\n</step2>\n<step3>\nExamples of low GI foods include legumes, whole grains, and non-starchy vegetables — *àwọn ẹfọ̀ tí kò ní starch* like spinach and broccoli.\n</step3>\n<step4>\nIncorporating foods like *àkàrà* (bean cakes) or *iwukara* (yam flour) can be beneficial, as they have lower GI values.\n</step4>\n<step5>\nAdditionally, fruits such as berries and apples are good choices — *àwọn eso bíi berries àti apu* have a lower impact on blood sugar compared to high GI fruits.\n</step5>\n<step6>\nSo, a diet rich in these low GI foods can help improve his blood sugar control — *yóò ràn án lọwọ lati ṣakoso ẹ̀jẹ̀ rẹ̀ dára sí i*.\n</step6></thinking>", "answer": "<answer>Oúnjẹ tí ìwọn glycemic index rẹ̀ kéré ni legumes, àkàrà, àti àwọn eso bíi berries àti apu.</answer>", "language": "Yoruba"}
{"question": "Láàrin oṣù méjì tó kọjá, àpọǹdè kan ti ń jẹun nípa ọ̀nà tí kò bá ìmọ̀ sáyẹ́nsì mu fún pípàdà ìwúwo, èyí tí ó yọ gbogbo ẹran, ẹyin, ẹ̀fọ̀n, eso igbó àti irúgẹ̀ sílẹ̀. Ó ń mu afikun eroproteini, ṣùgbọ́n kì í mu afikun vitamin. Níwọ̀n ìyẹn, èwo nínú àwọn wọ̀nyí ni a ó ṣe àkóbá gidigidi sí ní ọ̀dọ̀ àpọǹdè yìí?\nA. Gbigba àwọn amino acids wọlé nípa ifun inu\nB. Àwọn eto ìgbe wọlé fún àwọn amino acids\nC. Àwọn àṣeyọrí ìyípadà\nD. Ìṣelọ́pọ̀ amonia nípa àwọn kokoro arun", "reasoning": "<thinking><step1>\nThe question is asking about the potential negative effects on a person following a specific diet that excludes various food groups, including meat, eggs, vegetables, and fruits, while only increasing protein intake — *àpọǹdè* (diet) that lacks vitamins.\n</step1>\n<step2>\nThis diet could lead to deficiencies, particularly in essential nutrients that are typically obtained from the excluded food groups — *awọn eroja pataki* (essential elements).\n</step2>\n<step3>\nOne major concern is the absorption of amino acids, which are crucial for protein synthesis — *gbigba awọn amino acids* (absorption of amino acids) is vital for maintaining muscle and overall health.\n</step3>\n<step4>\nIf the diet lacks variety, it may hinder the body's ability to utilize these amino acids effectively — *ìṣe amuṣiṣẹpọ* (utilization process) could be compromised.\n</step5>\n<step5>\nAmong the options provided, the most significant impact would likely be related to the absorption of amino acids through the digestive system — *gbigba àwọn amino acids wọlé nípa ifun inu* (absorption of amino acids through digestion).\n</step6>\n<step6>\nThus, the answer focuses on the negative consequence of amino acid absorption due to the restrictive nature of the diet.\n</step6></thinking>", "answer": "<answer>Gbigba àwọn amino acids wọlé nípa ifun inu.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun meji kan ni a ti ṣe ayẹwo nipa aisan diphtheria lọwọ, o si ni àmì àrùn kan tí ó dàbí fíìmù funfun didan ni ayika tonsils rẹ̀. Ọmọ naa ní arakunrin ọdun mẹfa ni ile ti a ti fún ni gbogbo awọn oogun idiwọ gẹgẹ bi eto ìgbàdọgbọ́. Ṣe àwọn iṣẹ wo ni a gbọdọ ṣe lati dènà aisan diphtheria fun arakunrin naa?", "reasoning": "<thinking><step1>\nThe question asks: “What measures should be taken to prevent [aisan diphtheria = diphtheria] for the six-year-old brother?” It indicates that a two-year-old has been diagnosed with diphtheria and shows symptoms like a white film around the tonsils.\n</step1>\n<step2>\nDiphtheria is a serious bacterial infection that can lead to severe complications, especially in children — *àwọn ọmọde* are particularly vulnerable.\n</step2>\n<step3>\nTo prevent diphtheria, vaccination is crucial. The DTaP vaccine protects against diphtheria, tetanus, and pertussis — *àwọn ajẹsara DTaP* ni a nlo.\n</step3>\n<step4>\nSince the six-year-old lives with the infected child, it’s important to ensure he is up to date with his vaccinations — *jẹ́ kí a rí i pé ó ti gba gbogbo ajẹsara rẹ*.\n</step4>\n<step5>\nAdditionally, practicing good hygiene can help prevent the spread of the bacteria — *mú ìmúrasílẹ̀ tó dára* like frequent handwashing and avoiding close contact with the infected child.\n</step5>\n<step6>\nMonitoring for any symptoms in the older brother is also essential, as early detection can lead to prompt treatment — *ìmúlò àkíyèsí àkúnya*.\n</step6>\n<step7>\nIn summary, vaccination, hygiene practices, and monitoring are key steps to prevent diphtheria in the six-year-old.\n</step7></thinking>", "answer": "<answer>Lati dènà aisan diphtheria fun arakunrin naa, a gbọdọ ṣe àtúnṣe ajẹsara rẹ, mu ìmúrasílẹ̀ tó dára, àti ṣàkíyèsí àkúnya rẹ.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọlọdun 74 kan sọ pe ó ní àwọn ìkọlu àrùn gout púpọ̀ ní ika ẹsẹ̀ òsìrìì kan.  Kò ní àrùn kan ní ìsinsin yìí, a sì ti kọ́kọ́ fún un ní oogun allopurinol fun ìdènà àrùn gout.  Ní àwọn wọ̀nyí, èwo ni ọ̀nà tí oogun yìí ṣeé ṣe jùlọ láti ṣiṣẹ́?\nA. pọ̀ sí iṣẹ́ ṣiṣe ti uric acid\nB. dídènà jíjẹ́ kí renal tubular ṣe ìgbàjámọ́ uric acid\nC. dídènà xanthine oxidase\nD. dín didààmú àrùn gout tí ó gbóná", "reasoning": "<thinking><step1>\nThe question asks: “In a 74-year-old man with multiple gout attacks in his left foot, who is currently not experiencing an attack and has been prescribed allopurinol for gout prevention, which mechanism does this medication primarily work through?” \n</step1>\n<step2>\nAllopurinol is primarily used to lower uric acid levels in the body — *oògùn yìí n ṣiṣẹ́ láti dín uric acid kù*.\n</step2>\n<step3>\nIt does this by inhibiting xanthine oxidase, an enzyme involved in the production of uric acid — *xanthine oxidase ni àyàfi ti o n fa uric acid*.\n</step3>\n<step4>\nBy blocking this enzyme, allopurinol reduces the formation of uric acid, thus preventing gout attacks — *dídènà àrùn gout*.\n</step4>\n<step5>\nThe other options, such as increasing uric acid excretion or affecting renal tubular function, are not the primary actions of allopurinol — *kò jẹ́ iṣẹ́ àkọ́kọ́ rẹ*.\n</step6>\n<step7>\nTherefore, the correct answer is that allopurinol primarily works by inhibiting xanthine oxidase — *dídènà xanthine oxidase*.\n</step8></thinking>", "answer": "<answer>Dídènà xanthine oxidase.</answer>", "language": "Yoruba"}
{"question": "Ṣé kí ló jẹ́ orúkọ ẹ̀ka ìpínṣẹ̀ tí Ẹgbẹ́ Ìwádìí Lymphoma Àgbáyé ṣe lórí lymphoma tí kì í ṣe Hodgkin?", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé kí ló jẹ́ orúkọ ẹ̀ka ìpínṣẹ̀ tí Ẹgbẹ́ Ìwádìí Lymphoma Àgbáyé ṣe lórí lymphoma tí kì í ṣe Hodgkin?” — meaning it wants to know the name of the classification for non-Hodgkin lymphoma.\n</step1>\n<step2>\nNon-Hodgkin lymphoma (NHL) is a diverse group of blood cancers — *àwọn àrùn ẹ̀jẹ̀* — that includes many different subtypes.\n</step2>\n<step3>\nThe classification system for NHL is based on various factors, including the type of cells involved — *irú àwọn sẹẹli tí ó ní í ṣe pẹ̀lú*.\n</step3>\n<step4>\nThe World Health Organization (WHO) provides a comprehensive classification, which includes categories like B-cell and T-cell lymphomas — *lymphoma sẹẹli B* àti *lymphoma sẹẹli T*.\n</step4>\n<step5>\nIn summary, the term for the classification of lymphoma that is not Hodgkin is simply “non-Hodgkin lymphoma” — *lymphoma tí kì í ṣe Hodgkin*.\n</step5></thinking>", "answer": "<answer>Orúkọ ẹ̀ka ìpínṣẹ̀ tí Ẹgbẹ́ Ìwádìí Lymphoma Àgbáyé ṣe lórí lymphoma tí kì í ṣe Hodgkin ni \"non-Hodgkin lymphoma.\"</answer>", "language": "Yoruba"}
{"question": "Ọmọ obirin ọdun meji kan ní iba, ikọ́ àti ìṣòro ìgbìyẹn. Ní ọ̀rọ̀ aworan X-ray àyè ara, a rí ìkúnlẹ̀ nínú ẹ̀gbẹ́ ọ̀tún ìsàlẹ̀. Ó sàn pẹ̀lú àwọn oògùn apakò, ṣùgbọ́n nígbà tí a ṣe àtẹ̀léwò ní ọ̀sẹ̀ mẹ́jọ, a rí i pé ìkúnlẹ̀ náà pọ̀ sí i ní ẹ̀gbẹ́ ọ̀tún ìsàlẹ̀ àti iba. Ìwádìí rẹ̀ tó tẹ̀lé e yẹ ki o jẹ́:\nA. Bronchoscopy\nB. Ìgbẹ́ràn àkòkò bacteria ti nasopharynx\nC. CT scan ti àyè ara\nD. Ìdánwò àrùn àìlera", "reasoning": "<thinking><step1>\nThe question describes a two-year-old girl with fever, cough, and respiratory distress, and an X-ray shows a mass in the right lower lobe. It asks what the follow-up investigation should be.\n</step1>\n<step2>\nGiven the symptoms and the presence of a mass, we need to consider the likelihood of a serious condition — *àìlera tó ṣeé ṣe* like pneumonia or a tumor.\n</step2>\n<step3>\nA bronchoscopy — *ìtẹ̀sí àyẹ̀wò ẹ̀dá afẹ́fẹ́* — could help visualize the airways but may not be the best first step for a mass.\n</step3>\n<step4>\nA CT scan of the chest — *CT scan ti àyè ara* — provides detailed imaging and is crucial for assessing the mass's characteristics and extent.\n</step4>\n<step5>\nThe nasopharyngeal swab for bacteria — *ìgbẹ́ràn àkòkò bacteria ti nasopharynx* — is useful for infections but less relevant here since we already have a mass.\n</step5>\n<step6>\nConsidering the need for detailed imaging to guide further management, the best follow-up investigation is a CT scan.\n</step6></thinking>", "answer": "<answer>CT scan ti àyè ara.</answer>", "language": "Yoruba"}
{"question": "Ti ile-iṣẹ ẹrù ABC ba gba owo sisan ti $0.084 fun poun lati gbe awọn ohun elo, melo ni wọn yoo gba lati gbe ẹrọ fifọ 275-poun lati Ilu New York si Albany?", "reasoning": "<thinking><step1>\nThe question asks: “Ti ile-iṣẹ ẹrù ABC ba gba owo sisan ti $0.084 fun poun” — meaning it wants to know how much it will cost to ship a 275-pound machine from New York to Albany at a rate of $0.084 per pound.\n</step1>\n<step2>\nTo find the total cost, we need to multiply the weight of the machine by the shipping rate — *iyẹn ni, a gbọdọ ṣe iṣiro 275 poun* times $0.084.\n</step2>\n<step3>\nCalculating this gives us: 275 * 0.084 = $23.1 — *iyẹn ni, $23.10*.\n</step3>\n<step4>\nThis means that the shipping cost for the machine is $23.10 — *nitorinaa, idiyele gbigbe fun ẹrọ naa ni $23.10*.\n</step5>\n<step5>\nThus, the company will charge $23.10 to ship the 275-pound machine — *nitorinaa, ile-iṣẹ naa yoo gba $23.10*.\n</step6></thinking>", "answer": "<answer>Ile-iṣẹ ẹrù ABC yoo gba $23.10 lati gbe ẹrọ fifọ 275-poun lati Ilu New York si Albany.</answer>", "language": "Yoruba"}
{"question": "Okunrin kan fi awọn àmì àrùn wọnyi hàn: ailera, irora ikun apa oke, hyperpigmentation, arthritis, hyperglycemia, ati ẹdọ ti o tobi ti o le mu. Kini ayẹwo ti o ṣeeṣe julọ ti a fun ni apapọ awọn àmì àrùn wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “Okunrin kan fi awọn àmì àrùn wọnyi hàn: ailera [fatigue], irora ikun apa oke [upper abdominal pain], hyperpigmentation, arthritis, hyperglycemia [high blood sugar], ati ẹdọ ti o tobi [enlarged liver] ti o le mu.” — meaning it wants to know the most likely diagnosis given these symptoms.\n</step1>\n<step2>\nThe symptoms listed suggest a systemic issue, particularly with the liver and metabolism — *àwọn àrùn ti o ni ibatan si ẹdọ* and *ìṣoro àtọgbẹ*.\n</step2>\n<step3>\nHyperglycemia indicates potential diabetes, while the enlarged liver could suggest fatty liver disease — *àtọgbẹ ati àrùn ẹdọ fatty*.\n</step3>\n<step4>\nArthritis and fatigue may indicate an autoimmune component or chronic inflammation — *ìfarapa àtọgbẹ* or *ìfarapa àtọgbẹ ti ara*.\n</step4>\n<step5>\nConsidering all these factors, a likely diagnosis could be non-alcoholic fatty liver disease (NAFLD) with associated metabolic syndrome — *àrùn ẹdọ fatty ti kii ṣe oti*.\n</step6>\n<step6>\nThis condition often presents with the symptoms described, including fatigue and joint pain.\n</step6></thinking>", "answer": "<answer>Ayẹwo ti o ṣeeṣe julọ ni àrùn ẹdọ fatty ti kii ṣe oti pẹlu àtọgbẹ.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun 11 ni a mu wa si onísègùn fún àyẹ̀wò atẹle. Ó ti ní ìṣòro pẹ̀lú iṣẹ́ ilé-ẹ̀kọ́ rẹ̀ fún ọdún mẹrin sẹ́yìn. Ó ní àrùn ikọlu tí a tọ́jú pẹ̀lú valproic acid. Ó lè rìn láìsí ìrànlọ́wọ́ ní ọjọ́-orí ọdún mẹta, ó sì lè lo fọ́kì àti sọǹgbì ní ọjọ́-orí ọdún mẹrin. Ó wà ní ìpín 40th fún gíga àti ìpín 60th fún ìwúwo. Àwọn àmì ìlera jẹ́ àwọn tí ó wà láàrin àwọn àdánù. Àyẹ̀wò fi hàn ní ọ̀pọ̀lọpọ̀ freckles ní àwọn ìṣírí àkọ́kọ́ àti àwọn ìṣírí ẹ̀gbà, àti pẹ̀lú scoliosis. Ọ̀pọ̀lọpọ̀ àwọn macules hyperpigmented wa lórí ẹ̀gbà àti àyà. Ọ̀pọ̀lọpọ̀ àwọn nodules tí ó rọ, tí kò ní irora wa lórí àwọn ẹ̀yà àti àyà. Àyẹ̀wò ophthalmic fi hàn ní àwọn nodules iris hyperpigmented ní ìṣọ̀kan. Ẹnìyàn yìí ní ewu pọ̀ sí i fún èyíkéyí nínú àwọn ipo tókàn?\nA. Optic glioma\nB. Glaucoma\nC. Renal cell carcinoma\nD. Giant cell astrocytoma\n\"", "reasoning": "<thinking><step1>\nThe question is asking about the risk factors associated with a specific condition in an 11-year-old boy who has a history of educational difficulties and has been treated with valproic acid for a seizure disorder. Key terms include [scoliosis = scoliose] and [hyperpigmented nodules = nodules hyperpigmentés].\n</step1>\n<step2>\nGiven the patient's history, the presence of multiple freckles and hyperpigmented macules, as well as the ophthalmic findings of hyperpigmented iris nodules, suggests a possible genetic syndrome. This could indicate a higher risk for certain tumors.\n</step2>\n<step3>\nIn particular, the combination of these symptoms raises concern for conditions like neurofibromatosis, which is associated with optic gliomas — *gliomes optiques* — and other tumors.\n</step3>\n<step4>\nThe presence of nodules and the age of the patient are critical; optic gliomas are more common in children with neurofibromatosis type 1, especially when there are skin manifestations like freckles.\n</step4>\n<step5>\nWhile glaucoma and renal cell carcinoma are serious conditions, they are less directly linked to the symptoms presented. Giant cell astrocytoma is also a possibility but is less common than optic glioma in this context.\n</step5>\n<step6>\nThus, considering all the factors, the most likely risk for this patient is optic glioma due to the combination of his symptoms and medical history.\n</step6></thinking>", "answer": "<answer>Ewu pọ̀ sí i fún gliome optique.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 43 kan ti o ni àrùn àtọgbẹ ti irú keji, ti o ti n lo iwọn oògùn metformin tó pọ̀jùlọ, ati pe BMI rẹ̀ jẹ́ 31 kg/m^2. Bí ó tilẹ̀ jẹ́ pé ó ń tẹ̀lé ìtọ́ni oogun rẹ̀ dáadáa, tí ó sì ń ṣe eré ṣíṣe ojoojúmọ, HbA1c rẹ̀ ti pèsè sí 7.6% nìkan, ó sì fẹ́ padanu ìwúwo sí i. Nítorí àwọn èrò tí a ti gbé yè wọnyi, kí ni àṣàyàn tí ó dára jùlọ fún oògùn àtọgbẹ keji tí ó lè ràn wọ́n lọ́wọ́ láti dinku ìwúwo?", "reasoning": "<thinking><step1>\nThe question is asking: \"What is the best medication option for a 43-year-old woman with type 2 diabetes who is already on maximum metformin and has a BMI of 31 kg/m², but her HbA1c is still at 7.6%?\" \n</step1>\n<step2>\nThis patient is managing her diabetes well with metformin, but her HbA1c indicates that her blood sugar levels are not fully controlled — *nítorí náà, a nilo àṣàyàn míràn*.\n</step2>\n<step3>\nGiven her BMI of 31, she is classified as overweight — *ó jẹ́ ẹni tó ní ìwúwo tó pọ̀jù*. Weight loss can significantly improve her diabetes management.\n</step3>\n<step4>\nOptions for additional medications include GLP-1 receptor agonists, which can help with weight loss and improve glycemic control — *àwọn oògùn bíi liraglutide*.\n</step5>\n<step5>\nAnother option could be SGLT2 inhibitors, which also promote weight loss and have cardiovascular benefits — *àwọn oògùn bíi empagliflozin*.\n</step6>\n<step6>\nConsidering her situation, a GLP-1 receptor agonist might be the best choice due to its dual benefit of lowering blood sugar and aiding in weight loss.\n</step6></thinking>", "answer": "<answer>Àṣàyàn tí ó dára jùlọ fún un ni GLP-1 receptor agonist, gẹ́gẹ́ bí liraglutide, nitori pé ó lè ràn wọ́n lọ́wọ́ láti dinku ìwúwo àti ṣàkóso àtọgbẹ rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ọpá idẹ̀ kan tí apá ìkọ́rì rẹ̀ jẹ́ yíká, tí radius rẹ̀ jẹ́ 2.1 cm, ń gbé ṣiṣan sinusoidal kan ní iye tí í ṣe 1590 àwọn àyíká lọ́ṣọ̀ọ́kán. Ìwọ̀n ìṣàn ìgbòòrò àwọn axis J jẹ́ J = 0.01e^\\pir sin (\\omegat+\\pir) ampere/cm^2 níbi tí \\omega = 10^4 ti wà, ati r ń tọ́ka sí ìtòsí ní centimeters láti àárín waya náà. Wá agbára tí a ti sọ di ẹ̀gún ní iye centimeters kan ti iye gigùn. Ìwọ̀n itọ́kasi idẹ̀ náà jẹ́ 1.57 × 10^5 mhos/cm.\nA. 6.28 maikiro wati/cm\nB. 2.44 maikiro wati/cm\nC. 31.8 maikiro wati/cm\nD. 12.2 maikiro wati/cm\nE. 4.15 maikiro wati/cm\nF. 8.75 maikiro wati/cm\nG. 5.06 maikiro wati/cm\nH. 3.31 maikiro wati/cm\nI. 9.67 maikiro wati/cm\nJ. 1.59 maikiro wati/cm", "reasoning": "<thinking><step1>\nThe question asks about the power transmitted through a cylindrical conductor with a radius of 2.1 cm, carrying a sinusoidal current density described by J = 0.01e^(πr) sin(ωt + π) ampere/cm², where ω = 10^4. The goal is to find the power per unit length in micro-watts per centimeter.\n</step1>\n<step2>\nFirst, we need to calculate the total current flowing through the conductor. The current density J is given, and we can find the total current I by integrating J over the cross-sectional area A of the cylinder — *I = ∫ J dA*.\n</step2>\n<step3>\nThe area A for a circle is A = πr². Here, r = 2.1 cm, so A = π(2.1)². This gives us the area in cm², which we will use to find the total current.\n</step3>\n<step4>\nNext, we substitute the value of J into the integral to find I: *I = ∫(0.01e^(πr) sin(ωt + π)) dA*. We will evaluate this integral over the area of the circle.\n</step4>\n<step5>\nAfter finding the total current, we can calculate the power using the formula P = I²R, where R is the resistance per unit length. The resistance can be derived from the conductivity of the material, which is given as 1.57 × 10^5 mhos/cm.\n</step5>\n<step6>\nFinally, we convert the power into micro-watts per centimeter. The options provided will help us identify the correct answer based on our calculations.\n</step6></thinking>", "answer": "<answer>6.28 maikiro wati/cm</answer>", "language": "Yoruba"}
{"question": "Obirin ọdún 28 kan tí ó ní ìtàn àrùn migraine ati ìṣẹ̀lẹ̀ ìríra ìríra ojú ọ̀tún rẹ̀ nígbà díẹ̀ sẹ́yìn, tí ó bá pẹlu ìṣòro sísọ̀rọ̀, farahàn pẹlu awọn ìṣẹ̀lẹ̀ tí ó mú kí àrùn naa ṣe kedere ní iṣan ojú ọ̀tún lórí MRI. Nígbà tí a bá gbé yẹ̀wò àwọn àmì-àìsàn tí ó dàbí èyí rí tẹ́lẹ̀, ati àwòrán àrùn náà, oògùn wo ni a lò láti dènà kí àrùn náà má ṣe burú sí i ní ipò yìí tí a ṣàpẹẹrẹ rẹ̀ pẹlu àìní àìlera ati optic neuritis?", "reasoning": "<thinking><step1>\nThe question asks about a 28-year-old woman with a history of [àrùn migraine = migraine] and recent symptoms of [ìríra ojú = eye pain] on the right side, along with speech difficulties. It seeks to identify the treatment options to prevent worsening of her condition, which is linked to findings on an MRI.\n</step1>\n<step2>\nMigraine can sometimes present with neurological symptoms, such as *ìṣòro sísọ̀rọ̀* (speech difficulties) and *ìríra ojú* (eye pain), especially if there are complications like *optic neuritis*.\n</step2>\n<step3>\nThe MRI findings likely indicate inflammation or other changes in the optic nerve, which can be associated with migraines or other conditions — *àwọn àyípadà ninu iṣan ojú*.\n</step3>\n<step4>\nIn managing migraines, especially with neurological symptoms, medications like *triptans* are commonly used to relieve acute attacks, but in this case, we may need to consider preventive treatments.\n</step4>\n<step5>\nPreventive treatments could include *beta-blockers* or *antidepressants*, which help reduce the frequency and severity of migraine attacks — *dènà kí àrùn naa má ṣe burú sí i*.\n</step5>\n<step6>\nAdditionally, if there is a concern for *optic neuritis*, corticosteroids might be indicated to reduce inflammation and protect the optic nerve.\n</step6>\n<step7>\nThus, the treatment plan should focus on both migraine management and addressing any potential complications related to the optic nerve.\n</step7></thinking>", "answer": "<answer>Oògùn ti a le lo ni beta-blockers ati corticosteroids lati dènà kí àrùn migraine naa má ṣe burú sí i ati lati dinku ìtàn àrùn optic neuritis.</answer>", "language": "Yoruba"}
{"question": "Ìwò mélòó kálì níí ṣe pàtàkì láti pese àwọn kalori tó tó fún ènìyàn fún ọdún kan?\nA. 3*10^3 kg/yr\nB. 5*10^4 kg/yr\nC. 2*10^3 kg/yr\nD. 2*10^5 kg/yr\nE. 2*10^6 kg/yr\nF. 2*10^7 kg/yr\nG. 1*10^6 kg/yr\nH. 4*10^5 kg/yr\nI. 2*10^2 kg/yr\nJ. 2*10^4 kg/yr", "reasoning": "<thinking><step1>\nThe question asks: “Ìwò mélòó kálì níí ṣe pàtàkì láti pese àwọn kalori tó tó fún ènìyàn fún ọdún kan?” — which translates to “How many calories are necessary to provide for a person in a year?”\n</step1>\n<step2>\nTo answer this, we need to consider the average daily caloric intake required for a person — *ìdíyelé kalori ojoojúmọ́*.\n</step2>\n<step3>\nTypically, an adult requires about 2,000 to 2,500 calories per day, depending on factors like age, sex, and activity level — *ìdíyelé kalori yìí yàtọ̀ síra*.\n</step3>\n<step4>\nCalculating for a year, we multiply the daily requirement by the number of days in a year — *365 ọjọ́*.\n</step4>\n<step5>\nFor example, if we take an average of 2,200 calories per day, that would be 2,200 * 365 = 803,000 calories per year.\n</step5>\n<step6>\nNow, converting calories to kilograms, we know that 1 kg of body weight is approximately equivalent to 7,700 calories — *kílọ́gírámù*.\n</step6>\n<step7>\nThus, 803,000 calories divided by 7,700 calories/kg gives us about 104 kg per year — *104 kílọ́gírámù*.\n</step7>\n<step8>\nLooking at the options provided, the closest value to 104 kg is 1*10^2 kg/yr, which is 100 kg.\n</step8></thinking>", "answer": "<answer>2*10^2 kg/yr</answer>", "language": "Yoruba"}
{"question": "Iṣe ti ara ti o dàbí ti agbaṣiṣẹ́ ni o wọ́pọ̀ jùlọ ninu obinrin ti o kú pẹlu -a) Ikun pa tẹ́lẹ̀ ikú b) Ikun lẹ́yìn ikú c) Ìkùnrẹ̀rẹ̀ afẹ́fẹ́ d) Majele monoxide karboni\nA. ac\nB. ab\nC. ad\nD. bc", "reasoning": "<thinking><step1>\nThe question asks: “Iṣe ti ara ti o dàbí ti agbaṣiṣẹ́ ni o wọ́pọ̀ jùlọ ninu obinrin ti o kú” — meaning it is inquiring about the most common physiological response in women who die from certain conditions.\n</step1>\n<step2>\nThe options provided include: a) *Ikun pa tẹ́lẹ̀ ikú* (death before death), b) *Ikun lẹ́yìn ikú* (death after death), c) *Ìkùnrẹ̀rẹ̀ afẹ́fẹ́* (asphyxia), and d) *Majele monoxide karboni* (carbon monoxide poisoning).\n</step2>\n<step3>\nTo analyze these, we consider that *Ìkùnrẹ̀rẹ̀ afẹ́fẹ́* is a common cause of death due to lack of oxygen, which is particularly relevant in cases of suffocation or drowning.\n</step3>\n<step4>\nOn the other hand, *Majele monoxide karboni* can also lead to death, but it is less common compared to asphyxia in women.\n</step4>\n<step5>\nThus, the most prevalent physiological response leading to death in women is likely *Ìkùnrẹ̀rẹ̀ afẹ́fẹ́*, as it directly relates to the body's inability to breathe.\n</step5>\n<step6>\nConsidering the options, the correct answer aligns with c) *Ìkùnrẹ̀rẹ̀ afẹ́fẹ́*.\n</step6></thinking>", "answer": "<answer>Ìkùnrẹ̀rẹ̀ afẹ́fẹ́.</answer>", "language": "Yoruba"}
{"question": "Okunrin kan ti ọdun mejilelọgbọn (72) ti o sanra pupọ, ti o ṣẹṣẹ gbe lọ si Denver, ti n ṣe afihan irẹlẹ ati ikọlu afẹfẹ kukuru.  O ni itan igba ti o mu siga, iṣọn-ẹjẹ jinlẹ, abẹrẹ kansẹẹ ọpọlọ, ati itan-ẹbi aarun ọpọlọ ti o ni ihamọ. Awọn iye idanwo ile-iwosan rẹ fihan titẹ okisijini ninu afẹfẹ ti a gbà ni 130 mmHg, titẹ erogba ti a fi agbara mu ninu alveolar ni 48 mmHg, titẹ okisijini ti ọna-ara ni 58 mmHg, ipin okisijini-erogba ti 0.80, iyara mimi ni 20/min, ati iwọn didun ninu mimi kọọkan ni 500 mL.  Iṣẹ ṣiṣe ti ara wo ni o baamu pẹlu awọn iye idanwo ile-iwosan wọnyi?", "reasoning": "<thinking><step1>\nThe question describes a 72-year-old man who is very overweight and recently moved to Denver, experiencing shortness of breath and respiratory distress. It mentions his medical history, including smoking, deep vein thrombosis, a stroke, and a family history of respiratory diseases.\n</step1>\n<step2>\nHis lab results show an oxygen pressure of 130 mmHg, which is relatively high, but the alveolar carbon dioxide pressure is 48 mmHg — *titẹ erogba ti a fi agbara mu ninu alveolar* — indicating potential respiratory issues.\n</step2>\n<step3>\nThe arterial oxygen pressure is 58 mmHg, which is low, suggesting *hypoxemia* — a deficiency in the amount of oxygen reaching the tissues.\n</step3>\n<step4>\nThe oxygen-carbon dioxide ratio of 0.80 indicates that while he is getting some oxygen, the exchange is not optimal, likely due to his history of lung issues and current symptoms.\n</step4>\n<step5>\nHis respiratory rate of 20/min and tidal volume of 500 mL suggest he is trying to compensate for low oxygen levels, which is common in patients with respiratory distress.\n</step5>\n<step6>\nGiven these values, the most fitting physiological condition would be *insuffisance respiratoire* — respiratory failure, likely due to a combination of his obesity, history of smoking, and possible chronic obstructive pulmonary disease (COPD).\n</step6></thinking>", "answer": "<answer>Ipo ti o baamu ni *insuffisance respiratoire* nitori awọn iṣoro atẹgun ati itan iṣoogun rẹ.</answer>", "language": "Yoruba"}
{"question": "\"Eyi ni ariyanjiyan ti o peye: Àkọ́kọ́, jíjẹ́ ọmọbìnrin Alicia ṣe pàtàkì fún àìjẹ́ ọmọ ìyá Theresa. Èkejì, jíjẹ́ ọmọbìnrin Alicia ṣe pàtàkì fún àìjẹ́ ẹgbẹ́ Priscilla níbi iṣẹ́. Ẹ̀kẹta, gbogbo àbúrò Dawn jẹ́ ọmọ ìyá Theresa àti ẹgbẹ́ Priscilla níbi iṣẹ́. A lè parí èrò sí: Gbogbo àbúrò Dawn tún jẹ́ ọmọbìnrin Alicia.\"\nṢé ariyanjiyan náà péye tàbí kò péye, ní ìbámu pẹ̀lú àwọn àlàyé tí a sọ̀rọ̀ nípa wọn?\nÀwọn àṣàyàn:\n- péye\n- kò péye", "reasoning": "<thinking><step1>\nThe question asks: “Is this argument valid or invalid based on the statements provided?” It presents a logical structure involving Alicia, Theresa, and Priscilla.\n</step1>\n<step2>\nFirst, we note that Alicia is important for Theresa's childlessness — *jíjẹ́ ọmọbìnrin Alicia ṣe pàtàkì fún àìjẹ́ ọmọ ìyá Theresa*. This suggests a significant relationship.\n</step2>\n<step3>\nNext, it states that Alicia is also important for Priscilla's group at work — *jíjẹ́ ọmọbìnrin Alicia ṣe pàtàkì fún àìjẹ́ ẹgbẹ́ Priscilla níbi iṣẹ́*. This indicates that Alicia has a role in both contexts.\n</step4>\n<step5>\nThe third point mentions that all of Dawn's siblings are children of Theresa and part of Priscilla's group — *gbogbo àbúrò Dawn jẹ́ ọmọ ìyá Theresa àti ẹgbẹ́ Priscilla níbi iṣẹ́*. This connects Dawn to both Theresa and Priscilla.\n</step6>\n<step7>\nFrom these statements, we can infer that if all of Dawn's siblings are related to both Theresa and Priscilla, and Alicia is crucial to both, then it follows that all of Dawn's siblings must also be Alicia's children — *Gbogbo àbúrò Dawn tún jẹ́ ọmọbìnrin Alicia*.\n</step8>\n<step9>\nThus, the argument logically concludes that if the premises are true, the conclusion must also be true, making the argument valid.\n</step9></thinking>", "answer": "<answer>Ariyanjiyan náà péye.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹta kan wà ni ayẹwo fun ìṣàn ìmú nigbagbogbo pẹlu ayẹwo ara ti o fihan petechiae ti o tan kaakiri lori awọn ẹya ara rẹ ati smear ẹjẹ agbegbe ti o fihan pe ko si platelet clumping. Ayẹwo ELISA binding fihan aini awọn oniwọn GpIIb/IIIa lori awọn dada platelet.  Ewo ni oogun ti o ṣe afiwe ipo aini oniwọn yii lori awọn platelet, ti o jọra si awọn abajade ni alaisan yii?", "reasoning": "<thinking><step1>\nThe question is asking about a three-year-old boy undergoing tests for a bleeding disorder, specifically mentioning *ìṣàn ìmú* [bleeding disorder] and *petechiae* [small red or purple spots on the skin]. It also notes that the blood smear shows no platelet clumping and that the ELISA test indicates a lack of GpIIb/IIIa receptors on the platelets.\n</step1>\n<step2>\nIn this context, the absence of GpIIb/IIIa receptors suggests a condition similar to *syndrome de Glanzmann*, which is characterized by defective platelet aggregation.\n</step2>\n<step3>\nThe question seeks a medication that mimics the effects of this receptor deficiency. Typically, *les médicaments anti-agrégants plaquettaires* [antiplatelet drugs] are used to manage similar conditions.\n</step3>\n<step4>\nOne common medication that could be relevant here is *l'abciximab*, which is a monoclonal antibody that inhibits GpIIb/IIIa receptors, thus preventing platelet aggregation.\n</step4>\n<step5>\nIn essence, the treatment would aim to manage bleeding by mimicking the lack of receptor function, similar to what is observed in this patient.\n</step5>\n<step6>\nTherefore, the drug that aligns with this condition is one that targets the GpIIb/IIIa pathway, effectively reducing platelet aggregation.\n</step6></thinking>", "answer": "<answer>Oògùn ti o ṣe afiwe ipo aini oniwọn yii ni *abciximab*, ti o dènà iṣọpọ awọn platelet.</answer>", "language": "Yoruba"}
{"question": "Obirin ọlọdun 80 kan ti ní ìṣòro níní ilẹ̀mọ, ẹ̀mí ṣíṣe buburu fún oṣù mẹrin, ati ṣiṣe crepitations ninu ẹ̀dòfóró rẹ̀. A ṣe idanwo barium swallow. Kini aisan ti o ṣee ṣe julọ da lori awọn ami aisan wọnyi ati awọn esi idanwo naa?", "reasoning": "<thinking><step1>\nThe question asks: “Obirin ọlọdun 80 kan ti ní ìṣòro níní ilẹ̀mọ [difficulty swallowing], ẹ̀mí ṣíṣe buburu [shortness of breath] fún oṣù mẹrin [for four months], ati ṣiṣe crepitations [crepitations] ninu ẹ̀dòfóró rẹ̀ [in her lungs]. A ṣe idanwo barium swallow [barium swallow test]. Kini aisan ti o ṣee ṣe julọ [What is the most likely condition] da lori awọn ami aisan wọnyi ati awọn esi idanwo naa?” \n</step1>\n<step2>\nThe symptoms indicate a potential issue with the esophagus, as difficulty swallowing can suggest *dysphagia* or an obstruction. \n</step2>\n<step3>\nThe shortness of breath and crepitations in the lungs may imply that there is a respiratory component, possibly due to aspiration or a related condition.\n</step3>\n<step4>\nThe barium swallow test helps visualize the esophagus and can reveal structural abnormalities or motility issues — *awọn iṣoro iṣipopada*.\n</step4>\n<step5>\nGiven the age of the patient and the symptoms, one possible diagnosis could be *esophageal cancer* or *stricture*, which can lead to both swallowing difficulties and respiratory issues due to aspiration.\n</step5>\n<step6>\nIn summary, the combination of these symptoms and the results from the barium swallow test suggest a serious underlying condition affecting both the esophagus and potentially the lungs.\n</step6></thinking>", "answer": "<answer>Aisan ti o ṣee ṣe julọ ni *iṣoro ẹnu-ọna* tabi *cancer ẹnu-ọna* ti o fa ìṣòro níní ilẹ̀mọ ati ẹ̀mí ṣíṣe buburu.</answer>", "language": "Yoruba"}
{"question": "Nígbà tí àrùn ìgbóná tí ó bá ẹ̀dùn-ẹ̀jẹ̀ (febrile neutropenia) bá wà, tí ìwádìí ẹ̀jẹ̀ sì fi hàn pé Pseudomonas aeruginosa tí ó ń ṣe extended spectrum beta-lactamase ni ó fa àrùn náà, kí ni ọ̀nà ìtọ́jú àrùn tí ó dára jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “What is the best treatment for febrile neutropenia caused by Pseudomonas aeruginosa producing extended spectrum beta-lactamase?” — it seeks to understand the optimal management for this specific infection.\n</step1>\n<step2>\nFebrile neutropenia occurs when a patient has a fever and a low white blood cell count — *àrùn ìgbóná* àti *ìkúnà ẹ̀dùn-ẹ̀jẹ̀* can lead to serious infections.\n</step2>\n<step3>\nPseudomonas aeruginosa is a common pathogen in these cases, especially when it produces extended spectrum beta-lactamase — *Pseudomonas aeruginosa* le fa àrùn tí ó nira lati tọju.\n</step3>\n<step4>\nThe first-line treatment typically involves broad-spectrum antibiotics — *antibiotics ti o ni ibamu* to cover resistant organisms.\n</step4>\n<step5>\nIn this case, using a combination of piperacillin-tazobactam or ceftazidime with an aminoglycoside may be effective — *piperacillin-tazobactam* ni a maa n lo fun Pseudomonas.\n</step5>\n<step6>\nAdditionally, monitoring for clinical response and adjusting therapy based on culture results is crucial — *ìmúlò àyẹ̀wò ẹ̀jẹ̀* jẹ́ pataki.\n</step6>\n<step7>\nTherefore, the best approach is to initiate empirical therapy promptly and adjust as needed based on sensitivity — *ìtọ́jú àrùn yẹ ki o bẹ̀rẹ̀ ni kiakia*.\n</step7></thinking>", "answer": "<answer>Ìtọ́jú àrùn tí ó dára jùlọ ni piperacillin-tazobactam pẹ̀lú aminoglycoside, pẹ̀lú ìmúlò àyẹ̀wò ẹ̀jẹ̀.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun 67 kan ni ọkọ rẹ̀ mú wá sí ile-iwosan nítorí àyípadà nínú ìwà rẹ̀. Ọkọ rẹ̀ sọ pé ọdún mẹta sẹ́yìn ni ó bẹ̀rẹ̀ sí í gbàgbé àwọn nǹkan ojoojúmọ (fún àpẹẹrẹ, ibì tí àwọn bọtini rẹ̀ wà àti ọ̀nà ilé). Ó máa ń gbàgbé àwọn ọ̀rẹ́ rẹ̀ nígbà míì, ó sì máa ń fi rimo sinu firiji. Láìpẹ́ yìí, ọkọ rẹ̀ kíyèsí àwọn àyípadà tó burú jáì nínú ìwà rẹ̀ bí ó ti di aláìgbàdúrà, oníwà ìbínú, àti nígbà míì, olóògùn. Kò sọ pé ó ní iba, ìpalára, àìṣiṣẹ́ ti ara ẹni, tàbí àyípadà ìmọ̀lára. Ìtàn àìsàn rẹ̀ ti ìṣáájú jẹ́ pàtàkì fún àrùn suga àti àtìgbàgbọ́ ẹ̀jẹ̀, tí ó fi metformin àti lisinopril ń gbà. Ìwádìí ara kò sí ohun pàtàkì. Níwọn ìwọ̀n wo nínú àwọn àwòrán wọ̀nyí ni ó ṣe afihan àrùn rẹ̀?\nA. A\nB. B\nC. C\nD. D", "reasoning": "<thinking><step1>\nThe question is asking about a 67-year-old woman whose husband brought her to the hospital due to changes in her behavior. Key terms include [àyípadà nínú ìwà = changes in behavior] and [àrùn suga = diabetes].\n</step1>\n<step2>\nThe husband reports that three years ago, she started forgetting daily things — *gbàgbé àwọn nǹkan ojoojúmọ* — like where her keys are and the way home.\n</step2>\n<step3>\nShe also forgets her friends sometimes and puts items in the refrigerator, indicating possible cognitive decline — *ìdàgbàsókè ọpọlọ*.\n</step3>\n<step4>\nRecently, her husband noticed significant behavioral changes, such as becoming apathetic, irritable, and occasionally aggressive — *aláìgbàdúrà, oníwà ìbínú, àti olóògùn*.\n</step4>\n<step5>\nHer medical history includes diabetes and hypertension, for which she takes metformin and lisinopril, but there are no acute physical symptoms reported — *kò sọ pé ó ní iba tàbí àìṣiṣẹ́ ti ara ẹni*.\n</step6>\n<step6>\nGiven these symptoms, the changes in her behavior could suggest a form of dementia or cognitive impairment, which is often reflected in imaging studies — *àwòrán*.\n</step7>\n<step7>\nThe question asks for the extent of her condition as shown in imaging, which typically would be classified into categories A, B, C, or D based on severity.\n</step8>\n<step8>\nConsidering her symptoms and history, it is likely that the imaging would show significant changes consistent with dementia, possibly aligning with category C or D.\n</step8></thinking>", "answer": "<answer>C</answer>", "language": "Yoruba"}
{"question": "Bí X àti Y kì í ṣe àwọn àyíkáwòrán ìṣẹ̀lẹ̀ tí wọn jọ ṣiṣẹ́, báwo lo ṣe lè sọ ìyàtọ̀ àyíkáwòrán ìṣẹ̀lẹ̀ Z = X + Y?", "reasoning": "<thinking><step1>\nThe question asks: “Báwo lo ṣe lè sọ ìyàtọ̀ àyíkáwòrán ìṣẹ̀lẹ̀ Z = X + Y?” — meaning it wants to know how to express the difference in the event space Z when X and Y are not overlapping.\n</step1>\n<step2>\nIn probability theory, when we say X and Y are not overlapping, we mean they are *disjoint events* — *àwọn ìṣẹ̀lẹ̀ tí kò ní àfihàn*.\n</step2>\n<step3>\nTo find the event space Z, we consider the union of X and Y — *ìkànsí X àti Y* — which means we combine all outcomes from both events.\n</step3>\n<step4>\nHowever, since they are disjoint, the probability of Z is simply the sum of the probabilities of X and Y — *P(Z) = P(X) + P(Y)*.\n</step4>\n<step5>\nThus, the difference in the event space Z can be expressed as the total outcomes from both events without any overlap — *àwọn abajade ti X àti Y pẹ̀lú*.\n</step5>\n<step6>\nIn conclusion, the event space Z = X + Y represents the combined outcomes of two separate events.\n</step6></thinking>", "answer": "<answer>Àyíkáwòrán ìṣẹ̀lẹ̀ Z = X + Y jẹ́ àkópọ̀ àwọn abajade ti X àti Y, nígbà tí wọn kò ní àfihàn.</answer>", "language": "Yoruba"}
{"question": "Labẹ apawo ni Ìgbéwọ́ Ẹ̀ṣẹ̀ India ni iṣẹ́ tí ó jẹ́ pé a máa pa ẹnikan mọ́ lábẹ́ agbára ẹni, tí a sì máa ṣe ìṣẹ̀lẹ̀kùn sí i láìní ìpinnu láti pa á ni a ti gbékalẹ̀?", "reasoning": "<thinking><step1>\nThe question translates to: \"What is the [law = ofin] in India that allows someone to be detained under personal authority without a decision to kill them?\" This indicates a focus on legal provisions regarding detention.\n</step1>\n<step2>\nIn India, the law that permits such detention is often referred to as *Preventive Detention Act* — *Ofin Idena*.\n</step2>\n<step3>\nThis law allows authorities to detain individuals to prevent them from committing future crimes — *lati dena wọn lọwọ lati ṣe ẹṣẹ*.\n</step3>\n<step4>\nThe detention can occur without a formal charge or trial, which raises concerns about *ilana ododo* (due process).\n</step4>\n<step5>\nThe law is intended to maintain public order and security, but it can be misused, leading to *iṣoro ti ẹtọ eniyan* (human rights issues).\n</step5>\n<step6>\nIn summary, the *Ofin Idena* allows for detention without trial, aiming to prevent potential threats to society.\n</step6></thinking>", "answer": "<answer>Ofin Idena ni India n gba laaye lati pa ẹnikan mọ́ lábẹ́ agbára ẹni láìní ìpinnu láti pa á, lati dena wọn lọwọ lati ṣe ẹṣẹ.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 52 kan ti ṣe iwọn ara pẹlu aiṣiṣẹ́ oúnjẹ, ó sì nfẹ́rẹ̀ẹ́ sun gbogbo akoko. Ó hàn bí ẹni tí kò nífẹ̀ẹ́ ohunkóhun, ó sì ní ìdààmú ọkàn, ó ń kùn pe ó ń rí gbàrà gbogbo ìgbà, irun rẹ̀ gbẹ́, ó sì gbẹ́, ojú rẹ̀ sì gbòò. Ṣe àyẹ̀wò ilé-iṣẹ́ wo ni ó ṣeé ṣe julọ láti gbé ga ní ipò rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What type of [ilè-iṣẹ́ = workplace] is most suitable for a 52-year-old woman who is experiencing various health issues?” It describes her as having low energy, feeling depressed, and showing signs of physical deterioration.\n</step1>\n<step2>\nFirst, we need to consider her symptoms: *aiṣiṣẹ́ oúnjẹ* (poor nutrition), *ìdààmú ọkàn* (mental distress), and physical signs like *irun gbẹ́* (dry hair) and *ojú gbòò* (puffy face).\n</step2>\n<step3>\nThese symptoms suggest she may benefit from a supportive work environment that accommodates her health needs — perhaps a job that allows for flexible hours or less physical strain.\n</step3>\n<step4>\nA suitable workplace could be one that focuses on *ilera ati itọju* (health and wellness), such as a health clinic or a wellness center, where she can engage in activities that promote her recovery.\n</step4>\n<step5>\nAdditionally, a role that involves *iṣẹ́ àkóso* (administrative work) or *iṣẹ́ àjọṣepọ* (collaborative work) might be less physically demanding and provide a supportive atmosphere.\n</step5>\n<step6>\nUltimately, the best workplace for her would prioritize her well-being and allow her to gradually reintegrate into work while managing her health challenges.\n</step6></thinking>", "answer": "<answer>Ilé-iṣẹ́ to dára jùlọ fún un ni ilé-iṣẹ́ ilera tabi ilé-iṣẹ́ itọju, nibi ti yóò ti lè ṣiṣẹ́ ni irọrun ati ni àyíká to ní atilẹyin.</answer>", "language": "Yoruba"}
{"question": "Alice, Bob, Claire, Dave, àti Eve ń ṣe eré pàṣípààrọ̀ ẹ̀bùn kan tí wọ́n ń pè ní erin funfun. Ní ìbẹ̀rẹ̀ ayẹyẹ náà, ọ̀kọ̀ọ̀kan wọn mú ẹ̀bùn aláwọ̀ ọ̀tọ̀ọ̀tọ̀ lọ́wọ́: Alice mú ẹ̀bùn aláwọ̀ ilẹ̀ (brown) lọ́wọ́, Bob mú ẹ̀bùn funfun lọ́wọ́, Claire mú bọ́ọ̀lù dúdú lọ́wọ́, Dave mú ẹ̀bùn pupa lọ́wọ́, àti Eve mú ẹ̀bùn aláwọ̀ elésè àlùkò (purple) lọ́wọ́.\nBí ayẹyẹ náà ti ń lọ síwájú, àwọn ènìyàn ní méjì méjì ń pàṣípààrọ̀ ẹ̀bùn. Lákọ̀ọ́kọ́, Bob àti Claire pàṣípààrọ̀ ẹ̀bùn wọn. Lẹ́yìn náà, Eve àti Alice pàṣípààrọ̀ ẹ̀bùn wọn. Lẹ́yìn náà, Bob àti Claire tún pàṣípààrọ̀ ẹ̀bùn wọn. Lẹ́yìn náà, Claire àti Dave pàṣípààrọ̀ ẹ̀bùn wọn. Níkẹyìn, Eve àti Dave pàṣípààrọ̀ ẹ̀bùn wọn. Ní òpin ayẹyẹ náà, Eve ní\nÀwọn Àṣàyàn:\n(A) ẹ̀bùn aláwọ̀ ilẹ̀ (brown)\n(B) ẹ̀bùn funfun\n(C) bọ́ọ̀lù dúdú\n(D) ẹ̀bùn pupa\n(E) ẹ̀bùn aláwọ̀ elésè àlùkò (purple)", "reasoning": "<thinking><step1>\nThe question describes a gift exchange game involving Alice, Bob, Claire, Dave, and Eve, where each person starts with a uniquely colored gift. It asks what gift Eve has at the end of the game.\n</step1>\n<step2>\nInitially, the gifts are: Alice has a *brown gift*, Bob has a *white gift*, Claire has a *black ball*, Dave has a *red gift*, and Eve has a *purple gift*.\n</step2>\n<step3>\nThe exchange sequence starts with Bob and Claire swapping their gifts. After this swap, Bob has the *black ball* and Claire has the *white gift*.\n</step3>\n<step4>\nNext, Eve and Alice swap their gifts. Now, Eve has the *brown gift* and Alice has the *purple gift*.\n</step4>\n<step5>\nThen, Bob and Claire swap again. Bob returns to having the *white gift* while Claire has the *black ball*.\n</step5>\n<step6>\nAfter that, Claire and Dave swap gifts. Claire now has the *red gift* and Dave has the *black ball*.\n</step6>\n<step7>\nFinally, Eve and Dave swap gifts. Eve ends up with the *red gift* while Dave takes the *purple gift*.\n</step7></thinking>", "answer": "<answer>Ẹ̀bùn pupa.</answer>", "language": "Yoruba"}
{"question": "Ṣé gbólóhùn tó tẹ̀ lé e yìí ṣeé gbàgbọ́? \"John Carlson wọ agbègbè ìgbéjàkò ní Stanley Cup.\"", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé gbólóhùn tó tẹ̀ lé e yìí ṣeé gbàgbọ́?” — meaning it wants to know if the statement “John Carlson won the Stanley Cup” is believable.\n</step1>\n<step2>\nTo assess the truth of this statement, we need to consider the context of the Stanley Cup — *ìdíje Stanley Cup* — which is a prestigious ice hockey championship.\n</step2>\n<step3>\nJohn Carlson is a well-known player, and he plays for the Washington Capitals — *Washington Capitals ni ẹgbẹ́ rẹ*.\n</step3>\n<step4>\nThe Capitals won the Stanley Cup in 2018, which means Carlson was part of that victory — *Carlson jẹ́ apá kan nínú àṣeyọrí yẹn*.\n</step4>\n<step5>\nTherefore, the statement is true because it reflects a historical fact about Carlson's achievement in the Stanley Cup.\n</step5></thinking>", "answer": "<answer>Bẹẹni, gbolohun naa jẹ́ otitọ; John Carlson ṣẹ́gun ìdíje Stanley Cup ní 2018.</answer>", "language": "Yoruba"}
{"question": "Kini ilana kan tí kò ka si ilana kékeré gẹ́gẹ́ bí àwọn ìlànà NADA fún ṣíṣàyẹ̀wò àrùn ọkàn ọmọdé?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ilana kan tí kò ka si ilana kékeré gẹ́gẹ́ bí àwọn ìlànà NADA fún ṣíṣàyẹ̀wò àrùn ọkàn ọmọdé?” — meaning it wants to know about a process that is not a minor procedure according to NADA guidelines for assessing childhood mental health.\n</step1>\n<step2>\nNADA, which stands for *National Acupuncture Detoxification Association*, provides protocols for mental health assessments — *ìmúlò àyẹ̀wò àrùn ọkàn*.\n</step2>\n<step3>\nA major process in this context could be a comprehensive evaluation, which includes *ìtẹ́numọ̀ àyẹ̀wò* and possibly psychological testing.\n</step3>\n<step4>\nThis evaluation would assess various factors such as *ìtàn ìlera*, family dynamics, and social environment — all crucial for understanding the child's mental health.\n</step4>\n<step5>\nUnlike minor procedures, this comprehensive approach requires collaboration with healthcare professionals — *àwọn amọ̀ja ilera* — to ensure accurate diagnosis and treatment planning.\n</step5>\n<step6>\nIn summary, a major process not classified as a minor procedure involves thorough assessments and interdisciplinary collaboration.\n</step6></thinking>", "answer": "<answer>Ilana kan tí kò ka si ilana kékeré ni ìtẹ́numọ̀ àyẹ̀wò pẹ̀lú ìfọwọsowọpọ̀ àwọn amọ̀ja ilera.</answer>", "language": "Yoruba"}
{"question": "Ẹni tí ó jẹ́ ọ̀tọ̀lọ́wọ́ ṣe ni yóò dáhùn sí àwọn ìbéèrè wọ̀nyí nípa ìdí ìṣẹ̀lẹ̀ báwo?\nWayne ní agogo tuntun kan tí ó ga lọ́wọ́lọ́wọ́, tí ó ń ṣe ìtẹ̀jáde ọkàn rẹ̀ nígbà tí ó bá ń ṣiṣẹ́. Ó gbọ́dọ̀ gbé agogo náà sórí ìtòsọ́nṣọ̀n kí ó tó lo ó ní alẹ́ yìí. Ẹ̀rọ náà yóò kún fún agbára ní wákàtí kan bí a bá so ó mọ́ àtọ́ka tàbí kí ó wà lórí ìtòsọ́nṣọ̀n. Ní wakati mejì ọ̀sán, a so ẹ̀rọ náà mọ́ àtọ́ka, ẹ̀rọ náà sì kò sí lórí ìtòsọ́nṣọ̀n. Ní àkókò yẹn, Wayne ṣayẹ̀wò láti rí i bí ẹ̀rọ náà ti wà lórí ìtòsọ́nṣọ̀n, ó sì rí i pé kò sí. Nítorí náà, ó yí ipò ẹ̀rọ náà padà, ó sì gbé e sí orí ìtòsọ́nṣọ̀n. Nítorí pé ẹ̀rọ náà yóò kún fún agbára ní wákàtí kan bí a bá so ó mọ́ àtọ́ka tàbí kí ó wà lórí ìtòsọ́nṣọ̀n, ẹ̀rọ náà kún fún agbára ní wakati mẹta ọ̀sán. Ṣé ẹ̀rọ náà kún fún agbára nítorí pé Wayne yí ipò ẹ̀rọ náà padà?\nÀwọn ìdáhùn:\n- Bẹ́ẹ̀ni\n- Rárá", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé ẹ̀rọ náà kún fún agbára nítorí pé Wayne yí ipò ẹ̀rọ náà padà?” — meaning it wants to know if the device is charged because Wayne moved it.\n</step1>\n<step2>\nWayne's device needs to be connected to a power source — *ìtòsọ́nṣọ̀n* — to charge properly. Initially, it was connected for one hour.\n</step2>\n<step3>\nAfter two hours, the device was disconnected from the power source, which means it was not charging during that time — *kò sí lórí ìtòsọ́nṣọ̀n*.\n</step4>\n<step4>\nWhen Wayne checked, he found that the device was not on the power source, so it couldn't charge during those two hours.\n</step5>\n<step5>\nAfter he moved the device back to the power source, it was stated that it would charge for one hour if connected — *yóò kún fún agbára*.\n</step6>\n<step6>\nSince the device was only connected for one hour after being moved, it would not have enough time to charge fully if it was previously disconnected for two hours.\n</step7>\n<step7>\nThus, the answer to whether the device is charged is based on the fact that it was not connected for a sufficient time after being moved.\n</step8></thinking>", "answer": "<answer>Rárá.</answer>", "language": "Yoruba"}
{"question": "Oníṣegun kan ti o jẹ́ ọ̀mọ̀wé ìmọ̀ ìṣègùn ń wá ọ̀nà tí ó dára jù lọ láti tọ́jú àrùn HIV. Àwọn àrùn náà tí àrùn HIV ti bà jẹ́ ń gbé ìdáàbòbò ara wọn kalẹ̀ nípa ṣiṣe àwọn antibody sí àwọn protein tí ó bojúmọ̀ HIV. Àwọn antibody wọ̀nyí ni àwọn kan náà tí a ń rí nípa lílo ELISA àti western blot assays tí a fi ń wádìí àrùn náà. Oníṣegun náà ń gbiyanjú láti ṣe àgbékalẹ̀ antibody tuntun tí ó lágbára jù lọ sí àwọn protein tí ó bojúmọ̀ HIV kan náà tí ìdáàbòbò ara tí ó wà ládúùrọ̀ ń gbà. Láàrin àwọn protein tó wà nísàlẹ̀ yìí, èwo ni ó ṣeé ṣe jù lọ láti jẹ́ ohun tí antibody tí ó ń ṣe ń fojú tó?\nA. gp120\nB. CXCR4\nC. p24\nD. p17", "reasoning": "<thinking><step1>\nThe question asks: “Which protein is most likely to be targeted by a new, stronger antibody against HIV?” — it mentions proteins like [gp120], [CXCR4], [p24], and [p17].\n</step1>\n<step2>\nHIV has several proteins that are crucial for its structure and function. Among these, *gp120* is known for its role in the virus's ability to attach to host cells — *o jẹ́ pataki fún ìbáṣepọ̀ pẹ̀lú àwọn ẹ̀yà ara*.\n</step2>\n<step3>\nThe *p24* protein is part of the viral core and is often used in diagnostics — *a máa n lo p24 nínú ìwádìí àrùn HIV*.\n</step3>\n<step4>\n*CXCR4* is a co-receptor that HIV uses to enter cells, but it is not a direct target for antibodies — *kò jẹ́ protein tí a máa fojú kọ́*.\n</step5>\n<step5>\nFinally, *p17* is a structural protein, but it is less exposed to the immune system compared to *gp120* — *p17 kò ní irọrun tó*.\n</step6>\n<step6>\nGiven that *gp120* is the primary target for neutralizing antibodies due to its exposure on the virus surface, it is the most likely candidate for a new antibody development.\n</step7>\n<step7>\nThus, the strongest antibody would likely focus on *gp120* to effectively neutralize HIV.\n</step8></thinking>", "answer": "<answer>gp120 ni protein tí ó ṣeé ṣe jù lọ láti jẹ́ ohun tí antibody tuntun náà ń fojú tó.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 70 kan wá pẹlu irora àyà tí ó burú jáì ní abẹ́ ìyàrá àyà, ati electrocardiogram tí ó fi hàn pé ST elevations wà ní awọn leads inferior II, III, ati avF, ati bẹ̃ẹ̀ ni ní awọn leads V5 ati V6. Da lori awọn abajade wọnyi, ẹyawo ọkan wo ni ó ṣeé ṣe julọ lati ni ipa?", "reasoning": "<thinking><step1>\nThe question is asking: “Based on the results, which heart condition is most likely to be affected?” — it describes a 70-year-old man with severe chest pain and an electrocardiogram showing ST elevations in inferior leads II, III, and avF, as well as in leads V5 and V6.\n</step1>\n<step2>\nST elevations in these leads suggest a myocardial infarction — *àkúnya àyà* — particularly affecting the inferior wall of the heart.\n</step2>\n<step3>\nThe inferior leads indicate that the right coronary artery — *àkúnya ọtun* — is likely involved, which supplies blood to the inferior part of the heart.\n</step3>\n<step4>\nAdditionally, the presence of ST elevations in V5 and V6 suggests that there may also be lateral wall involvement — *ìfarapa ẹgbẹ́* — possibly indicating a more extensive myocardial injury.\n</step4>\n<step5>\nGiven the age of the patient and the symptoms, this scenario is consistent with an acute inferior ST-elevation myocardial infarction — *àkúnya àyà ST-elevation*.\n</step5>\n<step6>\nTherefore, the most likely heart condition affecting this patient is an inferior ST-elevation myocardial infarction.\n</step6></thinking>", "answer": "<answer>Àkúnya àyà ST-elevation àgbàlagbà ni ó ṣeé ṣe julọ lati ni ipa.</answer>", "language": "Yoruba"}
{"question": "Ẹ̀gbà ọmọ ìyá wo ni ó dá ipò fún ìṣiṣẹ́ ti ductus arteriosus?", "reasoning": "<thinking><step1>\nThe question asks: “Ẹ̀gbà ọmọ ìyá wo ni ó dá ipò fún ìṣiṣẹ́ ti [ductus arteriosus = ductus arteriosus]?” — meaning it wants to know at what stage of pregnancy the ductus arteriosus functions.\n</step1>\n<step2>\nThe ductus arteriosus is a blood vessel in a fetus that connects the pulmonary artery to the aorta — *ó jẹ́ ẹ̀rọ ẹjẹ* ti n ṣiṣẹ́ láti yago fún ẹjẹ lọ́wọ́ àyà.\n</step2>\n<step3>\nThis structure is crucial during fetal development because it allows blood to bypass the lungs, which are not yet functioning — *nítorí pé àwọn àyà kò ti ṣiṣẹ́*.\n</step3>\n<step4>\nThe ductus arteriosus begins to function early in pregnancy, typically around the 16th week — *nígbà tí ọmọ náà bá ti pé ọ̀sẹ̀ mẹ́rìndínlógún*.\n</step4>\n<step5>\nAfter birth, the ductus arteriosus usually closes within the first few days of life — *ó máa pa àtẹ́gùn náà mọ́*.\n</step5>\n<step6>\nThus, the ductus arteriosus is operational during the later stages of fetal development, specifically from around the 16th week until birth.\n</step6></thinking>", "answer": "<answer>Ductus arteriosus dá ipò fún ìṣiṣẹ́ láàárín ọ̀sẹ̀ mẹ́rìndínlógún sí ìbí.</answer>", "language": "Yoruba"}
{"question": "Loni, Anthony lọ sí ilé iwe ìtànà.  Láàrin àkókò wo ni ó lè ti lọ?\nA mọ̀ pé:\nAnthony jí ní 7am.\nDavid rí Anthony tí ń ṣiṣẹ́ ní ọ́fíìsì láti 7am sí 8am.\nLeslie rí Anthony tí ń ra kọfí ní ibi tita kọfí láti 8am sí 11am.\nSarah rí Anthony tí ń wo fíìmù ní sinima láti 1pm sí 9pm.\nIlé iwe ìtànà ti sínú lẹ́yìn 9pm.\nLáàrin àkókò wo ni Anthony lè ti lọ sí ilé iwe ìtànà?\nÀwọn àṣàyàn:\n(A) 11am sí 1pm\n(B) 8am sí 11am\n(C) 7am sí 8am\n(D) 1pm sí 9pm", "reasoning": "<thinking><step1>\nThe question asks: “Láàrin àkókò wo ni Anthony lè ti lọ sí ilé iwe ìtànà?” — meaning it wants to know during which time frame Anthony can go to the library after his activities.\n</step1>\n<step2>\nWe know that Anthony wakes up at 7am and is busy until 11am — *Anthony ní iṣẹ́ láti 7am sí 11am*.\n</step2>\n<step3>\nFrom 7am to 8am, he is at the office, and from 8am to 11am, he is buying coffee — *Anthony ń ra kọfí*.\n</step3>\n<step4>\nAfter 11am, he is free until 1pm, but he has to be at the cinema from 1pm to 9pm — *Anthony ní fíìmù láti 1pm sí 9pm*.\n</step4>\n<step5>\nSince the library opens after 9pm, the only time he can go is between 11am and 1pm — *lààrin 11am sí 1pm*.\n</step5>\n<step6>\nThus, the correct time frame for Anthony to go to the library is clear.\n</step6></thinking>", "answer": "<answer>11am sí 1pm</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 55 kan fi iba gbona ti a ko mọ̀ orisun rẹ̀ (FUO), ọpọlọpọ awọn iṣọn ọrùn ti o le, ti o ya sọtọ, ati ipele enzyme angiotensin-converting ti o ga hàn. Da lori awọn ami aisan wọnyi, kini ayẹwo ti o ṣeeṣe julọ?", "reasoning": "<thinking><step1>\nThe question asks: “Based on the symptoms of a 55-year-old man with a fever of unknown origin (FUO), multiple isolated lymphadenopathy, and elevated angiotensin-converting enzyme (ACE) levels, what is the most likely diagnosis?” \n</step1>\n<step2>\nA fever of unknown origin indicates that the cause of the fever is not immediately clear — *iba ti a ko mọ orisun rẹ̀* can suggest various underlying conditions.\n</step2>\n<step3>\nMultiple isolated lymphadenopathy — *iyapa lymphadenopathy* — often points to infections, malignancies, or autoimmune diseases.\n</step3>\n<step4>\nElevated ACE levels are particularly associated with conditions like sarcoidosis — *sarcoidosis* — and tuberculosis — *tuberculosis*.\n</step5>\n<step5>\nGiven the combination of these symptoms, the most likely diagnosis could be sarcoidosis, especially since it commonly presents with elevated ACE and lymphadenopathy.\n</step6></thinking>", "answer": "<answer>Ayẹwo ti o ṣeeṣe julọ ni sarcoidosis.</answer>", "language": "Yoruba"}
{"question": "Obinrin ọdun 25 kan wá sí ọ̀dọ̀ rẹ̀ fún ṣayẹwo ilera deede. Ó kò ní ẹ̀dùn kan. Ìtàn ìdílé ṣe pataki nítorí arakunrin meji rẹ̀ tí wọ́n ti kú nítorí àrùn Tay-Sachs, ṣùgbọ́n òun àti àwọn òbí rẹ̀ dára nípa irisi. Èwo ni àwọn àṣeyọrí wọ̀nyí jẹ́ pé ọmọ ẹ̀yìn yìí jẹ́ olùgbà pẹlú ìyípadà tí ó fa àrùn Tay-Sachs?\nA. 25%\nB. 33%\nC. 66%\nD. 50%", "reasoning": "<thinking><step1>\nThe question asks about the likelihood that this 25-year-old woman is a carrier of the Tay-Sachs disease gene, given her family history — *ìtàn ìdílé* — where two of her brothers have died from this condition.\n</step1>\n<step2>\nTay-Sachs is an autosomal recessive disorder, meaning that both parents must be carriers for a child to be affected — *àrùn autosomal recessive*.\n</step3>\n<step3>\nIf both parents are carriers, each child has a 25% chance of being affected, a 50% chance of being a carrier, and a 25% chance of being unaffected — *àwọn ọmọ kọọkan ni 25% ànfààní láti ní àrùn*.\n</step4>\n<step4>\nSince two of her brothers have the disease, it suggests that both parents are likely carriers — *òun àti àwọn òbí rẹ̀*.\n</step5>\n<step5>\nThus, the probability that she is a carrier is 50%, as she has a 50% chance of being a carrier if both parents are carriers.\n</step6>\nSo, the answer to the question is that the likelihood she is a carrier of the Tay-Sachs gene is 50%.\n</step6></thinking>", "answer": "<answer>50%</answer>", "language": "Yoruba"}
{"question": "Ninu ipo ti dida okuta kidiní, ipo wo ni o kere julo lati ja si dida okuta kidiní ti o ni kalsiamu?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu ipo ti dida okuta kidiní, ipo wo ni o kere julo lati ja si dida okuta kidiní ti o ni kalsiamu?” — meaning it wants to know which position is least likely to lead to the formation of calcium-containing kidney stones.\n</step1>\n<step2>\nKidney stones, or *okuta kidiní*, can form due to various factors, including diet and hydration levels — *iṣeduro omi* is crucial in preventing stone formation.\n</step2>\n<step3>\nWhen considering positions, *ipo* refers to body posture; certain postures may affect kidney function and stone formation risk.\n</step4>\n<step4>\nFor example, lying down for extended periods can lead to reduced urine flow — *iṣan omi* — which increases the risk of stone formation.\n</step5>\n<step5>\nConversely, maintaining an upright position encourages better urine flow and reduces the concentration of calcium — *kalsiamu* — in the urine.\n</step6>\n<step6>\nThus, the best position to minimize the risk of calcium-containing kidney stones is to remain upright or active, as this promotes healthy kidney function.\n</step6></thinking>", "answer": "<answer>Ipo ti o kere julo lati ja si dida okuta kidiní ti o ni kalsiamu ni lati wa ni ipo ti o ga, tabi lati maa gbe ara.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 70 kan ti o ní ìtàn àrùn Alzheimer ti ọdún 2 ti wá síbi pẹlu ipo èrò tí ó yipada ati ìṣubú ìrora ni ọjọ́ diẹ̀ sẹ́yìn. Awọn oogun ti ó gbà lọwọlọwọ̀ ni donepezil ati galantamine. Àwọn àmì àrùn rẹ̀ ni: iwọn otutu ara 36.0°C (96.8°F), ẹ̀ru ẹ̀jẹ̀ 90/60 mm Hg, ìṣiṣẹ́ ọkàn 102/min, ati ìṣiṣẹ́ ẹ̀dùn 22/min. Ìwádìí ara fi hàn pé ó ní ọ̀pọ̀lọpọ̀ igbágbé lórí ori rẹ̀ ati awọn ẹ̀yà ara rẹ̀. Ó mọ̀ ara rẹ̀ nìkan. Ẹ̀dùn ati ẹ̀jẹ̀ rẹ̀ gbàdúrà E. coli. A gbà á wọlé, ati ìtọ́jú ìṣàájú pẹlu omi onísèdáṣèdá IV, antibiotics, ati subcutaneous prophylactic heparin. Ni ọjọ́ kejì tí a gbà á wọlé, a rí ẹ̀jẹ̀ tí ó tàn káàkiri láti ibi tí a ti fi abẹrẹ ya ẹjẹ̀ rẹ̀ ati awọn igbágbé rẹ̀. Awọn àbájáde idanwo ẹjẹ rẹ̀ fihan thrombocytopenia, PT ati PTT tí ó gun, ati D-dimer tí ó dára. Èwo ni ìgbésẹ̀ tó tọ́ jùlọ tó tẹ̀lé láti ṣe níbi ṣíṣe ìtọ́jú àrùn alààyè yìí?\nA. Dákẹ́ heparin therapy lẹsẹkẹsẹ ati kọ oogun miiran tí ó ṣeé ṣe fun anticoagulant\nB. Bẹ̀rẹ̀ ìtọ́jú pẹlu prednisone\nC. Cryoprecipitate, FFP ati low dose SC heparin\nD. Ìyípadà ẹjẹ̀ pẹlẹpẹlẹ\nE. Splenectomy", "reasoning": "<thinking><step1>\nThe question is asking about the best course of action for a 70-year-old man with a history of Alzheimer’s who has recently experienced changes in mental status and pain, along with specific lab findings indicating thrombocytopenia and prolonged PT and PTT.\n</step1>\n<step2>\nGiven the patient's condition, *àwọn àmì àrùn* suggest a potential bleeding risk due to low platelet count — *thrombocytopenia* — and prolonged clotting times.\n</step2>\n<step3>\nThe options provided include various treatments, but we need to consider the immediate risk of bleeding and the underlying cause of the thrombocytopenia.\n</step4>\n<step4>\nOption A suggests stopping heparin therapy and considering another anticoagulant, which may not address the immediate bleeding risk effectively.\n</step4>\n<step5>\nOption C, which involves administering cryoprecipitate and FFP (fresh frozen plasma), along with low-dose subcutaneous heparin, seems to be the most appropriate as it addresses both the bleeding and the need for anticoagulation.\n</step5>\n<step6>\nThus, the best step to take in managing this patient's acute condition is to provide supportive treatment that can stabilize his blood parameters while considering his overall health status.\n</step6></thinking>", "answer": "<answer>Cryoprecipitate, FFP ati low dose SC heparin ni ìgbésẹ̀ tó tọ́ jùlọ.</answer>", "language": "Yoruba"}
{"question": "Gẹgẹ́ bí ìwé ìlànà ADA nọ́mbà 5, ìpín iye ìwọ̀n tí a nilò fún irin àgbàwọ́ àgbàyanu tí a lò fún síse ìkọ́lọ́pọ̀?", "reasoning": "<thinking><step1>\nThe question translates to: \"According to the ADA guidelines number 5, what is the recommended dosage for the universal anticoagulant used in the treatment of thrombosis?\" — here, *ìwé ìlànà ADA* refers to the ADA guidelines and *irin àgbàwọ́ àgbàyanu* means universal anticoagulant.\n</step1>\n<step2>\nThe ADA guidelines provide specific recommendations for anticoagulant dosages based on patient factors — *ìpín iye ìwọ̀n* is crucial for effective treatment.\n</step2>\n<step3>\nFor instance, the dosage may vary depending on the patient's weight, age, and renal function — *àwọn àfihàn wọnyi* are important considerations.\n</step3>\n<step4>\nTypically, the guidelines suggest a standard initial dose, followed by adjustments based on *ìdáhùn àìlera* and monitoring of coagulation parameters.\n</step4>\n<step5>\nIn practice, healthcare providers must ensure that the dosage aligns with the latest ADA recommendations to minimize risks — *ìdènà àìlera* is a key goal.\n</step5>\n<step6>\nThus, the recommended dosage for the universal anticoagulant is tailored to individual patient needs as outlined in the ADA guidelines.\n</step6></thinking>", "answer": "<answer>Ìpín iye ìwọ̀n tí a nilò fún irin àgbàwọ́ àgbàyanu ni a ṣe àtúnṣe gẹ́gẹ́ bí ìwé ìlànà ADA ṣe sọ, nípa ìdáhùn àìlera àti àwọn àfihàn aláìlera.</answer>", "language": "Yoruba"}
{"question": "Èlément ọ̀nà SVG yii <path d=\"M 74.15,65.82 L 62.73,69.82 M 62.73,69.82 L 70.21,58.22 L 84.00,58.77 M 84.00,58.77 L 74.15,65.82\"/> ṣe àwòrán\nÀwọn àṣàyàn:\n(A) yíká\n(B) apàta méje\n(C) apàta mẹ́fà\n(D) afẹ́fẹ́\n(E) ìlà\n(F) apàta mẹ́jọ\n(G) apàta márùn-ún\n(H) àyàká\n(I) apá\n(J) kọ́kọ́rọ́", "reasoning": "<thinking><step1>\nThe question asks: \"Èlément ọ̀nà SVG yii <path d='M 74.15,65.82 L 62.73,69.82 M 62.73,69.82 L 70.21,58.22 L 84.00,58.77 M 84.00,58.77 L 74.15,65.82'/> ṣe àwòrán?\" — meaning it wants to know what shape or figure this SVG path represents.\n</step1>\n<step2>\nThe SVG path commands indicate a series of lines connecting specific points — *pẹlu awọn aaye ti a tọka si*.\n</step2>\n<step3>\nThe path starts at (74.15, 65.82) and connects to (62.73, 69.82), then to (70.21, 58.22), and finally to (84.00, 58.77) before returning to the starting point — *iyẹn ni, o n ṣe àtúnṣe*.\n</step3>\n<step4>\nThis creates a closed shape, and by analyzing the coordinates, it appears to form a polygon — *apàta*.\n</step5>\n<step6>\nGiven the options, we need to determine which one corresponds to the number of sides in this polygon.\n</step7>\n<step8>\nThe path connects four distinct points, suggesting it is a quadrilateral — *apàta mẹ́rin*.\n</step9>\n<step10>\nHowever, since \"apàta mẹ́rin\" is not an option, we must consider the closest match, which is \"apàta mẹ́fà\" — indicating a six-sided figure.\n</step10></thinking>", "answer": "<answer>Apàta mẹ́fà</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 22 kan ti o ni àrùn ikọ́lù ati àrùn sẹẹli ethmoidal ẹhin ti n ni isonu ojú tí ó ń pọ̀ sí i.  Ẹ̀yà ara wo ni ó ṣeé ṣe kí ó kan jùlọ ninu ipo yii?", "reasoning": "<thinking><step1>\nThe question asks: “What part of the body is most likely affected in a 22-year-old man with [àrùn ikọ́lù = sinusitis] and [àrùn sẹẹli ethmoidal = ethmoidal cell disease] who is experiencing increasing vision loss?” \n</step1>\n<step2>\nIn this case, the patient has sinusitis, which can lead to complications affecting nearby structures — *àwọn ẹya ara to wa nitosi*.\n</step2>\n<step3>\nThe ethmoidal cells are located near the eyes, and inflammation or infection can spread — *ìfarapa tabi àrùn le tan kaakiri*.\n</step4>\n<step4>\nVision loss suggests that the optic nerve or the eye itself may be involved — *nkan ti o le fa isonu ojú ni a le pe ni*.\n</step5>\n<step5>\nIn particular, the optic nerve is at risk due to its proximity to the ethmoidal sinuses — *nitori ibiti wọn ti wa nitosi*.\n</step6>\n<step6>\nThus, the most likely affected part in this scenario is the optic nerve — *nervi optic*.\n</step6></thinking>", "answer": "<answer>Nervi optic ni ẹ̀yà ara ti o ṣeé ṣe kí ó kan jùlọ ninu ipo yii.</answer>", "language": "Yoruba"}
{"question": "Ṣe àwọn iṣẹ́ pàtàkì wo ni àwọn èso lumbrical ní ọwọ́ ń ṣe?", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe àwọn iṣẹ́ pàtàkì wo ni àwọn èso lumbrical ní ọwọ́ ń ṣe?” — meaning it wants to know what important functions the lumbrical muscles in the hand perform.\n</step1>\n<step2>\nLumbrical muscles are unique because they originate from the tendons of the flexor muscles — *àwọn èso flexor* — and they play a crucial role in hand movements.\n</step2>\n<step3>\nOne primary function is to facilitate flexion at the metacarpophalangeal joints while allowing extension at the interphalangeal joints — *ìkànsí ni àárín*.\n</step3>\n<step4>\nThis means they help in actions like gripping and holding objects, which is essential for daily tasks — *ìṣe ojoojúmọ́*.\n</step5>\n<step5>\nAdditionally, they contribute to fine motor skills, enabling precise movements of the fingers — *ìmúṣẹ́ àkúnya*.\n</step6>\n<step6>\nIn summary, the lumbrical muscles are vital for coordinated finger movements and overall hand function.\n</step6></thinking>", "answer": "<answer>Àwọn èso lumbrical ní ọwọ́ ń ṣe àfikún fún ìkànsí, ìmúṣẹ́ àkúnya, àti ìṣe ojoojúmọ́.</answer>", "language": "Yoruba"}
{"question": "Kini o ṣẹlẹ̀ sí iye ìṣísẹ̀ àtọ̀dọ̀po ẹ̀jẹ̀ ninu aja nigbati a ba gé ẹ̀yìn sinus ni ìgbà ìṣẹ̀lẹ̀ ẹ̀jẹ̀ díẹ̀, ati idi ti idahùn yii fi le waye laibikita boya iye ìṣísẹ̀ àtọ̀dọ̀po ẹ̀jẹ̀ ìbẹ̀rẹ̀ jẹ́ 85 mm Hg tabi 60 mm Hg?", "reasoning": "<thinking><step1>\nThe question asks: “Kini o ṣẹlẹ̀ sí iye [ìṣísẹ̀ àtọ̀dọ̀po ẹ̀jẹ̀ = blood pressure] ninu aja nigbati a ba gé [ẹ̀yìn sinus = sinus node]?” — meaning it wants to know what happens to blood pressure in a dog when the sinus node is cut.\n</step1>\n<step2>\nThe sinus node is crucial for initiating heartbeats — *o jẹ́ pataki fún ìbẹ̀rẹ̀ ìkópa ọkàn* and regulates heart rate.\n</step2>\n<step3>\nWhen the sinus node is damaged, the heart may not beat effectively — *ọkàn le ma ṣiṣẹ́ dáadáa*, leading to a drop in blood pressure.\n</step3>\n<step4>\nIf blood pressure is initially at 85 mm Hg, it may decrease significantly; however, if it starts at 60 mm Hg, the heart's compensatory mechanisms might still maintain some function — *ìmúlò àtúnṣe le jẹ́ kó ṣee ṣe*.\n</step4>\n<step5>\nFactors like the dog's overall health and the extent of the damage also play a role — *ilera gbogbogbo aja náà* and how much of the sinus node is affected.\n</step6>\n<step6>\nIn summary, cutting the sinus node can lead to a decrease in blood pressure due to impaired heart function, regardless of the initial blood pressure level.\n</step6></thinking>", "answer": "<answer>Gé ẹ̀yìn sinus le fa ìdíwọ̀n ìṣísẹ̀ àtọ̀dọ̀po ẹ̀jẹ̀, nípa ti àìlera ọkàn, láìka iye ìṣísẹ̀ àtọ̀dọ̀po ẹ̀jẹ̀ ìbẹ̀rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Àṣìṣe ìrònú wo ni a fi hàn nípa ṣíṣe kàyéfì pé Heather yẹ kí ó yan àṣàyàn kẹta gẹ́gẹ́ bí ìdáhùn tó tọ́ nítorí pé ó kò tíì ṣe bẹ́ẹ̀ fún ìgbà díẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Àṣìṣe ìrònú wo ni a fi hàn nípa ṣíṣe kàyéfì pé Heather yẹ kí ó yan àṣàyàn kẹta gẹ́gẹ́ bí ìdáhùn tó tọ́ nítorí pé ó kò tíì ṣe bẹ́ẹ̀ fún ìgbà díẹ̀?” — meaning it wants to know what cognitive bias is demonstrated by Heather's hesitation to choose the third option as the correct answer since she hasn't done so for a while.\n</step1>\n<step2>\nThis situation suggests a potential *bias de statu quo* — the tendency to prefer things to remain the same or unchanged.\n</step2>\n<step3>\nHeather might be experiencing *l'angoisse de la décision* — decision anxiety, which can lead to overthinking her options.\n</step3>\n<step4>\nAdditionally, there could be an element of *confirmation bias* at play, where she favors information that aligns with her previous choices.\n</step4>\n<step5>\nIn this context, Heather's reluctance to choose the third option reflects a common cognitive error where past behavior influences current decisions.\n</step5>\n<step6>\nThus, the cognitive bias here is likely related to her discomfort with change and the influence of her past choices.\n</step6></thinking>", "answer": "<answer>Àṣìṣe ìrònú tó hàn ni pé Heather ní ìbànújẹ́ pẹ̀lú àṣàyàn tuntun, tó sì ń fa àìlera láti yàn àṣàyàn kẹta.</answer>", "language": "Yoruba"}
{"question": "Nínú àdánwò ìwádìí fún àrùn kanṣánṣà oyún ọmú pẹ̀lú ìṣàṣeyọrí ìwádìí 90% àti ìdánilójú 98%, kini àṣeyọrí tí àìsàn náà kò ní farahàn ní àdánwò náà ní ọdún méjì tí ó tèlé ara wọn?", "reasoning": "<thinking><step1>\nThe question asks: “Nínú àdánwò ìwádìí fún àrùn kanṣánṣà oyún ọmú pẹ̀lú ìṣàṣeyọrí ìwádìí 90% àti ìdánilójú 98%, kini àṣeyọrí tí àìsàn náà kò ní farahàn ní àdánwò náà ní ọdún méjì tí ó tèlé ara wọn?” — meaning it wants to know the success rate of a disease not showing up in a test after two years, given a test sensitivity of 90% and specificity of 98%.\n</step1>\n<step2>\nTo find this, we need to understand the terms: *ìṣàṣeyọrí* (sensitivity) indicates how well the test identifies those with the disease, while *ìdánilójú* (specificity) indicates how well it identifies those without the disease.\n</step2>\n<step3>\nIf the sensitivity is 90%, this means that 90% of true cases will be detected — *90% ti awọn ọran gidi ni a yoo ri*. Conversely, the specificity of 98% means that 98% of healthy individuals will test negative.\n</step3>\n<step4>\nNow, we need to calculate the probability that a person who does not have the disease will test negative after two years. This is done using the specificity: *p = 1 - (1 - specificity)^n*, where n is the number of years.\n</step4>\n<step5>\nSubstituting the values, we have: *p = 1 - (1 - 0.98)^2 = 1 - (0.02)^2 = 1 - 0.0004 = 0.9996*.\n</step5>\n<step6>\nThus, the probability that the disease will not show up in the test after two years is approximately 99.96% — *99.96% ti àìsàn náà kò ní farahàn*.\n</step6></thinking>", "answer": "<answer>Àṣeyọrí tí àìsàn náà kò ní farahàn ní àdánwò náà ní ọdún méjì tí ó tèlé ara wọn ni 99.96%.</answer>", "language": "Yoruba"}
{"question": "Nínú àrùn ẹ̀jẹ̀ ẹ̀dùn tí ó léwu lọ́wọ́, kí ni ìwádìí náà báà jẹ́ bí àwòrán immunophenotype náà bá jẹ́ CD19 rere, CD10 rere, CD33 rere, àti CD13 rere?", "reasoning": "<thinking><step1>\nThe question asks: “In a severe blood cancer [àrùn ẹ̀jẹ̀ ẹ̀dùn = blood cancer], how does the research indicate if the immunophenotype is positive for CD19, CD10, CD33, and CD13?” — meaning it wants to understand the significance of these markers.\n</step1>\n<step2>\nImmunophenotyping is crucial in diagnosing blood cancers — *ìwádìí immunophenotype* helps identify specific cell types based on surface markers.\n</step2>\n<step3>\nCD19 is a pan-B-cell marker, indicating the presence of B-cells — *CD19 jẹ́ àmì àfihàn B-cell gbogbo*.\n</step3>\n<step4>\nCD10 is associated with early B-cell development, while CD33 and CD13 are myeloid markers — *CD10 ni a mọ̀ pé ó ní í ṣe pẹ̀lú ìdàgbàsókè B-cell*.\n</step4>\n<step5>\nIf all these markers are positive, it suggests a specific type of leukemia or lymphoma — *ó fi hàn pé àrùn ẹ̀jẹ̀ ẹ̀dùn kan wa*.\n</step6>\n<step6>\nThus, the presence of these markers indicates a particular immunophenotype that can guide treatment options — *ìwádìí yìí ṣe pàtàkì fún ìtọ́jú*.\n</step7>\n<step7>\nIn summary, a positive immunophenotype for CD19, CD10, CD33, and CD13 suggests a specific classification of the blood cancer.\n</step7></thinking>", "answer": "<answer>Ìwádìí náà fi hàn pé àwòrán immunophenotype CD19 rere, CD10 rere, CD33 rere, àti CD13 rere tọ́ka sí àrùn ẹ̀jẹ̀ ẹ̀dùn kan pato.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdún mẹ́ẹ̀ẹ́dọ́gbọ̀n kan tó jẹ́ agbẹ́gi-ìrókò ní orí fọ́ òun gidigidi nígbà tó ń ṣe ìdárayá, ayẹ̀wò omi ọpọlọ (CSF) sì fi hàn pé ẹjẹ wà nínú rẹ̀. Kí ni àrùn tó ṣeé ṣe kó jẹ́?", "reasoning": "<thinking><step1>\nThe question asks: “What illness could a 35-year-old [agbẹ́gi-ìrókò = athlete] have if they experience severe headaches during exercise and a cerebrospinal fluid (CSF) test shows blood?” \n</step1>\n<step2>\nSevere headaches during physical activity can indicate a serious condition — *àrùn tó le fa irora tó lágbára*.\n</step2>\n<step3>\nThe presence of blood in the CSF suggests possible bleeding in the brain — *ìjẹ̀pàtàkì nínú ọpọlọ*.\n</step3>\n<step4>\nOne potential diagnosis is a subarachnoid hemorrhage, which occurs when there is bleeding in the space surrounding the brain — *ìjẹ̀pàtàkì nínú àyíká tó yí ọpọlọ ká*.\n</step4>\n<step5>\nOther possibilities include a cerebral aneurysm or a traumatic brain injury, especially if there was a recent impact — *ìfarapa tó ṣẹlẹ̀ laipẹ́*.\n</step5>\n<step6>\nIn summary, the symptoms and CSF findings strongly suggest a serious neurological condition that requires immediate medical attention — *ìtọ́jú pàtàkì*.\n</step6></thinking>", "answer": "<answer>Àrùn tó ṣeé ṣe kó jẹ́ ni ìjẹ̀pàtàkì nínú àyíká tó yí ọpọlọ ká.</answer>", "language": "Yoruba"}
{"question": "Ní àpọnà ọmọ-aláìsàn CKD tí ó wà lórí ìtọ́jú ẹ̀jẹ̀ (haemodialysis) tí ó ní ìrora ọmu àti ìrora ẹ̀yìn ní kété lẹ́yìn ìbẹ̀rẹ̀ ìtọ́jú ẹ̀jẹ̀ náà, èyí tí ó tán lẹ́yìn ìtùnú láìsí ìtọ́jú èyíkéyìí, kí ni ìdí tí ó ṣeé ṣe jùlọ fún àwọn àmì àìlera yìí tí ó kàn sí?", "reasoning": "<thinking><step1>\nThe question asks: “What could be the most likely cause of chest pain and back pain shortly after starting haemodialysis for a patient with CKD [chronic kidney disease]?” \n</step1>\n<step2>\nChest pain and back pain can occur due to various reasons during haemodialysis — *ìtọ́jú ẹ̀jẹ̀* can lead to changes in blood pressure and fluid shifts.\n</step2>\n<step3>\nOne common cause is hypotension — *ìkànsí ẹ̀jẹ̀* — which can happen when fluid is removed too quickly from the body.\n</step3>\n<step4>\nAdditionally, muscle cramps may occur due to electrolyte imbalances — *ìdàpọ̀ àtọ́ka* — especially with low calcium or magnesium levels.\n</step4>\n<step5>\nAnother possibility is that the patient may be experiencing a reaction to the dialysis membrane — *ìfaramọ́ si àtẹ́gùn* — which can cause discomfort.\n</step6>\n<step6>\nIn summary, the most likely causes of these symptoms are hypotension, muscle cramps, or a reaction to the dialysis process.\n</step6></thinking>", "answer": "<answer>Ìdí tí ó ṣeé ṣe jùlọ fún àwọn àmì àìlera yìí ni ìkànsí ẹ̀jẹ̀, ìdàpọ̀ àtọ́ka, tàbí ìfaramọ́ si àtẹ́gùn.</answer>", "language": "Yoruba"}
{"question": "Àwọn ọ̀rọ̀ wo ni a máa ń lò láti ṣàpẹẹrẹ àmì ìdí kan tí a gbà kalẹ̀ fún àwọn ètò ìgbà pípẹ́ tí kò lè ṣeé kà sí iye tàbí wíwọn?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn ọ̀rọ̀ wo ni a máa ń lò láti ṣàpẹẹrẹ [àmì ìdí = reason] kan tí a gbà kalẹ̀ fún [ètò ìgbà pípẹ́ = long-term plans] tí kò lè ṣeé kà sí iye tàbí wíwọn?” — meaning it wants to know what terms are used to exemplify a reason for long-term plans that cannot be quantified.\n</step1>\n<step2>\nIn English, we often refer to qualitative factors when discussing long-term plans — *àwọn ifosiwewe ti ko le ṣeé kà sí iye*.\n</step2>\n<step3>\nFor instance, terms like *àkókò* (time), *ìdàgbàsókè* (development), and *àkóso* (management) are relevant in this context.\n</step3>\n<step4>\nThese terms highlight aspects that are crucial but not easily measurable — *àwọn ohun tí kò le ṣeé kà sí wíwọn*.\n</step4>\n<step5>\nAdditionally, we might use phrases like *ìmọ̀lára* (sentiment) or *ìbáṣepọ̀* (relationship) to describe the intangible benefits of such plans.\n</step5>\n<step6>\nThus, when discussing reasons for long-term plans, we focus on qualitative aspects rather than quantitative metrics.\n</step6></thinking>", "answer": "<answer>Àwọn ọ̀rọ̀ bíi àkókò, ìdàgbàsókè, àti ìbáṣepọ̀ ni a máa ń lò láti ṣàpẹẹrẹ àmì ìdí kan fún ètò ìgbà pípẹ́ tí kò lè ṣeé kà sí iye tàbí wíwọn.</answer>", "language": "Yoruba"}
{"question": "Kini ami aisan akọkọ ti o fihan hypermagnesemia ninu obinrin ti o loyun ti a ti lo magnesium sulfate fun pre-eclampsia?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ami aisan akọkọ ti o fihan [hypermagnesemia = hypermagnesemia] ninu [obirin ti o loyun = pregnant woman] ti a ti lo [magnesium sulfate = magnesium sulfate] fun [pre-eclampsia = pre-eclampsia]?” — meaning it wants to know the primary symptom of hypermagnesemia in a pregnant woman treated with magnesium sulfate for pre-eclampsia.\n</step1>\n<step2>\nHypermagnesemia occurs when there is too much magnesium in the blood — *iyẹn ni, nigbati magnesium ba pọ ju ti a nilo lọ*.\n</step2>\n<step3>\nIn pregnant women, especially those receiving magnesium sulfate, symptoms can include muscle weakness — *agbara iṣan ti o dinku* and lethargy.\n</step3>\n<step4>\nOne of the earliest signs to watch for is decreased deep tendon reflexes — *idinku awọn ifamọra tendon jinlẹ*.\n</step4>\n<step5>\nIf magnesium levels continue to rise, more severe symptoms like respiratory depression may occur — *iṣoro mimi*.\n</step6>\n<step6>\nThus, the primary symptom indicating hypermagnesemia in this context is reduced deep tendon reflexes.\n</step6></thinking>", "answer": "<answer>Ami aisan akọkọ ti o fihan hypermagnesemia ni obirin ti o loyun ti a ti lo magnesium sulfate fun pre-eclampsia ni idinku awọn ifamọra tendon jinlẹ.</answer>", "language": "Yoruba"}
{"question": "Fọtọni kan ti o ni agbara hν ńgbe lọ si ẹgbẹ Oz ti fireemu ile-ẹkọ giga (R) o sì ńlu pẹlu ohun kan ti o ní ìwọ̀n m ti o wà láìgbòògùn nínú (R). Ṣàlàyé \\( \\alpha = \\frac{h\\nu}{mc^{2}} \\). Kí ni àtúmọ̀ fún \\( \\beta \\), èyí tí ó ṣàpẹrẹ ìwọ̀n iyara ti fireemu ààrin àárín (R') sí fireemu ile-ẹkọ giga (R)?", "reasoning": "<thinking><step1>\nThe question asks about the equation \\( \\alpha = \\frac{h\\nu}{mc^{2}} \\) and its relation to the concept of \\( \\beta \\), which represents the speed of light in a different frame of reference, specifically from frame (R') to frame (R).\n</step1>\n<step2>\nIn this context, \\( h \\) is Planck's constant, \\( \\nu \\) is the frequency of the photon, \\( m \\) is the mass, and \\( c \\) is the speed of light — *iyara imọlẹ*.\n</step2>\n<step3>\nThe equation \\( \\alpha \\) describes the ratio of energy to mass-energy equivalence — *iyato laarin agbara ati agbara masi*.\n</step3>\n<step4>\nTo understand \\( \\beta \\), we need to consider how the speed of light is perceived in different inertial frames — *fireemu ààrin*.\n</step4>\n<step5>\nIn special relativity, \\( \\beta \\) is defined as the ratio of the speed of an object to the speed of light, expressed as \\( \\beta = \\frac{v}{c} \\), where \\( v \\) is the object's speed in frame (R').\n</step5>\n<step6>\nThus, \\( \\beta \\) quantifies how fast the object is moving relative to the speed of light — *iyara ti ohun kan n lọ ni ibamu si iyara imọlẹ*.\n</step6>\n<step7>\nIn summary, \\( \\beta \\) is crucial for understanding relativistic effects when transitioning between different reference frames.\n</step7></thinking>", "answer": "<answer>\\( \\beta \\) jẹ́ àtúmọ̀ ti iyara ohun kan ni fireemu ààrin (R') sí iyara imọlẹ.</answer>", "language": "Yoruba"}
{"question": "Ọmọ obìnrin ọdun mẹjọ kan ti ní eyín mẹrin akọkọ rẹ̀ tí ó fi hàn ní ọ̀pọ̀lọpọ̀ àwọn ìṣòro tí ó yàtọ̀ síra, àwọn ìṣòro tí ó ní àwọn ìwọ̀n àwọ̀ tí ó yàtọ̀ síra, pẹ̀lú èròjà èyín díẹ̀.  Kí ni ìwọ̀n ohun kan tí ó pọ̀ jù lójú ti mú àìṣe pàtàkì eyín yìí wá?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ìwọ̀n ohun kan tí ó pọ̀ jù lójú ti mú àìṣe pàtàkì eyín yìí wá?” — meaning it wants to know what common factor has led to the dental issues in an eight-year-old girl with four primary teeth showing various problems.\n</step1>\n<step2>\nDental issues in children can arise from several factors, but one common cause is poor oral hygiene — *ìtọ́jú ẹnu tó péye*.\n</step2>\n<step3>\nAt this age, children often struggle with brushing effectively, leading to plaque buildup — *ìkó àkópọ̀* that can cause cavities.\n</step3>\n<step4>\nAdditionally, dietary habits play a significant role; high sugar intake — *ìjẹun tó ní suga púpọ̀* — can contribute to tooth decay.\n</step4>\n<step5>\nAnother factor could be genetic predisposition to dental problems — *ìfarapa ẹbí* that might affect the strength of the teeth.\n</step5>\n<step6>\nIn summary, the most common factor leading to these dental issues is likely inadequate oral hygiene combined with poor dietary choices.\n</step6></thinking>", "answer": "<answer>Ìwọ̀n ohun kan tí ó pọ̀ jù lójú ni àìtọ́jú ẹnu tó péye pẹ̀lú ìjẹun tó ní suga púpọ̀.</answer>", "language": "Yoruba"}
{"question": "A wà ọmọ ọjọ́ kan ṣú sí ẹ̀ka ìṣègùn pajawiri nítorí pé ó ńkọ̀kọ̀ nígbà tí wọ́n ńbọ́ oúnjẹ fún un, ó sì di bulu. Ìyá rẹ̀ sọ pé àwọ̀ bulu náà ṣàn nígbà tí ó gbé ọmọ náà sókè ó sì mú ẹsẹ̀ rẹ̀ dé ẹ̀gbẹ́ àyà rẹ̀. Ọ̀gbẹ́ni oníṣègùn paṣẹ fún X-ray àyà tí ó fi ọkàn tí ó dàbí bata hàn, ó sì sọ fún ìyá rẹ̀ pé ọmọ náà ní àrùn kan tí ìdí rẹ̀ jẹ́ ìṣípò anterosuperior ti infundibular septum. Kí ni àwọn àpẹẹrẹ mẹ́rin ti àrùn ọkàn ọmọ náà?\nA. Pulmonary stenosis, hypertrophy ọkàn òsì, ventricular septal defect, overriding aorta\nB. Pulmonary regurgitation, hypertrophy ọkàn òsì, ventricular septal defect, overriding aorta\nC. Pulmonary stenosis, hypertrophy ọkàn ọ̀tún, atrial septal defect, overriding pulmonary artery\nD. Pulmonary stenosis, hypertrophy ọkàn ọ̀tún, ventricular septal defect, overriding aorta", "reasoning": "<thinking><step1>\nThe question is asking for examples of heart diseases in a child who has a specific condition related to the heart's anatomy — *ìṣípò anterosuperior ti infundibular septum* refers to a position affecting the heart's structure.\n</step1>\n<step2>\nThis condition is often associated with congenital heart defects, which can include various abnormalities — *àrùn ọkàn àtọkànwá*.\n</step2>\n<step3>\nThe options provided list different combinations of heart conditions. For instance, *pulmonary stenosis* is a narrowing of the outflow tract from the right ventricle.\n</step3>\n<step4>\n*Hypertrophy ọkàn* refers to the thickening of the heart muscle, which can occur in response to increased workload, often seen in conditions like *pulmonary stenosis*.\n</step4>\n<step5>\n*Ventricular septal defect* is a common defect where there is a hole in the wall separating the two ventricles, leading to mixing of oxygenated and deoxygenated blood.\n</step5>\n<step6>\n*Overriding aorta* occurs when the aorta is positioned directly over a ventricular septal defect, which is a critical feature in some congenital heart diseases.\n</step6>\n<step7>\nNow, looking at the options: \n- Option A includes pulmonary stenosis, which fits, and overriding aorta, which is relevant.\n- Option B has pulmonary regurgitation, which is less likely in this context.\n- Option C includes atrial septal defect, which is not typically associated with the specified condition.\n- Option D includes hypertrophy of the right ventricle, which is plausible.\n</step7>\n<step8>\nAfter analyzing the options, the most fitting combination that aligns with the condition described is option A, as it includes all relevant heart defects associated with the anatomical position mentioned.\n</step8></thinking>", "answer": "<answer>A. Pulmonary stenosis, hypertrophy ọkàn òsì, ventricular septal defect, overriding aorta</answer>", "language": "Yoruba"}
{"question": "Loni, Richard lọ sí ibi ere ìdárayá. Láàrin àkókò wo ni ó lè ti lọ?\nA mọ̀ pé:\nRichard jí dìde ní 5am.\nMary rí Richard tí ń rà foonu ní ilé itàjà ẹrọ alágbàlà láti 11am sí 6pm.\nLeslie rí Richard tí ń ṣe eré ṣiṣe ní gímu láti 6pm sí 8pm.\nKimberly rí Richard tí ń lọ sí kilasi ní ilé ẹ̀kọ́ láti 8pm sí 9pm.\nNancy rí Richard tí ń rà kuki ní ile itaja akara láti 9pm sí 10pm.\nIbi ere ìdárayá ti sínú lẹ́yìn 10pm.\nLáàrin àkókò wo ni Richard lè ti lọ sí ibi ere ìdárayá náà?\nÀwọn àṣàyàn:\n(A) 6pm sí 8pm\n(B) 5am sí 11am\n(C) 11am sí 6pm\n(D) 8pm sí 9pm", "reasoning": "<thinking><step1>\nThe question asks: “Láàrin àkókò wo ni Richard lè ti lọ sí ibi ere ìdárayá?” — meaning it wants to know during which time Richard could have gone to the amusement park.\n</step1>\n<step2>\nWe know Richard woke up at 5am. From 11am to 6pm, he was seen buying a phone — *Richard rí ní ilé itàjà*.\n</step2>\n<step3>\nAfter that, from 6pm to 8pm, he was engaged in a sport activity — *Richard ń ṣe eré ṣiṣe*.\n</step3>\n<step4>\nNext, he attended class from 8pm to 9pm — *Richard lọ sí kilasi*.\n</step4>\n<step5>\nFinally, he was seen buying cookies from 9pm to 10pm — *Richard rí ní ile itaja akara*.\n</step5>\n<step6>\nThe amusement park opens after 10pm, so we need to find a time before that when he could have gone.\n</step6>\n<step7>\nThe only time slot available before 10pm is from 5am to 11am, as he was busy during the other times.\n</step7></thinking>", "answer": "<answer>Richard lè ti lọ sí ibi ere ìdárayá láàrin 5am sí 11am.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun mẹrinlélógún kan ni a mú wá sí ẹka pajawiri pẹlu irora ikun tó burú jáde lóòkànlẹ́, ìrírorirọ̀, àti ẹ̀gbẹ́. Ó ní ìtàn àìlera àìtóòtú, lupus sisitemiki, àrùn ìdààmú ọkàn ńlá, àti irora ẹsẹ̀ ọ̀tún tó gbàgbé. Awọn oogun rẹ̀ pẹlu levothyroxine, prednisone, fluoxetine, naproxen, àti afikun chondroitin sulfate. Ní àyẹ̀wò, ó fi ikun rígidì hàn pẹlu irora rebound àti awọn ohun ọ̀fọ̀ inu ikun tí kò lágbára. Awọn idanwo ile-iwosan fi nọmba leukocyte gíga àti iyara sedimentation erythrocyte hàn. Bí a bá gbé eyi àti ayika iṣẹ́-ṣiṣe yìí yẹ̀wò, kini igbesẹ tó tọ́ julọ tó tẹle ní iṣakoso alaisan yii?", "reasoning": "<thinking><step1>\nThe question is asking: \"What is the most appropriate next step in managing a 24-year-old woman with severe abdominal pain, nausea, and vomiting, who has a medical history of lupus [lupus = lupus], heart failure [àrùn ìdààmú ọkàn ńlá = heart failure], and right leg pain [irora ẹsẹ̀ ọ̀tún = right leg pain]?\" \n</step1>\n<step2>\nGiven her symptoms and medical history, it’s crucial to assess for potential complications related to lupus and heart failure, as these conditions can lead to serious abdominal issues — *àwọn iṣoro inu ikun*.\n</step2>\n<step3>\nThe presence of rebound tenderness indicates possible peritoneal irritation, which could suggest an acute abdomen — *àbáwọlé àkúnya* — requiring urgent evaluation.\n</step3>\n<step4>\nAdditionally, the elevated leukocyte count and erythrocyte sedimentation rate suggest an inflammatory process, possibly indicating an infection or flare-up of her lupus — *ìfarapa lupus*.\n</step4>\n<step5>\nIn this context, imaging studies like an abdominal ultrasound or CT scan would be essential to rule out conditions such as appendicitis or pancreatitis — *àrùn àpẹ́ndíṣítìs*.\n</step6>\n<step6>\nThus, the most appropriate next step is to obtain imaging studies to further evaluate her abdominal pain and guide treatment — *ìwádìí àyẹ̀wò*.\n</step6></thinking>", "answer": "<answer>Igbesẹ tó tọ́ jùlọ ni lati gba àyẹ̀wò àwòrán lati ṣe àyẹ̀wò irora ikun rẹ.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹrindilogun kan fi ìgbẹ́rìsí ojú ilẹ̀kùn tí ó mọ́, àti ikọ́fù hàn fún ọ̀sẹ̀ méjì sẹ́yìn, pẹ̀lú ìṣòro ríru, ìgbẹ́rìsí orí, àti ibà tí kò lágbára. Òògùn tí a rà láìsí àṣẹ dókítà mú ìṣeéṣe rẹ̀ dara sí díẹ̀, ṣùgbọ́n ọjọ́ márùn-ún sẹ́yìn, ìgbẹ́rìsí ojú ilẹ̀kùn rẹ̀ di èyí tí ó ní òwú, ikọ́fù rẹ̀ sì pọ̀ sí i, pẹ̀lú ibà tí ó jẹ́ 37.9°C (100.2°F). Bí a bá gbé àwọn àmì àrùn yìí yẹ̀ wò, orí ilẹ̀kùn tí ó yára, òwú tí ó wà ní ẹ̀gbẹ́ ẹ̀yìn orí ilẹ̀kùn, ìmí òfúùfù, àti òwú púpọ̀ ní inú imú, kí ni àrùn tó jẹ́ èyí tó ṣeé ṣe jùlọ?", "reasoning": "<thinking><step1>\nThe question describes a 16-year-old boy with symptoms including a [runny nose = ìgbẹ́rìsí ojú ilẹ̀kùn], cough [ikọ́fù], and fever [ibà] for two weeks, along with headaches [ìṣòro ríru] and mild fever. It asks what illness is most likely based on these symptoms.\n</step1>\n<step2>\nThe symptoms suggest a respiratory infection, possibly viral. The presence of a runny nose and cough indicates *àrùn àtọ́runwá* (common cold) or *influenza* (flu).\n</step2>\n<step3>\nThe fever of 37.9°C (100.2°F) is mild, which is common in viral infections. In this case, *ìgbẹ́rìsí ojú ilẹ̀kùn* and *ikọ́fù* are significant indicators.\n</step3>\n<step4>\nIf the symptoms have worsened over the last five days, it could indicate a secondary bacterial infection, such as *sinusitis* or *bronchitis*.\n</step5>\n<step5>\nConsidering the duration and worsening of symptoms, the most likely illness is *influenza* or a viral upper respiratory infection that may have led to complications.\n</step6></thinking>", "answer": "<answer>Àrùn tó ṣeé ṣe jùlọ ni influenza tàbí àrùn àtọ́runwá pẹ̀lú àkúnya.</answer>", "language": "Yoruba"}
{"question": "Níwọn àwọn orílẹ̀-èdè wọ̀nyí, èwo ni ó ń sapá gidigidi láti dáàbò bò ọ̀rọ̀ ìbílẹ̀ wọn mọ́ kúrò lọ́wọ́ ìkọlu èdè Gẹ̀ẹ́sì tàbí àwọn èdè mìíràn?\nA. Brazil\nB. Australia\nC. Japan\nD. Amẹ́ríkà\nE. India\nF. South Africa", "reasoning": "<thinking><step1>\nThe question asks: “Níwọn àwọn orílẹ̀-èdè wọ̀nyí, èwo ni ó ń sapá gidigidi láti dáàbò bò ọ̀rọ̀ ìbílẹ̀ wọn mọ́ kúrò lọ́wọ́ ìkọlu èdè Gẹ̀ẹ́sì tàbí àwọn èdè mìíràn?” — meaning which of these countries is making significant efforts to preserve their indigenous languages against the influence of English or other languages.\n</step1>\n<step2>\nTo answer this, we need to consider countries with strong cultural heritage and active language preservation initiatives — *ìdàgbàsókè èdè*.\n</step2>\n<step3>\nBrazil has a diverse range of indigenous languages, and there are movements to protect them, but the influence of Portuguese is strong — *èdè Pọtugali* dominates.\n</step3>\n<step4>\nAustralia has faced challenges with its indigenous languages, but there are ongoing efforts to revitalize them — *ìmúlò èdè aboriginal* is being promoted.\n</step4>\n<step5>\nJapan, on the other hand, has a strong national identity and actively promotes the Japanese language, but there are concerns about regional dialects — *ìbílẹ̀* are at risk.\n</step5>\n<step6>\nIndia is home to many languages, and while there are efforts to preserve them, English is widely used in education and business — *èdè Gẹ̀ẹ́sì* has a significant presence.\n</step6>\n<step7>\nSouth Africa recognizes multiple official languages and has initiatives to promote indigenous languages, but English remains dominant in many areas — *ìkọ̀wé Gẹ̀ẹ́sì* is prevalent.\n</step7>\n<step8>\nConsidering all these factors, Japan stands out for its strong cultural emphasis on preserving its language and heritage against external influences.\n</step8></thinking>", "answer": "<answer>Japan ni orílẹ̀-èdè tó ń sapá gidigidi láti dáàbò bò ọ̀rọ̀ ìbílẹ̀ wọn.</answer>", "language": "Yoruba"}
{"question": "Ọ̀dọ́mọ́kùnrin kan tí ó ní àrùn ìgbàgbọ́ ọ̀ṣẹ̀ (UTI) wá síbi iwòsàn, nígbà tí a ṣe àyẹ̀wò ìgbàgbọ́ ọ̀ṣẹ̀ rẹ̀, a rí sẹ́ẹ̀lì pùṣù síbẹ̀ kò sí àwọn ẹ̀dá alààyè. Ọ̀nà wo ni ó dára jù fún ìmọ̀ ẹ̀dá alààyè—\nA. Ìgbékalẹ̀ sẹ́ẹ̀lì McCoy\nB. Ààyò Thayer Martin\nC. Ààyò L.J.\nD. Ààyò Levinthal", "reasoning": "<thinking><step1>\nThe question asks about the best method for identifying microorganisms in a patient with a urinary tract infection (UTI) — *àrùn ìgbàgbọ́ ọ̀ṣẹ̀* — where no living organisms were found in the culture.\n</step1>\n<step2>\nIn cases like this, it’s crucial to use a culture medium that supports the growth of specific bacteria — *ẹ̀dá alààyè* — that might be present but not easily detectable.\n</step2>\n<step3>\nThe options provided include various culture media: McCoy's, Thayer Martin, L.J., and Levinthal. Each has its specific use in microbiology.\n</step3>\n<step4>\nThayer Martin is particularly known for isolating *Neisseria gonorrhoeae* and other fastidious organisms, making it a strong candidate for UTI cases.\n</step4>\n<step5>\nOn the other hand, McCoy's is used for certain viruses and L.J. is primarily for mycobacteria, while Levinthal is less common for UTIs.\n</step5>\n<step6>\nGiven that the goal is to identify potential pathogens in a UTI, the best choice would be Thayer Martin, as it is designed to support the growth of specific bacteria that may not thrive in standard media.\n</step6></thinking>", "answer": "<answer>Ààyò Thayer Martin ni ó dára jù fún ìmọ̀ ẹ̀dá alààyè nínú àrùn ìgbàgbọ́ ọ̀ṣẹ̀.</answer>", "language": "Yoruba"}
{"question": "Àdánwò wo ni a máa ń lò láti ṣàpèjúwe ilana tí onímọ̀-ìṣirò fi ṣàyẹ̀wò bóyá àwọn ìṣirò bá àwọn ireti rẹ̀ mu, pàápàá nípa fífi ojú sí àwọn apá tí ó hàn gbangba?", "reasoning": "<thinking><step1>\nThe question translates to: “What method do we use to describe the process that a statistician uses to examine whether the data meets their expectations, especially by focusing on the visible parts?” \n</step1>\n<step2>\nThis refers to a statistical method, often involving *ìtẹ́numọ̀* (hypothesis testing) to evaluate data against expectations.\n</step2>\n<step3>\nIn this context, a statistician might use *àwọn àpẹẹrẹ* (samples) to analyze the data and check for *ìbáṣepọ̀* (correlation) with their hypotheses.\n</step3>\n<step4>\nThey often focus on *àwọn apá tí ó hàn gbangba* (visible parts) of the data, such as trends or patterns that can be easily observed.\n</step4>\n<step5>\nThe process may involve calculating *ìṣirò* (statistics) like the mean or standard deviation to summarize the data.\n</step5>\n<step6>\nUltimately, the statistician assesses whether the observed data aligns with their *ireti* (expectations) through visualizations or statistical tests.\n</step6></thinking>", "answer": "<answer>Àdánwò wo ni a máa ń lò láti ṣàpèjúwe ilana tí onímọ̀-ìṣirò fi ṣàyẹ̀wò bóyá àwọn ìṣirò bá àwọn ireti rẹ̀ mu ni ìtẹ́numọ̀.</answer>", "language": "Yoruba"}
{"question": "Ninu àgọ̀ fùmu to to lita 6000, tí a tọ́jú pẹ̀lú titẹ́ iwọ̀n kan ti 1.00 atm àti otutu ti 27°C, kini iwuwo kere jùlọ ti yinyin gbígbẹ (CO_2 tí ó le gbẹ) tí ó gbọ́dọ̀ yipada sí gaasi lati de ìwọ̀n CO_2 ti 10% nípa iwọ̀n, èyí tí ó lè lewu fún ẹnìkan tí kò ní ìgbọ́kànlé lati farada CO_2? Jẹ́ ká gba pé kò sí CO_2 níbẹ̀ ní ìbẹ̀rẹ̀.", "reasoning": "<thinking><step1>\nThe question asks: “Ninu àgọ̀ fùmu to to lita 6000, tí a tọ́jú pẹ̀lú titẹ́ [iwọn = pressure] kan ti 1.00 atm àti [otutu = temperature] ti 27°C, kini [iwuwo = weight] kere jùlọ ti yinyin gbígbẹ (CO_2) tí ó le gbẹ?” — meaning it wants to find the minimum weight of dry ice (CO₂) that must sublimate to reach a CO₂ concentration of 10% in a 6000-liter container.\n</step1>\n<step2>\nTo solve this, we first need to convert the temperature to Kelvin: 27°C + 273.15 = 300.15 K. This is important for using the ideal gas law.\n</step2>\n<step3>\nUsing the ideal gas law, PV = nRT, we can find the number of moles of CO₂ needed to achieve 10% concentration in the container. The total volume is 6000 liters, so 10% of that is 600 liters of CO₂.\n</step3>\n<step4>\nWe convert liters to cubic meters for calculations: 600 liters = 0.6 m³. The density of CO₂ at 1 atm and 300.15 K can be calculated using the ideal gas law, where R = 0.0821 L·atm/(K·mol).\n</step4>\n<step5>\nCalculating the number of moles: n = PV/RT = (1 atm)(0.6 m³)/(0.0821 L·atm/(K·mol) * 300.15 K). This gives us the moles of CO₂ needed.\n</step5>\n<step6>\nFinally, we multiply the number of moles by the molar mass of CO₂ (approximately 44.01 g/mol) to find the minimum weight of dry ice required to reach that concentration.\n</step6></thinking>", "answer": "<answer>Iwuwo kere jùlọ ti yinyin gbígbẹ (CO₂) tí ó gbọ́dọ̀ yipada sí gaasi ni 1320.6 giramu.</answer>", "language": "Yoruba"}
{"question": "Àtọ́ka wo ni wọ́n máa ń lò láti ṣe ìwọ̀n bí àrùn ẹ́yín ṣe le tó nínú àwọn ìwádìí àjàkálẹ̀ àrùn lórí ọ̀pọ̀ ènìyàn?", "reasoning": "<thinking><step1>\nThe question asks: “Àtọ́ka wo ni wọ́n máa ń lò láti ṣe ìwọ̀n bí àrùn ẹ́yín ṣe le tó nínú àwọn ìwádìí àjàkálẹ̀ àrùn lórí ọ̀pọ̀ ènìyàn?” — meaning it wants to know which metrics are used to measure how severe a disease can be in epidemiological studies.\n</step1>\n<step2>\nIn epidemiology, *àtọ́ka* refers to metrics or indicators that help assess disease severity — for example, *ìwọn àrùn* (disease burden) is crucial.\n</step2>\n<step3>\nCommon metrics include incidence rates — *ìwọn ìfarapa* — which measure new cases over time, and prevalence rates — *ìwọn àkúnya* — which assess total cases at a given time.\n</step3>\n<step4>\nAnother important metric is mortality rate — *ìwọn ikú* — indicating how many people die from the disease, which reflects its severity.\n</step4>\n<step5>\nAdditionally, researchers may use disability-adjusted life years (DALYs) — *ọdún ìgbé ayé tí a ṣe àtúnṣe* — to quantify the overall impact of the disease on quality of life.\n</step5>\n<step6>\nIn summary, these metrics help provide a comprehensive view of how severe a disease can be in a population — *nípa àkópọ̀ àwọn àtọ́ka*.\n</step6></thinking>", "answer": "<answer>Àtọ́ka tí wọ́n máa ń lò ni ìwọn ìfarapa, ìwọn àkúnya, àti ìwọn ikú láti ṣe ìwọ̀n bí àrùn ẹ́yín ṣe le tó nínú àwọn ìwádìí àjàkálẹ̀ àrùn.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹ́wàá kan farapa ní orí, ó sì dùbúlẹ̀ láìṣeé ríran fún ọ̀sẹ̀ mẹ́rin. Wọ́n ti fi igbò onígbàlóde sínú rẹ̀ báyìí.  Igbóná rẹ̀ gòkè sí 38.7°C (103°F) ati afẹ́fẹ́ oxygen sì nira síi.  Àwòrán X-ray ọmu tún fihan ṣíṣàn omi sí igbá ọmu ati ọ̀pọ̀lọpọ̀ apá kan ní inú ẹ̀dọ̀fóró.  Ní àwọn àkójọpọ̀ èyíkéyí nínú àwọn èròjà ìgbàlódé wọ̀nyí ni èyí tí ó gbọ́dọ̀ jẹ́ ìdí fún àrùn ẹ̀dọ̀fóró yìí?\nA. Legionella pneumophila\nB. Mycoplasma pneumoniae\nC. Pneumocystis carinii\nD. Staphylococcus aureus", "reasoning": "<thinking><step1>\nThe question is asking about the cause of a lung infection in a 10-year-old boy who has been experiencing symptoms for four weeks, including a high fever and difficulty breathing. Key terms include [àrùn ẹ̀dọ̀fóró = lung infection] and [igbóná = fever].\n</step1>\n<step2>\nGiven the symptoms, we need to consider common pathogens that cause lung infections in children. The presence of a high fever, difficulty breathing, and fluid in the lungs suggests a serious infection.\n</step2>\n<step3>\nLegionella pneumophila is known for causing severe pneumonia, especially in older adults, but can affect younger individuals too. However, it’s less common in children.\n</step3>\n<step4>\nMycoplasma pneumoniae is a common cause of pneumonia in children and can lead to prolonged symptoms, making it a strong candidate. It often presents with a gradual onset of symptoms.\n</step4>\n<step5>\nPneumocystis carinii is typically associated with immunocompromised patients, which may not apply here unless there are underlying health issues. \n</step5>\n<step6>\nStaphylococcus aureus can cause severe lung infections, especially post-viral, but the chronic nature of the symptoms leans away from this option.\n</step6>\n<step7>\nConsidering all these factors, Mycoplasma pneumoniae seems to be the most likely cause of the lung infection in this case due to its prevalence in children and the symptom profile.\n</step7></thinking>", "answer": "<answer>Mycoplasma pneumoniae ni àrùn ẹ̀dọ̀fóró yìí.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 61 kan wá sí ER pẹlu irora ikun ati aisan gbogbogbo fun ọsẹ meji sẹyin. O sọ pe ó ti gbeyawo ati pe ó jẹ́ ẹni tí kò bá obìnrin mìíràn sùn. Ó ní iwọn otutu ara ti 39.4°C (102.9°F) ó sì ń kùn pe òun ní irora ṣíṣàn ní alẹ́ pẹ̀lú. Nínú àyẹ̀wò ara, ó ní ṣíṣan ẹ̀dọ̀fóró pẹ̀lú irora díẹ̀ ati awọn ika ẹsẹ̀ pupa. Ọ̀gbẹ̀dẹ̀dẹ̀ tó pọn dín-dín wà nibẹ̀, ati àyẹ̀wò àìsàn ẹ̀dọ̀fóró fi hàn pe ó ní ìdánilẹ́kọ̀ọ́ sí gbogbo ibi. Ìgbàdọgbọ́ ẹ̀jẹ̀ pípé ṣe afihan ẹ̀jẹ̀-àìtẹ́lẹ̀, ìdinku ẹjẹ̀-pẹpẹrẹ, ati ìpọ̀sí ìwọ̀n ẹ̀jẹ̀-funfun pẹ̀lú ipò tí ó pọ̀ jùlọ ni lymphocyte. A gbero lati ya ẹjẹ lati inu egungun ni owurọ̀ keji lori awọn abajade iwadi ẹjẹ, ṣugbọn ko ṣe afihan nkan rara nitori pe ko pọ̀ to. A gbà á wọ́lé si ile-iwosan nitori ẹ̀jẹ̀-àìtẹ́lẹ̀ náà, a sì fun un ni ẹjẹ pupa tí a ti kó jọ ati awọn oògùn onibaje gbogbo. Wọ́n tú ù sílé ni ọjọ́ keji pẹ̀lu awọn itọnisọna fun atẹle itọju ni ile-iṣẹ ilera akọkọ. Nibo ni iwadi ile-ẹjẹ wo ni o ṣe deede julọ fun idi akọkọ ti aisan yi?\nA. Àyẹ̀wò iyara fun streptococcal antigen\nB. Quantiferon Gold\nC. Monospot\nD. Tartrate-resistant acid phosphatase (TRAP)\nE. CD 25", "reasoning": "<thinking><step1>\nThe question is asking: \"Nibo ni iwadi ile-ẹjẹ wo ni o ṣe deede julọ fun idi akọkọ ti aisan yi?\" — which translates to \"Which blood test is most appropriate for the primary cause of this illness?\" \n</step1>\n<step2>\nThe patient is a 61-year-old man with symptoms like abdominal pain and fever — *irora ikun ati iwọn otutu ara ti 39.4°C* — indicating a possible infection or inflammatory process.\n</step2>\n<step3>\nGiven the symptoms and the presence of *irora ṣíṣàn* at night, we need to consider tests that can identify common infections or conditions that could cause these symptoms.\n</step4>\n<step4>\nThe options include tests for streptococcal infection, tuberculosis (Quantiferon Gold), infectious mononucleosis (Monospot), and others. The fever and systemic symptoms suggest a need to rule out infections.\n</step5>\n<step5>\nAmong the options, the *àyẹ̀wò iyara fun streptococcal antigen* is particularly relevant if we suspect a streptococcal infection, which can cause fever and abdominal pain.\n</step6>\n<step6>\nThus, the most appropriate blood test for the primary cause of this illness, considering the symptoms presented, would be the rapid test for streptococcal antigen.\n</step6></thinking>", "answer": "<answer>Àyẹ̀wò iyara fun streptococcal antigen.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹ́rìndínlọ́gbọ̀n kan tí ó ní ìtàn ìdààmú ẹ̀jẹ̀ ṣíṣàn jáde lọ́pọ̀lọpọ̀ nítorí Extrahepatic Portal Venous Obstruction (EHPVO) ti wá pẹ̀lú irora ikùn apa òsì oke ati ṣíṣe ńlá ti spleen.  Lórí àwọn àmì àrùn wọnyi ati ìtàn ìṣègùn rẹ̀, àrùn wo ni ó ṣeé ṣe kí ó ń jiya lọ́wọ́ nìṣinṣin?", "reasoning": "<thinking><step1>\nThe question asks about a 35-year-old male with a history of [ìdààmú ẹ̀jẹ̀ ṣíṣàn = blood flow disturbance] due to Extrahepatic Portal Venous Obstruction (EHPVO), who presents with pain in the upper left abdomen and splenomegaly — *ìṣòro ikùn* and *ìtẹ̀sí ẹ̀jẹ̀*.\n</step1>\n<step2>\nEHPVO can lead to complications such as portal hypertension — *ìtẹ̀sí ẹ̀jẹ̀ àgbà* — which causes increased pressure in the portal venous system.\n</step2>\n<step3>\nThis condition often results in symptoms like abdominal pain and splenomegaly, as seen in this patient — *àwọn àmì àrùn wọnyi* are indicative of underlying issues.\n</step3>\n<step4>\nIn cases of portal hypertension, one might also consider the risk of variceal bleeding — *ìkó ẹ̀jẹ̀ láti àwọn varices* — which can occur due to increased venous pressure.\n</step4>\n<step5>\nAdditionally, the patient may experience ascites — *ìkó omi nínú ikùn* — as a result of fluid accumulation due to portal hypertension.\n</step5>\n<step6>\nGiven the symptoms and medical history, the patient is likely suffering from complications related to EHPVO, particularly portal hypertension and its associated effects.\n</step6></thinking>", "answer": "<answer>Àrùn tí ó ṣeé ṣe kí ó ń jiya lọ́wọ́ nìṣinṣin ni ìtẹ̀sí ẹ̀jẹ̀ àgbà àti àwọn àkúnya rẹ̀.</answer>", "language": "Yoruba"}
{"question": "A fìtí yàrá kan ni a fún ni afẹ́fẹ́ sí titẹ́ iwọn 24 lb in^{-2} ní ọjọ́ òtútù kan tí ó jẹ́ -5°C.  Tí a bá gbà pé kò sí ìdààmú sílẹ̀ àti iwọn didùn kan náà, iwọn titẹ́ wo ni yàrá náà yóò dé ní ọjọ́ ooru kan tí iwọn otutu rẹ̀ bá jẹ́ 35°C?", "reasoning": "<thinking><step1>\nThe question asks: “A fìtí yàrá kan ni a fún ni afẹ́fẹ́ sí titẹ́ [24 lb in^{-2}] ní ọjọ́ òtútù kan tí ó jẹ́ [-5°C]?” — meaning it wants to know the pressure in a room when the temperature changes from -5°C to 35°C.\n</step1>\n<step2>\nTo solve this, we can use the ideal gas law, which states that pressure is directly proportional to temperature when volume is constant — *p ∝ T*.\n</step2>\n<step3>\nFirst, we need to convert the temperatures from Celsius to Kelvin: -5°C is 268.15 K and 35°C is 308.15 K.\n</step3>\n<step4>\nNow, we can set up a ratio using the initial and final conditions: *P1/T1 = P2/T2*, where P1 is 24 lb in^{-2}, T1 is 268.15 K, and T2 is 308.15 K.\n</step4>\n<step5>\nRearranging gives us P2 = P1 * (T2/T1). Plugging in the values: P2 = 24 lb in^{-2} * (308.15 K / 268.15 K).\n</step5>\n<step6>\nCalculating this gives us P2 ≈ 27.5 lb in^{-2}. Thus, the pressure in the room at 35°C will be higher due to the increase in temperature.\n</step6></thinking>", "answer": "<answer>Iwọn titẹ́ yàrá náà yóò dé ní ọjọ́ ooru kan tí iwọn otutu rẹ̀ bá jẹ́ 35°C ni 27.5 lb in^{-2}.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun 15 kan ni a mú wá sọ́dọ̀ oníṣègùn nítorí irora ẹsẹ̀ òsì tí ó ń pọ̀ sí i fún oṣù méjì sẹ́yìn. Irora náà burú sí i nígbà tí ó bá ń sáré àti ní òru. Ìwádìí ẹsẹ̀ òsì fi hàn pé ó gbẹ̀rẹ̀ àti pé ó ní ìrora níbi tí ó sunmọ́ ẹsẹ̀ ìrẹwẹ̀sì. Ìwádìí ilé-ìṣèwádìí fi hàn pé iye alkaline phosphatase jẹ́ 200 U/L. Fọ́tò X-ray ẹsẹ̀ òsì fi hàn pé ó ní sclerosis, ìbajẹ́ cortical, àti ìṣe àwọn egungun tuntun ní àwọn ara òjò ní ayika distal femur. Àwọn spiculae púpọ̀ ń tàn ká sí etí egungun. Àrùn búburú arọ́mọdé yìí ṣeé ṣe kí ó ti ṣẹ̀lẹ̀ láti inú sẹ́ẹ̀lì ninu èyíkéyìí nínú àwọn àkóso wọ̀nyí?\nA. Periosteum\nB. Bone marrow\nC. Epiphyseal plate\nD. Neural crest\n\"", "reasoning": "<thinking><step1>\nThe question is asking about a 15-year-old boy with left leg pain that has worsened over two months, particularly during running and at night. It mentions findings like *sclerosis* and *cortical damage* in the X-ray, and elevated alkaline phosphatase levels.\n</step1>\n<step2>\nThe symptoms and X-ray findings suggest a possible bone pathology, which could be related to abnormal cell activity in the bone. The elevated alkaline phosphatase level indicates increased bone turnover — *une augmentation du métabolisme osseux*.\n</step2>\n<step3>\nThe options provided include different anatomical structures: *periosteum*, *moelle osseuse* (bone marrow), *plaque épiphysaire* (epiphyseal plate), and *crête neurale* (neural crest). \n</step3>\n<step4>\nGiven the age of the patient and the nature of the findings, the *plaque épiphysaire* is crucial for growth and can be involved in conditions like osteosarcoma or other growth-related disorders.\n</step4>\n<step5>\nThe presence of new bone formation and cortical damage suggests that the issue likely originates from the growth plate, where rapid cell division and activity occur — *la division cellulaire rapide*.\n</step5>\n<step6>\nThus, the most likely source of the problem, considering the symptoms and findings, is the epiphyseal plate, which is responsible for longitudinal bone growth and can be affected in various pathologies.\n</step6></thinking>", "answer": "<answer>Àrùn búburú arọ́mọdé yìí ṣeé ṣe kí ó ti ṣẹ̀lẹ̀ láti inú *plaque épiphysaire*.</answer>", "language": "Yoruba"}
{"question": "Nígbà tí a bá ń pinnu iwọn oògùn ìṣíṣe akọkọ tí ó yẹ fún oògùn ìdánwò tí ó ṣeé ṣeé yọrí sí epo pupọ, ES 62, láti gba iye ògùṣọ tí a ń retí tí ó jẹ́ 100 mmol/dL, àbáṣiṣẹpọ̀ ìṣiṣẹ́ oògùn wo ni ó ṣe pàtàkì jùlọ fún ìṣirò?", "reasoning": "<thinking><step1>\nThe question asks: \"Nígbà tí a bá ń pinnu [dosage = iwọn oògùn] for a drug trial that could lead to high levels of [lipids = epo pupọ], ES 62, to achieve a target level of 100 [millimoles per deciliter = mmol/dL], which pharmacokinetic parameter is most important for the calculation?\" \n</step1>\n<step2>\nIn pharmacokinetics, we consider parameters like absorption, distribution, metabolism, and excretion — *ìkànsí, pinpin, ìyípadà, àti ìyọkuro*.\n</step2>\n<step3>\nFor achieving a specific concentration, the most critical parameter is often the volume of distribution — *ìwọn pinpin* — because it affects how the drug disperses in the body.\n</step3>\n<step4>\nAdditionally, the clearance rate — *ìyọkuro* — is vital as it determines how quickly the drug is eliminated, impacting the steady-state concentration.\n</step4>\n<step5>\nIn this case, to reach 100 mmol/dL, understanding the volume of distribution will help in calculating the necessary dosage to achieve that target concentration effectively.\n</step5>\n<step6>\nThus, the most important pharmacokinetic parameter for this calculation is the volume of distribution.\n</step6></thinking>", "answer": "<answer>Ìwọn pinpin ni àbáṣiṣẹpọ̀ ìṣiṣẹ́ oògùn tó ṣe pàtàkì jùlọ fún ìṣirò yìí.</answer>", "language": "Yoruba"}
{"question": "Kini gigun ìgbìkanṣe àtọ́ka tó wà ní apá ìkún ilẹ̀kùn èjìká ọ̀nà kan, tí a ṣe ìwọ̀n rẹ̀ láti ẹ̀gbẹ̀ òkè sí apá ọrùn, nípa lílo oṣù January àti February?", "reasoning": "<thinking><step1>\nThe question asks: “Kini gigun [ìgbìkanṣe àtọ́ka = the length of a specific measurement] tó wà ní apá [ìkún ilẹ̀kùn = the base of a door frame] èjìká [ọ̀nà = pathway] kan?” — meaning it wants to know the length of a specific measurement related to a door frame in a pathway, using January and February as reference points.\n</step1>\n<step2>\nTo understand this, we need to consider what *ìgbìkanṣe àtọ́ka* refers to — it could be a measurement related to construction or design.\n</step2>\n<step3>\nIn construction, the length from the top of the door frame to the floor is crucial — *gigun ilẹ̀kùn* is often standardized.\n</step3>\n<step4>\nUsing January and February suggests a seasonal context, possibly indicating when construction is typically done — *àkókò iṣẹ́* can affect measurements due to temperature changes.\n</step4>\n<step5>\nIn many regions, January and February are cold months, which can influence materials used — *àwọn ohun elo* may contract or expand based on temperature.\n</step6>\n<step6>\nThus, the length of the measurement in question is likely standardized but can vary slightly depending on the conditions during these months.\n</step6></thinking>", "answer": "<answer>Gigun ìgbìkanṣe àtọ́ka tó wà ní apá ìkún ilẹ̀kùn èjìká ọ̀nà kan jẹ́ 2.1 mèta, ṣùgbọ́n ó lè yí padà nípa àkókò iṣẹ́.</answer>", "language": "Yoruba"}
{"question": "Ion Agba Cu(II) kan gbe awọn ila mẹrin jade pẹlu iwọn iyatọ 500 MHz. Ka ipinya hyperfine ni awọn iwọn magnetic field (mT) ati asopọ hyperfine ni awọn iwọn nọmba wẹẹbu (cm-1).", "reasoning": "<thinking><step1>\nThe question asks: “Ion Agba Cu(II) kan gbe awọn ila mẹrin jade pẹlu iwọn iyatọ 500 MHz” — meaning it refers to the Cu(II) ion producing four lines with a frequency difference of 500 MHz.\n</step1>\n<step2>\nIn electron paramagnetic resonance (EPR), the hyperfine splitting occurs due to interactions between the magnetic moments of the nucleus and the unpaired electrons — *iyipada hyperfine*.\n</step2>\n<step3>\nThe frequency difference of 500 MHz can be related to the hyperfine splitting constant, which is influenced by the magnetic field strength — *agbara aaye mọnamọna*.\n</step3>\n<step4>\nTo find the hyperfine splitting in magnetic fields (mT), we can use the formula: Δν = gμB/h * B, where Δν is the frequency difference, g is the g-factor, μB is the Bohr magneton, and h is Planck's constant.\n</step4>\n<step5>\nNext, we convert the hyperfine splitting to wavenumbers (cm-1) using the relation: ν = c/λ, where c is the speed of light and λ is the wavelength corresponding to the frequency.\n</step5>\n<step6>\nThus, we can calculate the hyperfine splitting in both magnetic fields and wavenumbers based on the given frequency difference.\n</step6></thinking>", "answer": "<answer>Ipinya hyperfine ni awọn iwọn aaye mọnamọna (mT) ati asopọ hyperfine ni awọn iwọn nọmba wẹẹbu (cm-1) le ṣe iṣiro lati iwọn iyatọ 500 MHz.</answer>", "language": "Yoruba"}
{"question": "Ninu àwọn àtúnṣe ti Ẹgbẹ́ Àgbáyé fún Àwọn Òṣìṣẹ́ Àwọn Àṣàyàn (ISO) sí eto FDI, kini koodu 05 ṣe tọ́ka sí gan-an?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu àwọn àtúnṣe ti Ẹgbẹ́ Àgbáyé fún Àwọn Òṣìṣẹ́ Àwọn Àṣàyàn (ISO) sí eto FDI, kini koodu 05 ṣe tọ́ka sí gan-an?” — meaning it wants to know what code 05 refers to in the context of ISO amendments related to FDI (Foreign Direct Investment).\n</step1>\n<step2>\nISO standards are crucial for ensuring quality and consistency in international business practices — *àwọn ìṣàkóso ISO* help organizations meet global benchmarks.\n</step2>\n<step3>\nIn the context of FDI, code 05 typically refers to specific guidelines or classifications — *koodu 05* le tọ́ka sí àtúnṣe kan pato.\n</step3>\n<step4>\nThis code might relate to the classification of investments or the reporting requirements for foreign entities — *ìtẹ́wọ́gba àwọn idoko-owo*.\n</step4>\n<step5>\nUnderstanding these codes is essential for compliance and strategic planning in international investments — *ìmọ̀ koodu yìí ṣe pataki fún ìmúṣiṣẹ́pọ̀*.\n</step6>\n<step6>\nThus, code 05 in the ISO context for FDI likely indicates a specific regulatory framework or classification standard.\n</step6></thinking>", "answer": "<answer>Koodu 05 tọ́ka sí àtúnṣe kan pato ninu ìṣàkóso ISO fún àtúnṣe àkọsílẹ̀ idoko-owo àjèjì.</answer>", "language": "Yoruba"}
{"question": "Ninu ipo itọju oníṣẹ́-ẹnu tí obìnrin ọmọ ọdún 18 kan ti yọ awọn eyín 1st premolars kuro ninu gbogbo awọn quadrant, tí o sì n fihan bayi 3 mm ti aaye laarin awọn eyín canine ati awọn eyín 2nd premolars, pẹlu awọn elastics Class II ti bẹrẹ lati tii awọn aaye wọnyi, kini irú anchorage pàtó ti a pese nipasẹ awọn elastics naa?", "reasoning": "<thinking><step1>\nThe question asks: “In a treatment scenario where an 18-year-old woman has had her 1st premolars extracted from all quadrants, and there is now a 3 mm space between the canines and 2nd premolars, with Class II elastics starting to close these spaces, what type of anchorage is provided by the elastics?” \n</step1>\n<step2>\nIn orthodontics, anchorage refers to the resistance to unwanted tooth movement — *iṣeduro si gbigbe awọn eyín ti a ko fẹ*.\n</step2>\n<step3>\nClass II elastics are used to correct the relationship between the upper and lower teeth — *lati mu ibasepọ laarin awọn eyín oke ati isalẹ ṣiṣẹ*.\n</step4>\n<step4>\nIn this case, the elastics are likely providing a form of *anchorage réciproque*, where the force applied helps to move the canines forward while stabilizing the molars.\n</step5>\n<step5>\nThis means that the elastics are not just closing the space but also ensuring that the molars remain in their position — *ki awọn molars ma ba gbe*.\n</step6>\n<step6>\nThus, the specific anchorage provided by the Class II elastics in this scenario is a combination of reciprocal anchorage and possibly some form of skeletal anchorage, depending on the overall treatment plan.\n</step6></thinking>", "answer": "<answer>Anchorage réciproque ni a pese nipasẹ awọn elastics Class II ninu ipo yii.</answer>", "language": "Yoruba"}
{"question": "Lọ́dún ọmọdé kan tí ó ní ìṣòro ìmímú afẹ́fẹ́ àti àìdàgbàsókè, tí iye epo chloridi ninu ẹ̀ẹ́rùn rẹ̀ jẹ́ 35 meq/L àti 41 meq/L, kí ni àdánwò ìwádìí tí ó tọ́ jùlọ tókàn fún ààrùn cystic fibrosis?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àdánwò ìwádìí tí ó tọ́ jùlọ tókàn fún ààrùn [cystic fibrosis = cystic fibrosis]?” — meaning it wants to know the most appropriate diagnostic test for cystic fibrosis in a child with respiratory issues and abnormal chloride levels.\n</step1>\n<step2>\nCystic fibrosis is characterized by thick mucus production and can lead to respiratory problems — *ìṣòro afẹ́fẹ́* and *àìdàgbàsókè* in children.\n</step2>\n<step3>\nThe chloride levels mentioned, 35 meq/L and 41 meq/L, suggest a potential issue, as normal levels are typically lower — *iyẹn ni pé, iye epo chloridi ti o ga ju ti a ṣe yẹ lọ*.\n</step3>\n<step4>\nThe gold standard test for diagnosing cystic fibrosis is the sweat test — *àdánwò ìmímú ẹ̀jẹ̀* — which measures the concentration of chloride in sweat.\n</step4>\n<step5>\nIn this case, if the sweat test shows elevated chloride levels, it would confirm the diagnosis of cystic fibrosis — *àdánwò yìí jẹ́ àfihàn ààrùn cystic fibrosis*.\n</step6>\n<step6>\nThus, the most appropriate diagnostic test for this child is the sweat test.\n</step6></thinking>", "answer": "<answer>Àdánwò ìwádìí tó tọ́ jùlọ fún ààrùn cystic fibrosis ni àdánwò ìmímú ẹ̀jẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ègbògi wo ni, tí a bá mu ju ọ̀pọ̀lọpọ̀ lọ, tí ó ṣeé ṣe kí ó fa àwọn àmì bí bradycardia, hypotension, ìdinku òòrùn, àti ìdinku òjò sílẹ̀ nínú àpọnà tí a ń tọ́jú fún àrùn ọpọlọ?", "reasoning": "<thinking><step1>\nThe question asks: “What poison, if taken in large quantities, could cause symptoms like bradycardia, hypotension, decreased consciousness, and decreased urine output in a patient being treated for a brain disease?” — here, *ègbògi* refers to poison or drug.\n</step1>\n<step2>\nBradycardia means a slow heart rate, while hypotension refers to low blood pressure — *ìdinku ẹjẹ*.\n</step2>\n<step3>\nIn cases of poisoning, certain substances can lead to these symptoms; for example, opioids can cause respiratory depression — *ìdinku àfiyèsí*.\n</step3>\n<step4>\nAdditionally, if a patient has taken too much of a sedative, it can lead to decreased consciousness — *ìdinku ìmọ̀lára* — and affect kidney function, resulting in decreased urine output.\n</step4>\n<step5>\nIn the context of brain disease treatment, medications like benzodiazepines or barbiturates could be involved, as they are known to cause such effects when overdosed.\n</step5>\n<step6>\nTherefore, a likely candidate for this scenario is an overdose of sedative drugs — *ègbògi àfiyèsí* — which can lead to the mentioned symptoms.\n</step6></thinking>", "answer": "<answer>Ègbògi àfiyèsí ni, tí a bá mu ju lọ, tí ó lè fa bradycardia, hypotension, ìdinku òòrùn, àti ìdinku òjò sílẹ̀.</answer>", "language": "Yoruba"}
{"question": "Àpọnà kan ń ṣe ìrora ní ojú òsì, tí ìríran rẹ̀ sì ń dẹ́kun, lẹ́yìn ìṣẹ̀lẹ̀ ìbàjẹ́ ojú tí ó ṣẹlẹ̀ oṣù mẹrin sẹ́yìn. Ṣé ìwádìí wo ni ó yẹ kí a ṣe àkọ́kọ́ láti ṣàgbéyẹ̀wò ipò náà?", "reasoning": "<thinking><step1>\nThe question translates to: \"A patient is experiencing pain in the left eye, with vision impairment, following an eye injury that occurred four months ago. What initial investigations should be conducted to assess the condition?\" \n</step1>\n<step2>\nFirst, we need to consider the potential causes of pain and vision issues — *ìrora* and *ìríran dẹ́kun* could indicate complications from the injury.\n</step2>\n<step3>\nA thorough history should be taken, focusing on the nature of the injury — *ìṣẹ̀lẹ̀ ìbàjẹ́ ojú* — and any symptoms that have developed since then.\n</step3>\n<step4>\nNext, a comprehensive eye examination is essential, including visual acuity tests — *àyẹ̀wò ìríran* — to determine the extent of the vision impairment.\n</step4>\n<step5>\nAdditionally, imaging studies like an ultrasound or CT scan may be necessary to check for any structural damage — *ìfarapa* — or foreign bodies in the eye.\n</step5>\n<step6>\nFinally, assessing intraocular pressure is crucial, as it can indicate conditions like glaucoma that may arise post-injury — *ìpinnu titẹ̀ inú ojú*.\n</step6></thinking>", "answer": "<answer>Àkọ́kọ́, a yẹ kí a ṣe àyẹ̀wò ojú, àyẹ̀wò ìríran, àti ìmúlò àwòrán láti ṣàgbéyẹ̀wò ipò náà.</answer>", "language": "Yoruba"}
{"question": "Ọmọbirin ọdun mẹrindilogun kan ti o ti n mu oogun fun irora fún ọdun meji sẹhin ni a ti rí pẹlu awọ bulu-dudu lori awọn eekanna rẹ.  Oogun wo ni o ṣeese jẹ́  ẹ̀bi fún awọ yii?", "reasoning": "<thinking><step1>\nThe question asks: “What medication is likely responsible for the blue-black discoloration on the fingers of a 16-year-old girl who has been taking pain medication for the past two years?” — here, *awọ bulu-dudu = blue-black discoloration* and *oogun fun irora = pain medication*.\n</step1>\n<step2>\nCertain medications can cause skin discoloration as a side effect — *awọn oogun kan le fa iyipada awọ bi abajade*.\n</step3>\n<step3>\nFor instance, medications like *minocycline* are known to cause a blue-gray discoloration of the skin — *iyipada awọ bulu-dudu*.\n</step4>\n<step4>\nAdditionally, some non-steroidal anti-inflammatory drugs (NSAIDs) can lead to skin reactions, although less commonly — *awọn oogun NSAID le fa awọn iṣoro awọ*.\n</step5>\n<step5>\nGiven the duration of use and the specific discoloration, *minocycline* seems to be a likely culprit in this case.\n</step6>\n<step6>\nThus, the medication that is likely responsible for the blue-black discoloration is *minocycline*.\n</step6></thinking>", "answer": "<answer>Oogun ti o ṣee ṣe jẹ́ ẹ̀bi fún awọ bulu-dudu ni *minocycline*.</answer>", "language": "Yoruba"}
{"question": "Obìnrin kan tí ó lóyún nígbà kẹta (AG2P1) ní ìtàn ìbí ọmọ nígbà tí kò pé ní ọsẹ̀ 32 ní ìlóyún rẹ̀ tẹ́lẹ̀. Ṣe ìpín ọgọ́rùn-ún àǹfààní rẹ̀ fún ìmúbirẹ̀ ọmọ nígbà tí kò pé nínú ìlóyún lọ́wọ́lọ́wọ́ yìí?", "reasoning": "<thinking><step1>\nThe question translates to: \"A woman who is pregnant at the third trimester (AG2P1) during childbirth at 32 weeks in her pregnancy. What is the percentage benefit for the survival of the baby during this current pregnancy?\" This asks about the survival rates of preterm infants.\n</step1>\n<step2>\nAt 32 weeks, a baby is considered preterm — *ọmọ tí kò pé* — and survival rates can vary significantly based on medical advancements and care.\n</step2>\n<step3>\nResearch indicates that the survival rate for infants born at 32 weeks is approximately 90% — *ìpín àǹfààní* ti o ga ju 90% lọ.\n</step3>\n<step4>\nFactors influencing this include the health of the mother, access to neonatal care, and the presence of any complications — *ìlera mẹta, ìtẹ́wọ́gbà sí ìtọ́jú ọmọ tuntun*.\n</step5>\n<step6>\nIn many cases, babies born at this stage may face challenges but can thrive with proper medical support — *àwọn ọmọ tí a bí ní ipele yìí le ni ìṣòro, ṣùgbọ́n wọn le yè pẹ̀lú ìtọ́jú tó péye*.\n</step7>\n<step8>\nThus, the percentage benefit for the survival of the baby at 32 weeks is quite high, reflecting advancements in neonatal care.\n</step8></thinking>", "answer": "<answer>Ìpín àǹfààní rẹ̀ fún ìmúbirẹ̀ ọmọ nígbà tí kò pé nínú ìlóyún ni 90%.</answer>", "language": "Yoruba"}
{"question": "Da ara iṣẹ́-ṣe iṣoogun ọkunrin ọdun mẹ́rìnlélógún (78) kan tí ó ní ìtàn àrùn ọ̀kan tí ó ń lo aspirin àti clopidogrel, tí a rí pẹ̀lú ẹ̀jẹ̀ ńlá ní apa ọ̀tún parietal intracranial, tí ó sì ti ní ìṣelọ́pọ̀ ìṣàn oṣupa tí ó pọ̀ sí i, kí ni iwọ yóò retí láti rí ní ti iwuwo pato ti oṣupa, osmolality oṣupa, plasma osmolality, ati awọn ipele sọ́diọ́mu ẹ̀jẹ̀, ati idi?", "reasoning": "<thinking><step1>\nThe question asks about a 78-year-old man with a history of heart disease who is taking aspirin and clopidogrel, and has been found with a large intracranial parietal hemorrhage — *ẹ̀jẹ̀ ńlá ní apa ọ̀tún parietal intracranial*. It wants to know what to expect regarding specific lab values: cerebrospinal fluid (CSF) weight, CSF osmolality, plasma osmolality, and blood sodium levels.\n</step1>\n<step2>\nIn cases of intracranial hemorrhage, the CSF may show changes due to the presence of blood — *ìfarapa ẹ̀jẹ̀* can lead to increased protein levels in the CSF, affecting its osmolality.\n</step2>\n<step3>\nTypically, CSF osmolality might be elevated due to the breakdown of blood components — *ìyípadà àwọn eroja ẹ̀jẹ̀* can increase the solute concentration.\n</step3>\n<step4>\nPlasma osmolality is usually maintained unless there are significant metabolic disturbances — *ìyípadà àtọka* can occur if the patient is dehydrated or has renal issues.\n</step4>\n<step5>\nBlood sodium levels may be affected by the patient's overall fluid status; in cases of hemorrhage, one might expect hyponatremia — *ìkànsí sodium* could occur due to dilution from fluid shifts.\n</step5>\n<step6>\nIn summary, one would expect elevated CSF osmolality and possibly altered sodium levels due to the hemorrhage and the patient's medication regimen.\n</step6></thinking>", "answer": "<answer>Iwọ yóò retí pé osmolality oṣupa yóò ga, sodium ẹ̀jẹ̀ le dín kù, ati pe iwuwo pato ti oṣupa le yipada nitori ìfarapa ẹ̀jẹ̀.</answer>", "language": "Yoruba"}
{"question": "Àgbẹ̀rún eeyan wo ni ó sábà máa ń fa àrùn endocarditis tí ó ń bẹ̀rẹ̀ sí í hàn lẹ́yìn oṣù mẹ́jọ lẹ́yìn ìṣiṣẹ́ àtúnṣe àtẹ̀gùn artifical?", "reasoning": "<thinking><step1>\nThe question asks: “Àgbẹ̀rún eeyan wo ni ó sábà máa ń fa àrùn [endocarditis = endocarditis] tí ó ń bẹ̀rẹ̀ sí í hàn lẹ́yìn oṣù mẹ́jọ lẹ́yìn ìṣiṣẹ́ àtúnṣe àtẹ̀gùn [artificial heart valve = artificial heart valve]?” — meaning it wants to know which risk factors typically lead to endocarditis after an artificial heart valve surgery.\n</step1>\n<step2>\nEndocarditis is an infection of the heart's inner lining, often caused by bacteria — *bakteria* that enter the bloodstream.\n</step2>\n<step3>\nAfter surgery, *àtúnṣe àtẹ̀gùn*, patients are at risk due to potential exposure to bacteria during the procedure or from other sources.\n</step3>\n<step4>\nCommon risk factors include having a history of heart valve disease, *àrùn àtẹ̀gùn*, or previous endocarditis episodes.\n</step4>\n<step5>\nAdditionally, poor oral hygiene can lead to bacteria entering the bloodstream — *ìtọ́jú ẹnu to dara* is crucial to prevent this.\n</step5>\n<step6>\nPatients with weakened immune systems or chronic conditions like diabetes are also at higher risk — *àwọn alaisan tí kò ni ààbò to dára*.\n</step6>\n<step7>\nIn summary, factors like previous heart conditions, poor dental health, and compromised immunity increase the likelihood of developing endocarditis after surgery.\n</step7></thinking>", "answer": "<answer>Àgbẹ̀rún eeyan tí ó sábà máa ń fa àrùn endocarditis lẹ́yìn ìṣiṣẹ́ àtúnṣe àtẹ̀gùn ni àrùn àtẹ̀gùn, ìtọ́jú ẹnu to dara, àti àìlera àkúnya.</answer>", "language": "Yoruba"}
{"question": "Àpọnà kan tí ó wà labẹ́ ìtọ́jú tara nípa ọ̀nà ìtọ́jú gbọ̀ngọ̀n fún àrùn ìgbàgbọ́ (DOTS) ti pari oṣù 6 ìtọ́jú rẹ̀. Ní ìbẹ̀rẹ̀, èémí rẹ̀ ní àmì àrùn, ó sì yí padà sí èémí tí kò ní àmì àrùn lẹ́yìn ìpele ìṣiṣẹ́ lọ́wọ́, ó sì wà ní èémí tí kò ní àmì àrùn oṣù méjì sí ìpele ìtẹ̀síwájú. Ọ̀rọ̀ wo ni ó yẹ̀ ní àṣeyọrí fún ipò ìtọ́jú àpọnà yìí?", "reasoning": "<thinking><step1>\nThe question asks about the treatment success criteria for a patient undergoing Directly Observed Treatment, Short-course (DOTS) for tuberculosis (TB) after completing six months of treatment. \n</step1>\n<step2>\nInitially, the patient had symptoms of the disease — *àmì àrùn* — but after treatment, they transitioned to a state without symptoms — *èémí tí kò ní àmì àrùn*.\n</step2>\n<step3>\nThe key indicators of successful treatment include the resolution of symptoms and negative sputum tests — *àyẹ̀wò àtọ́ka* — indicating no active TB.\n</step3>\n<step4>\nIn addition, the patient should maintain a stable health status for at least two months post-treatment — *ipò ìtẹ̀síwájú* — to confirm the treatment's effectiveness.\n</step4>\n<step5>\nMonitoring for any potential relapse is also crucial, as TB can recur if not fully eradicated — *àìlera àrùn*.\n</step5>\n<step6>\nThus, the success criteria for this treatment regimen would be the absence of symptoms, negative sputum tests, and sustained health improvement.\n</step6></thinking>", "answer": "<answer>Àṣeyọrí ìtọ́jú yìí ni àìmọ̀ àmì àrùn, àyẹ̀wò àtọ́ka tó dájú pé kò sí àrùn, àti ipò ìtẹ̀síwájú tó péye.</answer>", "language": "Yoruba"}
{"question": "Ṣe àwọn ọ̀rọ̀ wọ̀nìí jáde ní ìmúlẹ̀ ìwé: Àtò: cornerstone, green, brindle, prowl, nonce, ballard, scrappy, credulous, des, pitney, difluoride, toward, predilect, nostalgic, rape, mixup, horseplay, jew, curio", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe àwọn ọ̀rọ̀ wọ̀nìí jáde ní ìmúlẹ̀ ìwé?” — meaning it wants to know if these words can be found in a written context or text.\n</step1>\n<step2>\nTo determine this, we need to analyze each word: *cornerstone* is often used in discussions about foundations, both literally and metaphorically — *ìpìlẹ̀*.\n</step2>\n<step3>\n*Green* can refer to color or environmental topics — *àwọn ọrọ̀ ayika* — making it common in various texts.\n</step3>\n<step4>\n*Brindle* describes a specific coat pattern in animals, particularly dogs — *àpẹẹrẹ àwọ̀* that might appear in literature about pets.\n</step4>\n<step5>\n*Prowl* suggests stealthy movement, often used in narratives involving animals or crime — *ìtàn àkúnya*.\n</step5>\n<step6>\nThe word *nonce* is more specialized, often appearing in legal or linguistic contexts — *ìtàn ofin*.\n</step6>\n<step7>\n*Ballard* could refer to a type of poem or a surname, which might be found in literary discussions — *ìtàn ìmọ̀*.\n</step7>\n<step8>\n*Scrappy* describes a determined or feisty character, often used in character descriptions — *àwọn àkòrí*.\n</step8>\n<step9>\n*Credulous* refers to someone who is easily deceived, a term often found in critical writing — *ìtàn àkíyèsí*.\n</step9>\n<step10>\nThe remaining words like *des*, *pitney*, *difluoride*, *toward*, *predilect*, *nostalgic*, *rape*, *mixup*, *horseplay*, *jew*, and *curio* can also appear in various contexts, from scientific to cultural discussions — *ìtàn ìmọ̀, àṣà, àti ẹ̀sìn*.\n</step10></thinking>", "answer": "<answer>Bẹẹni, àwọn ọ̀rọ̀ wọ̀nìí le jáde ní ìmúlẹ̀ ìwé, nítorí pé wọ́n ní ìtàn àti àkópọ̀ tó dára.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹrindilogun kan, lakoko ti o n gun kekere laisi aṣọ bo ori, ni ijamba ọkọ ayọkẹlẹ. Wọ́n mu u wá sí ibi ìtọ́jú àwọn tó farapa lọ́kàn, a sì ṣe awọn ayẹwo aworan fun u. A ṣe ayẹwo rẹ̀ pé ó ní ibajẹ́ egungun igun iwaju apa osi ati ibajẹ́ ara ọpọlọ. Ko ní àrùn iṣàn, ati GCS rẹ̀ jẹ́ 10. Ọ̀gbìn ogun arun iṣàn ninu alaisan yii\nA. Ko yẹ̀ nitori ewu àkàn\nB. Yẹ̀ lati dinku iṣẹlẹ ti awọn iṣàn ti o bẹrẹ ni kutukutu lẹhin ibajẹ\nC. Ó ṣeé ṣe ki ó fa ki ìgbóná ọpọlọ pọ̀ sí i\nD. Yẹ̀ lati dinku iṣẹlẹ ti awọn iṣàn ti o bẹrẹ lẹhin ibajẹ", "reasoning": "<thinking><step1>\nThe question describes a 16-year-old boy who had a car accident and was found to have a fracture in the left front leg and a brain injury, with a GCS (Glasgow Coma Scale) of 10. It asks about the appropriateness of administering a certain treatment for this patient.\n</step1>\n<step2>\nGiven the brain injury, we need to consider the risks associated with treatment — *ewu ti aisan* and potential complications.\n</step2>\n<step3>\nThe GCS of 10 indicates a moderate level of consciousness impairment, which raises concerns about *iṣeduro* and the risk of further complications.\n</step3>\n<step4>\nOption A suggests that treatment should not be given due to the risk of cancer — *ewu àkàn*, which is not directly relevant here.\n</step4>\n<step5>\nOption B states that treatment is necessary to reduce the incidence of complications that may arise early after the injury — *lati dinku iṣẹlẹ ti awọn iṣàn*.\n</step5>\n<step6>\nOption C implies that treatment could exacerbate the brain injury — *fa ki ìgbóná ọpọlọ pọ̀ sí i*, which is a valid concern.\n</step6>\n<step7>\nOption D suggests that treatment should be given to reduce the incidence of complications that may arise after the injury — *lati dinku iṣẹlẹ ti awọn iṣàn ti o bẹrẹ lẹhin ibajẹ*.\n</step7>\n<step8>\nConsidering the patient's condition, the best approach would be to minimize complications while being cautious of the brain injury.\n</step8></thinking>", "answer": "<answer>Yẹ̀ lati dinku iṣẹlẹ ti awọn iṣàn ti o bẹrẹ ni kutukutu lẹhin ibajẹ.</answer>", "language": "Yoruba"}
{"question": "Okùnrin ọdun 45 kan ti ní ìṣòro ìrántí tí ó ń pọ̀ sí i fún oṣù 6, tí ó sì ń kàn sí iṣẹ́ rẹ̀ gẹ́gẹ́ bí akọọ̀lẹ̀, ìṣàn-ṣàn-ṣàn kíkún fún ìgbà pípẹ̀, àti ìṣòro rírìn tí a ṣàpẹẹrẹ sí bí ìrìn tí ó lọra, pẹ̀lú àwọn igbesẹ́ kékeré, ipilẹ̀ gbòògì, àti ìmọ̀lẹ̀ bíi pé ó di mọ́ ilẹ̀ mọ́. Ó ti ní ìtàn jíjẹ́ ẹni tí ó ń mu siga ṣùgbọ́n ìtàn iṣẹ́-ìlera rẹ̀ kò ní ohun mìíràn tí ó ṣe pàtàkì. Ìwádìí ìṣàkóso àìlera ẹ̀dá ara ni ó fi hàn pé àwọn ìṣiṣẹ́ ojú tí ó wà ní ita jẹ́ déédéé, kò sì sí àmì Romberg. Pẹ̀lú àwọn àmì wọ̀nyí àti ẹ̀rọ CT ti ori, kini àyèwò tó ṣeé ṣe jùlọ fún aláìsàn yìí?", "reasoning": "<thinking><step1>\nThe question describes a 45-year-old man experiencing memory problems for 6 months, affecting his work as a writer, along with symptoms like *ataxia* (difficulty walking) and *dizziness*.\n</step1>\n<step2>\nMemory issues can be linked to various conditions, including neurological disorders — *àìlera ẹ̀dá ara* — which might explain his symptoms.\n</step2>\n<step3>\nThe mention of *ìtàn jíjẹ́* (history of smoking) could suggest potential vascular issues or cognitive decline, but his health history is otherwise unremarkable.\n</step3>\n<step4>\nThe examination shows no *Romberg sign*, indicating that balance issues may not stem from vestibular problems, which narrows down the possibilities.\n</step4>\n<step5>\nGiven the CT scan results and the symptoms, one might consider a neurodegenerative disorder or a vascular cause, such as a stroke or transient ischemic attack.\n</step5>\n<step6>\nA comprehensive evaluation, including MRI or neuropsychological testing, would be essential to clarify the diagnosis and rule out other conditions.\n</step6>\n<step7>\nIn this case, an MRI of the brain would be the most appropriate next step to investigate potential structural changes or lesions.\n</step7></thinking>", "answer": "<answer>Àyèwò tó ṣeé ṣe jùlọ fún aláìsàn yìí ni MRI ti ori.</answer>", "language": "Yoruba"}
{"question": "Nínú àpọǹá tó ní ìṣìnkú ìdíyelé ẹ̀jẹ̀, irú àrùn wo ni kò bá ìwádìí yìí mu, tí ó sì máa ń jẹ́ pé kò ní ìsopọ̀ pẹ̀lú àìlera ìdíyelé ẹ̀jẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Nínú àpọǹá tó ní [ìṣìnkú ìdíyelé ẹ̀jẹ̀ = blood coagulation disorders], irú àrùn wo ni kò bá ìwádìí yìí mu?” — meaning it wants to know which diseases are not associated with blood coagulation disorders.\n</step1>\n<step2>\nBlood coagulation disorders can lead to conditions like *ìfarapa ẹ̀jẹ̀* (bleeding) or *ìkó ẹ̀jẹ̀* (thrombosis), but some diseases do not relate to these issues.\n</step2>\n<step3>\nFor example, *àrùn àtọ́kànwá* (autoimmune diseases) like lupus may not directly affect blood coagulation, even though they can cause other complications.\n</step3>\n<step4>\nAdditionally, conditions such as *àrùn àtọ́ka* (metabolic disorders) or *àrùn àkúnya* (infectious diseases) do not typically involve blood coagulation issues.\n</step4>\n<step5>\nIt's important to note that while these diseases may not directly impact coagulation, they can still affect overall health and lead to other complications.\n</step5>\n<step6>\nIn summary, diseases like *àrùn àtọ́kànwá* and *àrùn àkúnya* are examples that do not have a direct connection to blood coagulation disorders.\n</step6></thinking>", "answer": "<answer>Àrùn àtọ́kànwá àti àrùn àkúnya ni irú àrùn tí kò ní ìsopọ̀ pẹ̀lú ìṣìnkú ìdíyelé ẹ̀jẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọlọdun 83 kan ti ó ní ìtàn àrùn fòòfòò ṣinṣin ati itọju pneumonia tuntun dé pẹlu àwọn àkókò ìrora ìwòran ati ìdùnnu níbi ìtọju. Ti a bá ronú nípa àwọn àrùn ati ihuwasi rẹ̀ lọ́wọ́lọ́wọ́, kini ìtọju oogun tí ó bá ṣe kedere jùlọ lati ṣakoso ìdùnnu ati ìwòran rẹ̀ tí ó gbọ́n, yàtọ̀ sí àtúnṣe?", "reasoning": "<thinking><step1>\nThe question asks: “What is the most effective medication treatment to manage the pain and discomfort of an 83-year-old man with a history of chronic obstructive pulmonary disease (COPD) and recent pneumonia?” — here, *ìtàn àrùn fòòfòò ṣinṣin* refers to COPD and *itọju pneumonia tuntun* means recent pneumonia.\n</step1>\n<step2>\nIn managing pain and discomfort, we need to consider both the respiratory condition and the recent pneumonia. *Àrùn fòòfòò* can lead to breathing difficulties, which may exacerbate pain perception.\n</step2>\n<step3>\nCommon medications for pain relief include non-steroidal anti-inflammatory drugs (NSAIDs) and opioids, but we must be cautious with opioids in elderly patients due to potential side effects — *àkóbá* like sedation or respiratory depression.\n</step3>\n<step4>\nAdditionally, bronchodilators may be necessary to ease breathing — *les bronchodilatateurs* can help open the airways, which might reduce discomfort associated with breathing.\n</step4>\n<step5>\nIn this case, a combination of a mild opioid for pain management and a bronchodilator for respiratory support could be the most effective approach — *ìtọju oogun* should be tailored to the patient's specific needs.\n</step5>\n<step6>\nTherefore, the most straightforward medication treatment would likely involve a low-dose opioid alongside bronchodilators to manage both pain and respiratory symptoms effectively.\n</step6></thinking>", "answer": "<answer>Ìtọju oogun tó dára jùlọ ni àkóbá opioid pẹ̀lú bronchodilator láti ṣakoso ìdùnnu àti ìwòran.</answer>", "language": "Yoruba"}
{"question": "A ṣe ayẹwo kan ti ohun elo tuntun kan ti a ń lò láti ṣe àyẹ̀wò àrùn Alzheimer (AD). Ìwádìí náà pinnu láti lo àpẹẹrẹ ti awọn àlùfáà 1,000, ọ̀kan lara ìdajì awọn àlùfáà tí a gbà láti kópa ní àrùn Alzheimer. Nínú ẹgbẹ́ awọn àlùfáà tí wọ́n ní àrùn Alzheimer, a rí i pé 400 ni wọ́n rí ni rere ní àyẹ̀wò PET tuntun yìí. Nínú ẹgbẹ́ àkóṣó, a rí i pé 50 ni wọ́n rí ni rere. Kí ni PPV ti àyẹ̀wò tuntun yìí?\nA. 400 / (400+100)\nB. 450 / (450 + 50)\nC. 400 / (400+50)\nD. 400 / (400 + 150)\nE. 450 / (450 + 100)", "reasoning": "<thinking><step1>\nThe question asks for the Positive Predictive Value (PPV) of a new test for Alzheimer’s disease (AD) using data from a study involving 1,000 participants — *àlùfáà* in Yoruba.\n</step1>\n<step2>\nPPV is calculated as the number of true positives divided by the total number of positive test results — *nọ́mbà ti awọn abajade to tọ́*.\n</step2>\n<step3>\nIn this case, we have 400 true positives from the Alzheimer’s group who tested positive with the new PET scan — *ayẹwo PET tuntun*.\n</step3>\n<step4>\nWe also need to consider the false positives from the control group, which is 50 who tested positive — *nọ́mbà ti awọn abajade aṣiṣe*.\n</step4>\n<step5>\nThus, the formula for PPV becomes: 400 / (400 + 50) — this gives us the proportion of true positives among all positive results.\n</step5>\n<step6>\nCalculating this, we find that PPV = 400 / 450, which corresponds to option B.\n</step6></thinking>", "answer": "<answer>450 / (450 + 50)</answer>", "language": "Yoruba"}
{"question": "Ninu obinrin ọdun 25 kan ti n ni iṣoro jijẹun (dysphagia) tí ó buru sí i fun omi ju ounjẹ gbígbẹ lọ, ipo wo ni ó fi hàn gidigidi?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu obinrin ọdun 25 kan ti n ni iṣoro jijẹun [dysphagia = difficulty swallowing] tí ó buru sí i fun omi ju ounjẹ gbígbẹ lọ” — meaning it wants to know what condition is indicated by a 25-year-old woman having more trouble swallowing liquids than solids.\n</step1>\n<step2>\nDysphagia can be caused by various factors, including neurological disorders or structural issues in the throat — *awọn aisan ti n fa iṣoro ni ẹnu ati ẹsẹ̀ àyà*.\n</step2>\n<step3>\nWhen a person has more difficulty swallowing liquids, it may suggest a problem with the *muscles or nerves* involved in swallowing — *awọn iṣan tabi awọn ẹdọfu*.\n</step3>\n<step4>\nConditions like *esophageal stricture* or *neuromuscular disorders* could be at play, leading to this specific symptom — *iyipada ni ọna jijẹ*.\n</step4>\n<step5>\nIn this case, it is crucial to evaluate for possible *dysphagia oropharyngeal*, which affects the initial phase of swallowing — *iṣoro jijẹ ni ibẹrẹ*.\n</step6>\n<step6>\nThus, the condition likely indicates a significant issue with the swallowing mechanism, particularly affecting liquids more than solids.\n</step6></thinking>", "answer": "<answer>Ipo ti obinrin naa fi hàn ni iṣoro jijẹ ti o ni ibatan si iṣan tabi ẹdọfu, ti o n fa iṣoro pẹlu omi ju ounjẹ gbígbẹ lọ.</answer>", "language": "Yoruba"}
{"question": "Ọmọ alaisan ọdun mẹ́wàá kan ṣe afihan rirọ́ ati aimọlara lori apá ulnar ọwọ́ rẹ̀, lẹ́yìn ọdún mẹrin tí ó ti gbàgbé egungun ni ibùgbà. Bí a bá gbé èyí yẹ̀wò, irú gbígbé egungun ibùgbà wo ni ó ṣeé ṣe kí ó fa àwọn àmì àrùn wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “What type of [fracture = egungun] could cause symptoms like weakness and numbness in the ulnar aspect of a 10-year-old's hand after four years of neglect?” This indicates a concern about long-term effects of a previous injury.\n</step1>\n<step2>\nIn this case, the ulnar nerve could be affected due to a previous fracture — *egungun ibùgbà* — that may have healed improperly or caused complications.\n</step2>\n<step3>\nA common type of fracture that could lead to these symptoms is a *fracture of the medial epicondyle* of the humerus, which can impact the ulnar nerve — *nẹ́twọ́ọ̀kù ulnar*.\n</step3>\n<step4>\nIf the fracture was not treated properly, it might have led to *compression* or *entrapment* of the nerve, causing *aimọlara* (numbness) and *rirọ́* (weakness).\n</step4>\n<step5>\nAdditionally, *malunion* or *nonunion* of the fracture could contribute to ongoing issues, leading to chronic symptoms in the hand.\n</step5>\n<step6>\nThus, the type of fracture that could cause these symptoms is likely related to the ulnar nerve's proximity to the site of the previous injury.\n</step6></thinking>", "answer": "<answer>Iru egungun ibùgbà ti o le fa awọn àmì àrùn wọnyi ni egungun medial epicondyle ti humerus.</answer>", "language": "Yoruba"}
{"question": "((-5 + 6 + -6 * -1) + (-5 + -5 + 9 + -2)) =", "reasoning": "<thinking><step1>\nThe question asks to solve the expression: \"((-5 + 6 + -6 * -1) + (-5 + -5 + 9 + -2))\". We need to break it down step by step.\n</step1>\n<step2>\nFirst, we handle the multiplication: *-6 * -1* equals *6*, since multiplying two negative numbers gives a positive result.\n</step2>\n<step3>\nNow, we substitute that back into the expression: *(-5 + 6 + 6) + (-5 + -5 + 9 + -2)*.\n</step3>\n<step4>\nNext, we simplify the first part: *-5 + 6 + 6* equals *7*.\n</step4>\n<step5>\nFor the second part, we calculate: *-5 + -5 + 9 + -2*. This simplifies to *-10 + 9 - 2*, which equals *-3*.\n</step5>\n<step6>\nNow we combine the results: *7 + -3* equals *4*.\n</step6></thinking>", "answer": "<answer>4</answer>", "language": "Yoruba"}
{"question": "Àpẹẹrẹ ọmọ alaisan ọdun 45 kan tí ó ní ìgbóná apò ìkúnrin tó gbóná (acute cholecystitis) tí iye bilirubin rẹ̀ gòkè, tí ó sì wà bẹ́ẹ̀ lẹ́yìn tí irora náà ti dákẹ́, a rí ìṣàn láàrin apò ìkúnrin àti ọ̀nà ìkúnrin gbogbogbò (cholecystocholedochal fistula) nígbà tí a ṣe ERCP. Kí ni àìsàn tó ṣeé ṣe jùlọ nínú ọ̀ràn yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àìsàn tó ṣeé ṣe jùlọ nínú ọ̀ràn yìí?” — meaning it wants to know the most likely disease in the case of a 45-year-old patient with acute cholecystitis and elevated bilirubin levels.\n</step1>\n<step2>\nAcute cholecystitis occurs due to inflammation of the gallbladder, often caused by gallstones — *àpò ìkúnrin* ti wa ni ìfarapa. \n</step2>\n<step3>\nThe elevated bilirubin indicates possible obstruction in the bile duct — *ìdènà nínú ọ̀nà ìkúnrin* which can lead to jaundice.\n</step3>\n<step4>\nThe presence of a cholecystocholedochal fistula suggests a connection between the gallbladder and the common bile duct — *ìṣàn láàrin apò ìkúnrin àti ọ̀nà ìkúnrin*.\n</step5>\n<step5>\nIn this context, the most likely complication is cholangitis, an infection of the bile duct due to obstruction — *àìsàn àtọ́kànwá nínú ọ̀nà ìkúnrin*.\n</step6>\n<step6>\nCholangitis can present with fever, jaundice, and abdominal pain, known as *triad của Charcot*.\n</step7></thinking>", "answer": "<answer>Àìsàn tó ṣeé ṣe jùlọ nínú ọ̀ràn yìí ni cholangitis.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdún mẹ́ẹ̀ẹ́dógún (27) tí ó lóyún ní ṣùgbọ̀n kò tíì bí, tí ó wà ní ọ̀sẹ̀ kọkàndínlọ́gbọ̀n (17) ti o fẹ́ láti kopa nínú àdánwò ìṣègùn kan fún ìṣèdárára àìrígbàdùn nínú oyun. Àdánwò náà yóò ṣàyẹ̀wò ipa lílo ginger lọ́pọ̀lọpọ̀ lórí àwọn àmì àìrígbàdùn. Ṣáájú kí ó tó wọlé sí àdánwò náà, àwọn onímọ̀ ìṣègùn ṣàlàyé fún aláìsàn náà pé wọn yóò ṣe àyẹ̀wò gbogbo ara rẹ̀ àti àwọn àdánwò pàtàkì kan láti ríi dajú pé ó ní oyun tólera. Níwọ̀n ìgbà tí àwọn abajade wo ni ó ṣeé ṣe kí ó máà dára nígbà oyun?\nA. Ẹ̀rùjẹ̀jẹ̀\nB. Ìṣèrègbé ọkàn tí ó pọ̀ sí i\nC. Ìpọ̀sí i nínú factor VII\nD. Àrùn ẹ̀jẹ̀\nE. Ẹ̀gún afẹ́fẹ́", "reasoning": "<thinking><step1>\nThe question asks about a 27-year-old woman who is pregnant but has not yet given birth, currently in her 17th week of pregnancy, and wants to participate in a clinical trial for the management of pregnancy-related discomfort. It mentions that the trial will examine the effects of ginger on discomfort symptoms. \n</step1>\n<step2>\nBefore she can join the trial, the medical professionals will conduct a thorough examination — *àyẹ̀wò gbogbo ara rẹ̀* — and specific tests to ensure she has a viable pregnancy — *ní oyun tólera*.\n</step2>\n<step3>\nThe question also inquires about potential outcomes that might not be favorable during pregnancy. This could relate to various complications or conditions that can arise.\n</step3>\n<step4>\nAmong the options provided, we need to identify which one is a possible negative outcome during pregnancy. For instance, *ẹ̀rùjẹ̀jẹ̀* refers to anxiety, which can affect pregnancy but is not a direct medical condition.\n</step4>\n<step5>\nOn the other hand, *ìṣèrègbé ọkàn tí ó pọ̀ sí i* refers to increased heart rate, which can occur but is not a specific pregnancy complication. \n</step5>\n<step6>\n*Ìpọ̀sí i nínú factor VII* relates to blood clotting issues, which can be serious during pregnancy, while *àrùn ẹ̀jẹ̀* refers to blood disorders that can also pose risks.\n</step6>\n<step7>\nFinally, *ẹ̀gún afẹ́fẹ́* translates to respiratory issues, which may not be directly linked to pregnancy complications. \n</step7>\n<step8>\nConsidering all these factors, the most relevant option that indicates a potential negative outcome during pregnancy is *àrùn ẹ̀jẹ̀*, as it can lead to significant complications.\n</step8></thinking>", "answer": "<answer>Àrùn ẹ̀jẹ̀.</answer>", "language": "Yoruba"}
{"question": "Gbolohun wo ni o ni ilana orukọ-oríṣìíriṣìí tó tọ́?\nAwọn aṣayan:\n(A) Obọ́ ẹ̀rù tí ó ti pẹ́, India, tí a fi ń wakọ̀.\n(B) Obọ́ tí ó ti pẹ́, ẹ̀rù, India, tí a fi ń wakọ̀.", "reasoning": "<thinking><step1>\nThe question asks: “Gbolohun wo ni o ni ilana orukọ-oríṣìíriṣìí tó tọ́?” — meaning it wants to know which sentence has the correct structure for a noun phrase.\n</step1>\n<step2>\nIn English, a proper noun phrase typically includes a descriptor followed by the noun — *a descriptive adjective precedes the noun*.\n</step2>\n<step3>\nIn the options provided, we have two sentences: (A) and (B). We need to analyze their structures.\n</step3>\n<step4>\nOption (A) is: “Obọ́ ẹ̀rù tí ó ti pẹ́, India, tí a fi ń wakọ̀.” Here, *“Obọ́ ẹ̀rù”* (the noun phrase) is followed by a relative clause, which is a correct structure.\n</step4>\n<step5>\nOption (B) is: “Obọ́ tí ó ti pẹ́, ẹ̀rù, India, tí a fi ń wakọ̀.” In this case, *“Obọ́”* is the noun, but it is followed by a relative clause and then the noun *“ẹ̀rù”*, which disrupts the typical noun phrase structure.\n</step6>\n<step7>\nThus, option (A) maintains a clearer and more logical noun phrase structure compared to option (B).\n</step7></thinking>", "answer": "<answer>(A) Obọ́ ẹ̀rù tí ó ti pẹ́, India, tí a fi ń wakọ̀.</answer>", "language": "Yoruba"}
{"question": "Kallu, ọkunrin ọdun 22 kan, lọ jáde pẹlu awọn ọrẹ rẹ̀, ó sì ní iba 38.50C, àìgbọ́ra, àti ẹ̀gbẹ́ lẹ́yìn tí ó jẹ́ ṣaláti ẹyẹ, wákàtí 24 sẹ́yìn.  Àwọn ọrẹ rẹ̀ méjì sì ní àwọn àmì kan náà.  Àyẹ̀wò rẹ̀ ni\nA. Salmonella enteritis\nB. Bacillus cereus\nC. Staphylococcus aureus\nD. Vibrio cholerae", "reasoning": "<thinking><step1>\nThe question describes a 22-year-old man, Kallu, who has a fever of 38.5°C, malaise, and abdominal pain after eating chicken 24 hours ago. It also mentions that two of his friends have similar symptoms. This suggests a foodborne illness.\n</step1>\n<step2>\nThe symptoms of fever and abdominal pain indicate a possible gastrointestinal infection — *àìlera inu* — which is often caused by bacteria from contaminated food.\n</step2>\n<step3>\nConsidering the timing, since symptoms appeared 24 hours after eating, we can narrow down the options. *Salmonella enteritis* is known for causing symptoms within 6 to 72 hours after ingestion of contaminated food, particularly poultry.\n</step3>\n<step4>\nOn the other hand, *Bacillus cereus* typically causes symptoms more rapidly, often within 1 to 6 hours, and is associated with rice dishes. *Staphylococcus aureus* also causes quick onset symptoms due to preformed toxins, usually within hours.\n</step5>\n<step5>\n*Vibrio cholerae* is primarily associated with severe diarrhea and is more common in contaminated water rather than poultry. Given Kallu's symptoms and the food source, *Salmonella enteritis* is the most likely cause.\n</step6>\nThus, the most probable diagnosis for Kallu and his friends is *Salmonella enteritis*.</thinking>", "answer": "<answer>Salmonella enteritis</answer>", "language": "Yoruba"}
{"question": "Àpọnà ọkùnrin ọmọ ọdún 45 kan tí ó ní àrùn àtìgbàgbọ́ sùn wọ́ ọ̀gbà ìṣègùn pẹ̀lú ìrora ikùn, ìgbàárà, ìtàjẹ̀ sílẹ̀, ìgbàgbọ́, iye suga ẹ̀jẹ̀ ti 402 mg%, ara ketone tí a ríi nínú ito, tachycardia, àti orthostatic hypotension. Ìwádìí ilé-ìṣègùn fi hàn pé iye potasiomu jẹ́ 3 meq/L.  Kí ni ìgbésẹ̀ tó dára jùlọ tókàn nínú ìṣiṣẹ́ àpọnà yìí?", "reasoning": "<thinking><step1>\nThe question describes a 45-year-old male patient with diabetes who presents with abdominal pain, nausea, vomiting, tachycardia, and orthostatic hypotension. It also mentions a blood sugar level of 402 mg% and a potassium level of 3 meq/L.\n</step1>\n<step2>\nGiven these symptoms, the patient likely has diabetic ketoacidosis (DKA) — *asidiosis keto diabeetiki* — which is a serious condition that can occur in individuals with diabetes.\n</step2>\n<step3>\nThe high blood sugar indicates severe hyperglycemia, and the presence of ketones in the urine suggests that the body is using fat for energy instead of glucose — *ara n lo ọra fun agbara*.\n</step3>\n<step4>\nThe low potassium level (3 meq/L) is concerning because potassium can drop further with insulin treatment, which is necessary to correct the hyperglycemia and acidosis.\n</step4>\n<step5>\nIn managing DKA, the first step is usually to provide intravenous fluids and insulin — *iyọ̀risi omi ati insulini* — to stabilize the patient's condition.\n</step6>\n<step6>\nHowever, it is crucial to monitor and potentially supplement potassium to prevent complications like cardiac arrhythmias — *iyipada ọkan*.\n</step7>\n<step7>\nThus, the best immediate step in this case is to start IV fluids and insulin while closely monitoring potassium levels.\n</step8></thinking>", "answer": "<answer>Ìgbésẹ̀ tó dára jùlọ ni láti bẹ̀rẹ̀ ìtọju omi pẹ̀lú insulini, nígbàtí a tún ń tọ́jú iye potasiomu.</answer>", "language": "Yoruba"}
{"question": "Yàtò sí iṣẹ́ ìṣàn omi nínú ìkọ̀kọ̀ 1 àti ti ìkọ̀kọ̀ 2 báà ṣe, bí a bá gba pé àtìlẹ́yìn náà dúró, tí ìṣàn omi náà sì jẹ́ lójúréré?", "reasoning": "<thinking><step1>\nThe question asks: “Yàtò sí [iṣẹ́ ìṣàn omi = water flow] nínú [ìkọ̀kọ̀ 1 = reservoir 1] àti [ìkọ̀kọ̀ 2 = reservoir 2] báà ṣe?” — meaning it wants to know the differences in water flow between the two reservoirs, assuming the support remains constant and the water flow is steady.\n</step1>\n<step2>\nTo analyze the water flow, we first need to consider the capacity of each reservoir — *kapasiti* — and how it affects the flow rate.\n</step2>\n<step3>\nIf both reservoirs have the same capacity, the flow rate might depend on factors like *ìpinnu àtúnṣe* (regulation decisions) or *ìṣàkóso* (management) of the water.\n</step3>\n<step4>\nFor instance, if reservoir 1 has a higher elevation, it could lead to a greater gravitational pull, resulting in a faster flow — *ìṣàn omi tó yara*.\n</step4>\n<step5>\nConversely, if reservoir 2 has more obstacles or narrower channels, this could slow down the flow — *ìṣàn omi tó lọra*.\n</step5>\n<step6>\nThus, the differences in water flow between the two reservoirs could be significant based on these factors, even with constant support.\n</step6></thinking>", "answer": "<answer>Yàtò sí iṣẹ́ ìṣàn omi nínú ìkọ̀kọ̀ 1 àti ìkọ̀kọ̀ 2 le jẹ́ pataki da lori àpapọ̀, ìpinnu àtúnṣe, àti ìṣàkóso.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin ọmọ ogún ọdún kan ni wọ́n gbé wá pẹ̀lú ọkọ̀ tí ń gbé aláìsàn lọ sí yàrá ìgbàṣàrá (emergency room) ní ipò àìlera tó burú jàì. Ó fẹ́rẹ̀ má mọ nǹkan kan nípa ara rẹ̀, ìfúnpá rẹ̀ lọ sílẹ̀, ó sì ń mí hẹlẹhẹlẹ (tí ó yára), èémí rẹ̀ sì ń gbóòórùn bíi èso (fruity). Àyẹ̀wò ẹ̀jẹ̀ àti ti ìṣètò ara (metabolic panel) fi hàn pé ó ní ìṣòro 'anion gap metabolic acidosis' (àìdọ́gba ásíìdì nínú ẹ̀jẹ̀). Èwo nínú àwọn ìgbésẹ̀ ìṣètò ara (metabolic actions) wọ̀nyí ni ó ṣeé ṣe jù lọ pé ó dínkù lára aláìsàn yìí?\nA. Dída àwọn èròjà 'ketone bodies'\nB. Ṣíṣe 'glucose' (súgà inú ara)\nC. Ìtújáde èròjà 'cortisol'\nD. Gbigba 'glucose' (súgà inú ara) sínú àwọn sẹ́ẹ̀lì ara", "reasoning": "<thinking><step1>\nThe question is asking which metabolic action is most likely to decrease in a patient with an anion gap metabolic acidosis — *àìdọ́gba ásíìdì nínú ẹ̀jẹ̀*.\n</step1>\n<step2>\nIn this condition, the body accumulates acids, leading to a decrease in bicarbonate levels — *ìdínkù àwọn ipele bicarbonate*.\n</step2>\n<step3>\nOne common cause of anion gap metabolic acidosis is the production of *ketone bodies* due to uncontrolled diabetes — *ìṣòro àtọ́gbẹ́*.\n</step3>\n<step4>\nIf the patient is producing more ketones, it indicates that the body is not effectively utilizing glucose — *súgà inú ara* — for energy.\n</step4>\n<step5>\nThus, the action of producing ketone bodies would be increased, while the utilization of glucose would be decreased — *dínkù*.\n</step6>\n<step6>\nTherefore, the metabolic action that is most likely to decrease in this patient is the utilization of glucose by the cells — *gbigba glucose sínú àwọn sẹ́ẹ̀lì ara*.\n</step6></thinking>", "answer": "<answer>Gbigba 'glucose' sínú àwọn sẹ́ẹ̀lì ara ni ó dínkù jùlọ.</answer>", "language": "Yoruba"}
{"question": "Àyípadà wo ni, tí ó bá ṣú, kì í pọ̀sí iye ìṣẹ̀dá thrombus?", "reasoning": "<thinking><step1>\nThe question asks: “Àyípadà wo ni, tí ó bá ṣú, kì í pọ̀sí iye ìṣẹ̀dá [thrombus = thrombus formation]?” — meaning it wants to know what changes occur that do not increase the amount of thrombus formation.\n</step1>\n<step2>\nThrombus formation is a process where blood clots form in the vessels — *ìṣẹ̀dá thrombus* n ṣẹlẹ̀ nígbà tí ẹ̀jẹ̀ ba dákẹ́. \n</step2>\n<step3>\nFactors like blood flow, vessel injury, and platelet activation are crucial — *ìṣàkóso ẹ̀jẹ̀*, *ìfarapa ẹ̀dá*, àti *ìmúlẹ̀ platelets*.\n</step3>\n<step4>\nIf there is a change that does not increase thrombus formation, it could be related to maintaining normal blood flow — *ìṣàkóso ẹ̀jẹ̀ tó péye*.\n</step4>\n<step5>\nFor instance, if the blood vessels remain intact and there is no excessive platelet activation, thrombus formation will not increase — *kò ní pọ̀sí*.\n</step5>\n<step6>\nIn summary, maintaining normal conditions in the blood vessels and flow prevents excessive thrombus formation — *ìdájọ́ àyípadà tó péye*.\n</step6></thinking>", "answer": "<answer>Àyípadà tó péye ní ìṣàkóso ẹ̀jẹ̀ àti ìfarapa ẹ̀dá kì í pọ̀sí iye ìṣẹ̀dá thrombus.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 55 kan ni irora lẹhin igbaya rẹ̀ tí kò ní ṣiṣẹ́pọ̀ pẹ̀lú iṣẹ́ ṣiṣe ara, ó sì burú sí i lẹ́yìn tí ó bá dùbúlẹ̀, àti pé awọn oògùn antacid ṣe iranlọwọ́ díẹ̀.  Tí a bá gbé àwọn àmì ìṣẹ̀lẹ̀ wọnyi yẹ̀ wò, kini àìsàn tí ó ṣeé ṣe jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “Tí a bá gbé àwọn àmì ìṣẹ̀lẹ̀ wọnyi yẹ̀ wò, kini àìsàn tí ó ṣeé ṣe jùlọ?” — meaning it wants to identify the most likely condition based on the symptoms described.\n</step1>\n<step2>\nThe patient is a 55-year-old man experiencing pain after eating — *irora lẹhin igbaya* — which worsens after bending down.\n</step2>\n<step3>\nThe mention of antacids providing some relief suggests a possible issue related to stomach acid — *ìṣòro pẹ̀lú ácido*.\n</step3>\n<step4>\nCommon conditions that fit these symptoms include gastroesophageal reflux disease (GERD) — *àìsàn reflux esophageal* — where stomach acid flows back into the esophagus.\n</step4>\n<step5>\nAdditionally, the worsening pain when bending down could indicate increased pressure on the abdomen, which is typical in cases of GERD.\n</step5>\n<step6>\nConsidering the age and symptoms, it’s also important to rule out more serious conditions like peptic ulcers — *ìkànsí àtọ́ka* — but the antacid response leans towards GERD.\n</step6>\n<step7>\nThus, the most likely diagnosis based on the symptoms is GERD, characterized by heartburn and discomfort after meals.\n</step7></thinking>", "answer": "<answer>Àìsàn tí ó ṣeé ṣe jùlọ ni GERD (àìsàn reflux esophageal).</answer>", "language": "Yoruba"}
{"question": "Lóòótọ́ ọ̀rọ̀ kan tí ó ní ìṣẹ̀ṣẹ̀ ìgbàlódé nítorí ìṣòro àìsàn ìṣú, àwọ̀ dúdú ní ẹnu àti ahọ́n, àti ọ̀pọ̀lọpọ̀ ìṣú ní inu ara tí ó fi hàn nípa àwòrán onírúurú gẹ̀gẹ́ bí ìwádìí ìṣòro ara, ibì kan ni wọ́n ti máa ń rí i jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “Lóòótọ́ ọ̀rọ̀ kan tí ó ní ìṣẹ̀ṣẹ̀ ìgbàlódé nítorí ìṣòro àìsàn ìṣú” — meaning it is inquiring about a modern issue related to the disease of *ìṣú* [sickle cell disease], specifically regarding symptoms like *àwọ̀ dúdú* [darkening of the mouth and gums] and *ìṣú* [crises].\n</step1>\n<step2>\nSickle cell disease is a genetic disorder that affects hemoglobin, leading to various complications — *ìṣòro àìsàn* that can cause pain and organ damage.\n</step2>\n<step3>\nThe symptoms mentioned, such as *àwọ̀ dúdú* and pain crises, are common manifestations of this condition — *ìwádìí ìṣòro ara* shows that these symptoms can indicate severe complications.\n</step3>\n<step4>\nIn terms of where these symptoms are most often observed, *ibì kan ni wọ́n ti máa ń rí i jùlọ* could refer to hospitals or clinics specializing in hematology or sickle cell management.\n</step4>\n<step5>\nPatients often seek treatment in these specialized centers to manage their symptoms and prevent crises — *ìṣòro àìsàn* can be debilitating without proper care.\n</step6>\n<step7>\nThus, the question highlights the importance of recognizing these symptoms and understanding where to seek help — *ibè ni a ti máa rí i jùlọ* for effective management of sickle cell disease.\n</step7></thinking>", "answer": "<answer>Ibè ni a ti máa rí i jùlọ ni ilé-iwosan tó ní amọ̀ja nípa ìṣú àti ìṣòro àìsàn rẹ.</answer>", "language": "Yoruba"}
{"question": "Àgbàyanu wo ni o jẹmọ si ofin ibo ti o kere julo lati ṣalaye iṣipopada ibo kekere fun idibo kan?", "reasoning": "<thinking><step1>\nThe question asks: “Àgbàyanu wo ni o jẹmọ si [ofin ibo = voting law] ti o kere julo lati ṣalaye [iṣipopada ibo kekere = minor voting movement] fun [idibo kan = a specific election]?” — meaning it seeks to understand the minimum voting law related to a minor voting movement for an election.\n</step1>\n<step2>\nIn many jurisdictions, there are specific laws that govern how voting movements can be organized — *ofin wọnyi le ni awọn ibeere pataki*.\n</step2>\n<step3>\nFor a minor voting movement, the law often requires a certain number of signatures or support from the community — *iyẹn ni, awọn ibuwọlu tabi atilẹyin lati ọdọ awọn olugbe*.\n</step4>\n<step4>\nAdditionally, there may be deadlines for submitting these signatures to ensure the movement is recognized in time for the election — *akoko ipari fun ifisilẹ*.\n</step5>\n<step5>\nUnderstanding these laws is crucial for any group aiming to mobilize voters effectively — *o ṣe pataki lati mọ ofin wọnyi*.\n</step6>\n<step6>\nThus, the minimum voting law for a minor voting movement typically involves signature requirements and submission deadlines.\n</step6></thinking>", "answer": "<answer>Ofin ibo ti o kere julo fun iṣipopada ibo kekere ni awọn ibeere ibuwọlu ati akoko ipari fun ifisilẹ.</answer>", "language": "Yoruba"}
{"question": "Èlément ọ̀nà SVG yii <path d=\"M 18.51,5.48 L 34.19,27.80 A 27.27,27.27 243.03 0,1 8.20,30.73 L 18.51,5.48\"/> ṣe àtẹ̀jáde\nAwọn aṣayan:\n(A) yíká\n(B) apáàrọ̀ méje\n(C) apáàrọ̀ mẹfa\n(D) afefè\n(E) ila\n(F) apáàrọ̀ mẹ́jọ\n(G) apáàrọ̀ márùn-ún\n(H) térétángùlì\n(I) apá kan\n(J) kọ́ńńì", "reasoning": "<thinking><step1>\nThe question asks: “Èlément ọ̀nà SVG yii [this SVG path] ṣe àtẹ̀jáde?” — meaning it wants to know what this SVG path represents.\n</step1>\n<step2>\nThe SVG path command starts with \"M 18.51,5.48\", which means it moves to the point (18.51, 5.48) — *o n lọ si ipo kan*.\n</step2>\n<step3>\nNext, \"L 34.19,27.80\" indicates a line to the point (34.19, 27.80) — *o n fa ila si ipo yẹn*.\n</step3>\n<step4>\nThe \"A 27.27,27.27 243.03 0,1 8.20,30.73\" part describes an arc — *o n ṣe àtẹ̀jáde arc kan* with specific radii and angles.\n</step4>\n<step5>\nFinally, it returns to the starting point with \"L 18.51,5.48\", completing the shape — *o pari apẹrẹ naa*.\n</step6>\n<step6>\nConsidering the options, the path creates a closed shape, which is typically a circle or an arc, so the best choice is (A) yíká [circle].\n</step6></thinking>", "answer": "<answer>yíká</answer>", "language": "Yoruba"}
{"question": "Okùnrin ọdun 52 kan wá sí yàrá pajawiri lẹ́yìn ìṣẹ̀lẹ̀ ìṣàn ara. Aláìsàn náà jí, ó sì mọ̀ràn; sibẹsibẹ, orí rẹ̀ máa ń fà nígbàkigbà tí ó bá gbiyanju láti jókòó. Ìtàn ìṣòro ilera rẹ̀ ṣe pàtàkì fún àrùn àṣepọ̀ ìmọ́ ilà, àti angina tí ó dáradára, èyí tí a ń ṣakoso pẹ̀lú simvastatin àti isosorbide dinitrate, lóríṣiríṣi. Ẹ̀rùjẹ̀ẹ́jẹ̀ẹ́ jẹ́ 70/45 mm Hg, ìwọ̀n ọ̀kan sì jẹ́ 110/min; gbogbo àwọn àmì ìlera mìíràn dáradára. A bẹ̀rẹ̀ sí fún un ni omi nípa ìṣan, nígbà tí a mú un lọ sí ìwádìí CT ní orí. Lójú ọ̀nà sí ibi ìwádìí náà, aláìsàn náà sọ pé ó mu oogun tuntun kan fún àìlera ìbálòpọ̀ nígbà tí ó ṣẹ̀ṣẹ̀ bẹ̀rẹ̀ sí rí ìrora. Kí ni ìdí abàjẹ́ ọ̀ná ìṣelọ́rùn ti àwọn àmì àrùn aláìsàn yìí?\nA. PDE-5 tí ó pọ̀ sí i\nB. NO tí ó pọ̀ sí i\nC. cGMP tí ó pọ̀ sí i\nD. Ìdènà nitric oxide synthase", "reasoning": "<thinking><step1>\nThe question is asking about the underlying cause of the patient's symptoms after taking a new medication for erectile dysfunction — *àìlera ìbálòpọ̀* — and how it relates to his health issues.\n</step1>\n<step2>\nThe patient has a history of cardiovascular problems, including *angina* and is on medications like simvastatin and isosorbide dinitrate. These conditions can affect blood flow and pressure.\n</step2>\n<step3>\nThe symptoms described, such as low blood pressure — *ẹ̀rùjẹ̀ẹ́jẹ̀ẹ́ 70/45 mm Hg* — suggest a possible vasodilatory effect from the new medication.\n</step3>\n<step4>\nErectile dysfunction medications often work by increasing levels of *cGMP* (cyclic guanosine monophosphate), which leads to vasodilation and can lower blood pressure.\n</step4>\n<step5>\nIf the patient has taken a PDE-5 inhibitor, it would inhibit the breakdown of cGMP, leading to increased levels of cGMP and potentially causing hypotension — *ìdàgbàsókè ẹ̀jẹ̀*.\n</step5>\n<step6>\nThus, the most likely cause of the patient's symptoms is an increase in cGMP levels due to the new medication, which is consistent with the effects of PDE-5 inhibitors.\n</step6></thinking>", "answer": "<answer>cGMP tí ó pọ̀ sí i.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 46 kan wá sọ́dọ̀ oníṣègùn nítorí ìrora ìgbàgbà tí ó ti pọ̀ sí i fún oṣù mẹrin, àti ìdinku ìṣe àkún. Ọdun márùn-ún sẹ́yìn, ó gba àtọwọ́da kidinì ní ọwọ́ ẹni tí ó wà nínú ìdílé rẹ̀. Àwọn oògùn tí ó ń mu lóríṣiríṣi ni sirolimus àti mycophenolate. Ẹ̀rù ẹ̀jẹ̀ rẹ̀ jẹ́ 150/95 mm Hg. Ìwádìí ẹ̀jẹ̀ fi hàn pé àìlera ẹ̀jẹ̀ tí kò ní àyípadà nínú iwọn àti àwọ̀ rẹ̀, àti ìwọ̀n creatinine ní ọ̀pọ̀lọpọ̀ ẹ̀jẹ̀ tó jẹ́ 3.1 mg/dL; àwọn àmì ìlera rẹ̀ àti ìwádìí ẹ̀jẹ̀ gbogbo wọn dára oṣù mẹ́fà sẹ́yìn. Nínú àwọn wọ̀nyí, èwo ni òkìkí ṣe pàtàkì jùlọ fún ìpọ̀sí ìwọ̀n creatinine alààyè yìí?\nA. Ìbajẹ́ sẹ́ẹ̀li ara nípasẹ̀ CD8+ T sẹ́ẹ̀li\nB. Ìbajẹ́ sẹ́ẹ̀li epithelial nípasẹ̀ T sẹ́ẹ̀li àtọwọ́da\nC. Ìbajẹ́ sẹ́ẹ̀li endothelial àtọwọ́da nípasẹ̀ àwọn antibodies tí ó ti wà tẹ́lẹ̀ ní ara\nD. Ìṣe àgbàye iṣan ti o múná lórí intimal nípasẹ̀ CD4+ T sẹ́ẹ̀li\nE. Ìbajẹ́ sẹ́ẹ̀li tubular nípasẹ̀ oògùn", "reasoning": "<thinking><step1>\nThe question is asking about the most significant cause of elevated creatinine levels in a 46-year-old man with a history of kidney transplant and current medications like sirolimus and mycophenolate. Key terms include [ìrora ìgbàgbà = chronic pain], [ìdinku ìṣe àkún = decreased function], and [ìwọ̀n creatinine = creatinine level].\n</step1>\n<step2>\nElevated creatinine levels often indicate kidney dysfunction. In this case, the patient has a history of transplant and is on immunosuppressants, which can affect kidney health — *àwọn oògùn àtọwọ́da le fa ìbajẹ́ sí ẹ̀dá ara*.\n</step2>\n<step3>\nThe options provided suggest different mechanisms of kidney injury. For instance, option A mentions CD8+ T cells, which are involved in cellular immunity and can cause damage to transplanted organs — *ìbajẹ́ sẹ́ẹ̀li ara*.\n</step3>\n<step4>\nOption B refers to epithelial cell damage via T cell-mediated rejection, which is a common cause of acute rejection in transplants — *ìbajẹ́ sẹ́ẹ̀li epithelial*.\n</step4>\n<step5>\nOption C discusses endothelial cell injury due to pre-existing antibodies, which can lead to chronic rejection — *ìbajẹ́ sẹ́ẹ̀li endothelial àtọwọ́da*.\n</step6>\n<step7>\nOption D mentions global glomerular injury mediated by CD4+ T cells, which can also contribute to kidney dysfunction — *ìṣe àgbàye iṣan*.\n</step8>\n<step9>\nFinally, option E suggests tubular cell injury due to medications, which is a well-known side effect of drugs like sirolimus and mycophenolate — *ìbajẹ́ sẹ́ẹ̀li tubular*.\n</step9>\n<step10>\nConsidering the patient's history and current medications, the most likely significant cause of elevated creatinine is tubular injury due to the drugs he is taking.\n</step10></thinking>", "answer": "<answer>Ìbajẹ́ sẹ́ẹ̀li tubular nípasẹ̀ oògùn.</answer>", "language": "Yoruba"}
{"question": "Obirin ọmọ ọdun mẹrinlelogun (38) ti a n tọju fun àtìgbàgbọ́ ẹ̀jẹ̀ gíga àti àtìgbàgbọ́ àtọ́lẹ̀sẹ̀ máa ní ìgbàgbọ́ jíjìnnà ti ìgbóná ati irora ni awọn ika ọwọ́ ati awọn ọwọ́.  Lọ́wọ́ ṣíwájú, ó gbóná ara ati ki o rú. A gbọ́ ohun ti o dàbí irú ìgbàgbọ́ ní ìhà òsì isalẹ̀ ẹ̀gbẹ́ ọkàn.  Ewo ni ninu awọn oògùn wọnyi ti o ṣeé ṣe julọ lati jẹ́ idi ti awọn ami wọnyi?\nA. Metformin\nB. Hydralazine\nC. Minoxidil\nD. Nitroprusside", "reasoning": "<thinking><step1>\nThe question is asking about a 38-year-old woman with high blood pressure and symptoms like *ìgbàgbọ́ jíjìnnà* (heat sensation) and pain in her fingers and hands. It wants to identify which medication could be causing these symptoms.\n</step1>\n<step2>\nThe symptoms described, such as *gbóná ara* (body heat) and *irora ni awọn ika ọwọ́* (pain in the fingers), suggest a possible side effect of a medication.\n</step2>\n<step3>\nAmong the options, *Hydralazine* is known to cause side effects like *ìgbàgbọ́ jíjìnnà* and can lead to peripheral neuropathy, which might explain the pain in the hands.\n</step3>\n<step4>\n*Metformin* is primarily used for diabetes and is less likely to cause these symptoms. *Minoxidil* is used for hypertension but is more associated with hair growth and not typically with heat sensations.\n</step4>\n<step5>\n*Nitroprusside* is used for acute hypertension but can cause cyanide toxicity, which does not align with the symptoms presented.\n</step5>\n<step6>\nThus, the most likely medication causing these symptoms is *Hydralazine*, as it can lead to the described sensations and pain.\n</step6></thinking>", "answer": "<answer>Hydralazine ni oògùn ti o ṣeé ṣe julọ lati jẹ́ idi ti awọn ami wọnyi.</answer>", "language": "Yoruba"}
{"question": "Ninú àpòtí ìṣòwò àbòṣẹ̀ tí kò ní ìwàdíí, pẹ̀lú ìwọ̀n ìgbàgbọ́ tí kò yí padà, gbé àwọn ẹ̀rọ ìṣòwò méjì tí kò san owó ìpèsè yẹ̀wò pẹ̀lú àwọn ilana iye owo $S_1(t)=S_1(0)e^{0.1t+0.2Z(t)}$ àti $S_2(t)=S_2(0)e^{0.125t+0.3Z(t)}$, níbi tí $Z(t)$ jẹ́ ìgbòkègbodò Brownian ti o wọpọ̀.  Kí ni ìwọ̀n ìgbàgbọ́ tí kò ní ìwàdíí ní àwọn nọ́mbà tí ó wà lójú rẹ̀ nínú àpòtí yìí?", "reasoning": "<thinking><step1>\nThe question is asking about the \"risk-neutral measure\" in the context of two financial instruments with given price dynamics — *ìṣòwò àbòṣẹ̀* — represented by the equations $S_1(t)=S_1(0)e^{0.1t+0.2Z(t)}$ and $S_2(t)=S_2(0)e^{0.125t+0.3Z(t)}$, where $Z(t)$ is a standard Brownian motion.\n</step1>\n<step2>\nIn finance, the risk-neutral measure allows us to price derivatives without considering risk preferences — *ìwàdíí* here refers to risk aversion.\n</step2>\n<step3>\nTo find the risk-neutral measure, we need to adjust the drift terms in the price equations. The drift for $S_1(t)$ is 0.1 and for $S_2(t)$ is 0.125.\n</step3>\n<step4>\nUnder the risk-neutral measure, we set the drift to the risk-free rate, which is typically denoted as $r$. Here, we can assume $r = 0.1$ for simplicity.\n</step4>\n<step5>\nThus, we need to find a measure where the drift of both processes equals the risk-free rate — meaning we adjust the drift of $S_2(t)$ to match $r$.\n</step5>\n<step6>\nThis leads us to conclude that the risk-neutral measure will have a drift of 0.1 for both processes, implying that the measure is consistent across the two instruments.\n</step6>\n<step7>\nIn summary, the risk-neutral measure ensures that the expected growth rate of the asset prices equals the risk-free rate, which is a fundamental concept in financial mathematics.\n</step7></thinking>", "answer": "<answer>Ìwọ̀n ìgbàgbọ́ tí kò ní ìwàdíí jẹ́ 0.1.</answer>", "language": "Yoruba"}
{"question": "Oṣiṣẹ́ ní ilé iṣẹ́ ìṣeṣẹ́ péépà ní ìṣòro ìmí, pẹ̀lú àrùn ẹ̀dọ̀fó tí ó jẹ́yọ láti iṣẹ́ rẹ̀. Àìsàn tí ó ṣeé ṣe jùlọ ni -\nA. Byssinosis\nB. Bagassosis\nC. Asbestosis\nD. Anthracosis", "reasoning": "<thinking><step1>\nThe question asks: “Oṣiṣẹ́ ní ilé iṣẹ́ ìṣeṣẹ́ péépà ní ìṣòro ìmí, pẹ̀lú àrùn ẹ̀dọ̀fó tí ó jẹ́yọ láti iṣẹ́ rẹ̀” — meaning it is about a worker in a textile factory experiencing respiratory issues due to a disease related to their work.\n</step1>\n<step2>\nThe key terms here are “ìṣòro ìmí” [respiratory issues] and “àrùn ẹ̀dọ̀fó” [lung disease]. We need to identify which disease is most likely linked to textile work.\n</step2>\n<step3>\nByssinosis is a lung disease caused by inhaling cotton dust — *àrùn ẹ̀dọ̀fó tí ó jẹ́yọ láti eruku àtẹ́gùn*. This is common in textile workers.\n</step3>\n<step4>\nBagassosis is related to sugarcane dust, while asbestosis is linked to asbestos exposure — *àrùn tí ó jẹ́yọ láti eruku asbesto*. Anthracosis is caused by coal dust.\n</step4>\n<step5>\nGiven the context of a textile factory, byssinosis is the most relevant condition, as it directly relates to cotton exposure — *eruku àtẹ́gùn*.\n</step6>\n<step6>\nThus, the most likely disease affecting the worker is byssinosis.\n</step6></thinking>", "answer": "<answer>Àrùn tí ó ṣeé ṣe jùlọ ni byssinosis.</answer>", "language": "Yoruba"}
{"question": "Kini igbesẹ ti o tọ julọ lati tẹle ninu itọju sisan omi inu apata ninu alaisan ọdun 43 kan ti o ti ṣe abẹrẹ yọkuro apata inu?", "reasoning": "<thinking><step1>\nThe question asks: “Kini igbesẹ ti o tọ julọ lati tẹle ninu itọju sisan omi inu apata?” — meaning it wants to know the best steps to follow in treating fluid accumulation in a cyst in a 43-year-old patient who has had a cyst removed.\n</step1>\n<step2>\nFluid accumulation, or *sisan omi*, can occur after a surgical procedure like cyst removal — *yọkuro apata*.\n</step2>\n<step3>\nFirst, it’s essential to assess the patient’s symptoms — *awọn aami aisan* such as pain, swelling, or redness around the area.\n</step3>\n<step4>\nNext, imaging studies like an ultrasound may be necessary to evaluate the extent of the fluid collection — *iwadi aworan*.\n</step4>\n<step5>\nIf the fluid is significant, a procedure called aspiration may be performed to remove the fluid — *yiyọ omi* from the cyst.\n</step5>\n<step6>\nPost-procedure, monitoring for infection or recurrence is crucial — *itoju fun ikolu tabi atunwi*.\n</step6>\n<step7>\nIn summary, the best steps involve assessment, imaging, aspiration if needed, and careful monitoring.\n</step7></thinking>", "answer": "<answer>Igbesẹ ti o tọ julọ ni lati ṣe ayẹwo, ṣe iwadi aworan, yọ omi ti o ba wulo, ati ṣetọju fun ikolu.</answer>", "language": "Yoruba"}
{"question": "Kini oogun kimoterapi ti o yẹ ki a yẹra fun ni alaisan akàn ẹdọforo ọmọ ọdun 35 ti o ni itan arun ẹdọforo nitori agbara rẹ lati fa majele si ẹdọforo?", "reasoning": "<thinking><step1>\nThe question asks: “Kini oogun kimoterapi ti o yẹ ki a yẹra fun ni alaisan akàn [liver cancer] ẹdọforo [liver] ọmọ ọdun 35 ti o ni itan arun [liver disease] nitori agbara rẹ lati fa majele si ẹdọforo?” — meaning it wants to know which chemotherapy drugs should be avoided in a 35-year-old patient with a history of liver disease due to their potential toxicity to the liver.\n</step1>\n<step2>\nChemotherapy drugs can have varying effects on the liver, and some are known to be hepatotoxic — *ti o le fa ipalara si ẹdọforo*.\n</step2>\n<step3>\nFor instance, drugs like *doxorubicin* and *cyclophosphamide* can cause liver damage, especially in patients with pre-existing liver conditions — *arun ẹdọforo to wa tẹlẹ*.\n</step3>\n<step4>\nAdditionally, *methotrexate* is another drug that can lead to elevated liver enzymes, indicating liver stress — *iyipada ninu awọn ẹjẹ ti o le fihan wahala ẹdọforo*.\n</step4>\n<step5>\nIn this case, it is crucial to consider alternatives that are less harmful to the liver, such as *gemcitabine* or *cisplatin*, which have a better safety profile in patients with liver issues.\n</step5>\n<step6>\nThus, the focus should be on avoiding drugs that are known to exacerbate liver toxicity in this patient.\n</step6></thinking>", "answer": "<answer>Oogun kimoterapi ti o yẹ ki a yẹra fun ni alaisan akàn ẹdọforo ni doxorubicin, cyclophosphamide, ati methotrexate.</answer>", "language": "Yoruba"}
{"question": "Ní ọ̀rọ̀ ọkùnrin ọdún mẹ́tádínlógún kan tí ó ní àìlera ìṣàn ẹ̀jẹ̀ ní awọn iṣan brachiocephalic mejeeji ṣáájú kí wọ́n tó wọ vena cava ṣiṣe, iṣan wo ni ó ṣeé ṣe kí ó tóbi sí i nítorí ipò yìí?", "reasoning": "<thinking><step1>\nThe question translates to: \"In a 35-year-old man with blood flow issues in both brachiocephalic veins before they enter the vena cava, which vein is likely to be more enlarged due to this condition?\" \n</step1>\n<step2>\nIn this scenario, we are considering the anatomy of the veins — specifically, the *iṣan brachiocephalic* which drains blood from the head and arms into the *vena cava*.\n</step2>\n<step3>\nWhen there is a blockage or compression in the blood flow, the vein before the obstruction can become enlarged — *iṣan naa le tobi si i*.\n</step4>\n<step4>\nSince both brachiocephalic veins are affected, we need to determine which one is more likely to show enlargement. Typically, the left brachiocephalic vein is longer and can be more susceptible to compression.\n</step5>\n<step5>\nIn this case, if there is a problem affecting both veins, the left brachiocephalic vein — *iṣan brachiocephalic osi* — is likely to be more enlarged due to its anatomical position and length.\n</step6>\n<step6>\nThus, the left brachiocephalic vein is the one that would likely be larger in this situation — *iṣan brachiocephalic osi ni o ṣee ṣe ki o tobi sí i*.\n</step6></thinking>", "answer": "<answer>Iṣan brachiocephalic osi ni o ṣee ṣe ki o tobi sí i nítorí ipò yìí.</answer>", "language": "Yoruba"}
{"question": "Àpẹẹrẹ ọmọ alaisan ọdún mẹ́rìnlélọ́gójì kan wà pẹ̀lú ìrora orí, ìgbàgbé, àti irora ní àgbègbè tẹ́mpọ́rálì.  Lórí àwọn àmì wọnyi, kini àlàyé tí ó bá ṣeé ṣe jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “Àpẹẹrẹ ọmọ alaisan ọdún mẹ́rìnlélọ́gójì kan wà pẹ̀lú ìrora orí, ìgbàgbé, àti irora ní àgbègbè tẹ́mpọ́rálì” — meaning it describes a 14-year-old patient with headaches, nausea, and pain in the temporal region. It seeks the most likely explanation for these symptoms.\n</step1>\n<step2>\nHeadaches in children can have various causes, but common ones include tension headaches or migraines — *àkúnya orí* or *migrain*. \n</step2>\n<step3>\nThe presence of nausea suggests that this might be more than just a simple headache; it could indicate a migraine, which often comes with gastrointestinal symptoms — *àmì àìlera*.\n</step3>\n<step4>\nAdditionally, pain in the temporal region — *irora ní àgbègbè tẹ́mpọ́rálì* — is characteristic of migraines, which can be triggered by stress or certain foods.\n</step4>\n<step5>\nGiven the age of the patient, hormonal changes could also play a role in the frequency and intensity of headaches — *iyipada homonu*.\n</step5>\n<step6>\nThus, the most likely explanation for this combination of symptoms is a migraine, possibly exacerbated by stress or dietary factors.\n</step6></thinking>", "answer": "<answer>Àlàyé tí ó bá ṣeé ṣe jùlọ ni migraine, tí ó le jẹ́ pé a fa a nipasẹ ìbànújẹ tàbí ounjẹ kan.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹ́ta [7] kan wá pẹ̀lú ìgbóná gbogbo ara, ìwádìí ìṣàn-ikan sì fi hàn pé ó ní albuminuria pupọ̀. Àwọn ìwádìí kémi-ẹ̀jẹ̀ fi hàn pé ó ní hypoalbuminaemia pẹ̀lú hyperlipidemia. Ìwádìí àpòòtọ́ kíkún fún ìgbọ̀nà ẹ̀dọ̀fóró fi hàn pé ó dàbí àdánù lábẹ́ ìwádìí fífúnrá. Kí ni ìwádìí ìwé-èlékítírónìkì yóò ṣeé ṣe kí ó fi hàn ní ipò yìí?", "reasoning": "<thinking><step1>\nThe question asks: “What will the electronic medical record (EMR) investigations show in this case?” — referring to a three-year-old boy with *ìgbóná gbogbo ara* [fever], *albuminuria* [high levels of albumin in urine], *hypoalbuminaemia* [low albumin levels], and *hyperlipidemia* [high lipid levels].\n</step1>\n<step2>\nGiven the symptoms, the EMR will likely reflect the boy's overall health status, including *àdánù lábẹ́ ìwádìí fífúnrá* [possible kidney loss].\n</step2>\n<step3>\nThe presence of *albuminuria* indicates kidney damage or dysfunction, which could be due to conditions like nephrotic syndrome — *àkóbá ẹ̀dọ̀fóró*.\n</step3>\n<step4>\nAdditionally, *hypoalbuminaemia* suggests that the body is losing protein, which is often seen in kidney diseases — *àìlera ẹ̀dọ̀fóró*.\n</step4>\n<step5>\nThe EMR might also show elevated lipid levels due to the body's response to low protein levels — *ìdáhùn ara si àìlera*.\n</step5>\n<step6>\nIn summary, the EMR will likely document these findings, indicating a possible nephrotic syndrome or related kidney issue — *ìṣòro ẹ̀dọ̀fóró*.\n</step6></thinking>", "answer": "<answer>Ìwádìí ìwé-èlékítírónìkì yóò fi hàn pé ó ní àkóbá ẹ̀dọ̀fóró pẹ̀lú ìṣòro lipid.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 29 kan wá sọ́dọ̀ oníṣẹ́gun nítorí ìṣòro ìríra ìwòye tí ń pọ̀ sí i ní oju òsì rẹ̀ àti ìríra ìwòye tí ń gbàgbà ní oju ọ̀tún rẹ̀ fún oṣù méjì sẹ́yìn. Ó tún sọ pé ó ti ní ìgbà ìgbà orírí, ó sì ti kíyèsí ìdinku nínú ìmọ̀ràn rẹ̀ nígbà àìpẹ́ yìí. Oògùn kan ṣoṣo tí àpẹẹrẹ náà gbà ni fexofenadine fún àrùn àìlera akúkọ́. Òkìkí rẹ̀ jẹ́ 158 cm (5 ft 2 in) gígùn, ó sì wọn 61 kg (135 lbs); BMI jẹ́ 24.7 kg/m2. Àwọn àmì ààyò jẹ́ ìwọ̀n déédéé. Ìwòye ríran jẹ́ 20/40 ní oju ọ̀tún, àti ìríra fìfẹ̀ẹ̀ ìkàn sí i ní oju òsì. Nínú ìdánwò fìlàṣì tí ń yípadà, àwọn ojú méjèèjì rẹ̀ gbòòrò bí ìmọ́lẹ̀ ṣe ń yí padà láti ojú ọ̀tún lọ sí ojú òsì. Ìwádìí fundus fi hàn papilledema ní ọ̀pá ìwòye ọ̀tún àti ọ̀pá ìwòye òsì tí ó fẹ́rẹ̀ẹ́ jẹ́ funfun. Èyí tí ó kù nínú àyẹ̀wò kò fi hàn àìlera kankan. Èwo nínú àwọn wọ̀nyí ni ìwádìí tí ó ṣeé ṣe jùlọ?\nA. Àrùn ìwòye ipa-ọ̀dọ̀\nB. Pseudotumor cerebri\nC. Àrùn ìwòye ischemic ṣáájú\nD. Meningioma\nE. Àrùn ìgbàgbọ́ pupọ̀", "reasoning": "<thinking><step1>\nThe question is asking about a 29-year-old woman who has been experiencing visual disturbances, specifically pain in her left eye and blurriness in her right eye for the past two months. It also mentions a history of migraines and a recent decline in her vision. \n</step1>\n<step2>\nShe has been prescribed fexofenadine for allergic rhinitis, which indicates that her symptoms may not be solely related to allergies — *àìlera akúkọ́* might not be the primary issue here.\n</step2>\n<step3>\nHer height is 158 cm (5 ft 2 in) and weight is 61 kg (135 lbs), giving her a BMI of 24.7 kg/m², which is within the normal range — *ìwọn BMI rẹ̀ jẹ́ àtọkànwá*.\n</step3>\n<step4>\nThe visual acuity is 20/40 in the right eye and there is significant pain in the left eye. The examination shows papilledema in both eyes, which suggests increased intracranial pressure — *ìdàgbàsókè àtọkànwá*.\n</step5>\n<step5>\nThe differential diagnoses include conditions that could cause papilledema and visual disturbances, such as pseudotumor cerebri, which is characterized by increased intracranial pressure without a mass — *àìlera tí kò ní àpẹẹrẹ*.\n</step6>\n<step6>\nGiven her symptoms and the findings, pseudotumor cerebri seems to be the most likely diagnosis, especially considering her history of migraines and the recent visual changes.\n</step7>\n<step7>\nOther options like ischemic optic neuropathy or meningioma are less likely given the presentation of bilateral papilledema and the absence of other neurological deficits.\n</step8></thinking>", "answer": "<answer>Pseudotumor cerebri ni ìwádìí tí ó ṣeé ṣe jùlọ.</answer>", "language": "Yoruba"}
{"question": "Ẹni tí ó jẹ́ ọ̀tọ̀lọ́wọ́ ṣe ni yóò dáhùn sí àwọn ìbéèrè wọ̀nyí nípa ìdí ìṣẹ̀lẹ̀ báwo?\nWayne ní agogo tuntun kan tí ó ga lọ́wọ́lọ́wọ́, tí ó ń ṣe ìtẹ̀jáde ọkàn rẹ̀ nígbà tí ó bá ń ṣiṣẹ́. Ó gbọ́dọ̀ gbé agogo náà sórí ìtòsọ́nṣọ̀n kí ó tó lo ó ní alẹ́ yìí. Ẹ̀rọ náà yóò kún fún agbára ní wákàtí kan bí a bá so ó mọ́ àtọ́ka tàbí kí ó wà lórí ìtòsọ́nṣọ̀n. Ní wakati mejì ọ̀sán, a so ẹ̀rọ náà mọ́ àtọ́ka, ẹ̀rọ náà sì kò sí lórí ìtòsọ́nṣọ̀n. Ní àkókò yẹn, Wayne ṣayẹ̀wò láti rí i bí ẹ̀rọ náà ti wà lórí ìtòsọ́nṣọ̀n, ó sì rí i pé kò sí. Nítorí náà, ó yí ipò ẹ̀rọ náà padà, ó sì gbé e sí orí ìtòsọ́nṣọ̀n. Nítorí pé ẹ̀rọ náà yóò kún fún agbára ní wákàtí kan bí a bá so ó mọ́ àtọ́ka tàbí kí ó wà lórí ìtòsọ́nṣọ̀n, ẹ̀rọ náà kún fún agbára ní wakati mẹta ọ̀sán. Ṣé ẹ̀rọ náà kún fún agbára nítorí pé Wayne yí ipò ẹ̀rọ náà padà?\nÀwọn ìdáhùn:\n- Bẹ́ẹ̀ni\n- Rárá", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé ẹ̀rọ náà kún fún agbára nítorí pé Wayne yí ipò ẹ̀rọ náà padà?” — meaning it wants to know if the device is charged because Wayne moved it.\n</step1>\n<step2>\nWayne has a new device that charges when connected to a power source — *agogo tuntun* tí ó ń ṣe ìtẹ̀jáde. \n</step2>\n<step3>\nThe device will charge for one hour if it is plugged in or placed on a charging station — *kún fún agbára* ní wákàtí kan.\n</step3>\n<step4>\nInitially, the device was connected for two hours, but Wayne found it was not on the charging station — *kò sí lórí ìtòsọ́nṣọ̀n*.\n</step4>\n<step5>\nAfter moving the device back to the charging station, it should start charging again — *yí ipò ẹ̀rọ náà padà*.\n</step6>\n<step6>\nSince it was connected to the power source for a total of three hours, it should indeed be charged now.\n</step6></thinking>", "answer": "<answer>Bẹ́ẹ̀ni, ẹ̀rọ náà kún fún agbára.</answer>", "language": "Yoruba"}
{"question": "Àwọn ohun tòótọ́ nípa àrùn àníyàn gbogbogbòò jẹ́: a. Ọ̀rùn-tí-kò-dẹ́  b. Ọ̀rùn-tí-pọ̀  c. Àwọn ìṣẹ̀lẹ̀ náà máa ń gba ìṣẹ́jú sí wákàtí d. Àníyàn tí kò ní ìdí kan  e. Benzodiazepine ni ìtọ́jú tí a yàn  f. Àwọn àmì àrùn ara\nA. gbogbo àwọn wọ̀nyí\nB. a,b,d,f\nC. a,d,e,f\nD. a,b,c,d", "reasoning": "<thinking><step1>\nThe question asks about the true statements regarding [àrùn àníyàn = anxiety disorder]. It provides several options to choose from.\n</step1>\n<step2>\nFirst, we need to evaluate each statement. Statement a, *ọ̀rùn-tí-kò-dẹ́* (non-specific symptoms), can be true for anxiety disorders as they often present with vague symptoms.\n</step2>\n<step3>\nStatement b, *ọ̀rùn-tí-pọ̀* (specific symptoms), is also relevant since anxiety can manifest with specific symptoms like panic attacks.\n</step3>\n<step4>\nNext, statement c, *àwọn ìṣẹ̀lẹ̀ náà máa ń gba ìṣẹ́jú sí wákàtí* (events can last for minutes to hours), aligns with how anxiety episodes can vary in duration.\n</step4>\n<step5>\nStatement d, *àníyàn tí kò ní ìdí kan* (anxiety without a specific cause), is a hallmark of anxiety disorders, making it true as well.\n</step5>\n<step6>\nStatement e, *Benzodiazepine ni ìtọ́jú tí a yàn* (Benzodiazepines are chosen treatment), is accurate as these medications are often prescribed for anxiety.\n</step6>\n<step7>\nFinally, statement f, *àwọn àmì àrùn ara* (physical symptoms), is also true since anxiety can cause physical manifestations like increased heart rate.\n</step7>\n<step8>\nNow, we analyze the options: A includes all statements, B includes a, b, d, f, C includes a, d, e, f, and D includes a, b, c, d. Since all statements are true, the correct answer is A.\n</step8></thinking>", "answer": "<answer>Gbogbo àwọn wọ̀nyí.</answer>", "language": "Yoruba"}
{"question": "Àgbàlagbà obìnrin ọdun 69 kan tí ó ní àṣààrà onjẹ tí kò dára àti àìsàn ọtí, tí ó ní àrùn ẹ̀jẹ̀ pupa tí ẹ̀jẹ̀ rẹ̀ tóbi (macrocytic anemia) àti àwọn neutrophils tí ó pọ̀ sí i (hypersegmented neutrophils),  ìwádìí tó yẹ kí a ṣe láti mọ̀ bóyà òfùrùfù vitamin ni ó fa àrùn náà kí ni?", "reasoning": "<thinking><step1>\nThe question asks: “What tests should be done to determine if vitamin deficiency is causing macrocytic anemia in a 69-year-old woman with poor dietary habits and alcohol-related illness?” — here, *àrùn ẹ̀jẹ̀ pupa* refers to macrocytic anemia.\n</step1>\n<step2>\nMacrocytic anemia is characterized by larger than normal red blood cells — *ẹ̀jẹ̀ pupa tó tóbi ju ti àtọkànwá lọ* — and can be caused by deficiencies in vitamins like B12 or folate.\n</step2>\n<step3>\nIn this case, we should first check the levels of vitamin B12 — *iwadii fun vitamin B12* — and folate in the blood to see if they are low.\n</step3>\n<step4>\nAdditionally, a complete blood count (CBC) would help assess the overall blood health — *iwadii gbogbo ẹ̀jẹ̀* — and confirm the presence of hypersegmented neutrophils.\n</step4>\n<step5>\nIf the vitamin levels are low, further tests might include a methylmalonic acid test — *iwadii acid methylmalonic* — to differentiate between B12 deficiency and other causes.\n</step5>\n<step6>\nFinally, checking for intrinsic factor antibodies could help determine if there is an autoimmune component — *iwadii fun awọn antibody intrinsic factor*.\n</step6></thinking>", "answer": "<answer>Iwadii ti a yẹ ki a ṣe ni: iwadii fun vitamin B12, folate, ati methylmalonic acid, pẹlu iwadii gbogbo ẹ̀jẹ̀.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìtumọ̀ tí wọ́n ṣe láti èdè German sí èdè Gẹ̀ẹ́sì tó wà níbẹ̀ ni àṣìṣe kan wà. Àṣìṣe yẹn yóò jẹ́ ọ̀kan nínú àwọn irú àṣìṣe wọnyi: Àwọn orúkọ ẹ̀dá: Orúkọ ẹ̀dá kan (orúkọ, ibùgbé, àwọn ibi tí ó wà, àti bẹ́ẹ̀ bẹ́ẹ̀ lọ) yí pa dà sí ẹ̀dá míràn. Àwọn iye nọ́mbà: Àwọn iye nọ́mbà (àwọn nọ́mbà tó jẹ́ àkọ́kọ́ tàbí tí kò jẹ́ àkọ́kọ́), ọjọ́, àti/tàbí àwọn ìwọn dídùn yí pa dà. Àwọn ohun tí ń ṣàlàyé tàbí àwọn orúkọ oríṣiríṣi: Àwọn ohun tí ń ṣàlàyé àti àwọn orúkọ oríṣiríṣi tó jẹ́ ti orúkọ kan yí pa dà. Ṣíṣàìní tàbí Àwọn ọ̀rọ̀ tó yàtọ̀: Fi ṣíṣàìní sílẹ̀ tàbí mú un kúrò tàbí yí àwọn ohun tó jẹ́ àfiwé pa dà sí àwọn ohun tó yàtọ̀ sí wọn. Òtítọ́: Àwọn àṣìṣe òtítọ́ kékeré tí kò jẹ́ ti àwọn ẹ̀ka tí ó wà lórí yí pa dà sí àwọn ìtumọ̀. Ohun tí a fi sílẹ̀: Ọ̀rọ̀ pàtàkì kan nínú ìtumọ̀ yí pa dà. Jọ̀wọ́, ṣàkíyèsí àṣìṣe yẹn. Ọ̀rọ̀ ìbẹ̀rẹ̀: Der Obere Stadtfriedhof, auch Friedhof Obere Stadt, ist ein städtischer Friedhof in Klosterneuburg in Niederösterreich.\nÌtumọ̀: The Lower Town Cemetery is an urban cemetery in Klosterneuburg, Lower Austria.\nÀṣìṣe kan wà nínú ìtumọ̀ náà tó jẹ́ ti\nÀwọn àṣàyàn:\n(A) Àwọn ohun tí ń ṣàlàyé tàbí àwọn orúkọ oríṣiríṣi\n(B) Àwọn iye nọ́mbà\n(C) Ṣíṣàìní tàbí Àwọn ọ̀rọ̀ tó yàtọ̀\n(D) Àwọn orúkọ ẹ̀dá\n(E) Ohun tí a fi sílẹ̀\n(F) Òtítọ́", "reasoning": "<thinking><step1>\nThe question is asking about a translation error in the phrase: “Der Obere Stadtfriedhof, auch Friedhof Obere Stadt, ist ein städtischer Friedhof in Klosterneuburg in Niederösterreich.” — which translates to “The Lower Town Cemetery is an urban cemetery in Klosterneuburg, Lower Austria.”\n</step1>\n<step2>\nThe key term here is “Obere Stadtfriedhof,” which means “Upper Town Cemetery,” not “Lower Town Cemetery” — *Friedhof Obere Stadt* indicates the upper part, so the translation is incorrect.\n</step2>\n<step3>\nThis error falls under the category of *Àwọn orúkọ ẹ̀dá* (proper names), as it misrepresents the name of the cemetery.\n</step3>\n<step4>\nIn translation, maintaining the correct names is crucial; otherwise, it leads to confusion about the location — *ibùgbé*.\n</step4>\n<step5>\nThus, the mistake is not about numbers or descriptions but specifically about the proper name of the cemetery.\n</step5>\n<step6>\nTherefore, the correct answer is that the error is related to *Àwọn orúkọ ẹ̀dá*.\n</step6></thinking>", "answer": "<answer>Àṣìṣe yẹn jẹ́ ti Àwọn orúkọ ẹ̀dá.</answer>", "language": "Yoruba"}
{"question": "Fi ẹ́kún ọ̀nà tí ó ku sílẹ̀, dáàrúdààrú kí ìwọ̀n àwọn ìwọ̀n ìṣirò tókàn náà wà ní ọ̀nà tó tọ́.  Ohun tí a fún ọ̀ ní: [ ( ) { [ ] } [ ] [ ] { < { ( ( { } ) ) { [ { } ] } } > [ ] }", "reasoning": "<thinking><step1>\nThe question asks: “Fi ẹ́kún ọ̀nà tí ó ku sílẹ̀, dáàrúdààrú kí ìwọ̀n àwọn ìwọ̀n ìṣirò tókàn náà wà ní ọ̀nà tó tọ́” — which translates to \"Given the remaining path, arrange the brackets so that the counts of the brackets are correct.\"\n</step1>\n<step2>\nTo solve this, we need to ensure that every opening bracket has a corresponding closing bracket — *kí gbogbo àkọ́kọ́ àpò àtẹ̀jáde ni*.\n</step2>\n<step3>\nWe have various types of brackets: parentheses ( ), curly braces { }, and square brackets [ ]. Each type must be balanced — *kí gbogbo irú àpò náà jẹ́ dídá*.\n</step3>\n<step4>\nStarting with the provided sequence: [ ( ) { [ ] } [ ] [ ] { < { ( ( { } ) ) { [ { } ] } } > [ ] }, we can analyze the pairs.\n</step4>\n<step5>\nWe count the opening and closing brackets: for every ( there should be a ), for every { there should be a }, and for every [ there should be a ]. This means we need to check the arrangement carefully — *kí a ṣe àyẹ̀wò àtẹ̀jáde náà pẹ̀lú ìtẹ́lọ́run*.\n</step5>\n<step6>\nAfter arranging them correctly, we can ensure that the sequence is valid and follows the rules of bracket pairing — *kí a lè rí i pé gbogbo àpò náà wà ní àtẹ̀jáde tó pé*.\n</step6></thinking>", "answer": "<answer>Àtẹ̀jáde tó pé ni: [ ( { [ ] } ) { [ ] [ ] } { < { ( ( { } ) ) [ { } ] } > } ].</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 30 kan ni ijamba, kò sì le gbe ẹsẹ̀ rẹ̀, bẹ́ẹ̀ ni kò le ṣe idọ̀. A gbàgbọ́ pe àrùn ti bà lórí ọ̀rùn rẹ̀.  Ṣe irú wo ni o dára jùlọ?\nA. X-ray Ẹ̀gbà ọ̀rùn, Ẹ̀gbẹ́ àti iwaju\nB. Dokita gbọdọ̀ bá aládààmú náà lọ sí ibi tí wọ́n ń ṣe X-ray\nC. Ṣàkíyèsí àwọn àìlera eyikeyii ti ara\nD. Fi ọ̀rùn ọgbọ̀ rẹ̀ mọ́, kí o sì ṣe X-ray ẹ̀gbà ọ̀rùn rẹ̀", "reasoning": "<thinking><step1>\nThe question translates to: \"A 30-year-old man has an accident, cannot move his leg, and also cannot perform a diagnosis. It is believed that an injury has affected his [ọ̀rùn = neck]. What is the best option?\" \n</step1>\n<step2>\nThe options provided suggest different approaches to handling the situation. The first option, A, mentions an X-ray of the neck, back, and front — *X-ray Ẹ̀gbà ọ̀rùn, Ẹ̀gbẹ́ àti iwaju* — which could help identify any fractures or dislocations.\n</step2>\n<step3>\nOption B suggests that a doctor must take the patient to where X-rays are performed — *Dokita gbọdọ̀ bá aládààmú náà lọ sí ibi tí wọ́n ń ṣe X-ray*. This emphasizes the need for professional medical assistance.\n</step3>\n<step4>\nOption C focuses on observing any physical symptoms — *Ṣàkíyèsí àwọn àìlera eyikeyii ti ara* — which is important but may not provide immediate help for a serious injury.\n</step4>\n<step5>\nOption D recommends stabilizing the neck and then performing an X-ray — *Fi ọ̀rùn ọgbọ̀ rẹ̀ mọ́, kí o sì ṣe X-ray ẹ̀gbà ọ̀rùn rẹ̀*. This is crucial because moving the neck could worsen any potential injury.\n</step6>\n<step6>\nConsidering the severity of the situation, the best option is to stabilize the neck first and then proceed with an X-ray to assess the injury properly.\n</step6></thinking>", "answer": "<answer>Fi ọ̀rùn ọgbọ̀ rẹ̀ mọ́, kí o sì ṣe X-ray ẹ̀gbà ọ̀rùn rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Labẹ́ ìpínlẹ̀ àìsàn placenta previa, irú wo ni a ó fi sí i nígbà tí placenta bá fẹ̀ sí apá àárín ìpín agbára ilé-ọmọ?", "reasoning": "<thinking><step1>\nThe question asks: “Labẹ́ ìpínlẹ̀ àìsàn [placenta previa = placenta previa], irú wo ni a ó fi sí i nígbà tí placenta bá fẹ̀ sí apá àárín ìpín agbára ilé-ọmọ?” — meaning it wants to know what happens when the placenta is positioned in the lower part of the uterus during pregnancy.\n</step1>\n<step2>\nIn cases of placenta previa, the placenta covers the cervix, which can lead to complications during delivery — *iyalẹnu le waye nigba ti a ba n ṣe ìbí*.\n</step2>\n<step3>\nWhen the placenta is low-lying, it can cause bleeding — *ìjẹ́rè* — and may require careful monitoring.\n</step3>\n<step4>\nIf the placenta is too close to the cervix, a cesarean section — *ìbí àtẹ́gùn* — is often recommended to avoid risks during vaginal delivery.\n</step4>\n<step5>\nIn some cases, if the placenta moves up as the pregnancy progresses, a vaginal delivery may still be possible — *ṣùgbọ́n, a gbọdọ̀ ṣe àyẹ̀wò pẹ̀lú dokita*.\n</step5>\n<step6>\nUltimately, the management of placenta previa depends on its severity and the gestational age of the pregnancy — *àkókò ìyá*.\n</step6></thinking>", "answer": "<answer>Nígbà tí placenta bá fẹ̀ sí apá àárín ìpín agbára ilé-ọmọ, a ó fi sí i nígbà tí a ba n ṣe ìbí àtẹ́gùn.</answer>", "language": "Yoruba"}
{"question": "Obirin ọmọ ọdun 63 kan ti o ní itan-akọọlẹ aarun oyinbo ti o wa labẹ itọju lọwọlọwọ ni iṣoro ẹmi titẹsẹ kan ti o ṣẹlẹ lọna ti o yara, ṣugbọn kò ní irora ọmu, ikọ, ikọlu tabi iba. Awọn ami-iṣẹ ṣe afihan iṣẹ-ṣiṣe ọkan ti 100/min, ati iwadii iṣoogun ko fihan awọn ami ti thrombosis inu iṣan jinlẹ. Ni ifọkansi si awọn alaye wọnyi ati aini lati yọ embolism inu ọpọlọ kuro, iwadii wo ni yoo jẹ ipinnu ninu fifunmi pe ipo yii ko si?", "reasoning": "<thinking><step1>\nThe question is asking about a 63-year-old woman with a history of [arun oyinbo = stroke] who is currently experiencing a sudden [iṣoro ẹmi titẹsẹ = respiratory issue] without chest pain, cough, or fever. \n</step1>\n<step2>\nGiven her heart rate of 100/min and the absence of signs of [thrombosis inu iṣan jinlẹ = deep vein thrombosis], we need to consider what tests would rule out a potential [embolism inu ọpọlọ = cerebral embolism].\n</step2>\n<step3>\nIn such cases, a common diagnostic tool is a CT scan of the head — *CT ti ori* — to check for any signs of an embolism or stroke.\n</step3>\n<step4>\nAdditionally, an MRI may be useful for more detailed imaging, especially if the CT results are inconclusive — *MRI le jẹ iranlọwọ fun iwadii jinlẹ*.\n</step4>\n<step5>\nWe should also consider blood tests to evaluate for any underlying conditions that could contribute to her symptoms, such as [hypoxia = hypoxia] or electrolyte imbalances.\n</step5>\n<step6>\nFinally, monitoring her oxygen saturation levels — *iwọn dida atẹgun* — would be crucial to assess her respiratory status.\n</step6>\n<step7>\nThus, the primary investigation to rule out a cerebral embolism would likely be a CT scan of the head, followed by an MRI if necessary.\n</step7></thinking>", "answer": "<answer>Iwadi akọkọ lati yọ embolism inu ọpọlọ kuro ni CT ti ori.</answer>", "language": "Yoruba"}
{"question": "Ṣàwọn àrùn tí àjàkálẹ̀-àrùn RNA paramyxovirus fa, tí àkókò ìgbàtí ó gbà láti bẹ̀rẹ̀ sí í hàn jẹ́ ọjọ́ 14 sí 21, tí ó sì ní ìwọ̀n ìtànṣẹ́ àrùn gíga, pẹ̀lú àrùn aseptic meningitis gẹ́gẹ́ bí ìṣòro tí ó wọ́pọ̀ jùlọ. A óò rí àkàwé alààyè tí a ti dinku agbára rẹ̀, tí a sì ń lò Jeryl Lynn strain fún àrùn yìí.", "reasoning": "<thinking><step1>\nThe question discusses diseases caused by the [RNA paramyxovirus], specifically mentioning the incubation period of 14 to 21 days and the high morbidity rate, with *aseptic meningitis* as a common complication.\n</step1>\n<step2>\nDiseases caused by this virus include *mumps*, which is characterized by swelling of the salivary glands — *glandula parotidis*.\n</step2>\n<step3>\nThe incubation period is crucial because it indicates how long it takes for symptoms to appear after exposure — *àkókò ìgbàtí*.\n</step3>\n<step4>\nIn addition to *aseptic meningitis*, other complications can arise, such as orchitis and oophoritis, which affect reproductive organs.\n</step4>\n<step5>\nThe Jeryl Lynn strain is a live attenuated vaccine used to prevent mumps, demonstrating how vaccination can reduce the incidence of these diseases.\n</step5>\n<step6>\nOverall, the high morbidity rate indicates that while many may recover, the complications can lead to serious health issues — *ìṣòro ilera*.\n</step6>\n<step7>\nThus, understanding the implications of the RNA paramyxovirus is essential for public health and vaccination strategies.\n</step7></thinking>", "answer": "<answer>Àrùn tí àjàkálẹ̀-àrùn RNA paramyxovirus fa ni mumps, tí ó ní àkókò ìgbàtí 14 sí 21 ọjọ́, pẹ̀lú àrùn aseptic meningitis gẹ́gẹ́ bí ìṣòro wọ́pọ̀, tí a sì ń lò Jeryl Lynn strain fún àkóso àrùn yìí.</answer>", "language": "Yoruba"}
{"question": "Gbolohun wo ni o ni tito ọ̀rọ̀-ìṣe-apẹrẹ ti o tọ́:\nAwọn aṣayan:\n(A) bata kekere, ọ̀rànjì, Amẹrika, onigbelegbe\n(B) bata kekere, onigbelegbe, ọ̀rànjì, Amẹrika", "reasoning": "<thinking><step1>\nThe question asks: “Gbolohun wo ni o ni tito [ọ̀rọ̀-ìṣe-apẹrẹ = correct sentence structure] ti o tọ́?” — meaning it wants to identify which sentence has the correct structure.\n</step1>\n<step2>\nTo determine the correct structure, we need to analyze the options provided: (A) and (B).\n</step2>\n<step3>\nIn option (A), the order is: *bata kekere* (small shoes), *ọ̀rànjì* (orange), *Amẹrika* (America), *onigbelegbe* (designer). This sequence seems to mix adjectives and nouns without a clear hierarchy.\n</step3>\n<step4>\nIn option (B), the order is: *bata kekere*, *onigbelegbe*, *ọ̀rànjì*, *Amẹrika*. Here, the adjective *onigbelegbe* is placed after *bata kekere*, which is more logical as it describes the shoes directly.\n</step4>\n<step5>\nThe correct structure typically places adjectives before the nouns they modify in Yoruba, making option (B) more appropriate.\n</step5>\n<step6>\nThus, option (B) maintains a clearer and more logical flow in the sentence structure.\n</step6></thinking>", "answer": "<answer>Bata kekere, onigbelegbe, ọ̀rànjì, Amẹrika ni o ni tito ọ̀rọ̀-ìṣe-apẹrẹ ti o tọ́.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìgbésẹ̀ ìtòlẹ́sẹ̀ ìdánwò Gram. a. Ìtọ́jú pẹ̀lú iodine b. Safranin c. Crystal violet d. Wíwẹ̀ pẹ̀lú ọti\nA. a>b>c>d\nB. b>c>a>d\nC. c>a>d>b\nD. b>a>d>c", "reasoning": "<thinking><step1>\nThe question asks about the steps in the Gram staining procedure, specifically: \"Àwọn ìgbésẹ̀ ìtòlẹ́sẹ̀ ìdánwò Gram\" — meaning it wants to know the correct order of the staining steps.\n</step1>\n<step2>\nIn Gram staining, the first step is to apply crystal violet — *crystal violet* is the primary stain that colors all cells.\n</step2>\n<step3>\nNext, iodine is used as a mordant — *iodine* helps to fix the crystal violet in the cells, forming a complex.\n</step3>\n<step4>\nAfter that, the cells are washed with alcohol or acetone — *wíwẹ̀ pẹ̀lú ọti* dehydrates the cells and can remove the stain from Gram-negative bacteria.\n</step4>\n<step5>\nFinally, safranin is applied as a counterstain — *safranin* colors the Gram-negative bacteria pink, allowing differentiation.\n</step6>\n<step6>\nThus, the correct order of steps is: c (crystal violet) > a (iodine) > d (washing with alcohol) > b (safranin).\n</step6></thinking>", "answer": "<answer>C. c>a>d>b</answer>", "language": "Yoruba"}
{"question": "Àgbéyẹ̀wò ìtàn ọmọdé ọdún mẹ́ẹ̀ẹ́dógún kan tí ó ní àrùn ibà lọ́pọ̀lọpọ̀ láti ọjọ́ tí ó pé oṣù mẹ́fà, láìsí ìrẹ̀wẹ̀sì, ẹ̀dùn, ìdènà, tàbí ẹ̀gbẹ́, tí a sì gbé àkọsílẹ̀ ìdàgbàsókè rẹ̀ yẹ̀wò, èyí tí ó fi hàn pé ìdàgbàsókè rẹ̀ yàtọ̀ sí bí a ṣe retí, àrùn wo ni èyí fi hàn?", "reasoning": "<thinking><step1>\nThe question asks: “Àgbéyẹ̀wò ìtàn ọmọdé ọdún mẹ́ẹ̀ẹ́dógún kan tí ó ní àrùn ibà” — meaning it wants to evaluate the development of a 15-year-old child with a chronic illness since the age of six, without any signs of regression, pain, or disability.\n</step1>\n<step2>\nIn this context, the child’s development is being monitored for any abnormalities — *àìlera* or deviations from typical growth patterns.\n</step2>\n<step3>\nChronic illnesses like *àrùn ibà* (sickle cell disease) can affect growth, but if there are no signs of regression, it suggests that the child is managing the illness well.\n</step3>\n<step4>\nThe absence of symptoms like *ìrẹ̀wẹ̀sì* (fatigue), *ẹ̀dùn* (pain), or *ìdènà* (disability) indicates that the child’s overall health is stable.\n</step4>\n<step5>\nIn such cases, one might consider conditions like *àrùn àtọ́kànwá* (asthma) or *àrùn àtọ́kànwá àìlera* (chronic illness) that do not necessarily impede growth.\n</step5>\n<step6>\nThus, the child’s development being atypical could suggest a condition like *àrùn ibà* that is well-managed, allowing for normal growth despite the illness.\n</step6></thinking>", "answer": "<answer>Ìtàn ọmọdé yìí fi hàn pé ó ní àrùn ibà, ṣùgbọ́n ìdàgbàsókè rẹ̀ yàtọ̀ sí bí a ṣe retí.</answer>", "language": "Yoruba"}
{"question": "Alisi, Bobu, ati Klea jẹ́ ọ̀rẹ́, wọ́n sì jẹ́ àwọn onkawe tí wọ́n máa ń pààrọ̀ ìwé déédé. Ní ìbẹ̀rẹ̀ ọdún ẹ̀kọ́, olúkúlùkù wọn ra ìwé tuntun kan: Alisi gba Catch-22, Bobu gba Moby Dick, ati Klea gba The Great Gatsby.\nBí ọdún ẹ̀kọ́ ṣe ń lọ síwájú, wọ́n bẹ̀rẹ̀ sí í pààrọ̀ àwọn ìwé tuntun náà. Àkọ́kọ́, Klea ati Bobu pààrọ̀ ìwé. Lẹ́yìn náà, Klea ati Alisi pààrọ̀ ìwé. Níkẹyìn, Bobu ati Klea pààrọ̀ ìwé. Ní òpin ọdún ẹ̀kọ́ náà, ohun tí Klea ní ni:\nÀwọn Àṣàyàn:\n(A) Catch-22\n(B) Moby Dick\n(C) The Great Gatsby", "reasoning": "<thinking><step1>\nThe question describes a scenario where three friends, Alisi, Bobu, and Klea, are exchanging books throughout the school year. It asks what book Klea has at the end of the year.\n</step1>\n<step2>\nInitially, Alisi has *Catch-22*, Bobu has *Moby Dick*, and Klea has *The Great Gatsby*. So, at the start, Klea's book is *The Great Gatsby*.\n</step2>\n<step3>\nFirst, Klea and Bobu exchange books. After this exchange, Klea now has *Moby Dick* and Bobu has *The Great Gatsby*.\n</step3>\n<step4>\nNext, Klea and Alisi exchange books. Klea gives *Moby Dick* to Alisi and receives *Catch-22* from Alisi. Now, Klea has *Catch-22*.\n</step4>\n<step5>\nFinally, Bobu and Klea exchange books again. Bobu gives *The Great Gatsby* to Klea, and Klea gives *Catch-22* to Bobu. At this point, Klea ends up with *The Great Gatsby*.\n</step5>\n<step6>\nThus, by the end of the school year, Klea has *The Great Gatsby*.\n</step6></thinking>", "answer": "<answer>The Great Gatsby</answer>", "language": "Yoruba"}
{"question": "Ṣàwọn oríṣi àrùn àìlera ọpọlọ tí ó máa ń bẹ̀rẹ̀ ní ìgbà ọmọdé, tí àwọn àmì rẹ̀ sì jẹ́ àìṣànímọ́lera tàbí ìdákẹ́ṣẹ̀ fún ìṣẹ́jú díẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What are the types of [àrùn àìlera ọpọlọ = mental health disorders] that typically begin in childhood, with symptoms like [àìṣànímọ́lera = inattention] or [ìdákẹ́ṣẹ̀ = hyperactivity] for a few minutes?”\n</step1>\n<step2>\nCommon childhood mental health disorders include Attention Deficit Hyperactivity Disorder (ADHD) — *àrùn àìlera àkópọ̀* — which is characterized by inattention and hyperactivity.\n</step2>\n<step3>\nAnother disorder is Oppositional Defiant Disorder (ODD) — *àrùn ìkànsí àìlera*, where children may show defiant behavior and irritability.\n</step3>\n<step4>\nAnxiety disorders can also start in childhood, leading to symptoms like excessive worry — *ìbànújẹ àìlera* — and avoidance of certain situations.\n</step4>\n<step5>\nThese disorders often manifest with symptoms that can fluctuate, such as brief episodes of inattention or hyperactivity, which can be confusing for parents and teachers.\n</step5>\n<step6>\nEarly identification and intervention are crucial for managing these disorders effectively — *ìmúlò àkóso*.\n</step6></thinking>", "answer": "<answer>Àwọn oríṣi àrùn àìlera ọpọlọ tí ó bẹ̀rẹ̀ ní ìgbà ọmọdé ni ADHD, ODD, àti àrùn ìbànújẹ, tí ó ní àmì àìṣànímọ́lera àti ìdákẹ́ṣẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin ọmọ ọdún mẹ́rìndínlọ́gbọ̀n kan wá pẹ̀lú àárẹ̀ gbogbo ara tó ń pọ̀ sí i, inú rírun tó máa ń mú ni gbà mú ní ìsàlẹ̀ ikùn, àti ìgbẹ́ ẹlẹ́jẹ̀ lẹ́ẹ̀kọ̀ọ̀kan fún ọ̀sẹ̀ mélòó kan sẹ́yìn. Ní fífi àwọn àmì àìsàn rẹ̀ wò àti ìtàn àrùn jẹjẹrẹ ìfun nínú ìdílé rẹ̀, kí ni ìgbésẹ̀ tó tọ́ jùlọ láti ṣe nínú ìtọ́jú láti ṣe àyẹ̀wò ipò rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What is the best course of action for a 35-year-old man with general body pain, abdominal discomfort, and intermittent bleeding for several weeks?” — it seeks to determine the appropriate medical evaluation for his symptoms.\n</step1>\n<step2>\nThe symptoms described suggest possible serious conditions — *àìlera tó lewu* — such as gastrointestinal issues or infections.\n</step2>\n<step3>\nGiven the abdominal pain and bleeding, it is crucial to consider conditions like *ìfarapa àyà* or even *ìkànsí* (internal bleeding).\n</step3>\n<step4>\nIn such cases, the best step is to seek immediate medical attention — *ìtọ́jú lẹsẹkẹsẹ* — for a thorough examination and possibly diagnostic tests.\n</step4>\n<step5>\nTests may include blood work, imaging studies like an ultrasound or CT scan, and possibly an endoscopy — *ìtẹ́wọ́gbà* — to assess the gastrointestinal tract.\n</step5>\n<step6>\nTherefore, the most appropriate action is to consult a healthcare professional for a comprehensive evaluation of his condition.\n</step6></thinking>", "answer": "<answer>Kí ni àkọ́kọ́ ni láti bẹ̀rẹ̀ ìtọ́jú ni láti wá àyẹ̀wò ìlera lẹsẹkẹsẹ.</answer>", "language": "Yoruba"}
{"question": "Àpọǹ pé ọ̀pọ̀ǹ kan tí ó jẹ́ ọlọ́mọ ọdún mẹ́tádínlógún, tí ó sì jẹ́ oníṣọ̀ṣọ́, ní àìsàn ọkàn-àyà tí ó ń mú kí ọkàn-àyà rẹ̀ ṣiṣẹ́ ju bí ó ti yẹ lọ, ìṣẹ́ ọkàn-àyà yára, ìtẹ́lẹ̀ ọkàn-àyà tí ó lágbára, àti àwọn ẹ̀yà ara tí ó gbóná. Ìwádìí ẹ̀jẹ̀ fi hàn pé ó ní àìtọ́ òṣó kan. Òṣó wo ni ó ṣeé ṣe jù lọ láti dá ìdààmú yìí sí?", "reasoning": "<thinking><step1>\nThe question asks: “Àpọǹ pé ọ̀pọ̀ǹ kan tí ó jẹ́ ọlọ́mọ ọdún mẹ́tádínlógún” — meaning it describes a 17-year-old individual with heart disease that causes the heart to work harder than normal.\n</step1>\n<step2>\nThis condition can lead to symptoms like *ìṣẹ́ ọkàn-àyà yára* (rapid heartbeat), *ìtẹ́lẹ̀ ọkàn-àyà tí ó lágbára* (strong heartbeats), and *àwọn ẹ̀yà ara tí ó gbóná* (warm body parts).\n</step2>\n<step3>\nThe blood test indicates an *àìtọ́ òṣó kan* (electrolyte imbalance), which can affect heart function significantly.\n</step3>\n<step4>\nCommon electrolytes include sodium, potassium, and calcium — if any of these are out of balance, it can lead to serious complications.\n</step4>\n<step5>\nTo address this imbalance, treatment often involves *ìtọ́jú òṣó* (electrolyte management) through dietary changes or supplements.\n</step5>\n<step6>\nIn this case, the most likely electrolyte imbalance could be related to potassium, as it plays a crucial role in heart rhythm.\n</step6>\n<step7>\nThus, the best approach to resolve this issue would be to restore the potassium levels to normal.\n</step7></thinking>", "answer": "<answer>Ó ṣeé ṣe jù lọ láti dá àìtọ́ òṣó potassium sí.</answer>", "language": "Yoruba"}
{"question": "Gẹgẹ́ bí ọ̀nà Knutson ṣe ń lò fún lílo sodium fluoride tí kò ní agbára kankan, báwo ni àwọn àkókò tí ó wà láàrin ìgbà kejì, ìgbà kẹta, àti ìgbà kẹrin tí a fi fluoride sí i ṣe wà, ṣé a sì ń ṣe ìwẹnu irógbọ̀dọ̀mọ̀ ṣáájú gbogbo ìgbà tí a fi sí i?", "reasoning": "<thinking><step1>\nThe question translates to: \"According to Knutson's method for using sodium fluoride that has no strength, what are the intervals between the second, third, and fourth applications of fluoride, and should we perform a *rinse* before each application?\" \n</step1>\n<step2>\nKnutson's method involves using sodium fluoride to prevent dental caries — *caries dentaires*. The intervals between applications are crucial for effectiveness.\n</step2>\n<step3>\nTypically, the second application occurs after a certain period, often around 6 months, while the third and fourth applications follow at similar intervals — *environ 6 mois entre chaque application*.\n</step3>\n<step4>\nBefore applying fluoride, it is generally recommended to perform a rinse — *un rinçage* — to remove any debris and ensure better absorption of the fluoride.\n</step4>\n<step5>\nThus, the intervals are structured to maximize the fluoride's effectiveness while maintaining oral hygiene through rinsing.\n</step5></thinking>", "answer": "<answer>Àwọn àkókò tí ó wà láàrin ìgbà kejì, ìgbà kẹta, àti ìgbà kẹrin ni 6 oṣù, a sì ń ṣe ìwẹnu irógbọ̀dọ̀mọ̀ ṣáájú gbogbo ìgbà tí a fi fluoride sí i.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 45 kan ti o ni telangiectasias, awọ bulu lori awọn ika ọwọ rẹ nigbati o ba fara hàn si otutu, ati irora ẹmu inu ọmu ti o jó, ni iwọn antibody anti-centromere ti o ga ju. Ti a ba gbero ipo rẹ̀, aami aisan wo ni o kere ju lati wa?", "reasoning": "<thinking><step1>\nThe question asks: “What is the least likely symptom to expect in a 45-year-old woman with [telangiectasias = telangiectasias], blue discoloration on her fingers when exposed to cold, and burning pain in her chest, with elevated anti-centromere antibodies?” \n</step1>\n<step2>\nTelangiectasias are small dilated blood vessels, often seen in conditions like *sclérodermie* (scleroderma), which is associated with anti-centromere antibodies.\n</step2>\n<step3>\nThe symptoms mentioned suggest a possible diagnosis of *sclérodermie*, which can lead to skin changes and vascular issues — *problèmes vasculaires*.\n</step4>\n<step4>\nCommon symptoms of scleroderma include skin thickening, Raynaud's phenomenon, and internal organ involvement — *atteinte des organes internes*.\n</step5>\n<step5>\nHowever, symptoms like joint pain or muscle weakness are less characteristic of scleroderma compared to the vascular and skin symptoms mentioned.\n</step6>\n<step6>\nThus, the least likely symptom to find in this case would be *douleur articulaire* (joint pain), as it is not a primary feature of scleroderma.\n</step6></thinking>", "answer": "<answer>Douleur articulaire ni aami aisan ti o kere ju lati wa.</answer>", "language": "Yoruba"}
{"question": "Ninu awọn gbolohun atẹle wọnyi, ṣalaye ẹniti orukọ-ìdákòwò náà tọ́ka sí (ohun tí orukọ-ìdákòwò náà tọ́ka sí), tàbí sọ pé ó ṣòro láti mọ̀.\nGbolohun: Oluṣowo-ori pàdé pẹlu akọọlẹ lati mọ̀ bóyá wọn lè ràn lọ́wọ́ nínú ṣiṣe ìṣe-ori.\nAwọn aṣayan:\n(A) Oluṣowo-ori lè ràn lọ́wọ́\n(B) Akọọlẹ lè ràn lọ́wọ́\n(C) Ó ṣòro láti mọ̀", "reasoning": "<thinking><step1>\nThe question asks: “In the following sentence, explain what the [orukọ-ìdákòwò = noun phrase] refers to, or say it is difficult to know.” The sentence provided is about a tax consultant meeting with an accountant.\n</step1>\n<step2>\nThe sentence states: “Oluṣowo-ori [tax consultant] pàdé pẹlu akọọlẹ [accountant]” which implies a collaboration or inquiry regarding tax matters.\n</step2>\n<step3>\nIn this context, the tax consultant is likely seeking assistance or information from the accountant — *nítorí náà, wọn lè ràn lọ́wọ́ nínú ṣiṣe ìṣe-ori [in carrying out tax duties]*.\n</step3>\n<step4>\nThe options provided suggest that either the tax consultant or the accountant could be the one providing help, or it could be unclear who is assisting.\n</step5>\n<step5>\nHowever, since the sentence emphasizes the meeting between the two professionals, it indicates that the tax consultant is the one who may need help, thus making option (A) more likely.\n</step6>\n<step6>\nTherefore, the most logical conclusion is that the [orukọ-ìdákòwò] refers to the tax consultant, as they are the one initiating the meeting for assistance.\n</step6></thinking>", "answer": "<answer>Oluṣowo-ori ni orukọ-ìdákòwò náà tọ́ka sí, nítorí pé ó ń wa ìrànlọ́wọ́ láti ọdọ akọọlẹ.</answer>", "language": "Yoruba"}
{"question": "Awọn àkóràn fúngàsì wo ni a kà sí àkóràn tí ó gbòde gbòde ní àwọn àgbègbè ilẹ̀ ayé kan pato, kí o sì mẹ́nu ba àpẹẹrẹ mẹ́ta, pẹ̀lú Coccidioides immitis, kí o sì sọ orúkọ wọn?", "reasoning": "<thinking><step1>\nThe question asks: “Which fungal infections are considered endemic in certain regions of the world, and provide three examples, including Coccidioides immitis?” — it seeks to identify specific fungi that are prevalent in particular geographical areas.\n</step1>\n<step2>\nFungal infections that are endemic are those that are consistently found in specific locations — *àkóràn fúngàsì tí ó gbòde gbòde* can be linked to environmental factors.\n</step2>\n<step3>\nCoccidioides immitis is a well-known example, causing *coccidioidomycosis*, particularly in the southwestern United States — *ìpẹ̀yà fúngàsì* ti a mọ̀ sí *valley fever*.\n</step3>\n<step4>\nAnother example is Histoplasma capsulatum, which is prevalent in areas with bird or bat droppings — *àkóràn fúngàsì* yìí fa *histoplasmosis*.\n</step4>\n<step5>\nA third example is Blastomyces dermatitidis, found in the Midwest and parts of Canada, causing *blastomycosis* — *àkóràn fúngàsì* yìí ni *ìpẹ̀yà fúngàsì* ti a mọ̀ sí *blastomycosis*.\n</step5>\n<step6>\nIn summary, endemic fungal infections include Coccidioides immitis, Histoplasma capsulatum, and Blastomyces dermatitidis, each associated with specific regions and environmental conditions.\n</step6></thinking>", "answer": "<answer>Àwọn àkóràn fúngàsì tí ó gbòde gbòde ni Coccidioides immitis, Histoplasma capsulatum, àti Blastomyces dermatitidis.</answer>", "language": "Yoruba"}
{"question": "Kini orukọ àrùn náà tí ó jẹ́ abajade ìgbóná ara tí ó pọ̀ sí i nítorí ìgbàlà eto ajẹ́rọ́ ara lẹ́yìn ìtọ́jú tó tọ́̀nà pẹ̀lú oogun tí ó ṣeé ṣe láti dènà àrùn tí ó fa nipasẹ àrùn HIV, tí a ṣàpẹẹrẹ rẹ̀ pẹ̀lù àbájáde sí àwọn àrùn ànfàní tí kò hàn kedere?", "reasoning": "<thinking><step1>\nThe question asks: “Kini orukọ àrùn náà tí ó jẹ́ abajade ìgbóná ara tí ó pọ̀ sí i nítorí ìgbàlà eto ajẹ́rọ́ ara lẹ́yìn ìtọ́jú tó tọ́̀nà pẹ̀lú oogun tí ó ṣeé ṣe láti dènà àrùn tí ó fa nipasẹ àrùn HIV?” — meaning it wants to know the name of a disease resulting from immune system failure after proper treatment with medication that can prevent diseases caused by HIV.\n</step1>\n<step2>\nThis condition is known as *àrùn àìlera ajẹ́rọ́ ara* or *AIDS* (Acquired Immunodeficiency Syndrome), which occurs when the immune system is severely compromised.\n</step2>\n<step3>\nAfter effective treatment with antiretroviral therapy (ART), the immune system can still be weakened, leading to opportunistic infections — *àrùn ànfàní*.\n</step3>\n<step4>\nThese opportunistic infections can manifest in various ways, often not showing clear symptoms initially — *kò hàn kedere*.\n</step5>\n<step5>\nIn summary, the disease that results from this immune system failure is referred to as *AIDS*, which is a critical stage of HIV infection.\n</step5></thinking>", "answer": "<answer>Orukọ àrùn náà ni AIDS, tí ó jẹ́ abajade ìgbóná ara lẹ́yìn ìtọ́jú HIV.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 69 kan wa pẹlu ìṣòro ìgbàgbé síṣàn-yòò, nocturia, irora ẹ̀gbà ẹ̀gbà isalẹ ti n pọ̀ sí i tí kò dá sí ibuprofen, prostate ti pọ̀ tí kò bá ara rẹ̀ mu, iye prostate-specific antigen ti gòkè, ati abajade biopsy tí ó fihan adenocarcinoma ti gíga. CT scan fihan ọpọlọpọ awọn iṣẹku osteoblastic ni ẹ̀gbà ẹ̀gbà lumbar. Ti a bá gbé e wò, ati ibẹ̀rẹ itọju pẹlu oògùn kan ti o dije pẹlu androgens ni awọn olugba testosterone, oògùn wo ni a ṣe lórí fún itọju rẹ̀?", "reasoning": "<thinking><step1>\nThe question is asking about a 69-year-old man with multiple symptoms including [ìṣòro ìgbàgbé síṣàn-yòò = urinary incontinence], nocturia, lower back pain unresponsive to ibuprofen, an enlarged prostate, elevated prostate-specific antigen (PSA) levels, and a biopsy showing high-grade adenocarcinoma. It also mentions osteoblastic lesions in the lumbar spine from a CT scan.\n</step1>\n<step2>\nGiven the diagnosis of high-grade adenocarcinoma of the prostate, the treatment typically involves hormonal therapy — *itọju homonu* — to manage the cancer.\n</step2>\n<step3>\nSince the patient has elevated testosterone levels, a common approach is to use androgen deprivation therapy (ADT) — *itọju idena androgens* — which reduces testosterone production.\n</step3>\n<step4>\nMedications like GnRH agonists, such as leuprolide or goserelin, are often used in this context to suppress testosterone — *lati dinku iṣelọpọ testosterone*.\n</step4>\n<step5>\nAdditionally, anti-androgens like bicalutamide may be combined with GnRH agonists to block the action of testosterone on prostate cancer cells — *lati dènà iṣe testosterone*.\n</step5>\n<step6>\nTherefore, the most likely medication prescribed for this patient would be a GnRH agonist, as it effectively targets the underlying hormonal influence on the cancer.\n</step6></thinking>", "answer": "<answer>Oògùn ti a ṣe lórí fún itọju rẹ̀ ni GnRH agonist, gẹgẹ bi leuprolide tabi goserelin.</answer>", "language": "Yoruba"}
{"question": "Nigbati igbimo ile-iwosan kan bá fẹ́ ṣe idiwọ́ iṣẹ́ abẹ̀ tí a kò bá ṣe ní ibi tó yẹ́ ṣáájú kí àkọ̀nàkọ̀nà kan tó ṣẹlẹ̀ nípa ṣíṣàgbéyẹ̀wò àwọn ọ̀ràn eto, àpẹrẹ̀, ilana, àti iṣẹ́, ẹ̀ka pàtó wo ni wọ́n máa gbé yọ sínú àgbéyẹ̀wò wọn tí ó dojú kọ́ ìdánilójú àwọn àìṣẹ́lẹ̀ tí ó ṣeeṣe nínú eto náà?", "reasoning": "<thinking><step1>\nThe question asks: “When a hospital committee wants to prevent a surgical procedure that should not be performed without prior review of the system's issues, which specific department will they include in their review to address potential adverse events?” \n</step1>\n<step2>\nIn this context, the committee is likely concerned with *àìṣẹ́lẹ̀* (adverse events) that could arise from the surgical procedure. \n</step2>\n<step3>\nTypically, the *ẹ̀ka àyẹ̀wò* (review department) involved would be the *ẹ̀ka iṣoogun* (medical department) or *ẹ̀ka iṣakoso didara* (quality control department) to ensure patient safety.\n</step3>\n<step4>\nThey would analyze *ilana* (protocols) and *ọ̀ràn eto* (system issues) to identify any risks associated with the procedure.\n</step4>\n<step5>\nFurthermore, collaboration with *ẹ̀ka ẹ̀kọ́* (education department) may be necessary to train staff on recognizing and mitigating these risks.\n</step5>\n<step6>\nThus, the department that would be included in the review is primarily the *ẹ̀ka iṣoogun* to ensure comprehensive evaluation of potential risks.\n</step6></thinking>", "answer": "<answer>Ẹ̀ka iṣoogun ni wọ́n máa gbé yọ sínú àgbéyẹ̀wò wọn láti dojú kọ́ ìdánilójú àwọn àìṣẹ́lẹ̀ tí ó ṣeeṣe.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọmọ ọdun 70 kan ní ìdánwò ìtẹ̀sílẹ̀ tí a gbìn lórí agar ẹ̀jẹ̀ 5%, tí ó fihan àwọn àgbẹ̀dá àlùfà-hemolytic ní ọjọ́ kejì.  Lẹ́yìn ìṣiṣẹ́ síwájú sí i, kini àwọn ànímọ́ tí ó ṣeé ṣe ti ẹ̀dá alààyè yìí, pẹ̀lú àwọn ànímọ́ Gram staining rẹ̀, abajade idanwo catalase, àti ìgbòògùn bile?", "reasoning": "<thinking><step1>\nThe question is asking about a 70-year-old man who underwent a blood test showing 5% [hemolytic anemia = àgbẹ̀dá àlùfà-hemolytic] on the second day. It wants to know the possible organisms involved, including their Gram staining results, catalase test outcomes, and bile sensitivity.\n</step1>\n<step2>\nIn cases of hemolytic anemia, one common organism is *Staphylococcus aureus*, which is typically Gram-positive — *Gram-positif* — and shows clusters under the microscope.\n</step2>\n<step3>\nThe catalase test for *Staphylococcus aureus* is positive — *testi catalase jẹ́ àfihàn rere* — indicating that it can break down hydrogen peroxide.\n</step3>\n<step4>\nAnother possible organism could be *Streptococcus pneumoniae*, which is also Gram-positive but appears in chains — *ninu ẹ̀ka*.\n</step4>\n<step5>\nFor the bile sensitivity, *Streptococcus pneumoniae* is bile soluble, meaning it can be lysed by bile — *ó le jẹ́ kí bile pa a*.\n</step5>\n<step6>\nIn summary, the possible organisms include *Staphylococcus aureus* and *Streptococcus pneumoniae*, with their respective Gram staining and catalase results indicating their characteristics.\n</step6></thinking>", "answer": "<answer>Àwọn ànímọ́ tí ó ṣeé ṣe ni *Staphylococcus aureus* àti *Streptococcus pneumoniae*, pẹ̀lú *Staphylococcus aureus* jẹ́ Gram-positif, test catalase rẹ̀ jẹ́ àfihàn rere, àti *Streptococcus pneumoniae* jẹ́ bile soluble.</answer>", "language": "Yoruba"}
{"question": "Àwọn ẹya wo ni a fẹ̀ sùgbọ́n fún didimu atunṣe kan ní eyín tí ó ní àìsàn pit and fissure, nígbà tí ọ̀pọ̀lọpọ̀ atunṣe wúrà wà, tí alaisan sì fẹ́ràn atunṣe wúrà fún eyín yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn ẹya wo ni a fẹ̀ sùgbọ́n fún didimu atunṣe kan ní eyín tí ó ní àìsàn [pit and fissure = pit and fissure disease]?” — meaning it wants to know what features are desired for a dental restoration in teeth affected by pit and fissure disease.\n</step1>\n<step2>\nIn dentistry, a restoration for pit and fissure disease should ideally be durable and resistant to wear — *dáàbò bo* against further decay.\n</step2>\n<step3>\nMaterials like composite resins or glass ionomer cements are often used — *àwọn ohun elo wọnyi* provide good adhesion and aesthetics.\n</step4>\n<step4>\nPatients often prefer gold restorations due to their strength and longevity — *àtunṣe wúrà* is highly regarded for its durability.\n</step5>\n<step5>\nHowever, the choice may depend on factors like cost, aesthetics, and the specific condition of the tooth — *ìdílé, àṣà, àti ipo eyín* all play a role in the decision.\n</step6>\n<step6>\nUltimately, the desired features for a restoration include strength, aesthetics, and compatibility with the patient's preferences.\n</step6></thinking>", "answer": "<answer>Àwọn ẹya ti a fẹ̀ sùgbọ́n fún didimu atunṣe kan ni agbara, ẹwa, àti ibamu pẹ̀lú àfẹ́fẹ́ alaisan.</answer>", "language": "Yoruba"}
{"question": "Iye apawo wo ni Oṣuwọn Idaabobo Tọkọtaya gbọdọ kọja fun Oṣuwọn Atọrọda Net lati jẹ dogba si ọkan?", "reasoning": "<thinking><step1>\nThe question asks: “Iye apawo wo ni [Oṣuwọn Idaabobo Tọkọtaya = Required Rate of Return] gbọdọ kọja fun [Oṣuwọn Atọrọda Net = Net Present Value] lati jẹ dogba si ọkan?” — meaning it wants to know what the required rate of return must exceed for the net present value to equal one.\n</step1>\n<step2>\nTo determine this, we need to understand that when the net present value is equal to one, it indicates that the investment is expected to generate returns that just cover the cost of capital — *iyẹn ni, o n ṣe afihan pe awọn ipadabọ ti o wa lati idoko-owo naa jẹ deede si iye ti a fi silẹ*.\n</step2>\n<step3>\nThe required rate of return is the minimum return that investors expect for the risk taken — *o jẹ iwọn ti o yẹ ki idoko-owo kan ni lati jẹ ki o wulo*.\n</step3>\n<step4>\nIf the net present value is one, it means that the cash inflows discounted at the required rate of return equal the initial investment — *iyẹn ni, awọn owó ti n wọle ti a dinku ni oṣuwọn idaabobo ti o yẹ jẹ dogba si idoko-owo akọkọ*.\n</step4>\n<step5>\nThus, for the net present value to equal one, the required rate of return must be set at a level that matches the expected cash flows — *o gbọdọ jẹ pe oṣuwọn idaabobo ti o yẹ kọja iye ti a ti ṣe iṣiro fun awọn owó ti n wọle*.\n</step6>\n<step6>\nIn conclusion, the required rate of return must exceed the rate that results in a net present value of one.\n</step6></thinking>", "answer": "<answer>Oṣuwọn Idaabobo Tọkọtaya gbọdọ kọja oṣuwọn ti o fa Oṣuwọn Atọrọda Net di ọkan.</answer>", "language": "Yoruba"}
{"question": "Ṣe iṣiro iye owo ti o wa lọwọlọwọ ti idoko-owo kan pẹlu iye owo didinku ti 10%, awọn owo sisan ti $3,000 ni opin ọdun kọọkan fun ọdun marun, ati idoko-owo ibẹrẹ ti $11,000.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe iṣiro iye owo ti o wa lọwọlọwọ ti idoko-owo kan...” — meaning it wants to calculate the present value of an investment with a discount rate of 10%, annual cash flows of $3,000 for five years, and an initial investment of $11,000.\n</step1>\n<step2>\nTo find the present value (PV), we use the formula: *PV = C / (1 + r)^n*, where *C* is the cash flow, *r* is the discount rate, and *n* is the year.\n</step2>\n<step3>\nHere, *C = $3,000*, *r = 0.10*, and we will calculate for *n = 1, 2, 3, 4, 5*.\n</step3>\n<step4>\nCalculating each year: \n- For year 1: *PV1 = 3000 / (1 + 0.10)^1 = 2727.27*.\n- For year 2: *PV2 = 3000 / (1 + 0.10)^2 = 2479.34*.\n- For year 3: *PV3 = 3000 / (1 + 0.10)^3 = 2253.94*.\n- For year 4: *PV4 = 3000 / (1 + 0.10)^4 = 2051.76*.\n- For year 5: *PV5 = 3000 / (1 + 0.10)^5 = 1864.25*.\n</step4>\n<step5>\nNow, we sum these present values: *PV_total = PV1 + PV2 + PV3 + PV4 + PV5* which equals approximately *$12,276.56*.\n</step5>\n<step6>\nFinally, to find the net present value (NPV), we subtract the initial investment: *NPV = PV_total - Initial Investment = 12276.56 - 11000*.\n</step6>\n<step7>\nThus, the NPV is approximately *$1,276.56*.\n</step7></thinking>", "answer": "<answer>Iye owo ti o wa lọwọlọwọ ti idoko-owo naa jẹ $1,276.56.</answer>", "language": "Yoruba"}
{"question": "Nínú àrùn ẹ̀jẹ̀ ẹ̀dùn tí ó léwu lọ́wọ́, kí ni ìwádìí náà báà jẹ́ bí àwòrán immunophenotype náà bá jẹ́ CD19 rere, CD10 rere, CD33 rere, àti CD13 rere?", "reasoning": "<thinking><step1>\nThe question asks: “In a severe blood cancer, how does the immunophenotype appear if it is positive for CD19, CD10, CD33, and CD13?” — meaning it wants to understand the significance of these markers in the context of the disease.\n</step1>\n<step2>\nIn hematological malignancies, *immunophenotyping* is crucial for diagnosis — it helps identify specific cell types based on surface markers.\n</step2>\n<step3>\nCD19 is a pan-B-cell marker, indicating that the cells are of B-cell lineage — *àwọn sẹẹli B*.\n</step3>\n<step4>\nCD10 is associated with precursor B-cells, suggesting an early stage of development — *ìpele ibẹrẹ*.\n</step4>\n<step5>\nCD33 and CD13 are myeloid markers, often found in acute myeloid leukemia (AML) — *àkúnya ẹ̀jẹ̀ àtọkànwá*.\n</step5>\n<step6>\nWhen all these markers are positive, it indicates a mixed lineage or a specific type of leukemia, which can affect treatment decisions — *ìpinnu ìtọ́jú*.\n</step6>\n<step7>\nThus, the presence of these markers suggests a complex immunophenotype that may require targeted therapies.\n</step7></thinking>", "answer": "<answer>Ìwádìí náà fi hàn pé àrùn ẹ̀jẹ̀ ẹ̀dùn náà jẹ́ àkúnya ẹ̀jẹ̀ àtọkànwá pẹ̀lú àfihàn CD19 rere, CD10 rere, CD33 rere, àti CD13 rere.</answer>", "language": "Yoruba"}
{"question": "Nígbàwo gan-an ni adehun náà dá sí láàrin Berg àti Jones lẹ́yìn tí Jones dáhùn pẹ̀lú ìbéèrè fún ìsanwó ní àwọn ìpinlẹ̀ sí ṣíwájú tí Berg ṣe láti ta ilẹ̀ fún $75,000?", "reasoning": "<thinking><step1>\nThe question asks: “Nígbàwo gan-an ni adehun náà dá sí láàrin [Berg] àti [Jones]?” — meaning it wants to know when the contract was formed between Berg and Jones after Jones responded to an offer regarding payment for land.\n</step1>\n<step2>\nIn this context, the contract formation depends on the acceptance of an offer — *ìfọwọ́si àdéhùn* — which in this case is Jones's response to Berg's offer to sell land for $75,000.\n</step2>\n<step3>\nAccording to contract law, an agreement is typically formed when one party accepts the terms proposed by another — *nígbà tí ẹni kan bá fọwọ́si àwọn àdéhùn*.\n</step3>\n<step4>\nIf Jones accepted Berg's offer, the contract would be effective immediately upon acceptance — *nígbà tí Jones bá fọwọ́si àdéhùn náà*.\n</step4>\n<step5>\nTherefore, the exact timing of the contract's formation would be the moment Jones communicated his acceptance to Berg — *nígbà tí Jones sọ pé ó gba*.\n</step6>\n<step7>\nIf there were no conditions or delays mentioned, we can conclude that the contract was formed at that moment of acceptance.\n</step7></thinking>", "answer": "<answer>Adehun náà dá sí láàrin Berg àti Jones nígbà tí Jones fọwọ́si àdéhùn náà.</answer>", "language": "Yoruba"}
{"question": "Ṣe iṣiro gbigbe ooru (q) ni Joules fun ìgbòòrò adiabatic ti eto kan tí ó ní 2.0 mol CO2(g), ní ìbẹ̀rẹ̀ ni 25°C ati 10 atm, tí a fi sí inú silinda kan tí apá rẹ̀ jẹ́ 10.0 cm², nígbà tí ó gbòòrò adiabatic lodi si titẹ́ òde oniṣẹ́ 1.0 atm ati piston náà sì gbé lọ sí ita nipasẹ 20 cm, ní ṣíṣe wípé gaasi kabọ́ni dioksidi náà ń hùwà bí gaasi pípé.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe iṣiro gbigbe ooru (q) ni Joules fun ìgbòòrò adiabatic” — meaning it wants to calculate the heat transfer (q) in Joules for an adiabatic expansion of a system with 2.0 mol of CO2(g) at an initial temperature of 25°C and pressure of 10 atm.\n</step1>\n<step2>\nIn an adiabatic process, there is no heat exchange with the surroundings — *ko si gbigbe ooru pẹlu ayika*. The gas expands and does work on the piston.\n</step2>\n<step3>\nUsing the ideal gas law, we can find the initial volume: *PV = nRT*. Here, P = 10 atm, n = 2.0 mol, R = 0.0821 L·atm/(K·mol), and T = 298 K (25°C).\n</step3>\n<step4>\nCalculating the initial volume, we find: *V = (nRT)/P = (2.0 mol * 0.0821 L·atm/(K·mol) * 298 K) / 10 atm* which gives us approximately 4.9 L.\n</step4>\n<step5>\nDuring the adiabatic expansion, the work done by the gas can be calculated using the formula: *W = PΔV*. The change in volume (ΔV) is the final volume minus the initial volume, where the final volume can be calculated based on the piston moving 20 cm.\n</step5>\n<step6>\nFinally, since the process is adiabatic, the heat transfer q is equal to the negative of the work done: *q = -W*. Thus, we can find the value of q in Joules.\n</step6></thinking>", "answer": "<answer>Iṣiro gbigbe ooru (q) ni Joules fun ìgbòòrò adiabatic jẹ́ -W, tí a ṣe iṣiro rẹ̀ láti iṣẹ́ tí gaasi ṣe.</answer>", "language": "Yoruba"}
{"question": "Nínú àpẹ̀ẹ́rẹ̀ obìnrin ọmọ ọdún 45 kan tí ó ní àwọn àmì àrùn ìrora ọkàn, pẹ̀lú pípadánù ìbẹ̀rù, àìnífẹ̀ẹ́ sí àwọn iṣẹ́, àti ìmọ̀lára pé ìgbàayé kò tọ́, báwo ni ìpínogún ìdùn REM, ìpínogún ìdùn delta, àti ìdákẹ́rẹ̀ REM ṣe yíyí pẹ̀lu àwọn àṣà ìdùn tí ó wọ́pọ̀?", "reasoning": "<thinking><step1>\nThe question asks about a 45-year-old woman experiencing symptoms of heart disease, including feelings of despair, loss of interest in activities, and a sense that life is not worth living. It inquires how REM sleep, delta sleep, and REM sleep cycles relate to common sleep patterns — *àpẹẹrẹ ìdùn*.\n</step1>\n<step2>\nREM sleep, or *ìdùn REM*, is crucial for emotional regulation and memory consolidation. In individuals with depression, like this woman, REM sleep can be disrupted — *ìdùn REM le yí padà*.\n</step2>\n<step3>\nDelta sleep, known as *ìdùn delta*, is the deepest stage of sleep, important for physical restoration. Lack of delta sleep can lead to increased fatigue and exacerbate depressive symptoms — *ìdùn delta ko to, ó le fa ìrora*.\n</step3>\n<step4>\nIn a typical sleep cycle, REM and delta sleep alternate, but in depressed individuals, this balance can be altered — *ìpínogún ìdùn le yí padà* leading to insufficient restorative sleep.\n</step4>\n<step5>\nThe common sleep patterns may show reduced time in delta sleep and altered REM cycles, which can worsen feelings of despair and lack of interest — *ìdùn REM le fa àìnífẹ̀ẹ́ sí àwọn iṣẹ́*.\n</step6>\n<step6>\nThus, the interplay between REM and delta sleep is significant in understanding the sleep disturbances in this woman, impacting her mental health — *ìdùn REM àti ìdùn delta ní ipa pataki*.\n</step7></thinking>", "answer": "<answer>Ìpínogún ìdùn REM àti ìdùn delta ní ipa pataki lórí ìlera ọkàn obìnrin yìí, nítorí pé àìlera wọn le fa ìrora àti àìnífẹ̀ẹ́ sí àwọn iṣẹ́.</answer>", "language": "Yoruba"}
{"question": "Ọna wo ni kan ṣoṣo ti a le fi ṣayẹwo ìwọ̀n suga ẹ̀jẹ̀ tó máa fi hàn bí ìwọ̀n suga ẹ̀jẹ̀ gbogbo rẹ̀ ti jẹ́ láàrin ọ̀sẹ̀ diẹ̀ sẹ́yìn fún obìnrin ọmọ ọdún 78 kan tó ní àrùn àtọ́ka suga ẹ̀jẹ̀ ìru keji, tí kò sì ti ṣe àyẹ̀wò ìwọ̀n suga ẹ̀jẹ̀ rẹ̀ déédéé?", "reasoning": "<thinking><step1>\nThe question asks: “Ọna wo ni kan ṣoṣo ti a le fi ṣayẹwo [ìwọ̀n suga ẹ̀jẹ̀ = blood sugar level]?” — specifically, it seeks to know the method to check the blood sugar level for a 78-year-old woman with type 2 diabetes who hasn't had her blood sugar checked recently.\n</step1>\n<step2>\nFor someone with type 2 diabetes, regular monitoring is crucial — *ìmúlò àyẹ̀wò suga ẹ̀jẹ̀ jẹ́ pataki*. The most common method is using a glucometer.\n</step2>\n<step3>\nA glucometer measures blood sugar levels quickly — *o n ṣe àyẹ̀wò ìwọ̀n suga ẹ̀jẹ̀ ni kiakia*. The patient pricks her finger to obtain a blood sample.\n</step3>\n<step4>\nThis method provides immediate results, which is essential for managing diabetes — *o ṣe pataki fun iṣakoso àtọ́ka suga ẹ̀jẹ̀*.\n</step5>\n<step5>\nAdditionally, for a more comprehensive view, a healthcare provider might recommend an A1C test — *àyẹ̀wò A1C* — which reflects average blood sugar levels over the past few months.\n</step6>\n<step6>\nIn summary, the best way to check her blood sugar level is through a glucometer for immediate results, and possibly an A1C test for a broader perspective.\n</step6></thinking>", "answer": "<answer>Ọna ti o dara julọ lati ṣayẹwo ìwọ̀n suga ẹ̀jẹ̀ rẹ̀ ni lilo glucometer, ati pe àyẹ̀wò A1C le jẹ́ afikun to wulo.</answer>", "language": "Yoruba"}
{"question": "Àsọ̀dà ìbaraẹnisọ̀rọ̀ láàrin àwọn àtẹ̀lé onírú ẹ̀rọ dípòlù meji (\\lambda/2) ni a dá sílẹ̀ pẹ̀lú agbègbè òkùnràn ọ̀fẹ́. Bí ẹ̀rọ gbigbe iránṣẹ̀ bá fi agbára 1 (kW) ránṣẹ́ sí àtẹ̀lé onírú ẹ̀rọ tí ń ránṣẹ́ náà, iye agbára wo ni ẹ̀rọ gbàgbà tí a so mọ́ àtẹ̀lé onírú ẹ̀rọ tí ń gbà náà yóò gbà ní 500 (km) láti ọ̀dọ̀ ẹ̀rọ tí ń ránṣẹ́ náà bí iye ìwọ̀n ìṣiṣẹ́ bá jẹ́ 200 (MHz)? Jẹ̀ ká gba pé ọ̀nà láàrin àwọn àtẹ̀lé dípòlù náà tọ́ka sí àtẹ̀lé dípòlù kọ̀ọ̀kan; ìyẹn ni pé, \\texttheta = 90°, àti pé àwọn àtẹ̀lé dípòlù náà wà ní ìlà.\nA. 7.85 × 10^-10 W\nB. 3.21 × 10^-11 W\nC. 1.53 × 10^-10 W\nD. 1.03 × 10^-10 W\nE. 5.67 × 10^-11 W\nF. 1.64 × 10^-10 W\nG. 2.05 × 10^-9 W\nH. 4.28 × 10^-11 W\nI. 9.42 × 10^-10 W\nJ. 2.53 × 10^-10 W", "reasoning": "<thinking><step1>\nThe question asks about the power received by a receiving antenna when a transmitting antenna sends a signal with a power of 1 kW over a distance of 500 km, using a dipole antenna configuration with a frequency of 200 MHz.\n</step1>\n<step2>\nTo find the received power, we can use the Friis transmission equation, which states that the power received is proportional to the power transmitted and inversely proportional to the square of the distance — *P_r = P_t * (G_t * G_r * λ^2) / (16 * π^2 * d^2)*.\n</step2>\n<step3>\nHere, *P_t* is the transmitted power (1 kW), *d* is the distance (500 km), and *λ* (wavelength) can be calculated using the frequency: *λ = c / f*, where *c* is the speed of light (approximately 3 × 10^8 m/s).\n</step3>\n<step4>\nCalculating the wavelength: *λ = 3 × 10^8 m/s / 200 × 10^6 Hz = 1.5 m*. Now we can substitute this into the equation.\n</step4>\n<step5>\nAssuming both antennas have a gain of 1 (for simplicity), we can calculate the received power: *P_r = 1000 W * (1 * 1 * (1.5 m)^2) / (16 * π^2 * (500,000 m)^2)*.\n</step5>\n<step6>\nAfter calculating, we find that the received power is approximately 1.03 × 10^-10 W, which corresponds to option D.\n</step6></thinking>", "answer": "<answer>1.03 × 10^-10 W</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin kan ti ó ní ilera, ọmọ ọdun mẹ́wàá, tí ó ṣèbẹ̀wò sí oko ní oṣù July, ni àrùn ibà, ikọ́, àti àrùn ẹ̀dọ̀fóró isalẹ̀ tí ó bá àrùn ẹ̀dọ̀fóró mu, ṣùgbọ́n kò ní àwọn àrùn ẹ̀dọ̀fóró oke, fún ọjọ́ márùn-ún. Àwọn ìwádìí nípa titẹ́ sí ọmú fi àrùn ẹ̀dọ̀fóró hàn, a sì ti ṣe àyẹ̀wò fọ́tóògíráfù àyà àti àyẹ̀wò ìtẹ̀gbẹ́ ìwọ̀n. Òògùn wo ni a ó lò ní àkọ́kọ́ láti tójú àrùn yìí?", "reasoning": "<thinking><step1>\nThe question is asking: “What medication should be used first to treat a child with [àrùn ẹ̀dọ̀fóró = lower respiratory infection] and [ikọ́ = cough]?” It specifies a 10-year-old boy who has been ill for five days with these symptoms.\n</step1>\n<step2>\nIn cases of lower respiratory infections, especially in children, it’s important to assess the severity of the symptoms — *a ṣe àyẹ̀wò ìlera* to determine the appropriate treatment.\n</step2>\n<step3>\nCommon treatments for lower respiratory infections include antibiotics if a bacterial infection is suspected — *òògùn àtọ́kànwá* — but if it’s viral, supportive care is key.\n</step3>\n<step4>\nFor cough relief, *òògùn ikọ́* like cough suppressants or expectorants may be used, depending on whether the cough is dry or productive.\n</step4>\n<step5>\nGiven that the child has been ill for five days, it’s crucial to monitor for any signs of complications — *a gbọdọ̀ ṣọ́ra fún àkúnya* that may require more aggressive treatment.\n</step5>\n<step6>\nIn this case, starting with a cough suppressant might be appropriate to ease discomfort while further evaluation continues — *a le bẹ̀rẹ̀ pẹ̀lú òògùn ikọ́*.\n</step6></thinking>", "answer": "<answer>Akọ́kọ́, a ó lò òògùn ikọ́ gẹ́gẹ́ bí ìtọ́jú fún àrùn ẹ̀dọ̀fóró yìí.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹta kan ti ó ní itan-akọọlẹ ìgbàgbọ́ àìsàn ẹ̀dùn-ọrùn (asthma) dé ẹ̀ka ìṣẹ̀ṣọ́ àkànṣe pẹ̀lú ikọ́, ìkùkùtù ẹ̀mí díẹ̀, àti ìdínkù sí àwọn ohun tí a gbọ́ nígbà tí a gbọ́ ẹ̀mí rẹ̀, pẹ̀lú ìfọ́ ẹ̀mí díẹ̀ ní apá ọ̀tun ẹ̀dùn-ọrùn rẹ̀.  Àwọn àwòrán X-ray àyẹ̀wò ẹ̀dùn-ọrùn fi hàn pé apá ọ̀tun ẹ̀dùn-ọrùn rẹ̀ ràn jù lọ, pẹ̀lú ìdínkù sí àwọn àmì ẹ̀dùn-ọrùn.  Nígbà tí a bá gbé àwọn nǹkan wọ̀nyí yèwo, kí ni ìgbésẹ̀ tó tọ́ jùlọ tí a gbọ́dọ̀ gbé láti ṣe ìtọ́jú rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: \"What is the best step to take for a three-year-old boy with a history of [ìgbàgbọ́ àìsàn ẹ̀dùn-ọrùn = asthma] who presents with cough, slight shortness of breath, and decreased breath sounds on the right lung?\" \n</step1>\n<step2>\nThis child shows signs of an asthma exacerbation, indicated by *ìkùkùtù ẹ̀mí díẹ̀* and *ìdínkù sí àwọn ohun tí a gbọ́* — meaning he has difficulty breathing and reduced lung sounds.\n</step2>\n<step3>\nThe X-ray findings suggest that the right lung is more affected, which could indicate *ìdínkù sí àwọn àmì ẹ̀dùn-ọrùn* — a decrease in asthma symptoms or possibly an infection.\n</step3>\n<step4>\nIn such cases, the immediate step is to assess the severity of the asthma attack — *ìtẹ́numọ́ àkúnya àìsàn* — and determine if the child needs urgent treatment.\n</step4>\n<step5>\nTypically, administering a bronchodilator like *albuterol* is crucial to relieve bronchospasm and improve airflow — *ìmúra ẹ̀dùn-ọrùn*.\n</step5>\n<step6>\nIf the child does not improve quickly, further evaluation and possibly systemic corticosteroids may be necessary to reduce inflammation — *ìdínkù àkúnya*.\n</step6>\n<step7>\nThus, the best immediate action is to provide a bronchodilator and monitor the child's response closely.\n</step7></thinking>", "answer": "<answer>Ìgbésẹ̀ tó tọ́ jùlọ ni láti fi bronchodilator ranṣẹ́ sí i, kí a sì tọ́pa ìdáhùn rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Fi ẹ̀yìn jùlọ àwọn ẹ̀rọ̀ àkọ́kọ́ yìí, kí o sì rí i dájú pé àwọn àkọ́kọ́ yìí ti wà ní ìtẹ́lọ́rùn.  Àkọ́kọ́: [ < > ] [ { < { } > { [ ( [ ( ) ] ) ]", "reasoning": "<thinking><step1>\nThe question translates to: \"After these primary devices, ensure that these devices are in good condition.\" It seems to be asking about the maintenance or checking of primary devices.\n</step1>\n<step2>\nIn this context, \"primary devices\" could refer to essential tools or equipment used in a specific field — *ẹ̀rọ̀ àkọ́kọ́* could mean foundational tools in technology or healthcare.\n</step2>\n<step3>\nTo ensure these devices are in good condition, one must perform regular checks — *ṣe àyẹ̀wò àkókò* — to identify any issues.\n</step3>\n<step4>\nCommon maintenance tasks include cleaning, testing functionality, and replacing worn parts — *mú un kó, ṣe àyẹ̀wò iṣẹ́, àti rọ́pò àwọn apá tó ti wọ́*.\n</step4>\n<step5>\nDocumentation of maintenance activities is also crucial — *ìkọ̀wé àwọn iṣẹ́ àtúnṣe* helps track the condition over time.\n</step5>\n<step6>\nFinally, it's important to follow manufacturer guidelines for each device — *tẹ̀lé àwọn ìtọnisọna olùṣelọpọ* to ensure optimal performance.\n</step6></thinking>", "answer": "<answer>Rí i dájú pé àwọn ẹ̀rọ̀ àkọ́kọ́ wà ní ìtẹ́lọ́rùn nípa ṣiṣe àyẹ̀wò àkókò, mímú un kó, àti tẹ̀lé àwọn ìtọnisọna olùṣelọpọ.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹta kan ni iya rẹ̀ mú wá sọ́dọ̀ oníṣègùn ọmọdé nígbà tí ara rẹ̀ di pupa, ó sì ń jó, ó sì ń korò, ó sì ní irora gidigidi ní gbogbo apá rẹ̀, ẹsẹ̀ isalẹ̀ rẹ̀, ọrùn rẹ̀ àti ojú rẹ̀. Ìyá rẹ̀ sọ pé ó ṣẹ̀ṣẹ̀ bẹ̀rẹ̀ sí í mú un lọ sí ibi ìdáná ìwòsí ní ààlà ọ̀sán. Ó jẹ́ ká mọ̀ pé ó fi ọ̀pọ̀lọpọ̀ sunscreeen sí ara rẹ̀ ṣáájú àti nígbà tí wọ́n wà ní ìta. Ó sọ pé wọ́n wà ní ibi ìdáná ìwòsí fún iṣẹ́jú 30 sí wakati kan ní ojoojumọ fún ọjọ́ mẹta tó kọjá. Ọmọ náà ti ní àwọn àkókò ṣíṣeé rí tí ara rẹ̀ ń di pupa àti irora lẹ́yìn tí ó ti wà ní ìta, ṣùgbọ́n wọ́n kéré sí i, wọ́n sì dára lẹ́yìn wakati 12. Ó sọ pé bí ara rẹ̀ ṣe rí nísinsìnyí burú jùlọ, ó sì ní irora tó burú jù lọ ju ti tẹ́lẹ̀ lọ. Àwọn àmì ìlera ọmọ náà jẹ́: T 37.2 C, HR 98, BP 110/62, RR 16, àti SpO2 99%. Ìwádìí ara fi hàn pé omi ń tú sí ara rẹ̀, ara rẹ̀ di pupa, àti petechiae lórí ojú rẹ̀, ọrùn rẹ̀, apá rẹ̀, àti ẹsẹ̀ isalẹ̀ rẹ̀. Kò sí ìbàkíbákì tàbí ìṣòfò lórí ara rẹ̀. Ẹ̀yà wo nínú àwọn wọ̀nyí ni àṣàyàn ìtọ́jú tí ó dára jùlọ fún àìsàn ọmọ yìí?\nA. Gba imọ̀ràn nípa lílo sunscreen tó ga lórí SPF\nB. Bẹ̀rẹ̀ sí í dín dexamethasone\nC. Bẹ̀rẹ̀ sí í ṣe therapeutic phlebotomy\nD. Bẹ̀rẹ̀ sí í fi beta carotene sí ara rẹ̀\nE. Fà á chloroquine", "reasoning": "<thinking><step1>\nThe question describes a three-year-old boy who has developed a rash, fever, and pain after being exposed to the sun for an extended period. The mother reports that he has used a lot of sunscreen before and during their time outside.\n</step1>\n<step2>\nThe symptoms include *ara rẹ̀ di pupa* (skin turning red), *irora gidigidi* (severe pain), and *petichiae* (small red or purple spots) on his face, neck, arms, and legs. This suggests a possible allergic reaction or sunburn.\n</step2>\n<step3>\nGiven that he has been outside for 30 minutes to an hour daily for three days, and his symptoms have worsened, it indicates a significant reaction to sun exposure — *ìdáná ìwòsí* (sun exposure).\n</step3>\n<step4>\nThe vital signs show a mild fever (T 37.2 C) and stable heart rate and oxygen saturation, which means he is not in immediate danger but requires treatment for his skin condition.\n</step4>\n<step5>\nAmong the options, starting *dexamethasone* (a corticosteroid) could help reduce inflammation and manage the rash effectively, especially if it is an allergic reaction.\n</step5>\n<step6>\nOther options like *therapeutic phlebotomy* or *chloroquine* are not appropriate for this scenario, as they do not address the immediate symptoms of sun exposure.\n</step6>\n<step7>\nTherefore, the best choice for treatment in this case is to begin *dexamethasone* to alleviate the symptoms and prevent further complications.\n</step7></thinking>", "answer": "<answer>B. Bẹ̀rẹ̀ sí í dín dexamethasone.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 75 kan fi ara rẹ̀ hàn ọsẹ̀ mẹfa lẹhin ìṣẹlẹ̀ aisan ọkan (myocardial infarction) pẹlu àìlera ọkan tí ó rọ̀rùn (mild congestive heart failure). Ó ti ṣe abẹrẹ ọrùn fun àrùn parathyroid adenoma ọdun marun sẹyin. ECG rẹ̀ fihan afibrillation atrial tí ó lọra, ati pe calcium ninu ẹ̀jẹ̀ rẹ̀ jẹ 13.0 mg/dL pẹlu ìgbàgbọ́ calcium ninu ito rẹ̀ ti 300 mg/24h.  Ninu àyẹ̀wò, ìṣú kan tí ó kéré wà ni ipo paratracheal lẹhin clavicle ọtun.  Kini itọju ti o yẹ fun alaisan yii ni akoko yii?", "reasoning": "<thinking><step1>\nThe question asks about the appropriate treatment for a 75-year-old patient who presented six weeks after a myocardial infarction with mild congestive heart failure. Key terms include [myocardial infarction = aisan ọkan] and [congestive heart failure = àìlera ọkan].\n</step1>\n<step2>\nThis patient has a history of parathyroid adenoma surgery five years ago, which is relevant because it may affect calcium metabolism — *metabolism calcium*.\n</step2>\n<step3>\nThe ECG shows slow atrial fibrillation, which can complicate heart failure management — *afibrillation atrial* is a concern for this patient.\n</step3>\n<step4>\nThe elevated calcium level at 13.0 mg/dL indicates possible hypercalcemia, which can exacerbate heart failure symptoms — *hypercalcemia* can lead to increased cardiac workload.\n</step4>\n<step5>\nGiven the presence of a paratracheal mass, further evaluation is necessary to rule out malignancy or other complications — *ayẹwo siwaju* is crucial in this scenario.\n</step6>\n<step6>\nThe treatment should focus on managing heart failure and addressing hypercalcemia, possibly with diuretics and bisphosphonates — *diuretics* can help reduce fluid overload.\n</step7>\n<step7>\nAdditionally, anticoagulation may be necessary for atrial fibrillation to prevent thromboembolic events — *anticoagulation* is important in this context.\n</step8>\n<step8>\nIn summary, the patient requires a comprehensive approach to manage heart failure, hypercalcemia, and atrial fibrillation.\n</step8></thinking>", "answer": "<answer>Itọju ti o yẹ ni diuretics, bisphosphonates, ati anticoagulation fun afibrillation atrial.</answer>", "language": "Yoruba"}
{"question": "Àpọnà kan fi àìtóògùn ọgbọ́n ìgbá-alágbàà tó sì ní irúgbìn ìgbóná lórí ìhà apá òsì ọwọ́ rẹ̀ lé lórí ọdún mẹ́ta lẹ́yìn tí ó bá ara rẹ̀ jẹ́ lára ní apá òkè. Irú ìpalára wo ni àwọn àmì wọ̀nyí ṣe fi hàn gangan?", "reasoning": "<thinking><step1>\nThe question asks: “Àpọnà kan fi àìtóògùn ọgbọ́n ìgbá-alágbàà tó sì ní irúgbìn ìgbóná lórí ìhà apá òsì ọwọ́ rẹ̀ lé lórí ọdún mẹ́ta lẹ́yìn tí ó bá ara rẹ̀ jẹ́ lára ní apá òkè?” — meaning it wants to know what specific injuries or conditions are indicated by these symptoms.\n</step1>\n<step2>\nThe symptoms described suggest a chronic condition, possibly related to *l'arthrite* or *l'arthrose*, which can cause pain and swelling in the joints.\n</step2>\n<step3>\nThe mention of *irúgbìn ìgbóná* (hot sensation) could indicate inflammation — *l'inflammation* — which is common in joint disorders.\n</step4>\n<step4>\nIn English, we might say that the patient experiences *douleur* (pain) and *raideur* (stiffness) in the affected area, particularly after periods of inactivity.\n</step5>\n<step5>\nAdditionally, the fact that these symptoms have persisted for three years suggests a long-term degenerative process, possibly leading to *la déformation* of the joint.\n</step6>\n<step6>\nThus, the signs point towards a chronic joint condition, likely *l'arthrite* ou *l'arthrose*, characterized by pain, swelling, and reduced mobility.\n</step6></thinking>", "answer": "<answer>Àwọn àmì wọ̀nyí ṣe fi hàn pé irú ìpalára kan ni àìtóògùn ọgbọ́n ìgbá-alágbàà, gẹ́gẹ́ bí àpẹẹrẹ, arthrite tàbí arthrose.</answer>", "language": "Yoruba"}
{"question": "Kini okunfa ti o lagbara julọ ti o le fa arun inu-ara-ara cervix ti iwọn giga ni obinrin ọdun 32 kan ti o ni aarun polycystic ovary syndrome, ti o bẹrẹ ibalopọ ni ọjọ-ori ọdun 14, ti o ni BMI ti 29 kg/m2, ati itan-iṣẹ-ẹbi aarun oyinbo?", "reasoning": "<thinking><step1>\nThe question asks: “Kini okunfa ti o lagbara julọ ti o le fa arun inu-ara-ara cervix?” — meaning it wants to know the strongest risk factor for cervical cancer in a 32-year-old woman with specific health conditions.\n</step1>\n<step2>\nCervical cancer is often linked to human papillomavirus (HPV) infection — *arun HPV* — which is a major risk factor.\n</step2>\n<step3>\nIn this case, the woman has polycystic ovary syndrome (PCOS) — *arun polycystic ovary* — which can influence hormonal balance and may increase cancer risk.\n</step3>\n<step4>\nStarting sexual activity at a young age, like 14, can also elevate the risk of HPV exposure — *ibẹrẹ ibalopọ ni ọjọ-ori kekere*.\n</step4>\n<step5>\nHer BMI of 29 kg/m2 indicates she is overweight, which is another potential risk factor for various cancers, including cervical cancer — *BMI ti o ga le fa arun*.\n</step5>\n<step6>\nAdditionally, a family history of cancer — *itan-iṣẹ-ẹbi aarun oyinbo* — can further increase her risk.\n</step6>\n<step7>\nConsidering all these factors, the strongest risk factor here is likely the HPV infection, especially given her early sexual activity.\n</step7></thinking>", "answer": "<answer>Okunfa ti o lagbara julọ ni arun HPV, paapaa pẹlu ibẹrẹ ibalopọ ni ọjọ-ori ọdun 14.</answer>", "language": "Yoruba"}
{"question": "Egbogi wo ni a lo gege bi itọju akọkọ fun arun reflux gastroesophageal, ṣugbọn ko ṣe alekun agbara isunmọ sphincter esophageal isalẹ tabi ko ṣe idiwọ reflux gastroesophageal?", "reasoning": "<thinking><step1>\nThe question asks: “Egbogi wo ni a lo gege bi itọju akọkọ fun [arun reflux gastroesophageal = gastroesophageal reflux disease (GERD)], ṣugbọn ko ṣe alekun agbara [isunmọ sphincter esophageal isalẹ = lower esophageal sphincter (LES)] tabi ko ṣe idiwọ reflux gastroesophageal?” — meaning it seeks to identify the first-line treatment for GERD that does not enhance LES pressure or prevent reflux.\n</step1>\n<step2>\nFirst, it’s important to note that GERD is often treated with medications that reduce stomach acid — *awọn oogun ti o dinku acid inu ikun*.\n</step2>\n<step3>\nThe primary treatment for GERD typically involves proton pump inhibitors (PPIs) — *awọn olutọju proton pump* — which decrease acid production without directly affecting the LES.\n</step3>\n<step4>\nWhile PPIs are effective in managing symptoms, they do not strengthen the LES or prevent reflux itself — *wọn ko mu ki isunmọ sphincter esophageal isalẹ lagbara*.\n</step4>\n<step5>\nOther options like H2 receptor antagonists may also be used, but they similarly do not enhance LES function — *wọn ko tun mu iṣẹ isunmọ sphincter pọ si*.\n</step6>\n<step6>\nThus, the first-line treatment for GERD that does not increase LES pressure or prevent reflux is primarily the use of PPIs.\n</step6></thinking>", "answer": "<answer>Itọju akọkọ fun arun reflux gastroesophageal ni lilo awọn olutọju proton pump (PPIs) ti ko mu ki isunmọ sphincter esophageal isalẹ lagbara.</answer>", "language": "Yoruba"}
{"question": "Alisi, Bobu, Klea, Deifu, Ifi, Fred, ati Gertude nṣere ere kan. Ni ibẹrẹ ere naa, wọn kòkòrò bọ́ọ̀lù kan: Alisi ni bọ́ọ̀lù alawọ ewe, Bobu ni bọ́ọ̀lù alawọ pupa, Klea ni bọ́ọ̀lù alẹ́wà, Deifu ni bọ́ọ̀lù ofeefee, Ifi ni bọ́ọ̀lù funfun, Fred ni bọ́ọ̀lù pupa, ati Gertude ni bọ́ọ̀lù awọ san.\nBi ere naa ti nlọ siwaju, awọn tọkọtaya ti awọn ẹrọ orin ṣe paṣipaarọ awọn bọ́ọ̀lù. Ni akọkọ, Ifi ati Deifu ṣe paṣipaarọ awọn bọ́ọ̀lù. Lẹhinna, Klea ati Ifi ṣe paṣipaarọ awọn bọ́ọ̀lù. Lẹhinna, Deifu ati Klea ṣe paṣipaarọ awọn bọ́ọ̀lù. Lẹhinna, Bobu ati Fred ṣe paṣipaarọ awọn bọ́ọ̀lù. Lẹhinna, Fred ati Deifu ṣe paṣipaarọ awọn bọ́ọ̀lù. Lẹhinna, Ifi ati Alisi ṣe paṣipaarọ awọn bọ́ọ̀lù. Nikẹhin, Deifu ati Gertude ṣe paṣipaarọ awọn bọ́ọ̀lù. Ni opin ere naa, Ifi ni\nAwọn aṣayan:\n(A) bọ́ọ̀lù alawọ ewe\n(B) bọ́ọ̀lù alawọ pupa\n(C) bọ́ọ̀lù alẹ́wà\n(D) bọ́ọ̀lù ofeefee\n(E) bọ́ọ̀lù funfun\n(F) bọ́ọ̀lù pupa\n(G) bọ́ọ̀lù awọ san", "reasoning": "<thinking><step1>\nThe question describes a game involving players Alisi, Bobu, Klea, Deifu, Ifi, Fred, and Gertude, each starting with a different colored ball. It asks what ball Ifi has at the end of the game.\n</step1>\n<step2>\nInitially, Ifi has a *bọ́ọ̀lù funfun* (white ball). The players exchange balls multiple times throughout the game.\n</step2>\n<step3>\nFirst, Ifi and Deifu exchange balls. Deifu has a *bọ́ọ̀lù ofeefee* (yellow ball), so now Ifi has that ball.\n</step3>\n<step4>\nNext, Klea and Ifi exchange balls. Klea has a *bọ́ọ̀lù alẹ́wà* (beautiful ball), so Ifi now has the *bọ́ọ̀lù alẹ́wà*.\n</step4>\n<step5>\nThen, Deifu and Klea exchange balls. Deifu now takes the *bọ́ọ̀lù alẹ́wà*, and Klea gets back the *bọ́ọ̀lù ofeefee*.\n</step5>\n<step6>\nAfter that, Bobu and Fred exchange balls. Bobu has a *bọ́ọ̀lù alawọ pupa* (red ball), and Fred has a *bọ́ọ̀lù pupa* (red ball), but this does not affect Ifi.\n</step6>\n<step7>\nNext, Fred and Deifu exchange balls. Fred gives Deifu his *bọ́ọ̀lù pupa*, but again, this does not affect Ifi.\n</step7>\n<step8>\nThen, Ifi and Alisi exchange balls. Alisi has a *bọ́ọ̀lù alawọ ewe* (green ball), so Ifi now has the *bọ́ọ̀lù alawọ ewe*.\n</step8>\n<step9>\nFinally, Deifu and Gertude exchange balls. This last exchange does not involve Ifi, so he retains the *bọ́ọ̀lù alawọ ewe*.\n</step9></thinking>", "answer": "<answer>Ifi ni bọ́ọ̀lù alawọ ewe.</answer>", "language": "Yoruba"}
{"question": "((5 - 6 - 7 + 6) - (-1 - 1 * -7 + 9)) =", "reasoning": "<thinking><step1>\nThe question asks to solve the expression: “((5 - 6 - 7 + 6) - (-1 - 1 * -7 + 9))” — we need to simplify this step by step.\n</step1>\n<step2>\nFirst, let's simplify the inner expression: *5 - 6 - 7 + 6*. \nCalculating this, we have: *5 - 6 = -1*, then *-1 - 7 = -8*, and finally *-8 + 6 = -2*.\n</step2>\n<step3>\nNow, we move to the second part: *-1 - 1 * -7 + 9*. \nHere, we first handle the multiplication: *1 * -7 = -7*, so it becomes *-1 - (-7) + 9*.\n</step3>\n<step4>\nThis simplifies to: *-1 + 7 + 9*. \nCalculating this gives us: *-1 + 7 = 6*, and then *6 + 9 = 15*.\n</step4>\n<step5>\nNow we substitute back into the main expression: *(-2 - 15)*. \nThis results in: *-2 - 15 = -17*.\n</step5></thinking>", "answer": "<answer>-17</answer>", "language": "Yoruba"}
{"question": "Àpọn ọ̀tọ̀ kan tí a ń tọ́jú fún àrùn leukemia ní ìrora ẹ̀gbẹ̀ kan ṣoṣo. Àwọn ìwádìí onímọ̀-ẹ̀rọ̀ fi hàn pé àpò ìṣan-èrè pẹ̀lú ìgbàgbọ́ òkè-nǹkan ẹ̀yọ́ ìṣan-èrè náà ti fẹ̀. Irú òkúta wo ni ó ṣeé ṣe jùlọ láti fa ìdènà yìí nípa ti ọ̀rọ̀ àrùn yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Àpọn ọ̀tọ̀ kan tí a ń tọ́jú fún àrùn leukemia” — meaning it is inquiring about a specific treatment for leukemia.\n</step1>\n<step2>\nLeukemia is a type of cancer that affects the blood and bone marrow — *àrùn kan tó ní ipa lórí ẹ̀jẹ̀ àti ẹ̀dá-ara*.\n</step2>\n<step3>\nOne common treatment is chemotherapy, which uses drugs to kill cancer cells — *ìtọju pẹ̀lú kemotherapi*.\n</step3>\n<step4>\nHowever, the question mentions “ìrora ẹ̀gbẹ̀ kan ṣoṣo,” indicating a focus on pain management related to a specific area.\n</step4>\n<step5>\nIn this context, pain can be managed with medications like opioids or non-steroidal anti-inflammatory drugs (NSAIDs) — *àwọn oogun bi opioids tàbí NSAIDs*.\n</step6>\n<step6>\nThe question also refers to “ìgbàgbọ́ òkè-nǹkan,” which suggests the use of alternative therapies or holistic approaches to support treatment.\n</step7>\n<step7>\nThus, the most likely stone or method to alleviate this blockage in terms of leukemia treatment could involve a combination of conventional pain relief and supportive therapies — *ìtọju pẹ̀lú àpọn àtìlẹyìn*.\n</step8>\n<step8>\nIn summary, managing pain in leukemia often requires a multifaceted approach, integrating both medical and alternative strategies.\n</step9></thinking>", "answer": "<answer>Ìtọju àrùn leukemia ní ìrora ẹ̀gbẹ̀ kan ṣoṣo le ní àpọn kemotherapi pẹ̀lú àtìlẹyìn àtọkànwá.</answer>", "language": "Yoruba"}
{"question": "Kini glycoprotein agbegbe ti o maa n han julọ ninu awọn sẹẹli aboyun hematopoietic eniyan?", "reasoning": "<thinking><step1>\nThe question asks: “Kini [glycoprotein = glycoprotein] agbegbe ti o maa n han julọ ninu [sẹẹli aboyun hematopoietic = human hematopoietic cells]?” — meaning it wants to know which glycoprotein is most commonly expressed in human hematopoietic cells.\n</step1>\n<step2>\nIn human hematopoietic cells, the most prominent glycoprotein is often *CD34*. This protein plays a crucial role in cell adhesion and is a marker for hematopoietic stem cells.\n</step2>\n<step3>\n*CD34* is essential for the identification of stem cells in *ilana iṣe-ara* (stem cell therapy) and is used in clinical settings for transplantation.\n</step3>\n<step4>\nThis glycoprotein is involved in the interaction between stem cells and the bone marrow microenvironment — *ilana ibaraenisepo*.\n</step4>\n<step5>\nAdditionally, *CD34* expression can be used to assess the purity of stem cell populations in research and therapeutic applications.\n</step5>\n<step6>\nThus, the glycoprotein that is most commonly found in human hematopoietic cells is *CD34*.\n</step6></thinking>", "answer": "<answer>Glycoprotein ti o maa n han julọ ninu awọn sẹẹli aboyun hematopoietic eniyan ni *CD34*.</answer>", "language": "Yoruba"}
{"question": "Àpọǹ lára tí ó ní àrùn Kòrókòrò tí kò lè tọ́jú pẹ̀lú oògùn gbogbo, ó wà lórí oògùn ìtọ́jú Kòrókòrò. Lẹ́yìn oṣù díẹ̀, ó ní àìrírí àwọ̀ pupa àti alawọ̀ ewe. Oògùn tí ó ṣeé ṣe jùlọ tí ó fa àmì ìyàrá yìí ni:\nA. Rifampicin\nB. Ethambutol\nC. Isoniazid\nD. Streptomycin", "reasoning": "<thinking><step1>\nThe question is asking about a patient with [Kòrókòrò = tuberculosis] who cannot be treated with all medications and has developed symptoms like [àìrírí àwọ̀ pupa = red discoloration] and [alawọ̀ ewe = greenish discoloration] after a few months.\n</step1>\n<step2>\nIn tuberculosis treatment, certain medications can cause side effects, including changes in skin color — *changement de couleur de la peau*.\n</step2>\n<step3>\nRifampicin is known to cause reddish discoloration of body fluids, which could explain the *àìrírí àwọ̀ pupa*.\n</step3>\n<step4>\nEthambutol can lead to vision problems but is less likely to cause skin discoloration — *il est moins probable qu'il provoque une décoloration de la peau*.\n</step5>\n<step5>\nIsoniazid is effective but typically does not cause these specific symptoms; it’s more associated with liver toxicity — *toxicité hépatique*.\n</step6>\n<step6>\nStreptomycin is an aminoglycoside that can cause ototoxicity but not skin discoloration — *il ne provoque pas de décoloration de la peau*.\n</step7>\n<step7>\nGiven the symptoms, the most likely medication causing the red discoloration is Rifampicin — *Rifampicine est le médicament le plus probable*.\n</step7></thinking>", "answer": "<answer>Rifampicin ni oògùn tí ó fa àmì ìyàrá yìí.</answer>", "language": "Yoruba"}
{"question": "Ní ọmọ tuntun tí kò ní àrùn hypoglycemia, ìtọ́jú lójú ẹsẹ̀ yóò ní ẹ̀yà wo nínú àwọn wọ̀nyí?\nA. 100 mg/kg Dextrose\nB. 2 mg/kg 10% Dextrose\nC. 2 ml/kg 25% Dextrose\nD. Kò sí", "reasoning": "<thinking><step1>\nThe question asks: “Ní ọmọ tuntun tí kò ní àrùn [hypoglycemia = hypoglycemia], ìtọ́jú lójú ẹsẹ̀ yóò ní ẹ̀yà wo nínú àwọn wọ̀nyí?” — meaning it wants to know which treatment is appropriate for a newborn without hypoglycemia.\n</step1>\n<step2>\nIn this context, *ìtọ́jú lójú ẹsẹ̀* refers to intravenous treatment options for a newborn. Since the baby does not have hypoglycemia, we need to consider the safety and appropriateness of the options provided.\n</step2>\n<step3>\nOption A, *100 mg/kg Dextrose*, is a high dose and typically used for treating hypoglycemia, which is not applicable here.\n</step3>\n<step4>\nOption B, *2 mg/kg 10% Dextrose*, is also a treatment for hypoglycemia but may not be necessary for a healthy newborn.\n</step4>\n<step5>\nOption C, *2 ml/kg 25% Dextrose*, is a concentrated solution and could be risky if the baby does not need it, as it might lead to hyperglycemia.\n</step5>\n<step6>\nFinally, option D, *Kò sí*, suggests that no treatment is needed, which aligns with the fact that the newborn does not have hypoglycemia.\n</step6>\n<step7>\nThus, the most appropriate answer is that no treatment is necessary for a newborn without hypoglycemia.\n</step7></thinking>", "answer": "<answer>Kò sí.</answer>", "language": "Yoruba"}
{"question": "Ní ipò tí ọ̀daràn kan ti fọ́ ọmọ̀wé rẹ̀ ní àìfẹ́, nítorí pé a sọ̀rọ̀ òtítọ́ fún un pé àgbàlà náà ò ní ìbọn, tí a sì gbé ìlànà kan kalẹ̀ pé ikú ènìyàn ní ìgbà àkọ́kọ́ ni ìkọ̀lù ni fífẹ́ pa ẹni tí a bá ṣe ètò sí, nípa ìmọ̀kòkòrò ṣíṣe burúkú, ikú ènìyàn ní ìgbà kejì ni ìkọ̀lù nígbà tí ẹ̀ṣẹ̀ tí ó lewu ń ṣẹlẹ̀, àti ikú ènìyàn nípa àìṣe tó yẹ ni gbogbo irú ikú ènìyàn tí kò bá tọ́ sí miiran, ohun tí àjọjú yóò dá ọ̀daràn náà lẹ́bi rẹ̀ ni bí àjọjú bá gbàgbọ́ ẹ̀rí rẹ̀ pé kò mọ̀ pé àgbàlà náà ní ìbọn?", "reasoning": "<thinking><step1>\nThe question is asking about the legal implications for a doctor who has harmed a patient, specifically regarding the circumstances of the harm and the evidence of intent — *àjọjú yóò dá ọ̀daràn náà lẹ́bi rẹ̀* if they believe the doctor was unaware of the weapon.\n</step1>\n<step2>\nIn this case, the doctor is accused of causing harm to a patient due to negligence — *ìmọ̀kòkòrò ṣíṣe burúkú* — which means failing to act with the appropriate standard of care.\n</step2>\n<step3>\nThe law typically requires proof of intent or negligence to establish liability — *ìdájọ́* — in cases of medical malpractice.\n</step3>\n<step4>\nIf the doctor can demonstrate that they had no knowledge of the weapon, it may mitigate their responsibility — *kò mọ̀ pé àgbàlà náà ní ìbọn* could be a key defense.\n</step4>\n<step5>\nHowever, if it is found that the doctor should have known about the risks involved, they may still be held liable for the consequences — *ikú ènìyàn ní ìgbà àkọ́kọ́ ni ìkọ̀lù*.\n</step5>\n<step6>\nUltimately, the outcome will depend on the evidence presented and the interpretation of negligence by the court — *àjọjú* will weigh the facts carefully.\n</step6></thinking>", "answer": "<answer>Àjọjú yóò dá ọ̀daràn náà lẹ́bi rẹ̀ ti a bá rí i pé ó ní àìmọ̀ nípa ìbọn, ṣùgbọ́n ti a bá rí i pé ó yẹ kí ó mọ̀, ó lè jẹ́ ẹ̀bi.</answer>", "language": "Yoruba"}
{"question": "Kini ọ̀nà àyẹ̀wò tó gbẹ́ṣẹ̀ jùlọ láti yàtọ̀ sí ara wọn láàrin ìdààmú ìgbàgbọ́ irúgbìn àti ìgbóná ìgbàgbọ́ àti ẹ̀gbà irúgbìn nínú ọkùnrin kan tó ní ìrora ìgbàgbọ́ tó léwu?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ọ̀nà àyẹ̀wò tó gbẹ́ṣẹ̀ jùlọ láti yàtọ̀ sí ara wọn láàrin ìdààmú ìgbàgbọ́ irúgbìn [fungal infection] àti ìgbóná ìgbàgbọ́ [bacterial infection] àti ẹ̀gbà irúgbìn [fungal allergy] nínú ọkùnrin kan tó ní ìrora ìgbàgbọ́ tó léwu?” — meaning it seeks to identify the best method to differentiate between these conditions in a man with severe pain.\n</step1>\n<step2>\nTo distinguish between a fungal infection and a bacterial infection, one must consider symptoms — *àwọn aami* such as redness, swelling, and discharge.\n</step2>\n<step3>\nA fungal infection often presents with *ìfarapa* that is itchy and may have a characteristic odor, while a bacterial infection typically shows more pronounced *ìkó* and pus formation.\n</step3>\n<step4>\nTesting methods include laboratory cultures — *ìdánwò àkópọ̀* — where samples from the affected area are analyzed to identify the pathogen.\n</step4>\n<step5>\nFor a fungal allergy, skin tests — *ìdánwò awọ* — can help determine sensitivity to specific fungi, which is crucial for diagnosis.\n</step5>\n<step6>\nIn summary, the best approach involves a combination of clinical evaluation and laboratory testing to accurately differentiate these conditions.\n</step6></thinking>", "answer": "<answer>Ọ̀nà àyẹ̀wò tó gbẹ́ṣẹ̀ jùlọ ni ìdánwò àkópọ̀ àti ìdánwò awọ.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun 49 kan wà pẹlu àwọn àmì àrùn bíi ìgbà ìgbẹ̀rùn tí ó kúrú sí i ati tí kò pọ̀ mọ, ìyípadà ìṣe-ìmọ̀lára, ìdinku ìwúwo, ati ìgbona orúkọ.  Nígbà tí a bá gbé àwọn àmì àrùn rẹ̀ àti àìsí àwọn àìṣedeede lórí ṣíṣayẹ̀wò ara rẹ̀ yẹ̀wò, ìwádìí ilé-ìṣèwò wo ni ó yẹ kí a ṣe láti ṣàyẹ̀wò àrùn endocrine tí ó lè wà nínú rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks about a 49-year-old woman presenting with symptoms like *ìgbà ìgbẹ̀rùn tí ó kúrú sí i* [shortened menstrual periods], *ìyípadà ìṣe-ìmọ̀lára* [mood changes], *ìdinku ìwúwo* [weight loss], and *ìgbona orúkọ* [hot flashes]. It seeks to identify which endocrine disorder investigations should be conducted.\n</step1>\n<step2>\nGiven her age and symptoms, one potential condition to consider is *ìyàlẹ́nu menopause* [perimenopause], which can cause hormonal fluctuations leading to these signs.\n</step2>\n<step3>\nAnother possibility is *hypothyroidism* or *hyperthyroidism*, as thyroid disorders can also lead to weight changes and mood alterations — *àìlera àtọ́kànwá*.\n</step3>\n<step4>\nTo investigate these conditions, we should start with blood tests to check hormone levels, including *TSH* [Thyroid Stimulating Hormone] and *free T4* [free thyroxine].\n</step4>\n<step5>\nAdditionally, measuring *estradiol* and *FSH* [Follicle Stimulating Hormone] can help assess ovarian function and confirm if she is in menopause.\n</step5>\n<step6>\nFinally, a comprehensive metabolic panel could provide insights into other potential endocrine issues, such as *àìlera àtọ́kànwá* or adrenal gland disorders.\n</step6></thinking>", "answer": "<answer>Àwọn ìwádìí ilé-ìṣèwò tó yẹ ni: ìdánwò ẹ̀jẹ̀ fún TSH, free T4, estradiol, àti FSH.</answer>", "language": "Yoruba"}
{"question": "Irú àpáàlà immunológico wo ni a mọ̀ fún àwọn àmì bíi ìgbòòrò ara gbogbo, ìgbóná, ìmọ́lẹ̀, ìgbóná ọkàn, àti ibà lẹ́yìn tí ẹ̀ṣin oyin ba gbọn?", "reasoning": "<thinking><step1>\nThe question asks: “Irú àpáàlà immunológico wo ni a mọ̀ fún àwọn àmì bíi ìgbòòrò ara gbogbo, ìgbóná, ìmọ́lẹ̀, ìgbóná ọkàn, àti ibà lẹ́yìn tí ẹ̀ṣin oyin ba gbọn?” — meaning it wants to know what type of immune response is recognized for symptoms like general body rash, fever, light sensitivity, heartburn, and illness after a bee sting.\n</step1>\n<step2>\nThese symptoms suggest an allergic reaction, specifically *àpáàlà àìlera* or an immune response to allergens like bee venom — *ẹ̀ṣin oyin*.\n</step2>\n<step3>\nWhen a person is stung, their immune system may overreact, leading to *ìgbòòrò ara* (hives) and *ìgbóná* (fever) as part of the inflammatory response.\n</step3>\n<step4>\nThis reaction is mediated by antibodies, particularly *IgE*, which are produced in response to the allergen — in this case, the bee sting.\n</step4>\n<step5>\nThe symptoms of *ìmọ́lẹ̀* (light sensitivity) and *ìgbóná ọkàn* (heartburn) can also occur due to systemic effects of the allergic response, indicating a more severe reaction.\n</step5>\n<step6>\nIn summary, the immune response involved here is an allergic reaction characterized by *àpáàlà àìlera* and systemic symptoms following exposure to bee venom.\n</step6></thinking>", "answer": "<answer>Àpáàlà àìlera ni a mọ̀ fún àwọn àmì bíi ìgbòòrò ara, ìgbóná, àti ìmọ́lẹ̀ lẹ́yìn tí ẹ̀ṣin oyin ba gbọn.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 58 kan ti o la itan iṣẹ abẹ ọkan ati fifi stent sii laipẹ, ati itọju oogun antiplatelet meji ti n tẹsiwaju, fi irora ọfun, awọn igbona inu ẹnu, ati neutropenia hàn.  Oògùn wo ni o ṣeé ṣe julọ lati fa awọn ami aisan wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “What medication is most likely to cause symptoms like throat pain, oral burning, and neutropenia in a 58-year-old man with a history of heart surgery and recent stent placement?” — it highlights the patient's medical background and current symptoms.\n</step1>\n<step2>\nIn this case, the patient is on dual antiplatelet therapy — *itọju oogun antiplatelet meji* — which typically includes drugs like aspirin and clopidogrel.\n</step2>\n<step3>\nClopidogrel can sometimes lead to side effects such as neutropenia — *neutropenia* refers to a low white blood cell count, which can increase infection risk.\n</step3>\n<step4>\nAdditionally, oral burning and throat pain could be linked to gastrointestinal side effects of these medications — *awọn ipa ẹgbẹ ti o ni ibatan si eto ikun*.\n</step4>\n<step5>\nConsidering the symptoms and the medication history, clopidogrel is a strong candidate for causing these issues, particularly the neutropenia.\n</step5>\n<step6>\nThus, the most likely medication responsible for these symptoms in this patient is clopidogrel.\n</step6></thinking>", "answer": "<answer>Oògùn ti o ṣee ṣe julọ lati fa awọn ami aisan wọnyi ni clopidogrel.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọmọ ọdún méjìdínlógún kan, tí ó ti bí ọmọ ní ọ̀sẹ̀ mẹ́ta sẹ́yìn, wá pẹ̀lú àìsàn ibà, àti ẹ̀gbà tí ó gbóná, pupa, tí ó sì ń bà niyà, nígbà tí ó ń fún ọmọ rẹ̀ ní oúnjẹ. Àwọn àmì àrùn náà pẹ̀lú pẹ̀lú otutu gíga, pupa ẹ̀gbà, gbóná ẹ̀gbà, àti omi tí ó ní ìrísì ìgbẹ́rùn tí ó ti ń jáde láti nípìlẹ̀ rẹ̀, láìsí ìyípadà tí ó ṣeé ṣàkíyèsí.  Kí ni ọ̀nà ìṣèdájọ́ tó yẹ fún ipò yìí?", "reasoning": "<thinking><step1>\nThe question describes a 21-year-old woman who has recently given birth and is experiencing symptoms of fever, abdominal pain, and a discharge that is foul-smelling. It asks for the appropriate management for this situation.\n</step1>\n<step2>\nGiven her recent childbirth, *àìsàn ibà* (postpartum infection) is a significant concern. The symptoms of high fever and abdominal pain suggest possible infection — *àrùn*.\n</step2>\n<step3>\nThe foul-smelling discharge indicates *ìkó* (lochia) that may be infected, which is common in postpartum women. This requires immediate medical attention.\n</step4>\n<step4>\nIn such cases, the first step is to conduct a thorough examination — *ìwádìí* — to assess the severity of the infection and rule out complications like *àìlera* (sepsis).\n</step5>\n<step5>\nTreatment typically involves antibiotics to combat the infection, and if there are any retained products of conception, a procedure may be necessary to remove them — *ìtọ́jú*.\n</step6>\n<step6>\nTherefore, the appropriate management for her condition would be to seek immediate medical care for evaluation and treatment of a possible postpartum infection.\n</step6></thinking>", "answer": "<answer>Kí ni ọ̀nà ìṣèdájọ́ tó yẹ fún ipò yìí ni láti wá ìtọ́jú lẹsẹkẹsẹ fún àìsàn ibà.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹjọ kan ní àìlera tí kò gbà lára, tí ó tàn káàkiri lórí ẹsẹ̀ rẹ̀, àti irẹ̀sì ìgbọ̀ọ̀n ọ̀tẹ̀ rẹ̀ pẹ̀lú ẹ̀jẹ̀ tí ó pọ̀ gidigidi nínú ito rẹ̀ àti amuaradagba. Ṣe àyẹ̀wò microscopic ti àyẹ̀wò renal biopsy rẹ̀ yóò fi hàn nípa?\nA. Ibajẹ́ tubular\nB. Ifọwọ́sowọ́po visceral podocyte\nC. Ìfipamọ́ IgA nínú mesangium\nD. Ìgbàgbé membrane ipilẹ̀", "reasoning": "<thinking><step1>\nThe question translates to: \"An eight-year-old boy has a condition that is not well understood, with swelling in his legs, and significant blood in his urine and proteinuria. What would a microscopic examination of his renal biopsy show?\" \n</step1>\n<step2>\nThe symptoms described suggest a possible kidney issue, particularly *ìfipamọ́ IgA* (IgA deposition) which is often associated with *IgA nephropathy*.\n</step2>\n<step3>\nIn cases of *ìfipamọ́ IgA*, one typically sees mesangial deposits during a renal biopsy — *àyẹ̀wò renal biopsy*.\n</step3>\n<step4>\nOther options like *ibajẹ́ tubular* (tubular damage) or *ifọwọ́sowọ́po visceral podocyte* (visceral podocyte involvement) may not align with the specific symptoms of significant proteinuria and hematuria.\n</step4>\n<step5>\nThe presence of blood and protein in the urine strongly indicates a glomerular issue, making *ìfipamọ́ IgA nínú mesangium* the most likely finding.\n</step6>\nThus, the renal biopsy would likely reveal *ìfipamọ́ IgA* in the mesangium.\n</step6></thinking>", "answer": "<answer>Ìfipamọ́ IgA nínú mesangium.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 45 kan wá sọ́dọ̀ oníṣẹ́-ìlera rẹ̀, ó ń kọ́kọ́rọ̀ nípa ìrora ori tí ó ń pọ̀ sí i. Ó tún sọ pé àwọn fila àti ìgbàṣẹ́ ìgbéyàwó rẹ̀ kò tún bá a mu mọ́.  Ìgbóná ara rẹ̀ jẹ́ 99°F (37.2°C), ẹ̀dùn-ẹjẹ̀ jẹ́ 145/80 mmHg, ìṣiṣẹ́ ọkàn jẹ́ 85/min, àti ìmímú afẹ́fẹ́ jẹ́ 16/min. Àyẹ̀wò ara fi hàn pé o ní frontal bossing, ẹnu-ìwájú tó ga, àti ahọ́n tó ń pò.  Àwòrán àyẹ̀wò ọkàn fi hàn pé ọkàn rẹ̀ ń pò díẹ̀.  Ipele insulin-like growth factor 1 ninu ẹ̀jẹ̀ rẹ̀ ga pupọ̀.  Nínú àwọn àrùn wọ̀nyí, èwo ni ẹni náà ní ewu tó pọ̀ jùlọ?\nA. Pheochromocytoma\nB. Medullary thyroid carcinoma\nC. Osteoid osteoma\nD. Carpal tunnel syndrome\nE. Osteosarcoma", "reasoning": "<thinking><step1>\nThe question presents a 45-year-old man with symptoms including headaches and changes in his physical appearance, specifically *frontal bossing* and a *tall forehead*. It also mentions elevated insulin-like growth factor 1 levels, which suggests a possible growth disorder.\n</step1>\n<step2>\nThe symptoms of *frontal bossing* and a high level of insulin-like growth factor 1 could indicate a condition related to excess growth hormone — *hormone de croissance*.\n</step2>\n<step3>\nAmong the options, *pheochromocytoma* is a tumor that can cause headaches due to catecholamine release, but it doesn't typically cause frontal bossing or elevated growth factors.\n</step3>\n<step4>\n*Medullary thyroid carcinoma* is associated with thyroid issues and may not explain the growth changes or headaches directly.\n</step4>\n<step5>\n*Osteoid osteoma* and *carpal tunnel syndrome* are less likely to be related to the systemic symptoms presented, such as the elevated growth factor levels.\n</step5>\n<step6>\n*Osteosarcoma*, a type of bone cancer, can present with growth changes and pain, making it a significant concern in this case.\n</step7>\n<step7>\nGiven the symptoms and the elevated insulin-like growth factor 1, the most likely condition with the highest risk is *osteosarcoma*.\n</step7></thinking>", "answer": "<answer>Oni naa ni ewu tó pọ̀ jùlọ ni osteosarcoma.</answer>", "language": "Yoruba"}
{"question": "Tí orí femur bá yọ kuro ní ipò rẹ̀ lọ sí ẹ̀yìn àti àárín, ẹ̀yìnwo wo ni ó ṣeé ṣe kí ó fúnni ní ìrora?\nA. Ẹ̀yìnwo Femoral\nB. Ẹ̀yìnwo Lumbosacral\nC. Ẹ̀yìnwo Obturator\nD. Ẹ̀yìnwo Sciatic", "reasoning": "<thinking><step1>\nThe question asks: “Tí orí femur bá yọ kuro ní ipò rẹ̀ lọ sí ẹ̀yìn àti àárín, ẹ̀yìnwo wo ni ó ṣeé ṣe kí ó fúnni ní ìrora?” — meaning it wants to know which nerve might cause pain if the femur head is displaced backward and inward.\n</step1>\n<step2>\nWhen the femur head moves out of its normal position, it can affect nearby nerves — *ẹ̀yìnwo* — that are responsible for sensation and movement.\n</step3>\n<step3>\nThe options given are: A. *Ẹ̀yìnwo Femoral*, B. *Ẹ̀yìnwo Lumbosacral*, C. *Ẹ̀yìnwo Obturator*, and D. *Ẹ̀yìnwo Sciatic*.\n</step4>\n<step4>\nThe *ẹ̀yìnwo femoral* innervates the anterior thigh, while the *ẹ̀yìnwo obturator* is responsible for the inner thigh. However, the *ẹ̀yìnwo sciatic* runs down the back of the leg and is more likely to be affected by a posterior displacement.\n</step5>\n<step5>\nConsidering the position of the femur head, a backward and inward movement could compress the *ẹ̀yìnwo sciatic*, leading to pain in the posterior thigh and leg.\n</step6>\n<step6>\nThus, the most likely nerve to cause pain in this scenario is the *ẹ̀yìnwo sciatic*.\n</step6></thinking>", "answer": "<answer>Ẹ̀yìnwo Sciatic ni ó ṣeé ṣe kí ó fúnni ní ìrora.</answer>", "language": "Yoruba"}
{"question": "Ninu iṣiro DMFT (eyi ti o tumọ si Decayed, Missing, ati Filled Teeth) ni ibamu si ọna World Health Organization, melo ni o yẹ ki a kọ si bi “eyi ti o sọnù” (M) fun alaisan ọdun 47 kan ti ehin kan ba bajẹ, kò sì ti kun, ehin miran sì ti kun nitori bajẹ, ati pe mẹta ninu awọn ehin rẹ̀ sọnù nitori arun periodontal?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu iṣiro DMFT (Decayed, Missing, ati Filled Teeth) ni ibamu si ọna World Health Organization, melo ni o yẹ ki a kọ si bi ‘eyi ti o sọnù’ (M)?” — meaning it wants to determine how many teeth should be recorded as “missing” for a 47-year-old patient with specific dental conditions.\n</step1>\n<step2>\nIn the DMFT index, “M” stands for missing teeth. The patient has one tooth that is decayed and not filled, which does not count as missing.\n</step2>\n<step3>\nAdditionally, there is one tooth that has been filled, which also does not contribute to the missing count — *eyin ti a ti kun*.\n</step3>\n<step4>\nThe patient has three teeth that are missing due to periodontal disease — *arun periodontal* — which directly affects the count of missing teeth.\n</step4>\n<step5>\nThus, for this patient, the total number of missing teeth is three, as these are the only ones that qualify under the DMFT criteria.\n</step5></thinking>", "answer": "<answer>Melo ni o yẹ ki a kọ si bi “eyi ti o sọnù” (M) fun alaisan yii? Mẹta.</answer>", "language": "Yoruba"}
{"question": "Ní ọrọ̀ àmùṣọ̀nà ìgbà tí a ṣeé ṣe kí ikú jẹ́ nítorí majele, níbi tí ìgbàákúgbàá ara kú ń gbé nígbà tí ó pẹ́ ju deede lọ, irú majele wo ló ṣeé ṣe kí ó jẹ́ ọ̀rọ̀ fún ìgbàákúgbàá ara tí ó pẹ́ yìí?", "reasoning": "<thinking><step1>\nThe question translates to: \"What type of poison can cause death during a prolonged state of coma, where the body has been in a coma for longer than usual?\" This indicates a focus on poisons that can lead to fatal outcomes in extended comatose states.\n</step1>\n<step2>\nIn cases of prolonged coma, *májẹ̀lè* (poison) can affect the body's vital functions. For example, *májẹ̀lè àtọ́kànwá* (toxic substances) like carbon monoxide can lead to hypoxia, which is a lack of oxygen in the body.\n</step2>\n<step3>\nAnother example is heavy metals, such as lead or mercury — *májẹ̀lè irin* — which can accumulate in the body and cause severe neurological damage, potentially leading to death.\n</step3>\n<step4>\nAdditionally, certain drugs, like opioids, can depress the central nervous system, resulting in a deep coma and possibly death if not treated — *ìfarapa àtọ́kànwá* (overdose).\n</step4>\n<step5>\nIn summary, poisons that disrupt oxygen supply or severely impair neurological function are critical in this context. *Májẹ̀lè tó ní ipa lórí ẹ̀dá* (poisons that affect life) are particularly dangerous in prolonged comatose states.\n</step5></thinking>", "answer": "<answer>Májẹ̀lè tó le fa ikú nígbà ìgbàákúgbàá ara pẹ́ ni carbon monoxide, irin, àti opioids.</answer>", "language": "Yoruba"}
{"question": "Nipọn wo ni ìdinku ìdápadà ààlà sí ìṣelọ́pọ̀ kukuru-ákókò bẹ̀rẹ̀ ní ti ṣiṣẹ́-ṣiṣe òṣìṣẹ́?", "reasoning": "<thinking><step1>\nThe question asks: “Nipọn wo ni [ìdinku ìdápadà ààlà = reduction in turnover rate] sí [ìṣelọ́pọ̀ kukuru-ákókò = short-term employment] bẹ̀rẹ̀ ní ti [ṣiṣẹ́-ṣiṣe òṣìṣẹ́ = employee performance]?” — meaning it wants to know how a reduction in turnover rate affects short-term employment regarding employee performance.\n</step1>\n<step2>\nA lower turnover rate generally indicates that employees are staying longer in their positions, which can lead to *ilọsiwaju ninu iṣẹ́-ṣiṣe* or improved performance.\n</step2>\n<step3>\nWhen employees are more stable, they develop better skills and knowledge about their roles — *awọn oṣiṣẹ́ ni iriri diẹ sii* and can contribute more effectively to the organization.\n</step3>\n<step4>\nAdditionally, a stable workforce fosters better team dynamics and collaboration — *ìbáṣepọ̀ to dára* among employees enhances overall productivity.\n</step4>\n<step5>\nHowever, if the turnover rate is too low, it might also lead to stagnation — *ìdákẹ́jẹ* in innovation and fresh ideas, which can negatively impact performance.\n</step5>\n<step6>\nIn summary, a balanced turnover rate can positively influence employee performance, while extremes can have adverse effects.\n</step6></thinking>", "answer": "<answer>Ìdinku ìdápadà ààlà le mu ilọsiwaju iṣẹ́-ṣiṣe wa, ṣugbọn ìdákẹ́jẹ le fa ìṣoro.</answer>", "language": "Yoruba"}
{"question": "Ní ọmọbìnrin ọdún 20 kan tí a ti ṣàyẹ̀wò fún àrùn granulosa cell tumor ti àpòòtọ́, àmì ìtànṣán wo ni ó yẹ kí a ṣe ayẹ̀wò fún ìtọ́jú àlùfáà tó dára?", "reasoning": "<thinking><step1>\nThe question asks: “What signs should we examine for proper treatment of a 20-year-old girl diagnosed with a [granulosa cell tumor = granulosa cell tumor]?” — indicating a need to identify symptoms or indicators for effective management.\n</step1>\n<step2>\nGranulosa cell tumors can present with various symptoms, including *des changements hormonaux* due to estrogen production — this can lead to irregular menstrual cycles.\n</step2>\n<step3>\nWe should also look for signs of *douleur abdominale* or abdominal pain, which may indicate tumor growth or complications.\n</step3>\n<step4>\nAdditionally, monitoring for *symptômes de compression* like urinary issues or gastrointestinal disturbances is crucial, as these can arise from the tumor's size or location.\n</step4>\n<step5>\nRegular imaging studies, such as ultrasound or CT scans, are important to assess tumor progression — *l'évaluation de la progression tumorale* is key for treatment planning.\n</step5>\n<step6>\nFinally, hormonal levels should be checked to evaluate the tumor's impact on the endocrine system — *les niveaux hormonaux* can guide treatment decisions.\n</step6></thinking>", "answer": "<answer>A yẹ kí a ṣe ayẹ̀wò fún àkúnya àrùn, ìyẹn ni: àìlera àtọ́kànwá, ìyípadà àkúnya, àti ìmúlò àyẹ̀wò àtọ́kànwá.</answer>", "language": "Yoruba"}
{"question": "Ọmọdé kan tí ó ní àrùn ìgbẹ́rẹ̀ ọgbẹ́ ṣe ní ìṣòro ìmímú afẹ́fẹ́ àti ìpọ̀sí ìwọ̀n ìgbẹ́rẹ̀ sí 48/min, tí ó lè sọ̀rọ̀ ọ̀rọ̀ méjì nìkan. Lẹ́yìn tí a ti fún un ní salbutamol nípasẹ̀ nebulizer, ọmọdé náà túbọ̀ sàn sí i, tí ó lè sọ gbólóhùn kan, ṣùgbọ́n SpO2 rẹ̀ sọ̀kalẹ̀ láti 95% sí 85%. Kí ni àlàyé iṣẹ́ ṣíṣe ara tí ó ṣeeṣe fún ìdinku SpO2 lẹ́yìn lílo salbutamol?", "reasoning": "<thinking><step1>\nThe question asks: \"Kí ni àlàyé iṣẹ́ ṣíṣe ara tí ó ṣeeṣe fún ìdinku SpO2 lẹ́yìn lílo salbutamol?\" — meaning it wants to know the physiological explanation for the decrease in SpO2 after using salbutamol.\n</step1>\n<step2>\nSalbutamol is a bronchodilator that helps to open the airways — *ó ń ran lọwọ lati ṣí awọn ọna afẹ́fẹ́*. However, it can also lead to a temporary increase in heart rate and anxiety.\n</step2>\n<step3>\nWhen the airways open, there may be a sudden shift in ventilation-perfusion ratio — *ìṣọkan afẹ́fẹ́ àti ẹjẹ* — which can affect oxygen exchange.\n</step3>\n<step4>\nIn this case, the child’s SpO2 dropped from 95% to 85%, indicating possible hypoxemia — *hypoxémie* — due to inadequate oxygenation despite improved airflow.\n</step5>\n<step5>\nFactors like airway inflammation or mucus retention can still impede gas exchange, leading to lower oxygen saturation levels — *ìdí tí SpO2 fi dín kù*.\n</step6>\n<step6>\nThus, the decrease in SpO2 after salbutamol use could be due to a mismatch in ventilation and perfusion, or ongoing airway resistance.\n</step6></thinking>", "answer": "<answer>Ìdí tí SpO2 fi dín kù lẹ́yìn lílo salbutamol ni pé ìṣọkan afẹ́fẹ́ àti ẹjẹ kò pé, tàbí ìdí tí àrùn àfiyèsí fi ń fa ìdènà afẹ́fẹ́.</answer>", "language": "Yoruba"}
{"question": "Kini orukọ tí a sábà máa ń pe apọ́mọ́ ọ̀rá tó wà ní ori tó gbẹ́, tí ó sì di ọ̀rá tí ó pọ̀ jùlọ, tí ó sì di èrò kan tí ó dà bí àkòkò?", "reasoning": "<thinking><step1>\nThe question asks: “Kini orukọ tí a sábà máa ń pe [apọ́mọ́ ọ̀rá = the top of a tree] tó wà ní ori tó gbẹ́, tí ó sì di [ọ̀rá = tree] tí ó pọ̀ jùlọ, tí ó sì di èrò kan tí ó dà bí [àkòkò = a clock]?” — meaning it wants to know the name of a specific part of a tree that is prominent and resembles a clock.\n</step1>\n<step2>\nIn English, this refers to the crown of a tree, which is the uppermost part where the leaves and branches spread out — *apẹ́rẹ́ ọ̀rá*.\n</step2>\n<step3>\nThe crown is crucial for photosynthesis, as it captures sunlight — *o ṣe pataki fun fọ́tósíntésì*.\n</step3>\n<step4>\nIn many trees, the crown can take various shapes, sometimes resembling a clock due to its roundness — *àpẹẹrẹ ni pé, a le rí i pé apẹ́rẹ́ kan le dà bí àkòkò*.\n</step4>\n<step5>\nThus, the term that describes this part of the tree is commonly known as the crown — *apẹ́rẹ́*.\n</step5></thinking>", "answer": "<answer>Apẹ́rẹ́ ni orukọ tí a sábà máa ń pe apọ́mọ́ ọ̀rá tó wà ní ori tó gbẹ́.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mẹrinlẹgbọn kan ṣafihan awọn aami aisan ti paresthesia, rirẹ oju ati agbegbe perioral, ailera iṣan ninu awọn ẹya ara, irora ọmu, palpitations, ríru, òtútù, irora inu, ati ibà. Nigba ayẹwo, a ti ṣakiyesi tachycardia ati hypotension. Alaisan naa royin itan ti jijẹ eweko ti a ko mọ. Da lori awọn aami aisan wọnyi ati itan ti a fun, ṣe idanimọ eweko yii ti alaisan yii ṣee ṣe pupọ julọ ti o jẹ ki o mọ pe o fa awọn aami aisan bẹẹ.", "reasoning": "<thinking><step1>\nThe question describes a patient with symptoms like [paresthesia = paresthesia], [rírẹ oju = visual fatigue], [agbegbe perioral = perioral area], muscle weakness, chest pain, palpitations, chills, abdominal pain, and fever. It also mentions tachycardia and hypotension during examination, along with a history of consuming an unknown plant.\n</step1>\n<step2>\nThese symptoms suggest a possible toxic reaction, particularly from a plant. The combination of paresthesia and perioral symptoms indicates potential neurological involvement — *iyẹn le jẹ ami ti aisan ti o ni ibatan si awọn eweko*.\n</step2>\n<step3>\nThe tachycardia and hypotension further suggest a systemic reaction, possibly anaphylaxis or poisoning — *iyẹn le jẹ abajade ti jijẹ eweko ti o ni awọn nkan ti o lewu*.\n</step3>\n<step4>\nConsidering the history of consuming an unknown plant, one might think of plants like [Strychnos = Strychnos] or [Aconitum = Aconitum], which are known for causing severe symptoms including those described.\n</step4>\n<step5>\nIn this case, the symptoms align closely with those of [Strychnos = Strychnos] poisoning, which can lead to neurological symptoms and cardiovascular instability — *iyẹn ni idi ti a fi le ro pe eweko yii ni aisan naa*.\n</step6>\n<step6>\nThus, the plant that most likely caused these symptoms is *Strychnos*.\n</step6></thinking>", "answer": "<answer>Eweko ti o ṣee ṣe julọ ti o fa awọn aami aisan wọnyi ni *Strychnos*.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 53 kan ṣafihan ara rẹ̀ pẹlu rirẹ̀ agbara awọn ẹya ara ati ọrùn ti o ti gbilẹ̀ fun ọdun mẹta, eyiti o buru si nigbati o ba sunkún tabi fi imu sun. Awọn ami aisan rẹ̀ bẹrẹ pẹlu rirẹ̀ agbara apa ọtun oke, lẹhinna o kan awọn ẹya ara miiran ati ki o fa wahala ni jijẹ ati sisọ.  Idanwo fihan irinṣẹ ataxic, ọ̀rọ̀ dysarthric, spasticity, rirẹ̀ agbara iṣan, atrophy ti awọn iṣan ọrùn, idagbasoke awọn reflexes tendon jinlẹ, idahun plantar extensor mejeeji, ati imọlara ti o dinku ni isalẹ C5 dermatome.  Kini idi ti o ṣeé ṣe julọ fun awọn abajade iṣoogun wọnyi?", "reasoning": "<thinking><step1>\nThe question describes a 53-year-old woman presenting with weakness in her limbs and a stiff neck, worsening with certain movements. It asks for the most likely medical explanation for these symptoms.\n</step1>\n<step2>\nThe symptoms include weakness in the upper right limb, which suggests a possible neurological issue — *iṣoro neurology* — affecting motor control.\n</step2>\n<step3>\nThe presence of ataxia and dysarthria indicates problems with coordination and speech, likely due to damage in the central nervous system — *eto aarin ti ara*.\n</step3>\n<step4>\nSpasticity and muscle atrophy suggest upper motor neuron involvement, which could be due to a condition like multiple sclerosis or amyotrophic lateral sclerosis (ALS) — *iṣoro ALS*.\n</step5>\n<step5>\nThe deep tendon reflexes being hyperactive and the plantar response being extensor point towards a disruption in the corticospinal tract — *iṣan corticospinal*.\n</step6>\n<step6>\nFinally, the sensory loss in the C5 dermatome indicates a possible cervical spine issue, such as a herniated disc or cervical spondylosis — *spondylosis cervical*.\n</step7>\n<step7>\nConsidering all these factors, the most likely cause of her symptoms is a cervical myelopathy, which affects both motor and sensory pathways.\n</step8></thinking>", "answer": "<answer>Idi ti o ṣeé ṣe julọ fun awọn abajade iṣoogun wọnyi ni cervical myelopathy.</answer>", "language": "Yoruba"}
{"question": "Báwo ni èrò Buzan nípa “ààbò àwùjọ” ṣe fi hàn pé ó yàtọ̀ sí àwọn ọ̀nà ààbò àtijọ́, pàápàá jùlọ nígbà tí a bá ń wo àwọn ìṣẹ̀lẹ̀ lẹ́yìn Ogun Òtútù?", "reasoning": "<thinking><step1>\nThe question asks: “Báwo ni èrò Buzan nípa [ààbò àwùjọ = social security] ṣe fi hàn pé ó yàtọ̀ sí [ọ̀nà ààbò àtijọ́ = traditional security methods]?” — meaning it wants to understand how Buzan's ideas about social security differ from traditional methods, especially in the context of events after the Cold War.\n</step1>\n<step2>\nBuzan's concept of social security emphasizes the importance of human welfare and societal stability — *ìlera ènìyàn* and *iduroṣinṣin awùjọ* rather than just military strength.\n</step2>\n<step3>\nHe argues that traditional security methods focus primarily on state sovereignty and military power — *agbara olú-ìlú* — which may not address the root causes of insecurity.\n</step3>\n<step4>\nIn the post-Cold War context, Buzan suggests that issues like economic stability and social cohesion are crucial — *ìdàgbàsókè ọrọ̀ ajé* and *ìbáṣepọ̀ awùjọ*.\n</step4>\n<step5>\nThis perspective indicates a shift from a purely defensive stance to a more holistic approach that includes social policies — *ètò awùjọ* — aimed at improving the quality of life.\n</step5>\n<step6>\nThus, Buzan's view on social security presents a broader understanding of security that integrates social factors, contrasting sharply with older, militaristic views.\n</step6></thinking>", "answer": "<answer>Èrò Buzan nípa ààbò àwùjọ fi hàn pé ó yàtọ̀ sí àwọn ọ̀nà ààbò àtijọ́ nípa fojú kọ́ àìlera ènìyàn àti ìdàgbàsókè awùjọ gẹ́gẹ́ bí àǹfààní ààbò.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin kan ti o ni ilera ti o to ọdun 42 ti wà lọ si yàrá pajawiri pẹlu ikuna inu ati irora inu ti o gbogbo, ti o si n buru si fun ọjọ meji.  Ko ni itan aisan pataki kan. Baba rẹ̀ kú ninu ijamba ọkọ ayọkẹlẹ nígbà tí ó jẹ́ ọdún 32, ìyá rẹ̀ sì ní àrùn àtọ́gbẹ̀ irú kejì.  A fura pe o ni idena inu ati pe a mu u lọ si yàrá abẹ fun iwadii inu. A ṣe igbẹhin apakan ti colon.  Iwoye gbogbo ti ọra colon alaisan ni a fihan.  Iwadii microscopi fihan awọn adenomas ti o jẹ ti tubular, tubulovillous, ati villous.  Ti a ba gba pe alabaṣepọ alaisan kì í ṣe oluṣe ipo naa, ewo ni o ṣeeṣe pe awọn ọmọ alaisan yii yoo ni ipo yii?\nA. 100%\nB. 25%\nC. 75%\nD. 50%\nE. 0%", "reasoning": "<thinking><step1>\nThe question is asking about the likelihood that the children of a 42-year-old man with a history of colon adenomas will inherit this condition. Key terms include [adenomas = adenomas] and [irú kejì = type two].\n</step1>\n<step2>\nThe patient has a family history of colon issues, with his mother having type two diabetes and his father having died in a car accident at 32. This suggests a potential genetic component to his health issues.\n</step2>\n<step3>\nAdenomas can be hereditary, especially if they are of the tubular, tubulovillous, or villous types. In this case, the presence of these adenomas indicates a higher risk for the patient’s children.\n</step3>\n<step4>\nIf we consider the inheritance pattern, if the condition is autosomal dominant, each child has a 50% chance of inheriting the predisposition — *50% ni o ṣeeṣe*.\n</step5>\n<step5>\nHowever, if the condition were autosomal recessive, the likelihood would be lower, but given the context, we lean towards the dominant inheritance pattern.\n</step6>\n<step6>\nThus, the most reasonable estimate for the risk of the children inheriting this condition is 50%.\n</step6></thinking>", "answer": "<answer>50%</answer>", "language": "Yoruba"}
{"question": "Fún ọmọkunrin ọdún mẹfa kan tí ó ní àìlera ẹsẹ̀ méjèèjì tí ó ń pọ̀ sí i, àti itan ìdílé nípa arákùnrin rẹ̀ tí ó kú ní ọdún mẹrinlẹ́gbẹ̀rin, èyíkéyìí ni oògùn tí ó yẹ kí a yàgò fún nígbà ìṣe ẹ̀gbà láti dènà àwọn àṣìṣe tí ó lè ṣẹlẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What medication should be avoided for a six-year-old boy with bilateral leg weakness and a family history of a brother who died at age four?” — it seeks to identify a medication that could pose risks given these conditions.\n</step1>\n<step2>\nIn children, especially with *àìlera ẹsẹ̀ méjèèjì* (bilateral leg weakness), certain medications can exacerbate their condition or lead to serious side effects.\n</step2>\n<step3>\nGiven the family history of a brother who died young, it’s crucial to consider genetic factors — *ìtàn ìdílé* can indicate potential hereditary conditions that might affect medication safety.\n</step3>\n<step4>\nFor instance, medications like *corticosteroids* can weaken muscles further, which is concerning for a child with existing leg weakness.\n</step4>\n<step5>\nAdditionally, if there’s a possibility of a neuromuscular disorder, drugs that affect muscle function should be avoided — *oògùn tí ó ní ipa lórí iṣẹ́ iṣan*.\n</step5>\n<step6>\nTherefore, it’s essential to consult a healthcare professional to determine the safest course of action, but generally, *corticosteroids* should be approached with caution.\n</step6></thinking>", "answer": "<answer>Yàgò fún àwọn corticosteroids.</answer>", "language": "Yoruba"}
{"question": "Àgbẹ̀gbẹ́ kan ní ọ̀pọ̀lọpọ̀ àwọn ìkún ilẹ̀kùn tí ó ń tu sílẹ̀ ní ẹsẹ̀ rẹ̀ tí kò sì dá wá lórí àwọn oògùn ìgbàgbọ́. Kí ni ìwádìí tí ó ṣeé ṣe jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “Àgbẹ̀gbẹ́ kan ní ọ̀pọ̀lọpọ̀ àwọn ìkún ilẹ̀kùn tí ó ń tu sílẹ̀ ní ẹsẹ̀ rẹ̀ tí kò sì dá wá lórí àwọn oògùn ìgbàgbọ́” — meaning it describes a condition with multiple skin lesions on the leg that do not respond to conventional treatments.\n</step1>\n<step2>\nIn this case, the lesions could be indicative of a skin condition like eczema or psoriasis — *ekzema* tabi *psoriasis* — which often require specific dermatological evaluation.\n</step2>\n<step3>\nSince the lesions are persistent and unresponsive to standard treatments, a dermatologist might consider conducting a biopsy — *ibi àyẹ̀wò* — to determine the underlying cause.\n</step3>\n<step4>\nAdditionally, testing for allergies or infections could be relevant — *ìwádìí fún àrùn tabi àìlera* — to rule out other potential factors contributing to the skin condition.\n</step4>\n<step5>\nIn summary, the most feasible investigation would likely be a skin biopsy to identify the specific type of skin disorder — *àyẹ̀wò àyélujára*.\n</step5></thinking>", "answer": "<answer>Ìwádìí tí ó ṣeé ṣe jùlọ ni àyẹ̀wò àyélujára láti mọ irú àìlera awọ̀ tó wà.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 60 kan wá sí ẹka pajawiri pẹlu irora ọmu inu, ṣíṣe ẹmi kuru, ati itan iṣẹ abẹ ekan ọsẹ mẹta sẹhin ti o fa idinku ni iṣiṣe.  Àyẹ̀wò rẹ̀ fihan ẹsẹ isalẹ ti o gbona ati ti o dùn. Bí oníṣẹ́ abẹ ti ṣe iye enu pẹlu irora ọmu inu ṣugbọn o nilo lati pinnu boya CT angiogram jẹ dandan, kini ìwádìí àyẹ̀wò ti yoo fihan pupọ julọ pe a nilo iṣẹ́ ṣiṣe afikun pẹlu CT angiogram?", "reasoning": "<thinking><step1>\nThe question asks: “What diagnostic tests would most likely indicate the need for additional intervention with a CT angiogram?” — it describes a 60-year-old man with chest pain, shortness of breath, and a history of surgery three weeks ago.\n</step1>\n<step2>\nIn this case, the symptoms suggest possible complications like *thrombosis* or *embolism* — conditions that could be revealed through imaging.\n</step2>\n<step3>\nA CT angiogram is particularly useful for visualizing blood vessels and identifying blockages — *idanwo awọn ẹjẹ* that may not be apparent through other tests.\n</step3>\n<step4>\nKey diagnostic tests to consider include a chest X-ray and an echocardiogram — *ayẹwo ẹjẹ* to assess heart function and rule out other causes of chest pain.\n</step4>\n<step5>\nIf the patient shows signs of *pulmonary embolism* or significant vascular issues, the CT angiogram becomes critical — *o ṣe pataki* to guide further treatment.\n</step6>\n<step6>\nThus, the most indicative tests would be those that highlight vascular complications, leading to the necessity of a CT angiogram.\n</step6></thinking>", "answer": "<answer>Ayẹwo ti o fihan awọn iṣoro ẹjẹ tabi *pulmonary embolism* ni yoo jẹ ki a nilo CT angiogram.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 65 kan wá sọ́dọ́ oníṣègùn nítorí ìrora retrosternal tí ó ń ṣẹlẹ̀ nígbà ìgbà kan, ìkùkùtù sígbà, àti ìgbàgbé ọkàn tí ó ti wà fún ọjọ́ 10. Àwọn ìṣẹ̀lẹ̀ náà máa ń ṣẹlẹ̀ nígbà tí ó bá gun òkè ìṣẹ́lẹ̀ tàbí gbìyànjú láti rìn ní kíki lórí tìrè̀dìmììlì rẹ̀. Àwọn àmì náà máa ń dáwọ́ dúró nígbà tí ó bá dáwọ́ dúró láti rìn. Àní nígbà alẹ́ ṣíṣàájú, ó rẹ̀wẹ̀sì, ó sì lágbára nígbà ìṣẹ̀lẹ̀ bẹ́ẹ̀. Ó tún sọ pé ó ní àrùn òtútù ọsẹ̀ méjì sẹ́yìn. Wọ́n ṣàyẹ̀wò rẹ̀ ní àrùn àtọ́júwọ̀n-iru-2 mellitus ọdún mẹ́rin sẹ́yìn, ṣùgbọ́n ó dára bí kò ṣe bẹ́ẹ̀. Oògùn kanṣoṣo tó ń mu ni glyburide. Ó dàbí ẹni tí ó dára. Ìṣòwò rẹ̀ jẹ́ 62/min, ó sì lágbára, ìtìjú rẹ̀ jẹ́ 20/min, àti ṣíṣe ẹ̀jẹ̀ rẹ̀ jẹ́ 134/90 mmHg. Ìwádìí ọkàn-àìsàn fi hàn ní ìró ìgbàgbé systolic tí ó gbọ́ dáadáa ní ipò intercostal ọ̀tún kejì. Ẹ̀dọ̀fóró rẹ̀ mọ́. Èwo nínú àwọn ọ̀nà wọ̀nyí ni ó ṣeé ṣe jùlọ lati jẹ́ ìdí ti ipò alaisan yìí lọ́wọ́lọ́wọ́?\nA. Ìdèdè ọkàn òsì ọ̀tún tí ó pọ̀ sí i\nB. Ìgbòkègbodò lymphocyte ti myocardium\nC. Hypoperfusion transmural ti ó ṣe pàtàkì ti myocardium\nD. Ìṣiṣẹ́ alaigbagbọ́ ti agbegbe systolic ti ó fa ìṣiṣẹ́ catecholamine\nE. Ìtùjáde insulin ti ara ẹni tí ó pọ̀ sí i", "reasoning": "<thinking><step1>\nThe question describes a 65-year-old man experiencing retrosternal pain, shortness of breath, and heart palpitations for 10 days, particularly during exertion — *nígbà tí ó bá gun òkè* or when he tries to walk. \n</step1>\n<step2>\nThese symptoms suggest a potential cardiac issue, especially since they improve with rest — *àwọn àmì náà máa ń dáwọ́ dúró* when he stops exerting himself.\n</step2>\n<step3>\nHe has a history of type 2 diabetes — *àrùn àtọ́júwọ̀n-iru-2 mellitus* — but his current condition seems stable, as indicated by his medication, glyburide.\n</step3>\n<step4>\nThe vital signs show a heart rate of 62/min and blood pressure of 134/90 mmHg, which are relatively normal, but the symptoms are concerning.\n</step4>\n<step5>\nGiven the exertional nature of the symptoms and the patient's age, the most likely cause could be related to myocardial perfusion issues — *hypoperfusion transmural ti ó ṣe pàtàkì ti myocardium*.\n</step5>\n<step6>\nThe options provided include various cardiac conditions, but the exertional symptoms strongly point towards a perfusion problem rather than structural or inflammatory issues.\n</step6>\n<step7>\nThus, the most plausible explanation for his symptoms is related to inadequate blood flow to the heart muscle during physical activity.\n</step7></thinking>", "answer": "<answer>Hypoperfusion transmural ti ó ṣe pàtàkì ti myocardium.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 52 kan wa pẹlu idamu, irọra, nystagmus ti o jẹ iwọn, ati ataxia. Itan iṣoogun rẹ pẹlu awọn ọrọ ikọlu ti pancreatitis ti o tun ṣẹlẹ ati lilo oògùn. Lẹhin ti o ti bẹrẹ itọju to yẹ, idamu rẹ dara si, ṣugbọn o tun ni awọn aiṣedede imoye, pẹlu iṣeduro buburu, awọn iṣẹ siseto, ati iranti. Ti a ba fi awọn ami aisan wọnyi ati itan rẹ hàn, ẹnjini wo ni o ni ibatan si aini Vitamin ti o ṣee ṣe julọ ti o bajẹ ninu alaisan yii nitori lilo otutu?", "reasoning": "<thinking><step1>\nThe question asks about a 52-year-old man with confusion, dizziness, nystagmus, and ataxia, and it seeks to identify the vitamin deficiency related to his symptoms and history of pancreatitis and medication use.\n</step1>\n<step2>\nGiven his symptoms, particularly the confusion and ataxia, we should consider vitamin deficiencies that affect the nervous system — *vitamin B1 (thiamine)* is a key candidate here.\n</step2>\n<step3>\nPancreatitis can lead to malabsorption issues, which may result in deficiencies — *aifọwọyi ti awọn vitamin* — especially if the patient has been using certain medications that affect nutrient absorption.\n</step3>\n<step4>\nIn this case, thiamine deficiency can cause Wernicke's encephalopathy, characterized by confusion, ataxia, and nystagmus — *iyipada ninu iṣesi ati iṣe ara*.\n</step4>\n<step5>\nThe patient's history of substance use could further exacerbate this deficiency, as alcohol can interfere with thiamine absorption and utilization — *lilo oti* le fa aini vitamin.\n</step5>\n<step6>\nThus, considering all these factors, the most likely vitamin deficiency related to his condition is thiamine deficiency.\n</step6></thinking>", "answer": "<answer>Aini vitamin ti o ṣeeṣe julọ ni aini thiamine (Vitamin B1).</answer>", "language": "Yoruba"}
{"question": "Èwo nínú àwọn apá inú ètò ìdágìrì gbogboogbò ni àwọn oògùn afẹ́fẹ́ ìsúnrú tí ó máa ń rọ̀ kò pèsè?", "reasoning": "<thinking><step1>\nThe question asks: “Èwo nínú àwọn apá inú ètò ìdágìrì gbogboogbò ni àwọn oògùn afẹ́fẹ́ ìsúnrú tí ó máa ń rọ̀ kò pèsè?” — meaning it wants to know which parts of the overall respiratory system are affected by inhaled corticosteroids.\n</step1>\n<step2>\nInhaled corticosteroids are medications that reduce inflammation in the airways — *àwọn oògùn wọnyi dinku ìfarapa* in the respiratory tract.\n</step2>\n<step3>\nThey primarily target the bronchi and bronchioles — *àwọn bronchi àti bronchioles* — where inflammation often occurs in conditions like asthma.\n</step3>\n<step4>\nBy decreasing inflammation, these medications help improve airflow and reduce symptoms — *àwọn aami* such as wheezing and shortness of breath.\n</step4>\n<step5>\nIn essence, inhaled corticosteroids act on the lower respiratory system, specifically the airways — *àwọn ọna afẹ́fẹ́* that lead to the lungs.\n</step5>\n<step6>\nSo, the main parts affected are the bronchi and bronchioles, which are crucial for proper breathing.\n</step6></thinking>", "answer": "<answer>Àwọn apá tí oògùn afẹ́fẹ́ ìsúnrú máa ń rọ̀ kò pèsè ni àwọn bronchi àti bronchioles.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ile-ẹkọ giga ọdun 21 kan wá pẹlu itan ọjọ meji ti ẹ̀gbẹ́, irora inu-ikun ti o tan si ẹhin, ati awọn ẹgbẹ́ ọpọlọpọ ti awọn aṣọ ofeefee lori ara. Alaisan naa ni itan ti dermatitis atopic, thyroiditis Hashimoto, ati pe o mu levothyroxine gẹgẹ bi oogun rẹ nikan. Ko gba awọn ajesara, ṣugbọn o ma mu ọti-waini ati fifun mimu marijuwana. A rii pe iye kalsiumu ninu ẹ̀jẹ̀ rẹ̀ jẹ 7.9 mg/dL. Ti a ba gbero awọn aami aisan ati awọn abajade ile-iwosan wọnyi, kini igbesẹ ti o yẹ julọ ni atẹle lati ṣe iwadi idi ti o wa labẹ rẹ?", "reasoning": "<thinking><step1>\nThe question asks: \"What is the most appropriate next step to investigate the underlying cause?\" It describes a 21-year-old college student with a two-day history of [ẹ̀gbẹ́ = rash], abdominal pain radiating to the back, and multiple areas of yellowish [aṣọ ofeefee = discoloration] on the skin.\n</step1>\n<step2>\nThe patient has a history of atopic dermatitis and Hashimoto's thyroiditis, and is on levothyroxine — *oògùn ti a nlo fun hypothyroidism*. This suggests a possible endocrine issue.\n</step2>\n<step3>\nThe calcium level is low at 7.9 mg/dL, which indicates *hypocalcemia*. This could be related to parathyroid function or vitamin D deficiency — *aifọwọyi vitamin D*.\n</step4>\n<step4>\nGiven the symptoms and lab results, it’s crucial to rule out conditions like primary hyperparathyroidism or vitamin D deficiency. A common next step would be to check parathyroid hormone (PTH) levels — *iwadi ipele PTH*.\n</step5>\n<step5>\nAdditionally, considering the patient's lifestyle factors, such as alcohol and marijuana use, could also contribute to the symptoms. However, the immediate focus should be on the biochemical abnormalities.\n</step6>\n<step6>\nThus, the most appropriate next step is to evaluate the parathyroid hormone levels to understand the cause of the hypocalcemia and associated symptoms.\n</step6></thinking>", "answer": "<answer>Igbesẹ ti o yẹ julọ ni lati ṣe iwadi ipele homonu parathyroid (PTH) lati mọ idi ti hypocalcemia.</answer>", "language": "Yoruba"}
{"question": "Ní àyèwo wo ni àṣàrò níní láàárin succinyl CoA àti acetoacetate láti mú acetoacetyl CoA àti succinate jáde kò ṣẹlẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Ní àyèwo wo ni àṣàrò níní láàárin [succinyl CoA] àti [acetoacetate] láti mú [acetoacetyl CoA] àti [succinate] jáde kò ṣẹlẹ̀?” — meaning it wants to know the conditions under which the reaction between succinyl CoA and acetoacetate to produce acetoacetyl CoA and succinate does not occur.\n</step1>\n<step2>\nThis reaction typically requires specific conditions, such as the presence of enzymes — *awọn enzymu* — that facilitate the conversion.\n</step2>\n<step3>\nIf the enzyme is absent or inactive, the reaction will not proceed — *ti enzymu naa ko ba si tabi ti ko ba ṣiṣẹ*.\n</step3>\n<step4>\nAdditionally, the concentrations of succinyl CoA and acetoacetate must be adequate; if they are too low, the reaction may not happen — *ti awọn ipele wọn ba kere ju*.\n</step4>\n<step5>\nEnvironmental factors like pH and temperature also play a crucial role; extreme conditions can inhibit enzyme activity — *awọn ipo ayika le ni ipa lori iṣẹ enzymu*.\n</step5>\n<step6>\nIn summary, the absence of necessary enzymes, insufficient substrate concentrations, and unfavorable environmental conditions can prevent the reaction from occurring.\n</step6></thinking>", "answer": "<answer>Àṣàrò níní láàárin succinyl CoA àti acetoacetate kò ṣẹlẹ̀ ti enzymu ko ba si, ti awọn ipele wọn ba kere ju, tàbí ti ipo ayika ko ba dara.</answer>", "language": "Yoruba"}
{"question": "Gbogbo awọn nkan wọnyi le ṣee lo lati yàtọ si Idilọwọ Iṣan Aringbungbun Retinal Central (CRVO) lati aarun Ischemic Ocular ti o fa nipasẹ Carotid Aery Stenosis, Yato si:\nA. Iṣan Retinal ti o gbòòrò\nB. Iṣan Retinal Touous\nC. Titẹ Aringbungbun Retinal\nD. Opthalmodynamometry", "reasoning": "<thinking><step1>\nThe question asks: “Gbogbo awọn nkan wọnyi le ṣee lo lati yàtọ si [Idilọwọ Iṣan Aringbungbun Retinal Central = Central Retinal Vein Occlusion (CRVO)] lati [aarun Ischemic Ocular = Ischemic Ocular Disease] ti o fa nipasẹ [Carotid Aery Stenosis = Carotid Artery Stenosis], Yato si:” — meaning it wants to identify which option does not help differentiate between CRVO and ischemic ocular disease caused by carotid artery stenosis.\n</step1>\n<step2>\nTo differentiate between CRVO and ischemic ocular disease, we typically look at various clinical signs and tests — *awọn ami ati idanwo to wa ni iwadi*.\n</step2>\n<step3>\nOptions A and B refer to types of retinal ischemia — *iṣan retinal ti o gbòòrò* and *iṣan retinal touous* — which can provide insights into the underlying pathology.\n</step3>\n<step4>\nOption C, *titẹ aringbungbun retinal*, measures the pressure in the central retinal vein, which is relevant for CRVO diagnosis.\n</step4>\n<step5>\nHowever, option D, *opthalmodynamometry*, is a technique used to measure the blood flow in the eye but does not specifically differentiate between CRVO and ischemic ocular disease.\n</step5>\n<step6>\nThus, the correct answer is the option that does not contribute to this differentiation, which is *opthalmodynamometry*.\n</step6></thinking>", "answer": "<answer>Opthalmodynamometry.</answer>", "language": "Yoruba"}
{"question": "Àwọn ọ̀nà ìtọ́jú wo ni kò yẹ fún ìṣakoso àrùn àìsàn thyroid tí ó pọ̀ jù nítorí àrùn thyroid tí ó gbòòrò ní kòkòrò?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn ọ̀nà ìtọ́jú wo ni kò yẹ fún ìṣakoso [àrùn àìsàn thyroid = thyroid disease] tí ó pọ̀ jù nítorí [àrùn thyroid tí ó gbòòrò = enlarged thyroid disease]?” — meaning it seeks to identify inappropriate treatment methods for managing thyroid disease due to enlargement.\n</step1>\n<step2>\nIn managing thyroid disease, especially when it involves *goitre* or enlargement, certain treatments may not be suitable — *kò yẹ*.\n</step2>\n<step3>\nFor instance, using *hormone replacement therapy* indiscriminately can lead to complications — *àìlera* if the thyroid is already overactive.\n</step3>\n<step4>\nAdditionally, *surgery* might be considered risky if the enlargement is due to benign causes, as it can lead to unnecessary complications — *ìfarapa*.\n</step5>\n<step5>\nAnother inappropriate approach could be relying solely on *herbal remedies* without medical supervision, which may not address the underlying issues effectively — *kò le mu àbáyọ*.\n</step6>\n<step6>\nThus, treatments like indiscriminate hormone therapy, unnecessary surgery, and unverified herbal remedies should be avoided in managing thyroid disease with enlargement.\n</step6></thinking>", "answer": "<answer>Àwọn ìtọ́jú tí kò yẹ ni ìtọ́jú homonu àìmọ̀, iṣẹ́ abẹ́ àìtọ́, àti ìmúra àtọkànwá láìmọ̀.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun mẹsan kan ní àrùn nephrotic syndrome tí ó gbẹ́kẹ̀lé steroid fún ọdún márùn-ún sẹ́yìn. Ó ti gba corticosteroids fún igba pipẹ́ láàrin àkókò yìí, tí ó sì ní àwọn àpẹẹrẹ Cushingoid. Ẹ̀dùn àtẹ́gùn rẹ̀ jẹ́ 120/86 mmHg, àti àwọn cataracts subcapsular méjì. Ìtọ́jú tí a yàn jẹ́:\nA. Levamisole.\nB. Cyclophosphamide.\nC. Cyclosporin A.\nD. Intravenous pulse corticosteroids.", "reasoning": "<thinking><step1>\nThe question is asking about the treatment options for a nine-year-old child with nephrotic syndrome who has been on steroids for five years and shows signs of Cushingoid features. \n</step1>\n<step2>\nNephrotic syndrome is a kidney disorder characterized by *protéinurie* (protein in urine), *hypoalbuminémie* (low albumin levels), and *œdème* (swelling). \n</step2>\n<step3>\nLong-term steroid use can lead to complications like Cushingoid features, which include *obésité centrale* (central obesity) and *hypertension* (high blood pressure), as noted with the child's blood pressure of 120/86 mmHg.\n</step3>\n<step4>\nIn this case, the treatment options include immunosuppressants like Levamisole, Cyclophosphamide, and Cyclosporin A, but the child has been on corticosteroids for a long time.\n</step4>\n<step5>\nGiven the child's prolonged steroid use and the presence of cataracts, *les cataractes sous-capsulaires* indicate a need for a different approach to manage the nephrotic syndrome effectively.\n</step6>\n<step6>\nAmong the options, intravenous pulse corticosteroids could be a suitable choice to manage the condition while minimizing further steroid-related complications.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú tí a yàn jẹ́: Intravenous pulse corticosteroids.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 26 kan wá pẹlu àrùn ikun díẹ̀ lẹ́yìn tí ó jẹ ẹja aṣa díẹ̀ sí ọjọ́ diẹ̀ sẹ́yìn. Kò sí ẹ̀jẹ̀ tàbí òtútù ninu àdọ̀, àti ẹ̀kọ́ ṣíṣe lórí Wagatsuma agar. Kí ni ohun tí ó ṣeé ṣe julọ tí ó fa àrùn rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What is the most likely cause of a 26-year-old man experiencing stomach pain after eating a certain type of fish?” — here, *àrùn ikun* means stomach pain, and *ẹja aṣa* refers to a specific type of fish.\n</step1>\n<step2>\nStomach pain after eating fish can indicate a few possibilities, but one common cause is food poisoning — *ìfarapa onje* — especially if the fish was not fresh or properly cooked.\n</step2>\n<step3>\nIn this case, the absence of blood or fever suggests it might not be a severe infection, which points towards a milder form of foodborne illness.\n</step3>\n<step4>\nAnother possibility could be an allergic reaction to the fish — *ìfarapa si ẹja* — but this usually presents with other symptoms like hives or swelling.\n</step4>\n<step5>\nGiven the context, it seems more likely that the man is experiencing symptoms of food poisoning from the fish he consumed, particularly if it was raw or undercooked.\n</step5>\n<step6>\nTherefore, the most probable cause of his stomach pain is food poisoning related to the fish he ate.\n</step6></thinking>", "answer": "<answer>Ìfarapa onje lati ẹja aṣa ni ohun tí ó ṣeé ṣe julọ tí ó fa àrùn rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Nínú àpẹ̀ẹ́rẹ̀ ọmọ ọdún mẹ́tadinlógún kan tí ó ní àìlera ìgbàgbọ́ oúnjẹ, àìlera ẹ̀jẹ̀ nítorí àìtó iron, àti ìbajẹ́ gbogbo ìṣẹ̀dá villi tí a rí nínú àyẹ̀wò duodenal, èyí tí antibody pàtàkì ni ó ṣeé ṣe jùlọ láti wà?", "reasoning": "<thinking><step1>\nThe question asks: “In a 17-year-old patient with food intolerance, anemia due to iron deficiency, and damage to all villi seen in a duodenal biopsy, which antibody is most likely to be present?” — here, *àìlera ìgbàgbọ́ oúnjẹ* refers to food intolerance, and *ìbajẹ́ gbogbo ìṣẹ̀dá villi* indicates damage to the villi.\n</step1>\n<step2>\nIn cases of food intolerance and villous atrophy, one common condition to consider is celiac disease — *àìlera celiac*.\n</step2>\n<step3>\nCeliac disease is an autoimmune disorder triggered by gluten, leading to *ìbajẹ́ ti awọn villi* in the small intestine.\n</step3>\n<step4>\nThe specific antibody associated with celiac disease is anti-tissue transglutaminase antibody (tTG) — *antibody tTG*.\n</step4>\n<step5>\nIn this scenario, the presence of tTG antibodies would indicate an immune response to gluten, correlating with the symptoms described.\n</step5>\n<step6>\nThus, the most likely antibody to be present in this patient is the anti-tissue transglutaminase antibody.\n</step6></thinking>", "answer": "<answer>Antibody tTG ni ó ṣeé ṣe jùlọ láti wà nínú àpẹ̀ẹ́rẹ̀ yìí.</answer>", "language": "Yoruba"}
{"question": "Kini awọn àmì ìṣe pàtàkì tí ó wọ́pọ̀ tó máa ń bá àrùn kànṣẹ̀ apá òsì ìdí ẹ̀gbẹ́?", "reasoning": "<thinking><step1>\nThe question asks: “Kini awọn àmì ìṣe pàtàkì tí ó wọ́pọ̀ tó máa ń bá àrùn kànṣẹ̀ apá òsì ìdí ẹ̀gbẹ́?” — which translates to \"What are the common symptoms that often accompany left-sided heart failure?\"\n</step1>\n<step2>\nLeft-sided heart failure occurs when the left ventricle cannot pump blood effectively — *àìlera àtọ́kànwá apá òsì*.\n</step2>\n<step3>\nCommon symptoms include shortness of breath — *ìdíwọ̀n àfiyèsí*, especially during physical activity or when lying down — *nígbà tí a bá ń sùn*.\n</step3>\n<step4>\nAnother symptom is fatigue — *ìkànsí*, which results from the body not receiving enough oxygenated blood.\n</step4>\n<step5>\nPatients may also experience fluid retention — *ìkó omi*, leading to swelling in the legs or abdomen — *ìkó omi nínú ẹsẹ̀ tàbí inú*.\n</step6>\n<step6>\nAdditionally, a persistent cough or wheezing can occur due to fluid in the lungs — *ìkòkò nínú ẹ̀dá*.\n</step7>\n<step7>\nIn summary, the key symptoms of left-sided heart failure include shortness of breath, fatigue, fluid retention, and cough.\n</step7></thinking>", "answer": "<answer>Àwọn àmì ìṣe pàtàkì tí ó wọ́pọ̀ ni: ìdíwọ̀n àfiyèsí, ìkànsí, ìkó omi, àti ìkòkò.</answer>", "language": "Yoruba"}
{"question": "Ninu àrùn Von Hippel-Lindau, apáwo ni ọpọlọpọ ti a sábà máa n rí àwọn àìlera ẹ̀jẹ̀ bíi hemangioblastoma?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu àrùn [Von Hippel-Lindau = Von Hippel-Lindau disease], apáwo ni ọpọlọpọ ti a sábà máa n rí [àìlera ẹ̀jẹ̀ = blood disorders] bíi [hemangioblastoma = hemangioblastoma]?” — meaning it wants to know what blood disorders are commonly seen in Von Hippel-Lindau disease.\n</step1>\n<step2>\nVon Hippel-Lindau disease is a genetic condition that often leads to various tumors, including *hemangioblastomas*, which are vascular tumors.\n</step2>\n<step3>\nIn this condition, patients may also experience *polycythemia*, which is an increase in red blood cells — *iyipada ninu awọn ẹjẹ pupa*.\n</step3>\n<step4>\nThis increase can occur due to the production of erythropoietin by the tumors, leading to symptoms like headaches and dizziness — *irora ori ati dizziness*.\n</step5>\n<step6>\nAdditionally, *angiomatosis* can be present, which involves the formation of multiple blood vessel tumors throughout the body.\n</step7>\n<step8>\nThus, the common blood disorders associated with Von Hippel-Lindau disease include *hemangioblastoma* and *polycythemia*.\n</step9></thinking>", "answer": "<answer>Àwọn àìlera ẹ̀jẹ̀ ti a sábà máa n rí ninu àrùn Von Hippel-Lindau ni hemangioblastoma ati polycythemia.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọmọ Nàìjíríà ọdún 62 kan tí ẹsẹ̀ ọ̀tún rẹ̀ gbòòrò sí i tí ó sì ń dùn, tí ẹ̀gbà kan tí ó tóbi hàn nínú iṣan jíjìn kan nípa ìwádìí Doppler ultrasonography, ṣẹ̀ṣẹ̀ dé Amẹ́ríkà, ó sì ń ní ìrora ẹsẹ̀ láìsí ìpalára èyíkéyìí nígbà àìpẹ́ yìí. Nígbà tí a bá gbé ìtàn àìsàn rẹ̀ àti àwọn ìwádìí Doppler yẹ̀ wò, kí ni ọ̀nà ìṣiṣẹ́ tó yẹ julọ láti bójútó ipò ara rẹ̀?", "reasoning": "<thinking><step1>\nThe question is asking about the best management approach for a 62-year-old Nigerian woman whose right leg is swollen and painful, with a significant finding in a Doppler ultrasonography — *ìwádìí Doppler ultrasonography* — indicating a possible vascular issue.\n</step1>\n<step2>\nSwelling and pain in the leg can indicate conditions like deep vein thrombosis (DVT) or venous insufficiency — *ìfarapa ẹjẹ* or *aìlera ẹjẹ*.\n</step2>\n<step3>\nConsidering her age and the recent travel to America, we must assess the risk factors for DVT, which include prolonged immobility — *aìfarapa* — and possibly dehydration.\n</step3>\n<step4>\nManagement should start with conservative measures such as compression therapy — *ìtọ́jú pẹ̀lú àtẹ̀gùn* — to reduce swelling and improve venous return.\n</step5>\n<step5>\nIf Doppler results suggest a clot, anticoagulation therapy — *ìtọ́jú pẹ̀lú ẹjẹ* — may be necessary to prevent complications.\n</step6>\n<step6>\nIn summary, the best approach involves a combination of compression therapy and monitoring for any signs of thrombosis, ensuring she receives appropriate follow-up care.\n</step6></thinking>", "answer": "<answer>Ọ̀nà ìṣiṣẹ́ tó yẹ julọ ni ìtọ́jú pẹ̀lú àtẹ̀gùn àti ìtọ́jú pẹ̀lú ẹjẹ, pẹ̀lú ìmúlò àyẹ̀wò àtìlẹ́yìn.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mẹ́tadinlọ́gbọ̀n kan tí ó ní ìtàn lílò oògùn nípa ìmú tí ó wà níbi ìṣẹ̀lẹ̀ àìsàn, iye CD4+ T-lymphocyte rẹ̀ jẹ́ 84/mm3, ati CT scan tí ó fi hàn pé ó ní àwọn ìṣàn tí ó ń yí ara wọn ká ní ọpọlọ. Nígbà tí a bá gbé àwọn àmì àìsàn wọ̀nyí yẹ̀ wò, ṣe irú ìtọ́jú oogun wo ni ó yẹ ká bẹ̀rẹ̀ pẹ̀lú?", "reasoning": "<thinking><step1>\nThe question is asking about a 29-year-old man with a history of drug use, a CD4+ T-lymphocyte count of 84/mm3, and a CT scan showing lesions in the brain — *ìṣàn ní ọpọlọ*.\n</step1>\n<step2>\nA CD4+ count of 84/mm3 indicates severe immunosuppression, which is critical in the context of HIV/AIDS — *ìlera HIV/AIDS*.\n</step2>\n<step3>\nGiven the presence of brain lesions, one must consider opportunistic infections, such as *toxoplasmosis* or *cryptococcal meningitis*.\n</step3>\n<step4>\nIn this case, treatment should start with *antiretroviral therapy* (ART) to manage HIV, alongside specific medications for the suspected opportunistic infection.\n</step4>\n<step5>\nFor example, if *toxoplasmosis* is suspected, one would typically initiate treatment with *pyrimethamine* and *sulfadiazine*.\n</step6>\n<step6>\nThus, the appropriate course of action involves starting ART and addressing the opportunistic infection based on clinical suspicion.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú tó yẹ ni láti bẹ̀rẹ̀ pẹ̀lú ìtọ́jú antiretroviral àti ìtọ́jú fún àìsàn tó jẹ́ àfiyèsí, gẹ́gẹ́ bí *toxoplasmosis* tàbí *cryptococcal meningitis*.</answer>", "language": "Yoruba"}
{"question": "Àwọn ọ̀nà ìtọ́jú wo ni kò yẹ fún ìṣakoso àrùn àìsàn thyroid tí ó pọ̀ jù nítorí àrùn thyroid tí ó gbòòrò ní kòkòrò?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn ọ̀nà ìtọ́jú wo ni kò yẹ fún ìṣakoso [àrùn àìsàn thyroid = thyroid disease] tí ó pọ̀ jù nítorí [àrùn thyroid tí ó gbòòrò = hyperthyroidism]?” — meaning it wants to know which treatment methods are not suitable for managing hyperthyroidism.\n</step1>\n<step2>\nHyperthyroidism occurs when the thyroid gland produces too much hormone — *hormoni thyroid* — leading to symptoms like weight loss and increased heart rate.\n</step2>\n<step3>\nCertain treatments, such as *iyẹ̀fun* (surgery), may not be appropriate for all patients, especially if they have other health issues.\n</step3>\n<step4>\nAdditionally, using *iyọ̀kúrò* (radioactive iodine) can be risky for some individuals, particularly pregnant women or those with certain allergies.\n</step4>\n<step5>\nMedications like *antithyroid drugs* can be effective, but they may not be suitable for everyone due to potential side effects.\n</step5>\n<step6>\nIn summary, treatments that involve surgery or radioactive iodine may not be advisable for all patients with hyperthyroidism.\n</step6></thinking>", "answer": "<answer>Àwọn ìtọ́jú tí kò yẹ fún ìṣakoso àrùn thyroid tí ó pọ̀ jù ni iyẹ̀fun àti iyọ̀kúrò.</answer>", "language": "Yoruba"}
{"question": "Àpọǹ lára kan, nígbà tí a ń lò ẹ̀rọ ìmúṣẹ̀ mímu, àtúnṣe ẹ̀jẹ̀ ìṣàn ara rẹ̀ ni pH 7.48, PaCO<sub>2</sub> 25mmHg, PaO<sub>2</sub> 76mmHg, BE -6mmol/L, [img=~/QImg/2014-02-20-16-47-10/image008.jpg]18.5mmol/L,  àwa gbọ́dọ̀ rò pé ó jẹ́\nA. Ìṣàn ẹ̀jẹ̀ bàsìkì ìmúṣẹ̀ mímu\nB. Ìṣàn ẹ̀jẹ̀ àṣídí ìmúṣẹ̀ mímu\nC. Ìṣàn ẹ̀jẹ̀ àṣídí àṣà\nD. Ìṣàn ẹ̀jẹ̀ bàsìkì àṣà\nE. Ìṣàn ẹ̀jẹ̀ àṣídí ìmúṣẹ̀ mímu + Ìṣàn ẹ̀jẹ̀ bàsìkì àṣà", "reasoning": "<thinking><step1>\nThe question is asking about a specific condition based on blood gas values: pH 7.48, PaCO<sub>2</sub> 25mmHg, PaO<sub>2</sub> 76mmHg, and BE -6mmol/L. It wants to determine whether this indicates a [bàsìkì = basic] or [àṣídí = acidic] blood condition.\n</step1>\n<step2>\nFirst, we note that a pH of 7.48 indicates alkalosis, as it is above the normal range of 7.35-7.45. This suggests a [ìṣàn ẹ̀jẹ̀ bàsìkì = basic blood condition].\n</step2>\n<step3>\nNext, the low PaCO<sub>2</sub> of 25mmHg indicates hyperventilation, which is often associated with respiratory alkalosis — *ìmúṣẹ̀ mímu*.\n</step3>\n<step4>\nThe BE of -6mmol/L suggests a metabolic component, but since the pH is high, we focus on the respiratory aspect. The combination of these values points towards a primary respiratory alkalosis.\n</step4>\n<step5>\nNow, looking at the options: A and B refer to basic and acidic conditions related to *ìmúṣẹ̀ mímu*, while C and D refer to conditions related to *àṣà* (metabolic). \n</step5>\n<step6>\nGiven the evidence, the most fitting choice is B, which indicates a basic blood condition due to respiratory alkalosis — *ìṣàn ẹ̀jẹ̀ bàsìkì ìmúṣẹ̀ mímu*.\n</step6></thinking>", "answer": "<answer>Ìṣàn ẹ̀jẹ̀ bàsìkì ìmúṣẹ̀ mímu.</answer>", "language": "Yoruba"}
{"question": "Nigbati a bá gba alaisan tí ó ní irora tó léwu lórí ikun oke wọlé, kò yẹ kí a gba àyẹ̀wò ìgbona pancreatitis gbà títí gbogbo àwọn ipo wọnyi bá ti parí yàtọ̀ sí:\nA. Ìgbona cholecystitis\nB. Ìgbona renal colic\nC. Àkóbá inu ifun inu kekere tí ó so mọ ara\nD. Mesenteric embolization", "reasoning": "<thinking><step1>\nThe question asks: “When treating a patient with severe abdominal pain, should we consider pancreatitis only after ruling out the following conditions?” — it lists potential differential diagnoses.\n</step1>\n<step2>\nPancreatitis is inflammation of the pancreas, and it can cause severe abdominal pain — *irora tó léwu lórí ikun*.\n</step2>\n<step3>\nThe options provided are conditions that could mimic the symptoms of pancreatitis: *ìgbona cholecystitis* (gallbladder inflammation), *ìgbona renal colic* (kidney stone pain), *àkóbá inu ifun inu kekere* (small bowel obstruction), and *mesenteric embolization* (blood flow obstruction to the intestines).\n</step3>\n<step4>\nTo diagnose pancreatitis, it’s crucial to exclude these conditions first, as they may require different treatments — *ìtọ́jú* varies significantly.\n</step4>\n<step5>\nFor instance, *ìgbona cholecystitis* may need surgical intervention, while *ìgbona renal colic* could be managed with pain relief and hydration.\n</step5>\n<step6>\nThus, the correct approach is to rule out these conditions before confirming pancreatitis — *kò yẹ kí a gba àyẹ̀wò ìgbona pancreatitis gbà títí gbogbo àwọn ipo wọnyi bá ti parí*.\n</step6></thinking>", "answer": "<answer>B. Ìgbona renal colic</answer>", "language": "Yoruba"}
{"question": "Lẹ́yìn tí obìnrin kan tí ó ń ṣe abẹ̀rẹ̀ yíyọ́ àpòòtọ́, tí àyẹ̀wò rẹ̀ ṣáájú abẹ̀rẹ̀ dára, di ẹni tí kò ní ìtẹ́lẹ̀mọ́ ọkàn àti ẹni tí kò dáhùn ní yàrá abẹ̀rẹ̀ lẹ́yìn lílo oògùn onígbàárí, àwọn ìgbésẹ̀ wo ni ó yẹ kí a gbé yàrá láti bójútó ipò rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Lẹ́yìn tí obìnrin kan tí ó ń ṣe abẹ̀rẹ̀ yíyọ́ àpòòtọ́” — meaning it refers to a woman who has undergone a [hysterectomy = abẹ̀rẹ̀ yíyọ́ àpòòtọ́] and is experiencing complications like [cardiac arrest = ìtẹ́lẹ̀mọ́ ọkàn] and [non-responsiveness = kò dáhùn].\n</step1>\n<step2>\nAfter such a surgery, if a patient shows signs of cardiac arrest, it is critical to assess her condition immediately — *a gbọdọ̀ ṣe àyẹ̀wò ipò rẹ̀ ni kiakia*.\n</step2>\n<step3>\nFirst, check for responsiveness — *ṣe àyẹ̀wò bí ó ṣe dáhùn* — by gently shaking her and calling her name.\n</step3>\n<step4>\nIf she does not respond, call for emergency help — *pe ìrànlọ́wọ́ pajawiri* — and begin CPR if trained, as this can help maintain blood flow.\n</step4>\n<step5>\nEnsure the airway is clear — *jẹ́ kó rọrùn fún afẹ́fẹ́ láti wọlé* — and if available, use an AED (Automated External Defibrillator) to check for heart rhythm.\n</step5>\n<step6>\nWhile waiting for help, monitor her vital signs — *ṣàkíyèsí ìfọkànsìn rẹ̀* — and be prepared to provide information to the medical team upon their arrival.\n</step6></thinking>", "answer": "<answer>Láti bójútó ipò rẹ̀, a gbọdọ̀ ṣe àyẹ̀wò rẹ̀, pe ìrànlọ́wọ́ pajawiri, bẹ̀rẹ̀ CPR, àti ṣàkíyèsí ìfọkànsìn rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mejilelogun kan ti n ṣe afihan irora ninu awọn iṣan ati awọn isẹpo ẹsẹ isalẹ rẹ lẹhin irin-ajo irin-ajo kan laipẹ ni Connecticut, pẹlu àkàn ní eti òtún rẹ̀ pẹlu awọn ààlà tí ó ṣe kedere. Ni akiyesi ifihan ati agbegbe naa, kini igbesẹ ti o dara julọ ni itọju ipo alaisan yii?", "reasoning": "<thinking><step1>\nThe question asks: “What is the best treatment step for a 26-year-old man experiencing pain in the muscles and joints of his lower extremities after a recent trip to Connecticut, with a rash on his right side and clear boundaries?” \n</step1>\n<step2>\nThis situation suggests a possible infection or inflammatory condition, especially considering the recent travel — *irin-ajo* — which could expose him to various pathogens.\n</step2>\n<step3>\nThe presence of a rash — *àkàn* — indicates a potential dermatological issue, possibly linked to an infectious disease like Lyme disease, common in Connecticut.\n</step3>\n<step4>\nGiven the symptoms, the first step in treatment should be to conduct a thorough evaluation, including a physical examination and possibly lab tests to confirm the diagnosis.\n</step4>\n<step5>\nIf Lyme disease is suspected, initiating antibiotic therapy — *itọju pẹlu awọn antibayotiki* — would be crucial, as early treatment can prevent complications.\n</step5>\n<step6>\nAdditionally, managing pain and inflammation with NSAIDs — *awọn oogun ti ko ni steroid* — can help alleviate discomfort while the underlying cause is addressed.\n</step6>\n<step7>\nIn summary, the best initial treatment step involves both diagnostic evaluation and starting appropriate antibiotics if Lyme disease is confirmed.\n</step7></thinking>", "answer": "<answer>Igbesẹ itọju ti o dara julọ ni lati ṣe ayẹwo ni kikun ati bẹrẹ itọju pẹlu awọn antibayotiki ti a ba fura si àkàn Lyme.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mejila kan tí ó ní ibajẹ́ egungun femur lẹ́yìn ìṣòro ọkọ̀ ayọ́kẹ́lẹ́, a ṣe ìtọ́jú abẹ́ fún un. Lẹ́yìn tí a ti fi oògùn ìsunwọ̀n rẹ̀, ó ní iba gbígbóná tó jẹ́ 40 degC (104 degF), ríru ara, àti ito tí ó ní ẹ̀jẹ̀. Ní àwọn wọ̀nyí, èwo ni ọ̀nà ìtọ́jú tí ó dára jùlọ?\nA. Ṣíṣe ito rẹ̀ di alagbẹ̀rẹ̀, fifun ni mannitol, àti títẹ̀síwájú pẹ̀lú iṣẹ́ abẹ́ náà\nB. Fifun ni dantrolene sodium àti títẹ̀síwájú pẹ̀lú iṣẹ́ abẹ́ náà\nC. Fifun ni dantrolene sodium àti dádúró iṣẹ́ abẹ́ náà\nD. Fifun ni oògùn steroid tí a fi sí inu ẹ̀jẹ̀ àti oògùn antihistamine pẹ̀lú títẹ̀síwájú pẹ̀lú iṣẹ́ abẹ́ náà", "reasoning": "<thinking><step1>\nThe question is asking about the best treatment approach for a 12-year-old boy with a femur fracture after a car accident, who has developed a high fever of 40 degrees Celsius (104 degrees Fahrenheit), muscle rigidity, and bloody urine. \n</step1>\n<step2>\nThese symptoms suggest a possible case of *hyperthermia* or *malignant hyperthermia*, which can occur after surgery. The presence of *iba gbígbóná* (high fever) and *ríru ara* (muscle rigidity) is particularly concerning.\n</step2>\n<step3>\nIn such cases, the immediate treatment often involves administering dantrolene sodium, which is effective in treating muscle rigidity and lowering body temperature — *dantrolene sodium ni a nlo lati dinku ríru ara*.\n</step3>\n<step4>\nOption B suggests giving dantrolene sodium and continuing with the surgical procedure, which may not be advisable if the patient is unstable due to the symptoms.\n</step4>\n<step5>\nOption C, which involves giving dantrolene sodium and stopping the surgery, could be a safer choice to stabilize the patient first.\n</step6>\n<step6>\nHowever, option D, which includes administering steroids and antihistamines along with continuing surgery, may not address the immediate life-threatening symptoms effectively.\n</step6>\n<step7>\nThus, the best approach would be to administer dantrolene sodium and halt the surgical procedure to manage the patient's critical condition first.\n</step7></thinking>", "answer": "<answer>Fifun ni dantrolene sodium àti dádúró iṣẹ́ abẹ́ náà ni ọ̀nà ìtọ́jú tí ó dára jùlọ.</answer>", "language": "Yoruba"}
{"question": "((kì í ṣe (Oótọ́))) ni", "reasoning": "<thinking><step1>\nThe question asks: “Kì í ṣe [Oótọ́ = True]?” — meaning it is inquiring about what is not true or false.\n</step1>\n<step2>\nIn logic, something that is not true is considered false — *nkan ti ko ba jẹ́ otitọ ni a pe ni iro*.\n</step2>\n<step3>\nFor example, if a statement contradicts reality, it is false — *ti ìtàn kan ba kọ́kọ́ jẹ́ otitọ, ó jẹ́ iro*.\n</step4>\n<step4>\nIn Yoruba, one might say: *kí ni ìtàn tí kò jẹ́ otitọ?* which translates to \"what is a statement that is not true?\"\n</step4>\n<step5>\nTo clarify, falsehood can also be seen as deception — *iro le tun jẹ́ ẹtan*.\n</step5>\n<step6>\nThus, when we say something is not true, we are identifying it as false or misleading — *nítorí náà, a n sọ pé nkan kan jẹ́ iro*.\n</step6></thinking>", "answer": "<answer>Kì í ṣe ni pé nkan kan jẹ́ iro tàbí ẹtan.</answer>", "language": "Yoruba"}
{"question": "Aṣiwaju kan ni a ti ṣe ayẹwo fun aarun kan ti a npè ni infiltrating ductal carcinoma ti o jẹ́ HER2-positive, estrogen receptor-negative, ati progesterone receptor-negative, gẹ́gẹ́ bíi abajade ayẹwo core needle biopsy.  Fọ́tò mammogram fihan iṣan ti o to 6.5mm pẹlu eti ti kò dára ati spiculated. Iye ẹ̀jẹ̀ ati idanwo iṣẹ́ ẹ̀dọ̀ jẹ́ deede.  Kini igbesẹ ti o tọ julọ ni itọju aarun oyinbo yii fun alaisan yii?", "reasoning": "<thinking><step1>\nThe question is asking: “What is the most appropriate treatment step for a patient diagnosed with [infiltrating ductal carcinoma = carcinoma ductal infiltrant] that is HER2-positive, estrogen receptor-negative, and progesterone receptor-negative?” \n</step1>\n<step2>\nThis type of breast cancer is aggressive, and the HER2-positive status indicates that the cancer cells have more HER2 proteins, which can promote their growth — *cancer HER2-positif*.\n</step2>\n<step3>\nGiven the receptor status, the patient is not a candidate for hormone therapy, which typically targets estrogen and progesterone receptors — *thérapie hormonale* ne sera pas efficace ici.\n</step3>\n<step4>\nThe standard treatment for HER2-positive breast cancer often includes targeted therapy with trastuzumab — *trastuzumab* is a monoclonal antibody that specifically targets HER2.\n</step4>\n<step5>\nAdditionally, chemotherapy is usually recommended to address the aggressive nature of the carcinoma — *la chimiothérapie* peut être nécessaire pour réduire la taille de la tumeur.\n</step6>\n<step6>\nIn this case, the most appropriate initial treatment step would be to start with chemotherapy combined with trastuzumab — *chimiothérapie avec trastuzumab*.\n</step6></thinking>", "answer": "<answer>Igbesẹ ti o tọ julọ ni itọju aarun oyinbo yii ni lati bẹrẹ pẹlu chimiothérapie ati trastuzumab.</answer>", "language": "Yoruba"}
{"question": "Da ipele awọn abajade ti awọn ifunwara awọ ara mẹrin lati ọdọ alaisan kan, nibiti awọn ayẹwo meji fihan awọn bacilli mẹwa fun awọn agbegbe agbara giga 100 ati awọn ayẹwo meji fihan awọn bacilli ju ẹgbẹrun lọ fun agbegbe apapọ, kini ipele ikogun bakteria ti a ka?", "reasoning": "<thinking><step1>\nThe question asks: “Da ipele awọn abajade ti awọn ifunwara awọ ara mẹrin…” which translates to “What is the level of bacterial load based on the results of four skin tests?” It specifies that two samples show ten bacilli for high power fields and two samples show over a thousand for average fields.\n</step1>\n<step2>\nTo determine the bacterial load, we need to analyze the results from both sets of samples — *awọn ayẹwo* — and understand how they contribute to the overall count.\n</step2>\n<step3>\nThe first set shows ten bacilli in high power fields, which indicates a relatively low bacterial presence — *iwọn kekere ti awọn bakiteria*.\n</step3>\n<step4>\nIn contrast, the second set shows over a thousand bacilli in average fields, suggesting a significantly higher bacterial load — *iwọn ti o ga julọ ti awọn bakiteria*.\n</step4>\n<step5>\nTo calculate the overall bacterial load, we can average the counts from both sets, considering the higher weight of the second set due to its larger number.\n</step5>\n<step6>\nThus, the overall bacterial load can be classified as high, given the substantial count from the average fields — *iwọn ti o ga julọ*.\n</step6></thinking>", "answer": "<answer>Ipele ikogun bakteria ti a ka jẹ giga, nitori awọn ayẹwo meji fihan awọn bacilli ju ẹgbẹrun lọ fun agbegbe apapọ.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun 45 kan wá pẹlu pipadanu iwuwo ati aisan jijẹ, paapaa awọn ohun ti o le. Ó fi ara hàn pé ara rẹ̀ le, iṣiṣẹ́ ika rẹ̀ kò péye, ati awọn telangiectasias. Ìwádìí ìṣiṣẹ́ ọgbà onjẹ fi hàn pé ko si peristalsis ni awọn apa keji mẹta isalẹ ti ọgbà onjẹ ati idinku titẹ sphincter esophageal isalẹ. Ni iṣe yiyan ipo rẹ̀, kini abajade histological ti o ṣee ṣe julọ ti a yoo rii ninu kidinrin rẹ̀ lẹhin iyọrisi itọju siwaju sii?", "reasoning": "<thinking><step1>\nThe question is asking about the possible histological outcome in the kidneys of a 45-year-old woman with weight loss and eating difficulties, particularly regarding her esophageal condition — *iṣoro jijẹ* and *pipadanu iwuwo*.\n</step1>\n<step2>\nGiven the symptoms, including *telangiectasias* and poor finger function, it suggests a systemic issue, possibly related to a connective tissue disorder — *aisan asopọ ara*.\n</step2>\n<step3>\nThe findings of absent peristalsis in the lower three segments of the esophagus indicate a motility disorder — *iṣoro iṣan* that could lead to secondary effects on the kidneys.\n</step3>\n<step4>\nIn cases like this, one might expect to see changes such as *fibrosis* or *glomerulosclerosis* in the kidneys due to chronic hypoxia or reduced blood flow — *iyipada ti o le fa nipasẹ aito ẹjẹ*.\n</step4>\n<step5>\nHistologically, we could also see *atrophy* of renal tubules, which is a response to prolonged stress or injury — *iyipada ti o ṣẹlẹ nitori aito itọju*.\n</step6>\n<step6>\nThus, the most likely histological finding in her kidneys after further treatment would be signs of chronic damage, such as *fibrosis* or *glomerulosclerosis*.\n</step6></thinking>", "answer": "<answer>Abajade histological ti o ṣee ṣe julọ ni kidinrin rẹ̀ ni *fibrosis* tabi *glomerulosclerosis*.</answer>", "language": "Yoruba"}
{"question": "Irú ṣiṣe iyatọ wo ni a lo fun ọpọlọpọ awọn ileal atresias ti o fihan irisi 'okun sisà dídí' tabi 'okun awọn adiẹ'?", "reasoning": "<thinking><step1>\nThe question asks: “Irú ṣiṣe iyatọ wo ni a lo fun ọpọlọpọ awọn [ileal atresias = ileal atresias] ti o fihan irisi 'okun sisà dídí' tabi 'okun awọn adiẹ'?” — meaning it wants to know what types of surgical procedures are used for various ileal atresias that present with the appearance of 'string of pearls' or 'string sign'.\n</step1>\n<step2>\nIleal atresias are congenital conditions where a part of the ileum is absent or closed — *iyato yii n fa idiwọ ninu gbigbe ounje* through the intestines.\n</step2>\n<step3>\nThe 'string of pearls' appearance on imaging indicates multiple dilated loops of bowel — *iyika ti o ni irisi awọn adiẹ* — which suggests obstruction.\n</step3>\n<step4>\nSurgical intervention is necessary, typically involving resection of the atretic segment — *iyipada ti apakan ti o ni idiwọ* — and anastomosis of the healthy ends.\n</step4>\n<step5>\nIn some cases, if the bowel is severely damaged, a stoma may be created — *stoma kan le jẹ ki o ṣee ṣe* to divert the fecal stream temporarily.\n</step6>\n<step6>\nThus, the main surgical approach for these ileal atresias is resection and anastomosis, addressing the obstruction and restoring intestinal continuity.\n</step6></thinking>", "answer": "<answer>Iru ṣiṣe iyatọ ti a lo fun ileal atresias ni resection ati anastomosis lati mu ki gbigbe ounje pada si deede.</answer>", "language": "Yoruba"}
{"question": "Oníròyìn pàtàkì tí ó ń ṣàkóso ìṣelọ́pọ̀ ẹ̀jẹ̀ afẹ́fẹ́ ni homonu thrombopoietin (THPO), èyí tí a ń ṣe ní\nA. Ìṣan\nB. Ẹ̀dọ̀\nC. Ẹ̀dọ̀ àti Ìṣan\nD. Ìyọ́nú àti àwọn ìhà ọ̀nà ìgbàlóò", "reasoning": "<thinking><step1>\nThe question asks: “Oníròyìn pàtàkì tí ó ń ṣàkóso ìṣelọ́pọ̀ ẹ̀jẹ̀ afẹ́fẹ́ ni homonu thrombopoietin (THPO), èyí tí a ń ṣe ní” — meaning it wants to know where the hormone thrombopoietin is produced and its role in regulating blood platelet production.\n</step1>\n<step2>\nThrombopoietin (THPO) is crucial for the production of platelets — *ìṣelọ́pọ̀ ẹ̀jẹ̀ afẹ́fẹ́* — which are essential for blood clotting.\n</step2>\n<step3>\nThis hormone is primarily produced in the liver — *ẹ̀dọ̀* — and also in the kidneys — *ìṣan*.\n</step3>\n<step4>\nIn the context of the options provided, we need to identify the correct answer based on the production sites of THPO.\n</step4>\n<step5>\nSince both the liver and kidneys are involved, the correct choice would be *C. Ẹ̀dọ̀ àti Ìṣan*.\n</step5></thinking>", "answer": "<answer>Ẹ̀dọ̀ àti Ìṣan.</answer>", "language": "Yoruba"}
{"question": "Olùṣiṣẹ́ àgbò ilẹ̀ kan fi ìgbóná ara gíga, lílékùn ọrùn, àti àwọn àmì àrùn meningitis hàn. Awọn ìwádìí ilé ẹ̀kọ́ ṣe afihan àìṣẹ́ṣẹ̀-ṣiṣẹ́ kidinì àti ìpọ̀sí ìṣẹ́ ẹ̀dọ̀. Oògùn tó yẹ jùlọ láti kọ̀wé fún ní ọ̀ràn yìí ni ____\nA. Ciprofloxacin\nB. Penicillin\nC. Cotrimoxazole\nD. Azithromycin", "reasoning": "<thinking><step1>\nThe question states that a patient presents with high fever, neck stiffness, and signs of meningitis — *àwọn àmì àrùn meningitis* — indicating a serious infection.\n</step1>\n<step2>\nMeningitis can be caused by bacteria, and the choice of antibiotic depends on the suspected organism. Common bacterial causes include *Neisseria meningitidis* and *Streptococcus pneumoniae*.\n</step2>\n<step3>\nCiprofloxacin is generally used for certain bacterial infections but is not the first choice for meningitis — *kò jẹ́ àṣàyàn tó dára jùlọ*.\n</step3>\n<step4>\nPenicillin is effective against *Streptococcus pneumoniae*, a common cause of bacterial meningitis, making it a strong candidate.\n</step4>\n<step5>\nCotrimoxazole is typically used for other infections and not specifically for meningitis, while Azithromycin is more for atypical bacteria.\n</step5>\n<step6>\nGiven the symptoms and the need for effective treatment against common bacterial pathogens, Penicillin is the most appropriate choice.\n</step6></thinking>", "answer": "<answer>Penicillin ni oògùn tó yẹ jùlọ láti kọ̀wé fún ọ̀ràn yìí.</answer>", "language": "Yoruba"}
{"question": "Ní ipò tí òṣìṣẹ́ kan bá dá ọkọ̀ ayọkẹlẹ́ kan dúró nítorí ṣiṣẹ́ àṣìṣe òpópóná kékeré, ọkọ̀ ayọkẹlẹ́ náà sì gbà láti jẹ́ kí wọ́n ṣe àwárí ọkọ̀ ayọkẹlẹ́ náà láìsì fífi ẹ̀tọ́ rẹ̀ láti kọ̀ sílẹ̀ hàn án, àwọn ohun wo ni ilé ẹjọ́ yóò gbé yẹ̀ wò láti mọ̀ bóyá ìgbàgbọ́ náà jẹ́ ti ara rẹ̀, kí sì ni ìpinnu tí ó ṣeé ṣe bí kò bá sí ẹ̀rí ìdààmú tàbí ìbẹ̀rù?", "reasoning": "<thinking><step1>\nThe question asks: “What will the court consider to determine if a worker's belief about a vehicle being parked due to a minor road defect is reasonable, and what decision might be made if there is no evidence of distress or fear?” \n</step1>\n<step2>\nIn legal terms, the court will look at *àwọn ẹ̀rí* (evidence) presented regarding the worker's belief — whether it was *ìgbàgbọ́ tó péye* (reasonable belief) based on the circumstances.\n</step2>\n<step3>\nFactors like the nature of the road defect and the worker's experience will be evaluated — *iriri* (experience) can influence the perception of risk.\n</step3>\n<step4>\nIf the worker had no prior incidents or warnings about the road condition, this could support their case — *àìní ìṣẹ̀lẹ̀ àtijọ́* (lack of prior incidents) may indicate a reasonable belief.\n</step4>\n<step5>\nHowever, if there is no evidence of distress or fear, the court might conclude that the worker's belief was not justified — *ìpinnu ilé ẹjọ́* (court's decision) could lean towards dismissing the claim.\n</step6>\n<step6>\nUltimately, the court will weigh all these factors to determine the validity of the worker's belief and the appropriateness of their actions.\n</step6></thinking>", "answer": "<answer>Ilé ẹjọ́ yóò kà àwárí, iriri, àti àìní ẹ̀rí ìdààmú, kí o lè pinnu bóyá ìgbàgbọ́ náà jẹ́ ti ara rẹ̀; bí kò bá sí ẹ̀rí, ìpinnu le jẹ́ pé ìgbàgbọ́ náà kò péye.</answer>", "language": "Yoruba"}
{"question": "Nínú àpọǹ pẹ́tíẹ́ńtì kan tí ó ní ìdákúṣẹ̀ ní codon 508th ti gẹ́ẹ̀ní kan lórí chromosome 7, tí ó fà á sí àṣiṣe ìṣiṣẹ́ pósì-tránṣlẹ́ṣọ̀n àti ìgbé̀kẹ̀lé eròpìn tí kò tọ́ ní rough endoplasmic reticulum, iṣẹ́ ṣíṣe ìṣàn ayọ̀ǹ kan pàtó wo ni ó pọ̀jù ní àwọn sẹ́ẹ̀lì ìgbìtìṣẹ̀ ìgbìyẹn tí ó wà ní ara?", "reasoning": "<thinking><step1>\nThe question asks: “Nínú àpọǹ pẹ́tíẹ́ńtì kan tí ó ní ìdákúṣẹ̀ ní codon 508th” — this refers to a patient with a mutation at the 508th codon of a gene on chromosome 7, specifically related to cystic fibrosis.\n</step1>\n<step2>\nThis mutation leads to a misfolded protein, which is a common issue in cystic fibrosis — *àṣiṣe ìṣiṣẹ́ pósì-tránṣlẹ́ṣọ̀n* means the protein does not fold correctly.\n</step2>\n<step3>\nThe misfolded protein is not properly processed in the rough endoplasmic reticulum — *rough endoplasmic reticulum* is where proteins are synthesized and folded.\n</step3>\n<step4>\nIn cystic fibrosis, this results in a defective CFTR protein, which is crucial for chloride ion transport — *ìgbé̀kẹ̀lé eròpìn* that regulates salt and water movement in cells.\n</step4>\n<step5>\nConsequently, the most affected cellular function in these cells is the regulation of ion transport, leading to thick mucus production — *mucus ti o nipọn* in the lungs and digestive system.\n</step6>\n<step6>\nThus, the specific function that is most impaired in these cells is the transport of chloride ions across the cell membrane.\n</step6></thinking>", "answer": "<answer>Iṣẹ́ ṣíṣe ìṣàn ayọ̀ǹ kan pàtó tí ó pọ̀jù ní àwọn sẹ́ẹ̀lì ìgbìtìṣẹ̀ ìgbìyẹn ni ìgbé̀kẹ̀lé eròpìn.</answer>", "language": "Yoruba"}
{"question": "Báwo ni onimọ̀-ẹ̀rọ̀-kẹ́míkà ṣe lè múra ojutu 50 ml ti ọ̀ṣẹ̀ hydrochloric pẹlu pH ti 1.25 bí ojutu ọ̀ṣẹ̀ hydrochloric tí ó wà níbẹ̀ ti wọn fi ami sí bí 11.6 M?", "reasoning": "<thinking><step1>\nThe question asks: “Báwo ni onimọ̀-ẹ̀rọ̀-kẹ́míkà ṣe lè múra ojutu 50 ml ti [ọ̀ṣẹ̀ hydrochloric = hydrochloric acid] pẹlu [pH = pH] ti 1.25 bí ojutu [ọ̀ṣẹ̀ hydrochloric] tí ó wà níbẹ̀ ti wọn fi ami sí bí 11.6 M?” — meaning it wants to know how a chemist can prepare a 50 ml solution of hydrochloric acid with a pH of 1.25 from a stock solution of 11.6 M.\n</step1>\n<step2>\nTo find the concentration needed for a pH of 1.25, we first convert pH to hydrogen ion concentration — *[H⁺]*. The formula is *[H⁺] = 10^(-pH)*, so *[H⁺] = 10^(-1.25)*.\n</step2>\n<step3>\nCalculating this gives us approximately *[H⁺] = 0.056 M*. This means we need a hydrochloric acid solution with this concentration.\n</step3>\n<step4>\nNext, we use the dilution formula: *C₁V₁ = C₂V₂*, where *C₁* is the concentration of the stock solution (11.6 M), *V₁* is the volume we need to find, *C₂* is the desired concentration (0.056 M), and *V₂* is the final volume (50 ml).\n</step4>\n<step5>\nRearranging the formula gives us *V₁ = (C₂V₂) / C₁*. Plugging in the values: *V₁ = (0.056 M * 50 ml) / 11.6 M*.\n</step5>\n<step6>\nCalculating this results in approximately *V₁ = 0.242 ml*. Therefore, the chemist needs to measure about 0.242 ml of the stock solution and dilute it with water to reach a total volume of 50 ml.\n</step6></thinking>", "answer": "<answer>Onimọ̀-ẹ̀rọ̀-kẹ́míkà gbọdọ́ mú 0.242 ml ti ọ̀ṣẹ̀ hydrochloric 11.6 M ki o sì tú u pọ̀ sí 50 ml.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdún mẹ́fà kan ní ìtàn ìṣòro èémí nígbà ìbí (birth asphyxia), kò bá ènìyàn sọ̀rọ̀ dáradára, ìdàgbàsókè ọpọlọ àti ti ara rẹ̀ lọ́ra, kò darapọ̀ mọ́ àwọn ènìyàn, kò ní ìfẹ́ sí ọ̀pọ̀lọpọ̀ nǹkan, àti pé inú rẹ̀ máa ń bàjẹ́ púpọ̀ tí a bá yọ ọ́ lẹ́nu. Ní ìwọ̀n ìrí àmì àìsàn wọ̀nyí àti ìtàn rẹ̀, kí ni àyẹ̀wò tí ó ṣeé ṣe jù lọ?", "reasoning": "<thinking><step1>\nThe question asks: \"Kí ni àyẹ̀wò tí ó ṣeé ṣe jù lọ?\" — meaning it wants to know what tests are most likely to be done for a six-year-old child with a history of [ìṣòro èémí = birth asphyxia] and developmental issues.\n</step1>\n<step2>\nGiven the child's background, *àyẹ̀wò àkọ́kọ́* would likely include a comprehensive developmental assessment to evaluate cognitive and motor skills.\n</step2>\n<step3>\nAdditionally, *ìtàn ìlera* should be reviewed, focusing on any previous medical interventions or therapies that the child has undergone.\n</step3>\n<step4>\nA neurological evaluation is crucial, as it helps determine if there are any underlying issues affecting *ìdàgbàsókè ọpọlọ*.\n</step4>\n<step5>\nTests like MRI or CT scans may be recommended to visualize brain structure and identify any abnormalities — *àwọn àyẹ̀wò àwòrán*.\n</step5>\n<step6>\nFinally, psychological assessments could be conducted to understand the child's emotional and social development, especially since they have difficulty interacting with others.\n</step6></thinking>", "answer": "<answer>Àyẹ̀wò tí ó ṣeé ṣe jù lọ ni àyẹ̀wò ìdàgbàsókè, àyẹ̀wò ọpọlọ, àti àyẹ̀wò ìmọ̀ràn ọpọlọ.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 60 kan ni irora àyà tó burú jáì fún wakati mẹrin, ó sì kú láàrin wakati 24 lẹ́yìn tí wọ́n gbé e lọ sí ilé-iwosan.  Àyẹ̀wo lẹ́yìn ikú fi hàn pé àyà rẹ̀ ni àwọn ẹ̀jẹ̀ san gbà lórí apá septum àti òpópóná iwájú ilé-àyà òsì.  Kí ni àyẹ̀wo microscope tí ó rọ̀rùn yóò ṣeé ṣe láti fi hàn nínú ọ̀ràn yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àyẹ̀wo microscope tí ó rọ̀rùn yóò ṣeé ṣe láti fi hàn nínú ọ̀ràn yìí?” — meaning it wants to know what a simple microscopic examination could reveal in this case.\n</step1>\n<step2>\nThe patient, a 60-year-old man, experienced severe chest pain for four hours and died within 24 hours after being taken to the hospital — *irora àyà tó burú* indicates a serious condition.\n</step2>\n<step3>\nThe autopsy findings show blood accumulation in the septum and the anterior wall of the left ventricle — *àwọn ẹ̀jẹ̀ san gbà lórí apá septum* suggests a possible myocardial infarction.\n</step3>\n<step4>\nA simple microscopic examination could reveal necrosis of cardiac muscle cells — *ìkú àwọn sẹẹli àyà* — which is indicative of a heart attack.\n</step5>\n<step5>\nAdditionally, one might observe inflammatory cells, such as neutrophils, in the affected area — *àwọn sẹẹli àìlera* indicating an inflammatory response.\n</step6>\n<step6>\nThus, the findings from the microscope would likely show signs of myocardial damage and inflammation.\n</step6></thinking>", "answer": "<answer>Àyẹ̀wo microscope yóò fi hàn ìkú àwọn sẹẹli àyà àti àìlera nínú àyà, tó jẹ́ àmì pé ikọlu àyà ni ó ṣẹlẹ̀.</answer>", "language": "Yoruba"}
{"question": "Kini idi pataki julọ tí a fí ń wọ̀ ìgbàlẹ̀ ní ọjọ́ oní?\nA. Ìgàà Islamu\nB. Ìṣọtẹ̀ Islamu\nC. Ìyàgbàn Islamu\nD. Aabo Islamu\nE. Aṣa Islamu\nF. Ìdámọ̀ràn Islamu\nG. Aṣọ Islamu\nH. Ìyàgbà Islamu", "reasoning": "<thinking><step1>\nThe question asks: “Kini idi pataki julọ tí a fí ń wọ̀ ìgbàlẹ̀ ní ọjọ́ oní?” — which translates to \"What is the most important reason we wear traditional attire today?\" \n</step1>\n<step2>\nWearing traditional attire, or *ìgbàlẹ̀*, often reflects cultural identity and heritage — *ìdánimọ̀ àṣà*.\n</step2>\n<step3>\nIn many cultures, including among Muslims, traditional clothing signifies respect for *ìṣọtẹ̀ Islamu* and adherence to cultural values.\n</step3>\n<step4>\nFor instance, during religious gatherings, wearing appropriate attire can symbolize *aabo Islamu* — safety and respect within the community.\n</step4>\n<step5>\nAdditionally, traditional attire can foster a sense of belonging and unity among people — *ìbáṣepọ̀* within the community.\n</step5>\n<step6>\nConsidering these factors, the most significant reason for wearing traditional attire today is likely tied to cultural expression and identity.\n</step6>\n<step7>\nThus, the answer relates closely to the importance of cultural values and identity in the context of Islam.\n</step7></thinking>", "answer": "<answer>Ìgàà Islamu ni idi pataki julọ tí a fí ń wọ̀ ìgbàlẹ̀ ní ọjọ́ oní.</answer>", "language": "Yoruba"}
{"question": "Ọmọ kan ni ìgbóná kan tí ó wà ní ààrin ọrùn rẹ̀, lábẹ́ egungun hyoid. Kí ni ìgbóná yìí ṣeé ṣe kí ó jẹ́ àmì rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Ọmọ kan ni ìgbóná kan tí ó wà ní ààrin ọrùn rẹ̀, lábẹ́ egungun hyoid” — meaning it describes a child with a lump in the neck area, under the hyoid bone. It seeks to understand what this lump could indicate.\n</step1>\n<step2>\nA lump in the neck, especially in children, can be caused by various factors — *àwọn ìdí pupọ ni ó le fa ìgbóná yìí*. \n</step2>\n<step3>\nCommon causes include infections, such as *ìfarapa* or *ìkànsí*, which can lead to swollen lymph nodes — *àwọn àtọ́ka lymph*.\n</step3>\n<step4>\nAnother possibility is a congenital issue, like a thyroglossal duct cyst — *cyst tí ó wà ní ààrin ọrùn*, which is often present from birth.\n</step4>\n<step5>\nIn some cases, it could also indicate a more serious condition, such as a tumor — *ìkànsí àtọ́ka*, though this is less common in children.\n</step5>\n<step6>\nTo summarize, the lump could be a sign of infection, a cyst, or something more serious, and medical evaluation is essential — *ìtẹ́wọ́gba ìwádìí ìlera jẹ́ pataki*.\n</step6></thinking>", "answer": "<answer>Ìgbóná yìí lè jẹ́ àmì àìlera, cyst, tàbí àtọ́ka tó ṣeé ṣe, àti pé ìwádìí ìlera jẹ́ pataki.</answer>", "language": "Yoruba"}
{"question": "Àdánù pàtàkì wo ni lílò ìpìlẹ̀ irun didùn tí a ṣe pẹ̀lú irin ní ipò ìlàjà tí ó gunlẹ̀ ju ìpìlẹ̀ résine lọ?", "reasoning": "<thinking><step1>\nThe question asks: “Àdánù pàtàkì wo ni lílò ìpìlẹ̀ irun didùn tí a ṣe pẹ̀lú irin ní ipò ìlàjà tí ó gunlẹ̀ ju ìpìlẹ̀ résine lọ?” — meaning it wants to know the significant disadvantages of using a sweet-scented base made with metal in a situation where it is more advantageous than a resin base.\n</step1>\n<step2>\nUsing a metal base can lead to *ìfarapa* (corrosion) over time, especially in humid environments — *àwọn agbegbe ti o ni ọriniinitutu*.\n</step2>\n<step3>\nAdditionally, metal bases can be heavier than resin, making them less practical for certain applications — *iyẹn le fa iṣoro ni gbigbe*.\n</step3>\n<step4>\nThere is also the risk of *ìfarapa si ilera* (health hazards) due to potential toxic substances released from metals when heated.\n</step4>\n<step5>\nIn contrast, resin bases are often lighter and can be more versatile in terms of design — *àwọn ipinnu apẹrẹ*.\n</step6>\n<step6>\nSo, the significant disadvantages of using a metal base include corrosion, weight issues, and potential health risks.\n</step6></thinking>", "answer": "<answer>Àdánù pàtàkì ti lílò ìpìlẹ̀ irun didùn tí a ṣe pẹ̀lú irin ni: ìfarapa, iwuwo, àti ìfarapa si ilera.</answer>", "language": "Yoruba"}
{"question": "Awọn iṣoro wo ni o le ṣẹlẹ lẹhin itọju ti ko ni abẹrẹ fun ipalara apakan ọkan, ati ṣe a nilo abẹrẹ iwadii fun gbogbo alaisan ti o ni ipalara apakan ọkan?", "reasoning": "<thinking><step1>\nThe question asks: “What problems can occur after non-invasive treatment for [injury to the heart = ipalara apakan ọkan], and do we need [diagnostic tests = abẹrẹ iwadii] for all patients with heart injury?”\n</step1>\n<step2>\nAfter non-invasive treatment, complications like *iṣoro ẹjẹ* (blood issues) or *iṣoro atẹgun* (oxygen problems) may arise due to inadequate monitoring of the heart's condition.\n</step2>\n<step3>\nPatients might experience *irora* (pain) or *aifọkanbalẹ* (anxiety) as their body adjusts post-treatment, which can complicate recovery.\n</step3>\n<step4>\nRegarding diagnostic tests, not every patient requires them; however, *abẹrẹ iwadii* is crucial for those showing symptoms like *iṣoro ikọlu* (arrhythmias) or persistent pain.\n</step4>\n<step5>\nIn summary, while some patients may not need extensive testing, monitoring is essential to prevent complications after treatment for heart injury.\n</step5></thinking>", "answer": "<answer>Iṣoro le ṣẹlẹ lẹhin itọju ti ko ni abẹrẹ, ṣugbọn abẹrẹ iwadii jẹ pataki fun awọn alaisan ti o ni awọn aami aisan to ṣe pataki.</answer>", "language": "Yoruba"}
{"question": "Lórí ilẹ̀, ó wà ibẹ̀ ìwọ̀n àgbàlá onírun pupa, ohun èlò ẹlẹ́dẹ̀ onírun gbogboro, àti ìwé kékeré onírun mauve. Ṣé ìwé kékeré náà jẹ́ mauve?\nÀwọn àṣàyàn:\n(A) bẹ́ẹ̀ni\n(B) rara", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé ìwé kékeré náà jẹ́ mauve?” — meaning it wants to know if the small book is mauve.\n</step1>\n<step2>\nIn English, \"mauve\" refers to a pale purple color — *àwọ̀ pupa pẹ̀lú àwọ̀ bulu*.\n</step2>\n<step3>\nThe context mentions other items: *ìwọ̀n àgbàlá onírun pupa* (a large red object) and *ẹlẹ́dẹ̀ onírun gbogboro* (a large yellow item), but focuses on the small book.\n</step3>\n<step4>\nTo determine if the small book is mauve, we need to consider the description given — if it is explicitly stated or implied.\n</step4>\n<step5>\nSince the question directly asks about the color of the small book, we can conclude that it is indeed mauve if the context supports it.\n</step5>\n<step6>\nThus, if the context confirms that the small book is mauve, the answer would be affirmative.\n</step6></thinking>", "answer": "<answer>Bẹ́ẹ̀ni.</answer>", "language": "Yoruba"}
{"question": "Ni obinrin ọmọ ọdun aadọta kan ti o ti ni ilera tẹlẹ ti o wa pẹlu iran meji, ptosis, itojúka die ati idiwọ awọn išipopada oju (ayafi ni ẹgbẹ́), ọmọlẹyin ti o tobi ti ko ni idahun daradara, ati pe ko si papilledema, kini ipo ti o ṣeeṣe julọ?", "reasoning": "<thinking><step1>\nThe question asks: “Ni obinrin ọmọ ọdun aadọta kan ti o ti ni ilera tẹlẹ ti o wa pẹlu iran meji, ptosis, itojúka die ati idiwọ awọn išipopada oju (ayafi ni ẹgbẹ́), ọmọlẹyin ti o tobi ti ko ni idahun daradara, ati pe ko si papilledema, kini ipo ti o ṣeeṣe julọ?” — meaning it describes a 50-year-old woman with specific symptoms and asks for the most likely condition.\n</step1>\n<step2>\nThe symptoms include *ptosis* (drooping eyelids), *itojúka die* (slight weakness), and *idiwọ awọn išipopada oju* (restriction of eye movements), which are significant in diagnosing neurological conditions.\n</step2>\n<step3>\nThe absence of *papilledema* (swelling of the optic disc) suggests that there is no increased intracranial pressure, which rules out certain conditions like tumors or severe intracranial hypertension.\n</step3>\n<step4>\nConsidering the age and symptoms, one possible diagnosis could be *myasthenia gravis*, a condition characterized by weakness in the voluntary muscles, particularly affecting eye movements and eyelids.\n</step4>\n<step5>\nIn *myasthenia gravis*, the body produces antibodies that block or destroy *acetylcholine receptors*, leading to muscle weakness that worsens with activity — *iṣẹ́-ṣiṣe*.\n</step5>\n<step6>\nThe combination of *ptosis*, *weakness*, and the specific eye movement restrictions aligns well with this diagnosis, especially in a middle-aged woman.\n</step6></thinking>", "answer": "<answer>Ipo ti o ṣeeṣe julọ ni myasthenia gravis.</answer>", "language": "Yoruba"}
{"question": "Ọ̀dọ́mọkùnrin ọmọ ọdún mẹ́rìndínlógún kan ti wà níbi ìtójú fún ìtànṣán ilé-ìṣan. Wọ́n tọ́jú rẹ̀ pẹ̀lú ceftriaxone IM, ṣùgbọ́n ìtànṣán náà kò tíì dá, àti ètò ìdánwò ṣíwá pé kò sí ohun tí ó ń dagba síbẹ̀. Nínú àwọn wọ̀nyí, èwo ni pàtàkì olórí ìdí ti àrùn yìí?\nA. Awọn gonococci tí ó le ṣe ìjàkadì pẹ̀lú ceftriaxone\nB. Chlamydia psittaci\nC. Chlamydia trachomatis\nD. Herpes simplex virus", "reasoning": "<thinking><step1>\nThe question is asking about the important cause of a persistent infection in a 17-year-old male being treated with ceftriaxone for a urinary tract infection — *ìtànṣán ilé-ìṣan* — that hasn't improved.\n</step1>\n<step2>\nCeftriaxone is effective against many bacteria, but if the infection persists, it suggests a resistant organism or a different pathogen altogether.\n</step2>\n<step3>\nAmong the options, *gonococci* are known to cause infections that can be resistant to ceftriaxone, especially if the strain is resistant — *ìjàkadì pẹ̀lú ceftriaxone*.\n</step3>\n<step4>\nChlamydia trachomatis is also a common cause of urinary infections, and it is not treated by ceftriaxone, which could explain the lack of improvement.\n</step4>\n<step5>\nChlamydia psittaci and herpes simplex virus are less likely to be the primary causes of a urinary tract infection in this context.\n</step5>\n<step6>\nThus, the most likely important cause of the ongoing infection in this case is *Chlamydia trachomatis*, as it is not effectively treated by ceftriaxone.\n</step6></thinking>", "answer": "<answer>Chlamydia trachomatis ni pàtàkì olórí ìdí ti àrùn yìí.</answer>", "language": "Yoruba"}
{"question": "Ṣé gbólóhùn tó wà ní isalẹ̀ yìí dára tó? \"Toni Kroos gba bọ́ọ̀lù kan ní ìdíje àjọṣepọ̀ Champions League Semifinal.\"", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé gbólóhùn tó wà ní isalẹ̀ yìí dára tó?” — meaning it wants to know if the sentence about Toni Kroos is correct.\n</step1>\n<step2>\nThe sentence states: “Toni Kroos gba bọ́ọ̀lù kan ní ìdíje àjọṣepọ̀ Champions League Semifinal,” which translates to “Toni Kroos received a ball in the Champions League Semifinal match.”\n</step2>\n<step3>\nTo evaluate its correctness, we need to consider the context of a Champions League Semifinal — *ìdíje àjọṣepọ̀* is a significant match in football.\n</step3>\n<step4>\nIn football, it is common for players like Toni Kroos to receive the ball during crucial moments — *gbà bọ́ọ̀lù* is a typical action in a match.\n</step4>\n<step5>\nHowever, we should check if this specific event actually occurred in a recent match — *ṣé ó ṣẹlẹ̀ ní ìdíje kan?*.\n</step5>\n<step6>\nIf the statement is based on a real event, then it is correct; otherwise, it may be inaccurate.\n</step6></thinking>", "answer": "<answer>Bẹẹni, gbolohun naa dára tó, ti Toni Kroos ba gba bọ́ọ̀lù ní ìdíje àjọṣepọ̀ Champions League Semifinal.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mẹtadinlogun (37) tí ó gba ìgbàṣẹ̀ ẹ̀dọ̀ fún ọdún meje sẹ́yìn ń ṣe àkọsílẹ̀ àrùn jaundice ati àwọn àdánwò iṣẹ́ ẹ̀dọ̀ tí kò dáa, pẹ̀lú ìdinku ìṣàn ẹ̀jẹ̀ sí ẹ̀dọ̀ tó pọ̀ gidigidi lórí Doppler ultrasound.  Nítorí ìfihàn àrùn yìí ati àwọn ìwádìí ilé-iwosan lọ́wọ́lọ́wọ́, àwọn ẹ̀ya ìṣe-ara wo ni a lè retí lórí ìṣàtúntú ẹ̀dọ̀ tí a gbà?", "reasoning": "<thinking><step1>\nThe question is asking about a 37-year-old man who has a history of jaundice and abnormal liver function tests, along with significant blood flow reduction to the liver as seen on Doppler ultrasound. It seeks to understand what types of liver interventions can be expected based on these findings.\n</step1>\n<step2>\nJaundice indicates a problem with liver function — *àrùn ẹ̀dọ̀* — which can be due to various causes like hepatitis or cirrhosis. The abnormal liver tests suggest that the liver is not functioning properly.\n</step2>\n<step3>\nThe significant reduction in blood flow to the liver, noted on the Doppler ultrasound, could indicate conditions like portal hypertension — *ìdí ẹ̀dọ̀* — which can lead to complications requiring intervention.\n</step3>\n<step4>\nIn such cases, interventions might include procedures like a transjugular intrahepatic portosystemic shunt (TIPS) — *ìtẹ̀síwájú TIPS* — to relieve pressure in the portal vein.\n</step4>\n<step5>\nAdditionally, if there are signs of liver failure, a liver transplant may be considered — *ìyípadà ẹ̀dọ̀* — especially if the liver is severely damaged.\n</step5>\n<step6>\nMonitoring for complications such as variceal bleeding or hepatic encephalopathy is also crucial — *ìfarapa àtọkànwá* — as these can arise from the underlying liver issues.\n</step6>\n<step7>\nOverall, the expected interventions will depend on the severity of the liver disease and the specific findings from ongoing evaluations.\n</step7></thinking>", "answer": "<answer>Àwọn ìṣàtúntú ẹ̀dọ̀ tí a lè retí ni TIPS tàbí ìyípadà ẹ̀dọ̀, pẹ̀lú ìmúlò àyẹ̀wò fún àwọn ìfarapa àtọkànwá.</answer>", "language": "Yoruba"}
{"question": "Ninu ọkunrin ọdun 56 kan ti o ti ṣe abẹrẹ fun idena inu-ikun ńlá ti o fa nipasẹ ìṣòro inu-ikun mẹta ọjọ sẹyin, ati pe o wa bayi pẹlu ileus ṣugbọn o ni itunu, pẹlu afẹfẹ ọfẹ labẹ diaphragm lori awọn aworan X-ray, ikun ti o ṣàn, ati irora aarin, kini idi ti afẹfẹ ọfẹ ti o ri labẹ diaphragm?", "reasoning": "<thinking><step1>\nThe question asks: “What is the reason for the free air seen under the diaphragm in a 56-year-old man who had a recent large bowel obstruction?” — here, *afẹfẹ ọfẹ = free air* and *ìṣòro inu-ikun = bowel obstruction*.\n</step1>\n<step2>\nFree air under the diaphragm typically indicates a perforation in the gastrointestinal tract — *perforation du tube digestif*.\n</step2>\n<step3>\nIn this case, the patient had a recent bowel obstruction, which can lead to increased pressure and potential rupture — *rupture de l'intestin*.\n</step4>\n<step4>\nThe presence of free air suggests that air has escaped from the intestines into the abdominal cavity — *l'air s'est échappé dans la cavité abdominale*.\n</step5>\n<step5>\nThis condition can cause symptoms like abdominal pain and discomfort, which aligns with the patient’s reported *irora aarin = central pain*.\n</step6>\n<step6>\nTherefore, the free air under the diaphragm is likely due to a perforation resulting from the bowel obstruction.\n</step6></thinking>", "answer": "<answer>Afẹfẹ ọfẹ labẹ diaphragm jẹ nitori perforation ti o ṣẹlẹ lati ìṣòro inu-ikun.</answer>", "language": "Yoruba"}
{"question": "Ṣiṣẹ́to ti orílẹ̀-èdè wo ni ó ń pèsè ìṣirò tí ó gbẹ́kẹ̀lé ní ìpele orílẹ̀-èdè àti ìpínlẹ̀ lójúọdún fún ṣíṣàṣàyàn?", "reasoning": "<thinking><step1>\nThe question asks: “Ṣiṣẹ́to ti orílẹ̀-èdè wo ni ó ń pèsè ìṣirò tí ó gbẹ́kẹ̀lé ní ìpele orílẹ̀-èdè àti ìpínlẹ̀ lójúọdún fún ṣíṣàṣàyàn?” — meaning it wants to know which country provides statistics that rely on national and state levels annually for planning.\n</step1>\n<step2>\nCountries often use statistical systems for planning — *sistemu iṣiro* — that include data collection at both national and state levels.\n</step2>\n<step3>\nFor example, the United States has the Census Bureau, which conducts a census every ten years and provides annual estimates — *ìṣirò ọdún* — for various demographics.\n</step3>\n<step4>\nIn Nigeria, the National Bureau of Statistics (NBS) plays a similar role, offering data that supports *ìmúlò àtúnṣe* and development planning.\n</step4>\n<step5>\nThese statistical systems are crucial for understanding population trends, economic indicators, and social issues — *ìṣòro awujọ*.\n</step5>\n<step6>\nThus, countries like the United States and Nigeria have established frameworks for annual statistical reporting that aid in effective planning.\n</step6></thinking>", "answer": "<answer>Orílẹ̀-èdè bíi Amẹrika àti Nàìjíríà ni wọ́n ń pèsè ìṣirò tí ó gbẹ́kẹ̀lé ní ìpele orílẹ̀-èdè àti ìpínlẹ̀ lójúọdún fún ṣíṣàṣàyàn.</answer>", "language": "Yoruba"}
{"question": "Yàtò sí iṣẹ́ ìṣàn omi nínú ìkọ̀kọ̀ 1 àti ti ìkọ̀kọ̀ 2 báà ṣe, bí a bá gba pé àtìlẹ́yìn náà dúró, tí ìṣàn omi náà sì jẹ́ lójúréré?", "reasoning": "<thinking><step1>\nThe question asks: “Yàtò sí [iṣẹ́ ìṣàn omi = water flow] nínú [ìkọ̀kọ̀ 1 = reservoir 1] àti [ìkọ̀kọ̀ 2 = reservoir 2] báà ṣe?” — meaning it wants to know the difference in water flow between the two reservoirs if the support remains constant.\n</step1>\n<step2>\nTo analyze this, we need to consider the factors affecting water flow — *factors like pressure, elevation, and outlet size*.\n</step2>\n<step3>\nIf both reservoirs have the same support, we can assume that *ìṣàn omi* will depend on their respective heights and outlet configurations.\n</step3>\n<step4>\nFor instance, if *ìkọ̀kọ̀ 1* is higher than *ìkọ̀kọ̀ 2*, the water flow from *ìkọ̀kọ̀ 1* will be greater due to gravitational pull — *ìtẹ̀sí àtọkànwá*.\n</step4>\n<step5>\nAdditionally, if the outlet of *ìkọ̀kọ̀ 1* is larger, it will allow more water to flow out compared to *ìkọ̀kọ̀ 2* — *ìṣàn omi tó pọ̀ síi*.\n</step5>\n<step6>\nThus, the difference in water flow between the two reservoirs can be significant based on these parameters.\n</step6></thinking>", "answer": "<answer>Ìyàtọ̀ sí iṣẹ́ ìṣàn omi nínú ìkọ̀kọ̀ 1 àti ìkọ̀kọ̀ 2 lè jẹ́ ńlá, da lori ìtẹ̀sí àtọkànwá àti iwọń àtẹ̀gùn.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 25 kan wá sí Ẹ̀ka Ìtọ́jú Ìpàdàbọ̀ Àkànṣe pẹ̀lú àìlera ìgbàgbọ́, ìgbóná ara tí ó tàn káàkiri, ríru, ẹ̀gbọ̀n, àti ìgbóná ara fún ọjọ́ méjì. Ìwádìí ara fi hàn pé ọ̀pọ́n àbẹ́rẹ̀ tí ó gbẹ́ wà nínú àpò-ẹ̀yìn rẹ̀, àti ẹ̀jẹ̀ tí a mú fún ìwádìí kò ní ààrùn, èyí tí ó fi hàn pé àrùn ìgbóná ara tí ó gbóná gan-an. Àyọ̀kà tí ó yàtọ̀ sí i lórí sẹ́ẹ̀li T ni majẹ̀mu náà ṣe pàtàkì jù lọ láti so mọ́?", "reasoning": "<thinking><step1>\nThe question is asking about a 25-year-old woman who presents to the Emergency Department with symptoms of fever, generalized body aches, chills, and fever for two days. It mentions that a physical examination shows multiple tender lymphadenopathy in her neck, and blood tests reveal no infection, indicating a significant systemic condition. The question also asks about the importance of a specific cell line in relation to this case.\n</step1>\n<step2>\nIn this context, *àìlera ìgbàgbọ́* refers to a condition that may affect the immune system, possibly indicating an autoimmune disorder or malignancy. The symptoms suggest a systemic issue rather than a localized infection.\n</step2>\n<step3>\nThe presence of *àbẹ́rẹ̀* (lymphadenopathy) and the absence of infection in blood tests could point towards conditions like lymphoma or other hematological disorders. This is crucial for diagnosis.\n</step3>\n<step4>\nThe mention of *àyọ̀kà* (cell line) likely refers to a specific type of cell that is important for understanding the underlying pathology. For example, *sẹẹli T* (T cells) are vital in immune response and could indicate a lymphoproliferative disorder.\n</step4>\n<step5>\nUnderstanding the role of T cells is essential because they can help determine if the body is responding appropriately to infections or if there is an underlying malignancy affecting the immune system.\n</step5>\n<step6>\nThus, the significance of the T cell line in this case is to assess the immune function and potential malignancy, which is critical for guiding further diagnostic and therapeutic decisions.\n</step6></thinking>", "answer": "<answer>Ìmúrasílẹ̀ sẹẹli T jẹ́ pàtàkì nítorí ó ṣe iranlọwọ láti mọ ìpinnu àrùn àìlera ìgbàgbọ́ tàbí àrùn majẹ̀mu.</answer>", "language": "Yoruba"}
{"question": "Àpẹẹrẹ àrùn àtìgbàgbọ́ kan fi ìtìjú ẹ̀jẹ̀ ní imú, ìgbóná ojú, àti irora hàn. Ìwádìí ẹ̀gbà irúgbìn ní ìgbóná ojú fi àwọn hyphae tí ó gbìnà lóríṣìíríṣì hàn.  Àrùn wo ni ó ṣeé ṣe jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “Àrùn wo ni ó ṣeé ṣe jùlọ?” — meaning it wants to know which disease is most likely given the symptoms of *ìtìjú ẹ̀jẹ̀* [blood in the nose], *ìgbóná ojú* [fever], and *irora* [pain].\n</step1>\n<step2>\nThe symptoms suggest a possible infection or inflammatory condition. The presence of blood in the nose could indicate *sinusite* [sinusitis] or another upper respiratory issue.\n</step2>\n<step3>\nThe mention of *hyphae* indicates a fungal infection, which is often associated with conditions like *aspergillose* [aspergillosis] or other fungal sinus infections.\n</step3>\n<step4>\nFungal infections can cause fever and pain, especially if they lead to *inflammation* in the sinuses — *ilana àìlera*.\n</step4>\n<step5>\nConsidering the symptoms and the presence of hyphae, the most likely condition is *aspergillose*, which can present with these signs.\n</step6></thinking>", "answer": "<answer>Àrùn tí ó ṣeé ṣe jùlọ ni *aspergillose*.</answer>", "language": "Yoruba"}
{"question": "Ẹ jẹ́ kí a wo bí a ṣe ń lo glutaraldehyde tó ní ìwọ̀n 4% lórí ìpẹkun ehin tó bá jábọ́ nígbà ìtọ́jú pulpotomy. Àkókò melo ló yẹ kí a fi síbẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Ẹ jẹ́ kí a wo bí a ṣe ń lo [glutaraldehyde = glutaraldehyde] tó ní ìwọ̀n 4% lórí [ìpẹkun ehin = dental pulp] tó bá jábọ́ nígbà [ìtọ́jú pulpotomy = pulpotomy treatment].” This means it wants to know how to use 4% glutaraldehyde on the dental pulp during pulpotomy and the duration of application.\n</step1>\n<step2>\nGlutaraldehyde is often used as a disinfectant in dental procedures — *ó jẹ́ ohun èlò tó ń pa kokoro arun* and helps in tissue fixation.\n</step2>\n<step3>\nDuring pulpotomy, the glutaraldehyde is applied to the exposed pulp to disinfect and preserve the remaining tissue — *lati pa àtọ́run* and prevent infection.\n</step3>\n<step4>\nTypically, the application time for 4% glutaraldehyde is around 5 to 10 minutes — *àkókò tó yẹ kí a fi síbẹ̀ ni 5 sí 10 ìṣẹ́jú*.\n</step4>\n<step5>\nAfter the application, it is crucial to rinse the area thoroughly to remove any residual glutaraldehyde — *lati yọkúrò ni glutaraldehyde tó kù*.\n</step5>\n<step6>\nIn summary, the use of 4% glutaraldehyde in pulpotomy involves a careful application for a short duration to ensure effective disinfection.\n</step6></thinking>", "answer": "<answer>A yẹ kí a fi glutaraldehyde tó ní ìwọ̀n 4% síbẹ̀ fún ìṣẹ́jú 5 sí 10, kí a sì yọkúrò ni kó tó parí ìtọ́jú pulpotomy.</answer>", "language": "Yoruba"}
{"question": "Ta ni ṣe afiwe pe plaque kokoro arun le fa pipadanu egungun laarin agbegbe ipa ti o to 1.5 si 2.5 mm?", "reasoning": "<thinking><step1>\nThe question asks: “Ta ni ṣe afiwe pe [plaque kokoro arun = bacterial plaque] le fa [pipadanu egungun = bone loss] laarin agbegbe ipa ti o to 1.5 si 2.5 mm?” — meaning it wants to compare how bacterial plaque can cause bone loss in an area measuring between 1.5 to 2.5 mm.\n</step1>\n<step2>\nBacterial plaque can lead to inflammation in the gums — *ilufin ni awọn gumi* — which is a precursor to periodontal disease.\n</step2>\n<step3>\nThis disease causes the surrounding bone to deteriorate — *egungun ti o wa ni ayika* — as the body responds to the infection.\n</step3>\n<step4>\nIn the specified area of 1.5 to 2.5 mm, the bone loss can be significant, especially if the plaque is not removed — *ti a ko ba yọ plaque naa kuro*.\n</step4>\n<step5>\nResearch shows that even small amounts of plaque can initiate a cascade of bone resorption — *iyipada egungun* — leading to loss of support for teeth.\n</step5>\n<step6>\nThus, the presence of bacterial plaque in this range can indeed result in measurable bone loss — *pipadanu egungun ti o le ṣe akiyesi*.\n</step6></thinking>", "answer": "<answer>Bacterial plaque le fa pipadanu egungun laarin agbegbe ipa ti o to 1.5 si 2.5 mm.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun mẹta kan ṣe afihan awọn ami aiṣan ti iṣọn-ara, petechiae gbogbo ara, itan-ara aisan kokoro arun ọsẹ meji sẹyin, hemoglobin deede, hematocrit, iye WBC ati iyatọ, ṣugbọn iye platelet ti 19,000/iL. Ni akiyesi awọn ami aisan ati awọn abajade ile-iwosan wọnyi, arun kokoro eyi ni o kere julọ lati ni asopọ pẹlu ipo ọmọ yii?", "reasoning": "<thinking><step1>\nThe question asks: \"Considering the symptoms and lab results of a three-year-old child, which infectious disease is least likely associated with this condition?\" It mentions symptoms like petechiae, a history of infection two weeks ago, and a very low platelet count of 19,000/iL.\n</step1>\n<step2>\nPetechiae are small red or purple spots on the skin caused by bleeding — *petechiae jẹ ami ti aisan ti o le fa nipasẹ iṣọn-ara*. This suggests a possible issue with blood clotting or platelet production.\n</step2>\n<step3>\nThe child has normal hemoglobin and hematocrit levels, which indicates that there is no significant anemia — *ko si aisan ẹjẹ pataki*. However, the very low platelet count is concerning.\n</step3>\n<step4>\nCommon infectious diseases that can cause low platelet counts include dengue fever and viral infections like measles — *arun kokoro bi dengue ati arun kokoro measles le fa iṣoro yii*. However, we need to identify which one is least likely.\n</step4>\n<step5>\nDengue fever typically presents with thrombocytopenia (low platelet count) and petechiae, while measles usually does not cause significant changes in platelet levels — *measles ko maa n fa iyipada pataki ninu iye platelet*.\n</step5>\n<step6>\nGiven the symptoms and lab results, measles is the least likely infectious disease associated with this child's condition due to the absence of significant thrombocytopenia.\n</step6></thinking>", "answer": "<answer>Arun kokoro ti o kere julọ lati ni asopọ pẹlu ipo ọmọ yii ni measles.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọmọ ọdún méjìdínlọ́gbọ̀n kan ti ní ìbísí ìwọ̀n ẹ̀ẹ́wàá kíló nínú ọdún mẹ́ta, ó sì ń sọ nípa díẹ̀díẹ̀ tí nǹkan oṣù rẹ̀ ń wá sí títí ó fi dáwọ́ dúró pátápátá fún oṣù mẹ́jọ sẹ́yìn, pẹ̀lú ìwọ̀n ìfúnpá tó jẹ́ 160/100 mm Hg. Ní ríronú lórí àwọn àmì wọ̀nyí, kí ni ìwádìí hómónù tó yẹ kí á ṣe láti mọ ohun tó ń fa àrùn náà?", "reasoning": "<thinking><step1>\nThe question asks about a 29-year-old woman with a blood pressure reading of 160/100 mm Hg, and it wants to know what hormonal investigations should be conducted to understand the cause of her condition.\n</step1>\n<step2>\nA blood pressure of 160/100 mm Hg indicates *ìkànsí ẹjẹ* (hypertension), which can be influenced by various factors, including hormonal imbalances.\n</step2>\n<step3>\nIn this case, we should consider testing for conditions like *Cushing's syndrome* — which is caused by excess cortisol — and *pheochromocytoma*, a tumor that can lead to increased catecholamines.\n</step3>\n<step4>\nAdditionally, measuring levels of *aldosterone* and *renin* can help assess for primary hyperaldosteronism, which is another potential cause of hypertension.\n</step4>\n<step5>\nIt’s also important to evaluate thyroid function, as *àìlera àtọ́kànwá* (thyroid disorders) can contribute to high blood pressure.\n</step5>\n<step6>\nThus, the hormonal investigations should include cortisol levels, catecholamines, aldosterone, renin, and thyroid function tests to identify the underlying cause of her hypertension.\n</step6></thinking>", "answer": "<answer>Ìwádìí hómónù tó yẹ kí á ṣe ni: ìwọn cortisol, catecholamines, aldosterone, renin, àti ìwádìí iṣẹ́ àtọ́kànwá.</answer>", "language": "Yoruba"}
{"question": "Kini orukọ ìṣọpọ́ àwọn ìlà ìwọ̀n àtọ́ka ní àárín ojú àgbọnrin rààmù tí ó fi hàn ní ìdàgbàsókè fífẹ̀rẹ̀gbẹ̀ ní ojú ilẹ̀ àgbọnrin?", "reasoning": "<thinking><step1>\nThe question asks: “Kini orukọ ìṣọpọ́ [the name of the combination] àwọn ìlà ìwọ̀n àtọ́ka [of the coordinate axes] ní àárín ojú àgbọnrin [in the Cartesian plane]?” — meaning it wants to know the name of the combination of coordinate axes in the Cartesian plane.\n</step1>\n<step2>\nIn mathematics, the Cartesian plane is defined by two perpendicular lines — *àwọn ìlà méjì tí ó nìkan* — which are the x-axis and y-axis.\n</step2>\n<step3>\nThese axes intersect at a point called the origin — *ibi ìbẹ̀rẹ̀* — which is represented as (0,0).\n</step3>\n<step4>\nThe combination of these axes creates four quadrants — *àwọn kóòdìnà mẹ́rin* — where each quadrant has specific coordinates.\n</step4>\n<step5>\nIn summary, the name of the combination of the coordinate axes in the Cartesian plane is simply referred to as the Cartesian coordinate system — *ìṣọpọ́ kóòdìnà Cartesian*.\n</step5></thinking>", "answer": "<answer>Ìṣọpọ́ kóòdìnà Cartesian ni orukọ ìṣọpọ́ àwọn ìlà ìwọ̀n àtọ́ka ní àárín ojú àgbọnrin.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdọ kan ni ìṣòro ìgbàlódé tí ó pẹ́, pẹ̀lú ìdinku FSH, LH, àti testosterone. Nínú àwọn wọ̀nyí, èwo ni kò ṣeé ṣe?\nA. Àrùn Kallmann\nB. Àrùn Klinefelter\nC. Ìdákẹ́jẹ́pọ̀ ìgbàlódé\nD. Ìyípadà gẹ́ẹ́sì DAX-1", "reasoning": "<thinking><step1>\nThe question asks: “Okunrin ọdọ kan ni ìṣòro ìgbàlódé tí ó pẹ́, pẹ̀lú ìdinku [FSH = follicle-stimulating hormone], [LH = luteinizing hormone], àti [testosterone = testosterone].” This means it is inquiring about which condition among the options does not occur with low levels of these hormones.\n</step1>\n<step2>\nIn young men, low levels of FSH, LH, and testosterone can indicate various conditions — *àwọn àrùn* that affect hormonal balance and sexual development.\n</step2>\n<step3>\nOption A, *Àrùn Kallmann*, is characterized by hypogonadism and often presents with low testosterone levels — *ìdinku testosterone* is common here.\n</step3>\n<step4>\nOption B, *Àrùn Klinefelter*, typically involves an extra X chromosome and leads to low testosterone and elevated FSH and LH — *ìdinku FSH àti LH* is not typical in this condition.\n</step4>\n<step5>\nOption C, *Ìdákẹ́jẹ́pọ̀ ìgbàlódé*, refers to delayed puberty, which can also present with low levels of these hormones — *ìdinku FSH, LH, àti testosterone* is expected.\n</step5>\n<step6>\nOption D, *Ìyípadà gẹ́ẹ́sì DAX-1*, is associated with disorders of sexual development and can lead to low hormone levels as well — *ìdinku FSH àti LH* is also seen here.\n</step7>\n<step8>\nHowever, Klinefelter syndrome is unique because it often presents with elevated FSH and LH, making it the exception among the options.\n</step8></thinking>", "answer": "<answer>Àrùn Klinefelter ni kò ṣeé ṣe pẹ̀lú ìdinku FSH, LH, àti testosterone.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹ́ta [7] kan wá pẹ̀lú ìgbóná gbogbo ara, ìwádìí ìṣàn-ikan sì fi hàn pé ó ní albuminuria pupọ̀. Àwọn ìwádìí kémi-ẹ̀jẹ̀ fi hàn pé ó ní hypoalbuminaemia pẹ̀lú hyperlipidemia. Ìwádìí àpòòtọ́ kíkún fún ìgbọ̀nà ẹ̀dọ̀fóró fi hàn pé ó dàbí àdánù lábẹ́ ìwádìí fífúnrá. Kí ni ìwádìí ìwé-èlékítírónìkì yóò ṣeé ṣe kí ó fi hàn ní ipò yìí?", "reasoning": "<thinking><step1>\nThe question is asking: \"What will the electronic medical record (EMR) investigations show for a three-year-old boy with generalized body swelling, significant albuminuria, hypoalbuminemia, and hyperlipidemia?\" \n</step1>\n<step2>\nThe symptoms suggest a possible case of nephrotic syndrome — *syndrome néphrotique* — characterized by heavy proteinuria and edema.\n</step2>\n<step3>\nIn this context, the EMR will likely document the patient's history, physical examination findings, and laboratory results — *résultats de laboratoire* — indicating the severity of the condition.\n</step3>\n<step4>\nThe presence of hypoalbuminemia indicates low levels of albumin in the blood, which is a hallmark of nephrotic syndrome — *une caractéristique du syndrome néphrotique*.\n</step4>\n<step5>\nHyperlipidemia, or elevated lipids, often accompanies nephrotic syndrome due to the liver's response to low protein levels — *réaction du foie aux faibles niveaux de protéines*.\n</step5>\n<step6>\nThe EMR will also track any treatments administered, such as corticosteroids, and monitor the patient's response over time — *réponse du patient au traitement*.\n</step6>\n<step7>\nOverall, the EMR will provide a comprehensive view of the patient's condition, including trends in protein levels and kidney function — *fonction rénale*.\n</step7></thinking>", "answer": "<answer>Ìwé-èlékítírónìkì yóò fi hàn pé ọmọkunrin náà ní àdánù àtọkànwá, hypoalbuminaemia, àti hyperlipidemia, pẹ̀lú ìtẹ́lọ́run àtúnṣe.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin ọlọ́dún ọgọ́ta (60) kan wá sí ilé ìwòsàn alábàápàdé (OPD) pẹ̀lú ìtàn àmúlò òpìọ̀mù líle fún ogún (20) ọdún sẹ́yìn. Ó ti jáwọ́ nínú lílo òpìọ̀mù láti ọjọ́ méjì sẹ́yìn. Àwọn àmì ìfàsẹ́yìn yóò ní nínú:\nA. Ìtọ̀gbẹ / Oríṣùn\nB. Ojú kíkí kékeré\nC. Imú sísun (Rhinorhea)\nD. Ìfúnpá tí ó lọ sílẹ̀ / Tí ó dínkù", "reasoning": "<thinking><step1>\nThe question presents a case of a 60-year-old man who visits an outpatient department (OPD) with a history of heavy opioid use for 20 years. He has stopped using opioids two days ago. It asks about the withdrawal symptoms he might experience.\n</step1>\n<step2>\nWithdrawal from opioids can lead to various symptoms, which are often uncomfortable. In Yoruba, we refer to these symptoms as *àmì ìfàsẹ́yìn*.\n</step2>\n<step3>\nCommon withdrawal symptoms include *ìtọ̀gbẹ* (diarrhea), which is often one of the first signs. This is due to the body's reaction to the absence of the drug.\n</step3>\n<step4>\nAnother symptom is *imú sísun* (rhinorrhea), which means a runny nose. This occurs as the body adjusts to the lack of opioids.\n</step4>\n<step5>\nAdditionally, *oju kíkí kékeré* (small pupils) can be a sign of withdrawal, as the body reacts to the absence of the drug.\n</step6>\n<step6>\nLastly, *ìfúnpá tí ó lọ sílẹ̀* (sweating) is also common, as the body may experience increased perspiration during withdrawal.\n</step7>\n<step7>\nConsidering these symptoms, the man is likely to experience a combination of these withdrawal signs as he has recently stopped using opioids.\n</step7></thinking>", "answer": "<answer>Àwọn àmì ìfàsẹ́yìn yóò ní: Ìtọ̀gbẹ, Imú sísun, Ojú kíkí kékeré, àti Ìfúnpá tí ó lọ sílẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọlọ́gbo ogbógi ọdún 55 kan ti ń ṣe àṣefúnni ní sísọ̀rọ̀ tí kò bá ara rẹ̀ mu, ègún, àti híhù, lẹ́yìn tí ó ti fi ògìrì sílẹ̀ fún ọjọ́ mẹ́ta sẹ́yìn.  Lórí àwọn àmì wọ̀nyí, kí ni àyẹ̀wò tí ó ṣeé ṣe julọ?", "reasoning": "<thinking><step1>\nThe question asks: “What is the most likely examination for a 55-year-old man experiencing confusion, agitation, and hallucinations after stopping alcohol for three days?” — here, *àṣefúnni* means confusion, *ègún* refers to agitation, and *híhù* means hallucinations.\n</step1>\n<step2>\nThese symptoms suggest a possible case of alcohol withdrawal syndrome — *àìlera ọti* — which can occur after abrupt cessation of alcohol intake.\n</step2>\n<step3>\nIn such cases, a common examination is the *CIWA-Ar* scale, which assesses withdrawal symptoms — *ìwọn àìlera*.\n</step3>\n<step4>\nAdditionally, it’s important to check for other complications, such as electrolyte imbalances — *ìdàpọ̀ àtọka* — that can exacerbate these symptoms.\n</step4>\n<step5>\nThe patient may also require a complete blood count and liver function tests to evaluate overall health — *ìdánwò ẹ̀jẹ̀* àti *ìdánwò iṣẹ́ ẹdọ*.\n</step5>\n<step6>\nGiven the context, the most appropriate examination to start with would be the CIWA-Ar scale to assess the severity of withdrawal symptoms.\n</step6></thinking>", "answer": "<answer>Àyẹ̀wò tí ó ṣeé ṣe julọ ni CIWA-Ar láti ṣe àyẹ̀wò àìlera ọti.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọmọ ọdun 70 kan ní ìdánwò ìtẹ̀sílẹ̀ tí a gbìn lórí agar ẹ̀jẹ̀ 5%, tí ó fihan àwọn àgbẹ̀dá àlùfà-hemolytic ní ọjọ́ kejì.  Lẹ́yìn ìṣiṣẹ́ síwájú sí i, kini àwọn ànímọ́ tí ó ṣeé ṣe ti ẹ̀dá alààyè yìí, pẹ̀lú àwọn ànímọ́ Gram staining rẹ̀, abajade idanwo catalase, àti ìgbòògùn bile?", "reasoning": "<thinking><step1>\nThe question is asking about a 70-year-old man who underwent a blood test showing 5% [hemolytic anemia = àgbẹ̀dá àlùfà-hemolytic] on the second day. It wants to know the possible organisms involved, including their Gram staining characteristics, catalase test results, and bile sensitivity.\n</step1>\n<step2>\nIn cases of hemolytic anemia, common organisms include *Staphylococcus aureus* and *Streptococcus pneumoniae*. The Gram staining would show *Staphylococcus* as Gram-positive cocci in clusters and *Streptococcus* as Gram-positive cocci in chains.\n</step2>\n<step3>\nThe catalase test is crucial; *Staphylococcus aureus* is catalase-positive, meaning it produces bubbles when hydrogen peroxide is applied, while *Streptococcus pneumoniae* is catalase-negative, showing no reaction.\n</step3>\n<step4>\nRegarding bile sensitivity, *Streptococcus pneumoniae* is bile-soluble, which means it can be lysed by bile, while *Staphylococcus aureus* is not affected by bile.\n</step4>\n<step5>\nThus, the possible organisms causing the hemolytic anemia could be *Staphylococcus aureus* and *Streptococcus pneumoniae*, with their respective Gram staining, catalase test results, and bile sensitivity providing diagnostic clues.\n</step5></thinking>", "answer": "<answer>Àwọn ànímọ́ tí ó ṣeé ṣe ni *Staphylococcus aureus* àti *Streptococcus pneumoniae*, pẹ̀lú Gram staining wọn jẹ́ Gram-positive, catalase test *Staphylococcus* jẹ́ positive, àti *Streptococcus* jẹ́ negative; *Streptococcus* jẹ́ bile-soluble, *Staphylococcus* kò.</answer>", "language": "Yoruba"}
{"question": "Ọjọ kan lẹhin ti a ti ṣe abẹrẹ carotid endarterectomy osi fun ọkunrin ọdun 63 kan, ori rẹ ti ń bà ṣe kedere. Ó ṣàpèjúwe rẹ̀ gẹ́gẹ́ bí 9 nínú 10 ní agbára. Ó ní ìrírí ìgbóná. Ó ní 80% stenosis ni àtẹ̀gùn carotid osi, ó sì gba heparin ṣáájú abẹrẹ náà. Òun ní itan-àkọọlẹ ti awọn ikọlu ischemic ti ko gun, meji ati oṣu mẹrin sẹyin. Ó ní àtẹ̀gùn gíga, àrùn suga iru 2, ati hypercholesterolemia. Ó ti mu siga pakẹ̀ẹ̀ kan lójoojú fún ọdún 40. Ó mu 1–2 biari ní ọ̀sẹ̀. Àwọn oogun lọ́wọ́lọ́wọ́ pẹlu lisinopril, metformin, sitagliptin, ati aspirin.  Igbona rẹ̀ jẹ́ 37.3°C (99.1°F), ìṣísẹ̀ rẹ̀ jẹ́ 111/min, ati àtẹ̀gùn ẹ̀jẹ̀ rẹ̀ jẹ́ 180/110 mm Hg. Ó dàbí ẹni tí ó rú, tí ó sì mọ̀ ara rẹ̀ nìkan.  Àyẹ̀wò fi hàn pé àwọn ọmọ-aláìdáà fi hàn pé àwọn ọmọ-aláìdáà fi hàn pé àwọn akọ́kọ́ ṣe àyípadà ní ṣọwọ́n sí ìmọ́lẹ̀. Àgbàlà ojú ọtun wà níbẹ̀. Agbára èso jẹ́ dinni ní apá ọtun oke ati isalẹ. Awọn reflexes tendon jinlẹ jẹ 3+ ni apa ọtun.  Àgbàlà abẹrẹ ọrùn òsì wà tí kò fi hàn kedere tabi tu silẹ. Àyẹ̀wò ọkàn kò fi hàn kedere. Iye ẹjẹ gbogbo ati iye serum ti creatinine, electrolytes, ati glucose wa laarin ibiti o yẹ.  A ṣe ayẹwo CT ti ori.  Ewo ni ọkan ninu awọn wọnyi ti o jẹ okunfa ti o lagbara julọ fun ipo alaisan yii?\nA. Iye ti carotid stenosis\nB. Itọju Aspirin\nC. Heparin perioperative\nD. Àtẹ̀gùn gíga\nE. Sisigẹ", "reasoning": "<thinking><step1>\nThe question asks: \"Which of the following is the strongest contributing factor for this patient's condition?\" — it describes a 63-year-old man post carotid endarterectomy with significant symptoms.\n</step1>\n<step2>\nThe patient has a history of 80% carotid stenosis, which is a major risk factor for ischemic events — *ìtàn àkọọlẹ ti stenosis carotid*.\n</step2>\n<step3>\nHe also has hypertension — *àtẹ̀gùn gíga* — and diabetes, both of which can exacerbate vascular issues.\n</step3>\n<step4>\nThe use of aspirin and heparin perioperatively is standard, but they are not as significant as the underlying conditions.\n</step4>\n<step5>\nGiven the patient's history of ischemic attacks and current symptoms, the carotid stenosis is likely the most critical factor contributing to his condition.\n</step5>\n<step6>\nIn summary, while multiple factors are at play, the severity of carotid stenosis stands out as the primary concern.\n</step6></thinking>", "answer": "<answer>Iye ti carotid stenosis ni okunfa ti o lagbara julọ fun ipo alaisan yii.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọlọ́dún méjìdínlógójì kan wá sí ọ̀dọ̀ dókítà àgbà pẹ̀lú ẹ̀dùn pé òun ń tọ̀jẹ̀ láìsí ìrora fún ọjọ́ márùn-ún sẹ́yìn. Ìtàn rẹ̀ fi hàn pé ó ti mu sìgá fún ogún ọdún (20 pack-year), àti pé nǹkan oṣù rẹ̀ kẹ́yìn wáyé ní ọjọ́ mẹ́wàá sẹ́yìn. Ìfúnpá rẹ̀ jẹ́ 130/80 mm Hg, ìlù ọkàn rẹ̀ jẹ́ 86/min, ìyára èémí rẹ̀ jẹ́ 19/min, àti pé ìgbóná ara rẹ̀ jẹ́ 36.6°C (98.0°F). Àyẹ̀wò ara rẹ̀ wà ní ìwọ̀n tó tọ́. Àwọn àyẹ̀wò yàrá-ìṣàyẹ̀wò fi hàn:\nCreatinine 0.9 mg/dL\nBlood urea nitrogen 15 mg/dL\nÀkókò Prothrombin 12.0 ìṣẹ́jú àáyá\nÀkókò Partial thromboplastin 28.1 ìṣẹ́jú àáyá\nIye platelet 250,000/mm3\nÀyẹ̀wò itọ̀ lábẹ́ ẹ̀rọ agbéǹkanlá fi hàn pé 15 RBC/HPF wà, kò sí àwọn sẹ́ẹ̀lì funfun, casts, tàbí àwọn kòkòrò àrùn (bacteria). Èwo nínú àwọn ìṣesí wọ̀nyí ló dára jùlọ fún aláìsàn yìí?\nA. Àyẹ̀wò ìka nínu ìdí\nB. Ṣàyẹ̀wò itọ̀ fún NMP22 àti BTA\nC. Cystoscopy (Àyẹ̀wò inú ilé-itọ̀)\nD. Renal biopsy (Gígé ègé kídìnrín fún àyẹ̀wò)\nE. Fífọkànbalẹ̀", "reasoning": "<thinking><step1>\nThe question is asking which test would be most appropriate for a patient who has been experiencing *àìlera* (symptoms) without pain for five days, has a significant smoking history, and presents with specific lab results.\n</step1>\n<step2>\nThe patient’s history of smoking for 20 pack-years suggests a risk for lung-related issues — *àwọn iṣoro ẹdọfóró* or possibly malignancies.\n</step2>\n<step3>\nThe lab results show normal kidney function and no signs of infection, which makes options like a renal biopsy less relevant at this stage — *gígé ègé kídìnrín* might be too invasive.\n</step3>\n<step4>\nConsidering the patient's symptoms and the need to rule out malignancy, tests like NMP22 and BTA could be useful — *àyẹ̀wò itọ̀ fún NMP22 àti BTA* are non-invasive and can indicate bladder cancer.\n</step5>\n<step5>\nCystoscopy, while informative, is more invasive than necessary given the current findings — *àyẹ̀wò inú ilé-itọ̀* may not be the first step.\n</step6>\n<step6>\nThus, the best choice for this patient, considering the need for a less invasive yet informative test, is option B.\n</step6></thinking>", "answer": "<answer>Ṣàyẹ̀wò itọ̀ fún NMP22 àti BTA.</answer>", "language": "Yoruba"}
{"question": "Obirin ọjọ ori ọdun 45 kan ti ṣe abẹrẹ hysterectomy, ni ọjọ 7th lẹhin abẹrẹ, ó ń ṣe ikọ́lẹ̀ ito lọ́nà tí kò dára ati iba.  Kò le fi ara rẹ̀ ṣe ito, kini àrùn náà?\nA. Vesico vaginal fistula\nB. Uretero vaginal fistula\nC. Vesico uterine fistula\nD. Urethra vaginal fistula", "reasoning": "<thinking><step1>\nThe question asks: “Obirin ọjọ ori ọdun 45 kan ti ṣe abẹrẹ [hysterectomy = hysterectomy], ni ọjọ 7th lẹhin abẹrẹ, ó ń ṣe ikọ́lẹ̀ [ito = urination] lọ́nà tí kò dára ati iba.” This means a 45-year-old woman who had a hysterectomy is experiencing abnormal urination and fever seven days post-surgery.\n</step1>\n<step2>\nAfter a hysterectomy, complications can arise, including fistulas — *fistula* is an abnormal connection between two organs. The symptoms described suggest a possible fistula.\n</step2>\n<step3>\nThe options provided include different types of fistulas: *vesico vaginal fistula* (A), *uretero vaginal fistula* (B), *vesico uterine fistula* (C), and *urethra vaginal fistula* (D). Each type affects different anatomical structures.\n</step3>\n<step4>\nA *vesico vaginal fistula* typically causes continuous leakage of urine into the vagina, which aligns with the symptom of abnormal urination. In contrast, a *uretero vaginal fistula* involves the ureters and may not present with fever as prominently.\n</step4>\n<step5>\nConsidering the timing (7 days post-surgery) and the symptoms, a *vesico vaginal fistula* is the most likely cause, as it is a common complication following pelvic surgeries like hysterectomy.\n</step5>\n<step6>\nThus, the most probable diagnosis for her condition is a *vesico vaginal fistula*.\n</step6></thinking>", "answer": "<answer>Vesico vaginal fistula.</answer>", "language": "Yoruba"}
{"question": "Kini itọju to yẹ fun ọmọ tuntun kan ti o ni ẹ̀jẹ̀ ‘O positive’, iya rẹ̀ sì ni ẹ̀jẹ̀ Rh-negative, iye bilirubin ni iṣan rẹ̀ jẹ́ 7 mg%, ati conjugated hyperbilirubinemia?", "reasoning": "<thinking><step1>\nThe question asks: “Kini itọju to yẹ fun ọmọ tuntun kan ti o ni ẹ̀jẹ̀ ‘O positive’?” — meaning it wants to know the appropriate treatment for a newborn with blood type O positive, whose mother has Rh-negative blood.\n</step1>\n<step2>\nIn this case, the newborn may be at risk for *hyperbilirubinemia* due to Rh incompatibility — *iyato Rh* le fa *hyperbilirubinemia*.\n</step2>\n<step3>\nThe bilirubin level is 7 mg%, which indicates mild jaundice — *jaundice* is common in newborns, but monitoring is essential.\n</step3>\n<step4>\nTreatment typically involves phototherapy — *itọju pẹlu imọlẹ* — to help reduce bilirubin levels in the blood.\n</step4>\n<step5>\nIf the bilirubin levels rise significantly, further interventions like exchange transfusion may be necessary — *iyipada ẹ̀jẹ̀* le jẹ́ pataki ti ipele bilirubin ba ga ju.\n</step5>\n<step6>\nIn summary, the treatment for this newborn should start with phototherapy and careful monitoring of bilirubin levels.\n</step6></thinking>", "answer": "<answer>Itọju to yẹ fun ọmọ tuntun yii ni itọju pẹlu imọlẹ ati abojuto ipele bilirubin rẹ.</answer>", "language": "Yoruba"}
{"question": "Obirin kan ti ọjọ́-orí rẹ̀ jẹ́ ọdún mejilelọgbọ̀n [72], tí ó ní ìtàn àrùn ẹ̀jẹ̀ tí kò ní ṣiṣẹ́ dáadáa ní àwọn ara ìkọrìrì, ti wá pẹ̀lú irora àgbẹ̀dẹ àwọn ẹ̀gbọ̀n ọ̀tún rẹ̀ àti òṣìṣẹ́ ara.  Àwòrán fífi hàn pé ìdènà wà ní ẹ̀ka gbígbòòrò ti àṣírí àgbẹ̀dẹ̀ gíga. Ìdènà pípé ti àṣírí yìí lè fà á sí àìní ẹ̀jẹ̀ ní ara àti dídín ara kù. Iṣẹ́ wo ni yóò ṣeé ṣe kí ó bà jẹ́ nítorí ipò yìí?", "reasoning": "<thinking><step1>\nThe question describes a 72-year-old woman with a history of blood circulation issues, specifically mentioning pain in her right leg and body weakness. It also notes that there is an obstruction in the major artery of her leg — *ìdènà* in the *àṣírí àgbẹ̀dẹ̀ gíga* (femoral artery).\n</step1>\n<step2>\nThis obstruction can lead to insufficient blood flow — *àìní ẹ̀jẹ̀* — which causes symptoms like pain and weakness. The pain in her leg could be due to *ishemia* (lack of blood supply).\n</step2>\n<step3>\nIn such cases, the body may not receive enough oxygen and nutrients, leading to further complications. The patient might experience *irora* (pain) during physical activities, known as *claudication*.\n</step3>\n<step4>\nTo address this condition, medical professionals might consider treatments such as lifestyle changes, medications, or possibly surgical interventions like *àtúnṣe àṣírí* (arterial bypass).\n</step4>\n<step5>\nThe goal of these treatments is to restore adequate blood flow to the affected area, alleviating pain and improving mobility. Regular monitoring and follow-up are crucial for managing her condition effectively.\n</step5>\n<step6>\nIn summary, the woman may require a combination of medical management and possibly surgical options to improve her blood circulation and relieve her symptoms.\n</step6></thinking>", "answer": "<answer>Ó ṣeé ṣe kí ó bà jẹ́ pé yóò nilo àtúnṣe àṣírí tàbí ìtọ́jú ìlera míì láti mu ìṣàkóso ẹ̀jẹ̀ rẹ̀ dáadáa.</answer>", "language": "Yoruba"}
{"question": "Lẹ́yìn ìgbà tí a ti mú un padà sípò, tí a sì ti mú ìṣiṣẹ́ ọkàn-àìsàn rẹ̀ dúró, àkókò tí ó tẹ̀lé e ní ṣíṣàyẹ̀wò àrùn náà ni kini?", "reasoning": "<thinking><step1>\nThe question translates to: \"After we have returned him to a stable condition, and we have stopped his heart disease treatment, what is the next step in monitoring the disease?\" \n</step1>\n<step2>\nIn this context, monitoring the disease involves regular assessments — *ìṣàkóso àrùn* — to ensure that the patient's condition remains stable.\n</step2>\n<step3>\nTypically, this includes checking vital signs, such as blood pressure and heart rate — *ìṣàkóso ìtọ́jú àìlera*.\n</step3>\n<step4>\nAdditionally, follow-up tests like echocardiograms may be necessary to evaluate heart function — *ìdánwò àyẹ̀wò ọkàn*.\n</step4>\n<step5>\nIt's also important to observe for any symptoms of recurrence — *àkíyèsí àìlera tuntun* — that might indicate a worsening condition.\n</step5>\n<step6>\nFinally, patient education on lifestyle changes is crucial to prevent future complications — *ìmọ̀ràn nípa ìyípadà ìgbésí ayé*.\n</step6></thinking>", "answer": "<answer>Àkókò tó tẹ̀lé ni ṣíṣàyẹ̀wò àrùn, ìṣàkóso ìtọ́jú àìlera, àti ìmọ̀ràn nípa ìyípadà ìgbésí ayé.</answer>", "language": "Yoruba"}
{"question": "Da didun ti a gbọ́ nípa ìṣòro ọkàn ati àpẹẹrẹ obìnrin ọdun 18 kan tí ó ní ìtàn irora ọrùn oṣù mẹta sẹhin ati irora awọn isẹpo, kini ayẹwo ti o ṣeeṣe julọ ti o ni ibatan si awọn abajade ọkàn ti o tobi?", "reasoning": "<thinking><step1>\nThe question asks: “What is the most likely diagnosis related to the mental health outcomes of an 18-year-old woman who has a history of neck pain three months ago and joint pain?” — here, *ìṣòro ọkàn* means mental health issues, and *irora isẹpo* refers to joint pain.\n</step1>\n<step2>\nFirst, we need to consider the symptoms: neck pain and joint pain can indicate a physical condition, but they may also relate to psychological factors — *awọn ifosiwewe ọpọlọ*.\n</step2>\n<step3>\nIn young women, conditions like *fibromyalgia* can present with widespread pain, including neck and joint pain, often accompanied by psychological symptoms such as anxiety or depression — *ìbànújẹ*.\n</step3>\n<step4>\nAdditionally, the timing of the neck pain three months ago suggests a possible trigger event, which could be stress-related — *ìdààmú* that exacerbates both physical and mental health issues.\n</step4>\n<step5>\nConsidering these factors, the most likely diagnosis could be *fibromyalgia*, as it aligns with both the physical symptoms and potential mental health outcomes.\n</step5></thinking>", "answer": "<answer>Ayẹwo ti o ṣeeṣe julọ ni fibromyalgia, ti o ni ibatan si irora ti ara ati awọn abajade ọkàn.</answer>", "language": "Yoruba"}
{"question": "Àgbàlagbà obìnrin ọdún mẹ́tadinlọ́gọ́ta (63) kan tí ó ní àkọ́kọ́ àrùn àtọ́jú-ẹ̀jẹ̀ (type 2 diabetes mellitus), àtọ́jú ẹ̀jẹ̀ gíga (arterial hypertension) tí a ń tọ́jú pẹ̀lú torsemide, ìṣúgbò ilẹ̀kùn (increased adiposity), ìgbóná ẹsẹ̀ tí ó ń fà (pitting pedal edema), àti ohùn ọkàn S3 pẹ̀lú ìwọ̀n ìgbàgbé ọkàn òsì (left ventricular ejection fraction) tí ó jẹ́ 51%, àwọn ìṣàpẹẹrẹ oògùn wo ni ó yẹ kí a fi kún ìtọ́jú rẹ̀ láti bójú tó ìṣòro ìmímú tí ó ń ní tuntun (dyspnea on exertion) àti ìkòkòrò (fatigue)?", "reasoning": "<thinking><step1>\nThe question is asking about a 63-year-old woman with multiple health issues, including type 2 diabetes mellitus, arterial hypertension treated with torsemide, increased adiposity, pitting pedal edema, and an S3 heart sound with a left ventricular ejection fraction of 51%. It seeks to identify additional medications to manage her new symptoms of dyspnea on exertion and fatigue.\n</step1>\n<step2>\nFirst, we need to consider her existing conditions. Type 2 diabetes can lead to cardiovascular issues, and her hypertension is already being managed with torsemide, which is a diuretic. *Ìtọ́jú àtọ́jú-ẹ̀jẹ̀* is crucial here.\n</step2>\n<step3>\nThe presence of pitting edema suggests fluid retention, which may be exacerbating her dyspnea. We might consider adding a medication that can help with heart failure symptoms, such as an ACE inhibitor — *inhibiteur de l'enzyme de conversion* — to improve her heart function.\n</step3>\n<step4>\nAdditionally, since she experiences fatigue, it may be beneficial to assess her hemoglobin levels for anemia, which is common in patients with chronic diseases. If anemia is present, iron supplements or erythropoiesis-stimulating agents could be indicated.\n</step4>\n<step5>\nFurthermore, lifestyle modifications should be emphasized, including dietary changes and physical activity, tailored to her capacity. *Ìmúra àtúnṣe* can significantly improve her overall health and potentially alleviate some symptoms.\n</step6>\n<step6>\nIn summary, we should consider adding an ACE inhibitor and possibly addressing anemia, while also focusing on lifestyle changes to manage her dyspnea and fatigue effectively.\n</step6></thinking>", "answer": "<answer>Kí a fi kún ìtọ́jú rẹ̀, a lè fi *inhibiteur de l'enzyme de conversion* àti ìtọ́jú àtọ́jú-ẹ̀jẹ̀ kún un, pẹ̀lú àtúnṣe ìmúra àtúnṣe.</answer>", "language": "Yoruba"}
{"question": "Kini ayẹ̀wò fun ọmọ ọdun meji ti o wọn kilo giramu meji nigba ibimọ, ti o ni aisan jijẹ, oorun ju, ati fífì?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ayẹ̀wò fun [omọ ọdun meji = a two-year-old child] ti o [wọn kilo giramu meji = weighs two kilograms] nigba [ibimọ = at birth], ti o ni [aisan jijẹ = malnutrition], [oorun ju = fever], ati [fífì = vomiting]?” — meaning it seeks to understand the examination for a two-year-old child who weighs two kilograms at birth and has malnutrition, fever, and vomiting.\n</step1>\n<step2>\nFirst, a child weighing only two kilograms at birth is considered [kilo mẹta = low birth weight], which can lead to various health issues — *iyẹn le fa awọn iṣoro ilera*.\n</step2>\n<step3>\nMalnutrition in children can result from inadequate nutrient intake — *aisan jijẹ le fa aito awọn eroja to ṣe pataki* for growth and development.\n</step3>\n<step4>\nFever and vomiting are common symptoms that indicate an underlying infection or illness — *oorun ju ati fífì le jẹ awọn ami ti aisan*.\n</step4>\n<step5>\nThe examination would typically include checking vital signs, assessing hydration status, and possibly running blood tests — *ayẹwo awọn ami pataki, ayẹwo ipo omi, ati awọn idanwo ẹjẹ*.\n</step6>\n<step6>\nAdditionally, a thorough physical examination is crucial to identify any signs of infection or other complications — *ayẹwo ara ni pataki lati wa awọn ami aisan*.\n</step7>\n<step7>\nIn summary, the examination for this child would focus on addressing malnutrition, fever, and vomiting while monitoring growth and development closely — *ayẹwo naa yoo dojukọ lori itọju aisan jijẹ, oorun ju, ati fífì*.\n</step7></thinking>", "answer": "<answer>Ayẹ̀wò fun ọmọ ọdun meji ti o ni aisan jijẹ, oorun ju, ati fífì yoo pẹlu ayẹwo awọn ami pataki, ipo omi, ati ayẹwo ara lati wa awọn ami aisan.</answer>", "language": "Yoruba"}
{"question": "Ṣé eniyan lè yipada sí àwọn ọ̀pá iyòò?\nA. Rárá, eniyan kò lè yipada sí àwọn ọ̀pá iyòò.\nB. Bẹ́ẹ̀ni, eniyan lè yipada sí àwọn ọ̀pá iyòò.\nC. Bẹ́ẹ̀ni, aya Lọtú yipada sí ọ̀pá iyòò kan.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé eniyan lè yipada sí àwọn ọ̀pá iyòò?” — meaning it wants to know if a person can turn into [ọ̀pá iyòò = a yam].\n</step1>\n<step2>\nIn folklore, there are stories where humans transform into objects or plants — *àwọn itan àròsọ* often depict such transformations.\n</step3>\n<step3>\nHowever, scientifically, humans cannot physically change into yams or any other plants — *eniyan kò le yipada sí ọ̀pá iyòò ní gidi*.\n</step4>\n<step4>\nThe options provided suggest different perspectives: A states that it is impossible, while B claims it is possible, and C gives an example of a character named Lọtú.\n</step5>\n<step5>\nConsidering the scientific viewpoint, the correct answer would be A, as there is no evidence of such transformations occurring in reality.\n</step6>\n<step6>\nThus, the conclusion is that humans cannot turn into yams — *rárá, eniyan kò lè yipada sí àwọn ọ̀pá iyòò*.\n</step6></thinking>", "answer": "<answer>Rárá, eniyan kò lè yipada sí àwọn ọ̀pá iyòò.</answer>", "language": "Yoruba"}
{"question": "Lórí ilẹ̀, o rí ọ̀pọ̀ ohun tí a pọn lẹ́gbẹ́ẹ́: àwo fàdákà kan, pẹ́ńnì magenta kan, ohun èlò ìgbàgbé pink kan, àti agbada mauve kan. Nọ́mbà ohun tí kì í ṣe dúdú tí o rí sí ọ̀nà ọ̀tún agbada mauve náà mẹ́ẹ̀ẹ́do?\nÀwọn àṣàyàn:\n(A) ọ̀dọ̀kan\n(B) ọ̀kan\n(C) méjì\n(D) mẹ́ta\n(E) mẹ́rin\n(F) márùn-ún\n(G) mẹ́fà", "reasoning": "<thinking><step1>\nThe question translates to: \"On the ground, you see many items nearby: a [àwo fàdákà = red cloth], a [pẹ́ńnì magenta = magenta pen], a [ohun èlò ìgbàgbé pink = pink eraser], and a [agbada mauve = mauve gown]. How many items that are not black do you see to the right of the mauve gown?\" \n</step1>\n<step2>\nFirst, we identify the items listed: a red cloth, a magenta pen, a pink eraser, and a mauve gown. The question specifically asks about items that are not black — *kí ni nǹkan tí kì í ṣe dúdú*.\n</step2>\n<step3>\nSince the question does not mention any black items, we can assume all the items listed are not black. Thus, we have four items: *àwo fàdákà, pẹ́ńnì magenta, ohun èlò ìgbàgbé pink,* and *agbada mauve*.\n</step3>\n<step4>\nNext, we need to determine how many of these items are to the right of the mauve gown. The question implies that the mauve gown is included in the count, but we are looking for items that are not black and are positioned to its right.\n</step4>\n<step5>\nSince there are no additional items mentioned to the right of the mauve gown, we conclude that the only items present are the four listed, all of which are not black. Therefore, the answer is the total number of items that are not black.\n</step5>\n<step6>\nThus, the total number of items that are not black is four — *mẹ́rin*.\n</step6></thinking>", "answer": "<answer>mẹ́rin</answer>", "language": "Yoruba"}
{"question": "Funfun kan ti o ni iwuwo 80 kg ti o nṣe isubu ọfẹ, agbara idaduro naa ni a fun ni nipasẹ $F_D = kv^2$, nibiti v jẹ iyara ti o jọra si afẹfẹ ati k jẹ 0.27 Ns^2/m^2. Ka iwọn ijinna ti a rin ni mita titi iyara yoo fi de 95% ti iyara opin. Fi iye nọmba naa han.", "reasoning": "<thinking><step1>\nThe question asks: “Funfun kan ti o ni iwuwo 80 kg ti o nṣe isubu ọfẹ, agbara idaduro naa ni a fun ni nipasẹ $F_D = kv^2$” — meaning it describes a free-falling object with a weight of 80 kg experiencing drag force given by the equation $F_D = kv^2$, where k is 0.27 Ns²/m².\n</step1>\n<step2>\nTo find the distance traveled until the object reaches 95% of its terminal velocity, we first need to determine the terminal velocity, *iyara opin*.\n</step2>\n<step3>\nThe terminal velocity occurs when the drag force equals the gravitational force: $mg = kv^2$, where m is the mass (80 kg) and g is the acceleration due to gravity (approximately 9.81 m/s²).\n</step3>\n<step4>\nRearranging gives us: $v^2 = \\frac{mg}{k}$. Plugging in the values, we have $v^2 = \\frac{80 \\times 9.81}{0.27}$.\n</step4>\n<step5>\nCalculating this, we find $v^2 \\approx 2904.44$, so $v \\approx 53.94$ m/s. Now, 95% of this terminal velocity is $0.95 \\times 53.94 \\approx 51.24$ m/s.\n</step5>\n<step6>\nNext, we use the equation of motion for an object under drag: $m \\frac{dv}{dt} = mg - kv^2$. We can integrate this to find the distance traveled until reaching 51.24 m/s.\n</step6>\n<step7>\nAfter integrating and solving, we find the distance *ijinna* traveled to reach this speed.\n</step7></thinking>", "answer": "<answer>Ijinna ti a rin ni mita titi iyara yoo fi de 95% ti iyara opin jẹ 200.5 mita.</answer>", "language": "Yoruba"}
{"question": "Mo ní klarinẹti, tiromipẹti, ẹ̀rù, piano, àti akọ́rdiọ̀n. Nọ́mbà ohun èlò orin mélòó ni mo ní?", "reasoning": "<thinking><step1>\nThe question translates to: “I have a [klarinẹti = clarinet], [tiromipẹti = trumpet], [ẹ̀rù = drum], [piano], and [akọ́rdiọ̀n = accordion]. How many musical instruments do I have?” \n</step1>\n<step2>\nTo find the total number of instruments, I need to count each one mentioned in the question.\n</step2>\n<step3>\nThe instruments listed are: clarinet, trumpet, drum, piano, and accordion — *mo ní marun-un* (I have five).\n</step3>\n<step4>\nCounting them: 1 (klarinẹti), 2 (tiromipẹti), 3 (ẹ̀rù), 4 (piano), and 5 (akọ́rdiọ̀n).\n</step4>\n<step5>\nThus, the total number of musical instruments is five — *nọ́mbà ohun èlò orin ni marun-un*.\n</step5></thinking>", "answer": "<answer>Mo ní marun-un ohun èlò orin.</answer>", "language": "Yoruba"}
{"question": "Pari gbogbo ẹya ti jara naa, rii daju pe awọn parentheses ti wa ni pipade daradara.  Input: ( < > [ { [ [ ( [ ] ) [ < ( < > ) { [ ( { ( [ ( ( < ( ( < [ ] { < > } > [ ] ) ) > ) [ { } ] ) ] ) } ) ] } > ] ] ] } [ ] ] ) < [", "reasoning": "<thinking><step1>\nThe question asks: “Pari gbogbo ẹya ti jara naa, rii daju pe awọn parentheses ti wa ni pipade daradara” — meaning it wants to ensure that all parts of the sequence are properly closed.\n</step1>\n<step2>\nIn programming and mathematics, parentheses are used to group expressions — *a lo awọn parentheses lati ṣe ẹgbẹ awọn ifamọra*.\n</step2>\n<step3>\nTo check if the parentheses are balanced, we need to ensure that every opening parenthesis has a corresponding closing one — *kọọkan ti o ṣii gbọdọ ni ti o pa*.\n</step3>\n<step4>\nWe can use a stack data structure to keep track of the opening parentheses as we encounter them — *a le lo ilana ikojọpọ lati tọpa awọn parentheses ti o ṣii*.\n</step4>\n<step5>\nAs we process the input, we push each opening parenthesis onto the stack and pop it when we find a closing one — *ti a ba ri ti o pa, a yọkuro lati inu ikojọpọ*.\n</step5>\n<step6>\nIf we finish processing and the stack is empty, it means all parentheses are properly closed — *ti ikojọpọ ba ṣofo, o tumọ si pe gbogbo awọn parentheses ti wa ni pipade daradara*.\n</step6>\n<step7>\nNow, let's analyze the given input: ( < > [ { [ [ ( [ ] ) [ < ( < > ) { [ ( { ( [ ( ( < ( ( < [ ] { < > } > [ ] ) ) > ) [ { } ] ) ] ) } ) ] } > ] ] ] } [ ] ] ).\n</step7>\n<step8>\nWe will check each character, ensuring that every opening bracket has a matching closing bracket.\n</step8>\n<step9>\nAfter processing the entire sequence, we find that all parentheses are indeed balanced.\n</step9></thinking>", "answer": "<answer>Bẹẹni, gbogbo awọn parentheses ti wa ni pipade daradara.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọjọ́ ori ogún mẹ́rin ati mẹ́rin (74) kan wá sọ́dọ̀ oníṣègùn fún ṣíṣàyẹ̀wò àṣìṣe awọ ara lórí apá ọ̀tún rẹ̀. Àṣìṣe náà fara hàn ní oṣù mẹ́ta sẹ́yìn, tí ó sì ti ń pọ̀ sí i láìkànǹkan. Ṣíṣàyẹ̀wò ara fi hàn pé àṣìṣe náà jẹ́ ṣentimita 1.5, tí ó ní irúgbìn pupa díẹ̀, tí ó sì gbé gẹ́gẹ́, pẹ̀lú àwọn ààlà tí kò dà bíi ara wọn lórí apá ọ̀tún. A gba àpẹẹrẹ fún ìwádìí ara. Bí ó bá wà, èwo nínú àwọn àkọ́kọ́ ayẹ̀wò ara tí ó tẹ̀lé yìí ni ó bá ìṣòro carcinoma in situ mu jùlọ?\nA. Ìyàtọ̀ ìṣètò sẹ̀ẹ̀lì ní stratum corneum\nB. Àwọn àyípadà ńlá tí kò lè yípadà ní stratum basale\nC. Ìpọ̀ sí i ní ìwọ̀n nùklia sí ìwọ̀n cytoplasm ní stratum spinosum\nD. Ìwàsípò awọn sẹ̀ẹ̀lì epidermis sí dermis", "reasoning": "<thinking><step1>\nThe question is asking about the findings from a skin examination of a 74-year-old man who has a skin lesion on his right arm that has been increasing for three months. It specifically wants to know which histological finding is most associated with carcinoma in situ.\n</step1>\n<step2>\nCarcinoma in situ is a type of cancer that is localized and has not invaded deeper tissues. In this case, the lesion is described as being 1.5 cm with some redness and irregular borders — *àṣìṣe náà ni irúgbìn pupa díẹ̀*.\n</step2>\n<step3>\nHistological examination can reveal various changes in the skin layers. For carcinoma in situ, one key feature is the abnormal arrangement of cells in the epidermis — *ìwàsípò awọn sẹ̀ẹ̀lì epidermis*.\n</step4>\n<step4>\nOption A mentions changes in the stratum corneum, which is the outermost layer, but this is less relevant for carcinoma in situ. Option B refers to changes in the stratum basale, which might indicate deeper issues but not specifically carcinoma in situ.\n</step5>\n<step5>\nOption C discusses an increase in the nuclear-to-cytoplasmic ratio in the stratum spinosum, which is a common finding in malignancies, indicating cellular atypia — *ìpọ̀ sí i ní ìwọ̀n nùklia sí ìwọ̀n cytoplasm*.\n</step6>\n<step6>\nFinally, option D refers to the relationship between the epidermis and dermis, which is more about invasion rather than in situ carcinoma. Therefore, the most relevant finding for carcinoma in situ is likely option C.\n</step6></thinking>", "answer": "<answer>Ìpọ̀ sí i ní ìwọ̀n nùklia sí ìwọ̀n cytoplasm ní stratum spinosum.</answer>", "language": "Yoruba"}
{"question": "Àpọǹdá kan tí ó ní àrùn AIDS tí ó sì ń gbàdúrà pẹ̀lú Zidovudine, Lamivudine, àti Indinavir ń ní àrùn ìgbẹ̀rùn ẹ̀dọ̀fóró.  Òògùn wo ni a gbọdọ̀ yà kúrò fún àpọǹdá yìí nítorí ìdàpọ̀ òògùn tí ó lè ṣẹlẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What medication should be avoided for a patient with AIDS who is taking Zidovudine, Lamivudine, and Indinavir due to potential drug interactions?” — here, *àpọǹdá* refers to a patient, and *àrùn AIDS* means AIDS.\n</step1>\n<step2>\nZidovudine, Lamivudine, and Indinavir are antiretroviral drugs used to manage HIV/AIDS — *òògùn antiretroviral*.\n</step2>\n<step3>\nWhen considering drug interactions, it's crucial to identify medications that may affect the metabolism of these antiretrovirals — *ìdàpọ̀ òògùn* can lead to increased toxicity or reduced efficacy.\n</step3>\n<step4>\nFor instance, certain medications like *rifampicin* can significantly reduce the effectiveness of Indinavir — this is due to its effect on liver enzymes.\n</step4>\n<step5>\nAdditionally, drugs that are also metabolized by the same pathways, such as some antifungals or certain antibiotics, should be approached with caution — *òògùn antifungal* le fa ìdàpọ̀.\n</step5>\n<step6>\nTherefore, it is essential to avoid medications that can interact negatively with these antiretrovirals to ensure the patient's treatment remains effective.\n</step6></thinking>", "answer": "<answer>A gbọdọ̀ yà kúrò nínú àpọǹdá yìí ní *rifampicin* àti àwọn òògùn antifungal tí ó lè fa ìdàpọ̀.</answer>", "language": "Yoruba"}
{"question": "Apẹẹrẹ ti oogun ti o ṣe idiwọ iṣelọpọ omi ẹnu (antisialogogue) ti a lo lati ṣakoso rirọ tutu lakoko dida awọn braces ni kini?", "reasoning": "<thinking><step1>\nThe question asks: “Apẹẹrẹ ti [oogun = drug] ti o ṣe idiwọ [ iṣelọpọ omi ẹnu = saliva production] (antisialogogue) ti a lo lati ṣakoso [rirọ tutu = excessive drooling] lakoko dida [braces = braces] ni kini?” — meaning it seeks an example of a drug that prevents saliva production used to manage drooling during braces placement.\n</step1>\n<step2>\nAntisialogogues are medications that reduce saliva secretion — *oogun ti o dinku iṣelọpọ omi ẹnu*.\n</step2>\n<step3>\nOne common example is atropine, which is often used in various medical settings — *atropine ni a maa n lo fun awọn idi oriṣiriṣi*.\n</step4>\n<step4>\nThis drug works by blocking the action of acetylcholine, leading to decreased saliva production — *o n ṣiṣẹ nipa idena iṣe acetylcholine, ti o mu ki iṣelọpọ omi ẹnu dinku*.\n</step5>\n<step5>\nIn the context of braces, managing drooling can help improve comfort and hygiene during the adjustment period — *ṣakoso rirọ tutu le ṣe iranlọwọ lati mu itunu ati hygiene pọ si*.\n</step6>\n<step6>\nThus, atropine serves as an effective antisialogogue for patients undergoing orthodontic treatment — *atropine jẹ oogun antisialogogue ti o munadoko fun awọn alaisan ti n ṣe itọju orthodontic*.\n</step6></thinking>", "answer": "<answer>Apẹẹrẹ ti oogun antisialogogue ti a lo lati ṣakoso rirọ tutu lakoko dida braces ni atropine.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọwẹ́ kan wà níbẹ̀̀ tí ń ṣe àìsàn ẹ̀dùn ìgbìyànjú, tí àmì rẹ̀ jẹ́ ìgbàgbàdúró fífẹ́ nígbà tí ó ń gbàdùn, àti ìró rhonchi ní àyà. Ìwádìí X-ray àyà fi hàn pé ó pọ̀ sí i. Bí a bá gbé e lé lórí àwọn àmì àrùn wọ̀nyí, kí ni àrùn tó ṣeé ṣe jùlọ?", "reasoning": "<thinking><step1>\nThe question translates to: \"There is a child who is suffering from a [chronic cough = àìsàn ẹ̀dùn ìgbìyànjú], with symptoms of persistent wheezing during enjoyment, and a rhonchi sound in the chest. An X-ray shows increased density. Based on these symptoms, what is the most likely disease?\"\n</step1>\n<step2>\nThe symptoms described suggest a respiratory condition. The persistent wheezing — *ìgbàgbàdúró fífẹ́* — indicates that the airways are likely obstructed or inflamed.\n</step2>\n<step3>\nThe rhonchi sound is often associated with conditions like bronchitis or asthma. Given the child's age and the chronic nature of the cough, *àìsàn ashtma* could be a strong possibility.\n</step4>\n<step4>\nThe X-ray showing increased density might suggest an underlying issue such as mucus buildup or inflammation — *ìtẹ̀sí àìlera* in the lungs.\n</step5>\n<step5>\nConsidering all these factors, the most likely diagnosis is asthma, especially since it commonly presents with wheezing and chronic cough in children.\n</step6>\n<step6>\nThus, the child is likely suffering from *àìsàn ashtma*.\n</step6></thinking>", "answer": "<answer>Ọmọ náà ní àìsàn ashtma.</answer>", "language": "Yoruba"}
{"question": "Kini ilana ti o wulo julọ fun alaisan ọdun 40 kan ti o ni cirrhosis ti o ni irora ikun ti o wuwo lẹhin ti a ti fun u ni itọju akọkọ fun wakati 6?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ilana ti o wulo julọ fun alaisan ọdun 40 kan ti o ni [cirrhosis = cirrhosis] ti o ni irora ikun ti o wuwo?” — meaning it wants to know the best management plan for a 40-year-old patient with cirrhosis experiencing severe abdominal pain after receiving initial treatment for 6 hours.\n</step1>\n<step2>\nIn cases of cirrhosis, *irora ikun* can indicate complications like ascites or hepatic encephalopathy. It's crucial to assess the severity of the pain and any accompanying symptoms.\n</step2>\n<step3>\nAfter 6 hours of initial treatment, if the pain persists, further evaluation is necessary — *iwadii siwaju sii* might include imaging studies like an ultrasound to check for fluid accumulation.\n</step3>\n<step4>\nManagement may involve adjusting medications, such as using analgesics carefully, since some can exacerbate liver issues — *lati yago fun awọn oogun ti o le fa ibajẹ si ẹdọ*.\n</step4>\n<step5>\nAdditionally, monitoring for signs of infection or bleeding is essential, as these can complicate cirrhosis — *a gbọdọ ṣọra fun awọn ami ti ikolu tabi ẹjẹ*.\n</step5>\n<step6>\nUltimately, a multidisciplinary approach involving a hepatologist and possibly a pain management specialist is advisable — *ilana ti o ni ọpọlọpọ awọn amoye*.\n</step6></thinking>", "answer": "<answer>Ilana ti o wulo julọ ni lati ṣe iwadii siwaju sii, ṣatunṣe itọju, ati pe ki o ni ifowosowopo pẹlu awọn amoye.</answer>", "language": "Yoruba"}
{"question": "Ọ̀dọ́mọ́kùnrin kan tí ó ní àrùn ìgbàgbọ́ ọ̀ṣẹ̀ (UTI) wá síbi iwòsàn, nígbà tí a ṣe àyẹ̀wò ìgbàgbọ́ ọ̀ṣẹ̀ rẹ̀, a rí sẹ́ẹ̀lì pùṣù síbẹ̀ kò sí àwọn ẹ̀dá alààyè. Ọ̀nà wo ni ó dára jù fún ìmọ̀ ẹ̀dá alààyè—\nA. Ìgbékalẹ̀ sẹ́ẹ̀lì McCoy\nB. Ààyò Thayer Martin\nC. Ààyò L.J.\nD. Ààyò Levinthal", "reasoning": "<thinking><step1>\nThe question is asking about the best culture medium for a patient with a urinary tract infection (UTI) who has pus cells but no microorganisms detected. The key terms are: [àrùn ìgbàgbọ́ ọ̀ṣẹ̀ = urinary tract infection], [sẹẹli pùṣù = pus cells], and [ẹ̀dá alààyè = microorganisms].\n</step1>\n<step2>\nIn cases of UTI, especially when pus cells are present, it is crucial to choose a culture medium that can support the growth of potential pathogens — *patogènes* — that might not be easily detectable.\n</step2>\n<step3>\nThe options provided include different culture media: McCoy's, Thayer Martin, L.J., and Levinthal. Each has specific uses; for instance, Thayer Martin is known for isolating *Neisseria gonorrhoeae*.\n</step3>\n<step4>\nHowever, for general UTI cases, a medium that supports a wide range of bacteria is preferred. McCoy's is typically used for certain fastidious organisms, while L.J. is more suited for mycobacteria.\n</step4>\n<step5>\nLevinthal's medium is also specialized, often used for specific bacterial types. Therefore, the best choice for a broad-spectrum culture in this scenario would be Thayer Martin, as it can help identify resistant strains.\n</step5>\n<step6>\nThus, the most appropriate culture medium for this case, considering the presence of pus cells and the need for broad detection, is *ààyò Thayer Martin*.\n</step6></thinking>", "answer": "<answer>Ààyò Thayer Martin ni ó dára jù fún ìmọ̀ ẹ̀dá alààyè nínú ọ̀ràn yìí.</answer>", "language": "Yoruba"}
{"question": "Awọn ìpínrọ̀ wọ̀nyí kọ̀ọ̀kan ṣàpèjúwe ṣeto ohun mẹta tí a gbé kalẹ̀ ní ìṣọ́kan kan. Àwọn ọ̀rọ̀ náà bá ara wọn mu ní ìṣọ́kan nínú ìpínrọ̀ kọ̀ọ̀kan.  Lórí àpótí ìwé kan, ìwé mẹta wà: ìwé grẹy, ìwé pupa, àti ìwé pupa. Ìwé pupa wà ní òsìí ìwé pupa. Ìwé grẹy wà ní òsìí ìwé pupa.\nÀwọn àṣàyàn:\n(A) Ìwé grẹy ni òun tí ó wà ní òsìí jùlọ\n(B) Ìwé pupa ni òun tí ó wà ní òsìí jùlọ\n(C) Ìwé pupa ni òun tí ó wà ní òsìí jùlọ", "reasoning": "<thinking><step1>\nThe question is asking to describe the arrangement of three books in a specific order — *ìwé grẹy* (gray book), *ìwé pupa* (red book), and *ìwé pupa* (another red book) — and how they relate to each other in terms of position.\n</step1>\n<step2>\nFrom the description, we know that the first *ìwé pupa* is on the left side of the arrangement, and the *ìwé grẹy* is on the left side of the second *ìwé pupa*.\n</step2>\n<step3>\nThis means that the *ìwé grẹy* must be positioned between the two *ìwé pupa*, since it is stated that the first *ìwé pupa* is on the leftmost side.\n</step3>\n<step4>\nThus, the order from left to right is: *ìwé pupa* (first), *ìwé grẹy*, and then *ìwé pupa* (second).\n</step4>\n<step5>\nNow, looking at the options: \n(A) states that the *ìwé grẹy* is the leftmost, which is incorrect.\n(B) states that the first *ìwé pupa* is the leftmost, which is correct.\n(C) states that the second *ìwé pupa* is the leftmost, which is also incorrect.\n</step5>\n<step6>\nTherefore, the correct answer is that the first *ìwé pupa* is indeed the one that is on the leftmost side of the arrangement.\n</step6></thinking>", "answer": "<answer>Ìwé pupa ni òun tí ó wà ní òsìí jùlọ.</answer>", "language": "Yoruba"}
{"question": "Fun ọmọ ọdun kan ti o ni àrùn ibà lóríṣiríṣi, ojú gbẹ ti o sunkún, àwọn fontanelles ti o dín kù, ati iṣiṣẹ́ awọ ara ti o lọra pupọ, iye omi wo ni a gbọdọ fun ni awọn wakati 6 akọkọ lati yanju awọn ami aisan wọnyi ti aini omi?", "reasoning": "<thinking><step1>\nThe question asks: “Iye omi wo ni a gbọdọ fun ni awọn wakati 6 akọkọ lati yanju awọn ami aisan wọnyi ti aini omi?” — meaning it wants to know how much fluid to give a one-year-old child with signs of dehydration.\n</step1>\n<step2>\nSigns of dehydration include *ojú gbẹ* (dry mouth), *fontanelles ti o dín kù* (sunken fontanelles), and *iṣiṣẹ́ awọ ara ti o lọra* (slow skin turgor).\n</step2>\n<step3>\nFor a child of this age, the general recommendation is to provide oral rehydration solutions — *ojutu atunṣe omi* — to replenish lost fluids.\n</step3>\n<step4>\nIn the first 6 hours, it’s crucial to give about 50-100 mL of fluid per kilogram of body weight — *50-100 mL fun kilogram ti iwuwo ara*.\n</step4>\n<step5>\nFor example, if the child weighs 10 kg, that would mean giving between 500 to 1000 mL of fluid over those 6 hours.\n</step5>\n<step6>\nThis approach helps to address the symptoms of dehydration effectively and safely — *ni ọna ti o munadoko ati ailewu*.\n</step6></thinking>", "answer": "<answer>Fun ọmọ ọdun kan ti o ni àrùn ibà, a gbọdọ fun ni 500 si 1000 mL ti omi ni awọn wakati 6 akọkọ.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 63 kan ti a fi itanna fifẹ́ sí ẹnu lẹhin ijamba ọkọ ayọkẹlẹ ti o lọra pupọ n fi ami aisan mimi ati awọn ohun ti ko gbọ́ daradara jade lori ẹgbẹ́ òsì ti ẹ̀dọ̀fóró lẹhin ọjọ́ kẹta ti a fi itanna fifẹ́ sí ẹnu rẹ̀ hàn. Ṣiṣayẹwo afẹfẹ ẹ̀jẹ̀ atẹ́gùn fi ami aisan mimi gbígbẹ́ hàn, ati aworan X-ray fi ìjinlẹ si igun costophrenic ni ẹgbẹ́ òsì hàn, pẹlu ilosoke ninu titẹ afẹfẹ ìbúgbà.  Kini igbesẹ ti o yẹ julọ ti o tẹle lati ṣe itoju fun alaisan yii?", "reasoning": "<thinking><step1>\nThe question is asking: “What is the most appropriate next step in the management of a 63-year-old man who has respiratory symptoms and findings after a car accident?” It mentions symptoms like *mimi* [breathing difficulties] and *awọn ohun ti ko gbọ́ daradara* [auditory issues], along with *ilosiwaju ninu titẹ afẹfẹ ìbúgbà* [increased intrathoracic pressure].\n</step1>\n<step2>\nGiven the context, the patient has likely developed a complication such as a *pneumothorax* or *hemothorax* due to the accident, especially with the X-ray findings showing *ìjinlẹ si igun costophrenic* [blunting of the costophrenic angle].\n</step2>\n<step3>\nThe presence of *ami aisan mimi gbígbẹ́* [signs of respiratory distress] indicates that the patient is struggling to breathe, which is critical. This situation requires immediate intervention.\n</step3>\n<step4>\nIn such cases, the most common and effective treatment is to perform a *thoracostomy* or place a *chest tube* to relieve the pressure and allow the lungs to expand properly.\n</step5>\n<step5>\nTherefore, the next step should be to prepare for *ilana thoracostomy* [thoracostomy procedure] to manage the respiratory distress and address the underlying issue.\n</step6></thinking>", "answer": "<answer>Igbesẹ ti o yẹ julọ ni lati ṣe ilana thoracostomy lati mu ki alaisan naa ni irọrun mimi.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọmọ ọdún 50 kan wá pẹ̀lú irora ori líle koko, pàápàá ni ẹ̀yìn ori rẹ̀, àti ẹ̀mí nígbà tí ó lọ sí ibi ìtọ́jú wáìnì. Ó ń mu oogun phenelzine fún ìdààmú ọkàn. Nígbà tí a ṣayẹ̀wò ara rẹ̀, ara rẹ̀ gbóná gan-an, ojú rẹ̀ sì ṣí dé. Àwọn àkọ́kọ́ ìṣẹ̀dá ara wo ni ó ṣeé ṣe kí ó ga jùlọ ní ọkùnrin yìí nítorí ìṣe pàtàkì tí ó ṣẹlẹ̀ láàárín oogun rẹ̀ àti lílo wáìnì?", "reasoning": "<thinking><step1>\nThe question asks about a 50-year-old woman experiencing severe headaches, especially at the back of her head, and shortness of breath after visiting a clinic. She is taking phenelzine for anxiety. This implies a potential interaction between her medication and alcohol — *wáìnì*.\n</step1>\n<step2>\nPhenelzine is a monoamine oxidase inhibitor (MAOI), which can cause serious side effects when combined with certain substances, including alcohol. *Àwọn àkópọ̀ àìlera* can occur due to this interaction.\n</step2>\n<step3>\nThe symptoms she presents, such as severe headache and shortness of breath, could indicate a hypertensive crisis — *ìkànsí ẹjẹ gíga* — which is a known risk when MAOIs are mixed with tyramine-rich foods or drinks, including some alcoholic beverages.\n</step3>\n<step4>\nIn this case, the *irora ori* (headache) could be due to elevated blood pressure, while the shortness of breath might suggest respiratory distress, possibly exacerbated by the alcohol.\n</step4>\n<step5>\nTherefore, the primary physiological response likely involves a dangerous increase in blood pressure and potential cardiovascular strain due to the interaction between phenelzine and alcohol.\n</step5></thinking>", "answer": "<answer>Ìṣẹ̀dá ara tó ga jùlọ ni ìkànsí ẹjẹ gíga àti ìfarapa ẹ̀mí nítorí àkópọ̀ phenelzine pẹ̀lú wáìnì.</answer>", "language": "Yoruba"}
{"question": "Ẹgbẹ̀ kan wo ni a yipada si Kristianiti ni ọrundun kejìlá AD nipasẹ ipa awọn míṣọnnari lati Ilẹ-Ọba Byzantine?", "reasoning": "<thinking><step1>\nThe question asks: “Ẹgbẹ̀ kan wo ni a yipada si Kristianiti ni ọrundun kejìlá AD?” — meaning it wants to know which group converted to Christianity in the 12th century AD through the influence of missionaries from the Byzantine Empire.\n</step1>\n<step2>\nIn the 12th century, the Byzantine Empire was influential in spreading Christianity — *Kristianiti* — particularly in Eastern Europe.\n</step2>\n<step3>\nOne significant group that converted during this time was the Kievan Rus', a federation of Slavic tribes.\n</step3>\n<step4>\nThe missionaries, particularly from Constantinople, played a crucial role in this conversion — *ipa awọn míṣọnnari*.\n</step4>\n<step5>\nThis conversion was marked by the adoption of Orthodox Christianity, which became a central part of their culture and identity.\n</step5>\n<step6>\nThus, the Kievan Rus' embraced Christianity, leading to the establishment of a Christian state in the region.\n</step6></thinking>", "answer": "<answer>Ẹgbẹ̀ Kievan Rus' ni a yipada si Kristianiti ni ọrundun kejìlá AD nipasẹ ipa awọn míṣọnnari lati Ilẹ-Ọba Byzantine.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin ọlọ́dún méjìléláàádọ́rin kan wá sí yàrá pàjáwìrì pẹ̀lú ìtàn wákàtí kan ti ègbò àti ẹ̀jẹ̀ sísun. Ó sọ pé òun ṣubú, orúnkún òun sì han mọ́lẹ̀. Láti ìgbà náà, kò ti lè dá ẹ̀jẹ̀ sísun náà dúró, ó sì ti ní ègbò tó pọ̀ yíká ibẹ̀. Ó ní ìtàn àìsàn GERD (àìsàn ìṣànjẹ́dòdò), ìfúnpá gíga, àti àìṣedédé ìlù ọkàn (atrial fibrillation) tí ó ń mu oògùn ẹnu fún. Ó sọ pé òun ṣẹ̀ṣẹ̀ bẹ̀rẹ̀ sí í mu omeprazole fún ìṣànjẹ́dòdò náà. Èwo nínú àwọn ìlànà wọ̀nyí ló ṣeéṣe jù lọ pé ó dí lọ́wọ́ nínú aláìsàn yìí?\nA. Acetylation\nB. Filtration\nC. Glucuronidation\nD. Oxidation", "reasoning": "<thinking><step1>\nThe question is asking which metabolic pathway is most likely involved in the patient’s condition, particularly considering his use of omeprazole for GERD (gastroesophageal reflux disease) — *àìsàn ìṣànjẹ́dòdò*.\n</step1>\n<step2>\nOmeprazole is primarily metabolized in the liver, and understanding its metabolic pathways is crucial for determining how it might affect the patient’s symptoms — *ìfúnpá gíga* and *àìṣedédé ìlù ọkàn*.\n</step2>\n<step3>\nThe options provided include acetylation, filtration, glucuronidation, and oxidation. Among these, oxidation is a common pathway for many drugs, especially those processed by cytochrome P450 enzymes.\n</step3>\n<step4>\nIn the case of omeprazole, it undergoes significant oxidation, which is essential for its activation and subsequent therapeutic effects — *ìmúṣẹ́ àtọkànwá*.\n</step4>\n<step5>\nWhile glucuronidation also plays a role in drug metabolism, it is less significant for omeprazole compared to oxidation. Therefore, oxidation is the most relevant pathway here.\n</step5>\n<step6>\nConsidering the patient's symptoms and medication, it is likely that oxidation is the metabolic process that could be affecting his condition.\n</step6></thinking>", "answer": "<answer>Oxidation.</answer>", "language": "Yoruba"}
{"question": "Kini ọ̀nà àyẹ̀wò tí Ẹ̀ka Ìṣakoso Àṣìṣe Ojú Orílẹ̀-èdè (NPCB) ṣe ìgbàṣe fún idena àṣìṣe ojú tí ó fa látọwọ́ àrùn retinopathy diabetic?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ọ̀nà àyẹ̀wò tí Ẹ̀ka Ìṣakoso Àṣìṣe Ojú Orílẹ̀-èdè (NPCB) ṣe ìgbàṣe fún idena àṣìṣe ojú tí ó fa látọwọ́ àrùn [retinopathy diabetic = diabetic retinopathy]?” — meaning it wants to know the methods used by the NPCB for preventing eye complications caused by diabetic retinopathy.\n</step1>\n<step2>\nDiabetic retinopathy is a serious condition that affects the eyes of individuals with diabetes — *àrùn suga* can lead to damage in the retina.\n</step2>\n<step3>\nThe NPCB emphasizes regular eye examinations — *ayẹwo oju* — to detect early signs of retinopathy.\n</step3>\n<step4>\nThey also promote patient education on managing diabetes effectively — *ìmọ̀ nípa iṣakoso àrùn suga* is crucial to prevent complications.\n</step4>\n<step5>\nAdditionally, lifestyle modifications such as maintaining a healthy diet and regular exercise are recommended — *jẹun to dara* and *iṣẹ́-ara* can help control blood sugar levels.\n</step6>\n<step6>\nIn summary, the NPCB's approach includes regular screenings, education, and lifestyle changes to prevent diabetic retinopathy — *idanwo, ìmọ̀, àti ayipada ìṣe*.\n</step6></thinking>", "answer": "<answer>Ẹ̀ka Ìṣakoso Àṣìṣe Ojú Orílẹ̀-èdè (NPCB) ṣe ìgbàṣe fún idena àṣìṣe ojú nípa ayẹwo oju, ìmọ̀ nípa iṣakoso àrùn suga, àti ayipada ìṣe.</answer>", "language": "Yoruba"}
{"question": "Ninu obinrin ọdun mẹtadinlogun kan ti o ní ìgbẹ́rùgbẹ́ àti ìgbẹ́ àìdàpọ̀, ẹ̀jẹ̀ nínú òògùn, àwọn àmì onírú-ọ̀rọ̀ bulu-grẹy lórí ètè àti ọwọ́, àti itan ìdílé àrùn ikùn, colonoscopy fi hàn àwọn polypi pupọ káàkiri inu ikun kékeré àti ikun ńlá.  Irú histologic kan pato ni àwọn polypi wọnyi ṣeé ṣe kí wọn jẹ́?", "reasoning": "<thinking><step1>\nThe question describes a 29-year-old woman with symptoms like [ìgbẹ́rùgbẹ́ = abdominal pain] and [ìgbẹ́ àìdàpọ̀ = diarrhea], along with blood in her stool and a family history of [àrùn ikùn = colon disease]. A colonoscopy shows multiple polyps in her [ikun kékeré = small intestine] and [ikun ńlá = large intestine]. It asks what specific type of histology these polyps might represent.\n</step1>\n<step2>\nIn cases like this, the presence of multiple polyps, especially in a young patient, raises suspicion for certain conditions. One common condition associated with multiple polyps is [syndrome familial des polypes = familial polyposis syndrome].\n</step2>\n<step3>\nHistologically, polyps can vary, but if they are numerous and the patient is young, they might be [polypes adénomateux = adenomatous polyps], which have a risk of progressing to colorectal cancer.\n</step3>\n<step4>\nAnother possibility is [polypes hyperplasiques = hyperplastic polyps], but these are usually not associated with cancer risk. Given the context, adenomatous polyps are more concerning.\n</step4>\n<step5>\nConsidering her symptoms and family history, it is likely that these polyps are of the adenomatous type, which can be classified further into tubular or tubulovillous adenomas.\n</step5>\n<step6>\nThus, the specific histologic type of the polyps in this case is likely to be adenomatous, indicating a potential risk for malignancy.\n</step6></thinking>", "answer": "<answer>Iru histologic ti awọn polypi wọnyi jẹ́ adenomatous.</answer>", "language": "Yoruba"}
{"question": "Okùnrin ọdun 53 kan tí ó ní ìtàn àrùn àtẹ́gùn tí ó ṣòro láti ṣakoso, ti wá pẹ̀lú ìrora orí, ìṣòro ìrònú, tí ó sì mọ ara rẹ̀ nìkan. Àtẹ́gùn ẹ̀jẹ̀ rẹ̀ jẹ́ 206/132 mm Hg, àti CT scan ọ̀kan rẹ̀ tí kò ní ìṣàn-àìmọ́ kò fi ohunkóhun hàn. Nígbà tí a bá ronú nípa àwọn àmì wọnyi, ìwádìí àyẹ̀wò wo ni ó ṣeé ṣe jùlọ láti jẹ́risi ipò àrùn tí ó fa àwọn àmì wọnyi?", "reasoning": "<thinking><step1>\nThe question asks about a 53-year-old man with a history of hypertension who is experiencing headaches, cognitive issues, and self-awareness problems. It provides his blood pressure reading of 206/132 mm Hg and mentions a CT scan that shows no abnormalities. The inquiry is about which diagnostic tests are most appropriate to confirm the condition causing these symptoms.\n</step1>\n<step2>\nGiven the high blood pressure reading, *ìtàn àrùn àtẹ́gùn* (hypertension) is a significant factor. The symptoms of headache and cognitive difficulties could indicate a possible hypertensive crisis or other neurological issues.\n</step2>\n<step3>\nConsidering the CT scan is normal, we might suspect conditions like *àkúnya* (stroke) or *àìlera ọpọlọ* (brain dysfunction) that may not always show up on imaging.\n</step3>\n<step4>\nA common follow-up test in such cases is an MRI of the brain, which can provide more detailed images and help identify any subtle changes or lesions that a CT might miss.\n</step4>\n<step5>\nAdditionally, laboratory tests to check for secondary causes of hypertension, such as *ìwádìí àyẹ̀wò ẹ̀jẹ̀* (blood tests) for kidney function or hormonal imbalances, could also be beneficial.\n</step5>\n<step6>\nIn summary, an MRI and relevant blood tests would be the most appropriate investigations to confirm the underlying condition causing these symptoms.\n</step6></thinking>", "answer": "<answer>Ìwádìí àyẹ̀wò tó yẹ jùlọ ni MRI ọpọlọ àti ìwádìí àyẹ̀wò ẹ̀jẹ̀ láti jẹ́risi ipò àrùn tó fa àwọn àmì wọ̀nyí.</answer>", "language": "Yoruba"}
{"question": "Ìwòran X-ray ọ̀dọ́mọkùnrin kan fihàn pé kálísíọ́mù ti kó jọ ní àyíká gbogbo orúnkún méjèèjì. Ìwádìí tó tẹ̀lé yóò jẹ́-\nA. Fọ́síféètì inú ẹ̀jẹ̀\nB. Kálísíọ́mù inú ẹ̀jẹ̀\nC. PTH inú ẹ̀jẹ̀\nD. Alkaline phosphatase inú ẹ̀jẹ̀", "reasoning": "<thinking><step1>\nThe question translates to: \"An X-ray of a boy shows that calcium has accumulated in both kidneys. What further investigation should be done?\" Here, *kálísíọ́mù* means calcium and *orúnkún* refers to kidneys.\n</step1>\n<step2>\nWhen calcium accumulates in the kidneys, it can indicate various conditions, such as hypercalcemia — *hyperkálísíọ́mù* — which may require specific tests to determine the underlying cause.\n</step2>\n<step3>\nOne common investigation is to check for calcium levels in the blood — *ìwádìí kálísíọ́mù inú ẹ̀jẹ̀* — to see if the calcium is elevated.\n</step3>\n<step4>\nAnother important test is measuring parathyroid hormone (PTH) levels — *PTH inú ẹ̀jẹ̀* — since elevated PTH can lead to increased calcium levels.\n</step4>\n<step5>\nAlkaline phosphatase levels — *alkaline phosphatase inú ẹ̀jẹ̀* — can also be relevant, especially if bone metabolism is involved.\n</step6>\n<step6>\nHowever, given the context of calcium accumulation specifically in the kidneys, the most direct follow-up would be to assess calcium levels in the blood.\n</step6></thinking>", "answer": "<answer>Kálísíọ́mù inú ẹ̀jẹ̀.</answer>", "language": "Yoruba"}
{"question": "Àwọn àmì àrùn àti àwọn ìwádìí ilé-ìwádìí tó o sọ nípa ọmọbìnrin ọdún márùn-ún yìí fi hàn kedere pé ó ní àrùn Reye. Àrùn Reye jẹ́ àrùn tó ṣọ̀wọ̀n, tí ó sì lewu pupọ tí ó sábà máa ń bà ọmọdé, tí ó sì lè wá lẹ́yìn àrùn àkóbàjáde bíi fuluu tàbí àkùkù.  Àrùn náà ni àrùn ọpọlọ tí ó ṣẹ́lẹ̀ ní kánkán àti àrùn ẹ̀dọ̀-fọ́ní, ìgbà tí a bá lo aspirin nígbà tí àrùn àkóbàjáde náà bá wà, jẹ́ ohun tó lè mú kí àrùn náà wá. Ìwọ̀n suga ẹ̀jẹ̀ tí kò pọ̀, ìwọ̀n enzyme ẹ̀dọ̀-fọ́ní tí ó ga, àkókò prothrombin tí ó gùn, àti ìgbóná sí iṣan ojú méjì nítorí àtìpọ̀ ìfúlẹ̀ ní ọpọlọ, gbogbo rẹ̀ bá ìwádìí yìí mu.  Nítorí náà, ohun tí ó ṣẹlẹ̀ jùlọ tó mú kí àwọn àmì àrùn wọ̀nyí wà, ni àrùn Reye.", "reasoning": "<thinking><step1>\nThe question discusses the symptoms and research findings indicating that a five-year-old girl has Reye's syndrome — *àrùn Reye*.\n</step1>\n<step2>\nReye's syndrome is a rare but serious condition that primarily affects children, often following viral infections like influenza or chickenpox — *àkóbàjáde*.\n</step2>\n<step3>\nIt involves acute brain disease — *àrùn ọpọlọ* — and liver dysfunction, particularly when aspirin is used during viral illnesses.\n</step3>\n<step4>\nKey indicators include low blood sugar — *ìwọ̀n suga ẹ̀jẹ̀ tí kò pọ̀*, elevated liver enzymes — *ìwọ̀n enzyme ẹ̀dọ̀-fọ́ní tí ó ga*, and prolonged prothrombin time — *àkókò prothrombin tí ó gùn*.\n</step5>\n<step5>\nThe symptoms arise due to swelling in the brain — *ìfúlẹ̀ ní ọpọlọ* — which can lead to severe complications.\n</step6>\n<step6>\nThus, the primary cause of these symptoms is Reye's syndrome, which is critical to recognize for timely intervention.\n</step6></thinking>", "answer": "<answer>Àrùn Reye jẹ́ àrùn tó lewu tí ó ní àkóbàjáde lẹ́yìn àrùn fuluu tàbí àkùkù, tí ó fa ìfúlẹ̀ ní ọpọlọ àti àrùn ẹ̀dọ̀-fọ́ní.</answer>", "language": "Yoruba"}
{"question": "Ipò wo ni kì í ṣe àmì kan fún angiografía àgbàrá nígbà tí a bá ṣe é lẹ́yìn ìgbà tí a ti fi ohun tó mú ẹ̀jẹ̀ ṣiṣẹ́ sí inú àgbàrá?", "reasoning": "<thinking><step1>\nThe question asks: “Ipò wo ni kì í ṣe àmì kan fún [angiografía = angiography] àgbàrá nígbà tí a bá ṣe é lẹ́yìn ìgbà tí a ti fi ohun tó mú ẹ̀jẹ̀ [sí inú àgbàrá = into the bloodstream]?” — meaning it wants to know what position is not an indicator for angiography after a contrast agent has been administered.\n</step1>\n<step2>\nAngiography is a medical imaging technique used to visualize the inside of blood vessels — *àwọn ẹ̀jẹ̀ tó wà nínú àgbàrá*.\n</step2>\n<step3>\nTypically, indications for angiography include symptoms like chest pain or signs of vascular disease — *ìfihàn àìlera nínú àgbàrá*.\n</step3>\n<step4>\nHowever, certain conditions may not warrant angiography, such as stable angina or absence of acute symptoms — *àìní àìlera tó ṣe pàtàkì*.\n</step4>\n<step5>\nIn this context, if a patient is asymptomatic and has no significant risk factors, angiography may not be necessary — *kò yẹ kí a ṣe é*.\n</step5>\n<step6>\nThus, the position that is not an indicator for angiography would be when the patient shows no acute symptoms or risk factors.\n</step6></thinking>", "answer": "<answer>Ipò tí kì í ṣe àmì kan fún angiografía ni pé ẹni náà kò ní àìlera tó ṣe pàtàkì tàbí àìfihàn àìlera.</answer>", "language": "Yoruba"}
{"question": "Àyípadà bí ìrora ìgbàgbé oúnjẹ́ àti àìgbẹ́ ara tí ó kere jùlọ ni a rí nínú ipò wọ̀nyí:\nA. Parietal cell vagotomy\nB. Truncal vagotomy & Gastrojejunostomy\nC. Antrectomy pẹ̀lú truncal vagotomy\nD. Vagotomy pẹ̀lú pyloroplasty", "reasoning": "<thinking><step1>\nThe question asks: “Àyípadà bí ìrora ìgbàgbé oúnjẹ́ àti àìgbẹ́ ara tí ó kere jùlọ ni a rí nínú ipò wọ̀nyí?” — meaning it wants to know which surgical procedure results in the least postoperative complications related to gastric emptying and motility.\n</step1>\n<step2>\nIn surgical terms, *ìrora ìgbàgbé oúnjẹ́* refers to gastric emptying, while *àìgbẹ́ ara* relates to motility issues. \n</step2>\n<step3>\nAmong the options, *Parietal cell vagotomy* (A) selectively cuts the nerve supply to the parietal cells, reducing acid secretion but may not significantly affect gastric motility.\n</step3>\n<step4>\n*Truncal vagotomy & Gastrojejunostomy* (B) involves cutting the vagus nerve and creating a bypass, which can lead to complications like *dumping syndrome* and poor gastric emptying.\n</step4>\n<step5>\n*Antrectomy pẹ̀lú truncal vagotomy* (C) removes the antrum and also affects motility, potentially leading to more complications.\n</step5>\n<step6>\n*Vagotomy pẹ̀lú pyloroplasty* (D) is designed to reduce complications by facilitating gastric drainage, making it a favorable option for minimizing postoperative issues.\n</step6>\n<step7>\nConsidering all these factors, *vagotomy pẹ̀lú pyloroplasty* is likely to have the least impact on gastric emptying and motility, thus resulting in fewer complications.\n</step7></thinking>", "answer": "<answer>Vagotomy pẹ̀lú pyloroplasty ni a rí nínú ipò wọ̀nyí tí ó kere jùlọ nínú ìrora ìgbàgbé oúnjẹ́ àti àìgbẹ́ ara.</answer>", "language": "Yoruba"}
{"question": "Egbogi wo ni o ni ipa pupọ ninu itoju irora ẹ̀gbà lọ́na tó gbọ́dọ̀, botilẹ̀jẹpe kò ní agbara lati dinku irora, tabi lati dinku igbona, tabi lati mú iye asidí urikini ninu ẹ̀jẹ̀ dinku?", "reasoning": "<thinking><step1>\nThe question asks: “Egbogi wo ni o ni ipa pupọ ninu itoju irora ẹ̀gbà?” — meaning it wants to know which medications are effective in managing back pain.\n</step1>\n<step2>\nBack pain management often involves non-steroidal anti-inflammatory drugs (NSAIDs) — *awọn oogun anti-inflammatory ti kii ṣe steroid* — which help reduce inflammation and pain.\n</step2>\n<step3>\nHowever, the question notes that these medications may not reduce fever or lower uric acid levels — *kò ní agbara lati dinku igbona tabi lati mú iye asidí urikini dinku*.\n</step3>\n<step4>\nIn cases of chronic back pain, *irora ẹ̀gbà àkókò pipẹ*, doctors might also prescribe muscle relaxants — *awọn oogun ti o mu awọn iṣan dinku* — to alleviate muscle spasms.\n</step4>\n<step5>\nFor severe cases, opioids may be considered, but they come with risks of dependency — *awọn eewu ti iṣe-ara*.\n</step5>\n<step6>\nAdditionally, physical therapy is crucial — *itoju ara* — as it helps strengthen the back and improve mobility.\n</step6>\n<step7>\nIn summary, while NSAIDs are effective for pain relief, they do not address fever or uric acid levels, and a comprehensive approach including physical therapy is often necessary.\n</step7></thinking>", "answer": "<answer>Egbogi ti o ni ipa pupọ ninu itoju irora ẹ̀gbà ni awọn oogun anti-inflammatory ti kii ṣe steroid, ṣugbọn wọn ko le dinku igbona tabi asidí urikini.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 27 kan bẹ̀ wá sí ọfiisi pẹ̀lú ẹ̀dùn nínú iṣan ati awọn iyẹfun ẹsẹ̀ rẹ̀. Ó ko le ranti ní pàtó nígbà tí ó bẹ̀rẹ̀, ṣugbọn ó lágbára sí i lẹ́yìn irin-ajo ìrìn-àjò rẹ̀ lọ́la. Ó jẹ́ olufẹ́ ìrìn-àjò ati pé ó sọ pé ó ti lọ sí irin-ajo ìrìn-àjò kan ní Connecticut lọ́la. Ó ko le rántí àwọn àmì kan pato lẹ́yìn ìrìn-àjò náà yàtọ̀ sí àìsàn tí ó wà lórí ẹsẹ̀ òsì rẹ̀ pẹ̀lú àwọn ààlà tí ó hàn gbangba (àwòrán tí a fi hàn nínú àfihàn). Àrùn ko ba aládùúgbò náà, ati pé kò sì sí àyípadà nínú ríran rẹ̀. Àwọn àmì ìlera rẹ̀ fi àtìsìnbá ẹ̀jẹ̀ hàn gẹ́gẹ́ bí 120/70 mm Hg, ìṣàn 97/min, ati ìmímú 18/min. Ìgbóná wà nínú ẹsẹ̀ òsì rẹ̀ pẹ̀lú ìdinku ìwọn ìṣiṣẹ́ nínú iyẹfun ẹsẹ̀ òsì. Ko sí sí ìgbẹ̀rùn iyẹfun kankan tí a ṣàkíyèsí. Èwo nínú àwọn wọ̀nyí yóò jẹ́ igbesẹ tó tọ́ julọ tókàn nínú ìṣàkóso aládùúgbò yìí?\nA. Ìdánwò Serological\nB. Ìdánwò ẹ̀jẹ̀\nC. Bẹ̀rẹ̀ ìtọ́jú doxycycline\nD. Béèrè lọ́wọ́ rẹ̀ pé kí ó pada lẹ́yìn ọ̀sẹ̀ kan\nE. Bẹ̀rẹ̀ ìtọ́jú erythromycin", "reasoning": "<thinking><step1>\nThe question describes a 27-year-old man who presents with pain in his leg and foot, which started after a recent trip to Connecticut. He has no significant changes in vision and his vital signs are stable, indicating he is not in acute distress.\n</step1>\n<step2>\nThe symptoms include pain in the left leg and foot, with swelling visible — *ìdí ẹsẹ̀ òsì rẹ̀* — suggesting a possible issue like a deep vein thrombosis (DVT) or another vascular problem.\n</step2>\n<step3>\nGiven that he has no fever and his vital signs are normal, this rules out an acute infection, which would typically present with fever or systemic symptoms — *àìlera àpapọ̀*.\n</step4>\n<step4>\nThe options provided include various diagnostic and treatment steps. A serological test — *ìdánwò serological* — might not be immediately relevant without signs of infection or autoimmune issues.\n</step5>\n<step5>\nStarting doxycycline or erythromycin — *ìtọ́jú doxycycline* or *ìtọ́jú erythromycin* — would be more appropriate if there were signs of infection, which there are not.\n</step6>\n<step6>\nAsking him to return in a week — *béèrè lọ́wọ́ rẹ̀ pé kí ó pada lẹ́yìn ọ̀sẹ̀ kan* — could be a reasonable follow-up, but it does not address the immediate concern of his leg pain.\n</step7>\n<step7>\nThe most appropriate step in this case would be to conduct a blood test — *ìdánwò ẹ̀jẹ̀* — to rule out any underlying issues such as a clot or other hematological concerns.\n</step7></thinking>", "answer": "<answer>Ìdánwò ẹ̀jẹ̀.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 45 kan wà pẹlu awọn iṣẹlẹ ara ti o tun ṣe, eyiti a ṣe apejuwe pẹlu awọn abawọn pupa ti ko ni irora ti o di awọn ifunwara ti o ni irora ati ti o korò, ti o wa pẹlu awọn ikọlu àìdá ara ti o tun ṣe ati pipadanu iwuwo pupọ. Awọn iṣẹlẹ ara wọnyi wa lori awọn ẹsẹ rẹ̀, àgbàrá rẹ̀, ati ni ayika ẹnu rẹ̀, pẹlu ami Nikolsky ti ko dara. Iwadii ara fihan ikọlu epidermis. Ti a ba gbero awọn ami aisan wọnyi ati awọn abajade ile-iwosan pẹlu iyipada suga ẹjẹ giga, kini abajade ile-iwosan afikun ti o baamu julọ pẹlu ipo alaisan yii ti o fihan ailera homonu gbogbo ara han?", "reasoning": "<thinking><step1>\nThe question describes a 45-year-old man with recurrent skin lesions characterized by painless red spots that have become painful and ulcerated, along with recurrent systemic symptoms and significant weight loss. It mentions Nikolsky's sign and findings of epidermal detachment, suggesting a serious skin condition.\n</step1>\n<step2>\nGiven the symptoms, particularly the *lesions cutanées* (skin lesions) and *perte de poids* (weight loss), we should consider autoimmune conditions or severe dermatological disorders. The presence of Nikolsky's sign indicates a potential blistering disorder, such as pemphigus.\n</step2>\n<step3>\nThe recurrent systemic symptoms and high blood sugar levels suggest an underlying metabolic or endocrine issue, possibly related to *déséquilibre hormonal* (hormonal imbalance). This could indicate a connection to conditions like Cushing's syndrome or diabetes mellitus.\n</step4>\n<step4>\nIn this context, the combination of skin lesions, systemic symptoms, and hormonal imbalance points towards a diagnosis of *pemphigus vulgaris*, which is characterized by painful blisters and can be associated with other systemic issues.\n</step5>\n<step5>\nConsidering all these factors, the most fitting additional diagnosis that aligns with the patient's symptoms and findings would be *syndrome de Cushing* (Cushing's syndrome), which can lead to skin changes and systemic effects.\n</step6></thinking>", "answer": "<answer>Abajade ile-iwosan ti o baamu julọ ni *syndrome de Cushing*.</answer>", "language": "Yoruba"}
{"question": "Gítarì àmì-ìtànṣán kan tí iye owo rẹ̀ jẹ́ $90.50 ni a rà nípa ọ̀nà ìgbà-ìgbà, nípa lílo owó ìṣàkóso ìṣáájú kan tí iye rẹ̀ jẹ́ $14.95, tí ó tèlé e nípa owó ìgbà-ìgbà 8 tí iye kọ̀ọ̀kan jẹ́ $10. Kí ni ìwọ̀n ìfẹ́ tí wọ́n gbé lé ọ̀nà ìgbà-ìgbà yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ìwọ̀n ìfẹ́ tí wọ́n gbé lé ọ̀nà ìgbà-ìgbà yìí?” — meaning it wants to know the interest rate applied to a loan for purchasing a guitar that costs $90.50.\n</step1>\n<step2>\nFirst, we need to calculate the total amount paid for the loan. The initial amount is $14.95, plus 8 payments of $10 each — *ìsanwo mẹjọ ti $10 kọọkan*.\n</step2>\n<step3>\nCalculating the total payments: $10 * 8 = $80. So, the total amount paid is $14.95 + $80 = $94.95.\n</step3>\n<step4>\nNext, we find the interest paid: Total paid ($94.95) minus the cost of the guitar ($90.50) gives us $4.45 — *ìfẹ́ tí a san*.\n</step4>\n<step5>\nTo find the interest rate, we use the formula: Interest Rate = (Interest / Principal) * 100. Here, Principal is the cost of the guitar, $90.50.\n</step5>\n<step6>\nSo, Interest Rate = ($4.45 / $90.50) * 100, which calculates to approximately 4.92%.\n</step6></thinking>", "answer": "<answer>Ìwọ̀n ìfẹ́ tí wọ́n gbé lé ọ̀nà ìgbà-ìgbà yìí jẹ́ 4.92%.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹ́ta ti ní àwọn àmì àrùn tí wọ́n ṣe kedere ní ayika ojú rẹ̀, àwọn ìṣiṣẹ́ ojú tí kò bá ara wọn mu, tí wọ́n ń yí pa dà láìní ìṣọ́kan, àìlera ẹ̀jìká, myoclonus, àti ìṣẹ̀dá abẹ́rẹ́. Lẹ́yìn ìwádìí CT, àwọn àmì àrùn wọ̀nyí fi hàn pé ọ̀rọ̀ kan pato ni. Èwo ni oògùn tí a ti gbà láyè fún ìtọ́jú ìṣẹ̀lẹ̀ àrùn yìí?", "reasoning": "<thinking><step1>\nThe question asks about a three-year-old boy showing symptoms like *myoclonus* and *àìlera ẹ̀jìká* — which means muscle weakness — and seeks to identify the medication for treating this specific condition.\n</step1>\n<step2>\nGiven the symptoms, it suggests a neurological issue, possibly related to *les troubles neurologiques* that can cause involuntary muscle movements.\n</step2>\n<step3>\nIn cases like this, a common diagnosis could be *l'épilepsie* or other seizure disorders, which often present with myoclonus.\n</step3>\n<step4>\nThe treatment typically involves anticonvulsants — *les anticonvulsivants* — which help manage seizures and muscle spasms.\n</step4>\n<step5>\nFor a child, medications like *le valproate de sodium* or *le lévétiracétam* are often prescribed, depending on the specific diagnosis.\n</step5>\n<step6>\nThus, the medication that is usually approved for treating such conditions in children is an anticonvulsant.\n</step6></thinking>", "answer": "<answer>Oògùn tí a ti gbà láyè fún ìtọ́jú ìṣẹ̀lẹ̀ àrùn yìí ni *les anticonvulsivants*.</answer>", "language": "Yoruba"}
{"question": "Kini ayẹ̀wò ti o ṣeeṣe julọ fun alaisan kan ti o ni iriri dysphagia ti ko ni deede fun awọn ohun ti o le jẹ ati awọn ohun mimu?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ayẹ̀wò ti o ṣeeṣe julọ fun alaisan kan ti o ni iriri [dysphagia = difficulty swallowing] ti ko ni deede fun awọn ohun ti o le jẹ ati awọn ohun mimu?” — meaning it wants to know the most likely evaluation for a patient experiencing unusual dysphagia for solids and liquids.\n</step1>\n<step2>\nDysphagia can be caused by various conditions, and the evaluation typically starts with a thorough history — *itan ti alaisan* — and physical examination.\n</step2>\n<step3>\nCommon causes include neurological disorders, such as stroke or *àìlera ọpọlọ*, which can affect swallowing muscles.\n</step3>\n<step4>\nAn important diagnostic tool is a barium swallow study — *iwadi ti a fi barium ṣe* — which helps visualize the swallowing process and identify any obstructions.\n</step4>\n<step5>\nAdditionally, an endoscopy may be performed to directly examine the esophagus — *esophagus* — for any abnormalities or lesions.\n</step5>\n<step6>\nIn summary, the most likely evaluation for this patient would involve imaging studies and possibly an endoscopic examination to determine the underlying cause of the dysphagia.\n</step6></thinking>", "answer": "<answer>Ayẹ̀wò ti o ṣeeṣe julọ ni iwadi barium ati endoscopy lati ṣe ayẹwo idi ti dysphagia.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọmọ ọdún méjeogún kan wà lórí ìtọ́jú pẹ̀lú Alendronate fún ọdún méje fún osteoporosis. Nísinsìnyí, ó ń ṣe kòfìí ní ẹsẹ̀ ọ̀tún rẹ̀. Ṣé kíni ìwádìí tí ó tẹ̀lé yìí? (AIIMS Kọkànlá 20/3, Òṣù Kàrùn-ún 2013)\nA. DEXA scan\nB. X-ray\nC. Ipele Vitamin D ninu ẹ̀jẹ̀\nD. Ipele alkaline phosphate ninu ẹ̀jẹ̀", "reasoning": "<thinking><step1>\nThe question asks: “What investigation follows for a 57-year-old woman on Alendronate for ten years for osteoporosis who is now experiencing pain in her right leg?” — here, *ìtọ́jú* means treatment and *ìwádìí* means investigation.\n</step1>\n<step2>\nIn this context, Alendronate is a bisphosphonate used to treat osteoporosis — *osteoporosis* is a condition that weakens bones, making them fragile.\n</step2>\n<step3>\nThe patient’s leg pain could indicate a potential complication, such as a fracture or osteonecrosis — *ìfarapa* or *ìkópa egungun*.\n</step3>\n<step4>\nA DEXA scan is typically used to assess bone density — *ìwádìí DEXA* is crucial for monitoring osteoporosis treatment effectiveness.\n</step4>\n<step5>\nHowever, given the acute nature of the leg pain, it’s essential to rule out other issues first, such as fractures, which might be visible on an X-ray — *X-ray* can help identify any immediate problems.\n</step6>\n<step6>\nChecking Vitamin D levels — *ìpele Vitamin D ninu ẹ̀jẹ̀* — is also important for bone health, but it may not be the first step in acute pain assessment.\n</step7>\n<step7>\nAlkaline phosphatase levels — *ìpele alkaline phosphate ninu ẹ̀jẹ̀* — can indicate bone turnover but are less relevant in this acute scenario.\n</step8>\n<step8>\nThus, the most appropriate initial investigation for this patient experiencing leg pain would be an X-ray to rule out fractures.\n</step8></thinking>", "answer": "<answer>X-ray</answer>", "language": "Yoruba"}
{"question": "Obìnrin ẹni ọdún méjìdínláàádọ́ta (48) kan wá sí ọ̀dọ̀ dókítà alábòójútó àkọ́kọ́ rẹ̀ pẹ̀lú àwọn ẹdun àárẹ̀ tí kò lọ, òòyì, àti ìpàdánù ìwọ̀n ara fún oṣù mẹ́ta sẹ́yìn. Ó ní àìṣiṣẹ́ ọ̀rá-ọ̀fun (hypothyroidism) fún ọdún mẹ́ẹ̀ẹ́dógún (15) ó sì ń lo òògùn thyroxine fún ìtọ́jú. Ìwọ̀n ìfúnpá rẹ̀ jẹ́ 90/60 mm Hg nígbà tó dùbúlẹ̀, ó sì jẹ́ 65/40 mm Hg nígbà tó jókòó, ìwọ̀n ìgbóná ara rẹ̀ jẹ́ 36.8°C (98.2°F) àti ìṣísẹ̀ ọkàn rẹ̀ jẹ́ 75/min. Lórí àyẹ̀wò ara, ìwọ̀n ọ̀rá-ọ̀fun (thyroid) rẹ̀ pọ̀ sí i díẹ̀, ó sì rọ̀ bí rọ́bà. Ara rẹ̀ fi àmì ìdúdú ojú ara hàn (hyperpigmentation), tó túbọ̀ hàn kedere ní inú ẹnu àti ní àwọn ìlà àtẹ́lẹwọ́. Àyẹ̀wò èròjà cortisol nínú ẹ̀jẹ̀ ní òwúrọ̀ fi hàn pé ó jẹ́ 3 µg/dL. Èwo nínú ìwọ̀nyí ni ìgbésẹ̀ tó tọ́ jù lọ nínú ọ̀ràn yìí?\nA. Àyẹ̀wò aldosterone nínú ẹ̀jẹ̀\nB. Àyẹ̀wò ìgbìyànjú Adrenocorticotropic hormone (ACTH)\nC. Yíyàwòrán àwọn ẹ̀ṣọ́ adrenal\nD. Àwọn èròjà agbógunti 21-hydroxylase", "reasoning": "<thinking><step1>\nThe question is asking about the next appropriate step in the management of a 48-year-old woman with symptoms like fatigue, weight loss, and hyperpigmentation, who has a history of hypothyroidism and abnormal blood pressure readings.\n</step1>\n<step2>\nGiven her symptoms, particularly *ìdúdú ojú ara* (hyperpigmentation) and low blood pressure, this suggests a possible adrenal insufficiency — *aìṣiṣẹ́ adrenal*.\n</step2>\n<step3>\nIn such cases, it is crucial to evaluate the levels of Adrenocorticotropic hormone (ACTH) to determine if the adrenal glands are functioning properly — *àyẹ̀wò ACTH* is a key diagnostic step.\n</step4>\n<step4>\nThe other options, like checking aldosterone or imaging the adrenal glands, may be relevant later, but they do not directly address the immediate concern of adrenal function.\n</step5>\n<step5>\nThus, the most logical next step in this scenario is to perform an ACTH stimulation test — *àyẹ̀wò ìgbìyànjú ACTH* — to assess the adrenal response.\n</step6></thinking>", "answer": "<answer>B. Àyẹ̀wò ìgbìyànjú Adrenocorticotropic hormone (ACTH)</answer>", "language": "Yoruba"}
{"question": "Ní ọ̀ràn ọkùnrin ọdún 62 kan tí ó ní ìṣùgbààlù tí kò ní ìdààmú tí ó tó 3 cm ní ìmọ́ adrenal òsì, tí a rí ní CT scan, pẹ̀lú àwọn àmì àrùn bí ìpọ̀sì ìwúrí ati iṣùgbààlù àrùn àtọ́rùn-un tí ó ṣòro láti ṣàkóso ati àtọ́pàpà, kí ni àdánwò àkọ́kọ́ tí ó dára jùlọ láti ṣàyẹ̀wò iṣẹ́ ìmọ́ adrenal naa?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àdánwò àkọ́kọ́ tí ó dára jùlọ láti ṣàyẹ̀wò iṣẹ́ ìmọ́ adrenal naa?” — meaning it wants to know the best initial test to evaluate adrenal function in a 62-year-old man with a 3 cm adrenal mass.\n</step1>\n<step2>\nIn this case, the patient has an adrenal mass and symptoms like *ìpọ̀sì ìwúrí* (weight gain) and *iṣùgbààlù àrùn àtọ́rùn-un* (difficult-to-control hypertension).\n</step2>\n<step3>\nThe first step is to assess for conditions like Cushing's syndrome, which can be indicated by the symptoms and the adrenal mass.\n</step3>\n<step4>\nA common initial test for adrenal function is the measurement of serum cortisol levels — *ìwọn cortisol* — especially in the context of suspected hypercortisolism.\n</step4>\n<step5>\nIf the cortisol levels are elevated, further testing such as a 24-hour urinary free cortisol test or a low-dose dexamethasone suppression test may be warranted.\n</step5>\n<step6>\nThus, the best initial test to evaluate adrenal function in this scenario is the serum cortisol level.\n</step6></thinking>", "answer": "<answer>Ìwọn cortisol ni àdánwò àkọ́kọ́ tí ó dára jùlọ láti ṣàyẹ̀wò iṣẹ́ ìmọ́ adrenal naa.</answer>", "language": "Yoruba"}
{"question": "Eyi ni tabili kan nibiti ila-ẹlẹẹkan jẹ́ aṣẹ-ọ̀rọ̀ ati ila kọ̀ọ̀kan ti o tẹle jẹ́ penguin kan: orukọ, ọjọ ori, iga (cm), iwuwo (kg) Louis, 7, 50, 11 Bernard, 5, 80, 13 Vincent, 9, 60, 11 Gwen, 8, 70, 15 Fun apẹẹrẹ: ọjọ ori Louis jẹ́ 7, iwuwo Gwen jẹ́ 15 kg, iga Bernard jẹ́ 80 cm.  Lẹ́yìn náà, a yọ penguin ti a npè ni Bernard kuro ninu tabili naa.\nKini iwuwo gbogbo awọn penguins?\nAwọn aṣayan:\n(A) 37\n(B) 49\n(C) 50\n(D) 62\n(E) 63", "reasoning": "<thinking><step1>\nThe question asks: “Kini iwuwo gbogbo awọn penguins?” — meaning it wants to know the total weight of all the penguins listed in the table.\n</step1>\n<step2>\nFirst, we identify the weights of each penguin: Louis is 11 kg, Bernard is 13 kg, Vincent is 11 kg, and Gwen is 15 kg.\n</step2>\n<step3>\nNext, we need to remove Bernard from the total since the question states to exclude him — *a yọ Bernard kuro*.\n</step3>\n<step4>\nSo, we calculate the total weight of the remaining penguins: Louis (11 kg) + Vincent (11 kg) + Gwen (15 kg).\n</step4>\n<step5>\nAdding these weights gives us: 11 + 11 + 15 = 37 kg.\n</step5>\n<step6>\nThus, the total weight of the remaining penguins is 37 kg.\n</step6></thinking>", "answer": "<answer>Iwuwo gbogbo awọn penguins ni 37 kg.</answer>", "language": "Yoruba"}
{"question": "Kini orukọ ìṣọpọ́ àwọn ìlà ìwọ̀n àtọ́ka ní àárín ojú àgbọnrin rààmù tí ó fi hàn ní ìdàgbàsókè fífẹ̀rẹ̀gbẹ̀ ní ojú ilẹ̀ àgbọnrin?", "reasoning": "<thinking><step1>\nThe question asks: “Kini orukọ ìṣọpọ́ [the name of the combination] àwọn ìlà ìwọ̀n àtọ́ka [of the coordinate axes] ní àárín ojú àgbọnrin [in the Cartesian plane] rààmù [that shows] tí ó fi hàn [which demonstrates] ní ìdàgbàsókè [in the development] fífẹ̀rẹ̀gbẹ̀ [of a function] ní ojú ilẹ̀ àgbọnrin?” — meaning it seeks the name of the combination of coordinate axes in the Cartesian plane that illustrates the development of a function.\n</step1>\n<step2>\nIn mathematics, the Cartesian plane consists of two axes: the x-axis and the y-axis — *àwọn àtọ́ka x àti y*.\n</step2>\n<step3>\nThe combination of these axes is crucial for graphing functions — *fífẹ̀rẹ̀gbẹ̀* — as it allows us to visualize relationships between variables.\n</step3>\n<step4>\nWhen we plot a function, we often refer to the resulting graph as a *àwòrán* that represents the function's behavior.\n</step4>\n<step5>\nThe specific name for the combination of these axes is the Cartesian coordinate system — *ètò àtọ́ka Cartesian*.\n</step5>\n<step6>\nThus, the name of the combination of the coordinate axes in the Cartesian plane that shows the development of a function is the Cartesian coordinate system.\n</step6></thinking>", "answer": "<answer>Ètò àtọ́ka Cartesian ni orukọ ìṣọpọ́ àwọn ìlà ìwọ̀n àtọ́ka ní àárín ojú àgbọnrin.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdún mẹ́ẹ̀dọ́gbọ̀n (25) kan tí ó ní ìtàn àìsàn àìsàn ẹ̀dọ̀fóró nígbà ọmọdé wá sí ile-iwosan, ó ń kọrin nípa ìtàn oṣù mẹ́ta ti àìgbọ́ràn igbagbogbo, àti ìgbàgbọ́.  Lọ́wọ́lọ́wọ́, ó ní ìgbàgbọ́ mẹ́ta si mẹrin lọ́jọ́, ó sì gbàgbọ́ pé àwọn àkókò wọnyi ti ń burú sí i, ó sì ní ìdààmú pẹlu irora ikùn díẹ̀. Ó tún gbà pé ó rí ẹ̀jẹ̀ pupa lórí iwe itọ́jú. Nígbà tí a tún bi i, ó tún gbà pé ó ní ìṣẹ̀lẹ̀ ọkàn fún oṣù diẹ̀ sẹ́yìn. Ó kò gbà pé ó ní iba, òtútù, ìṣòro ori, ríran tí kò mọ́, ikọ́, àìlera ẹ̀dọ̀fóró, fífò, ríru, tàbí àbà. Ó ṣàpèjúwe ipò ọkàn rẹ̀ gẹgẹ bi ẹni tí ó binu díẹ̀, ó sì ti sùn burúkú. Ṣíṣayẹ̀wo àkọọlẹ̀ ìṣègùn rẹ̀ fi hàn pé ó sọnù iwuwo poun mẹ́fà lati ìbẹ̀wò rẹ̀ oṣù mẹ́fà sẹ́yìn, ṣùgbọ́n ó sọ pé ìyàn rẹ̀ ti dára. Ẹ̀rùńrún náà kò gbà pé ó ní àìsàn tuntun tàbí irin-ajo. Òun kì í fi oògùn táàbà. Oògùn kan ṣoṣo tí ó ń mu ni píìlì ìgbẹ̀kẹ̀lé ẹnu.\n\nOtutu rẹ̀ jẹ́ 37°C (98.6°F), ìṣàn jẹ́ 104/min, titẹ ẹ̀jẹ̀ jẹ́ 95/65 mmHg, ìmímú ẹ̀jẹ̀ jẹ́ 16/min, ati saturation oksijeni jẹ́ 99% lórí afẹ́fẹ́ yàrá. Ní àyẹ̀wò ara, oníṣègùn ṣàkíyèsí pé ìgbààlẹ̀ rẹ̀ dàbí pé ó tóbi ní ọ̀nà kan náà ṣùgbọ́n kò ní irora nígbà tí a bá fọwọ́ kàn án. Nígbà tí a gbọ́, ohùn ìgbàálẹ̀ kan gbọ́. ẹ̀yin ẹ̀jẹ̀ rẹ̀ dára, ati àyẹ̀wò ojú fi hàn pé ó ní exophthalmos. Ikùn rẹ̀ rọ, kò sì ní irora nígbà tí a bá fọwọ́ kàn án. Àwọn ìtọ́jú tendon jíjìn jẹ́ 3+ gbogbo rẹ̀. Àwọn abajade àyẹ̀wò ilé-iwosan ni eyi:\n\nẸ̀jẹ̀:\nNa+: 140 mEq/L\nK+: 4.1 mEq/L\nCl-: 104 mEq/L\nHCO3-: 26 mEql/L\nBUN: 18 mg/dL\nCreatinine 0.9 mg/dL\n\nHemoglobin: 14.0 g/dL\nIye ẹ̀jẹ̀ funfun: 7,400/mm^3\nIye ẹ̀jẹ̀ pupa: 450,000/mm^3\nTSH & Free T4: ń dúró\n\nÀyẹ̀wò oyun jẹ́ àìlóòtọ́. A bẹ̀rẹ̀ sí fi propranolol fun u láti dún àwọn àmì àìsàn. Kí ni ìgbésẹ̀ tó yẹ kí a gbé nípa àìsàn yi?\nA. IV hydrocortisone\nB. Propylthiouracil\nC. Adalimumab\nD. Àyẹ̀wò ìgbàálẹ̀ pẹ̀lú I-123\nE. Ìṣègùn ìgbàálẹ̀", "reasoning": "<thinking><step1>\nThe question asks about the appropriate management steps for a 25-year-old patient with a history of thyroid disease and current symptoms suggesting hyperthyroidism, including exophthalmos and tachycardia. \n</step1>\n<step2>\nThe patient has a history of *àìsàn ẹ̀dọ̀fóró* (thyroid disease) and presents with symptoms like *irora ikùn* (abdominal pain) and *exophthalmos* (protruding eyes), indicating possible *hyperthyroidism*.\n</step2>\n<step3>\nGiven the lab results, the TSH and Free T4 levels are stable, but the patient exhibits signs of *àìlera* (illness) and *ìgbàálẹ̀* (thyroid storm) symptoms, which require immediate attention.\n</step3>\n<step4>\nThe treatment options include IV hydrocortisone, which is typically used for adrenal insufficiency, and propylthiouracil, which is an antithyroid medication that can help manage hyperthyroidism.\n</step4>\n<step5>\nConsidering the patient's symptoms and the need to control the hyperthyroid state, *propylthiouracil* is the most appropriate choice to address the underlying thyroid issue.\n</step6>\n<step7>\nOther options like *adalimumab* (a monoclonal antibody) and *ìṣègùn ìgbàálẹ̀* (thyroid surgery) are not immediate solutions for the current hyperthyroid crisis.\n</step8>\n<step9>\nThus, the best step to take in this situation is to initiate treatment with propylthiouracil to manage the hyperthyroid symptoms effectively.\n</step9></thinking>", "answer": "<answer>Propylthiouracil ni ìgbésẹ̀ tó yẹ kí a gbé nípa àìsàn yi.</answer>", "language": "Yoruba"}
{"question": "Àwọn ọmọ méjì tó jẹ́ ọmọdé, tó jẹ́ ọjọ́gbọn kan náà, tí ọ̀kan ní gbogbo eyín tí kò ní yẹ̀ kù, yàtọ̀ sí àwọn eyín ọgbọ́n, tí ó sì ti jáde, àti èkejì tí kò ní eyín agbọn tàbí eyín ọ̀pá kan tí ó ti jáde, ní ìgbà wo ni idagbasoke eyín yìí máa ń ṣẹlẹ̀ déédé?", "reasoning": "<thinking><step1>\nThe question translates to: \"At what age do two children, one with all their teeth intact and the other with no molars or canines, experience the development of these teeth?\" This refers to the timing of tooth development in children.\n</step1>\n<step2>\nTooth development, or *idagbasoke eyín*, typically follows a specific timeline. For most children, *eyín akọkọ* (primary teeth) begin to emerge around 6 months of age.\n</step2>\n<step3>\nThe first molars usually appear between ages 6 to 7 — *eyín agbọn* — while canines come in a bit later, around ages 9 to 12.\n</step4>\n<step4>\nIn this case, the child with all teeth intact likely has completed the primary dentition phase, while the other child, lacking molars and canines, may still be in the process of developing their teeth.\n</step5>\n<step5>\nTherefore, the development of *eyín agbọn* and *eyín ọ̀pá* typically occurs between ages 6 and 12, depending on the individual child's growth.\n</step6>\n<step6>\nIn summary, the age range for the development of these teeth is generally from 6 to 12 years.\n</step7></thinking>", "answer": "<answer>Idagbasoke eyín agbọn àti eyín ọ̀pá máa ń ṣẹlẹ̀ láàárín ọdún mẹ́fa sí mẹ́wàá.</answer>", "language": "Yoruba"}
{"question": "Obirin Afrika-Amerika ọdun 40 kan ti o ti bí ọmọ lẹẹ mẹrin, ti o lóyún lẹẹ mẹrin, ti o sì bí ọmọ nipasẹ ọna àbẹ́ láìsí ìṣẹ̀lẹ̀ kankan oṣù mẹrin sẹyin, wá pẹlu ẹ̀dùn-ara ìkùnrẹ̀rẹ̀.  Ninu àyẹ̀wo, alaisan ni titẹ ẹjẹ jugular ti gbé gẹ̀rẹ̀gẹ̀rẹ, S3, ìkùn ìgbìgbẹ́, ati ìgbóná ẹsẹ̀ méjèèjì.  Àyẹ̀wo X-ray ọmu fihan àwọn ọ̀pá ìgbìgbẹ́, omi ninu fissure, ati omi ninu pleural.  Iṣẹ́ ṣíṣàn rẹ̀ jẹ́ 38% lori echocardiogram.  Ewo ni ohun pàtàkì ninu àyẹ̀wo ti o ṣeeṣe julọ?\nA.  Àìṣiṣẹ́ itanna\nB.  Gbigbẹ\nC.  Infarction\nD.  Pericarditis\nE.  Gbigbẹ àwọn atẹgun", "reasoning": "<thinking><step1>\nThe question describes a 40-year-old African American woman who has had four children and is experiencing symptoms like chest pain — *ẹ̀dùn-ara ìkùnrẹ̀rẹ̀* — four months after giving birth. \n</step1>\n<step2>\nShe presents with signs such as elevated jugular venous pressure — *titẹ ẹjẹ jugular ti gbé gẹ̀rẹ̀gẹ̀rẹ* — and an S3 heart sound, which indicates possible heart failure or fluid overload.\n</step2>\n<step3>\nThe chest X-ray shows signs of cardiomegaly — *àwọn ọ̀pá ìgbìgbẹ́* — and fluid in the fissures and pleural space, suggesting a significant fluid accumulation.\n</step4>\n<step4>\nHer echocardiogram shows a reduced ejection fraction of 38%, indicating impaired cardiac function — *iṣẹ́ ṣíṣàn rẹ̀*.\n</step5>\n<step5>\nGiven these findings, the most likely diagnosis is related to fluid overload or heart failure, which could be due to peripartum cardiomyopathy or other cardiac issues.\n</step6>\n<step6>\nAmong the options, *D. Pericarditis* is a potential cause of chest pain and could explain some of the symptoms, but the overall presentation leans more towards fluid overload.\n</step7>\n<step7>\nThus, the most critical finding in this case is likely related to heart failure due to fluid overload, which aligns with the symptoms and echocardiogram results.\n</step7></thinking>", "answer": "<answer>Gbigbẹ.</answer>", "language": "Yoruba"}
{"question": "Àpọnà kan tí ó ní ìṣòro ọkàn tí ó ti pẹ́, tí ó sì ń pọ̀ sí i kú nítorí ìṣòro ìmímú. Ẹ̀dọ̀fóró rẹ̀ nígbà ayẹ̀wò lẹ́yìn ikú jẹ́ mẹ́ta irú iwuwo wọn tí ó ṣeé ṣe. Nípa ìwádìí ọ̀rọ̀-ara, awọn alveoli fihan ìfìwéràn granular proteinaceous, awọn capillaries alveolar tí ó tobi sí i, àti awọn macrophages tí ó ní hemosiderin. Àwọn sẹ́ẹ̀li ìgbóná mìíràn kò hàn.  Èwo nínú àwọn wọ̀nyí ni ìwádìí tó pọ̀jù?\nA. Pneumonia Candida\nB. Pneumonia Pneumococcal\nC. Pneumonia Pneumocystis\nD. Ẹ̀dọ̀fóró edema", "reasoning": "<thinking><step1>\nThe question is asking about a specific type of pneumonia based on certain pathological findings. It mentions a patient with a chronic heart problem who has died due to respiratory issues, and the autopsy shows three key findings: *granular proteinaceous material in the alveoli*, enlarged *alveolar capillaries*, and *hemosiderin-laden macrophages*.\n</step1>\n<step2>\nThese findings suggest a type of pneumonia that is associated with immunocompromised states. The presence of *macrophages avec hemosidérine* indicates that there has been bleeding or chronic inflammation in the lungs.\n</step2>\n<step3>\nIn this context, *Pneumonia Pneumocystis* is often seen in patients with weakened immune systems, such as those with HIV/AIDS. The *granular proteinaceous material* in the alveoli aligns with the typical presentation of this type of pneumonia.\n</step3>\n<step4>\nOn the other hand, *Pneumonia Pneumococcal* usually presents with different findings, such as neutrophilic infiltration and does not typically show hemosiderin-laden macrophages. \n</step4>\n<step5>\nGiven the chronic heart issue and the specific autopsy findings, the most likely diagnosis is *Pneumonia Pneumocystis*, as it fits the profile of an immunocompromised patient with the described lung pathology.\n</step5></thinking>", "answer": "<answer>Ìwádìí tó pọ̀jù ni Pneumonia Pneumocystis.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ile-ẹkọ giga ọdun 21 kan wá pẹlu itan ọjọ meji ti ẹ̀gbẹ́, irora inu-ikun ti o tan si ẹhin, ati awọn ẹgbẹ́ ọpọlọpọ ti awọn aṣọ ofeefee lori ara. Alaisan naa ni itan ti dermatitis atopic, thyroiditis Hashimoto, ati pe o mu levothyroxine gẹgẹ bi oogun rẹ nikan. Ko gba awọn ajesara, ṣugbọn o ma mu ọti-waini ati fifun mimu marijuwana. A rii pe iye kalsiumu ninu ẹ̀jẹ̀ rẹ̀ jẹ 7.9 mg/dL. Ti a ba gbero awọn aami aisan ati awọn abajade ile-iwosan wọnyi, kini igbesẹ ti o yẹ julọ ni atẹle lati ṣe iwadi idi ti o wa labẹ rẹ?", "reasoning": "<thinking><step1>\nThe question asks: “What is the most appropriate next step to investigate the underlying cause?” It describes a 21-year-old college student with a two-day history of [ẹ̀gbẹ́ = rash], abdominal pain radiating to the back, and multiple areas of [aṣọ ofeefee = yellowish lesions] on the body.\n</step1>\n<step2>\nThe patient has a history of atopic dermatitis and Hashimoto's thyroiditis, and is currently taking levothyroxine — *oògùn ti a nlo fun hypothyroidism*. This suggests a possible autoimmune component.\n</step2>\n<step3>\nThe calcium level is low at 7.9 mg/dL, which indicates *hypocalcemia*. This could be related to parathyroid dysfunction or vitamin D deficiency — *aifọwọyi vitamin D*.\n</step3>\n<step4>\nGiven the symptoms and lab results, it’s crucial to assess the parathyroid hormone (PTH) levels — *iwadi ipele PTH* — to determine if there is a parathyroid issue contributing to the hypocalcemia.\n</step5>\n<step5>\nAdditionally, considering the patient's lifestyle choices, such as alcohol and marijuana use, it’s important to evaluate for any potential substance-related effects on calcium metabolism.\n</step6>\n<step6>\nThus, the most appropriate next step is to check the PTH levels to investigate the cause of the hypocalcemia and related symptoms.\n</step6></thinking>", "answer": "<answer>Igbesẹ ti o yẹ julọ ni lati ṣayẹwo ipele PTH lati ṣe iwadi idi ti hypocalcemia ati awọn aami aisan ti o ni ibatan.</answer>", "language": "Yoruba"}
{"question": "Gbolohun wo ni o ni ilana orukọ-ara to tọ́?\nAwọn aṣayan:\n(A) enormous new triangular Nigerian lead cat\n(B) enormous Nigerian triangular new lead cat", "reasoning": "<thinking><step1>\nThe question asks: “Gbolohun wo ni o ni ilana orukọ-ara to tọ́?” — meaning it wants to know which sentence has the correct order of adjectives in English.\n</step1>\n<step2>\nIn English, adjectives typically follow a specific order: opinion, size, age, shape, color, origin, material, and purpose — *ilana orukọ-ara*.\n</step2>\n<step3>\nLooking at the options, (A) “enormous new triangular Nigerian lead cat” and (B) “enormous Nigerian triangular new lead cat,” we need to analyze the order.\n</step3>\n<step4>\nIn option (A), we have *enormous* (size), *new* (age), *triangular* (shape), *Nigerian* (origin), and *lead* (material) — this follows the correct order.\n</step4>\n<step5>\nIn option (B), the order is *enormous* (size), *Nigerian* (origin), *triangular* (shape), *new* (age), which disrupts the typical adjective sequence.\n</step5>\n<step6>\nThus, option (A) maintains the proper adjective order according to English grammar rules.\n</step6></thinking>", "answer": "<answer>Gbolohun to ni ilana orukọ-ara to tọ́ ni (A) enormous new triangular Nigerian lead cat.</answer>", "language": "Yoruba"}
{"question": "Bí omi didi sun-blocker bá ní Sun-Protection-Factor (SPF) tó jẹ́ 15, iye ìgbà tí ó ń dáàbò bò láti ìgbà ìtànṣán ultraviolet (UV) kò tó?", "reasoning": "<thinking><step1>\nThe question asks: “Bí omi didi sun-blocker bá ní [Sun-Protection-Factor (SPF) = SPF] tó jẹ́ 15, iye ìgbà tí ó ń dáàbò bò láti ìgbà ìtànṣán ultraviolet (UV) kò tó?” — meaning it wants to know how long a sunscreen with SPF 15 protects against ultraviolet (UV) rays.\n</step1>\n<step2>\nSPF indicates the level of protection from UV rays — *ìtànṣán ultraviolet*. Specifically, SPF 15 means that it theoretically allows you to stay in the sun 15 times longer than without protection.\n</step2>\n<step3>\nFor example, if your skin would normally burn after 10 minutes of sun exposure, with SPF 15, you could stay out for about 150 minutes — *150 iṣẹ́ ìṣẹ́jú*.\n</step3>\n<step4>\nHowever, this is under ideal conditions, and factors like sweating, swimming, or not applying enough sunscreen can reduce effectiveness — *ìmúlò to peye*.\n</step5>\n<step5>\nIn practice, it’s recommended to reapply sunscreen every two hours or immediately after swimming — *lákòókò tí o bá wẹ́*.\n</step6>\n<step6>\nSo, the effective protection time with SPF 15 is approximately 150 minutes, but this can vary based on conditions and application.\n</step6></thinking>", "answer": "<answer>Iye ìgbà tí omi didi sun-blocker SPF 15 ń dáàbò bò ni 150 iṣẹ́ ìṣẹ́jú, ṣùgbọ́n ó lè yàtọ̀ sí i da lori ipo àti ìmúlò.</answer>", "language": "Yoruba"}
{"question": "Ọmọdé kan tí ó ní irora iṣan ati ìgbàgbé tí ó máa ń pada. Nígbà tí a ṣe àyẹ̀wò, a rí hypokalemia, metabolic alkalosis, hypocalciuria ṣùgbọ́n magnesium tí ó pọ̀ sí i nínú ito. Kí ni àyẹ̀wò tó pọ̀jú julọ?\nA. Àrùn Bartter\nB. Àrùn Gittelman\nC. Àrùn Liddle\nD. Kò sí èyíkéyìí nínú àwọn wọ̀nyí", "reasoning": "<thinking><step1>\nThe question is asking: \"What is the most likely diagnosis for a child with muscle pain and weakness, along with findings of hypokalemia [low potassium], metabolic alkalosis, hypocalciuria [low calcium in urine], but elevated magnesium in urine?\" \n</step1>\n<step2>\nHypokalemia and metabolic alkalosis suggest a condition affecting electrolyte balance — *àwọn àbájáde ti electrolyte*. \n</step2>\n<step3>\nIn this context, hypocalciuria indicates that calcium is not being excreted properly, which can be linked to certain renal disorders — *àwọn àrùn ẹdọfóró*.\n</step3>\n<step4>\nElevated magnesium in urine is particularly interesting; it suggests that the kidneys are excreting magnesium excessively, which is not typical in many conditions.\n</step4>\n<step5>\nAmong the options, Bartter syndrome is characterized by hypokalemia, metabolic alkalosis, and hypercalciuria, while Gitelman syndrome also presents with hypokalemia and metabolic alkalosis but with hypocalciuria — *àwọn àbájáde ti Gitelman*.\n</step6>\n<step6>\nLiddle syndrome typically presents with hypertension and hypokalemia but does not fit the metabolic alkalosis and hypocalciuria profile.\n</step7>\n<step7>\nGiven the combination of symptoms and lab findings, the most fitting diagnosis is Gitelman syndrome, as it aligns with hypokalemia, metabolic alkalosis, and hypocalciuria.\n</step8></thinking>", "answer": "<answer>Àrùn Gittelman.</answer>", "language": "Yoruba"}
{"question": "Ninu itọju ti àtọgbẹ ẹ̀jẹ̀ gíga tó lewu lórí àwọn àgbàlagbà, ewo ni oògùn tí a kò gba nímọ̀ràn fún lílo?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu itọju ti àtọgbẹ ẹ̀jẹ̀ gíga tó lewu lórí àwọn àgbàlagbà, ewo ni oògùn tí a kò gba nímọ̀ràn fún lílo?” — meaning it wants to know which medications are not recommended for treating high blood sugar in elderly patients.\n</step1>\n<step2>\nIn managing high blood sugar, certain medications can pose risks for older adults — *àgbàlagbà* may have different metabolic responses.\n</step2>\n<step3>\nFor instance, *sulfonylureas* can increase the risk of hypoglycemia — *ìdílé ẹ̀jẹ̀ gíga* — which is particularly dangerous for the elderly.\n</step3>\n<step4>\nAdditionally, *thiazolidinediones* may lead to fluid retention and heart failure, which are serious concerns in older patients — *àìlera ọkàn*.\n</step4>\n<step5>\nMoreover, *insulin* therapy can be tricky; while it’s effective, it requires careful monitoring to avoid complications — *ìmúlò àkóso*.\n</step5>\n<step6>\nTherefore, medications like *sulfonylureas* and *thiazolidinediones* are generally not recommended for elderly patients due to their potential side effects.\n</step6></thinking>", "answer": "<answer>Àwọn oògùn bíi sulfonylureas àti thiazolidinediones ni a kò gba nímọ̀ràn fún lílo lórí àwọn àgbàlagbà.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mejilelọgbọ̀n [78] kan ti o ni àrùn kidinì tí ó bá ara rẹ̀ jẹ́ lọ sí ipò pajawiri nítorí pé òun kò dárí, ara rẹ̀ sì rẹ̀ sí gbogbo ibù. Itan ara rẹ̀ ni àrùn ọkàn, àtìgbàgbà ẹ̀jẹ̀, àti àrùn suga iru keji, ó sì ń mu oogun kan, pẹlu ramipril, insulin, furosemide, àti metoprolol. Nígbà tí a ṣe ayẹwo rẹ̀, ẹ̀jẹ̀ rẹ̀ gòkè sí 155/90 mm Hg, ọ̀pọlọpọlọ ọkàn rẹ̀ sì wà ní 100/min, ìmí rẹ̀ sì wà ní 24/min, pẹlu ohùn ọkàn tí ó dára, kò sí ìgbóná, àti ẹ̀dòfóró tí ó mọ́lẹ̀ nígbà tí a gbọ́.  Nítorí ìwé itan aisàn yìí àti ECG tí ó fi hàn pé àwọn T waves gíga àti QRS complex tí ó fẹ̀, kí ni àrùn tó gbàdúró jùlọ?", "reasoning": "<thinking><step1>\nThe question asks about a 78-year-old man with multiple health issues, including heart disease, hypertension, and type 2 diabetes, who is in an emergency situation. It seeks to identify the most likely condition based on his medical history and ECG findings.\n</step1>\n<step2>\nThe patient has a history of heart disease — *àrùn ọkàn* — and is taking medications like ramipril and metoprolol, which are used for hypertension and heart conditions.\n</step2>\n<step3>\nHis blood pressure is elevated at 155/90 mm Hg, indicating *ìkànsí ẹ̀jẹ̀* (hypertension), and his heart rate is 100/min, which is tachycardic — *ìkànsí ọkàn*.\n</step3>\n<step4>\nThe ECG shows high T waves and a flattened QRS complex, which can suggest issues like hyperkalemia — *ìkànsí potassium gíga* — often seen in patients with kidney problems or those on certain medications.\n</step4>\n<step5>\nGiven his symptoms and the ECG findings, the most likely condition he is experiencing is related to his heart and possibly electrolyte imbalances due to his medications and underlying conditions.\n</step5>\n<step6>\nIn summary, the combination of his medical history, elevated blood pressure, and ECG changes points towards a serious cardiac issue, likely exacerbated by his diabetes and hypertension.\n</step6></thinking>", "answer": "<answer>Àrùn tó gbàdúró jùlọ ni àrùn ọkàn tí ó ní ìkànsí potassium gíga.</answer>", "language": "Yoruba"}
{"question": "Àwọn ọmọ mẹ́jọ kan ní ọjọ́-orí wọ̀nyí: 9, 11, 8, 15, 14, 12, 17, àti 14.  Kàlìkúlàtì  ààyè, àárín, ìṣẹ̀lẹ̀ tí ó pọ̀ jùlọ, àti ìyàtọ̀ àwọn ọjọ́-orí wọ̀nyí.", "reasoning": "<thinking><step1>\nThe question asks: “Calculate the [moyenne = average], [écart-type = standard deviation], [mode = mode], and [écart = range] of the ages” of eight children aged 9, 11, 8, 15, 14, 12, 17, and 14.\n</step1>\n<step2>\nFirst, to find the average, we sum the ages: 9 + 11 + 8 + 15 + 14 + 12 + 17 + 14 = 100. Then, we divide by the number of children, which is 8. So, the average is 100 / 8 = 12.5.\n</step2>\n<step3>\nNext, the mode is the age that appears most frequently. Here, 14 appears twice, while all other ages appear only once. Thus, the mode is 14.\n</step3>\n<step4>\nNow, to calculate the range, we subtract the smallest age from the largest age: 17 - 8 = 9. This means the range of ages is 9.\n</step4>\n<step5>\nFinally, for the standard deviation, we first find the variance. We calculate the differences from the mean, square them, and then average those squared differences. The variance is approximately 7.69, leading to a standard deviation of about √7.69 ≈ 2.77.\n</step5>\n<step6>\nIn summary, we have: average = 12.5, mode = 14, range = 9, and standard deviation ≈ 2.77.\n</step6></thinking>", "answer": "<answer>Àwọn abajade ni: ààyè = 12.5, ìṣẹ̀lẹ̀ = 14, ìyàtọ̀ = 9, àti ìṣẹ̀lẹ̀ tí ó pọ̀ jùlọ ≈ 2.77.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 55 kan ti a ṣe ayẹwo tuntun pẹlu leukemia ṣe awọn ẹkọ jiini ti o fihan gbigbe t(9;22) (kromosome Philadelphia).  Ewo ninu awọn wọnyi ni iye gbogbo ẹjẹ yoo ṣe afihan julọ?\nA. Iye lymphocyte ti pọ si\nB. Iye neutrophil ti pọ si\nC. Awọn lymphoblasts pupọ\nD. Awọn myeloblasts pupọ", "reasoning": "<thinking><step1>\nThe question asks: “Which of the following will most likely be reflected in the total blood count for a 55-year-old man newly diagnosed with leukemia showing the t(9;22) translocation (Philadelphia chromosome)?” \n</step1>\n<step2>\nIn leukemia, particularly with the Philadelphia chromosome, there is often an increase in abnormal white blood cells — *ẹjẹ funfun*. \n</step2>\n<step3>\nThe presence of t(9;22) indicates a specific type of leukemia, commonly *leukemia myeloid aigbọn* or *leukemia lymphoblastic*, which can lead to an increase in immature cells.\n</step3>\n<step4>\nAmong the options, *iyẹn ni* (that is) the presence of many lymphoblasts would be a significant indicator, as they are immature lymphocytes that proliferate in this condition.\n</step4>\n<step5>\nWhile increased neutrophils or myeloblasts can occur, the hallmark of this specific leukemia is the presence of lymphoblasts — *lymphoblasts pupọ*.\n</step5>\n<step6>\nThus, the total blood count will most likely show an increase in lymphoblasts due to the nature of the disease.\n</step6></thinking>", "answer": "<answer>Awọn lymphoblasts pupọ ni yoo ṣe afihan julọ ninu iye gbogbo ẹjẹ.</answer>", "language": "Yoruba"}
{"question": "Ọgbọ́n ọdún mẹ́ẹ́dógún kan tí í ṣe aṣàgùn, wá pẹ̀lú ìtàn ìgbóná gbígbóná gíga fún ọjọ́ méje ati ìyípadà ìrísí fún ọjọ́ méjì. Nígbà àyẹ̀wo, ó wà ní ìṣòro ìṣẹ́-òwò, tí ó sì ní ẹ̀jẹ̀ ìfò sí ojú. Àwọn ìwádìí tí a yára ṣe fi hàn pé hemoglobin rẹ̀ jẹ́ 11 gm/dl, serum bilirubin 8 mg/dl ati urea 78 mg/d1. Àyẹ̀wò ẹ̀jẹ̀ tí ó wà ní àgbègbè jẹ́ èyí tí kò ní àkóràn malaria. Kí ni àìsàn tí ó ṣeé ṣe jùlọ -\nA. Brucellosis\nB. Àìsàn Weil\nC. Àìsàn ẹ̀dùn ẹ̀jẹ̀ onígbàákúkù\nD. Àìsàn Q", "reasoning": "<thinking><step1>\nThe question is asking about a 15-year-old patient who presents with high fever for seven days and changes in appearance, along with business-related issues and conjunctival bleeding. The lab results show hemoglobin at 11 gm/dl, serum bilirubin at 8 mg/dl, and urea at 78 mg/dl, with no malaria infection detected.\n</step1>\n<step2>\nGiven the symptoms, *ìtàn ìgbóná gbígbóná gíga* (high fever) and *ìyípadà ìrísí* (changes in appearance), we need to consider possible diagnoses. The low hemoglobin suggests *ìkó ẹ̀jẹ̀* (anemia), which could be due to various infections or conditions.\n</step2>\n<step3>\nThe elevated bilirubin indicates possible *ìfarapa ẹ̀dá* (hemolysis) or liver dysfunction. In this context, *àìsàn Weil* (Weil's disease) could be a consideration due to its association with jaundice and renal impairment.\n</step3>\n<step4>\nHowever, *àìsàn ẹ̀dùn ẹ̀jẹ̀ onígbàákúkù* (hemolytic anemia) is also a strong contender, especially with the conjunctival bleeding and anemia. This condition can arise from various infections or autoimmune processes.\n</step5>\n<step5>\nBrucellosis and Q fever are less likely given the acute presentation and specific lab findings. The absence of malaria further narrows down the possibilities.\n</step6>\nBased on the symptoms and lab results, the most likely diagnosis is *àìsàn ẹ̀dùn ẹ̀jẹ̀ onígbàákúkù*.</thinking>", "answer": "<answer>Àìsàn ẹ̀dùn ẹ̀jẹ̀ onígbàákúkù.</answer>", "language": "Yoruba"}
{"question": "Ní ọjọ́ ọmọdé ọmọ tuntun tí a bí, nígbà wo ni iye suga ẹ̀jẹ̀ rẹ̀ fi de ìwọ̀n tó kéré jùlọ, tó jẹ́ 30 mg/dl?", "reasoning": "<thinking><step1>\nThe question asks: “Ní ọjọ́ ọmọdé ọmọ tuntun tí a bí, nígbà wo ni iye suga ẹ̀jẹ̀ rẹ̀ fi de ìwọ̀n tó kéré jùlọ, tó jẹ́ 30 mg/dl?” — meaning it wants to know when a newborn's blood sugar level reaches the minimum threshold of 30 mg/dl.\n</step1>\n<step2>\nIn newborns, blood sugar levels can fluctuate significantly after birth — *nígbà tí a bí ọmọ tuntun, suga ẹ̀jẹ̀ le yí padà* due to various factors.\n</step2>\n<step3>\nTypically, a newborn's blood sugar should stabilize within the first few hours of life — *ní àkókò yẹn, suga ẹ̀jẹ̀ yẹ ki o wa ni ibè*.\n</step3>\n<step4>\nIf the blood sugar drops below 30 mg/dl, it can indicate hypoglycemia — *hypoglycemia* is a condition that can be dangerous for newborns.\n</step4>\n<step5>\nMonitoring is crucial, especially in the first 24 hours — *àkíyèsí jẹ́ pataki* to ensure the baby maintains healthy glucose levels.\n</step6>\n<step6>\nIn summary, a newborn's blood sugar level can reach the minimum of 30 mg/dl typically within the first few hours after birth.\n</step6></thinking>", "answer": "<answer>Iye suga ẹ̀jẹ̀ ọmọ tuntun le de ìwọ̀n tó kéré jùlọ, 30 mg/dl, ní àkókò mẹ́ta tàbí mẹ́rin lẹ́yìn bí.</answer>", "language": "Yoruba"}
{"question": "Ninu àwùjọ kan tí iye ènìyàn rẹ̀ jẹ́ 10,000, àti ìwọ̀n ìbí ti 36 fun 1000, a royin ikú iya tí ó tó 6 ní ọdún yìí. Ka ìwọ̀n ikú iya (MMR) fún àwùjọ náà.", "reasoning": "<thinking><step1>\nThe question asks: “Ka ìwọ̀n ikú iya (MMR) fún àwùjọ náà” — meaning it wants to calculate the maternal mortality ratio for a population of 10,000 with a birth rate of 36 per 1,000 and 6 maternal deaths this year.\n</step1>\n<step2>\nTo find the MMR, we use the formula: MMR = (Number of maternal deaths / Number of live births) × 100,000.\n</step2>\n<step3>\nFirst, we need to calculate the number of live births in the population. With a birth rate of 36 per 1,000, for a population of 10,000, we have: \n*Live births = (36/1000) × 10,000 = 360*.\n</step3>\n<step4>\nNow, we can substitute the values into the MMR formula: MMR = (6 / 360) × 100,000.\n</step4>\n<step5>\nCalculating this gives us: MMR = (0.01667) × 100,000 = 1666.67.\n</step5>\n<step6>\nThus, the maternal mortality ratio for this community is approximately 1667 per 100,000 live births.\n</step6></thinking>", "answer": "<answer>Ìwọ̀n ikú iya (MMR) fún àwùjọ náà ni 1667 fún 100,000 ìbí àyé.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdọmọkunrin kan ti o wẹ́ 4800 giramu (10.6 poun), a bí i nígbà tí ó yẹ̀, fún obìnrin ọdún mẹ́tadinlọ́gọ́rin kan, gravida 1, para 1. A nílò fifà ọrùn rẹ̀ sí ẹ̀gbẹ́ gidigidi nígbà ìbí. Àwọn nọmba Apgar jẹ́ 9 àti 9 ní iṣẹ́jú kan àti iṣẹ́jú márùn-ún, lẹ́yìn náà. Àwọn àmì ìṣèdá-ara wà ní ìwọ̀n deede. Ní ìsinmi, ejika ọwọ́ ọ̀tún rẹ̀ ti dín kù sí ìpínlẹ̀ àti yípadà sí inú. Ọmọ náà ńkún sígbà tí a bá gbé ọwọ́ rẹ̀ yípadà. Àwọn ìwádìí iléeṣẹ́ náà fi hàn pé:\nHematocrit 66%\nIye ẹ̀jẹ̀ funfun 9000/mm3\nSerum\nNa+ 142 mEq/L\nCl- 103 mEq/L\nK+ 5.1 mEq/L\nHCO3- 20 mEq/L\nUrea nitrogen 8 mg/dL\nGlucose 34 mg/dL\nCreatinine 0.6 mg/dL\nNí èyíkéyí nínú àwọn wọ̀nyí ni ó ṣeé ṣe jù lọ láti dá ìṣòro ọmọ kékeré yìí dòró?\nA. Ṣíṣe àìgbọ̀dọ̀mọ̀ wàrà tí ó rọ̀\nB. Fífún ni insulin\nC. Yíyẹ̀ kúrò lórí kókénì\nD. Ṣíṣe àìgbọ̀dọ̀mọ̀ ìgbàlóògùn ògògòrò\nE. Gbigba oògùn gbígbà tí ó lòdì sí rubella", "reasoning": "<thinking><step1>\nThe question is asking which of the listed options is most likely to resolve the issue of a newborn with specific clinical findings, including a low blood glucose level of 34 mg/dL — *iyẹ̀kúrò ẹ̀jẹ̀*.\n</step1>\n<step2>\nThe newborn's glucose level indicates *hypoglycemia*, which is a common issue in newborns, especially those who are large for gestational age or have other risk factors.\n</step2>\n<step3>\nAmong the options, providing insulin (B) would not be appropriate since the problem is low glucose, not high. Instead, we need to raise the glucose level.\n</step3>\n<step4>\nOption A, administering a *àìgbọ̀dọ̀mọ̀ wàrà tí ó rọ̀* (dextrose), is a common treatment for hypoglycemia in newborns.\n</step4>\n<step5>\nOptions C, D, and E do not directly address the immediate need to correct the low blood sugar level. For instance, option C, *yíyẹ̀ kúrò lórí kókénì* (removing from the breast), is not relevant here.\n</step5>\n<step6>\nThus, the most appropriate action to take for this newborn is to provide dextrose to quickly correct the hypoglycemia.\n</step6></thinking>", "answer": "<answer>Ṣíṣe àìgbọ̀dọ̀mọ̀ wàrà tí ó rọ̀ ni ó ṣeé ṣe jù lọ láti dá ìṣòro ọmọ kékeré yìí dòró.</answer>", "language": "Yoruba"}
{"question": "Iru iyipada ohùn wo ni kì í sábà jẹ́ abajade ibajẹ́ iṣan laryngeal ita gbangba lẹ́yìn iṣẹ́ abẹ thyroidectomy?", "reasoning": "<thinking><step1>\nThe question asks: “Iru iyipada ohùn wo ni kì í sábà jẹ́ abajade ibajẹ́ iṣan laryngeal ita gbangba lẹ́yìn iṣẹ́ abẹ thyroidectomy?” — meaning it wants to know what type of voice change is typically a result of external laryngeal nerve damage after a thyroidectomy.\n</step1>\n<step2>\nAfter a thyroidectomy, *ibajẹ́ iṣan laryngeal* can occur, affecting the voice. The external laryngeal nerve controls the cricothyroid muscle, which is crucial for pitch modulation.\n</step2>\n<step3>\nWhen this nerve is damaged, patients often experience a change in voice quality — *iyipada ohùn* — such as a hoarse or weak voice.\n</step4>\n<step4>\nThis condition is known as *dysphonia*, where the voice may sound breathy or strained, making it difficult to reach higher pitches.\n</step5>\n<step5>\nIn summary, the typical voice change after such nerve damage is characterized by a loss of vocal range and clarity — *iyipada ninu dida ohùn*.\n</step6></thinking>", "answer": "<answer>Iyipada ohùn ti o wọpọ ni ibajẹ́ iṣan laryngeal ita gbangba lẹ́yìn iṣẹ́ abẹ thyroidectomy ni dysphonia, pẹlu ohùn ti o ni irọrun tabi ti o nira.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọlọ́dún 54 kan tó ní àrùn ẹ̀jẹ̀ gíga gbà láti bẹ̀rẹ̀ ìtọ́jú pẹ̀lú oògùn diuretic thiazide. Nítorí ìtọ́jú yìí, ìgbàjáde ito sí ilẹ̀kùn únrin wo ni ó ṣeé ṣe jùlọ láti dinku?", "reasoning": "<thinking><step1>\nThe question asks: “What is the most likely urinary output change for a 54-year-old woman with hypertension starting treatment with thiazide diuretics?” — here, *àrùn ẹ̀jẹ̀ gíga* means hypertension and *oògùn diuretic thiazide* refers to thiazide diuretics.\n</step1>\n<step2>\nThiazide diuretics work by promoting the excretion of sodium and water — *ìtọ́jú yìí n fa àtẹ́gùn sodium àti omi* to help lower blood pressure.\n</step2>\n<step3>\nAs a result, the patient will likely experience increased urinary output — *ìgbàjáde ito* will increase due to the diuretic effect.\n</step3>\n<step4>\nThis increase in urine production is a common response to diuretics, as they help the body eliminate excess fluid — *nítorí pé wọn n ran ara lọwọ lati yọ omi tó pọ̀ jù*.\n</step4>\n<step5>\nIn clinical terms, one might expect a significant increase in urine volume, especially in the initial stages of treatment — *ni ibẹrẹ ìtọ́jú, ìgbàjáde ito le pọ̀ si*.\n</step5>\n<step6>\nTherefore, the most likely change in urinary output is an increase, which is a desired effect of thiazide diuretics.\n</step6></thinking>", "answer": "<answer>Ìgbàjáde ito yóò pọ̀ sí i.</answer>", "language": "Yoruba"}
{"question": "Níwọ̀n ìpìlẹ̀ṣẹ̀ wo ni ori ọmọ tí ó tẹ̀lé lẹ́yìn nígbà tí ọmọ bá ń jáde ní ọ̀nà ìyá ibàjẹ́ kò sábàá ní ìṣòro?", "reasoning": "<thinking><step1>\nThe question asks: “Níwọ̀n ìpìlẹ̀ṣẹ̀ wo ni ori ọmọ tí ó tẹ̀lé lẹ́yìn nígbà tí ọmọ bá ń jáde ní ọ̀nà ìyá ibàjẹ́ kò sábàá ní ìṣòro?” — meaning it wants to know what developmental milestones are typical for a child when they start walking, particularly in relation to *iyá ibàjẹ́* (the mother's influence) and common challenges.\n</step1>\n<step2>\nWhen a child begins to walk, they typically reach several key milestones — *àwọn ìpìlẹ̀ṣẹ̀ pataki* such as standing independently and taking their first steps.\n</step2>\n<step3>\nDevelopmentally, children usually start walking around 12 months, but this can vary — *ó le yàtọ̀ sí i* depending on individual growth and environmental factors.\n</step3>\n<step4>\nChallenges may arise, such as balance issues or fear of falling — *ìṣòro bíi ìdàgbàsókè àtì ìbànújẹ* can affect their confidence in walking.\n</step4>\n<step5>\nThe role of the mother, or *iyá*, is crucial; providing encouragement and a safe environment can help mitigate these challenges — *iyá le ṣe iranlọwọ* by supporting their attempts to walk.\n</step5>\n<step6>\nIn summary, typical milestones include standing, cruising along furniture, and walking independently, while challenges often involve balance and confidence issues.\n</step6></thinking>", "answer": "<answer>Àwọn ìpìlẹ̀ṣẹ̀ tí ó wọpọ̀ ni: dídá, jàde ní àyíká, àti rìn ní ìkànsí, pẹ̀lú ìṣòro bíi ìdàgbàsókè àti ìbànújẹ.</answer>", "language": "Yoruba"}
{"question": "Onísẹ́ ọ̀dàágbà kan ní ọgbẹ́ tí ó ń tú. Ìwádìí ilé-ìwòsàn fi hàn ní diplococci gram-negative àti ìdàgbàsíwá lórí àwọn èròjà Thayer Martin tí a yí pọ̀. Kí ni àyèwò náà?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àyèwò náà?” — meaning it wants to know what the test is based on the provided medical information.\n</step1>\n<step2>\nThe patient has a wound that is discharging, which suggests an infection — *ìfarapa* or *ìkópa*.\n</step2>\n<step3>\nThe presence of gram-negative diplococci indicates a specific type of bacteria, likely *Neisseria gonorrhoeae* or *Neisseria meningitidis*.\n</step3>\n<step4>\nThe use of Thayer Martin medium suggests that the test is designed to isolate these bacteria, as it is selective for *Neisseria* species.\n</step4>\n<step5>\nIn summary, the test is likely a culture test to identify the causative organism of the infection — *àyèwò àkópọ̀*.\n</step6>\n<step7>\nThis type of test helps in diagnosing conditions like gonorrhea or meningitis, depending on the clinical context.\n</step7></thinking>", "answer": "<answer>Àyèwò náà ni àyèwò àkópọ̀ láti ṣe àfihàn *Neisseria gonorrhoeae* tàbí *Neisseria meningitidis*.</answer>", "language": "Yoruba"}
{"question": "Ẹni tí ó jẹ́ gbogbo ènìyàn máa dáhùn sí àwọn ìbéèrè wọ̀nyí nípa ìdí ìṣẹ̀lẹ̀ báwo?\nWọ́n gbé ẹ̀rọ kan kalẹ̀ ní ọ̀nà tí yóò mú kí inú rẹ̀ gbóná bí waya dudu àti waya pupa bá fẹ́ sí bàtẹ́rì ní àkókò kan náà. Ẹ̀rọ náà kì yóò gbóná bí ọ̀kan nínú àwọn waya yìí bá fẹ́ sí bàtẹ́rì. Wọ́n pè waya dudu ní ẹni tí ó yẹ kí ó fẹ́ sí bàtẹ́rì, nígbà tí waya pupa yẹ kí ó wà ní apá míràn nínú ẹ̀rọ náà. Ní ọjọ́ kan, waya dudu àti waya pupa bá fẹ́ sí bàtẹ́rì ní àkókò kan náà. Inú ẹ̀rọ náà gbóná. Ṣé waya pupa ló mú kí inú ẹ̀rọ náà gbóná?\nÀwọn ìdáhùn:\n- Bẹ́ẹ̀ni\n- Rárá", "reasoning": "<thinking><step1>\nThe question asks: “Did the red wire cause the device to heat up?” — it describes a scenario where both the black wire and the red wire are connected to a battery at the same time, leading to the device heating up.\n</step1>\n<step2>\nIn this context, the black wire is said to be the one that should connect to the battery — *eni tí ó yẹ kí ó fẹ́ sí bàtẹ́rì* — while the red wire is in a different part of the device.\n</step2>\n<step3>\nWhen both wires connect to the battery simultaneously, the device heats up — *inú ẹ̀rọ náà gbóná* — indicating that there is a current flow.\n</step4>\n<step4>\nHowever, since the black wire is the designated wire for connection, it suggests that the red wire should not cause the device to heat up on its own — *waya pupa kì yóò gbóná*.\n</step5>\n<step5>\nThus, the heating of the device could be attributed to the black wire, which is the correct connection, rather than the red wire.\n</step6>\n<step6>\nTherefore, the answer to whether the red wire caused the device to heat up is likely no.\n</step6></thinking>", "answer": "<answer>Rárá, waya pupa kì yóò mú kí inú ẹ̀rọ náà gbóná.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdún mẹ́tálélọ́gbọ̀n kan wá sọ́dọ̀ oníṣègùn nítorí ìrora ori àti ìríro ní ọ̀sẹ̀ méjì. Ìrora ori náà burú sí i nígbà tí ó ṣíṣẹ̀, ó sì ṣàpẹẹrẹ rẹ̀ gẹ́gẹ́ bí 7 nínú 10 ní agbára rẹ̀. Nígbà yìí, ó ti kíyèsí àwọn àkókò kukuru ti ìṣòro ríran ní ojú mejeeji tí ó gbàgbà fún iṣẹ́jú díẹ̀, pàápàá nígbà tí ó dìde lóòótọ̀ tàbí tí ó tẹ̀bà. Òkèkè rẹ̀ jẹ́ 165 cm (5 ft 5 in) gíga, ó sì wẹ́rẹ̀ 98 kg (216 lb); BMI jẹ́ 36 kg/m2. Àwọn àmì ìlera wà nínú àwọn ààlà déédéé. Ìwádìí fi hàn ní ìríran 20/20 ní ojú mejeeji pẹ̀lú ìṣòro ríran ní àgbègbè. Ìwádìí Fundoscopic fi hàn ní ìgbóná disc optic bilateral. MRI ti ọpọlọ fi hàn pé kò sí àìlọ́gbọ́n. A ṣe lumbar puncture; àtẹ́wọ́gbà agbara jẹ́ 310 mm H2O. Ìwádìí omi ọpọlọ fi hàn ní iye leukocyte ti 4/mm3 (75% lymphocytes), iye protein ti 35 mg/dL, àti iye glucose ti 45 mg/dL. Ẹ̀yà wo nínú àwọn wọ̀nyí ni ìgbésẹ̀ tó tọ́ jùlọ tókàn ní àṣàkóso?\nA. Ìtọ́jú Acetazolamide\nB. Ìtọ́jú Prednisone\nC. Ìfà nípa optic nerve sheath fenestration\nD. Ìgbòkègbòdò Ventricular\nE. Ìtọ́jú Furosemide", "reasoning": "<thinking><step1>\nThe question is asking about a 35-year-old woman who has been experiencing severe headaches and visual disturbances for two weeks. The headache intensity is rated as 7 out of 10, and she has noticed brief episodes of vision problems in both eyes, especially when standing up or bending over. \n</step1>\n<step2>\nHer height is 165 cm (5 ft 5 in) and weight is 98 kg (216 lb), giving her a BMI of 36 kg/m², which indicates obesity — *ìdíwọ̀n àdáni* that can contribute to increased intracranial pressure.\n</step2>\n<step3>\nThe examination shows 20/20 vision in both eyes but with visual disturbances, and the fundoscopic exam reveals bilateral optic disc edema — *ìgbóná disc optic bilateral*, suggesting increased intracranial pressure.\n</step4>\n<step4>\nThe MRI of the brain shows no abnormalities, which rules out structural causes for her symptoms. The lumbar puncture results indicate elevated opening pressure at 310 mm H2O, which is significantly high — *ìwọn titobi* that confirms the suspicion of increased intracranial pressure.\n</step5>\n<step5>\nGiven these findings, the most appropriate management step would be to relieve the pressure. Among the options, *ìtọ́jú Acetazolamide* is a carbonic anhydrase inhibitor that can help reduce cerebrospinal fluid production, making it a suitable choice for managing idiopathic intracranial hypertension.\n</step6>\n<step6>\nThus, the best management step in this case is to initiate treatment with Acetazolamide.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú Acetazolamide ni ìgbésẹ̀ tó tọ́ jùlọ tókàn ní àṣàkóso.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 70 kan ni a mú wá sí ẹka pajawiri pẹlu awọn ẹsun irora ọmu fun awọn wakati 2 sẹhin. Wọn ti tú u silẹ lati ile-iwosan ọjọ 10 sẹhin nigbati wọn gba a fun iṣẹlẹ ọkan ti o gbona. A tọju rẹ daradara pẹlu idena iṣẹ-ọkan ti o farapamọ. Nigba ayewo ara, alaisan fẹ lati yọ ara rẹ siwaju nitori eyi dinku irora ọmu rẹ. O sọ pe irora naa wa ni aarin ọmu ati pe o tan si ẹhin rẹ. Botilẹjẹpe o ni rilara ti ko dara, alaisan kọ eyikeyi iṣẹ ọkan tabi ṣiṣe mimu afẹfẹ kukuru. Awọn ami-ọrọ pataki pẹlu: iyara ọkan 90/min, iyara mimi 20/min, titẹ ẹjẹ 134/82 mm Hg, ati iwọn otutu 36.8°C (98.2°F). Alaisan naa ni wahala ti o han gbangba ati pe o n mu afẹfẹ sisan nitori afẹfẹ ti o jinlẹ mu irora ọmu rẹ buru si. ECG fihan awọn gbigbe ST ti o tan kaakiri. Ewo ni o yẹ ki a fun alaisan yii?\nA. Ibuprofen\nB. Heparin\nC. Levofloxacin\nD. Propranolol\nE. Warfarin", "reasoning": "<thinking><step1>\nThe question presents a case of a 70-year-old man with chest pain for the last 2 hours, who was discharged 10 days ago after a myocardial infarction — *iṣẹlẹ ọkan ti o gbona*.\n</step1>\n<step2>\nHe is experiencing pain in the center of his chest that radiates to his back, which suggests a possible cardiac issue — *iwulo ọkan*.\n</step3>\n<step3>\nThe vital signs show a heart rate of 90/min and a respiratory rate of 20/min, indicating he is somewhat stable but in distress — *wahala ti o han gbangba*.\n</step4>\n<step4>\nThe ECG shows ST segment changes, which could indicate ischemia or ongoing myocardial injury — *iwulo ọkan ti n lọ lọwọ*.\n</step5>\n<step5>\nGiven the history of recent myocardial infarction and current symptoms, the most appropriate treatment would be anticoagulation to prevent further clot formation — *idena iṣẹ-ọkan*.\n</step6>\n<step6>\nAmong the options, Heparin is the best choice as it is commonly used in acute coronary syndrome — *iwulo ọkan to ṣẹṣẹ*.\n</step7></thinking>", "answer": "<answer>Heparin</answer>", "language": "Yoruba"}
{"question": "Ninu ile-ẹkọ giga kan, a ti ṣakiyesi pe sisẹpo si itanna ionizing fun igba pipẹ ti fa ibajẹ DNA, ti o si ja si aiṣiṣẹ protein kan ti yoo maa da sẹẹli duro ni ipele G1 ti ilana sẹẹli.  Eyi ni ọja gẹẹsi wo, nigbati ko ba wa, yoo fa ki sẹẹli naa gba ohun-ini idagbasoke ti ko ni iṣakoso nitori pipadanu iṣẹ G1 yii?", "reasoning": "<thinking><step1>\nThe question asks: “What is the English term for the product that, when absent, causes a cell to acquire uncontrolled growth properties due to the loss of G1 function?” — here, *itanna ionizing* refers to ionizing radiation, and *ilana sẹẹli* means cell cycle.\n</step1>\n<step2>\nIn the context of the cell cycle, the G1 phase is crucial for cell growth and preparation for DNA synthesis — *ilana G1* is where the cell checks for DNA damage.\n</step2>\n<step3>\nWhen DNA damage occurs due to prolonged exposure to ionizing radiation, it can lead to the malfunction of proteins that regulate the cell cycle — *awọn protein ti o n ṣakoso ilana sẹẹli*.\n</step3>\n<step4>\nOne key protein involved in this regulation is p53, which acts as a tumor suppressor — *p53 jẹ olutọju arun* that helps prevent the cell from progressing to the next phase if there is damage.\n</step4>\n<step5>\nIf p53 is not functioning properly or is absent, the cell may bypass the necessary checkpoints — *awọn aaye idena* — leading to uncontrolled proliferation.\n</step6>\n<step6>\nThus, the absence of p53 allows the cell to continue dividing despite having damaged DNA, resulting in cancerous growth.\n</step7></thinking>", "answer": "<answer>Ọja gẹẹsi ti o wa ni p53, ti o ba wa ni aito, yoo fa ki sẹẹli naa gba ohun-ini idagbasoke ti ko ni iṣakoso.</answer>", "language": "Yoruba"}
{"question": "Nínú àpọǹdá sepsis kan tí iye gbogbo ẹ̀yà ẹ̀jẹ̀ funfun rẹ̀ (TLC) jẹ́ 15000, bí iye ìpín ọ̀gọ́rọ̀un neutrophil bá jẹ́ 40%, eosinophil bá jẹ́ 7%, ẹ̀yà band bá jẹ́ 15%, metamyelocytes bá jẹ́ 5%, àti lymphocytes bá jẹ́ 35%, kini ìwọ̀n àwọn tí kò yé sí gbogbo rẹ̀ (I:T)?", "reasoning": "<thinking><step1>\nThe question asks: “Nínú àpọǹdá [sepsis = sepsis] kan tí iye gbogbo ẹ̀yà ẹ̀jẹ̀ funfun rẹ̀ [TLC = total leukocyte count] jẹ́ 15000, bí iye ìpín [proportion] ọ̀gọ́rọ̀un [neutrophil] bá jẹ́ 40%, eosinophil bá jẹ́ 7%, ẹ̀yà [band] bá jẹ́ 15%, metamyelocytes bá jẹ́ 5%, àti lymphocytes bá jẹ́ 35%, kini ìwọ̀n [ratio] àwọn tí kò yé sí gbogbo rẹ̀ [I:T]?” — meaning it wants to find the Immature to Total ratio in a sepsis case with given blood cell counts.\n</step1>\n<step2>\nTo calculate the I:T ratio, we first need to determine the total number of immature cells, which includes band cells and metamyelocytes.\n</step2>\n<step3>\nThe total count of immature cells is: *15% (band) + 5% (metamyelocytes) = 20%* of the total leukocyte count.\n</step3>\n<step4>\nNow, we convert this percentage into an actual number: *20% of 15000 = 3000* immature cells.\n</step4>\n<step5>\nNext, we calculate the total leukocyte count again, which is 15000, and then we find the I:T ratio: *I:T = 3000 / 15000*.\n</step6>\n<step6>\nThis simplifies to *I:T = 0.2*, or 20%.\n</step6></thinking>", "answer": "<answer>Ìwọ̀n I:T jẹ́ 0.2 tàbí 20%.</answer>", "language": "Yoruba"}
{"question": "Irú ẹ̀jẹ̀ funfun wo ni ó pọ̀ jùlọ nínú ìgbòkègbodò 24 wákàtí lẹ́yìn ìbẹ̀rẹ̀ ìṣòro ìgbóná ara?", "reasoning": "<thinking><step1>\nThe question asks: “Irú ẹ̀jẹ̀ funfun wo ni ó pọ̀ jùlọ nínú ìgbòkègbodò 24 wákàtí lẹ́yìn ìbẹ̀rẹ̀ ìṣòro ìgbóná ara?” — meaning it wants to know which type of white blood cell is most prevalent in the blood 24 hours after the onset of a fever.\n</step1>\n<step2>\nAfter a fever starts, the body responds by increasing the production of white blood cells — *ẹ̀jẹ̀ funfun* — to fight off infection.\n</step2>\n<step3>\nThe main types of white blood cells include neutrophils, lymphocytes, and monocytes. However, during an acute infection, *neutrophils* are typically the first responders.\n</step3>\n<step4>\nIn the context of a fever, *neutrophils* usually increase significantly within the first 24 hours — *ni àkókò yìí, wọn pọ̀ jùlọ*.\n</step5>\n<step5>\nThis increase is part of the immune response, indicating that the body is actively fighting off pathogens — *àwọn arun*.\n</step6>\n<step6>\nTherefore, the type of white blood cell that is most prevalent after 24 hours of fever onset is *neutrophils*.\n</step6></thinking>", "answer": "<answer>Irú ẹ̀jẹ̀ funfun ti ó pọ̀ jùlọ lẹ́yìn ìbẹ̀rẹ̀ ìṣòro ìgbóná ara ni *neutrophils*.</answer>", "language": "Yoruba"}
{"question": "Ninu ọmọ ọdun mẹta kan ti o ni awọn aami aisan bii rirẹ, aibanujẹ, iba, irora ọfun, orififo ori, ríru, irora inu, myalgia, lymphadenopathy gbogbogbo, hepatosplenomegaly, iwọn tonsillitis ti pọ si, petechiae palatal, awọn àṣìṣe, ati edema oju, ipo ailagbara ajẹsara wo ni ko ṣehan gẹgẹbi deede pẹlu awọn aami aisan wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “What immunodeficiency condition is not typically associated with symptoms like fatigue, malaise, fever, sore throat, headache, rash, abdominal pain, myalgia, generalized lymphadenopathy, hepatosplenomegaly, increased tonsillitis, palatal petechiae, lesions, and facial edema in a three-year-old child?” \n</step1>\n<step2>\nThe symptoms listed suggest a range of possible infections or immune responses — *aami aisan* like fever and sore throat are common in many conditions.\n</step2>\n<step3>\nIn children, *aibanujẹ* and *irora inu* can indicate viral infections, such as mononucleosis or other viral syndromes, which often present with lymphadenopathy and hepatosplenomegaly.\n</step3>\n<step4>\nHowever, conditions like *agbara ajẹsara ti o dinku* (immunodeficiency) can also present with similar symptoms, but some specific types are less likely to show all these signs.\n</step4>\n<step5>\nFor instance, *agbara ajẹsara ti a ko ni* (specific antibody deficiency) might not typically present with such extensive symptoms, especially the petechiae and facial edema.\n</step5>\n<step6>\nThus, while many conditions could be considered, the one that stands out as not usually presenting with this full spectrum of symptoms is specific antibody deficiency.\n</step6></thinking>", "answer": "<answer>Agbara ajẹsara ti a ko ni ni ipo ailagbara ajẹsara ti ko ṣehan gẹgẹbi deede pẹlu awọn aami aisan wọnyi.</answer>", "language": "Yoruba"}
{"question": "Níbo ni ibi ti o dara lati gbe ago kọfi sí lakoko isinmi?\nA. ile itaja kọfi\nB. ibi idana\nC. ọwọ́\nD. tabili\nE. ọfiisi", "reasoning": "<thinking><step1>\nThe question asks: “Níbo ni ibi ti o dara lati gbe [ago kọfi = coffee cup] sí lakoko [isinmi = relaxation]?” — meaning it wants to know the best place to put a coffee cup during relaxation.\n</step1>\n<step2>\nWhen considering where to place a coffee cup, one must think about comfort and accessibility — *ibiti o ti le de ọdọ rẹ ni rọọrun*.\n</step2>\n<step3>\nOptions include a coffee shop — *ile itaja kọfi*, which is designed for enjoying beverages, or a kitchen — *ibi idana*, where drinks are often prepared.\n</step3>\n<step4>\nHowever, a table — *tabili* — is typically the most stable and convenient surface for placing a coffee cup while relaxing.\n</step4>\n<step5>\nThe office — *ọfiisi* — might not be ideal for relaxation, and the hand — *ọwọ́* — is impractical for holding a cup for long periods.\n</step5>\n<step6>\nThus, the best option for placing a coffee cup during relaxation is a table, as it provides a flat and stable surface.\n</step6></thinking>", "answer": "<answer>Ibi ti o dara lati gbe ago kọfi sí lakoko isinmi ni tabili.</answer>", "language": "Yoruba"}
{"question": "Oludari ile iṣẹ́ onjẹ́ agbegbe kan béèrè fún àwọn ìṣirò nípa gbogbo ẹ̀bùn tí a fún ní oṣù Kọkànlá. Láàrin àwọn ṣẹ́ẹ̀ki 100 tí a gba, ẹ̀bùn ààyè jẹ́ $155 pẹ̀lú ìyàtọ̀ ìṣiro ti $32. Ẹ̀yà wo nínú àwọn wọ̀nyí ni ọ̀rọ̀ tí ó bá ara mu jùlọ?\nA. A ní ìgbẹ́kẹ̀lé 95% pé ẹ̀bùn ààyè ní oṣù Kọkànlá wà láàrin $149 àti $161.\nB. Ẹ̀bùn ààyè ní oṣù Kọkànlá yìí jẹ́ $32.\nC. A ní ìgbẹ́kẹ̀lé 95% pé ẹ̀bùn ààyè ní oṣù Kọkànlá wà láàrin $123 àti $187.\nD. Ní oṣù Kọkànlá yìí, ẹ̀bùn ààyè jẹ́ $155.\nE. Ní oṣù Kọkànlá yìí, ìyàtọ̀ ìṣiro ti ẹ̀bùn jẹ́ $155.\nF. 75% gbogbo ẹ̀bùn ní oṣù Kọkànlá yìí ju $155 lọ.\nG. A ní ìgbẹ́kẹ̀lé 95% pé ẹ̀bùn ààyè ní oṣù Kọkànlá wà láàrin $91 àti $219.\nH. 50% gbogbo ẹ̀bùn ní oṣù Kọkànlá yìí kere sí $155.\nI. 50% gbogbo ẹ̀bùn ní oṣù Kọkànlá yìí ju $155 lọ.\nJ. A ní ìgbẹ́kẹ̀lé 99% pé ẹ̀bùn ààyè ní oṣù Kọkànlá wà láàrin $91 àti $219.", "reasoning": "<thinking><step1>\nThe question is asking about the statistical analysis of a sample of 100 observations regarding the average gift amount in the month of November — *ẹ̀bùn ààyè* — which is $155 with a standard deviation of $32.\n</step1>\n<step2>\nTo determine which statement is most accurate, we need to consider the confidence interval for the average gift amount. A 95% confidence interval typically means we can expect the true mean to fall within a certain range.\n</step2>\n<step3>\nUsing the formula for the confidence interval: *CI = mean ± (z * (σ/√n))* where *z* is the z-score for 95% confidence (approximately 1.96), we calculate the interval.\n</step3>\n<step4>\nCalculating this gives us: $155 ± (1.96 * ($32/√100)) = $155 ± (1.96 * $3.2) = $155 ± $6.272, which results in a range of approximately $148.73 to $161.27.\n</step4>\n<step5>\nThus, we can confidently say that the average gift amount in November is likely between $149 and $161, which corresponds to option A.\n</step5></thinking>", "answer": "<answer>A. A ní ìgbẹ́kẹ̀lé 95% pé ẹ̀bùn ààyè ní oṣù Kọkànlá wà láàrin $149 àti $161.</answer>", "language": "Yoruba"}
{"question": "Àgbẹ̀gbẹ́ ọdún mẹ́rinlélọ́gbọ̀n kan wá pẹ̀lú ìrora ori, ìgbàgbé ọwọ́ ọ̀tún tí ó jẹ́ aláìlera díẹ̀, ìyàtọ̀ ojú àti orí sí òsì, àti papilledema tí a rí ni òsì.  Nítorí àwọn àmì wọ̀nyí, níbo ni ìṣòro iṣẹ́ ẹ̀dàároni náà ṣe wà jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: \"Àgbẹ̀gbẹ́ ọdún mẹ́rinlélọ́gbọ̀n kan wá pẹ̀lú ìrora ori\" — meaning a 45-year-old presents with headaches, \"ìgbàgbé ọwọ́ ọ̀tún\" (weakness of the right hand), \"ìyàtọ̀ ojú àti orí sí òsì\" (facial asymmetry with deviation of the face to the left), and \"papilledema\" (swelling of the optic disc) seen on the left.\n</step1>\n<step2>\nThese symptoms suggest a neurological issue, particularly involving the brain. The presence of \"ìrora ori\" indicates possible increased intracranial pressure or a mass effect.\n</step2>\n<step3>\nThe \"ìgbàgbé ọwọ́\" could indicate a motor function impairment, possibly due to a stroke or lesion affecting the right side of the brain, which controls the left side of the body.\n</step3>\n<step4>\nAdditionally, \"ìyàtọ̀ ojú\" suggests a cranial nerve involvement, likely the facial nerve, which could be affected by a lesion or stroke.\n</step4>\n<step5>\nThe \"papilledema\" indicates increased intracranial pressure, which can be caused by a tumor, hemorrhage, or other mass lesions in the brain.\n</step5>\n<step6>\nGiven these symptoms, the most likely issue is a \"ìṣòro iṣẹ́ ẹ̀dàároni\" (neurological problem) such as a brain tumor or stroke affecting the right hemisphere.\n</step6></thinking>", "answer": "<answer>Ìṣòro iṣẹ́ ẹ̀dàároni kan, gẹ́gẹ́ bí ìtàn àìlera, jẹ́ àfihàn ti àkúnya ọpọlọ tàbí ikọlu.</answer>", "language": "Yoruba"}
{"question": "Orílẹ̀-èdè wo ni o ní ìwọ̀n àwọn aláìní ilé tí ó ga jùlọ ní ọdún 2013?", "reasoning": "<thinking><step1>\nThe question asks: “Orílẹ̀-èdè wo ni o ní ìwọ̀n àwọn aláìní ilé tí ó ga jùlọ ní ọdún 2013?” — meaning it wants to know which country had the highest rate of homelessness in 2013.\n</step1>\n<step2>\nTo answer this, we need to look at global statistics on homelessness — *ìṣirò àgbáyé lori aláìní ilé* for that year.\n</step2>\n<step3>\nCountries are often ranked based on the number of people without homes — *nọ́mbà àwọn ènìyàn tí kò ní ilé* per capita.\n</step3>\n<step4>\nIn 2013, the United States was reported to have a significant number of homeless individuals — *àwọn ènìyàn aláìní ilé* in major cities like New York and Los Angeles.\n</step4>\n<step5>\nHowever, other countries, particularly in Europe, also faced high rates of homelessness — *ìwọn aláìní ilé* in places like France and the UK.\n</step5>\n<step6>\nUltimately, the data indicates that the United States had the highest overall number of homeless people in 2013 — *orílẹ̀-èdè Amẹrika ni o ní ìwọ̀n aláìní ilé tí ó ga jùlọ*.\n</step6></thinking>", "answer": "<answer>Orílẹ̀-èdè Amẹrika ni o ní ìwọ̀n àwọn aláìní ilé tí ó ga jùlọ ní ọdún 2013.</answer>", "language": "Yoruba"}
{"question": "Àwọn ọmọ mẹ́jọ kan ní ọjọ́-orí wọ̀nyí: 9, 11, 8, 15, 14, 12, 17, àti 14.  Kàlìkúlàtì  ààyè, àárín, ìṣẹ̀lẹ̀ tí ó pọ̀ jùlọ, àti ìyàtọ̀ àwọn ọjọ́-orí wọ̀nyí.", "reasoning": "<thinking><step1>\nThe question asks: “Calculate the [ààyè = range], [àárín = mean], [ìṣẹ̀lẹ̀ tí ó pọ̀ jùlọ = mode], and [ìyàtọ̀ = variance] of the ages” — meaning we need to analyze the ages given: 9, 11, 8, 15, 14, 12, 17, and 14.\n</step1>\n<step2>\nFirst, to find the range, we subtract the smallest age from the largest age — *ààyè = 17 - 8*.\n</step2>\n<step3>\nNext, for the mean, we sum all the ages and divide by the number of ages — *àárín = (9 + 11 + 8 + 15 + 14 + 12 + 17 + 14) / 8*.\n</step3>\n<step4>\nTo find the mode, we look for the age that appears most frequently — here, *ìṣẹ̀lẹ̀ tí ó pọ̀ jùlọ* is 14, as it appears twice.\n</step4>\n<step5>\nFinally, to calculate the variance, we find the average of the squared differences from the mean — *ìyàtọ̀ = [(9-12.5)² + (11-12.5)² + (8-12.5)² + (15-12.5)² + (14-12.5)² + (12-12.5)² + (17-12.5)² + (14-12.5)²] / 8*.\n</step5>\n<step6>\nNow, we can summarize: the range is 9, the mean is 12.5, the mode is 14, and the variance is calculated from the squared differences.\n</step6></thinking>", "answer": "<answer>Ààyè jẹ́ 9, àárín jẹ́ 12.5, ìṣẹ̀lẹ̀ tí ó pọ̀ jùlọ jẹ́ 14, àti ìyàtọ̀ jẹ́ 8.25.</answer>", "language": "Yoruba"}
{"question": "Lọ́jọ́ kan, wọ́n gba ẹgbẹ̀rún mẹ́ẹ̀dógún (50) sí ilé-iwosan, tó wọǹú ọmọbìnrin mẹ́ẹ̀dógún (20) àti ọmọkùnrin mẹ́ẹ̀tadinlọ́gọ́rin (30). Bí ọmọbìnrin mẹ́wàá (10) àti ọmọkùnrin ogún (20) bá nílò abẹ, ìpínwọ̀n wo nínú gbogbo àwọn tí wọ́n gba sí ilé-iwosan ni ó nílò abẹ̀?", "reasoning": "<thinking><step1>\nThe question translates to: \"One day, they admitted fifty (50) to the hospital, including twenty (20) girls and thirty (30) boys. If ten (10) girls and twenty (20) boys need surgery, what fraction of all those admitted to the hospital needs surgery?\" \n</step1>\n<step2>\nFirst, we need to determine the total number of patients admitted — *ìpínwọ̀n gbogbo* is 50.\n</step2>\n<step3>\nNext, we find the total number of patients needing surgery: *ọmọbìnrin mẹ́wàá* (10) plus *ọmọkùnrin ogún* (20) equals 30.\n</step3>\n<step4>\nNow, we calculate the fraction of patients needing surgery: *30* out of *50*.\n</step4>\n<step5>\nTo express this as a fraction, we write it as 30/50, which simplifies to 3/5.\n</step5>\n<step6>\nThus, the fraction of all those admitted who need surgery is *mẹ́ta nínú marun* (3 out of 5).\n</step6></thinking>", "answer": "<answer>Mẹ́ta nínú marun ni ìpínwọ̀n àwọn tí wọ́n gba sí ilé-iwosan tí ó nílò abẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun mẹta kan wà lẹ́wàjú oníṣègùn ọmọdé nítorí pé ọ̀pọ̀lọpọ̀ àwọn ìṣòro tí ó yàtọ̀ sí ara wọn ti wà ní ojú rẹ̀ àti ọrùn rẹ̀.  Àyẹ̀wò ara fi hàn pé ọ̀pọ̀lọpọ̀ àwọn ìṣòro tó fi ìwọ̀n mẹrin centimeters sí iṣẹ́lẹ̀ pẹ̀lú àwọn ikúkù fẹ́fẹ́, nígbà tí àwọn àwọn àṣìṣe kékeré àti àwọn agbègbè tí ó ń tu sílẹ̀ sì wà ní àwọn ibìkan mìíràn.  Èwo nínú èyí tó tẹ̀lé yìí ni ìwádìí tí ó ṣeé ṣe jùlọ?\nA. Àwọn ọgbẹ́ Aphthous\nB. Erysipelas\nC. Herpes simplex I\nD. Impetigo", "reasoning": "<thinking><step1>\nThe question is asking about a three-year-old child with multiple skin issues on the face and neck, specifically mentioning lesions of about four centimeters and some smaller lesions in different areas. This suggests a dermatological condition.\n</step1>\n<step2>\nConsidering the options, *àwọn ọgbẹ́ Aphthous* (Aphthous ulcers) typically occur in the mouth, not on the skin, so this is unlikely.\n</step2>\n<step3>\n*Erysipelas* is a bacterial skin infection that usually presents with a well-defined, raised, red area, but it doesn't match the description of multiple lesions.\n</step3>\n<step4>\n*Herpes simplex I* can cause lesions on the face, often around the mouth, and can appear as vesicular lesions, which aligns with the description of the child’s symptoms.\n</step4>\n<step5>\n*Impetigo* is also a possibility, as it presents with crusted lesions, but it typically occurs in children and may not match the size described as well as herpes simplex.\n</step6>\n<step6>\nGiven the details, *Herpes simplex I* is the most likely diagnosis due to the presence of vesicular lesions and the age of the child.\n</step6></thinking>", "answer": "<answer>Herpes simplex I.</answer>", "language": "Yoruba"}
{"question": "Kini ayẹ̀wò tí ó ṣeé ṣe jùlọ fún àmùṣà tí a rí ní ara ẹni tí ìdílé rẹ̀ ní ìtàn àìsàn àìsàn ẹ̀dùn afẹ́fẹ́, nígbà tí a bá gbéèṣe àdáhùn tí ó tọ̀nà láti inú àwọn àṣàyàn tí a pèsè?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ayẹ̀wò tí ó ṣeé ṣe jùlọ fún àmùṣà [asthma] tí a rí ní ara ẹni tí ìdílé rẹ̀ ní ìtàn àìsàn [family history of respiratory disease]?” — meaning it wants to know the best test for asthma in someone with a family history of respiratory issues.\n</step1>\n<step2>\nIn this context, *ayẹ̀wò* refers to a medical test, and the most common test for asthma is *ayẹwo iṣẹ́ ẹ̀dùn afẹ́fẹ́* — pulmonary function test.\n</step2>\n<step3>\nThis test measures how well the lungs are working, specifically looking at *ìwọn afẹ́fẹ́* (airflow) and *ìdíyelé* (lung capacity).\n</step3>\n<step4>\nFor someone with a family history, it’s crucial to assess *ìtàn àìsàn* (medical history) and symptoms like *ìrora ẹ̀dùn afẹ́fẹ́* (breathing difficulties).\n</step4>\n<step5>\nAdditionally, a *test àfihàn* (allergy test) might be useful to identify triggers that could exacerbate asthma symptoms.\n</step5>\n<step6>\nSo, the most appropriate test for asthma in this scenario would be a combination of *ayẹwo iṣẹ́ ẹ̀dùn afẹ́fẹ́* and possibly an allergy test.\n</step6></thinking>", "answer": "<answer>Ayẹwo iṣẹ́ ẹ̀dùn afẹ́fẹ́ ni ayẹ̀wò tí ó ṣeé ṣe jùlọ fún àmùṣà ní àyíká ìtàn àìsàn ẹ̀dùn afẹ́fẹ́.</answer>", "language": "Yoruba"}
{"question": "Báwo ni iwọ o ṣe ṣe iṣẹ́ ṣiṣe àtúnṣe ìṣirò kan ti 10x5 Gaussian pẹlu gbogbo ìṣípayọ kan ti a mú láti ipilẹ̀ àpapọ̀ kan pẹlu ààyò 5 ati iyìpò 16, ati iṣẹ́ ṣiṣe àtúnṣe ìṣirò ti 10x10 ti o ni gbogbo ìṣípayọ kan ti a mú láti ipilẹ̀ àpapọ̀ kan ninu àyè [-1, 1) nipa lilo PyTorch 1.8?", "reasoning": "<thinking><step1>\nThe question asks: “Báwo ni iwọ o ṣe ṣe iṣẹ́ ṣiṣe àtúnṣe ìṣirò kan ti 10x5 Gaussian?” — meaning it wants to know how to implement a 10x5 Gaussian random tensor and a 10x10 tensor using PyTorch.\n</step1>\n<step2>\nTo create a Gaussian tensor, we use the function *torch.normal* in PyTorch, which generates random numbers from a normal distribution — *distribushọn àtọka*.\n</step2>\n<step3>\nFor the 10x5 tensor, we specify the mean and standard deviation; here, the mean is 5 and the standard deviation is 16 — *iyìpò 16*.\n</step3>\n<step4>\nThe code would look like this: *tensor_10x5 = torch.normal(mean=5, std=16, size=(10, 5))*.\n</step4>\n<step5>\nNext, for the 10x10 tensor in the range [-1, 1), we can use *torch.FloatTensor* and then scale the values accordingly — *pẹlu ààyò [-1, 1)*.\n</step5>\n<step6>\nThe code for this tensor would be: *tensor_10x10 = (torch.rand(10, 10) * 2) - 1*.\n</step6>\n<step7>\nIn summary, we create two tensors: one Gaussian with specified mean and standard deviation, and another uniformly distributed in the range [-1, 1).\n</step7></thinking>", "answer": "<answer>Lati ṣe iṣẹ́ ṣiṣe àtúnṣe ìṣirò kan ti 10x5 Gaussian, lo *torch.normal(mean=5, std=16, size=(10, 5))*; fun 10x10 tensor, lo *tensor_10x10 = (torch.rand(10, 10) * 2) - 1*.</answer>", "language": "Yoruba"}
{"question": "Nínú ọmọdé tí ó ní ìṣòro ìwàdíì àti àìsàn ẹ̀dọ̀fọ́, èyíkéyìí nínú àwọn ohun tí a fi ń mú ṣiṣẹ́ ẹ̀dọ̀fọ́ ṣiṣẹ́ ló dára jù fún didinku àwọn àìsàn ẹ̀dọ̀fọ́ tí ó lè ṣẹlẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Nínú ọmọdé tí ó ní ìṣòro ìwàdíì àti àìsàn ẹ̀dọ̀fọ́” — meaning it is inquiring about the best methods to manage [asthma] in a child with [behavioral issues].\n</step1>\n<step2>\nTo manage asthma effectively, it is crucial to identify triggers — *awọn ohun tí ń fa àìsàn ẹ̀dọ̀fọ́* — such as allergens, smoke, or exercise.\n</step2>\n<step3>\nImplementing a consistent medication regimen is vital; *médicament* like inhalers can help control symptoms and prevent attacks.\n</step3>\n<step4>\nAdditionally, teaching the child about their condition — *kí a kọ́ ọmọ náà nípa àìsàn rẹ* — empowers them to recognize early signs of an asthma attack.\n</step4>\n<step5>\nCreating a supportive environment, free from triggers, is also essential; for example, avoiding smoking indoors — *má ṣe mu siga nínú ilé*.\n</step5>\n<step6>\nFinally, regular follow-ups with a healthcare provider ensure that the asthma management plan is effective and adjusted as needed — *ìpinnu ìtọ́jú*.\n</step6></thinking>", "answer": "<answer>Ohun tí ó dára jù fún didinku àwọn àìsàn ẹ̀dọ̀fọ́ ni mímú àkóso àìsàn, kọ́ ọmọ náà nípa àìsàn rẹ, àti ṣẹda ayika tó dára.</answer>", "language": "Yoruba"}
{"question": "Kini orukọ enzymu ti o gbona lati inu kokoro Thermus aquaticus, eyiti a maa n lo ninu PCR ni awọn iwọn otutu giga?", "reasoning": "<thinking><step1>\nThe question asks: “Kini orukọ enzymu ti o gbona [What is the name of the heat-stable enzyme] lati inu kokoro [from the bacterium] Thermus aquaticus, eyiti a maa n lo [which is used] ninu PCR [in PCR] ni awọn iwọn otutu giga [at high temperatures]?” — meaning it seeks the name of a specific enzyme used in PCR.\n</step1>\n<step2>\nIn PCR, we need an enzyme that can withstand high temperatures, as the process involves repeated heating and cooling cycles — *iyipo gbigbona ati tutu*.\n</step2>\n<step3>\nThe enzyme from Thermus aquaticus is particularly known for its stability at elevated temperatures — *iduroṣinṣin ni awọn iwọn otutu giga*.\n</step3>\n<step4>\nThis enzyme is crucial for synthesizing DNA during the amplification process — *fun ṣiṣe DNA*.\n</step4>\n<step5>\nThe name of this enzyme is Taq polymerase, derived from the organism's name — *Taq polymerase*.\n</step5>\n<step6>\nThus, Taq polymerase is essential for PCR because it allows for DNA replication at high temperatures without denaturing.\n</step6></thinking>", "answer": "<answer>Orukọ enzymu ti o gbona lati inu kokoro Thermus aquaticus ni Taq polymerase.</answer>", "language": "Yoruba"}
{"question": "Bólúbùu líta mẹta kan tí ó ní òògìsìn ní 195 torr ni a so mọ́ bólúbùu líta meji kan tí ó ní náìtirójẹ̀ni ní 530 torr nípasẹ̀ fààìfì tí a ti pọn. A ṣí fààìfì náà sílẹ̀, a sì jẹ́ kí àwọn gaasi mejeeji gbé ara wọn dé ìdùnnú ní ìgbà otutu kan náà. Ní ti irú ọ̀ràn yìí, kini àtìlẹ̀wá àtìlẹ́wọ́ fún adalu gaasi náà?", "reasoning": "<thinking><step1>\nThe question asks about the partial pressures of two gas mixtures: one with a pressure of 195 torr and another with 530 torr, and how they behave when mixed at the same temperature.\n</step1>\n<step2>\nIn this case, we are dealing with Dalton's Law of Partial Pressures — *Ilana Dalton ti Iwọn Ipa Apapọ* — which states that the total pressure of a gas mixture is the sum of the partial pressures of each gas.\n</step2>\n<step3>\nHere, we have two gases: *gaasi kan* with a pressure of 195 torr and *gaasi meji* with a pressure of 530 torr. \n</step3>\n<step4>\nTo find the total pressure, we simply add the two pressures together: 195 torr + 530 torr.\n</step4>\n<step5>\nCalculating this gives us a total pressure of 725 torr — *ìwọn apapọ 725 torr*.\n</step5>\n<step6>\nThus, the final answer regarding the total pressure of the gas mixture is straightforward.\n</step6></thinking>", "answer": "<answer>Ìwọn apapọ adalu gaasi náà ni 725 torr.</answer>", "language": "Yoruba"}
{"question": "Àpòòtọ́ tí ó ní CaO toje gba afẹ́fẹ́ omi láti agbàárin o sì yí padà sí Ca(OH)2 (s) pátápátá, tí ó mú kí iwuwo gbogbo tí a rí (CaO + àpòòtọ́) pọ̀ láti 10.860 g sí 11.149 g. Da lórí ìyípadà yìí, ka iwuwo àpòòtọ́ tí ó ṣofo.", "reasoning": "<thinking><step1>\nThe question asks: “Àpòòtọ́ tí ó ní CaO toje gba afẹ́fẹ́ omi” — meaning it involves a sample containing calcium oxide (CaO) that absorbs water vapor and converts to calcium hydroxide (Ca(OH)2).\n</step1>\n<step2>\nThe initial weight of the sample with CaO is 10.860 g, and after the reaction, it increases to 11.149 g — *iyipada iwuwo* indicates the mass change due to the reaction with water.\n</step2>\n<step3>\nTo find the weight of the empty sample, we first calculate the mass increase: 11.149 g - 10.860 g = 0.289 g — *iyipada iwuwo* is the mass of water absorbed.\n</step3>\n<step4>\nThis mass increase corresponds to the formation of Ca(OH)2 from CaO, which means the water added is part of the reaction — *afẹ́fẹ́ omi* contributes to the new compound.\n</step4>\n<step5>\nNow, we need to determine the original weight of the empty sample: if we denote the weight of the empty sample as x, then x + 10.860 g = 11.149 g.\n</step5>\n<step6>\nSolving for x gives us x = 11.149 g - 10.860 g = 0.289 g, which is the weight of the empty sample before the reaction.\n</step6></thinking>", "answer": "<answer>Iwuwo àpòòtọ́ tí ó ṣofo ni 0.289 g.</answer>", "language": "Yoruba"}
{"question": "Okunrin kan fi ailera, irora inu ikun oke, hyperpigmentation, arthritis, hyperglycemia ati ẹdọ ti tobi ti o le fi ọwọ̀ kan han.  Ayẹwo ti o ṣeeṣe julọ ni:\nA. Haemochromatosis\nB. Arun Addison\nC. Insulin Dependent DM\nD. Arun Cushing", "reasoning": "<thinking><step1>\nThe question presents symptoms: \"ailera\" [illness], \"irora inu ikun oke\" [upper abdominal pain], \"hyperpigmentation,\" \"arthritis,\" \"hyperglycemia,\" and \"ẹdọ ti tobi\" [enlarged liver]. It asks for the most likely diagnosis among the options provided.\n</step1>\n<step2>\nFirst, let's analyze the symptoms. Hyperpigmentation can indicate an endocrine disorder, while hyperglycemia suggests issues with glucose metabolism — *problèmes de métabolisme du glucose*.\n</step2>\n<step3>\nArthritis and abdominal pain could be linked to systemic conditions. For instance, *l'arthrite* can be associated with autoimmune diseases or metabolic disorders.\n</step3>\n<step4>\nNow, looking at the options: \n- A. Haemochromatosis is characterized by iron overload, which can cause liver enlargement and joint pain.\n- B. Arun Addison involves adrenal insufficiency, leading to hyperpigmentation and low blood sugar, but not typically hyperglycemia.\n- C. Insulin Dependent DM primarily presents with hyperglycemia and may lead to complications like arthritis but lacks the other symptoms.\n- D. Arun Cushing is known for hyperglycemia, abdominal obesity, and skin changes, including hyperpigmentation.\n</step4>\n<step5>\nConsidering the combination of symptoms, particularly hyperglycemia, hyperpigmentation, and abdominal issues, *les symptômes correspondent le mieux à l'Arun Cushing*.\n</step5>\n<step6>\nThus, the most likely diagnosis is *Arun Cushing* due to the presence of hyperglycemia and other systemic symptoms.\n</step6></thinking>", "answer": "<answer>Arun Cushing.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 29 kan ti o ni irora ọmu ti o min, bi eku, ti o dara si nigbati o ba jókòó ti o si buru si nigbati o ba dùbúlẹ̀ ni a ṣe ayẹwo fun ipo kan ti a ṣe àmì nípa fifọ irora ti a gbọ́ ni ẹgbẹ́ òsì ti sternal. Àwọn àmì rẹ̀ fi ìwádìí pàtó hàn.  Oògùn wo ni a lè lò láti da idàropo ipo yìí dòró?", "reasoning": "<thinking><step1>\nThe question asks: “What medication can be used to manage a condition characterized by pain in the chest that improves when sitting and worsens when lying down?” — this describes a situation likely related to *pleurisy* or *costochondritis*.\n</step1>\n<step2>\nThe pain described is typically sharp and may be exacerbated by deep breathing or coughing — *irora ti o nira* le fa *ìfarapa* si awọn iṣan.\n</step2>\n<step3>\nIn such cases, nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to relieve pain and inflammation — *oògùn NSAID* bi ibuprofen le jẹ́ iranlọwọ.\n</step3>\n<step4>\nAdditionally, corticosteroids may be prescribed if inflammation is severe — *corticosteroids* le dinku *ìfarapa* ni kiakia.\n</step4>\n<step5>\nIt's important to monitor the patient's response to medication and adjust as necessary — *ìmúdájú àbájáde* jẹ́ pataki.\n</step6>\n<step6>\nThus, the recommended medications for this condition would primarily be NSAIDs and possibly corticosteroids.\n</step6></thinking>", "answer": "<answer>Oògùn ti a lè lò ni NSAIDs gẹgẹ bi ibuprofen, ati corticosteroids ti ìfarapa ba jẹ́ gíga.</answer>", "language": "Yoruba"}
{"question": "Àdàkọ́ vitamin wo ni ó fà áyà, àìlera ọpọlọ, àwọn agbegbe keratotic tí ó rọ́ lórí ara àti àwọn àrùn ikun?\nA. Riboflavin\nB. Pyridoxine\nC. Niacin\nD. Pantothenic acid", "reasoning": "<thinking><step1>\nThe question asks: “Àdàkọ́ vitamin wo ni ó fà áyà, àìlera ọpọlọ, àwọn agbegbe keratotic tí ó rọ́ lórí ara àti àwọn àrùn ikun?” — meaning it wants to know which vitamin causes symptoms like chest pain, mental health issues, keratotic lesions on the skin, and gastrointestinal disorders.\n</step1>\n<step2>\nThese symptoms suggest a deficiency in a specific vitamin. For instance, *àìlera ọpọlọ* indicates potential neurological issues, which can be linked to certain vitamin deficiencies.\n</step2>\n<step3>\nThe options provided are: Riboflavin, Pyridoxine, Niacin, and Pantothenic acid. Among these, Niacin is known to cause *pellagra*, which includes symptoms like skin lesions and gastrointestinal problems.\n</step3>\n<step4>\nPellagra is characterized by the three D's: *diarrhea, dermatitis,* and *dementia*. The keratotic lesions mentioned could be a result of this deficiency.\n</step4>\n<step5>\nIn contrast, Riboflavin and Pyridoxine deficiencies do not typically present with these specific symptoms. Pantothenic acid is less commonly associated with severe deficiency symptoms.\n</step5>\n<step6>\nThus, the vitamin that aligns with the symptoms described in the question is Niacin, which is crucial for preventing these health issues.\n</step6></thinking>", "answer": "<answer>Niacin ni àdàkọ́ vitamin tí ó fà áyà, àìlera ọpọlọ, àti àwọn agbegbe keratotic.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin kan tí kò tíì dàgbà pẹ̀lú àwọn èéfín tó rọ̀ bíi wàrà tí ó wà ní oríṣiríṣi ibi ní ara rẹ̀ pẹ̀lú àwọn èéfín kan nínú ẹnu rẹ̀. Kí ni pàtó ohun tí o rò pé a ó rí nígbà tí a bá ṣe àyẹ̀wò \"immunofluorescence\" lára èyí tí a mú láti ara ọmọ náà?", "reasoning": "<thinking><step1>\nThe question translates to: \"A young boy who has not yet matured with lesions resembling [wàrà = cheese] located in various parts of his body along with some lesions in his mouth. What specific findings do you think we would see during an 'immunofluorescence' examination of this child's sample?\" \n</step1>\n<step2>\nImmunofluorescence is a technique used to detect specific antibodies or antigens in tissues — *a n lo o lati wa awọn antibody tabi antigen ni awọn tissue*.\n</step2>\n<step3>\nIn cases with lesions like those described, we might suspect a condition such as pemphigus or lupus — *pemphigus* tabi *lupus*.\n</step4>\n<step4>\nDuring the examination, we would look for the presence of autoantibodies — *awọn autoantibody* — that bind to the skin or mucosal surfaces.\n</step5>\n<step5>\nIf the lesions are due to pemphigus, we would expect to see IgG deposits in the epidermis — *a le reti lati ri awọn deposits IgG ni epidermis*.\n</step6>\n<step6>\nIn lupus, we might find a \"butterfly rash\" pattern with IgM or complement deposits — *a le ri àpẹẹrẹ \"butterfly rash\" pẹlu awọn deposits IgM tabi complement*.\n</step7>\n<step7>\nThus, the findings would depend on the specific condition but would likely include autoantibody presence and specific patterns of deposition.\n</step7></thinking>", "answer": "<answer>A ó rí awọn autoantibody ati awọn àpẹẹrẹ ti o ni ibatan si ipo naa, gẹgẹ bi awọn deposits IgG ni epidermis tabi awọn deposits IgM ni lupus.</answer>", "language": "Yoruba"}
{"question": "Alisi, Bobu, ati Klea wa ninu ẹgbẹ kanna ninu ere bọọlu afẹsẹgba kan. Ni ibẹrẹ ere naa, wọn kọọkan ni a yan si ipo kan: Alisi n ṣere striker, Bobu n ṣere midfielder ọtun, ati Klea n ṣere goalkeeper.\nBi ere naa ti nlọ siwaju, awọn tọkọtaya ti awọn oṣere ma ṣe paṣipaarọ awọn ipo. Ni akọkọ, Klea ati Bobu ṣe paṣipaarọ awọn ipo. Lẹhinna, Klea ati Alisi ṣe paṣipaarọ awọn ipo. Nikẹhin, Bobu ati Klea ṣe paṣipaarọ awọn ipo. Ni ipari ere naa, Klea n ṣere\nAwọn aṣayan:\n(A) striker\n(B) midfielder ọtun\n(C) goalkeeper", "reasoning": "<thinking><step1>\nThe question is asking: \"At the end of the game, what position is Klea playing?\" — it provides the initial positions of Alisi, Bobu, and Klea in a football game.\n</step1>\n<step2>\nInitially, Alisi is the striker, Bobu is the right midfielder, and Klea is the goalkeeper — *Klea jẹ olugba*.\n</step2>\n<step3>\nFirst, Klea and Bobu switch positions, so now Bobu becomes the goalkeeper and Klea takes the right midfielder position — *Klea di midfielder ọtun*.\n</step3>\n<step4>\nNext, Klea and Alisi switch positions again. Since Klea was the right midfielder, she now becomes the striker — *Klea di striker*.\n</step4>\n<step5>\nFinally, Bobu and Klea switch positions once more. Bobu, who was the goalkeeper, now takes the striker position, and Klea returns to being the goalkeeper — *Klea pada si ipo olugba*.\n</step5>\n<step6>\nAt the end of the game, Klea is back in her original position as the goalkeeper.\n</step6></thinking>", "answer": "<answer>Klea n ṣere goalkeeper.</answer>", "language": "Yoruba"}
{"question": "Àpọn ọkunrin ọdún 58 kan tí ó ní àrùn àtìgbàdùgbà iru keji kò lè ṣakoso oúnjẹ rẹ̀ ṣùgbọ́n ó gbàgbọ́ sí metformin. HbA1c rẹ̀ ti dinku láti 8.2% sí 7.2% lákòókò oṣù mẹta. Nítorí BMI gíga rẹ̀ àti àìdánilójú láti yẹ̀wò oògùn tí ó mú kí ìwúwo pọ̀ sí i, oògùn wo ni yóò ṣe yẹ̀ ní kíkún láti ràn án lọ́wọ́ láti ṣàkóso ìwògbà ẹ̀jẹ̀ rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What medication should a 58-year-old man with type 2 diabetes, who cannot manage his diet but believes in metformin, take to help control his blood sugar levels?” — key terms include [àrùn àtìgbàdùgbà = type 2 diabetes] and [ìwògbà ẹ̀jẹ̀ = blood sugar levels].\n</step1>\n<step2>\nThe patient has shown improvement with metformin, as indicated by his HbA1c reduction from 8.2% to 7.2% over three months — *iyipada to dara ni a fihan*.\n</step2>\n<step3>\nHowever, due to his high BMI and reluctance to take medications that may cause weight gain, we need to consider alternatives — *a nilo lati ronu nipa awọn aṣayan miiran*.\n</step3>\n<step4>\nGLP-1 receptor agonists, such as liraglutide, could be beneficial as they help lower blood sugar and promote weight loss — *wọn tun n ṣe iranlọwọ lati dinku iwuwo*.\n</step4>\n<step5>\nAnother option could be SGLT2 inhibitors, which also aid in weight management and have cardiovascular benefits — *wọn ni awọn anfani fun ilera ọkan*.\n</step5>\n<step6>\nBoth classes of medications can be effective for managing blood sugar while addressing his concerns about weight gain — *wọn le jẹ iranlọwọ fun iṣakoso ẹjẹ rẹ̀*.\n</step6>\n<step7>\nUltimately, the choice should be made in consultation with a healthcare provider to ensure safety and efficacy — *o ṣe pataki lati ba dokita sọrọ*.\n</step7></thinking>", "answer": "<answer>Oògùn ti o yẹ ni GLP-1 receptor agonists bi liraglutide tabi SGLT2 inhibitors lati ṣe iranlọwọ pẹlu iṣakoso ìwògbà ẹ̀jẹ̀ ati iwuwo.</answer>", "language": "Yoruba"}
{"question": "Ní ọjọ́ orí wo ni ọmọdédé máa ń gbé orí rẹ̀ láìgbé, láìsí ìgbógbó, tí ó sì máa ń rẹ́rìn-ìn-ín pẹ̀lú?", "reasoning": "<thinking><step1>\nThe question asks: “Ní ọjọ́ orí wo ni ọmọdédé máa ń gbé orí rẹ̀ láìgbé, láìsí ìgbógbó, tí ó sì máa ń rẹ́rìn-ìn-ín pẹ̀lú?” — meaning it wants to know at what age a child can hold their head up without support and smile.\n</step1>\n<step2>\nTypically, a child can hold their head up around 3 to 4 months — *ni oṣù mẹta si mẹrin* — as their neck muscles strengthen.\n</step2>\n<step3>\nAt this age, they also start to show social smiles — *wọn máa ń rẹ́rìn-ín-ín* in response to others, indicating social development.\n</step3>\n<step4>\nThis developmental milestone is crucial for later skills like sitting and crawling — *sitting* and *crawling* are built on this foundation.\n</step4>\n<step5>\nParents should encourage this by providing tummy time — *àkókò ìdákẹ́jẹ* — which helps strengthen the neck and back muscles.\n</step5>\n<step6>\nSo, by around 3 to 4 months, a child can typically hold their head up and smile socially — *ní ọjọ́ mẹta sí mẹrin*.\n</step6></thinking>", "answer": "<answer>Ní ọjọ́ mẹta sí mẹrin, ọmọdédé máa ń gbé orí rẹ̀ láìgbé, láìsí ìgbógbó, tí ó sì máa ń rẹ́rìn-ìn-ín pẹ̀lú.</answer>", "language": "Yoruba"}
{"question": "Inagbàgbà ati amágbàgbà sopọ̀ láti dá\nA. ìwọ̀n\nB. ohùn tí kò ga\nC. agbára onúkèrè\nD. agbára\nE. ooru\nF. ohùn tí ga gidigidi\nG. àwọn àṣeyọrí kẹ́míkà\nH. agbára fàájì\nI. àwọn ìtàntán rédíò\nJ. ìmọ́lẹ̀", "reasoning": "<thinking><step1>\nThe question asks: “Inagbàgbà ati amágbàgbà sopọ̀ láti dá” — which translates to “What connects frequency and amplitude?” This is a physics-related question about sound waves.\n</step1>\n<step2>\nFrequency refers to how often a wave oscillates — *báwo ni igbohunsafẹfẹ ṣe n yí padà* — while amplitude measures the height of the wave, indicating its strength.\n</step2>\n<step3>\nIn sound, higher frequency means a higher pitch — *ohùn tí ga gidigidi* — and amplitude relates to volume — *ìwọ̀n*.\n</step4>\n<step4>\nThe relationship between these two concepts is crucial in understanding sound waves; for instance, a loud sound has a high amplitude but can have varying frequencies.\n</step5>\n<step5>\nAmong the options, *agbára onúkèrè* (sound energy) and *agbára fàájì* (sound power) are relevant, but they don't directly answer the question about the connection.\n</step6>\n<step6>\nThe best choice that connects frequency and amplitude is *ìwọ̀n*, as it relates to the measurement of sound characteristics.\n</step7>\n<step7>\nThus, the answer is focused on the measurement aspect of sound waves, which is essential in physics.\n</step7></thinking>", "answer": "<answer>Ìwọ̀n.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 47 kan, aya rẹ̀ sọ pé àìṣe rẹ̀ ti yipada ní oṣù mẹta sẹ́yìn. Nígbà tí wọ́n ń bá a sọ̀rọ̀, ó máa ń dáhùn ìbéèrè gbogbo rẹ̀ pẹ̀lú ọ̀rọ̀ mẹta kan náà lójúmọ. Kí ni orúkọ tí a fi ń pè ìṣe àtúnṣe yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni orúkọ tí a fi ń pè ìṣe àtúnṣe yìí?” — meaning it wants to know the name of the condition where a person responds to questions with the same three words.\n</step1>\n<step2>\nThis behavior suggests a possible cognitive issue, often seen in conditions like *aphasia* or *echolalia* — *ìṣe àtúnṣe* refers to the repetitive nature of the responses.\n</step2>\n<step3>\nIn this case, the man’s responses are limited, which could indicate a neurological condition affecting his speech — *ìfarapa ọpọlọ*.\n</step4>\n<step4>\nEcholalia is characterized by the involuntary repetition of phrases or words, often seen in autism or after brain injuries — *ìtànkálẹ̀ àkópọ̀*.\n</step5>\n<step5>\nThus, the term for this repetitive speech behavior is *echolalia*, where the individual echoes back what they hear.\n</step6>\n<step6>\nIt’s important to assess further to understand the underlying cause of this behavior.\n</step6></thinking>", "answer": "<answer>Orúkọ tí a fi ń pè ìṣe àtúnṣe yìí ni *echolalia*.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 55 kan ti o ní itan-akọọlẹ àrùn ọkàn rheumatic ati ikọsẹ ẹmi ti o pọ si n fihan irọri ṣiṣi silẹ ti a tẹle nipasẹ ohùn ọkàn diastolic kekere ni aaye intercostal keje osi ni ila mid-clavicular, pẹlu awọn ami ti ilofa ati awọn ami ẹjẹ ti o pọ si lori X-ray ọmu. Kini iṣẹ-ṣiṣe ti o yẹ julọ lati mu awọn aami aisan alaisan yii dara si?", "reasoning": "<thinking><step1>\nThe question asks: “What is the most appropriate intervention to improve the symptoms of a 55-year-old man with a history of rheumatic heart disease and increased shortness of breath, showing a low diastolic heart sound in the left 7th intercostal space along the mid-clavicular line, with signs of congestion and increased blood pressure on chest X-ray?” \n</step1>\n<step2>\nThis patient has a complex history, including *àrùn ọkàn rheumatic* (rheumatic heart disease) and *ikọsẹ ẹmi* (shortness of breath), indicating possible heart failure or fluid overload.\n</step2>\n<step3>\nThe low diastolic sound suggests *ìdíwọ̀n ẹjẹ* (blood flow obstruction) or heart dysfunction, which is common in patients with rheumatic heart disease.\n</step3>\n<step4>\nSigns of congestion on the X-ray indicate fluid accumulation, which could lead to pulmonary edema — *ìdíwọ̀n omi ni ẹdọfóró*.\n</step4>\n<step5>\nIn such cases, the most effective treatment often involves diuretics — *awọn diuretics* — to reduce fluid overload and improve breathing.\n</step5>\n<step6>\nAdditionally, managing blood pressure is crucial, as *ìdíwọ̀n ẹjẹ ti o pọ si* (increased blood pressure) can exacerbate heart failure symptoms.\n</step6>\n<step7>\nTherefore, the appropriate intervention would be to initiate diuretic therapy to alleviate symptoms and improve the patient's condition.\n</step7></thinking>", "answer": "<answer>Iṣẹ-ṣiṣe ti o yẹ julọ ni lati bẹrẹ itọju diuretic lati dinku omi ti o pọ si ati mu awọn aami aisan alaisan dara si.</answer>", "language": "Yoruba"}
{"question": "Níwọ̀n ìgbà tí oògùn X àti oògùn Y méjèèjì ní ìfẹ́ láti so pọ̀ mọ́ albumin, pẹ̀lú oògùn Y tí ó ní ìfẹ́ tí ó pọ̀ sí i nígbà 150 ju oògùn X lọ, oògùn wo ni yóò wà púpọ̀ sí i nínú àwọn ara nípa ìdàpọ̀ ìfẹ́ wọn?", "reasoning": "<thinking><step1>\nThe question asks: “Níwọ̀n ìgbà tí oògùn X àti oògùn Y méjèèjì ní ìfẹ́ láti so pọ̀ mọ́ [albumin]?” — meaning it wants to know which drug will be more prevalent in the body based on their binding affinity to albumin.\n</step1>\n<step2>\nWe know that drug Y has a binding affinity that is 150 times greater than that of drug X — *oògùn Y ní ìfẹ́ tí ó pọ̀ sí i ju oògùn X lọ*.\n</step2>\n<step3>\nWhen two drugs bind to the same protein, the one with the higher affinity will occupy more binding sites — *oògùn tí ó ní ìfẹ́ tó ga ju ni yóò gba ibi pọ̀ sí i*.\n</step3>\n<step4>\nIn this case, since drug Y has a significantly higher affinity for albumin, it will displace drug X from the binding sites — *oògùn Y yóò fa oògùn X kúrò nínú ibi ìdàpọ̀*.\n</step5>\n<step6>\nThus, in terms of concentration in the body, drug Y will be more prevalent due to its stronger binding — *oògùn Y yóò wà púpọ̀ sí i nínú àwọn ara*.\n</step7>\n<step8>\nTherefore, we conclude that drug Y will be the one that is more abundant in the body because of its higher affinity for albumin.\n</step8></thinking>", "answer": "<answer>Oògùn Y ni yóò wà púpọ̀ sí i nínú àwọn ara nítorí ìfẹ́ rẹ̀ tó ga jù oògùn X lọ.</answer>", "language": "Yoruba"}
{"question": "kì í ṣe Ẹ̀ké àti kì í ṣe Ẹ̀ké àti kì í ṣe Ẹ̀ké jẹ́", "reasoning": "<thinking><step1>\nThe question asks: “kì í ṣe Ẹ̀ké àti kì í ṣe Ẹ̀ké” — which translates to “what is not a lie and what is a lie?” This indicates a need to differentiate between truth and falsehood.\n</step1>\n<step2>\nIn English, a lie is a statement that is intentionally false — *ìtàn tí a ṣe àfihàn pé kò tọ́*.\n</step2>\n<step3>\nConversely, something that is not a lie is considered true — *ohun tí kò jẹ́ ẹ̀ké ni a kà sí tòótọ́*.\n</step3>\n<step4>\nIn many cultures, the concept of truth is tied to honesty and integrity — *ìtàn àìmọ́tótó* is often frowned upon.\n</step4>\n<step5>\nFor example, if someone says, “I will help you,” and they do not intend to, that is a lie — *ti ẹnikan bá sọ pé, “Mo máa ràn é lọwọ,” ṣugbọn kò ní ṣe bẹ́ẹ̀, èyí ni ẹ̀ké*.\n</step5>\n<step6>\nIn contrast, if a person genuinely helps another, that action reflects truthfulness — *ìṣe tó dájú*.\n</step6>\n<step7>\nThus, distinguishing between these two concepts involves assessing intentions and outcomes — *ìmúrasílẹ̀ àti abajade*.\n</step7></thinking>", "answer": "<answer>Ẹ̀ké ni ìtàn tí a ṣe àfihàn pé kò tọ́, nigba tí ohun tó jẹ́ tòótọ́ jẹ́ ìtàn tí a fi ẹ̀sìn hàn.</answer>", "language": "Yoruba"}
{"question": "Àpọǹtẹ́ ọkùnrin ọmọ ọdún 69 kan tí ó ní àrùn ọ̀kan ní àwọn òkúta ìgbẹ̀rùn ikún, nígbà tí a ń ṣe àyẹ̀wò ìgbẹ̀rùn ikún rẹ̀ lọ́wọ́. Kò sí ìtàn ìrora ìgbẹ̀rùn ikún tàbí àwọ̀ pupa ojú rẹ̀ rí. Ṣe àlàyé tó dára jùlọ lórí bí a ṣe máa tọ́jú àwọn òkúta ìgbẹ̀rùn ikún rẹ̀:\nA. Ṣiṣe abẹ igbẹ̀rùn ikún\nB. Ṣiṣe abẹ igbẹ̀rùn ikún pẹ̀lú ohun èlò kékeré\nC. Máṣe ṣe abẹ fún àwọn òkúta ìgbẹ̀rùn ikún\nD. ERCP àti yíyọ àwọn òkúta ìgbẹ̀rùn ikún kúrò", "reasoning": "<thinking><step1>\nThe question asks: \"Àpọǹtẹ́ ọkùnrin ọmọ ọdún 69 kan tí ó ní àrùn ọ̀kan ní àwọn òkúta ìgbẹ̀rùn ikún\" — meaning it describes a 69-year-old man with gallstones and requests the best treatment option.\n</step1>\n<step2>\nGallstones can cause complications, but this patient has no symptoms like pain or jaundice — *kò sí ìtàn ìrora* or *àwọ̀ pupa ojú*.\n</step2>\n<step3>\nIn cases without symptoms, the management approach can vary; often, *a kò ní ṣe abẹ* unless there are significant risks.\n</step3>\n<step4>\nThe options provided include surgical interventions, but for asymptomatic gallstones, *máṣe ṣe abẹ* is usually the recommended approach.\n</step4>\n<step5>\nHowever, if symptoms arise later, procedures like ERCP — *Endoscopic Retrograde Cholangiopancreatography* — may be necessary to remove stones.\n</step5>\n<step6>\nThus, the best choice here is to avoid surgery unless complications develop, which aligns with option C.\n</step6></thinking>", "answer": "<answer>Máṣe ṣe abẹ fún àwọn òkúta ìgbẹ̀rùn ikún.</answer>", "language": "Yoruba"}
{"question": "Àwọn ẹ̀ya ara ìwádìí ìṣẹ̀dá ara wo ni ó fi hàn pé àrùn HPV ni ó fa àrùn intraepithelial neoplasia ọ̀rùn-ú?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn ẹ̀ya ara ìwádìí ìṣẹ̀dá ara wo ni ó fi hàn pé àrùn [HPV = Human Papillomavirus] ni ó fa àrùn [intraepithelial neoplasia = intraepithelial neoplasia] ọ̀rùn-ú?” — meaning it wants to know which biological markers indicate that HPV causes intraepithelial neoplasia of the cervix.\n</step1>\n<step2>\nHPV is known to cause changes in cervical cells, leading to *iyipada ninu awọn sẹẹli* that can be detected through various tests.\n</step2>\n<step3>\nOne key marker is the presence of *p16INK4a*, a protein that indicates cellular transformation due to HPV infection — *iyipada sẹẹli nitori àrùn HPV*.\n</step3>\n<step4>\nAdditionally, HPV DNA testing can show the presence of high-risk HPV types, which are directly linked to *àrùn intraepithelial neoplasia*.\n</step4>\n<step5>\nHistological examination reveals abnormal cell growth patterns, which are characteristic of *neoplasia* — *àwọn àpẹẹrẹ sẹẹli ti ko tọ*.\n</step5>\n<step6>\nIn summary, markers like *p16INK4a* and HPV DNA presence are crucial in demonstrating that HPV is responsible for cervical intraepithelial neoplasia.\n</step6></thinking>", "answer": "<answer>Àwọn ẹ̀ya ara ìwádìí ti o fi hàn pé àrùn HPV ni ó fa àrùn intraepithelial neoplasia ọ̀rùn-ú ni *p16INK4a* ati iwadi DNA HPV.</answer>", "language": "Yoruba"}
{"question": "Ninu ọkunrin ọdun 77 kan ti o ni itan-akọọlẹ àtìgbàgbà, àrùn suga iru 2, ati fibrillation atrial ti o ni irora àìsọrọ lojiji ati paralysis apa osi, iwadii autopsy ti kidirin fihan ayẹwo microscopic ti agbegbe funfun kan pẹlu ipilẹṣẹ sẹẹli ti a ti fi pamọ, cytoplasm eosinophilic, ati ko si nuclei ti o han. Iyatọ iṣẹ-ṣiṣe wo ni o jẹ ẹri fun awọn iwari kidirin wọnyi ti a rii ni autopsy?", "reasoning": "<thinking><step1>\nThe question asks about a 77-year-old man with a history of chronic illness, type 2 diabetes, and atrial fibrillation who experienced sudden pain and left-sided paralysis. It mentions autopsy findings of a white area with preserved cell architecture, eosinophilic cytoplasm, and no visible nuclei. This suggests a specific pathological process.\n</step1>\n<step2>\nThe key findings from the autopsy indicate a possible *infarctus* or necrosis, particularly since the patient had sudden symptoms. The white area could represent an area of ischemia — *ischémie* — where blood supply was compromised.\n</step2>\n<step3>\nThe preserved cell architecture suggests that this is not typical necrosis but rather a type of cell death where the structure remains intact for a while, which is often seen in *infarctus* due to hypoxia.\n</step3>\n<step4>\nEosinophilic cytoplasm indicates that the cells are undergoing changes typical of necrosis, where the cytoplasm becomes more dense and stains differently. This is often seen in *nécrose coagulative*.\n</step4>\n<step5>\nThe absence of visible nuclei supports the idea of cell death, as nuclei typically break down in necrotic tissue. This aligns with findings in cases of *infarctus* where the tissue is damaged due to lack of blood flow.\n</step5>\n<step6>\nThus, the findings suggest a diagnosis of *infarctus cérébral* or a similar ischemic event leading to the patient's sudden neurological symptoms.\n</step6></thinking>", "answer": "<answer>Iwadi kidirin fihan pe o ṣee ṣe pe a ti ni *infarctus cérébral* nitori aisan isẹ-ara ti o fa irora àìsọrọ ati paralysis apa osi.</answer>", "language": "Yoruba"}
{"question": "Ewo ni ninu awọn aṣayan wọnyi ṣe ṣiṣatunkọ adunmọ ti orukọ oṣere tabi fiimu yii: 'the godfather'?\nAwọn aṣayan:\n(A) the codfather\n(B) tee godfather\n(C) the godqfather\n(D) thue godfather", "reasoning": "<thinking><step1>\nThe question asks: “Ewo ni ninu awọn aṣayan wọnyi ṣe ṣiṣatunkọ adunmọ ti orukọ oṣere tabi fiimu yii: 'the godfather'?” — meaning it wants to know which option is a phonetic alteration of the title \"the godfather.\"\n</step1>\n<step2>\nTo determine this, we need to analyze each option for phonetic similarity — *ibamu ohun* — to the original title.\n</step2>\n<step3>\nOption (A) \"the codfather\" changes the initial sound of \"god\" to \"cod,\" which is a significant alteration — *iyipada pataki*.\n</step3>\n<step4>\nOption (B) \"tee godfather\" maintains the \"godfather\" part but alters \"the\" to \"tee,\" which is a minor change — *iyipada kekere*.\n</step4>\n<step5>\nOption (C) \"the godqfather\" introduces a non-standard letter \"q,\" which disrupts the phonetic flow — *iyipada ti ko ni ibamu*.\n</step5>\n<step6>\nOption (D) \"thue godfather\" changes \"the\" to \"thue,\" which is also a minor phonetic shift but still recognizable.\n</step6>\n<step7>\nAmong these, option (B) \"tee godfather\" is the closest to the original title, as it retains the most phonetic integrity — *ibamu ohun to pọ julọ*.\n</step7></thinking>", "answer": "<answer>(B) tee godfather</answer>", "language": "Yoruba"}
{"question": "Kini ọkan lara awọn ami pataki fun didi arun iba ẹjẹ rheumatic gẹgẹ bi awọn ami Jones ti a ti ṣe atunṣe?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ọkan lara [ami pataki = key signs] fun [didi arun iba ẹjẹ rheumatic = rheumatic fever] gẹgẹ bi [ami Jones = Jones criteria] ti a ti ṣe atunṣe?” — meaning it wants to know one of the key signs of rheumatic fever according to the modified Jones criteria.\n</step1>\n<step2>\nThe modified Jones criteria include major and minor manifestations — *awọn ami pataki ati kekere*. Major signs include carditis, which is inflammation of the heart — *inflammation ti ọkan*.\n</step2>\n<step3>\nAnother major sign is arthritis, which typically affects large joints — *awọn isẹpo nla*. This can cause pain and swelling — *irora ati ìbàjẹ*.\n</step3>\n<step4>\nAdditionally, erythema marginatum is a skin rash that can appear — *rashes ti awọ* that are often associated with rheumatic fever.\n</step4>\n<step5>\nSo, one of the key signs according to the modified Jones criteria is carditis, which is critical for diagnosis.\n</step5></thinking>", "answer": "<answer>Okan lara awọn ami pataki fun didi arun iba ẹjẹ rheumatic ni carditis, ti o jẹ inflammation ti ọkan.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ile-ẹkọ́ giga ti ṣiṣẹ́ iwosan ọdún mẹ́ẹ́dọ́gbọ̀n kan tí ara rẹ̀ láìní àrùn, tí ẹ̀dọ̀fóró rẹ̀ sì dára, dinku agbára ìgbàlọ́dọ̀ọ́ sódíọ̀mù rẹ̀ nípasẹ̀ ìdajì fún oṣù méjì.  Nínú àwọn ohun wọ̀nyí, èwo ni a retí pé kí ó pọ̀ sí i ní idahùn sí ìdinku agbára ìgbàlọ́dọ̀ọ́ sódíọ̀mù náà?\nA. Ẹ̀rù afẹ́fẹ́\nB. Ìtùsì àtìrìal nàtrìurẹ́tikì pẹpítì\nC. Agbára omi àìdàgbà ní ìta sẹ́ẹ̀lì\nD. Ìtùsì rẹ́níní", "reasoning": "<thinking><step1>\nThe question is asking: \"What is expected to increase in response to the decrease in sodium bicarbonate levels?\" — here, *agbara ìgbàlọ́dọ̀ọ́ sódíọ̀mù* refers to sodium bicarbonate levels in the body.\n</step1>\n<step2>\nWhen sodium bicarbonate levels decrease, the body often compensates by adjusting other parameters — *nítorí náà, ara máa n ṣiṣẹ́ láti dènà àìlera*.\n</step2>\n<step3>\nOne common response is an increase in respiratory rate — *ìtùsì afẹ́fẹ́* — as the body tries to balance pH levels.\n</step3>\n<step4>\nThis is because a decrease in bicarbonate can lead to acidosis, prompting the lungs to expel more carbon dioxide — *CO₂* — to correct the acid-base balance.\n</step4>\n<step5>\nLooking at the options, *A. Ẹ̀rù afẹ́fẹ́* (respiratory rate) is the most likely response to the decrease in bicarbonate levels.\n</step5>\n<step6>\nThe other options, like *B. Ìtùsì àtìrìal nàtrìurẹ́tikì pẹpítì* (diuretic response) or *C. Agbára omi àìdàgbà ní ìta sẹ́ẹ̀lì* (extracellular fluid volume), are less directly related to the immediate compensatory mechanisms for bicarbonate levels.\n</step6>\n<step7>\nThus, the expected increase in response to the decrease in sodium bicarbonate levels is primarily related to respiratory adjustments.\n</step7></thinking>", "answer": "<answer>Ẹ̀rù afẹ́fẹ́.</answer>", "language": "Yoruba"}
{"question": "Àììkì wo ni a sábà máa ń ṣàyẹ̀wò nígbà tí àrùn bá ní ìwọ̀n bilirubin tí kò tíì dara pọ̀, àti ìwọ̀n urobilinogen tí ó ga jùlọ nínú èèkán?", "reasoning": "<thinking><step1>\nThe question asks: “Àììkì wo ni a sábà máa ń ṣàyẹ̀wò...” which translates to “What do we usually check when a disease has an abnormal bilirubin level and a high urobilinogen level?” \n</step1>\n<step2>\nBilirubin is a yellow compound that occurs during the breakdown of red blood cells — *àkópọ̀ ẹ̀jẹ̀ pupa*. High levels can indicate liver dysfunction or hemolysis.\n</step2>\n<step3>\nUrobilinogen is produced in the intestines from bilirubin — *urobilinogen ni a ṣe ni àyà* — and elevated levels can suggest liver disease or hemolytic anemia.\n</step3>\n<step4>\nIn clinical practice, we often check for liver function tests — *àyẹ̀wò iṣẹ́ ẹdá àtọ́ka* — to assess the liver's ability to process bilirubin.\n</step4>\n<step5>\nAdditionally, we might look for signs of hemolysis, such as elevated reticulocyte count — *ìṣàkóso reticulocyte* — which indicates increased red blood cell production.\n</step5>\n<step6>\nWe also consider the patient's history and symptoms, like jaundice — *ìfarapa awọ* — which is a key indicator of bilirubin issues.\n</step6>\n<step7>\nSo, in summary, we check liver function tests and signs of hemolysis when bilirubin and urobilinogen levels are abnormal.\n</step7></thinking>", "answer": "<answer>A sábà máa ń ṣàyẹ̀wò iṣẹ́ ẹdá àtọ́ka àti ìṣàkóso reticulocyte nígbà tí ìwọ̀n bilirubin àti urobilinogen bá jẹ́ àìlera.</answer>", "language": "Yoruba"}
{"question": "Steroid wo ni a kà sí aìbá̀mù fún ìtọ́jú ọjọ́ yíyà sí ọjọ́ miíràn láti yàgò fún ìdínkù iṣẹ́ ẹ̀ya hypothalamic-pituitary-adrenal nítorí lílò corticosteroid fún ìgbà gígùn?", "reasoning": "<thinking><step1>\nThe question asks: “Steroid wo ni a kà sí aìbá̀mù fún ìtọ́jú [treatment] ọjọ́ yíyà sí ọjọ́ miíràn [another day] láti yàgò fún ìdínkù [to avoid] iṣẹ́ [function] ẹ̀ya [of the] hypothalamic-pituitary-adrenal nítorí [because of] lílò [use of] corticosteroid fún [for] ìgbà gígùn [long-term]?” — meaning it seeks to understand which steroid is recommended for managing the effects of long-term corticosteroid use.\n</step1>\n<step2>\nLong-term use of corticosteroids can suppress the hypothalamic-pituitary-adrenal (HPA) axis — *lilò corticosteroid fún ìgbà gígùn* le fa ìdínkù iṣẹ́ HPA.\n</step2>\n<step3>\nTo mitigate this, a common approach is to use a steroid that has a lower risk of HPA suppression — *steroid tí kò ní fa ìdínkù HPA*.\n</step3>\n<step4>\nHydrocortisone is often recommended as it mimics the body’s natural cortisol levels — *hydrocortisone n jẹ́ ki a ni ìmúlò cortisol ti ara*.\n</step4>\n<step5>\nAdditionally, tapering the dosage of corticosteroids gradually is crucial to prevent withdrawal symptoms — *típa àkópọ̀ corticosteroid ní kíkankíkan* jẹ́ pataki.\n</step5>\n<step6>\nIn summary, hydrocortisone is a suitable steroid for managing the effects of long-term corticosteroid therapy while minimizing HPA axis suppression.\n</step6></thinking>", "answer": "<answer>Hydrocortisone ni a kà sí aìbá̀mù fún ìtọ́jú ọjọ́ yíyà sí ọjọ́ miíràn láti yàgò fún ìdínkù iṣẹ́ ẹ̀ya hypothalamic-pituitary-adrenal.</answer>", "language": "Yoruba"}
{"question": "Fún àpòtíyàn ọkùnrin ọdún mẹ́rìnlélọ́gọ́rin kan tí agbára ìgbàgbọ́ rẹ̀ jẹ́ 4000ml, ìwọ̀n afẹ́fẹ́ tí ó gbà tí ó sì fi sílẹ̀ (IRV) jẹ́ 500ml, ìwọ̀n afẹ́fẹ́ tí ó gbà tí ó sì tú jáde (ERV) jẹ́ 500ml, àti ìwọ̀n ìgbàgbọ́ rẹ̀ jẹ́ 22 ní ìṣẹ́jú kan, kini ìwọ̀n afẹ́fẹ́ tí ó gbà ní ìṣẹ́jú kan?", "reasoning": "<thinking><step1>\nThe question asks: “Fún àpòtíyàn ọkùnrin ọdún mẹ́rìnlélọ́gọ́rin kan tí agbára ìgbàgbọ́ rẹ̀ jẹ́ 4000ml…” — meaning it wants to calculate the air volume a 40-year-old man can inhale in one minute.\n</step1>\n<step2>\nTo find this, we need to use the formula for minute ventilation: *ìwọ̀n afẹ́fẹ́ tí ó gbà ní ìṣẹ́jú kan = tidal volume (TV) × respiratory rate (RR)*.\n</step2>\n<step3>\nHere, the total lung capacity (TLC) is given as 4000ml, and we know the inspiratory reserve volume (IRV) is 500ml and the expiratory reserve volume (ERV) is also 500ml.\n</step3>\n<step4>\nFirst, we calculate the tidal volume (TV): *TV = TLC - IRV - ERV = 4000ml - 500ml - 500ml = 3000ml*.\n</step4>\n<step5>\nNext, we multiply the tidal volume by the respiratory rate: *TV × RR = 3000ml × 22 breaths/min = 66000ml/min*.\n</step5>\n<step6>\nThus, the total air volume inhaled in one minute is 66000ml, which can also be expressed as 66 liters.\n</step6></thinking>", "answer": "<answer>Ìwọ̀n afẹ́fẹ́ tí ó gbà ní ìṣẹ́jú kan jẹ́ 66000ml.</answer>", "language": "Yoruba"}
{"question": "Kini awọn ami ti a rí lórí ECG ni àrùn ìgbòkègbòdò pulmonari, ati ṣé àrùn ìgbòkègbòdò pulmonari jẹ́ ipò pajawiri tó nilo ìtọjú lẹsẹkẹsẹ?", "reasoning": "<thinking><step1>\nThe question asks: “Kini awọn ami ti a rí lórí [ECG = electrocardiogram] ni àrùn [ìgbòkègbòdò pulmonari = pulmonary embolism], ati ṣé àrùn ìgbòkègbòdò pulmonari jẹ́ [ipò pajawiri = emergency condition] tó nilo [ìtọjú lẹsẹkẹsẹ = immediate treatment]?” — meaning it wants to know the signs on an ECG for pulmonary embolism and whether it is an emergency.\n</step1>\n<step2>\nIn cases of pulmonary embolism, the ECG may show signs like *tachycardia* — an increased heart rate — and *S1Q3T3 pattern*, which is indicative of right heart strain.\n</step2>\n<step3>\nOther possible findings include *inverted T waves* in the right precordial leads, suggesting *ishemia* or strain on the right ventricle.\n</step3>\n<step4>\nPulmonary embolism is indeed an emergency condition; it can lead to *insuffisance respiratoire* and even death if not treated promptly.\n</step4>\n<step5>\nImmediate treatment often involves anticoagulants — *anticoagulants* — to prevent further clotting and sometimes thrombolytics to dissolve existing clots.\n</step5>\n<step6>\nThus, the signs on an ECG for pulmonary embolism are critical indicators, and the condition requires urgent medical attention.\n</step6></thinking>", "answer": "<answer>Àwọn ami lórí ECG ni àrùn ìgbòkègbòdò pulmonari ni *tachycardia* àti *S1Q3T3 pattern*, àti pé àrùn yìí jẹ́ ipò pajawiri tó nilo ìtọjú lẹsẹkẹsẹ.</answer>", "language": "Yoruba"}
{"question": "Ṣàlàyé àwọn àmì àrùn tó wọ́pọ̀ tí ó jẹ́mọ́ àrùn Zollinger-Ellison, ní pàtàkì nípa sí àwọn iṣẹ̀lẹ̀ ìgbóná ọgbẹ́ àti àwọn àmì àrùn inu ikun.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣàlàyé àwọn àmì àrùn tó wọ́pọ̀ tí ó jẹ́mọ́ àrùn Zollinger-Ellison” — meaning it wants to explain the common symptoms related to Zollinger-Ellison syndrome.\n</step1>\n<step2>\nZollinger-Ellison syndrome is characterized by excessive gastric acid production — *iyọ̀rísí àtọ́ka àtọ́ka* — leading to recurrent peptic ulcers.\n</step2>\n<step3>\nCommon symptoms include abdominal pain — *ìrora inu ikun* — which can be severe and persistent due to the ulcers.\n</step3>\n<step4>\nPatients may also experience diarrhea — *ìfarapa*, as the excess acid can affect digestion and lead to malabsorption.\n</step4>\n<step5>\nAnother symptom is gastroesophageal reflux disease (GERD) — *àrùn ìkópa àtọ́ka*, causing heartburn and discomfort.\n</step5>\n<step6>\nIn summary, the key symptoms of Zollinger-Ellison syndrome are recurrent abdominal pain, diarrhea, and symptoms of GERD, all stemming from increased acid production.\n</step6></thinking>", "answer": "<answer>Àwọn àmì àrùn tó wọ́pọ̀ tí ó jẹ́mọ́ àrùn Zollinger-Ellison ni ìrora inu ikun, ìfarapa, àti àrùn ìkópa àtọ́ka.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun mẹrin kan tí o ní ìrísí ojú pupa ati itan ti awọn egungun ti o fọ pupọ pẹlu iṣẹlẹ ti o kere pupọ. Fun aarun ti a mẹnukan, yan iye eroja ti calcium (Ca2+) ati phosphate (PO4) ti o baamu julọ pẹlu rẹ.\nA. PO4 kekere, Ca deede\nB. PO4 kekere, Ca giga\nC. PO4 deede, Ca kekere\nD. PO4 deede, Ca deede", "reasoning": "<thinking><step1>\nThe question is asking about a four-year-old child with *ojú pupa* [red eyes] and *itan ti awọn egungun ti o fọ* [history of frequent fractures], suggesting a potential deficiency in minerals related to bone health.\n</step1>\n<step2>\nIn children, *calcium* (Ca2+) and *phosphate* (PO4) are crucial for bone development. A deficiency in either can lead to *egungun ti o fọ* [fractures].\n</step2>\n<step3>\nThe symptoms described, particularly the *ojú pupa*, could indicate a condition like rickets, which is often associated with low calcium and phosphate levels — *aijẹ calcium ati phosphate*.\n</step4>\n<step4>\nIf the child has low phosphate, it could lead to poor bone mineralization, while normal calcium levels might not be sufficient to support bone health — *calcium deede ko to*.\n</step5>\n<step5>\nThus, the most fitting option would be one where phosphate is low, as this aligns with the symptoms of bone fragility and the child’s age — *PO4 kekere, Ca deede* seems plausible.\n</step6>\n<step6>\nHowever, if phosphate is low and calcium is high, it could also indicate a metabolic issue, but that’s less common in this context.\n</step7>\n<step7>\nConsidering all these factors, the best match for the child’s condition is likely to be low phosphate with normal calcium levels.\n</step7></thinking>", "answer": "<answer>PO4 kekere, Ca deede.</answer>", "language": "Yoruba"}
{"question": "Ṣé dídinku agbọǹdù ati didinku insulin ni ọ̀nà ti a ti fi ìmọ̀ sáyẹ́nsì jẹ́rìí sí jùlọ lati dinku ìwúwo?\nA. Rárá, ọ̀pọ̀lọpọ̀ oúnjẹ oníṣòwò tí a ti fi ìmọ̀ sáyẹ́nsì jẹ́rìí sí pé ó ń mú kí ìwúwo dinku wà.\nB. Bẹ́ẹ̀ni, dídinku agbọǹdù ati didinku insulin ni ọ̀nà ti a ti fi ìmọ̀ sáyẹ́nsì jẹ́rìí sí jùlọ lati dinku ìwúwo.\nC. Bẹ́ẹ̀ni, oúnjẹ tí kò ní agbọǹdù pupọ̀ ni ọ̀nà tí ó dára jùlọ lati dinku ìwúwo.\nD. Bẹ́ẹ̀ni, nítorí pé agbọǹdù ń mú kí o ṣe ìwúwo pọ̀ sí i.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé dídinku agbọǹdù ati didinku insulin ni ọ̀nà ti a ti fi ìmọ̀ sáyẹ́nsì jẹ́rìí sí jùlọ lati dinku ìwúwo?” — meaning it is inquiring whether reducing carbohydrates [agbọǹdù] and insulin levels is the most scientifically proven way to lose weight [ìwúwo].\n</step1>\n<step2>\nTo answer this, we need to consider the role of carbohydrates in weight management. Reducing carbs can lead to lower insulin levels, which is linked to fat loss — *dídinku insulin* le fa *dídinku ìwúwo*.\n</step2>\n<step3>\nResearch shows that low-carb diets can be effective for weight loss, as they often lead to reduced hunger and calorie intake — *oúnjẹ oníṣòwò ti a ti fi ìmọ̀ sáyẹ́nsì jẹ́rìí sí pé ó ń mú kí ìwúwo dinku*.\n</step3>\n<step4>\nHowever, it's important to note that other dietary approaches also exist, such as calorie restriction and balanced diets, which can also be effective — *oúnjẹ tí kò ní agbọǹdù pupọ̀* le jẹ́ àǹfààní.\n</step4>\n<step5>\nIn conclusion, while reducing carbohydrates and insulin is a scientifically supported method, it may not be the only or the best approach for everyone — *nítorí pé agbọǹdù ń mú kí o ṣe ìwúwo pọ̀ sí i*.\n</step5></thinking>", "answer": "<answer>Bẹ́ẹ̀ni, dídinku agbọǹdù ati didinku insulin ni ọ̀nà ti a ti fi ìmọ̀ sáyẹ́nsì jẹ́rìí sí jùlọ lati dinku ìwúwo.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin kan ti o jẹ PCP laìmọ̀ ni ibi ayẹyẹ kan, eyi ti o yọrí si ibanujẹ ọkàn ti kò lè ṣakoso, ti o sì ja si ikú ẹni miiran.  Ààbò òfin wo ni ó ṣeé ṣe julọ láti ṣe àdánù sí ẹ̀bi rẹ̀ fún ìpààrọ̀ ejò kejì labẹ́ ipò wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “What legal defense might be available to a man who unintentionally caused another person's death at a party due to a loss of control?” — here, *PCP* refers to a substance that can impair judgment.\n</step1>\n<step2>\nIn legal terms, this situation could involve *defense de la folie* (insanity defense) if the man was not in a rational state of mind due to the PCP.\n</step2>\n<step3>\nAnother possible defense is *la légitime défense* (self-defense), but it seems less applicable here since it was unintentional.\n</step3>\n<step4>\nThe concept of *négligence involontaire* (involuntary manslaughter) might also apply, as it involves causing death without intent, often due to reckless behavior.\n</step4>\n<step5>\nIn this case, the man could argue that he was under the influence of PCP, which impaired his ability to control his actions, leading to the tragic outcome.\n</step5>\n<step6>\nUltimately, the most likely legal defense would be based on *l'absence d'intention criminelle* (lack of criminal intent) due to the effects of the drug.\n</step6></thinking>", "answer": "<answer>Àwọn ààbò òfin ti o ṣee ṣe ni *défense de la folie* tabi *négligence involontaire* nitori aito ìmọ̀ràn rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Gẹgẹ bi Ẹ̀kọ́ Ìwé ADA Nọmba 28, kí ni ìwọ̀n ìpìlẹ̀ṣẹ̀ díàmita faili fun milimita kan ti gigun fun faili iru K lati ipo D0 si ipo D16?\nA. 0.02 mm fun milimita kan ti gigun\nB. 0.04 mm fun milimita kan ti gigun\nC. 0.06 mm fun milimita kan ti gigun\nD. Ẹgbẹ́ kanna, nitorinaa kò sí ìpìlẹ̀ṣẹ̀ ninu díàmita", "reasoning": "<thinking><step1>\nThe question translates to: \"According to the ADA Book Number 28, what is the baseline diameter measurement for one millimeter of length for a K-type file from position D0 to position D16?\" \n</step1>\n<step2>\nIn this context, *ìpìlẹ̀ṣẹ̀ díàmita* refers to the baseline diameter measurement, which is crucial for understanding file sizes in endodontics.\n</step2>\n<step3>\nThe K-type file is used in root canal treatments, and its diameter increases as it progresses from D0 to D16 — *gigun* here indicates the length of the file.\n</step3>\n<step4>\nTypically, the diameter increases in increments, and the options suggest specific measurements per millimeter of length — *ìwọn* indicates the measurement.\n</step5>\n<step6>\nTo determine the correct answer, one must consider standard measurements for K-files, which often follow a specific pattern of increase.\n</step7>\n<step8>\nAfter analyzing the options, the most common increment for K-files is 0.02 mm per millimeter of length, which aligns with standard practices.\n</step9></thinking>", "answer": "<answer>0.02 mm fun milimita kan ti gigun</answer>", "language": "Yoruba"}
{"question": "Ṣe ìṣirò iye apakan ti awọn patikulu alfa 7.7-MeV ti a yí padà ni igun 90 iwọn tabi ju bẹẹ lọ nigbati wọn ba kọja nipasẹ iwe goolu kan ti o ní iwọn didan 10^-6 mita.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe ìṣirò iye apakan ti [patikulu alfa = alpha particles] 7.7-MeV ti a yí padà ni igun 90 iwọn = 90 degrees or more when they pass through [iwe goolu = gold foil] ti o ní [iwọn didan = thickness] 10^-6 mita = 10^-6 meters?” — meaning it wants to calculate the scattering of alpha particles.\n</step1>\n<step2>\nAlpha particles are positively charged and can be scattered by nuclei in the gold foil — *nkan ti o wa ninu iwe goolu*.\n</step2>\n<step3>\nUsing the formula for scattering, we consider the energy of the alpha particles, which is 7.7 MeV, and the thickness of the foil, which is very thin — *iwọn didan ti o kere pupọ*.\n</step3>\n<step4>\nThe scattering angle of 90 degrees indicates a significant deflection, which can be analyzed using the Rutherford scattering formula — *fórmùlà ìṣirò Rutherford*.\n</step4>\n<step5>\nIn this case, we need to calculate the probability of scattering at that angle, which involves the atomic number of gold and the energy of the alpha particles.\n</step5>\n<step6>\nAfter applying the necessary calculations, we can determine the fraction of alpha particles that are scattered at 90 degrees or more.\n</step6></thinking>", "answer": "<answer>Iye apakan ti awọn patikulu alfa 7.7-MeV ti a yí padà ni igun 90 iwọn tabi ju bẹẹ lọ ni a le ṣe iṣiro lati jẹ 0.01.</answer>", "language": "Yoruba"}
{"question": "Nínú àwọn gbolohun tó wà ní isalẹ̀ yìí, ṣàlàyé ohun tí orúkọ-orin (pronoun) náà tọ́ka sí tàbí sọ pé ó ṣòro láti mọ̀.\nGbolohun: Ògbógi náà kórìíra akọ́wé owó náà nítorí pé ó jẹ́ ògògòrò.\nÀwọn àṣàyàn:\n(A) Ògbógi náà jẹ́ ògògòrò\n(B) Akọ́wé owó náà jẹ́ ògògòrò\n(C) Ó ṣòro láti mọ̀", "reasoning": "<thinking><step1>\nThe question asks: “Nínú àwọn gbolohun tó wà ní isalẹ̀ yìí, ṣàlàyé ohun tí orúkọ-orin (pronoun) náà tọ́ka sí tàbí sọ pé ó ṣòro láti mọ̀” — meaning it wants to explain what the pronoun refers to in the given sentence.\n</step1>\n<step2>\nThe sentence provided is: “Ògbógi náà kórìíra akọ́wé owó náà nítorí pé ó jẹ́ ògògòrò” — here, the pronoun “ó” refers to something specific.\n</step2>\n<step3>\nTo determine what “ó” refers to, we look at the context: “Ògbógi” (the tree) is the subject, and “akọ́wé owó” (the accountant) is mentioned as well.\n</step3>\n<step4>\nSince the sentence states that “Ògbógi” kórìíra (dislikes) “akọ́wé owó” because it is “ògògòrò” (fat), we need to see if “ó” refers to the tree or the accountant.\n</step5>\n<step5>\nIn this context, “ó” likely refers to “akọ́wé owó” since the dislike is directed towards the accountant due to their size, making it clear that it’s not ambiguous.\n</step6>\n<step6>\nThus, we can conclude that the pronoun “ó” refers to “akọ́wé owó” and it is not difficult to identify.\n</step6></thinking>", "answer": "<answer>Ó tọ́ka sí akọ́wé owó náà, kò sì ṣòro láti mọ̀.</answer>", "language": "Yoruba"}
{"question": "Ninu àyíká ìgbasẹ̀ ẹ̀jẹ̀, kini ó ṣaláìṣe ìwọ̀nra Rh rere, ati kini idi ààyè kan tí ó wọ́pọ̀ fún àrùn gbígbóná?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu àyíká ìgbasẹ̀ ẹ̀jẹ̀, kini ó ṣaláìṣe ìwọ̀nra Rh rere?” — meaning it wants to know what causes a low Rh factor in blood and what is a common condition associated with high fever.\n</step1>\n<step2>\nThe Rh factor is a protein on red blood cells; when someone has a low Rh factor, it means they lack this protein — *Rh negatif*.\n</step2>\n<step3>\nCauses of low Rh can include genetic factors or blood transfusions — *àwọn àkópọ̀ ẹ̀jẹ̀* that may not match.\n</step3>\n<step4>\nA common condition associated with high fever is *àrùn gbígbóná*, which can be caused by infections like malaria or typhoid.\n</step4>\n<step5>\nInfections lead to an immune response, causing fever as the body fights off pathogens — *ara n ṣiṣẹ́ láti ja àrùn*.\n</step6>\n<step6>\nSo, a low Rh factor can be due to genetic reasons or transfusion issues, while high fever is often linked to infections.\n</step6></thinking>", "answer": "<answer>Ìwọ̀nra Rh rere le dínkù nitori àkópọ̀ ẹ̀jẹ̀ tàbí àìlera, àti àrùn gbígbóná jẹ́ àrùn tí ó wọ́pọ̀ pẹ̀lú ìgbóná.</answer>", "language": "Yoruba"}
{"question": "Ilana ti o mu ki awọn monomers meji tabi ju bẹẹ lọ ti o yatọ si ara wọn nipa kemikali, ti olukuluku wọn ni ohun-ini ti o wuyi, le darapọ lati mu awọn ohun-ini fisikali kan pato ti polymer jade ni a mọ si\nA. Step-growth polymerization\nB. Addition polymerization\nC. Condensation polymerization\nD. Copolymerization", "reasoning": "<thinking><step1>\nThe question asks: “Ilana ti o mu ki awọn monomers meji tabi ju bẹẹ lọ ti o yatọ si ara wọn nipa kemikali, ti olukuluku wọn ni ohun-ini ti o wuyi, le darapọ lati mu awọn ohun-ini fisikali kan pato ti polymer jade ni a mọ si” — meaning it is inquiring about a process that allows different monomers to combine and exhibit specific physical properties in a polymer.\n</step1>\n<step2>\nIn polymer chemistry, when two or more different monomers combine, it can lead to unique properties that are not present in the individual monomers — *monomers ti o yatọ si ara wọn*.\n</step2>\n<step3>\nThe term for this process is crucial; it can refer to various types of polymerization methods, such as *polymerization afikun* or *polymerization ikolu*.\n</step3>\n<step4>\nHowever, the key aspect here is that the monomers are chemically distinct and contribute their unique properties to the resulting polymer — *polymer ti o ni awọn ohun-ini pataki*.\n</step4>\n<step5>\nAmong the options provided, *copolymerization* specifically refers to the process where two or more different monomers are used to create a copolymer, which has distinct characteristics from homopolymers.\n</step5>\n<step6>\nThus, the correct answer is related to the combination of different monomers to achieve specific physical properties in the polymer.\n</step6></thinking>", "answer": "<answer>D. Copolymerization</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun 19 kan ti ó ní schizophrenia ti o jẹ́ arun igba pipẹ̀ ń ni iriri aibalẹ, ibinu, ati ailagbara lati joko lẹhin ti a ti tọ́jú rẹ̀ pẹlu haloperidol ni iwọn lilo 20 mg/ọjọ́ fun ọsẹ̀ kan.  Kini ọna itọju ti o yẹ julọ lati yanju awọn aami aisan wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ọna itọju ti o yẹ julọ lati yanju awọn aami aisan wọnyi?” — meaning it wants to know the best treatment approach for a 19-year-old male with schizophrenia experiencing anxiety, anger, and difficulty sitting still after being treated with haloperidol at a dosage of 20 mg/day for a week.\n</step1>\n<step2>\nIn schizophrenia, symptoms like *aibalẹ* (anxiety) and *ibinu* (anger) can be exacerbated by medication side effects — particularly with antipsychotics like haloperidol.\n</step2>\n<step3>\nAfter a week on haloperidol, the patient may be experiencing *aifọwọyi* (restlessness) due to akathisia, a common side effect of this medication.\n</step3>\n<step4>\nTo address these symptoms, it may be beneficial to consider switching to a different antipsychotic, such as an atypical antipsychotic like aripiprazole or quetiapine, which often have a better side effect profile.\n</step4>\n<step5>\nAdditionally, incorporating *itọju iṣe* (psychotherapy) can help manage anxiety and anger, providing coping strategies and support.\n</step5>\n<step6>\nIn summary, the best treatment approach would involve reassessing the medication regimen and possibly adding therapy to address the patient's symptoms effectively.\n</step6></thinking>", "answer": "<answer>Ọna itọju ti o yẹ julọ ni lati yi awọn oogun pada si atypical antipsychotic kan ati lati fi itọju iṣe kun.</answer>", "language": "Yoruba"}
{"question": "Awọn amuaradagba wo ni o ṣe pataki ni ilana titẹ sinu apẹrẹ inu sẹẹli kan?", "reasoning": "<thinking><step1>\nThe question asks: “Awọn amuaradagba wo ni o ṣe pataki ni ilana titẹ sinu apẹrẹ inu sẹẹli kan?” — meaning it wants to know which proteins are important in the process of entering a cell.\n</step1>\n<step2>\nIn cellular biology, the process of entering a cell is often referred to as *endocytosis* — *ilana titẹ sinu sẹẹli*.\n</step2>\n<step3>\nKey proteins involved in this process include *receptors* that recognize specific molecules — *awọn amuaradagba ti o nṣe idanimọ*.\n</step3>\n<step4>\nFor example, *clathrin* is a protein that plays a crucial role in forming vesicles during endocytosis — *o n ṣe iranlọwọ lati ṣẹda awọn vesicles*.\n</step4>\n<step5>\nAdditionally, *dynamin* is important for pinching off the vesicle from the membrane — *o ṣe pataki fun didi vesicle naa*.\n</step6>\n<step6>\nThus, proteins like *clathrin* and *dynamin* are essential for the successful entry of substances into a cell.\n</step6></thinking>", "answer": "<answer>Awọn amuaradagba pataki ni ilana titẹ sinu sẹẹli kan ni *clathrin* ati *dynamin*.</answer>", "language": "Yoruba"}
{"question": "((6 * -6 * 8 * 1) * (-1 * 7 * -6 + -2)) =", "reasoning": "<thinking><step1>\nThe question asks to evaluate the expression: “((6 * -6 * 8 * 1) * (-1 * 7 * -6 + -2))” — we need to calculate the result step by step.\n</step1>\n<step2>\nFirst, let's simplify the inner multiplication: *6 * -6 * 8 * 1*. This equals *-48* because *6 * -6 = -36* and then *-36 * 8 = -288*.\n</step2>\n<step3>\nNext, we evaluate the expression inside the parentheses: *-1 * 7 * -6 + -2*. The multiplication gives us *42* because *-1 * 7 = -7* and *-7 * -6 = 42*.\n</step3>\n<step4>\nNow, we add *42 + -2*, which results in *40*.\n</step4>\n<step5>\nFinally, we multiply the two results: *-288 * 40*. This equals *-11520*.\n</step5></thinking>", "answer": "<answer>-11520</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 58 kan ti o ni cirrhosis ń ṣe ikọlu inu ríru ati iṣiṣẹ́ ọpọlọ ti o buru si ni ọjọ́ marun sẹhin. Ó tun sọ pe ni awọn wakati 48 sẹhin, ìṣàn ito rẹ ti dinku.  Nígbà ayẹwo, ó ti gbẹ́ ati ki ó ní awọ̀ ofeefee. Ó ní ascites ti o lagbara ati iwọn ẹdọ ti 7 cm ni ila midclavicular.  Àbájáde ẹ̀kọ́ ẹ̀jẹ̀ fi hàn pe WBC 4600/mm3, Hb 9.4 g/dL, ati PCB 29%. BUN ti 34 mg/dL ati creatinine ti 3.1 mg/dL.  Sodium ito kere ju 10 mEq/L.  Itọju ti o yẹ julọ fun BUN ati creatinine rẹ ti o ga ju?\nA. Paracentesis iwọn pupọ\nB. Hemodialysis\nC. Mesocaval shunt\nD. Gbigbe ẹdọ", "reasoning": "<thinking><step1>\nThe question describes a 58-year-old man with cirrhosis who is experiencing worsening abdominal pain and mental status changes over the past five days. It also mentions a decrease in urine output in the last 48 hours, signs of dehydration, jaundice, ascites, and specific lab results indicating elevated BUN and creatinine levels.\n</step1>\n<step2>\nIn this case, the patient has *ascites* and signs of renal impairment, indicated by the high BUN (34 mg/dL) and creatinine (3.1 mg/dL) levels. This suggests possible *insufisiensi renal* due to cirrhosis.\n</step2>\n<step3>\nThe management of elevated BUN and creatinine in a cirrhotic patient often involves addressing the underlying causes, which may include fluid overload or renal hypoperfusion. *Paracentesis* could help relieve abdominal pressure from ascites, but it may not directly address renal function.\n</step3>\n<step4>\n*Hemodialysis* is a treatment option for acute kidney injury, especially when creatinine levels are significantly elevated. Given the patient's renal status, this could be a critical intervention.\n</step4>\n<step5>\nOther options like *mesocaval shunt* or *liver transplantation* are more invasive and may not be immediately appropriate given the acute nature of the renal failure.\n</step6>\n<step6>\nThus, the most appropriate treatment for his elevated BUN and creatinine levels is likely hemodialysis, as it directly addresses the renal impairment.\n</step6></thinking>", "answer": "<answer>Hemodialysis ni itọju ti o yẹ julọ fun BUN ati creatinine rẹ ti o ga ju.</answer>", "language": "Yoruba"}
{"question": "Ninu àṣàrò ilé-ẹ̀kọ́ kan tí ó ní ìmúlò acid-catalyst, ọmọ-ẹ̀kọ́ kan lo 3-methylpyrrolidine pẹ̀lú èròjà kan àti olùṣe ìṣe kan lábẹ́ ooru, tí ó yọrí sí ìṣẹ̀dá 1-(cyclohexylidenemethyl)-3-methylpyrrolidine. Ṣàwárí èròjà àti olùṣe ìṣe tí a lo nínú àṣàrò yìí.", "reasoning": "<thinking><step1>\nThe question asks about a chemical reaction involving an acid-catalyst, specifically mentioning the use of 3-methylpyrrolidine and a reagent under heat, leading to the formation of 1-(cyclohexylidenemethyl)-3-methylpyrrolidine.\n</step1>\n<step2>\nIn this context, *èròjà* refers to the reagent used in the reaction. A common reagent for such transformations could be an aldehyde or a ketone, which can react with 3-methylpyrrolidine.\n</step2>\n<step3>\nThe *olùṣe ìṣe* or catalyst in this reaction is likely an acid, such as hydrochloric acid (HCl) or sulfuric acid (H2SO4), which facilitates the reaction by protonating the nitrogen in 3-methylpyrrolidine.\n</step3>\n<step4>\nThe reaction occurs under heat, which helps to drive the reaction forward, promoting the formation of the imine intermediate before it rearranges to form the final product.\n</step4>\n<step5>\nThus, the overall process involves the nucleophilic attack of 3-methylpyrrolidine on the carbonyl carbon of the reagent, followed by dehydration to yield the final compound.\n</step5>\n<step6>\nIn summary, the *èroja* is likely an aldehyde or ketone, and the *olùṣe ìṣe* is an acid catalyst that aids in the reaction.\n</step6></thinking>", "answer": "<answer>Èròjà ni aldehyde tàbí ketone, olùṣe ìṣe ni acid catalyst.</answer>", "language": "Yoruba"}
{"question": "Kini ọ̀nà ìtọ́jú tí ó báàmu jùlọ fún àpọǹbà obìnrin tí kò tíì bí ọmọ, tí ó ní oyun àìṣàṣájú, tí ìṣùpọ̀ àpòòtó ní iwọn 2.5 x 3 cm, àti ìwọ̀n Beta HCG tí ó jẹ́ 1500 mIU/mL?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ọ̀nà ìtọ́jú tí ó báàmu jùlọ fún àpọǹbà obìnrin tí kò tíì bí ọmọ, tí ó ní oyun àìṣàṣájú, tí ìṣùpọ̀ àpòòtó ní iwọn 2.5 x 3 cm, àti ìwọ̀n Beta HCG tí ó jẹ́ 1500 mIU/mL?” — meaning it seeks the best treatment approach for a woman with an early pregnancy complication, specifically a [pregnancy of uncertain viability = oyun àìṣàṣájú].\n</step1>\n<step2>\nIn this case, the presence of a 2.5 x 3 cm [ectopic mass = ìṣùpọ̀ àpòòtó] and a Beta HCG level of 1500 mIU/mL indicates a potential issue with the pregnancy.\n</step2>\n<step3>\nThe management of such a condition often involves monitoring the HCG levels — *ìtọ́jú HCG* — to see if they rise or fall, which helps determine the viability of the pregnancy.\n</step3>\n<step4>\nIf the HCG levels are stable or decreasing, *ìtọ́jú abẹ́* (surgical treatment) may be necessary, especially if there are signs of rupture or significant pain.\n</step4>\n<step5>\nConversely, if the levels are rising, it may indicate a viable pregnancy, but further imaging like an ultrasound is needed to confirm the location and status of the pregnancy.\n</step5>\n<step6>\nIn summary, the best approach involves careful monitoring and possibly surgical intervention if complications arise — *ìtọ́jú pẹ̀lú abẹ́* if necessary.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú tó dára jùlọ ni ìtọ́jú pẹ̀lú abẹ́, pẹ̀lú ìmúlò ìtọ́jú HCG àti àyẹ̀wò ultrasound.</answer>", "language": "Yoruba"}
{"question": "Kini abajade gigun-igba ti ipinnu lati lo ẹgbẹẹrun-mẹrinlelogun (38th) apakan gẹgẹbi ila pinpin lẹhin ti Japan fi ara rẹ hàn?", "reasoning": "<thinking><step1>\nThe question asks: “Kini abajade gigun-igba ti ipinnu lati lo ẹgbẹẹrun-mẹrinlelogun (38th) apakan gẹgẹbi ila pinpin lẹhin ti Japan fi ara rẹ hàn?” — meaning it wants to know the long-term effects of using the 38th parallel as a dividing line after Japan revealed itself.\n</step1>\n<step2>\nThe 38th parallel became significant after World War II when Korea was divided into North and South — *Korea ti pin si Ariwa ati Guusu*.\n</step2>\n<step3>\nThis division led to the establishment of two separate governments, which created political tension — *iyapa iṣelu* that persists to this day.\n</step3>\n<step4>\nThe Korean War (1950-1953) solidified this division, resulting in a heavily militarized border — *aala ti o ni awọn ọmọ ogun pupọ*.\n</step5>\n<step5>\nEconomically, the two Koreas developed very differently; South Korea became a global economic powerhouse while North Korea faced isolation — *iyato nla ni idagbasoke eto-ọrọ*.\n</step6>\n<step6>\nCulturally, the division has led to a significant divergence in language, traditions, and social norms — *iyato ninu aṣa ati awọn aṣa*.\n</step7>\n<step7>\nThus, the long-term effects of using the 38th parallel as a dividing line have been profound and multifaceted, affecting politics, economy, and culture.\n</step8></thinking>", "answer": "<answer>Abajade gigun-igba ti ipinnu lati lo ẹgbẹẹrun-mẹrinlelogun gẹgẹbi ila pinpin ni Korea ni ipa nla lori iṣelu, eto-ọrọ, ati aṣa.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin aláìnílé ọdun 64 kan wá pẹlu irora eti ọtun ati irora gbọ́gbọ́ fún ọsẹ̀ meji, ti ó bá ìtùjáde, iba, ati àìṣòro ojú ara tí ó fi hàn gẹ́gẹ́ bí ìṣòro iṣan ewu ojú ìkẹ́kẹ̀ẹ́kẹ̀ẹ́.  Àyẹ̀wò otoscopic fi hàn pé ọ̀pọ̀ irú èso kan wà ní àyíká ibì tí ẹ̀rọ ara ati egungun eti bá pàapà.  Níwíwòye àwọn ìwòyí, ipò iṣelọ́pọ̀ wo ni ó ṣeé ṣe jùlọ láti sopọ mọ̀ ipò eti alaisan yìí?", "reasoning": "<thinking><step1>\nThe question asks about a 64-year-old man presenting with right ear pain and generalized pain for two weeks, along with fever and systemic symptoms indicating a possible ear infection — *ìṣòro iṣan ewu*.\n</step1>\n<step2>\nThe otoscopic examination shows multiple lesions around the area where the ear canal and bone meet — *àyíká ibì tí ẹ̀rọ ara ati egungun eti bá pàapà*.\n</step2>\n<step3>\nGiven the symptoms, this could indicate an external ear infection, possibly *otitis externa*, which is common in such cases.\n</step3>\n<step4>\nThe presence of fever and systemic symptoms suggests that the infection might be more severe, potentially leading to complications like *cellulitis* or even *osteomyelitis* of the temporal bone.\n</step4>\n<step5>\nConsidering the age of the patient and the duration of symptoms, a diagnosis of *otitis externa* with possible complications is likely.\n</step5>\n<step6>\nIn summary, the most probable diagnosis related to the patient's ear condition is *otitis externa* with associated systemic symptoms.\n</step6></thinking>", "answer": "<answer>Ìṣòro iṣan ewu ti eti, *otitis externa*, pẹ̀lú àwọn àkóónú àìlera àtàwọn àkúnya àìlera.</answer>", "language": "Yoruba"}
{"question": "Lẹ́yìn ìpín testicular vein fún ìtọ́jú varicose vein, iṣẹ́ ìgbàgbọ́ ẹ̀jẹ̀ tẹ́stìsì nipa?\nA. Ẹ̀jẹ̀ Cremasteric\nB. Ẹ̀jẹ̀ dorsal ti àgbàdà\nC. Pampiniform plexus\nD. Ẹ̀jẹ̀ internal pudendal", "reasoning": "<thinking><step1>\nThe question translates to: \"After the testicular vein is ligated for varicose vein treatment, what is the blood supply to the testis?\" This indicates that we need to identify the remaining blood supply to the testis after the ligation.\n</step1>\n<step2>\nThe testicular vein is responsible for draining blood from the testis, and when it is ligated, other sources must compensate for blood supply — *ìtọ́jú ẹ̀jẹ̀*.\n</step2>\n<step3>\nThe options provided include various blood vessels: *ẹ̀jẹ̀ Cremasteric* (Cremasteric vein), *ẹ̀jẹ̀ dorsal ti àgbàdà* (dorsal vein of the penis), *pampiniform plexus*, and *ẹ̀jẹ̀ internal pudendal* (internal pudendal vein).\n</step3>\n<step4>\nThe pampiniform plexus is a network of veins that surrounds the testicular artery and is crucial for thermoregulation and drainage — *ìdájọ́ ẹ̀jẹ̀*.\n</step4>\n<step5>\nWhen the testicular vein is ligated, the pampiniform plexus can still provide some blood supply to the testis, making it a key player in this scenario.\n</step5>\n<step6>\nThus, the correct answer is that the blood supply to the testis after ligation of the testicular vein is primarily through the *pampiniform plexus*.\n</step6></thinking>", "answer": "<answer>Pampiniform plexus ni ẹ̀jẹ̀ tó ń pèsè fún tẹ́stìsì lẹ́yìn ìpín testicular vein.</answer>", "language": "Yoruba"}
{"question": "Tọkọtaya kan, ti ìtàn ìdílé wọn ní Beta Thalassemia Major ni ẹni ti ó jìnnà sí wọn, wá fún ìmọran. Ọkọ oní HbA2 ti 4.8% ati aya oní HbA2 ti 2.3%. Ewu nini ọmọ ti ó ní Beta Thalassemia Major ni -\nA. 50%\nB. 25%\nC. 5%\nD. 0%", "reasoning": "<thinking><step1>\nThe question asks about the risk of having a child with [Beta Thalassemia Major] given the HbA2 levels of the parents. It specifies that the father has an HbA2 of 4.8% and the mother has an HbA2 of 2.3%.\n</step1>\n<step2>\nBeta Thalassemia Major is a severe form of thalassemia, and it occurs when both parents are carriers of the gene — *les deux parents doivent être porteurs*.\n</step2>\n<step3>\nIn this case, the father’s HbA2 level indicates he is likely a carrier, while the mother’s lower HbA2 suggests she might also be a carrier, but we need to confirm this.\n</step3>\n<step4>\nIf both parents are carriers, the risk of having a child with Beta Thalassemia Major is 25% — *le risque est de 25%*.\n</step4>\n<step5>\nHowever, if one parent is not a carrier, the risk drops to 0% — *le risque devient 0%*.\n</step5>\n<step6>\nGiven the HbA2 levels, it seems both parents could be carriers, leading to a 25% chance of having a child with the condition.\n</step6>\n<step7>\nThus, the answer to the question about the risk of having a child with Beta Thalassemia Major is 25%.\n</step7></thinking>", "answer": "<answer>25%</answer>", "language": "Yoruba"}
{"question": "Àwọn apá ara meji wo ni a maa ṣe ipalara si gidigidi ninu ipalara ikun tí ó gbọn?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn apá ara meji wo ni a maa ṣe ipalara si gidigidi ninu ipalara ikun tí ó gbọn?” — meaning it wants to know which two body parts are most severely injured in a [severe abdominal injury].\n</step1>\n<step2>\nIn a severe abdominal injury, *ipalara ikun* can affect various organs, but the most critical ones are usually the liver and spleen — *ẹdọ ati ẹdọfóró*.\n</step2>\n<step3>\nThe liver is particularly vulnerable due to its size and location; it can sustain significant damage from blunt force trauma — *ipalara ti o fa nipasẹ agbara to lagbara*.\n</step4>\n<step5>\nSimilarly, the spleen can rupture easily, leading to internal bleeding — *iyapa inu ti o le fa ẹjẹ inu*.\n</step6>\n<step6>\nBoth organs are essential for filtering blood and immune function, making their injury quite serious — *ipalara wọn le fa awọn iṣoro ilera to ṣe pataki*.\n</step7>\n<step7>\nThus, in cases of severe abdominal trauma, the liver and spleen are the two organs most likely to be severely injured.\n</step7></thinking>", "answer": "<answer>Àwọn apá ara meji ti a maa ṣe ipalara si gidigidi ninu ipalara ikun tí ó gbọn ni ẹdọ ati ẹdọfóró.</answer>", "language": "Yoruba"}
{"question": "Kini ipo yara ti a nilo fun autoclaving nipa otutu ati akoko?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ipo yara ti a nilo fun [autoclaving = autoclaving] nipa [otutu = temperature] ati [akoko = time]?” — meaning it wants to know the conditions required for autoclaving in terms of temperature and time.\n</step1>\n<step2>\nAutoclaving is a sterilization process that uses steam under pressure — *o nlo eefin labẹ titẹ* lati pa awọn kokoro arun run.\n</step2>\n<step3>\nTypically, the standard temperature for autoclaving is 121 degrees Celsius — *121 iwọn Celsius* — which is effective for most sterilization needs.\n</step3>\n<step4>\nThe time required at this temperature is usually around 15 to 30 minutes — *15 si 30 iṣẹju* — depending on the load and type of materials being sterilized.\n</step4>\n<step5>\nFor more challenging organisms, higher temperatures or longer times may be necessary — *fun awọn kokoro arun to nira, o le nilo akoko to gun ju*.\n</step5>\n<step6>\nIn summary, the ideal conditions for autoclaving are 121 degrees Celsius for 15 to 30 minutes — *121 iwọn Celsius fun iṣẹju 15 si 30*.\n</step6></thinking>", "answer": "<answer>Ipo yara ti a nilo fun autoclaving ni 121 iwọn Celsius fun iṣẹju 15 si 30.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 26 kan ṣe abẹrẹ ọtun orchiectomy nitori iṣọn-ọ̀fun 1.5 cm ti o jẹ ẹ̀jẹ̀ ati rirọ ninu apa ọtun testis, pẹlu idasilẹ lymph node retroperitoneal ti o fihan neoplasm kan pẹlu necrosis ati ẹ̀jẹ̀ ti o gbòòrò. Iwadii microscópico fihan awọn sẹẹli cuboidal ti o pò pẹlu awọn sẹẹli syncytial eosinophilic ńlá pẹlu ọpọlọpọ awọn nukleoli dudu, pleomorphic.  Aami immunohistochemical pato wo ni o ṣee ṣe julọ lati jẹ rere ninu awọn sẹẹli syncytial ti egbòogi yii?", "reasoning": "<thinking><step1>\nThe question asks about the specific immunohistochemical marker that is likely to be positive in the syncytial cells of a neoplasm found in a 26-year-old man who underwent an orchiectomy due to a 1.5 cm tumor in the right testis.\n</step1>\n<step2>\nThe tumor shows characteristics like necrosis and hemorrhage, which are common in aggressive neoplasms — *neoplasia* — particularly in testicular cancer.\n</step2>\n<step3>\nThe presence of large eosinophilic syncytial cells with multiple dark, pleomorphic nucleoli suggests a germ cell tumor, possibly a *seminoma* or *non-seminomatous germ cell tumor*.\n</step3>\n<step4>\nIn such tumors, specific immunohistochemical markers are used for diagnosis; for instance, *placental alkaline phosphatase (PLAP)* is often positive in seminomas.\n</step4>\n<step5>\nAdditionally, *CD30* is another marker that can be expressed in certain types of non-seminomatous tumors, particularly in embryonal carcinoma.\n</step5>\n<step6>\nGiven the description of the cells, the most likely immunohistochemical marker to be positive in the syncytial cells of this neoplasm is *PLAP*.\n</step6></thinking>", "answer": "<answer>Aami immunohistochemical ti o ṣee ṣe julọ lati jẹ rere ni awọn sẹẹli syncytial ti egbòogi yii ni *placental alkaline phosphatase (PLAP)*.</answer>", "language": "Yoruba"}
{"question": "Ka a ka iye owo ti owo sisan ti $100 ti a o gba laarin odun 5 pẹlu oṣuwọn idinku ti 5%.", "reasoning": "<thinking><step1>\nThe question asks: “Ka a ka iye owo ti owo sisan ti $100 ti a o gba laarin odun 5 pẹlu oṣuwọn idinku ti 5%?” — meaning it wants to calculate the present value of $100 received in 5 years with a discount rate of 5%.\n</step1>\n<step2>\nTo find the present value, we use the formula: *PV = FV / (1 + r)^n*, where *PV* is present value, *FV* is future value, *r* is the discount rate, and *n* is the number of years.\n</step2>\n<step3>\nHere, *FV* is $100, *r* is 0.05 (5%), and *n* is 5 years. So, we substitute these values into the formula.\n</step3>\n<step4>\nCalculating this gives us: *PV = 100 / (1 + 0.05)^5*. First, we calculate *1 + 0.05 = 1.05*.\n</step4>\n<step5>\nNext, we raise 1.05 to the power of 5, which is approximately 1.27628. Then, we divide $100 by this value: *PV ≈ 100 / 1.27628*.\n</step5>\n<step6>\nFinally, this results in a present value of approximately $78.35. In Yoruba, we can say: *Iye owo ti a o gba ni ọdun marun ni $78.35*.\n</step6></thinking>", "answer": "<answer>Iye owo ti a o gba ni ọdun marun pẹlu oṣuwọn idinku ti 5% ni $78.35.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin ọdún ogún kan fi àrùn ibà, irora iṣan, àti ìgbóná sí apá òsì rẹ̀ hàn lẹ́yìn ọjọ́ mẹ́ta tí ó ti lọ sí igbó ní apá àríwá Kalifornia. Ó ní ìgbóná apá ikọ̀, àti ìṣàn tó ń ṣàn láti apá ikọ̀ tí ó ti bàjẹ́. Ìwádìí microscópic fi hàn pé ọ̀dàá gram-negative coccobacilli pẹ̀lú ìfínra bipolar àti irisi aṣọ ààbò. Ṣàkíyèsí ibi tí àrùn náà ti wà ní ìpilẹ̀ṣẹ̀ fún kòṣeémọ̀ tí ó ṣeé ṣe kí ó fa ìṣòro rẹ̀.", "reasoning": "<thinking><step1>\nThe question describes a 20-year-old man with symptoms of fever, muscle pain, and localized swelling in his left side after spending three days in a forest in Northern California. It asks for the possible origin of his illness.\n</step1>\n<step2>\nThe symptoms suggest a potential infection, particularly given the presence of *irora iṣan* (muscle pain) and *ìgbóná* (fever). The mention of *ọ̀dàá gram-negative coccobacilli* indicates a bacterial infection.\n</step2>\n<step3>\nConsidering the environment, *igbó* (forest) exposure could imply contact with vectors like ticks, which are known to transmit diseases such as Lyme disease or other tick-borne infections.\n</step3>\n<step4>\nThe *ìfínra bipolar* (bipolar staining) of the bacteria suggests a specific type of gram-negative bacteria, which could be linked to infections like *Bartonella* or *Brucella*, common in certain regions.\n</step5>\n<step5>\nThe localized swelling in the left side, along with the muscle pain, could indicate an abscess or localized infection, possibly from a tick bite or other zoonotic transmission.\n</step6>\n<step6>\nThus, the origin of his illness is likely related to exposure to tick-borne pathogens in the forest, leading to a bacterial infection characterized by the symptoms described.\n</step6></thinking>", "answer": "<answer>Ìpẹ̀yà àrùn rẹ̀ jẹ́ àbájáde àkúnya àrùn tí a fa nipasẹ àkúnya tàbí àrùn tí a fa nipasẹ ikọ̀, gẹgẹ bí àkúnya tí ó wà ní igbó.</answer>", "language": "Yoruba"}
{"question": "Lórin tó ní àrùn ẹ̀jẹ̀ ẹ̀gbà gbàrà, àpòtí immunophenotype rẹ̀ ni CD 19+ve, CD 10+ve, CD33+ve, CD13+ve. Ó ṣeé ṣe kí ó ní-\nA. Àrùn ẹ̀jẹ̀ ẹ̀gbà gbàrà méjì\nB. ALL\nC. AML-M2\nD. AML-M0", "reasoning": "<thinking><step1>\nThe question asks: “Lórin tó ní àrùn ẹ̀jẹ̀ ẹ̀gbà gbàrà, àpòtí immunophenotype rẹ̀ ni CD 19+ve, CD 10+ve, CD33+ve, CD13+ve. Ó ṣeé ṣe kí ó ní-” which translates to “A patient with leukemia, whose immunophenotype is CD 19 positive, CD 10 positive, CD 33 positive, CD 13 positive. What could they have?” \n</step1>\n<step2>\nTo analyze this, we need to understand the significance of the immunophenotype markers. CD 19 and CD 10 are typically associated with acute lymphoblastic leukemia (ALL) — *àrùn ẹ̀jẹ̀ ẹ̀gbà gbàrà*.\n</step2>\n<step3>\nOn the other hand, CD 33 and CD 13 are more commonly found in acute myeloid leukemia (AML) — *àrùn ẹ̀jẹ̀ ẹ̀gbà gbàrà myeloid*.\n</step3>\n<step4>\nGiven that the patient has both lymphoid markers (CD 19, CD 10) and myeloid markers (CD 33, CD 13), this suggests a complex case. It could indicate a mixed lineage leukemia.\n</step4>\n<step5>\nAmong the options provided, ALL (B) is a strong candidate due to the presence of CD 19 and CD 10, but the presence of myeloid markers complicates the diagnosis.\n</step5>\n<step6>\nHowever, the combination of all these markers does not fit neatly into AML-M0 or AML-M2 categories, which are more specific to myeloid lineage without lymphoid markers.\n</step6>\n<step7>\nThus, the most likely diagnosis considering the immunophenotype is ALL, but with a note that the presence of myeloid markers could suggest a more complex scenario.\n</step7></thinking>", "answer": "<answer>B. ALL</answer>", "language": "Yoruba"}
{"question": "Ṣàlàyé ìyàtọ̀ pàtàkì ní ti iranti àti àtúnyẹ̀wò láàrin àwọn àgbékalẹ̀ ìṣọ̀kan àti àwọn àgbékalẹ̀ ṣíṣàtò.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣàlàyé ìyàtọ̀ pàtàkì ní ti [iranti = memory] àti [àtúnyẹ̀wò = review] láàrin [àwọn àgbékalẹ̀ ìṣọ̀kan = unified frameworks] àti [àwọn àgbékalẹ̀ ṣíṣàtò = modular frameworks].” This means it wants to explain the important differences between memory and review in the context of unified and modular frameworks.\n</step1>\n<step2>\nIn a unified framework, memory refers to the way information is stored and retrieved as a whole — *iranti nibi ni gbogbo alaye ti wa ni fipamọ́ pẹ̀lú* a single structure.\n</step2>\n<step3>\nConversely, in a modular framework, memory might be more segmented, allowing for specific parts to be accessed independently — *àtúnyẹ̀wò nibi ni a ṣe àyẹ̀wò kọọkan* of the modules separately.\n</step3>\n<step4>\nThe key difference is that in unified frameworks, the focus is on holistic understanding, while modular frameworks emphasize flexibility and adaptability — *ìyàtọ̀ yìí jẹ́ pé* one is more integrated and the other is more compartmentalized.\n</step4>\n<step5>\nWhen it comes to review, in a unified framework, it might involve revisiting the entire system, whereas in a modular framework, it could mean assessing individual modules — *àtúnyẹ̀wò le jẹ́* more targeted and specific.\n</step5>\n<step6>\nThus, the distinction lies in how memory and review are approached: unified frameworks favor a comprehensive view, while modular frameworks allow for detailed analysis of components.\n</step6></thinking>", "answer": "<answer>Ìyàtọ̀ pàtàkì ni pé iranti nínú àgbékalẹ̀ ìṣọ̀kan jẹ́ gbogbo alaye pẹ̀lú, ṣùgbọ́n nínú àgbékalẹ̀ ṣíṣàtò, iranti jẹ́ pípa kọọkan. Àtúnyẹ̀wò nínú àgbékalẹ̀ ìṣọ̀kan jẹ́ àyẹ̀wò gbogbo, ṣùgbọ́n nínú àgbékalẹ̀ ṣíṣàtò, ó jẹ́ àyẹ̀wò àyípadà.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun 60 kan fi itan irora àyà àti ṣíṣe kí afẹ́fẹ́ ṣoro hàn fún ọsẹ̀ kan sẹ́yìn. Ẹ̀jẹ̀ tí wọ́n fà yọ̀ fi àwọ̀ pupa brown tó rẹ̀wẹ̀sì hàn. Àyèwò rẹ̀ kò?\nA. Àrùn ẹ̀jẹ̀ sikulu,\nB. Àrùn ẹ̀jẹ̀ tí ó bàjẹ́\nC. Àrùn Meth-hemoglobinaemia\nD. Àìtó ẹ̀jẹ̀ G-6-P", "reasoning": "<thinking><step1>\nThe question is asking about a 60-year-old patient who has shown symptoms of chest pain and difficulty breathing for a week, with brownish-red blood observed during a test. The key terms here are [irora àyà = chest pain], [afẹ́fẹ́ ṣoro = difficulty breathing], and [àwọ̀ pupa brown = brownish-red color].\n</step1>\n<step2>\nThe symptoms suggest a possible underlying condition affecting the blood or lungs. The presence of brownish-red blood indicates a potential issue with oxygenation or hemoglobin.\n</step2>\n<step3>\nOne possible condition is *Meth-hemoglobinaemia*, where hemoglobin is altered and cannot effectively carry oxygen, leading to symptoms like cyanosis and respiratory distress.\n</step3>\n<step4>\nAnother possibility is *àìtó ẹ̀jẹ̀ G-6-P*, which can lead to hemolytic anemia and might cause similar symptoms, but the brownish blood is more indicative of a different issue.\n</step4>\n<step5>\n*Àrùn ẹ̀jẹ̀ sikulu* and *àrùn ẹ̀jẹ̀ tí ó bàjẹ́* are less likely given the specific symptoms and blood color. The brownish hue is more characteristic of Meth-hemoglobinaemia.\n</step5>\n<step6>\nThus, considering the symptoms and the blood characteristics, the most likely diagnosis is *Meth-hemoglobinaemia*.\n</step6></thinking>", "answer": "<answer>Àrùn Meth-hemoglobinaemia.</answer>", "language": "Yoruba"}
{"question": "Aṣiwaju ọdun mẹ́ẹ́dọ́gbọ̀n kan tí a ń pè ní Vasanti sọ pé, ọwọ́ rẹ̀ ń gbẹ́, ó sì ní ìtàn ìṣòro ìgba mì.  Lórí àwọn àmì àrùn yìí, kí ni ìwádìí tó pọ̀ jùlọ?", "reasoning": "<thinking><step1>\nThe question translates to: \"A 35-year-old named Vasanti says her hands are dry and she has a history of menstrual problems. Based on these symptoms, what is the most common diagnosis?\" \n</step1>\n<step2>\nDry hands can indicate several conditions, but in this context, we should consider *les problèmes hormonaux* due to her menstrual history — *l'historique menstruel*.\n</step2>\n<step3>\nCommon causes of dry skin include *la déshydratation* and skin conditions like eczema, but hormonal imbalances can also lead to dryness — *un déséquilibre hormonal*.\n</step4>\n<step4>\nGiven her age and symptoms, conditions like hypothyroidism could be relevant — *l'hypothyroïdie* can cause dry skin and menstrual irregularities.\n</step5>\n<step5>\nTherefore, the most common diagnosis considering her symptoms would likely be related to hormonal issues, particularly hypothyroidism.\n</step6></thinking>", "answer": "<answer>Ìwádìí tó pọ̀ jùlọ ni hypothyroidism, nípa ìtàn ìṣòro ìgba mì àti ọwọ́ gbẹ́.</answer>", "language": "Yoruba"}
{"question": "Ewo ni o yẹ julọ ninu awọn atọju wọnyi fun atunṣe alaisan ti o ní igbọrọ-gbọrọ gbọn-gbọn mejeeji lẹhin abẹrẹ fun acoustic schwannoma mejeeji:\nA. Ẹrọ gbọ́ tí ó ní agbara mejeeji\nB. Awọn atọju cochlear mejeeji\nC. Atọju cochlear ṣoṣo kan\nD. Atọju ọpọlọ-ara", "reasoning": "<thinking><step1>\nThe question asks: “Ewo ni o yẹ julọ ninu awọn atọju wọnyi fun atunṣe alaisan ti o ní [igbọrọ-gbọrọ gbọn-gbọn = bilateral vestibular schwannomas] lẹhin abẹrẹ fun [acoustic schwannoma = acoustic neuroma]?” — meaning it seeks the best treatment option for a patient with bilateral vestibular schwannomas after surgery for acoustic neuroma.\n</step1>\n<step2>\nIn cases of bilateral vestibular schwannomas, patients often experience hearing loss and balance issues — *nitori awọn iṣoro ni igbọ́ran ati iwọntunwọnsi*.\n</step2>\n<step3>\nThe treatment options listed include: A. *Ẹrọ gbọ́ tí ó ní agbara mejeeji* (hearing aids for both ears), B. *Awọn atọju cochlear mejeeji* (bilateral cochlear implants), C. *Atọju cochlear ṣoṣo kan* (single cochlear implant), and D. *Atọju ọpọlọ-ara* (brain surgery).\n</step3>\n<step4>\nBilateral cochlear implants are often recommended for patients with significant hearing loss in both ears — *nitori wọn le mu igbọ́ran pọ si ni gbogbo awọn eti*.\n</step4>\n<step5>\nWhile a single cochlear implant may help, it does not address the hearing loss in the other ear, which is crucial for balance and sound localization — *iyẹn ni pe, o le fa awọn iṣoro ni iwọntunwọnsi*.\n</step6>\n<step6>\nTherefore, the best option for a patient with bilateral vestibular schwannomas is likely to be B: *Awọn atọju cochlear mejeeji*.\n</step6></thinking>", "answer": "<answer>Awọn atọju cochlear mejeeji ni o yẹ julọ fun atunṣe alaisan ti o ní igbọrọ-gbọrọ gbọn-gbọn.</answer>", "language": "Yoruba"}
{"question": "Níwọ̀n ìgbà tí iwọ̀n otutu ara déédéé jẹ́ ìwọ̀n 98 Fahrenheit pẹ̀lú ìyàtọ̀ ìwọ̀n kan, kini iwọ̀n isalẹ̀ otutu ara fún 95% awọn ènìyàn?", "reasoning": "<thinking><step1>\nThe question asks: “Níwọ̀n ìgbà tí iwọ̀n otutu ara déédéé jẹ́ ìwọ̀n 98 Fahrenheit pẹ̀lú ìyàtọ̀ ìwọ̀n kan, kini iwọ̀n isalẹ̀ otutu ara fún 95% awọn ènìyàn?” — meaning it wants to know the lower limit of body temperature for 95% of people when the average is 98 Fahrenheit with a certain standard deviation.\n</step1>\n<step2>\nIn statistics, the average body temperature is often considered to be around 98.6°F, but here it’s given as 98°F — *ìwọn otutu ara àtẹ́yìnwá*.\n</step2>\n<step3>\nTo find the lower limit for 95% of the population, we typically use the normal distribution — *ìpinpin àtọka* — and the concept of standard deviation.\n</step3>\n<step4>\nAssuming a standard deviation of about 0.7°F, we can calculate the lower limit using the z-score for 95%, which is approximately -1.96.\n</step4>\n<step5>\nThe formula is: Lower limit = Mean - (Z * Standard Deviation). So, we calculate: 98 - (1.96 * 0.7).\n</step5>\n<step6>\nThis gives us a lower limit of approximately 96.6°F, meaning that for 95% of people, their body temperature would not drop below this value — *ìwọn otutu ara wọn kò ní dín kù sí i*.\n</step6></thinking>", "answer": "<answer>Iwọn isalẹ̀ otutu ara fún 95% awọn ènìyàn ni 96.6 Fahrenheit.</answer>", "language": "Yoruba"}
{"question": "Ṣe iṣiro iyipada iwọn didun lẹhin didapọ  ethanol to tobi pupọ pẹlu 3.75 mol omi lati gba ipin moleku ti omi, x_H2O, ti 0.45 ni 25°C, ti a ba fi iwọn didun patikulu ti omi ati ethanol jẹ 17.0 cm³/mol ati 57.5 cm³/mol, lọtọ. Iwuwo ti omi ati ethanol jẹ 0.997 g/cm³ ati 0.7893 g/cm³, lọtọ, ni iwọn otutu yii.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe iṣiro iyipada iwọn didun [calculate volume change] lẹhin didapọ [after mixing] ethanol with water to find the mole fraction of water, x_H2O, at 25°C.” \n</step1>\n<step2>\nTo find the mole fraction, we first need to calculate the number of moles of water and ethanol. The volume of water is given as 3.75 mol, and the molar volume of water is 17.0 cm³/mol.\n</step2>\n<step3>\nCalculating the volume of water: *Iwọn didun omi = 3.75 mol × 17.0 cm³/mol = 63.75 cm³*.\n</step3>\n<step4>\nNext, we calculate the volume of ethanol. The density of ethanol is 0.7893 g/cm³, and its molar volume is 57.5 cm³/mol. We need to find the mass of ethanol that corresponds to its volume.\n</step4>\n<step5>\nAssuming we mix a significant amount of ethanol, we can use the density to find the volume of ethanol needed to achieve a certain number of moles. For example, if we take 1 mol of ethanol, it would have a volume of *57.5 cm³*.\n</step5>\n<step6>\nNow, we need to consider the total volume after mixing. The total volume is not simply the sum of the volumes due to volume contraction upon mixing. We will assume a contraction factor based on typical values for ethanol and water mixtures.\n</step6>\n<step7>\nFinally, we calculate the mole fraction of water: *x_H2O = moles of water / (moles of water + moles of ethanol)*. With the values we have, we can find x_H2O.\n</step7></thinking>", "answer": "<answer>x_H2O jẹ 0.45 ni 25°C.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọwẹ kan tí a bí ní ọsẹ̀ 35 ti oyun, láti ọ̀dọ̀ ìyá kan tí kò gba ìtọ́jú ìwòsàn nígbà oyun rẹ̀, a ṣàkíyèsí pé ó ń wárìrì, ó sì ń bínú, ó sì ń ni ìṣòro láti jẹun.  A rí àwọn ìṣàn gbòògìòògìò lórí ṣiṣayẹ̀wò. Àwọn nọ́ọ̀sì jẹ́ ká mọ̀ pé ó ń kígbe ohùn gíga, wọ́n sì ṣàkíyèsí àwọn ìṣẹ̀lẹ̀pupọ̀ ti àìgbàgbọ́ àti ògbólògbò.  O rò pé ọmọ ọwẹ náà ń fàjáde láti\nA. Ọti\nB. Ẹ̀rùkù\nC. Ẹ̀fẹ̀\nD. Kokeni", "reasoning": "<thinking><step1>\nThe question describes a newborn baby who was born at 35 weeks of gestation and is showing signs of distress, such as crying loudly and having difficulty feeding. It mentions that the mother did not receive proper medical care during her pregnancy.\n</step1>\n<step2>\nIn this context, the baby is likely experiencing withdrawal symptoms — *ìfàjádé* — due to the mother's lack of prenatal care, which can lead to complications.\n</step2>\n<step3>\nThe symptoms described, like excessive crying and difficulty feeding, suggest that the baby might be reacting to substances the mother may have used during pregnancy — *àwọn ohun mímu tàbí àkúnya*.\n</step3>\n<step4>\nConsidering the options, *ọti* (alcohol) and *ẹ̀rùkù* (drugs) are substances that can cause withdrawal symptoms in newborns, while *ẹ̀fẹ̀* (air) and *kokeni* (unknown) are less likely to be relevant in this context.\n</step5>\n<step5>\nGiven the signs of distress and the mother's lack of care, it is reasonable to conclude that the baby is experiencing withdrawal from a substance, most likely *ẹ̀rùkù*.\n</step6>\nThus, the most appropriate answer is that the baby is likely experiencing withdrawal from drugs.\n</step6></thinking>", "answer": "<answer>Ẹ̀rùkù ni ọmọ ọwẹ náà ń fàjáde láti.</answer>", "language": "Yoruba"}
{"question": "Àpọn ẹni ọdún mẹ́ẹ́dógún-dínlógún kan wá sí ẹ̀ka ìtọ́jú pajawiri pẹ̀lú irora ọmu tí ó gbóná gidigidi tí ó burú sí i nígbà tí ó bá gbìyànjú láti mú ìmú gbìmọ̀ sílẹ̀ tàbí kí ó kó. Ó ní ìtàn ìṣẹ̀lẹ̀ ìṣàkóso kátẹ́tà ọkàn-àyà tí ó ṣẹlẹ̀ ní ọ̀sẹ̀ méjì sẹ́yìn lẹ́yìn àrùn ìṣàn ọkàn-àyà tí ó léwu. Ìwádìí ara fi hàn pé ohùn tí ó rọ̀rọ̀ gidigidi tí a gbọ́ dáadáa nígbà tí ó bá jókòó sí ipele gíga àti nígbà ìmú sílẹ̀, ati ECG fi hàn pé gbigbàgede ST elevations pẹlu ST depression ni aVR ati V1. Bí a bá gbé e yẹ̀ wò pẹ̀lú àwọn àyẹ̀wò yìí àti àwọn oògùn rẹ̀ lọ́wọ́lọ́wọ́, aspirin, ticagrelor, atorvastatin, metoprolol, àti lisinopril, kí ni ìtọ́jú tó yẹ jùlọ láti bójútó ipò rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks about the appropriate treatment for a 17-year-old patient presenting to the emergency department with severe chest pain — *irora ọmu* — and a history of recent myocardial infarction — *ìṣẹ̀lẹ̀ ìṣàkóso kátẹ́tà ọkàn-àyà*.\n</step1>\n<step2>\nThe patient has a significant history of heart disease, which complicates the situation. The presence of ST elevations and depressions on the ECG indicates possible ongoing ischemia — *ìṣàn ọkàn-àyà*.\n</step2>\n<step3>\nGiven the medications already administered, including aspirin and ticagrelor, it’s crucial to ensure that the patient is on appropriate antiplatelet therapy to prevent further clot formation.\n</step3>\n<step4>\nIn addition, the use of beta-blockers like metoprolol is essential to reduce myocardial oxygen demand — *ìdinku ìbéèrè àyà* — and manage the chest pain effectively.\n</step4>\n<step5>\nAtorvastatin is also important for long-term management of cholesterol levels, while lisinopril helps in managing blood pressure and reducing cardiac workload.\n</step5>\n<step6>\nConsidering all these factors, the most immediate treatment should focus on stabilizing the patient’s condition and addressing the acute chest pain.\n</step6>\n<step7>\nTherefore, administering additional doses of beta-blockers and ensuring continuous monitoring in the emergency setting is critical.\n</step7></thinking>", "answer": "<answer>Ìtọ́jú tó yẹ jùlọ ni láti fi beta-blockers sí i, pẹ̀lú àyẹ̀wò àtìlẹ́yìn àyà, àti ìmúra sílẹ̀ pẹ̀lú àwọn oògùn tó wà.</answer>", "language": "Yoruba"}
{"question": "Ninu àyípadà ìṣẹ̀lẹ̀ ìdènà ìbajẹ́ tí ìtànṣán ìṣàgbàyanu fà sí awọn sẹ́ẹ̀li afẹ́fẹ́ nígbà ìtọ́jú ìtànṣán ìṣàgbàyanu, iṣẹ́ ṣiṣe pàtàkì wo ni ìtúnṣe DNA tó ṣe iṣẹ́ ìtúnṣe àwọn ìṣẹ́lẹ̀ ìfọ́lẹ̀gbà méjì-sí-méjì ninu DNA, pàápàá nígbà tí àgbàyanu arábìnrin kò sí?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu àyípadà ìṣẹ̀lẹ̀ ìdènà ìbajẹ́ tí ìtànṣán ìṣàgbàyanu fà sí awọn sẹ́ẹ̀li afẹ́fẹ́ nígbà ìtọ́jú ìtànṣán ìṣàgbàyanu, iṣẹ́ ṣiṣe pàtàkì wo ni ìtúnṣe DNA tó ṣe iṣẹ́ ìtúnṣe àwọn ìṣẹ́lẹ̀ ìfọ́lẹ̀gbà méjì-sí-méjì ninu DNA, pàápàá nígbà tí àgbàyanu arábìnrin kò sí?” — meaning it wants to know the important role of DNA repair in fixing double-strand breaks during a specific type of cellular stress.\n</step1>\n<step2>\nDouble-strand breaks (DSBs) are critical lesions that can occur in DNA, often due to environmental factors or during replication — *ìdènà àyípadà* le fa wọn.\n</step2>\n<step3>\nIn response to DSBs, cells utilize DNA repair mechanisms such as homologous recombination — *ìtúnṣe àfihàn àtúnṣe* — which is particularly important when the cell is under stress.\n</step3>\n<step4>\nWhen a cell experiences stress, like during *ìtọ́jú ìtànṣán*, the efficiency of these repair processes can be compromised, leading to genomic instability.\n</step4>\n<step5>\nThe absence of certain proteins, like those involved in homologous recombination, can exacerbate the effects of stress on the cell, making DNA repair even more crucial.\n</step5>\n<step6>\nThus, the role of DNA repair in this context is to maintain genomic integrity and prevent cell death — *ìdènà ikú sẹ́ẹ̀li* — especially when the cell is under duress.\n</step6></thinking>", "answer": "<answer>Ìtúnṣe DNA ṣe pataki lati pa ààbò àtúnṣe sẹ́ẹ̀li mọ́ nígbà ìtọ́jú ìtànṣán, pàápàá jùlọ nígbà tí àgbàyanu arábìnrin kò sí.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun 11 ni a mu wa si onísègùn fún àyẹ̀wò atẹle. Ó ti ní ìṣòro pẹ̀lú iṣẹ́ ilé-ẹ̀kọ́ rẹ̀ fún ọdún mẹrin sẹ́yìn. Ó ní àrùn ikọlu tí a tọ́jú pẹ̀lú valproic acid. Ó lè rìn láìsí ìrànlọ́wọ́ ní ọjọ́-orí ọdún mẹta, ó sì lè lo fọ́kì àti sọǹgbì ní ọjọ́-orí ọdún mẹrin. Ó wà ní ìpín 40th fún gíga àti ìpín 60th fún ìwúwo. Àwọn àmì ìlera jẹ́ àwọn tí ó wà láàrin àwọn àdánù. Àyẹ̀wò fi hàn ní ọ̀pọ̀lọpọ̀ freckles ní àwọn ìṣírí àkọ́kọ́ àti àwọn ìṣírí ẹ̀gbà, àti pẹ̀lú scoliosis. Ọ̀pọ̀lọpọ̀ àwọn macules hyperpigmented wa lórí ẹ̀gbà àti àyà. Ọ̀pọ̀lọpọ̀ àwọn nodules tí ó rọ, tí kò ní irora wa lórí àwọn ẹ̀yà àti àyà. Àyẹ̀wò ophthalmic fi hàn ní àwọn nodules iris hyperpigmented ní ìṣọ̀kan. Ẹnìyàn yìí ní ewu pọ̀ sí i fún èyíkéyí nínú àwọn ipo tókàn?\nA. Optic glioma\nB. Glaucoma\nC. Renal cell carcinoma\nD. Giant cell astrocytoma\n\"", "reasoning": "<thinking><step1>\nThe question is asking about the risk factors associated with a specific condition in an 11-year-old boy who has a history of health issues, including treatment with valproic acid and various physical symptoms. \n</step1>\n<step2>\nThe boy has had educational difficulties for four years and has a history of seizures treated with valproic acid — *àrùn ikọlu* indicates a neurological condition that may relate to his current health status.\n</step2>\n<step3>\nHe has physical findings such as multiple freckles, scoliosis, and hyperpigmented macules, which could suggest a genetic syndrome — *àwọn àmì ìlera* are significant in determining potential risks.\n</step4>\n<step4>\nThe presence of iris nodules — *nodules iris hyperpigmented* — is particularly concerning as it can be associated with certain tumors, including optic glioma, which is a common complication in conditions like neurofibromatosis.\n</step5>\n<step5>\nGiven the symptoms and the age of the patient, the most likely risk factor among the options provided is optic glioma, as it is often linked to the findings observed in this case.\n</step6>\nThus, the boy has a higher risk for optic glioma due to his symptoms and medical history.\n</step6></thinking>", "answer": "<answer>Ẹnìyàn yìí ní ewu pọ̀ sí i fún optic glioma.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin ọmọ ọdún mẹ́ẹ̀ẹ́dógún kan wà, tí ara rẹ̀ ń fà á níbi kan, àti àwọn àṣìṣe oníyàrá pupa ní orí ikùn rẹ̀, àyà rẹ̀, àwọn ọwọ́ rẹ̀, àti isalẹ̀ ẹsẹ̀ rẹ̀, pẹ̀lú ìgbóná irúgbìn, àti àwọn àṣìṣe irun tí ó ga sókè, tí ó dà bí ewé ẹ̀gbà ní ayika agbó.  Nítorí àwọn àmì wọ̀nyí, ṣé ìwádìí ilé-iwosan wo ni ó gbọ́dọ̀ ṣe láti jẹ́ kí a mọ̀ pé kí a lè mọ̀ ohun tí àrùn náà jẹ́?", "reasoning": "<thinking><step1>\nThe question asks: “What medical investigations should be conducted to determine the illness of a 14-year-old boy with symptoms like [ìgbóná irúgbìn = fever], [àṣìṣe oníyàrá pupa = red rashes], and other signs?” \n</step1>\n<step2>\nFirst, we need to consider the symptoms: *ìgbóná irúgbìn* suggests an infection or inflammatory response, while *àṣìṣe oníyàrá pupa* indicates a possible allergic reaction or skin condition.\n</step2>\n<step3>\nA thorough physical examination is essential — *ìwádìí ara* — to assess the extent of the rashes and any other systemic signs.\n</step3>\n<step4>\nLaboratory tests like a complete blood count (CBC) can help identify signs of infection or inflammation — *àwọn àmì àrùn*.\n</step4>\n<step5>\nAdditionally, skin tests or allergy tests may be necessary to rule out allergic reactions — *ìwádìí àrùn àlérò*.\n</step6>\n<step6>\nFinally, imaging studies like a chest X-ray might be warranted if respiratory symptoms are present, to check for any underlying issues — *ìwádìí àyà*.\n</step7></thinking>", "answer": "<answer>Ìwádìí ilé-iwosan tó yẹ kí a ṣe ni: ìwádìí ara, àtẹ̀jáde ẹ̀jẹ̀, ìwádìí àrùn àlérò, àti ìwádìí àyà.</answer>", "language": "Yoruba"}
{"question": "Ninu iṣẹ abẹ ti ilokulo ẹkun ọtun ẹdọ, ẹya wo ni a le lo lati tẹriba ẹgbẹ ẹdọ ti a ge?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu [iṣẹ abẹ = surgery] ti [ilokulo ẹkun ọtun ẹdọ = right lobe of the liver resection], ẹya wo ni a le lo lati tẹriba [egbe ẹdọ ti a ge = the liver segment that was cut]?” — meaning it wants to know which part can be used to support the remaining liver after a resection.\n</step1>\n<step2>\nAfter a liver resection, it’s crucial to ensure that the remaining liver can function properly — *lati rii daju pe ẹdọ to ku le ṣiṣẹ daradara*.\n</step2>\n<step3>\nOne common approach is to use the remaining liver segments to regenerate — *lati lo awọn ẹya ẹdọ to ku lati tun gbe*.\n</step3>\n<step4>\nIn some cases, a technique called liver transplantation may be considered if the remaining liver is insufficient — *ti ẹdọ to ku ko ba to*.\n</step4>\n<step5>\nAdditionally, the use of grafts from other parts of the body or even from a donor can be an option — *lati lo awọn grafts lati awọn apakan miiran ti ara tabi lati ọdọ olutaja*.\n</step6>\n<step6>\nUltimately, the goal is to ensure that the liver can maintain its functions and support the body’s needs — *lati rii daju pe ẹdọ le pa awọn iṣẹ rẹ mọ*.\n</step7></thinking>", "answer": "<answer>A le lo awọn ẹya ẹdọ to ku lati tun gbe tabi awọn grafts lati ọdọ olutaja lati tẹriba ẹgbẹ ẹdọ ti a ge.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 43 kan ti o ni HIV ti o ni iye CD4 ti 98, ti o ni awọn ami ati awọn aami aisan ti o ṣe aniyan fun arun fungal, ṣugbọn kii ṣe lori awọn oogun antiretroviral. Irú arun candidal wo ni o ṣee ṣe julọ lati waye ninu alaisan ti o ni aisan aabo ara yii, ṣugbọn a ka si ohun ti o lewu pupọ fun ẹnikan ti o ni eto ajẹsara deede?", "reasoning": "<thinking><step1>\nThe question asks about a 43-year-old man with HIV and a CD4 count of 98, who shows symptoms concerning a fungal infection but is not on antiretroviral medication. It specifically inquires about the type of candidal infection that is most likely to occur in someone with such a low immune status, while also considering what would be very dangerous for a person with a normal immune system.\n</step1>\n<step2>\nWith a CD4 count this low, the patient is at high risk for opportunistic infections — *arun to n gba anfani* of the weakened immune system. In this case, *candidiasis* is a common fungal infection that can occur.\n</step2>\n<step3>\nThe most likely type of candidal infection in this scenario is *candidiasis oropharyngeal* — also known as oral thrush. This occurs when *Candida albicans* overgrows in the mouth and throat.\n</step3>\n<step4>\nFor someone with a normal immune system, *candidiasis* is usually not severe and can be treated easily. However, in immunocompromised individuals, it can lead to more serious complications, such as esophageal candidiasis, which can be life-threatening.\n</step4>\n<step5>\nIn summary, the risk of developing *candidiasis oropharyngeal* is significant for this patient, and it poses a serious threat due to his compromised immune status.\n</step5></thinking>", "answer": "<answer>Arun candidal ti o ṣee ṣe julọ ni *candidiasis oropharyngeal*, ti o le fa awọn iṣoro to ṣe pataki fun alaisan ti o ni HIV pẹlu iye CD4 ti 98.</answer>", "language": "Yoruba"}
{"question": "Àṣàrò ọ̀nà tí ó túbọ̀ dára jù fún ṣíṣe àṣàyàn àti ìyípadà ìwọ̀n ìgbà fún ìwádìí eré karbọnni le jẹ́:\nA. owó ṣíṣe àwọn ọkọ̀ ojú omi àtijọ́.\nB. ìwádìí ìdílé igi.\nC. gbogbo àwọn wọ̀nyí.\nD. ṣíṣàwòye àwọn ṣíṣàn yinyin.\nE. ìwé kíkọ.\nF. ìwádìí egungun àwọn ènìyàn àtijọ́.\nG. ṣíṣàyẹ̀wò àwọn ìpele erùpẹ̀.\nH. àwòrán satẹlaiti.\nI. àwọn ìwé ìtàn ìgbà àtijọ́.\nJ. ìwádìí eré karbọnni ti àwọn ilé ìgbà àtijọ́.", "reasoning": "<thinking><step1>\nThe question asks: “Àṣàrò ọ̀nà tí ó túbọ̀ dára jù fún ṣíṣe àṣàyàn àti ìyípadà ìwọ̀n ìgbà fún ìwádìí eré karbọnni le jẹ́?” — meaning it seeks the best method for selecting and changing time scales for carbon dating research.\n</step1>\n<step2>\nIn carbon dating, researchers often need to choose methods that provide accurate results — *àwọn ọna tí ó dájú*.\n</step2>\n<step3>\nOptions like *ìwádìí egungun àwọn ènìyàn àtijọ́* (study of ancient human remains) can provide insights into historical timelines.\n</step3>\n<step4>\nAdditionally, *àwòrán satẹlaiti* (satellite imagery) can help in understanding geographical changes over time, which is relevant for carbon dating.\n</step4>\n<step5>\nHowever, *ìwádìí eré karbónni ti àwọn ilé ìgbà àtijọ́* (carbon dating of ancient structures) directly relates to the question's focus on time scales.\n</step5>\n<step6>\nConsidering all options, *gbogbo àwọn wọ̀nyí* (all of these) could potentially contribute to the research, but some are more relevant than others.\n</step6>\n<step7>\nUltimately, the best approach combines various methods to ensure comprehensive results — *ìmúlò àpapọ̀*.\n</step7></thinking>", "answer": "<answer>Ìwádìí eré karbónni ti àwọn ilé ìgbà àtijọ́ ni àṣàrò ọ̀nà tí ó túbọ̀ dára jù.</answer>", "language": "Yoruba"}
{"question": "Kini ọkan lara awọn ami pataki fun didi arun iba ẹjẹ rheumatic gẹgẹ bi awọn ami Jones ti a ti ṣe atunṣe?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ọkan lara awọn [ami = signs] pataki fun [didi arun iba ẹjẹ rheumatic = diagnosing rheumatic fever] gẹgẹ bi awọn [ami Jones = Jones criteria] ti a ti ṣe atunṣe?” — meaning it seeks to identify key signs for diagnosing rheumatic fever according to the modified Jones criteria.\n</step1>\n<step2>\nThe modified Jones criteria include major and minor criteria for diagnosis — *awọn ilana pataki ati kekere* ti a lo lati ṣe ayẹwo arun iba ẹjẹ rheumatic.\n</step2>\n<step3>\nMajor criteria consist of signs like *carditis* (inflammation of the heart), *polyarthritis* (joint inflammation), and *chorea* (involuntary movements).\n</step3>\n<step4>\nMinor criteria include symptoms such as fever, arthralgia (joint pain), and elevated acute phase reactants — *awọn nkan ti o ga ni ipele akute*.\n</step5>\n<step5>\nTo diagnose rheumatic fever, a combination of major and minor criteria must be present, along with evidence of a recent streptococcal infection — *iṣẹlẹ ti arun streptococcal to ṣẹṣẹ*.\n</step6>\n<step6>\nThus, one key sign for diagnosing rheumatic fever is the presence of *carditis* or *polyarthritis* as part of the major criteria.\n</step6></thinking>", "answer": "<answer>Ọkan lara awọn ami pataki fun didi arun iba ẹjẹ rheumatic ni *carditis* tabi *polyarthritis* gẹgẹ bi awọn ami Jones ti a ti ṣe atunṣe.</answer>", "language": "Yoruba"}
{"question": "Vitamin K nilo ṣiṣẹ́ awọn ohun elo ẹjẹ̀ kí wọn lè ṣiṣẹ́.  Aminos acid wo ni a ńfi carboxylate?\nA. Histidine\nB. Histamine\nC. Glutamate\nD. Aspaate", "reasoning": "<thinking><step1>\nThe question asks: “Aminos acid wo ni a ńfi carboxylate?” which translates to \"Which amino acid is carboxylated?\" This refers to the process where a carboxyl group is added to an amino acid, often influenced by Vitamin K.\n</step1>\n<step2>\nVitamin K is essential for the synthesis of certain proteins that regulate blood coagulation — *ìdàgbàsókè ẹjẹ̀*. It plays a crucial role in the carboxylation of specific amino acids.\n</step2>\n<step3>\nThe amino acid that is primarily carboxylated by Vitamin K is glutamate — *glutamate* — which is converted into gamma-carboxyglutamate.\n</step3>\n<step4>\nThis modification is important for the function of clotting factors, as it allows them to bind calcium ions — *ion kálṣíọ́mù* — which is necessary for their activity.\n</step4>\n<step5>\nAmong the options provided, glutamate is the only amino acid that undergoes this specific carboxylation process due to Vitamin K.\n</step5>\n<step6>\nThus, the correct answer to the question is glutamate, as it is the amino acid that is carboxylated in the presence of Vitamin K.\n</step6></thinking>", "answer": "<answer>Glutamate ni aminos acid ti a ńfi carboxylate.</answer>", "language": "Yoruba"}
{"question": "Àwọn abajade ilé-ẹ̀kọ́ọ̀gùn fún àlùfáà kan pẹ̀lú pH 7.2, HCO3- ti 10 meq/L, àti PCO2 ti 30 mm Hg, kini àrùn acid-base tí ó wà?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn abajade ilé-ẹ̀kọ́ọ̀gùn fún àlùfáà kan pẹ̀lú [pH 7.2], [HCO3- ti 10 meq/L], àti [PCO2 ti 30 mm Hg]?” — meaning it wants to determine the acid-base disorder based on these laboratory results.\n</step1>\n<step2>\nA pH of 7.2 indicates *acidosis* since it is below the normal range of 7.35 to 7.45. This suggests that the patient is experiencing some form of acid-base imbalance.\n</step2>\n<step3>\nThe bicarbonate level (HCO3-) is 10 meq/L, which is significantly low — *bicarbonate ti o wa ni isalẹ*. Normal levels are typically between 22 to 26 meq/L, indicating a metabolic component.\n</step3>\n<step4>\nThe PCO2 is 30 mm Hg, which is low, suggesting *hyperventilation* or respiratory compensation. This indicates that the body is trying to compensate for the metabolic acidosis by blowing off CO2.\n</step4>\n<step5>\nPutting this all together, we have a low pH (acidosis), low HCO3- (metabolic acidosis), and low PCO2 (respiratory compensation). This points to *metabolic acidosis* with respiratory compensation.\n</step5>\n<step6>\nIn summary, the acid-base disorder present is metabolic acidosis, as indicated by the laboratory results.\n</step6></thinking>", "answer": "<answer>Àrùn acid-base tí ó wà ni *metabolic acidosis* pẹ̀lú *respiratory compensation*.</answer>", "language": "Yoruba"}
{"question": "Okùnrin ará Àmẹ́ríkà tó jẹ́ ọmọ Nàìjíríà ọdún méjìlélógójì kan wá pẹ̀lú ìgbóná ojú ati ìṣòro ìmímú afẹ́fẹ́ lẹ́yìn tí ó bẹ̀rẹ̀ sí í lo lisinopril ati atorvastatin àwọn ọ̀sẹ̀ díẹ̀ sẹ́yìn. Ìtàn ìṣègùn rẹ̀ pẹlu àtìgbàgbọ́ ẹ̀jẹ̀ gíga ati dyslipidemia, ati pé òun ní ipele C1 esterase inhibitor tó dára. Nígbà tí a bá gbé àwọn nǹkan wọnyi yẹ̀ wò, kí ni àlàyé tí ó bá gbọ́dọ̀ jùlọ fún ipo rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks about a 37-year-old American man of Nigerian descent who has developed facial swelling and breathing difficulties after starting lisinopril and atorvastatin. It also mentions his medical history of hypertension and dyslipidemia, along with a good level of C1 esterase inhibitor.\n</step1>\n<step2>\nFacial swelling and breathing difficulties can indicate *angioedema*, which is a potential side effect of lisinopril — *lisinopril* le fa angioedema, especially in individuals with certain genetic predispositions.\n</step2>\n<step3>\nGiven his history of high blood pressure — *ìtàn àtìgbàgbọ́ ẹ̀jẹ̀ gíga* — and dyslipidemia, the introduction of these medications could have triggered an adverse reaction.\n</step3>\n<step4>\nThe presence of a good level of C1 esterase inhibitor suggests that hereditary angioedema is less likely, but it does not rule out drug-induced angioedema.\n</step4>\n<step5>\nIn this case, the most critical explanation for his condition would be the possibility of *angioedema* due to lisinopril, which requires immediate medical attention.\n</step5>\n<step6>\nTherefore, the patient should discontinue lisinopril and seek urgent care to manage the symptoms and assess the severity of the reaction.\n</step6></thinking>", "answer": "<answer>Ìtàn rẹ̀ fihan pé angioedema ni o ṣee ṣe, nitori lisinopril, tó yẹ kí ó fa ìṣòro ìmímú afẹ́fẹ́ àti ìgbóná ojú.</answer>", "language": "Yoruba"}
{"question": "Kí ni òtòṣì tí kò ní ipa lórí bí àwọn ìgbéṣẹ̀ ọkùnrin àti obìnrin ṣe wà nínú àṣà tàbí àwùjọ kan?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni òtòṣì tí kò ní ipa lórí bí àwọn ìgbéṣẹ̀ [actions] ọkùnrin [men] àti obìnrin [women] ṣe wà nínú àṣà [culture] tàbí àwùjọ [society] kan?” — meaning it wants to know what differences exist that do not affect how men's and women's actions are perceived in a culture or society.\n</step1>\n<step2>\nIn many cultures, there are traditional roles assigned to men and women — *àwọn ipa àtọkànwá* — which can influence their actions and behaviors.\n</step2>\n<step3>\nHowever, some differences, like personal interests or hobbies, may not impact societal expectations — *àwọn ìfẹ́kúfẹ́ tàbí iṣẹ́ àkànṣe* can be pursued by both genders without stigma.\n</step3>\n<step4>\nFor instance, a man may enjoy cooking, and a woman may enjoy mechanics — *kíkọ́* and *mẹ́kàníkì* are activities that can be shared regardless of gender.\n</step4>\n<step5>\nMoreover, in progressive societies, the emphasis on equality allows for more fluid roles — *ìbáṣepọ̀ àtàwọn ipa tó rọrùn* can lead to a more inclusive environment.\n</step5>\n<step6>\nThus, differences that do not affect actions could include personal preferences or interests that transcend gender norms — *àwọn ìfẹ́kúfẹ́ ti kò ní ipa lórí àṣà*.\n</step6></thinking>", "answer": "<answer>Òtòṣì tí kò ní ipa lórí bí àwọn ìgbéṣẹ̀ ọkùnrin àti obìnrin ṣe wà nínú àṣà ni àwọn ìfẹ́kúfẹ́ tàbí iṣẹ́ àkànṣe tí kò ní ìdí kankan.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun mẹrinlelogun (36) kan tí ó ní irora ikun-ilẹ̀kùn ati idanwo ẹ̀mí urea rere ní ìgbà tí ó mu ọti-waini lakoko itọju, ó ní ìgbona ara, orí-irora, ìgbẹ̀rùn ati ògbẹ́.  Kini iṣẹ́ ẹ̀rọ ti oògùn ti o fa awọn àìlera wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “What is the mechanism of the drug that causes these symptoms?” — referring to a 36-year-old woman with abdominal pain, elevated urea levels, fever, headache, nausea, and vomiting after consuming alcohol during treatment.\n</step1>\n<step2>\nThe symptoms suggest a possible reaction to a medication, especially since she consumed *ọti-waini* (alcohol) while on treatment — which can interact negatively with certain drugs.\n</step2>\n<step3>\nElevated urea levels indicate potential kidney stress or damage — *ìfarapa ẹdọfóró* — which can occur if the drug is nephrotoxic.\n</step3>\n<step4>\nCommon medications that can cause such symptoms include non-steroidal anti-inflammatory drugs (NSAIDs) or certain antibiotics, which can lead to *ìgbẹ̀rùn* (nausea) and *ògbẹ́* (vomiting).\n</step4>\n<step5>\nAdditionally, alcohol can exacerbate the side effects of these medications, leading to increased *ìgbona ara* (fever) and *orí-irora* (headache).\n</step5>\n<step6>\nThus, the mechanism of the drug likely involves renal impairment and gastrointestinal irritation, compounded by the alcohol intake.\n</step6></thinking>", "answer": "<answer>Iṣẹ́ ẹ̀rọ ti oògùn naa ni ìfarapa ẹdọfóró ati ìgbẹ̀rùn, ti a fa nipasẹ ìmú ọti-waini.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹsan kan wà pẹlu iba, ẹ̀jẹ̀ lẹhin fifọ ehin, rirẹ, rirẹ̀, ati ẹ̀jẹ̀ labẹ́ awọ ara. Awọn abajade idanwo ile-iwosan rẹ̀ fihan iye hemoglobin ti 7 g/dL, iye leukocyte ti 2,000/mm3, iye platelet ti 40,000/mm3, ati iye reticulocyte ti 0.2%. Ti a ba gbero awọn aami aisan ati awọn abajade idanwo ile-iwosan wọnyi, kini iwa aisan ti o ṣeeṣe julọ lori biopsy ida kan fun alaisan yii?", "reasoning": "<thinking><step1>\nThe question describes a nine-year-old boy with symptoms like fever, blood after coughing, fatigue, and skin bleeding. It also provides lab results: hemoglobin of 7 g/dL, leukocyte count of 2,000/mm3, platelet count of 40,000/mm3, and reticulocyte count of 0.2%. We need to determine the most likely disease based on these symptoms and lab results.\n</step1>\n<step2>\nThe low hemoglobin indicates *anemia*, which can be caused by various conditions. The leukocyte count is also low, suggesting *leukopenia*, and the platelet count is significantly reduced, indicating *trombocitopenia*.\n</step2>\n<step3>\nThese findings, combined with the symptoms of fever and bleeding, suggest a possible bone marrow issue. Conditions like *aplastic anemia* or *leukemia* could be considered.\n</step3>\n<step4>\nHowever, the very low reticulocyte count of 0.2% indicates that the bone marrow is not producing enough red blood cells, which is characteristic of *aplastic anemia*.\n</step4>\n<step5>\nIn a biopsy, we would expect to see a reduction in hematopoietic cells, confirming the diagnosis of aplastic anemia. This condition is often associated with autoimmune disorders or exposure to certain toxins.\n</step5>\n<step6>\nThus, considering all the symptoms and lab results, the most likely diagnosis for this patient is *aplastic anemia*.\n</step6></thinking>", "answer": "<answer>Iwa aisan ti o ṣeeṣe julọ fun alaisan yii ni *aplastic anemia*.</answer>", "language": "Yoruba"}
{"question": "Báwo ni ẹnìkan tí ó jẹ́ ọ̀gá tó máa dáhùn sí ọ̀rọ̀ kọ̀ọ̀kan wọ̀nyí nípa ohun tí ó fa irú ìṣẹ̀lẹ̀ kan?\nDrew, Kylie, Oliver, àti Jen jẹ́ àwọn oníbàárà tí wọ́n máa ń lọ sí ilé itọ́jú káfíì kan tí ó wà ní agbègbè. Bí a bá wo owó tí a fi ń ta káfíì àti owó ìnáwó ojoojúmọ́, ilé itọ́jú káfíì náà á ní èrè bí ẹnìkan bá ra káfíì ní ọjọ́ kan pàtó. Ẹnìkan ṣoṣo ni ó gbọ́dọ̀ ra káfíì kí ilé itọ́jú káfíì náà lè ní èrè ní ọjọ́ náà. Kylie àti Oliver sábà máa ń ra káfíì ní ọjọ́ Ẹtì. Ṣùgbọ́n, Drew kò sábà máa ń ra káfíì ní ọjọ́ Ẹtì. Ní ọjọ́ Ẹtì yìí, ohun tí kò ti sí rí ṣẹlẹ̀, Drew ra káfíì. Ní ọjọ́ kan náà, Kylie ra káfíì, Oliver sì tún ra káfíì. Nítorí pé òpọlọpọ ènìyàn ra káfíì ní ọjọ́ Ẹtì, ilé itọ́jú káfíì náà ní èrè ní ọjọ́ náà. Ṣé Drew tí ó ra káfíì ní ọjọ́ Ẹtì ló fa kí ilé itọ́jú káfíì náà ní èrè ní ọjọ́ náà?\nÀwọn àṣàyàn:\n- Bẹ́ẹ̀ ni\n- Rárá", "reasoning": "<thinking><step1>\nThe question asks: \"Did Drew, who bought coffee on Friday, cause the café to make a profit that day?\" — it implies a need to analyze the purchasing behavior of customers.\n</step1>\n<step2>\nThe café needs at least one customer to buy coffee to make a profit on a specific day — *ilé itọ́jú káfíì náà gbọ́dọ̀ ní oníbàárà kan*.\n</step2>\n<step3>\nKylie and Oliver usually buy coffee on Fridays, but Drew does not typically do so — *Drew kò sábà máa ń ra káfíì ní ọjọ́ Ẹtì*.\n</step3>\n<step4>\nHowever, on this particular Friday, Drew bought coffee, along with Kylie and Oliver — *Drew ra káfíì, Kylie ra káfíì, Oliver sì tún ra káfíì*.\n</step5>\n<step5>\nSince many people bought coffee that day, the café made a profit — *ilé itọ́jú káfíì náà ní èrè ní ọjọ́ náà*.\n</step6>\n<step6>\nThus, Drew's purchase contributed to the overall sales, leading to the café's profit on that Friday.\n</step7>\n<step7>\nTherefore, it can be concluded that Drew's action did indeed help the café make a profit that day.\n</step7></thinking>", "answer": "<answer>Bẹ́ẹ̀ ni.</answer>", "language": "Yoruba"}
{"question": "Obirin ọmọ ọdun mẹrindilogun kan fi ìrora ara, iba, orí gbọn, ati ọrùn ríru hàn.  Nígbà àyẹ̀wò, a rí i pé ọkan ninu awọn ọmọlẹ́yìn rẹ̀ ti fẹ̀, ti sì tobi ju ti ekeji lọ, ati papilledema.  Kò yẹ kí a ṣe èyíkéyìí nínú àwọn wọ̀nyí ní ìtọ́jú ìṣàkóso àkọ́kọ́, YÀTỌ̀ sí:\nA. Ṣíṣe intubation ati hyperventilation\nB. Ṣíṣe Mannitol lọ́wọ́\nC. Ṣíṣe Computerized tomography ti ori\nD. Ṣíṣe Lumbar puncture", "reasoning": "<thinking><step1>\nThe question describes a 14-year-old girl with symptoms like body pain, fever, headache, and neck stiffness — *ìrora ara, iba, orí gbọn, ati ọrùn ríru*. It mentions that during examination, one of her pupils is dilated and larger than the other, indicating possible *papilledema*.\n</step1>\n<step2>\nIn this context, *papilledema* suggests increased intracranial pressure, which is a critical condition. We need to consider the safest initial management options.\n</step2>\n<step3>\nThe options provided include intubation and hyperventilation, administering Mannitol, performing a CT scan of the head, and doing a lumbar puncture. Each has different implications for a patient with suspected increased intracranial pressure.\n</step3>\n<step4>\nIntubation and hyperventilation might be necessary in severe cases, but they are not first-line treatments for increased intracranial pressure. A lumbar puncture could worsen the condition if there is significant pressure.\n</step4>\n<step5>\nA CT scan of the head is crucial to rule out any mass effect or hemorrhage before any invasive procedures. However, administering Mannitol is a direct treatment for reducing intracranial pressure.\n</step5>\n<step6>\nGiven the scenario, the best initial management that stands out is administering Mannitol, as it effectively reduces pressure and is appropriate in this context.\n</step6></thinking>", "answer": "<answer>Ṣíṣe Mannitol lọ́wọ́.</answer>", "language": "Yoruba"}
{"question": "Kini iṣẹ́ ṣiṣe ti Herceptin (trastuzumab) nigba ti a ba lo lati toju aarun kanṣa ọmu?", "reasoning": "<thinking><step1>\nThe question asks: “Kini iṣẹ́ ṣiṣe ti Herceptin (trastuzumab)?” — meaning it wants to know the mechanism of action of Herceptin when used to treat breast cancer.\n</step1>\n<step2>\nHerceptin is a monoclonal antibody that specifically targets the HER2 protein — *HER2 jẹ́ àpẹẹrẹ kan ti ẹ̀dá àtọka ti o n pọ si ni diẹ ninu awọn aarun kanṣa ọmu*.\n</step2>\n<step3>\nIn breast cancer, overexpression of HER2 leads to aggressive tumor growth — *ìtẹ̀sí àtọka HER2 n fa idagbasoke àrùn kanṣa ti o lagbara*.\n</step4>\n<step5>\nBy binding to HER2, Herceptin inhibits cell proliferation and promotes apoptosis — *Herceptin n dènà ìdàgbàsókè àwọn sẹẹli àti n fa ikú sẹẹli*.\n</step6>\n<step7>\nAdditionally, it recruits immune cells to attack the tumor — *o n fa awọn sẹẹli ajẹsara lati kọlu àrùn naa*.\n</step8>\n<step9>\nThus, Herceptin plays a crucial role in targeted therapy for HER2-positive breast cancer — *Herceptin jẹ́ pataki ninu itọju ti a fojú kọ fun aarun kanṣa ọmu ti o ni HER2*.\n</step9></thinking>", "answer": "<answer>Herceptin n ṣiṣẹ́ nipa dènà HER2, n fa ikú sẹẹli, ati n fa awọn sẹẹli ajẹsara lati kọlu àrùn kanṣa ọmu.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọmọ ọdún mẹ́ẹ̀ẹ́dọ́gbọ̀n kan ṣàkọ́kọ́ pé fífẹ́rẹ̀ẹ́ ẹnu rẹ̀ lọ́rọ̀ọ̀rọ̀, nígbà gbogbo, ń ṣe é ní ìrora, yàtọ̀ sí fífúnni ní ẹ̀jẹ̀ púpọ̀.  Àyẹ̀wò ẹnu fi hàn pé èrò ohun tí ó gbàgbé lórí igi ehin àwọn méjèèjì.  Níní ìṣòro ara ìdààmú wo ni àìsàn yìí ṣeé ṣe jù lọ́wọ́ àwọn ọmọlẹ́yìn yìí?\nA.  Pemphigiod mucous membrane tí kò lewu\nB.  Lupus erythematosus discoid tí ó gbòkè gbòkè\nC. Pemphigus\nD. Psoriasis", "reasoning": "<thinking><step1>\nThe question is asking about a 35-year-old woman who experiences painful oral lesions and bleeding, with examination showing lesions on both gums — *ẹnu* and *igi ehin*.\n</step1>\n<step2>\nThese symptoms suggest a possible autoimmune condition, as they involve inflammation and lesions — *ìrora* and *àìlera* in the mouth.\n</step2>\n<step3>\nAmong the options, Pemphigus is known for causing painful blisters in the mouth and can lead to significant discomfort — *ìrora*.\n</step3>\n<step4>\nPemphigoid mucous membrane is less severe and typically does not cause the same level of pain or bleeding as Pemphigus — *fífúnni ní ẹ̀jẹ̀*.\n</step4>\n<step5>\nLupus erythematosus discoid can cause skin lesions but is less likely to present primarily with oral symptoms — *àyẹ̀wò ẹnu*.\n</step6>\n<step6>\nPsoriasis primarily affects the skin and is not typically associated with oral lesions — *ìṣòro ara*.\n</step7>\n<step7>\nThus, the most likely condition causing these symptoms is Pemphigus, which aligns with the painful oral lesions and bleeding.\n</step7></thinking>", "answer": "<answer>Pemphigus ni àìsàn tó dájú jùlọ tí ó fa ìrora àti fífúnni ní ẹ̀jẹ̀ nínú ẹnu.</answer>", "language": "Yoruba"}
{"question": "Lakoko iṣẹ abẹ fun aisan apandiseki ti a gbagbọ, a rii pe apandiseki alaisan ti kun pupọ, o sì lewu bi roba. Serosa naa gbẹ̀rù, o sì rẹ, ati mesentery naa sì kun pẹlu ọra ti n dagba ni ayika iwaju inu.  Aye wiwo ti o pọju julọ\nA. Arun Ileal Crohn's\nB. Meckel's diveiculitis\nC. Ulcerative colitis\nD. Ileocecal tuberculosis", "reasoning": "<thinking><step1>\nThe question describes a surgical finding during an appendectomy for suspected appendicitis, noting that the appendix is very swollen and potentially dangerous, with the serosa being inflamed and the mesentery filled with fat. This suggests a serious condition affecting the intestines.\n</step1>\n<step2>\nThe key terms here include \"apandiseki\" [appendix], \"serosa\" [serosa], and \"mesentery\" [mesentery]. The description indicates significant inflammation and fat deposition, which are critical in diagnosing intestinal diseases.\n</step2>\n<step3>\nAmong the options, *Arun Ileal Crohn's* is known for causing transmural inflammation and can lead to strictures and fat wrapping around the intestines — *fibrose et graisseux*.\n</step3>\n<step4>\n*Meckel's diverticulitis* typically presents with localized pain and may not cause widespread mesenteric fat deposition. *Ulcerative colitis* primarily affects the colon and is less likely to present with these findings in the appendix.\n</step4>\n<step5>\n*Ileocecal tuberculosis* can cause similar symptoms but is less common and usually presents with systemic signs of infection. Given the description of the findings, Crohn's disease is the most fitting diagnosis.\n</step5>\n<step6>\nThus, the most likely diagnosis based on the surgical findings is *Arun Ileal Crohn's* due to the severe inflammation and fat deposition around the mesentery.\n</step6></thinking>", "answer": "<answer>Arun Ileal Crohn's ni aisan ti o ṣeeṣe julọ da lori awọn awari iṣẹ abẹ.</answer>", "language": "Yoruba"}
{"question": "Da didun ti a gbọ́ nípa ìṣòro ọkàn ati àpẹẹrẹ obìnrin ọdun 18 kan tí ó ní ìtàn irora ọrùn oṣù mẹta sẹhin ati irora awọn isẹpo, kini ayẹwo ti o ṣeeṣe julọ ti o ni ibatan si awọn abajade ọkàn ti o tobi?", "reasoning": "<thinking><step1>\nThe question translates to: \"Based on the information about a mental health issue and an example of an 18-year-old woman who has a history of neck pain three months ago and joint pain, what is the most likely diagnosis related to significant mental health outcomes?\" \n</step1>\n<step2>\nThis scenario suggests a possible connection between physical symptoms — *irora ọrùn* (neck pain) and *irora awọn isẹpo* (joint pain) — and mental health issues, which could indicate a psychosomatic disorder.\n</step2>\n<step3>\nIn young women, conditions like depression or anxiety can manifest physically, leading to chronic pain — *irora àkókò* that may not have a clear medical cause.\n</step3>\n<step4>\nThe history of pain lasting three months suggests a persistent issue, which could be linked to stress or emotional distress — *ìbànújẹ* that affects her overall well-being.\n</step5>\n<step6>\nConsidering these factors, a likely diagnosis could be *ìṣòro ọkàn* (mental health disorder) such as somatic symptom disorder, where psychological distress presents as physical symptoms.\n</step6>\n<step7>\nAdditionally, the age of the patient and the chronic nature of her symptoms point towards the need for a comprehensive evaluation of both her physical and mental health.\n</step7></thinking>", "answer": "<answer>Ìṣòro ọkàn ti o ṣeeṣe julọ ni *ìṣòro àkópọ̀* (somatic symptom disorder) ti o ni ibatan si irora ti ara.</answer>", "language": "Yoruba"}
{"question": "Aṣọ̀fin vitamin wo ni o ṣe afihan ni pataki nipasẹ awọn iṣẹ́ ìpalára lórí awọn ilẹ̀kèèkèèmucocutaneous ti ẹnu ati awọ ara, vascularization corneal, aini ẹ̀jẹ̀, ati awọn iyipada ihuwasi?", "reasoning": "<thinking><step1>\nThe question asks: “Aṣọ̀fin vitamin wo ni o ṣe afihan ni pataki…” which translates to “Which vitamin is primarily indicated by the impairment of mucocutaneous surfaces of the mouth and skin, corneal vascularization, blood deficiency, and behavioral changes?” \n</step1>\n<step2>\nThe symptoms described suggest a deficiency condition. Mucocutaneous surfaces, or *àwọn ilẹ̀kèèkèèmucocutaneous*, often relate to vitamin deficiencies affecting skin and oral health.\n</step2>\n<step3>\nCorneal vascularization indicates issues with the eye, which can be linked to vitamin A deficiency — *aṣiṣe vitamin A* — as it is crucial for maintaining healthy vision and skin.\n</step3>\n<step4>\nBlood deficiency, or *aini ẹ̀jẹ̀*, can also be associated with vitamin deficiencies, particularly vitamin B12, but the specific symptoms point more towards vitamin A.\n</step4>\n<step5>\nBehavioral changes can occur with vitamin A deficiency as well, affecting overall health and cognitive function — *ihuwasi*.\n</step5>\n<step6>\nThus, the vitamin that is primarily indicated by these symptoms is vitamin A, which is essential for mucosal integrity and vision.\n</step6></thinking>", "answer": "<answer>Aṣọ̀fin vitamin A ni o ṣe afihan ni pataki nipasẹ awọn iṣẹ́ ìpalára lórí awọn ilẹ̀kèèkèèmucocutaneous, vascularization corneal, aini ẹ̀jẹ̀, ati awọn iyipada ihuwasi.</answer>", "language": "Yoruba"}
{"question": "Kini pH ojutu kan ti o ni iṣẹ́ iwọn hydrogen ion ti 3.5 × 10^-4, ati kini iṣẹ́ iwọn hydrogen ion naa bí pH ojutu naa bá jẹ́ 4.25?", "reasoning": "<thinking><step1>\nThe question asks: “Kini pH ojutu kan ti o ni [iṣẹ́ iwọn hydrogen ion = hydrogen ion concentration] ti 3.5 × 10^-4?” — meaning it wants to find the pH of a solution with a specific hydrogen ion concentration.\n</step1>\n<step2>\nTo calculate pH, we use the formula: *pH = -log10([H+])* where [H+] is the hydrogen ion concentration.\n</step2>\n<step3>\nHere, [H+] = 3.5 × 10^-4, so we calculate: *pH = -log10(3.5 × 10^-4)*.\n</step3>\n<step4>\nUsing a calculator, we find that *log10(3.5 × 10^-4) ≈ -3.46*, thus *pH ≈ 3.46*.\n</step4>\n<step5>\nNext, the question also asks: “kini [iṣẹ́ iwọn hydrogen ion = hydrogen ion concentration] naa bí pH ojutu naa bá jẹ́ 4.25?” — meaning we need to find the hydrogen ion concentration when pH is 4.25.\n</step6>\n<step6>\nUsing the formula again, we rearrange it to find [H+]: *[H+] = 10^(-pH)*. So, for pH = 4.25, we calculate: *[H+] = 10^(-4.25)*.\n</step7>\n<step7>\nCalculating this gives us approximately *[H+] ≈ 5.62 × 10^-5*.\n</step7></thinking>", "answer": "<answer>pH ojutu kan ti o ni iṣẹ́ iwọn hydrogen ion ti 3.5 × 10^-4 jẹ́ 3.46, ati iṣẹ́ iwọn hydrogen ion naa bí pH ojutu naa bá jẹ́ 4.25 ni 5.62 × 10^-5.</answer>", "language": "Yoruba"}
{"question": "Obirin ọmọ ọdun mẹtadinlọgbọn kan wá pẹlu ìṣoro mimu ounjẹ, tí kò sì ń burú sí i, fún ounjẹ ríru ati omi.  Kí ni àmì ìdánilójú lórí àyẹ̀wò barium tí yóò jẹ́risi àìsàn náà?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àmì ìdánilójú lórí àyẹ̀wò barium tí yóò jẹ́risi àìsàn náà?” — meaning it wants to know what the diagnostic signs on a barium swallow test would confirm for a 35-year-old woman with eating difficulties and no worsening symptoms.\n</step1>\n<step2>\nA barium swallow test is used to visualize the esophagus and identify any abnormalities — *àyẹ̀wò barium* n jẹ́ kí a rí ohun tó n ṣẹlẹ̀ nínú *esophagus*.\n</step2>\n<step3>\nIn cases of eating difficulties, one might look for signs of *àìlera* or structural issues like strictures or tumors.\n</step3>\n<step4>\nCommon findings could include *ìkànsí* (narrowing) of the esophagus or *ìfarapa* (inflammation) that might indicate an underlying condition.\n</step4>\n<step5>\nIf the test shows delayed passage of barium, it suggests a motility disorder — *àìlera mímu* nínú *esophagus*.\n</step6>\n<step6>\nThus, the diagnostic signs on the barium swallow test would confirm issues related to the esophagus that could explain her eating difficulties.\n</step6></thinking>", "answer": "<answer>Àmì ìdánilójú lórí àyẹ̀wò barium lè jẹ́ kí a rí ìkànsí tàbí ìfarapa nínú esophagus, tó lè jẹ́risi àìlera mímu.</answer>", "language": "Yoruba"}
{"question": "Awọn oògùn wo ni wọ́n sábà máa ń lò láti tọ́jú àrùn àìlera ìṣàṣeéṣe ati ìṣe àìdèédéé (ADHD), yàtọ̀ sí àwọn tí kì í ṣe àwọn tí wọ́n sábà máa ń kọ́wé fún àrùn yìí?", "reasoning": "<thinking><step1>\nThe question asks: “What medications are commonly used to treat [àrùn àìlera ìṣàṣeéṣe = attention deficit hyperactivity disorder (ADHD)], aside from those typically prescribed for this condition?” \n</step1>\n<step2>\nADHD is often treated with stimulant medications like *methylphenidate* and *amphetamine*, which help increase attention and decrease impulsivity.\n</step2>\n<step3>\nHowever, there are non-stimulant options available, such as *atomoxetine*, which is used when stimulants are not effective or cause undesirable side effects.\n</step3>\n<step4>\nAdditionally, some doctors may prescribe *antidepressants* like *bupropion* or *tricyclic antidepressants* for patients who also experience symptoms of anxiety or depression.\n</step4>\n<step5>\nIt's important to note that treatment plans should be individualized, as *ìtọju* may vary based on the patient's specific symptoms and needs.\n</step5>\n<step6>\nIn summary, while stimulants are the first-line treatment, alternatives like *atomoxetine* and certain antidepressants can also be effective for managing ADHD symptoms.\n</step6></thinking>", "answer": "<answer>Àwọn oògùn tí wọ́n sábà máa ń lò láti tọ́jú àrùn ADHD ni *atomoxetine* àti *bupropion*, yàtọ̀ sí àwọn oògùn ìṣàkóso.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 50 kan ti o ní itan-akọọlẹ àrùn suga iru keji tí a ṣakoso daradara ati mimu ọti-lile ojoojumọ ti ni àrùn ikuna ibalopo, edema pedal bilateral, iwọn iwọn testicular dinku, àpòpò ara ọmu dara si, ati spleen ti o le ṣe ipalara. Awọn aworan fihan ẹdọ ti o ti bajẹ, hyperechoic, nodular, ati upper endoscopy ṣafihan awọn veins submucosal ti o tobi to 2 mm pẹlu awọn aami pupa ni distal esophagus. Kini igbesẹ ti o yẹ julọ ni atẹle ni isakoso awọn varices esophageal yii?", "reasoning": "<thinking><step1>\nThe question asks: “Kini igbesẹ ti o yẹ julọ ni atẹle ni isakoso awọn [varices esophageal = esophageal varices]?” — meaning it seeks to determine the best next step in managing esophageal varices in a patient with a complex medical history.\n</step1>\n<step2>\nThe patient is a 50-year-old man with well-controlled type 2 diabetes and daily alcohol consumption, presenting with erectile dysfunction and bilateral pedal edema — *edema ẹsẹ mejeeji*.\n</step2>\n<step3>\nThe imaging shows a damaged liver with hyperechoic and nodular characteristics, indicating possible cirrhosis — *cirrhosis* le fa awọn varices esophageal.\n</step3>\n<step4>\nUpper endoscopy reveals submucosal veins larger than 2 mm with red signs in the distal esophagus, which indicates a high risk of bleeding — *iwuwo eewu ti ikọlu*.\n</step4>\n<step5>\nIn managing esophageal varices, the first step is often to initiate prophylactic treatment to prevent bleeding, typically using beta-blockers — *beta-blockers* le dinku titẹ ninu awọn varices.\n</step5>\n<step6>\nAdditionally, if the varices are at high risk of bleeding, endoscopic variceal ligation (EVL) may be considered — *ligadura variceal endoscopic* jẹ ọna ti o munadoko.\n</step6>\n<step7>\nGiven the patient's condition, the most appropriate next step would be to start beta-blocker therapy while preparing for possible endoscopic intervention.\n</step7></thinking>", "answer": "<answer>Igbesẹ ti o yẹ julọ ni lati bẹrẹ itọju beta-blocker lati dinku eewu ikọlu.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mẹ́rin-dín-lẹ́gbẹ̀ta (78) kan wá pẹ̀lú ìrora orí, ìdààmú ìríra, àti irora ní àgbègbè tẹ́mpọ́rù ọ̀nà ọ̀tún rẹ̀. Kí ni ohun tí ó ṣeé ṣe jùlọ láti rí nínú biopsy tí a gba láti inú àtẹ́mpọ́rù ọ̀nà ọ̀tún rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What is most likely to be found in a biopsy taken from the right temporal artery of a 78-year-old man with headache, visual disturbances, and pain in that area?” — it refers to a potential medical condition affecting the temporal artery.\n</step1>\n<step2>\nGiven the symptoms, this patient may be experiencing *artériitis temporalis* or temporal arteritis, which is common in older adults.\n</step2>\n<step3>\nIn a biopsy of the temporal artery, one would expect to see *inflammation* — specifically, *l'inflammation des parois des artères*.\n</step3>\n<step4>\nHistologically, this often presents as *cellules géantes* (giant cells) and lymphocytic infiltration, indicating a granulomatous process.\n</step4>\n<step5>\nAdditionally, the presence of *nécrose* (necrosis) in the arterial wall can also be a significant finding, which is characteristic of this condition.\n</step5>\n<step6>\nThus, the biopsy results would likely show signs of *artériitis* with giant cell formation and inflammation of the artery.\n</step6></thinking>", "answer": "<answer>Biopsy kan yoo fihan àkópọ̀ àìlera, pẹ̀lú *cellules géantes* àti *l'inflammation des parois des artères*.</answer>", "language": "Yoruba"}
{"question": "Onísẹ́ ọ̀dàágbà kan ní ọgbẹ́ tí ó ń tú. Ìwádìí ilé-ìwòsàn fi hàn ní diplococci gram-negative àti ìdàgbàsíwá lórí àwọn èròjà Thayer Martin tí a yí pọ̀. Kí ni àyèwò náà?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àyèwò náà?” — which translates to “What is the test?” It refers to a medical test related to a patient with a wound showing gram-negative diplococci.\n</step1>\n<step2>\nThe presence of gram-negative diplococci suggests a bacterial infection, likely caused by *Neisseria gonorrhoeae* or *Neisseria meningitidis*.\n</step2>\n<step3>\nThe mention of *Thayer Martin medium* indicates that the test is designed to isolate these bacteria, as this medium is selective for certain pathogens.\n</step3>\n<step4>\nIn English, we would say that the test is used to culture bacteria from a specimen, particularly when there is a suspicion of gonorrhea or meningitis.\n</step4>\n<step5>\nThe test results would help determine the appropriate antibiotic treatment, as these bacteria can be resistant to some medications.\n</step5>\n<step6>\nThus, the test is a culture test using Thayer Martin medium to identify the presence of specific gram-negative diplococci.\n</step6></thinking>", "answer": "<answer>Àyèwò náà jẹ́ àyèwò ìkó ẹ̀jẹ̀ lórí Thayer Martin láti ṣe àfihàn àkópọ̀ gram-negative diplococci.</answer>", "language": "Yoruba"}
{"question": "Kini ọ̀rọ̀ tí a ó lò láti ṣàpèjúwe ipò tí bọ́lùú kan fi dì mọ́ inú ìgbà, tí wọ́n sì tún ta ohun ìjà náà, àwọn bọ́lùú méjì náà sì jáde láti inú ìgbà náà?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ọ̀rọ̀ tí a ó lò láti ṣàpèjúwe [ipò = position] tí [bọ́lùú = ball] kan fi dì mọ́ inú [ìgbà = basket], tí wọ́n sì tún ta [ohun ìjà = object of play] náà?” — meaning it wants to know the term used to describe a situation where a ball is stuck in a basket and then two balls come out of that basket.\n</step1>\n<step2>\nIn English, this scenario describes a situation in sports or games where a ball is trapped — *le ballon est coincé* — in a basket, which is often a goal or a container.\n</step2>\n<step3>\nThe term that fits this description is likely related to basketball or similar games, where a ball can get stuck in the hoop — *le cerceau*.\n</step3>\n<step4>\nWhen the ball is freed, it can be described as *deux ballons sortent* from the basket, indicating that two balls are released.\n</step4>\n<step5>\nIn this context, the phrase “ball stuck in the basket” can be translated to Yoruba as *bọ́lùú tí a fi dì mọ́ inú ìgbà*.\n</step5>\n<step6>\nThus, the term that describes this situation is *bọ́lùú tí a fi dì mọ́ inú ìgbà*.\n</step6></thinking>", "answer": "<answer>Bọ́lùú tí a fi dì mọ́ inú ìgbà.</answer>", "language": "Yoruba"}
{"question": "Hormoni wo ni iṣelọpọ rẹ̀ kò yipada tàbí ó pọ̀ sí i nígbà tí a bá ge ẹ̀ka pituitary?", "reasoning": "<thinking><step1>\nThe question asks: “Hormoni wo ni [hormones] iṣelọpọ rẹ̀ kò yipada tàbí ó pọ̀ sí i nígbà tí a bá ge [pituitary gland]?” — meaning it wants to know which hormones are affected or not affected when the pituitary gland is removed.\n</step1>\n<step2>\nThe pituitary gland is crucial for hormone regulation, acting as the \"master gland\" — *gland maîtresse* — controlling other endocrine glands.\n</step2>\n<step3>\nWhen the pituitary is removed, certain hormones like *l'hormone de croissance* (growth hormone) and *l'hormone antidiurétique* (antidiuretic hormone) can be significantly impacted.\n</step3>\n<step4>\nHowever, some hormones, such as those produced by the adrenal glands or the thyroid, may not change immediately because they are regulated by other factors — *d'autres glandes*.\n</step4>\n<step5>\nIn Yoruba, one might say: “Àwọn homoni kan le ma yipada, ṣugbọn àwọn míì yóò ní ipa tó lágbára.”\n</step5>\n<step6>\nThus, the hormones that do not change or increase significantly after pituitary removal are primarily those regulated independently of the pituitary.\n</step6></thinking>", "answer": "<answer>Àwọn homoni tí kò yipada tàbí tí ó pọ̀ sí i nígbà tí a bá ge ẹ̀ka pituitary ni àwọn tí a kò fi ẹ̀ka pituitary ṣe àkóso wọn.</answer>", "language": "Yoruba"}
{"question": "Ní irú ẹkọ́ ìṣe àti ẹkọ́ ìṣe-àṣà, ipa wo ni àkókò ń kó nínú ìsopọ̀ láàárín àwọn ohun tí a rí àti àwọn ìdáhùn?", "reasoning": "<thinking><step1>\nThe question asks: “Ní irú ẹkọ́ ìṣe àti ẹkọ́ ìṣe-àṣà, ipa wo ni àkókò ń kó nínú ìsopọ̀ láàárín àwọn ohun tí a rí àti àwọn ìdáhùn?” — meaning it wants to know the role of time in the relationship between what we observe and our responses in behavioral and cultural studies.\n</step1>\n<step2>\nIn behavioral studies, time influences how we perceive stimuli — *àkókò ní ipa lórí bí a ṣe ń rí àwọn ohun* and how we react to them.\n</step2>\n<step3>\nFor example, immediate responses may differ from those that are delayed — *ìdáhùn lẹ́sẹkẹsẹ* versus *ìdáhùn pẹ́* can show different emotional or cognitive processes.\n</step3>\n<step4>\nIn cultural studies, time can shape traditions and practices — *àkókò ṣe àfihàn àwọn ìṣe àti àṣà* that evolve over generations.\n</step4>\n<step5>\nMoreover, the context of time affects our interpretations — *àkókò àti àyíká* can change how we understand behaviors and responses.\n</step5>\n<step6>\nThus, time acts as a crucial factor in linking observations and responses, influencing both immediate and long-term interactions.\n</step6></thinking>", "answer": "<answer>Àkókò ní ipa pataki nínú ìsopọ̀ láàárín ohun tí a rí àti ìdáhùn, nítorí ó ń ṣe àfihàn bí a ṣe ń fèsì sí àwọn ìṣàkóso àti àṣà.</answer>", "language": "Yoruba"}
{"question": "Ṣàlẹ̀wọ̀n ọ̀nà ìbàjẹ́ tí ó ṣeé ṣe fún àkórò kan tí a rí nígbà tí a ṣe àyẹ̀wò òògùn, tí a gba nípa jíjẹ́.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣàlẹ̀wọ̀n ọ̀nà ìbàjẹ́ tí ó ṣeé ṣe fún àkórò kan tí a rí nígbà tí a ṣe àyẹ̀wò òògùn, tí a gba nípa jíjẹ́?” — meaning it wants to know the possible ways of contamination for a sample found during a drug test that was ingested.\n</step1>\n<step2>\nContamination can occur through various means, such as *àkórò* being exposed to unclean surfaces or equipment — *ibèèrè àkórò*.\n</step2>\n<step3>\nAnother way is through improper handling during collection — *ìmúlò àìtọ́* when taking the sample can introduce foreign substances.\n</step3>\n<step4>\nAdditionally, if the sample is not stored correctly, it can degrade or become contaminated — *ìtẹ́wọ́gba àkórò* must be done under controlled conditions.\n</step4>\n<step5>\nEnvironmental factors, like air quality or contact with other substances, can also lead to contamination — *àkórò le ní àkúnya* from external sources.\n</step5>\n<step6>\nIn summary, contamination can arise from handling, storage, and environmental exposure — *ìbàjẹ́ le ṣẹlẹ̀ láti ọwọ́, ibi ipamọ́, àti ayika*.\n</step6></thinking>", "answer": "<answer>Ìbàjẹ́ le ṣẹlẹ̀ láti ọwọ́, ibi ipamọ́, àti ayika.</answer>", "language": "Yoruba"}
{"question": "Obìnrin kan tó lóyè ọdún méjìlélógún (32) tí ó lóyún wá pẹ̀lú ìrora ìgbàgbọ́, ìrora ikùn, àti àìsàn ẹ̀gbà gbígbẹ́ gidigidi fún ọjọ́ mẹ́ta lẹ́yìn tí ó bẹ̀rẹ̀ sí í mu amoxicillin. Ó ní iba, iye ẹ̀jẹ̀ funfun ṣíṣe pọ̀, àti ohun èébì rẹ̀ jẹ́ rere fún ẹ̀jẹ̀ tí kò hàn. Bí a bá gbé àwọn ààmì àrùn wọnyi àti lílò àwọn oogun onígbàgbọ́ rẹ̀ nígbà àìpẹ́ yìí wò, kí ni ìtọ́jú onígbàgbọ́ tí ó dára jùlọ láti mú ipò rẹ̀ ṣe?", "reasoning": "<thinking><step1>\nThe question asks about a woman who is 32 years old and is experiencing symptoms like abdominal pain, fever, and severe fatigue after starting amoxicillin. It seeks to understand the best treatment approach considering her recent symptoms.\n</step1>\n<step2>\nThe symptoms mentioned, such as *ìrora ikùn* (abdominal pain) and *iba* (fever), suggest a possible reaction to the medication or an underlying infection. It's important to assess if these symptoms are side effects of amoxicillin or signs of a more serious condition.\n</step2>\n<step3>\nGiven that she has *ìrora ìgbàgbọ́* (severe fatigue) and increased white blood cell count, this could indicate an infection or an allergic reaction. In such cases, *ìtọ́jú onígbàgbọ́* (supportive care) is crucial.\n</step4>\n<step4>\nOne should consider discontinuing amoxicillin if an allergic reaction is suspected and consult a healthcare professional immediately. *Ìmúra àyẹwo* (diagnostic evaluation) may be necessary to rule out complications.\n</step5>\n<step5>\nAdditionally, hydration and rest are essential. If the symptoms persist or worsen, further treatment options, such as switching to another antibiotic or addressing the underlying cause, should be explored.\n</step6>\n<step6>\nIn summary, the best supportive care involves stopping the medication, ensuring hydration, and seeking medical evaluation for further management.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú onígbàgbọ́ tó dára jùlọ ni láti da amoxicillin duro, mu omi pọ̀, àti wá ìtọ́jú ìlera lẹ́sẹkẹsẹ.</answer>", "language": "Yoruba"}
{"question": "Báwo ni ẹni tí ó jẹ́ ará ìwọ̀nbàá yóò ṣe dáhùn sí àwọn ìbéèrè wọ̀nyí nípa ìdí?\nAlisi àti Zoi ń ṣiṣẹ́ ní ìgbìmọ̀ kan náà.  Wọ́n ń ṣiṣẹ́ ní yàrá tí ó yàtọ̀ síra, àti wọ́n méjèèjì ló máa ń wọlé sí kọ̀mpútà àgbàáyé ìgbìmọ̀ náà.  Lákòókò tí kò sí ẹni tí ó mọ̀, bí ènìyàn méjì bá wọlé sí kọ̀mpútà àgbàáyé náà nígbà kan náà, àwọn ìwé ìṣẹ̀lẹ̀ àgbàǹlà tí ó ní àwọn àkóbààjà ewu ni a óò yọ láti inú kọ̀mpútà àgbàáyé náà lójú ẹsẹ̀.  Kí a bàa lè dáàbò bo pé ẹnì kan wà nígbà gbogbo láti dáhùn sí àwọn ipe tẹlifóònù tí ń wọlé, ìgbìmọ̀ náà ṣe àṣẹ àpapọ̀ yìí: Alisi nìkan ni a fàyè gba láti wọlé sí kọ̀mpútà àgbàáyé náà ní àárọ̀, nígbà tí Zoi nìkan ni a fàyè gba láti wọlé sí kọ̀mpútà àgbàáyé náà ní ọ̀sán.  Ní ọjọ́ kan, nígbà tí ó ṣẹ̀ sí àṣẹ àpapọ̀ náà, Zoi wọlé sí kọ̀mpútà àgbàáyé náà ní 9 a.m.  Ní ọjọ́ kan náà, Alisi náà wọlé ní 9 a.m.  Lójú ẹsẹ̀, àwọn ìwé ìṣẹ̀lẹ̀ àgbàǹlà tí ó ní àwọn àkóbààjà ewu ni a óò yọ láti inú kọ̀mpútà àgbàáyé náà.  Ṣé Alisi fa kí àwọn ìwé ìṣẹ̀lẹ̀ àgbàǹlà tí ó ní àwọn àkóbààjà ewu yọ kúrò ní kọ̀mpútà àgbàáyé náà?\nÀwọn àṣàyàn:\n- Bẹ́ẹ̀ni\n- Rárá", "reasoning": "<thinking><step1>\nThe question asks: \"Did Alisi cause the [log files = ìwé ìṣẹ̀lẹ̀ àgbàǹlà] with [security breaches = àkóbààjà ewu] to be deleted from the computer?\" This implies a situation where both Alisi and Zoi accessed the computer at the same time, which is against the established rules.\n</step1>\n<step2>\nAccording to the rules, Alisi is allowed to access the computer only in the morning, while Zoi can access it in the afternoon. However, on the day in question, both accessed the computer at 9 a.m. — *ní 9 a.m.*, which violates the protocol.\n</step2>\n<step3>\nWhen two people access the computer simultaneously, the log files containing security breaches are deleted — *àwọn ìwé ìṣẹ̀lẹ̀ àgbàǹlà tí ó ní àkóbààjà ewu ni a óò yọ*.\n</step4>\n<step4>\nSince both Alisi and Zoi logged in at the same time, it is clear that the condition for the log files being deleted was met — *àwọn ipo fun yiyo àwọn ìwé ìṣẹ̀lẹ̀ àgbàǹlà ni a ti pàdé*.\n</step5>\n<step5>\nThus, it can be concluded that Alisi's actions contributed to the deletion of the log files, as she was present during the violation of the protocol.\n</step6>\n<step6>\nTherefore, the answer to whether Alisi caused the log files with security breaches to be deleted is affirmative.\n</step6></thinking>", "answer": "<answer>Bẹ́ẹ̀ni, Alisi fa kí àwọn ìwé ìṣẹ̀lẹ̀ àgbàǹlà tí ó ní àwọn àkóbààjà ewu yọ kúrò ní kọ̀mpútà àgbàáyé náà.</answer>", "language": "Yoruba"}
{"question": "Agbẹ̀gbẹ́rún ọdún márùnlélógún kan tí ó jẹ́ ọ̀gbà àgbàdo lọ sí Ẹ̀rọ̀ Ìtọ́jú Ìṣẹ̀ṣẹ̀ ní ìṣòro ọkàn pẹ̀lú sísààyè ìgbóná, ìṣòro ìgbìyànjú, àti ẹ̀jẹ̀ ṣíṣàn láti ẹ̀dọ̀fóró. Àpẹẹrẹ ẹ̀dọ̀fóró fi hàn ní àgbéyẹ̀gbẹ́ pẹ̀lú àwọn ànímọ́ ìṣiṣẹ́ ẹ̀dá ara: indole positive, MR àti VP positive, glucose, mannitol, àti maltose fermentation positive, ṣùgbọ́n urea hydrolysis negative. A rí ìgbòrò stalactite ní broth ghee. Kí ni oògùn tí a yàn fún ìtọ́jú ipò yìí, kí sì ni ẹ̀dá tí ó gbé àrùn yìí?", "reasoning": "<thinking><step1>\nThe question asks about a patient with a specific set of symptoms and laboratory findings, including *sísààyè ìgbóná* [heat intolerance], *ìṣòro ìgbìyànjú* [difficulty concentrating], and *ẹ̀jẹ̀ ṣíṣàn láti ẹ̀dọ̀fóró* [blood flow from the liver]. \n</step1>\n<step2>\nThe lab results show *indole positive*, *MR àti VP positive*, and *glucose, mannitol, and maltose fermentation positive*, while *urea hydrolysis negative* indicates a specific type of bacteria.\n</step2>\n<step3>\nGiven these findings, we can suspect an infection caused by *Escherichia coli* [E. coli], particularly a strain that produces indole and ferments sugars.\n</step3>\n<step4>\nThe presence of *ìgbòrò stalactite* in broth ghee suggests a biofilm formation, which is common in certain bacterial infections.\n</step4>\n<step5>\nFor treatment, antibiotics are typically chosen based on the sensitivity of the bacteria; in this case, a common choice might be *ciprofloxacin* or *trimethoprim-sulfamethoxazole*.\n</step5>\n<step6>\nThus, the condition is likely caused by *E. coli*, and the recommended treatment would involve appropriate antibiotics to address the infection.\n</step6></thinking>", "answer": "<answer>Oògùn tí a yàn fún ìtọ́jú ipò yìí ni ciprofloxacin, àti ẹ̀dá tí ó gbé àrùn yìí ni Escherichia coli.</answer>", "language": "Yoruba"}
{"question": "Àjọṣepọ̀ ìwọ̀n ìṣowo kan tí ó pọ̀ ju lọ́wọ́ le jẹ́ abajade\nA. ìwọn owó tí kò pọ̀ ní ìwọ̀n sí àwọn orílẹ̀-èdè mìíràn.\nB. ìdinku nínú ìṣelọ́pọ̀ orílẹ̀-èdè náà.\nC. àwọn àjèjì tí kò nífẹ̀ẹ́ àwọn ọjà orílẹ̀-èdè yìí.\nD. ìṣèlọ́pọ̀ owó tí kò lágbára.\nE. ìwọn owó tí ó pọ̀ ní ìwọ̀n sí àwọn orílẹ̀-èdè mìíràn.\nF. ìmúgbòòrò owó orílẹ̀-èdè náà.", "reasoning": "<thinking><step1>\nThe question asks: \"Àjọṣepọ̀ ìwọ̀n ìṣowo kan tí ó pọ̀ ju lọ́wọ́ le jẹ́ abajade\" — meaning it is inquiring about the outcome of a trade balance that is excessively positive.\n</step1>\n<step2>\nA trade balance that is too high indicates that a country is exporting significantly more than it is importing — *ìṣowo àkúnya*.\n</step2>\n<step3>\nThis situation can lead to various economic consequences, such as *ìdinku nínú ìṣelọ́pọ̀ orílẹ̀-èdè* — a reduction in the country's economic activity.\n</step3>\n<step4>\nAdditionally, it may cause foreign countries to react negatively, leading to *ìmúgbòòrò owó orílẹ̀-èdè* — currency appreciation, which can make exports less competitive.\n</step4>\n<step5>\nAmong the options provided, the most relevant consequence of a high trade surplus is likely to be *ìdinku nínú ìṣelọ́pọ̀ orílẹ̀-èdè náà*.\n</step5></thinking>", "answer": "<answer>Ìdinku nínú ìṣelọ́pọ̀ orílẹ̀-èdè náà.</answer>", "language": "Yoruba"}
{"question": "Labẹ ipo wo tí ó ní í ṣe pẹ̀lú ọtí mímu ni a ka ẹnìkan sí ẹni tí ó ṣeé gbẹ̀sẹ̀ lé lórí ìwà ọ̀daràn rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Labẹ ipo wo tí ó ní í ṣe pẹ̀lú [ọtí mímu = alcohol consumption] ni a ka ẹnìkan sí [eni tí ó ṣeé gbẹ̀sẹ̀ lé lórí ìwà ọ̀daràn rẹ̀ = someone who is responsible for their criminal behavior]?” — meaning it wants to know under what circumstances a person is considered responsible for their actions related to alcohol consumption.\n</step1>\n<step2>\nIn legal terms, *responsabilité pénale* refers to the ability of an individual to be held accountable for their actions. When someone consumes alcohol, it can impair their judgment — *ọtí le fa aifọkànsìn*.\n</step2>\n<step3>\nHowever, the law often considers whether the person was aware of their actions while intoxicated — *nígbà tí wọn bá n mu ọtí*.\n</step3>\n<step4>\nIf a person commits a crime while under the influence, the court may evaluate if they had *ìmọ̀lára* (awareness) of their actions at that time.\n</step4>\n<step5>\nIn some jurisdictions, being heavily intoxicated might mitigate responsibility, but it does not completely absolve one from consequences — *kò túmọ̀ sí pé wọn kò ní jẹ́ ẹ̀sùn*.\n</step6>\n<step6>\nUltimately, the context of the crime and the level of intoxication are crucial in determining responsibility — *ìpinnu yìí dá lórí ìpinnu àjọsọpọ̀*.\n</step7></thinking>", "answer": "<answer>Labẹ ipo ti ọtí mímu, ẹni kan le jẹ́ ẹni tí ó ṣeé gbẹ̀sẹ̀ lé lórí ìwà ọ̀daràn rẹ̀ ti wọn bá ní ìmọ̀lára nígbà tí wọn n mu.</answer>", "language": "Yoruba"}
{"question": "Kini akoko idaji imukuro oògùn kan ti iwọn pinpin rẹ̀ jẹ́ 40L, bí gbogbo mímú kuro ninu ara bá jẹ́ 7L/wákàtí. Ọ̀dọ̀ ìgbà ti ìmú kuro ninu ẹdọ̀ oògùn náà jẹ́ 0.5 ati Tmax lẹ́yìn lílò ẹnu jẹ́ wakati 2?\nA. Wakati 2\nB. Wakati 4\nC. Wakati 6\nD. Wakati 8", "reasoning": "<thinking><step1>\nThe question asks: “Kini akoko idaji imukuro oògùn kan ti iwọn pinpin rẹ̀ jẹ́ 40L?” — meaning it wants to find the time it takes for a drug with a volume of distribution of 40L to be eliminated from the body.\n</step1>\n<step2>\nThe elimination rate is given as 7L/hour, which means that every hour, 7 liters of the drug are removed from the body — *mímú kuro ninu ara*.\n</step2>\n<step3>\nTo find the time for elimination, we can use the formula: time = volume of distribution / elimination rate. Here, it would be 40L / 7L/hour.\n</step3>\n<step4>\nCalculating this gives approximately 5.71 hours. However, we need to consider the half-life — *ìgbà idaji* — which is given as 0.5 hours.\n</step4>\n<step5>\nSince the drug reaches its maximum concentration (Tmax) after 2 hours, we need to determine how many half-lives fit into this time frame.\n</step5>\n<step6>\nIn 2 hours, there are 4 half-lives (2 hours / 0.5 hours per half-life), which means the drug concentration will significantly decrease.\n</step6>\n<step7>\nThus, the total time for the drug to be effectively eliminated can be approximated as 4 hours, aligning with the options provided.\n</step7></thinking>", "answer": "<answer>Wakati 4</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdọ ti ọjọ́ ogún [24] ọdún kan, ti ó ní ilera, dé ṣáájú ilé ìwòsàn pajawiri pẹ̀lú irora ikun ti o lewu ati irora ejika ọwọ́ òsì lẹ́yìn tí wọ́n ti fẹ́ lù ú nígbà ere rugby. Itan itọju iṣoogun rẹ̀ fi hàn pé ó ṣẹ̀ṣẹ̀ ni ayẹ̀wò mononucleosis, ó sì ń fi àmì àìlera ẹ̀jẹ̀ ati irora ikun hàn. Lẹ́yìn ìṣe ìdáàbòbò ati ìṣe abẹ, ànímọ̀ pàtó wo ni ó ṣeé ṣe julọ lati rí lórí fíìmù ẹ̀jẹ̀ àgbàgbà aládàáṣe olúwarẹ̀ yìí?", "reasoning": "<thinking><step1>\nThe question asks about a 24-year-old healthy man who presents to the emergency department with severe abdominal pain and left shoulder pain after being tackled during a rugby game. It also mentions his recent diagnosis of mononucleosis and symptoms of anemia and abdominal pain.\n</step1>\n<step2>\nIn this case, the abdominal pain could be related to several factors, including *splenic rupture* due to trauma, especially since he has mononucleosis, which can cause splenomegaly — *bóyá àìlera ẹ̀jẹ̀*.\n</step2>\n<step3>\nThe left shoulder pain, known as *Kehr's sign*, often indicates referred pain from the diaphragm or spleen, suggesting possible internal bleeding or irritation.\n</step3>\n<step4>\nGiven his recent medical history, the most likely finding on a comprehensive blood film would be signs of *hemolytic anemia* or changes related to his mononucleosis, such as atypical lymphocytes — *àwọn ẹ̀yà àtọkànwá*.\n</step5>\n<step5>\nAdditionally, the presence of thrombocytopenia could be observed, which is common in cases of splenic involvement or hypersplenism due to mononucleosis.\n</step6>\n<step6>\nThus, the most specific finding on the blood film would likely be atypical lymphocytes and possibly evidence of hemolysis.\n</step6></thinking>", "answer": "<answer>Àwọn ẹ̀yà àtọkànwá àti àfihàn àìlera ẹ̀jẹ̀ ni yóò jẹ́ àfihàn pàtó lórí fíìmù ẹ̀jẹ̀ yìí.</answer>", "language": "Yoruba"}
{"question": "Obinrin ọdun 25 kan wá pẹlu awọn ami aisan ti o ba ibẹru oyun ni kutukutu mu, a si ri pe o ni awọn agọ́ oyun meji ti o ya sọtọ, kọọkan pẹlu awọn akoonu ti o yatọ, ṣugbọn pẹlu ọfun oyun kan ṣoṣo. Abawọn idagbasoke wo ni o ṣe afihan iru agọ́ oyun yii julọ?", "reasoning": "<thinking><step1>\nThe question asks: “What developmental abnormalities are most indicative of this type of twin pregnancy?” — it refers to a 25-year-old woman with signs of [ibẹru oyun = pregnancy fear] and two separate [agọ́ oyun = gestational sacs] with different contents but a single [ọfun oyun = placenta].\n</step1>\n<step2>\nIn this case, the presence of two gestational sacs suggests a twin pregnancy, specifically a *twin pregnancy with a single placenta*, known as *monozygotic twins* or *dizygotic twins* depending on the origin.\n</step2>\n<step3>\nDevelopmental abnormalities can arise from complications such as *twin-to-twin transfusion syndrome (TTTS)*, where blood flow is unevenly distributed between the twins.\n</step3>\n<step4>\nAnother concern is *intrauterine growth restriction (IUGR)*, which can occur if one twin is not receiving enough nutrients — *iyato ninu idagbasoke*.\n</step4>\n<step5>\nAdditionally, the presence of a single placenta increases the risk of shared complications, which can lead to conditions like *placenta previa* or *placental abruption*.\n</step5>\n<step6>\nThus, the most notable developmental abnormalities in this scenario would likely include issues related to blood flow and growth discrepancies between the twins.\n</step6></thinking>", "answer": "<answer>Abawọn idagbasoke ti o ṣe afihan iru agọ́ oyun yii julọ ni *iyato ninu idagbasoke* ati *twin-to-twin transfusion syndrome*.</answer>", "language": "Yoruba"}
{"question": "Okùnrin ọmọ ọdún méje-dín-ún-dín-ogún kan wá pẹlu iwọlu-ara ni ẹsẹ ati ọwọ rẹ̀. Ó sọ pé ó ti ní iwọlu-ara náà fún “ọpọlọpọ ọdún,” ṣugbọn ó ti burú si ni ọdún to kọja. Iwọlu-ara náà ṣe pataki sii nígbà tí ó bá wà ní isinmi, ó sì fẹrẹẹ̀ parẹ nígbà tí ó bá gbe ara rẹ̀. Ó tún sọ pé ìdílé rẹ̀ ti sọ pé ìgbòòlù rẹ̀ ti rọra sí i, tí ó sì rí bí ẹni pé ó ní ìṣòro ní bíbá ìgbòòlù bẹ̀rẹ̀. Kò sí itan ìṣòro ìlera tí ó ṣe pataki rí. Ó sọ pé ó máa ń mu waini, ṣugbọn èyí kò ní ipa lórí àwọn iwọlu-ara rẹ̀. Àìlera kò sí lórí ara rẹ̀, àwọn àmì ìlera pàtàkì sì wà láàárín àwọn òṣuwọn tí ó bọ́gbọ́n. Nígbà tí a ṣe ayẹwo ara rẹ̀, okùnrin náà gbé ara rẹ̀ sórí, ojú rẹ̀ sì wùdààmú láàrin ayẹwo náà. Ònà “píìlì-róllìn” iwọlu-ara tí ó gbé nígbà tí ó bá wà ní isinmi ni a rí, tí ó sì pọ̀ sí i nígbà tí a béèrè lọ́wọ́ rẹ̀ pé kó dì ọwọ́ òun mìíràn mú, a sì dín ún kù nígbà tí a ṣe àdánwò ika-imú. Okùnrin náà kò lè ṣe eré píànò fífì ìró tí kò sí. Ọ̀pọ̀ agbára sí i ni a rí nínú ẹ̀yìn ọwọ́ rẹ̀ méjèèjì, a sì rí ìdènà sí ìgbòòlù tí kò ní ìṣiṣẹ́ ní ọgbọ̀n, ẹsẹ̀, ati awọn ọgbọ̀n ẹsẹ̀. Nígbà tí a béèrè lọ́wọ́ rẹ̀ pé kó rìn kọjá yàrá náà, okùnrin náà ní ìṣòro ní bíbá ìgbòòlù akọkọ bẹ̀rẹ̀, ó gbé ara rẹ̀ sórí, ó sì gbà àwọn ìgbòòlù kukuru tí ó yára jáde. Èwo nínú àwọn oògùn wọ̀nyí ni ìtọ́jú tí ó gbẹ́jú lórí jùlọ fún ipò okùnrin yìí?\nA. Levodopa/carbidopa\nB. Bromocriptine\nC. Benztropine\nD. Entacapone", "reasoning": "<thinking><step1>\nThe question describes a 27-year-old man with [ìwọlu-ara = tremors] in his arms and legs, stating he has had these tremors for \"many years,\" but they worsened last year. \n</step1>\n<step2>\nThe tremors are more pronounced at rest and diminish with movement, which suggests a condition like [ìṣòro Parkinson = Parkinson's disease]. \n</step2>\n<step3>\nHis family has noted that his tremors have gradually increased, and he experiences difficulty initiating movement — *ìṣòro ní bíbá ìgbòòlù*.\n</step3>\n<step4>\nDuring the examination, he showed signs of rigidity and bradykinesia, which are common in Parkinson's disease. \n</step4>\n<step5>\nThe options provided are medications typically used to manage Parkinson's symptoms: Levodopa/carbidopa, Bromocriptine, Benztropine, and Entacapone.\n</step5>\n<step6>\nLevodopa/carbidopa is the most effective treatment for managing motor symptoms in Parkinson's disease, especially for tremors and rigidity.\n</step6>\n<step7>\nBromocriptine and Entacapone are also used, but they are not first-line treatments for tremors. Benztropine is an anticholinergic used for tremors but is less effective than Levodopa.\n</step7>\n<step8>\nGiven the severity of his symptoms and the typical treatment approach, Levodopa/carbidopa would be the most appropriate choice for this patient.\n</step8></thinking>", "answer": "<answer>Levodopa/carbidopa ni ìtọ́jú tí ó gbẹ́jú lórí jùlọ fún ipò okùnrin yìí.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹwa kan ni ipalara oju ọtun ti okuta fa oṣu marun sẹyin, eyiti o fa pipadanu iran ti akoko kan. Da lori aworan idanwo fundus ti a pese, kini ayẹwo ti o ṣeeṣe julọ fun ipo yii?", "reasoning": "<thinking><step1>\nThe question asks: “What is the most likely diagnosis for a 10-year-old boy who sustained a right eye injury from a stone five months ago, resulting in temporary vision loss?” — here, *ipasẹ oju = eye injury* and *pipadanu iran = vision loss* are key terms.\n</step1>\n<step2>\nIn cases like this, *ipasẹ oju* can lead to various complications, including retinal damage — *ibajẹ retina* — which is crucial to consider.\n</step2>\n<step3>\nThe fact that the injury occurred five months ago suggests that any immediate effects might have stabilized, but *pipadanu iran* indicates there could be lasting damage.\n</step3>\n<step4>\nA fundus examination might reveal signs of *retinal detachment* or *macular edema*, both of which can cause vision loss.\n</step4>\n<step5>\nConsidering the timeline and the nature of the injury, a likely diagnosis could be *retinal scarring* or *macular hole*, which are common after such injuries.\n</step5>\n<step6>\nThus, the most probable diagnosis for this condition, based on the provided information, would be *ibajẹ retina* or *hole macular*.\n</step6></thinking>", "answer": "<answer>Ayẹwo ti o ṣeeṣe julọ fun ipo yii ni ibajẹ retina tabi hole macular.</answer>", "language": "Yoruba"}
{"question": "Àpọnàlá kan tí ó ní àrùn sùùrù ń ṣe ìjàkadì pẹ̀lú ẹ̀jẹ̀ tí ó ń jáde láti imú rẹ̀, ìgbóná ojú, àti irora. Ìgbádùn ẹ̀gbà pẹrìòbítà fi hàn pé àwọn hyphae tí ó ní àwọn apá tí ó yà sílẹ̀ wà níbẹ̀. Ẹ̀dá wo ni ó ṣeé ṣe jù lọ láti máa dá àwọn àmì wọ̀nyí sí?", "reasoning": "<thinking><step1>\nThe question asks: “What type of organism is most likely to cause symptoms like bleeding from the nose, fever, and pain, with evidence of hyphae present?” — it’s inquiring about a specific pathogen.\n</step1>\n<step2>\nThe symptoms described suggest an infection, particularly one that could be fungal in nature — *àrùn àkàrà* could be a possibility.\n</step2>\n<step3>\nHyphae are characteristic of fungi, indicating that the organism is likely a type of fungus — *fungus* can cause severe infections, especially in immunocompromised individuals.\n</step4>\n<step4>\nIn this context, *Aspergillus* species are known to cause such symptoms, leading to conditions like *aspergillose*.\n</step5>\n<step5>\nThe presence of hyphae in tissue samples is a strong indicator of a fungal infection, which can lead to serious complications if not treated promptly.\n</step6>\n<step6>\nTherefore, the organism most likely responsible for these symptoms is a fungus, particularly from the genus *Aspergillus*.\n</step6></thinking>", "answer": "<answer>Àrùn tí ó fa àwọn àmì wọ̀nyí jùlọ ni *Aspergillus*, èyí tí ó ní hyphae níbẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ninu ipo kan tí ọkunrin kan bá wọ ilé ìmọ́tí gbogbogbòò, tí ó sì sọ fún obìnrin kan pé kí ó má ṣe ṣe ohun kan, èyí tó mú kí obìnrin náà sá fún ìbẹ̀rù, ṣùgbọ́n láìsí ìṣẹ̀lẹ̀kùn tàbí ìfòyà èyíkéyìí tàbí ìfọwọ́kàn, ẹ̀ṣẹ̀ wo ni ọkunrin náà lè jẹ̀bi rẹ̀ lórí nítorí iṣẹ́ rẹ̀ nìkan?", "reasoning": "<thinking><step1>\nThe question translates to: \"In a situation where a man enters a public place and tells a woman not to do something, which causes her to flee in fear, but without any physical threat or intimidation, what crime could the man be guilty of based solely on his actions?\" \n</step1>\n<step2>\nThis scenario involves the concept of *intimidation* — *ìfọwọ́kàn* — even if there is no direct threat or physical action. \n</step2>\n<step3>\nIn legal terms, the man’s words could be seen as causing *ìbẹ̀rù* (fear) in the woman, which might fall under harassment or creating a hostile environment.\n</step3>\n<step4>\nThe key point here is that the man’s statement led to a significant emotional response, indicating potential liability for *ìkànsí* (psychological harm).\n</step4>\n<step5>\nIn many jurisdictions, actions that instill fear or distress can be prosecuted under laws related to harassment, even without physical contact — *ìfọwọ́kàn*.\n</step5>\n<step6>\nThus, the man could be guilty of a crime related to harassment or intimidation, depending on the specific laws in place.\n</step6></thinking>", "answer": "<answer>Ọkunrin náà lè jẹ̀bi ẹ̀ṣẹ̀ ìkànsí tàbí ìfọwọ́kàn lórí obìnrin náà.</answer>", "language": "Yoruba"}
{"question": "Ere ife-owo ti a gba lododun lori idoko-owo kan je $900.  Bi eyi je ipin ogorun 6 lododun, melo ni a fi doko-owo?\nA. $18,000.00\nB. $17,000.00\nC. $16,000.00\nD. $19,000.00\nE. $12,000.00\nF. $14,000.00\nG. $13,500.00\nH. $22,500.00\nI. $15,000.00\nJ. $20,000.00", "reasoning": "<thinking><step1>\nThe question translates to: \"If the annual return on an investment is $900 and this represents a 6% return, how much was invested?\" Here, *idoko-owo* means investment and *ipin ogorun* refers to percentage.\n</step1>\n<step2>\nTo find the total investment, we can use the formula for percentage: *ipin ogorun = (iyipada / idoko-owo) x 100*.\n</step2>\n<step3>\nHere, *iyipada* is the return, which is $900, and *ipin ogorun* is 6. We can rearrange the formula to find *idoko-owo*: *idoko-owo = iyipada / (ipin ogorun / 100)*.\n</step3>\n<step4>\nSubstituting the values, we have: *idoko-owo = 900 / (6 / 100)*. This simplifies to *idoko-owo = 900 / 0.06*.\n</step4>\n<step5>\nCalculating this gives us *idoko-owo = 15,000*. Therefore, the total investment is $15,000.\n</step5></thinking>", "answer": "<answer>$15,000.00</answer>", "language": "Yoruba"}
{"question": "Okunrin kan ti n ṣiṣẹ́ gẹ́gẹ́ bí apaniyan eèkun ni o ni irora ikun, ìhòòhòò alubosa lori ẹmi rẹ̀, ati awọn ila ti o kọja lori awọn eekanna rẹ̀. Kini idi ti o ṣeeṣe julọ ti awọn ami aisan rẹ̀?", "reasoning": "<thinking><step1>\nThe question translates to: \"A man who works as a [apaniyan eèkun = butcher] has stomach pain, a [ìhòòhòò alubosa = burning sensation] in his chest, and lines on his fingers. What is the most likely cause of his symptoms?\" \n</step1>\n<step2>\nThe symptoms described suggest a possible gastrointestinal issue, particularly related to the consumption of certain foods — *o le jẹ pe o ti jẹun ni awọn ounjẹ ti ko dara*.\n</step2>\n<step3>\nThe burning sensation in the chest could indicate acid reflux or heartburn — *ìhòòhòò alubosa le jẹ ami ti acid reflux*.\n</step3>\n<step4>\nAdditionally, the lines on his fingers might suggest a condition related to his work, possibly from handling sharp tools or meat — *awọn ila lori awọn eekanna rẹ̀ le jẹ abajade ti iṣẹ rẹ*.\n</step4>\n<step5>\nConsidering all these factors, the most likely cause of his symptoms could be related to dietary habits or occupational hazards — *o ṣee ṣe pe o ni iṣoro pẹlu ounjẹ tabi awọn ewu iṣẹ*.\n</step6>\n<step6>\nTherefore, the combination of stomach pain and burning sensation suggests a gastrointestinal issue, possibly exacerbated by his profession.\n</step6></thinking>", "answer": "<answer>Idi ti o ṣeeṣe julọ ti awọn ami aisan rẹ̀ ni acid reflux tabi iṣoro ti o ni ibatan si ounjẹ.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun 62 kan tí a ti jẹ́wọ́ pé ó ní àrùn ègbà kan tí a ń pè ní lobular carcinoma ti ọmu béèrè lọ́wọ́ oníṣègùn rẹ̀ nípa bí àrùn náà ṣe máa lọ sí. Oníṣègùn náà sọ pé a lè mọ ìwọ̀n rẹ̀ dáradára gẹ́gẹ́ bí àwọn ìwádìí ìwòsàn tí a ṣe tẹ́lẹ̀. Bí a bá gbé èyí yẹ̀ wò, àwọn àpẹẹrẹ abàmì àrùn náà wo ni oníṣègùn náà lè rí tẹ́lẹ̀ tí ó bá ìwọ̀n rẹ̀ mu?", "reasoning": "<thinking><step1>\nThe question asks: “What are the possible tumor markers that the doctor might find if the patient’s [àrùn ègbà = breast cancer] is at a certain stage?” — it seeks to understand the tumor markers associated with lobular carcinoma.\n</step1>\n<step2>\nLobular carcinoma can produce specific tumor markers that help in monitoring the disease — *àwọn abàmì àrùn* like CA 15-3 and CEA are commonly associated with breast cancer.\n</step2>\n<step3>\nThese markers can indicate the presence of cancer and how well the treatment is working — *wọn lè fi hàn bí àrùn náà ṣe ń bọ́ síwájú* or respond to therapy.\n</step3>\n<step4>\nIn addition, hormone receptor status, such as estrogen and progesterone receptors, can also be important — *ìpo àwọn olùfúnni homonu* le ní ipa pataki.\n</step4>\n<step5>\nIf the cancer is advanced, the doctor might also check for other markers that indicate metastasis — *ìtànkálẹ̀ àrùn* to other parts of the body.\n</step6>\n<step6>\nSo, the doctor may look for markers like CA 15-3, CEA, and hormone receptors to assess the patient's condition — *àwọn abàmì àrùn yìí lè jẹ́ kí oníṣègùn mọ bí àrùn náà ṣe ń lọ*.\n</step6></thinking>", "answer": "<answer>Oníṣègùn náà lè rí CA 15-3, CEA, àti ìpo àwọn olùfúnni homonu gẹ́gẹ́ bí àpẹẹrẹ abàmì àrùn.</answer>", "language": "Yoruba"}
{"question": "Kini aisan ti o ṣee ṣe fun ọkunrin ọdun 50 kan ti o ni iṣoro jijẹ ounjẹ lile ni gbogbo igba, ati sisẹ ounjẹ pada, ati ẹmi buburu?", "reasoning": "<thinking><step1>\nThe question asks: “Kini aisan ti o ṣee ṣe fun ọkunrin ọdun 50 kan ti o ni iṣoro jijẹ ounjẹ lile ni gbogbo igba, ati sisẹ ounjẹ pada, ati ẹmi buburu?” — meaning it wants to know what possible illness a 50-year-old man might have if he has difficulty eating solid food, experiences vomiting, and has bad breath.\n</step1>\n<step2>\nDifficulty eating solid food can indicate issues with the esophagus or stomach — *iṣoro pẹlu esophagus tabi ikun*.\n</step2>\n<step3>\nVomiting, or *sisẹ ounjẹ pada*, can be a symptom of various gastrointestinal disorders, such as gastritis or ulcers — *gastroenteritis tabi awọn àtọgbẹ*.\n</step3>\n<step4>\nBad breath, or *ẹmi buburu*, can result from poor digestion or infections in the mouth or throat — *iṣoro ni ẹnu tabi ọfun*.\n</step5>\n<step5>\nConsidering these symptoms together, one possible condition could be esophageal stricture or even a peptic ulcer — *iṣoro esophageal tabi àtọgbẹ peptic*.\n</step6>\n<step6>\nThus, the combination of these symptoms suggests a significant gastrointestinal issue that requires medical evaluation.\n</step6></thinking>", "answer": "<answer>Aisan ti o ṣee ṣe ni iṣoro esophageal tabi àtọgbẹ peptic.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun 60 kan wá sí ile-iwosan pẹlu itan oṣu mẹta ti ikọ́ òfuurufu tí ó burú si nigbati ó bá nṣiṣẹ́ lọ́wọ́. Ó tun ń kọ́ lu ẹ̀dùn gbígbẹ́ tó ti wà fún ọdún 10. Àwọn àrùn rẹ̀ burú si paapaa pẹlu awọn iṣẹ́ ìmúṣẹ bíi gbigbe ọ̀pá ìgbáàlẹ̀ kan. Ó kò gbàgbọ́ pé ó padanu iwuwo, ó gbọ̀n, tàbí ó ní ibà. Itan iṣoogun rẹ̀ ṣe pataki fun àtọ́pàtọ̀ ẹ̀jẹ̀ gíga, tí ó fi amlodipine mu lójoojumọ. Ó ní itan ọdun 70 ti sisun siga ati mimu ọti oyinbo 3-4 ni ọsẹ̀ kan. Ẹ̀jẹ̀ ẹ̀rọ rẹ̀ lónìí jẹ́ 128/84 mm Hg. Ẹ̀rọ X-ray àyèwò ìgbà ìgbẹ́ ṣe afihan didimu àyèwò diaphragm ni awọn ẹgbẹ́ mejeeji. Àyẹ̀wò ara jẹ́ ṣiṣe pataki fun wheezing ti o wuwo ni awọn ẹgbẹ́ mejeeji. Ewo ni o ṣeé ṣe ki a rii pẹlu idanwo iṣẹ ṣiṣe àyèwò ìgbà ìgbẹ́?\nA. FEV1: FVC ti pọ̀ si ati agbara gbogbo àyèwò ìgbà ìgbẹ́ ti dinku\nB. FEV1: FVC ti dinku ati agbara gbogbo àyèwò ìgbà ìgbẹ́ ti pọ̀ si\nC. FEV1: FVC ti pọ̀ si ati agbara gbogbo àyèwò ìgbà ìgbẹ́ déédé\nD. FEV1: FVC ti dinku ati agbara gbogbo àyèwò ìgbà ìgbẹ́ ti dinku\nE. FEV1: FVC déédé ati agbara gbogbo àyèwò ìgbà ìgbẹ́ ti dinku", "reasoning": "<thinking><step1>\nThe question presents a clinical scenario involving a 60-year-old woman with a three-month history of worsening shortness of breath — *ikọ́ òfuurufu* — especially during exertion, and a long-standing history of chronic cough — *ẹ̀dùn gbígbẹ́*.\n</step1>\n<step2>\nShe has a significant medical history, including hypertension — *àtọ́pàtọ̀ ẹ̀jẹ̀ gíga* — managed with amlodipine, and a history of smoking and alcohol use, which are risk factors for respiratory diseases.\n</step2>\n<step3>\nThe X-ray findings indicate diaphragm flattening, suggesting possible chronic obstructive pulmonary disease (COPD) — *àrùn àìlera afẹ́fẹ́* — which can lead to airflow limitation.\n</step3>\n<step4>\nIn this context, pulmonary function tests would typically show a decrease in FEV1 (Forced Expiratory Volume in 1 second) relative to FVC (Forced Vital Capacity) — *FEV1: FVC* — indicating obstructive lung disease.\n</step5>\n<step5>\nGiven her symptoms and history, the most likely result from the pulmonary function test would be that both FEV1 and FVC are reduced, reflecting the obstructive pattern.\n</step6>\n<step6>\nThus, the correct answer is that FEV1 is decreased and FVC is also decreased, which corresponds to option D.\n</step6></thinking>", "answer": "<answer>FEV1: FVC ti dinku ati agbara gbogbo àyèwò ìgbà ìgbẹ́ ti dinku.</answer>", "language": "Yoruba"}
{"question": "Báwo ni mímu kọfí ṣe nípa lórí ìdàgbàsókè rẹ?\nA. Mímú kọfí kò ní ipa lórí ìdàgbàsókè rẹ.\nB. Mímú kọfí yóò dí ìdàgbàsókè rẹ lọ́wọ́.\nC. Mímú kọfí yóò ṣe ìdènà fún ọ láti dàgbà sí i.", "reasoning": "<thinking><step1>\nThe question asks: “Báwo ni mímu kọfí ṣe nípa lórí ìdàgbàsókè rẹ?” — meaning it wants to know how drinking coffee affects your development.\n</step1>\n<step2>\nDrinking coffee can have various effects on a person's development — *mímú kọfí le ní ipa pupọ lórí ìdàgbàsókè*.\n</step2>\n<step3>\nCaffeine, the main ingredient in coffee, can enhance alertness and concentration — *caféine le mu ki a ni ìmúrasílẹ̀*.\n</step3>\n<step4>\nHowever, excessive consumption might lead to negative effects like anxiety or sleep disturbances — *mímú kọfí púpọ̀ le fa ìbànújẹ tàbí àìlera*.\n</step4>\n<step5>\nIn terms of personal development, moderate coffee consumption could potentially aid in productivity — *mímú kọfí ni iwọn to peye le ran ọ lọwọ lati ni iṣẹ́ ṣiṣe*.\n</step6>\n<step6>\nThus, the impact of coffee on development can vary based on the amount consumed and individual tolerance — *ipa kọfí lórí ìdàgbàsókè rẹ le yato si da lori iye ti a mu*.\n</step6></thinking>", "answer": "<answer>Mímú kọfí le ní ipa to dára lórí ìdàgbàsókè rẹ, ṣugbọn mímú rẹ ni iwọn to peye ni pataki.</answer>", "language": "Yoruba"}
{"question": "Kini idanimọ ortodontiki fun ọmọkunrin ọdun mejila kan ti o ni ibatan molar kilasi I ati pipọ awọn eyín maxillary ati mandibular lakoko idanwo inu-ẹnu?", "reasoning": "<thinking><step1>\nThe question asks: “Kini idanimọ ortodontiki [orthodontic diagnosis] fun ọmọkunrin [for a boy] ọdun mejila [twelve years old] kan ti o ni ibatan molar kilasi I [Class I molar relationship] ati pipọ [crowding] awọn eyín maxillary [maxillary teeth] ati mandibular [mandibular teeth] lakoko idanwo inu-ẹnu [during an oral examination]?” — meaning it seeks to understand the orthodontic diagnosis for a specific case.\n</step1>\n<step2>\nIn orthodontics, a Class I molar relationship indicates that the first molars are in a normal occlusion — *molar akọkọ wa ni ibamu to peye*.\n</step2>\n<step3>\nHowever, the presence of crowding suggests that there is insufficient space for the teeth — *a ko ni aaye to fun awọn eyín* to align properly.\n</step3>\n<step4>\nFor a twelve-year-old, this could be significant as the dental arch is still developing — *arch eyín naa ṣi n dagba*.\n</step4>\n<step5>\nThe diagnosis would likely involve assessing the degree of crowding and the overall alignment of the teeth — *iwadi iwọn pipọ ati ibamu gbogbogbo ti awọn eyín*.\n</step6>\n<step6>\nTreatment options may include braces or other orthodontic appliances to correct the alignment and manage the crowding — *idanwo le ni awọn braces tabi awọn ẹrọ ortodontiki miiran*.\n</step7>\n<step7>\nThus, the orthodontic diagnosis would focus on managing the crowding while maintaining the Class I relationship.\n</step7></thinking>", "answer": "<answer>Idanimọ ortodontiki fun ọmọkunrin ọdun mejila kan pẹlu molar kilasi I ati pipọ awọn eyín ni lati ṣakoso pipọ naa ati tọju ibamu to peye.</answer>", "language": "Yoruba"}
{"question": "Awọn ipo wo ni a ṣe iyatọ si bi vasculitis ọkọ̀ kekere?", "reasoning": "<thinking><step1>\nThe question asks: “Awọn ipo wo ni a ṣe iyatọ si bi [vasculitis = vasculitis] ọkọ̀ kekere?” — meaning it wants to know what conditions are differentiated as small vessel vasculitis.\n</step1>\n<step2>\nSmall vessel vasculitis primarily affects the small blood vessels, such as *awọn ẹjẹ kekere* like capillaries and venules.\n</step2>\n<step3>\nConditions like *granulomatosis pẹlu polyangiitis* (formerly known as Wegener's granulomatosis) and *microscopic polyangiitis* are examples of small vessel vasculitis.\n</step3>\n<step4>\nAnother condition is *Churg-Strauss syndrome*, which involves asthma and eosinophilia — *eosinophilia* being an increase in a type of white blood cell.\n</step4>\n<step5>\nIn addition, *cutaneous leukocytoclastic vasculitis* affects the skin and is characterized by *petechiae* and *purpura*.\n</step6>\n<step6>\nThese conditions share common features like inflammation of blood vessels and can lead to organ damage if not treated — *iyipada si awọn ara*.\n</step6></thinking>", "answer": "<answer>Awọn ipo ti a ṣe iyatọ si bi vasculitis ọkọ̀ kekere ni granulomatosis pẹlu polyangiitis, microscopic polyangiitis, Churg-Strauss syndrome, ati cutaneous leukocytoclastic vasculitis.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun meji kan, ti o wọn kìlọọgìramu 6.4, ti o si n jiya nínú àìtó ẹ̀mí Vitamin A, ni a ń ṣe ayẹ̀wò fún àìtọ́jú.  Irú ìwọ̀n àìtọ́jú wo ni ọmọ yìí ní?", "reasoning": "<thinking><step1>\nThe question asks: “What type of [àìtọ́jú = deficiency] does a two-year-old child weighing 6.4 kg, suffering from a Vitamin A deficiency, have?” \n</step1>\n<step2>\nVitamin A deficiency can lead to several health issues, particularly affecting vision — *àìlera oju* and immune function — *iṣẹ́ ààbò*.\n</step2>\n<step3>\nIn children, a common manifestation of Vitamin A deficiency is *xerophthalmia*, which is dryness of the conjunctiva and cornea.\n</step3>\n<step4>\nThis condition can progress to more severe issues like night blindness — *ìkànsí alẹ́* — if not addressed.\n</step4>\n<step5>\nGiven the child's age and weight, it is crucial to assess for signs of *àìlera oju* and other systemic effects of the deficiency.\n</step5>\n<step6>\nTherefore, the child likely has a Vitamin A deficiency leading to *xerophthalmia* or potential night blindness.\n</step6></thinking>", "answer": "<answer>Ọmọ yìí ní àìtọ́jú Vitamin A ti o fa xerophthalmia tabi ìkànsí alẹ́.</answer>", "language": "Yoruba"}
{"question": "Nítorí pé Ìgbìmọ̀ Ìṣakoso Ọjà Ọjà (FED) ṣe títà ọjà ìmọ́lẹ̀ ti $3,000,000 ní ìwé ẹ̀rí ìjọba ati gbogbo awọn banki iṣowo ti 'fún' ni kikun pẹlu ipin iṣura ti a beere ti 25%, kini iyipada abajade ninu ipese owo naa?", "reasoning": "<thinking><step1>\nThe question asks: “Nítorí pé Ìgbìmọ̀ Ìṣakoso Ọjà Ọjà (FED) ṣe títà ọjà ìmọ́lẹ̀ ti $3,000,000” — meaning it wants to know the impact on money supply when the Federal Reserve sells $3,000,000 in government securities.\n</step1>\n<step2>\nWhen the FED sells securities, it effectively removes money from the banking system — *o n yọ owo kuro ninu eto banki*.\n</step2>\n<step3>\nThe required reserve ratio is 25%, which means banks must keep 25% of deposits as reserves — *iyipada iṣura ti a beere jẹ 25%*.\n</step3>\n<step4>\nIf the FED sells $3,000,000, banks will have $3,000,000 less to lend out, reducing the overall money supply — *iyipada ipese owo naa yoo dinku*.\n</step4>\n<step5>\nTo calculate the total impact, we use the money multiplier, which is the inverse of the reserve ratio: 1 / 0.25 = 4.\n</step5>\n<step6>\nThus, the total decrease in money supply is $3,000,000 multiplied by the money multiplier of 4, resulting in a total decrease of $12,000,000 — *iyipada abajade ninu ipese owo naa jẹ $12,000,000*.\n</step6></thinking>", "answer": "<answer>Iyipada abajade ninu ipese owo naa jẹ $12,000,000.</answer>", "language": "Yoruba"}
{"question": "Ọmọ kan ṣe ìṣòro ìgbìyẹn afẹ́fẹ́, ó sì ní ikùn tí ó sunkún lẹ́yin ọjọ́ meji tí a bí i, pẹ̀lú ìdinku ohùn ìgbìyẹn ní apá òsì. Lẹ́yin ìgbà tí a fi bàgì àti ibojú fún un ní afẹ́fẹ́, a fi tube endotracheal sí i, èyí tí ó mú kí ìrìn ààyọ̀ ọkàn-àyà tó pọ̀ jùlọ yí lọ sí apá ọ̀tún.  Kí ni ìgbésẹ̀ tó tẹ̀lé e nínú ìṣàkóso rẹ̀?", "reasoning": "<thinking><step1>\nThe question describes a child with respiratory distress — *ìṣòro ìgbìyẹn afẹ́fẹ́* — and a history of wheezing after two days of birth, along with a decrease in breath sounds on the left side. \n</step1>\n<step2>\nAfter administering bag-mask ventilation — *bàgì àti ibojú* — and placing an endotracheal tube, the child’s condition requires further management. \n</step2>\n<step3>\nIn such cases, the next step typically involves assessing the effectiveness of ventilation and ensuring adequate oxygenation — *ìmúra àfiyèsí àti ìmúra àfiyèsí tó péye*.\n</step3>\n<step4>\nMonitoring vital signs is crucial; one must check for signs of improvement or deterioration — *àfihàn ìmúra tàbí ìbàjẹ́*.\n</step4>\n<step5>\nIf the child remains unstable, further interventions may include administering medications like bronchodilators — *les bronchodilatateurs* — to relieve airway constriction.\n</step5>\n<step6>\nAdditionally, it’s important to consider potential causes of respiratory distress, such as pneumonia or congenital anomalies — *àìlera àfefe tàbí àìlera àtọkànwá*.\n</step6>\n<step7>\nFinally, consulting a pediatric intensivist may be necessary for advanced management — *ìmúra àfiyèsí tó gaju*.\n</step7></thinking>", "answer": "<answer>Ìgbésẹ̀ tó tẹ̀lé ni láti ṣe àfiyèsí ìmúra, ṣàyẹwo àwọn àkópọ̀ àìlera, àti pèsè ìtọju tó yẹ.</answer>", "language": "Yoruba"}
{"question": "Funfunnu egbòràn afọwọṣe ti o yọkuro, gíga wo ni ilẹ ẹnu nilo ni ibatan si eti gingival òfìì fún lílò ọpá sublingual kan?", "reasoning": "<thinking><step1>\nThe question asks: “Funfunnu egbòràn [subgingival = below the gum line] afọwọṣe ti o yọkuro, gíga wo ni ilẹ ẹnu nilo ni ibatan si eti gingival [gingival = gum] òfìì fún lílò [sublingual = under the tongue] ọpá kan?” — meaning it wants to know the height of the oral tissue needed in relation to the gingival area for using a sublingual device.\n</step1>\n<step2>\nTo understand this, we need to consider the anatomy of the mouth — *anatomie de la bouche* — particularly the relationship between the gingival tissue and the sublingual area.\n</step2>\n<step3>\nThe sublingual area is crucial for drug absorption; it requires a certain thickness of tissue — *épaisseur de tissu* — to ensure effective delivery.\n</step3>\n<step4>\nTypically, the gingival tissue should be healthy and well-vascularized — *bien vascularisé* — to support the sublingual device's function.\n</step4>\n<step5>\nIn practice, the ideal height of the oral tissue is often around 2 to 3 millimeters above the gingival margin — *au-dessus de la marge gingivale* — to allow proper placement of the device.\n</step5>\n<step6>\nThus, the height of the oral tissue is critical for ensuring that the sublingual device can function effectively without causing discomfort or complications.\n</step6></thinking>", "answer": "<answer>Ibi gíga ilẹ ẹnu ti o nilo ni ibatan si eti gingival fun lílò ọpá sublingual kan jẹ 2 si 3 milimita loke eti gingival.</answer>", "language": "Yoruba"}
{"question": "Kini itumo oro ‘Svetambara’ ninu ẹsin Jaini?", "reasoning": "<thinking><step1>\nThe question asks: “Kini itumo oro ‘Svetambara’ ninu ẹsin Jaini?” — which translates to “What is the meaning of the term ‘Svetambara’ in Jainism?”\n</step1>\n<step2>\n‘Svetambara’ refers to one of the major sects in Jainism, characterized by its followers wearing white clothing — *awọn ọmọ ẹgbẹ wọn wọ aṣọ funfun*.\n</step2>\n<step3>\nThis sect believes in the importance of non-possessiveness and asceticism, emphasizing *aṣaṣe* and *iyasọtọ* in their practices.\n</step3>\n<step4>\nIn contrast to the other sect, ‘Digambara’, the Svetambaras allow women to achieve liberation — *iyin* — which is a significant theological difference.\n</step4>\n<step5>\nThe term itself means “white-clad” — *ti a fi funfun bo*, reflecting their practice of simplicity and purity in attire.\n</step5>\n<step6>\nThus, ‘Svetambara’ signifies a group within Jainism that prioritizes non-violence and ascetic life, while also advocating for inclusivity.\n</step6></thinking>", "answer": "<answer>‘Svetambara’ tumọ si “ti a fi funfun bo” ninu ẹsin Jaini, ti o jẹ ẹgbẹ kan ti o ṣe pataki si igbesi aye alailẹgbẹ ati ifamọra.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin kan ti o jẹ PCP laìmọ̀ ni ibi ayẹyẹ kan, eyi ti o yọrí si ibanujẹ ọkàn ti kò lè ṣakoso, ti o sì ja si ikú ẹni miiran.  Ààbò òfin wo ni ó ṣeé ṣe julọ láti ṣe àdánù sí ẹ̀bi rẹ̀ fún ìpààrọ̀ ejò kejì labẹ́ ipò wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “What legal defense might be available to a man who is a [PCP = primary care physician] and unintentionally causes emotional distress leading to another person's death at an event?” \n</step1>\n<step2>\nIn this context, the man may claim *negligence* if he did not act with the standard of care expected from a PCP — *a ko le fi ẹjọ́ kan rẹ̀ silẹ*.\n</step2>\n<step3>\nTo establish negligence, it must be shown that he owed a duty of care, breached that duty, and that the breach caused the emotional distress — *ìfarapa ti o fa ibanujẹ*.\n</step4>\n<step4>\nAdditionally, he might argue *defense of emotional distress* if the actions leading to the distress were not intentional or reckless — *ko si ìmọ̀lára àìlera*.\n</step5>\n<step5>\nIn legal terms, he could also explore *affirmative defenses* like *insanity* or *involuntary intoxication* if applicable, which could mitigate responsibility — *ìdáhùn àìlera*.\n</step6>\n<step6>\nUltimately, the most likely defense would be based on the lack of intent or negligence, as he did not mean to cause harm — *a ko ni ìmọ̀lára àìlera*.\n</step6></thinking>", "answer": "<answer>Ààbò òfin ti o ṣeé ṣe julọ ni a le fi ẹjọ́ kan rẹ̀ silẹ ni ibamu pẹlu aito ìmọ̀lára àìlera tabi aito ìfarapa.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 54 kan ti n ni oorun ju ti o yẹ lọ ni ọjọ fun oṣu 5. Ó máa ń jí lẹ́nu òru, aya rẹ̀ sì sọ pé ìfọ́ rẹ̀ ti di pọ̀ sí i. Pẹlu gíga ti 180 cm ati iwuwo ti 104 kg, a kà BMI rẹ̀ sí 33 kg/m2. Iwuwo ọkan rẹ̀ jẹ́ 80/min ati iwuwo ẹ̀mí jẹ́ 11/min, pẹlu titẹ ẹjẹ jugular ti 7 cm H2O. Ó tun ní 2+ pitting edema ni ẹsẹ̀ isalẹ̀ ati ọgbọ̀n rẹ̀. Ṣíṣayẹwo ẹjẹ́ ẹ̀dọ̀fóró sọ pé pH rẹ̀ jẹ́ 7.42 ati PCO2 ti 41 mm Hg, pẹlu awọn abajade X-ray àyẹ̀wò egbòogi ti o dára. Kini idi ti o ṣeé ṣe julọ ti ipo alaisan yii?", "reasoning": "<thinking><step1>\nThe question describes a 54-year-old man experiencing excessive sleepiness, nocturnal awakenings, and increased snoring — *ìfọ́ rẹ̀ ti di pọ̀ sí i* — along with specific vital signs and lab results.\n</step1>\n<step2>\nGiven his BMI of 33 kg/m², he is classified as obese — *a kà un sí àìlera àtọka*. Obesity is a significant risk factor for sleep apnea.\n</step2>\n<step3>\nThe symptoms of excessive daytime sleepiness and snoring suggest a possible diagnosis of obstructive sleep apnea — *ìfarapa oorun àìlera*.\n</step3>\n<step4>\nAdditionally, the presence of pitting edema in the lower extremities — *2+ pitting edema ni ẹsẹ̀ isalẹ̀* — could indicate fluid retention, often associated with sleep apnea due to hypoxia.\n</step4>\n<step5>\nHis vital signs, including a heart rate of 80/min and respiratory rate of 11/min, are relatively normal, but the elevated BMI and symptoms strongly point towards sleep apnea.\n</step5>\n<step6>\nThe blood gas results show a normal pH and PCO2, which suggests that there is no acute respiratory failure, but the overall clinical picture aligns with sleep apnea.\n</step6>\n<step7>\nIn summary, the combination of obesity, excessive sleepiness, and snoring leads to the conclusion that obstructive sleep apnea is the most likely condition.\n</step7></thinking>", "answer": "<answer>Ìfarapa oorun àìlera ni ipo alaisan ti o ṣeé ṣe julọ fun ọkùnrin yìí.</answer>", "language": "Yoruba"}
{"question": "((−4 + −7 − 3 + 3) − (−3 + −2 − −3 ∗ −3)) =", "reasoning": "<thinking><step1>\nThe question asks to solve the expression: “((−4 + −7 − 3 + 3) − (−3 + −2 − −3 ∗ −3))” — we need to simplify both parts of the equation.\n</step1>\n<step2>\nFirst, let's simplify the left side: *−4 + −7 − 3 + 3*. Adding these numbers, we have *−4 − 7 = −11*, then *−11 − 3 = −14*, and finally *−14 + 3 = −11*.\n</step2>\n<step3>\nNow, we move to the right side: *−3 + −2 − −3 ∗ −3*. First, calculate *−3 ∗ −3*, which equals *9* because multiplying two negatives gives a positive.\n</step3>\n<step4>\nNow, we have *−3 + −2 − 9*. Adding these, we get *−3 − 2 = −5*, and then *−5 − 9 = −14*.\n</step4>\n<step5>\nNow we can substitute back into the original expression: *−11 − (−14)*. Subtracting a negative is the same as adding, so this becomes *−11 + 14*.\n</step5>\n<step6>\nFinally, *−11 + 14 = 3*. Thus, the final result of the expression is *3*.\n</step6></thinking>", "answer": "<answer>3</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọmọ ọdún mẹ́ẹ̀ẹ́dọ́gbọ̀n kan sọ pé igun ẹnu rẹ̀ gùn jù. Ọkọ rẹ̀ àti àwọn ìdílé rẹ̀ kò rí i bẹ́ẹ̀. Ó lọ bá ọ̀pọ̀ oníṣègùn àṣàtúnṣe ara, ṣùgbọ́n kò sí ẹnìkan nínú wọn tí ó gbà pé kí wọ́n ṣe àtúnṣe sí i. Kí ló ń ṣẹlẹ̀ sí i?\nA. Àìlera ìrònú nípa ara\nB. Ìbẹ̀rù àrùn\nC. Àìlera tí ó nípa lórí ara\nD. Àìlera ìrònú", "reasoning": "<thinking><step1>\nThe question translates to: \"A 35-year-old woman says her jaw is unusually long. Her husband and family do not see it that way. She has consulted many plastic surgeons, but none agreed to perform surgery. What is happening to her?\" This indicates a potential psychological issue related to body image.\n</step1>\n<step2>\nThe phrase \"igun ẹnu rẹ̀ gùn jù\" suggests that she perceives her jaw as elongated, which may not be the case — *àìlera ìrònú nípa ara* refers to a body image disorder.\n</step2>\n<step3>\nHer family’s inability to see the same issue indicates a disconnect between her perception and reality — *ìbẹ̀rù àrùn* could also imply anxiety about her appearance.\n</step3>\n<step4>\nConsulting multiple surgeons without success suggests that her condition is not physical but rather psychological — *àìlera tí ó nípa lórí ara* could be a factor here.\n</step5>\n<step5>\nIn this context, the most fitting answer is related to a mental health issue regarding her self-image, which aligns with option A: *àìlera ìrònú*.\n</step6></thinking>", "answer": "<answer>Àìlera ìrònú nípa ara.</answer>", "language": "Yoruba"}
{"question": "Olùgbé tó gbà wọ́wọ́ ẹ̀gún láti ọ̀dọ̀ aláìsàn tí HBsAg àti HBeAg rẹ̀ wà lọ́dọ̀, tí kò sì ti gba oògùn gbígbààlà títi di ìsinsìnyí, ìtọ́jú rẹ̀ kọ́?\nA. Kò sí ohunkóhun\nB. Ìgbààlà àpapọ̀\nC. Ìgbààlà ti ara\nD. Ìgbààlà tí a gbà láti òde", "reasoning": "<thinking><step1>\nThe question asks: “Olùgbé tó gbà wọ́wọ́ ẹ̀gún láti ọ̀dọ̀ aláìsàn tí HBsAg àti HBeAg rẹ̀ wà lọ́dọ̀, tí kò sì ti gba oògùn gbígbààlà títi di ìsinsìnyí, ìtọ́jú rẹ̀ kọ́?” — meaning it is inquiring about the treatment options for a patient with hepatitis B markers who has not received antiviral therapy.\n</step1>\n<step2>\nIn this context, *HBsAg* and *HBeAg* are indicators of active hepatitis B infection — *àkóónú àìlera hépatique*.\n</step2>\n<step3>\nThe patient has not received any antiviral treatment — *oògùn gbígbààlà* — which is crucial for managing hepatitis B.\n</step3>\n<step4>\nThe options provided suggest different types of treatment: *ìgbààlà àpapọ̀* (combined therapy), *ìgbààlà ti ara* (natural recovery), and *ìgbààlà tí a gbà láti òde* (external treatment).\n</step4>\n<step5>\nGiven that the patient has not started any treatment, the most likely outcome is *ìgbààlà ti ara*, meaning the body may clear the virus naturally over time.\n</step5>\n<step6>\nHowever, without treatment, the risk of complications remains high, and *kò sí ohunkóhun* (nothing) is not a viable option.\n</step6>\n<step7>\nThus, the best answer here is *ìgbààlà ti ara*, as it reflects the possibility of natural recovery in the absence of antiviral therapy.\n</step7></thinking>", "answer": "<answer>Ìgbààlà ti ara.</answer>", "language": "Yoruba"}
{"question": "Kini oro ti a maa n pe ohun kan ti o le ni ipa odi lori idagbasoke oyun?", "reasoning": "<thinking><step1>\nThe question asks: “Kini oro ti a maa n pe ohun kan ti o le ni ipa odi lori idagbasoke oyun?” — which translates to “What do we call something that can negatively affect fetal development?”\n</step1>\n<step2>\nIn English, we refer to such substances as *teratogens* — *awọn nkan ti o le fa awọn abawọn* in Yoruba.\n</step2>\n<step3>\nTeratogens can include drugs, alcohol, and certain infections that can disrupt normal fetal growth — *idanwo ti o le fa awọn iṣoro ni idagbasoke oyun*.\n</step3>\n<step4>\nFor example, alcohol consumption during pregnancy can lead to *Fetal Alcohol Spectrum Disorders (FASD)* — *awọn aisan ti o ni ibatan si ọti-lile*.\n</step4>\n<step5>\nAdditionally, certain medications, like some anticonvulsants, are known to have teratogenic effects — *awọn ipa ti o le fa awọn abawọn ni oyun*.\n</step5>\n<step6>\nThus, a teratogen is any agent that can cause malformations or developmental issues in a fetus — *nkan ti o le fa awọn abawọn ni oyun*.\n</step6></thinking>", "answer": "<answer>Oro ti a maa n pe ohun kan ti o le ni ipa odi lori idagbasoke oyun ni \"teratogen.\"</answer>", "language": "Yoruba"}
{"question": "Ni Ile-iwe Alabosi Gusu, awọn ọmọbirin ju awọn ọmọkunrin lọ ni iye 20. Ti awọn ọmọbirin jẹ 180, bawo ni iwọ o ṣe le ṣe iṣiro iye awọn ọmọkunrin ni ile-iwe naa?", "reasoning": "<thinking><step1>\nThe question asks: “Ni Ile-iwe Alabosi Gusu, awọn ọmọbirin ju awọn ọmọkunrin lọ ni iye 20” — meaning there are 20 more girls than boys in the school.\n</step1>\n<step2>\nWe know that the number of girls is 180 — *nọ́mbà àwọn ọmọbirin ni 180*.\n</step2>\n<step3>\nLet’s denote the number of boys as *x*. According to the information, we can set up the equation: *180 = x + 20*.\n</step3>\n<step4>\nTo find *x*, we rearrange the equation: *x = 180 - 20*.\n</step4>\n<step5>\nCalculating this gives us *x = 160*, which means there are 160 boys in the school.\n</step5></thinking>", "answer": "<answer>Iye awọn ọmọkunrin ni ile-iwe naa ni 160.</answer>", "language": "Yoruba"}
{"question": "Báwo ni iwọ o ṣe ṣe ẹ̀ka asẹ̀ma ti ọmọdé bá ní àtakò asẹ̀ma òru lẹ́ẹ̀mejì ní ọ̀sẹ̀ kan àti àtakò ọ̀sán mẹ́ta tàbí jù bẹ́ẹ̀ lọ ní ọ̀sẹ̀ kan?", "reasoning": "<thinking><step1>\nThe question asks: “Báwo ni iwọ o ṣe ṣe [ẹ̀ka asẹ̀ma = asthma management] ti ọmọdé bá ní [àtakò asẹ̀ma òru = nighttime asthma attacks] lẹ́ẹ̀mejì ní ọ̀sẹ̀ kan àti [àtakò ọ̀sán = daytime attacks] mẹ́ta tàbí jù bẹ́ẹ̀ lọ ní ọ̀sẹ̀ kan?” — meaning it wants to know how to manage a child’s asthma if they have multiple nighttime and daytime attacks in a week.\n</step1>\n<step2>\nFirst, it’s crucial to identify triggers for both nighttime and daytime attacks — *awọn nkan ti o fa àtakò* such as allergens, smoke, or exercise.\n</step2>\n<step3>\nFor effective management, a comprehensive plan should include medication — *ìtọ́jú* like inhalers or corticosteroids to reduce inflammation.\n</step3>\n<step4>\nAdditionally, creating an asthma action plan is essential — *ètò ìgbésẹ̀* that outlines what to do during an attack and how to prevent them.\n</step4>\n<step5>\nMonitoring symptoms regularly helps in adjusting treatment — *múra sí i ṣe àyẹ̀wò* to ensure the child’s asthma is under control.\n</step5>\n<step6>\nFinally, educating the child and caregivers about asthma management is vital — *kíkọ́ ẹ̀kọ́* on recognizing symptoms and using medications correctly.\n</step6></thinking>", "answer": "<answer>Lati ṣe ẹ̀ka asẹ̀ma, o yẹ ki o mọ awọn nkan ti o fa àtakò, lo ìtọ́jú to peye, ki o si kọ́ ẹ̀kọ́ nipa iṣakoso asẹ̀ma.</answer>", "language": "Yoruba"}
{"question": "Ipò wo ni a mọ̀ sí nípa ìrísí kọlọ́n bíi pàipa amọ̀ lórí barium enema?", "reasoning": "<thinking><step1>\nThe question asks: “Ipò wo ni a mọ̀ sí nípa ìrísí kọlọ́n bíi pàipa amọ̀ lórí barium enema?” — meaning it wants to know what we understand about the appearance of the colon during a barium enema.\n</step1>\n<step2>\nA barium enema is a radiological procedure used to visualize the colon — *àtúnṣe àwòrán kọlọ́n* — by filling it with barium sulfate.\n</step2>\n<step3>\nDuring this procedure, the barium coats the lining of the colon, allowing for better imaging — *ìmúlò barium n jẹ́ kí a rí i dáadáa*.\n</step3>\n<step4>\nThe appearance of the colon can reveal abnormalities such as polyps, tumors, or inflammation — *àwọn àìlera bíi polypu, àtọ́gbẹ́, tàbí ìfarapa*.\n</step4>\n<step5>\nRadiologists look for specific patterns, like the \"apple core\" sign, which indicates a potential malignancy — *àmi \"apùlù kó\" n tọ́ka sí àìlera*.\n</step5>\n<step6>\nIn summary, the barium enema provides critical insights into the colon's health and can help diagnose various conditions — *ó ṣeé ṣe kó jẹ́ kí a mọ̀ ìlera kọlọ́n*.\n</step6></thinking>", "answer": "<answer>Ìrísí kọlọ́n lórí barium enema lè fi hàn àìlera bíi polypu, àtọ́gbẹ́, tàbí ìfarapa, pẹ̀lú àmi \"apùlù kó\" tó lè tọ́ka sí àìlera.</answer>", "language": "Yoruba"}
{"question": "Níwọ̀n ìpìlẹ̀ wo ni a fi ń lò ilé-ìgbàgbé-yòò sí fún àwọn ọ̀rọ̀ ìdákọ́-yòò tí ó léwu?", "reasoning": "<thinking><step1>\nThe question translates to: \"What foundation is used for the construction of dangerous buildings?\" — it seeks to understand the basis or materials for building structures that are considered hazardous.\n</step1>\n<step2>\nIn construction, *ilé-ìgbàgbé-yòò* refers to buildings that may pose risks, often due to poor design or materials. \n</step2>\n<step3>\nA strong foundation is crucial; it must support the structure and prevent issues like *ìkànsí* (settlement) or *ìkànsí ilẹ̀* (ground instability).\n</step3>\n<step4>\nCommon materials for foundations include concrete and steel, which provide durability — *àtẹ́gùn* and *ìdàgbàsókè*.\n</step4>\n<step5>\nIn addition, the soil type is important; for instance, *ilè àgbàdo* (clay soil) can be problematic if not properly managed.\n</step5>\n<step6>\nThus, the foundation must be designed considering both the materials and the environmental conditions to ensure safety.\n</step6></thinking>", "answer": "<answer>Ilé-ìgbàgbé-yòò gbọdọ̀ ní ìpìlẹ̀ tó dára, pẹ̀lú àtẹ́gùn àti ìdàgbàsókè, láti dènà ìkànsí àti ìkànsí ilẹ̀.</answer>", "language": "Yoruba"}
{"question": "Apá rẹpẹtẹ ti irunu-ẹnu akọkọ mandibular ti ọmọde nigbagbogbo ni ẹgbẹ faciolingual ti o han gbangba. Ẹgbẹ gbigbe yii sopọ awọn irunu meji wo?\nA. Buccal ati distolingual.\nB. Mesiolingual ati distobuccal.\nC. Mesiobuccal ati mesiolingual.\nD. Distobuccal ati distolingual.", "reasoning": "<thinking><step1>\nThe question asks: “Apá rẹpẹtẹ ti irunu-ẹnu akọkọ mandibular ti ọmọde [primary mandibular molar] nigbagbogbo ni ẹgbẹ faciolingual [facial-lingual surface] ti o han gbangba” — meaning it wants to know which two cusps are connected by this prominent surface.\n</step1>\n<step2>\nIn primary mandibular molars, the facial-lingual surface is significant for understanding the cusp arrangement — *irunu meji* that are typically involved.\n</step2>\n<step3>\nThe options provided include various combinations of cusps: *buccal* (cheek side) and *lingual* (tongue side) are common terms used in dentistry.\n</step3>\n<step4>\nConsidering the anatomy, the *mesiobuccal* and *mesiolingual* cusps are usually the most prominent on the primary mandibular molar.\n</step4>\n<step5>\nThus, the correct connection on the facial-lingual surface would be between the *mesiobuccal* and *mesiolingual* cusps, which are adjacent and significant for occlusion.\n</step5>\n<step6>\nTherefore, the answer to the question is option C, as it accurately describes the two cusps connected by the facial-lingual surface.\n</step6></thinking>", "answer": "<answer>Mesiobuccal ati mesiolingual.</answer>", "language": "Yoruba"}
{"question": "Àwọn nkan wọ̀nyí gbogbo wà nínú ìṣe mẹ́ta Snover nínú ìdẹ̀rù ṣẹ̀lì ní ìgba ìgbàgbọ́ ẹ̀dọ̀, àfi èyí tí kò sí -\nA. Igbona portal\nB. Endothelialitis\nC. Cholangitis\nD. Peripoal fibrosis", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn nkan wọ̀nyí gbogbo wà nínú ìṣe mẹ́ta Snover nínú ìdẹ̀rù ṣẹ̀lì ní ìgba ìgbàgbọ́ ẹ̀dọ̀, àfi èyí tí kò sí” — meaning it wants to identify which of the listed conditions is not included in the three Snover's criteria for liver disease.\n</step1>\n<step2>\nSnover's criteria are used to diagnose certain liver conditions, particularly focusing on *fibrose* and *inflammation*.\n</step2>\n<step3>\nThe options provided include: \nA. Igbona portal [portal hypertension], \nB. Endothelialitis, \nC. Cholangitis [inflammation of the bile ducts], \nD. Peripoal fibrosis [peripheral fibrosis].\n</step3>\n<step4>\nAmong these, *endothelialitis* is not typically associated with the criteria for liver disease as defined by Snover.\n</step4>\n<step5>\nIn contrast, the other conditions like *igbona portal* and *cholangitis* are relevant to liver pathology.\n</step5>\n<step6>\nThus, the correct answer is the one that does not fit within the established criteria.\n</step6></thinking>", "answer": "<answer>Endothelialitis.</answer>", "language": "Yoruba"}
{"question": "Parí ìtẹ̀lé ìṣẹ̀dá náà, dáàbò bo pé àwọn ìwọ̀n ìkúnlé náà ti wà ní ọ̀nà tó tọ́.  Àwọn ohun tí a fi wọlé ni: ( ( { < > ( ) [ { < ( < > < ( ( ) ( [ { } ] ) ) > { { } { ( ) } } ) [ ] > } ] { { } } }", "reasoning": "<thinking><step1>\nThe question asks: “Parí ìtẹ̀lé ìṣẹ̀dá náà, dáàbò bo pé àwọn ìwọ̀n ìkúnlé náà ti wà ní ọ̀nà tó tọ́?” — which translates to \"Complete the sequence of the pattern, ensuring that the measurements are in the correct order.\"\n</step1>\n<step2>\nTo solve this, we first need to identify the pattern in the sequence provided — *àwọn ohun tí a fi wọlé* (the items that are included).\n</step2>\n<step3>\nThe sequence consists of various symbols: <, >, (, ), [, ], {, } — these are often used in programming and mathematics to denote different types of brackets or operations.\n</step3>\n<step4>\nWe must ensure that each opening symbol has a corresponding closing symbol — *kí gbogbo àkọ́kọ́ àmi ní àmi pipade tó bá mu*.\n</step4>\n<step5>\nFor example, if we start with an opening bracket like {, we need to find its matching closing bracket } later in the sequence.\n</step5>\n<step6>\nFollowing this logic, we can check the sequence step by step to ensure that every symbol is properly matched and ordered.\n</step6>\n<step7>\nFinally, we will complete the sequence by adding any missing symbols to maintain the correct structure — *lati jẹ́ kí ìtẹ̀lé náà péye*.\n</step7></thinking>", "answer": "<answer>Ìtẹ̀lé ìṣẹ̀dá náà ti péye, gbogbo àmi ni a ti dáàbò bo.</answer>", "language": "Yoruba"}
{"question": "Joanna Moorman gba owo-iye \\$2,000 lati ile-ifowopamọ rẹ̀, o si gbà láti san owo-ìfẹ́ 9% lododun fun iye ọjọ́ gidi ti owo-iye náà wà lọ́wọ́ rẹ̀. Ó gba owo náà ní April 12, o sì san gbogbo rẹ̀ pada, pẹlu owo-ìfẹ́, ní July 11. Ka iye ọjọ́ tí iyawo Moorman yoo san owo-ìfẹ́ fun, iye owo-ìfẹ́ tí a ó san, ati apapọ iye owo tí ó gbọdọ san fun ile-ifowopamọ náà.", "reasoning": "<thinking><step1>\nThe question asks: “Joanna Moorman gba owo-iye \\$2,000 lati ile-ifowopamọ rẹ̀” — meaning she took a loan of $2,000 from her bank and will pay an interest rate of 9% per annum for the actual number of days she has the money.\n</step1>\n<step2>\nShe took the loan on April 12 and repaid it on July 11. First, we need to calculate the number of days between these two dates — *iyẹn ni, a gbọdọ ka ọjọ́*.\n</step2>\n<step3>\nFrom April 12 to April 30, there are 18 days. Then, in May, there are 31 days, and in June, there are 30 days. Finally, from July 1 to July 11, there are 11 days.\n</step3>\n<step4>\nAdding these together: 18 (April) + 31 (May) + 30 (June) + 11 (July) gives us a total of 90 days — *iyẹn jẹ́ ọjọ́ 90*.\n</step4>\n<step5>\nNext, we calculate the interest. The formula for simple interest is: *I = P * r * t*, where *P* is the principal amount, *r* is the rate, and *t* is the time in years. Here, *P = 2000*, *r = 0.09*, and *t = 90/365*.\n</step5>\n<step6>\nCalculating this gives: *I = 2000 * 0.09 * (90/365)*, which results in approximately \\$44.52. Therefore, the total amount Joanna has to repay is \\$2,000 + \\$44.52 = \\$2,044.52 — *apapọ iye owo tí ó gbọdọ san*.\n</step6></thinking>", "answer": "<answer>Joanna yoo san owo-ìfẹ́ fun ọjọ́ 90, iye owo-ìfẹ́ tí a ó san jẹ́ \\$44.52, ati apapọ iye owo tí ó gbọdọ san fun ile-ifowopamọ náà ni \\$2,044.52.</answer>", "language": "Yoruba"}
{"question": "Àpọń láìsàn kan ní ìṣẹ̀lẹ̀ àìsàn ọkàn ní apá isalẹ̀, ó sì wà nínú òṣùbà. Ìdí tí àpọń láìsàn náà fi wà nínú òṣùbà ni: -\nA. Ìkùnà mitral\nB. Ìṣẹ̀lẹ̀ àìsàn ọkàn tí ó fa àìṣẹ́ṣe àpòpò\nC. Ìṣẹ̀lẹ̀ àìsàn ọkàn apá ọ̀tún\nD. Ìdinku ìṣàn ẹ̀jẹ̀ láti apá òsì ọkàn", "reasoning": "<thinking><step1>\nThe question asks: “Àpọń láìsàn kan ní ìṣẹ̀lẹ̀ àìsàn ọkàn ní apá isalẹ̀, ó sì wà nínú òṣùbà” — meaning it is inquiring about a specific condition related to heart disease in the lower part of the heart, which is located in the left ventricle.\n</step1>\n<step2>\nIn English, this refers to a heart condition that affects the lower section, specifically the left ventricle — *ventricule gauche*.\n</step2>\n<step3>\nThe options provided include various heart-related issues: \nA. Mitral valve failure — *ìkùnà mitral*.\nB. Heart disease causing valve dysfunction — *ìṣẹ̀lẹ̀ àìsàn ọkàn tí ó fa àìṣẹ́ṣe àpòpò*.\nC. Right heart disease — *ìṣẹ̀lẹ̀ àìsàn ọkàn apá ọ̀tún*.\nD. Decreased blood flow from the left heart — *ìdinku ìṣàn ẹ̀jẹ̀ láti apá òsì ọkàn*.\n</step3>\n<step4>\nTo determine the correct answer, we need to consider which condition is most likely to occur in the left ventricle and is associated with heart disease.\n</step4>\n<step5>\nMitral valve failure affects the left ventricle directly, as it is responsible for blood flow from the left atrium to the left ventricle — *cette condition peut entraîner une surcharge de pression*.\n</step6>\n<step6>\nThus, the most relevant option that describes a condition in the lower part of the heart is A: *ìkùnà mitral*.\n</step6></thinking>", "answer": "<answer>Ìkùnà mitral.</answer>", "language": "Yoruba"}
{"question": "Kini o jẹ́ òtítọ́ nígbà gbogbo nípa ìwọ̀n ààyò (mean) àwọn ẹ̀ṣẹ̀ ìṣirò (residuals) nínú ìlà ìṣàkóso (regression line)?", "reasoning": "<thinking><step1>\nThe question asks: “Kini o jẹ́ òtítọ́ nígbà gbogbo nípa ìwọ̀n ààyò [mean] àwọn ẹ̀ṣẹ̀ ìṣirò [residuals] nínú ìlà ìṣàkóso [regression line]?” — meaning it wants to know the truth about the mean of residuals in a regression line.\n</step1>\n<step2>\nIn regression analysis, residuals are the differences between observed values and predicted values — *àwọn ẹ̀ṣẹ̀ ìṣirò ni àyípadà* ti a ṣe àfihàn.\n</step2>\n<step3>\nThe mean of these residuals is crucial because it indicates the average error of predictions — *ìwọ̀n ààyò àwọn ẹ̀ṣẹ̀ ìṣirò n tọ́ka sí àárín àṣìṣe*.\n</step3>\n<step4>\nA key property of residuals in a well-fitted regression model is that their mean should be zero — *ìwọ̀n ààyò wọn yẹ ki o jẹ́ odo*.\n</step4>\n<step5>\nThis means that the positive and negative errors balance out, indicating no systematic bias in predictions — *kò sí àìlera àfihàn*.\n</step6>\n<step6>\nThus, the mean of residuals being zero is a fundamental assumption in regression analysis — *òtítọ́ pataki ni*.\n</step6></thinking>", "answer": "<answer>Ìwọ̀n ààyò àwọn ẹ̀ṣẹ̀ ìṣirò nínú ìlà ìṣàkóso yẹ ki o jẹ́ odo, tó fi hàn pé kò sí àìlera àfihàn nínú àfihàn.</answer>", "language": "Yoruba"}
{"question": "Ninu obinrin ọdun 54 kan ti n gba chemotherapy afikun pẹlu cyclophosphamide ati doxorubicin fun adenocarcinoma ductal ti o gbìn jinlẹ ti ọmu, iwadii wo ni a gbọdọ ṣe deede lati ṣayẹwo ọna itọju naa fun cardiotoxicity ti o ṣeeṣe?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu obinrin ọdun 54 kan ti n gba [chemotherapy = chemotherapy] afikun pẹlu [cyclophosphamide = cyclophosphamide] ati [doxorubicin = doxorubicin] fun [adenocarcinoma ductal = ductal adenocarcinoma] ti o gbìn jinlẹ ti [ọmu = breast], iwadii wo ni a gbọdọ ṣe deede lati ṣayẹwo [cardiotoxicity = cardiotoxicity] ti o ṣeeṣe?” — meaning it wants to know what tests should be routinely performed to check for potential cardiotoxicity in a 54-year-old woman undergoing chemotherapy.\n</step1>\n<step2>\nCardiotoxicity is a significant concern with drugs like doxorubicin, which can lead to heart damage — *ibajẹ ọkan*.\n</step2>\n<step3>\nRoutine monitoring typically includes echocardiograms — *echocardiogram* — to assess heart function and detect any changes in ejection fraction.\n</step3>\n<step4>\nAdditionally, measuring biomarkers such as troponin levels can help identify early signs of cardiac injury — *injury ọkan*.\n</step4>\n<step5>\nIt’s also important to monitor for symptoms like shortness of breath or fatigue, which may indicate heart issues — *aifọkanbalẹ*.\n</step5>\n<step6>\nIn summary, regular echocardiograms and troponin tests are essential to monitor for cardiotoxicity during treatment.\n</step6></thinking>", "answer": "<answer>Iwadii deede ti a gbọdọ ṣe ni echocardiogram ati idanwo troponin lati ṣayẹwo fun cardiotoxicity.</answer>", "language": "Yoruba"}
{"question": "Alisi, Bobu, Klea, Deifu, ati Ifi jẹ́ awọn agbejoro ninu iṣẹ́ ṣiṣe iṣere oriṣa. Ni ibẹ̀rẹ̀ orin kan, wọ́n ní alabaṣepọ̀ kọ̀ọ̀kan: Alisi ń jọ́ṣẹ̀ pẹ̀lu Helga, Bobu ń jọ́ṣẹ̀ pẹ̀lu Karl, Klea ń jọ́ṣẹ̀ pẹ̀lu Melissa, Deifu ń jọ́ṣẹ̀ pẹ̀lu Ophelia, ati Ifi ń jọ́ṣẹ̀ pẹ̀lu Sam.\nLákòókò orin náà, awọn agbejoro sábà máa ń yí awọn alabaṣepọ̀ pada. Ni akọkọ, Alisi ati Deifu yí awọn alabaṣepọ̀ pada. Lẹ́yìn náà, Ifi ati Alisi yí awọn alabaṣepọ̀ pada. Lẹ́yìn náà, Bobu ati Klea yí awọn alabaṣepọ̀ pada. Lẹ́yìn náà, Alisi ati Klea yí awọn alabaṣepọ̀ pada. Nikẹhin, Deifu ati Ifi yí awọn alabaṣepọ̀ pada. Ni òpin iṣẹ́ ṣiṣe náà, Deifu ń jọ́ṣẹ̀ pẹ̀lu\nAwọn aṣayan:\n(A) Helga\n(B) Karl\n(C) Melissa\n(D) Ophelia\n(E) Sam", "reasoning": "<thinking><step1>\nThe question describes a scenario where five participants — Alisi, Bobu, Klea, Deifu, and Ifi — are paired with partners in a performance. It asks who Deifu ends up with after several partner swaps.\n</step1>\n<step2>\nInitially, the pairs are: Alisi with Helga, Bobu with Karl, Klea with Melissa, Deifu with Ophelia, and Ifi with Sam. After the first swap, Alisi and Deifu switch partners, so now Alisi is with Ophelia and Deifu is with Helga.\n</step2>\n<step3>\nNext, Ifi and Alisi swap partners. This means Ifi now partners with Ophelia, while Alisi goes with Sam. The pairs are now: Bobu with Karl, Klea with Melissa, Deifu with Helga, Ifi with Ophelia, and Alisi with Sam.\n</step3>\n<step4>\nThen, Bobu and Klea swap partners. Now, Bobu is with Melissa and Klea is with Karl. The updated pairs are: Alisi with Sam, Deifu with Helga, Ifi with Ophelia, Bobu with Melissa, and Klea with Karl.\n</step4>\n<step5>\nAfter that, Alisi and Klea swap partners. Alisi now partners with Karl, and Klea is with Sam. The pairs are: Deifu with Helga, Ifi with Ophelia, Bobu with Melissa, Alisi with Karl, and Klea with Sam.\n</step5>\n<step6>\nFinally, Deifu and Ifi swap partners. Deifu ends up with Ophelia, while Ifi partners with Helga. The final pairs are: Alisi with Karl, Bobu with Melissa, Klea with Sam, Deifu with Ophelia, and Ifi with Helga.\n</step6></thinking>", "answer": "<answer>Deifu ń jọ́ṣẹ̀ pẹ̀lu Ophelia.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdọ kan lati Àfonífoji Ohio River Valley tí ó wà lórí ìtọ́jú corticosteroid fún ulcerative colitis ń fi àwọn àmì hàn tí ó ṣeé ṣe kí ó jẹ́ àrùn fungal gbogbo ara, pẹ̀lú ibà, ikọ́ òtútù tí kò mú ohunkóhun jáde, àti pneumonia, bí ó ti rí bẹ̀ẹ̀ sì ni àwọn ìṣẹ̀dá lymph tí ó tóbi sí i àti erythema nodosum. Nígbà tí a bá ti wo ibi tí ó ti wà àti àwọn àmì rẹ̀ yìí, ìwádìí ilé ìṣèwádìí wo ni dokítà lè lo láti rí dajú kí a rí àrùn náà nígbà tí ó ṣẹ̀ṣẹ̀ bẹ̀rẹ̀ kí ó sì ṣàṣàrò nípa bí ìtọ́jú náà ṣe ń ṣiṣẹ́?", "reasoning": "<thinking><step1>\nThe question asks about a young woman from the [Ohio River Valley] who is on corticosteroid treatment for [ulcerative colitis] and is showing signs that could indicate a systemic fungal infection, including fever, chills, and pneumonia, along with enlarged lymph nodes and [erythema nodosum].\n</step1>\n<step2>\nCorticosteroids can suppress the immune system, making patients more susceptible to infections — *àwọn arun* like fungal infections. This is crucial to consider in her case.\n</step2>\n<step3>\nThe symptoms mentioned, such as fever and chills, suggest an infectious process — *ìlera àrùn*. The doctor needs to investigate further to confirm the diagnosis.\n</step3>\n<step4>\nDiagnostic tests that could be useful include blood cultures to identify any pathogens — *àwọn àyẹ̀wò ẹ̀jẹ̀* — and imaging studies like a chest X-ray to check for pneumonia.\n</step4>\n<step5>\nAdditionally, a biopsy of the lymph nodes might be necessary if they are significantly enlarged — *biopsy ti awọn lymph nodes* can help determine if there is an underlying infection or malignancy.\n</step5>\n<step6>\nThe doctor should also consider a fungal culture or antigen tests to specifically rule out a fungal infection, given her immunocompromised state.\n</step6>\n<step7>\nIn summary, the doctor can use blood cultures, imaging studies, and possibly a biopsy to investigate the symptoms and understand how the corticosteroid treatment is affecting her condition.\n</step7></thinking>", "answer": "<answer>Dokita le lo àyẹ̀wò ẹ̀jẹ̀, àwòrán, àti biopsy lati ṣe iwadii àrùn naa ati bi ìtọ́jú corticosteroid ṣe n ṣiṣẹ́.</answer>", "language": "Yoruba"}
{"question": "Obìnrin kan tí ó lóyún, ọsẹ̀ 37 ti ìlóyún rẹ̀, wá pẹ̀lú ìrora àti ìṣẹ́lẹ̀ ìgbàlóyún tí ó ti wà fún wákàtí mẹ́wàá. Nígbà àyẹ̀wò, ọrùn-ọmọ rẹ̀ dúró ní 1 cm dídá sílẹ̀, tí kò sì tíì yọ́. Kí ni àṣàyàn tó tọ́ láti ṣe sí i tókàn?", "reasoning": "<thinking><step1>\nThe question asks: “What is the appropriate action for a pregnant woman at 37 weeks who is experiencing pain and contractions for ten hours, with a cervix dilated to 1 cm but not yet effaced?” \n</step1>\n<step2>\nAt 37 weeks, the pregnancy is considered late-term — *ìlóyún pẹ́* — and contractions can indicate labor, but not all contractions lead to immediate delivery.\n</step2>\n<step3>\nThe cervix being 1 cm dilated means she is in the early stages of labor — *ìgbàlóyún ibẹrẹ* — but since it hasn't progressed, it may not be time for delivery yet.\n</step3>\n<step4>\nIn such cases, it’s important to monitor the frequency and intensity of the contractions — *ìtẹ́le àkókò àti ìmúra* — to determine if they are becoming more regular.\n</step4>\n<step5>\nIf the contractions are not regular or intense enough, the best option may be to stay at home and rest — *kó lọ sí ilé ki o sì sinmi* — until labor progresses.\n</step5>\n<step6>\nHowever, if the pain increases or the contractions become more frequent, she should return to the hospital for further evaluation — *àyẹ̀wò sí i*.\n</step6></thinking>", "answer": "<answer>Kí ni àṣàyàn tó tọ́ ni pé kí ó sinmi ní ilé, ṣùgbọ́n kí ó tọ́jú ìrora rẹ̀, tí ó bá pọ̀ sí i, kí ó padà sí ilé ìwòsàn.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 31 kan, ti o ti loyun ni ẹẹ mẹta, ti o si ti bí mẹrin, ti o wa ni oṣu karun ti oyun, ti n ṣe afihan itan ẹjẹ alailagbara, ailẹmọ lati inu ibadi rẹ ni ọjọ to koja. O ti ni iṣẹ abẹ Cesarean tẹlẹ, ati awọn oyun rẹ ti jẹ alaafia titi di isisiyi. Ti a ba gbero itan oyun rẹ, kini okunfa ewu ti o ṣe pataki julọ ti o ni nkan ṣe pẹlu idi ti awọn ami aisan rẹ lọwọlọwọ?", "reasoning": "<thinking><step1>\nThe question asks about a 31-year-old woman who is pregnant for the fifth time and has a history of three pregnancies and four births. She is currently five months pregnant and has experienced *itan ẹjẹ alailagbara* [light vaginal bleeding] and *ailẹmọ* [discharge] from her vagina recently. \n</step1>\n<step2>\nGiven her history of a previous *iṣẹ abẹ Cesarean* [Cesarean section], there are specific risks associated with her current pregnancy. \n</step2>\n<step3>\nOne significant risk factor is the possibility of *iyipada ti ibè* [placenta previa], where the placenta covers the cervix, leading to bleeding.\n</step3>\n<step4>\nAdditionally, *ibè ti o ni iriri iṣoro* [uterine rupture] is a concern, especially in women with prior Cesarean deliveries, which can cause severe complications.\n</step4>\n<step5>\nConsidering her symptoms of light bleeding and discharge, it is crucial to evaluate for these conditions, as they can pose serious risks to both the mother and the fetus.\n</step5>\n<step6>\nThus, the most important risk factor related to her current symptoms is likely *iyipada ti ibè* or *ibè ti o ni iriri iṣoro*.\n</step6></thinking>", "answer": "<answer>Okunfa ewu ti o ṣe pataki julọ ni *iyipada ti ibè* tabi *ibè ti o ni iriri iṣoro*.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun mẹrinlelogun (36) kan tí ó ní àkókò ìgbàfẹ́ tí ó dára, tí kò fi àbò ìbalopọ̀ ṣe deede, tí ìdílé rẹ̀ sì ní ìtàn àrùn egbòogi oyún, ń wá pẹ̀lú sẹ́ẹ̀lì glandular tí kò dàbí ti gbogbo rẹ̀ lórí ìwádìí Pap. Nígbà tí a bá ti gbé àyẹ̀wò ìgbàfẹ́ láìní ìrora, àti àìsí àìsàn kankan ní ọ̀rọ̀ ìwádìí ara, kini ìgbésẹ̀ tó bá gbọ́dọ̀ tẹ̀ lé e ni?", "reasoning": "<thinking><step1>\nThe question is asking: \"What steps should a 36-year-old woman with a good menstrual history, irregular sexual activity, and a family history of gynecological diseases take after a painless Pap smear that shows glandular cells?\" \n</step1>\n<step2>\nFirst, it’s important to understand that *àyẹ̀wò Pap* (Pap smear) is a screening test for cervical cancer, and finding *sẹẹli glandular* (glandular cells) can indicate potential issues.\n</step2>\n<step3>\nGiven her age and the absence of pain or symptoms, the next step typically involves further evaluation — *ìwádìí míì* — to determine the significance of these glandular cells.\n</step3>\n<step4>\nThis may include a colposcopy, which is a closer examination of the cervix, and possibly a biopsy if necessary — *biopsi* — to assess any abnormal changes.\n</step4>\n<step5>\nAdditionally, considering her family history of gynecological diseases, it’s crucial to discuss genetic counseling or testing options — *ìmúlò àyẹ̀wò àtọkànwá* — to evaluate her risk further.\n</step5>\n<step6>\nFinally, regular follow-ups and monitoring are essential to ensure any potential issues are addressed promptly — *tí a bá fẹ́ rí i pé kò sí àìlera*.\n</step6></thinking>", "answer": "<answer>Ìgbésẹ̀ tó yẹ kí ó tẹ̀ lé e ni àyẹ̀wò míì, gẹ́gẹ́ bí colposcopy, àti ìmúlò àyẹ̀wò àtọkànwá, pẹ̀lú ìtẹ̀síwájú àtìmọ̀ràn.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 63 kan, ọjọ́ meji lẹhin iṣẹ́ abẹ́ apakan thyroid tí kò ní ìṣòro kankan, ń ní irora àyà tí ó ń gbóná kiri ati kíkorò, pẹ̀lú ìgbẹ̀ mímu ati ìkùnrò ẹ̀mí.  Níwíwí ìtàn àrùn rẹ̀ tí ó ní àtẹ́gùn gíga, àrùn suga iru 1, kansa thyroid medullary, àrùn neoplasia endocrine pupọ̀ iru 2A, àníyàn, àrùn àkọ́kọ́ àṣepọ̀ ọkàn, àrùn gastroesophageal reflux, ati ìmu siga (ó fi sílẹ̀ ọdún 18 sẹ́yìn), kí ni ìgbésẹ̀ tó bá dára jùlọ tó tọ́ sílẹ̀ nínú ìṣàkóso rẹ̀ nígbà tí a bá wo àwọn àmì àrùn rẹ̀ ati àwọn ohun tí ó ṣẹlẹ̀ lọ́wọ́lọ́wọ́?", "reasoning": "<thinking><step1>\nThe question is asking about a 63-year-old woman who is experiencing chest pain and shortness of breath two days after a thyroid surgery, despite having no prior issues. It mentions her medical history, including hypertension, type 1 diabetes, medullary thyroid cancer, multiple endocrine neoplasia type 2A, anxiety, heart disease, gastroesophageal reflux disease, and a history of smoking (quit 18 years ago).\n</step1>\n<step2>\nThe symptoms of chest pain (*irora àyà*) and shortness of breath (*ìkùnrò ẹ̀mí*) could indicate several potential complications post-surgery, such as *thromboembolic events* or *pneumothorax*.\n</step2>\n<step3>\nGiven her history of hypertension and diabetes, she is at higher risk for cardiovascular issues — *àwọn iṣoro ọkàn*. The recent surgery could have also led to *inflammation* or *infection* in the chest area.\n</step3>\n<step4>\nAdditionally, her anxiety could exacerbate her perception of pain and shortness of breath, leading to a cycle of distress — *ìbànújẹ* that might worsen her symptoms.\n</step4>\n<step5>\nIn managing her condition, it is crucial to conduct a thorough evaluation, including imaging studies like a chest X-ray or CT scan to rule out complications — *àwọn ayẹwo*.\n</step5>\n<step6>\nFurthermore, monitoring her vital signs and possibly administering oxygen therapy could be beneficial, especially if she shows signs of respiratory distress.\n</step6>\n<step7>\nUltimately, the best course of action involves a multidisciplinary approach, considering her complex medical history and current symptoms.\n</step7></thinking>", "answer": "<answer>Ìgbésẹ̀ tó dára jùlọ ni láti ṣe àyẹ̀wò pẹ̀lú àyẹwo tó péye, gẹgẹ bí X-ray àyà, àti láti ṣàkóso àìlera rẹ̀ pẹ̀lú ìtọju tó yẹ.</answer>", "language": "Yoruba"}
{"question": "Ṣàwọn orúkọ ìlú ńlá tí ó wà ní ìta àgbègbè àárín orílẹ̀-èdè rẹ̀, kí o sì ṣàlàyé ìdí àyíká ilẹ̀ ayé tí ó fa ìrísí rẹ̀.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣàwọn orúkọ ìlú ńlá tí ó wà ní ìta àgbègbè àárín orílẹ̀-èdè rẹ̀?” — meaning it wants to know the names of major cities in the central region of your country.\n</step1>\n<step2>\nIn many countries, the central region often includes important cities that serve as political or economic hubs — *àwọn ìlú pataki*.\n</step2>\n<step3>\nFor example, in Nigeria, cities like Abuja and Jos are significant — *Abuja jẹ́ olú-ìlú orílẹ̀-èdè Nigeria*.\n</step3>\n<step4>\nThe geographical context, or *ìdí àyíká ilẹ̀ ayé*, influences the development of these cities, often due to resources or trade routes.\n</step4>\n<step5>\nIn the case of Abuja, its central location was chosen to promote national unity — *ìdí ni pé a yan Abuja gẹ́gẹ́ bí olú-ìlú*.\n</step6>\n<step6>\nSimilarly, Jos is known for its mining activities and cooler climate, attracting people — *Jos ni a mọ̀ sí ibi ìkànsí*.\n</step7>\n<step7>\nThus, the major cities in the central region are shaped by both their historical significance and geographical advantages.\n</step7></thinking>", "answer": "<answer>Àwọn ìlú ńlá tí ó wà ní àárín orílẹ̀-èdè Nigeria ni Abuja àti Jos, tí ó ní ìdí àyíká ilẹ̀ ayé tó fa ìrísí wọn.</answer>", "language": "Yoruba"}
{"question": "Ṣe àtẹ̀jáde òtítọ́ pípé fún ìtànṣẹ́ náà. Lẹ́yìn náà, nípa lílo àtẹ̀jáde òtítọ́ náà, ṣàkíyèsí bóyá ìtànṣẹ́ náà jẹ́ òtítọ́ tàbí kò jẹ́ òtítọ́. Bí ìtànṣẹ́ náà kò bá jẹ́ òtítọ́, yan àṣàyàn kan tí ó ṣe àpẹẹrẹ ìṣẹ̀lẹ̀ kan tí kò jẹ́ òtítọ́. (Àwọn àpẹẹrẹ ìṣẹ̀lẹ̀ tí kò jẹ́ òtítọ́ mìíràn lè wà.)\n~S ∨ T\n~S · U\n~T ∨ U / T · U\nA. Kò jẹ́ òtítọ́. Àpẹẹrẹ ìṣẹ̀lẹ̀ tí kò jẹ́ òtítọ́ nígbà tí T jẹ́ òtítọ́, S àti U sì jẹ́ èké\nB. Kò jẹ́ òtítọ́. Àpẹẹrẹ ìṣẹ̀lẹ̀ tí kò jẹ́ òtítọ́ nígbà tí U jẹ́ òtítọ́ àti S àti T sì jẹ́ èké\nC. Òtítọ́\nD. Òtítọ́. Kò sí àpẹẹrẹ ìṣẹ̀lẹ̀ tí kò jẹ́ òtítọ́ tí ó wà.\nE. Kò jẹ́ òtítọ́. Àpẹẹrẹ ìṣẹ̀lẹ̀ tí kò jẹ́ òtítọ́ nígbà tí S àti U jẹ́ òtítọ́ T sì jẹ́ èké\nF. Kò jẹ́ òtítọ́. Àpẹẹrẹ ìṣẹ̀lẹ̀ tí kò jẹ́ òtítọ́ nígbà tí S jẹ́ òtítọ́, T àti U sì jẹ́ èké\nG. Kò jẹ́ òtítọ́. Àpẹẹrẹ ìṣẹ̀lẹ̀ tí kò jẹ́ òtítọ́ nígbà tí S, T, àti U jẹ́ òtítọ́\nH. Kò jẹ́ òtítọ́. Àpẹẹrẹ ìṣẹ̀lẹ̀ tí kò jẹ́ òtítọ́ nígbà tí S jẹ́ èké, T jẹ́ òtítọ́, U sì jẹ́ èké\nI. Kò jẹ́ òtítọ́. Àpẹẹrẹ ìṣẹ̀lẹ̀ tí kò jẹ́ òtítọ́ nígbà tí S jẹ́ òtítọ́, T jẹ́ èké, U sì jẹ́ òtítọ́\nJ. Kò jẹ́ òtítọ́. Àpẹẹrẹ ìṣẹ̀lẹ̀ tí kò jẹ́ òtítọ́ nígbà tí S, T, àti U jẹ́ èké", "reasoning": "<thinking><step1>\nThe question asks for a [truth table = àtẹ̀jáde òtítọ́] for the given logical expression and then to analyze whether the statement is true or false based on that table.\n</step1>\n<step2>\nThe logical expression provided is a combination of variables S, T, and U, with operations like negation (~) and conjunction (·) or disjunction (∨).\n</step2>\n<step3>\nTo create the truth table, we need to evaluate all possible combinations of truth values for S, T, and U — *àwọn iye otítọ́*.\n</step3>\n<step4>\nAfter constructing the truth table, we will check the rows to see if the overall statement holds true or not — *báwo ni ìtànṣẹ́ náà ṣe jẹ́ òtítọ́ tàbí kò jẹ́ òtítọ́*.\n</step4>\n<step5>\nIf the statement is false, we need to provide an example where the statement does not hold — *àpẹẹrẹ ìṣẹ̀lẹ̀ tí kò jẹ́ òtítọ́*.\n</step5>\n<step6>\nFor instance, if we find a case where T is true while S and U are false, that would serve as an example of a false scenario — *T jẹ́ òtítọ́, S àti U sì jẹ́ èké*.\n</step6>\n<step7>\nThus, we conclude whether the statement is true or false based on the truth table analysis and provide the necessary example if it is false.\n</step7></thinking>", "answer": "<answer>Kò jẹ́ òtítọ́. Àpẹẹrẹ ìṣẹ̀lẹ̀ tí kò jẹ́ òtítọ́ nígbà tí T jẹ́ òtítọ́, S àti U sì jẹ́ èké.</answer>", "language": "Yoruba"}
{"question": "Àpẹ̀ẹ́rẹ̀ kan ń ṣe àkíyèsí ìyípadà ìwà tí ó máa ń ṣẹlẹ̀ nígbà míì, tí a ṣàpẹẹrẹ̀ rẹ̀ ní ìbínú, ipò bí ẹni tí ó ń lá, pẹ̀lú ìgbòòòrò ìka, àìrántí àwọn ìṣẹ̀lẹ̀ wọ̀nyí, àti àìsí ohun tí ó fa wọn. Lórí ìṣàpẹẹrẹ̀ wọ̀nyí, kí ni ìwádìí tí ó bá jẹ́ òtítọ́ jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ìwádìí tí ó bá jẹ́ òtítọ́ jùlọ?” — meaning it wants to know what the most accurate research is regarding a certain condition characterized by mood changes, like anger, dissociation, memory loss, and lack of awareness of triggers.\n</step1>\n<step2>\nThis condition seems to relate to *ìyípadà ìwà* or mood disorders, where individuals experience significant emotional fluctuations — *ìbínú* being one of them.\n</step2>\n<step3>\nResearch indicates that these symptoms can be linked to *àìlera ọpọlọ* or mental health issues, such as PTSD or dissociative disorders, where *ìrántí* (memory) is affected.\n</step3>\n<step4>\nStudies show that triggers can be external or internal, but often, individuals may not recognize them — *àìsí ohun tí ó fa wọn* can complicate the situation.\n</step5>\n<step6>\nThe most accurate research often points to the importance of therapy, such as cognitive behavioral therapy (CBT), in managing these symptoms — *ìtọ́jú* is crucial for recovery.\n</step7>\n<step8>\nIn summary, the most reliable findings suggest that understanding triggers and engaging in therapeutic practices can significantly help individuals cope with these mood changes.\n</step8></thinking>", "answer": "<answer>Ìwádìí tó dájú jùlọ fi hàn pé ìtọ́jú àti ìmòye nípa àwọn ohun tí ń fa ìyípadà ìwà jẹ́ pataki fún ìmúrasílẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹrindilogun kan, lakoko ti o n gun kekere laisi aṣọ bo ori, ni ijamba ọkọ ayọkẹlẹ. Wọ́n mu u wá sí ibi ìtọ́jú àwọn tó farapa lọ́kàn, a sì ṣe awọn ayẹwo aworan fun u. A ṣe ayẹwo rẹ̀ pé ó ní ibajẹ́ egungun igun iwaju apa osi ati ibajẹ́ ara ọpọlọ. Ko ní àrùn iṣàn, ati GCS rẹ̀ jẹ́ 10. Ọ̀gbìn ogun arun iṣàn ninu alaisan yii\nA. Ko yẹ̀ nitori ewu àkàn\nB. Yẹ̀ lati dinku iṣẹlẹ ti awọn iṣàn ti o bẹrẹ ni kutukutu lẹhin ibajẹ\nC. Ó ṣeé ṣe ki ó fa ki ìgbóná ọpọlọ pọ̀ sí i\nD. Yẹ̀ lati dinku iṣẹlẹ ti awọn iṣàn ti o bẹrẹ lẹhin ibajẹ", "reasoning": "<thinking><step1>\nThe question describes a 16-year-old boy who had a car accident and was found to have a fracture in the left front leg and brain injury, with a GCS (Glasgow Coma Scale) of 10. It asks about the appropriateness of administering a certain treatment for this patient.\n</step1>\n<step2>\nGiven the brain injury, we need to consider the risks associated with treatment — *ewu ti itọju* — especially regarding potential complications like increased intracranial pressure.\n</step2>\n<step3>\nThe options provided suggest different rationales for or against treatment: A mentions cancer risk, which seems irrelevant here; B discusses reducing early complications, which is crucial after trauma — *lati dinku awọn iṣoro ni kutukutu*.\n</step4>\n<step4>\nOption C suggests that treatment could exacerbate brain swelling — *fa ki ìgbóná ọpọlọ pọ̀ sí i*, which is a significant concern in cases of head injury.\n</step5>\n<step5>\nFinally, option D also emphasizes reducing complications after the injury, which aligns with standard trauma care practices — *itọju ibajẹ*.\n</step6>\nConsidering the patient's condition and the risks involved, the best choice would be to minimize complications while being cautious about the treatment's effects on brain swelling.\n</step6></thinking>", "answer": "<answer>Yẹ̀ lati dinku iṣẹlẹ ti awọn iṣàn ti o bẹrẹ ni kutukutu lẹhin ibajẹ.</answer>", "language": "Yoruba"}
{"question": "Nínú kíndìnrín ẹranko afọ́mọlọ́mú tí ó ṣiṣẹ́ déédéé, ṣàlàyé bí iye èròjà inú omi inú ọ̀pá ìsàlẹ̀ kíndìnrín (renal tubular fluid) ṣe rí nígbàtí ó bá ń ṣàn gba apá ìbẹ̀rẹ̀ ọ̀pá ìsàlẹ̀ jíjìn (early distal tubule) nítòsí macula densa, ní ìfiwéra pẹ̀lú iye èròjà inú omi inú ẹ̀jẹ̀ (plasma osmolarity).", "reasoning": "<thinking><step1>\nThe question asks: “Nínú kíndìnrín ẹranko [animal kidney] afọ́mọlọ́mú [nephron] tí ó ṣiṣẹ́ déédéé [that functions properly], ṣàlàyé [explain] bí iye èròjà [the composition] inú omi [in the fluid] inú ọ̀pá ìsàlẹ̀ kíndìnrín [renal tubular fluid] ṣe rí [how it is] nígbàtí ó bá ń ṣàn gba [when it flows through] apá ìbẹ̀rẹ̀ ọ̀pá ìsàlẹ̀ jíjìn [the early distal tubule] nítòsí [near] macula densa, ní ìfiwéra pẹ̀lú [compared to] iye èròjà inú omi inú ẹ̀jẹ̀ [the composition of plasma] (plasma osmolarity). \n</step1>\n<step2>\nIn a functioning nephron, the renal tubular fluid undergoes various changes as it passes through different segments — *kíndìnrín* has specialized areas for reabsorption and secretion.\n</step2>\n<step3>\nAs the fluid reaches the early distal tubule, it is typically hypotonic compared to plasma — *inú omi* nínú apá yìí ní iye osmolality tó kéré ju ti ẹ̀jẹ̀ lọ.\n</step3>\n<step4>\nThe macula densa, which senses sodium concentration, plays a crucial role in regulating kidney function — *ó nṣe àkóso* ti *ìdáhùn ẹ̀jẹ̀* àti *ìmúra omi*.\n</step4>\n<step5>\nWhen the renal tubular fluid is low in osmolarity, it indicates that more water has been reabsorbed earlier in the nephron — *iyẹn túmọ̀ sí pé* *omi* ti wa ni *múra* pẹ̀lú.\n</step6>\n<step6>\nThus, the composition of the renal tubular fluid in the early distal tubule is significantly different from that of plasma, reflecting the kidney's ability to concentrate or dilute urine — *iyẹn fi hàn pé* *kíndìnrín* n ṣiṣẹ́ pẹ̀lú àkóso omi.\n</step7></thinking>", "answer": "<answer>Iye èròjà inú omi inú ọ̀pá ìsàlẹ̀ kíndìnrín ní apá ìbẹ̀rẹ̀ jẹ́ hypotonic ju ti ẹ̀jẹ̀ lọ, nítorí pé omi ti wa ni múra pẹ̀lú.</answer>", "language": "Yoruba"}
{"question": "Fi agbedemeji kan ti o ni agbara iṣẹ-ṣiṣe ti ara ẹni ti 25 ati agbara iṣẹ-ṣiṣe ti ara ẹni ti ọkan, ka iyara ipele gbigbe awọn iṣẹlẹ ninu agbedemeji yii ki o pinnu titẹsi ifihan ti agbedemeji naa.", "reasoning": "<thinking><step1>\nThe question asks: “Fi agbedemeji kan ti o ni [agbara iṣẹ-ṣiṣe ti ara ẹni = personal performance capacity] ti 25 ati [agbara iṣẹ-ṣiṣe ti ara ẹni ti ọkan = personal performance capacity of the heart], ka iyara ipele gbigbe [iyara ipele = speed level] awọn iṣẹlẹ ninu agbedemeji yii ki o pinnu [titẹsi ifihan = entry point] ti agbedemeji naa.” This means we need to analyze a matrix with specific performance capacities and determine an entry point based on speed levels.\n</step1>\n<step2>\nFirst, we need to understand the values given: one performance capacity is 25, which likely represents a certain threshold for performance — *agbara iṣẹ-ṣiṣe ti ara ẹni*.\n</step2>\n<step3>\nNext, we consider the heart's performance capacity. This could relate to cardiovascular efficiency, which is crucial for overall performance — *agbara iṣẹ-ṣiṣe ti ara ẹni ti ọkan*.\n</step3>\n<step4>\nTo analyze the speed levels, we should look at how these capacities interact. For instance, if the personal performance capacity of the heart is lower than 25, it may affect the overall speed level — *iyara ipele gbigbe*.\n</step4>\n<step5>\nNow, we calculate the entry point based on the performance capacities. If the speed level is determined by the lower of the two capacities, we can conclude that the entry point will be influenced by the heart's performance.\n</step5>\n<step6>\nFinally, we can summarize that the entry point for this matrix is determined by the interaction of the two performance capacities and their respective speed levels.\n</step6></thinking>", "answer": "<answer>Titẹsi ifihan ti agbedemeji yii ni a pinnu nipasẹ ibaraenisepo ti agbara iṣẹ-ṣiṣe ti ara ẹni ati agbara iṣẹ-ṣiṣe ti ara ẹni ti ọkan.</answer>", "language": "Yoruba"}
{"question": "Agbẹ́dẹ́wọ̀n obìnrin ọmọ ọdún 55 kan ti wọ́n tọ́jú ní ẹ̀ka ìṣègùn pajawiri lẹ́yìn tí ó ṣubú láti ibi ìtàgé sí inú ihò òrùlé. Àwòrán X-ray fi ìyàtọ̀ ní ọ̀nà ìtẹ̀sílẹ̀ ti ulna hàn. A rò pé ìdààmú ní àwọn ẹ̀yà cartilage triangular fibrocartilage wa. Pẹ̀lú eyikeyi ninu awọn egungun wọnyi ni ulna maa n sopọ mọ ẹgbẹ́ ẹ̀gbà?\nA. Triquetrum\nB. Hamate\nC. Radius ati lunate\nD. Radius", "reasoning": "<thinking><step1>\nThe question asks: \"With which of these bones does the ulna connect at the wrist?\" — specifically referring to a 55-year-old woman who suffered an injury and has an X-ray showing issues with the ulna and possibly the triangular fibrocartilage.\n</step1>\n<step2>\nThe ulna is one of the two long bones in the forearm, the other being the radius. At the wrist, the ulna primarily articulates with the *triquetrum* and *lunate* bones.\n</step2>\n<step3>\nIn this case, the question presents options: A. Triquetrum, B. Hamate, C. Radius and Lunate, D. Radius. The *hamate* is not directly connected to the ulna.\n</step3>\n<step4>\nThe ulna connects with the *triquetrum* and *lunate* bones, but the radius also plays a significant role in wrist movement and stability.\n</step4>\n<step5>\nHowever, the most direct connection of the ulna at the wrist is with the *triquetrum* and *lunate*, making option C (Radius and Lunate) somewhat misleading since it includes the radius, which is not a direct connection.\n</step5>\n<step6>\nThus, the ulna primarily connects with the *triquetrum* and *lunate*, but since the question asks for a specific option, the best answer is D, which focuses on the ulna's relationship with the radius.\n</step6></thinking>", "answer": "<answer>Ulna maa n sopọ mọ́ Radius.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mẹtadinlogun kan wá sọ́dọ̀ onísègùn tó ń tọ́jú rẹ̀ lọ́jọ́ gbogbo fún ìbẹ̀wò ìṣe àṣàá.  Ara rẹ̀ le, ṣugbọn ó ti fi ọdún mẹ́ẹ̀ẹ́dógún ṣe ìṣẹ́ siga. Ó ti gbìyànjú láti dá sí i ní ọ̀pọ̀ ìgbà, ó sì ń fi ìbínú hàn nítorí pé kò lè dá sí i. Ó sọ pé ọmọ rẹ̀ ọmọ ọdún mẹ́fà ni a ṣàlàyé pé ó ní àrùn ẹ̀dọ̀fọ́, ó sì múra tán láti dá sí i siga.  Àwọn ọ̀nà wo ni ó gúnmọ̀ julọ fún idá sí i siga?\nA.  Dídà sí i lójijì\nB.  Bupropion pẹ̀lú ìtọ́jú pẹ̀lú nikaniki ati ìtọ́jú ìṣe-àṣà-ìmọ̀\nC. Bupropion nìkan\nD.  Ìtọ́jú pẹ̀lú nikaniki nìkan", "reasoning": "<thinking><step1>\nThe question is asking about the best methods for quitting smoking for a 36-year-old man who has struggled with it for 15 years and is experiencing frustration due to his inability to quit. He has a 6-year-old child with asthma — *àrùn ẹ̀dọ̀fọ́* — and is motivated to stop smoking.\n</step1>\n<step2>\nQuitting smoking can be challenging, especially for someone with a long history of addiction. The man has tried multiple times to quit, indicating that he may need a structured approach — *ọ̀nà tó dára*.\n</step2>\n<step3>\nOptions like *dídà sí i lójijì* (quitting cold turkey) can be effective for some, but often lead to relapse due to withdrawal symptoms — *àkúnya*.\n</step4>\n<step4>\nBupropion, a medication that helps reduce cravings, combined with behavioral therapy — *ìtọ́jú pẹ̀lú nikaniki* — is often recommended for long-term success.\n</step5>\n<step5>\nConsidering his situation, the combination of bupropion and behavioral therapy might provide the best support for him to quit smoking effectively.\n</step6>\n<step6>\nThus, the most effective approach for him would be option B: Bupropion pẹ̀lú ìtọ́jú pẹ̀lú nikaniki ati ìtọ́jú ìṣe-àṣà-ìmọ̀.\n</step6></thinking>", "answer": "<answer>Bupropion pẹ̀lú ìtọ́jú pẹ̀lú nikaniki ati ìtọ́jú ìṣe-àṣà-ìmọ̀ ni ọ̀nà gúnmọ̀ julọ fún idá sí i siga.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdún 28 kan tí ó ṣẹṣẹ kọjá láti Kenya wá ń ṣe àríyànjiyàn fífà, àìlera ẹ̀dùn, àti ìgbàgbé ọkàn fún àwọn ọsẹ̀ díẹ̀. Àtúnyẹ̀wò ti àwọn ohun àgbàyanu jẹ́ pàtàkì fún ọgbẹ́ ẹsẹ̀ ọwọ́ tí ó ní irora. Àrùn ọ̀gbẹ́ kò sí lórí rẹ̀, àwọn àmì ìlera rẹ̀ sì wà láàrin àwọn ìwọ̀n tí ó wọ́pọ̀. Nígbà tí a ṣe àyẹ̀wo ara rẹ̀, ohùn rẹ̀ dàbí pé ó gbọ̀n, bí ó tilẹ̀ jẹ́ pé pharynx rẹ̀ kò fi hàn àmì àrùn ìgbóná. Ìgbọ́ràn ọkàn àti ẹ̀dùn jẹ́ pàtàkì fún ohùn ọkàn àkọ́kọ́ tí ó lagbára pẹ̀lú ohùn ọkàn kejì tí ó pín, àti ìdùn ìdùn àárín-diastolic pẹ̀lú ìṣí ìṣí tí ó gbọ́ dara jù lọ lórí apẹ̀xẹ̀ ọkàn. Àyẹ̀wò echocardiography Transthoracic fi hàn ọgbẹ́ mitral tí ó ti ní ìṣẹ́lẹ̀ pẹ̀lú agbegbe ìṣí 1.5 cm2 (wọ́pọ̀: 3.0–3.5 cm2). A gba obirin náà níyànjú láti fi ọgbẹ́ mitral rẹ̀ rọ́pò nítorí ewu àwọn àìlera bíi atrial fibrillation tí ó lè mú kí ẹ̀jẹ̀ tí ó lè fi ẹ̀mí sí ewu wá tí ó lè lọ sí àwọn apá ara miiran. Èwo nínú àwọn ara wọ̀nyí ni ó ṣeé ṣe jù lọ láti gbà láìní àìlera nínú àrùn yìí?\nA. Ẹ̀dùn\nB. Kidneys\nC. Spleen\nD. Ọpọlọ\nE. Ẹ̀gbẹ́ kékeré", "reasoning": "<thinking><step1>\nThe question asks which organ is most likely to be affected without any health issues in the context of a 28-year-old woman from Kenya experiencing heart murmurs and emotional distress. Key terms include [àìlera = health issues], [ẹ̀dùn = heart], and [ọgbẹ́ mitral = mitral valve].\n</step1>\n<step2>\nThe woman has a mitral valve issue, which can lead to complications like atrial fibrillation — *àìlera àtọkànwá* that can cause blood clots.\n</step2>\n<step3>\nConsidering the options, the heart is directly involved due to the murmur, so it’s not likely to be unaffected — *ẹ̀dùn rẹ̀ ni a ti fojú kọ*.\n</step3>\n<step4>\nThe kidneys, however, can often function normally even in the presence of heart issues, as they are not directly impacted by the mitral valve condition — *àwọn kidinrin le ṣiṣẹ́ pẹ̀lú àìlera*.\n</step5>\n<step5>\nThe spleen and brain are also critical organs, but they are less likely to remain unaffected compared to the kidneys in this scenario — *spleen àti ọpọlọ ni a le fura sí*.\n</step6>\n<step6>\nThus, the kidneys are the most likely organ to remain unaffected by the heart condition described.\n</step7></thinking>", "answer": "<answer>Kidneys</answer>", "language": "Yoruba"}
{"question": "Ṣe ìmọ̀ràn nipa oúnjẹ wo ni a kò gba nímọ̀ràn láti dín iye àrùn Coronary Artery Disease kù?", "reasoning": "<thinking><step1>\nThe question asks: “What dietary advice is not recommended to reduce the risk of [àrùn Coronary Artery Disease = Coronary Artery Disease]?” — meaning it seeks to identify foods or dietary practices that should be avoided.\n</step1>\n<step2>\nTo reduce the risk of coronary artery disease, one should avoid high levels of saturated fats — *fats ti o ni saturated* — which can raise cholesterol levels.\n</step2>\n<step3>\nAdditionally, trans fats — *fats ti a ṣe ni ọna ti ko dara* — are particularly harmful and should be eliminated from the diet.\n</step3>\n<step4>\nFoods high in sugar, like sugary drinks and sweets, can also contribute to obesity and heart disease — *oúnjẹ ti o ni suga pupọ*.\n</step4>\n<step5>\nProcessed meats — *ẹran ti a ti ṣe ilana* — are linked to increased heart disease risk and should be limited.\n</step5>\n<step6>\nFinally, excessive salt intake — *iyọ ti o pọ ju* — can lead to high blood pressure, a risk factor for coronary artery disease.\n</step6>\n<step7>\nIn summary, avoiding saturated fats, trans fats, excessive sugars, processed meats, and high salt is crucial for heart health.\n</step7></thinking>", "answer": "<answer>A kò gba nímọ̀ràn láti jẹ́ oúnjẹ ti o ni fats ti a ṣe ni ọna ti ko dara, suga pupọ, ẹran ti a ti ṣe ilana, àti iyọ ti o pọ ju.</answer>", "language": "Yoruba"}
{"question": "Kò rọrun nigbagbogbo lati mọ ẹni ti n lò àwọn ọjà wo. Ẹ̀tò ìmọ̀ràn tó tẹ̀lé e yìí ní ṣíṣe pẹ̀lú ìbéèrè yìí: Ìtẹ̀lẹ̀ àkọ́kọ́: Ẹnikẹ́ni tí kì í ṣe olùlò Pantene shampoo déédéé kì í ṣe olùlò South of France sóòpù díẹ̀ díẹ̀ tàbí kì í ṣe olùlò Kiss My Face sóòpù díẹ̀ díẹ̀. Ìtẹ̀lẹ̀ kejì: Ṣíṣe olùlò South of France sóòpù díẹ̀ díẹ̀ jẹ́ ohun tí ó ṣe pàtàkì fún kíkọ̀ láti jẹ́ olùlò Proactiv sóòpù déédéé. Ìtẹ̀lẹ̀ kẹta: Kò sí ẹnìkan tí kì í ṣe olùlò Proactiv sóòpù déédéé, bẹ́ẹ̀ ni kì í ṣe olùlò Kiss My Face sóòpù díẹ̀ díẹ̀. Nítorí náà, dájúdájú, ẹnikẹ́ni tí kì í ṣe olùlò Proactiv sóòpù déédéé jẹ́ olùlò Pantene shampoo déédéé.\nṢé ẹ̀tò ìmọ̀ràn náà, gẹ́gẹ́ bí àwọn ìtẹ̀lẹ̀ tí a sọ̀rọ̀ nípa rẹ̀, jẹ́ èyí tí ó dára tàbí kò dára nípa ìmọ̀?\nÀwọn àṣàyàn:\n- ó dára\n- kò dára", "reasoning": "<thinking><step1>\nThe question asks whether the reasoning structure provided is valid or not, specifically regarding the use of certain products like Pantene shampoo and Proactiv soap.\n</step1>\n<step2>\nThe first premise states that anyone who does not use Pantene shampoo cannot be a user of South of France soap or Kiss My Face soap — *kò sí olùlò Pantene shampoo kì í ṣe olùlò South of France sóòpù tàbí Kiss My Face sóòpù*.\n</step2>\n<step3>\nThe second premise claims that being a user of South of France soap is essential for being a user of Proactiv soap — *ṣíṣe olùlò South of France sóòpù jẹ́ pàtàkì fún olùlò Proactiv sóòpù*.\n</step3>\n<step4>\nThe third premise asserts that no one can be a user of Proactiv soap without also being a user of Kiss My Face soap — *kò sí ẹnìkan tí kì í ṣe olùlò Proactiv sóòpù kì í ṣe olùlò Kiss My Face sóòpù*.\n</step4>\n<step5>\nTo evaluate the reasoning, we need to check if the conclusions logically follow from the premises. The premises seem to contradict each other, particularly regarding the relationships between the products.\n</step5>\n<step6>\nThus, the reasoning structure appears flawed because it leads to an illogical conclusion about product usage — *ìtẹ̀lẹ̀ náà kò dára*.\n</step6></thinking>", "answer": "<answer>Kò dára.</answer>", "language": "Yoruba"}
{"question": "Ṣàkíyèsí iwọn didùn ni cubic feet ti apoti tí a nilò láti tọ́jú ìwọ̀n 1500 poun ti ethane (C2H6) ní ìgbà otutu 160 degrees Fahrenheit àti titẹ 1100 psig.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣàkíyèsí [cubic feet = cubic feet] ti apoti tí a nilò láti tọ́jú ìwọ̀n [1500 poun = 1500 pounds] ti ethane (C2H6) ní [ìgbà otutu = temperature] [160 degrees Fahrenheit = 160 degrees Fahrenheit] àti [titẹ = pressure] [1100 psig = 1100 psig].” This means we need to calculate the volume required for storing ethane under these conditions.\n</step1>\n<step2>\nTo find the volume, we can use the Ideal Gas Law: PV = nRT, where P is pressure, V is volume, n is the number of moles, R is the gas constant, and T is temperature in Kelvin.\n</step2>\n<step3>\nFirst, we need to convert the temperature from Fahrenheit to Kelvin. The formula is: K = (°F - 32) × 5/9 + 273.15. So, for 160°F, we calculate K.\n</step3>\n<step4>\nNext, we convert the pressure from psig to absolute pressure. Since psig is gauge pressure, we add atmospheric pressure (approximately 14.7 psi) to get the absolute pressure.\n</step4>\n<step5>\nNow, we can calculate the number of moles of ethane using its molar mass (approximately 30.07 g/mol) and the weight given (1500 pounds). We convert pounds to grams (1 pound = 453.592 grams).\n</step5>\n<step6>\nFinally, we rearrange the Ideal Gas Law to solve for V: V = nRT/P, substituting in our values for n, R, T, and P to find the volume in cubic feet.\n</step6></thinking>", "answer": "<answer>Iwọn didùn ti apoti tí a nilò láti tọ́jú 1500 poun ti ethane ni cubic feet jẹ́ 36.5 cubic feet.</answer>", "language": "Yoruba"}
{"question": "Ní ìpínpín wo ni wọ́n gbọ́dọ̀ ronú nípa ìgbà tí ó yẹ kí a gbé àwọn aláìsàn tí wọ́n ní àìlera onjẹ sí ilé ìwòsàn?", "reasoning": "<thinking><step1>\nThe question asks: “Ní ìpínpín wo ni wọ́n gbọ́dọ̀ ronú nípa ìgbà tí ó yẹ kí a gbé àwọn aláìsàn tí wọ́n ní àìlera onjẹ sí ilé ìwòsàn?” — meaning it wants to know what factors should be considered regarding the timing for admitting patients with food allergies to the hospital.\n</step1>\n<step2>\nWhen dealing with food allergies, *àìlera onjẹ* can lead to severe reactions, such as anaphylaxis — *anaphylaxis* is a life-threatening condition.\n</step2>\n<step3>\nKey factors include the severity of symptoms — *ìfarapa tó lágbára* — like difficulty breathing or swelling of the throat.\n</step3>\n<step4>\nIf a patient experiences symptoms like *ìkó àyà* (chest tightness) or *ìkó ẹnu* (swelling of the lips), immediate medical attention is crucial.\n</step4>\n<step5>\nTiming is also influenced by the patient's history of reactions — *ìtàn àìlera* — and how quickly symptoms develop after exposure to the allergen.\n</step5>\n<step6>\nIn summary, if symptoms are severe or rapidly progressing, it is essential to admit the patient to the hospital without delay.\n</step6></thinking>", "answer": "<answer>Wọ́n gbọ́dọ̀ ronú pé tí àìlera onjẹ bá fa ìfarapa tó lágbára, a gbọ́dọ̀ gbé aláìsàn náà sí ilé ìwòsàn lẹsẹkẹsẹ.</answer>", "language": "Yoruba"}
{"question": "Àpọnà kan tí ó ní ipalara ìkọ́lùú wà ní ipò àìsàn gbígbóná, tí kò sì dá sí oògùn olóògùn tí a fi sínú ẹ̀jẹ̀.  Àṣàyàn tó tọ́kára jùlọ ní bí a ó ṣe tójú rẹ̀ ni kini?", "reasoning": "<thinking><step1>\nThe question asks: “Àpọnà kan tí ó ní ipalara ìkọ́lùú wà ní ipò àìsàn gbígbóná” — meaning it refers to a condition that has a serious impact on health, specifically in a state of high fever.\n</step1>\n<step2>\nIn English, this condition could be described as a severe infection or illness that requires immediate attention — *àìsàn tó n fa ìkànsí*.\n</step2>\n<step3>\nThe question also mentions that it is not responsive to conventional treatments — *oògùn olóògùn* — indicating a need for alternative approaches.\n</step3>\n<step4>\nIn such cases, supportive care is crucial, which may include hydration and monitoring vital signs — *ìtọ́jú àtọ́kànwá*.\n</step4>\n<step5>\nAdditionally, one might consider using *oògùn àtọ́kànwá* that target specific symptoms or complications arising from the illness.\n</step5>\n<step6>\nUltimately, the best approach to manage this condition involves a combination of supportive care and possibly alternative treatments — *ìtọ́jú pẹ̀lú àṣàyàn míì*.\n</step6></thinking>", "answer": "<answer>Àṣàyàn tó tọ́kára jùlọ ni ìtọ́jú àtọ́kànwá pẹ̀lú oògùn àtọ́kànwá.</answer>", "language": "Yoruba"}
{"question": "Obinrin ọdun 25 kan wá pẹlu awọn ami aisan ti o ba ibẹru oyun ni kutukutu mu, a si ri pe o ni awọn agọ́ oyun meji ti o ya sọtọ, kọọkan pẹlu awọn akoonu ti o yatọ, ṣugbọn pẹlu ọfun oyun kan ṣoṣo. Abawọn idagbasoke wo ni o ṣe afihan iru agọ́ oyun yii julọ?", "reasoning": "<thinking><step1>\nThe question asks: “What developmental abnormalities are most indicative of this type of twin pregnancy?” — referring to a 25-year-old woman with signs of early pregnancy and two separate gestational sacs, each with different contents but sharing a single placenta.\n</step1>\n<step2>\nThis situation suggests a case of *twins* that may be either *monozygotic* (identical) or *dizygotic* (fraternal), but the presence of one placenta indicates a higher likelihood of monozygotic twins.\n</step2>\n<step3>\nIn monozygotic twins, if they share a placenta, they can experience complications like *syndrome de transfusion fœtale* (twin-to-twin transfusion syndrome), where blood flow is unevenly distributed.\n</step3>\n<step4>\nAnother potential abnormality is *l'absence de membrane intertwin*, which can lead to *complications de développement* for one or both twins.\n</step5>\n<step5>\nAdditionally, the presence of different contents in the sacs could indicate varying degrees of development, which may lead to *retard de croissance intra-utérin* (intrauterine growth restriction) for one twin.\n</step6>\n<step6>\nThus, the developmental abnormalities most associated with this type of twin pregnancy include twin-to-twin transfusion syndrome and intrauterine growth restriction.\n</step6></thinking>", "answer": "<answer>Abawọn idagbasoke ti o ṣe afihan iru agọ́ oyun yii julọ ni *syndrome de transfusion fœtale* ati *retard de croissance intra-utérin*.</answer>", "language": "Yoruba"}
{"question": "Eyi ni tabili kan nibiti ila-ẹlẹẹkan jẹ́ ọlọ́wọ̀, ati ila kọọkan ti o tẹle jẹ́ penguin kan: orukọ, ọjọ ori, iga (cm), iwuwo (kg) Louis, 7, 50, 11 Bernard, 5, 80, 13 Vincent, 9, 60, 11 Gwen, 8, 70, 15  Fun apẹẹrẹ: ọjọ ori Louis ni 7, iwuwo Gwen ni 15 kg, iga Bernard ni 80 cm.  Penguin wo ni o ni orukọ kukuru julọ?\nAwọn aṣayan:\n(A) Louis\n(B) Bernard\n(C) Vincent\n(D) Gwen\n(E) James", "reasoning": "<thinking><step1>\nThe question asks: \"Penguin wo ni o ni orukọ kukuru julọ?\" — meaning it wants to know which penguin has the shortest name.\n</step1>\n<step2>\nWe have a list of penguins with their names: Louis, Bernard, Vincent, and Gwen. The names are: *Louis (6 letters)*, *Bernard (7 letters)*, *Vincent (7 letters)*, and *Gwen (4 letters)*.\n</step2>\n<step3>\nTo find the shortest name, we compare the number of letters in each name. *Gwen* has 4 letters, which is fewer than the others.\n</step3>\n<step4>\n*Louis* has 6 letters, while both *Bernard* and *Vincent* have 7 letters each. Thus, they are longer than *Gwen*.\n</step4>\n<step5>\nTherefore, the penguin with the shortest name is *Gwen*.\n</step5></thinking>", "answer": "<answer>Gwen ni penguin ti o ni orukọ kukuru julọ.</answer>", "language": "Yoruba"}
{"question": "((-5 - -7 - 4 - 8) - (-4 + 4 + 1 + 0)) =", "reasoning": "<thinking><step1>\nThe question asks to solve the expression: “((-5 - -7 - 4 - 8) - (-4 + 4 + 1 + 0))”. We need to simplify both parts of the equation.\n</step1>\n<step2>\nFirst, let's simplify the left side: *(-5 - -7 - 4 - 8)*. The double negative means we add, so it becomes: *-5 + 7 - 4 - 8*.\n</step2>\n<step3>\nCalculating this step-by-step: *7 - 5 = 2*, then *2 - 4 = -2*, and finally *-2 - 8 = -10*.\n</step3>\n<step4>\nNow, we simplify the right side: *(-4 + 4 + 1 + 0)*. Here, *-4 + 4 = 0*, so it simplifies to *1 + 0 = 1*.\n</step4>\n<step5>\nNow we have: *(-10 - 1)*. This means we subtract 1 from -10, which gives us *-11*.\n</step5></thinking>", "answer": "<answer>-11</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 49 kan ti o ni itan igba pipẹ ti sisun siga pupọ ati COPD, ti o ni irora ikun ati edema opu, ṣugbọn o ni titẹ ẹjẹ deede. A ṣe echocardiogram gẹgẹbi apakan ti iṣẹ iṣẹ ọkan. Ni ibamu si ifihan iṣoogun rẹ ati itan rẹ, kini abajade echocardiographic ti o ṣeeṣe julọ?", "reasoning": "<thinking><step1>\nThe question asks about a 49-year-old man with a long history of heavy smoking and COPD (Chronic Obstructive Pulmonary Disease), who presents with abdominal pain and edema — *edema = swelling* — but has normal blood pressure. It also mentions that an echocardiogram was performed as part of a cardiac workup.\n</step1>\n<step2>\nGiven his history of heavy smoking and COPD, we can infer that he may have some degree of right heart strain or cor pulmonale — *cor pulmonale = right heart failure due to lung disease*.\n</step2>\n<step3>\nThe abdominal pain and edema could suggest fluid retention, which is often associated with heart failure — *insufisiensi ọkan*.\n</step3>\n<step4>\nIn patients with COPD, echocardiographic findings may show right ventricular hypertrophy — *hipertrofia ventrikulu otun* — due to increased pressure in the pulmonary circulation.\n</step4>\n<step5>\nAdditionally, we might expect to see right ventricular dilation or even signs of pulmonary hypertension — *hypertension pulmonary* — as a consequence of his lung condition.\n</step5>\n<step6>\nConsidering all these factors, the most likely echocardiographic outcome would be evidence of right heart dysfunction or strain.\n</step6></thinking>", "answer": "<answer>Abajade echocardiographic ti o ṣeeṣe julọ ni awọn ami ti iṣoro ọkan otun tabi ikolu.</answer>", "language": "Yoruba"}
{"question": "Labẹ ipo wo ni ofin tí ó gba gbogbo ere ìdárayá lórí awọn ile-iṣẹ́ ere ìdárayá ti ara ẹni ní ìpínlẹ̀ kan, tí a gbé kalẹ̀ láti dènà ìwà ipá, tí ọ̀pọ̀ awọn ile-iṣẹ́ ere ìdárayá sì jẹ́ ti awọn ènìyàn láti ìpínlẹ̀ mìíràn, yóò dà bíi pé ó wà lábẹ́ òfin?", "reasoning": "<thinking><step1>\nThe question asks: “Labẹ ipo wo ni [ofin = law] tí ó gba gbogbo [ere ìdárayá = gambling profits] lórí [ile-iṣẹ́ ere ìdárayá = gambling establishments] ti ara ẹni ní [ìpínlẹ̀ = state] kan?” — meaning it seeks to understand the legal framework governing gambling profits in a specific state.\n</step1>\n<step2>\nIn many states, laws regulate how gambling profits are handled, especially to prevent *ìwà ipá* (violence) and ensure fairness — *lati jẹ́ ki gbogbo ènìyàn ní ànfààní*.\n</step2>\n<step3>\nIf a gambling establishment is owned by individuals from another state, it may face additional scrutiny — *ìtẹ́numọ̀ àtẹ̀yìnwá* from local laws.\n</step3>\n<step4>\nThe law might require that profits be taxed or allocated for community programs — *àwọn eto ìdàgbàsókè* to support local initiatives.\n</step4>\n<step5>\nFurthermore, if the law is designed to curb violence, it could impose strict regulations on how profits are used — *báwo ni a ṣe le lo èrè* to promote safety and community welfare.\n</step5>\n<step6>\nThus, the legal status of such gambling profits would depend on compliance with both state and federal regulations — *òfin àgbègbè àti àgbáyé*.\n</step6></thinking>", "answer": "<answer>Ofin náà yóò dá lórí bí a ṣe n tẹ̀le àwọn ìlànà àgbègbè àti àgbáyé, pẹ̀lú àfihàn pé a gbọdọ̀ lo èrè náà fún ìdàgbàsókè àdúgbò.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 57 kan wá pẹlu ikọ́ ọ̀gbà ti o ti pẹ́, ati awọn ẹ̀kọ́ aworan fihan ìṣù ọpọlọ lori ẹ̀dọ̀fọ́. Bronchoscopy pẹlu lavage ati biopsy fihan iṣù kan ti o ṣe àpapọ̀ ti awọn sẹẹli neoplastic kékeré pẹlu artifact fifọ ti o han gbangba ti ko ni iboju fun lymphocyte common antigen (LCA). Onkogene wo ni a ti sopọ mọ iru iṣù yii?", "reasoning": "<thinking><step1>\nThe question is asking: \"Which oncogene is associated with a tumor that shows small neoplastic cells and lacks expression for lymphocyte common antigen (LCA)?\" — here, *iṣù* means tumor and *onkojene* refers to oncogene.\n</step1>\n<step2>\nIn this case, the patient is 57 years old and has a history of chronic cough — *ikọ́ ọ̀gbà ti o ti pẹ́* — which suggests a possible lung-related issue.\n</step2>\n<step3>\nThe biopsy results indicate a tumor with small neoplastic cells, which often points to specific types of lung cancer — *iṣù ẹdọ̀fọ́*.\n</step4>\n<step4>\nThe absence of LCA expression suggests that this tumor may not be of lymphoid origin, which is crucial for identifying the correct oncogene.\n</step4>\n<step5>\nCommon oncogenes associated with small cell lung cancer include *oncogene MYC* and *oncogene RAS*, but the specific context here suggests a connection to *oncogene ALK*.\n</step5>\n<step6>\nThus, given the characteristics of the tumor and the lack of LCA, the oncogene most likely associated with this type of tumor is *ALK*.\n</step6></thinking>", "answer": "<answer>Onkogene ti a ti sopọ mọ iru iṣù yii ni ALK.</answer>", "language": "Yoruba"}
{"question": "Obirin ọmọ ọdun 21 kan, to jẹ́ arẹwa funfun, wá sí ibi iṣẹ́ oníṣẹ́ aboyun rẹ̀ pẹlu ẹ̀gún gbogbo akoko ìgbà míì. Ninu ọdun meji to kọja, ó ti máa ń lọ ju oṣù mẹta lọ láìní ìgbà míì. Ìgbà míì rẹ̀ bẹ̀rẹ̀ ní ọdun 13, ati ṣaaju ọdun meji to kọja, ó ní ìgbà míì déédéé ní gbogbo ọjọ́ 28 tí ó gbà ọjọ́ márùn-ún pẹlu ìṣàn déédéé láìsí irora. Ó kọ̀ láti ní àwọn àmì míì bí orírí, iyipada ìríra, ìrẹ̀lẹ̀ ju àṣà, tabi ìdọ̀gbà, ìrírí ọkàn-ìrora, tabi ìdínà irun. Láti ìgbà tí ó bẹ̀rẹ̀ sí kọ́lẹ́jì, ó ti dààmú nípa ìpọ̀ ìwúwo ati àkànmọ́ tí ó ṣe àfikún sí àṣà rẹ̀ ti píṣà ati french fries alẹ́. Lórí àyẹ̀wò, ó wulẹ̀ dáadáa pẹlu àkànmọ́ tó burú já, ati otutu rẹ̀ jẹ́ 98.6°F (37°C), titẹ̀ ẹ̀jẹ̀ jẹ́ 120/80 mmHg, ìṣàn jẹ́ 60/min, ati BMI jẹ́ 30 kg/m^2. Iṣẹ́ ẹ̀jẹ̀ jẹ́risi àyẹ̀wò tí ó ṣeé ṣe julọ ati pẹlu Hemoglobin A1c ti 5.4. Bí ó bá kòfẹ́ sí bíbí ọmọ ní àkókò yìí, kini oògùn akọkọ tí ó dára jùlọ lati tọ́jú àrùn yìí?\nA. Ethinyl estradiol - norgestimate\nB. Leuprolide\nC. Metformin\nD. Spironolactone\nE. Simvastatin", "reasoning": "<thinking><step1>\nThe question is asking: \"If a 21-year-old woman, who has irregular menstrual cycles and a history of heavy bleeding, is not planning to conceive at this time, what is the best medication to manage her condition?\" Key terms include [ìgbà míì = menstrual cycle], [àrùn = condition], and [oògùn = medication].\n</step1>\n<step2>\nThe patient has a history of irregular cycles, with periods occurring more than three months apart, which indicates *dysfonction menstruelle*.\n</step2>\n<step3>\nGiven her symptoms and the fact that she has a high BMI of 30 kg/m^2, this suggests a possible case of *syndrome des ovaires polykystiques (SOPK)*, which is often associated with insulin resistance.\n</step3>\n<step4>\nAmong the options, Metformin is known to help with insulin sensitivity and can regulate menstrual cycles in women with PCOS — *règle les cycles menstruels*.\n</step4>\n<step5>\nEthinyl estradiol combined with norgestimate is also a common treatment for menstrual irregularities, but since she is not planning to conceive, Metformin would be more beneficial for her overall metabolic health.\n</step5>\n<step6>\nLeuprolide is typically used for endometriosis or fibroids, while spironolactone is often used for hirsutism, and simvastatin is for cholesterol management, which are not the primary concerns here.\n</step6>\n<step7>\nThus, considering her symptoms and the best approach to manage her condition without the intent to conceive, Metformin stands out as the most appropriate choice.\n</step7></thinking>", "answer": "<answer>Metformin ni oògùn akọkọ tí ó dára jùlọ lati tọ́jú àrùn yìí.</answer>", "language": "Yoruba"}
{"question": "Ní ọràn ọmọ tuntun tí kò ń mí dáadáa lẹ́yìn ìrìbọ̀ tó gùn pẹ̀lú ìṣòwòwò ọkàn tó jẹ́ ìlù 88 ní ìṣẹ́jú kan lẹ́yìn tí ó gba oògùn afẹ́fẹ́ 100% fún ìṣẹ́jú 30 nípa apo àti iboju, kini ìgbésẹ̀ tó tẹ̀lé e nínú ìṣàkóso?", "reasoning": "<thinking><step1>\nThe question asks: “Ní ọràn ọmọ tuntun tí kò ń mí dáadáa” — meaning it is about a newborn who is not breathing well after receiving treatment. The context includes a specific heart rate of 88 beats per minute after administering 100% oxygen for 30 minutes via a mask and nasal cannula.\n</step1>\n<step2>\nIn this scenario, the newborn's low heart rate — *ìyàtọ̀ ọkàn* — and poor breathing indicate potential respiratory distress or failure, which is critical to address.\n</step2>\n<step3>\nFirst, it’s essential to assess the newborn’s airway — *àtúnṣe àyà* — to ensure it is clear and not obstructed, as this can significantly impact breathing.\n</step3>\n<step4>\nNext, continuous monitoring of vital signs is crucial; this includes checking the heart rate and oxygen saturation levels — *ìwọn àkópọ̀ afẹ́fẹ́* — to evaluate the effectiveness of the oxygen therapy.\n</step4>\n<step5>\nIf the newborn continues to show signs of distress, further interventions may be necessary, such as administering additional oxygen or considering mechanical ventilation — *ìmúlò afẹ́fẹ́ ẹrọ* — if the situation does not improve.\n</step5>\n<step6>\nFinally, consulting with a pediatric specialist is vital for further evaluation and management — *ìmúlò amọ̀ja ọmọ* — to ensure the newborn receives appropriate care.\n</step6></thinking>", "answer": "<answer>Ìgbésẹ̀ tó tẹ̀lé nínú ìṣàkóso ni láti ṣàtúnṣe àyà, tọ́ka sí ìwọn àkópọ̀ afẹ́fẹ́, àti pé bí a kò bá rí ìmúlò, a lè ròyìn ìmúlò afẹ́fẹ́ ẹrọ.</answer>", "language": "Yoruba"}
{"question": "Apẹẹrẹ kan tí ó ní 3.00 moli ti awọn patikulu gaasi pipe didiatomiki ni 200 K ni a ti fún paapaa ati itusilẹ titi di iwọn otutu rẹ fi de 250 K.  Níwí pé agbara ooru moli kan ní iwọn didùn, C_V,m, jẹ́ 27.5 J K^-1 mol^-1, ka iyipada ninu agbara inu, ΔU, fun ilana naa.", "reasoning": "<thinking><step1>\nThe question asks for the change in internal energy, ΔU, for a system with 3.00 moles of an ideal diatomic gas that is heated from 200 K to 250 K. The specific heat capacity at constant volume, C_V,m, is given as 27.5 J K^-1 mol^-1.\n</step1>\n<step2>\nTo find ΔU, we can use the formula: ΔU = n * C_V,m * ΔT, where n is the number of moles and ΔT is the change in temperature.\n</step2>\n<step3>\nHere, n = 3.00 mol and ΔT = 250 K - 200 K = 50 K. So, we need to calculate the product of these values.\n</step3>\n<step4>\nNow, substituting the values into the formula: ΔU = 3.00 mol * 27.5 J K^-1 mol^-1 * 50 K.\n</step4>\n<step5>\nCalculating this gives: ΔU = 3.00 * 27.5 * 50 = 4125 J. Thus, the change in internal energy for the process is 4125 J.\n</step5></thinking>", "answer": "<answer>Iyipada ninu agbara inu, ΔU, jẹ́ 4125 J.</answer>", "language": "Yoruba"}
{"question": "Ẹ̀ka iye tí ó ní dígítì mélòó ni ẹ̀ka ìkọ̀wé àpapọ̀?\nA. 0\nB. 1\nC. 2\nD. 10", "reasoning": "<thinking><step1>\nThe question asks: “Ẹ̀ka iye tí ó ní dígítì mélòó ni ẹ̀ka ìkọ̀wé àpapọ̀?” — which translates to \"How many digits are in the decimal system?\" \n</step1>\n<step2>\nIn the decimal system, also known as *ẹ̀ka ìkọ̀wé àpapọ̀*, the digits range from 0 to 9 — *dígítì mẹ́wàá*.\n</step2>\n<step3>\nThis means there are ten unique digits used to represent numbers — *nọ́mbà* in this system.\n</step3>\n<step4>\nSo, when considering the options provided, the correct answer must reflect the total count of these digits.\n</step4>\n<step5>\nThus, the answer is straightforward: there are 10 digits in the decimal system, which corresponds to option D.\n</step5></thinking>", "answer": "<answer>Ẹ̀ka ìkọ̀wé àpapọ̀ ní dígítì mẹ́wàá.</answer>", "language": "Yoruba"}
{"question": "Ewo ni ninu awọn aṣayan wọnyi ṣe atunṣe ti o ni iyin ti orukọ oṣere tabi fiimu yii: ‘the police’?\nAwọn aṣayan:\n(A) tpe police\n(B) thy police\n(C) toe police\n(D) thezpolice", "reasoning": "<thinking><step1>\nThe question asks: “Ewo ni ninu awọn aṣayan wọnyi ṣe atunṣe ti o ni iyin ti orukọ oṣere tabi fiimu yii: ‘the police’?” — meaning it wants to know which option correctly modifies the name of the artist or film \"the police.\"\n</step1>\n<step2>\nTo answer this, we need to identify the correct form that maintains the integrity of the original name — *orukọ atilẹba*.\n</step2>\n<step3>\nThe original name is \"the police,\" which is a proper noun — *orukọ to tọ* — and should not be altered significantly.\n</step3>\n<step4>\nLooking at the options: (A) tpe police, (B) thy police, (C) toe police, and (D) thezpolice, we need to find the one that keeps the essence of \"the police.\"\n</step4>\n<step5>\nOption (D) thezpolice combines \"the\" and \"police\" without unnecessary changes, making it the most suitable choice — *aṣayan to dara julọ*.\n</step5>\n<step6>\nThus, the correct modification that retains the name's integrity is option (D).\n</step6></thinking>", "answer": "<answer>Aṣayan to tọ ni (D) thezpolice.</answer>", "language": "Yoruba"}
{"question": "Ninu ọkunrin ọlọdun 64 kan ti o ni irora ori ati ailera apa ọwọ apa osi, awoṣe aworan wo ni a rii lori MRI ọpọlọ rẹ pẹlu iyọkuro inu iṣan?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu ọkunrin ọlọdun 64 kan ti o ni irora ori ati ailera apa ọwọ apa osi, awoṣe aworan wo ni a rii lori MRI ọpọlọ rẹ pẹlu iyọkuro inu iṣan?” — meaning it inquires about the MRI findings in a 64-year-old man with headaches and left arm weakness, specifically looking for signs of [iyọkuro inu iṣan = edema].\n</step1>\n<step2>\nIn cases like this, the symptoms suggest possible neurological issues — *awọn iṣoro neurology* that could be due to various conditions.\n</step2>\n<step3>\nMRI scans are crucial for identifying abnormalities in the brain — *awọn aiyede ninu ọpọlọ* such as tumors, strokes, or other lesions.\n</step3>\n<step4>\nThe presence of edema indicates swelling, which can be a sign of inflammation or injury — *iyọkuro le jẹ ami ti ibajẹ tabi aisan*.\n</step4>\n<step5>\nIn this scenario, one might expect to see findings like *iyọkuro inu iṣan* around a specific area of the brain, possibly indicating a stroke or a mass effect.\n</step5>\n<step6>\nThus, the MRI might reveal localized edema, which correlates with the patient's symptoms of headache and weakness — *irora ori ati ailera*.\n</step6></thinking>", "answer": "<answer>MRI yoo fihan iyọkuro inu iṣan ni agbegbe kan ti ọpọlọ, ti o le jẹ ami ti ikọlu tabi ibajẹ.</answer>", "language": "Yoruba"}
{"question": "Ẹni tí ó jẹ́ ẹni bíi ti ara wa yóò dáhùn sí àwọn ìbéèrè wọ̀nyí nípa ìdí ìṣẹ̀lẹ̀ báyìí rẹ́rẹ̀?\nTọ́mù ní ọgbà ńlá kan, ó sì nífẹ̀ẹ́ awọn ododo. Ó gbé agbẹ̀ nǹkan méjì, Alẹ́kìsì àti Bẹ́nì, tí wọ́n ń bójú tó awọn ododo rẹ̀ tí wọ́n wà ní ibùgbé ododo mẹ́tàlélógún. Mẹ́nnìkan wọn lè pinnu àkókò iṣẹ́ wọn, wọ́n sì lè ṣètò ẹni tí yóò bójú tó ibùgbé ododo kan. Alẹ́kìsì àti Bẹ́nì gbẹ́kẹ̀lé gidigidi, Tọ́mù sì dùn ún sí iṣẹ́ wọn. Síbẹ̀, ó fẹ́ mú kí ìdàgbà ododo rẹ̀ sunwọ̀n sí i. Nítorí pé Tọ́mù kà ní ìwé ìròyìn pé awọn ododo máa ń dàgbà dáadáa nígbà tí wọ́n bá lo amọ̀dún, ó pinnu láti jẹ́ kí Alẹ́kìsì àti Bẹ́nì lo amọ̀dún fún awọn ododo rẹ̀. Ìwé ìròyìn náà gbà pé kí wọ́n lo ohun èlò amọ̀dún A X200R tàbí B Y33R, nítorí pé wọ́n ní ipa tí ó gbayì. Bí ó ti wù kí ó rí, Tọ́mù tún kà pé ó lè ba awọn ododo jẹ́ bí wọ́n bá fi ọ̀pọ̀lọpọ̀ iru ohun èlò amọ̀dún ṣiṣẹ́. Nítorí náà, Tọ́mù pinnu pé ó kàn fẹ́ lo amọ̀dún kan ṣoṣo. Ó yàn A X200R. Tọ́mù pàṣẹ fún Alẹ́kìsì àti Bẹ́nì láti ra ohun èlò amọ̀dún A X200R, kí wọ́n sì lo amọ̀dún yìí nìkan. Alẹ́kìsì fẹ́ ra ọ̀pọ̀lọpọ̀ igo ohun èlò amọ̀dún yìí fún ara rẹ̀ àti fún Bẹ́nì. Lẹ́yìn ọ̀sẹ̀ díẹ̀, Tọ́mù rìn kiri ọgbà rẹ̀. Ó rí i pé àwọn ododo kan dára jù kí ó tó, wọ́n sì tobi jù. Bí ó ti wù kí ó rí, ó tún rí i pé àwọn ododo kan ti sọnù ẹwà wọn, wọ́n sì gbẹ. Èyí mú kí Tọ́mù ṣọ̀fọ̀, ó sì bẹ̀rẹ̀ sí ronú. Ó gbà pé gbígbẹ awọn ododo rẹ̀ lè ní ìsopọ̀ pẹ̀lú lílò amọ̀dún. Ó fẹ́ ṣèwádìí lórí ọ̀rọ̀ yìí, ó sì bá Alẹ́kìsì àti Bẹ́nì sọ̀rọ̀. Alẹ́kìsì sọ fún un pé ó tẹ̀lé àṣẹ Tọ́mù, ó sì ra ohun èlò amọ̀dún A X200R nìkan, ó sì lo ó nìkan. Síbẹ̀, Bẹ́nì sọ fún un pé òun lo ohun èlò amọ̀dún B Y33R. Ó ṣì ní àwọn igo ohun èlò amọ̀dún yìí ní ilé, ó sì fẹ́ lo wọn tán. Tọ́mù rí i pé awọn ododo gbẹ ní ibùgbé ododo tí wọ́n fi A X200R àti B Y33R ṣiṣẹ́. Ṣé Alẹ́kìsì ló fà kí awọn ododo gbẹ?\nÀwọn àṣàyàn:\n- Bẹ́ẹ̀ ni\n- Bẹ́ẹ̀ kọ́", "reasoning": "<thinking><step1>\nThe question asks: \"Did Alẹ́kìsì cause the flowers to dry?\" — it implies a need to determine if Alẹ́kìsì's actions led to the flowers' condition.\n</step1>\n<step2>\nTọ́mù noticed that some flowers were thriving while others were wilting — *àwọn ododo kan dára jù kí ó tó, wọ́n sì tobi jù*.\n</step2>\n<step3>\nAlẹ́kìsì followed Tọ́mù's instructions and only used the A X200R fertilizer, while Bẹ́nì used B Y33R — *Bẹ́nì sọ fún un pé òun lo ohun èlò amọ̀dún B Y33R*.\n</step3>\n<step4>\nThe drying of the flowers could be linked to Bẹ́nì's use of a different fertilizer, which might not be suitable — *amọ̀dún B Y33R lè jẹ́ àbáyọ̀*.\n</step5>\n<step6>\nSince Alẹ́kìsì adhered strictly to the instructions, it is unlikely that he caused the flowers to dry — *Alẹ́kìsì tẹ̀lé àṣẹ Tọ́mù*.\n</step6>\n<step7>\nThus, the evidence suggests that Bẹ́nì's actions may have contributed to the issue, not Alẹ́kìsì's — *Bẹ́nì ni ó fa kí àwọn ododo gbẹ*.\n</step7></thinking>", "answer": "<answer>Bẹ́ẹ̀ kọ́.</answer>", "language": "Yoruba"}
{"question": "Ṣe igbese wo ni yoo tẹle lẹsẹkẹsẹ ninu itọju obinrin ti o loyun oṣu mẹsan (36) pẹlu aarun pre-eclampsia, ríran òkùnkùn, orififo ori, ati titẹ ẹjẹ ti 160/110 mmHg?", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe igbese wo ni yoo tẹle lẹsẹkẹsẹ ninu itọju obinrin ti o loyun oṣu mẹsan (36) pẹlu aarun [pre-eclampsia = pre-eclampsia], ríran òkùnkùn [blurred vision], orififo ori [headache], ati titẹ ẹjẹ ti 160/110 mmHg?” — meaning it wants to know the immediate steps in treating a pregnant woman at 36 weeks with pre-eclampsia and associated symptoms.\n</step1>\n<step2>\nIn cases of pre-eclampsia, especially with high blood pressure like 160/110 mmHg, *a gbọdọ ṣe akiyesi* the risk of complications for both the mother and the fetus.\n</step2>\n<step3>\nThe first step is to stabilize the mother's condition — *a nilo lati dènà titẹ ẹjẹ* by administering antihypertensive medications.\n</step3>\n<step4>\nNext, monitoring for severe symptoms is crucial; *a gbọdọ ṣe ayẹwo* for signs of eclampsia, which can include seizures.\n</step4>\n<step5>\nAdditionally, the patient should be placed on bed rest — *a gbọdọ fi obinrin naa si ibusun* to reduce stress and blood pressure.\n</step5>\n<step6>\nFinally, if the condition does not improve, delivery may be necessary, as it is the only definitive treatment for pre-eclampsia — *iyẹn ni, a le nilo lati bi ọmọ naa* to ensure safety.\n</step6></thinking>", "answer": "<answer>Igbese akọkọ ni lati dènà titẹ ẹjẹ pẹlu awọn oogun antihypertensive, lẹhinna ṣe ayẹwo fun awọn aami aisan to ṣe pataki, ki o si fi obinrin naa si ibusun, ati nikẹhin, ti ko ba dara, a le nilo lati bi ọmọ naa.</answer>", "language": "Yoruba"}
{"question": "Ninu glaucoma iṣiṣiṣe ṣii àgbàlá àkọ́kọ́, nípasẹ̀ ẹ̀yà ara pàtó wo ni pilocarpine ń fi agbára rẹ̀ hàn láti dín titẹ inu ojú kù?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu glaucoma iṣiṣiṣe ṣii àgbàlá àkọ́kọ́, nípasẹ̀ ẹ̀yà ara pàtó wo ni pilocarpine ń fi agbára rẹ̀ hàn láti dín titẹ inu ojú kù?” — meaning it wants to know which specific part of the body pilocarpine acts on to reduce intraocular pressure in open-angle glaucoma.\n</step1>\n<step2>\nPilocarpine is a medication that works by stimulating the *muscarinic receptors* in the eye — *awọn olugba muscarinic*.\n</step2>\n<step3>\nThis stimulation causes the ciliary muscle to contract — *iṣan ciliary* — which increases the outflow of aqueous humor.\n</step3>\n<step4>\nAs a result, the drainage of fluid from the eye improves, leading to a decrease in intraocular pressure — *titẹ inu ojú*.\n</step5>\n<step5>\nIn essence, pilocarpine primarily acts on the ciliary muscle to facilitate this process.\n</step5>\n<step6>\nThus, it is through the action on the *iṣan ciliary* that pilocarpine demonstrates its effectiveness in managing glaucoma.\n</step6></thinking>", "answer": "<answer>Pilocarpine ń fi agbára rẹ̀ hàn nípasẹ̀ iṣan ciliary láti dín titẹ inu ojú kù nínú glaucoma iṣiṣiṣe ṣii.</answer>", "language": "Yoruba"}
{"question": "Ọgbọ́n ọdún mẹ́ẹ́dógún kan tí í ṣe aṣàgùn, wá pẹ̀lú ìtàn ìgbóná gbígbóná gíga fún ọjọ́ méje ati ìyípadà ìrísí fún ọjọ́ méjì. Nígbà àyẹ̀wo, ó wà ní ìṣòro ìṣẹ́-òwò, tí ó sì ní ẹ̀jẹ̀ ìfò sí ojú. Àwọn ìwádìí tí a yára ṣe fi hàn pé hemoglobin rẹ̀ jẹ́ 11 gm/dl, serum bilirubin 8 mg/dl ati urea 78 mg/d1. Àyẹ̀wò ẹ̀jẹ̀ tí ó wà ní àgbègbè jẹ́ èyí tí kò ní àkóràn malaria. Kí ni àìsàn tí ó ṣeé ṣe jùlọ -\nA. Brucellosis\nB. Àìsàn Weil\nC. Àìsàn ẹ̀dùn ẹ̀jẹ̀ onígbàákúkù\nD. Àìsàn Q", "reasoning": "<thinking><step1>\nThe question is asking about a 15-year-old patient with high fever for seven days and changes in appearance, who also has business-related issues and conjunctival bleeding. Key terms include [ìtàn ìgbóná gbígbóná gíga = high fever] and [ìrísí = appearance].\n</step1>\n<step2>\nThe patient has a hemoglobin level of 11 gm/dl, which indicates possible anemia — *anemia* can lead to symptoms like fatigue and weakness.\n</step2>\n<step3>\nThe serum bilirubin level is 8 mg/dl, suggesting some degree of jaundice — *ìfarapa awọ* could be present due to liver involvement or hemolysis.\n</step4>\n<step4>\nThe urea level of 78 mg/dl indicates possible renal impairment — *ìṣòro kidinrin* could be a concern, especially with the patient's symptoms.\n</step5>\n<step5>\nThe blood test shows no malaria infection, which rules out one common cause of fever and bleeding — *àkóràn malaria* is not the issue here.\n</step6>\n<step6>\nConsidering the symptoms and lab results, the most likely disease is *Àìsàn Weil*, which is associated with liver dysfunction and renal issues.\n</step7></thinking>", "answer": "<answer>Àìsàn Weil ni àìsàn tí ó ṣeé ṣe jùlọ.</answer>", "language": "Yoruba"}
{"question": "Obirin ọlọ́jọ́ mẹ́rìndínlógún (84) kan wá pẹ̀lú ìtàn ọjọ́ meji ti ibà, irora ori tí ó burú jáì, irora ọrùn, fọ́tòfóbià, ati ìgbọ̀gbọ́ ẹsẹ̀ ati ẹsẹ̀ ìsàlẹ̀ láìkáàrùn nígbà tí a bá gbìdàn ọrùn rẹ̀.  Àtúnṣe omi ara ọpọlọ wí pé iye ẹ̀dùn-ara funfun jẹ́ 1200/mm3 pẹ̀lú 76% neutrophils ti a pin ya, ìwọ̀n protein jẹ́ 113 mg/dL, ati ìwọ̀n glucose jẹ́ 21 mg/dL.  Àyẹ̀wò CT fihan ilọsiwaju leptomeningeal.  Da lori ìtọ́kasi àrùn yìí ati àwọn àbájáde ilé ẹ̀kọ́, kini ọgbọ́n orí ìṣègùn àkọ́kọ́ tí ó yẹ julọ fún alaisan yìí?", "reasoning": "<thinking><step1>\nThe question is asking about the primary treatment approach for a patient with symptoms like severe headache, neck pain, and neurological signs, along with specific lab results indicating elevated white blood cells and neutrophils — *ìtàn ọjọ́ meji ti ibà* (two-day history of fever).\n</step1>\n<step2>\nGiven the symptoms and lab findings, this suggests a possible central nervous system infection, such as meningitis — *àrùn meningitis*.\n</step2>\n<step3>\nThe elevated white blood cell count of 1200/mm3 with 76% neutrophils indicates a likely bacterial infection, which is critical for diagnosis — *ìdílé àrùn*.\n</step4>\n<step4>\nThe CT findings of leptomeningeal enhancement further support this diagnosis, suggesting inflammation of the meninges — *ìtàn àrùn meningitis*.\n</step4>\n<step5>\nIn such cases, the first-line treatment typically involves the administration of intravenous antibiotics — *antibiotics intraveinous* — to target the suspected bacteria.\n</step5>\n<step6>\nAdditionally, corticosteroids may be considered to reduce inflammation and complications — *corticosteroids*.\n</step6>\n<step7>\nThus, the primary treatment approach for this patient should focus on aggressive management of the suspected meningitis.\n</step7></thinking>", "answer": "<answer>Ìtọ́jú àkọ́kọ́ fún alaisan yìí ni lati fi antibiotics intraveinous àti corticosteroids.</answer>", "language": "Yoruba"}
{"question": "Kí ni àpẹẹrẹ ìfìwéránṣẹ́ méjì-nínú-ọ̀kan níbi tí ọ̀rọ̀ ènìyàn ti tako ohùn tàbí ìṣesí ara wọn?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àpẹẹrẹ [ìfìwéránṣẹ́ méjì-nínú-ọ̀kan = double entendre] níbi tí ọ̀rọ̀ ènìyàn [tako = oppose] ohùn tàbí [ìṣesí ara = body language] wọn?” — meaning it seeks examples of double entendres where a person's words oppose their tone or body language.\n</step1>\n<step2>\nA double entendre is a phrase that has two meanings, often one being humorous or risqué — *àpẹẹrẹ kan ni “I’m fine” when someone is clearly upset*.\n</step2>\n<step3>\nIn this case, the words *“I’m fine”* contradict the person’s tone, which may be flat or sad — *ohùn wọn le jẹ́ ìbànújẹ*.\n</step4>\n<step4>\nAnother example could be when someone says, *“Great job!”* with a sarcastic tone, indicating the opposite of praise — *ìtẹ́wọ́gba*.\n</step5>\n<step5>\nIn Yoruba, one might say: *“Ó dára!”* while rolling their eyes, which shows they actually mean the opposite.\n</step6>\n<step6>\nThus, a double entendre can reveal a conflict between spoken words and non-verbal cues, highlighting the complexity of communication.\n</step7></thinking>", "answer": "<answer>Àpẹẹrẹ ìfìwéránṣẹ́ méjì-nínú-ọ̀kan ni “I’m fine” pẹ̀lú ohùn tí kò ní ìfẹ́, tàbí “Ó dára!” pẹ̀lú ìfihàn àìtẹ́wọ́gba.</answer>", "language": "Yoruba"}
{"question": "Aláisàn obìnrin ọmọ ọdún mẹ́rìndínlọ́gbọ̀n kan kérora pé kò lè fojúsí àwọn nǹkan tó súnmọ́, ṣùgbọ́n ó lè rí àwọn nǹkan tó jìnnà kedere. Àwọn ẹ̀yà ara inú ojú wo gan-an, tí wọ́n bá bàjẹ́, ló ṣeé ṣe jù lọ tó fa ìṣòro yìí?", "reasoning": "<thinking><step1>\nThe question translates to: \"A 35-year-old woman claims she cannot see objects nearby, but she can see distant objects clearly.\" It asks what part of the eye, if damaged, could cause this issue.\n</step1>\n<step2>\nThis condition suggests a problem with *fokansi* (focusing) on nearby objects, which is often related to the lens of the eye — *lénsì*.\n</step2>\n<step3>\nIn particular, this could indicate *presbyopia*, a common condition where the lens loses elasticity, making it hard to focus on close objects — *nǹkan tó súnmọ́*.\n</step3>\n<step4>\nThe lens must change shape to focus on nearby items, and if it cannot do so, the person experiences blurred vision for those objects.\n</step4>\n<step5>\nAdditionally, if the *muscles* around the lens are weak or not functioning properly, this could exacerbate the problem — *ìṣòro yìí*.\n</step5>\n<step6>\nThus, the likely culprit for her inability to see nearby objects clearly is the lens of the eye, which may be affected by age-related changes.\n</step6></thinking>", "answer": "<answer>Ìṣòro yìí jẹ́ pé lénsì ojú ni kò lè fojúsí àwọn nǹkan tó súnmọ́.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mẹ́tadinlọ́gbọ̀n kan tí ó ní ìtàn lílò oògùn nípa ìmú tí ó wà níbi ìṣẹ̀lẹ̀ àìsàn, iye CD4+ T-lymphocyte rẹ̀ jẹ́ 84/mm3, ati CT scan tí ó fi hàn pé ó ní àwọn ìṣàn tí ó ń yí ara wọn ká ní ọpọlọ. Nígbà tí a bá gbé àwọn àmì àìsàn wọ̀nyí yẹ̀ wò, ṣe irú ìtọ́jú oogun wo ni ó yẹ ká bẹ̀rẹ̀ pẹ̀lú?", "reasoning": "<thinking><step1>\nThe question asks about a 39-year-old man with a history of drug use and a CD4+ T-lymphocyte count of 84/mm3, along with a CT scan showing lesions in the brain. This indicates a serious health condition, likely related to HIV/AIDS.\n</step1>\n<step2>\nA CD4+ count of 84/mm3 is significantly low, suggesting *imú àìlera* (immunocompromised state), which increases the risk for opportunistic infections — *àìsàn àìlera*.\n</step2>\n<step3>\nThe presence of brain lesions could indicate conditions like *toxoplasmosis* or *primary CNS lymphoma*, common in patients with advanced HIV.\n</step3>\n<step4>\nIn such cases, treatment typically starts with *antiretroviral therapy* (ART) to manage HIV, alongside specific treatments for the lesions, such as *pyrimethamine* for toxoplasmosis.\n</step4>\n<step5>\nIt's crucial to monitor the patient closely for any signs of *àìlera* or worsening symptoms during treatment, as the immune system begins to recover.\n</step5>\n<step6>\nTherefore, the initial treatment should focus on both managing HIV and addressing the brain lesions effectively.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú àkọ́kọ́ yẹ kí ó ní *antiretroviral therapy* (ART) àti ìtọ́jú pàtó fún àwọn ìṣàn ọpọlọ, gẹ́gẹ́ bí *pyrimethamine* fún toxoplasmosis.</answer>", "language": "Yoruba"}
{"question": "Labẹ ipò wo ni kòṣeṣe ẹnikan lati ṣiṣẹ́ le ja si jijẹ ẹ̀bi fun ìpaniyan lọ́dọọ̀ òfin, paapaa nigbati o ba ni ojuse lati kìlọ̀ nipa ewu ti o sunmọ?", "reasoning": "<thinking><step1>\nThe question asks: “Labẹ ipò wo ni kòṣeṣe ẹnikan lati ṣiṣẹ́ le ja si jijẹ ẹ̀bi fun ìpaniyan lọ́dọọ̀ òfin?” — meaning it wants to know under what circumstances someone can be held liable for manslaughter, especially when they have a duty to warn about an imminent danger.\n</step1>\n<step2>\nIn legal terms, liability for manslaughter often arises from negligence — *aifọwọyi* — where a person fails to act when they have a duty to do so.\n</step2>\n<step3>\nIf someone is aware of a dangerous situation — *ipo ewu* — and does not warn others, they may be seen as contributing to the harm that occurs.\n</step3>\n<step4>\nFor example, if a person knows that a violent act is likely to happen and does not inform the authorities, they could be liable if someone gets hurt — *ti ẹnikan ba ni ipalara*.\n</step4>\n<step5>\nThe legal principle here is that having a duty to warn creates a responsibility; failing to fulfill that duty can lead to serious consequences, including criminal charges.\n</step5>\n<step6>\nThus, if a person has a clear obligation to alert others about a threat and neglects this duty, they could face charges of manslaughter — *ìpaniyan* — if harm results.\n</step6></thinking>", "answer": "<answer>Ẹnikan le jẹ ẹ̀bi fun ìpaniyan ti o ba ni ojuse lati kìlọ̀ nipa ewu ti o sunmọ ṣugbọn ko ṣe bẹ́ẹ̀, ti ipalara ba ṣẹlẹ.</answer>", "language": "Yoruba"}
{"question": "Ọmọdé kan lu ni ojú pẹ̀lú bọ́ọ̀lù tẹ́nìsì, lẹ́yìn èyí, ó ní ìṣòro ìrírí tí ó dinku.  Níwọ̀n ìgbà tí ìpalára tí kò jẹ́ ọlọ́gbọ́n ni ó fa ìṣòro náà, èwo nínú àwọn wọ̀nyí ni ó fi hàn?\nA.  Optic neuritis\nB. Pars planitis\nC. Vitreous base detachment\nD. Equatorial edema", "reasoning": "<thinking><step1>\nThe question translates to: \"A child was hit in the eye with a tennis ball, and afterward, he has a problem with decreased vision. Since the injury is not serious, which of the following could be indicated?\" \n</step1>\n<step2>\nThe key terms here are \"decreased vision\" — *ìṣòro ìrírí tí ó dinku* — and the context of an eye injury from a tennis ball. \n</step2>\n<step3>\nIn cases like this, one might consider conditions that can arise from blunt trauma to the eye. For example, *ìpalára* can lead to various complications.\n</step3>\n<step4>\nOptic neuritis — *ìtànkálẹ̀ ojú* — typically involves inflammation of the optic nerve and is often associated with serious conditions, so it may not fit here.\n</step4>\n<step5>\nPars planitis — *pars planitis* — is a type of uveitis that can cause vision problems but is usually more chronic and not directly linked to a recent injury.\n</step5>\n<step6>\nVitreous base detachment — *ìyapa ibèré vitreous* — can occur after trauma and may lead to decreased vision, making it a plausible option.\n</step6>\n<step7>\nEquatorial edema — *èdè equatorial* — is less common and typically relates to more severe conditions, so it might not be the best fit for a minor injury.\n</step7>\n<step8>\nConsidering the context of a minor injury, vitreous base detachment seems to be the most likely cause of the decreased vision.\n</step8></thinking>", "answer": "<answer>Ìyapa ibèré vitreous ni ó fi hàn.</answer>", "language": "Yoruba"}
{"question": "Obìnrin kan tí ó ní ìṣòro ìbí ọmọ tí a ṣe abẹrẹ fún, ń ṣe kòṣeémọ̀ nípa ìṣàn ẹ̀jẹ̀ ìgbà ìgbà ní ọ̀ṣẹ̀ rẹ̀.  Ibo ni ibi tí fístúlà tó ṣeé ṣe jùlọ wà tí ó fa àmì ìṣèròyìn yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Obìnrin kan tí ó ní ìṣòro ìbí ọmọ tí a ṣe abẹrẹ fún, ń ṣe kòṣeémọ̀ nípa ìṣàn ẹ̀jẹ̀ ìgbà ìgbà ní ọ̀ṣẹ̀ rẹ̀” — meaning it refers to a woman with childbirth complications who experiences recurrent bleeding during her menstrual cycle. \n</step1>\n<step2>\nThis situation suggests a possible connection to a fistula — *fístúlà* — which is an abnormal connection between two body parts, often occurring after childbirth.\n</step2>\n<step3>\nIn this context, the most common type of fistula is a vesicovaginal fistula — *fístúlà vesicovaginal* — which can lead to continuous leakage of urine and may also cause bleeding.\n</step3>\n<step4>\nThe bleeding could be due to damage to blood vessels during childbirth, leading to *ìṣàn ẹ̀jẹ̀* that is not normal for her menstrual cycle.\n</step4>\n<step5>\nFistulas are often located in the pelvic region, particularly between the bladder and the vagina, which is where the complications arise.\n</step5>\n<step6>\nThus, the most likely location for the fistula causing these symptoms would be in the pelvic area, affecting the urinary and reproductive systems.\n</step6></thinking>", "answer": "<answer>Ibi tí fístúlà tó ṣeé ṣe jùlọ wà ni àgbègbè pelviki, níbi tí ó ti fa àmì ìṣèròyìn yìí.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin aláìsàn kan wá pẹ̀lú orí fífo, òógùn tó pọ̀ àti ìgbàyà kíkan pẹ̀lú ìwọ̀n ẹ̀jẹ̀ rírìn ti 180/120 mmHg. Òògùn tó yẹ jù lọ yóò jẹ́ -\nA. Nifedipine\nB. Labetalol\nC. Prazocin\nD. Phenoxy benzamine", "reasoning": "<thinking><step1>\nThe question describes a patient with high blood pressure, specifically a reading of 180/120 mmHg, and symptoms like *orí fífo* [headache] and *òógùn tó pọ̀* [excessive medication]. It asks which medication would be most appropriate.\n</step1>\n<step2>\nIn this case, the patient is likely experiencing a hypertensive crisis, which requires immediate treatment to lower blood pressure — *ìdènà ẹjẹ*.\n</step2>\n<step3>\nAmong the options, Nifedipine is a calcium channel blocker that can quickly reduce blood pressure, but it may not be the best choice for acute management.\n</step3>\n<step4>\nLabetalol, on the other hand, is a beta-blocker that is effective in treating severe hypertension and can be administered intravenously — *labetalol jẹ́ òògùn tó dára fún ìtọ́jú àìlera ẹjẹ*.\n</step4>\n<step5>\nPrazosin is primarily used for treating hypertension but is not typically used in acute situations, while Phenoxybenzamine is an irreversible alpha-blocker, which is not suitable for this scenario.\n</step5>\n<step6>\nGiven the urgency of the situation and the need for effective blood pressure control, Labetalol is the most appropriate choice for this patient.\n</step6></thinking>", "answer": "<answer>Labetalol ni òògùn tó yẹ jù lọ fún aláìsàn yìí.</answer>", "language": "Yoruba"}
{"question": "Àpọnà kan tí ó ti ń gbàdúrà pẹ̀lú trifluperazine ń fi àwọn àmì àrùn bí hyperthermia, lethargy, àti ìgbàgbé hàn. Ṣe àwọn ìwádìí ilé-ìṣèwádìí wo ni ó yẹ kí a ṣe láti ṣàyẹ̀wò ipò rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What diagnostic tests should be conducted to evaluate a patient showing symptoms like [hyperthermia = elevated body temperature], lethargy, and [ìgbàgbé = confusion] while on trifluperazine?” \n</step1>\n<step2>\nFirst, we need to consider that trifluperazine is an antipsychotic medication, and these symptoms could indicate a serious condition like neuroleptic malignant syndrome (NMS) — *syndrome malin des neuroleptiques*.\n</step2>\n<step3>\nTo evaluate the patient's condition, a complete blood count (CBC) is essential to check for signs of infection or other hematological issues — *compte complet de sang*.\n</step3>\n<step4>\nAdditionally, liver function tests (LFTs) should be performed to assess any hepatic impairment — *tests de fonction hépatique*.\n</step4>\n<step5>\nElectrolyte levels must also be monitored, particularly potassium and sodium, as imbalances can exacerbate symptoms — *surveillance des électrolytes*.\n</step6>\n<step6>\nFinally, a creatine kinase (CK) test is crucial to rule out muscle breakdown, which can occur in NMS — *test de créatine kinase*.\n</step6></thinking>", "answer": "<answer>Àwọn ìwádìí ilé-ìṣèwádìí tó yẹ kí a ṣe ni: compte complet de sang, tests de fonction hépatique, surveillance des électrolytes, àti test de créatine kinase.</answer>", "language": "Yoruba"}
{"question": "Kí a lè sọ̀rọ̀ nípa ìtẹ̀síwájú iṣẹ́-ṣiṣe f(x) ní aaye kan x = c bí a bá mọ̀ pé f máa ṣeé yàtọ̀ sí i ní x = c?", "reasoning": "<thinking><step1>\nThe question asks: “Kí a lè sọ̀rọ̀ nípa [ìtẹ̀síwájú = derivative] iṣẹ́-ṣiṣe f(x) ní aaye kan x = c?” — meaning it wants to discuss the derivative of the function f(x) at the point x = c, given that f is not continuous at that point.\n</step1>\n<step2>\nTo find the derivative, we typically look at the limit of the difference quotient as x approaches c — *a fi ọwọ́ kan àkóónú àtẹ̀jáde*.\n</step2>\n<step3>\nHowever, if f is not continuous at x = c, this means that *f(c)* may not equal the limit of f(x) as x approaches c — *ìtẹ̀síwájú f(x) kò ní jẹ́ pé f(c)*.\n</step3>\n<step4>\nIn such cases, we can say that the derivative does not exist at that point — *ìtẹ̀síwájú f(c) kò sí*.\n</step4>\n<step5>\nWe can also analyze the left-hand and right-hand limits separately to see if they approach different values — *a lè wo àkóónú àtẹ̀jáde láti ọwọ́ òsì àti ọwọ́ ọ̀tún*.\n</step5>\n<step6>\nThus, if f is discontinuous at x = c, we conclude that we cannot define the derivative there — *nítorí náà, a kò lè sọ ìtẹ̀síwájú f(x) ní x = c*.\n</step6></thinking>", "answer": "<answer>A kò lè sọ ìtẹ̀síwájú f(x) ní x = c bí f kò bá jẹ́ pé àtẹ̀síwájú f(x) wà níbẹ.</answer>", "language": "Yoruba"}
{"question": "Orúkọ àjàkálẹ̀ kan, yàtọ̀ sí HSV-1 àti HSV-2, tí ó fa àwọn ìṣẹ̀lẹ̀ cytopathic tí a ṣàpẹẹrẹ̀ nípa àwọn sẹ̀lù ńlá tí ó ní ọ̀pọ̀lọpọ̀ njúkì.", "reasoning": "<thinking><step1>\nThe question asks for the name of a virus, different from HSV-1 and HSV-2, that causes cytopathic effects in large cells with multiple nuclei — *àjàkálẹ̀* refers to a virus or infection.\n</step1>\n<step2>\nCytopathic effects indicate that the virus damages the host cells, leading to visible changes — *ìyípadà* in the cell structure.\n</step2>\n<step3>\nOne virus that fits this description is Cytomegalovirus (CMV) — *Cytomegalovirus* ni a mọ̀ sí àjàkálẹ̀ kan tí ó fa ìyípadà yìí.\n</step3>\n<step4>\nCMV is known for causing large cells with multiple nuclei — *sẹẹli ńlá tí ó ní ọ̀pọ̀lọpọ̀ njúkì*.\n</step4>\n<step5>\nIt is particularly significant in immunocompromised individuals, leading to severe complications — *àwọn ẹni tí kò ní ààbò ara*.\n</step5>\n<step6>\nThus, the virus that causes these cytopathic effects, distinct from HSV-1 and HSV-2, is Cytomegalovirus.\n</step6></thinking>", "answer": "<answer>Cytomegalovirus ni àjàkálẹ̀ tí ó fa àwọn ìṣẹ̀lẹ̀ cytopathic ní sẹẹli ńlá tí ó ní ọ̀pọ̀lọpọ̀ njúkì.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìtọ́jú wo ni a kà sí ohun tí ó lè mú kí èso rẹ̀ jáde fún ọmọ ọdún mẹ́rin tó ní ọgbọ́n ẹnu-ìṣán kan tí kò ní èso mọ́, tí àrùn ibàá ti bà á nítorí ìpalára?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn ìtọ́jú wo ni a kà sí ohun tí ó lè mú kí èso rẹ̀ jáde fún ọmọ ọdún mẹ́rin tó ní ọgbọ́n ẹnu-ìṣán kan tí kò ní èso mọ́, tí àrùn ibàá ti bà á nítorí ìpalára?” — meaning it wants to know what treatments can help a four-year-old child with a speech delay and no fruits, who has been affected by a disease due to trauma.\n</step1>\n<step2>\nIn this context, *ìtọ́jú* refers to treatments or interventions that can support the child's development — particularly in speech and nutrition.\n</step2>\n<step3>\nFirst, addressing the speech delay, *ìtọ́jú àkọ́kọ́* could involve speech therapy — *ìtọ́jú ẹnu-ìṣán* — where a specialist works with the child to improve communication skills.\n</step3>\n<step4>\nNext, since the child does not consume fruits, introducing a balanced diet is crucial. This could include *èso* in forms like smoothies or purees to ensure they receive essential vitamins.\n</step4>\n<step5>\nAdditionally, engaging the child in interactive play can enhance both speech and social skills — *ìdárayá* that encourages verbal expression.\n</step5>\n<step6>\nFinally, regular check-ups with a pediatrician are important to monitor progress and adjust treatments as necessary — *ìmúlò àyẹ̀wò* to ensure the child is on the right track.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú tó yẹ ni ìtọ́jú ẹnu-ìṣán, ìmúlò èso, àti ìdárayá pẹ̀lú àyẹ̀wò àtọkànwá.</answer>", "language": "Yoruba"}
{"question": "Awọn apawo ni iwe ofin ti o ṣe idaniloju ẹ̀tọ́ ọmọde?", "reasoning": "<thinking><step1>\nThe question asks: “Awọn apawo ni iwe ofin ti o ṣe idaniloju ẹ̀tọ́ ọmọde?” — which translates to “What are the laws that guarantee children's rights?”\n</step1>\n<step2>\nIn many countries, there are specific laws and conventions that protect children's rights — *awọn ofin ati awọn ajọṣepọ* ti o daabobo ẹ̀tọ́ ọmọde.\n</step2>\n<step3>\nOne of the most significant is the United Nations Convention on the Rights of the Child (UNCRC) — *Iwe adehun ti United Nations lori ẹ̀tọ́ ọmọde*.\n</step3>\n<step4>\nThis convention outlines various rights, including the right to education, health care, and protection from abuse — *ẹ̀tọ́ si ẹkọ, itọju ilera, ati aabo lati ọdọ iwa-ipa*.\n</step5>\n<step5>\nIn Nigeria, the Child Rights Act of 2003 also plays a crucial role — *Ofin ẹ̀tọ́ ọmọde ti 2003* ti o ṣe idaniloju pe awọn ọmọde ni awọn ẹtọ to peye.\n</step6>\n<step6>\nThese laws aim to ensure that children are treated with dignity and respect, promoting their well-being and development — *lati mu ki awọn ọmọde ni itọju to dara ati idagbasoke*.\n</step6></thinking>", "answer": "<answer>Awọn ofin ti o ṣe idaniloju ẹ̀tọ́ ọmọde ni Iwe adehun ti United Nations ati Ofin ẹ̀tọ́ ọmọde ti 2003 ni Naijiria.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun mẹtadinlọgbọn (35) kan wá pẹlu irora oju, irora ikun, ati itan iṣẹ ọgba ṣaaju ki awọn ami aisan naa ki o bẹrẹ. Ọgbẹ́ iṣoogun rẹ̀ ni àrùn àtọ́gbẹ́ tí a ṣe àyẹ̀wò laipẹ́ yìí ati àtẹ́lẹwọ́, ati awọn oogun lọwọlọwọ rẹ̀ pẹlu lisinopril, metformin, ati glipizide. Àyẹ̀wò ara fi hàn pe edema ti ọwọ́ rẹ̀, ẹnu, ati oju, pẹlu edema laryngeal fẹ́ẹ́rẹ́. Da lori awọn ami aisan wọnyi, kini iṣakoso igba pipẹ ti o yẹ fun ọran ti a fura pe o jẹ angioedema ti o ni ibatan si lilo ACE inhibitor?", "reasoning": "<thinking><step1>\nThe question is asking about the long-term management for a patient suspected of having [angioedema = angioedema] related to the use of an [ACE inhibitor = ACE inhibitor]. \n</step1>\n<step2>\nThe patient is 35 years old and presents with symptoms like facial pain, abdominal pain, and a history of [hypertension = àrùn àtọ́gbẹ́]. \n</step2>\n<step3>\nGiven the current medications, including lisinopril, which is an ACE inhibitor, it is likely that this medication is causing the angioedema — *oògùn yìí lè fa angioedema*.\n</step3>\n<step4>\nManagement should involve discontinuing the ACE inhibitor immediately — *yẹ ki a dawọ́ ACE inhibitor duro* — to prevent further episodes.\n</step4>\n<step5>\nAlternative antihypertensive medications, such as angiotensin receptor blockers (ARBs), can be considered — *a le ronu nipa lilo ARBs*.\n</step5>\n<step6>\nAdditionally, monitoring for any signs of airway compromise is crucial, especially with laryngeal edema present — *a gbọdọ̀ ṣọ́ra fun eyikeyi ami ti iṣoro ọna afẹfẹ*.\n</step6>\n<step7>\nLong-term management may also include educating the patient about recognizing symptoms of angioedema and when to seek immediate care — *kí a kọ́ wọn nípa bi a ṣe le mọ̀ awọn ami angioedema*.\n</step7></thinking>", "answer": "<answer>Iṣakoso igba pipẹ yẹ ki o pẹlu idaduro ACE inhibitor, lilo ARBs, ati ikẹkọ fun alaisan lori awọn ami angioedema.</answer>", "language": "Yoruba"}
{"question": "Nígbà tí iwọn didun moli ti mercury ní P = 0 ati T = 273°K jẹ́ 14.72 cm^3/mol ati irọrun titẹ́ β jẹ́ ìyídájú ní 3.88 × 10^-11 m^2 N^-1, ka ìyípadà agbara òmìnira fún titẹ́ mercury lati 0 si 3000 kg cm^-2.", "reasoning": "<thinking><step1>\nThe question asks: “Calculate the change in free energy for the pressure of mercury from 0 to 3000 kg cm^-2” — it involves understanding the volume of mercury at standard conditions and the compressibility factor.\n</step1>\n<step2>\nAt P = 0 and T = 273 K, the molar volume of mercury is given as 14.72 cm^3/mol — *ìwọn didun moli ti mercury*.\n</step2>\n<step3>\nThe compressibility, β, is provided as 3.88 × 10^-11 m^2 N^-1 — *irọrun titẹ́* — which indicates how much the volume changes with pressure.\n</step3>\n<step4>\nTo find the change in free energy, we can use the formula: ΔG = -V * ΔP, where ΔP is the change in pressure from 0 to 3000 kg cm^-2.\n</step4>\n<step5>\nFirst, we convert the pressure: 3000 kg cm^-2 = 3000 × 98.0665 kPa = 294199.5 kPa.\n</step5>\n<step6>\nNow, we calculate ΔG using the molar volume in m^3: V = 14.72 cm^3/mol = 14.72 × 10^-6 m^3/mol.\n</step6>\n<step7>\nThus, ΔG = - (14.72 × 10^-6 m^3/mol) * (294199.5 kPa) = -4.334 × 10^-1 J/mol.\n</step7>\n<step8>\nThis negative value indicates that the process is spontaneous as pressure increases.\n</step8></thinking>", "answer": "<answer>Ìyípadà agbara òmìnira fún titẹ́ mercury lati 0 si 3000 kg cm^-2 jẹ́ -4.334 × 10^-1 J/mol.</answer>", "language": "Yoruba"}
{"question": "Àyíká sígìrì ti àwọn ọ̀rá ọ̀rá ń ṣẹlẹ̀ ní èyíkéyìí nínú àwọn àwòrán tí a fi hàn nínú Àwòrán náà?\nA. Àwòrán A\nB. Àwòrán B\nC. Àwòrán C\nD. Àwòrán D", "reasoning": "<thinking><step1>\nThe question asks: “Àyíká sígìrì ti àwọn ọ̀rá ọ̀rá ń ṣẹlẹ̀ ní èyíkéyìí nínú àwọn àwòrán tí a fi hàn nínú Àwòrán náà?” — which translates to “Which area of the image shows the most significant changes among the images presented?”\n</step1>\n<step2>\nTo answer this, I need to analyze the images — *àwòrán* — and identify where the most noticeable changes occur.\n</step2>\n<step3>\nI will compare the details in each image, looking for elements like color shifts, structural differences, or any other visual alterations — *iyipada*.\n</step4>\n<step4>\nFor instance, if *Àwòrán A* shows a drastic change in color saturation compared to the others, it might be the correct choice.\n</step5>\n<step5>\nAfter evaluating all options, I will determine which image has the most pronounced differences — *iyato* — that stand out clearly.\n</step6>\nBased on my analysis, I will select the image that best fits the criteria of significant change.\n</step7></thinking>", "answer": "<answer>Àwòrán B</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun 49 kan wà pẹlu àwọn àmì àrùn bíi ìgbà ìgbẹ̀rùn tí ó kúrú sí i ati tí kò pọ̀ mọ, ìyípadà ìṣe-ìmọ̀lára, ìdinku ìwúwo, ati ìgbona orúkọ.  Nígbà tí a bá gbé àwọn àmì àrùn rẹ̀ àti àìsí àwọn àìṣedeede lórí ṣíṣayẹ̀wò ara rẹ̀ yẹ̀wò, ìwádìí ilé-ìṣèwò wo ni ó yẹ kí a ṣe láti ṣàyẹ̀wò àrùn endocrine tí ó lè wà nínú rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks about a 49-year-old woman presenting with symptoms like *ìgbà ìgbẹ̀rùn tí ó kúrú sí i* [shortened menstrual periods], *ìyípadà ìṣe-ìmọ̀lára* [mood changes], *ìdinku ìwúwo* [weight loss], and *ìgbona orúkọ* [hot flashes]. It seeks to identify what endocrine disorder investigations should be conducted.\n</step1>\n<step2>\nGiven her age and symptoms, one must consider conditions like *ìyàtọ̀ àtọ́kànwá* [premature menopause] or *àìlera àtọ́kànwá* [hypothyroidism]. These can cause significant hormonal changes.\n</step2>\n<step3>\nA common investigation would be to check her *ìwọn oestrogen* [estrogen levels] and *ìwọn FSH* [FSH levels], as these can indicate ovarian function.\n</step3>\n<step4>\nAdditionally, testing for *ìwọn TSH* [TSH levels] is crucial to rule out thyroid dysfunction, which can also lead to weight loss and mood changes.\n</step4>\n<step5>\nOne might also consider a *ìwádìí àtọ́kànwá* [pelvic ultrasound] to assess the ovaries and uterus for any abnormalities.\n</step5>\n<step6>\nIn summary, the investigations should focus on hormonal assays and imaging to evaluate potential endocrine disorders affecting her symptoms.\n</step6></thinking>", "answer": "<answer>Àwọn ìwádìí tí ó yẹ kí a ṣe ni: ìwọn oestrogen, ìwọn FSH, ìwọn TSH, àti ìwádìí àtọ́kànwá.</answer>", "language": "Yoruba"}
{"question": "Lẹ́yìn tí obìnrin kan tí ó ń ṣe abẹ̀rẹ̀ yíyọ́ àpòòtọ́, tí àyẹ̀wò rẹ̀ ṣáájú abẹ̀rẹ̀ dára, di ẹni tí kò ní ìtẹ́lẹ̀mọ́ ọkàn àti ẹni tí kò dáhùn ní yàrá abẹ̀rẹ̀ lẹ́yìn lílo oògùn onígbàárí, àwọn ìgbésẹ̀ wo ni ó yẹ kí a gbé yàrá láti bójútó ipò rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Lẹ́yìn tí obìnrin kan tí ó ń ṣe abẹ̀rẹ̀ yíyọ́ àpòòtọ́” — meaning it refers to a woman who has undergone a [surgery = abẹ̀rẹ̀] to remove a [tumor = àpòòtọ́]. It inquires about the steps to take when she experiences [heart failure = ìtẹ́lẹ̀mọ́ ọkàn] and does not respond in the recovery room after using [anesthesia = oògùn onígbàárí].\n</step1>\n<step2>\nFirst, it’s crucial to monitor her vital signs closely — *àwọn ami pataki* like heart rate and blood pressure should be checked regularly.\n</step2>\n<step3>\nIf she shows signs of heart failure, immediate action is needed; *ìgbésẹ̀ àkọ́kọ́* would be to ensure her airway is clear and she is breathing adequately.\n</step3>\n<step4>\nNext, administering oxygen may be necessary — *fún un ní àfiyèsí* to help with her breathing if she is hypoxic.\n</step4>\n<step5>\nCalling for medical assistance is vital; *pé ẹgbẹ́ ìtọ́jú* to provide further evaluation and treatment options.\n</step5>\n<step6>\nLastly, documenting all observations and actions taken is essential for ongoing care — *kọ́ gbogbo ohun tí a ṣe* for future reference.\n</step6></thinking>", "answer": "<answer>Láti bójútó ipò obìnrin náà, a gbọdọ̀ ṣàkíyèsí àmi pataki rẹ̀, fún un ní àfiyèsí, pé ẹgbẹ́ ìtọ́jú, àti kọ́ gbogbo ohun tí a ṣe.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìpínrọ̀ tó tẹ̀lé yìí ṣàpèjúwe ṣeto àwọn ohun márùn-ún tí a gbé kalẹ̀ ní ọ̀nà kan ṣáá. Àwọn ọǹrọ̀ náà bá ara wọn mu ní gbogbo ìpínrọ̀. Àpótí èso kan ta èso márùn-ún: àpòòpò, òrànjì, ẹ̀gúsí, pèàrì, àti mango. Àpòòpò ń gbowó ju òrànjì lọ. Òrànjì ń gbowó ju mango lọ. Àpòòpò ni ẹ̀kẹta tí ó gbowó jùlọ. Pèàrì ń gbowó ju ẹ̀gúsí lọ.\nÀwọn àṣàyàn:\n(A) Àpòòpò ni ẹ̀kejì tí ó gbowó jùlọ\n(B) Òrànjì ni ẹ̀kejì tí ó gbowó jùlọ\n(C) Ẹ̀gúsí ni ẹ̀kejì tí ó gbowó jùlọ\n(D) Pèàrì ni ẹ̀kejì tí ó gbowó jùlọ\n(E) Mango ni ẹ̀kejì tí ó gbowó jùlọ", "reasoning": "<thinking><step1>\nThe question presents a scenario involving five fruits: [àpòòpò = pineapple], [òrànjì = orange], [ẹ̀gúsí = melon], [pèàrì = pear], and [mango = mango]. It asks which fruit ranks second in terms of price.\n</step1>\n<step2>\nFrom the information given, we know that àpòòpò is more expensive than òrànjì, and òrànjì is more expensive than mango. This means that àpòòpò > òrànjì > mango in terms of price.\n</step2>\n<step3>\nAdditionally, it states that àpòòpò is the third most expensive fruit, which implies that there are two fruits that are more expensive than it. Therefore, we need to identify those two fruits.\n</step3>\n<step4>\nSince pèàrì is more expensive than ẹ̀gúsí, we can conclude that the order of prices must be: 1) the most expensive fruit, 2) pèàrì, 3) àpòòpò, 4) òrànjì, and 5) mango.\n</step4>\n<step5>\nThus, the second most expensive fruit must be pèàrì, as it is the only one that fits this position based on the given relationships.\n</step5></thinking>", "answer": "<answer>Pèàrì ni ẹ̀kejì tí ó gbowó jùlọ.</answer>", "language": "Yoruba"}
{"question": "Kini John Frere ṣe rí ni ọdun 1797 tí ó fi hàn pé àwọn ará ìgbà àtijọ̀ wà?", "reasoning": "<thinking><step1>\nThe question asks: “Kini John Frere ṣe rí ni [ọdún = year] 1797 tí ó fi hàn pé [àwọn ará ìgbà àtijọ̀ = ancient people] wà?” — meaning it wants to know what John Frere discovered in 1797 that indicated the existence of ancient people.\n</step1>\n<step2>\nIn 1797, John Frere found flint tools in a layer of gravel — *irinṣẹ́ flint* — that was beneath the bones of extinct animals, suggesting human activity.\n</step2>\n<step3>\nThis discovery was significant because it implied that humans existed long before the known historical periods — *àkókò itan*.\n</step3>\n<step4>\nFrere's findings challenged the prevailing belief that humans had only existed for a short time, leading to a reevaluation of human history — *ìtàn ènìyàn*.\n</step4>\n<step5>\nHe presented his findings to the Society of Antiquaries, which helped to spark interest in archaeology — *ìtàn àtijọ̀*.\n</step5>\n<step6>\nThus, John Frere's discovery in 1797 was pivotal in establishing the timeline for human existence and the study of ancient peoples.\n</step6></thinking>", "answer": "<answer>John Frere rí irinṣẹ́ flint ni ọdún 1797 tí ó fi hàn pé àwọn ará ìgbà àtijọ̀ wà.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 62 kan ti ó ní ìgbìgbẹ́ ìsinmi, ríru li ọwọ́ òsì, ati rírìn-ìn níwọ̀n-wọ̀n ni a ti wòye pé ó ní àrùn kan tí wọ́n ti fún un ní ìtọ́jú tó gbàgbọ́ jùlọ. Kí ni ọ̀nà ìṣiṣẹ́ ti oògùn kejì tí a fi pọ̀ mọ́ ìtọ́jú yìí láti dènà àwọn àbájáde rẹ̀ tí kò dára?", "reasoning": "<thinking><step1>\nThe question translates to: \"A 62-year-old man with chronic obstructive pulmonary disease, left arm weakness, and difficulty walking has been observed to have a condition for which he has received the most trusted treatment. What is the mechanism of action of the second medication commonly associated with this treatment to prevent its adverse effects?\" \n</step1>\n<step2>\nThe condition mentioned is likely related to respiratory issues, specifically *àìlera ẹdọfóró* (chronic obstructive pulmonary disease). The treatment often involves bronchodilators and corticosteroids.\n</step2>\n<step3>\nThe second medication could be a long-acting beta-agonist (LABA) — *oògùn beta ti o n ṣiṣẹ́ pẹ́lú àkókò* — which helps to relax the muscles around the airways.\n</step3>\n<step4>\nThis relaxation leads to *ìtẹ̀síwájú àfiyèsí* (improved airflow) and reduces symptoms like wheezing and shortness of breath.\n</step4>\n<step5>\nThe mechanism of action involves binding to beta-2 adrenergic receptors in the lungs, causing bronchodilation — *ìtẹ̀síwájú àfiyèsí* — and improving overall lung function.\n</step5>\n<step6>\nAdditionally, using a LABA in combination with inhaled corticosteroids can help prevent exacerbations — *ìdènà àkúnya* — and improve the patient's quality of life.\n</step6></thinking>", "answer": "<answer>Ìmúlò oògùn beta ti o n ṣiṣẹ́ pẹ́lú àkókò n fa ìtẹ̀síwájú àfiyèsí nípa mímu pọ̀ mọ́ àwọn àkópọ̀ beta-2 adrenergic receptors, tó ń dènà àwọn àbájáde àìlera.</answer>", "language": "Yoruba"}
{"question": "Bí wọ́n bá ṣe ayẹ̀wò kí wọ́n sì rí i pé àwọn sẹẹ̀lì ìṣiṣẹ́ ti ara tí a ń pè ní parasympathetic nerves ti bàjẹ́ fún aláìsàn kan, ẹgbẹ́ ìṣan wo ni ó ṣeé ṣe jù lọ pé ó máa ní ipa lórí?", "reasoning": "<thinking><step1>\nThe question asks: “If they examine and find that the [sẹẹ̀lì ìṣiṣẹ́ ti ara = autonomic nerve cells] known as parasympathetic nerves are damaged in a patient, which muscle group is most likely to be affected?” \n</step1>\n<step2>\nThe parasympathetic nervous system primarily controls involuntary functions — *ìṣẹ́ àìmọ̀* — such as digestion and heart rate.\n</step2>\n<step3>\nDamage to these nerves can lead to issues with smooth muscles, particularly in the gastrointestinal tract — *àwọn iṣan ti ara ẹni*.\n</step3>\n<step4>\nFor example, if the parasympathetic nerves are compromised, it may result in decreased peristalsis — *ìdàgbàsókè àtẹ́gùn* — affecting digestion.\n</step5>\n<step5>\nAdditionally, the heart rate may become irregular, as the parasympathetic system helps to slow it down — *ìdáhùn àkúnya*.\n</step6>\n<step6>\nThus, the muscle group most affected would be the smooth muscles of the digestive system and the heart.\n</step6></thinking>", "answer": "<answer>Àwọn iṣan ti ara ẹni ti eto ìjẹun àti ọkan ni ó ṣeé ṣe jù lọ pé ó máa ní ipa lórí.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 45 kan, ti o ni itan-akọọlẹ àrùn ìṣanraju, àtọgbẹ, lílo ọtí líle, ati lilo hydrochlorothiazide laipẹ, dé ile iwosan pajawiri pẹlu irora ti o buru pupọ, pupa, ati gbígbòòrò ìka ẹsẹ ọtun rẹ̀. Wọn bẹrẹ sise fun alaisan naa lori oogun kan ti o ṣaṣeyọri lati dinku irora naa nipasẹ didinku sisẹ iyika ati ipin leukocyte, ṣugbọn o ni awọn ipa ẹgbẹ gẹgẹ bi ríru ati òtútù. Kini iṣẹ-ṣiṣe ipilẹ ti oogun tuntun yii?", "reasoning": "<thinking><step1>\nThe question asks about the primary mechanism of action of a new medication given to a 45-year-old man with a history of [àrùn ìṣanraju = hypertension], [àtọgbẹ = diabetes], alcohol use, and recent use of [hydrochlorothiazide] who presents with severe pain and swelling in his right leg.\n</step1>\n<step2>\nThe medication is effective in reducing pain by decreasing [sisẹ iyika = vascular permeability] and lowering [ipin leukocyte = leukocyte count], which suggests it may have anti-inflammatory properties.\n</step2>\n<step3>\nIn this context, the drug likely works by inhibiting certain pathways that lead to inflammation — *o le dinku iṣanraju ati irora*.\n</step3>\n<step4>\nCommon mechanisms for such medications include blocking cytokines or other inflammatory mediators, which can lead to reduced swelling and pain — *iyẹn ni pe, o n ṣiṣẹ lati dinku irora ati ìkànsí*.\n</step4>\n<step5>\nHowever, the side effects like [ríru = rash] and [òtútù = chills] indicate that the drug may also affect the immune system or cause hypersensitivity reactions.\n</step5>\n<step6>\nThus, the primary function of this new medication is to alleviate pain and inflammation by modulating the immune response and vascular dynamics.\n</step6></thinking>", "answer": "<answer>Iṣẹ-ṣiṣe ipilẹ ti oogun tuntun yii ni lati dinku irora ati ìkànsí nipa ṣiṣakoso idahun ajẹsara ati iyika ẹjẹ.</answer>", "language": "Yoruba"}
{"question": "Nígbà tí a bá wo ọpá mita kan tí ó dúró ní ìdákòkò, tí iye gigùn rẹ̀ tòótọ́ (L_0) jẹ́ mita kan, bí ó bá gbéra lọ síwájú pẹ̀lú iyara 2.7 × 10^8 m/s, kí ni gigùn tí a óò rí i ti ọpá mita náà gẹ́gẹ́ bí òfin ìmọ̀ ìṣe àkànṣe?", "reasoning": "<thinking><step1>\nThe question asks: “When we observe a [ọpá mita = meter stick] that is stationary, with its proper length (L_0) being one meter, if it moves forward at a speed of 2.7 × 10^8 m/s, what length will we observe for the meter stick according to the theory of relativity?”\n</step1>\n<step2>\nAccording to the theory of relativity, an object in motion appears shorter in the direction of motion — *gigùn rẹ̀ máa dín kù* due to relativistic effects.\n</step2>\n<step3>\nThe formula for length contraction is given by L = L_0 * √(1 - v^2/c^2), where v is the speed of the object and c is the speed of light, approximately 3 × 10^8 m/s.\n</step3>\n<step4>\nIn this case, we have v = 2.7 × 10^8 m/s. First, we calculate v^2/c^2: (2.7 × 10^8)^2 / (3 × 10^8)^2.\n</step4>\n<step5>\nCalculating this gives us approximately 0.81, so we find √(1 - 0.81) = √0.19, which is about 0.43589.\n</step5>\n<step6>\nNow, we can find the contracted length: L = 1 m * 0.43589, which results in approximately 0.43589 meters.\n</step6>\n<step7>\nThus, the observed length of the meter stick when it is moving at that speed will be significantly shorter than its proper length.\n</step7></thinking>", "answer": "<answer>Gigùn ti ọpá mita náà yóò jẹ́ 0.436 mita.</answer>", "language": "Yoruba"}
{"question": "Ọmọbìnrin ọdun 11 kan wá sí ọ̀dọ̀ oníṣègùn fún ṣíṣàyẹ̀wò ìṣẹ̀lẹ̀ ìdààmú ẹ̀jẹ̀ ìmu ní ìmú nígbà gbogbo láti ìgbà èwe rẹ̀. Ó ní ọ̀pọ̀lọpọ̀, àwọn iṣan kékeré tí a fa sí fèfèé lórí ètè, ìmú, àti àwọn ika ọwọ́ lórí àyẹ̀wò. Bàbá rẹ̀ ní ìtàn kan tí ó dàbí èyí kan náà nípa ìdààmú ẹ̀jẹ̀ ìmu nígbà gbogbo. Níwọ̀n ìyẹn, wo ninu àwọn ipo wọnyi ni aláìsàn yìí ní ewu tí ó pọ̀ sí i fún?\nA. Àwọn polyps inu ikun\nB. Àìṣàn ọkàn ti ẹ̀jẹ̀ tí ó ga ju\nC. Pheochromocytoma\nD. Glaucoma\nE. Àìsàn sẹ́ẹ̀lì kidinì", "reasoning": "<thinking><step1>\nThe question is asking about the potential risks associated with a condition described as *ìdààmú ẹ̀jẹ̀ ìmu* — which translates to \"blood flow issues in the nose\" — in an 11-year-old girl who has experienced this since childhood.\n</step1>\n<step2>\nGiven her symptoms, which include *ìmú* (nose) and *ìka ọwọ́* (fingers) issues, we need to consider conditions that could lead to increased risk of complications.\n</step3>\n<step3>\nThe options provided include various medical conditions. For instance, *àwọn polyps inu ikun* (polyps in the stomach) are not directly related to nasal blood flow issues.\n</step4>\n<step4>\n*Àìṣàn ọkàn ti ẹ̀jẹ̀ tí ó ga ju* (high blood pressure) could potentially lead to nosebleeds, but it’s not a direct cause of chronic nasal blood flow issues.\n</step5>\n<step5>\n*Pheochromocytoma* is a rare tumor that can cause high blood pressure and might be linked to symptoms like these, but it’s less common.\n</step6>\n<step6>\n*Glaucoma* is an eye condition and does not relate to nasal issues, while *àìsàn sẹ́ẹ̀lì kidinì* (sickle cell disease) can cause various complications, including blood flow problems.\n</step7>\n<step7>\nConsidering the chronic nature of her symptoms and the family history, *àìsàn sẹ́ẹ̀lì kidinì* is likely the most relevant condition that could increase her risk.\n</step8></thinking>", "answer": "<answer>Àìsàn sẹ́ẹ̀lì kidinì ni aláìsàn yìí ní ewu tí ó pọ̀ sí i fún.</answer>", "language": "Yoruba"}
{"question": "Obìnrin tó ríran dáadáa, tí bàbá rẹ̀ jẹ́ afọ́jú-àwọ̀, fẹ́ ọkùnrin tó ríran dáadáa. Kí ni àǹfààní kí ọmọkùnrin wọn jẹ́ afọ́jú-àwọ̀?\nA. 25%\nB. 50%\nC. 75%\nD. Kò sí àǹfààní rárá", "reasoning": "<thinking><step1>\nThe question asks: “Obìnrin tó ríran dáadáa, tí bàbá rẹ̀ jẹ́ afọ́jú-àwọ̀, fẹ́ ọkùnrin tó ríran dáadáa. Kí ni àǹfààní kí ọmọkùnrin wọn jẹ́ afọ́jú-àwọ̀?” — meaning it wants to know the probability that their son will be colorblind if the mother is not colorblind and the father is colorblind.\n</step1>\n<step2>\nIn genetics, colorblindness is often linked to the X chromosome. Since the mother is not colorblind, she has two normal X chromosomes — *XX*.\n</step2>\n<step3>\nThe father, being colorblind, has one X chromosome with the colorblind allele and one Y chromosome — *XcY*.\n</step3>\n<step4>\nWhen they have a son, he inherits the Y chromosome from the father and one X chromosome from the mother. Since the mother has normal vision, the son will inherit a normal X chromosome — *X*.\n</step4>\n<step5>\nThus, the son cannot be colorblind because he will have the genotype *XY* — meaning he has a normal vision X from his mother.\n</step5>\n<step6>\nTherefore, the probability that their son will be colorblind is 0% — *Kò sí àǹfààní rárá*.\n</step6></thinking>", "answer": "<answer>Kò sí àǹfààní rárá.</answer>", "language": "Yoruba"}
{"question": "Ninu ipo kan tí ọkunrin kan bá wọ ilé ìmọ́tí gbogbogbòò, tí ó sì sọ fún obìnrin kan pé kí ó má ṣe ṣe ohun kan, èyí tó mú kí obìnrin náà sá fún ìbẹ̀rù, ṣùgbọ́n láìsí ìṣẹ̀lẹ̀kùn tàbí ìfòyà èyíkéyìí tàbí ìfọwọ́kàn, ẹ̀ṣẹ̀ wo ni ọkunrin náà lè jẹ̀bi rẹ̀ lórí nítorí iṣẹ́ rẹ̀ nìkan?", "reasoning": "<thinking><step1>\nThe question asks: “In a situation where a man enters a public place and tells a woman not to do something, causing her to flee in fear, but without any physical threat or intimidation, what crime could the man be guilty of based solely on his actions?” \n</step1>\n<step2>\nThis scenario involves the concept of *intimidation* — *ìfọwọ́kàn* — even if there is no direct threat or physical contact.\n</step2>\n<step3>\nThe man’s words could be interpreted as creating a hostile environment, which may fall under *ìkànsí* or harassment laws.\n</step3>\n<step4>\nIn legal terms, if his statement caused *ìbẹ̀rù* (fear) that led to her fleeing, it could be seen as a form of psychological intimidation.\n</step4>\n<step5>\nAdditionally, if the woman felt that her safety was compromised, the man might be charged with *ìkànsí* or creating a public disturbance.\n</step5>\n<step6>\nThus, the man could potentially be guilty of harassment or intimidation, depending on the jurisdiction's laws regarding such behavior.\n</step6></thinking>", "answer": "<answer>Ọkunrin náà lè jẹ̀bi ìkànsí tàbí ìfọwọ́kàn lórí ìṣe rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Obirin Afrika-Amerika ọdun 40 kan ti o ti bí ọmọ lẹẹ mẹrin, ti o lóyún lẹẹ mẹrin, ti o sì bí ọmọ nipasẹ ọna àbẹ́ láìsí ìṣẹ̀lẹ̀ kankan oṣù mẹrin sẹyin, wá pẹlu ẹ̀dùn-ara ìkùnrẹ̀rẹ̀.  Ninu àyẹ̀wo, alaisan ni titẹ ẹjẹ jugular ti gbé gẹ̀rẹ̀gẹ̀rẹ, S3, ìkùn ìgbìgbẹ́, ati ìgbóná ẹsẹ̀ méjèèjì.  Àyẹ̀wo X-ray ọmu fihan àwọn ọ̀pá ìgbìgbẹ́, omi ninu fissure, ati omi ninu pleural.  Iṣẹ́ ṣíṣàn rẹ̀ jẹ́ 38% lori echocardiogram.  Ewo ni ohun pàtàkì ninu àyẹ̀wo ti o ṣeeṣe julọ?\nA.  Àìṣiṣẹ́ itanna\nB.  Gbigbẹ\nC.  Infarction\nD.  Pericarditis\nE.  Gbigbẹ àwọn atẹgun", "reasoning": "<thinking><step1>\nThe question describes a 40-year-old African American woman who has had four children and is experiencing symptoms like chest pain and shortness of breath. It asks what is the most significant finding in her examination.\n</step1>\n<step2>\nShe has elevated jugular venous pressure — *titẹ ẹjẹ jugular ti gbé gẹ̀rẹ̀gẹ̀rẹ* — which suggests possible heart failure or fluid overload.\n</step2>\n<step3>\nThe presence of S3 heart sound indicates volume overload — *ìkùn ìgbìgbẹ́* — often associated with congestive heart failure.\n</step4>\n<step4>\nThe X-ray findings show signs of pulmonary congestion — *omi ninu fissure* — and pleural effusion, which further supports the diagnosis of heart failure.\n</step5>\n<step5>\nGiven her recent history of childbirth and the echocardiogram showing 38% ejection fraction, this could indicate a condition like peripartum cardiomyopathy.\n</step6>\n<step6>\nAmong the options provided, the most relevant finding is likely related to heart failure, which aligns with the symptoms and examination results.\n</step7>\n<step7>\nThus, the most significant finding in this case is likely *Gbigbẹ* (congestion).\n</step7></thinking>", "answer": "<answer>Gbigbẹ.</answer>", "language": "Yoruba"}
{"question": "Àṣẹ̀rí wo ni ó ní ẹ̀dùn-ọ̀rọ̀?\nÀwọn àṣàyàn:\n(A) Ṣíṣe àṣàrò nípa ààbò àwọn obìnrin, àti bí wọ́n ṣe lè máa ronú fún ara wọn, yóo mú kí o gba àyàfi láti ọ̀dọ̀ àwọn obìnrin.\n(B) Ṣíṣe àṣàrò nípa ààbò àwọn obìnrin, àti bí wọ́n ṣe lè máa ronú fún ara wọn, yóo mú kí o padà sẹ́yìn láti ọ̀dọ̀ àwọn obìnrin.", "reasoning": "<thinking><step1>\nThe question asks: “Àṣẹ̀rí wo ni ó ní ẹ̀dùn-ọ̀rọ̀?” which translates to \"Which option has a negative implication?\" \n</step1>\n<step2>\nTo determine this, we need to analyze both options provided. The first option (A) discusses *àṣàrò nípa ààbò àwọn obìnrin* — reflecting on women's safety and how they can think for themselves, suggesting empowerment.\n</step2>\n<step3>\nThis empowerment is generally viewed positively, indicating that women are encouraged to take control of their own safety — *mú kí o gba àyàfi* means it leads to a positive outcome.\n</step3>\n<step4>\nOn the other hand, option (B) also discusses *àṣàrò nípa ààbò àwọn obìnrin*, but it states that it will lead to *padà sẹ́yìn* — going backward from women, which implies a negative outcome.\n</step4>\n<step5>\nThe phrase *padà sẹ́yìn* suggests regression or a return to a less favorable state, indicating a lack of progress in women's safety and autonomy.\n</step5>\n<step6>\nThus, option (B) has a negative implication as it suggests that the discussion will not lead to empowerment but rather to a setback.\n</step6></thinking>", "answer": "<answer>Àṣẹ̀rí B ni ó ní ẹ̀dùn-ọ̀rọ̀.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 22 kan wa pẹlu ailera ti n pọ si, ikun ti n ṣe, irọrun fifọ, ati awọ ara alawọ ewe, pẹlu hepatomegaly ati splenomegaly. Awọn abajade ile-iwosan fihan pancytopenia pẹlu hematocrit ti 25%, iye erythrocyte ti 2.5 x 10^6/mm3, ati iye thrombocyte ti 25,000/mm3. Biopsy egungun ọpọn fihan awọn macrophages pẹlu irisi iwe ti a fi rọ. Da lori awọn abajade iṣoogun wọnyi, ailagbara enzyme wo ni o ṣeese julọ fun ipo alaisan yii?", "reasoning": "<thinking><step1>\nThe question describes a 22-year-old man with increasing weakness, abdominal pain, easy bruising, and jaundice — *a awọ ara alawọ ewe* — along with hepatomegaly and splenomegaly. It asks which enzyme deficiency is most likely based on these medical findings.\n</step1>\n<step2>\nThe symptoms suggest a hematological issue, particularly with *pancytopenia*, which indicates a reduction in red blood cells, white blood cells, and platelets. The hematocrit of 25% and low erythrocyte count of 2.5 x 10^6/mm3 support this.\n</step2>\n<step3>\nThe presence of *macrophages* with a \"paper-like\" appearance in the bone marrow biopsy suggests a specific type of infiltration or storage disease. This could indicate a metabolic disorder.\n</step4>\n<step4>\nGiven the symptoms of jaundice and splenomegaly, one might consider conditions like *Gaucher's disease*, which is associated with glucocerebrosidase deficiency — *a ailagbara enzyme ti o ni ibatan si iṣoro yii*.\n</step5>\n<step5>\nThe combination of symptoms, particularly the bone marrow findings and the clinical presentation, strongly points towards this enzyme deficiency as the underlying cause of the patient's condition.\n</step6>\nThus, the most likely enzyme deficiency for this patient is glucocerebrosidase.\n</step6></thinking>", "answer": "<answer>Ailagbara enzyme ti o ṣeese julọ fun ipo alaisan yii ni glucocerebrosidase.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìpínrọ̀ tó tẹ̀lé e yìí ṣàpèjúwe ṣeto àwọn ohun méje tí a pín sí ipò kan pato. Àwọn ọ̀rọ̀ náà bá ara wọn mu nígbà gbogbo. Lórí ẹ̀ka igi kan, àwọn ẹyẹ méje wà: ẹyẹ buluu, òwú, akìnkàn, fàlkọ̀n, ẹyẹ oníṣùgbò, rọ́bì̀nì, àti kwàìlì. Ẹyẹ oníṣùgbò wà ní òsì fàlkọ̀n. Òwú wà ní ẹ̀kẹ́ta láti òsì. Rọ́bì̀nì wà ní òsì ẹyẹ oníṣùgbò. Kwàìlì wà ní ọ̀nà ọwọ́ ọ̀tún fàlkọ̀n. Rọ́bì̀nì wà ní ọ̀nà ọwọ́ ọ̀tún òwú. Ẹyẹ buluu wà ní ẹ̀kẹ́ta láti ọ̀nà ọwọ́ ọ̀tún.\nÀwọn àṣàyàn:\n(A) Ẹyẹ buluu ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ\n(B) Òwú ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ\n(C) Akìnkàn ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ\n(D) Fàlkọ̀n ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ\n(E) Ẹyẹ oníṣùgbò ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ\n(F) Rọ́bì̀nì ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ\n(G) Kwàìlì ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ", "reasoning": "<thinking><step1>\nThe question is asking to identify which bird is located furthest to the right on a tree, based on the given descriptions of their positions — *ipò* means position.\n</step1>\n<step2>\nWe have seven birds: *ẹyẹ buluu* (bluebird), *òwú* (sparrow), *akìnkàn* (finch), *fàlkọ̀n* (falcon), *ẹyẹ oníṣùgbò* (woodpecker), *rọ́bì̀nì* (robin), and *kwàìlì* (quail).\n</step2>\n<step3>\nFrom the clues, *ẹyẹ oníṣùgbò* is to the left of *fàlkọ̀n*, and *rọ́bì̀nì* is to the left of *ẹyẹ oníṣùgbò*.\n</step3>\n<step4>\nNext, *òwú* is in the third position from the left, which helps us place it relative to the others.\n</step4>\n<step5>\n*Kwàìlì* is to the right of *fàlkọ̀n*, and *rọ́bì̀nì* is to the right of *òwú*, indicating that *kwàìlì* is likely the furthest right.\n</step5>\n<step6>\nNow, we can summarize the positions: *rọ́bì̀nì* is to the right of *òwú*, and since *kwàìlì* is to the right of *fàlkọ̀n*, it suggests that *kwàìlì* is indeed the last on the right.\n</step6>\n<step7>\nThus, the bird that is furthest to the right is *kwàìlì*.\n</step7></thinking>", "answer": "<answer>Kwàìlì ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 43 kan wá pẹlu rirẹ gbogbo ara ati idinku agbara idojukọ fun oṣu pupọ, ikuna ikun, ati pipadanu iwuwo ti ko ni ero.  Ayẹwo ara fihan irisi rirẹ, ati awọn abajade ile-iwosan rẹ fihan kalisiomu giga ati protin ti o ni ibatan si homonu parathyroid, pẹlu fosfeti kekere ati awọn ipele homonu parathyroid deede.  Ni isalẹ awọn ami aisan ati awọn abajade ile-iwosan wọnyi, kini idi ti o ṣeeṣe julọ ti hypercalcemia alaisan naa?", "reasoning": "<thinking><step1>\nThe question asks: “What is the most likely cause of the patient's hypercalcemia?” — it describes a 43-year-old man with symptoms like fatigue, decreased concentration, and weight loss, alongside lab results showing high calcium levels.\n</step1>\n<step2>\nHypercalcemia, or *kalisiomu giga*, can result from various conditions, but the key here is the normal parathyroid hormone levels — *hormonu parathyroid deede*.\n</step2>\n<step3>\nSince the parathyroid hormone is normal, we can rule out primary hyperparathyroidism, which typically causes high calcium due to increased hormone secretion.\n</step3>\n<step4>\nAnother common cause of hypercalcemia is malignancy, particularly cancers that lead to *osteolytic metastases* or produce parathyroid hormone-related peptide (PTHrP).\n</step5>\n<step5>\nGiven the patient's symptoms of fatigue and weight loss, along with the lab findings, a malignancy could be a strong suspect — *a le ro pe o le jẹ arun kan*.\n</step6>\n<step6>\nThus, the most likely cause of this patient's hypercalcemia is malignancy, possibly due to a tumor causing calcium release into the bloodstream.\n</step6></thinking>", "answer": "<answer>Idi ti o ṣeeṣe julọ ti hypercalcemia alaisan naa ni arun kan, gẹgẹ bi ikolu ti o fa itusilẹ kalisiomu sinu ẹjẹ.</answer>", "language": "Yoruba"}
{"question": "Nigbati a ba n ṣàkíyèsí ìwòsàn ìyàrápọ̀ gbòǹgbò kan nibiti ìlà ìyàrápọ̀ náà ti hàn gẹ́gẹ́ bí ìlà tí ó gbòòrò lọ́ra, tí àwọn ẹ̀yà rẹ̀ sì ti sunmọra sí ara wọn, irú ọ̀rọ̀ èso wo ni ó ní ipa nínú ìlànà ìwòsàn náà?", "reasoning": "<thinking><step1>\nThe question translates to: \"When observing a [tumor = ìyàrápọ̀] that appears as a [mass = gbòǹgbò] with its parts closely packed together, what type of [fruit = èso] influences the treatment process?\" This indicates a focus on the relationship between tumor characteristics and treatment options.\n</step1>\n<step2>\nIn oncology, the characteristics of a tumor, such as its density and how the cells are arranged, can significantly affect treatment decisions — *ìwòsàn*.\n</step2>\n<step3>\nFor instance, a tumor that is dense and has tightly packed cells may indicate a more aggressive type of cancer — *ìyàrápọ̀ to n fa ìkànsí*.\n</step3>\n<step4>\nIn this context, the term \"fruit\" could refer to the metaphorical outcomes or results of treatment strategies, such as the effectiveness of chemotherapy or radiation — *ìmúlò ìwòsàn*.\n</step5>\n<step6>\nCertain types of tumors may respond better to specific treatments, much like how certain fruits are better suited for particular diets — *àwọn èso kan ni o ni ipa to dára ju*.\n</step7>\n<step8>\nThus, understanding the tumor's characteristics helps in selecting the most effective treatment plan — *ìlànà ìwòsàn to munadoko*.\n</step9>\n<step10>\nIn summary, the type of tumor and its characteristics play a crucial role in determining the appropriate treatment approach.\n</step10></thinking>", "answer": "<answer>Ìyàrápọ̀ tí ó ní ìlà gbòòrò àti ẹ̀yà rẹ̀ sunmọra le ní ipa tó lágbára nínú ìlànà ìwòsàn, bí ó ti ṣe pàtàkì láti yan ìwòsàn tó yẹ.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun marun kan wá pẹlu ikọ́ ati ibà tí ó ti bẹ̀ fún ọjọ́ mẹta, iwọn otutu ara rẹ̀ jẹ́ 39.6°C, iye ẹ̀mí tí ó gbà jẹ́ 48 ni iṣẹ́ju kan, ati didinku ohùn ẹ̀mí ni apa ọtun. Da lori awọn abajade ayẹwo X-ray àyà ati àwọn àmì àrùn rẹ̀, kini ẹ̀dá alààyè tí ó wọ́pọ̀ jùlọ tí ó fa àwọn àmì àrùn wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “Based on the X-ray results and symptoms, what is the most common organism causing these symptoms?” — it describes a five-year-old boy with a cough, fever of 39.6°C, a respiratory rate of 48 breaths per minute, and decreased breath sounds on the right side.\n</step1>\n<step2>\nThe symptoms suggest a respiratory infection, possibly pneumonia — *pneumonie* — which is often caused by bacteria or viruses.\n</step2>\n<step3>\nIn children, *Streptococcus pneumoniae* is a common bacterial cause of pneumonia, especially with high fever and cough.\n</step3>\n<step4>\nThe X-ray findings would likely show consolidation in the right lung, indicating an infection — *infiltration pulmonaire*.\n</step4>\n<step5>\nGiven the age of the child and the symptoms, it is reasonable to conclude that the most likely organism is *Streptococcus pneumoniae*.\n</step5></thinking>", "answer": "<answer>Ẹ̀dá alààyè tí ó wọ́pọ̀ jùlọ tí ó fa àwọn àmì àrùn wọnyi ni *Streptococcus pneumoniae*.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọlọdun 74 kan sọ pe ó ní àwọn ìkọlu àrùn gout púpọ̀ ní ika ẹsẹ̀ òsìrìì kan.  Kò ní àrùn kan ní ìsinsin yìí, a sì ti kọ́kọ́ fún un ní oogun allopurinol fun ìdènà àrùn gout.  Ní àwọn wọ̀nyí, èwo ni ọ̀nà tí oogun yìí ṣeé ṣe jùlọ láti ṣiṣẹ́?\nA. pọ̀ sí iṣẹ́ ṣiṣe ti uric acid\nB. dídènà jíjẹ́ kí renal tubular ṣe ìgbàjámọ́ uric acid\nC. dídènà xanthine oxidase\nD. dín didààmú àrùn gout tí ó gbóná", "reasoning": "<thinking><step1>\nThe question is asking about the mechanism of action of allopurinol in treating gout — *àrùn gout* — specifically how it helps in a 74-year-old man who has had multiple gout attacks in his left foot.\n</step1>\n<step2>\nAllopurinol is primarily used to lower uric acid levels in the blood — *ní dín uric acid* — which is crucial because high levels can lead to gout attacks.\n</step2>\n<step3>\nThe drug works by inhibiting an enzyme called xanthine oxidase — *xanthine oxidase* — which is responsible for the production of uric acid from purines.\n</step3>\n<step4>\nBy blocking this enzyme, allopurinol effectively reduces the synthesis of uric acid, thus preventing its accumulation — *ní dènà àkúnya uric acid*.\n</step4>\n<step5>\nThis mechanism is why option C, *dídènà xanthine oxidase*, is the most accurate description of how allopurinol works.\n</step5>\n<step6>\nOther options, like increasing uric acid excretion or directly reducing inflammation, do not accurately describe the primary action of allopurinol.\n</step6></thinking>", "answer": "<answer>Dídènà xanthine oxidase.</answer>", "language": "Yoruba"}
{"question": "Tí a bá gbé ìwọ̀n ìdààmú ilẹ̀ ayé sí ibi ìgbàgbọ́ apẹrẹ́ yíyọ̀, tí ó ní àyíká kan náà bí apẹrẹ́ oníṣòwò tí ó jẹ́ gbígbòòrò, báwo ni àkókò yíò gbà ti ilẹ̀ ayé tuntun yíò fi yí ara rẹ̀ ká, ati ìpín kan wo ni agbára ìgbòòrò ìṣiṣẹ́ ibẹ̀rẹ̀ yíò sọnù ninu iṣẹ́ yìí?", "reasoning": "<thinking><step1>\nThe question translates to: \"If you place the weight of the Earth's [ìdààmú ilẹ̀ ayé = Earth's mass] at a point of gravitational equilibrium, which has the same environment as a commercial [apẹrẹ́ oníṣòwò = business model], how long will it take for this new Earth to wrap around itself, and which part of the gravitational force will be lost in this process?\" \n</step1>\n<step2>\nTo understand this, we need to consider the concept of gravitational equilibrium — *ìdààmú àyíká*. This is where forces balance out, allowing the Earth to maintain its shape.\n</step2>\n<step3>\nWhen the Earth's mass is placed in such a way, it will take time for gravitational forces to redistribute — *àkókò yíò gba fún àtúnṣe agbára ìdààmú*.\n</step3>\n<step4>\nThe time it takes depends on factors like the mass distribution and the distance between points of mass — *ìpín agbára* will affect how quickly this happens.\n</step4>\n<step5>\nIn a commercial model, if we think of this as a business cycle, the gravitational force lost could be analogous to resources or energy dissipated during transitions — *agbára ìgbòòrò* that is not conserved.\n</step5>\n<step6>\nThus, the new Earth will take a significant amount of time to stabilize, and the gravitational force lost will likely be in the form of energy that cannot be recovered.\n</step6></thinking>", "answer": "<answer>Àkókò yíò gba pẹ́, ati agbára ìgbòòrò kan yóò sọnù gẹ́gẹ́ bí àkópọ̀ àkópọ̀ agbára.</answer>", "language": "Yoruba"}
{"question": "Obirin ọjọ́ ori mẹ́rinlélógún (72) kan ní ìṣọ̀tẹ̀ ọkàn tó burú jáì, ó sì ti ń ronú nípa ìgbàgbé ara rẹ̀ fún ọjọ́ méjì sẹ́yìn, pẹ̀lú èrò gidi láti kú. Ṣé ìtọ́jú wo ni ó yẹ jùlọ láti mú kí àwọn àmì àrùn rẹ̀ dín kù lẹ́yìn kíkàn?", "reasoning": "<thinking><step1>\nThe question asks: “What treatment is most appropriate to reduce the symptoms of a [ìṣọ̀tẹ̀ ọkàn = severe depression] in a 72-year-old woman who has been contemplating [ìgbàgbé ara rẹ̀ = self-harm] for two days?” \n</step1>\n<step2>\nSevere depression can lead to significant emotional distress — *ìbànújẹ tó lágbára* — and thoughts of self-harm are serious indicators of a need for immediate intervention.\n</step2>\n<step3>\nFirst, it’s crucial to ensure her safety; this might involve *ìtọ́jú pajawiri* (emergency care) if she is at risk of harming herself.\n</step3>\n<step4>\nNext, engaging a mental health professional for therapy — *ìmúlò ìmọ̀ràn* — is essential. Cognitive Behavioral Therapy (CBT) can be particularly effective.\n</step4>\n<step5>\nMedication, such as antidepressants — *ògùn àìlera ọkàn* — may also be necessary to help stabilize her mood and reduce symptoms.\n</step5>\n<step6>\nAdditionally, support from family and friends can provide emotional comfort — *ìtẹ́wọ́gbà láti ọdọ ẹbí àti ọ̀rẹ́* — which is vital during recovery.\n</step6>\n<step7>\nFinally, regular follow-ups with healthcare providers are important to monitor her progress and adjust treatment as needed — *ìtẹ́siwaju pẹ̀lú àwọn onímọ̀*.\n</step7></thinking>", "answer": "<answer>Ìtọ́jú tó yẹ jùlọ ni ìtọ́jú pajawiri, ìmúlò ìmọ̀ràn, àti ogun àìlera ọkàn.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹsan kan tí ó ní ìtàn ìgbóná àti ìgbòòrò ọwọ́ àti ẹsẹ̀, tí ó ṣẹṣẹ̀ kúrò ní Kenya, fi àbájáde ilé ẹ̀kọ́ nípa hemoglobin 7 g/dL, iwọn corpuscular to ṣeé ṣe ni 88 μm, iye reticulocyte ti 9%, ati iye leukocyte ti 12,000/mm3 hàn.  Nígbà tí a bá gbé àwọn àmì àrùn yìí yè wò, àìṣe déédéé wo ni o ṣe rẹ̀tẹ̀ láti rí lórí fífún ọ̀wọ̀n ẹ̀jẹ̀ òkèèrè?", "reasoning": "<thinking><step1>\nThe question is asking about a 9-year-old boy with a history of fever and joint pain, recently from Kenya, presenting with a hemoglobin level of 7 g/dL, mean corpuscular volume (MCV) of 88 μm, reticulocyte count of 9%, and leukocyte count of 12,000/mm3. It seeks to understand the implications of these findings on the diagnosis of *anémie* (anemia).\n</step1>\n<step2>\nA hemoglobin level of 7 g/dL indicates *anémie sévère* (severe anemia), which can be caused by various factors, including nutritional deficiencies or infections common in regions like Kenya.\n</step2>\n<step3>\nThe MCV of 88 μm suggests that the red blood cells are of normal size, indicating *anémie normocytaire* (normocytic anemia), which can occur in chronic disease or acute blood loss.\n</step3>\n<step4>\nThe reticulocyte count of 9% is elevated, suggesting that the bone marrow is responding to anemia, possibly due to *hémolyse* (hemolysis) or blood loss.\n</step4>\n<step5>\nThe leukocyte count of 12,000/mm3 indicates a possible infection or inflammation, which is consistent with his history of fever and joint pain — *fièvre et douleurs articulaires*.\n</step6>\n<step6>\nConsidering these factors, the boy may have an underlying condition such as *paludisme* (malaria) or another infectious disease that could explain both the anemia and the elevated leukocyte count.\n</step7>\n<step7>\nThus, the clinical picture suggests a significant risk of complications if the underlying cause is not addressed promptly.\n</step7></thinking>", "answer": "<answer>Ọmọkunrin náà ní àìlera tó lágbára, tí ó lè jẹ́ àbájáde àrùn gẹgẹ bí paludisme, tó ní àkúnya láti fa ìṣòro tó lewu.</answer>", "language": "Yoruba"}
{"question": "A ṣayẹwo ọmọ ọwẹkunrin tuntun kan ni iṣẹju kan lẹhin ibimọ rẹ̀. Ó bí ni ọsẹ̀ 38 ti oyun si iya kan tí ó ní àrùn suga oyun, pẹlu omi oyun tí ó mọ́. Ni akoko ṣayẹwo naa, iṣẹ ọkàn rẹ̀ ni 70/min, ati pe ó ń mí ní àìṣe deede pẹlu igbe tí ó lọra ati alagbà. Ó dahun si sisun fẹ́ẹ́rẹ̀ pẹlu ìmú, o si ní agbara iṣan to gbajúmọ̀ pẹlu igbẹ́ díẹ̀ ti awọn ẹya ara rẹ̀. Ara rẹ̀ pupa, ṣugbọn awọn ẹya ara rẹ̀ pupa dudu. Lẹhin ti a gbẹ́ ati gbe e sori ibùsùn ti o gbona, a mu omi ati ikun kuro ni ẹnu ati imú rẹ̀. Da lori awọn ami aisan wọnyi, kini igbesẹ atẹle yẹ ki o jẹ ni itọju ọmọ tuntun yii?", "reasoning": "<thinking><step1>\nThe question describes a newborn's condition after birth, asking what the next step in treatment should be based on the symptoms presented.\n</step1>\n<step2>\nThe newborn was delivered at 38 weeks gestation to a mother with gestational diabetes — *àrùn suga oyun*. The heart rate is 70 beats per minute, which is quite low for a newborn.\n</step2>\n<step3>\nAdditionally, the baby is exhibiting signs of respiratory distress — *ìṣoro ìmí*, with slow and irregular breathing patterns. This indicates potential complications.\n</step4>\n<step5>\nThe baby responds to stimulation, which is a positive sign, but the presence of cyanosis — *pupa dudu* — in the extremities suggests inadequate oxygenation.\n</step6>\n<step7>\nAfter drying and placing the baby on a warm surface, the next critical step is to ensure proper airway management — *itoju ọna afẹfẹ* — and possibly provide supplemental oxygen if needed.\n</step8>\n<step9>\nGiven the low heart rate and respiratory issues, immediate resuscitation measures may be necessary, including positive pressure ventilation — *ìmú afẹfẹ*.\n</step10></thinking>", "answer": "<answer>Igbesẹ atẹle ni lati ṣe itọju ọna afẹfẹ ati, ti o ba jẹ dandan, lati pese afẹfẹ afikun fun ọmọ tuntun yii.</answer>", "language": "Yoruba"}
{"question": "Aṣayan kan ti o ni 6.15 g ti kolesiterolu fun 100 ml ti oṣayan ni a ṣe. Nigbati apakan ti oṣayan yii wa ni inu tiubu polarimeter 5-cm kan, iyipada ti a ṣe akiyesi ni -1.2°. Ka iwọn iyipada pato ti kolesiterolu ninu oṣayan yii.", "reasoning": "<thinking><step1>\nThe question asks: “Ka iwọn iyipada pato ti kolesiterolu [cholesterol] ninu oṣayan [solution] yii?” — meaning it wants to calculate the specific rotation of cholesterol in the given solution.\n</step1>\n<step2>\nTo find the specific rotation, we use the formula: [α] = (observed rotation) / (concentration × path length). Here, the observed rotation is -1.2°.\n</step2>\n<step3>\nThe concentration of cholesterol is given as 6.15 g per 100 ml, which we need to convert to grams per liter for our calculations — *6.15 g/100 ml = 61.5 g/L*.\n</step3>\n<step4>\nThe path length of the polarimeter is 5 cm, which is equivalent to 0.05 m. Now we can substitute these values into the formula.\n</step4>\n<step5>\nCalculating the specific rotation: [α] = (-1.2°) / (61.5 g/L × 0.05 m) = -1.2° / 3.075 g·m/L = -0.39°·L/g·dm.\n</step5>\n<step6>\nThus, the specific rotation of cholesterol in this solution is approximately -0.39°·L/g·dm.\n</step6></thinking>", "answer": "<answer>Iwọn iyipada pato ti kolesiterolu ninu oṣayan yii jẹ -0.39°·L/g·dm.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 55 kan ṣafihan ara rẹ̀ pẹlu irora oju ọtun tó dé lọ́tẹ̀lẹ̀, pupa, ríru, ògbẹ̀, ati rírí iṣẹ́jú ní ayika awọn imọlẹ. Nígbà tí a ṣayẹwo rẹ̀, ó ní ṣíṣàn omijé, igbóná ojúlé, ṣíṣàn conjunctiva, cornea tí ó dàbí ẹ̀fúùfù, ọmọ-ọrùn tí ó dide déédéé tí ó sì gbòòòrò, titẹ inu oju tí ó ga pupọ, ati ojú iwoye ti 20/200 ni oju ọtun rẹ̀. Bí a bá gbàgbọ́ awọn àmì àti awọn ìwádìí wọnyi, kini àyèwò tí ó ṣeé ṣe julọ?", "reasoning": "<thinking><step1>\nThe question describes a 55-year-old woman presenting with symptoms like pain in the right eye, redness, tearing, and sensitivity to light — *irora oju*, *pupa*, *ògbẹ̀*, and *rírí iṣẹ́jú*.\n</step1>\n<step2>\nThese symptoms suggest an inflammatory condition, possibly involving the cornea — *cornea* — which appears cloudy, indicating potential *keratitis*.\n</step2>\n<step3>\nThe presence of conjunctival injection — *ṣíṣàn conjunctiva* — and high intraocular pressure suggests a serious condition, possibly *glaucoma* or *iritis*.\n</step3>\n<step4>\nThe visual acuity of 20/200 in the right eye indicates significant impairment, which could be due to corneal edema or other complications.\n</step4>\n<step5>\nGiven these findings, the most likely examination to consider is a *biomicroscopy* — *ayẹwo biomicroscopy* — to assess the anterior segment of the eye in detail.\n</step5>\n<step6>\nThis examination will help confirm the diagnosis and guide further management for her eye condition.\n</step6></thinking>", "answer": "<answer>Ayẹwo biomicroscopy ni àyèwò tí ó ṣeé ṣe julọ.</answer>", "language": "Yoruba"}
{"question": "Ní àpààlà kan tí ó ní àrùn Bell's palsy tí ó ti ń lo oògùn steroid fún ọ̀sẹ̀ méjì láìsí ìtẹ̀síwájú kankan, kini ìgbésẹ̀ tí ó tẹ̀lé e nínú ìtọ́jú rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Ní àpààlà kan tí ó ní àrùn [Bell's palsy] tí ó ti ń lo [oògùn steroid = steroid medication] fún ọ̀sẹ̀ méjì láìsí ìtẹ̀síwájú kankan, kini [ìgbésẹ̀ = step] tí ó tẹ̀lé e nínú [ìtọ́jú = treatment] rẹ̀?” — meaning it wants to know what steps to take next in the treatment of Bell's palsy after two weeks of steroid use without improvement.\n</step1>\n<step2>\nBell's palsy is a condition that causes sudden weakness in the muscles on one side of the face — *ìfarapa àyà kan*.\n</step2>\n<step3>\nIf there is no improvement after two weeks of steroid treatment, it is important to reassess the situation — *kó yẹ kí a tún wo àyípadà náà*.\n</step3>\n<step4>\nThe next step may involve further evaluation by a healthcare professional — *onímọ̀-èro ilera* — to rule out other causes of facial weakness.\n</step4>\n<step5>\nAdditional treatments could include physical therapy — *ìtọ́jú ara* — to help regain muscle strength and coordination.\n</step5>\n<step6>\nIn some cases, other medications or interventions might be considered if symptoms persist — *ti a bá rí i pé àìlera náà ń bá a lọ*.\n</step6>\n<step7>\nThus, the patient should consult their doctor for a comprehensive evaluation and possible adjustment of treatment.\n</step7></thinking>", "answer": "<answer>Kí ẹni tó ní àrùn Bell's palsy náà bá a ṣe àyẹ̀wò pẹ̀lú onímọ̀-èro ilera, kí a lè ṣe àtúnṣe ìtọ́jú rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ewo ni ọkan ninu awọn ipo pataki fun iwadii Arun Ẹ̀dùn-Ọkàn (RF) gẹgẹ bi awọn ilana Jones ti a ti ṣe atunṣe?\nA. Iye ASO\nB. Itan-ọla Arun Ẹ̀dùn-Ọkàn\nC. Iba\nD. Awọn iwọn ara labẹ awọ ara", "reasoning": "<thinking><step1>\nThe question asks: “Ewo ni ọkan ninu awọn ipo pataki fun iwadii [Arun Ẹ̀dùn-Ọkàn = Rheumatic Fever] gẹgẹ bi awọn ilana [Jones = Jones criteria] ti a ti ṣe atunṣe?” — meaning it wants to identify a key criterion for diagnosing Rheumatic Fever according to the modified Jones criteria.\n</step1>\n<step2>\nThe modified Jones criteria include major and minor manifestations — *awọn ami pataki ati kekere* — that help in diagnosing the condition.\n</step2>\n<step3>\nMajor criteria include *carditis*, *polyarthritis*, *chorea*, *erythema marginatum*, and *subcutaneous nodules*.\n</step3>\n<step4>\nMinor criteria involve *arthralgia*, *fever*, *elevated acute phase reactants*, and *prolonged PR interval* on an ECG.\n</step4>\n<step5>\nAmong the options provided, *Iye ASO* (Antistreptolysin O titer) is significant as it indicates a recent streptococcal infection, which is a trigger for Rheumatic Fever.\n</step5>\n<step6>\nThus, the correct answer is related to the laboratory findings that support the diagnosis of Rheumatic Fever.\n</step6></thinking>", "answer": "<answer>Iye ASO.</answer>", "language": "Yoruba"}
{"question": "Kini pH ojutu kan ti o ni iṣẹ́ iwọn hydrogen ion ti 3.5 × 10^-4, ati kini iṣẹ́ iwọn hydrogen ion naa bí pH ojutu naa bá jẹ́ 4.25?", "reasoning": "<thinking><step1>\nThe question asks: “Kini pH ojutu kan ti o ni [iṣẹ́ iwọn hydrogen ion = hydrogen ion concentration] ti 3.5 × 10^-4?” — meaning it wants to find the pH of a solution with a specific hydrogen ion concentration.\n</step1>\n<step2>\nTo find pH, we use the formula: *pH = -log10([H+])* where [H+] is the hydrogen ion concentration.\n</step2>\n<step3>\nHere, [H+] = 3.5 × 10^-4, so we calculate: *pH = -log10(3.5 × 10^-4)*.\n</step3>\n<step4>\nUsing a calculator, we find that *log10(3.5 × 10^-4) ≈ -3.46*, thus *pH ≈ 3.46*.\n</step4>\n<step5>\nNext, the question also asks: “kini [iṣẹ́ iwọn hydrogen ion = hydrogen ion concentration] naa bí pH ojutu naa bá jẹ́ 4.25?” — meaning we need to find the hydrogen ion concentration when pH is 4.25.\n</step6>\n<step6>\nUsing the formula again, we rearrange it to find [H+]: *[H+] = 10^(-pH)*. So, *[H+] = 10^(-4.25)*.\n</step7>\n<step7>\nCalculating this gives us approximately *[H+] ≈ 5.62 × 10^-5*.\n</step7></thinking>", "answer": "<answer>pH ojutu naa jẹ́ 3.46, ati [iṣẹ́ iwọn hydrogen ion] naa jẹ́ 5.62 × 10^-5.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun 61 kan wá sọ́dọ̀ oníṣègùn nítorí irora ori tí kò gbàgbé, tí ó dùn-dùn, àti irora ara gbogbo fún oṣù 8 sẹ́yìn. Ó tún ní ìṣòro gbọ́gbọ́ lati ẹgbẹ́ òsì rẹ̀, èyí tí ó bẹ̀rẹ̀ oṣù kan lẹ́yìn tí irora ori náà bẹ̀rẹ̀. Oṣù márùn-ún sẹ́yìn, ó ṣe abẹ̀rẹ̀ láti tọ́jú ìfàájì egungun ẹsẹ̀ ọ̀tún rẹ̀ tí ó ṣẹlẹ̀ láìsí ìṣubú tàbí ipalara tí ó ṣe pàtàkì. Ọdún márùn-ún sẹ́yìn, ó ṣe abẹ̀rẹ̀ gbogbo àìsàn thyroid fún kásìnà thyroid tí ó wà ní agbegbe kan. Ó mu levothyroxine àti afikun kalsiamu, èyí tí ó bẹ̀rẹ̀ sí í mu lẹ́yìn àkókò menopause. Ìwádìí ara fi hàn pé iwaju orí rẹ̀ ga pupọ, àti pé ojú orí rẹ̀ kò dára, ó sì ní irora. Irora egungun wà lórí ìṣípò èjìká àti ẹsẹ̀, pẹ̀lú ìdinku ìgbọ̀ràn ìṣípò èjìká ọ̀tún àti ìpọ̀sí ìgbàlópó ọ̀nà ẹ̀gbẹ́ ti awọn tibias mejeeji. Ìwádìí ilé-ìṣèwádìí fi hàn pé iye alkaline phosphatase gíga pupọ, pẹ̀lú awọn iye vitamin D, kalsiamu àti PTH láàrin àwọn ìwọ̀n deede. Ìwo ara X-ray ti ori yóò ṣeé ṣe julọ láti fi hàn ohun wo ninu awọn abajade wọnyi?\nA. Awọn àgbéyọ egungun tí kò ní àgbéyọ líle\nB. Ọpọlọpọ awọn àgbéyọ egungun tí ó dára, tí a fi hàn\nC. Awọn àgbéyọ egungun tí ó pò, tí ó sì ní líle\nD. Awọn àgbéyọ egungun tí ó ní hyperplasias egungun tí kò ní líle\nE. Egungun líle gbogbo", "reasoning": "<thinking><step1>\nThe question is asking about the likely findings from an X-ray of the head for a 61-year-old woman with persistent headaches, body pain, and a history of thyroid issues — *irora ori* (headache) and *irora ara* (body pain).\n</step1>\n<step2>\nShe has elevated alkaline phosphatase levels, which can indicate bone metabolism issues — *ìwọn phosphatase alkaline gíga*.\n</step3>\n<step4>\nGiven her symptoms and history, particularly with thyroid disease and the recent surgery, we need to consider conditions like *hyperparathyroidism* or *osteitis fibrosa*.\n</step5>\n<step5>\nThe options suggest various bone conditions, but the presence of high alkaline phosphatase often correlates with increased bone turnover — *ìyípadà egungun*.\n</step6>\n<step6>\nThus, the most likely X-ray finding would be *àgbéyọ egungun tí ó pò, tí ó sì ní líle* (multiple bone lesions that are hard).\n</step6></thinking>", "answer": "<answer>Àgbéyọ egungun tí ó pò, tí ó sì ní líle.</answer>", "language": "Yoruba"}
{"question": "((-3 + -4 * 3 - -8) + (8 - 1 - -4 - -1)) =", "reasoning": "<thinking><step1>\nThe question asks to solve the expression: \"((-3 + -4 * 3 - -8) + (8 - 1 - -4 - -1))\". We need to break it down step by step.\n</step1>\n<step2>\nFirst, we handle the multiplication: *-4 * 3 = -12*. So, the first part becomes: *-3 - 12 - -8*.\n</step2>\n<step3>\nNext, simplifying *-3 - 12* gives us *-15*. Now we have: *-15 + 8* (since - -8 is +8).\n</step3>\n<step4>\nNow, let's simplify the second part: *8 - 1 - -4 - -1*. Here, *- -4* becomes +4 and *- -1* becomes +1, so it simplifies to *8 - 1 + 4 + 1*.\n</step4>\n<step5>\nCalculating this gives us: *8 - 1 = 7*, then *7 + 4 = 11*, and finally *11 + 1 = 12*.\n</step5>\n<step6>\nNow we combine both parts: *-15 + 12 = -3*.\n</step6></thinking>", "answer": "<answer>-3</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun mẹ́tádínlógún kan ni wọ́n ti wá rí i pé ó ní àrùn gonorrhea, ó sì ń bè̀rù láti sọ fún ọkọ rẹ̀ àti ipò ilera nípa àrùn náà. Kí ni dokita náà gbọ́dọ̀ ṣàlàyé fún aláìsàn náà nípa àwọn ohun tí ó yẹ kí ó jẹ́ ká sọ nípa ipò ara rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What should the doctor explain to a 23-year-old woman diagnosed with [àrùn gonorrhea = gonorrhea] who is afraid to tell her husband and discuss her health status?” \n</step1>\n<step2>\nFirst, the doctor needs to reassure her that gonorrhea is a common sexually transmitted infection — *àrùn to n tan kaakiri* — and that it can be treated effectively.\n</step2>\n<step3>\nThe doctor should explain the importance of open communication with her partner — *ibaraẹnisọrọ pẹ̀lú ọkọ rẹ̀* — as it can help prevent further transmission and ensure both partners receive treatment.\n</step4>\n<step4>\nShe should also be informed about the symptoms of gonorrhea, which may include painful urination and unusual discharge — *irora nigba ti o n mu omi* — so she understands the seriousness of the condition.\n</step5>\n<step5>\nAdditionally, the doctor can discuss the potential complications if left untreated, such as infertility — *aibikita* — which emphasizes the need for timely treatment.\n</step6>\n<step6>\nFinally, the doctor should encourage her to seek support, whether from healthcare professionals or support groups, to help her cope with the emotional aspects of her diagnosis — *ìmọ̀ràn àti ìtìlẹ́yìn*.\n</step6></thinking>", "answer": "<answer>Dokita náà gbọ́dọ̀ ṣàlàyé pé àrùn gonorrhea jẹ́ àrùn to wọpọ, kí ó sọ fún un pé ó yẹ kí ó bá ọkọ rẹ̀ sọrọ, kí ó mọ̀ pé ìtẹ́wọ́gba ìtọ́jú jẹ́ pataki, àti pé àìtọ́jú le fa aibikita.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 43 kan wa pẹlu rirẹ, aisan ounjẹ, ati ẹ̀jẹ̀ pupa tí kò tó, pẹlu iwọn corpuscular lapapọ̀ (MCV) ti 108 fl. Ó mu ọti déédéé.  Ní àyẹ̀wò, o fara hàn pé o burújú ati pe o ni glossitis.  Nítorí àwọn àmì wọnyi ati awọn ìwádìí ilé-iwosan rẹ̀,  ìwọn eroja métabolikù wo ni ó ṣee ṣe julọ lati rii ninu ẹ̀jẹ̀ rẹ̀?", "reasoning": "<thinking><step1>\nThe question describes a 43-year-old woman with symptoms like fatigue, food intolerance, and low red blood cell count — *ẹ̀jẹ̀ pupa tí kò tó*. It also mentions a high mean corpuscular volume (MCV) of 108 fl, which indicates macrocytic anemia.\n</step1>\n<step2>\nMacrocytic anemia often results from deficiencies in vitamin B12 or folate — *vitamini B12 tabi folate*. Given her symptoms, particularly glossitis, this suggests a possible vitamin deficiency.\n</step2>\n<step3>\nThe presence of glossitis — *glossitis* — is commonly associated with vitamin B12 deficiency, which can lead to neurological issues if untreated.\n</step3>\n<step4>\nAdditionally, the history of alcohol consumption — *mu ọti déédéé* — can contribute to malabsorption of these vitamins, further supporting the likelihood of a deficiency.\n</step4>\n<step5>\nConsidering all these factors, the most probable metabolic element to find in her blood would be low levels of vitamin B12 — *vitamini B12 tó kéré*.\n</step5></thinking>", "answer": "<answer>Ìwọn vitamini B12 tó kéré ni a ó rí ninu ẹ̀jẹ̀ rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdún mẹ́ẹ̀ẹ́dọ́gbọ̀n kan tó jẹ́ agbẹ́gi-ìrókò ní orí fọ́ òun gidigidi nígbà tó ń ṣe ìdárayá, ayẹ̀wò omi ọpọlọ (CSF) sì fi hàn pé ẹjẹ wà nínú rẹ̀. Kí ni àrùn tó ṣeé ṣe kó jẹ́?", "reasoning": "<thinking><step1>\nThe question asks: “What illness could a 35-year-old [agbẹ́gi-ìrókò = athlete] have if they experience severe headaches during exercise and a cerebrospinal fluid (CSF) test shows blood?” \n</step1>\n<step2>\nSevere headaches during physical activity can indicate a serious condition — *àrùn tó le fa irora tó lagbara*.\n</step2>\n<step3>\nThe presence of blood in the CSF suggests potential bleeding in the brain — *ìjẹ̀pàtàkì nínú ọpọlọ*.\n</step3>\n<step4>\nOne possible condition is a subarachnoid hemorrhage — *ìjẹ̀pàtàkì subarachnoid*, which often presents with sudden, intense headaches.\n</step4>\n<step5>\nAnother possibility is a cerebral aneurysm — *àkúnya ọpọlọ* — which can rupture and lead to bleeding in the CSF.\n</step5>\n<step6>\nGiven the symptoms and CSF findings, it is crucial to seek immediate medical attention — *ìtẹ́wọ́gbà ìtọ́jú lẹ́sẹkẹsẹ*.\n</step6></thinking>", "answer": "<answer>Àrùn tó ṣeé ṣe kó jẹ́ ni ìjẹ̀pàtàkì subarachnoid tàbí àkúnya ọpọlọ.</answer>", "language": "Yoruba"}
{"question": "Eyi ni tabili kan nibiti ila ti akọkọ jẹ́ atokọ ati ila kọọkan ti o tẹle jẹ́ penguin kan: orukọ, ọjọ ori, iga (cm), iwuwo (kg) Louis, 7, 50, 11 Bernard, 5, 80, 13 Vincent, 9, 60, 11 Gwen, 8, 70, 15 Fun apẹẹrẹ: ọjọ ori Louis ni 7, iwuwo Gwen ni 15 kg, iga Bernard ni 80 cm.  A ti fi penguin kan kun si tabili bayi:\nJames, 12, 90, 12\nMelo ni ẹranko ti a ṣe akojọ ninu tabili naa?\nAwọn aṣayan:\n(A) 1\n(B) 2\n(C) 3\n(D) 4\n(E) 5", "reasoning": "<thinking><step1>\nThe question asks: “Melo ni ẹranko ti a ṣe akojọ ninu tabili naa?” — meaning it wants to know how many animals are listed in the table.\n</step1>\n<step2>\nThe table initially includes four penguins: Louis, Bernard, Vincent, and Gwen — *Louis, Bernard, Vincent, ati Gwen*.\n</step2>\n<step3>\nEach penguin has specific details: name, age, height, and weight — *orukọ, ọjọ ori, iga, ati iwuwo*.\n</step3>\n<step4>\nAfter adding James, who is 12 years old, the total number of penguins increases — *nítorí náà, a ni penguin marun*.\n</step4>\n<step5>\nSo, the total count of animals in the table is five — *nítorí náà, idahun ni 5*.\n</step5></thinking>", "answer": "<answer>5</answer>", "language": "Yoruba"}
{"question": "Ṣé Fred jẹ́ arakunrin ọ̀dọ̀ kan ti Robert? Ṣé Joe ní ìbatan pẹ̀lu Bob? Nínú ìdílé ńláńlá, ó máa n ṣòro láti mọ gbogbo àwọn ìbatan ẹni. Ẹ̀tọ́ náà tí a gbé kalẹ̀ yìí ń wá láti ṣàlàyé àwọn ìbatan irú bẹ́ẹ̀: Jíjẹ́ arakunrin ọ̀dọ̀ kan ti Guadalupe jẹ́ ohun tí ó pọn dandan fún jíjẹ́ arakunrin ọ̀dọ̀ kan ti Ronald. Jíjẹ́ ìgbàgbọ́ ti Tom tó ṣeé tó jẹ́ ohun tó tó fún jíjẹ́ arakunrin ọ̀dọ̀ kan ti Guadalupe. Láti jẹ́ arakunrin ọ̀dọ̀ kan ti Ronald tàbí ìgbàgbọ́ ti Tom jẹ́ ohun tí ó pọn dandan fún jíjẹ́ baba ńlá ti Francesco. Nítorí náà, ní pàtàkì, gbogbo baba ńlá ti Francesco jẹ́ arakunrin ọ̀dọ̀ kan ti Guadalupe.\nṢé ẹ̀tọ́ náà, gẹ́gẹ́ bí àwọn ìlànà tí a sọ kedere, ó dára ní ọ̀nà ìtumọ̀ tàbí kò dára?\nÀwọn àṣàyàn:\n- ó dára\n- kò dára", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé ẹ̀tọ́ náà, gẹ́gẹ́ bí àwọn ìlànà tí a sọ kedere, ó dára ní ọ̀nà ìtumọ̀ tàbí kò dára?” — meaning it wants to know if the reasoning about family relationships is correct or not.\n</step1>\n<step2>\nThe reasoning states that being a younger brother of Guadalupe is necessary for being a younger brother of Ronald. This implies a direct relationship — *ìbatan taara*.\n</step2>\n<step3>\nIt also mentions that Tom's belief is necessary for being a younger brother of Guadalupe, which suggests a conditional relationship — *ìbatan àkópọ̀*.\n</step3>\n<step4>\nFurthermore, it states that being a younger brother of Ronald or Tom's belief is necessary for being Francesco's grandfather — *baba ńlá Francesco*.\n</step4>\n<step5>\nThe conclusion drawn is that all grandfathers of Francesco are younger brothers of Guadalupe, which seems to follow the logic presented — *ìmọ̀ràn tó dára*.\n</step6>\n<step6>\nThus, the reasoning appears to be consistent with the relationships outlined, making it a valid interpretation.\n</step6></thinking>", "answer": "<answer>Ó dára.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ẹni ọdún mọ́kàndínláàádọ́ta (49) kan tó ti ní àìsàn wárápá fún ìgbà pípẹ́ wá sí ilé ìwòsàn pẹ̀lú àárẹ̀, ìbísíwájú nínú ìwúwo ara, àti ìrún pípa. Aláìsàn náà sọ pé àwọn àmì àìsàn náà ti ń burú sí i díẹ̀díẹ̀ láti oṣù kan sẹ́yìn kò sì tíì sí ìdàgbàsókè kankan. Ìtàn ìlera rẹ̀ tó ti kọjá fi hàn pé wọ́n ṣàwárí àìsàn wárápá fún un ní ọdún mẹ́wàá sẹ́yìn, èyí tí ó ṣẹ̀ṣẹ̀ pààrọ̀ oògùn rẹ̀ fún. Lọ́wọ́lọ́wọ́, ó ń mu phenytoin 300 mg lẹ́ẹ̀kan lójúmọ́ àti oògùn olórórójòórànjòran (multivitamin). Àtúnyẹ̀wò àwọn ètò ara fi hàn pé kò ní ọkàn sí oúnjẹ bíi ti tẹ́lẹ̀, ó ṣẹ̀ṣẹ̀ bẹ̀rẹ̀ sí ní ní ìṣòro láti ya ìgbẹ́ (constipation), kò sì lè fara da òtútù. Ìwọ̀n ìgbóná ara rẹ̀ jẹ́ 37.0°C (98.6°F), ìfúnpá rẹ̀ jẹ́ 100/80 mm Hg, ìṣísẹ̀ ọkàn rẹ̀ jẹ́ ọgọ́ta (60) ní ìṣẹ́jú kan, ìṣísẹ̀ èémí rẹ̀ jẹ́ mẹ́rìndínlógún (16) ní ìṣẹ́jú kan, àti ìwọ̀n oxygen nínú ẹ̀jẹ̀ rẹ̀ jẹ́ 98% ní afẹ́fẹ́ yàrá. Nígbà àyẹ̀wò ara, aláìsàn náà pẹ́ láti dáhùn ṣùgbọ́n ó fún ni ní ìfọwọ́sowọ́pọ̀. Àyẹ̀wò ọkàn rẹ̀ wà déédéé. Àyẹ̀wò ẹ̀dọ̀fóró fi hàn pé kò sí ìṣòro. Awọ ara rẹ̀ le tí ó sì gbẹ. Ìrún pípa díẹ̀ sí èyí tó pọ̀ díẹ̀ wà káàkiri ara rẹ̀, àwọn irun tó sì ṣẹ́ kù máa ń já kiribiti. Èwo nínú àwọn àwárí àfikún wọ̀nyí ni ìwọ yóò retí láti rí lára aláìsàn yìí?\nA. Ìdáhùnpadà ìsáǹsá (reflex) tó pọ̀ jù\nB. Ìdínkù nínú agbára ìgbọ́ ìtìtì (vibration) àti ìmọ̀ ipò ara (proprioception)\nC. Lílè ara (Spasticity)\nD. Ìrèmọ́lẹ̀ agbára ìrántí\nE. Ìṣípòpadà ara tí kò bófinmu tí ó ń fà látara lílo oògùn kan fún ìgbà pípẹ́ (Tardive dyskinesia)", "reasoning": "<thinking><step1>\nThe question asks about the expected findings in a 49-year-old woman with a long-standing history of [àìsàn wárápá = epilepsy] who presents with fatigue, weight gain, and constipation. \n</step1>\n<step2>\nShe has been on phenytoin, which can lead to various side effects — *oògùn wárápá* often causes issues like weight gain and changes in metabolism.\n</step2>\n<step3>\nGiven her symptoms, we need to consider the neurological effects of long-term phenytoin use — *lílè ara* or spasticity could be a potential finding.\n</step3>\n<step4>\nAdditionally, *ìdínkù nínú agbára ìgbọ́ ìtìtì* (reduced vibration sense) and proprioception might be affected due to the medication's impact on the nervous system.\n</step4>\n<step5>\nHowever, *ìṣípòpadà ara tí kò bófinmu* (tardive dyskinesia) is more commonly associated with antipsychotics rather than phenytoin, so it’s less likely here.\n</step6>\n<step6>\nConsidering her symptoms and medication history, the most likely finding would be *lílè ara* (spasticity) or possibly reduced proprioception.\n</step7>\n<step7>\nThus, the expected finding in this patient is likely to be related to spasticity or reduced sensory perception due to the long-term effects of her medication.\n</step8></thinking>", "answer": "<answer>Lílè ara (spasticity).</answer>", "language": "Yoruba"}
{"question": "Mo korira ise agbese odun yi ju koko iwe odun to koja lọ, nitori pe _______ nilo ise pupọ sii.\nA. ise agbese\nB. koko iwe", "reasoning": "<thinking><step1>\nThe question translates to: \"This year's project is more than last year's project because _______ needs more work.\" It asks us to determine what requires more effort.\n</step1>\n<step2>\nThe options are: A. *ise agbese* [project] and B. *koko iwe* [main topic]. We need to analyze which one typically demands more work.\n</step2>\n<step3>\nIn many contexts, a *koko iwe* can refer to the central theme or subject of a project, which often requires extensive research and development — *nilo iwadi jinlẹ*.\n</step3>\n<step4>\nOn the other hand, *ise agbese* refers to the overall project, which may vary in complexity but does not inherently mean it requires more work than the main topic.\n</step4>\n<step5>\nConsidering that a *koko iwe* often involves deeper exploration and detailed planning, it is reasonable to conclude that it usually needs more effort — *nilo iṣẹ pupọ*.\n</step5>\n<step6>\nThus, the correct completion of the sentence is that the *koko iwe* needs more work than the *ise agbese*.\n</step6></thinking>", "answer": "<answer>koko iwe</answer>", "language": "Yoruba"}
{"question": "Nínú ìwádìí kan tí a ṣe lórí ìṣòro ìrora ọkàn nípa lílò àwọn ìdáhùn ìwádìí Patient Health Questionnaire (PHQ-9) láti inú nẹ́ẹ̀tìwọ́ọ̀kì àwùjọ kan tí ó ní àwọn ọ̀tẹ̀lẹ̀wọ̀ 500,000, àwọn ènìyàn tí a yàn láti inú rẹ̀ ní ìṣirò ààyèdè 14 àti ìyàtọ̀ ìṣirò ààyèdè 4. Bí a bá gba pé àwọn ìṣirò náà jẹ́ àwọn ìpínlẹ̀ déédéé, ka iye àwọn ọ̀tẹ̀lẹ̀wọ̀ tí ó ní ìṣirò PHQ-9 tí ó ju 22 lọ.", "reasoning": "<thinking><step1>\nThe question is asking about a study on [ìṣòro ìrora ọkàn = heart pain issues] using the Patient Health Questionnaire (PHQ-9) from a social network with 500,000 participants, focusing on those with a score of 14 and a standard deviation of 4.\n</step1>\n<step2>\nTo find the number of participants with a PHQ-9 score greater than 22, we first need to understand the distribution of scores — *ìpínlẹ̀ déédéé* suggests a normal distribution.\n</step2>\n<step3>\nGiven the mean score is 14 and the standard deviation is 4, we can calculate the z-score for a PHQ-9 score of 22 using the formula: z = (X - μ) / σ, where X is the score, μ is the mean, and σ is the standard deviation.\n</step3>\n<step4>\nSubstituting the values: z = (22 - 14) / 4 = 2. This z-score indicates how many standard deviations the score of 22 is above the mean.\n</step4>\n<step5>\nUsing the z-table, a z-score of 2 corresponds to approximately 0.9772, meaning about 97.72% of participants score below 22. Therefore, the percentage scoring above 22 is 1 - 0.9772 = 0.0228 or 2.28%.\n</step5>\n<step6>\nNow, to find the number of participants with a score above 22, we multiply this percentage by the total number of participants: 0.0228 * 500,000 = 11,400.\n</step6></thinking>", "answer": "<answer>Iye àwọn ọ̀tẹ̀lẹ̀wọ̀ tí ó ní ìṣirò PHQ-9 tí ó ju 22 lọ ni 11,400.</answer>", "language": "Yoruba"}
{"question": "Tí iwọn didùn ohun kan bá jẹ́ ipilẹ̀, láìyí àwọn ayípadà ninu iwuwo rẹ̀, iwuwo rẹ̀ yóò\nA. jẹ́ mẹta.\nB. Kò sí ọkan ninu èyí.\nC. dín ní idaji.\nD. jẹ́ ipilẹ̀.\nE. wa kanna.\nF. pọ̀ sí i, ṣugbọn kì í ṣe ipilẹ̀ ní pàtàkì.\nG. dín ní ìdá mẹrin.\nH. wa kanna nikan bí ohun náà bá jẹ́ omi.\nI. pọ̀ sí i ní ìdá mẹrin.\nJ. dín kù, ṣugbọn kì í ṣe idaji ní pàtàkì.", "reasoning": "<thinking><step1>\nThe question translates to: \"If the density of a substance remains constant, without changing its weight, its weight will...\" This implies a focus on the relationship between density and weight.\n</step1>\n<step2>\nDensity is defined as mass per unit volume — *iwuwo = mass* and *ipin = volume*. If density remains constant, any change in weight must correlate with a change in volume.\n</step2>\n<step3>\nIf the weight does not change, then the volume must also remain the same — *ti iwuwo ko ba yipada, ipin naa yóò wa ni iduroṣinṣin*.\n</step3>\n<step4>\nConsidering the options, if the weight is constant and density is constant, the only logical conclusion is that the weight remains the same — *iwuwo naa wa kanna*.\n</step4>\n<step5>\nThus, the correct answer is that the weight will remain constant, which corresponds to option E.\n</step5></thinking>", "answer": "<answer>wa kanna.</answer>", "language": "Yoruba"}
{"question": "Nígbà wo ni àwọn tẹ́ńpìlì Jaina àkọ́kọ́ ṣe hàn?\nA. Ọ̀rúndún kejìdínlógún Sànmánì Kristẹni\nB. Ọ̀rúndún kọkànlá ṣáájú Sànmánì Kristẹni\nC. Ọ̀rúndún kìíní Sànmánì Kristẹni\nD. Ọ̀rúndún karùn-ún ṣáájú Sànmánì Kristẹni\nE. Ọ̀rúndún kejì Sànmánì Kristẹni\nF. Ọ̀rúndún kẹwàá ṣáájú Sànmánì Kristẹni\nG. Ọ̀rúndún kẹfà Sànmánì Kristẹni\nH. Ọ̀rúndún kẹta ṣáájú Sànmánì Kristẹni\nI. Ọ̀rúndún karùn-ún Sànmánì Kristẹni\nJ. Ọ̀rúndún kejìdínlógún Sànmánì Kristẹni", "reasoning": "<thinking><step1>\nThe question asks: “Nígbà wo ni àwọn tẹ́ńpìlì Jaina àkọ́kọ́ ṣe hàn?” which translates to \"When did the first Jaina temples appear?\" \n</step1>\n<step2>\nTo answer this, we need to consider the historical context of Jainism, which is an ancient Indian religion. The first temples were built during a specific period in history.\n</step2>\n<step3>\nJainism began around the 6th century BCE, and the earliest temples likely emerged shortly after this time. This aligns with the options provided, particularly those before the Common Era.\n</step3>\n<step4>\nAmong the choices, *ọ̀rúndún kọkànlá ṣáájú Sànmánì Kristẹni* (11th century BCE) and *ọ̀rúndún karùn-ún ṣáájú Sànmánì Kristẹni* (5th century BCE) are significant.\n</step4>\n<step5>\nHowever, the most widely accepted date for the establishment of the first Jaina temples is around the 5th century BCE, which corresponds to *ọ̀rúndún karùn-ún ṣáájú Sànmánì Kristẹni*.\n</step5>\n<step6>\nThus, the correct answer is the option that indicates the 5th century BCE, as it aligns with historical records of Jain temple construction.\n</step6></thinking>", "answer": "<answer>Ọ̀rúndún karùn-ún ṣáájú Sànmánì Kristẹni.</answer>", "language": "Yoruba"}
{"question": "Àwọn itumọ́ tí a túmọ̀ láti èdè German sí èdè Gẹ̀ẹ́sì tó wà ní isalẹ̀ ní àṣìṣe kan pàtó.  Àṣìṣe yẹn yóò jẹ́ ọ̀kan lára àwọn oríṣi wọ̀nyí: Àwọn Orúkọ Ẹ̀dá: Orúkọ ẹ̀dá kan (orúkọ, àwọn ibìkan, àwọn ipò, àti bẹ́ẹ̀ bẹ́ẹ̀ lọ) yí padà sí ẹ̀dá mìíràn. Àwọn Ọ̀nà Nọ́mbà: Àwọn ọnà nọ́mbà (àwọn ọnà tó jẹ́ àkọ́kọ́ tàbí àwọn tí kò jẹ́ àkọ́kọ́), ọjọ́, àti/tàbí àwọn ìwọn yí padà. Àwọn Ẹ̀tọ́ tàbí Àwọn Ọ̀rọ̀ Ṣàpẹẹrẹ: Àwọn ẹ̀tọ́ àti àwọn ọ̀rọ̀ ṣàpẹẹrẹ tí ó bá orúkọ kan mu yí padà. Ìkọ̀sílẹ̀ tàbí Àwọn Ọ̀rọ̀ Tọ̀tẹ̀lẹ: Fi ìkọ̀sílẹ̀ kun tàbí yọ̀ọ́, tàbí yí àwọn ohun tí ó fi hàn gangan padà sí àwọn ohun tí kò fi hàn gangan. Òtítọ́: Àwọn àṣìṣe òtítọ́ kékeré tí kò bá àwọn ẹ̀ka tó wà lókè yìí mu wà nínú àwọn itumọ́ náà. Ohun tí a kọ̀ sílẹ̀: Ẹ̀ka pàtàkì kan nínú itumọ́ náà yọ̀ọ́. Jọ̀wọ́, ṣàkíyèsí àṣìṣe yẹn.  Oríṣun: Àtòjọ àwọn agbègbè ìdáàbòbò àdá kọjá nínú ìlú Memmingen. \nItumọ: Àtòjọ àwọn agbègbè ìdáàbòbò àdá kọjá nínú ìlú Meninges.\nItumọ náà ní àṣìṣe kan tó bá… mu.\nÀwọn àṣàyàn:\n(A) Àwọn Ẹ̀tọ́ tàbí Àwọn Ọ̀rọ̀ Ṣàpẹẹrẹ\n(B) Àwọn Ọ̀nà Nọ́mbà\n(C) Ìkọ̀sílẹ̀ tàbí Àwọn Ọ̀rọ̀ Tọ̀tẹ̀lẹ̀\n(D) Àwọn Orúkọ Ẹ̀dá\n(E) Ohun tí a kọ̀ sílẹ̀\n(F) Òtítọ́", "reasoning": "<thinking><step1>\nThe question is asking about a specific error in a translation from German to English, particularly focusing on the phrase \"Àtòjọ àwọn agbègbè ìdáàbòbò àdá kọjá nínú ìlú Memmingen\" which translates to \"List of protected areas in the city of Memmingen.\"\n</step1>\n<step2>\nThe translation provided is \"Àtòjọ àwọn agbègbè ìdáàbòbò àdá kọjá nínú ìlú Meninges,\" which seems incorrect because \"Meninges\" refers to the protective membranes covering the brain and spinal cord, not a city.\n</step2>\n<step3>\nThis indicates a potential error in the category of \"Àwọn Orúkọ Ẹ̀dá\" — which means \"Names of Entities\" — as the name of the city has been incorrectly translated.\n</step3>\n<step4>\nIn this context, the correct translation should maintain the original city name, Memmingen, rather than substituting it with an unrelated term.\n</step4>\n<step5>\nThus, the error lies in the misidentification of the proper noun, which is crucial for accurate translation.\n</step5>\n<step6>\nTherefore, the correct answer to identify the type of error is \"Àwọn Orúkọ Ẹ̀dá.\"\n</step6></thinking>", "answer": "<answer>Àwọn Orúkọ Ẹ̀dá</answer>", "language": "Yoruba"}
{"question": "Àwọn ọ̀nà wọ̀nyí gbogbo lè ṣe iṣẹ́ ṣiṣe ìtọ́jú egungun tí kò ní ìdènà, àfi èyí tí:\nA. Pléétì Champy.\nB. Egúngún Lag.\nC. Waya Transosseous.\nD. Waya Kirschner.", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn ọ̀nà wọ̀nyí gbogbo lè ṣe iṣẹ́ ṣiṣe ìtọ́jú egungun tí kò ní ìdènà, àfi èyí tí:” — meaning it is inquiring about methods for bone fixation that do not involve obstruction, except for one option.\n</step1>\n<step2>\nIn English, this refers to techniques used in orthopedic surgery for bone stabilization — *stabilisation osseuse* — without causing any blockage or interference.\n</step2>\n<step3>\nThe options provided include various fixation methods: *Pléétì Champy* (Champy plate), *Egúngún Lag* (Lag screw), *Waya Transosseous* (Transosseous wire), and *Waya Kirschner* (Kirschner wire).\n</step3>\n<step4>\nAmong these, the *Waya Kirschner* is known for its potential to obstruct or interfere with the bone healing process due to its invasive nature — *nítorí pé ó ní ipa tó lágbára lórí ìtọ́jú egungun*.\n</step4>\n<step5>\nThe other methods, like *Pléétì Champy* and *Egúngún Lag*, are designed to provide stable fixation without obstructing the healing process — *nípa ti wọn kò ní fa ìdènà*.\n</step5>\n<step6>\nThus, the correct answer is the method that does cause obstruction, which is *Waya Kirschner*.\n</step6></thinking>", "answer": "<answer>Waya Kirschner.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọmọ ọdún 50 kan tí ó ní àtìgbàgbà ẹ̀jẹ̀ gíga, àrùn àtìgbàgbà suga, àti àtìgbàgbà ọ̀rá ń wá sí ìwádìí ìtẹ̀lé lẹ́yìn tí a ti fún un ní oògùn lisinopril fún ẹ̀jẹ̀ gíga. Láìka ìtọ́jú náà sí, ẹ̀jẹ̀ rẹ̀ ṣì wà ní 170/110 mm Hg. Ìwádìí ilé ẹ̀rọ rẹ̀ fi ìwọ̀n creatinine ẹ̀jẹ̀ 2.1 mg/dL hàn àti ìwọ̀n potasiomu kékeré tí ó jẹ́ 3.4 mEq/L. Nígbà tí a bá gbé ìtàn àrùn rẹ̀ àti àwọn ìwádìí ilé ẹ̀rọ wọ̀nyí yẹ̀ wò, kí ni ìwádìí tí ó bá ṣeé ṣe jùlọ fún ìdí àtìgbàgbà ẹ̀jẹ̀ gíga rẹ̀ tí kò lè tọ́jú?", "reasoning": "<thinking><step1>\nThe question is asking: \"What further investigations are most appropriate for a 50-year-old woman with hypertension [àtìgbàgbà ẹ̀jẹ̀ gíga = high blood pressure], diabetes [àrùn àtìgbàgbà suga = diabetes], and chronic kidney disease [àtìgbàgbà ọ̀rá = chronic kidney disease] who is on lisinopril but still has high blood pressure?\" \n</step1>\n<step2>\nDespite treatment with lisinopril, her blood pressure remains elevated at 170/110 mm Hg, indicating *hypertension résistante* or resistant hypertension.\n</step2>\n<step3>\nThe lab results show a creatinine level of 2.1 mg/dL, which suggests impaired kidney function — *ìfọwọ́ra ọ̀rá* — and a low potassium level of 3.4 mEq/L, indicating possible *hypokaliémie*.\n</step3>\n<step4>\nIn this context, it is crucial to investigate secondary causes of hypertension, such as *maladie rénale chronique* or renovascular disease.\n</step4>\n<step5>\nA renal ultrasound could be useful to assess for any structural abnormalities or renal artery stenosis — *stenose de l'artère rénale*.\n</step5>\n<step6>\nAdditionally, measuring aldosterone and renin levels could help evaluate for conditions like primary hyperaldosteronism — *hyperaldostéronisme primaire*.\n</step6>\n<step7>\nGiven her diabetes and kidney issues, a thorough evaluation of her renal function and potential secondary causes is essential for proper management.\n</step7></thinking>", "answer": "<answer>Ìwádìí tí ó bá ṣeé ṣe jùlọ ni àyẹ̀wò ilé ẹ̀rọ, àtẹ̀jáde aldosterone àti renin, àti àyẹ̀wò fun stenose de l'artère rénale.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 72 kan wá sí ẹka pajawiri lẹhin ti o ti ṣubu, itan iṣoogun rẹ̀ ni aarun Alzheimer ati falifu ti a fi ṣe, o si n mu donepezil ati warfarin lọwọlọwọ. Wọn rí i pe ẹ̀ru rẹ̀ kéré ati pe ọkàn rẹ̀ ń lu yara ní ìbẹ̀rẹ̀, ṣugbọn o dara si lẹhin omi IV. Awọn abajade idanwo ilọsiwaju akọkọ, aworan eiya ọmu, EKG, ati idanwo ara ko ṣe pataki, ati awọn ami-iṣẹ̀dá ara rẹ̀ ṣe deede ayafi fun iba kekere. Kini igbesẹ ti o tẹle ti o dara julọ ninu iṣakoso rẹ lati ṣe ayẹwo ipo rẹ siwaju sii?", "reasoning": "<thinking><step1>\nThe question asks: \"What is the best next step in managing a 72-year-old man with a history of Alzheimer's disease and recent fall?\" It provides details about his current medications, including [donepezil = donepezil] and [warfarin = warfarin].\n</step1>\n<step2>\nGiven his age and medical history, it’s crucial to assess for potential causes of his fall — *awọn idi ti o le fa ikuna* such as orthostatic hypotension or medication side effects.\n</step2>\n<step3>\nSince he is on warfarin, checking his INR levels is essential to rule out bleeding complications — *iyẹn ni lati rii daju pe ko si ẹjẹ ninu ara rẹ*.\n</step3>\n<step4>\nAdditionally, considering his Alzheimer's, cognitive assessment is important — *iwadii ti imọlara* to determine if there are any changes in his mental status.\n</step4>\n<step5>\nThe initial tests were unremarkable, but ongoing monitoring of his vital signs and hydration status is necessary — *iwadii ti awọn ami pataki rẹ*.\n</step6>\n<step6>\nTherefore, the best next step is to evaluate his INR levels and perform a cognitive assessment to ensure comprehensive management.\n</step6></thinking>", "answer": "<answer>Igbesẹ ti o tẹle ti o dara julọ ni lati ṣe ayẹwo awọn ipele INR rẹ ati ṣe iwadii ti imọlara.</answer>", "language": "Yoruba"}
{"question": "Onímọ̀-ìwádìí kan ń ṣe àkíyèsí ọmọdékùnrin ọlọ́dún mẹ́rin tí ó ní àrùn Duchenne muscular dystrophy, ó sì rí i wípé èròjà dystrophin rẹ̀ kéré gan-an ju ti ẹni tí ó ní ìlera lọ. Àwọn àyẹ̀wò síwájú fi hàn wípé ìyípadà nípa ìran kan nínú ìtẹ̀lé tí ó sábà máa ń ṣe àfihàn leucine, pẹ̀lú mRNA codon déédé tí í ṣe UUG. Ní fífi ìmọ̀ yìí àti àbùkù èròjà tí ó ṣẹ̀lẹ̀ sílẹ̀, mRNA codon wo ló ṣeé ṣe kí ó wà ní ipò kan náà nínú ọmọdékùnrin náà tí ó fa ìyípadà nínú ìwọ̀n èròjà náà?", "reasoning": "<thinking><step1>\nThe question discusses a four-year-old boy with Duchenne muscular dystrophy and notes that his dystrophin levels are significantly lower than those of a healthy individual. It also mentions a mutation affecting a specific codon, UUG, which typically codes for leucine.\n</step1>\n<step2>\nDuchenne muscular dystrophy is caused by mutations in the dystrophin gene — *àrùn Duchenne muscular dystrophy* — leading to insufficient dystrophin production. This results in muscle degeneration.\n</step2>\n<step3>\nThe mutation mentioned affects the mRNA codon UUG, which encodes for leucine — *leucine* is an important amino acid for muscle function. A change in this codon could lead to a premature stop codon or a different amino acid being incorporated.\n</step3>\n<step4>\nIf the mutation causes a change in the codon, it could result in a truncated protein or a dysfunctional dystrophin, which would explain the low levels observed in the boy — *ìyípadà nínú ìwọ̀n èròjà*.\n</step4>\n<step5>\nTo determine the specific mRNA codon that could lead to a similar situation, one must consider codons that could replace UUG while still resulting in a similar effect on dystrophin production.\n</step5>\n<step6>\nFor instance, if UUG changes to UUA, it still codes for leucine but could potentially affect the protein's folding or function due to the mutation's context — *ìtẹ̀lé*.\n</step6>\n<step7>\nThus, the mutation could lead to a codon that still encodes for leucine but alters the protein's overall structure or function, contributing to the observed dystrophin deficiency.\n</step7></thinking>", "answer": "<answer>Codon UUA le fa ìyípadà nínú ìwọ̀n èròjà dystrophin nínú ọmọdékùnrin náà.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 58 kan wá sí ẹka pajawiri nitori irora ikun oke ti o ti buru si fun ọjọ meji. O sọ pe ó ríru ati ẹ̀gbẹ́, ati pe kò le gba ohun mimu lọ́nu. Ó dà bí ẹni pe kò ni irọrun. Igbona rẹ̀ jẹ́ 38.1°C (100.6°F), iṣẹ́ ọkàn rẹ̀ jẹ́ 92/min, ìmì rẹ̀ jẹ́ 18/min, ati titẹ ẹ̀jẹ̀ rẹ̀ jẹ́ 132/85 mm Hg. Ẹ̀yẹ̀wò fi hàn pe awọ ofeefee ti wa lórí sclera rẹ̀. Ikùn rẹ̀ ní irora ni apa ọtun oke. Ko si ìfàájì ikùn tabi organomegaly. Awọn ẹkọ ile-iwosan fihan:\nHemoglobin 13 g/dL\nIye leukocyte 16,000/mm3\nSerum\nUrea nitrogen\n25 mg/dL\nCreatinine 2 mg/dL\nAlkaline phosphatase 432 U/L\nAlanine aminotransferase 196 U/L\nAspartate transaminase 207 U/L\nBilirubin\nGbogbo rẹ̀ 3.8 mg/dL\nTaara 2.7 mg/dL\nLipase 82 U/L (N = 14–280)\nAwọn aworan ultrasound ti apa ọtun oke fihan awọn iṣọn bile intrahepatic ati extrahepatic ti a fẹ̀, ati ọpọlọpọ awọn spheres hyperechoic ninu gallbladder. A ko le rii pancreas daradara. A bẹrẹ mimu omi sinu ara ati itọju oogun atẹgun pẹlu ceftriaxone ati metronidazole. Lẹhin wakati mejila, alaisan naa dabi ẹni ti o ṣaisan gidigidi ati pe kò mọ akoko. Igbona rẹ̀ jẹ́ 39.1°C (102.4°F), iṣẹ́ ọkàn rẹ̀ jẹ́ 105/min, ìmì rẹ̀ jẹ́ 22/min, ati titẹ ẹ̀jẹ̀ rẹ̀ jẹ́ 112/82 mm Hg. Ewo ni ọna atọkun ti o yẹ julọ ninu iṣakoso?\"\nA. Awọn aworan CT ikùn\nB. Laparoscopic cholecystectomy\nC. Percutaneous cholecystostomy\nD. Extracorporeal shock wave lithotripsy\nE. Endoscopic retrograde cholangiopancreatography\n\"", "reasoning": "<thinking><step1>\nThe question describes a 58-year-old woman who presents to the emergency department with worsening upper abdominal pain for two days. She reports nausea and vomiting, and she cannot tolerate oral intake — *ko le gba ohun mimu lọ́nu*.\n</step1>\n<step2>\nHer vital signs indicate a fever of 38.1°C (100.6°F), tachycardia at 92/min, and tachypnea at 18/min, which suggests a possible infection or significant distress — *iyẹn le jẹ́ àfihàn àìlera*.\n</step2>\n<step3>\nLaboratory results show elevated liver enzymes and bilirubin levels, indicating potential liver dysfunction or biliary obstruction — *iṣoro ni awọn ọna biliary*.\n</step4>\n<step4>\nThe ultrasound findings reveal intrahepatic and extrahepatic bile duct dilation and multiple hyperechoic spheres in the gallbladder, suggesting cholecystitis or gallstones — *iyẹn le jẹ́ cholecystitis*.\n</step5>\n<step5>\nGiven her deteriorating condition after 12 hours of treatment, with a rising fever to 39.1°C (102.4°F) and increased heart rate, immediate intervention is necessary — *a nilo itọju lẹsẹkẹsẹ*.\n</step6>\n<step6>\nAmong the options, percutaneous cholecystostomy is often indicated for patients who are too ill for surgery, as it can relieve biliary obstruction and manage infection — *iyẹn ni ọna ti o yẹ julọ*.\n</step7>\n<step7>\nOther options like laparoscopic cholecystectomy may be too risky at this moment due to her unstable condition — *iyẹn le ma jẹ́ aṣayan to dara*.\n</step8>\n<step8>\nTherefore, the best management approach in this scenario is to perform a percutaneous cholecystostomy to address the acute cholecystitis and stabilize her condition — *iyẹn ni ọna ti o yẹ julọ*.\n</step8></thinking>", "answer": "<answer>C. Percutaneous cholecystostomy</answer>", "language": "Yoruba"}
{"question": "Nínú ìwádìí tẹ̀lé-lẹ́yìn àwọn àrùn ìṣàn-ṣàn ọ̀mọ-ọ̀dọ̀ kan tí ó ní ìṣàn epo ovari, ọ̀nà ìwádìí àwòrán wo ni ó yẹ kí a lo láti ṣe àyẹ̀wò ìwọ̀nba CA 125 tí ó ga jù?", "reasoning": "<thinking><step1>\nThe question asks: “Nínú ìwádìí tẹ̀lé-lẹ́yìn [follow-up studies] àwọn àrùn [diseases] ìṣàn-ṣàn [reproductive system] ọ̀mọ-ọ̀dọ̀ [young women] kan tí ó ní ìṣàn epo [ovarian cyst], ọ̀nà ìwádìí àwòrán [imaging studies] wo ni ó yẹ kí a lo láti ṣe àyẹ̀wò [to evaluate] ìwọ̀nba CA 125 [CA 125 levels] tí ó ga jù [that is elevated]?” — meaning it seeks to identify the appropriate imaging studies for evaluating elevated CA 125 levels in young women with ovarian cysts.\n</step1>\n<step2>\nElevated CA 125 levels can indicate various conditions, including ovarian cancer — *àrùn àtọ́ka ọ̀mọ-ìyà* — but they can also be elevated due to benign conditions like ovarian cysts.\n</step2>\n<step3>\nIn this context, imaging studies such as ultrasound — *àwòrán àyẹ̀wò* — are typically the first step to assess the ovaries and any cysts present.\n</step3>\n<step4>\nIf the ultrasound shows abnormalities or if CA 125 levels remain high, further imaging like a CT scan — *àwòrán CT* — may be warranted to get a clearer picture of the pelvic area.\n</step4>\n<step5>\nAdditionally, MRI — *àwòrán MRI* — can be useful for detailed imaging, especially if there are concerns about malignancy.\n</step5>\n<step6>\nThus, the recommended imaging studies for evaluating elevated CA 125 in this scenario would start with ultrasound, followed by CT or MRI if necessary.\n</step6></thinking>", "answer": "<answer>Àwòrán àyẹ̀wò tó yẹ ni ultrasound, pẹ̀lú CT tàbí MRI bí a bá ní ìdí àtìlẹ́yìn.</answer>", "language": "Yoruba"}
{"question": "Antibiotic wo ni a maa n sọ pe ó maa n fa hypoplasia ati didan ti eyin ọmọ inu oyun?", "reasoning": "<thinking><step1>\nThe question asks: “Antibiotic wo ni a maa n sọ pe ó maa n fa [hypoplasia = hypoplasia] ati [didan ti eyin ọmọ inu oyun = enamel hypoplasia]?” — meaning it wants to know which antibiotics are associated with causing hypoplasia and enamel hypoplasia in fetuses.\n</step1>\n<step2>\nCertain antibiotics, particularly *tetracyclines*, are known to cause enamel hypoplasia when taken during pregnancy — *nigbati a ba mu wọn nigba oyun*.\n</step2>\n<step3>\nThis occurs because tetracyclines can affect the developing teeth of the fetus, leading to *didan ti eyin* or underdeveloped enamel.\n</step3>\n<step4>\nAnother antibiotic, *amoxicillin*, has also been linked to similar effects, although the evidence is less clear — *sugbon a ko le fi ẹri to daju ṣe afiwe*.\n</step4>\n<step5>\nIn summary, the use of certain antibiotics during pregnancy can lead to dental issues in the child, specifically hypoplasia — *eyin ti ko ni idagbasoke to*.\n</step5></thinking>", "answer": "<answer>Antibiotic ti a maa n sọ pe ó maa n fa hypoplasia ati didan ti eyin ọmọ inu oyun ni tetracycline.</answer>", "language": "Yoruba"}
{"question": "Apẹẹrẹ kan tí ó ní 3.00 moli ti awọn patikulu gaasi pipe didiatomiki ni 200 K ni a ti fún paapaa ati itusilẹ titi di iwọn otutu rẹ fi de 250 K.  Níwí pé agbara ooru moli kan ní iwọn didùn, C_V,m, jẹ́ 27.5 J K^-1 mol^-1, ka iyipada ninu agbara inu, ΔU, fun ilana naa.", "reasoning": "<thinking><step1>\nThe question asks for the change in internal energy, ΔU, for a system with 3.00 moles of an ideal diatomic gas that is heated from 200 K to 250 K. \n</step1>\n<step2>\nTo find ΔU, we use the formula: ΔU = n * C_V,m * ΔT, where n is the number of moles, C_V,m is the molar heat capacity at constant volume, and ΔT is the change in temperature.\n</step2>\n<step3>\nHere, n = 3.00 mol, C_V,m = 27.5 J K^-1 mol^-1, and ΔT = 250 K - 200 K = 50 K.\n</step3>\n<step4>\nNow, substituting the values into the formula: ΔU = 3.00 mol * 27.5 J K^-1 mol^-1 * 50 K.\n</step4>\n<step5>\nCalculating this gives: ΔU = 3.00 * 27.5 * 50 = 4125 J.\n</step5>\n<step6>\nThus, the change in internal energy for the process is 4125 J.\n</step6></thinking>", "answer": "<answer>Iyipada ninu agbara inu, ΔU, jẹ́ 4125 J.</answer>", "language": "Yoruba"}
{"question": "Pẹ̀lú àwọn àkọ́kọ́rọ̀ ìrìbọ̀ míì ti ilé Ọgbẹ́ni Fields àti àwọn àṣàyàn rẹ̀ fún títà tàbí fífipamọ́ ilé náà, nígbà tí a bá ti gbé ìdíwọ̀n owó tí ó rà á, ìdinku iye owó, owó tí a gba láti ìgbàgbọ́, iye owó tí a retí pé a óò tà á ní ọjọ́ iwájú, àwọn àṣepọ̀ òṣuwọ̀n, àti ìwọ̀n owó tí ó wù wá jùlọ, kí ni ìpinnu tí ó gbàrá jùlọ fún Ọgbẹ́ni Fields nípa boya kí ó tà ilé náà nísinsìnyí tàbí ní ọdún méjìdínlọ́gbọ̀n?", "reasoning": "<thinking><step1>\nThe question asks: \"Pẹ̀lú àwọn àkọ́kọ́rọ̀ ìrìbọ̀ míì ti ilé Ọgbẹ́ni Fields\" — meaning it wants to analyze the financial aspects of Mr. Fields' house sale or retention.\n</step1>\n<step2>\nTo make a decision, Mr. Fields needs to consider the *ìdíwọ̀n owó* (purchase price) and the *ìdinku iye owó* (depreciation) of the property.\n</step2>\n<step3>\nHe should also evaluate the *owó tí a gba láti ìgbàgbọ́* (expected income from the property) and the *iye owó tí a retí pé a óò tà á ní ọjọ́ iwájú* (future sale price).\n</step3>\n<step4>\nAdditionally, Mr. Fields must think about the *àṣepọ̀ òṣuwọ̀n* (market conditions) and *ìwọ̀n owó tí ó wù wá jùlọ* (most favorable financial terms).\n</step4>\n<step5>\nIf the current market is favorable and the expected future price is higher than the current value, selling now might be wise — *títà ilé náà nísinsìnyí* could yield immediate profit.\n</step5>\n<step6>\nConversely, if the market is expected to improve significantly in the next two years, holding onto the property could be more beneficial — *fífipamọ́ ilé náà* might maximize his returns.\n</step6>\n<step7>\nUltimately, Mr. Fields should weigh these factors carefully to make the best decision for his financial future.\n</step7></thinking>", "answer": "<answer>Ìpinnu tí ó gbàrá jùlọ fún Ọgbẹ́ni Fields ni láti tà ilé náà nísinsìnyí, bí ìpinnu owó bá dára, tàbí kí ó fi ilé náà pamọ́ tí ìrètí owó bá ga jùlọ ní ọdún méjìdínlọ́gbọ̀n.</answer>", "language": "Yoruba"}
{"question": "Loni, Ashley lọ si ibudó agbọn bọ́ọ̀lù. Láàrin àwọn àkókò wo ni ó lè ti lọ?\nÀwa mọ̀ pé:\nAshley jí ní àárọ̀ 11.\nDavid rí Ashley tí ń rà bà́ìkì ní ilé itàjá bà́ìkì láti 11 sí 12 ọ̀sán.\nWilliam rí Ashley tí ó jókòó sórí òrùlé láti 12 ọ̀sán sí 3 ìrọ̀lẹ́.\nElizabeth rí Ashley tí ó ń ṣiṣẹ́ ní ọ́fíìsì láti 3 sí 5 ìrọ̀lẹ́.\nIbudó agbọn bọ́ọ̀lù ti sùn lẹ́yìn 8 ìrọ̀lẹ́.\nLáàrin àwọn àkókò wo ni Ashley lè ti lọ sí ibudó agbọn bọ́ọ̀lù?\nÀwọn àṣàyàn:\n(A) 3 sí 5 ìrọ̀lẹ́\n(B) 12 ọ̀sán sí 3 ìrọ̀lẹ́\n(C) 5 sí 8 ìrọ̀lẹ́\n(D) 11 sí 12 ọ̀sán", "reasoning": "<thinking><step1>\nThe question asks: “Láàrin àwọn àkókò wo ni Ashley lè ti lọ sí ibudó agbọn bọ́ọ̀lù?” — meaning it wants to know during which time frame Ashley could have gone to the [ibudó agbọn bọ́ọ̀lù = bowling alley].\n</step1>\n<step2>\nWe know that Ashley wakes up at 11 AM — *Ashley jí ní àárọ̀ 11* — and is seen at various locations throughout the day.\n</step2>\n<step3>\nDavid sees Ashley buying a bike from 11 AM to 12 PM — *David rí Ashley tí ń rà bà́ìkì láti 11 sí 12 ọ̀sán*.\n</step3>\n<step4>\nThen, William sees her sitting on the roof from 12 PM to 3 PM — *William rí Ashley tí ó jókòó sórí òrùlé láti 12 ọ̀sán sí 3 ìrọ̀lẹ́*.\n</step4>\n<step5>\nAfter that, Elizabeth sees Ashley working in the office from 3 PM to 5 PM — *Elizabeth rí Ashley tí ó ń ṣiṣẹ́ ní ọ́fíìsì láti 3 sí 5 ìrọ̀lẹ́*.\n</step6>\n<step6>\nThe bowling alley closes after 8 PM — *Ibudó agbọn bọ́ọ̀lù ti sùn lẹ́yìn 8 ìrọ̀lẹ́*, so Ashley can only go there after her last seen time.\n</step7>\n<step7>\nThe only time frame left for Ashley to go to the bowling alley is between 5 PM and 8 PM — *làrin 5 sí 8 ìrọ̀lẹ́*.\n</step8>\n<step8>\nThus, the correct answer is option (C) 5 PM to 8 PM.\n</step9></thinking>", "answer": "<answer>5 sí 8 ìrọ̀lẹ́</answer>", "language": "Yoruba"}
{"question": "Gbolohun wo ni o ni ilana orukọ-ara to tọ́?\nAwọn aṣayan:\n(A) enormous new triangular Nigerian lead cat\n(B) enormous Nigerian triangular new lead cat", "reasoning": "<thinking><step1>\nThe question asks: “Gbolohun wo ni o ni ilana orukọ-ara to tọ́?” — meaning it wants to know which sentence has the correct order of adjectives in English.\n</step1>\n<step2>\nIn English, adjectives typically follow a specific order: opinion, size, age, shape, color, origin, material, and purpose — *ilana orukọ-ara*.\n</step2>\n<step3>\nLooking at the options, (A) “enormous new triangular Nigerian lead cat” and (B) “enormous Nigerian triangular new lead cat,” we need to analyze the adjective order.\n</step3>\n<step4>\nIn option (A), the order is: size (enormous), age (new), shape (triangular), origin (Nigerian), and purpose (lead) — this follows the correct structure.\n</step4>\n<step5>\nIn option (B), the order is: size (enormous), origin (Nigerian), shape (triangular), age (new), and purpose (lead) — this disrupts the typical adjective order.\n</step5>\n<step6>\nThus, the correct sentence that adheres to the adjective order is option (A).\n</step6></thinking>", "answer": "<answer>Gbolohun to tọ́ ni (A) enormous new triangular Nigerian lead cat.</answer>", "language": "Yoruba"}
{"question": "Bí o bá tẹ̀lé àwọn ìtọ́nisọ́nà wọ̀nyí, ṣé o máa padà sí ibi ìbẹ̀rẹ̀? Gbé ìṣísẹ̀ márùn-ún. Gbé ìṣísẹ̀ mẹ́wàá. Yí padà.\nÀwọn àṣàyàn:\n- Bẹ́ẹ̀ ni\n- Bẹ́ẹ̀ kọ́", "reasoning": "<thinking><step1>\nThe question translates to: \"If you follow these instructions, will you return to the starting point?\" It asks for a confirmation or denial regarding a specific process.\n</step1>\n<step2>\nTo analyze this, we need to consider what the instructions entail — *àwọn ìtọ́nisọ́nà* — and how they affect movement or position.\n</step2>\n<step3>\nIf the instructions involve moving forward and then reversing those steps, it’s likely that one would return to the starting point — *ibi ìbẹ̀rẹ̀*.\n</step4>\n<step4>\nFor example, if you move five steps forward — *gbé ìṣísẹ̀ márùn-ún* — and then ten steps back — *gbé ìṣísẹ̀ mẹ́wàá* — you would indeed return to where you started.\n</step5>\n<step5>\nThus, following the instructions as stated would lead to a return to the original position, confirming the answer is affirmative — *bẹ́ẹ̀ ni*.\n</step6></thinking>", "answer": "<answer>Bẹ́ẹ̀ ni.</answer>", "language": "Yoruba"}
{"question": "Fi ẹ́kúnrẹ́rẹ́ sísẹ̀ jọ́ sí ìṣẹ̀lẹ̀ yìí, dáàbò bo pé àwọn àmì ẹ̀kúnrẹ́rẹ̀ ti wà níṣẹ̀dárá. Ìkọ̀wọ́lé: { [ < [ < { < { } > } > ( ( < { [ ] } > { { } } ) { } ) ] > ]", "reasoning": "<thinking><step1>\nThe question asks: “Fi ẹ́kúnrẹ́rẹ́ sísẹ̀ jọ́ sí ìṣẹ̀lẹ̀ yìí, dáàbò bo pé àwọn àmì ẹ̀kúnrẹ́rẹ̀ ti wà níṣẹ̀dárá” — meaning it wants to know how to relate a detailed process to an event, ensuring that the signs of the process are present.\n</step1>\n<step2>\nTo approach this, we first need to identify the key elements of the event — *ìṣẹ̀lẹ̀* — and the detailed process — *ẹ́kúnrẹ́rẹ́ sísẹ̀*.\n</step2>\n<step3>\nIn English, we can say that a detailed process involves multiple steps or components that must be executed correctly — *ìgbésẹ̀ mẹta tàbí ju bẹ́ẹ̀ lọ*.\n</step3>\n<step4>\nNext, we must ensure that the signs or indicators — *àmì* — of this process are observable during the event.\n</step4>\n<step5>\nFor example, if the event is a project completion, the signs could include *ìtẹ́wọ́gba* from stakeholders or *àkópọ̀* of results.\n</step5>\n<step6>\nThus, we can conclude that to relate the detailed process to the event, we must ensure that all necessary signs are present and clearly visible.\n</step6></thinking>", "answer": "<answer>Lati fi ẹ́kúnrẹ́rẹ́ sísẹ̀ jọ́ sí ìṣẹ̀lẹ̀ yìí, dáàbò bo pé àwọn àmì ẹ̀kúnrẹ́rẹ̀ ti wà níṣẹ̀dárá, a gbọdọ jẹ́ kí gbogbo àmì náà hàn gbangba.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdún mẹtadinlọgbọn (37) kan wá sí ẹka pajawiri pẹlu ẹ̀dùn ọrọ́ tó burú jáì ní ojú rẹ̀. Ó sọ pé ní ọsẹ̀ to kọjá, ó ti ní irora tí ó gbẹ̀mìí sí i ní ojú rẹ̀, tí ó máa ń bẹ̀rẹ̀ ló kàn láìròtélé, tí ó sì máa ń dá sí ara rẹ̀. Ó sọ pé ó rí irora náà lórí ẹ̀yìn rẹ̀ àti ní etí ojú rẹ̀. Irora náà burú gan-an débi pé ó máa ń mú ojú rẹ̀ fà sílẹ̀, ó sì máa ń farapamọ̀ sí ara rẹ̀ nítorí àwọn àkókò náà. Ó bẹ̀rù láti jáde sí gbangba nítorí èyí, ó sì máa ń rò pé àwọn ààmì náà máa ń bẹ̀rẹ̀ nígbà tí ó bá rò pé ó máa ń ṣẹlẹ̀ ní gbangba. Nígbà tí ó ń dúró ní ẹka pajawiri, àwọn ààmì rẹ̀ dá sí ara rẹ̀. Aláìsàn náà ní ìtàn àìsàn tẹ́lẹ̀ ti àtìgbàgbọ́, ìgbẹ́, irritable bowel syndrome, àti àníyàn. A mọ̀ ọ́n dáadáa ní ẹka pajawiri fún wíwá pẹ̀lú àwọn ọ̀rọ̀ àìsàn tí kò sábà ní ìdí ti ara. Ìgbóná rẹ̀ jẹ́ 99.5°F (37.5°C), àtìgbàgbọ́ jẹ́ 177/108 mmHg, ìṣàn-ẹ̀jẹ̀ jẹ́ 90/min, ìmú jẹ́ 17/min, ati àṣeyọrí oxygen jẹ́ 98% ní afẹ́fẹ́ yàrá. Àwọn àyẹ̀wò ọkàn-àìsàn àti ikùn wà láàrin àwọn àṣàyàn deede. Àyẹ̀wò iṣẹ́ ẹ̀rọ àyàfihan pe cranial nerves II-XII wà ní ìdájú. Àwọn ọmọlúwàbí rẹ̀ dọ́gba ati àṣeyọrí sí imọlẹ. A kò rí irora nígbà tí a fi ọwọ́ fọwọ́ kan ojú aláìsàn náà. Ẹ̀yìn wo ni ìgbésẹ̀ àkọ́kọ́ tí ó dára jùlọ ní ìṣàkóso?\nA. Alprazolam\nB. Carbamazepine\nC. Oxygen gíga\nD. Ibuprofen\nE. Ìtẹ̀lé ọ̀rọ̀ àìsàn ní ita", "reasoning": "<thinking><step1>\nThe question asks: \"What is the best initial step in management for a 37-year-old woman presenting to the emergency department with severe facial pain?\" — it describes her symptoms and medical history, including [irritable bowel syndrome = irritable bowel syndrome] and anxiety.\n</step1>\n<step2>\nShe has been experiencing severe pain in her face, particularly around her eyes and ears, which worsens and causes her to withdraw — *irora naa burú gan-an* and leads to significant distress.\n</step2>\n<step3>\nGiven her vital signs, including a fever of 99.5°F (37.5°C) and elevated blood pressure, it suggests a possible acute condition — *àìlera to nira*.\n</step4>\n<step4>\nThe options provided include medications like Alprazolam, which is an anxiolytic, and Carbamazepine, which is used for neuropathic pain — *irora ti ara*.\n</step5>\n<step5>\nConsidering her symptoms and the need for immediate relief, Ibuprofen could help manage her pain and inflammation — *ibuprofen le ran lọwọ lati dinku irora*.\n</step6>\n<step6>\nHowever, if her pain is related to anxiety or stress, Alprazolam might be beneficial, but it does not address the pain directly.\n</step7>\n<step7>\nIn this case, the best initial step would be to provide pain relief, so Ibuprofen is the most appropriate choice — *ibuprofen ni aṣayan to dara jùlọ*.\n</step8>\n<step8>\nTherefore, the best initial management step is to administer Ibuprofen for her severe facial pain.\n</step8></thinking>", "answer": "<answer>Ibuprofen ni ìgbésẹ̀ àkọ́kọ́ tí ó dára jùlọ ní ìṣàkóso.</answer>", "language": "Yoruba"}
{"question": "Ìbéèrè: Kandi jẹ́ olóòótọ́. Millie sọ pé Kandi sọ òtítọ́. Lorine sọ pé Millie sọ òtítọ́. Michaela sọ pé Lorine sọ òtítọ́. Amberly sọ pé Michaela jẹ́ olóòótọ́. Ṣé Amberly sọ òtítọ́?", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé Amberly sọ òtítọ́?” — meaning it wants to know if Amberly is telling the truth.\n</step1>\n<step2>\nTo analyze this, we need to look at the chain of statements: Kandi is said to be truthful, and Millie claims Kandi is truthful.\n</step2>\n<step3>\nIf Millie is telling the truth, then Kandi is indeed truthful. Next, Lorine claims Millie is truthful, which would also make her statement valid if Millie is honest.\n</step3>\n<step4>\nMichaela states that Lorine is truthful. If Lorine is truthful, then Michaela's statement holds as well.\n</step5>\n<step5>\nFinally, Amberly claims that Michaela is truthful. If all previous statements are true, then Amberly must also be telling the truth.\n</step6>\n<step6>\nThus, if we assume the first statement is true, it creates a chain of truthfulness leading to Amberly.\n</step7></thinking>", "answer": "<answer>Bẹẹni, Amberly sọ òtítọ́.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹrin kan tí kò ní àìsàn rí ṣe àpèjúwe pẹ̀lú irora àti ìgbóná ní àgbálẹ̀ ẹsẹ̀ òsì rẹ̀ láìsí ìtàn ìṣẹ̀lẹ̀ ìpalára. Àgbàgbà bàbá ìyá rẹ̀ ní àìsàn ẹ̀jẹ̀ tí kò gbàdúró. Ẹsẹ̀ ọmọ naa pupa, gbóná, ní irora, ati ẹjẹ ti tu jade ni arthrocentesis. Ni ifojusi itan ebi re ati awon ami aisan re, kini abajade ile-iwosan ti o jasi julọ ni a o ri ni igba idanwo siwaju sii?", "reasoning": "<thinking><step1>\nThe question asks about a four-year-old boy who has pain and swelling in his left leg without any history of trauma. It mentions that his maternal grandfather has a blood disorder — *àìsàn ẹ̀jẹ̀ = blood disease*.\n</step1>\n<step2>\nThe symptoms described include redness, warmth, pain, and bleeding from the leg — *irora, ìgbóná, ati ẹjẹ ti tu jade* — which are indicative of inflammation or infection.\n</step2>\n<step3>\nGiven the family history of a blood disorder, one must consider conditions like hemophilia or other coagulopathies that could lead to bleeding issues — *ìṣoro ẹ̀jẹ̀*.\n</step4>\n<step4>\nThe presence of swelling and pain could suggest a hematoma or joint effusion, possibly requiring further investigation through imaging or laboratory tests — *idanwo siwaju sii*.\n</step5>\n<step5>\nIn this case, the most likely diagnosis could be a bleeding disorder exacerbated by trauma that went unnoticed, leading to the symptoms observed.\n</step6>\n<step6>\nTherefore, the medical outcome to expect would likely involve a diagnosis related to the blood disorder, possibly requiring treatment for the bleeding and inflammation.\n</step6></thinking>", "answer": "<answer>Abajade ile-iwosan ti o jasi julọ ni a o ri ni idanwo siwaju sii ni àìsàn ẹ̀jẹ̀, gẹgẹ bi hemophilia tabi ìṣoro ẹ̀jẹ̀ miiran.</answer>", "language": "Yoruba"}
{"question": "Ní ọ̀ràn tí àyẹ̀wò CT kan fi hàn pé àrùn diverticulitis ti wà ní apa sigmoid ti ìwọ̀nà nìkan láìsí àrùn abscess pericolic tí ó bá a pò, ṣe àlàyé ọ̀nà ìtọ́jú tí ó dára jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “In a case where a CT scan shows that diverticulitis is present in the sigmoid colon without a pericolic abscess, what is the best treatment approach?” — here, *àrùn diverticulitis* refers to diverticulitis and *apa sigmoid* means sigmoid colon.\n</step1>\n<step2>\nDiverticulitis occurs when diverticula, which are small pouches in the colon, become inflamed — *àwọn diverticula* can lead to symptoms like abdominal pain and fever.\n</step2>\n<step3>\nIn cases without complications like abscesses, the treatment usually starts with conservative management — *ìtọ́jú àtìlẹ́yìn* that includes dietary modifications and antibiotics.\n</step4>\n<step4>\nPatients are often advised to follow a low-fiber diet initially to allow the colon to heal — *jẹun pẹ̀lú àkúnya kekere* can help reduce inflammation.\n</step5>\n<step5>\nIf symptoms persist or worsen, further interventions may be necessary, but in uncomplicated cases, most patients respond well to this conservative approach.\n</step6>\n<step6>\nThus, the best treatment for diverticulitis without abscess is typically a combination of antibiotics and dietary changes — *ìtọ́jú pẹ̀lú àkúnya*.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú tó dára jùlọ fún àrùn diverticulitis láìsí abscess ni pẹ̀lú àkúnya àti antibiotics.</answer>", "language": "Yoruba"}
{"question": "Kini akoko to sunmọ ti o gba fun iye ATP ninu awọn sẹẹli ọkan ischemic lati dinku si 10% ti ipele atilẹba rẹ?", "reasoning": "<thinking><step1>\nThe question asks: “Kini akoko to sunmọ ti o gba fun iye [ATP = adenosine triphosphate] ninu awọn sẹẹli [ ọkan = heart] ischemic lati dinku si 10% ti ipele [a atilẹba = original level] rẹ?” — meaning it wants to know the approximate time it takes for ATP levels in ischemic heart cells to drop to 10% of their original levels.\n</step1>\n<step2>\nIn ischemic conditions, the heart cells experience a lack of oxygen — *aisi atẹgun* — which leads to a rapid depletion of ATP.\n</step2>\n<step3>\nTypically, ATP levels can decrease significantly within minutes; studies show that within about 10 minutes, levels can drop to around 30% of normal.\n</step3>\n<step4>\nTo reach just 10% of the original ATP level, it may take approximately 20 to 30 minutes — *iyẹn ni pe, o le gba to iṣẹju 20 si 30*.\n</step4>\n<step5>\nThis rapid decline is due to the high energy demands of the heart and the inability to regenerate ATP under ischemic conditions — *a ko le tun ATP ṣe ni ipo ischemic*.\n</step5>\n<step6>\nTherefore, the time frame for ATP to drop to 10% is critical for understanding heart cell viability during ischemia.\n</step6></thinking>", "answer": "<answer>Akoko to sunmọ ti o gba fun iye ATP ninu awọn sẹẹli ọkan ischemic lati dinku si 10% ti ipele atilẹba rẹ ni iṣẹju 20 si 30.</answer>", "language": "Yoruba"}
{"question": "Ní ọ̀dọ́ obìnrin ẹni ọdún méjìlélọ́gọ́ta (62) kan tí ó ní àìsàn keratoconjunctivitis sicca (ojú gbígbẹ), níbo ni ó ṣeé ṣe jù lọ kí iṣẹ́lẹ̀ abàwọ́n kọníà (corneal staining) wáyé lórí kọníà?", "reasoning": "<thinking><step1>\nThe question asks: “Níbo ni ó ṣeé ṣe jù lọ kí iṣẹ́lẹ̀ abàwọ́n kọníà (corneal staining) wáyé lórí kọníà?” — meaning it wants to know where corneal staining is most likely to occur in a woman aged 62 with keratoconjunctivitis sicca (dry eye).\n</step1>\n<step2>\nKeratoconjunctivitis sicca leads to dryness in the eyes — *ojú gbígbẹ* — which can cause damage to the cornea.\n</step2>\n<step3>\nIn this condition, the cornea may become more susceptible to staining due to lack of moisture — *aìní omi*.\n</step3>\n<step4>\nCorneal staining typically occurs in areas where the cornea is most exposed or damaged, such as the central cornea — *kọníà àárín*.\n</step4>\n<step5>\nAdditionally, the presence of any irregularities or abrasions on the cornea can increase the likelihood of staining — *àìlera tàbí àbáwọ̀n lórí kọníà*.\n</step5>\n<step6>\nThus, in a patient with dry eye, corneal staining is most likely to occur in the central area of the cornea due to its exposure and vulnerability.\n</step6></thinking>", "answer": "<answer>Iṣẹ́lẹ̀ abàwọ́n kọníà máa wáyé jùlọ lórí kọníà àárín.</answer>", "language": "Yoruba"}
{"question": "Ninu ọmọ ọdun mẹta kan ti o ni awọn aami aisan bii rirẹ, aibanujẹ, iba, irora ọfun, orififo ori, ríru, irora inu, myalgia, lymphadenopathy gbogbogbo, hepatosplenomegaly, iwọn tonsillitis ti pọ si, petechiae palatal, awọn àṣìṣe, ati edema oju, ipo ailagbara ajẹsara wo ni ko ṣehan gẹgẹbi deede pẹlu awọn aami aisan wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “What immunodeficiency condition is not typically associated with symptoms like fatigue, malaise, fever, sore throat, headache, rash, abdominal pain, myalgia, generalized lymphadenopathy, hepatosplenomegaly, increased tonsillitis, palatal petechiae, lesions, and facial edema in a three-year-old child?” \n</step1>\n<step2>\nThe symptoms listed suggest a range of possible infections or immune responses — *aami aisan* like *rírẹ* and *aibanujẹ* indicate the child is likely experiencing some form of illness.\n</step2>\n<step3>\nCommon conditions that could present with these symptoms include viral infections or certain types of immunodeficiencies — *aifọwọyi ajẹsara*.\n</step3>\n<step4>\nHowever, conditions like *severe combined immunodeficiency (SCID)* typically present with more severe and recurrent infections, not just these mild symptoms.\n</step4>\n<step5>\nIn contrast, *HIV/AIDS* might show similar symptoms but would also include opportunistic infections, which are not mentioned here.\n</step5>\n<step6>\nThus, the condition that is least likely to present with these specific symptoms in a three-year-old would be *aifọwọyi ajẹsara* that is not severe, like *common variable immunodeficiency (CVID)*.\n</step6></thinking>", "answer": "<answer>Aifọwọyi ajẹsara ti ko ni ipa pupọ, gẹgẹbi aifọwọyi ajẹsara oniruuru, ko ni awọn aami aisan wọnyi.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdọọdun mẹ́ẹ́dógún (25) kan wá síbi ìtọ́jú lẹ́yìn ìpalára orí, ó sì ń rìn kiri ní àkọ́kọ́, ó sì ní ìmọ̀, ó sì mọ ibi tí ó wà. Lẹ́yìn náà, ó sọ́kùn. Dàbí àwọn àmì àrùn wọnyi, kini àrùn tó ṣeé ṣe jùlọ?", "reasoning": "<thinking><step1>\nThe question describes a 25-year-old man who has sustained a head injury and initially shows signs of consciousness and awareness of his surroundings, but then becomes unresponsive — *sókun* means he is unresponsive or has lost consciousness.\n</step1>\n<step2>\nIn cases like this, we consider potential conditions such as *commotion cérébrale* (concussion) or more severe brain injuries — *lésion cérébrale*.\n</step2>\n<step3>\nThe fact that he was able to walk and was aware initially suggests that he might have had a mild injury, but the sudden change to unresponsiveness is concerning.\n</step3>\n<step4>\nThis could indicate a progression to a more serious condition, such as *hémorragie intracrânienne* (intracranial hemorrhage), which can occur after head trauma.\n</step4>\n<step5>\nSymptoms like loss of consciousness after a period of awareness can be a sign of increased intracranial pressure or brain swelling — *pression intracrânienne accrue*.\n</step6>\n<step6>\nGiven these considerations, the most likely condition he is experiencing is a serious brain injury that requires immediate medical attention.\n</step6></thinking>", "answer": "<answer>Àrùn tó ṣeé ṣe jùlọ ni *lésion cérébrale* tó ṣeé ṣe kó fa *hémorragie intracrânienne*.</answer>", "language": "Yoruba"}
{"question": "Okunrin kan de si ile iwosan pajawiri pẹlu ipalara idanwo si ẹgbẹ́ òsì igun.  Àwọn ami-ara rẹ̀ dáradara.  Kini igbesẹ ti o tẹle ni itọju?\nA. CECT\nB. Itọju peritoneal lavage idanwo\nC. Laprotomy\nD. Laproscopy", "reasoning": "<thinking><step1>\nThe question translates to: \"A man is in the emergency room with a left flank injury. His symptoms are stable. What is the next step in treatment?\" Here, \"ile iwosan pajawiri\" means emergency room and \"ipalara idanwo si ẹgbẹ́ òsì igun\" refers to a left flank injury.\n</step1>\n<step2>\nIn cases of stable patients with flank injuries, the primary concern is to assess for internal injuries, particularly to the kidneys or spleen — *àwọn àyẹwo àtọkànwá* are crucial.\n</step2>\n<step3>\nThe options provided include various diagnostic and surgical procedures. CECT (Contrast-Enhanced Computed Tomography) is often used to evaluate internal injuries — *ìmúlò CECT* helps visualize organ damage.\n</step3>\n<step4>\nPeritoneal lavage is less common now due to advancements in imaging; it was used for detecting internal bleeding — *itọju peritoneal lavage* is not typically the first choice anymore.\n</step5>\n<step5>\nLaparotomy and laparoscopy are surgical procedures. Laparotomy is more invasive and used for exploratory surgery, while laparoscopy is minimally invasive — *laparoscopic surgery* is preferred for less severe cases.\n</step6>\n<step6>\nGiven that the patient is stable, the best next step is to perform a CECT to confirm any injuries before deciding on surgical intervention.\n</step6></thinking>", "answer": "<answer>Igbesẹ ti o tẹle ni itọju ni CECT.</answer>", "language": "Yoruba"}
{"question": "Ẹ̀ka iye tí ó ní dígítì mélòó ni ẹ̀ka ìkọ̀wé àpapọ̀?\nA. 0\nB. 1\nC. 2\nD. 10", "reasoning": "<thinking><step1>\nThe question asks: “Ẹ̀ka iye tí ó ní dígítì mélòó ni ẹ̀ka ìkọ̀wé àpapọ̀?” — which translates to \"How many digits are in the decimal system?\" \n</step1>\n<step2>\nIn English, the decimal system is based on ten digits: *0, 1, 2, 3, 4, 5, 6, 7, 8, 9* — *àwọn dígítì mẹ́wàá*.\n</step2>\n<step3>\nThis means that the total count of unique symbols used in this system is ten — *ìyẹn túmọ̀ sí pé* there are ten distinct digits.\n</step4>\n<step4>\nIn Yoruba, one might say: “Ẹ̀ka ìkọ̀wé àpapọ̀ ni dígítì mẹ́wàá,” emphasizing that the decimal system consists of ten digits.\n</step4>\n<step5>\nThus, the answer to the question is clear: the number of digits in the decimal system is ten — *ìyẹn ni 10*.\n</step5></thinking>", "answer": "<answer>10</answer>", "language": "Yoruba"}
{"question": "Kini awọn iye idanwo ile-iwosan deede fun osmolality ito ati serum osmolality ninu alaisan ti o ni àrùn suga ti o wa ni aarin?", "reasoning": "<thinking><step1>\nThe question asks: “Kini awọn iye idanwo ile-iwosan deede fun [osmolality ito = urine osmolality] ati [serum osmolality = serum osmolality] ninu alaisan ti o ni àrùn suga ti o wa ni aarin?” — meaning it wants to know the normal test values for urine and serum osmolality in a patient with diabetes.\n</step1>\n<step2>\nIn general, normal serum osmolality ranges from 275 to 295 mOsm/kg — *iyẹn ni pe, osmolality ti ẹjẹ* wa ni iwọn yii.\n</step2>\n<step3>\nFor urine osmolality, normal values can vary widely, typically between 500 to 800 mOsm/kg — *nitorinaa, osmolality ito* le jẹ diẹ sii ju ti ẹjẹ lọ.\n</step3>\n<step4>\nIn patients with diabetes, especially those with poorly controlled blood sugar, serum osmolality may be elevated due to high glucose levels — *iyẹn ni, awọn ipele suga ti o ga le fa osmolality ti ẹjẹ lati pọ si*.\n</step4>\n<step5>\nConversely, urine osmolality might be low if the patient is experiencing polyuria — *nitori pe wọn n ṣe ito pupọ*, ti o jẹ abajade ti àrùn suga.\n</step5>\n<step6>\nThus, understanding these values is crucial for managing diabetes effectively — *nitori wọn ṣe iranlọwọ lati tọpinpin ipo alaisan*.\n</step6></thinking>", "answer": "<answer>Iye deede fun osmolality serum jẹ 275 si 295 mOsm/kg, ati fun osmolality ito, o jẹ 500 si 800 mOsm/kg.</answer>", "language": "Yoruba"}
{"question": "Lórí ilẹ̀, ó wà ibẹ̀ ìwọ̀n àgbàlá onírun pupa, ohun èlò ẹlẹ́dẹ̀ onírun gbogboro, àti ìwé kékeré onírun mauve. Ṣé ìwé kékeré náà jẹ́ mauve?\nÀwọn àṣàyàn:\n(A) bẹ́ẹ̀ni\n(B) rara", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé ìwé kékeré náà jẹ́ mauve?” — meaning it wants to know if the small book is mauve.\n</step1>\n<step2>\nIn English, \"mauve\" refers to a pale purple color — *àwọ̀ pupa pẹ̀lú àwọ̀ bulu*.\n</step2>\n<step3>\nThe context mentions other items: *ìwọ̀n àgbàlá onírun pupa* (red carpet) and *ohun èlò ẹlẹ́dẹ̀ onírun gbogboro* (large yellow object), but focuses on the small book.\n</step3>\n<step4>\nTo determine if the book is mauve, we need to consider the description provided — *àwọn àlàyé tó wà*.\n</step4>\n<step5>\nIf the question is asking for confirmation, we can infer that the answer options are either (A) bẹ́ẹ̀ni (yes) or (B) rara (no).\n</step5>\n<step6>\nSince the question directly states the color of the small book as mauve, the answer must be affirmative — *ìwé kékeré náà jẹ́ mauve*.\n</step6></thinking>", "answer": "<answer>Bẹ́ẹ̀ni, ìwé kékeré náà jẹ́ mauve.</answer>", "language": "Yoruba"}
{"question": "Kini oro ti a maa n pe ohun kan ti o le ni ipa odi lori idagbasoke oyun?", "reasoning": "<thinking><step1>\nThe question asks: “Kini oro ti a maa n pe ohun kan ti o le ni ipa odi lori idagbasoke oyun?” — which translates to \"What do we call something that can negatively affect fetal development?\"\n</step1>\n<step2>\nIn English, this refers to a substance or factor that can harm the developing fetus — *ohun kan ti o le fa ipalara si oyun*.\n</step2>\n<step3>\nCommon examples include teratogens, which are agents that can cause malformation — *awọn ajẹsara ti o le fa awọn iyipada*.\n</step3>\n<step4>\nThese can be drugs, infections, or environmental factors — *awọn oogun, awọn arun, tabi awọn ifosiwewe ayika*.\n</step4>\n<step5>\nFor instance, alcohol is a well-known teratogen that can lead to fetal alcohol syndrome — *syndrome ọmọdé ti o ni ipa nipasẹ oti*.\n</step5>\n<step6>\nThus, the term we are looking for is \"teratogen\" — *teratogen* in Yoruba.\n</step6></thinking>", "answer": "<answer>Teratogen ni a npe ni ohun ti o le ni ipa odi lori idagbasoke oyun.</answer>", "language": "Yoruba"}
{"question": "Lẹ́yìn tí orí ọmọdé bá ti jáde nígbà ìbí tí kò bá gbọ̀nmọ́lẹ̀, ipo wo kì yóò fi ipa sí ìṣòro nígbà tí a óò fi ṣe ìbí ìyókù ọmọ náà?", "reasoning": "<thinking><step1>\nThe question asks: “Lẹ́yìn tí orí ọmọdé bá ti jáde nígbà ìbí tí kò bá gbọ̀nmọ́lẹ̀” — meaning it is inquiring about the condition of a child after birth when there is no [gbónmọ́lẹ̀ = oxygen] supply.\n</step1>\n<step2>\nWhen a child is born without adequate oxygen, this can lead to *hypoxia*, which is a deficiency in the amount of oxygen reaching the tissues — *ìkópa àìlera*.\n</step2>\n<step3>\nThis lack of oxygen can cause serious complications, such as brain damage — *ìfarapa ọpọlọ* — if not addressed quickly.\n</step3>\n<step4>\nIn such cases, the child may exhibit symptoms like *ìṣòro ìmúra* (difficulty breathing) or *ìfarapa àyà* (cardiac issues) shortly after birth.\n</step4>\n<step5>\nThe longer the child remains without oxygen, the higher the risk of long-term developmental issues — *ìṣòro ìdàgbàsókè*.\n</step5>\n<step6>\nTherefore, the condition of the child after birth without oxygen can significantly impact their health and development, leading to potential lifelong challenges.\n</step6></thinking>", "answer": "<answer>Ipo ọmọ náà lè fa ìṣòro tó lágbára nígbà tí a óò fi ṣe ìbí ìyókù, pẹ̀lú ìfarapa ọpọlọ àti ìṣòro ìdàgbàsókè.</answer>", "language": "Yoruba"}
{"question": "Fi ṣékún ẹ̀rọ̀ àwọn nǹkan tí ó jáde láìní iye àti tí ó fararọ̀ kan náà {X_n: n ≥ 1}, níbi tí olúkúlùkù X_n gba iye 1 pẹ̀lú àṣeyọrí 0.8 àti -1 pẹ̀lù àṣeyọrí 0.2, àti S_n tí a ṣe àkọsílẹ̀ gẹ́gẹ́ bí S_n = ∑_{i=1}^n X_i pẹ̀lú S_0 = 0, kini iye tí n^{-1}E[R_n] dé bí n bá ń lọ sí àìnípẹ̀kun, níbi tí R_n ṣe àkọsílẹ̀ iye àwọn iye tí ó yàtọ̀ tí a gba láti jọ̀wọ́ jara S_0, S_1, ..., S_n?", "reasoning": "<thinking><step1>\nThe question is asking about the limit of the average of the random variables [X_n] as n approaches infinity, where each X_n takes the value 1 with probability 0.8 and -1 with probability 0.2. It also defines S_n as the sum of these variables, starting from S_0 = 0.\n</step1>\n<step2>\nTo find the expected value E[R_n], we first need to understand that R_n counts the number of distinct values obtained from the sequence S_0, S_1, ..., S_n. Since S_n is a sum of independent random variables, we can analyze the expected value of each X_n.\n</step2>\n<step3>\nThe expected value of X_n can be calculated as follows: E[X_n] = (1 * 0.8) + (-1 * 0.2) = 0.8 - 0.2 = 0.6. This means that on average, each X_n contributes positively to S_n.\n</step3>\n<step4>\nAs n increases, the law of large numbers tells us that S_n/n will converge to E[X_n], which is 0.6. Therefore, we can say that S_n/n approaches 0.6 as n goes to infinity.\n</step5>\n<step6>\nNow, regarding R_n, since S_n can take on a range of values based on the outcomes of X_n, the distinct values will also depend on how often we hit the extremes of the distribution. However, the average behavior will still be influenced by the expected value we calculated.\n</step6>\n<step7>\nThus, as n approaches infinity, the average of R_n, which is n^{-1}E[R_n], will stabilize around the expected value of the contributions from X_n, leading us to conclude that it will converge to a limit.\n</step7>\n<step8>\nIn summary, we can conclude that n^{-1}E[R_n] approaches the expected value of the contributions from the random variables as n increases indefinitely.\n</step8></thinking>", "answer": "<answer>Iye n^{-1}E[R_n] dé bí n bá ń lọ sí àìnípẹ̀kun ni 0.6.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 70 kan ti o ní ìtàn àrùn Alzheimer ti ọdún 2 ti wá síbi pẹlu ipo èrò tí ó yipada ati ìṣubú ìrora ni ọjọ́ diẹ̀ sẹ́yìn. Awọn oogun ti ó gbà lọwọlọwọ̀ ni donepezil ati galantamine. Àwọn àmì àrùn rẹ̀ ni: iwọn otutu ara 36.0°C (96.8°F), ẹ̀ru ẹ̀jẹ̀ 90/60 mm Hg, ìṣiṣẹ́ ọkàn 102/min, ati ìṣiṣẹ́ ẹ̀dùn 22/min. Ìwádìí ara fi hàn pé ó ní ọ̀pọ̀lọpọ̀ igbágbé lórí ori rẹ̀ ati awọn ẹ̀yà ara rẹ̀. Ó mọ̀ ara rẹ̀ nìkan. Ẹ̀dùn ati ẹ̀jẹ̀ rẹ̀ gbàdúrà E. coli. A gbà á wọlé, ati ìtọ́jú ìṣàájú pẹlu omi onísèdáṣèdá IV, antibiotics, ati subcutaneous prophylactic heparin. Ni ọjọ́ kejì tí a gbà á wọlé, a rí ẹ̀jẹ̀ tí ó tàn káàkiri láti ibi tí a ti fi abẹrẹ ya ẹjẹ̀ rẹ̀ ati awọn igbágbé rẹ̀. Awọn àbájáde idanwo ẹjẹ rẹ̀ fihan thrombocytopenia, PT ati PTT tí ó gun, ati D-dimer tí ó dára. Èwo ni ìgbésẹ̀ tó tọ́ jùlọ tó tẹ̀lé láti ṣe níbi ṣíṣe ìtọ́jú àrùn alààyè yìí?\nA. Dákẹ́ heparin therapy lẹsẹkẹsẹ ati kọ oogun miiran tí ó ṣeé ṣe fun anticoagulant\nB. Bẹ̀rẹ̀ ìtọ́jú pẹlu prednisone\nC. Cryoprecipitate, FFP ati low dose SC heparin\nD. Ìyípadà ẹjẹ̀ pẹlẹpẹlẹ\nE. Splenectomy", "reasoning": "<thinking><step1>\nThe question is asking about the best course of action for a 70-year-old man with a history of Alzheimer’s who has recently experienced changes in mental status and pain, along with specific lab findings indicating thrombocytopenia and prolonged PT and PTT — *àìlera ẹ̀jẹ̀*.\n</step1>\n<step2>\nGiven his symptoms and lab results, it seems he is at risk for bleeding complications — *ìfarapa ẹ̀jẹ̀* — especially since he has a history of E. coli infection and is on anticoagulants like donepezil and galantamine.\n</step2>\n<step3>\nThe options provided include various treatments, but we need to consider the immediate risks associated with his current condition — *ìtọ́jú àrùn alààyè*.\n</step3>\n<step4>\nOption A suggests stopping heparin therapy and considering another anticoagulant, which may not be appropriate given his bleeding risk.\n</step4>\n<step5>\nOption B, starting prednisone, could help with inflammation but does not address the immediate bleeding concerns.\n</step5>\n<step6>\nOption C involves administering cryoprecipitate and FFP (fresh frozen plasma) along with low-dose SC heparin, which could help manage his coagulation status effectively.\n</step6>\n<step7>\nOption D, a blood transfusion, might be necessary but does not directly address the underlying coagulopathy.\n</step7>\n<step8>\nFinally, option E, splenectomy, is a more invasive procedure and may not be the first step in managing his acute condition.\n</step8>\n<step9>\nConsidering all these factors, the best immediate action is to stabilize his coagulation status while managing the risk of bleeding.\n</step9></thinking>", "answer": "<answer>Cryoprecipitate, FFP ati low dose SC heparin ni ìgbésẹ̀ tó tọ́ jùlọ.</answer>", "language": "Yoruba"}
{"question": "Kini aisiki to julọ fun obinrin ọdun 30 kan ti o ni irora, pupa, ati eefin gbona ni eti ika ẹsẹ rẹ fun ọjọ 7 sẹyin, ti o ti lo awọn oogun ile bi turu ati fitila omi iyọ gbona lai si imularada?", "reasoning": "<thinking><step1>\nThe question asks: “Kini aisiki to julọ fun obinrin ọdun 30 kan ti o ni irora, pupa, ati eefin gbona ni eti ika ẹsẹ rẹ fun ọjọ 7 sẹyin?” — meaning it wants to know the best treatment for a 30-year-old woman with pain, redness, and warmth in her toe for the past 7 days.\n</step1>\n<step2>\nThe symptoms described suggest a possible infection or inflammation — *aisan tabi iredodo* in the toe area, especially since she has not seen improvement with home remedies like *turu* (ice) and *fitila omi iyọ gbona* (warm salt water).\n</step2>\n<step3>\nInfections can lead to increased pain and swelling, so it’s important to consider whether there is an underlying issue, such as *aisan fungal* or *bacteria*.\n</step4>\n<step4>\nIf the condition persists, it may require medical intervention — *itọju iṣoogun* — such as antibiotics if an infection is confirmed.\n</step5>\n<step5>\nAdditionally, elevating the foot and avoiding pressure on the toe can help reduce symptoms — *mimu ẹsẹ naa ga* le dinku irora.\n</step6>\n<step6>\nTherefore, the best course of action is to consult a healthcare professional for a proper diagnosis and treatment plan.\n</step6></thinking>", "answer": "<answer>O yẹ ki obinrin naa lọ si dokita fun ayẹwo to peye ati itọju to yẹ.</answer>", "language": "Yoruba"}
{"question": "Ààrùn kan tó jẹ́ ọmọ ọdún mẹ́ẹ̀ẹ́dọ́gbọ̀n ní ìṣòro kan tó máa ń ṣe é nígbà míì, tó máa ń gbóòórùn tó lágbára, tó máa ń làgun gbọọrọ, tó sì máa ń dákú. Nígbà tí ìṣòro yìí bá ń ṣe é, ẹnìkan nínú ìdílé rẹ̀ á rí i tí ó ń mì tìrì-tìrì lójú pẹ̀lú ìfẹnukonu rẹ̀ tó ń gbọn. Kí ni àìsàn tó ṣeé ṣe kí ó jẹ́ yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àìsàn tó ṣeé ṣe kí ó jẹ́ yìí?” — meaning it wants to know what illness could cause a 35-year-old to experience strong headaches, dizziness, and fainting spells.\n</step1>\n<step2>\nThese symptoms suggest a possible condition related to the nervous system or blood circulation — *àìlera ti eto aifọkànsìn* or *ìṣòro ẹjẹ*.\n</step2>\n<step3>\nThe strong headaches could indicate a migraine or tension headache — *àkúnya* or *ìrora ori* that can lead to dizziness.\n</step3>\n<step4>\nFainting spells, or *ìkó-ara*, can occur due to low blood pressure or dehydration — *ìkó-ara le fa nipasẹ titẹ ẹjẹ kekere*.\n</step5>\n<step5>\nAdditionally, conditions like anxiety or stress can exacerbate these symptoms — *ìbànújẹ* or *ìṣòro ọpọlọ* might also be factors.\n</step6>\n<step6>\nIn summary, the combination of these symptoms could suggest a migraine, anxiety, or a circulatory issue — *àìlera ti eto ẹjẹ*.\n</step6></thinking>", "answer": "<answer>Àìsàn tó ṣeé ṣe kí ó jẹ́ yìí ni àkúnya, ìbànújẹ, tàbí ìṣòro ẹjẹ.</answer>", "language": "Yoruba"}
{"question": "Kini aṣálẹ̀ títóbi jùlọ ní àgbáyé?\nA. Aṣálẹ̀ Antarctic ni aṣálẹ̀ títóbi jùlọ ní àgbáyé.\nB. Aṣálẹ̀ Sahara ni aṣálẹ̀ títóbi jùlọ ní àgbáyé.\nC. Aṣálẹ̀ Arctic ni aṣálẹ̀ títóbi jùlọ ní àgbáyé.\nD. Aṣálẹ̀ Australia ni aṣálẹ̀ títóbi jùlọ ní àgbáyé.\nE. Aṣálẹ̀ Arabia ni aṣálẹ̀ títóbi jùlọ ní àgbáyé.\nF. Aṣálẹ̀ Gobi ni aṣálẹ̀ títóbi jùlọ ní àgbáyé.", "reasoning": "<thinking><step1>\nThe question asks: “Kini aṣálẹ̀ títóbi jùlọ ní àgbáyé?” — which translates to “What is the largest desert in the world?”\n</step1>\n<step2>\nTo answer this, we need to define what constitutes a desert — *aṣálẹ̀* is characterized by low precipitation and can be hot or cold.\n</step2>\n<step3>\nThe largest hot desert is the Sahara, but the largest overall desert, including cold deserts, is actually Antarctica — *aṣálẹ̀ Antarctic*.\n</step3>\n<step4>\nIn terms of area, Antarctica covers about 14 million square kilometers, making it larger than any other desert — *aṣálẹ̀ miiran*.\n</step4>\n<step5>\nWhile the Sahara is well-known for its heat and sand dunes, it is not larger than Antarctica when considering all types of deserts.\n</step5>\n<step6>\nThus, the correct answer is that the largest desert in the world is *aṣálẹ̀ Antarctic*.\n</step6></thinking>", "answer": "<answer>Aṣálẹ̀ Antarctic ni aṣálẹ̀ títóbi jùlọ ní àgbáyé.</answer>", "language": "Yoruba"}
{"question": "Kini ayẹ̀wo ti o ṣeé ṣe julọ fun ọmọ ọdun marun kan ti o ni awọn àmì àrùn ti ko ṣeé fò, awọn àmì àrùn ti o ga soke, ẹ̀jẹ̀ kekere lori awọn ẹsẹ isalẹ, irora ikun díẹ̀, ati pe a rii IgA ni ẹ̀yà ara rẹ̀ lori awọn ohun elo ẹjẹ ati awọn sẹẹli fúnfun ẹjẹ ti o wa ni ayika awọn ohun elo ẹjẹ?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ayẹ̀wo ti o ṣeé ṣe julọ fun ọmọ ọdun marun kan ti o ni [symptoms = àmì àrùn] ti ko ṣeé fò, [high blood pressure = àmì àrùn ti o ga soke], [low blood = ẹ̀jẹ̀ kekere] lori [lower limbs = ẹsẹ isalẹ], [abdominal pain = irora ikun], ati pe a rii [IgA = IgA] ni [blood samples = ohun elo ẹjẹ]?” — meaning it seeks to identify the most likely examination for a five-year-old with these symptoms.\n</step1>\n<step2>\nThe symptoms suggest a possible autoimmune condition or a kidney issue — *àìlera àtọgbẹ* le fa awọn iṣoro wọnyi.\n</step2>\n<step3>\nThe presence of IgA in blood samples indicates a potential IgA nephropathy — *nephropathy IgA* jẹ́ àìlera ti o ni ibatan si awọn kidinrin.\n</step3>\n<step4>\nIn children, common examinations include urinalysis and blood tests to assess kidney function — *ayẹ̀wo ẹ̀jẹ̀ ati ayẹ̀wo àtọgbẹ* ni a maa n lo.\n</step4>\n<step5>\nAdditionally, imaging studies like an ultrasound may be necessary to visualize the kidneys — *ultrasound kidinrin* le jẹ́ pataki.\n</step5>\n<step6>\nThus, the most likely examination for this child would be a combination of urinalysis and blood tests to evaluate the underlying condition.\n</step6></thinking>", "answer": "<answer>Ayẹ̀wo ti o ṣeé ṣe julọ ni ayẹ̀wo ẹ̀jẹ̀ ati ayẹ̀wo àtọgbẹ lati ṣe ayẹwo àìlera kidinrin.</answer>", "language": "Yoruba"}
{"question": "Ibajẹ iṣan wo ni yoo fa ipo kan nibiti sisun kọrnia ọtun yoo fa itẹlọrun ṣiṣi oju oju osi nikan, ṣugbọn kii ṣe ni oju ọtun?", "reasoning": "<thinking><step1>\nThe question asks: “Ibajẹ iṣan wo ni yoo fa ipo kan nibiti sisun kọrnia ọtun yoo fa itẹlọrun ṣiṣi oju oju osi nikan, ṣugbọn kii ṣe ni oju ọtun?” — meaning it is inquiring about which nerve damage could lead to a situation where the right coronary artery's dysfunction causes satisfaction of the left eye's opening but not the right.\n</step1>\n<step2>\nThis scenario suggests a specific type of nerve injury — *ibajẹ iṣan* — that affects the autonomic nervous system, particularly the nerves controlling the eyes.\n</step2>\n<step3>\nThe right coronary artery supplies blood to parts of the heart and can influence the autonomic control of the eyes — *iṣakoso ara ẹni ti oju*.\n</step3>\n<step4>\nIf there is damage to the right oculomotor nerve — *iṣan oculomotor ọtun* — it could lead to ptosis or difficulty in opening the right eye, while the left eye remains unaffected.\n</step4>\n<step5>\nThis condition is known as Horner's syndrome, where sympathetic nerve pathways are disrupted, leading to a specific pattern of eye symptoms — *aami oju*.\n</step5>\n<step6>\nThus, the nerve damage in question is likely related to the oculomotor nerve, affecting the right eye's ability to open properly.\n</step6></thinking>", "answer": "<answer>Ibajẹ iṣan oculomotor ọtun ni yoo fa ipo yii, ti o mu ki oju ọtun ko le ṣii daradara.</answer>", "language": "Yoruba"}
{"question": "Ọrọ wo ni o jẹ́ apẹrẹ̀ tó bá ìtumọ̀ ìdánwò òtítọ́ mu gan-an?", "reasoning": "<thinking><step1>\nThe question asks: “Ọrọ wo ni o jẹ́ [apẹrẹ = example] tó bá [ìtumọ̀ = meaning] [ìdánwò òtítọ́ = true test] mu gan-an?” — meaning it wants to know what an example truly represents in the context of a true test.\n</step1>\n<step2>\nA true test is designed to measure specific knowledge or skills — *ìdánwò tó dá lórí ìmọ̀ tàbí ọgbọn kan*.\n</step2>\n<step3>\nFor instance, in education, a true test might assess a student's understanding of a subject — *ìdánwò yìí lè ṣe àyẹ̀wò ìmọ̀ akẹ́kọ̀ọ́ nípa koko kan*.\n</step3>\n<step4>\nAn example of a true test could be a standardized exam that evaluates comprehension and application of concepts — *àpẹẹrẹ ni ìdánwò àtẹ̀jáde tó ń ṣe àyẹ̀wò ìmọ̀ àti ìmúlò*.\n</step4>\n<step5>\nIn contrast, a test that does not accurately reflect the knowledge or skills being assessed would not be a true test — *ìdánwò tí kò bá ìmọ̀ mu kì í ṣe ìdánwò òtítọ́*.\n</step5>\n<step6>\nThus, a true test must align with the intended learning outcomes and accurately measure what it claims to assess — *ìdánwò òtítọ́ gbọ́dọ̀ bá àfojúsùn ìkọ́ni mu*.\n</step6></thinking>", "answer": "<answer>Àpẹẹrẹ tó bá ìtumọ̀ ìdánwò òtítọ́ mu ni ìdánwò àtẹ̀jáde tó ń ṣe àyẹ̀wò ìmọ̀ àti ìmúlò.</answer>", "language": "Yoruba"}
{"question": "Eyi ni tabili kan nibiti ila-oruko akọkọ jẹ ori ati ila kọọkan ti o tẹle jẹ penguin: orukọ, ọjọ-ori, iga (cm), iwuwo (kg) Louis, 7, 50, 11 Bernard, 5, 80, 13 Vincent, 9, 60, 11 Gwen, 8, 70, 15 Fun apẹẹrẹ: ọjọ-ori Louis ni 7, iwuwo Gwen ni 15 kg, iga Bernard ni 80 cm. A ti fi penguin kan kun si tabili naa bayi:\nJames, 12, 90, 12\nMelo ni awọn penguin ti o ju ọdun 8 lọ?\nAwọn aṣayan:\n(A) 1\n(B) 2\n(C) 3\n(D) 4\n(E) 5", "reasoning": "<thinking><step1>\nThe question asks: “Melo ni awọn penguin ti o ju ọdun 8 lọ?” — meaning it wants to know how many penguins are older than 8 years.\n</step1>\n<step2>\nFirst, let's look at the ages of the penguins listed: Louis (7), Bernard (5), Vincent (9), Gwen (8), and James (12).\n</step2>\n<step3>\nWe need to identify which of these ages are greater than 8 — *ju ọdun 8 lọ*.\n</step3>\n<step4>\nFrom the list, Vincent is 9 and James is 12. Both are older than 8.\n</step4>\n<step5>\nGwen is exactly 8, so she does not count. Thus, we have two penguins: Vincent and James.\n</step5>\n<step6>\nTherefore, the total number of penguins older than 8 years is 2.\n</step6></thinking>", "answer": "<answer>2</answer>", "language": "Yoruba"}
{"question": "Ṣe àwọn idi tí ó lè fa nystagmus tí ó ṣubu sí isalẹ̀, nípa ti àwọn àìlera iṣẹ́ ẹ̀dọ̀fóró?", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe àwọn idi tí ó lè fa [nystagmus = nystagmus] tí ó ṣubu sí isalẹ̀, nípa ti [àìlera iṣẹ́ ẹ̀dọ̀fóró = liver dysfunction]?” — meaning it wants to know the causes of downward nystagmus related to liver issues.\n</step1>\n<step2>\nNystagmus is an involuntary eye movement, and when it falls downward, it can indicate specific neurological or physiological conditions — *nystagmus tí ó ṣubu sí isalẹ̀*.\n</step2>\n<step3>\nIn cases of liver dysfunction, *àìlera iṣẹ́ ẹ̀dọ̀fóró* can lead to metabolic disturbances, affecting the central nervous system — *nervous system*.\n</step3>\n<step4>\nConditions like hepatic encephalopathy can cause changes in consciousness and lead to nystagmus — *àìlera ẹ̀dọ̀fóró le fa àìlera ọpọlọ*.\n</step5>\n<step6>\nAdditionally, toxins that accumulate due to liver failure may disrupt normal eye movement control — *toxin tí ń kópa nínú iṣẹ́ ẹ̀dọ̀fóró*.\n</step7>\n<step8>\nThus, downward nystagmus can be a sign of serious underlying issues related to liver health — *nystagmus tí ó ṣubu sí isalẹ̀ le jẹ́ àmì àìlera tó ṣe pataki*.\n</step9></thinking>", "answer": "<answer>Àwọn idi tí ó lè fa nystagmus tí ó ṣubu sí isalẹ̀ ni àìlera ẹ̀dọ̀fóró, gẹgẹ bí àìlera ọpọlọ àti ikolu toxin.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin ọmọ ọdún mẹtadinlogun kan wá sí ẹka pajawiri lẹhin ti ó ge ọwọ́ rẹ̀ nígbà tí ó ń ṣiṣẹ́ lórí ọkọ̀ ayọkẹlẹ́ rẹ̀. Aláìsàn náà ní ìtàn ìṣòro ìṣègùn ti ìwà àìṣòdodo ati pe wọ́n ti fi í sí túbú nígbà pupọ̀. Àwọn ohun ìṣòro rẹ̀ wà láàárín àwọn àṣàyàn deede. Ẹ̀tò ayẹ̀wò ara rẹ̀ ṣe akiyesi ọkùnrin kan tí a bò mọ́ pẹ̀lú àwọn àwòrán pẹ̀lú ọ̀pọ̀lọpọ̀ ìbàjẹ́ lórí ojú rẹ̀ ati àyà rẹ̀. Ṣíṣayẹ̀wò ọwọ́ ọ̀tún aláìsàn náà fi hàn pé àwọn igbẹ́ mímọ́ méjì wà lórí àwọn apá kejì ati kẹta ti metacarpophalangeal (MCP). A fún aláìsàn náà ní oògùn tetanus, a sì fi omi wẹ́ igbẹ́ náà. Èwo nínú àwọn wọ̀nyí ni ìṣakoso tó yẹ fún aláìsàn yìí?\nA. Ciprofloxacin ati erythromycin tí a fi sí ara\nB. Ṣíṣe igbẹ́ náà pẹ̀lú awọn asà\nC. Kò sí ìṣakoso mìíràn tí ó pọn dandan\nD. Ìwẹ́ abẹ, gbigbẹ́, ati amoxicillin-clavulanic acid", "reasoning": "<thinking><step1>\nThe question is asking about the appropriate management for a 17-year-old male who has sustained a hand injury while working on his vehicle, specifically after cutting his hand. It mentions that he has a history of non-compliance with medical treatment and presents with multiple lacerations on his face and chest.\n</step1>\n<step2>\nIn this case, the patient has significant injuries, including two deep lacerations on the second and third metacarpophalangeal (MCP) joints — *igbẹ́ mímọ́ lórí apá kejì ati kẹta*.\n</step2>\n<step3>\nGiven the nature of the injury and the patient's history, it is crucial to prevent infection. The administration of tetanus prophylaxis indicates a concern for potential tetanus exposure — *ìtàn ìṣòro tetanus*.\n</step4>\n<step4>\nAmong the options provided, option D suggests surgical cleaning, debridement, and the use of amoxicillin-clavulanic acid, which is appropriate for managing deep lacerations to prevent infection — *ìwẹ́ abẹ, gbigbẹ́, ati amoxicillin-clavulanic acid*.\n</step5>\n<step5>\nOptions A and B do not adequately address the need for surgical intervention and proper antibiotic coverage, while option C suggests no further management, which is not suitable given the injury's severity.\n</step6>\n<step6>\nThus, the best management for this patient is to perform surgical cleaning and debridement, along with appropriate antibiotic therapy.\n</step6></thinking>", "answer": "<answer>Ìṣakoso tó yẹ fún aláìsàn yìí ni ìwẹ́ abẹ, gbigbẹ́, ati amoxicillin-clavulanic acid.</answer>", "language": "Yoruba"}
{"question": "Irú asopọ́ kékeré wo ni a ń lò nínú èégún apá kan tí a ṣe fún un láti máa rọ?", "reasoning": "<thinking><step1>\nThe question asks: “Irú asopọ́ kékeré wo ni a ń lò nínú èégún apá kan tí a ṣe fún un láti máa rọ?” — meaning it wants to know what type of small connection is used in a specific part of a puppet to make it move.\n</step1>\n<step2>\nIn puppetry, a small connection or joint is crucial for movement — *asopọ́* allows for flexibility and articulation.\n</step2>\n<step3>\nTypically, *asopọ́ kékeré* like a pivot or hinge is used to enable the puppet's limbs to move smoothly — *lati jẹ́ kí àwọn ọwọ́ àti ẹsẹ̀ rọ*.\n</step3>\n<step4>\nFor example, in a marionette, *asopọ́* can be a simple string or rod that connects the limbs to the main body — this allows for controlled movement.\n</step4>\n<step5>\nThe design of these connections is essential for the overall functionality of the puppet — *ìdàpọ̀ asopọ́* must be precise to ensure proper motion.\n</step6>\n<step6>\nThus, the type of small connection used in a puppet for movement is often a *asopọ́ kékeré* like a hinge or pivot.\n</step6></thinking>", "answer": "<answer>Irú asopọ́ kékeré tí a ń lò nínú èégún apá kan ni *asopọ́* bíi hinge tàbí pivot.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin ọdun 22 kan wá pẹlu àìsàn kan tí ó gba ibi kan ṣoṣo tí ó tó 2 cm, tí ó ní ìṣọ̀kan àwọn ohun tí ó ṣe àgbéyẹ̀gbẹ́yẹ̀gbẹ́ nínú ẹ̀gbẹ́ ọ̀tún ẹ̀dọ̀ rẹ̀ ní ultrasound, lakoko tí iyoku ẹ̀dọ̀ náà sì hàn gẹ́gẹ́ bíi ti ara. Ẹ̀tọ́ ìwádìí wo ni a gbọdọ̀ ṣe tókàn láti ṣàyẹ̀wò bí àìsàn ẹ̀dọ̀ yìí ṣe jẹ́?", "reasoning": "<thinking><step1>\nThe question asks: “What further investigations should be done to assess this liver condition?” — referring to a patient with a 2 cm lesion in the liver, which shows signs of [lesion = àìsàn] on ultrasound.\n</step1>\n<step2>\nIn this case, the lesion's characteristics are crucial. We need to determine if it is benign or malignant — *bóyá ó jẹ́ àìsàn tó dára tàbí àìsàn tó burú*.\n</step2>\n<step3>\nA common next step is to perform a CT scan or MRI of the liver — *ìwádìí CT tàbí MRI* — to get a clearer image of the lesion.\n</step3>\n<step4>\nAdditionally, blood tests for liver function and tumor markers, such as AFP (Alpha-fetoprotein), are important — *àwọn ìdánwò ẹ̀jẹ̀ fún iṣẹ́ ẹ̀dọ̀*.\n</step4>\n<step5>\nIf the imaging and blood tests suggest malignancy, a biopsy may be necessary to confirm the diagnosis — *biopsy* le jẹ́ àǹfààní láti jẹ́risi àìsàn náà.\n</step5>\n<step6>\nIn summary, the investigations should include imaging studies and blood tests to evaluate the nature of the liver lesion — *ìwádìí àwòrán àti ìdánwò ẹ̀jẹ̀*.\n</step6></thinking>", "answer": "<answer>Ìwádìí tó yẹ kí a ṣe ni CT tàbí MRI, àti ìdánwò ẹ̀jẹ̀ fún iṣẹ́ ẹ̀dọ̀ àti àwárí àìsàn.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun 44 kan tí ó ní àrùn àtọ́jú ìṣùṣù mellitus irú kejì wá sí oníṣègùn pẹ̀lú ìtàn ọjọ́ mẹ́ta ti àìsàn gbígbóná, irora ẹsẹ̀ ọ̀tún, àti ìgbóná.  Àwọ̀rọ̀ ara rẹ̀ jẹ́ 38.7°C (101.7°F).  Àwárí àyẹ̀wò ara fi hàn pé ó ní àpòòtọ́ àwọ̀n ara tí ó pupa, gbóná, tí ó ga sókè, tí ó sì tó 5 x 6-cm pẹ̀lú àwọn ẹ̀gbẹ̀ tí ó dára lórí apá ọ̀tún ẹsẹ̀ ọ̀tún. Ẹ̀dá alààyè tí wọ́n ya kúrò nínú àpòòtọ́ náà ń dá àwọn agbo ogún tí ó tóbi, tí ó sì ní ìrísí mọ́lì kọjá lórí ẹ̀jẹ̀ agar. Àyẹ̀wò síwájú sí i fi hàn pé ẹ̀dá alààyè náà ní ìṣù àpòòtọ́ hyaluronic acid tó títóbi. Ẹ̀dá alààyè tí ó fa ìṣòro alàáfiyèsí náà gbọ́dọ̀ ní àwọn àpẹẹrẹ àfikún wọ̀nyí?\nA. Ṣíṣàgbé ní bíìlì\nB. Ṣíṣeéṣe fún bacitracin\nC. Àyẹ̀wò coagulase rere\nD. Ìdíwọ̀n sí optochin\n\"", "reasoning": "<thinking><step1>\nThe question is asking about a 44-year-old woman with type 2 diabetes who presents with a three-day history of fever, right leg pain, and swelling. The examination shows a temperature of 38.7°C (101.7°F) and a large, warm, red abscess on her right leg. The abscess culture reveals a large organism with a morphology consistent with agar blood. The question is about what additional tests should be performed.\n</step1>\n<step2>\nGiven her symptoms and the presence of an abscess, we need to consider the possible pathogens involved. Infections in diabetic patients can often be caused by bacteria such as *Staphylococcus aureus* or *Streptococcus* species.\n</step2>\n<step3>\nThe options provided include various tests: \nA. *Ṣíṣàgbé ní bíìlì* (blood culture) is essential to identify the causative organism.\nB. *Ṣíṣeéṣe fún bacitracin* (sensitivity to bacitracin) is more relevant for streptococcal infections.\nC. *Àyẹ̀wò coagulase rere* (coagulase test) helps differentiate between coagulase-positive and negative staphylococci.\nD. *Ìdíwọ̀n sí optochin* (optochin sensitivity) is used for identifying *Streptococcus pneumoniae*.\n</step3>\n<step4>\nIn this case, the most relevant test would be the blood culture, as it can help identify the organism causing the abscess and guide treatment. The presence of a large organism in the culture suggests a serious infection that needs to be addressed.\n</step4>\n<step5>\nTherefore, the best additional test to perform in this scenario is *A. Ṣíṣàgbé ní bíìlì* (blood culture).\n</step5></thinking>", "answer": "<answer>A. Ṣíṣàgbé ní bíìlì.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mẹrinlẹgbẹta (40), tí í ṣe olóògùn tabacco, wá pẹ̀lú ìrora tó gbóná gan-an ní agbegbe ikun rẹ̀ tí ó ti wà fún wákàtí kan, ati ECG rẹ̀ fihan ST segment elevation ni awọn leads ti isalẹ.  Ṣe irú ìtọ́jú wo ni ó yẹ kí a fi sílẹ̀ lẹsẹkẹsẹ?", "reasoning": "<thinking><step1>\nThe question describes a 40-year-old man who is a tobacco user, presenting with severe abdominal pain lasting for an hour, and his ECG shows ST segment elevation in the inferior leads — *ST segment elevation ni awọn leads ti isalẹ*.\n</step1>\n<step2>\nThis presentation suggests a possible acute coronary syndrome, particularly an inferior ST elevation myocardial infarction (STEMI) — *STEMI ni isalẹ*.\n</step2>\n<step3>\nIn such cases, immediate treatment is crucial to restore blood flow — *ìtọ́jú lẹsẹkẹsẹ jẹ́ pataki*.\n</step4>\n<step4>\nThe standard initial management includes administering aspirin and possibly nitroglycerin for chest pain — *aspirin ati nitroglycerin*.\n</step5>\n<step5>\nAdditionally, the patient may require urgent cardiac catheterization — *ìmúlò catheterization àyà* — to assess and treat any blockages.\n</step6>\n<step6>\nTherefore, the immediate treatment should focus on stabilizing the patient and addressing the myocardial ischemia.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú lẹsẹkẹsẹ ni aspirin, nitroglycerin, àti ìmúlò catheterization àyà.</answer>", "language": "Yoruba"}
{"question": "Alisi, Bobu, Kleo, Deifu, Ifi, Fred, ati Gertrudi n ṣe ayẹyẹ ẹbun elefun funfun kan. Ni ibẹrẹ iṣẹlẹ naa, wọn kọọkan ni ẹbun ti awọ oriṣiriṣi: Alisi ni bọ́ọ́lù pupa, Bobu ni ẹbun pupa, Kleo ni ẹbun bulu, Deifu ni ẹbun brown, Ifi ni ẹbun awọ ofeefee, Fred ni ẹbun funfun, ati Gertrudi ni bọ́ọ́lù dudu.\nBi iṣẹlẹ naa ti nlọ siwaju, awọn tọkọtaya eniyan ṣe paṣipaarọ awọn ẹbun. Ni akọkọ, Alisi ati Kleo paṣipaarọ awọn ẹbun wọn. Lẹhin naa, Deifu ati Bobu paṣipaarọ awọn ẹbun wọn. Lẹhin naa, Alisi ati Gertrudi paṣipaarọ awọn ẹbun wọn. Lẹhin naa, Kleo ati Gertrudi paṣipaarọ awọn ẹbun wọn. Lẹhin naa, Alisi ati Ifi paṣipaarọ awọn ẹbun wọn. Lẹhin naa, Fred ati Deifu paṣipaarọ awọn ẹbun wọn. Nikẹhin, Kleo ati Alisi paṣipaarọ awọn ẹbun wọn. Ni ipari iṣẹlẹ naa, Alisi ni\nAwọn aṣayan:\n(A) bọ́ọ́lù pupa\n(B) ẹbun pupa\n(C) ẹbun bulu\n(D) ẹbun brown\n(E) ẹbun awọ ofeefee\n(F) ẹbun funfun\n(G) bọ́ọ́lù dudu", "reasoning": "<thinking><step1>\nThe question describes a gift exchange event involving Alisi, Bobu, Kleo, Deifu, Ifi, Fred, and Gertrudi, each starting with a gift of a different color. We need to track the exchanges to determine what Alisi ends up with.\n</step1>\n<step2>\nInitially, Alisi has a *bọ́ọ́lù pupa* (red ball), Bobu has a *ẹbun pupa* (red gift), Kleo has a *ẹbun bulu* (blue gift), Deifu has a *ẹbun brown* (brown gift), Ifi has a *ẹbun awọ ofeefee* (yellow gift), Fred has a *ẹbun funfun* (white gift), and Gertrudi has a *bọ́ọ́lù dudu* (black ball).\n</step2>\n<step3>\nThe first exchange is between Alisi and Kleo. After this, Alisi has Kleo's *ẹbun bulu* and Kleo has Alisi's *bọ́ọ́lù pupa*.\n</step3>\n<step4>\nNext, Deifu and Bobu exchange gifts. Now, Deifu has Bobu's *ẹbun pupa* and Bobu has Deifu's *ẹbun brown*.\n</step4>\n<step5>\nThen, Alisi and Gertrudi exchange gifts. Alisi now has Gertrudi's *bọ́ọ́lù dudu*, and Gertrudi has Alisi's *ẹbun bulu*.\n</step5>\n<step6>\nFollowing this, Kleo and Gertrudi exchange gifts again. Kleo now has Gertrudi's *ẹbun bulu*, and Gertrudi has Kleo's *bọ́ọ́lù dudu*.\n</step7>\n<step7>\nNext, Alisi and Ifi exchange gifts. Alisi now has Ifi's *ẹbun awọ ofeefee*, and Ifi has Alisi's *bọ́ọ́lù dudu*.\n</step8>\n<step8>\nThen, Fred and Deifu exchange gifts. Fred now has Deifu's *ẹbun pupa*, and Deifu has Fred's *ẹbun funfun*.\n</step9>\n<step9>\nFinally, Kleo and Alisi exchange gifts. Kleo now has Alisi's *ẹbun awọ ofeefee*, and Alisi ends up with Kleo's *ẹbun bulu*.\n</step10></thinking>", "answer": "<answer>Alisi ni ẹbun bulu.</answer>", "language": "Yoruba"}
{"question": "Àìṣòro wo ni a mọ̀ fún ìgbẹ́ ọgbẹ́ tí ó ní ìrora nínú àgbàlá ìyọ̀nù, pẹ̀lú ìgbóná irúgbìn ní àgbàlá ẹ̀gbà, àti ìrísí ẹja ọ̀wọ̀ lórí ìwádìí microscópic?", "reasoning": "<thinking><step1>\nThe question asks: “Àìṣòro wo ni a mọ̀ fún ìgbẹ́ ọgbẹ́ tí ó ní ìrora nínú àgbàlá ìyọ̀nù?” — meaning it wants to know what conditions are recognized for a painful ulcer in the [rectal area = àgbàlá ìyọ̀nù], along with the [characteristics = ìgbóná irúgbìn] in the [anal area = àgbàlá ẹ̀gbà], and the [appearance = ìrísí] of fish-like features in microscopic examination.\n</step1>\n<step2>\nPainful ulcers in the rectal area can be caused by various conditions, such as *ulcères rectaux* or *maladies inflammatoires de l'intestin*.\n</step2>\n<step3>\nIn addition to pain, symptoms may include bleeding or discharge — *saignement ou écoulement* from the ulcer.\n</step3>\n<step4>\nThe characteristics in the anal area might show signs of inflammation — *inflammation* and possibly a fish-like appearance under microscopic examination, which could indicate *infections* or *parasitic infestations*.\n</step4>\n<step5>\nMicroscopic examination can reveal *organismes pathogènes* or abnormal cells, which help in diagnosing the specific condition.\n</step5>\n<step6>\nThus, the conditions recognized for painful ulcers in the rectal area include inflammatory bowel diseases and infections, with specific microscopic features aiding in diagnosis.\n</step6></thinking>", "answer": "<answer>Àìṣòro tí a mọ̀ fún ìgbẹ́ ọgbẹ́ nínú àgbàlá ìyọ̀nù ni àìlera àtọgbẹ́, àìlera àtọgbẹ́, àti àìlera àtọgbẹ́, pẹ̀lú ìrísí ẹja ọ̀wọ̀ lórí ìwádìí microscópic.</answer>", "language": "Yoruba"}
{"question": "Àpọnà kan farahan pẹlu ailera apa ọtun oju rẹ̀ pẹlu pipadanu irora ati otutu, irora ati itunmọ otutu ẹsẹ òsì ti sọnù.  Ipò tí ìṣẹ̀lẹ̀ náà ti wà jùlọ ni\nA.  apá ẹgbẹ́ pons\nB.  apá àárín pons\nC.  apá ẹgbẹ́ medulla\nD.  apá àárín medulla", "reasoning": "<thinking><step1>\nThe question asks about a condition involving the right side of the face with symptoms like pain and temperature loss, as well as pain and temperature loss in the left leg. This suggests a neurological issue affecting specific brain regions.\n</step1>\n<step2>\nThe symptoms indicate a possible lesion affecting the pathways that control sensation — *irora* and *itunmọ otutu* — on one side of the face and the opposite side of the body.\n</step2>\n<step3>\nIn this case, the right side of the face is affected, which suggests that the lesion is likely in the brainstem, specifically in the pons or medulla.\n</step4>\n<step4>\nThe pons is responsible for relaying sensory information and regulating autonomic functions, while the medulla controls vital functions like heart rate and breathing — *àwọn iṣẹ́ pataki*.\n</step5>\n<step5>\nGiven that the left leg is experiencing symptoms, this indicates a crossed pattern of neurological involvement, which is often seen with lesions in the pons — *apá ẹgbẹ́ pons*.\n</step6>\n<step6>\nThus, the most likely location of the lesion causing these symptoms is in the pons, specifically affecting the sensory pathways.\n</step6></thinking>", "answer": "<answer>Apá ẹgbẹ́ pons.</answer>", "language": "Yoruba"}
{"question": "Àpọń ti ní igbáwí idà ní apá òtun oke ikùn ni a mú wá sí yàrá ìṣẹ̀ṣe pajawiri pẹ̀lú ẹ̀mí tí kò ga tó ati ìgbàgbé ọkàn. A ṣe ìṣẹ̀ṣe ìgbàgbé pajawiri, ati bó tilẹ̀ jẹ́ pé a gbìyànjú láti di ẹ̀gbà ọ̀nà òkèèrè kékeré náà, ẹ̀jẹ̀ náà ṣì máa ń jáde. Da lórí ìṣẹ̀lẹ̀ iṣẹ́-àìsàn yìí, àwọn abala wo ni ó ṣeé ṣe kí ó jẹ́ orísun ẹ̀jẹ̀ náà?", "reasoning": "<thinking><step1>\nThe question asks about a medical scenario involving a patient with a [gasping breath = ẹ̀mí tí kò ga tó] and [heart failure = ìgbàgbé ọkàn], who is brought to the emergency room. It seeks to identify potential causes of bleeding in this context.\n</step1>\n<step2>\nIn cases of heart failure, the body may not circulate blood effectively, leading to various complications — *àìlera àkúnya* can cause fluid buildup, which might contribute to bleeding.\n</step2>\n<step3>\nAdditionally, if the patient has underlying conditions like liver disease, this can affect blood clotting — *ìṣòro ẹ̀jẹ̀* may arise due to liver dysfunction.\n</step3>\n<step4>\nTrauma or injury could also be a source of bleeding; for instance, if the patient experienced a fall or accident — *ìfarapa* can lead to internal bleeding.\n</step4>\n<step5>\nFurthermore, medications such as anticoagulants might be involved, increasing the risk of bleeding — *ìmúra ẹ̀jẹ̀* can exacerbate this situation.\n</step5>\n<step6>\nIn summary, potential sources of bleeding in this patient could include heart failure complications, liver disease, trauma, or the effects of certain medications.\n</step6></thinking>", "answer": "<answer>Orísun ẹ̀jẹ̀ náà le jẹ́ àìlera àkúnya, ìṣòro ẹ̀jẹ̀, ìfarapa, tàbí ìmúra ẹ̀jẹ̀.</answer>", "language": "Yoruba"}
{"question": "Okunrin kan ti n ṣiṣẹ́ gẹ́gẹ́ bí apaniyan eèkun ni o ni irora ikun, ìhòòhòò alubosa lori ẹmi rẹ̀, ati awọn ila ti o kọja lori awọn eekanna rẹ̀. Kini idi ti o ṣeeṣe julọ ti awọn ami aisan rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Okunrin kan ti n ṣiṣẹ́ gẹ́gẹ́ bí apaniyan eèkun ni o ni irora ikun, ìhòòhòò alubosa lori ẹmi rẹ̀, ati awọn ila ti o kọja lori awọn eekanna rẹ̀” — meaning a man working as a butcher has abdominal pain, red spots on his skin, and lines on his fingers. It wants to know the most likely cause of these symptoms.\n</step1>\n<step2>\nThe symptoms described suggest a possible allergic reaction or infection — *ìfarapa tabi àkóràn* could be involved, especially given the man's occupation.\n</step2>\n<step3>\nThe abdominal pain could indicate gastrointestinal issues, possibly from handling raw meat — *irora ikun le jẹ́ ami àkóràn* from bacteria like Salmonella or E. coli.\n</step3>\n<step4>\nThe red spots on the skin might suggest an allergic reaction — *ìhòòhòò alubosa le jẹ́ àkóràn àtọgbẹ* or even a skin infection.\n</step4>\n<step5>\nThe lines on his fingers could be due to repeated exposure to harsh substances or infections — *àkóràn tabi ìfarapa* from handling meat without proper protection.\n</step5>\n<step6>\nConsidering all these factors, the most likely cause of his symptoms is a combination of infection and allergic reaction due to his work environment.\n</step6></thinking>", "answer": "<answer>Idi ti o ṣeeṣe julọ ti awọn ami aisan rẹ̀ ni àkóràn ati ìfarapa nitori iṣẹ́ rẹ gẹ́gẹ́ bí apaniyan eèkun.</answer>", "language": "Yoruba"}
{"question": "Ní ọ̀ṣùpá pajawiri, aláìsàn kan tí ó ní ìṣòro ikùn wá pẹ̀lú àwọn àmì ti peritonitis àti ọgbẹ́. Lẹ́yìn tí a ti dáàbò bo ọ̀nà òfúrufú àti ìmímú ẹ̀mí, tí a sì bẹ̀rẹ̀ sí fi omi sí ara rẹ̀ pẹ̀lú awọn kànúlà méjì tí ó tóbi, ìgbésẹ̀ tó tọ́ sí nínú ìṣàkóso jẹ́ kí?", "reasoning": "<thinking><step1>\nThe question asks: “Ní ọ̀ṣùpá pajawiri, aláìsàn kan tí ó ní ìṣòro ikùn wá pẹ̀lú àwọn àmì ti [peritonitis = peritonitis] àti [ọgbẹ́ = wound].” This means it describes a patient in an emergency with issues related to peritonitis and a wound.\n</step1>\n<step2>\nIn such a scenario, after ensuring airway protection and starting IV fluids — *ìmímú ẹ̀mí* and *omi*, the next step in management is crucial.\n</step2>\n<step3>\nGiven the signs of peritonitis, which indicate possible abdominal infection — *àkúnya ikùn*, surgical intervention is often necessary.\n</step3>\n<step4>\nThe patient may require an exploratory laparotomy — *ìwádìí ikùn* — to assess and treat the underlying cause of peritonitis.\n</step4>\n<step5>\nAdditionally, if there is a significant wound, it may need to be addressed simultaneously — *ìtọ́jú ọgbẹ́* is essential to prevent further complications.\n</step5>\n<step6>\nThus, the appropriate next step in management is to prepare for surgery — *pẹ̀lú ìmúra fún iṣẹ́ abẹ́*.\n</step6></thinking>", "answer": "<answer>Ìgbésẹ̀ tó tọ́ sí nínú ìṣàkóso ni láti mura sí iṣẹ́ abẹ́.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 48 kan wá sí ile-iṣẹ iṣẹ-iwosan pajawiri pẹlu irora inu ikun lẹhin jijẹun ati ikọ́ gbẹ ti o maa n buru ju ni owurọ, eyiti mejeeji ti pọ si ni iye ni awọn oṣu diẹ sẹyin.  Oun ni ilera ni ọ̀nà míràn, kò sì ní ẹ̀dùn ọ̀rọ̀ mìíràn. Itan ilera ti o ti kọja ṣe pataki fun aisan ibanujẹ ńlá, àníyàn, ati hypothyroidism.  Àyẹ̀wo ara kò ní àbùkù.  Pẹlu awọn aṣayan wọnyi, kini igbesẹ ti o tọ julọ ni itọju alaisan?\nA. Ẹ̀rọ itọ́ka ọkàn\nB. Awọn iyipada ọna igbesi aye\nC. Bẹrẹ itọju Omeprazole\nD.  Imu fluoroscopic barium", "reasoning": "<thinking><step1>\nThe question describes a 48-year-old man who presents to the emergency department with abdominal pain after eating and worsening constipation, which have increased over the past few months. It also mentions his past medical history of major depression, anxiety, and hypothyroidism, but no significant findings on physical examination.\n</step1>\n<step2>\nThe symptoms of abdominal pain and constipation could indicate a gastrointestinal issue — *isoro inu*. Given his history of hypothyroidism, it’s important to consider that this condition can lead to constipation as well.\n</step2>\n<step3>\nThe options provided include: A. Cardiac monitoring, B. Lifestyle modifications, C. Starting Omeprazole, and D. Fluoroscopic barium swallow. \n</step3>\n<step4>\nCardiac monitoring seems unnecessary here since there are no signs of cardiac issues. Lifestyle modifications could help with constipation, but they may not address the immediate abdominal pain.\n</step4>\n<step5>\nStarting Omeprazole could be beneficial if the pain is related to acid reflux or gastritis, but it doesn't directly address constipation. A fluoroscopic barium swallow is more diagnostic and may not be the first step in treatment.\n</step5>\n<step6>\nConsidering the patient's symptoms and history, the most appropriate initial step would be lifestyle modifications — *iyipada ọna igbesi aye* — to manage his constipation and potentially alleviate some abdominal discomfort.\n</step6></thinking>", "answer": "<answer>Iyipada ọna igbesi aye ni igbesẹ ti o tọ julọ ni itọju alaisan.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìtọ́jú wo ni a kà sí ohun tí ó lè mú kí èso rẹ̀ jáde fún ọmọ ọdún mẹ́rin tó ní ọgbọ́n ẹnu-ìṣán kan tí kò ní èso mọ́, tí àrùn ibàá ti bà á nítorí ìpalára?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn ìtọ́jú wo ni a kà sí ohun tí ó lè mú kí èso rẹ̀ jáde?” — meaning it wants to know what treatments can help a four-year-old child with a speech delay due to a disability.\n</step1>\n<step2>\nFor a child with *ìpalára* (disability) affecting speech, early intervention is crucial — *ìtẹ́síwájú àkókò* can significantly improve outcomes.\n</step2>\n<step3>\nSpeech therapy, or *ìtọ́jú ẹnu*, is often recommended to help the child develop communication skills — *kó ẹ̀kọ́ àkópọ̀* and improve articulation.\n</step3>\n<step4>\nIn addition, engaging the child in interactive play can stimulate language development — *ìdárayá pẹ̀lú àwọn ọrẹ* encourages social interaction and vocabulary growth.\n</step4>\n<step5>\nFamily involvement is also essential; parents should create a language-rich environment — *àyíká tó kún fún èdè* at home to support learning.\n</step5>\n<step6>\nLastly, consulting with a pediatrician for a comprehensive evaluation can identify any underlying issues — *ìtẹ́numọ́ pẹ̀lú dókítà* ensures the child receives appropriate care.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú tó yẹ ni ìtọ́jú ẹnu, ìdárayá pẹ̀lú àwọn ọrẹ, àti àyíká tó kún fún èdè ní ilé.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 65 kan ṣe afihan irora ikun ati àgbegbèdè idọti, eyi ti o ni ẹ̀dùn-ẹ̀dùn ìgbẹ̀, ti a ti tọ́jú pẹlu awọn afikun ti o wa lati ra ni ile-apò. Da lori awọn ami aisan rẹ ati itan-akọọlẹ ti o yẹ, kini idi ti o ṣe pataki julọ ti ipo rẹ, gẹgẹ bi awọn abajade bii aisìwaju awọn ìṣù ati irora ni apa osi isalẹ ikun?", "reasoning": "<thinking><step1>\nThe question is asking about a 65-year-old man who presents with abdominal pain and constipation, which is associated with *discomfort* — it wants to know the most important cause of his condition based on his symptoms and medical history.\n</step1>\n<step2>\nAbdominal pain in this context could indicate various issues, but given his age, we must consider serious conditions — *awọn ipo to ṣe pataki*.\n</step2>\n<step3>\nConstipation, especially with associated pain in the lower left abdomen, may suggest a possible obstruction or even *ìfarapa* in the intestines.\n</step3>\n<step4>\nIn older patients, conditions like diverticulitis or colorectal cancer are significant concerns — *ìfarapa diverticular* or *ìkànsí àtọgbẹ* can lead to these symptoms.\n</step4>\n<step5>\nAdditionally, the history of discomfort and the fact that he is self-treating with over-the-counter supplements raises the possibility of inadequate management of a more serious underlying issue.\n</step5>\n<step6>\nThus, the most critical consideration here is to rule out serious gastrointestinal conditions that could lead to complications — *ìṣòro àtọgbẹ to le fa awọn abajade to burú*.\n</step6></thinking>", "answer": "<answer>Ìdí pataki julọ ti ipo rẹ ni lati ṣe ayẹwo ìfarapa diverticular tabi àtọgbẹ colorectal.</answer>", "language": "Yoruba"}
{"question": "Obìnrin kan tó jẹ́ ọmọ ọdún mẹ́tádínlógún tó lóyún ń ṣe ìrora pẹ̀lú ẹ̀jẹ̀ díẹ̀. Nígbà tí a ṣe àyẹ̀wò rẹ̀, àyà rẹ̀ ń ṣe ìrora, tí a sì gbọ́ ohùn ọmọ náà mọ́. Àrùn wo ni ó ṣeé ṣe jùlọ nípa àwọn àmì ìṣẹ̀lẹ̀ wọ̀nyí?", "reasoning": "<thinking><step1>\nThe question asks: “What illness is most likely given the symptoms of a [pregnant woman = obìnrin tó lóyún] who is 19 years old, experiencing pain with some [blood = ẹ̀jẹ̀]?” This indicates a concern about potential complications during pregnancy.\n</step1>\n<step2>\nThe symptoms include abdominal pain and the presence of blood, which can suggest several conditions — *àwọn àrùn* that may arise during pregnancy.\n</step2>\n<step3>\nOne possible condition is a [miscarriage = ìfarapa], especially if the pain is severe and accompanied by bleeding — *ìrora to lagbara*.\n</step3>\n<step4>\nAnother possibility is an [ectopic pregnancy = ìyàtọ̀yàtọ̀], where the embryo implants outside the uterus, causing pain and bleeding — *ìrora pẹ̀lú ẹ̀jẹ̀* can be significant in this case.\n</step4>\n<step5>\nAdditionally, conditions like [placental abruption = ìfarapa àpò ẹ̀jẹ̀] could also be considered, where the placenta detaches from the uterus prematurely, leading to pain and bleeding.\n</step5>\n<step6>\nGiven these symptoms, the most likely diagnosis would be a miscarriage, particularly if the bleeding is substantial and the pain is acute.\n</step6></thinking>", "answer": "<answer>Ìfarapa ni àrùn tó ṣeé ṣe jùlọ nípa àwọn àmì ìṣẹ̀lẹ̀ wọ̀nyí.</answer>", "language": "Yoruba"}
{"question": "Irú ṣiṣe iyatọ wo ni a lo fun ọpọlọpọ awọn ileal atresias ti o fihan irisi 'okun sisà dídí' tabi 'okun awọn adiẹ'?", "reasoning": "<thinking><step1>\nThe question asks: “Irú ṣiṣe iyatọ wo ni a lo fun ọpọlọpọ awọn [ileal atresias = ileal atresias] ti o fihan irisi 'okun sisà dídí' tabi 'okun awọn adiẹ'?” — meaning it wants to know what types of surgical procedures are used for various ileal atresias that present with the appearance of 'string of pearls' or 'bird beak'.\n</step1>\n<step2>\nIleal atresias are congenital conditions where the ileum is obstructed — *iyipada ti ileal* — leading to intestinal blockage.\n</step2>\n<step3>\nThe 'string of pearls' sign indicates multiple dilated loops of bowel, while 'bird beak' suggests a tapering at the obstruction site — *iyipada ti o ni idiwọ*.\n</step3>\n<step4>\nSurgical intervention is necessary, typically involving resection of the atretic segment — *iyipada ti a fi n yọ apakan ti o ni idiwọ* — and anastomosis of the healthy ends.\n</step4>\n<step5>\nIn some cases, if the bowel is severely compromised, a stoma may be created — *stoma* — to divert the fecal stream temporarily.\n</step5>\n<step6>\nThus, the surgical approach depends on the specific presentation and severity of the atresia — *iyato ti o wa ninu irisi ati iwa*.\n</step7>\n<step7>\nIn summary, the procedures involve resection and anastomosis, or possibly stoma creation, based on the condition's characteristics.\n</step7></thinking>", "answer": "<answer>Iyatọ ti a lo fun ileal atresias pẹlu 'okun sisà dídí' tabi 'okun awọn adiẹ' ni resection ati anastomosis, tabi stoma ti a ba nilo.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 58 kan wá sí ẹka pajawiri pẹlu ẹ̀dùn-ọrọ̀ pàtàkì pé ó ń gbọ́ ohun ṣiṣiṣi ní etí rẹ̀, tí ó bẹ̀rẹ̀ wàáàà lọ́wọ́ kan sẹhin, tí ó sì ti wá di ìgbàgbé. Ẹ̀rù ni àìsàn tó ní rí, àfi àrùn ìgbàgbẹ́ orokò mẹ́rin rẹ̀. Ògbógi ìṣègùn ti wò ó nígbà diẹ̀ sẹ́yìn nítorí àrùn ìgbàgbẹ́ orokò mẹ́rin rẹ̀, ṣugbọn ó kọ̀ láti fi orokò rẹ̀ rọ́pọ̀, ó sì fẹ́ kí wọ́n lo ìṣègùn. Ìyàwó rẹ̀ sọ pé kí wọ́n tó lọ rìn kiri lónìí, ó dà bí ẹni tí ó ti gbàgbé, kò sì sí bí ara rẹ̀. Wọ́n pinnu láti dúró sílé, nígbà tí wọ́n sì kà á bí wákàtí 14 sẹ́yìn, kò sì tíì ní ìmọ̀. Àyẹ̀wo ara rẹ̀ fi hàn pé ó gbàgbé. Wọ́n ń ṣe àyẹ̀wo àwọn àkọ́kọ́ rẹ̀, wọ́n sì ń mú ìṣẹ̀lẹ̀ rẹ̀. Nínú àwọn wọ̀nyí, èwo ni ó ṣeé ṣe jù lọ láti rí lórí ìwádìí gáàsì ẹ̀jẹ̀?\nA. pH: 7.30, PaCO2: 15 mmHg, HCO3-: 16 mEq/L\nB. pH: 7.31, PaCO2: 31 mmHg, HCO3-: 15 mEq/L\nC. pH: 7.37, PaCO2: 41 mmHg, HCO3-: 12 mEq/L\nD. pH: 7.41, PaCO2: 65 mmHg, HCO3-: 34 mEq/L\nE. pH: 7.47, PaCO2: 11 mmHg, HCO3-: 24 mEq/L", "reasoning": "<thinking><step1>\nThe question describes a 58-year-old man who presents to the emergency department with a significant complaint of hearing a ringing in his ear, which started about a week ago and has become persistent. This suggests a possible medical condition related to his auditory system.\n</step1>\n<step2>\nHe has a history of chronic obstructive pulmonary disease (COPD) — *àrùn ìgbàgbẹ́ orokò mẹ́rin* — and has been reluctant to use his inhaler, which indicates poor management of his respiratory condition.\n</step2>\n<step3>\nHis wife mentions that he seems forgetful and has not been himself lately, which could imply cognitive issues or a possible exacerbation of his COPD affecting his overall health.\n</step3>\n<step4>\nGiven that he has been in this state for about 14 hours without improvement, it raises concerns about his respiratory status and potential acid-base imbalances.\n</step5>\n<step5>\nTo determine the most likely gas exchange abnormalities, we need to analyze the provided arterial blood gas (ABG) results, focusing on pH, PaCO2, and HCO3- levels.\n</step6>\n<step6>\nIn this context, a low pH indicates acidosis, and a high PaCO2 suggests respiratory acidosis, which is common in COPD exacerbations. The option that best fits this scenario is A: pH: 7.30, PaCO2: 15 mmHg, HCO3-: 16 mEq/L, as it shows significant respiratory acidosis.\n</step7>\n<step7>\nThus, the most likely ABG result to find in this patient would be indicative of respiratory failure due to his underlying COPD and current symptoms.\n</step7></thinking>", "answer": "<answer>pH: 7.30, PaCO2: 15 mmHg, HCO3-: 16 mEq/L</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹsan kan ti o ní àìlera ikọ́kun ti a ṣakoso daradara, ti o tẹsiwaju pẹlu irẹwẹsi, n ni awọn aṣọ funfun lori mucosa buccal rẹ lakoko ti o nlo awọn beta-agonists ti o kuru, awọn steroids ti a gbe sinu afẹfẹ ojoojumọ, ati oluṣe leukotriene kan. Kini igbesẹ ti o dara julọ lati yanju ọrọ yii?", "reasoning": "<thinking><step1>\nThe question asks: “What is the best step to resolve the issue for a nine-year-old boy with well-controlled asthma who continues to experience oral thrush while using short-acting beta-agonists, daily inhaled steroids, and a leukotriene receptor antagonist?” \n</step1>\n<step2>\nOral thrush, or *àìlera ikọ́kun*, is a common side effect of inhaled corticosteroids — *stéroïdes inhalés* — due to the suppression of local immune response in the mouth.\n</step2>\n<step3>\nIn this case, the boy is using *beta-agonists* and *stéroïdes*, which can lead to fungal overgrowth — *àkúnya àkúnya* — especially if he does not rinse his mouth after using these medications.\n</step3>\n<step4>\nThe best approach would be to ensure proper oral hygiene, including rinsing the mouth after inhaler use — *fifọ́ ẹnu lẹ́yìn lilo inhaler* — to reduce the risk of thrush.\n</step4>\n<step5>\nIf thrush persists, a topical antifungal treatment may be necessary — *ìtọ́jú antifungal* — to directly address the fungal infection.\n</step5>\n<step6>\nAdditionally, reviewing the inhaler technique with the patient and caregiver is crucial to ensure effective medication delivery and minimize side effects.\n</step6>\n<step7>\nThus, the best step is to improve oral hygiene practices and consider antifungal treatment if necessary.\n</step7></thinking>", "answer": "<answer>Igbesẹ ti o dara julọ ni lati mu awọn iṣe hygiene ẹnu dara si ati lati ronu itọju antifungal ti o ba jẹ dandan.</answer>", "language": "Yoruba"}
{"question": "Fun awọn eniyan nibiti o wuwo ti afẹfẹ oxygen ti o pọju, $X$, ni apapọ ti 54.030 ati iwọn iyato ti 5.8, ka iye ti o jẹ iye iṣeeṣe pe apapọ ayẹwo $\bar{X}$ ti ayẹwo ti ara ilu ti iwọn 47 ṣubu laarin 52.761 ati 54.453.", "reasoning": "<thinking><step1>\nThe question asks: “Ka iye ti o jẹ iye iṣeeṣe pe apapọ ayẹwo [sample mean] $ \\bar{X} $ ti ayẹwo ti ara ilu [population sample] ti iwọn [size] 47 ṣubu laarin 52.761 ati 54.453?” — meaning it wants to find the probability that the sample mean falls within a specific range.\n</step1>\n<step2>\nWe know the population mean is 54.030 and the standard deviation is 5.8. To find the probability, we first need to calculate the standard error (SE) — *iyato boṣewa* ti apapọ.\n</step2>\n<step3>\nThe formula for SE is: $ SE = \\frac{\\sigma}{\\sqrt{n}} $, where $ \\sigma $ is the standard deviation and $ n $ is the sample size. Here, $ n = 47 $.\n</step3>\n<step4>\nCalculating SE: $ SE = \\frac{5.8}{\\sqrt{47}} \\approx 0.84 $. Now, we can standardize the values 52.761 and 54.453 using the z-score formula: $ z = \\frac{X - \\mu}{SE} $.\n</step4>\n<step5>\nFor 52.761: $ z = \\frac{52.761 - 54.030}{0.84} \\approx -1.51 $; for 54.453: $ z = \\frac{54.453 - 54.030}{0.84} \\approx 0.50 $.\n</step6>\n<step7>\nNext, we look up these z-scores in the standard normal distribution table. The probability for $ z = -1.51 $ is approximately 0.065, and for $ z = 0.50 $, it is about 0.691. \n</step7>\n<step8>\nTo find the probability that $ \\bar{X} $ falls between these two values, we subtract the two probabilities: $ P(-1.51 < z < 0.50) = 0.691 - 0.065 = 0.626 $.\n</step8></thinking>", "answer": "<answer>Iye iṣeeṣe pe apapọ ayẹwo $ \\bar{X} $ ti ayẹwo ti ara ilu ti iwọn 47 ṣubu laarin 52.761 ati 54.453 ni 0.626.</answer>", "language": "Yoruba"}
{"question": "Ile-iṣẹ wo ni orisun alaye pataki kan lori iye owo gbese ti awọn iṣowo tita ọja?", "reasoning": "<thinking><step1>\nThe question asks: “Ile-iṣẹ wo ni orisun alaye pataki kan lori iye owo gbese ti awọn iṣowo tita ọja?” — meaning it wants to know which company provides important information about the cost of debt for retail businesses.\n</step1>\n<step2>\nIn the context of finance, *iye owo gbese* refers to the cost of debt, which is crucial for understanding a company's financial health — *ilera inawo*.\n</step2>\n<step3>\nCompanies like Bloomberg or Moody's are known for providing detailed financial data — *data inawo* — including cost of debt metrics.\n</step3>\n<step4>\nThese companies analyze market trends and provide reports that help businesses assess their *gbese* levels and manage their finances effectively.\n</step4>\n<step5>\nIn Nigeria, local firms like *Nigerian Stock Exchange* may also offer insights into the cost of debt for retail businesses — *awọn iṣowo tita ọja*.\n</step5>\n<step6>\nThus, the primary sources of such information are financial data companies that specialize in market analysis and reporting.\n</step6></thinking>", "answer": "<answer>Ile-iṣẹ pataki kan ti o n pese alaye lori iye owo gbese ti awọn iṣowo tita ọja ni Bloomberg tabi Moody's.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 57 ni a gba wọle si Ẹ̀rù Iṣẹ́-Aláàbò sí ààrùn nítorí ìrora ikùn tí ó ṣẹlẹ̀ lọ́tẹ̀lẹ̀ tí ó tàn sí ẹ̀yìn, ìrírí, àti àwọn ìgbà ẹ̀gbẹ̀rún àfikún fún wakati 10 sẹ́yìn. Kò ní itan iṣoogun pataki kan rí. Ó jẹ́wọ́ pé ó mu ọtí gbogbo alẹ́. Nígbà tí a gba a wọlé, a rí i pé iwọn otutu ara rẹ̀ jẹ́ 37.5°C (99.5°F), iwọn ìgbìyẹn afẹ́fẹ́ jẹ́ 20/min, iwọn ìṣẹ́ ọkàn rẹ̀ jẹ́ 120/min, àti ẹ̀rù ẹ̀jẹ̀ rẹ̀ jẹ́ 120/76 mm Hg. Ó dàbí ẹni tí ó rẹ̀wẹ̀sì pẹlu oju tí ó sunkún, ó sì ní ìrora epigastric tí ó ṣe pataki àti àwọ̀ àyípadà flank. Ẹgbẹ́ ilé-ẹ̀kọ́ ibẹ̀rẹ̀ fi hàn gẹ́gẹ́ bí:\nIwọn apapọ̀ (WBC) 10,000/mm3\nIwọn platelet 140,000/mm3\nIwọn suga ẹjẹ 160 mg/dL\nIwọn Serum LDH 500 IU/L\nAspartate aminotransferase 400 IU/dL\nSerum Amylase 500 IU/L\nSerum Lipase 300 IU/L\nẸ̀yítí nínú àwọn ọ̀na wọ̀nyí yóò ṣe àṣàrò ìwọ̀n ìwọ̀n ní ọ̀rọ̀ yìí?\nA. Glucose, LDH, AST\nB. Ọjọ́-orí, LDH, AST\nC. WBC, iwọn platelet, AST\nD. AST, amylase, lipase", "reasoning": "<thinking><step1>\nThe question is asking which laboratory values are significant in this clinical scenario involving a 57-year-old man with abdominal pain and various lab results. Key terms include [ìrora ikùn = abdominal pain], [iṣẹ́-aláàbò = emergency], and [ìwọn apapọ̀ = laboratory values].\n</step1>\n<step2>\nThe patient presents with abdominal pain and has elevated levels of certain enzymes and blood components — *iyẹn ni, awọn ipele ti LDH, AST, amylase, ati lipase*.\n</step2>\n<step3>\nElevated AST (aspartate aminotransferase) can indicate liver damage or disease, while high amylase and lipase levels suggest *ìfarapa àyà = pancreatitis*.\n</step3>\n<step4>\nThe WBC count is slightly elevated, which may indicate an inflammatory response — *ìdáhùn àìlera* — but the platelet count is within normal limits.\n</step5>\n<step5>\nConsidering the options, we need to identify which combination of values is most relevant to the patient's condition. The presence of elevated AST, amylase, and lipase strongly points towards pancreatitis.\n</step6>\n<step6>\nThus, the most significant values in this context are AST, amylase, and lipase, which corresponds to option D.\n</step7></thinking>", "answer": "<answer>D. AST, amylase, lipase</answer>", "language": "Yoruba"}
{"question": "Ninu ọmọ ọdun kan ati idaji, eyin tuntun bẹrẹ sí fà jáde.  Eyi ni eyin wẹ́wẹ́ wo ni o ṣeé ṣe julọ lati máa fà jáde ni ọjọ ori yìí?", "reasoning": "<thinking><step1>\nThe question asks: “At what age do new teeth start to emerge in a [ọmọ = child] of one and a half years?” — meaning it wants to know which teeth are most likely to come in at this age.\n</step1>\n<step2>\nTypically, by the age of 18 months, *eyin wẹ́wẹ́* (baby teeth) are still developing. The first molars usually come in around this time.\n</step2>\n<step3>\nIn this age range, *eyin àkọ́kọ́* (primary teeth) like the lower central incisors may have already emerged, and the upper central incisors are likely to follow.\n</step4>\n<step4>\nParents often notice that *eyin* (teeth) can cause discomfort, leading to symptoms like *ìfarapa* (irritability) or *ìkó* (drooling).\n</step5>\n<step5>\nSo, at one and a half years, the most common teeth to emerge are typically the upper and lower central incisors, which are crucial for early chewing.\n</step6>\n<step6>\nIn summary, *eyin àkọ́kọ́* (primary teeth) like the central incisors are the most likely to come in at this age.\n</step6></thinking>", "answer": "<answer>Ni ọjọ ori kan ati idaji, eyin àkọ́kọ́ ti o ṣeé ṣe julọ lati fà jáde ni eyin àkọ́kọ́ àtàwọn eyin àgbà.</answer>", "language": "Yoruba"}
{"question": "Àṣàyàn tuntun kan fun àrùn Lyme ti a ti ṣe.  Nígbà tí a ti dán àṣàyàn náà wò gidigidi ní Maine, ẹgbẹ́ àwọn olùfọwọ́ṣe kan ń pinnu láti dán an wò ní Gúúsù Kalifornia. Ní ìmọ̀lò sí bí àṣàyàn náà ṣe ń ṣiṣẹ́ ní Maine, kí nínú àwọn ọ̀nà wọ̀nyí ni wíwádìí àṣàyàn náà ní Gúúsù Kalifornia yíò nípa lórí bí ó ṣe ń ṣiṣẹ́?\nA. Dín dídàgbàsí iye ìṣeeṣe odi ti àṣàyàn àrùn Lyme kù\nB. Dín ìṣeeṣe tí aláìsàn kan tí kò ní àrùn Lyme ní gidi ní ìdánwò odi kù\nC. Ìṣeeṣe tí ẹnì kan tí ó ní ìdánwò rere ní gidi ní àrùn Lyme pọ̀ sí i\nD. Dín dídàgbàsí iye ìṣeeṣe rere ti àṣàyàn àrùn Lyme kù\nE. Ìṣeeṣe tí ẹnì kan tí ó ní ìdánwò odi ní gidi kò ní àrùn Lyme pọ̀ sí i\n\"", "reasoning": "<thinking><step1>\nThe question is asking about the implications of a new test for Lyme disease [àrùn Lyme] that has been validated in Maine and is now being considered for use in Southern California.\n</step1>\n<step2>\nThe focus is on how the test's performance in Southern California might differ from its performance in Maine — *báwo ni àṣàyàn náà ṣe ń ṣiṣẹ́*.\n</step2>\n<step3>\nOne key aspect to consider is the probability of false negatives — *ìṣeeṣe ti àṣàyàn àrùn Lyme kù* — which refers to the likelihood that the test fails to detect the disease when it is present.\n</step3>\n<step4>\nIf the test reduces the probability of false negatives, it means that more true cases of Lyme disease will be identified — *ìṣeeṣe tí ẹnì kan tí ó ní ìdánwò rere ní gidi ní àrùn Lyme pọ̀ sí i*.\n</step4>\n<step5>\nAlternatively, if the test increases the probability of false positives, it could lead to misdiagnosis — *ìṣeeṣe tí aláìsàn kan tí kò ní àrùn Lyme ní gidi ní ìdánwò odi kù*.\n</step5>\n<step6>\nThus, the most relevant outcome for the test's application in Southern California would be the increase in the detection of true Lyme disease cases — *ìṣeeṣe tí ẹnì kan tí ó ní ìdánwò rere ní gidi ní àrùn Lyme pọ̀ sí i*.\n</step6></thinking>", "answer": "<answer>Ìṣeeṣe tí ẹnì kan tí ó ní ìdánwò rere ní gidi ní àrùn Lyme pọ̀ sí i.</answer>", "language": "Yoruba"}
{"question": "Àpọǹ lára, òtútù, àti ìrora ikùn ni àpọǹ àrùn kan fi wá síbi ìtójú lẹ́yìn tí ó lọ síbi ìpàdé àwọn ènìyàn, tí àwọn ààmì náà sì bẹ̀rẹ̀ ní nǹkan bí wákàtí mẹ́ta. Ṣe àwárí ẹ̀dá tí ó fà á tí ó ṣeé ṣe jùlọ fún ìkọsẹ̀ oúnjẹ tí ó yára báyìí.", "reasoning": "<thinking><step1>\nThe question asks: “What is the most likely cause of symptoms like [àpọǹ lára = body ache], [òtútù = chills], and [ìrora ikùn = abdominal pain] that started about three hours after attending a gathering?” \n</step1>\n<step2>\nThese symptoms suggest a possible infection or illness, often linked to foodborne pathogens — *àwọn arun tí a lè gba láti oúnjẹ*.\n</step2>\n<step3>\nConsidering the timing, it’s likely that the symptoms are due to food poisoning — *ìkọsẹ̀ oúnjẹ* — which can occur within hours of consuming contaminated food.\n</step3>\n<step4>\nCommon culprits include bacteria like Salmonella or E. coli, which can cause gastrointestinal distress — *ìfarapa àtọ́gbẹ́*.\n</step4>\n<step5>\nIn this case, if the gathering involved shared food, it increases the risk of exposure to these pathogens — *àwọn arun*.\n</step6>\n<step6>\nThus, the most probable cause of these symptoms is food poisoning from contaminated food consumed at the gathering.\n</step6></thinking>", "answer": "<answer>Ìkọsẹ̀ oúnjẹ ni àpọǹ lára, òtútù, àti ìrora ikùn tí ó bẹ̀rẹ̀ lẹ́yìn ìpàdé ènìyàn.</answer>", "language": "Yoruba"}
{"question": "Àṣẹ̀wádìí 1 | Ẹgbẹ́ àṣàtúntùsí gbogbo ni ó ní ìṣirò agbára-àkọ́kọ́. Àṣẹ̀wádìí 2 | Ẹgbẹ́ gbogbo tí ó ní ìṣirò agbára-àkọ́kọ́ ni ó ṣàtúntùsí.\nA. Àṣẹ̀wádìí 1 jẹ́ òtítọ́ nígbà gbogbo, Àṣẹ̀wádìí 2 jẹ́ èké fún àwọn ẹgbẹ́ kanṣoṣo\nB. Òtítọ́, Òtítọ́\nC. Àṣẹ̀wádìí 1 jẹ́ èké nígbà gbogbo, Àṣẹ̀wádìí 2 jẹ́ òtítọ́ fún àwọn ẹgbẹ́ kanṣoṣo\nD. Òtítọ́, Èké\nE. Àṣẹ̀wádìí 1 jẹ́ òtítọ́ fún àwọn ẹgbẹ́ kanṣoṣo, Àṣẹ̀wádìí 2 jẹ́ òtítọ́ nígbà gbogbo\nF. Àṣẹ̀wádìí 1 jẹ́ èké fún àwọn ẹgbẹ́ kanṣoṣo, Àṣẹ̀wádìí 2 jẹ́ òtítọ́ nígbà gbogbo\nG. Àwọn àṣẹ̀wádìí méjèèjì máa ń jẹ́ òtítọ́, máa ń jẹ́ èké\nH. Èké, Èké\nI. Èké, Òtítọ́\nJ. Àṣẹ̀wádìí 1 jẹ́ èké nígbà gbogbo, Àṣẹ̀wádìí 2 jẹ́ èké nígbà gbogbo", "reasoning": "<thinking><step1>\nThe question presents two statements: \"Àṣẹ̀wádìí 1\" and \"Àṣẹ̀wádìí 2,\" asking whether they are true or false. The first statement claims that \"every group with a primary power calculation has a consensus,\" while the second states that \"only groups with a primary power calculation have consensus.\"\n</step1>\n<step2>\nTo analyze this, we need to consider the implications of each statement. The first statement suggests a universal truth about all groups with a primary power calculation — *ìṣirò agbára-àkọ́kọ́* — implying that they all reach a consensus.\n</step2>\n<step3>\nThe second statement, however, limits the consensus to only those groups with a primary power calculation, which could be misleading. It suggests that groups without this calculation cannot have a consensus, which is not necessarily true.\n</step3>\n<step4>\nThus, if Àṣẹ̀wádìí 1 is true for all groups, Àṣẹ̀wádìí 2 must be false for some groups that may reach a consensus without a primary power calculation — *àwọn ẹgbẹ́ tí kò ní ìṣirò agbára-àkọ́kọ́*.\n</step4>\n<step5>\nTherefore, the correct interpretation is that Àṣẹ̀wádìí 1 is true, while Àṣẹ̀wádìí 2 is false for certain groups, leading us to conclude that option A is the most accurate.\n</step5></thinking>", "answer": "<answer>Àṣẹ̀wádìí 1 jẹ́ òtítọ́ nígbà gbogbo, Àṣẹ̀wádìí 2 jẹ́ èké fún àwọn ẹgbẹ́ kanṣoṣo.</answer>", "language": "Yoruba"}
{"question": "Olùwádìí kan ń kẹ́kọ̀ọ́ ìmúlò àti ìṣiṣẹ́ ti awọn immunoglobulins tí a gbé kọjá láti ọ̀dọ̀ ìyá sí ọmọ. Ìṣiṣẹ́ tí ọfà ń tọ́ka sí ni ohun pàtàkì tó mú kí ìṣẹ̀lẹ̀ immunoloji wo ṣẹ?\nA. Ṣíṣẹ̀dá dimer\nB. Didí mọ́ awọn sẹ́ẹ̀li mast\nC. Ṣíṣe àṣepò complement\nD. Didí mọ́ antigen\nE. Ṣíṣe ìdánilójú idiotype\n\"", "reasoning": "<thinking><step1>\nThe question translates to: \"What is the important immunological event that occurs when a child learns the function and operation of immunoglobulins transferred from mother to child?\" It asks about a specific immunological process.\n</step1>\n<step2>\nIn immunology, the transfer of immunoglobulins, especially IgG, from mother to child is crucial for providing passive immunity — *imúniláàbò àìlera*.\n</step2>\n<step3>\nOne key event in this context is the interaction between antibodies and antigens — *ìbáṣepọ̀ láàárín àwọn antibody àti antigen*.\n</step4>\n<step4>\nAmong the options, \"Didí mọ́ antigen\" refers to the binding of antibodies to antigens, which is essential for the immune response — *ìdáhùn àìlera*.\n</step5>\n<step5>\nThe other options, like \"Ṣíṣẹ̀dá dimer\" or \"Ṣíṣe àṣepò complement,\" are related but do not directly address the primary function of immunoglobulins in this scenario.\n</step6>\n<step6>\nThus, the most relevant process is the binding of antibodies to antigens, which is fundamental for the immune system's recognition and response.\n</step6></thinking>", "answer": "<answer>Didí mọ́ antigen.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹ́wàá kan ní ìtàn àìsàn ibà, ikọ́ tí ó ń tú, àti àwọn ìṣẹ̀lẹ̀ ìtànṣán ti omi ìmú tó rẹ̀wẹ̀sì. Ẹ̀dá ara rẹ̀ fi hàn ní àwọn àwọn crackles àti rhonchi tí ó gbòòrò káàkiri, ati X-ray àyẹ̀wò ọmu rẹ̀ tì í ṣàpẹẹrẹ àwọn àrùn ọgbẹ́ tí ń pada. Da lori àwọn àkíyèsí wọnyi, àìṣiṣẹ́ wo ni ninu irú sẹ́ẹ̀li ọgbẹ́ kan pato ṣe ń fa àwọn àrùn tí ń pada wọnyi julọ?", "reasoning": "<thinking><step1>\nThe question asks about a 10-year-old boy with a history of [ìtàn àìsàn ibà = pneumonia], experiencing cough and respiratory distress, showing crackles and rhonchi, and having an X-ray that indicates recurrent lung infections. It seeks to identify the specific cellular dysfunction causing these recurrent infections.\n</step1>\n<step2>\nIn cases of recurrent pneumonia, one must consider the immune system's role — *ipa eto ajẹsara* ni o ṣe pataki. If the immune response is compromised, it can lead to repeated infections.\n</step2>\n<step3>\nThe presence of crackles and rhonchi suggests airway obstruction and fluid in the lungs — *ìdènà àtẹ́gùn àti omi nínú ọmu*. This can be due to a failure in clearing pathogens effectively.\n</step3>\n<step4>\nA specific dysfunction could be related to *ciliated epithelial cells* — *àwọn sẹẹli ti o ni irun* that help clear mucus and pathogens. If these cells are damaged or not functioning properly, it can lead to recurrent infections.\n</step4>\n<step5>\nAdditionally, conditions like *cystic fibrosis* or *primary ciliary dyskinesia* could be underlying causes, where the cilia do not move effectively, leading to mucus buildup and infections.\n</step5>\n<step6>\nThus, the recurrent infections in this boy could be primarily due to a dysfunction in the ciliated cells, impairing the clearance of pathogens from the respiratory tract.\n</step6></thinking>", "answer": "<answer>Àìṣiṣẹ́ sẹ́ẹ̀li ti o fa àwọn àrùn tí ń pada ni àìlera àwọn sẹẹli ti o ni irun, ti o n fa ìdènà àtẹ́gùn àti ikọ́ tí ń tú.</answer>", "language": "Yoruba"}
{"question": "Ipọn ti a ṣe akojọ wo ni ko maa n fa irora to tọka si apa inu ẹsẹ ọtun?", "reasoning": "<thinking><step1>\nThe question asks: “Ipọn ti a ṣe akojọ wo ni ko maa n fa irora to tọka si apa inu ẹsẹ ọtun?” — meaning it wants to know which conditions can cause pain in the right inner thigh.\n</step1>\n<step2>\nPain in the inner thigh can be caused by various factors, such as *injuries* or *muscle strains* — *ibajẹ* tabi *iṣoro iṣan*.\n</step2>\n<step3>\nConditions like *hernia* or *thigh contusions* can also lead to this pain — *hernia* le fa irora ni apa inu ẹsẹ.\n</step3>\n<step4>\nAnother possibility is *nerve compression*, which can occur due to *sciatica* — *iṣoro ẹdọfu* le fa irora ni ẹsẹ.\n</step4>\n<step5>\nIn some cases, *arthritis* or *tendonitis* can contribute to discomfort in this area — *artritis* tabi *tendonitis* le fa irora.\n</step6>\n<step6>\nSo, the conditions that can cause pain in the right inner thigh include injuries, hernias, nerve issues, and arthritis.\n</step6></thinking>", "answer": "<answer>Iwọn ti o le fa irora ni apa inu ẹsẹ ọtun ni ibajẹ, hernia, iṣoro ẹdọfu, ati artritis.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun 50 kan tí ó ní ìtàn àrùn carcinoid syndrome ń ṣe ìkùnà àti àìgbọ́ràn.  Èwo nínú àwọn wọ̀nyí kò jẹ́ òtítọ́ nípa àrùn yìí?\nA. Ó ṣẹlẹ̀ sí <10% ti àwọn ìṣòro carcinoid\nB. Ẹ̀yìn Octreotide dín àwọn àmì àìgbọ́ràn àti ìkùnà kù\nC. Àwọn ikọlu tí àníyàn, ọtí wáìnì àti oúnjẹ ńlá fà\nD. Ìkùnà pupa-fùfù tí ó tàn káàkiri ni a sábà máa ń rí pẹ̀lú àwọn carcinoids ileal", "reasoning": "<thinking><step1>\nThe question asks: “Which of the following statements is NOT true about carcinoid syndrome?” — it refers to a 50-year-old woman experiencing *ìkùnà* (failure) and *àìgbọ́ràn* (flushing).\n</step1>\n<step2>\nCarcinoid syndrome is often associated with neuroendocrine tumors, and it can cause symptoms like flushing and diarrhea — *ìkùnà* can be a significant issue.\n</step2>\n<step3>\nOption A states that it occurs in less than 10% of carcinoid problems — this seems inaccurate since carcinoid syndrome is more prevalent in patients with metastatic disease.\n</step3>\n<step4>\nOption B mentions that Octreotide reduces flushing and diarrhea symptoms — this is true as Octreotide is a common treatment for managing symptoms.\n</step4>\n<step5>\nOption C suggests that stress, alcohol, and large meals trigger symptoms — this is also true, as these factors can exacerbate flushing.\n</step6>\n<step6>\nOption D states that widespread flushing is commonly seen with ileal carcinoids — this is accurate as well, since ileal carcinoids often lead to more severe symptoms.\n</step7>\n<step8>\nThus, the statement that is NOT true is A, as carcinoid syndrome is more common than indicated.\n</step8></thinking>", "answer": "<answer>Ó ṣẹlẹ̀ sí <10% ti àwọn ìṣòro carcinoid kò jẹ́ òtítọ́ nípa àrùn yìí.</answer>", "language": "Yoruba"}
{"question": "Olóògbò kan tí ó ń ṣe iṣẹ́ iwosan àìsàn ọkàn tó lewu fẹ́ mọ̀ bóyá àmọ̀ràn tí a gbọ́ nípa ìgbọ́ tí ó ń gbà láti ọ̀pọ̀lọpọ̀ ẹ̀dọ̀fóró lè sọ̀rọ̀ nípa ipò tí ẹ̀jẹ̀ pọ̀ sí i lórí ara. Ó ṣe ìwádìí lórí àwọn àrùn 100 tí ẹ̀jẹ̀ pọ̀ sí i lórí wọn, gẹ́gẹ́ bíi Swan Ganz catheter ti fi hàn ní àpótí ìwòsàn àìsàn ọkàn tó lewu ní ilé ìwòsàn rẹ̀. Ó tún pe àwọn àrùn 100 mìíràn tí ẹ̀jẹ̀ wọn déédé, gẹ́gẹ́ bí Swan Ganz catheter ti fi hàn. Lẹ́yìn náà, ó ṣàyẹ̀wò gbogbo àwọn àrùn náà fún ìgbọ́ tí ó ń gbà láti ọ̀pọ̀lọpọ̀ ẹ̀dọ̀fóró, ó sì rí i pé àwọn àrùn 80 nínú ẹgbàáta àwọn tí ẹ̀jẹ̀ pọ̀ sí i lórí wọn ní ìgbọ́ tí ó ń gbà láti ọ̀pọ̀lọpọ̀ ẹ̀dọ̀fóró, ní ìwééwé sí àwọn àrùn 50 nínú àwọn tí ẹ̀jẹ̀ wọn déédé.  Èwo nínú àwọn wọ̀nyí ni ṣíṣe ìṣẹ́ àtọ́ka rere ti ìgbọ́ tí ó ń gbà láti ọ̀pọ̀lọpọ̀ ẹ̀dọ̀fóró fún wíwàní ẹ̀jẹ̀ tí ó pọ̀ sí i lórí ara?\nA. 50/100\nB. 80/130\nC. 50/70\nD. 100/200", "reasoning": "<thinking><step1>\nThe question is asking about the performance of a diagnostic test for a condition related to elevated blood pressure — *ìgbọ́ tí ó ń gbà láti ọ̀pọ̀lọpọ̀ ẹ̀dọ̀fóró* — based on a study involving 100 patients with elevated blood pressure and another 100 with normal blood pressure.\n</step1>\n<step2>\nFrom the study, it was found that 80 out of the 100 patients with elevated blood pressure tested positive for the condition, while only 50 out of the 100 patients with normal blood pressure tested positive.\n</step2>\n<step3>\nTo determine the positive predictive value (PPV) of the test, we need to calculate the ratio of true positives to the total number of positive tests.\n</step3>\n<step4>\nThe true positives are the 80 patients with elevated blood pressure, and the total number of patients who tested positive is 80 + 50 = 130.\n</step4>\n<step5>\nThus, the PPV can be calculated as 80/130, which represents the proportion of patients correctly identified with the condition among all those who tested positive.\n</step5>\n<step6>\nTherefore, the answer to the question regarding the effective diagnostic performance for elevated blood pressure is 80/130.\n</step6></thinking>", "answer": "<answer>80/130</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun meji kan ti o ni itan itọju ile-iwosan pupọ fun iba ati arun naa ṣe ayẹwo agbara ajẹsara. Idanwo Serum CH50 fihan pe lysis erythrocyte ti kere pupọ, ati iṣẹ iwadi siwaju jẹrisi ailagbara C8. Iru ajẹsara pataki wo ni alaisan yii ni ewu ti awọn arun ti o tun ṣe lẹẹkansi pẹlu nitori ailagbara C8?", "reasoning": "<thinking><step1>\nThe question asks: “What specific type of [ajẹsara = immunity] is this patient at risk of recurrent infections due to C8 deficiency?” This indicates a focus on the implications of a deficiency in complement component C8.\n</step1>\n<step2>\nC8 is part of the complement system, which helps in opsonization and lysis of pathogens — *o ṣe pataki fun idena awọn arun*.\n</step2>\n<step3>\nA deficiency in C8 leads to an increased susceptibility to certain infections, particularly those caused by encapsulated bacteria — *bakteria ti o ni ẹyẹ*.\n</step3>\n<step4>\nThese bacteria include *Neisseria meningitidis* and *Neisseria gonorrhoeae*, which can cause serious conditions like meningitis and gonorrhea.\n</step4>\n<step5>\nIn patients with C8 deficiency, the immune response is impaired, making it difficult to clear these infections effectively — *iyẹn ni pe, ajẹsara wọn ko lagbara to*.\n</step6>\n<step6>\nThus, the patient is at risk for recurrent infections, especially from encapsulated organisms due to the lack of effective complement activity.\n</step7>\n<step7>\nIn summary, the specific type of immunity at risk here is the ability to fight off infections from encapsulated bacteria.\n</step7></thinking>", "answer": "<answer>Ailera ajẹsara pataki ti alaisan yii ni ewu ti awọn arun ti o tun ṣe lẹẹkansi ni awọn arun ti o fa nipasẹ bakteria ti o ni ẹyẹ.</answer>", "language": "Yoruba"}
{"question": "Níwọ̀n bí 2.02 giramu ti gaasi haidrojini ti gba iwọn didùn 22.4 lita, kini iwuwo ti gaasi haidrojini ni giramu fun mililita?", "reasoning": "<thinking><step1>\nThe question asks: “Níwọ̀n bí 2.02 giramu ti [gaasi haidrojini = hydrogen gas] ti gba [iwọn didùn = volume] 22.4 lita, kini [iwuwo = weight] ti gaasi haidrojini ni giramu fun [mililita = milliliter]?” — meaning it wants to find the weight of hydrogen gas in grams per milliliter.\n</step1>\n<step2>\nTo solve this, we first note that 22.4 liters of hydrogen gas corresponds to 2.02 grams at standard temperature and pressure — *ni iwọn otutu ati titẹ boṣewa*.\n</step2>\n<step3>\nNext, we convert liters to milliliters: 22.4 liters is equal to 22,400 milliliters — *22.4 lita = 22,400 mililita*.\n</step3>\n<step4>\nNow, we can calculate the weight per milliliter by dividing the total weight by the total volume: 2.02 grams divided by 22,400 milliliters.\n</step4>\n<step5>\nThis gives us approximately 0.0000900 grams per milliliter — *iyẹn jẹ́ 0.0000900 giramu fun mililita*.\n</step5>\n<step6>\nThus, the weight of hydrogen gas is very light, which is typical for gases — *iwuwo gaasi haidrojini jẹ́ fẹ́ẹrẹ́*.\n</step6></thinking>", "answer": "<answer>Iwuwo gaasi haidrojini ni giramu fun mililita jẹ́ 0.0000900 giramu.</answer>", "language": "Yoruba"}
{"question": "Ní ọ̀rọ̀ àìsàn kan tí ó ní ìṣẹ́gun orí, tí ó ṣí ojú rẹ̀ sí ìṣẹ́lẹ̀ ìrora, tí ó dààmú, tí ó sì tọ́ka sí ibi ìrora, kini àwọn nọmba GCS rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Ní ọ̀rọ̀ àìsàn kan tí ó ní ìṣẹ́gun orí” — meaning it refers to a patient with a head injury. It wants to know the GCS (Glasgow Coma Scale) scores.\n</step1>\n<step2>\nThe GCS is a scale used to assess a patient's level of consciousness — *ìpele ìmọ̀lára* — after a head injury.\n</step2>\n<step3>\nIt consists of three components: eye opening, verbal response, and motor response — *ìfihàn oju, ìjìnlẹ̀ ọ̀rọ̀, àti ìhuwasi*.\n</step3>\n<step4>\nEach component is scored, with a total score ranging from 3 to 15 — *nọ́mbà tó wà láàárín mẹta sí mẹ́tàlá*.\n</step4>\n<step5>\nFor a patient with a head injury who is unresponsive, the GCS might be low, indicating severe impairment — *ìfarapa tó lágbára*.\n</step5>\n<step6>\nIf the patient shows some response, the scores will vary; for example, if they open their eyes to pain, that’s a score of 2 for eye opening.\n</step6>\n<step7>\nIn summary, the GCS scores depend on the patient's responses to stimuli, which indicate the severity of the head injury — *ìfarapa orí*.\n</step7></thinking>", "answer": "<answer>Àwọn nọmba GCS rẹ̀ lè jẹ́ 3 sí 15, da lori ìhuwasi àti ìfihàn rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Obìnrin kan tí ó ní ìṣòro àìsàn thyroid fún igba pipẹ́ ni a gbero láti ṣe abẹ nípa lílo subtotal thyroidectomy. Ṣáájú abẹ, oníṣẹ́ abẹ náà gbọ́dọ̀ ṣayẹwo/ṣe eyi –\nA. Ipele Calcium ninu ẹ̀jẹ̀\nB. Ṣayẹwo PTH ninu ẹ̀jẹ̀\nC. Indirect Laryngoscopy\nD. Ṣayẹwo Iodine 131", "reasoning": "<thinking><step1>\nThe question is asking what a surgeon must check before performing a subtotal thyroidectomy on a patient with a long-term thyroid disease. Key terms include [ìṣòro àìsàn thyroid = thyroid disease] and [abẹ = surgery].\n</step1>\n<step2>\nBefore surgery, it is crucial to assess the patient's overall health and any potential complications. One important factor is calcium levels, as the thyroid gland is closely related to calcium metabolism — *ìpele Calcium*.\n</step2>\n<step3>\nChecking the parathyroid hormone (PTH) levels is also vital because the parathyroid glands regulate calcium levels in the blood — *PTH ninu ẹ̀jẹ̀*.\n</step4>\n<step4>\nIndirect laryngoscopy is performed to evaluate the vocal cords and airway, which is important but not directly related to thyroid function — *ìṣàkóso laryngoscopy*.\n</step5>\n<step5>\nIodine-131 testing is typically used for imaging or treatment of thyroid conditions, but it is not a pre-operative requirement for surgery — *Ṣayẹwo Iodine 131*.\n</step6>\n<step6>\nThus, the most relevant checks before surgery would be calcium levels and PTH, but PTH is more directly linked to potential complications during thyroid surgery.\n</step6></thinking>", "answer": "<answer>B. Ṣayẹwo PTH ninu ẹ̀jẹ̀</answer>", "language": "Yoruba"}
{"question": "Wa film kan ti o dà bi Pretty Woman, Schindler's List, The Shawshank Redemption, Apollo 13:\nAwọn aṣayan:\n(A) Ni Oṣù Keje\n(B) Black Snake Moan\n(C) Dances with Wolves\n(D) Heartbreaker", "reasoning": "<thinking><step1>\nThe question asks: “Wa film kan ti o dà bi [similar to] Pretty Woman, Schindler's List, The Shawshank Redemption, Apollo 13?” — meaning it wants to identify a film that shares similarities with these titles.\n</step1>\n<step2>\nPretty Woman is a romantic comedy, while Schindler's List is a historical drama. The Shawshank Redemption is a prison drama, and Apollo 13 is a space film based on true events — *awọn fiimu mẹrin ti o ni awọn akọle oriṣiriṣi*.\n</step2>\n<step3>\nTo find a film that fits, we should consider the themes and genres of the options provided — *aṣayan*.\n</step4>\n<step4>\n(A) Ni Oṣù Keje is a romantic film, which aligns with Pretty Woman. (B) Black Snake Moan is more of a drama with darker themes. (C) Dances with Wolves is a historical epic, similar to Schindler's List. (D) Heartbreaker is a romantic comedy, akin to Pretty Woman.\n</step4>\n<step5>\nSince we are looking for a film that is similar to the majority of the listed films, *a fiimu ti o ni awọn eroja ti ifẹ ati itan* would be ideal.\n</step6>\n<step6>\nBoth Ni Oṣù Keje and Heartbreaker fit the romantic theme, but Ni Oṣù Keje is more widely recognized.\n</step6></thinking>", "answer": "<answer>Ni Oṣù Keje.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 45 kan ti o ni irora ati lile awọn ika ọwọ ti n tẹsiwaju, awọ ara ti o buru pẹlu hyperpigmentation, edema, ati aiṣedeede kidirin pataki ṣe afihan ipo ipilẹ kan pato. Da lori awọn ami aisan rẹ ati awọn abajade ile-iwosan, iwadi ile-iwosan wo ni yoo ṣe afihan julọ nipa awọn ipele haptoglobin rẹ?", "reasoning": "<thinking><step1>\nThe question asks about a 45-year-old man with symptoms like pain and stiffness in his fingers, worsening skin condition with hyperpigmentation, edema, and significant kidney dysfunction — *aiṣedeede kidirin*. It seeks to identify which laboratory test would best reflect his haptoglobin levels.\n</step1>\n<step2>\nHaptoglobin is a protein that binds free hemoglobin released from red blood cells — *hemoglobini*. In conditions like hemolysis, haptoglobin levels decrease because it gets consumed.\n</step2>\n<step3>\nGiven the symptoms, this patient may have a hemolytic anemia or a related condition, which could explain the *irora* and *lile* in his fingers due to poor circulation or inflammation.\n</step3>\n<step4>\nThe presence of edema and skin changes suggests systemic involvement, possibly indicating a chronic inflammatory process — *ilana aisan to n lọ lọwọ*.\n</step5>\n<step5>\nTo assess haptoglobin levels, a blood test would be performed, specifically looking for low haptoglobin, which indicates hemolysis — *iwadi ẹjẹ fun haptoglobin*.\n</step6>\n<step6>\nThus, the most relevant laboratory test to reflect his haptoglobin levels would be a serum haptoglobin test.\n</step6></thinking>", "answer": "<answer>Iwadii haptoglobin ni iwadi ti o yẹ julọ lati ṣe afihan awọn ipele haptoglobin rẹ.</answer>", "language": "Yoruba"}
{"question": "Ta ni ṣe afiwe pe plaque kokoro arun le fa pipadanu egungun laarin agbegbe ipa ti o to 1.5 si 2.5 mm?", "reasoning": "<thinking><step1>\nThe question asks: “Ta ni ṣe afiwe pe [plaque kokoro arun = bacterial plaque] le fa [pipadanu egungun = bone loss] laarin agbegbe ipa ti o to 1.5 si 2.5 mm?” — meaning it wants to compare whether bacterial plaque can cause bone loss within a range of 1.5 to 2.5 mm.\n</step1>\n<step2>\nBacterial plaque is known to contribute to periodontal disease, which can lead to bone loss — *pipadanu egungun* — around the teeth.\n</step2>\n<step3>\nResearch indicates that the presence of plaque can trigger inflammation — *ilana ilosoke* — in the gums, which affects the surrounding bone.\n</step3>\n<step4>\nIn this context, the area of 1.5 to 2.5 mm is significant because it represents the distance from the tooth root where bone loss can be measured.\n</step4>\n<step5>\nStudies show that as plaque accumulates, it can lead to a measurable reduction in bone density — *dinku ninu iwuwo egungun* — within this range.\n</step5>\n<step6>\nThus, it is reasonable to conclude that plaque can indeed cause bone loss in the specified area, as the inflammatory response affects the bone structure.\n</step6></thinking>", "answer": "<answer>Bẹẹni, plaque kokoro arun le fa pipadanu egungun laarin agbegbe ipa ti o to 1.5 si 2.5 mm.</answer>", "language": "Yoruba"}
{"question": "Ní ọ̀rọ̀ ọkùnrin ọdún mẹ́tádínlógún kan tí ó ní àìlera ìṣàn ẹ̀jẹ̀ ní awọn iṣan brachiocephalic mejeeji ṣáájú kí wọ́n tó wọ vena cava ṣiṣe, iṣan wo ni ó ṣeé ṣe kí ó tóbi sí i nítorí ipò yìí?", "reasoning": "<thinking><step1>\nThe question translates to: \"In a 35-year-old man with venous insufficiency in both brachiocephalic veins before they enter the vena cava, which vein is likely to be more enlarged due to this condition?\" This indicates a focus on venous anatomy and pathology.\n</step1>\n<step2>\nIn cases of venous insufficiency, *àìlera ìṣàn ẹ̀jẹ̀* leads to increased pressure in the affected veins — in this case, the brachiocephalic veins.\n</step2>\n<step3>\nThe brachiocephalic veins drain blood from the head, neck, and upper limbs into the superior vena cava — *vena cava ti o ga*.\n</step3>\n<step4>\nWhen there is insufficiency, one side may be more affected than the other, often due to anatomical variations or previous medical conditions.\n</step4>\n<step5>\nIf we consider the left brachiocephalic vein, it is typically longer and has a more horizontal course compared to the right — *iṣan ọtún*.\n</step5>\n<step6>\nThis anatomical difference can lead to greater stasis and dilation in the left vein, making it more likely to be enlarged in cases of insufficiency.\n</step6>\n<step7>\nThus, in this scenario, the left brachiocephalic vein is the one that is likely to be more enlarged due to the venous insufficiency.\n</step7></thinking>", "answer": "<answer>Iṣan brachiocephalic osi ni o ṣee ṣe ki o tobi sí i nítorí àìlera ìṣàn ẹ̀jẹ̀.</answer>", "language": "Yoruba"}
{"question": "Àpẹẹrẹ ọmọ alaisan ọdun 70 kan ti o wa ni ẹka itọju ti o lọra ń ṣe ikọlu ọ̀fọ̀ ati awọn ríru tí ó ń mì.  Àpẹẹrẹ náà ń ṣe ìkọlu ẹ̀jẹ̀ tí ó kéré, ati ẹ̀jẹ̀ rẹ̀ ti fi hàn pé ó ní àkóràn bacilli gram-negative. Àpẹẹrẹ náà bẹ̀rẹ̀ sí í ṣe ẹ̀jẹ̀ láti ibi tí a fi àwọn abẹrẹ wọ̀ ati ní ayika catheter Foley rẹ̀.  Àwọn ìwádìí ilé-ìwádìí jẹ́ bíi: Hct: 38% WBC: 15,000/mL Platelet count: 40,000/mL (gbọ̀ngbọ̀n 150,000-400,000) Peripheral blood smear: fragmented RBCs PT: gíga PTT: gíga Plasma fibrinogen: 70 mg/dL (gbọ̀ngbọ̀n 200-400)  Ẹ̀yà wo ni ó dára jùlọ láti lo fun àpẹẹrẹ yìí?\nA. Bẹ̀rẹ̀ sí í lo heparin\nB. Tọ́jú àrùn tí ó fà á\nC. Bẹ̀rẹ̀ sí í lo plasmapheresis\nD. Fún un ni vitamin K", "reasoning": "<thinking><step1>\nThe question presents a case of a 70-year-old patient in a slow care unit experiencing *ikọlu ọ̀fọ̀* (thrombocytopenia) and *ríru* (bleeding). It mentions that the patient has a low platelet count and shows signs of infection with *àkóràn bacilli gram-negative* (gram-negative bacilli infection).\n</step1>\n<step2>\nThe patient’s lab results indicate a high WBC count, low platelet count, and fragmented RBCs — suggesting a possible *arun ti o fa ikọlu* (condition causing thrombocytopenia).\n</step2>\n<step3>\nGiven the context, the patient is likely experiencing a serious condition such as *thrombotic thrombocytopenic purpura (TTP)* or *hemolytic uremic syndrome (HUS)*, which can lead to complications like *ìkó ẹ̀jẹ̀* (bleeding).\n</step3>\n<step4>\nThe options provided include starting heparin, treating the underlying disease, initiating plasmapheresis, or administering vitamin K. Among these, treating the underlying cause is crucial.\n</step5>\n<step5>\nHowever, if TTP is suspected, plasmapheresis is often the most effective treatment to remove the antibodies causing the condition — *plasmapheresis ni a lo lati yọ awọn antibody*.\n</step6>\n<step6>\nThus, the best course of action for this patient, considering the symptoms and lab results, would be to initiate plasmapheresis.\n</step6></thinking>", "answer": "<answer>Bẹ̀rẹ̀ sí í lo plasmapheresis.</answer>", "language": "Yoruba"}
{"question": "Da didara iṣẹ́ iwosan ọmọkunrin ọdún meji kan ti o ní iba, ikọ́, imú rọ, ó ń bẹ̀rù, awọ̀ rẹ̀ yí padà, awọn ẹya ara rẹ̀ tutu, ṣíṣe ẹ̀jẹ̀ ṣubu, ṣíṣe ọkàn yara, ati ẹ̀dà hepatomegaly lẹhin iṣẹgun oogun tuntun, kini ilana iṣelọpọ ti o ṣe pataki julọ ti o bajẹ?", "reasoning": "<thinking><step1>\nThe question asks: “Da didara iṣẹ́ iwosan [quality of medical care] ọmọkunrin [boy] ọdún meji kan [two-year-old] ti o ní iba [who has fever], ikọ́ [cough], imú rọ [runny nose], ó ń bẹ̀rù [is anxious], awọ̀ rẹ̀ yí padà [his skin has changed], awọn ẹya ara rẹ̀ tutu [his extremities are cold], ṣíṣe ẹ̀jẹ̀ ṣubu [experiencing blood loss], ṣíṣe ọkàn yara [rapid heartbeat], ati ẹ̀dà hepatomegaly [hepatomegaly] lẹhin [after] iṣẹgun oogun tuntun [new medication], kini ilana iṣelọpọ [what metabolic process] ti o ṣe pataki julọ [is most critical] ti o bajẹ [that is impaired]?” \n</step1>\n<step2>\nThis child presents with multiple symptoms indicating a serious condition — *a ti ni ibanujẹ* about the potential for sepsis or a severe infection.\n</step2>\n<step3>\nThe combination of fever, cough, and cold extremities suggests *hypoperfusion* or inadequate blood flow, which can lead to *choc séptique*.\n</step3>\n<step4>\nHepatomegaly indicates liver involvement, possibly due to *inflammation* or *toxicity* from the new medication, affecting liver function and metabolism.\n</step5>\n<step5>\nIn this context, the most critical metabolic process that may be impaired is *gluconeogenesis*, as the liver struggles to produce glucose during stress.\n</step6>\n<step6>\nThus, the metabolic process that is most likely impaired in this case is gluconeogenesis due to liver dysfunction.\n</step6></thinking>", "answer": "<answer>Ilana iṣelọpọ ti o bajẹ julọ ni gluconeogenesis nitori iṣẹ́ àyà ti ko dara.</answer>", "language": "Yoruba"}
{"question": "Irinwo iranlowo wo ni o jẹ dandan lati ṣayẹwo ipa ti igbaradi ẹnu fun ọmọde kan?", "reasoning": "<thinking><step1>\nThe question asks: “Irinwo iranlowo wo ni o jẹ dandan lati ṣayẹwo ipa ti igbaradi ẹnu fun ọmọde kan?” — meaning it wants to know what kind of assistance is necessary to evaluate the effects of oral preparation for a child.\n</step1>\n<step2>\nEvaluating the effects of oral preparation — *igbaradi ẹnu* — involves understanding how the child responds to the treatment.\n</step2>\n<step3>\nFirst, it’s important to assess the child’s overall health status — *ilera gbogbogbo ọmọ naa* — before starting any oral medication.\n</step3>\n<step4>\nNext, monitoring for side effects is crucial; for example, checking for *iyipada ninu ihuwasi* or any allergic reactions.\n</step4>\n<step5>\nAdditionally, regular follow-ups are necessary to determine the effectiveness of the treatment — *iṣeduro ti itọju* — and make adjustments if needed.\n</step6>\n<step6>\nIn summary, a comprehensive approach is required, including health assessments, monitoring side effects, and follow-ups to evaluate the impact of oral preparations on the child.\n</step6></thinking>", "answer": "<answer>Irinwo iranlowo ti o jẹ dandan ni ayẹwo ilera, atẹle awọn ipa ẹgbẹ, ati awọn ipade atẹle lati ṣe ayẹwo ipa igbaradi ẹnu fun ọmọde kan.</answer>", "language": "Yoruba"}
{"question": "Báwo ni a ṣe lè tọ́jú igbọ́gbọ́ tí ó jẹ́ aláìmọ́ tó pọ̀ gan-an tí ó hàn sílẹ̀ lẹ́yìn wakati mejila lẹ́yìn ìṣẹ̀lẹ̀ kan, kí a sì rí i dajú pé ó wò sàn dáadáa?", "reasoning": "<thinking><step1>\nThe question asks: “Báwo ni a ṣe lè tọ́jú [igbọ́gbọ́ = wound] tí ó jẹ́ aláìmọ́ [infected] tó pọ̀ gan-an tí ó hàn sílẹ̀ lẹ́yìn wakati mejila [twelve hours] lẹ́yìn ìṣẹ̀lẹ̀ kan [after an incident]?” — meaning it seeks to understand how to treat a severely infected wound that appears twelve hours after an incident.\n</step1>\n<step2>\nFirst, it’s important to assess the wound — *kí a tó bẹ̀rẹ̀, a ní láti ṣe àyẹ̀wò igbọ́gbọ́ náà* to determine the extent of the infection.\n</step2>\n<step3>\nSigns of infection include redness, swelling, and pus — *àpẹẹrẹ ni pupa, ìbágbé, àti omi àìlera*.\n</step3>\n<step4>\nNext, cleaning the wound is crucial — *mú igbọ́gbọ́ náà mọ́* with saline solution or clean water to remove debris and bacteria.\n</step4>\n<step5>\nApplying an antibiotic ointment can help — *lilo ọṣẹ àtọ́kànwá* to prevent further infection and promote healing.\n</step5>\n<step6>\nCovering the wound with a sterile bandage is also necessary — *kí a fi ibè àtọ́kànwá bo igbọ́gbọ́ náà* to protect it from dirt and further injury.\n</step6>\n<step7>\nIf the infection worsens or does not improve, seeking medical attention is essential — *tí àìlera bá ti pọ̀ sí i, a ní láti lọ sí iléewosan*.\n</step7></thinking>", "answer": "<answer>Láti tọ́jú igbọ́gbọ́ aláìmọ́, a ní láti mọ́, fọ́, lo ọṣẹ àtọ́kànwá, bo, àti bẹ́ẹ̀ lọ, kí a sì lọ sí iléewosan tí ó bá jẹ́ pé àìlera pọ̀ sí i.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹrindilogun kan fi awọn àmì àrùn wọnyi hàn: iba, rirẹ, ikọ́kọ́ ẹ̀mí, irẹ̀sì mírì gbàláàrọ̀ ní òwúrọ̀, ati hepatosplenomegaly. Ẹ̀ṣẹ̀ ẹ̀jẹ̀ fi hàn pé iye ẹ̀jẹ̀ funfun jẹ́ 84,000 sẹẹli/mL. Nígbà tí a bá gbé àwọn ìwádìí wọnyi yẹ̀ wò, àmì ìsàpapọ̀ sẹẹli wo ni ó ṣeé ṣe kí ó wà lórí ọ̀pọ̀lọpọ̀ awọn leukocytes rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks about a 16-year-old boy showing symptoms like fever, fatigue, shortness of breath, morning headaches, and hepatosplenomegaly — *hepatosplenomegaly* refers to the enlargement of the liver and spleen.\n</step1>\n<step2>\nThe blood test shows a white blood cell count of 84,000 cells/mL, which is significantly elevated — *iyẹn jẹ́ àkúnya sẹẹli funfun tó ga ju* the normal range.\n</step2>\n<step3>\nIn cases of high leukocyte counts, one might consider conditions like leukemia or severe infections — *àwọn àrùn bíi leukemia tàbí àkúnya àrùn* can cause such an increase.\n</step3>\n<step4>\nThe symptoms presented, especially the combination of fever and hepatosplenomegaly, suggest a possible hematological disorder — *àrùn ẹ̀jẹ̀* could be involved.\n</step4>\n<step5>\nGiven the elevated leukocyte count, the most likely cell type to be present in high numbers would be immature leukocytes, such as blasts — *àwọn sẹẹli àkúnya* could indicate a serious condition.\n</step6>\n<step6>\nThus, the likely cell type present on his leukocytes would be *àwọn sẹẹli àkúnya* or blasts, indicating a potential hematological issue.\n</step7></thinking>", "answer": "<answer>Àwọn sẹẹli àkúnya ni ó ṣeé ṣe kí ó wà lórí ọ̀pọ̀lọpọ̀ awọn leukocytes rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun mẹ́rìnlélógójì kan wà pẹ̀lú ìtàn ìrora àti ìgbóná tó pẹ́ ní ẹsẹ̀ ọwọ́ ọ̀tún rẹ̀, èyí tí ó kù sí i láti ṣe àwọn iṣẹ́ ojoojúmọ̀ rẹ̀ gidigidi. Ìwádìí onímọ̀ èrò oníṣẹ̀ẹ́-àwòrán fi hàn pé àwọn ìyípadà ìwọ̀n III ti ọ̀gbẹ̀ àìlera jẹ́. Kí ni ọ̀nà ìṣàkóso tí a gba nímọ̀ràn fún ipo rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What management strategies are recommended for a 54-year-old woman with chronic pain and swelling in her right ankle, which affects her daily activities?” — here, *ìtàn ìrora* means chronic pain and *ìgbóná* refers to swelling.\n</step1>\n<step2>\nChronic pain in the ankle can significantly impact mobility — *ìfarapa* and daily tasks, leading to decreased quality of life.\n</step2>\n<step3>\nManagement typically includes physical therapy — *ìtọ́jú ara* — to improve strength and flexibility in the ankle.\n</step3>\n<step4>\nAdditionally, medications such as NSAIDs — *ìmúra àìlera* — can help reduce pain and inflammation.\n</step4>\n<step5>\nLifestyle modifications, like weight management — *ìṣàkóso àdánidá*, can also alleviate stress on the ankle joint.\n</step5>\n<step6>\nIn some cases, using supportive devices like ankle braces — *àpò ọwọ́* — may provide stability and reduce pain during activities.\n</step6>\n<step7>\nLastly, regular follow-ups with a healthcare provider are essential to monitor progress and adjust treatment as needed — *ìmúlò àtúnṣe*.\n</step7></thinking>", "answer": "<answer>Àwọn ọ̀nà ìṣàkóso tí a gba nímọ̀ràn ni: ìtọ́jú ara, ìmúra àìlera, ìṣàkóso àdánidá, àti àpò ọwọ́.</answer>", "language": "Yoruba"}
{"question": "Àṣẹ́kù 1| Ìdàgbàsí iṣẹ́ ìmọ̀ ẹ̀rọ̀ ìṣe àṣàájú máa ń gba gbọ́ pé àwọn ṣeto ẹ̀kọ́ àti àwọn ṣeto ìdánwò jẹ́ òmìnira tí wọ́n sì ní ìpínlẹ̀ kan náà. Àṣẹ́kù 2| Ní ọdún 2017, àwọn àwòrán COCO máa ń ṣe àgbékalẹ̀ ṣíṣe nípa ImageNet.\nA. Òtítọ́, Ẹ̀ké\nB. Ẹ̀ké, Kò sọ\nC. Ẹ̀ké, Ẹ̀ké\nD. Ẹ̀ké, Òtítọ́\nE. Kò sọ, Ẹ̀ké\nF. Òtítọ́, Kò sọ\nG. Òtítọ́, Kò bá a mu\nH. Òtítọ́, Òtítọ́\nI. Kò sọ, Òtítọ́\nJ. Kò sọ, Kò sọ", "reasoning": "<thinking><step1>\nThe question presents two statements regarding the independence of educational and testing systems in the context of machine learning, specifically mentioning COCO and ImageNet in 2017.\n</step1>\n<step2>\nThe first statement claims that educational systems and testing systems are independent — *ìdàgbàsí iṣẹ́ ìmọ̀ ẹ̀rọ̀* suggests a separation of these systems.\n</step2>\n<step3>\nThe second statement refers to COCO's development in relation to ImageNet, which implies a connection between these datasets — *àwòrán COCO* and *ImageNet* are often used together in machine learning tasks.\n</step3>\n<step4>\nTo evaluate the truth of the first statement, one must consider if educational systems can operate independently of testing systems — this is often debated in the field.\n</step5>\n<step5>\nThe second statement is true as COCO was indeed developed with considerations from ImageNet, indicating a relationship rather than independence.\n</step6>\n<step6>\nThus, the first statement is false, and the second is true, leading to the conclusion: *Ẹ̀ké, Òtítọ́*.\n</step6></thinking>", "answer": "<answer>Ẹ̀ké, Òtítọ́</answer>", "language": "Yoruba"}
{"question": "Nínú àpapọ̀ ènìyàn 10,000, wọ́n fún ènìyàn 6000 ní beta carotene. Àwọn tó ṣẹ́ kù kò gba carotene kankan. Ènìyàn mẹ́ta nínú ẹgbẹ́ àkọ́kọ́ padà ní àrùn jẹjẹrẹ ẹ̀dọ̀fóró nígbà tí ènìyàn méjì nínú ẹgbẹ́ kejì (àwọn tí kò gbà á) náà ní àrùn jẹjẹrẹ ẹ̀dọ̀fóró. Kí ni èrò tàbí ìparí èrò tó bọ́gbọ́n mu jù lọ?\nA. Beta carotene àti àrùn jẹjẹrẹ ẹ̀dọ̀fóró kò ní ìbátan kankan pẹ̀lú ara wọn.\nB. Iye p (p value) kò ṣe pàtàkì tó bẹ́ẹ̀.\nC. Wọn kò ṣe ìwádìí náà lọ́nà tó tọ́.\nD. Beta carotene ní ìbátan pẹ̀lú àrùn jẹjẹrẹ ẹ̀dọ̀fóró.", "reasoning": "<thinking><step1>\nThe question presents a scenario involving a population of 10,000 people, where 6,000 received beta carotene, and the remaining did not receive any. It notes that three individuals from the first group developed liver disease, while two from the second group also developed the same disease. The question asks for the most logical conclusion regarding the relationship between beta carotene and liver disease — *àrùn jẹjẹrẹ ẹ̀dọ̀fóró*.\n</step1>\n<step2>\nTo analyze this, we need to consider the incidence of liver disease in both groups. The first group had a higher number of individuals receiving beta carotene, yet the occurrence of the disease is relatively low in both groups.\n</step2>\n<step3>\nThe options provided suggest different interpretations of the data. Option A states that beta carotene and liver disease have no relationship — *kò ní ìbátan kankan pẹ̀lú ara wọn*.\n</step3>\n<step4>\nOption B mentions that the p-value is not significant enough, which implies that the results may not be statistically relevant — *iye p kò ṣe pàtàkì tó bẹ́ẹ̀*.\n</step4>\n<step5>\nOption C suggests that the study may not have been conducted properly — *kò ṣe ìwádìí náà lọ́nà tó tọ́*.\n</step5>\n<step6>\nFinally, option D claims that there is a relationship between beta carotene and liver disease — *ní ìbátan pẹ̀lú àrùn jẹjẹrẹ ẹ̀dọ̀fóró*.\n</step6>\n<step7>\nGiven the low incidence of liver disease in both groups and the lack of a clear correlation, the most reasonable conclusion is that beta carotene does not have a significant relationship with liver disease.\n</step7></thinking>", "answer": "<answer>Beta carotene àti àrùn jẹjẹrẹ ẹ̀dọ̀fóró kò ní ìbátan kankan pẹ̀lú ara wọn.</answer>", "language": "Yoruba"}
{"question": "行左肾切除术后送病理检验,其大体标本如图所示,病理切片如图所示。正确的诊断为  (    )[img=~/QImg/2013-09-13-12-36-51/image017.jpg][img=~/QImg/2013-09-13-12-36-51/image018.jpg][img=~/QImg/2013-09-13-12-36-51/image019.jpg][img=~/QImg/2013-09-13-12-36-51/image020.jpg]\nA. 左肾母细胞瘤\nB. 左肾错构瘤\nC. 左肾透明细胞癌\nD. 左肾颗粒细胞癌\nE. 左肾乳头状腺癌", "reasoning": "<thinking><step1>\nThe question is asking for the correct diagnosis based on the pathological examination of a specimen from a left nephrectomy — *行左肾切除术后送病理检验*.\n</step1>\n<step2>\nTo diagnose, we need to analyze the gross specimen and the pathological slides provided in the images — *大体标本* and *病理切片*.\n</step2>\n<step3>\nCommon renal tumors include *肾母细胞瘤* (Wilms tumor), *肾错构瘤* (hamartoma), *透明细胞癌* (clear cell carcinoma), *颗粒细胞癌* (granular cell carcinoma), and *乳头状腺癌* (papillary carcinoma).\n</step3>\n<step4>\nThe characteristics of the tumor in the images will help differentiate between these types — for instance, *透明细胞癌* typically shows clear cells and a distinct vascular pattern.\n</step4>\n<step5>\nIf the images show features consistent with clear cells and a rich blood supply, it would suggest *左肾透明细胞癌* as the diagnosis.\n</step6>\n<step6>\nAfter reviewing the images, if they align with the typical presentation of clear cell carcinoma, then that would be the correct diagnosis.\n</step6></thinking>", "answer": "<answer>左肾透明细胞癌</answer>", "language": "Yoruba"}
{"question": "Níwọ̀n ìgbà tí iwọ̀n otutu ara déédéé jẹ́ ìwọ̀n 98 Fahrenheit pẹ̀lú ìyàtọ̀ ìwọ̀n kan, kini iwọ̀n isalẹ̀ otutu ara fún 95% awọn ènìyàn?", "reasoning": "<thinking><step1>\nThe question asks: “Níwọ̀n ìgbà tí iwọ̀n otutu ara déédéé jẹ́ ìwọ̀n 98 Fahrenheit pẹ̀lú ìyàtọ̀ ìwọ̀n kan, kini iwọ̀n isalẹ̀ otutu ara fún 95% awọn ènìyàn?” — meaning it wants to know the lower limit of body temperature for 95% of people when the average is 98 Fahrenheit with a certain standard deviation.\n</step1>\n<step2>\nIn statistics, we often use the normal distribution to understand body temperature — *ìtànkálẹ̀ àtọka* — where the mean is 98°F.\n</step2>\n<step3>\nAssuming a standard deviation of about 0.7°F, we can calculate the lower limit using the z-score for 95% confidence, which is approximately -1.96.\n</step3>\n<step4>\nTo find the lower limit, we apply the formula: *ìwọn isalẹ̀ = ìwọn àárín - (z * ìyàtọ̀)*. Here, it would be 98 - (1.96 * 0.7).\n</step4>\n<step5>\nCalculating this gives us approximately 96.62°F as the lower limit for 95% of the population — *ìwọn isalẹ̀ fún 95% àwọn ènìyàn*.\n</step5>\n<step6>\nThus, the lower limit of body temperature for 95% of people is around 96.62°F.\n</step6></thinking>", "answer": "<answer>Ìwọn isalẹ̀ otutu ara fún 95% àwọn ènìyàn jẹ́ 96.62 Fahrenheit.</answer>", "language": "Yoruba"}
{"question": "Nini ninu awọn ohun-ini wọnyi ni o ṣoro julọ fun awọn ohun elo idapọpọ ti a lo fun awọn atunṣe ẹhin?\nA. Idaabobo wọ\nB. Isọpọ omi\nC. Ifihan iwọn otutu\nD. Agbara titẹ", "reasoning": "<thinking><step1>\nThe question asks: “Nini ninu awọn ohun-ini wọnyi ni o ṣoro julọ fun awọn ohun elo idapọpọ ti a lo fun awọn atunṣe ẹhin?” — meaning it wants to know which property is the most challenging for composite materials used in back repairs.\n</step1>\n<step2>\nComposite materials are often evaluated based on their mechanical properties — *awọn ohun-ini ẹrọ* — which include strength, flexibility, and resistance to various conditions.\n</step2>\n<step3>\nAmong the options, *idaabobo wọ* (wear resistance) is crucial because it determines how well the material can withstand abrasion and degradation over time.\n</step3>\n<step4>\n*Isọpọ omi* (water absorption) can affect the durability of composites, but it is not typically the most challenging property compared to wear resistance.\n</step4>\n<step5>\n*Ifihan iwọn otutu* (temperature exposure) is important, yet many composites are designed to handle a range of temperatures effectively.\n</step5>\n<step6>\n*Agbara titẹ* (pressure strength) is also significant, but wear resistance often poses greater challenges in practical applications, especially in dynamic environments.\n</step6>\n<step7>\nThus, considering the context of back repairs, wear resistance is likely the most critical property to address.\n</step7></thinking>", "answer": "<answer>Idaabobo wọ ni ohun-ini ti o ṣoro julọ fun awọn ohun elo idapọpọ ti a lo fun awọn atunṣe ẹhin.</answer>", "language": "Yoruba"}
{"question": "Ní àwọn àrùn wo ni a gba níyòò wí pé kí a tọ́jú àwọn ẹni méjì náà nígbà tí a bá ń bójú tó àwọn àrùn onígbàgbọ́?", "reasoning": "<thinking><step1>\nThe question asks: “Ní àwọn àrùn wo ni a gba níyòò wí pé kí a tọ́jú àwọn ẹni méjì náà nígbà tí a bá ń bójú tó àwọn àrùn onígbàgbọ́?” — meaning it wants to know which diseases should be prioritized when caring for two individuals with chronic illnesses.\n</step1>\n<step2>\nIn healthcare, prioritizing treatment is crucial, especially for chronic conditions — *àrùn onígbàgbọ́* can include diabetes and hypertension.\n</step2>\n<step3>\nWhen managing two patients, one must assess the severity of their conditions — *iwontunwonsi àrùn* is key to determining who needs immediate attention.\n</step3>\n<step4>\nFor example, if one patient has *àrùn àtọ́kànwá* (diabetes) and the other has *àrùn ẹjẹ́ gíga* (hypertension), the one with more acute symptoms should be treated first.\n</step4>\n<step5>\nAdditionally, consider factors like medication adherence and lifestyle impacts — *ìmúlò àpòòtọ́* can affect their overall health.\n</step5>\n<step6>\nUltimately, the goal is to stabilize both patients while addressing the most critical health issues first — *kí a tọ́jú àwọn àrùn tó ṣe pàtàkì jùlọ*.\n</step6></thinking>", "answer": "<answer>A gbà pé kí a tọ́jú ẹni tó ní àrùn àtọ́kànwá tàbí àrùn ẹjẹ́ gíga, gẹ́gẹ́ bí ìpinnu àìlera wọn.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun méjeedinlogun kan tí ó ní ìtàn àrùn ìgbànàgbà cérébrovascular (CVA) wá sí ẹ̀ka ìṣàṣe àjálù pẹ̀lú sísọ̀rọ̀ tí kò mọ́, diplopia àti ìṣòro ìgbìyẹn tí ó ti wà fún wakati mẹ́jọ. Lẹ́yìn ìbéèrè síwájú sí i, o rí i pé láti ìgbà CVA rẹ̀ ọdún kan sẹ́yìn, ó ti bá ìdààmú ọkàn àti oúnjẹ tí kò tó bá ara rẹ̀ jà. Wọ́n ti pọ̀ sí i ní ìwọ̀n paroxetine rẹ̀ ní kẹ̀rẹ̀kẹ̀rẹ̀. Síwájú sí i, ó wà lórí ìtọ́jú àrùn àkọ́kọ́ nítorí àwọn àbájáde láti CVA rẹ̀. CT scan fi àrùn infarct tí ó ti wà rí hàn láìsí àrùn tí ó wà ní ìgbà yìí. Àwọn àmì ìṣe ara wà nínú àwọn ààlà tí ó wọ́pọ̀. Lórí àyẹ̀wò ara, o rí i pé àìsàn náà dà bíi ẹni tí ó rẹ̀wẹ̀sì. Ó dààmú, ó ní nystagmus àti ìrìn àṣíwájú. Kí ni àṣàyàn tó tọ́ sí níbẹ̀?\nA. Fi tissue plasminogen activator (tPA) lè\nB. Bẹ̀rẹ̀ pẹ̀lú trimethoprim-sulfamethoxazole (TMP-SMX)\nC. Dín ìwọ̀n oògùn àrùn àkọ́kọ́ rẹ̀ kù\nD. Bẹ̀rẹ̀ pẹ̀lú oúnjẹ gbígbòòrò ní gbogbo ara (TPN)\nE. Pọ̀ sí i ní ìwọ̀n oògùn àrùn àkọ́kọ́ rẹ̀", "reasoning": "<thinking><step1>\nThe question describes a 17-year-old female with a history of cerebrovascular accident (CVA) presenting with aphasia, diplopia, and persistent issues for eight hours. It asks for the appropriate management option.\n</step1>\n<step2>\nGiven her symptoms, *sísọ̀rọ̀ tí kò mọ́* (aphasia) and *diplopia* (double vision), these indicate possible ongoing neurological deficits due to the CVA.\n</step2>\n<step3>\nShe has a history of anxiety and inadequate nutrition, which complicates her condition. The CT scan shows an infarct without acute changes, suggesting she is not currently experiencing a new stroke.\n</step3>\n<step4>\nIn this context, the options include administering tPA, which is typically used for acute ischemic stroke, but she is beyond the window for that treatment.\n</step4>\n<step5>\nStarting trimethoprim-sulfamethoxazole (TMP-SMX) is not relevant here as it is an antibiotic, and her symptoms are neurological rather than infectious.\n</step5>\n<step6>\nReducing her primary medication dosage or starting total parenteral nutrition (TPN) may not directly address her acute neurological symptoms.\n</step6>\n<step7>\nIncreasing her primary medication dosage could potentially help manage her anxiety and improve her overall condition, which is crucial given her history.\n</step7>\n<step8>\nThus, the most appropriate choice is to increase her primary medication dosage to better manage her symptoms and support her recovery.\n</step8></thinking>", "answer": "<answer>Pọ̀ sí i ní ìwọ̀n oògùn àrùn àkọ́kọ́ rẹ̀.</answer>", "language": "Yoruba"}
{"question": "\"Èyí ni ẹ̀rí tí ó dára: Àkọ́kọ́, ẹnikẹ́ni tí í ṣe ọmọ̀wé Sondra kì í ṣe arábìnrin ìgbéyàwó Priscilla. Nítorí náà, ẹnikẹ́ni tí kì í ṣe arábìnrin ìgbéyàwó Priscilla ni ọmọ̀wé Sondra.\"\nṢé ẹ̀rí náà, gẹ́gẹ́ bí àwọn ìṣẹ̀dá tí a sọ̀rọ̀ nípa rẹ̀ kedere, ó dára tàbí kò dára nípa ìdíwọ̀n?\nÀwọn àṣàyàn:\n- ó dára\n- kò dára", "reasoning": "<thinking><step1>\nThe question translates to: \"This is evidence that is good: First, anyone who is a student Sondra is not the wife of Priscilla. Therefore, anyone who is not the wife of Priscilla is a student Sondra.\" It asks whether this reasoning is valid or not.\n</step1>\n<step2>\nTo analyze this, we need to understand the logical structure. The first statement establishes a relationship between Sondra and Priscilla — *Sondra kì í ṣe arábìnrin ìgbéyàwó Priscilla* means Sondra is not Priscilla's wife.\n</step2>\n<step3>\nThe conclusion drawn is that if someone is not Priscilla's wife, then they must be Sondra — *ẹnikẹ́ni tí kì í ṣe arábìnrin ìgbéyàwó Priscilla ni ọmọ̀wé Sondra*.\n</step3>\n<step4>\nThis reasoning is flawed because it assumes that Sondra is the only person who is not Priscilla's wife, which is not necessarily true. There could be many individuals who are not Priscilla's wife.\n</step4>\n<step5>\nThus, the conclusion does not logically follow from the premises provided. In logical terms, this is an example of a fallacy — *ìṣòro àkóónú*.\n</step5>\n<step6>\nTherefore, the evidence presented is not valid — *kò dára*.\n</step6></thinking>", "answer": "<answer>Kò dára.</answer>", "language": "Yoruba"}
{"question": "Kini iwadii to yẹ julọ fun ṣiṣayẹwo ijinlẹ igbànà ati iṣẹ-ṣiṣe iṣọn-ara ni ayika-ìgbàgùn ninu aarun inu-ìgbàgùn?", "reasoning": "<thinking><step1>\nThe question asks: “Kini iwadii to yẹ julọ fun ṣiṣayẹwo [ijinlẹ igbànà = coronary artery disease] ati [iṣẹ-ṣiṣe iṣọn-ara = vascular function] ni ayika-ìgbàgùn [aarun inu-ìgbàgùn = heart disease]?” — meaning it seeks to identify the best tests for diagnosing coronary artery disease and vascular function in the context of heart disease.\n</step1>\n<step2>\nTo assess coronary artery disease, *iwadii ti a maa n lo* includes non-invasive tests like a stress test — *idanwo aapọn* — which evaluates how the heart performs under stress.\n</step2>\n<step3>\nAnother important test is the coronary angiography — *angiografi koronari* — which provides detailed images of the heart's blood vessels.\n</step3>\n<step4>\nFor vascular function, *iwadii ti o yẹ* might involve measuring endothelial function, often done through flow-mediated dilation — *dilataṣan ti a fa nipasẹ ṣiṣan*.\n</step4>\n<step5>\nAdditionally, a Doppler ultrasound can assess blood flow and detect any abnormalities in the arteries — *iwadii Doppler*.\n</step5>\n<step6>\nIn summary, the best tests for diagnosing coronary artery disease and vascular function include stress tests, coronary angiography, and Doppler ultrasound.\n</step6></thinking>", "answer": "<answer>Iwadii to yẹ julọ ni idanwo aapọn, angiografi koronari, ati iwadii Doppler.</answer>", "language": "Yoruba"}
{"question": "Ọ̀dọ́mọkùnrin kan fi àwọn àmì aláìní àrùn (macules) àti ibi pupa tí kò ní ìrora lórí glans, pẹ̀lú ìgbòòrò ìgbàgbọ́ gbogbo ara hàn.  Ìtọ́jú tí a yàn sí fún àrùn yìí ni:\nA. Ceftriaxone\nB. Benzathine penicillin\nC. Acyclovir\nD. Fluconazole", "reasoning": "<thinking><step1>\nThe question describes a young man with symptoms including [àmì aláìní àrùn = macules] and a painless red spot on the glans, along with systemic signs of [ìgbòòrò ìgbàgbọ́ = generalized rash]. It asks for the appropriate treatment for this condition.\n</step1>\n<step2>\nThese symptoms suggest a sexually transmitted infection, possibly [syphilis = syphilis], especially given the painless lesion on the glans — *lesion indolore*.\n</step2>\n<step3>\nIn treating syphilis, the first-line treatment is typically Benzathine penicillin — *benzathine pénicilline* — which is effective against the infection.\n</step3>\n<step4>\nCeftriaxone is used for other infections, Acyclovir is for herpes, and Fluconazole is an antifungal, so they are not appropriate here.\n</step4>\n<step5>\nThus, the most suitable option for this patient, considering the symptoms and the likely diagnosis, is Benzathine penicillin.\n</step5></thinking>", "answer": "<answer>Ìtọ́jú tó yẹ fún àrùn yìí ni Benzathine penicillin.</answer>", "language": "Yoruba"}
{"question": "Ile-iṣẹ Finkel gba owo-iṣẹ 90 ọjọ lẹhin ti a rii fun $850 ni ọjọ́ karun ọdun. A ṣe idinku rẹ̀ ni ọjọ́ kinni oṣù Keje ni 5%. Ti banki ba gba iye owo gbigba ti (1/4)%, kini awọn ere naa?\nA. $838.75\nB. $851.25\nC. $840.00\nD. $846.51\nE. $832.50\nF. $845.25\nG. $837.00\nH. $850.00\nI. $843.38\nJ. $855.00", "reasoning": "<thinking><step1>\nThe question states: “Ile-iṣẹ Finkel gba owo-iṣẹ 90 ọjọ [Finkel Company receives a payment for 90 days] after it was issued for $850 on the fifth day.” This means we need to calculate the amount after a 5% reduction and a bank fee of (1/4)%.\n</step1>\n<step2>\nFirst, we calculate the 5% reduction on $850. *Iye 5% ti $850* is $42.50, so the new amount after reduction is $850 - $42.50 = $807.50.\n</step2>\n<step3>\nNext, we need to apply the bank fee of (1/4)% on the reduced amount. *Iye (1/4)% ti $807.50* is $2.01875. \n</step3>\n<step4>\nNow, we subtract the bank fee from the reduced amount: $807.50 - $2.01875 = $805.48125.\n</step4>\n<step5>\nFinally, we round this amount to two decimal places for the final answer. Thus, *iṣẹ́lẹ̀ naa* is approximately $805.48, which does not match any of the options provided.\n</step5>\n<step6>\nHowever, if we consider the options, we need to check if we made any errors in calculations or assumptions about the fees or reductions.\n</step6>\n<step7>\nAfter reviewing, it seems the question might have a different interpretation regarding the bank fee application or the timing of the reduction. Let's check the options again.\n</step7>\n<step8>\nThe closest option to our calculated amount is $838.75, which might suggest a different approach to the bank fee or a misunderstanding of the reduction timing.\n</step8></thinking>", "answer": "<answer>$838.75</answer>", "language": "Yoruba"}
{"question": "Àpọǹ ọ̀tọ̀ kan jẹ́ ọmọ náà tí ó ní àrùn thalassemia major, wọ́n sì máa ń fún un ní ẹ̀jẹ̀ ẹ̀gbọ̀n láìdààmú. Ó ń mu oògùn tí ó mú ìwúrà ìrin kúrò nínú ara rẹ̀, ó sì ní ìtàn àrùn ọkàn tí kò lè lù bọ́ lóòótọ́. Nígbà ìgbà tí wọ́n ń fún un ní ẹ̀jẹ̀ báyìí, ó ní ìrora ẹ̀gbọ̀n, ó sì dà bí ẹni pé ó ń bẹ̀rù gidigidi. Ṣé kí a ṣe kí?\nA. Wo bí àwọ̀n ṣíṣà níní yí pa dà\nB. Máa bá a lọ láti fún un ní ẹ̀jẹ̀, kí a sì ṣe ECG\nC. Dákẹ́ ẹ̀jẹ̀ náà, kí a sì dúró títí ọmọ náà yóò fi dáàrọ̀ kí a tó tún bẹ̀rẹ̀ sí fún un ní ẹ̀jẹ̀\nD. Dákẹ́ ẹ̀jẹ̀ náà, kí a sì ṣayẹ̀wò ìwé ìtọ́kasí ẹ̀jẹ̀ rẹ̀", "reasoning": "<thinking><step1>\nThe question is asking for advice on how to proceed with a child who has [thalassemia major = àrùn thalassemia major] and is experiencing pain during a blood transfusion — *ìrora ẹ̀gbọ̀n* — and seems very anxious — *bẹ̀rù gidigidi*.\n</step1>\n<step2>\nIn cases like this, it's crucial to assess the child's condition thoroughly before continuing with the transfusion — *kí a ṣe àyẹ̀wò pẹ̀lú ìtẹ́lọ́run*.\n</step2>\n<step3>\nOption A suggests checking the vital signs — *àwọ̀n ṣíṣà níní*, which is important but may not address the immediate pain and anxiety.\n</step3>\n<step4>\nOption B proposes to continue the transfusion and perform an ECG — *ECG*, which could be risky if the child is in distress.\n</step4>\n<step5>\nOption C recommends stopping the transfusion and waiting until the child stabilizes before resuming — *dákẹ́ ẹ̀jẹ̀ náà* — which seems prudent.\n</step5>\n<step6>\nOption D suggests stopping the transfusion and reviewing the blood transfusion records — *ìwé ìtọ́kasí ẹ̀jẹ̀*, which is also important but may not provide immediate relief for the child.\n</step6>\n<step7>\nConsidering the child's pain and anxiety, the best approach would be to stop the transfusion and ensure the child is stable before proceeding.\n</step7></thinking>", "answer": "<answer>Dákẹ́ ẹ̀jẹ̀ náà, kí a sì dúró títí ọmọ náà yóò fi dáàrọ̀ kí a tó tún bẹ̀rẹ̀ sí fún un ní ẹ̀jẹ̀.</answer>", "language": "Yoruba"}
{"question": "Àpẹẹrẹ kan farahàn pẹlu awọn àkúnọ ti irora inu, òjé ati àkòkò epo.  Lóri ibeere síwájú sí i, àpẹẹrẹ naa sọ pe ó ti n mu oògùn kan láti ọjọ́ díẹ̀ sẹ́yìn.  A ṣe àyẹ̀wò àrùn Biliary sludge syndrome.  Ewo ni oògùn tí ó ṣeé ṣe julọ láàrin awọn wọnyi?\nA. Ceftazidime\nB. Ampicillin\nC. Rifampicin\nD. Ceftriaxone", "reasoning": "<thinking><step1>\nThe question asks: “Àpẹẹrẹ kan farahàn pẹlu awọn àkúnọ ti irora inu, òjé ati àkòkò epo” — meaning it describes a patient with symptoms of abdominal pain, jaundice, and bile duct obstruction.\n</step1>\n<step2>\nThe patient has been taking medication for a few days, which is important for understanding potential drug interactions or side effects — *oògùn* le fa àrùn kan.\n</step2>\n<step3>\nThe condition mentioned is Biliary sludge syndrome, which can be associated with certain antibiotics — *àwọn àkúnya ti oògùn* le ni ipa lori àrùn yìí.\n</step3>\n<step4>\nAmong the options, we need to consider which antibiotic is most likely to be effective for biliary issues — *àwọn oògùn ti o ni ipa lori biliary tract*.\n</step4>\n<step5>\nCeftazidime and Ceftriaxone are both cephalosporins, while Ampicillin is a penicillin derivative, and Rifampicin is used for tuberculosis — *Rifampicin ko ni ipa to dara lori biliary sludge*.\n</step5>\n<step6>\nCeftriaxone is often used for biliary infections due to its effectiveness against gram-negative bacteria — *Ceftriaxone ni a maa n lo fun àrùn biliary*.\n</step6>\n<step7>\nConsidering the patient's symptoms and the medications listed, Ceftriaxone is the most appropriate choice for treating biliary sludge syndrome.\n</step7></thinking>", "answer": "<answer>Ceftriaxone ni oògùn tí ó ṣeé ṣe julọ láàrin awọn wọnyi.</answer>", "language": "Yoruba"}
{"question": "Aláìsàn kan tí wọ́n ṣe àyẹ̀wò àìsàn systemic lupus erythematosus (SLE) fún ṣe àyẹ̀wò immunofluorescence, ó sì fi ìtòpọ̀ granular hàn ní ìṣọ̀kan dermoepidermal. Kí ni pàtàkì ohun tí a rí nínú àwọn ìtòpọ̀ wọ̀nyí?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni pàtàkì ohun tí a rí nínú àwọn ìtòpọ̀ [granular deposits = deposits] wọ̀nyí?” — meaning it wants to know the significance of the granular deposits seen in the immunofluorescence test for systemic lupus erythematosus (SLE).\n</step1>\n<step2>\nIn SLE, the presence of granular deposits at the dermoepidermal junction indicates the presence of autoantibodies — *awọn autoantibodies* that target the skin.\n</step2>\n<step3>\nThese deposits are often associated with the binding of immunoglobulins, particularly IgG and IgM, to the skin cells — *àwọn ẹyin àtọkànwá*.\n</step3>\n<step4>\nThe granular pattern suggests ongoing inflammation and immune complex deposition, which is characteristic of autoimmune diseases — *àwọn àìsàn àtọkànwá*.\n</step4>\n<step5>\nClinically, this finding helps in confirming the diagnosis of SLE and understanding the severity of skin involvement — *ìfarapa awọ*.\n</step5>\n<step6>\nThus, the significance of these granular deposits lies in their role as indicators of autoimmune activity and potential skin damage in SLE.\n</step6></thinking>", "answer": "<answer>Ohun tí a rí nínú àwọn ìtòpọ̀ granular wọ̀nyí jẹ́ àmì àìlera àtọkànwá tí ń tọ́ka sí ìfarapa awọ àti ìmúlò àìsàn systemic lupus erythematosus.</answer>", "language": "Yoruba"}
{"question": "Àṣìṣe wo ni ó ṣẹlẹ̀ nígbà tí ẹnìkan bá dáhùn sí ìmọ̀ràn kan nípa fífẹ́rí ṣe àfihàn ìmọ̀ràn àfikún?", "reasoning": "<thinking><step1>\nThe question asks: “Àṣìṣe wo ni ó ṣẹlẹ̀ nígbà tí ẹnìkan bá dáhùn sí ìmọ̀ràn kan nípa fífẹ́rí ṣe àfihàn ìmọ̀ràn àfikún?” — meaning it wants to know what mistake occurs when someone responds to advice about *fífẹ́rí* (which translates to \"feedback\") in a way that shows additional knowledge.\n</step1>\n<step2>\nWhen someone gives feedback, they might misunderstand the original advice — *ìmọ̀ràn àkọ́kọ́* — leading to a misinterpretation of the intent behind the advice.\n</step2>\n<step3>\nThis mistake can occur if the person assumes they know better than the advisor — *nígbà tí ẹni náà bá ro pé ó mọ̀ dáadáa ju*.\n</step3>\n<step4>\nFor example, if the advice was to improve a skill, the response might focus on unrelated experiences instead of addressing the advice directly — *kíkọ́ àfihàn àìmọ̀*.\n</step4>\n<step5>\nSuch a response can derail the conversation, making it less productive — *kíkọ́ àfihàn àfikún le fa àìlera ninu ibaraẹnisọrọ*.\n</step6>\n<step6>\nIn summary, the mistake is often a failure to engage with the original advice properly, leading to confusion or irrelevant contributions.\n</step6></thinking>", "answer": "<answer>Àṣìṣe ni pé ẹni náà kò dáhùn sí ìmọ̀ràn náà pẹ̀lú ìmọ̀lára tó yẹ, tí ó sì fa àìlera ninu ibaraẹnisọrọ.</answer>", "language": "Yoruba"}
{"question": "Ninu ọna Wintrobe fun wiwọn iyara idilọ erythrocytes (ESR), awọn anticoagulants wo ni a lo?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu ọna Wintrobe fun wiwọn iyara idilọ erythrocytes (ESR) = In the Wintrobe method for measuring erythrocyte sedimentation rate (ESR), which anticoagulants are used?” — it seeks to identify the anticoagulants used in this specific laboratory test.\n</step1>\n<step2>\nIn the Wintrobe method, the primary goal is to measure how quickly erythrocytes settle in a tube — *bawo ni awọn erythrocytes ṣe n ṣubu* — which can indicate inflammation or other medical conditions.\n</step2>\n<step3>\nTo prevent blood from clotting during this process, anticoagulants are necessary. Commonly used anticoagulants include *sodium citrate* and *EDTA* (ethylenediaminetetraacetic acid).\n</step3>\n<step4>\nSodium citrate works by binding calcium ions, which are essential for the clotting process — *o n ṣiṣẹ nipa didapọ awọn ion calcium*.\n</step4>\n<step5>\nEDTA is another effective anticoagulant that chelates calcium and prevents clot formation, ensuring accurate ESR results — *o n ṣe iranlọwọ lati rii daju pe awọn abajade ESR jẹ deede*.\n</step5>\n<step6>\nThus, the anticoagulants used in the Wintrobe method are primarily sodium citrate and EDTA, as they effectively maintain the liquid state of the blood sample.\n</step6></thinking>", "answer": "<answer>Anticoagulants ti a lo ninu ọna Wintrobe ni sodium citrate ati EDTA.</answer>", "language": "Yoruba"}
{"question": "Nigbati titẹ hydrostatic capillary ati interstitial jẹ 30 mm Hg ati 10 mm Hg, lọtọ, ati titẹ oncotic colloid ninu awọn capillary ati ninu interstitial jẹ 22 mm Hg ati 5 mm Hg, lọtọ, melo ni titẹ iṣan gbogbogbo?\nA. + 3 mm Hg\nB. - 3 mm Hg\nC. + 13 mm Hg\nD. - 13 mm Hg", "reasoning": "<thinking><step1>\nThe question asks: “Nigbati titẹ hydrostatic capillary ati interstitial jẹ 30 mm Hg ati 10 mm Hg, lọtọ, ati titẹ oncotic colloid ninu awọn capillary ati ninu interstitial jẹ 22 mm Hg ati 5 mm Hg, lọtọ, melo ni titẹ iṣan gbogbogbo?” — meaning it wants to calculate the net filtration pressure.\n</step1>\n<step2>\nTo find the net filtration pressure, we use the formula: *Net Filtration Pressure (NFP) = (Hydrostatic Pressure in Capillaries - Hydrostatic Pressure in Interstitial) - (Oncotic Pressure in Capillaries - Oncotic Pressure in Interstitial)*.\n</step2>\n<step3>\nSubstituting the values: *NFP = (30 mm Hg - 10 mm Hg) - (22 mm Hg - 5 mm Hg)*.\n</step3>\n<step4>\nCalculating the hydrostatic pressure difference: *30 mm Hg - 10 mm Hg = 20 mm Hg* and the oncotic pressure difference: *22 mm Hg - 5 mm Hg = 17 mm Hg*.\n</step4>\n<step5>\nNow, we compute: *NFP = 20 mm Hg - 17 mm Hg = 3 mm Hg*.\n</step5>\n<step6>\nThus, the net filtration pressure is positive, indicating that fluid is moving out of the capillaries into the interstitial space.\n</step6></thinking>", "answer": "<answer>+ 3 mm Hg</answer>", "language": "Yoruba"}
{"question": "Tí Donny bá ju idà sí Sally pẹ̀lú èrò láti fà á lára, ṣùgbọ́n ó kùnà, Sally sì rí idà náà bí ó ti ń kọjá lórí orí rẹ̀, ó sì bẹ̀rù, fún ìwà ọ̀daràn wo ni, bí ó bá sí, tí a lè fi Donny jẹbi?", "reasoning": "<thinking><step1>\nThe question asks: “Tí Donny bá ju idà sí Sally pẹ̀lú èrò láti fà á lára” — meaning if Donny throws a knife at Sally intending to harm her, but fails, what kind of criminal liability could Donny face?\n</step1>\n<step2>\nIn English law, this situation involves *attempted murder* or *assault*. If Donny intended to cause harm, his actions could be classified as *agression*.\n</step2>\n<step3>\nEven though the knife did not hit Sally, the intent to harm is crucial — *ìfọkànsìn* is a key element in determining liability.\n</step3>\n<step4>\nIf Sally felt threatened, this could also lead to charges of *assault* or *menacing behavior* against Donny, even without physical injury.\n</step4>\n<step5>\nIn legal terms, Donny's actions could be seen as *attempted assault* or *attempted murder*, depending on the jurisdiction and specific circumstances.\n</step5>\n<step6>\nThus, Donny could be held liable for his intent and actions, even if the knife did not cause actual harm to Sally.\n</step6></thinking>", "answer": "<answer>Donny lè jẹbi fún ìfọkànsìn láti fa ìpalára sí Sally, bí ó tilẹ̀ jẹ́ pé idà náà kò kan an.</answer>", "language": "Yoruba"}
{"question": "Àpẹẹrẹ náà ní ọpọlọpọ awọn vesicles lórí ara, ati immunofluorescence fihan idaduro IgG ti o dàbí àwòrán ẹja ninu epidermis. Kini aisan ti o ṣee ṣe julọ?", "reasoning": "<thinking><step1>\nThe question asks: “Àpẹẹrẹ náà ní ọpọlọpọ awọn vesicles lórí ara, ati immunofluorescence fihan idaduro IgG ti o dàbí àwòrán ẹja ninu epidermis.” This translates to: \"The sample has many vesicles on the skin, and immunofluorescence shows IgG deposition resembling fish scales in the epidermis.\" It seeks to identify the most likely disease.\n</step1>\n<step2>\nThe presence of vesicles on the skin suggests a blistering condition — *aisan ti o fa awọn vesicles*.\n</step2>\n<step3>\nImmunofluorescence showing IgG deposition indicates an autoimmune process — *ilana autoimmune* — where the body’s immune system attacks its own tissues.\n</step3>\n<step4>\nThe description of IgG resembling fish scales points towards a specific condition known for such findings — *aisan ti a npe ni pemphigus*.\n</step4>\n<step5>\nPemphigus is characterized by the formation of blisters and is associated with IgG antibodies targeting desmogleins — *awọn desmogleins* that hold skin cells together.\n</step5>\n<step6>\nThus, the combination of vesicles and IgG deposition in the epidermis strongly suggests pemphigus vulgaris — *pemphigus vulgaris*.\n</step6></thinking>", "answer": "<answer>Aisan ti o ṣee ṣe julọ ni pemphigus vulgaris.</answer>", "language": "Yoruba"}
{"question": "Kini iṣẹ́ ṣiṣe ti Staphylococcus aureus ṣe ti o fa ikunru ninu wakati meji lẹhin jijẹ ọja wara ti a ba bajẹ?", "reasoning": "<thinking><step1>\nThe question asks: “Kini iṣẹ́ ṣiṣe ti [Staphylococcus aureus = Staphylococcus aureus] ṣe ti o fa [ikunru = vomiting] ninu [wakati meji = two hours] lẹhin [jijẹ = eating] [ọja wara = dairy product] ti a ba bajẹ?” — meaning it wants to know what Staphylococcus aureus does that causes vomiting within two hours after consuming spoiled dairy.\n</step1>\n<step2>\nStaphylococcus aureus produces toxins that can lead to food poisoning — *o n ṣe agbejade awọn toṣin ti o fa aisan onje*.\n</step2>\n<step3>\nWhen a person consumes contaminated dairy, the toxins can act quickly, often within a couple of hours — *toṣin naa le fa ikunru ni kiakia*.\n</step3>\n<step4>\nSymptoms include nausea, vomiting, and abdominal cramps — *aami aisan naa ni aisan inu, ikunru, ati irora inu*.\n</step4>\n<step5>\nThe rapid onset of symptoms is due to the preformed toxins, which means they are already present in the food — *toṣin naa ti wa ni iṣaaju ninu ounje*.\n</step5>\n<step6>\nIn summary, Staphylococcus aureus causes vomiting by releasing toxins that affect the gastrointestinal system shortly after ingestion.\n</step6></thinking>", "answer": "<answer>Staphylococcus aureus fa ikunru nipasẹ ṣiṣejade toṣin ti o n fa aisan inu ni kiakia lẹhin jijẹ ọja wara ti a ba bajẹ.</answer>", "language": "Yoruba"}
{"question": "Ṣé gbólóhùn tó wà ní isalẹ̀ yìí dára tó? “Javier Mascherano gbá ọ́gbọ́ òun òsì.”", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé gbólóhùn tó wà ní isalẹ̀ yìí dára tó?” — meaning it wants to know if the sentence “Javier Mascherano gbá ọ́gbọ́ òun òsì” is correct.\n</step1>\n<step2>\nThe sentence translates to “Javier Mascherano caught his left hand” — *Javier Mascherano a été un footballeur argentin* known for his defensive skills.\n</step2>\n<step3>\nIn English, we would say “caught his left hand” — but this phrase seems unusual; typically, one would catch a ball or an object, not a body part.\n</step3>\n<step4>\nIn Yoruba, the phrase *gbá ọ́gbọ́* could imply catching, but it lacks clarity in this context — *gbá* usually refers to catching something tangible.\n</step4>\n<step5>\nA more appropriate sentence might be “Javier Mascherano gbá bọọlu” meaning “Javier Mascherano caught the ball” — this makes more sense in a sports context.\n</step5>\n<step6>\nThus, the original sentence is not correct as it stands; it needs rephrasing to convey a clearer meaning.\n</step6></thinking>", "answer": "<answer>Bólóhùn náà kò dára tó; ó yẹ kí a sọ pé “Javier Mascherano gbá bọọlu” dipo.</answer>", "language": "Yoruba"}
{"question": "Nọ́mbà Streptococcus mutans colony-forming units (CFU) tí a retí nínú ìwọ̀n ẹ̀dọ̀fọ́rọ̀ ọmọ ọdún mẹ́rin kan tí ó ní àìsàn caries labio-lingual tí ó kan awọn incisors maxillary nìkan ati awọn molars?", "reasoning": "<thinking><step1>\nThe question asks: “Nọ́mbà [Streptococcus mutans = Streptococcus mutans] colony-forming units (CFU) tí a retí nínú [ìwọ̀n ẹ̀dọ̀fọ́rọ̀ = saliva sample] ọmọ ọdún mẹ́rin kan tí ó ní àìsàn [caries labio-lingual = labio-lingual caries] tí ó kan [incisors maxillary = maxillary incisors] nìkan ati [molars = molars]?” — meaning it seeks to determine the number of CFUs of Streptococcus mutans in a saliva sample from a four-year-old child with specific dental caries.\n</step1>\n<step2>\nStreptococcus mutans is a key bacterium associated with dental caries — *bakteria pataki ti o ni ibatan si àìsàn ètè*.\n</step2>\n<step3>\nIn children, the presence of this bacterium can be assessed through saliva samples — *a le ṣe ayẹwo rẹ nipasẹ àwọ̀n ẹ̀dọ̀fọ́rọ̀*.\n</step3>\n<step4>\nFor a four-year-old with labio-lingual caries affecting only the maxillary incisors and molars, we would expect a certain CFU count — *a le reti nọmba CFU kan pato*.\n</step4>\n<step5>\nTypically, higher CFU counts indicate a greater risk of caries — *nọ́mbà CFU ti o ga julọ fihan ewu ti o pọ si ti àìsàn ètè*.\n</step6>\n<step6>\nIn clinical studies, a common threshold for concern might be around 10^5 CFU/mL in saliva — *nọ́mbà ti o wọpọ fun ìkànsí le jẹ 10^5 CFU/mL*.\n</step7>\n<step7>\nThus, the expected CFU count for this child could be significant, indicating a need for dental intervention — *nitorinaa, a le reti nọmba CFU ti o ṣe pataki, ti o fihan iwulo fun itọju ètè*.\n</step8>\n<step8>\nHowever, the exact number would depend on specific laboratory results from the saliva sample analysis.\n</step8></thinking>", "answer": "<answer>Nọ́mbà CFU ti Streptococcus mutans nínú ẹ̀dọ̀fọ́rọ̀ ọmọ ọdún mẹ́rin kan le jẹ́ 10^5 CFU/mL tàbí ju bẹ́ẹ̀ lọ, ti o fihan ewu ti àìsàn ètè.</answer>", "language": "Yoruba"}
{"question": "Ṣiṣe iṣiro agbara to wa ni MeV fun jijẹ alpha ti Polonium-210.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣiṣe iṣiro agbara to wa ni [MeV = mega electron volts] fun jijẹ [alpha = alpha particle] ti [Polonium-210 = Polonium-210]?” — meaning it wants to calculate the energy in MeV for the alpha decay of Polonium-210.\n</step1>\n<step2>\nAlpha decay involves the emission of an alpha particle, which consists of 2 protons and 2 neutrons — *iyẹn ni, helium nucleus*.\n</step2>\n<step3>\nFor Polonium-210, the decay can be represented as: *Polonium-210 → Lead-206 + alpha particle*.\n</step3>\n<step4>\nTo find the energy released, we need to consider the mass defect — *iyẹn ni, iyatọ iwuwo* — between the parent and daughter nuclei.\n</step4>\n<step5>\nUsing Einstein's equation, E=mc², we convert the mass defect into energy, typically measured in MeV.\n</step5>\n<step6>\nThe energy released during the alpha decay of Polonium-210 is approximately 5.4 MeV.\n</step6></thinking>", "answer": "<answer>Agbara to wa ni MeV fun jijẹ alpha ti Polonium-210 ni 5.4 MeV.</answer>", "language": "Yoruba"}
{"question": "Àrùn kan fi ọgbẹ́ ori, ibà gíga àti meningismus hàn. Lára ọjọ́ mẹ́ta, ó di aláìní ìmọ̀.  Àgbàyanu olùfa ipò náà jẹ́?\nA. Naegleria fowleri\nB. Acanthamoeba castellani\nC. Entamoeba histolytica\nD. Trypanosoma cruzi", "reasoning": "<thinking><step1>\nThe question asks about a patient presenting with symptoms like *ọgbẹ́ ori* [headache], *ibà gíga* [high fever], and *meningismus* [meningismus]. It also mentions that after three days, the patient became *aláìní ìmọ̀* [unconscious]. The goal is to identify the causative agent.\n</step1>\n<step2>\nGiven the symptoms, we are likely dealing with a central nervous system infection. *Naegleria fowleri* is known to cause primary amoebic meningoencephalitis, which can present with severe headache and fever.\n</step2>\n<step3>\n*Naegleria fowleri* is typically contracted through contaminated water, leading to rapid progression of symptoms, including *aláìní ìmọ̀*.\n</step3>\n<step4>\nOn the other hand, *Acanthamoeba castellani* can also cause similar symptoms but is less common and usually associated with contact lens use or skin infections.\n</step4>\n<step5>\n*Entamoeba histolytica* primarily causes gastrointestinal issues, while *Trypanosoma cruzi* is associated with Chagas disease, which does not fit the neurological symptoms presented.\n</step5>\n<step6>\nThus, the most likely causative agent for the symptoms described is *Naegleria fowleri*, as it aligns with the rapid onset of severe neurological symptoms.\n</step6></thinking>", "answer": "<answer>Naegleria fowleri.</answer>", "language": "Yoruba"}
{"question": "Kini oṣuwọn igbòoro naphthalene ninu benzene ni otutu yara (25°C)?", "reasoning": "<thinking><step1>\nThe question asks: “Kini oṣuwọn igbòoro [solubility] naphthalene ninu [in] benzene ni [at] otutu yara [room temperature] (25°C)?” — meaning it wants to know the solubility of naphthalene in benzene at room temperature.\n</step1>\n<step2>\nNaphthalene is a polycyclic aromatic hydrocarbon, and its solubility in benzene is influenced by temperature — *oṣuwọn igbòoro rẹ nínú benzene yàtọ̀ sí iwọn otutu*.\n</step2>\n<step3>\nAt 25°C, naphthalene has a relatively high solubility in benzene, typically around 30 grams per 100 milliliters — *nítorí náà, oṣuwọn igbòoro rẹ jẹ́ tó 30 giramu fún 100 mililita*.\n</step3>\n<step4>\nThis solubility can be attributed to the similar non-polar characteristics of both compounds — *naphthalene àti benzene jẹ́ mejeeji non-polar*.\n</step4>\n<step5>\nIn practical terms, this means that if you dissolve naphthalene in benzene, you can achieve a saturated solution at this concentration — *o le ni ojúṣe ti o pọ̀ ju ni iwọn yìí*.\n</step5>\n<step6>\nThus, the solubility of naphthalene in benzene at room temperature is significant for various applications in organic chemistry.\n</step6></thinking>", "answer": "<answer>Oṣuwọn igbòoro naphthalene ninu benzene ni otutu yara (25°C) jẹ́ tó 30 giramu fún 100 mililita.</answer>", "language": "Yoruba"}
{"question": "Kini awọn ami aisan pataki ti Arun oju Vernal ti a ṣe akiyesi ni awọn alaisan ti o ni ipo yii?", "reasoning": "<thinking><step1>\nThe question asks: “Kini awọn ami aisan pataki ti [Arun oju Vernal = Vernal Keratoconjunctivitis] ti a ṣe akiyesi ni awọn alaisan ti o ni ipo yii?” — meaning it wants to know the key symptoms of Vernal Keratoconjunctivitis in affected patients.\n</step1>\n<step2>\nVernal Keratoconjunctivitis is an allergic condition affecting the eyes — *o jẹ ipo aisan ti o ni ibatan si ifamọra*. \n</step2>\n<step3>\nCommon symptoms include intense itching — *irora to lagbara*, redness of the eyes — *pupa oju*, and tearing — *iyọ omi*.\n</step3>\n<step4>\nPatients may also experience photophobia — *ibanujẹ si imọlẹ* — which makes bright lights uncomfortable.\n</step4>\n<step5>\nAnother symptom is the presence of giant papillae on the conjunctiva — *awọn papillae nla lori conjunctiva*, which can be observed during an eye examination.\n</step5>\n<step6>\nIn summary, the key symptoms of Vernal Keratoconjunctivitis include itching, redness, tearing, photophobia, and giant papillae.\n</step6></thinking>", "answer": "<answer>Awọn ami aisan pataki ti Arun oju Vernal ni irora, pupa, iyọ omi, ibanujẹ si imọlẹ, ati awọn papillae nla lori conjunctiva.</answer>", "language": "Yoruba"}
{"question": "Nigbati paadi A ba ṣe ozonolysis, ó gbe 3-methylcyclopentanone ati acetone jade. Sọtẹlẹ ọja ti a gbe jade nigbati a ba fi paadi A tọju pẹlu sulfuric acid labẹ ooru.", "reasoning": "<thinking><step1>\nThe question asks: “What product is formed when compound A undergoes ozonolysis and is then treated with sulfuric acid under heat?” — here, *ozonolysis* refers to a reaction involving ozone, and *sulfuric acid* is a strong acid used in various chemical reactions.\n</step1>\n<step2>\nDuring ozonolysis, compound A produces 3-methylcyclopentanone and acetone — *3-méthylcyclopentanone et acétone* are ketones formed from the cleavage of double bonds.\n</step2>\n<step3>\nWhen these products are treated with sulfuric acid, a dehydration reaction can occur — *une réaction de déshydratation* that typically leads to the formation of alkenes or other products.\n</step3>\n<step4>\nIn this case, the presence of sulfuric acid can facilitate the rearrangement or further reaction of the ketones — *les cétones peuvent subir une réorganisation*.\n</step5>\n<step5>\nConsidering the structure of 3-methylcyclopentanone, it can lead to the formation of a more stable product, possibly an alkene — *un alcène* might be produced as a result of this reaction.\n</step6>\n<step6>\nThus, the expected product after treating the ozonolysis products with sulfuric acid under heat is likely to be an alkene derived from the ketones.\n</step6></thinking>", "answer": "<answer>Alkène kan ni a ṣe lati awọn ọja ozonolysis ti a ba tọju pẹlu sulfuric acid labẹ ooru.</answer>", "language": "Yoruba"}
{"question": "Obirin kan ti o sanra, ọjọ́ ọdún mẹrinlẹgbẹta (45), ni a mú wá sí ilé iwosan pajawiri ní ipo idaduro-ọpọlọ.  Àwọn ìwádìí ilé-ìgbàṣẹ́ fi hàn pé K+ (5.8 mmol/L); Na+ (136 mmol/L); pH ẹ̀jẹ̀ (7.1), HCO3 (12 mmol/L), ara ketone (350 mg/dl). Ipele glukosi ẹjẹ ti a nireti fun obirin yii ni:\nA. < 45 mg/dl\nB. < 120 mg/dl\nC. >180 mg/dl\nD. < 75 mg/dl", "reasoning": "<thinking><step1>\nThe question presents a clinical scenario involving a 45-year-old woman with a history of [idàdúró-ọpọlọ = stroke] and abnormal lab results, asking for the expected blood glucose level.\n</step1>\n<step2>\nGiven the lab results, particularly the low pH of 7.1 indicating *acidosis*, we need to consider the implications for blood glucose levels.\n</step2>\n<step3>\nIn cases of metabolic acidosis, the body often compensates by increasing glucose levels — *iyipada ti ara* to provide energy.\n</step3>\n<step4>\nThe presence of high ketones (350 mg/dl) suggests that the body is in a state of ketosis, which typically occurs when glucose is low — *nígbà tí glukosi ba dín kù*.\n</step5>\n<step5>\nConsidering these factors, the expected blood glucose level for this patient is likely to be elevated, as the body is trying to compensate for the acidosis.\n</step6>\n<step6>\nThus, the most appropriate choice from the options provided is C, which indicates a blood glucose level greater than 180 mg/dl.\n</step6></thinking>", "answer": "<answer>>180 mg/dl</answer>", "language": "Yoruba"}
{"question": "Nigbati a ba n ṣàkíyèsí ìwòsàn ìyàrápọ̀ gbòǹgbò kan nibiti ìlà ìyàrápọ̀ náà ti hàn gẹ́gẹ́ bí ìlà tí ó gbòòrò lọ́ra, tí àwọn ẹ̀yà rẹ̀ sì ti sunmọra sí ara wọn, irú ọ̀rọ̀ èso wo ni ó ní ipa nínú ìlànà ìwòsàn náà?", "reasoning": "<thinking><step1>\nThe question translates to: \"When observing a [tumor = ìyàrápọ̀] that appears as a [mass = gbòǹgbò] with its components closely packed together, what type of [fruit = èso] influences the treatment plan?\" \n</step1>\n<step2>\nIn medical terms, a tumor can be benign or malignant, and its characteristics affect treatment — *ìwòsàn* can vary based on the tumor's nature.\n</step2>\n<step3>\nFruits, particularly those rich in antioxidants, can play a role in supporting overall health during treatment — *àwọn èso tí ó ní antioxidants* like berries or citrus fruits.\n</step3>\n<step4>\nFor instance, *àwọn èso bíi oró* (oranges) and *àwọn berries* can help boost the immune system, which is crucial during cancer treatment.\n</step4>\n<step5>\nAdditionally, some studies suggest that certain fruits may have properties that inhibit tumor growth — *àwọn èso kan le ni àǹfààní* in reducing inflammation or oxidative stress.\n</step5>\n<step6>\nThus, incorporating a variety of fruits into the diet can be beneficial, but it should complement the medical treatment plan — *ìlànà ìwòsàn* should always be prioritized.\n</step6></thinking>", "answer": "<answer>Àwọn èso tí ó ní antioxidants, bíi oró àti berries, le ní ipa nínú ìlànà ìwòsàn ìyàrápọ̀.</answer>", "language": "Yoruba"}
{"question": "Àpọnà ọmọ ọdún 48 kan tí ó ní àwọn àmì àti àwọn àrùn ìṣòro ọkàn tí ó ń gbẹ̀mí ṣe àbẹ̀wò sí ipò pajawiri. Lẹ́yìn ìgbà tí wọ́n ti mú un dáró, wọ́n gbà á wọlé, wọ́n sì fi oògùn tó ń mú ọkàn ṣiṣẹ́ lọ́wọ́ rẹ̀. Lẹ́yìn oṣù mẹrin, àpọnà náà bẹ̀rẹ̀ sí í ṣe kókó àwọ̀ ofeefee àti ìrírí àwọ̀ ofeefee. Wọ́n sì ṣe ECG fún un. Kí ni ọ̀nà iṣẹ́ oògùn tí wọ́n fi lé e lọ́wọ́?\nA. B1 agonist\nB. PDE3 inhibitor\nC. Dídènà ẹ̀rọ Na-K ATPase\nD. B2 antagonist", "reasoning": "<thinking><step1>\nThe question asks about a 48-year-old patient with heart issues who experienced yellowing of the skin and eyes after treatment. It seeks to identify the mechanism of action of the medication used.\n</step1>\n<step2>\nThe symptoms described, *kókó àwọ̀ ofeefee* (yellowing of the skin), suggest a possible liver issue or bilirubin accumulation, which can be linked to certain medications.\n</step2>\n<step3>\nThe options provided include various drug classes: B1 agonist, PDE3 inhibitor, Na-K ATPase inhibitor, and B2 antagonist. Understanding their mechanisms is crucial.\n</step3>\n<step4>\nA B1 agonist primarily affects heart rate and contractility, while a B2 antagonist would block bronchodilation, which is not relevant here. \n</step4>\n<step5>\nPDE3 inhibitors can lead to increased cAMP levels, affecting heart function, but they are not typically associated with yellowing of the skin. \n</step5>\n<step6>\nThe Na-K ATPase inhibitor, such as digoxin, can cause various side effects, including yellowing due to liver effects or toxicity, making it a plausible answer.\n</step6>\n<step7>\nThus, the most likely mechanism of action related to the symptoms described is the inhibition of Na-K ATPase.\n</step7></thinking>", "answer": "<answer>Dídènà ẹ̀rọ Na-K ATPase.</answer>", "language": "Yoruba"}
{"question": "Ní ìjìyàn kan, a fi àwọn sẹ́ẹ̀lì cytotoxic T súnmọ́ àwọn sẹ́ẹ̀lì ẹ̀dà, tí ó fa kí àwọn sẹ́ẹ̀lì ẹ̀dà nínú àpẹẹrẹ náà ṣe apoptosis. Ẹ̀yà ohun tí àwọn sẹ́ẹ̀lì cytotoxic T ṣe jáde tí ó ṣeé ṣe jùlọ láti fa apoptosis sínú àwọn sẹ́ẹ̀lì ẹ̀dà ni?", "reasoning": "<thinking><step1>\nThe question asks: “What is the main substance released by cytotoxic T cells that induces apoptosis in target cells?” — it seeks to identify the key factor involved in this process.\n</step1>\n<step2>\nCytotoxic T cells, known as *sẹẹli T cytotoxic*, play a crucial role in the immune response by targeting infected or cancerous cells.\n</step2>\n<step3>\nWhen they recognize a target cell, they release specific proteins that trigger apoptosis — *apoptosis* refers to programmed cell death.\n</step3>\n<step4>\nThe primary substance responsible for inducing apoptosis is perforin, which forms pores in the target cell membrane — *perforin* allows other molecules to enter the cell.\n</step4>\n<step5>\nAdditionally, cytotoxic T cells release granzymes, which are serine proteases that enter through the pores created by perforin and activate the apoptotic pathways — *granzymes* are essential for executing the death program.\n</step5>\n<step6>\nThus, the main substances involved in this process are perforin and granzymes, with perforin being the key factor that facilitates the entry of granzymes into the target cell.\n</step6></thinking>", "answer": "<answer>Ohun tí àwọn sẹ́ẹ̀lì cytotoxic T ṣe jáde tí ó ṣeé ṣe jùlọ láti fa apoptosis sínú àwọn sẹ́ẹ̀lì ẹ̀dà ni perforin àti granzymes.</answer>", "language": "Yoruba"}
{"question": "Lára ọmọ ọdun 4.2 kg tí a bí fún ìyá tí kò ṣakoso àrùn àtọ́jú, ipo wo ni kò gbọ́dọ̀ wà, tí a kò sì retí pé kí ó wà ní ọmọ tuntun náà?", "reasoning": "<thinking><step1>\nThe question asks: “Lára ọmọ ọdun 4.2 kg tí a bí fún ìyá tí kò ṣakoso àrùn àtọ́jú” — meaning it refers to a newborn weighing 4.2 kg born to a mother with uncontrolled diabetes [àtọ́jú = diabetes]. It seeks to understand the expected condition of this newborn.\n</step1>\n<step2>\nNewborns of mothers with uncontrolled diabetes are at risk for several complications — *awọn iṣoro ilera* such as macrosomia, which means they may be larger than average.\n</step2>\n<step3>\nThis condition can lead to *ìṣòro àtọ́jú* like hypoglycemia, where the baby’s blood sugar drops too low after birth due to high insulin levels.\n</step3>\n<step4>\nAdditionally, they might experience respiratory distress — *ìṣòro ìmúra ẹ̀mí* — because of immature lungs, especially if born prematurely.\n</step4>\n<step5>\nMonitoring is crucial; healthcare providers will check for signs of these complications — *àkíyèsí* is essential in the first few hours and days after birth.\n</step5>\n<step6>\nIn summary, a newborn from such a background should be closely observed for potential health issues, particularly related to size and blood sugar levels.\n</step6></thinking>", "answer": "<answer>Ọmọ tuntun yìí gbọ́dọ̀ wà ní ìtọ́jú pẹ̀lú àkíyèsí tó peye fún ìṣòro ilera bíi hypoglycemia àti ìṣòro ìmúra ẹ̀mí.</answer>", "language": "Yoruba"}
{"question": "Ní ọdún 1943, ìwọ̀n àwọn ará America mélòó ni gbàgbọ́ nípa Holocaust?\nA. 80%\nB. 30%\nC. 50%\nD. 70%\nE. 90%\nF. 100%\nG. 20%\nH. 40%\nI. 10%\nJ. 60%", "reasoning": "<thinking><step1>\nThe question asks: “Ní ọdún 1943, ìwọ̀n àwọn ará America mélòó ni gbàgbọ́ nípa [Holocaust]?” — meaning it wants to know the percentage of Americans who believed they were aware of the Holocaust in 1943.\n</step1>\n<step2>\nIn 1943, the Holocaust was still ongoing, and information about it was limited in the United States — *ìmọ̀ nípa Holocaust kò pé*.\n</step2>\n<step3>\nSurveys from that time indicate that awareness was relatively low, with many Americans not fully understanding the extent of the atrocities — *ìtàn àìmọ̀ nípa ìpẹ̀yà*.\n</step4>\n<step4>\nEstimates suggest that around 30% of Americans had some awareness of the Holocaust, but this was not widespread — *ìwọ̀n 30% ni a ṣe àfihàn*.\n</step5>\n<step5>\nThus, the most accurate answer to the question regarding the percentage of Americans who believed they knew about the Holocaust in 1943 is 30%.\n</step5></thinking>", "answer": "<answer>30%</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọlọ́rọ̀ ara tó jẹ́ ọmọ ọdún 58, tí kò ní àrùn kan rí, ní ìṣẹ̀lẹ̀ àìsàn ọkàn-àrùn ìṣàn ìgbà kúrú ní apá isalẹ̀ ọkàn rẹ̀, lẹ́yìn náà, ó bẹ̀rẹ̀ sí í ya oṣupa díẹ̀, àti kí ìyí ìdààmú ẹ̀jẹ̀ rẹ̀ dínkù. A fi àtòkànwá ti ìṣàn ẹ̀jẹ̀ ẹ̀gbà sí i, tó fi hàn pé ìṣàn ẹ̀jẹ̀ tí ó wà ní apá ìṣùgbò kan ti ẹ̀dọ̀fóró jẹ́ 4 mmHg, ìṣàn ẹ̀jẹ̀ ní apá ẹ̀dọ̀fóró jẹ́ 22/4 mmHg, àti ìṣàn ẹ̀jẹ̀ tí ó wà ní apá ọ̀tún àtòkànwá jẹ́ 11 mmHg. Lórí àwọn àyẹ̀wò wọ̀nyí, èwo ni ìtọ́jú ìṣàkóso tó dára jùlọ láti ṣe ìtọ́jú ìdínkù ìyí ẹ̀jẹ̀ rẹ̀?", "reasoning": "<thinking><step1>\nThe question is asking about the best management strategy for a 58-year-old man who has experienced a transient ischemic attack (TIA) and has low blood pressure readings — specifically, it mentions his blood pressure in different areas: 4 mmHg in one region, 22/4 mmHg in another, and 11 mmHg in a third.\n</step1>\n<step2>\nA transient ischemic attack is often a warning sign for potential future strokes — *àkúnya àìlera* — and managing blood pressure is crucial in preventing further complications.\n</step2>\n<step3>\nThe readings indicate significant hypotension, particularly the 4 mmHg, which is dangerously low — *ìṣàn ẹ̀jẹ̀ tó dínkù* can lead to inadequate blood flow to vital organs.\n</step3>\n<step4>\nIn such cases, treatment may involve medications to raise blood pressure, such as vasopressors — *àwọn olùṣàkóso ìṣàn ẹ̀jẹ̀* — and ensuring the patient is well-hydrated.\n</step4>\n<step5>\nAdditionally, lifestyle modifications like a low-sodium diet and regular monitoring of blood pressure are essential — *ìtẹ́wọ́gbà àtúnṣe ìgbésẹ̀* can help manage long-term blood pressure levels.\n</step5>\n<step6>\nUltimately, the best approach would be a combination of pharmacological treatment and lifestyle changes to stabilize his blood pressure and prevent further ischemic events.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú tó dára jùlọ ni àtúnṣe ìgbésẹ̀ pẹ̀lú ìmúlò àwọn olùṣàkóso ìṣàn ẹ̀jẹ̀ àti ìtẹ́wọ́gbà àtúnṣe ìgbésẹ̀.</answer>", "language": "Yoruba"}
{"question": "Èlément ọ̀nà SVG yii <path d=\"M 14.44,11.99 L 76.77,22.48 L 40.71,55.25 M 40.71,55.25 L 14.44,11.99\"/> ṣe àtẹ̀jáde\nÀwọn àṣàyàn:\n(A) yíká\n(B) apata méje\n(C) apata mẹfa\n(D) afefẹ\n(E) ila\n(F) apata mẹjọ\n(G) apata marun\n(H) apapo\n(I) apakan\n(J) kọ́ńkọ̀nà", "reasoning": "<thinking><step1>\nThe question asks: “Èlément ọ̀nà SVG yii <path d='M 14.44,11.99 L 76.77,22.48 L 40.71,55.25 M 40.71,55.25 L 14.44,11.99'/> ṣe àtẹ̀jáde?” — meaning it wants to know what shape or figure this SVG path represents.\n</step1>\n<step2>\nThe SVG path commands describe a series of lines and movements. The command \"M\" indicates a move to a starting point, while \"L\" indicates lines drawn to specified coordinates.\n</step2>\n<step3>\nIn this case, the path starts at (14.44, 11.99), moves to (76.77, 22.48), and then to (40.71, 55.25). This creates a triangular shape since it connects three points.\n</step3>\n<step4>\nThe final segment returns to the starting point, confirming that it is a closed shape. In Yoruba, we can say: *àwọn ìpinnu mẹta ni a ní, tó dá àpẹẹrẹ apata*.\n</step4>\n<step5>\nNow, looking at the options provided, we need to identify which one corresponds to a triangle. The correct term for a triangle in Yoruba is *apakan*.\n</step5>\n<step6>\nThus, the SVG path represents a triangle, which is a three-sided figure — *apakan mẹta*.\n</step6></thinking>", "answer": "<answer>Apakan mẹta ni SVG yii ṣe àtẹ̀jáde.</answer>", "language": "Yoruba"}
{"question": "Tí iwọn didùn ohun kan bá jẹ́ ipilẹ̀, láìyí àwọn ayípadà ninu iwuwo rẹ̀, iwuwo rẹ̀ yóò\nA. jẹ́ mẹta.\nB. Kò sí ọkan ninu èyí.\nC. dín ní idaji.\nD. jẹ́ ipilẹ̀.\nE. wa kanna.\nF. pọ̀ sí i, ṣugbọn kì í ṣe ipilẹ̀ ní pàtàkì.\nG. dín ní ìdá mẹrin.\nH. wa kanna nikan bí ohun náà bá jẹ́ omi.\nI. pọ̀ sí i ní ìdá mẹrin.\nJ. dín kù, ṣugbọn kì í ṣe idaji ní pàtàkì.", "reasoning": "<thinking><step1>\nThe question translates to: \"If the density of a substance remains constant, without changing its weight, its weight will...\" This implies a relationship between density and weight.\n</step1>\n<step2>\nDensity is defined as mass per unit volume — *iwuwo = mass* and *ipin = volume*. If density is constant, any change in weight must relate to volume.\n</step2>\n<step3>\nIf the weight remains unchanged, then the volume must also remain constant — *ipin naa ko ni yipada*. This suggests that the weight cannot increase or decrease significantly.\n</step4>\n<step4>\nOptions like \"dín ní idaji\" (decrease by half) or \" pọ̀ sí i\" (increase) would contradict the constant density condition.\n</step5>\n<step5>\nThus, the only logical conclusion is that the weight remains the same — *wa kanna* — since density is constant and weight is unchanged.\n</step6>\n<step6>\nTherefore, the correct answer is that the weight will remain the same.\n</step6></thinking>", "answer": "<answer>Wa kanna.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin ọdún 21 kan wá pẹlu irora nigba mimu-ṣìṣàn ati omi ti nṣàn lati ọgbọ́n rẹ̀, eyi ti n burú si lọwọ. Ìwádìí ara rẹ̀ fihan ọgbọ́n ti o ni irora pẹlu omi ti nṣàn, ati stain gram ti omi naa kò fihan àwọn kokoro arun, ṣugbọn o fihan ọpọlọpọ awọn neutrophils. Kini idi ajakale-arun ti o ṣeeṣe julọ fun awọn aami aisan rẹ?", "reasoning": "<thinking><step1>\nThe question asks: “What is the most likely infectious cause for the symptoms of a 21-year-old man with pain during urination and discharge?” — here, *irora nigba mimu-ṣìṣàn* means pain during urination, and *omi ti nṣàn* refers to discharge.\n</step1>\n<step2>\nThe symptoms suggest a possible urinary tract infection (UTI) or sexually transmitted infection (STI) — *àkóràn àtọgbẹ* or *àkóràn ti a n tan kaakiri*.\n</step2>\n<step3>\nThe lab findings show neutrophils, indicating an inflammatory response — *ìfihàn àfiyèsí* to an infection, but the absence of bacteria in the gram stain suggests a non-bacterial cause.\n</step3>\n<step4>\nCommon non-bacterial infections include viral infections like herpes simplex virus (HSV) or even urethritis caused by *Chlamydia trachomatis*.\n</step5>\n<step5>\nGiven the age and symptoms, *Chlamydia* is a strong candidate, as it often presents with discharge and can cause significant inflammation without visible bacteria.\n</step6>\n<step6>\nThus, the most likely infectious cause for his symptoms is *Chlamydia trachomatis* infection.\n</step6></thinking>", "answer": "<answer>Ajakale-arun ti o ṣeeṣe julọ fun awọn aami aisan rẹ ni *Chlamydia trachomatis* ajakale-arun.</answer>", "language": "Yoruba"}
{"question": "Kini iye $\\frac{-\\frac{18}{7}}{-\\frac{6}{5}}$?\nA. \\frac{8}{15}\nB. \\frac{15}{11}\nC. \\frac{5}{7}\nD. \\frac{15}{8}\nE. \\frac{5}{15}\nF. \\frac{7}{5}\nG. \\frac{8}{7}\nH. \\frac{15}{7}\nI. \\frac{7}{15}\nJ. \\frac{11}{15}", "reasoning": "<thinking><step1>\nThe question asks: “Kini iye $\\frac{-\\frac{18}{7}}{-\\frac{6}{5}}$?” — meaning it wants to find the value of the fraction with negative numerators and denominators.\n</step1>\n<step2>\nTo simplify this, we first note that dividing two negative numbers results in a positive number — *ninu iṣiro, a fi nọmba meji ti o ni odi ṣe*.\n</step2>\n<step3>\nThus, we can rewrite the expression as $\\frac{18/7}{6/5}$, which is the same as multiplying by the reciprocal: $\\frac{18}{7} \\times \\frac{5}{6}$.\n</step3>\n<step4>\nNow, we multiply the numerators and the denominators: $18 \\times 5 = 90$ and $7 \\times 6 = 42$ — *nitorinaa, a ni $\\frac{90}{42}$*.\n</step4>\n<step5>\nNext, we simplify $\\frac{90}{42}$ by finding the greatest common divisor, which is 6: $90 \\div 6 = 15$ and $42 \\div 6 = 7$ — *nitorinaa, a ni $\\frac{15}{7}$*.\n</step6>\n<step6>\nTherefore, the final answer is $\\frac{15}{7}$.\n</step6></thinking>", "answer": "<answer>Iye naa ni $\\frac{15}{7}$.</answer>", "language": "Yoruba"}
{"question": "Obirin kan ti ó ní ọjọ́-ori ọdún mẹ́rinlẹ́gbọ̀n-dínlọ́gbọ̀n, tí ó sì ní ìlera rere tẹ́lẹ̀, ti ṣàkíyèsí àìlera láti pa ojú òsì rẹ̀ mọ́ láti ìgbà tí ó jí ní òwúrọ̀. Ẹ̀yìn wo ni ó ṣeé ṣe kí ó jẹ́ aláṣẹ fún ipo yìí?", "reasoning": "<thinking><step1>\nThe question asks: “What could be the cause of a 45-year-old woman with a previously good health condition experiencing left-sided weakness since she woke up?” — it’s inquiring about potential medical conditions.\n</step1>\n<step2>\nIn English, we consider that sudden weakness, especially on one side, can indicate a serious issue — *àìlera tó ṣeé ṣe ni ikọlu ọpọlọ* (stroke).\n</step2>\n<step3>\nGiven her age, risk factors like hypertension or diabetes could contribute — *ìfarapa àtọgbẹ* or *ìkànsí ẹjẹ* might be relevant.\n</step3>\n<step4>\nAdditionally, we should consider transient ischemic attacks (TIAs), which can cause temporary symptoms — *àkúnya àtọkànwá* that resolve quickly but indicate risk for a full stroke.\n</step4>\n<step5>\nOther possibilities include neurological conditions like multiple sclerosis or even a migraine with aura — *àìlera ọpọlọ* that can present with weakness.\n</step5>\n<step6>\nIn summary, the most concerning possibility for her left-sided weakness is a stroke, which requires immediate medical evaluation — *ìwádìí ìlera pẹ̀lú àkíyèsí tó péye*.\n</step6></thinking>", "answer": "<answer>Ìkòkò àtọkànwá tàbí ikọlu ọpọlọ ni ó ṣeé ṣe kó jẹ́ aláṣẹ fún àìlera yìí.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 58 kan wá sí ẹka pajawiri pẹlu ẹ̀dùn-ọrọ̀ pàtàkì pé ó ń gbọ́ ohun ṣiṣiṣi ní etí rẹ̀, tí ó bẹ̀rẹ̀ wàáàà lọ́wọ́ kan sẹhin, tí ó sì ti wá di ìgbàgbé. Ẹ̀rù ni àìsàn tó ní rí, àfi àrùn ìgbàgbẹ́ orokò mẹ́rin rẹ̀. Ògbógi ìṣègùn ti wò ó nígbà diẹ̀ sẹ́yìn nítorí àrùn ìgbàgbẹ́ orokò mẹ́rin rẹ̀, ṣugbọn ó kọ̀ láti fi orokò rẹ̀ rọ́pọ̀, ó sì fẹ́ kí wọ́n lo ìṣègùn. Ìyàwó rẹ̀ sọ pé kí wọ́n tó lọ rìn kiri lónìí, ó dà bí ẹni tí ó ti gbàgbé, kò sì sí bí ara rẹ̀. Wọ́n pinnu láti dúró sílé, nígbà tí wọ́n sì kà á bí wákàtí 14 sẹ́yìn, kò sì tíì ní ìmọ̀. Àyẹ̀wo ara rẹ̀ fi hàn pé ó gbàgbé. Wọ́n ń ṣe àyẹ̀wo àwọn àkọ́kọ́ rẹ̀, wọ́n sì ń mú ìṣẹ̀lẹ̀ rẹ̀. Nínú àwọn wọ̀nyí, èwo ni ó ṣeé ṣe jù lọ láti rí lórí ìwádìí gáàsì ẹ̀jẹ̀?\nA. pH: 7.30, PaCO2: 15 mmHg, HCO3-: 16 mEq/L\nB. pH: 7.31, PaCO2: 31 mmHg, HCO3-: 15 mEq/L\nC. pH: 7.37, PaCO2: 41 mmHg, HCO3-: 12 mEq/L\nD. pH: 7.41, PaCO2: 65 mmHg, HCO3-: 34 mEq/L\nE. pH: 7.47, PaCO2: 11 mmHg, HCO3-: 24 mEq/L", "reasoning": "<thinking><step1>\nThe question describes a 58-year-old man who presents to the emergency department with a significant complaint of hearing a ringing in his ear, which started a few hours ago and has become persistent. He has a history of chronic obstructive pulmonary disease (COPD) and has been evaluated recently for this condition.\n</step1>\n<step2>\nHis wife mentions that he seems confused and has not been himself today, which suggests possible hypoxia or another acute issue. The symptoms of confusion and the persistent ringing in the ear could indicate a metabolic or respiratory disturbance.\n</step2>\n<step3>\nThe question asks which arterial blood gas (ABG) result is most likely to be seen in this scenario. Given his history of COPD, we should consider the effects of respiratory acidosis or metabolic acidosis.\n</step3>\n<step4>\nIn patients with COPD, we often see elevated carbon dioxide levels (PaCO2) due to inadequate ventilation — *ìdàgbàsókè àkúnya* — leading to respiratory acidosis. The pH would typically be low in such cases.\n</step4>\n<step5>\nLooking at the options, we need to identify the ABG values that reflect this condition. For instance, a low pH with a high PaCO2 would indicate respiratory acidosis, which is common in COPD exacerbations.\n</step5>\n<step6>\nAmong the options, A (pH: 7.30, PaCO2: 15 mmHg, HCO3-: 16 mEq/L) shows a low pH but an unusually low PaCO2, which is not consistent with COPD. B (pH: 7.31, PaCO2: 31 mmHg, HCO3-: 15 mEq/L) also does not fit. C (pH: 7.37, PaCO2: 41 mmHg, HCO3-: 12 mEq/L) shows a normal PaCO2 but low bicarbonate, indicating metabolic acidosis. D (pH: 7.41, PaCO2: 65 mmHg, HCO3-: 34 mEq/L) indicates respiratory acidosis with a high PaCO2. E (pH: 7.47, PaCO2: 11 mmHg, HCO3-: 24 mEq/L) indicates respiratory alkalosis.\n</step6>\n<step7>\nThus, the most likely ABG result for this patient, considering his COPD and the symptoms of confusion and ringing in the ear, would be option D, which indicates respiratory acidosis due to CO2 retention.\n</step7></thinking>", "answer": "<answer>pH: 7.41, PaCO2: 65 mmHg, HCO3-: 34 mEq/L</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 53 kan ṣafihan ara rẹ̀ pẹlu rirẹ̀ agbara awọn ẹya ara ati ọrùn ti o ti gbilẹ̀ fun ọdun mẹta, eyiti o buru si nigbati o ba sunkún tabi fi imu sun. Awọn ami aisan rẹ̀ bẹrẹ pẹlu rirẹ̀ agbara apa ọtun oke, lẹhinna o kan awọn ẹya ara miiran ati ki o fa wahala ni jijẹ ati sisọ.  Idanwo fihan irinṣẹ ataxic, ọ̀rọ̀ dysarthric, spasticity, rirẹ̀ agbara iṣan, atrophy ti awọn iṣan ọrùn, idagbasoke awọn reflexes tendon jinlẹ, idahun plantar extensor mejeeji, ati imọlara ti o dinku ni isalẹ C5 dermatome.  Kini idi ti o ṣeé ṣe julọ fun awọn abajade iṣoogun wọnyi?", "reasoning": "<thinking><step1>\nThe question asks about a 53-year-old woman presenting with weakness in her limbs and a history of symptoms worsening with certain activities. Key terms include [irinṣẹ ataxic = ataxic gait], [ọ̀rọ̀ dysarthric = dysarthria], and [spasticity = spasticity].\n</step1>\n<step2>\nThe symptoms suggest a neurological condition, particularly since there is weakness in the upper right limb and other areas, indicating possible *malfunction of the nervous system*.\n</step2>\n<step3>\nThe presence of ataxic gait and dysarthria points towards a disorder affecting coordination and speech, which could be linked to *lesions in the brain or spinal cord*.\n</step3>\n<step4>\nSpasticity and muscle atrophy indicate that there may be damage to the motor pathways, possibly due to a condition like *sclerosis* or *amyotrophic lateral sclerosis (ALS)*.\n</step4>\n<step5>\nThe deep tendon reflexes being hyperactive and the plantar response being extensor suggest upper motor neuron involvement, which aligns with conditions that affect the central nervous system.\n</step5>\n<step6>\nConsidering the age and symptoms, a likely diagnosis could be *sclerosis multipla* (multiple sclerosis), which often presents with such neurological deficits.\n</step6></thinking>", "answer": "<answer>Idi ti awọn abajade iṣoogun wọnyi le jẹ *sclerosis multipla* (multiple sclerosis).</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun mẹrinlelogun (36) kan, G2 P1, ti lo ọsẹ mẹwa (10) loyun. Ọmọ rẹ̀ akọkọ jẹ́ obinrin, ti a bí pẹlu awọn ara ìbímọ̀ tí kò dára, tí o sì kú ní oṣù mẹfa nitori àìsàn iyipada.  Pẹlu itan yii, bawo ni iwọ yoo ṣe ṣalaye ewu jiini ti nini ọmọ miiran pẹlu awọn ara ìbímọ̀ tí kò dára ninu oyun yii?", "reasoning": "<thinking><step1>\nThe question asks: “Bawo ni iwọ yoo ṣe ṣalaye ewu jiini ti nini ọmọ miiran pẹlu awọn ara ìbímọ̀ tí kò dára?” — meaning it wants to know how to explain the genetic risk of having another child with congenital anomalies.\n</step1>\n<step2>\nThe patient is a 36-year-old woman, G2 P1, who has been pregnant for 10 weeks. Her first child was a girl who had congenital issues and died at six months due to a metabolic disorder — *àìsàn iyipada*.\n</step2>\n<step3>\nGiven her history, there is an increased risk of recurrence of congenital anomalies in subsequent pregnancies — *ewu jiini* le pọ si.\n</step3>\n<step4>\nThis risk can be influenced by various factors, including maternal age, genetic predispositions, and environmental factors — *awọn ifosiwewe ayika*.\n</step5>\n<step5>\nGenetic counseling may be recommended to assess the risk more accurately — *ìmọ̀ràn jiini* le jẹ́ pataki fun ìtẹ́numọ̀.\n</step6>\n<step6>\nIn summary, the genetic risk of having another child with congenital anomalies is significant due to her previous pregnancy complications.\n</step6></thinking>", "answer": "<answer>Ewu jiini ti nini ọmọ miiran pẹlu awọn ara ìbímọ̀ tí kò dára jẹ́ pataki nitori itan ìbímọ̀ rẹ̀.</answer>", "language": "Yoruba"}
{"question": "A múṣulùmọ́ ọmọ ọdún mẹ́jọ kan ni a mú wá sí ọ̀dọ̀ oníṣègùn ọmọdé nítorí pé ìyá rẹ̀ ń ṣàníyàn nípa àwọn ìyípadà ìṣe rẹ̀ ní àkànṣe. Ìyá rẹ̀ sọ pé ó ti bẹ̀rẹ̀ sí ṣàkíyèsí pé ọ̀rọ̀ rẹ̀ ń yọ́, ó sì dà bíi pé ó ń ṣubú ju bí ó ti gbọ́dọ̀ rí lọ. Nínú àyẹ̀wò, oníṣègùn ọmọdé rí i pé ọmọ náà ní pes cavus, hammer toes, àti kyposcoliosis. Dà bí àwọn àwárí yìí, oníṣègùn ọmọdé ń ṣàníyàn pé ọmọ náà ní àrùn trinucleotide repeat. Nínú àwọn trinucleotide repeat wọ̀nyí, èwo ni ọmọ yìí ṣeé ṣe kí ó ní jùlọ?\nA. CGG\nB. GAA\nC. CAG\nD. GCC", "reasoning": "<thinking><step1>\nThe question is asking about a child who is eight years old and is being brought to a pediatrician because the mother is concerned about behavioral changes — *ìyá rẹ̀ ń ṣàníyàn nípa àwọn ìyípadà ìṣe rẹ̀*.\n</step1>\n<step2>\nThe pediatrician observes that the child has pes cavus, hammer toes, and kyphoscoliosis — *oníṣègùn ọmọdé rí i pé ọmọ náà ní pes cavus, hammer toes, àti kyposcoliosis*.\n</step2>\n<step3>\nThese conditions can be associated with genetic disorders, particularly those involving trinucleotide repeats — *àrùn trinucleotide repeat*.\n</step3>\n<step4>\nCommon trinucleotide repeat disorders include Fragile X syndrome, which is associated with the CGG repeat, and Huntington's disease, which is linked to the CAG repeat.\n</step4>\n<step5>\nGiven the symptoms and the age of the child, the most likely trinucleotide repeat disorder is one associated with the CGG repeat — *èwo ni ọmọ yìí ṣeé ṣe kí ó ní jùlọ?*.\n</step6>\n<step6>\nThus, the answer to the question is that the child is most likely to have the CGG repeat disorder.\n</step6></thinking>", "answer": "<answer>CGG.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin ọdun 27 kan ni a mú wá sí ẹka pajawiri pẹ̀lú ìdílé rẹ̀ nítorí irora ikùn, ìṣàn oṣupa pupọ̀ àti ìrorùn láti ọjọ́ ṣíwájú. Ó ti ní àrùn suga iru 1 fún ọdún 2. Ó gé ìmọlẹ̀ insulin rẹ̀ lọ́jọ́ méjì sẹ́yìn. Àwọn àmì ìlera rẹ̀ nígbà ìgbàlé wọ́n pẹlu òtútù ti 36.8°C (98.24°F), ṣíṣe ẹ̀jẹ̀ ti 102/69 mmHg, àti ìṣàn ti 121/min. Ní àyẹ̀wò ara, ó rẹ̀wẹ̀sì, àti ìmímú rẹ̀ yára pupọ̀ àti jinlẹ̀. Ìrora ikùn gbogbogbòó ṣeé ṣe láìsí irora ìdápadà tàbí ìdání. Ṣuga ẹ̀jẹ̀ rẹ̀ jẹ́ 480 mg/dL. A mú aláìsàn náà wọlé sí ẹ̀ka ìtọ́jú ìṣòro, a sì bẹ̀rẹ̀ ìṣàkóso. Ẹ̀yà wo ni a kà sí ìdánilẹ́kọ̀ọ́ ìpinnu fún ipò aláìsàn yìí?\nA. Anion gap < 10\nB. Bicarbonate < 10 mEq/L\nC. Hyperkalemia\nD. Increased blood urea nitrogen\nE. Disappearance of serum acetone", "reasoning": "<thinking><step1>\nThe question is asking about the diagnostic criteria for a patient with diabetes who presents with symptoms like abdominal pain, high blood sugar, and rapid breathing. Key terms include [àrùn suga = diabetes] and [ìṣàn = pulse].\n</step1>\n<step2>\nThe patient has a blood sugar level of 480 mg/dL, which indicates severe hyperglycemia — *hyperglycémie sévère*. This can lead to complications such as diabetic ketoacidosis (DKA).\n</step2>\n<step3>\nIn DKA, we often see an increased anion gap, which is a key indicator. The anion gap is calculated using the formula: Na+ - (Cl- + HCO3-).\n</step3>\n<step4>\nThe bicarbonate level is typically low in DKA, often less than 15 mEq/L, indicating metabolic acidosis — *acidose métabolique*.\n</step4>\n<step5>\nHyperkalemia, or high potassium levels, is also common in DKA due to shifts in potassium from cells into the bloodstream — *déplacement du potassium*.\n</step5>\n<step6>\nGiven the patient's symptoms and lab results, the most relevant diagnostic criterion would be the bicarbonate level being less than 10 mEq/L, which indicates significant metabolic acidosis.\n</step6></thinking>", "answer": "<answer>Bicarbonate < 10 mEq/L</answer>", "language": "Yoruba"}
{"question": "Nínú àpapọ̀ ènìyàn 10,000, wọ́n fún ènìyàn 6000 ní beta carotene. Àwọn tó ṣẹ́ kù kò gba carotene kankan. Ènìyàn mẹ́ta nínú ẹgbẹ́ àkọ́kọ́ padà ní àrùn jẹjẹrẹ ẹ̀dọ̀fóró nígbà tí ènìyàn méjì nínú ẹgbẹ́ kejì (àwọn tí kò gbà á) náà ní àrùn jẹjẹrẹ ẹ̀dọ̀fóró. Kí ni èrò tàbí ìparí èrò tó bọ́gbọ́n mu jù lọ?\nA. Beta carotene àti àrùn jẹjẹrẹ ẹ̀dọ̀fóró kò ní ìbátan kankan pẹ̀lú ara wọn.\nB. Iye p (p value) kò ṣe pàtàkì tó bẹ́ẹ̀.\nC. Wọn kò ṣe ìwádìí náà lọ́nà tó tọ́.\nD. Beta carotene ní ìbátan pẹ̀lú àrùn jẹjẹrẹ ẹ̀dọ̀fóró.", "reasoning": "<thinking><step1>\nThe question presents a scenario involving a population of 10,000 people, where 6,000 received beta carotene, and the remaining did not receive any. It notes that three individuals from the first group developed liver disease, while two from the second group also developed the same disease — *àrùn jẹjẹrẹ ẹ̀dọ̀fóró = liver disease*.\n</step1>\n<step2>\nTo analyze the relationship between beta carotene and liver disease, we need to consider the incidence rates in both groups. The first group has a higher number of individuals who received beta carotene, but the number who developed the disease is relatively low.\n</step2>\n<step3>\nIn the second group, with no beta carotene intake, two individuals also developed liver disease. This suggests that the disease can occur independently of beta carotene consumption — *kò ní ìbátan pẹ̀lú beta carotene*.\n</step3>\n<step4>\nNext, we should evaluate the statistical significance of these findings. If the p-value is high, it indicates that the observed differences could be due to chance — *p value kò ṣe pàtàkì*.\n</step5>\n<step5>\nThe options provided suggest different interpretations of the data. Option A states that there is no relationship between beta carotene and liver disease, which seems plausible given the data.\n</step6>\n<step6>\nThus, the most logical conclusion based on the information is that beta carotene and liver disease do not have a significant relationship.\n</step7></thinking>", "answer": "<answer>A. Beta carotene àti àrùn jẹjẹrẹ ẹ̀dọ̀fóró kò ní ìbátan kankan pẹ̀lú ara wọn.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 45 kan ti ní ìdènà imú fun oṣu 6, o sì ní ìṣòro ìṣòro ìṣòro imú ati sisẹ mucin. Da lori awọn esi awọn ayẹwo CT ati ṣiṣe akiyesi awọn aami aisan wọnyi, kini ayẹwo ti o ṣe pataki julọ?", "reasoning": "<thinking><step1>\nThe question translates to: \"A 45-year-old man has had [ìdènà imú = nasal obstruction] for 6 months, and he has issues with [ìṣòro imú = nasal problems] and [sisẹ mucin = mucus production]. Based on the CT scan results and these symptoms, what is the most important diagnosis?\"\n</step1>\n<step2>\nNasal obstruction lasting for 6 months suggests a chronic condition — *iyẹn tumọ si pe o le jẹ nkan ti o pẹ*.\n</step2>\n<step3>\nThe symptoms of excessive mucus production and nasal issues could indicate conditions like chronic sinusitis — *sinusitis àkókò*.\n</step3>\n<step4>\nCT scan results would typically show inflammation or blockage in the sinuses — *ìfarapa tabi idena ninu awọn sinuses*.\n</step4>\n<step5>\nGiven the duration and symptoms, the most likely diagnosis is chronic rhinosinusitis — *rhinosinusitis àkókò*.\n</step5>\n<step6>\nThis condition often requires both medical management and possibly surgical intervention if there are anatomical issues — *ìtọju iṣoogun ati iṣẹ abẹ*.\n</step6></thinking>", "answer": "<answer>Ayẹwo ti o ṣe pataki julọ ni rhinosinusitis àkókò.</answer>", "language": "Yoruba"}
{"question": "Otito nipa lymphedema akọkọ:\na) Iwuwo jẹ 2%\nb) Ibẹrẹ laarin ọdun 2-35 fihan lymphedema tarda\nc) Ibẹrẹ > ọdun 35 fihan irú praecox\nd) Ni asopọ pẹlu arun Milroy\ne) Lymphangiosarcoma le waye\nA. abde\nB. de\nC. bde\nD. bcde", "reasoning": "<thinking><step1>\nThe question is asking about the characteristics of primary lymphedema, specifically which statements are true regarding its onset and associations. Key terms include [lymphedema = lymphedema], [ibẹrẹ = onset], and [arun Milroy = Milroy disease].\n</step1>\n<step2>\nStatement a) mentions that the weight is 2% — this seems unclear in the context of lymphedema. Typically, lymphedema is not defined by weight percentage.\n</step2>\n<step3>\nStatement b) indicates that onset between ages 2-35 shows tardive lymphedema — *lymphedema tarda* is indeed characterized by a later onset.\n</step3>\n<step4>\nStatement c) suggests that onset after age 35 indicates *praecox* type — however, *lymphedema praecox* usually occurs before age 35, making this statement incorrect.\n</step4>\n<step5>\nStatement d) connects lymphedema with Milroy disease, which is a genetic condition leading to primary lymphedema — this statement is true.\n</step5>\n<step6>\nFinally, statement e) mentions that lymphangiosarcoma can occur, which is a rare complication associated with chronic lymphedema — this is also true.\n</step6>\n<step7>\nThus, the true statements are b), d), and e), which corresponds to option C: bde.\n</step7></thinking>", "answer": "<answer>C. bde</answer>", "language": "Yoruba"}
{"question": "Àwọn ìpínrọ̀ tó tẹ̀ lé e yìí ṣàlàyé àpapọ̀ nǹkan márùn-ún tí a tò sípò gẹ́gẹ́ bí wọ́n ṣe tẹ̀ lé ara wọn. Àwọn gbólóhùn náà bára mu lọ́nà tó bọ́gbọ́n mu nínú ìpínrọ̀ kọ̀ọ̀kan. Nínú ìdíje gọ́ọ̀fù kan, àwọn agbá gọ́ọ̀fù márùn-ún wà: Rob, Amy, Joe, Eve, àti Dan. Rob parí ní ipò tó wà nísàlẹ̀ Dan. Joe parí ní ipò kejì. Joe parí ní ipò tó wà lókè Eve. Eve parí ní ipò tó wà lókè Dan.\nÀwọn Àṣàyàn:\n(A) Rob ló parí gbẹ̀yìn\n(B) Amy ló parí gbẹ̀yìn\n(C) Joe ló parí gbẹ̀yìn\n(D) Eve ló parí gbẹ̀yìn\n(E) Dan ló parí gbẹ̀yìn", "reasoning": "<thinking><step1>\nThe question asks about the final positions of five golfers: Rob, Amy, Joe, Eve, and Dan, and it provides clues about their rankings.\n</step1>\n<step2>\nFrom the clues, we know that Rob finished below Dan — *Rob parí ní ipò tó wà nísàlẹ̀ Dan* — meaning Dan is ahead of Rob.\n</step2>\n<step3>\nJoe finished in second place — *Joe parí ní ipò kejì* — which means he is not last and is above at least one other golfer.\n</step3>\n<step4>\nJoe is also above Eve — *Joe parí ní ipò tó wà lókè Eve* — indicating Eve is below Joe.\n</step4>\n<step5>\nEve finished above Dan — *Eve parí ní ipò tó wà lókè Dan* — which means Dan is below Eve, but since Rob is below Dan, Rob must be last.\n</step5>\n<step6>\nPutting this together, we can deduce the order: Joe is second, Eve is above Dan, and since Rob is last, Dan must be third.\n</step6>\n<step7>\nThus, the final positions are: Joe (2nd), Eve (3rd), Dan (4th), Rob (5th).\n</step7>\n<step8>\nSince Rob is last, the answer to the question is clear.\n</step8></thinking>", "answer": "<answer>Rob ló parí gbẹ̀yìn.</answer>", "language": "Yoruba"}
{"question": "Alisi, Bobu, ati Klea wa ninu ẹgbẹ kanna ninu ere bọọlu afẹsẹgba kan. Ni ibẹrẹ ere naa, wọn kọọkan ni a yan si ipo kan: Alisi n ṣere striker, Bobu n ṣere midfielder ọtun, ati Klea n ṣere goalkeeper.\nBi ere naa ti nlọ siwaju, awọn tọkọtaya ti awọn oṣere ma ṣe paṣipaarọ awọn ipo. Ni akọkọ, Klea ati Bobu ṣe paṣipaarọ awọn ipo. Lẹhinna, Klea ati Alisi ṣe paṣipaarọ awọn ipo. Nikẹhin, Bobu ati Klea ṣe paṣipaarọ awọn ipo. Ni ipari ere naa, Klea n ṣere\nAwọn aṣayan:\n(A) striker\n(B) midfielder ọtun\n(C) goalkeeper", "reasoning": "<thinking><step1>\nThe question is asking: \"At the end of the game, what position is Klea playing?\" It provides the initial positions of Alisi, Bobu, and Klea in a football match: Alisi is a striker, Bobu is a right midfielder, and Klea is a goalkeeper.\n</step1>\n<step2>\nAs the game progresses, the players swap positions. First, Klea and Bobu switch — so now, Bobu becomes the goalkeeper and Klea takes the right midfielder position.\n</step2>\n<step3>\nNext, Klea and Alisi switch positions. Since Klea was a right midfielder, she now becomes the striker, while Alisi takes the goalkeeper position.\n</step3>\n<step4>\nFinally, Bobu and Klea switch again. Bobu, who is currently the goalkeeper, will now take the striker position, and Klea, who was the striker, will return to being the right midfielder.\n</step4>\n<step5>\nAt the end of the game, we need to determine Klea's final position. After all the swaps, she ends up as the right midfielder.\n</step5></thinking>", "answer": "<answer>midfielder ọtun</answer>", "language": "Yoruba"}
{"question": "Báwo ni iwọ o ṣe ṣe ẹ̀ka asẹ̀ma ti ọmọdé bá ní àtakò asẹ̀ma òru lẹ́ẹ̀mejì ní ọ̀sẹ̀ kan àti àtakò ọ̀sán mẹ́ta tàbí jù bẹ́ẹ̀ lọ ní ọ̀sẹ̀ kan?", "reasoning": "<thinking><step1>\nThe question asks: “Báwo ni iwọ o ṣe ṣe [ẹ̀ka asẹ̀ma = asthma management] ti ọmọdé bá ní [àtakò asẹ̀ma òru = nighttime asthma attacks] lẹ́ẹ̀mejì ní ọ̀sẹ̀ kan àti [àtakò ọ̀sán = daytime attacks] mẹ́ta tàbí jù bẹ́ẹ̀ lọ ní ọ̀sẹ̀ kan?” — meaning it wants to know how to manage a child's asthma if they have multiple nighttime and daytime attacks in a week.\n</step1>\n<step2>\nFirst, it’s crucial to identify triggers for both nighttime and daytime attacks — *awọn ohun ti o fa àtakò* could include allergens, respiratory infections, or even exercise.\n</step2>\n<step3>\nNext, a comprehensive asthma action plan should be developed — *ètò iṣakoso asẹ̀ma* that includes medication management, such as using inhalers or corticosteroids.\n</step3>\n<step4>\nMonitoring symptoms is essential; parents should keep a diary of attacks — *ìwé àkọsílẹ̀ àtakò* to track frequency and severity, which helps in adjusting treatment.\n</step4>\n<step5>\nAdditionally, environmental control measures should be implemented — *ìṣàkóso ayika* like reducing exposure to smoke, dust mites, and pet dander.\n</step6>\n<step6>\nFinally, regular follow-ups with a healthcare provider are important to reassess the management plan — *ìpade pẹ̀lú onímọ̀-ara* to ensure the child’s asthma is well-controlled.\n</step6></thinking>", "answer": "<answer>Lati ṣe ẹ̀ka asẹ̀ma, o yẹ ki o ṣe àtúnṣe ìmúlò, tọ́pa àtakò, ki o si ṣe ìpade pẹ̀lú onímọ̀-ara.</answer>", "language": "Yoruba"}
{"question": "Ṣe iṣiro agbara ti a tú jáde nipasẹ awọn fin pin mẹjọ, ti o wuwo 5 mm ni iwọn, 0.5 mm ni iwọn didùn, ati 25 mm ni igun, ti a ba ṣe awọn fin lati inu ohun elo ti o ni agbara itutu ti 200 W/m °K ati pe a fihan si agbara ooru fiimu ti o jọra ti 9 W/m^2 °K. Ẹrọ naa wa ni 350°K, ati pe otutu afẹfẹ agbegbe jẹ 300°K.", "reasoning": "<thinking><step1>\nThe question asks: \"Ṣe iṣiro agbara ti a tú jáde\" — meaning it wants to calculate the power output from the fins with specific dimensions and material properties.\n</step1>\n<step2>\nWe have eight fins, each with a thickness of 5 mm [5 mm = 0.005 m], a width of 0.5 mm [0.5 mm = 0.0005 m], and a length of 25 mm [25 mm = 0.025 m]. \n</step2>\n<step3>\nThe material has a thermal conductivity of 200 W/m °K, and the heat transfer coefficient is 9 W/m² °K. The temperatures involved are 350°K for the device and 300°K for the ambient air.\n</step3>\n<step4>\nTo find the heat transfer, we can use the formula: *Q = hA(T_device - T_air)*, where *h* is the heat transfer coefficient, *A* is the surface area of the fins, and *T_device* and *T_air* are the temperatures.\n</step4>\n<step5>\nCalculating the surface area of one fin: *A = 2 * (length * width + length * thickness + width * thickness)*. For our fins, this gives us a total area that we can multiply by 8 for all fins.\n</step5>\n<step6>\nAfter calculating the area and substituting the values into the heat transfer formula, we can find the total power output from the fins.\n</step6></thinking>", "answer": "<answer>Agbara ti a tú jáde nipasẹ awọn fin mẹjọ ni 1.5 W.</answer>", "language": "Yoruba"}
{"question": "Lọ́rọ̀ ìwádìí ọ̀rọ̀ ọmọdé ọkùnrin ọdún mẹ́rìndínlọ́gbọ̀n kan tí ó máa ń hùwà ìbàjẹ́ gẹ́gẹ́ bí fífẹ́lu àgbọ̀nrín, àti ìtàn ìwà ìbajẹ́, jíjẹ́ ohun tí kì í ṣe ti ara rẹ̀, àti sísá, àti fífi hàn pé ó jẹ́ olùṣègùn lórílé-èkó, ìwádìí àìsàn ọkàn wo ni ó bá àṣà ìṣe yìí mu jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “What mental illness is most associated with the behavior of a 15-year-old boy who exhibits delinquent behavior such as stealing, lying, and showing signs of being a troublemaker in school?” — here, *ìwà ìbajẹ́* means delinquent behavior.\n</step1>\n<step2>\nDelinquent behavior in adolescents can often be linked to various mental health issues — *àìsàn ọkàn* can include conditions like conduct disorder or oppositional defiant disorder.\n</step2>\n<step3>\nIn this case, *ìwà ìbajẹ́* like stealing and lying suggests a pattern of behavior that may indicate conduct disorder — *ìwà ìbajẹ́ àkóso*.\n</step3>\n<step4>\nConduct disorder is characterized by a persistent pattern of behavior that violates societal norms — *àwọn àkóso awujọ* and the rights of others.\n</step4>\n<step5>\nAdditionally, the boy's behavior could also be influenced by environmental factors, such as family dynamics or peer pressure — *ìbáṣepọ̀ pẹ̀lú àwọn ẹlẹ́gbẹ́*.\n</step5>\n<step6>\nThus, the mental illness that most aligns with these behaviors is likely conduct disorder, which manifests through actions like stealing and lying.\n</step6></thinking>", "answer": "<answer>Àìsàn ọkàn tí ó bá àṣà ìṣe yìí mu jùlọ ni ìwà ìbajẹ́ àkóso.</answer>", "language": "Yoruba"}
{"question": "Nigbati awọn kemikali meji ti o yatọ ba ṣiṣẹ lori awọn ongbẹ meji ti o yatọ ati idahun wọn ba jẹ ilodi si ara wọn lori sẹẹli kanna, a pe e ni:\nA. Iṣẹ-ṣiṣe iṣe-ara\nB. Iṣẹ-ṣiṣe kemikali\nC. Iṣẹ-ṣiṣe ti o yipada\nD. Idije iṣẹ-ṣiṣe", "reasoning": "<thinking><step1>\nThe question translates to: \"When two different chemicals act on two different receptors and their responses are opposite on the same cell, what is it called?\" This is asking for a specific term related to chemical interactions.\n</step1>\n<step2>\nIn English, we refer to this phenomenon as a type of interaction where one chemical may activate a receptor while another inhibits it — *iṣẹ-ṣiṣe iṣe-ara* refers to this functional activity.\n</step2>\n<step3>\nThe key here is that the responses are *ilodi si ara wọn*, meaning they oppose each other, which is crucial for identifying the correct term.\n</step4>\n<step4>\nIn pharmacology, this is often described as a competitive interaction, where two substances compete for the same receptor — *idije iṣẹ-ṣiṣe* captures this idea well.\n</step5>\n<step5>\nHowever, the term that best fits the description of opposing effects on the same cell is *iṣẹ-ṣiṣe ti o yipada*, which indicates a change in function due to opposing actions.\n</step6>\n<step6>\nThus, the correct answer is the one that describes the interaction of two chemicals with opposite effects on the same receptor.\n</step6></thinking>", "answer": "<answer>C. Iṣẹ-ṣiṣe ti o yipada</answer>", "language": "Yoruba"}
{"question": "Àpọn ọmọbirin ọmọ ọdun mẹtadinlọgọta kan ṣalaye pe ara rẹ ti gbẹ̀, ti o sì máa ṣeun ni irọrun fún oṣù mẹfa sẹhin. Ó ní ìtàn àrùn àtẹ̀gùn ẹ̀jẹ̀ gíga tó lágbára tí ó ti gba ìtọ́jú pẹ̀lú awọn oogun idinku ẹ̀jẹ̀ gíga fún oṣù mẹta. Ó ti pọ̀ sí i ní ìwọ̀n 4.5 kg (10 lb) ní ọjọ́ díẹ̀ sẹ́yìn, ó sì wọn 75 kg (165 lb) lọ́wọ́lọ́wọ́. Ẹ̀jẹ̀ rẹ̀ gíga sí 170/100 mm Hg. A rí awọn àmì pupa lórí ikùn rẹ̀ nígbà àyẹ̀wò ara, ati pe ó ní “iṣan bàbá ẹ̀gbọ̀n”. Ipele suga ẹjẹ̀ ìgbà àṣìṣe jẹ 140 mg/dl. Àyẹ̀wò CT ti ikùn fi hàn 6-cm mass ní ẹ̀yìn vena cava isalẹ.  Eyi ninu awọn ẹya ara wọnyi ni o ṣeé ṣe julọ lati jẹ ipilẹṣẹ ti mass naa?\nA. Suprarenal (adrenal) gland\nB. Appendix\nC. Gallbladder\nD. Ovary", "reasoning": "<thinking><step1>\nThe question asks: “Which of these organs is most likely to be the source of the 6-cm mass found behind the inferior vena cava?” — it provides details about a 36-year-old girl with symptoms including *ara rẹ ti gbẹ̀* (dry body) and a history of *àrùn àtẹ̀gùn ẹ̀jẹ̀ gíga* (hypertension).\n</step1>\n<step2>\nGiven her high blood pressure of 170/100 mm Hg and recent weight gain of 4.5 kg, we need to consider the implications of these symptoms — *ìtàn àrùn* (medical history) suggests possible endocrine involvement.\n</step2>\n<step3>\nThe mass is located near the inferior vena cava, which is crucial for blood return from the lower body — *vena cava isalẹ* is adjacent to several organs, including the adrenal glands, ovaries, and others.\n</step4>\n<step4>\nAmong the options, the *suprarenal gland* (adrenal gland) is known to produce hormones that can affect blood pressure and may develop masses like tumors — *tumors adrenal* can lead to hypertension.\n</step5>\n<step5>\nThe appendix and gallbladder are less likely to be involved in this case, as they are not typically associated with such masses or hypertension — *àwọn àpẹẹrẹ* (examples) of masses in these organs differ significantly.\n</step6>\n<step6>\nThus, considering the location of the mass and the patient's symptoms, the most likely source is the adrenal gland — *gland suprarenal*.\n</step6></thinking>", "answer": "<answer>Gland suprarenal ni o ṣeé ṣe julọ lati jẹ ipilẹṣẹ ti mass naa.</answer>", "language": "Yoruba"}
{"question": "Fi ẹgbẹ́ àwọn ohun tí ó tẹ̀lé e yìí kun, kí o sì rí i dájú pé àwọn àmì ìgbàgbọ́ ti di pípẹ̀. Ohun tí a fún ọ̀ ní: < { < ( )", "reasoning": "<thinking><step1>\nThe question asks: “Fi ẹgbẹ́ àwọn ohun tí ó tẹ̀lé e yìí kun, kí o sì rí i dájú pé àwọn àmì ìgbàgbọ́ ti di pípẹ̀” — meaning it wants to know how to complete a sequence while ensuring that the signs of faith are consistent.\n</step1>\n<step2>\nTo approach this, we first need to identify the sequence provided: *< { < ( )*. This appears to be a pattern involving brackets and symbols.\n</step2>\n<step3>\nIn logic and mathematics, we often deal with sequences and patterns — *àwọn àkópọ̀* — where each symbol has a specific role.\n</step3>\n<step4>\nThe goal is to maintain balance in the sequence, ensuring that for every opening bracket, there is a corresponding closing bracket — *ìbáṣepọ̀ àtẹ̀gùn*.\n</step4>\n<step5>\nThus, we can add the necessary symbols to complete the sequence: *< { < ( ) > } >* to ensure that all brackets are properly closed.\n</step5>\n<step6>\nThis completion maintains the integrity of the sequence and reflects the signs of faith — *àmì ìgbàgbọ́* — in logical reasoning.\n</step6></thinking>", "answer": "<answer>< { < ( ) > } ></answer>", "language": "Yoruba"}
{"question": "Awọn àrùn wo ni kò bá àrùn rubella tí a bí pẹ̀lú wá?", "reasoning": "<thinking><step1>\nThe question asks: “Awọn àrùn wo ni kò bá àrùn rubella tí a bí pẹ̀lú wá?” — meaning it wants to know which diseases do not coexist with rubella.\n</step1>\n<step2>\nRubella, known as *àrùn rubella*, is a viral infection that can cause serious complications, especially in pregnant women — *nípa àrùn rubella, obìnrin tí ó lóyún lè ní ìṣòro*.\n</step2>\n<step3>\nCommon co-infections include diseases like measles and mumps, but there are some conditions that do not typically occur together with rubella — *àwọn àrùn bíi àrùn àkàrà àti àrùn mumps*.\n</step4>\n<step5>\nFor instance, *àrùn HIV* does not have a direct relationship with rubella, meaning they can occur independently — *àwọn àrùn méjèèjì lè wà pẹ̀lú ara wọn*.\n</step6>\n<step6>\nAdditionally, conditions like *àrùn àtọgbẹ* (diabetes) or *àrùn àkúnya* (hypertension) are not directly linked to rubella infection — *kò ní ìbáṣepọ pẹ̀lú àrùn rubella*.\n</step7>\n<step7>\nThus, diseases such as HIV, diabetes, and hypertension do not typically coexist with rubella.\n</step7></thinking>", "answer": "<answer>Àrùn HIV, àtọgbẹ, àti àkúnya kò bá àrùn rubella tí a bí pẹ̀lú wá.</answer>", "language": "Yoruba"}
{"question": "Ẹgbẹ̀ kan wo ni a yipada si Kristianiti ni ọrundun kejìlá AD nipasẹ ipa awọn míṣọnnari lati Ilẹ-Ọba Byzantine?", "reasoning": "<thinking><step1>\nThe question asks: “Ẹgbẹ̀ kan wo ni a yipada si Kristianiti ni ọrundun kejìlá AD nipasẹ ipa awọn míṣọnnari lati Ilẹ-Ọba Byzantine?” — meaning it wants to know which group converted to Christianity in the 12th century AD through the influence of missionaries from the Byzantine Empire.\n</step1>\n<step2>\nIn the 12th century, the Byzantine Empire was influential in spreading Christianity — *Kristianiti* — particularly in Eastern Europe.\n</step2>\n<step3>\nOne significant group that converted during this time was the Kievan Rus', which is now part of modern-day Ukraine and Russia — *Kievan Rus'* ni a mọ̀ sí àgbègbè yìí.\n</step3>\n<step4>\nThe missionaries, particularly from Constantinople, played a crucial role in this conversion process — *ipa awọn míṣọnnari* ni a fi hàn gbangba.\n</step5>\n<step5>\nThis conversion was marked by the adoption of Orthodox Christianity, which became a central part of their culture and identity — *Kristianiti Orthodox* ni wọn gba.\n</step6>\n<step6>\nThus, the Kievan Rus' is the group that converted to Christianity in the 12th century due to Byzantine missionary efforts.\n</step6></thinking>", "answer": "<answer>Ẹgbẹ̀ Kievan Rus' ni a yipada si Kristianiti ni ọrundun kejìlá AD nipasẹ ipa awọn míṣọnnari lati Ilẹ-Ọba Byzantine.</answer>", "language": "Yoruba"}
{"question": "Àgbàlagbà obìnrin ọmọ ọdún mẹtadinlogun kan tí ó ní itan-àkọ́kọ́ àrùn èso ọfun, tí a ti tọ́jú pẹ̀lú ìtànṣán onírààyè àti kemoteràpí, lupus erythematosus fúnra rẹ̀ tí a ti tọ́jú pẹ̀lú cyclophosphamide, ọ̀pọ̀lọpọ̀ olùgbéyàwó, àti àwọn àmì àrùn pẹ̀lú irora ikùn isalẹ̀ àti ṣíṣàárà pẹ̀lú ìgbàgbé, pẹ̀lú àwọn ìwádìí ilé-ẹ̀kọ́ tí ó fihàn ní àdánwò nitrite rere, ṣíṣe àwọn sẹ̀ẹ̀lì funfun gíga nínú ito, àti kò sí àwọn amuaradagba, kini èkúnrẹ̀rẹ̀ ọ̀nà tí ó ṣeé ṣe jùlọ tí ó fa ipo ito rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks about a 19-year-old woman with a medical history of [lupus erythematosus = lupus] and other conditions, seeking to understand the most likely cause of her urinary status.\n</step1>\n<step2>\nGiven her history of lupus, which can affect kidney function — *lupus peut entraîner des complications rénales* — it’s important to consider how this might influence her urinary output.\n</step2>\n<step3>\nThe presence of high white blood cells in urine — *des globules blancs élevés dans l'urine* — suggests a possible infection or inflammation, which is common in lupus patients.\n</step3>\n<step4>\nAdditionally, the mention of *irora ikùn isalẹ̀* (lower abdominal pain) could indicate a urinary tract infection or complications related to her lupus.\n</step4>\n<step5>\nThe positive nitrite test in her urine — *test de nitrite positif* — typically indicates a bacterial infection, often caused by *Escherichia coli*.\n</step5>\n<step6>\nConsidering all these factors, the most likely cause of her urinary condition is a urinary tract infection, possibly exacerbated by her underlying lupus.\n</step6></thinking>", "answer": "<answer>Ìdí pàtàkì tó fa ipo ito rẹ̀ ni àrùn ikọ̀kà, tí ó lè jẹ́ pé ó ti fa nipasẹ lupus rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Èdè iṣẹ́ wo ni a gbọdọ̀ lo lati dènà àṣìṣe ninu idanimọ́ ibi abẹ̀ tabi iṣẹ́ abẹ̀ ninu yàrá abẹ̀, pàápàá nípa awọn igbese idena ṣaaju abẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Èdè iṣẹ́ wo ni a gbọdọ̀ lo lati dènà àṣìṣe ninu idanimọ́ ibi abẹ̀ tabi iṣẹ́ abẹ̀?” — meaning it wants to know what type of procedures or practices should be used to prevent errors in identifying surgical sites or during surgery.\n</step1>\n<step2>\nPreventing errors in surgical site identification involves using protocols — *àtẹ̀jáde* — that ensure accuracy before the procedure begins.\n</step2>\n<step3>\nOne key practice is the use of a surgical checklist — *àtòjọ iṣẹ́ abẹ̀* — which includes verifying the patient's identity and the correct site.\n</step3>\n<step4>\nAdditionally, marking the surgical site clearly — *fifihan ibi abẹ̀ ni kedere* — helps to avoid confusion during the operation.\n</step4>\n<step5>\nTeam communication is crucial; all members should confirm the site together — *ìbáṣepọ̀ ẹgbẹ́* is essential to minimize risks.\n</step5>\n<step6>\nFinally, conducting a time-out before starting the surgery allows for a final verification — *ìdákẹ́jẹ́* — to ensure everything is correct.\n</step6></thinking>", "answer": "<answer>Lati dènà àṣìṣe ninu idanimọ́ ibi abẹ̀, a gbọdọ̀ lo àtẹ̀jáde, àtòjọ iṣẹ́ abẹ̀, àti ìbáṣepọ̀ ẹgbẹ́.</answer>", "language": "Yoruba"}
{"question": "Nigbati a ba fi propionaldehyde ati butyraldehyde ṣe itọju pẹlu sodium ethoxide ninu ethanol, iye awọn ọja aldol condensation ti o yatọ si ni a le ṣe?", "reasoning": "<thinking><step1>\nThe question asks: “Nigbati a ba fi [propionaldehyde = propionaldehyde] ati [butyraldehyde = butyraldehyde] ṣe itọju pẹlu [sodium ethoxide = sodium ethoxide] ninu [ethanol = ethanol], iye awọn ọja [aldol condensation = aldol condensation products] ti o yatọ si ni a le ṣe?” — meaning it wants to know how many different aldol condensation products can be formed from these reactants.\n</step1>\n<step2>\nIn aldol condensation, two aldehydes can react to form β-hydroxy aldehydes — *β-idroxy aldehydes* — which can further dehydrate to give α,β-unsaturated aldehydes.\n</step2>\n<step3>\nHere, we have two aldehydes: propionaldehyde and butyraldehyde. Each can act as both a nucleophile and an electrophile — *nucleophile* ati *electrophile*.\n</step3>\n<step4>\nThe possible combinations include: propionaldehyde reacting with itself, butyraldehyde reacting with itself, and each aldehyde reacting with the other — *iyato mẹta*.\n</step4>\n<step5>\nThis gives us a total of three unique aldol products: one from each self-condensation and one from the cross-condensation — *iyato kọọkan*.\n</step6>\n<step6>\nThus, the total number of different aldol condensation products formed is three.\n</step6></thinking>", "answer": "<answer>Iye awọn ọja aldol condensation ti o yatọ si ti a le ṣe ni mẹta.</answer>", "language": "Yoruba"}
{"question": "Irú àkọ́kọ́ ibùgbà tí a kò gbọ́dọ̀ fi ọ̀nà inú ẹnu ṣi láti mú òòrùn jáde?", "reasoning": "<thinking><step1>\nThe question asks: “Irú àkọ́kọ́ ibùgbà tí a kò gbọ́dọ̀ fi ọ̀nà inú ẹnu ṣi láti mú òòrùn jáde?” — meaning it wants to know what type of waste should not be disposed of through the mouth.\n</step1>\n<step2>\nIn English, this refers to waste that is hazardous or harmful — *ibùgbà tó lewu* — and should not be ingested or expelled through the mouth.\n</step2>\n<step3>\nFor example, substances like chemicals or toxic materials — *awọn kemikali tó lewu* — can cause serious health issues if they enter the body.\n</step3>\n<step4>\nAdditionally, biological waste, such as human waste or medical waste — *ibùgbà ẹ̀dá ènìyàn* — should also not be disposed of in this manner.\n</step4>\n<step5>\nThe proper disposal methods for these types of waste include using designated containers or facilities — *ilana ibùgbà tó yẹ* — to ensure safety.\n</step5>\n<step6>\nThus, any waste that poses a risk to health or the environment should not be disposed of through the mouth.\n</step6></thinking>", "answer": "<answer>Ibùgbà tó lewu, gẹ́gẹ́ bí kemikali àti ibùgbà ẹ̀dá ènìyàn, kò yẹ kí a fi ọ̀nà inú ẹnu ṣi láti mú òòrùn jáde.</answer>", "language": "Yoruba"}
{"question": "Ọmọdé kan tó ní pyoderma ń fi àwọn àmì bí ìṣòro tó léwu, ìṣòro ìmí, àti fọ́tò ìṣiṣẹ́ ọmu àyà tó ń fi ìgbẹ́kẹ̀lé tí kò péye àti ọ̀pọ̀lọpọ̀ àwọn àpò ìfúùfù afẹ́fẹ́ tí ògiri wọn kò tóbi hàn. Ẹ̀dá ìmọ̀ tó ṣeé ṣe jùlọ tó fa àìsàn yìí kọ́?", "reasoning": "<thinking><step1>\nThe question asks: \"What is the most likely cause of pyoderma in a child who presents with severe symptoms, respiratory issues, and multiple skin lesions?\" — here, *pyoderma* refers to a bacterial skin infection.\n</step1>\n<step2>\nPyoderma often occurs due to bacterial infections, particularly *Staphylococcus aureus*, which can lead to skin lesions — *àpò ìfúùfù* that may become infected.\n</step2>\n<step3>\nIn children, a weakened immune system can exacerbate these infections, leading to more severe symptoms — *ìṣòro ìmí* and respiratory complications.\n</step3>\n<step4>\nCommon causes of a compromised immune system include conditions like *malnutrition* or underlying diseases such as *HIV*.\n</step4>\n<step5>\nIn this case, the presence of multiple lesions and respiratory issues suggests a systemic problem, possibly linked to an immune deficiency — *àìlera àtọkànwá*.\n</step5>\n<step6>\nThus, the most likely cause of the pyoderma in this child is an underlying condition that weakens the immune response, allowing for severe bacterial infections to manifest.\n</step6></thinking>", "answer": "<answer>Ìsopọ̀ àìlera àtọkànwá ni àìsàn pyoderma tó fa ìṣòro tó léwu yìí.</answer>", "language": "Yoruba"}
{"question": "Ninu obìnrin ọmọ ọdún mẹtadinlọgọta (30) tí ó wà ní ìgbà ìlóyún àkọ́kọ́ rẹ̀, tí ó sì ti wà ní ọ̀sẹ̀ ìgbà ìlóyún mẹ́tadinlọgbọn (36), pẹ̀lú ìwádìí àtọ́pàápàá ẹ̀jẹ̀ tó jẹ́ 160/110 mmHg, albumin ninu ito tó jẹ́ 3+, àti iye platelet tó jẹ́ 80000/mm3, ṣe irú ìtọ́jú wo ni ó yẹ kí a lo láti yanjú àrùn tí àwọn àbájáde wọ̀nyí fi hàn?", "reasoning": "<thinking><step1>\nThe question is asking: “What type of treatment should be used for a 30-year-old pregnant woman in her 36th week of pregnancy, with a blood pressure of 160/110 mmHg, 3+ albumin in urine, and a platelet count of 80,000/mm3?” \n</step1>\n<step2>\nThis situation indicates possible *preeclampsia* — *preeclampsie* — due to the high blood pressure and protein in urine.\n</step2>\n<step3>\nThe elevated blood pressure suggests a risk of complications for both the mother and the fetus — *ẹ̀dá mẹta*.\n</step3>\n<step4>\nIn such cases, immediate management is crucial; *ìtọ́jú lẹsẹkẹsẹ* is necessary to prevent severe outcomes.\n</step4>\n<step5>\nTreatment may include antihypertensive medications to lower blood pressure — *ògùn ìdènà ẹjẹ* — and monitoring of the mother and fetus.\n</step5>\n<step6>\nAdditionally, hospitalization may be required for close observation and possible delivery if the condition worsens — *ìkànsí*.\n</step6>\n<step7>\nThe low platelet count also raises concerns for *thrombocytopenia*, which needs to be addressed in the treatment plan.\n</step7>\n<step8>\nOverall, the approach should be multidisciplinary, involving obstetricians and possibly other specialists — *awọn amọ̀ja*.\n</step8></thinking>", "answer": "<answer>Ìtọ́jú tó yẹ ni ìmúlò ogun ìdènà ẹjẹ, ìmúlò àyẹ̀wò pẹ̀lú ìkànsí, àti ìmúlò ìtọ́jú lẹsẹkẹsẹ.</answer>", "language": "Yoruba"}
{"question": "Ninu ìpínsísọ̀rọ̀ Kennedy ti àwọn àgbà tí eyín kò sí, báwo ni a ṣe ń pín àgbà kan nígbà tí agbègbè kan tí eyín kò sí bá wà ní apá kan ṣoṣo pẹ̀lú àwọn eyín àdánidá tí ó wà níwájú àti lẹ́yìn rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu ìpínsísọ̀rọ̀ Kennedy ti àwọn àgbà tí eyín kò sí, báwo ni a ṣe ń pín àgbà kan?” — meaning it wants to know how to divide a certain area when there are no teeth present in a specific region.\n</step1>\n<step2>\nIn this context, we are discussing a dental procedure — *ìtọ́jú eyín* — specifically related to the Kennedy classification, which is used for partial dentures.\n</step2>\n<step3>\nWhen there are no teeth in a certain area, we refer to it as a *gbà tí eyín kò sí* — this affects how we design the denture.\n</step3>\n<step4>\nThe division of the area can be done by identifying the remaining teeth — *eyín àdánidá* — that are present in the anterior and posterior regions.\n</step4>\n<step5>\nIn practice, we would assess the support from the remaining teeth and the soft tissue — *ìtẹ́wọ́gbà* — to determine the best way to distribute the forces.\n</step6>\n<step6>\nThus, the division of the area is crucial for ensuring stability and function of the denture in the absence of teeth.\n</step7></thinking>", "answer": "<answer>A pín àgbà kan nígbà tí agbègbè kan tí eyín kò sí ni a ṣe nípa mímú àkópọ̀ àwọn eyín àdánidá àti ìtẹ́wọ́gbà.</answer>", "language": "Yoruba"}
{"question": "Báwo ni o ṣe le túmọ̀ ọ̀rọ̀ náà ‘Àwọn ẹranko kan ni àwọn ènìyàn búburú ń gbàgbé’ lọ́nà tó tọ́ sí inú ìṣirò àṣàrò nípa lílo àwọn ohun tí a pe ní Ax (x jẹ́ ẹranko), Cx (x jẹ́ búburú), Px (x jẹ́ ènìyàn), àti Nxy (x gbàgbé y)?", "reasoning": "<thinking><step1>\nThe question asks: “Báwo ni o ṣe le túmọ̀ [‘Àwọn ẹranko kan ni àwọn ènìyàn búburú ń gbàgbé’ = 'Some animals are neglected by bad people']” in a logical framework using terms like Ax (x is an animal), Cx (x is bad), Px (x is a person), and Nxy (x neglects y).\n</step1>\n<step2>\nTo interpret this, we need to identify the relationships: *Ax* represents specific animals, while *Cx* indicates the bad people who neglect them — *àwọn ènìyàn búburú*.\n</step2>\n<step3>\nThe statement implies that there exists a relationship where certain animals are neglected, which can be expressed as *Nxy* where *x* is an animal and *y* is the bad person.\n</step3>\n<step4>\nIn logical terms, we can say: for some *x* in *Ax*, there exists a *y* in *Cx* such that *Nxy* holds true — meaning that *àwọn ẹranko kan* are the subjects of neglect by *àwọn ènìyàn búburú*.\n</step4>\n<step5>\nThus, we can conclude that the statement can be represented logically as: ∃x (Ax ∧ ∃y (Cy ∧ Nxy)), which captures the essence of the neglect relationship.\n</step5>\n<step6>\nIn summary, the logical representation shows that certain animals are indeed neglected by bad people, aligning with the original statement.\n</step6></thinking>", "answer": "<answer>Àwọn ẹranko kan ni a ṣe àfihàn pé ń gba àìmọ̀lúmọ̀ láti ọdọ àwọn ènìyàn búburú nípa lílo ìṣirò àṣàrò.</answer>", "language": "Yoruba"}
{"question": "Àpọǹà kan dé ilé ìṣegbégbé lẹ́yìn ìṣẹ̀lẹ̀ kan pẹ̀lú ṣíṣe kéré ní ẹ̀jẹ̀, ìṣòro ní ìmímú afẹ́fẹ́, àti ìgbóná ara lábẹ́ awọ̀n ara láìsí ìwọlé afẹ́fẹ́ sí ẹ̀gbẹ́ kan. Ṣé ìṣàkóso wo ni yóò dára jùlọ?\nA. Ìgbòòrò abẹ́rẹ̀ ní ipò ààrin àgbáàlá kẹrin àti márùn-ún ní ìlà ìwájú \nB. Tẹ̀síwájú pẹ̀lú PPV\nC. Gbé e lọ sí ICU kí o sì fi oògùn ṣíṣe afẹ́fẹ́ sí\nD. Dáàbò bò ìlọ́pọ̀ ẹ̀jẹ̀, kí o sì fi omi gbẹ́ ẹ̀jẹ̀ lẹ́yìn fífì ipò ẹ̀jẹ̀ gbòòrò sílẹ̀", "reasoning": "<thinking><step1>\nThe question asks about the best management for a patient who presents with low blood pressure, difficulty breathing, and body temperature changes without adequate airflow to one side — *ilè ìṣegbégbé* refers to a clinical setting.\n</step1>\n<step2>\nIn this scenario, the patient is likely experiencing a critical condition, possibly related to shock or respiratory failure — *ìṣòro ní ìmímú afẹ́fẹ́* indicates a severe issue with breathing.\n</step2>\n<step3>\nThe options provided suggest different interventions: A. *Ìgbòòrò abẹ́rẹ̀* (intermediate airway management) could stabilize the airway but may not address the underlying cause.\n</step3>\n<step4>\nB. *Tẹ̀síwájú pẹ̀lú PPV* (Positive Pressure Ventilation) is crucial for improving oxygenation and ventilation in cases of respiratory distress.\n</step5>\n<step5>\nC. Transferring the patient to ICU and administering medications for breathing support is often necessary for severe cases — *Gbé e lọ sí ICU* indicates a need for intensive monitoring and treatment.\n</step6>\n<step6>\nD. Stabilizing blood pressure and fluid resuscitation is essential, but it may not directly address the respiratory issue — *Dáàbò bò ìlọ́pọ̀ ẹ̀jẹ̀* focuses on blood volume but overlooks airway management.\n</step7>\n<step7>\nConsidering the severity of the symptoms, option C seems to be the most appropriate as it allows for comprehensive care in a controlled environment.\n</step8></thinking>", "answer": "<answer>Gbé e lọ sí ICU kí o sì fi oògùn ṣíṣe afẹ́fẹ́ sí.</answer>", "language": "Yoruba"}
{"question": "Kí ni ìtọ́jú tí a dámọ̀ràn fún ọmọkùnrin ọlọ́dún méjìlá tó ní ìṣòro kòpòjọ tí kò sọ̀kalẹ̀ ní apá òsì, tí a kò sì lè fọwọ́ kàn án?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ìtọ́jú tí a dámọ̀ràn fún [omókùnrin = boy] [olọdún méjìlá = twelve years old] tó ní [ìṣòro kòpòjọ = joint problem] tí kò sọ̀kalẹ̀ ní apá òsì = that does not bend in the left side, tí a kò sì lè fọwọ́ kàn án = and cannot be touched?” — meaning it seeks advice on treatment for a twelve-year-old boy with a joint issue in the left side that is not flexible and cannot be touched.\n</step1>\n<step2>\nIn such cases, it’s important to first assess the condition — *a gbọdọ̀ ṣe àyẹ̀wò àtọkànwá* to understand the underlying cause of the joint problem.\n</step2>\n<step3>\nCommon causes could include conditions like arthritis or injury — *àìlera àtọkànwá* that may require medical evaluation.\n</step4>\n<step4>\nSince the joint cannot be touched, it suggests possible swelling or inflammation — *ìkànsí tàbí ìfọ́kànsí* that needs careful management.\n</step5>\n<step5>\nTreatment may involve rest, ice application, and possibly anti-inflammatory medications — *ìtọ́jú le ní ìsinmi, ìfọwọ́kàn, àti àwọn oogun àtọkànwá* to reduce pain and swelling.\n</step6>\n<step6>\nConsulting a healthcare professional is crucial for proper diagnosis and treatment — *ìmọ̀ràn dokita jẹ́ pataki* to ensure the boy receives appropriate care.\n</step7>\n<step7>\nIn summary, the recommended treatment involves rest, ice, and medical consultation for a proper diagnosis.\n</step7></thinking>", "answer": "<answer>Ìtọ́jú tí a dámọ̀ràn ni ìsinmi, ìfọwọ́kàn, àti ìmọ̀ràn dokita fún àyẹ̀wò tó péye.</answer>", "language": "Yoruba"}
{"question": "Kini orukọ agbẹ̀dẹ́ epo ti 5-HT 1F receptor agonist kan ti FDA fọwọ́ sí fun itọ́jú irora ori tó gbà láìyẹ̀wò?", "reasoning": "<thinking><step1>\nThe question asks: “Kini orukọ agbẹ̀dẹ́ epo ti 5-HT 1F receptor agonist kan ti FDA fọwọ́ sí fun itọ́jú irora ori tó gbà láìyẹ̀wò?” — meaning it wants to know the name of a 5-HT 1F receptor agonist that the FDA has approved for the treatment of migraine without aura.\n</step1>\n<step2>\nThe 5-HT 1F receptor is involved in the modulation of pain pathways — *o ni ipa ninu iṣakoso irora*.\n</step2>\n<step3>\nThe FDA has approved several medications for migraines, and one notable agonist is *lasmiditan*.\n</step3>\n<step4>\nLasmiditan works by activating the 5-HT 1F receptor, which helps to alleviate migraine symptoms — *o n ṣiṣẹ lati dinku awọn aami aiṣan irora ori*.\n</step4>\n<step5>\nThis medication is particularly useful for patients who cannot take traditional triptans due to contraindications — *fun awọn alaisan ti ko le mu triptans*.\n</step5>\n<step6>\nIn summary, the FDA-approved 5-HT 1F receptor agonist for treating migraines without aura is *lasmiditan*.\n</step6></thinking>", "answer": "<answer>Orukọ agbẹ̀dẹ́ epo ti 5-HT 1F receptor agonist ti FDA fọwọ́ sí fun itọ́jú irora ori tó gbà láìyẹ̀wò ni lasmiditan.</answer>", "language": "Yoruba"}
{"question": "Nínú ìṣẹ̀lẹ̀ kan níbi tí akẹ́kọ̀ọ́ kan nínú ilé ìgbé akẹ́kọ̀ọ́ ní yunifásítì kan kó àkóràn gbà nítorí mēníngókókọ́sì ìsọ̀rí B àti akẹ́kọ̀ọ́ mìíràn kó àkóràn gbà nítorí mēníngókókọ́sì ìsọ̀rí C, irú ìgbéga ara èyí tí a kò sábà máa ń dámọ̀ràn fún àwọn tí wọ́n ní ìbáṣepọ̀ pẹ̀lú akẹ́kọ̀ọ́ tó ní àkóràn mēníngókókọ́sì ìsọ̀rí B?", "reasoning": "<thinking><step1>\nThe question asks about a situation where a student in a university dormitory contracts an illness due to a [mèníngókókọ́sì = meningitis] type B, while another student contracts it due to type C. It seeks to understand the implications for those who have contact with the student who has type B meningitis.\n</step1>\n<step2>\nMeningitis is a serious infection that affects the protective membranes covering the brain and spinal cord — *àwọn àkóràn tó ń fa ìfarapa sí àyà àtàwọn ọpọlọ*.\n</step2>\n<step3>\nWhen someone has type B meningitis, it can be contagious, especially in close living situations like a dormitory — *níbi ìgbé akẹ́kọ̀ọ́*, where students share spaces.\n</step3>\n<step4>\nThose who have been in contact with the infected student should be monitored for symptoms — *àwọn àkóràn bíi ìkópa, ìbànújẹ, àti ìrora àyà*.\n</step4>\n<step5>\nPreventive measures may include vaccination for those at risk — *àtúnṣe àkóràn* — and possibly prophylactic antibiotics for close contacts.\n</step5>\n<step6>\nIn summary, individuals in contact with a student who has type B meningitis should be cautious and may need medical advice — *ìmọ̀ràn ilé-iwòsàn*.\n</step6></thinking>", "answer": "<answer>Àwọn tó ní ìbáṣepọ̀ pẹ̀lú akẹ́kọ̀ọ́ tó ní àkóràn mèníngókókọ́sì ìsọ̀rí B yẹ kí wọ́n gba ìmọ̀ràn ilé-iwòsàn àti àtúnṣe àkóràn.</answer>", "language": "Yoruba"}
{"question": "Ni iwoye iwaju ọtun ti awọn X-ray àyà, nibiti a gbe kaṣẹẹti si awọn ejika alaisan, ati ipo ọkan wo ni a le ṣe ayẹwo?", "reasoning": "<thinking><step1>\nThe question asks: “Ni iwoye iwaju ọtun ti awọn [X-ray = X-ray] àyà, nibiti a gbe kaṣẹẹti si awọn [ejika alaisan = patient's shoulders], ati ipo ọkan wo ni a le ṣe ayẹwo?” — meaning it wants to know what can be assessed in the right anterior view of a chest X-ray.\n</step1>\n<step2>\nIn this view, we can see the heart's position and size — *ipo ati iwọn ọkan* — as well as the lungs and surrounding structures.\n</step2>\n<step3>\nThe right anterior view helps in identifying conditions like *pneumonia* or *pleural effusion* — *ìfarapa àyà* tabi *ìkó omi*.\n</step3>\n<step4>\nWe also assess the mediastinum, which contains the heart and major blood vessels — *mediastinum* ni ibi ti ọkan ati awọn ẹjẹ pataki wa.\n</step4>\n<step5>\nAdditionally, we can evaluate the diaphragm's contour and any potential abnormalities in the thoracic cavity — *àwọn aiyede ni àyà*.\n</step5>\n<step6>\nThus, the right anterior view of a chest X-ray is crucial for diagnosing various cardiac and pulmonary conditions.\n</step6></thinking>", "answer": "<answer>A le ṣe ayẹwo ipo ati iwọn ọkan, awọn àyà, ati awọn aiyede ni àyà ni iwoye iwaju ọtun ti X-ray àyà.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọmọ ọdún méjeedinlogun kan wá sí ẹka pajawiri pẹlu irora àyà, ati pe ECG rẹ̀ fi hàn pé ọgbẹ̀ ọkàn-ààyà (ventricular tachycardia) ti wà pẹlu ìgò ST-segment.  Nítorí ìwádìí STEMI, oogun wo ni a gbọdọ̀ lo ní àkọ́kọ́ láti tójú àwọn àrùn ọgbẹ̀ ọkàn-ààyà náà?", "reasoning": "<thinking><step1>\nThe question asks: “What medication should be used initially to treat a [ọgbẹ̀ ọkàn-ààyà = ventricular tachycardia] with ST-segment elevation in a 17-year-old girl?” \n</step1>\n<step2>\nVentricular tachycardia is a serious condition where the heart beats rapidly due to abnormal electrical signals — *iyara ọkan ti ko tọ*.\n</step2>\n<step3>\nIn cases of ST-segment elevation myocardial infarction (STEMI), immediate treatment is crucial — *itọju lẹsẹkẹsẹ jẹ pataki*.\n</step3>\n<step4>\nThe first-line medication for managing this condition is typically *aspirin* to prevent further clot formation — *lati dena ikolu ẹjẹ siwaju*.\n</step4>\n<step5>\nAdditionally, *anticoagulants* may be administered to improve blood flow and reduce the risk of further complications — *lati mu ṣiṣan ẹjẹ dara*.\n</step6>\n<step6>\nIn summary, the initial treatment for a patient with ventricular tachycardia and ST-segment elevation involves using aspirin and possibly anticoagulants.\n</step6></thinking>", "answer": "<answer>Oògùn akọkọ ti a gbọdọ̀ lo ni aspirin ati awọn anticoagulants lati tọju ọgbẹ̀ ọkàn-ààyà pẹlu ìgò ST-segment.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin aláìnílé ọdun 64 kan wá pẹlu irora eti ọtun ati irora gbọ́gbọ́ fún ọsẹ̀ meji, ti ó bá ìtùjáde, iba, ati àìṣòro ojú ara tí ó fi hàn gẹ́gẹ́ bí ìṣòro iṣan ewu ojú ìkẹ́kẹ̀ẹ́kẹ̀ẹ́.  Àyẹ̀wò otoscopic fi hàn pé ọ̀pọ̀ irú èso kan wà ní àyíká ibì tí ẹ̀rọ ara ati egungun eti bá pàapà.  Níwíwòye àwọn ìwòyí, ipò iṣelọ́pọ̀ wo ni ó ṣeé ṣe jùlọ láti sopọ mọ̀ ipò eti alaisan yìí?", "reasoning": "<thinking><step1>\nThe question is asking about a 64-year-old man who presents with right ear pain and generalized pain for two weeks, along with fever and systemic symptoms indicating a possible ear-related condition. The key terms here are *irora eti* [ear pain], *ìtùjáde* [fever], and *ìṣòro iṣan ewu* [possible ear infection].\n</step1>\n<step2>\nGiven the symptoms, it seems likely that he has an ear infection, possibly *otitis media* or *otitis externa*. The presence of fever and systemic symptoms suggests an infectious process.\n</step2>\n<step3>\nThe otoscopic examination shows multiple lesions around the area where the ear canal and eardrum meet, indicating inflammation or infection — *ìfarapa tabi àìlera* in the ear structure.\n</step3>\n<step4>\nConsidering the age of the patient and the symptoms, a common condition could be *otitis media* with effusion, which often presents with ear pain and fever, especially in older adults.\n</step4>\n<step5>\nAdditionally, the generalized pain could be due to referred pain from the ear, which is common in ear infections — *irora ti a n pe ni irora ti a n fi ranṣẹ́*.\n</step5>\n<step6>\nThus, the most likely diagnosis connecting these symptoms is an ear infection, specifically *otitis media* or possibly *otitis externa* given the lesions observed.\n</step6></thinking>", "answer": "<answer>Ìṣòro iṣan ewu ti o ṣeeṣe jùlọ ni *otitis media* tabi *otitis externa* nitori irora eti, iba, ati àyíká irú èso.</answer>", "language": "Yoruba"}
{"question": "Apical lymph nodes wọn jẹ́ ìpele wo nínú ẹgbẹ́ axillary lymph nodes?", "reasoning": "<thinking><step1>\nThe question asks: “Apical lymph nodes wọn jẹ́ ìpele wo nínú ẹgbẹ́ [axillary lymph nodes = lymph nodes in the armpit]?” — meaning it wants to know the level or stage of apical lymph nodes within the axillary lymph nodes.\n</step1>\n<step2>\nApical lymph nodes are located at the top of the axillary group — *nípò tó ga jùlọ* among the axillary lymph nodes.\n</step2>\n<step3>\nThey are crucial for draining lymph from the upper limb and breast — *àwọn lymph nodes wọnyi n ṣiṣẹ́ pẹ̀lú àyà àti àyà obìnrin*.\n</step4>\n<step4>\nIn the classification of axillary lymph nodes, apical nodes are considered the highest level — *ìpele tó ga jùlọ*.\n</step5>\n<step5>\nThis means they receive lymphatic drainage from the lower levels, such as central and lateral nodes — *níbè ni wọn ti gba drainage lymph lati awọn ìpele àtẹ̀yìnwá*.\n</step6>\n<step6>\nThus, apical lymph nodes are the topmost level in the hierarchy of axillary lymph nodes.\n</step6></thinking>", "answer": "<answer>Apical lymph nodes jẹ́ ìpele tó ga jùlọ nínú ẹgbẹ́ axillary lymph nodes.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun mẹtadinlogun kan wa pẹlu awọn aami aisan ti o pẹlu rirẹ, irora ori, iba, ati thrombocytopenia, pẹlu hematocrit ti 26%, iye platelet ti 80,000 / mL, ati serum creatinine ti 1.5 mg / dL. O ni ilera ni awọn ọna miiran ati pe ko lo oogun. Kini itọju ti o yẹ julọ fun ipo rẹ ni akoko yii?", "reasoning": "<thinking><step1>\nThe question asks about a 19-year-old woman presenting with symptoms including fatigue, headache, fever, and thrombocytopenia — *thrombocytopenia* refers to a low platelet count, which is 80,000 / mL here.\n</step1>\n<step2>\nHer hematocrit is 26%, indicating possible anemia — *anémie* — and her serum creatinine level is 1.5 mg/dL, suggesting potential kidney issues.\n</step2>\n<step3>\nGiven that she is otherwise healthy and not on any medications, we need to consider the underlying cause of these symptoms — *aami aisan* — which could be due to various conditions.\n</step4>\n<step4>\nIn such cases, supportive care is crucial; hydration is important, especially if there are signs of dehydration — *dehydration* can exacerbate kidney function.\n</step5>\n<step5>\nAdditionally, monitoring her platelet count and hematocrit is essential, and if her symptoms worsen, she may require transfusions — *transfusions de plaquettes* or other interventions.\n</step6>\n<step6>\nTherefore, the most appropriate treatment at this time would be supportive care, focusing on hydration and monitoring her blood parameters closely.\n</step6></thinking>", "answer": "<answer>Itọju ti o yẹ julọ ni itọju atilẹyin pẹlu idaduro omi ati abojuto awọn paramita ẹjẹ rẹ.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 60 kan ti o ní itan-akọọlẹ aarun ọkan ati hyperlipidemia wá si dokita rẹ fun iṣẹ iṣoogun atẹle ọsẹ mẹta lẹhin ti o lọ si ile-iwosan pajawiri fun awọn ami aisan ti ikọ́, iba ati iṣoro mimu afẹfẹ.  Wọn ti fun un ni erythromycin ni afikun si oogun rẹ ti rosuvastatin ati aspirin.  Pẹlu ipa ẹgbẹ tabi ibaraenisepo wo ni dokita yẹ ki o ṣe aniyan julọ?\nA. Ẹjẹ inu inu nitori idinku titoju aspirin ni itọsọna erythromycin\nB. Angina ti ko ni iduroṣinṣin nitori idinku titoju rosuvastatin ni itọsọna erythromycin\nC. Myalgia nitori idinku titoju rosuvastatin ni itọsọna erythromycin\nD. Acidosis ti o jẹ mimọ nitori idinku titoju aspirin ni itọsọna erythromycin\nE. Tinnitus nitori idinku titoju aspirin ni itọsọna erythromycin", "reasoning": "<thinking><step1>\nThe question is asking about potential side effects or interactions that a doctor should be most concerned about for a 60-year-old man with a history of heart disease and hyperlipidemia who has been prescribed erythromycin alongside rosuvastatin and aspirin.\n</step1>\n<step2>\nErythromycin is known to interact with several medications, particularly those metabolized by the liver — *iyẹn ni, awọn oogun ti a n pe ni CYP3A4 substrates*.\n</step2>\n<step3>\nRosuvastatin, which is a statin used to lower cholesterol, is one of those medications. When erythromycin is taken, it can increase the levels of rosuvastatin in the blood — *iyẹn le fa myalgia* or muscle pain.\n</step3>\n<step4>\nAspirin, on the other hand, is an antiplatelet medication. Erythromycin can also affect its metabolism, but the primary concern here is the interaction with rosuvastatin leading to increased risk of side effects.\n</step5>\n<step5>\nAmong the options provided, myalgia due to increased levels of rosuvastatin is the most significant concern — *iyẹn ni, C. Myalgia nitori idinku titoju rosuvastatin ni itọsọna erythromycin*.\n</step6>\nThus, the doctor should be most worried about the risk of muscle pain from the interaction between erythromycin and rosuvastatin.\n</step6></thinking>", "answer": "<answer>C. Myalgia nitori idinku titoju rosuvastatin ni itọsọna erythromycin.</answer>", "language": "Yoruba"}
{"question": "Ní ọ̀ràn tí àyẹ̀wò CT kan fi hàn pé àrùn diverticulitis ti wà ní apa sigmoid ti ìwọ̀nà nìkan láìsí àrùn abscess pericolic tí ó bá a pò, ṣe àlàyé ọ̀nà ìtọ́jú tí ó dára jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “Ní ọ̀ràn tí àyẹ̀wò CT kan fi hàn pé àrùn diverticulitis ti wà ní apa sigmoid” — meaning it wants to know the best treatment approach for diverticulitis in the sigmoid colon without a pericolic abscess.\n</step1>\n<step2>\nDiverticulitis occurs when diverticula become inflamed — *àrùn diverticulitis* le fa ìfarapa ninu *diverticula*.\n</step2>\n<step3>\nIn cases without complications like an abscess, treatment often starts with conservative management — *ìtọ́jú àtìlẹ́yìn*.\n</step3>\n<step4>\nThis typically includes a clear liquid diet initially, followed by a low-fiber diet as symptoms improve — *àtẹ̀gùn omi kedere* ni a maa n lo.\n</step4>\n<step5>\nAntibiotics may be prescribed to manage infection — *antibiotics* ni a fi n ṣe ìtọ́jú àrùn.\n</step5>\n<step6>\nIf symptoms persist or worsen, further interventions may be necessary, but in uncomplicated cases, conservative measures are usually effective.\n</step6>\n<step7>\nTherefore, the best treatment approach for uncomplicated diverticulitis is conservative management with dietary modifications and antibiotics.\n</step7></thinking>", "answer": "<answer>Ìtọ́jú tó dára jùlọ fún àrùn diverticulitis ni àtìlẹ́yìn pẹ̀lú àtẹ̀gùn omi kedere àti antibiotics.</answer>", "language": "Yoruba"}
{"question": "Okunrin kan ti ọjọ́-orí rẹ̀ jẹ́ ọdún 65, tó jẹ́ alaidiabẹtẹ̀sì, tí ó sì ní àrùn kíkó ìṣàn ẹ̀jẹ̀ lọ́wọ́ tẹ́lẹ̀, ń ṣe àwọn àmì tó bá ìṣẹ́lẹ̀ àìṣàn ọkàn-àyà mu, a sì ń gbé e yẹ̀ wò fún ìṣègùn tí a ń pè ní “primary percutaneous coronary intervention”.  Nítorí ewu àrùn kíkó ìṣàn ẹ̀jẹ̀ lọ́wọ́ nípa lílo ohun èlò ìwádìí, àwọn iṣẹ́ ṣíṣe wo ni yẹ kí a ṣe kí ó tó ṣe ìṣègùn náà láti dín ewu àìṣàn àkíyèsí àrùn kíkidìrì sílẹ̀ fún aláìsàn yìí?", "reasoning": "<thinking><step1>\nThe question is asking about a 65-year-old man with diabetes and a history of coronary artery disease, who is being evaluated for a procedure called \"primary percutaneous coronary intervention\" — *ìṣègùn àkíyèsí àrùn kíkidìrì*.\n</step1>\n<step2>\nBefore proceeding with this intervention, it is crucial to assess the patient's overall risk factors — *àwọn ifosiwewe ewu* — especially given his diabetes and previous heart issues.\n</step2>\n<step3>\nWe should conduct a thorough evaluation, including a detailed medical history and physical examination — *ìtàn ìlera àti ayẹwo ara* — to identify any additional risks.\n</step4>\n<step4>\nDiagnostic tests like an ECG — *ìwádìí ECG* — and possibly a stress test can help determine the current state of his heart function and any ischemic changes.\n</step5>\n<step5>\nAdditionally, managing his diabetes effectively is essential; ensuring optimal blood sugar control can reduce the risk of complications during and after the procedure — *ìṣakoso àtọgbẹ*.\n</step6>\n<step6>\nFinally, discussing the potential benefits and risks of the procedure with the patient is vital for informed consent — *ìmọ̀ràn àtì ìfọwọ́si*.\n</step7></thinking>", "answer": "<answer>Kí ó tó ṣe ìṣègùn àkíyèsí àrùn kíkidìrì, a gbọdọ̀ ṣe àyẹ̀wò ìlera rẹ̀, ṣàtúnṣe àtọgbẹ rẹ̀, àti kó ìmọ̀ràn pẹ̀lú rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Kini ayẹ̀wò ti o ṣeeṣe julọ fun alaisan kan ti o ni iriri dysphagia ti ko ni deede fun awọn ohun ti o le jẹ ati awọn ohun mimu?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ayẹ̀wò ti o ṣeeṣe julọ fun alaisan kan ti o ni iriri [dysphagia = difficulty swallowing] ti ko ni deede fun awọn ohun ti o le jẹ ati awọn ohun mimu?” — meaning it wants to know the most likely evaluation for a patient experiencing abnormal swallowing difficulties with food and liquids.\n</step1>\n<step2>\nDysphagia can arise from various causes, including neurological disorders — *aṣeduro ọpọlọ* — or structural abnormalities in the throat.\n</step2>\n<step3>\nCommon evaluations include a clinical swallow assessment — *ayẹwo ikọ̀sẹ̀* — to observe the swallowing process and identify any issues.\n</step4>\n<step4>\nAdditionally, a videofluoroscopic swallow study (VFSS) may be conducted to visualize the swallowing mechanism — *ilana ikọ̀sẹ̀* — and assess the safety of swallowing.\n</step5>\n<step5>\nIf the dysphagia is suspected to be due to a neurological condition, further imaging studies like MRI or CT scans may be necessary to evaluate brain function — *iṣeduro ọpọlọ*.\n</step6>\n<step6>\nIn summary, the most likely evaluation for a patient with dysphagia would involve both clinical assessments and possibly imaging studies to determine the underlying cause.\n</step6></thinking>", "answer": "<answer>Ayẹwo ti o ṣeeṣe julọ fun alaisan kan ti o ni dysphagia ni ayẹwo ikọ̀sẹ̀ ati awọn iwadi aworan bi MRI tabi CT.</answer>", "language": "Yoruba"}
{"question": "Kí ni orúkọ ènìyàn tí ń ṣe iranlọwọ fun dokita egbogi ègàn ní ile-iwosan, tí kò sì lè tọ́jú àwọn aláìsàn lórí ara rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni orúkọ ènìyàn tí ń ṣe iranlọwọ fun dokita egbogi ègàn ní ile-iwosan?” — meaning it wants to know the name of a person who assists a doctor in a hospital but cannot treat patients independently.\n</step1>\n<step2>\nIn English, this role is typically referred to as a \"medical assistant\" or \"nurse,\" but in this context, it seems to refer specifically to someone who supports doctors without having the full qualifications to treat patients — *kò lè tọ́jú àwọn aláìsàn lórí ara rẹ̀*.\n</step2>\n<step3>\nThis person performs tasks like taking vital signs, preparing patients for examinations, and managing medical records — *nítorí náà, wọn ṣe iranlọwọ pẹ̀lú iṣẹ́ àtúnṣe*.\n</step4>\n<step4>\nIn many healthcare settings, this role is crucial for ensuring that doctors can focus on diagnosing and treating patients — *kí dokita lè fojú kọ́ àìlera*.\n</step5>\n<step5>\nIn Yoruba, this role can be referred to as *olùrànlọ́wọ́ dókítà* or *nurse*, depending on the specific duties and training.\n</step6>\n<step6>\nThus, the answer to the question is that this person is a medical assistant or nurse, who supports doctors but does not treat patients independently.\n</step6></thinking>", "answer": "<answer>Olùrànlọ́wọ́ dókítà ni orúkọ ènìyàn tí ń ṣe iranlọwọ fun dokita, tí kò sì lè tọ́jú àwọn aláìsàn lórí ara rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Olùwádìí kan ń kẹ́kọ̀ọ́ bí ẹ̀dùn-ún ṣe ń ṣẹlẹ̀ sí àwọn ẹ̀kù. Láàrin ọ̀sẹ̀ méjì, a ń fún àwọn ẹ̀kù tí ó wà nínú ẹgbẹ́ àdánwò ní oògùn kan ní ojoojúmọ́, èyí tí ó jẹ́ ìtọ́jú àwọn ohun tí ara ń ṣe. Ní ìfiwéra pẹ̀lu ẹgbẹ́ ìṣàkóso, àwọn ẹ̀kù tí a fún ní oògùn náà ń jẹ́ púpọ̀ sí i, wọ́n sì ń kún púpọ̀ sí i. Nínú àwọn wọ̀nyí, èwo ni òye tí ó ṣeé ṣe jùlọ fún ìkún púpọ̀ tí a rí nínú ẹgbẹ́ àdánwò?\nA. Ìṣírí Cholecystokinin sí nucleus tractus solitarius\nB. Ìdènà Somatostatin sí anterior pituitary\nC. Ìṣírí Leptin sí ventromedial hypothalamus\nD. Ìṣírí Ghrelin sí lateral hypothalamus\nE. Ìṣírí Glucagon sí hepatocytes", "reasoning": "<thinking><step1>\nThe question is asking about the most likely mechanism for increased appetite observed in a group of subjects receiving a daily medication that influences bodily functions — specifically, it mentions *ìkún púpọ̀* (increased appetite).\n</step1>\n<step2>\nIn this context, we need to consider which hormone or signaling pathway is most associated with stimulating appetite — *ìṣírí* (hormone) that promotes hunger.\n</step2>\n<step3>\nAmong the options, *Ghrelin* is known as the \"hunger hormone\" that signals the brain to increase appetite, particularly acting on the *lateral hypothalamus*.\n</step3>\n<step4>\nIn contrast, *Leptin* typically signals satiety, while *Somatostatin* and *Cholecystokinin* are more involved in inhibiting appetite or regulating digestion.\n</step4>\n<step5>\nThus, the most relevant choice for increased appetite in this scenario is *ìṣírí Ghrelin sí lateral hypothalamus*.\n</step5></thinking>", "answer": "<answer>Ìṣírí Ghrelin sí lateral hypothalamus.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 29 kan ti wọn gba sínú ilé-iwosan nítorí ìsun-ọwọ́ ìgbà kejì tí ó gbòòrò káàkiri apá àti ọmu rẹ̀, ó ní ibà àti àìsàn ìgbòòrò láti ọjọ́ karùn-ún lẹ́yìn tí wọ́n gba a sí ilé-iwosan.  Ìgbóná ara rẹ̀ jẹ́ 38.8°C (101.8°F). Ìwádìí fi hàn pé ìgbòòrò sun-ọwọ́ náà yí pa dà, pẹ̀lú ìṣàn omi àti pupa ní ayika awọ ara rẹ̀. Àwọn ìgbòòrò náà ní ìhàn nígbàgbàgbà, ṣùgbọ̀n dùn-dùn. Ìgbádùn gbígbẹ́ èròjà ti a fa láti inú ara tí ó ní àìsàn náà fi hàn pé ó jẹ́ kokoro arun tó wà ní afẹ́fẹ́, tí ó sì jẹ́ gram-negative rod.  Kokoro arun tí ó fa àìsàn náà ṣeé ṣe kí ó ṣe àwọn nǹkan wọ̀nyí jùlọ?\nA. Tetanospasmin\nB. Streptolysin O\nC. Phospholipase C\nD. Alpha toxin\nE. Protein A", "reasoning": "<thinking><step1>\nThe question is asking about a 29-year-old man who was admitted to the hospital due to a severe [ìsun-ọwọ́ = hand infection] with systemic symptoms like fever and swelling. It mentions that the infection is caused by a gram-negative rod, which is crucial for identifying the pathogen.\n</step1>\n<step2>\nInfections caused by gram-negative rods often involve specific toxins that can lead to various symptoms. The presence of fever at 38.8°C (101.8°F) indicates a significant immune response — *ìbà* — to the infection.\n</step2>\n<step3>\nThe options provided include various toxins: Tetanospasmin, Streptolysin O, Phospholipase C, Alpha toxin, and Protein A. However, we need to focus on the characteristics of gram-negative bacteria.\n</step3>\n<step4>\nAmong the options, *Phospholipase C* and *Alpha toxin* are associated with gram-positive bacteria, while *Streptolysin O* is linked to Streptococcus species, which are gram-positive as well. This leaves us with *Tetanospasmin* and *Protein A*.\n</step5>\n<step6>\n*Protein A* is primarily associated with Staphylococcus aureus, which is a gram-positive bacterium, while *Tetanospasmin* is linked to Clostridium tetani, also gram-positive. Therefore, none of these options directly relate to a gram-negative rod.\n</step7>\n<step8>\nHowever, if we consider the context of a gram-negative rod causing severe infections, it is likely that the pathogen could produce toxins that lead to systemic effects. The most relevant option in this case would be *Alpha toxin*, which can be produced by certain gram-negative bacteria.\n</step8></thinking>", "answer": "<answer>Alpha toxin</answer>", "language": "Yoruba"}
{"question": "Ní ipò tí ọ̀daràn kan ti fọ́ ọmọ̀wé rẹ̀ ní àìfẹ́, nítorí pé a sọ̀rọ̀ òtítọ́ fún un pé àgbàlà náà ò ní ìbọn, tí a sì gbé ìlànà kan kalẹ̀ pé ikú ènìyàn ní ìgbà àkọ́kọ́ ni ìkọ̀lù ni fífẹ́ pa ẹni tí a bá ṣe ètò sí, nípa ìmọ̀kòkòrò ṣíṣe burúkú, ikú ènìyàn ní ìgbà kejì ni ìkọ̀lù nígbà tí ẹ̀ṣẹ̀ tí ó lewu ń ṣẹlẹ̀, àti ikú ènìyàn nípa àìṣe tó yẹ ni gbogbo irú ikú ènìyàn tí kò bá tọ́ sí miiran, ohun tí àjọjú yóò dá ọ̀daràn náà lẹ́bi rẹ̀ ni bí àjọjú bá gbàgbọ́ ẹ̀rí rẹ̀ pé kò mọ̀ pé àgbàlà náà ní ìbọn?", "reasoning": "<thinking><step1>\nThe question is asking about the legal implications for a defendant who claims ignorance of a weapon's presence during a crime — specifically, *àgbàlà* [the scene] not having a gun.\n</step1>\n<step2>\nIn legal terms, this relates to *ìmọ̀kòkòrò* [mens rea], which refers to the mental state of the defendant at the time of the crime.\n</step2>\n<step3>\nIf the defendant can prove that they genuinely did not know about the weapon, it may affect their culpability — *ìbáṣepọ̀ wọn* [their liability].\n</step3>\n<step4>\nHowever, the law often considers whether a reasonable person would have been aware of the weapon's presence — *àwọn ènìyàn to rọrùn* [reasonable people].\n</step4>\n<step5>\nIn cases of *ikú ènìyàn* [homicide], the severity of the crime can change based on the defendant's knowledge and intent — *ìmọ̀ àti ìfẹ́* [knowledge and intent].\n</step5>\n<step6>\nUltimately, if the court believes the defendant was unaware of the weapon, it could lead to a lesser charge or even acquittal — *ìdájọ́ tó rọrùn* [a more lenient judgment].\n</step6></thinking>", "answer": "<answer>Ti a ba gbagbọ́ pé ọ̀daràn náà kò mọ̀ pé àgbàlà náà ní ìbọn, ó le dín ẹ̀bi rẹ̀ kù tabi jẹ́ ki a da a lẹ́bi.</answer>", "language": "Yoruba"}
{"question": "Ọmọbirin ọdun mẹ́ẹ́ẹ́dógún kan wà pẹlu àìlera oúnjẹ, ikọ́, àti líle ọrùn. Ìwádìí CSF fi hàn ní ìwọ̀n glucose ti 40 mg%, ìwọ̀n protein ti 150 mg%, chloride ní 52 meq/l, àti ọ̀pọ̀lọpọ̀ lymphocytes. Da lórí àwọn àmì àrùn wọnyi àti ìwádìí CSF, kini àrùn tí ó ṣeé ṣe jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “Based on the symptoms of a 15-year-old girl with [àìlera oúnjẹ = food intolerance], [ikọ́ = cough], and [líle ọrùn = sore throat], along with CSF findings of glucose at 40 mg%, protein at 150 mg%, chloride at 52 meq/l, and many lymphocytes, what is the most likely disease?” \n</step1>\n<step2>\nThe symptoms suggest a possible infection or inflammatory condition. The presence of lymphocytes in the CSF indicates a viral or atypical bacterial infection — *une infection virale ou bactérienne atypique*.\n</step2>\n<step3>\nThe glucose level of 40 mg% is low, which is significant; typically, in viral infections, glucose levels remain normal, while in bacterial infections, they can be low — *les infections bactériennes peuvent entraîner une hypoglycorachie*.\n</step3>\n<step4>\nThe elevated protein level of 150 mg% also supports an inflammatory process — *un processus inflammatoire* is likely occurring, which is common in conditions like viral meningitis.\n</step4>\n<step5>\nConsidering all these factors, the combination of symptoms and CSF findings strongly suggests viral meningitis — *méningite virale*.\n</step6></thinking>", "answer": "<answer>Àwọn àmì àrùn àti ìwádìí CSF fihan pé àrùn tí ó ṣeé ṣe jùlọ ni méningite virale.</answer>", "language": "Yoruba"}
{"question": "Ọmọ alaisan ọdun mejila kan fi iba, irora ẹgbẹ kan lẹhin etí, sisẹ́ mastoid pẹlu sisẹ́ pinna siwaju ati si ita, ati pipadanu radiological ti awọn trabeculae egungun han. Alaisan naa tun ni itan sisẹ́ puru igba pipẹ lati eti kanna. Kini itọju ti a yan fun ipo yii?", "reasoning": "<thinking><step1>\nThe question asks: “Kini itọju ti a yan fun ipo yii?” — meaning it wants to know the treatment chosen for this condition involving a 12-year-old patient with fever, pain in one ear, mastoid surgery, and radiological loss of bone trabeculae.\n</step1>\n<step2>\nThis scenario suggests a possible case of *mastoiditis* or complications from previous ear surgery — *sisẹ́ etí*.\n</step2>\n<step3>\nThe symptoms indicate an infection or inflammation in the mastoid area, which can lead to serious complications if not treated properly — *iyalẹnu le fa awọn iṣoro to ṣe pataki*.\n</step4>\n<step4>\nIn such cases, treatment typically involves antibiotics to combat the infection — *antibiotics* are crucial for managing the infection effectively.\n</step5>\n<step5>\nIf the condition is severe or does not improve with medication, surgical intervention may be necessary to drain any abscess or remove infected tissue — *sisẹ́ le jẹ dandan*.\n</step6>\n<step6>\nTherefore, the chosen treatment for this patient would likely be a combination of antibiotics and possibly further surgical evaluation — *itọju pẹlu antibiotics ati ayẹwo sisẹ́*.\n</step7></thinking>", "answer": "<answer>Itọju ti a yan fun ipo yii ni antibiotics ati, ti o ba jẹ dandan, ayẹwo sisẹ́.</answer>", "language": "Yoruba"}
{"question": "Kini ààyọ̀ àìsàn tó gbòòrò jùlọ fún ọmọkunrin ọdún márùn-ún kan tí ohun kan ti n jade láti ẹnu-ìyẹ̀ ẹ̀, lórí ọ̀pá tí ó so mọ́ ògiri ìyẹ̀ ẹ̀ tàbí àpòòtó, tí ẹ̀jẹ̀ pupa dídán sì ń bá a?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ààyọ̀ àìsàn tó gbòòrò jùlọ fún ọmọkunrin ọdún márùn-ún kan…” — meaning it wants to know the most common disease for a five-year-old boy with blood coming from his mouth.\n</step1>\n<step2>\nIn English, this situation suggests a serious condition, possibly related to the respiratory system — *àwọn àìsàn ti ẹ̀dá àyà* or even a bleeding disorder.\n</step2>\n<step3>\nCommon causes could include infections like pneumonia or a severe throat infection — *àìsàn àtọ́kànwá* that can lead to bleeding.\n</step3>\n<step4>\nAnother possibility is trauma, such as an injury to the mouth or throat — *ìfarapa sí ẹnu tàbí àyà* that might cause bleeding.\n</step4>\n<step5>\nGiven the age of the child, one must also consider *àìsàn àtọ́kànwá* like hemophilia, which affects blood clotting.\n</step5>\n<step6>\nIn summary, the most likely condition could be a severe throat infection or trauma leading to bleeding from the mouth.\n</step6></thinking>", "answer": "<answer>Ààyọ̀ àìsàn tó gbòòrò jùlọ fún ọmọkunrin ọdún márùn-ún kan tí ẹ̀jẹ̀ pupa dídán ń bá a láti ẹnu-ìyẹ̀ ẹ̀ ni àìsàn àtọ́kànwá tàbí ìfarapa sí ẹnu.</answer>", "language": "Yoruba"}
{"question": "Ègbògi àrùn àìgbọ̀ràn wo ni a kò fi ṣe àṣàrò pé ó máa ṣe ìṣòro fún ọmọ tí ó wà lọ́yún?", "reasoning": "<thinking><step1>\nThe question asks: “Ègbògi àrùn àìgbọ̀ràn wo ni a kò fi ṣe àṣàrò pé ó máa ṣe ìṣòro fún ọmọ tí ó wà lọ́yún?” — meaning it wants to know which medications are contraindicated for pregnant women.\n</step1>\n<step2>\nCertain medications can harm the developing fetus — *àwọn àrùn àìgbọ̀ràn* can cross the placenta and affect the baby.\n</step2>\n<step3>\nFor example, *tetracyclines* are antibiotics that can cause *àìlera ẹ̀dá* in the fetus, leading to discoloration of teeth.\n</step3>\n<step4>\nAdditionally, *non-steroidal anti-inflammatory drugs (NSAIDs)* like ibuprofen can lead to complications during pregnancy — *ìṣòro nígbà ìbímọ*.\n</step4>\n<step5>\nAnother critical category is *antidepressants*, particularly *SSRIs*, which may increase the risk of *àìlera ọpọlọ* in newborns.\n</step5>\n<step6>\nTherefore, it is essential for pregnant women to avoid these medications to prevent potential harm to the fetus.\n</step6></thinking>", "answer": "<answer>Àwọn egboogi àrùn àìgbọ̀ràn tí a kò fi ṣe àṣàrò fún ọmọ tí ó wà lọ́yún ni tetracyclines, NSAIDs, àti SSRIs.</answer>", "language": "Yoruba"}
{"question": "Àwọn àrùn méjì wo nínú àwọn àrùn wọ̀nyí: Iba ti Rocky Mountain, Strongyloides, T. Solium, àti Onchocerca, ni a mọ̀ pé ó ní àkókò ìmúlò ìgbìyẹn?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn àrùn méjì wo nínú àwọn àrùn wọ̀nyí: [Rocky Mountain fever], [Strongyloides], [T. solium], àti [Onchocerca] ni a mọ̀ pé ó ní àkókò ìmúlò ìgbìyẹn?” — meaning it wants to identify which two diseases among these are known to have a specific incubation period.\n</step1>\n<step2>\nFirst, let's clarify what an incubation period is — *akókò ìmúlò* refers to the time between exposure to the pathogen and the onset of symptoms.\n</step2>\n<step3>\nRocky Mountain fever, caused by *Rickettsia rickettsii*, typically has an incubation period of 2 to 14 days — *akókò ìmúlò rẹ̀ jẹ́ ọjọ́ 2 sí 14*.\n</step3>\n<step4>\nStrongyloides, caused by a parasitic worm, has a variable incubation period, often ranging from weeks to months — *akókò ìmúlò rẹ̀ le jẹ́ ọsẹ̀ tàbí oṣù*.\n</step4>\n<step5>\nT. solium, which causes cysticercosis, can have an incubation period that varies widely, often depending on the host's immune response — *akókò ìmúlò rẹ̀ le yato si*.\n</step6>\n<step7>\nOnchocerca, responsible for river blindness, has an incubation period that can last several months to years — *akókò ìmúlò rẹ̀ le jẹ́ oṣù mẹta sí ọdún*.\n</step8>\n<step9>\nFrom this analysis, Rocky Mountain fever and Strongyloides are the two diseases with more defined incubation periods, while T. solium and Onchocerca have broader ranges.\n</step9></thinking>", "answer": "<answer>Iba ti Rocky Mountain àti Strongyloides ni a mọ̀ pé ó ní àkókò ìmúlò ìgbìyẹn.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìpínrọ̀ tó tẹ̀lé yìí kọ̀ọ̀kan ṣàpèjúwe ṣeto ohun márùn-ún tí a gbé ka sílẹ̀ ní àṣẹ tí a fìdí múlẹ̀. Àwọn ọǹrọ̀ náà bá ara wọn mu nínú ìpínrọ̀ kọ̀ọ̀kan. Ọjà èso kan ta èso márùn-ún: àpòòpò, ìmù, àgbàlógbà, pẹ́àrì, àti mango. Àpòòpò rọrun ju ìmù lọ. Ìmù rọrun ju mango lọ. Àpòòpò ni èkẹta tí ó rọrùn jùlọ. Pẹ́àrì rọrun ju àgbàlógbà lọ.\nÀwọn àṣàyàn:\n(A) Àpòòpò ni èkejì tí kò rọrùn jùlọ\n(B) Ìmù ni èkejì tí kò rọrùn jùlọ\n(C) Àgbàlógbà ni èkejì tí kò rọrùn jùlọ\n(D) Pẹ́àrì ni èkejì tí kò rọrùn jùlọ\n(E) Mango ni èkejì tí kò rọrùn jùlọ", "reasoning": "<thinking><step1>\nThe question asks to describe the order of five fruits based on their ease of handling, specifically: àpòòpò [orange], ìmù [banana], àgbàlógbà [pineapple], pẹ́àrì [pear], and mango.\n</step1>\n<step2>\nFrom the information given, we know that àpòòpò is easier to handle than ìmù, which means àpòòpò comes first in terms of ease.\n</step2>\n<step3>\nNext, it states that ìmù is easier than mango, placing ìmù before mango in the order.\n</step3>\n<step4>\nIt also mentions that àpòòpò is the third easiest fruit, which means there are two fruits easier than it.\n</step4>\n<step5>\nFurthermore, pẹ́àrì is easier than àgbàlógbà, indicating that pẹ́àrì must come before àgbàlógbà in the order.\n</step6>\n<step6>\nPutting this all together, we can deduce the order: àpòòpò is first, followed by ìmù, then pẹ́àrì, and finally àgbàlógbà and mango.\n</step7>\n<step7>\nThus, the second hardest fruit to handle must be ìmù, as it is easier than àpòòpò but harder than mango.\n</step8></thinking>", "answer": "<answer>Ìmù ni èkejì tí kò rọrùn jùlọ.</answer>", "language": "Yoruba"}
{"question": "Ọdọmọdún mẹ́ẹ́ẹ́dógún kan wà pẹ̀lú irọ́rùn tí ń pọ̀ sí i, àti àìlera nígbà tí ó bá ń ṣiṣẹ́, wíwádìí ara rẹ̀ sì fi hàn pé ìyàtọ̀ ńlá kan wà láàrin ohùn ọkàn rẹ̀ kejì, pẹ̀lú ohùn ọkàn tí ó jẹ́ nígbà ìdènà àti àkókò ìgbà tí ọkàn ń lu.  Ṣé kí èrò ṣíṣàyẹ̀wò ohun tí ó wà nínú ọkàn rẹ̀ yóò rí bí?", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé kí èrò ṣíṣàyẹ̀wò ohun tí ó wà nínú ọkàn rẹ̀ yóò rí bí?” — meaning it wants to know how an examination of the heart will appear given the symptoms described.\n</step1>\n<step2>\nThe symptoms include *irọ́rùn* (discomfort) and *àìlera* (weakness) during activity, which suggests potential heart issues.\n</step2>\n<step3>\nThe mention of a significant difference in the heart sounds — *ìyàtọ̀ ńlá kan wà láàrin ohùn ọkàn* — indicates possible abnormalities like murmurs or irregular rhythms.\n</step3>\n<step4>\nDuring an examination, a doctor might use a stethoscope to listen for *ohùn ọkàn tí ó jẹ́ nígbà ìdènà* (heart sounds during rest) versus those during exertion.\n</step4>\n<step5>\nIf there are changes in the heart sounds, it could suggest conditions like *àkókò ìgbà tí ọkàn ń lu* (arrhythmias) or other cardiac issues.\n</step5>\n<step6>\nThus, the examination will likely reveal variations in heart sounds that correlate with the patient's symptoms of discomfort and weakness.\n</step6></thinking>", "answer": "<answer>Ìwádìí ara rẹ̀ yóò fi hàn pé ìyàtọ̀ wà nínú ohùn ọkàn rẹ̀, tó lè jẹ́ àkókò ìgbà tí ọkàn ń lu tàbí àìlera míì.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 55 kan ti o ní itan igba sisun taba ati àtọ́pẹ̀ àtẹ́gùn tí a ṣakoso ati àtọ́pẹ̀ sùùgbà ń ṣe àkíyèsí ìgbààmì 12 mm ní ibi idánwò PPD rẹ̀, èyí tí ó fi hàn ní ààrùn àtọ́pẹ̀ àtẹ́gùn tí ó farapamọ.  Nítorí iṣẹ́ rẹ̀ ati ìlera rẹ̀,  ṣé kí ni àṣàyàn ìtọ́jú tí a gba nímọ̀ràn fún ààrùn àtọ́pẹ̀ àtẹ́gùn tí ó farapamọ ní ọkùnrin yìí?", "reasoning": "<thinking><step1>\nThe question asks about a 55-year-old man with a history of smoking and controlled hypertension who has a PPD test showing a 12 mm induration, indicating latent tuberculosis infection — *ààrùn àtọ́pẹ̀ àtẹ́gùn tí ó farapamọ*.\n</step1>\n<step2>\nIn this case, the presence of a 12 mm induration suggests that he has been exposed to the tuberculosis bacteria — *bakteria àtọ́pẹ̀ àtẹ́gùn*.\n</step2>\n<step3>\nGiven his smoking history, it is crucial to consider the risk factors for progression to active tuberculosis — *ààrùn àtọ́pẹ̀ àtẹ́gùn gidi*.\n</step3>\n<step4>\nThe recommended management for latent tuberculosis typically includes isoniazid or rifampin for a specific duration — *isoniazid tabi rifampin*.\n</step4>\n<step5>\nAdditionally, monitoring for any symptoms of active tuberculosis is essential, especially since he has a history of smoking which can complicate respiratory health — *ilera ẹdọfóró*.\n</step6>\n<step6>\nTherefore, the best course of action is to initiate treatment for latent tuberculosis and provide education on the importance of adherence to therapy.\n</step6></thinking>", "answer": "<answer>Àṣàyàn ìtọ́jú ti a gba nímọ̀ràn ni lati bẹ̀rẹ̀ itọju fún ààrùn àtọ́pẹ̀ àtẹ́gùn tí ó farapamọ pẹ̀lú isoniazid tabi rifampin.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹ́wàá kan wà pẹ̀lú ìgbóná tí ó ní ìrora, ìgbóná tó ń gbóná gidigidi ní ori, ọ̀pọ̀lọpọ̀ àwọn ihò tí ó ń tu omi tó dùn, irun tó rọrùn láti fà jáde, àti àwọn ìgbò orí occipital tí ó tóbi sí i. Ẹ̀kọ́ ṣíṣàyẹ̀wò wo ni yóò ṣe ràn wá lọ́wọ́ jùlọ nínú ṣíṣàyẹ̀wò àìsàn yìí?", "reasoning": "<thinking><step1>\nThe question describes a 10-year-old boy with symptoms like a high fever, severe headache, multiple rashes, and enlarged occipital lymph nodes. It asks which examination would be most helpful in diagnosing this condition.\n</step1>\n<step2>\nGiven the symptoms, particularly the *ìgbóná* (fever) and *ìrora* (pain), we should consider infections that commonly affect children, such as viral or bacterial meningitis.\n</step2>\n<step3>\nThe presence of *ihò* (rashes) and swollen lymph nodes suggests a systemic infection, possibly viral like *àkóràn meningitis* (meningitis).\n</step3>\n<step4>\nIn this case, a lumbar puncture — *ìfọwọ́kànsí àyẹ̀wò* — would be crucial to analyze cerebrospinal fluid for pathogens or inflammatory markers.\n</step4>\n<step5>\nAdditionally, a complete blood count — *ìtẹ̀síwájú ẹ̀jẹ̀* — can help identify signs of infection or inflammation.\n</step5>\n<step6>\nThus, the most informative examination would be the lumbar puncture to confirm or rule out meningitis.\n</step6></thinking>", "answer": "<answer>Ìfọwọ́kànsí àyẹ̀wò ni yóò jẹ́ ìṣàkóso tó dára jùlọ fún àìsàn yìí.</answer>", "language": "Yoruba"}
{"question": "Kini idi ti o ṣeé ṣe julọ ti awọn àmì àrùn ọmọkunrin ọdun mẹrin naa, ti a ba gbero ifihan rẹ laipẹ ati awọn àrùn ti o jọra ti ọpọlọpọ awọn ọmọde miiran royin ni ile-iwe alakọbẹrẹ rẹ?", "reasoning": "<thinking><step1>\nThe question asks: “Kini idi ti o ṣeé ṣe julọ ti awọn àmì àrùn [symptoms of illness] ọmọkunrin [boy] ọdun mẹrin [four years old] naa?” — meaning it wants to know the most likely reasons for the symptoms of a four-year-old boy, considering recent exposure and similar illnesses reported by other children in his primary school.\n</step1>\n<step2>\nFirst, we should consider common illnesses in young children, such as *ìkòkò [flu]* or *àkúnya [cold]*, which are prevalent in school settings.\n</step2>\n<step3>\nIf many children are experiencing similar symptoms, it suggests a contagious illness — *àrùn to n tan kaakiri* — likely due to close contact in the classroom.\n</step3>\n<step4>\nAdditionally, we must think about the boy's recent activities; for example, if he was exposed to a sick classmate, this increases the likelihood of him catching the same illness.\n</step4>\n<step5>\nOther factors could include seasonal allergies, which can present symptoms similar to a cold — *àkúnya* — especially if there are environmental triggers like pollen.\n</step5>\n<step6>\nIn summary, the most likely causes of the boy's symptoms are a contagious illness from peers or environmental factors affecting his health.\n</step6></thinking>", "answer": "<answer>Idi ti o ṣeé ṣe julọ ni àrùn to n tan kaakiri tabi awọn ifosiwewe ayika ti o ni ipa lori ilera rẹ.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹwa kan wá pẹlu irẹlẹ ara ati itan gbigbe ẹ̀jẹ̀ ni oṣu meji sẹyin.  Awọn iwadii ile-iwosan fihan hemoglobin ni 4.5 g/dL, iye gbogbo leukocyte jẹ 60,000/µL, iye platelet jẹ 200,000/µL, pẹlu awọn abajade immunophenotyping ti o tọkasi CD10 rere, CD19 rere, CD117 rere, myeloperoxidase rere, ati CD33 buburu.  Kini ayẹwo ti o ṣeeṣe julọ ti a fun awọn abajade wọnyi?", "reasoning": "<thinking><step1>\nThe question presents a clinical scenario involving a 10-year-old boy with *irẹlẹ ara* [pallor] and *itan gbigbe ẹ̀jẹ̀* [history of bleeding] two months ago. It asks for the most likely diagnosis based on laboratory findings.\n</step1>\n<step2>\nThe hemoglobin level is critically low at 4.5 g/dL, indicating *anemia* [anemia]. This is a significant concern, especially in a child.\n</step2>\n<step3>\nThe leukocyte count is very high at 60,000/µL, which suggests *leukocytosis* [leukocytosis]. This could indicate a possible hematological malignancy.\n</step4>\n<step4>\nThe immunophenotyping results show positivity for CD10, CD19, CD117, and myeloperoxidase, while CD33 is negative. These markers are often associated with *leukemia* [leukemia], particularly *leukemia lymphoblastique aiguë* [acute lymphoblastic leukemia].\n</step5>\n<step5>\nGiven the combination of severe anemia, high leukocyte count, and the specific immunophenotype, the most likely diagnosis is *leukemia lymphoblastique aiguë*.\n</step6>\n<step6>\nIn summary, the clinical picture aligns with acute lymphoblastic leukemia, which is common in children and presents with these laboratory findings.\n</step6></thinking>", "answer": "<answer>Ayẹwo ti o ṣeeṣe julọ ni leukemia lymphoblastique aiguë.</answer>", "language": "Yoruba"}
{"question": "Oludari ile iṣẹ́ onjẹ́ agbegbe kan béèrè fún àwọn ìṣirò nípa gbogbo ẹ̀bùn tí a fún ní oṣù Kọkànlá. Láàrin àwọn ṣẹ́ẹ̀ki 100 tí a gba, ẹ̀bùn ààyè jẹ́ $155 pẹ̀lú ìyàtọ̀ ìṣiro ti $32. Ẹ̀yà wo nínú àwọn wọ̀nyí ni ọ̀rọ̀ tí ó bá ara mu jùlọ?\nA. A ní ìgbẹ́kẹ̀lé 95% pé ẹ̀bùn ààyè ní oṣù Kọkànlá wà láàrin $149 àti $161.\nB. Ẹ̀bùn ààyè ní oṣù Kọkànlá yìí jẹ́ $32.\nC. A ní ìgbẹ́kẹ̀lé 95% pé ẹ̀bùn ààyè ní oṣù Kọkànlá wà láàrin $123 àti $187.\nD. Ní oṣù Kọkànlá yìí, ẹ̀bùn ààyè jẹ́ $155.\nE. Ní oṣù Kọkànlá yìí, ìyàtọ̀ ìṣiro ti ẹ̀bùn jẹ́ $155.\nF. 75% gbogbo ẹ̀bùn ní oṣù Kọkànlá yìí ju $155 lọ.\nG. A ní ìgbẹ́kẹ̀lé 95% pé ẹ̀bùn ààyè ní oṣù Kọkànlá wà láàrin $91 àti $219.\nH. 50% gbogbo ẹ̀bùn ní oṣù Kọkànlá yìí kere sí $155.\nI. 50% gbogbo ẹ̀bùn ní oṣù Kọkànlá yìí ju $155 lọ.\nJ. A ní ìgbẹ́kẹ̀lé 99% pé ẹ̀bùn ààyè ní oṣù Kọkànlá wà láàrin $91 àti $219.", "reasoning": "<thinking><step1>\nThe question is asking about the statistical analysis of a sample of 100 observations regarding the average gift amount in the month of November — *ẹ̀bùn ààyè* — which is $155 with a standard deviation of $32.\n</step1>\n<step2>\nTo determine which statement is most accurate, we need to consider the confidence interval for the average gift amount. A 95% confidence interval typically means we can expect the true mean to fall within a certain range around the sample mean.\n</step2>\n<step3>\nUsing the standard deviation, we can calculate the confidence interval: *$155 ± (1.96 * (32/√100))* — this gives us a range of approximately $149 to $161.\n</step3>\n<step4>\nThus, statement A, which claims that we are 95% confident the average gift amount is between $149 and $161, aligns with our calculations.\n</step4>\n<step5>\nOther options either misstate the average, the standard deviation, or the confidence levels, making them less accurate than option A.\n</step5></thinking>", "answer": "<answer>A. A ní ìgbẹ́kẹ̀lé 95% pé ẹ̀bùn ààyè ní oṣù Kọkànlá wà láàrin $149 àti $161.</answer>", "language": "Yoruba"}
{"question": "Ní ọjọ́-orí wo ni àwọn ọmọdé máa ń kọ́ ṣiṣe àwọn ohun bí: jijẹ oúnjẹ pẹ̀lú spúnu láìdán, wíwọ̀ àti yíyọ aṣọ̀ lórí ìtọ́jú, àti mímọ̀ ìdámọ̀ràn ìbálòpọ̀ wọn gẹ́gẹ́ bí ọmọbìnrin?", "reasoning": "<thinking><step1>\nThe question asks: “Ní ọjọ́-orí wo ni àwọn ọmọdé máa ń kọ́ [jijẹ oúnjẹ pẹ̀lú spúnu = eating with a spoon], [wíwọ̀ = washing], [yíyọ aṣọ̀ = dressing], and [mímọ̀ ìdámọ̀ràn ìbálòpọ̀ = understanding their gender identity]?” — meaning it wants to know at what age children learn these skills.\n</step1>\n<step2>\nTypically, children start learning to eat with a spoon around the age of 12 to 18 months — *ní àkókò yìí, wọn ti ń bẹ̀rẹ̀ sí í fọ́kàn tán*.\n</step2>\n<step3>\nWashing hands and dressing usually develop between ages 2 to 3 — *nígbà yìí, wọn ti ní ìmọ̀ràn tó dáa jùlọ*.\n</step3>\n<step4>\nUnderstanding gender identity can begin as early as age 3, when children start to express preferences — *ní àkókò yìí, wọn máa ń sọ pé wọn fẹ́ jẹ́ ọmọbìnrin tàbí ọmọkùnrin*.\n</step4>\n<step5>\nThese skills are part of *ìtọ́jú ara* and social development, which are crucial for their growth — *ìmọ̀ràn yìí ṣe pàtàkì fún ìdàgbàsókè wọn*.\n</step6>\n<step6>\nIn summary, children learn these skills at different ages, with eating skills starting around 1 year, washing and dressing by 2-3 years, and gender identity awareness beginning around age 3.\n</step6></thinking>", "answer": "<answer>Àwọn ọmọdé máa ń kọ́ ṣiṣe àwọn ohun yìí ní ọjọ́-orí 1 sí 3, gẹ́gẹ́ bí ìmọ̀ràn wọn ṣe ń dàgbà.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 50 kan ti a mọ̀ pe ó ní àrùn sùùgbà fún ọdún pípẹ́ ti wá pẹ̀lú ìṣàn-ìgbàgbọ́ tí kò dára, ìdùn-àdùn, ìṣòro nínú ìgbàgbọ́, àti àìlọ́gbọ́n láti gbàgbọ́ pátápátá. Kí ni ó ṣeé ṣe kí ó ń jìyà nípa rẹ̀?\nA. BPH\nB. UTI\nC. Àpòòṣì atonic\nD. Àrùn ìṣan ara", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ó ṣeé ṣe kí ó ń jìyà nípa rẹ̀?” — meaning it wants to know what condition the 50-year-old man might be suffering from, given his symptoms of poor urinary flow, discomfort, difficulty in belief, and lack of confidence.\n</step1>\n<step2>\nThe symptoms described suggest a problem with the urinary system — *ìṣòro nínú ìgbàgbọ́* could indicate psychological factors, but the physical symptoms are more pressing.\n</step2>\n<step3>\nConsidering his age and the urinary issues, one likely condition is Benign Prostatic Hyperplasia (BPH) — *àrùn sùùgbà* can lead to urinary retention and discomfort.\n</step3>\n<step4>\nA Urinary Tract Infection (UTI) could also cause discomfort, but it typically presents with more acute symptoms like burning during urination — *ìdùn-àdùn*.\n</step4>\n<step5>\nThe option \"Àpòòṣì atonic\" refers to a condition where the bladder doesn't contract properly, which could explain poor urinary flow but not the psychological symptoms.\n</step5>\n<step6>\nFinally, \"Àrùn ìṣan ara\" relates to systemic issues, which may not directly connect to the urinary symptoms described.\n</step6>\n<step7>\nThus, the most fitting diagnosis considering his age and symptoms is likely BPH, as it aligns with the urinary difficulties and discomfort he is experiencing.\n</step7></thinking>", "answer": "<answer>Àrùn sùùgbà (BPH) ni ó ṣeé ṣe kí ó ń jìyà nípa rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Kini ọ̀nà àyẹ̀wò tí Ẹ̀ka Ìṣakoso Àṣìṣe Ojú Orílẹ̀-èdè (NPCB) ṣe ìgbàṣe fún idena àṣìṣe ojú tí ó fa látọwọ́ àrùn retinopathy diabetic?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ọ̀nà àyẹ̀wò tí Ẹ̀ka Ìṣakoso Àṣìṣe Ojú Orílẹ̀-èdè (NPCB) ṣe ìgbàṣe fún idena àṣìṣe ojú tí ó fa látọwọ́ àrùn [retinopathy diabetic = diabetic retinopathy]?” — meaning it wants to know the methods used by the NPCB for preventing eye complications caused by diabetic retinopathy.\n</step1>\n<step2>\nDiabetic retinopathy occurs due to damage to the blood vessels in the retina — *àwọn ẹ̀jẹ̀ tó wà nínú retina* can leak fluid or bleed.\n</step2>\n<step3>\nThe NPCB emphasizes regular eye examinations — *àyẹ̀wò ojú àtijọ́* — to detect early signs of retinopathy.\n</step3>\n<step4>\nThey also promote controlling blood sugar levels — *ìṣàkóso ipele suga* — as a preventive measure against the progression of the disease.\n</step4>\n<step5>\nAdditionally, lifestyle changes such as a healthy diet and regular exercise are encouraged — *ounje to dara ati idaraya deede* — to manage diabetes effectively.\n</step5>\n<step6>\nIn summary, the NPCB employs a combination of regular screenings and lifestyle modifications to prevent diabetic retinopathy.\n</step6></thinking>", "answer": "<answer>Ẹ̀ka Ìṣakoso Àṣìṣe Ojú Orílẹ̀-èdè (NPCB) ṣe àyẹ̀wò ojú àtijọ́, ìṣàkóso ipele suga, àti àtúnṣe ìṣe àtọkànwá gẹ́gẹ́ bí ọ̀nà àyẹ̀wò fún idena àṣìṣe ojú.</answer>", "language": "Yoruba"}
{"question": "Lilo lílò sódíóómù tàbí potásíóómù flúoráìdì sí eyín ọmọdé ṣe dín iye ààrùn eyín wọn kù gidigidi. Ẹni tó fi èyí hàn ní àkọ́kọ́ ni\nA. Knutson\nB. Bibby\nC. Muhler\nD. Dean", "reasoning": "<thinking><step1>\nThe question asks: “Who first demonstrated that the use of [fluoride = flúoráìdì] in [toothpaste = sódíóómù] significantly reduces the incidence of [tooth decay = ààrùn eyín] in children?” \n</step1>\n<step2>\nThis is a historical question about dental research, specifically regarding the effectiveness of fluoride in preventing cavities — *ààrùn eyín*.\n</step2>\n<step3>\nThe key figure in fluoride research is often associated with studies that showed its benefits in oral health — *ilana ilera ẹnu*.\n</step3>\n<step4>\nAmong the options, *Knutson* is known for his work on fluoride, but *Dean* is particularly famous for his extensive studies on the relationship between fluoride levels in water and dental health.\n</step4>\n<step5>\nDean's research established that optimal fluoride levels can lead to a significant decrease in tooth decay — *dín iye ààrùn eyín kù gidigidi*.\n</step5>\n<step6>\nTherefore, the correct answer is the one who is most recognized for this specific contribution to dental health.\n</step6></thinking>", "answer": "<answer>D. Dean</answer>", "language": "Yoruba"}
{"question": "Àpọn ọkunrin ọdún 58 kan tí ó ní àrùn àtìgbàdùgbà iru keji kò lè ṣakoso oúnjẹ rẹ̀ ṣùgbọ́n ó gbàgbọ́ sí metformin. HbA1c rẹ̀ ti dinku láti 8.2% sí 7.2% lákòókò oṣù mẹta. Nítorí BMI gíga rẹ̀ àti àìdánilójú láti yẹ̀wò oògùn tí ó mú kí ìwúwo pọ̀ sí i, oògùn wo ni yóò ṣe yẹ̀ ní kíkún láti ràn án lọ́wọ́ láti ṣàkóso ìwògbà ẹ̀jẹ̀ rẹ̀?", "reasoning": "<thinking><step1>\nThe question is asking: “What medication should be considered for a 58-year-old man with type 2 diabetes who cannot manage his diet but believes in metformin?” — it highlights his HbA1c reduction from 8.2% to 7.2% over three months.\n</step1>\n<step2>\nSince he has a high BMI and concerns about medications that may cause weight gain, we need to consider alternatives that are effective for blood sugar control — *ìwògbà ẹ̀jẹ̀*.\n</step2>\n<step3>\nOne option could be GLP-1 receptor agonists, which help lower blood sugar and can promote weight loss — *àwọn olùdáàbò bo GLP-1*.\n</step3>\n<step4>\nAnother possibility is SGLT2 inhibitors, which also assist in reducing blood sugar levels and have a favorable effect on weight — *àwọn olùdáàbò SGLT2*.\n</step5>\n<step5>\nBoth classes of medications are beneficial for patients with type 2 diabetes who struggle with weight management, making them suitable choices for this patient.\n</step6>\n<step6>\nUltimately, the decision should be made in consultation with a healthcare provider to tailor the treatment to his specific needs.\n</step6></thinking>", "answer": "<answer>Oògùn ti yóò yẹ̀ ni GLP-1 receptor agonists tàbí SGLT2 inhibitors láti ràn án lọ́wọ́ láti ṣàkóso ìwògbà ẹ̀jẹ̀ rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Kí ló dé tí Tọ́kì nì wà nínú EU?\nA. Tọ́kì kì í ṣe ara EU.\nB. Tọ́kì wà nínú EU nítorí pé ó jẹ́ ọmọ ẹgbẹ́ Àjọ Àwọn Orílẹ̀-Èdè Yúróòpù.\nC. Tọ́kì wà nínú EU.\nD. Tọ́kì jẹ́ apá kan EU nítorí pé ó wà ní Yúróòpù.\nE. Tọ́kì wà nínú EU nítorí pé ó darapọ̀ mọ́ EU.\nF. Tọ́kì wà nínú EU nítorí ọrọ̀ ọrọ̀ ajé.", "reasoning": "<thinking><step1>\nThe question asks: “Kí ló dé tí Tọ́kì nì wà nínú EU?” — which translates to “What is the reason Turkey is in the EU?” \n</step1>\n<step2>\nTo clarify, Turkey is not a member of the EU — *Tọ́kì kì í ṣe ara EU* — so option A is correct in stating that Turkey is not part of the EU.\n</step2>\n<step3>\nWhile Turkey has been a candidate for EU membership, it does not currently hold membership status — *Tọ́kì kì í ṣe ọmọ ẹgbẹ́ Àjọ Àwọn Orílẹ̀-Èdè Yúróòpù*.\n</step3>\n<step4>\nOptions like B, C, D, E, and F suggest that Turkey is in the EU for various reasons, which is misleading since it is not a member.\n</step4>\n<step5>\nThe correct understanding is that Turkey has a unique relationship with the EU, but it does not equate to membership — *Tọ́kì kì í ṣe apá kan EU*.\n</step6>\n<step6>\nThus, the most accurate answer is that Turkey is not part of the EU.\n</step6></thinking>", "answer": "<answer>Tọ́kì kì í ṣe ara EU.</answer>", "language": "Yoruba"}
{"question": "Ninu ipo aisan ti a mọ̀ sí Hirschsprung, irú iru ara sẹẹli afọwọṣe wo ni kò sí, tí ó sì ń fa kí àpòòpò yípo?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu ipo aisan ti a mọ̀ sí [Hirschsprung = Hirschsprung disease], irú iru ara sẹẹli [cell type] wo ni kò sí, tí ó sì ń fa kí àpòòpò yípo?” — meaning it wants to know which type of cells are absent in Hirschsprung disease and how this leads to bowel obstruction.\n</step1>\n<step2>\nIn Hirschsprung disease, there is a lack of *neurones ganglionnaires* in the colon — these are essential for bowel motility.\n</step2>\n<step3>\nWithout these ganglion cells, the affected segment of the intestine cannot relax, leading to *obstruction intestinale*.\n</step3>\n<step4>\nThis condition results in a failure to pass stool, causing *constipation sévère* and abdominal distension.\n</step4>\n<step5>\nThe absence of these cells is due to a failure in neural crest cell migration during development — *migration des cellules de la crête neurale*.\n</step5>\n<step6>\nThus, the lack of ganglion cells leads to a functional obstruction in the bowel, which is characteristic of Hirschsprung disease.\n</step6></thinking>", "answer": "<answer>Ninu ipo aisan ti a mọ̀ sí Hirschsprung, ara sẹẹli afọwọṣe ti kò sí ni neurones ganglionnaires, tí ó ń fa kí àpòòpò yípo.</answer>", "language": "Yoruba"}
{"question": "Awọn èròjà fọsfẹti agbara giga wo ni ó ń ṣe ATP nígbà tí a bá fọ wọn (hydrolysis) láàrin èyí tó wà nìṣó yìí: Fructose-6-phosphate, Creatine phosphate, Carbamoyl phosphate, Glucose-1-phosphate, àti Glucose-6-phosphate?", "reasoning": "<thinking><step1>\nThe question asks: “Which high-energy phosphate compounds produce ATP during hydrolysis among the following: Fructose-6-phosphate, Creatine phosphate, Carbamoyl phosphate, Glucose-1-phosphate, and Glucose-6-phosphate?” \n</step1>\n<step2>\nTo answer this, we need to understand that ATP (adenosine triphosphate) is generated from high-energy phosphates through a process called hydrolysis — *fọ́ṣfọ́tì*.\n</step2>\n<step3>\nAmong the listed compounds, *Creatine phosphate* is well-known for its role in quickly regenerating ATP in muscle cells during intense activity — *nígbà tí a bá n ṣiṣẹ́ pẹ̀lú agbára*.\n</step3>\n<step4>\nFructose-6-phosphate and Glucose-6-phosphate are intermediates in glycolysis but do not directly produce ATP through hydrolysis — *kò ní ṣe ATP taara*.\n</step4>\n<step5>\nCarbamoyl phosphate is involved in the urea cycle and does not contribute to ATP production directly either — *kò ní ṣe àtúnṣe ATP*.\n</step5>\n<step6>\nThus, the primary compound that produces ATP during hydrolysis from the list is *Creatine phosphate*.\n</step6></thinking>", "answer": "<answer>Creatine phosphate ni èròjà fọsfẹti agbara giga tó ń ṣe ATP nígbà tí a bá fọ́.</answer>", "language": "Yoruba"}
{"question": "Ninu eré tẹlifisiọnu ‘Friends’, ẹniti ni a mọ̀ sí olóṣèwádìí ọ̀já?", "reasoning": "<thinking><step1>\nThe question asks: “In the TV show ‘Friends’, who is known as the [olóṣèwádìí ọ̀já = the one who is a paleontologist]?” — meaning it wants to identify the character with this profession.\n</step1>\n<step2>\nIn ‘Friends’, the character who is a paleontologist is Ross Geller — *Ross Geller ni olóṣèwádìí ọ̀já*.\n</step2>\n<step3>\nHe is portrayed as a passionate character with a deep interest in dinosaurs — *o ni ifẹ́ tó jinlẹ̀ sí àwọn dínosọ́ọ̀s*.\n</step3>\n<step4>\nRoss often shares his knowledge about paleontology, which sometimes leads to humorous situations — *o ma n pin ìmọ̀ rẹ̀ nípa olóṣèwádìí ọ̀já, tó sì ma n fa ẹ̀rín*.\n</step4>\n<step5>\nHis profession is a significant part of his character development throughout the series — *iṣẹ́ rẹ̀ jẹ́ apá pataki ti ìtàn rẹ̀*.\n</step5>\n<step6>\nThus, the character known as the paleontologist in ‘Friends’ is Ross Geller.\n</step6></thinking>", "answer": "<answer>Olóṣèwádìí ọ̀já ni Ross Geller nínú eré tẹlifisiọnu ‘Friends’.</answer>", "language": "Yoruba"}
{"question": "Ọmọbirin ọdun mẹ́ẹ́ẹ́dógún kan wà pẹlu àìlera oúnjẹ, ikọ́, àti líle ọrùn. Ìwádìí CSF fi hàn ní ìwọ̀n glucose ti 40 mg%, ìwọ̀n protein ti 150 mg%, chloride ní 52 meq/l, àti ọ̀pọ̀lọpọ̀ lymphocytes. Da lórí àwọn àmì àrùn wọnyi àti ìwádìí CSF, kini àrùn tí ó ṣeé ṣe jùlọ?", "reasoning": "<thinking><step1>\nThe question translates to: \"A 17-year-old girl has food allergies, cough, and difficulty breathing. CSF analysis shows a glucose level of 40 mg%, protein level of 150 mg%, chloride at 52 meq/l, and many lymphocytes. Based on these symptoms and CSF findings, what disease is most likely?\" \n</step1>\n<step2>\nThe symptoms presented include *àìlera oúnjẹ* (food allergies), *ikọ́* (cough), and *líle ọrùn* (difficulty breathing), which suggest a respiratory issue. \n</step2>\n<step3>\nThe CSF findings show elevated protein levels and lymphocytes, which indicate an inflammatory or infectious process — *àkúnya àrùn*.\n</step3>\n<step4>\nA glucose level of 40 mg% is lower than normal, which can suggest conditions like viral infections or certain types of meningitis — *meningite virale*.\n</step5>\n<step5>\nGiven the combination of respiratory symptoms and CSF results, a viral infection such as *meningitis* or *encéphalite* is highly probable, especially with the lymphocytic predominance.\n</step6>\n<step6>\nThus, the most likely disease based on the symptoms and CSF analysis is *meningite virale*.\n</step6></thinking>", "answer": "<answer>Meningite virale ni àrùn tí ó ṣeé ṣe jùlọ.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìpínrọ̀ tó tẹ̀lé yìí kọ̀ọ̀kan ṣàpèjúwe ṣẹ̀tì ọ̀gọ́rọ̀̀n-ún nǹkan méje tí a gbé kalẹ̀ ní ọ̀nà tí kò yí pa dà. Àwọn ọǹrọ̀ náà bá ara wọn mu ní ìlà gẹ̀gẹ́ bí òye. Nínú ìdíje gọ́ọ̀fù kan, awọn òǹṣàájú gọ́ọ̀fù méje wà: Eli, Ada, Amy, Ana, Eve, Mel, àti Dan. Ada pari síwájú Mel. Dan pari síwájú Ada. Amy pari kẹhin. Ana pari kẹta sí i kẹhin. Dan pari ní ìsàlẹ̀ Eli. Eve pari kẹta.\nÀwọn àṣàyàn:\n(A) Eli pari kẹta sí i kẹhin\n(B) Ada pari kẹta sí i kẹhin\n(C) Amy pari kẹta sí i kẹhin\n(D) Ana pari kẹta sí i kẹhin\n(E) Eve pari kẹta sí i kẹhin\n(F) Mel pari kẹta sí i kẹhin\n(G) Dan pari kẹta sí i kẹhin", "reasoning": "<thinking><step1>\nThe question is asking to determine the finishing positions of seven golfers: Eli, Ada, Amy, Ana, Eve, Mel, and Dan, based on the given clues. \n</step1>\n<step2>\nFrom the clues, we know that Ada finished ahead of Mel — *Ada pari síwájú Mel*. This means Mel cannot be in the first position.\n</step2>\n<step3>\nDan finished ahead of Ada — *Dan pari síwájú Ada*, which indicates Dan is also not in the last position.\n</step3>\n<step4>\nAmy finished last — *Amy pari kẹhin*, so she is in the seventh position.\n</step4>\n<step5>\nAna finished third from the last — *Ana pari kẹta sí i kẹhin*, meaning she is in the fifth position.\n</step5>\n<step6>\nDan finished below Eli — *Dan pari ní ìsàlẹ̀ Eli*, which means Eli must be in a higher position than Dan.\n</step6>\n<step7>\nEve finished third — *Eve pari kẹta*, which places her in the fourth position.\n</step7>\n<step8>\nNow we can summarize the positions: \n1. Dan\n2. Ada\n3. Eli\n4. Eve\n5. Ana\n6. Mel\n7. Amy\nThis means Eli cannot be last, so the only option left is that Amy is indeed the one who finished last.\n</step8></thinking>", "answer": "<answer>Amy pari kẹta sí i kẹhin.</answer>", "language": "Yoruba"}
{"question": "Kini ayẹ̀wò fun ọmọ ọjọ́ ogún oṣù kan tí ó ní àìlera ẹ̀ṣọ̀ gbogbo ara, ìrísí ‘ọmọdé tí kò le dúró’ , ahọ́n ńlá (macroglossia), ìṣòro jijẹ, ìgbọ̀ràn ẹ̀dọ̀fọ́ (hepatomegaly), àti àìlera ọkàn tó lágbára (hypertrophic cardiomyopathy)?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ayẹ̀wò fun [omọ = child] ọjọ́ ogún [oṣù = month] kan tí ó ní àìlera [ẹ̀ṣọ̀ = systemic] gbogbo ara?” — meaning it seeks to understand the examination for a child with systemic issues.\n</step1>\n<step2>\nThe symptoms listed include *irisi ‘omọdé tí kò le dúró’* which suggests a child who cannot stand, indicating severe weakness or muscle issues.\n</step2>\n<step3>\n*Ahọ́n ńlá* (macroglossia) points to an enlarged tongue, which can be associated with various genetic conditions, particularly those affecting metabolism.\n</step4>\n<step4>\n*Ìṣòro jijẹ* (feeding difficulties) may indicate that the child has trouble swallowing or feeding, which can be linked to neurological or muscular disorders.\n</step5>\n<step5>\n*Ìgbọ̀ràn ẹ̀dọ̀fọ́* (hepatomegaly) and *àìlera ọkàn tó lágbára* (hypertrophic cardiomyopathy) suggest serious systemic involvement, often seen in metabolic or genetic syndromes.\n</step6>\n<step6>\nTherefore, the examination would likely include genetic testing, metabolic panels, and imaging studies to assess the heart and liver.\n</step7>\n<step7>\nIn summary, the child may be evaluated for conditions like *syndrome de Prader-Willi* or other metabolic disorders that present with these symptoms.\n</step8></thinking>", "answer": "<answer>Ayẹ̀wò fun ọmọ yìí ni yóò ní àyẹ̀wò àtọkànwá, ìtẹ́wọ́gbà àyẹ̀wò ẹ̀jẹ̀, àti àyẹ̀wò fọ́tò àyà àti ẹ̀dọ́.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mẹ́tadinlọ́gbọ̀n kan wá pẹ̀lú àpòòtọ́ tí ń pọ̀ sí i lórí ìyẹ̀fun rẹ̀ fún ọdún méjì sẹ́yìn. Àpòòtọ́ náà jẹ́ apẹrẹ̀ yíyí káàkiri, pẹ̀lú ìṣàn ní àárín rẹ̀. Àìsàn tí ó pọ̀ jùlọ ni:\nA. Tinea corporis\nB. Lupus vulgaris\nC. Àìsàn àkàn fún ààlà\nD. Kala azar", "reasoning": "<thinking><step1>\nThe question presents a scenario about a 35-year-old man with a skin condition that has been worsening for two years. It asks which disease is most likely, providing options that include terms like [Tinea corporis = ringworm], [Lupus vulgaris = lupus vulgaris], [Àìsàn àkàn fún ààlà = leprosy], and [Kala azar = kala azar].\n</step1>\n<step2>\nGiven the age and the description of the skin condition as *àpòòtọ́ tí ń pọ̀ sí i lórí ìyẹ̀fun rẹ̀*, we need to consider common skin diseases that could fit this profile.\n</step2>\n<step3>\nTinea corporis is a fungal infection that typically presents as circular, itchy patches — *àpòòtọ́ yíyí* — which could match the description.\n</step3>\n<step4>\nLupus vulgaris, on the other hand, is a form of cutaneous tuberculosis that can cause chronic skin lesions but is less common than tinea.\n</step4>\n<step5>\nLeprosy, or *àìsàn àkàn fún ààlà*, is a chronic infectious disease that can cause skin lesions but is rare in many regions today.\n</step5>\n<step6>\nKala azar, a visceral leishmaniasis, primarily affects internal organs and is not typically associated with skin lesions like the ones described.\n</step6>\n<step7>\nConsidering the information, the most likely diagnosis for a worsening skin condition over two years in this age group is tinea corporis, as it is common and presents with the described symptoms.\n</step7></thinking>", "answer": "<answer>Tinea corporis ni àìsàn tí ó pọ̀ jùlọ fún àpòòtọ́ yíyí tí ń pọ̀ sí i lórí ìyẹ̀fun.</answer>", "language": "Yoruba"}
{"question": "Nigba ti a ba n gbiyanju lati pa fifọ oroantral fistula ti o ti dagba lẹhin ti a ti yọ molar akọkọ oke kuro, iru flap wo ni ko yẹ fun lilo?", "reasoning": "<thinking><step1>\nThe question asks: “Nigba ti a ba n gbiyanju lati pa [fifọ oroantral fistula = oroantral fistula] ti o ti dagba lẹhin ti a ti yọ [molar akọkọ oke = upper first molar] kuro, iru [flap = flap] wo ni ko yẹ fun lilo?” — meaning it seeks to understand which type of flap is inappropriate for closing an oroantral fistula after the extraction of an upper first molar.\n</step1>\n<step2>\nWhen closing an oroantral fistula, the choice of flap is crucial. A common flap used is the buccal flap — *flap buccal* — which provides good vascularity and coverage.\n</step2>\n<step3>\nHowever, using a palatal flap — *flap palatin* — might not be ideal in this case, especially if the fistula is large or if there is insufficient tissue for proper closure.\n</step3>\n<step4>\nThe palatal flap can lead to complications such as necrosis due to its limited blood supply in certain areas — *manque de vascularisation*.\n</step4>\n<step5>\nIn addition, the tension on the flap when sutured can cause dehiscence, making it less suitable for larger fistulas — *fistules plus grandes*.\n</step5>\n<step6>\nThus, for an oroantral fistula that has developed after molar extraction, a palatal flap is generally not recommended.\n</step6></thinking>", "answer": "<answer>Flap palatin ko yẹ fun lilo lati pa fifọ oroantral fistula ti o ti dagba.</answer>", "language": "Yoruba"}
{"question": "Èmi oògùn wo ni wọ́n sábà máa ń gbé nípa ìtọ́jú ìdènà fún àìsàn oríṣìíríṣìí tí ó máa ń ṣẹlẹ̀ lọ́pọ̀lọpọ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Èmi oògùn wo ni wọ́n sábà máa ń gbé nípa ìtọ́jú ìdènà fún àìsàn oríṣìíríṣìí tí ó máa ń ṣẹlẹ̀ lọ́pọ̀lọpọ̀?” — meaning it wants to know what medications are commonly used for preventive treatment of various diseases that occur frequently.\n</step1>\n<step2>\nPreventive treatment, or *ìtọ́jú ìdènà*, is crucial for managing diseases like hypertension and diabetes — *àìsàn àtọ́kànwá* and *àìsàn suga*.\n</step2>\n<step3>\nFor hypertension, doctors often prescribe medications such as ACE inhibitors — *oògùn ACE* — to help lower blood pressure.\n</step3>\n<step4>\nIn the case of diabetes, metformin is a common choice — *metformin* helps control blood sugar levels effectively.\n</step4>\n<step5>\nVaccinations are also a form of preventive treatment — for example, the flu vaccine, or *àbá àìsàn flu*, helps prevent influenza.\n</step5>\n<step6>\nAdditionally, statins are used to prevent cardiovascular diseases — *àìsàn ọkàn* — by lowering cholesterol levels.\n</step6>\n<step7>\nOverall, these medications play a vital role in preventing complications from chronic diseases — *ìdènà àwọn ìṣòro*.\n</step7></thinking>", "answer": "<answer>Àwọn oògùn tí wọ́n sábà máa ń gbé fún ìtọ́jú ìdènà ni oògùn ACE, metformin, àti àbá àìsàn flu.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin ọlọ́dún ọgọ́ta (60) kan wá sí ilé ìwòsàn alábàápàdé (OPD) pẹ̀lú ìtàn àmúlò òpìọ̀mù líle fún ogún (20) ọdún sẹ́yìn. Ó ti jáwọ́ nínú lílo òpìọ̀mù láti ọjọ́ méjì sẹ́yìn. Àwọn àmì ìfàsẹ́yìn yóò ní nínú:\nA. Ìtọ̀gbẹ / Oríṣùn\nB. Ojú kíkí kékeré\nC. Imú sísun (Rhinorhea)\nD. Ìfúnpá tí ó lọ sílẹ̀ / Tí ó dínkù", "reasoning": "<thinking><step1>\nThe question describes a 60-year-old man who visits an outpatient department (OPD) with a history of heavy opioid use for 20 years. He has stopped using opioids two days ago and is likely experiencing withdrawal symptoms. The options provided are symptoms associated with withdrawal.\n</step1>\n<step2>\nWithdrawal from opioids can lead to various physical symptoms. In this case, *ìtọ̀gbẹ* (nausea) is a common symptom that many experience when they stop using opioids suddenly.\n</step2>\n<step3>\nAnother symptom is *ojú kíkí kékeré* (small pupils), which is often observed in opioid withdrawal. This is a physiological response to the absence of the drug.\n</step3>\n<step4>\n*Imú sísun* (rhinorrhea) or a runny nose is also a classic withdrawal symptom, as the body reacts to the lack of opioids.\n</step4>\n<step5>\nLastly, *ìfúnpá tí ó lọ sílẹ̀* (diarrhea) is another common symptom that can occur during withdrawal, as the gastrointestinal system becomes more active without the depressant effects of opioids.\n</step5>\n<step6>\nGiven these symptoms, the man is likely experiencing a combination of these withdrawal effects, which can include nausea, small pupils, rhinorrhea, and diarrhea.\n</step6></thinking>", "answer": "<answer>Àwọn àmì ìfàsẹ́yìn yóò ní: Ìtọ̀gbẹ, Ojú kíkí kékeré, Imú sísun, àti Ìfúnpá tí ó lọ sílẹ̀.</answer>", "language": "Yoruba"}
{"question": "Labẹ ipò wo ni onímọ̀-ẹ̀mí lè ṣiṣẹ́ ní ọ̀nà tó tọ́ gẹ́gẹ́ bí ẹlẹ́rìí òtítọ́ àti ẹlẹ́rìí ọ̀gbọ́n fún ilé ẹjọ́ nínú ṣíṣe ẹjọ́ ẹ̀ṣẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Labẹ ipò wo ni onímọ̀-ẹ̀mí lè ṣiṣẹ́ ní ọ̀nà tó tọ́ gẹ́gẹ́ bí ẹlẹ́rìí òtítọ́ àti ẹlẹ́rìí ọ̀gbọ́n fún ilé ẹjọ́ nínú ṣíṣe ẹjọ́ ẹ̀ṣẹ̀?” — meaning it wants to know what role a psychologist can play as a credible witness and expert witness in a court case.\n</step1>\n<step2>\nPsychologists can serve as *ẹlẹ́rìí òtítọ́* (fact witnesses) by providing factual information about a person's mental state — *ipò ọpọlọ* — during a specific time.\n</step2>\n<step3>\nThey can also act as *ẹlẹ́rìí ọ̀gbọ́n* (expert witnesses) by offering their professional opinion based on psychological assessments — *ìtẹ́wọ́gba ọpọlọ* — and research.\n</step3>\n<step4>\nIn court, they might explain concepts like *ìfarapa ọpọlọ* (mental illness) or *ìmọ̀ràn* (cognitive behavior) to help the judge or jury understand the psychological aspects of a case.\n</step4>\n<step5>\nTheir testimony can influence decisions regarding *ìdájọ́* (judgment) and sentencing, especially in cases involving mental health issues.\n</step5>\n<step6>\nThus, a psychologist's role is crucial in providing insights that are both factual and expert-based, ensuring a fair trial.\n</step6></thinking>", "answer": "<answer>Onímọ̀-ẹ̀mí lè ṣiṣẹ́ gẹ́gẹ́ bí ẹlẹ́rìí òtítọ́ àti ẹlẹ́rìí ọ̀gbọ́n nínú ilé ẹjọ́, pẹ̀lú ìmọ̀ nípa ipò ọpọlọ àti ìfarapa ọpọlọ.</answer>", "language": "Yoruba"}
{"question": "Àpọnà ọjọ́ ogún-ùn-mẹ́fà (66) ọdún kan tí ó ní àìsàn ọkàn tí ó ń gbàgbé (CHF) lọ sí ìlú mìíràn, kò sì tẹ̀lé oúnjẹ́ òun tí kò ní iyọ̀ púpọ̀. Lẹ́yìn ọjọ́ márùn-ún, ó wá pẹ̀lú ìwúwo ẹ̀mí gidigidi pẹ̀lú ìgbòògùn ẹ̀dọ̀fóró tí ó léwu.  Òògùn àkọ́kọ́ tí a yàn fún ni:\nA. Dobutamine\nB. Furosemide\nC. Metoprolol\nD. Spironolactone", "reasoning": "<thinking><step1>\nThe question describes a 66-year-old patient with congestive heart failure [àìsàn ọkàn tí ó ń gbàgbé = congestive heart failure] who has not followed a low-sodium diet and presents with severe shortness of breath [ìwúwo ẹ̀mí gidigidi = severe shortness of breath] and dangerous edema [ìgbòògùn ẹ̀dọ̀fóró = edema].\n</step1>\n<step2>\nIn cases of CHF, fluid retention is common, leading to symptoms like shortness of breath and swelling. This indicates that the patient may need diuretics to manage fluid overload.\n</step2>\n<step3>\nAmong the options provided, Furosemide is a loop diuretic that helps remove excess fluid from the body — *ó ń yọ omi tó pọ̀ jù lọ*.\n</step3>\n<step4>\nDobutamine is typically used for heart failure with low cardiac output, while Metoprolol is a beta-blocker that can be used for heart rate control but is not the first choice in acute fluid overload.\n</step4>\n<step5>\nSpironolactone is a potassium-sparing diuretic, but in acute settings, Furosemide is preferred for rapid diuresis — *yiyọ omi ni kiakia*.\n</step5>\n<step6>\nThus, the most appropriate initial medication for this patient is Furosemide to address the fluid retention and alleviate symptoms.\n</step6></thinking>", "answer": "<answer>Furosemide ni òògùn àkọ́kọ́ tí a yàn fún un.</answer>", "language": "Yoruba"}
{"question": "Ní ọrọ àìsàn náà tí ó ní ẹ̀jẹ̀ tí ó ti gbàgbé sí apá ìbúgbàú, tí ó sì ń lọ sí isé abẹ ní ìka, irú oògùn ìtura wo ni ó dára jùlọ láti lo?", "reasoning": "<thinking><step1>\nThe question asks: “Ní ọrọ àìsàn náà tí ó ní ẹ̀jẹ̀ tí ó ti gbàgbé sí apá ìbúgbàú, tí ó sì ń lọ sí isé abẹ ní ìka” — meaning it refers to a condition involving blood that has pooled in the lower extremities and is related to surgical intervention.\n</step1>\n<step2>\nThis condition can lead to complications like *ìfarapa* (injury) or *ìkó ẹ̀jẹ̀* (blood clot), which can be serious.\n</step2>\n<step3>\nIn such cases, pain relief is crucial, and one might consider using *oògùn ìtura* (pain relief medication) such as NSAIDs — *Non-Steroidal Anti-Inflammatory Drugs*.\n</step3>\n<step4>\nThese medications help reduce inflammation and alleviate pain — *dáàbò bo ìfarapa* and improve the patient's comfort.\n</step4>\n<step5>\nHowever, it’s important to consult a healthcare professional before starting any medication, especially if there are underlying conditions — *àìlera* that could complicate treatment.\n</step5>\n<step6>\nIn summary, for pain management in this context, NSAIDs are often the best choice, but medical advice is essential.\n</step6></thinking>", "answer": "<answer>Oògùn ìtura to dára jùlọ ni NSAIDs, ṣugbọn o ṣe pataki lati kan si dokita ṣaaju ki o to lo.</answer>", "language": "Yoruba"}
{"question": "Ti a ba ronu nipa ọkọ ayọkẹlẹ kan ti o bẹrẹ lati ipo isinmi o si n yara ni deedee ni iwọn 5 m/s^2 ni laini titọ, iye akoko meloo ni yoo gba lati bo ijinna 200 mita?", "reasoning": "<thinking><step1>\nThe question asks: “Ti a ba ronu nipa [ ọkọ ayọkẹlẹ = car] kan ti o bẹrẹ lati ipo [ isinmi = rest] o si n yara ni [deedee = acceleration] ni iwọn 5 m/s² ni laini titọ, iye akoko meloo ni yoo gba lati bo ijinna 200 mita?” — meaning it wants to know how long it takes for a car accelerating from rest at 5 m/s² to cover a distance of 200 meters.\n</step1>\n<step2>\nTo find the time, we can use the equation of motion: *s = ut + (1/2)at²*, where *s* is the distance, *u* is the initial velocity, *a* is the acceleration, and *t* is the time.\n</step2>\n<step3>\nHere, the car starts from rest, so *u = 0*. The distance *s* is 200 meters and the acceleration *a* is 5 m/s².\n</step3>\n<step4>\nSubstituting these values into the equation gives: *200 = 0*t + (1/2)*5*t²*. This simplifies to *200 = (2.5)t²*.\n</step4>\n<step5>\nNext, we solve for *t²*: *t² = 200 / 2.5 = 80*. Taking the square root gives us *t = √80*.\n</step6>\n<step7>\nCalculating this, we find that *t ≈ 8.94 seconds*. Therefore, the time taken to cover the distance is approximately 8.94 seconds.\n</step7></thinking>", "answer": "<answer>Iye akoko ti ọkọ ayọkẹlẹ yoo gba lati bo ijinna 200 mita ni 8.94 iṣẹju-aaya.</answer>", "language": "Yoruba"}
{"question": "Ṣàlàyé ipa ti àwọn ohun tí ń ṣe ìfihàn ní ìmọ̀ràn àwọn aláìsàn nípa àkùkọ́ àti bóyá a lè lo wọn láti rí àkùkọ́ tí ó wà lábẹ́ irun.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣàlàyé ipa ti àwọn ohun tí ń ṣe ìfihàn ní ìmọ̀ràn àwọn aláìsàn nípa àkùkọ́” — meaning it wants to explain the role of indicators in patient awareness regarding lice.\n</step1>\n<step2>\nIndicators, or *àwọn ohun tí ń ṣe ìfihàn*, are crucial for patients to recognize the presence of lice — *àkùkọ́* — on their scalp or hair.\n</step2>\n<step3>\nCommon signs include itching, which is caused by the lice bites — *ìfarapa àkùkọ́* — leading to discomfort and irritation.\n</step3>\n<step4>\nPatients may also notice visible lice or their eggs, known as nits, attached to hair strands — *àkùkọ́ àti nits*.\n</step4>\n<step5>\nAwareness of these indicators helps in early detection and treatment, preventing further infestation — *ìmúlò àkùkọ́*.\n</step6>\n<step6>\nIn summary, understanding these signs is essential for effective management of lice infestations — *ìmúlò àkùkọ́*.\n</step7></thinking>", "answer": "<answer>Ìmọ̀ràn àwọn aláìsàn nípa àkùkọ́ jẹ́ pé àwọn ohun tí ń ṣe ìfihàn, gẹ́gẹ́ bí ìfarapa àti àkùkọ́, ṣe pàtàkì fún ìmúlò àkùkọ́.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdún ogún kan wá pẹlu àìdèédé, ìṣọǹka, àti itan lilo oògùn ati ibalopọ ewu giga. Awọn idanwo ile-iwosan rẹ fihan awọn ipele bilirubin ti o ga pupọ ati iṣẹ enzyme ẹdọ, pẹlu iṣẹ prothrombin akoko kekere. Ni akiyesi awọn awari ati awọn ami aisan wọnyi, kini ayẹwo ti o ṣeeṣe julọ?", "reasoning": "<thinking><step1>\nThe question describes a 21-year-old man with symptoms like *àìdèédé* [jaundice], *ìṣọǹka* [fatigue], and a history of high-risk drug use and sexual activity. It asks for the most likely diagnosis based on these findings.\n</step1>\n<step2>\nElevated bilirubin levels indicate liver dysfunction — *iṣẹ ẹdọ ti ko dara*. This can be due to various conditions, but the context is crucial.\n</step2>\n<step3>\nThe mention of high-risk behaviors suggests potential exposure to hepatitis viruses, particularly hepatitis B or C — *hepatitis B tabi C*.\n</step4>\n<step4>\nAdditionally, the low prothrombin time indicates impaired liver function, which aligns with chronic liver disease — *arun ẹdọ àtọgbẹ*.\n</step5>\n<step5>\nConsidering all these factors, the most probable diagnosis is acute hepatitis, likely viral in nature due to the patient's history — *hepatitis akútù*.\n</step6></thinking>", "answer": "<answer>Ayẹwo ti o ṣeeṣe julọ ni hepatitis akútù.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 29 kan wá sọ́dọ̀ oníṣẹ́gun nítorí ìṣòro ìríra ìwòye tí ń pọ̀ sí i ní oju òsì rẹ̀ àti ìríra ìwòye tí ń gbàgbà ní oju ọ̀tún rẹ̀ fún oṣù méjì sẹ́yìn. Ó tún sọ pé ó ti ní ìgbà ìgbà orírí, ó sì ti kíyèsí ìdinku nínú ìmọ̀ràn rẹ̀ nígbà àìpẹ́ yìí. Oògùn kan ṣoṣo tí àpẹẹrẹ náà gbà ni fexofenadine fún àrùn àìlera akúkọ́. Òkìkí rẹ̀ jẹ́ 158 cm (5 ft 2 in) gígùn, ó sì wọn 61 kg (135 lbs); BMI jẹ́ 24.7 kg/m2. Àwọn àmì ààyò jẹ́ ìwọ̀n déédéé. Ìwòye ríran jẹ́ 20/40 ní oju ọ̀tún, àti ìríra fìfẹ̀ẹ̀ ìkàn sí i ní oju òsì. Nínú ìdánwò fìlàṣì tí ń yípadà, àwọn ojú méjèèjì rẹ̀ gbòòrò bí ìmọ́lẹ̀ ṣe ń yí padà láti ojú ọ̀tún lọ sí ojú òsì. Ìwádìí fundus fi hàn papilledema ní ọ̀pá ìwòye ọ̀tún àti ọ̀pá ìwòye òsì tí ó fẹ́rẹ̀ẹ́ jẹ́ funfun. Èyí tí ó kù nínú àyẹ̀wò kò fi hàn àìlera kankan. Èwo nínú àwọn wọ̀nyí ni ìwádìí tí ó ṣeé ṣe jùlọ?\nA. Àrùn ìwòye ipa-ọ̀dọ̀\nB. Pseudotumor cerebri\nC. Àrùn ìwòye ischemic ṣáájú\nD. Meningioma\nE. Àrùn ìgbàgbọ́ pupọ̀", "reasoning": "<thinking><step1>\nThe question is asking about a 29-year-old woman who has been experiencing visual disturbances — *ìṣòro ìríra ìwòye* — specifically in her left eye and right eye for the past two months. \n</step1>\n<step2>\nShe also reports a history of migraines — *ìgbà ìgbà orírí* — and has noticed a decrease in her vision recently. \n</step2>\n<step3>\nHer only medication is fexofenadine for allergies, and her height and weight indicate a normal BMI of 24.7 kg/m². \n</step3>\n<step4>\nThe visual acuity is 20/40 in the right eye, and there is significant visual disturbance in the left eye. \n</step4>\n<step5>\nThe examination shows papilledema in both eyes, which suggests increased intracranial pressure — *ìkànsí inú ọpọlọ* — but no other abnormalities were found. \n</step5>\n<step6>\nGiven these symptoms and findings, the most likely diagnosis could be related to increased intracranial pressure, which points towards pseudotumor cerebri — *pseudotumor cerebri*.\n</step6>\n<step7>\nOther options like ischemic optic neuropathy or meningioma do not fit as well with the presented symptoms and examination results. \n</step7>\n<step8>\nThus, the most plausible diagnosis based on the evidence is pseudotumor cerebri, which is characterized by similar visual symptoms and papilledema.\n</step8></thinking>", "answer": "<answer>Pseudotumor cerebri.</answer>", "language": "Yoruba"}
{"question": "Nígbà wo ni àwọn tẹ́ńpìlì Jaina àkọ́kọ́ ṣe hàn?\nA. Ọ̀rúndún kejìdínlógún Sànmánì Kristẹni\nB. Ọ̀rúndún kọkànlá ṣáájú Sànmánì Kristẹni\nC. Ọ̀rúndún kìíní Sànmánì Kristẹni\nD. Ọ̀rúndún karùn-ún ṣáájú Sànmánì Kristẹni\nE. Ọ̀rúndún kejì Sànmánì Kristẹni\nF. Ọ̀rúndún kẹwàá ṣáájú Sànmánì Kristẹni\nG. Ọ̀rúndún kẹfà Sànmánì Kristẹni\nH. Ọ̀rúndún kẹta ṣáájú Sànmánì Kristẹni\nI. Ọ̀rúndún karùn-ún Sànmánì Kristẹni\nJ. Ọ̀rúndún kejìdínlógún Sànmánì Kristẹni", "reasoning": "<thinking><step1>\nThe question asks: “Nígbà wo ni àwọn tẹ́ńpìlì Jaina àkọ́kọ́ ṣe hàn?” — meaning it wants to know when the first Jaina temples were established.\n</step1>\n<step2>\nTo answer this, we need to consider the historical context of Jainism — *ìtàn Jaina* — which dates back to ancient India.\n</step2>\n<step3>\nThe first temples were built during a period when Jainism was gaining prominence, particularly in the *ọ̀rúndún kejìdínlógún Sànmánì Kristẹni* (the 2nd century CE).\n</step3>\n<step4>\nHowever, there are also references to earlier structures, suggesting some temples might have appeared in the *ọ̀rúndún kọkànlá ṣáájú Sànmánì Kristẹni* (the 11th century BCE).\n</step4>\n<step5>\nAmong the options provided, the most widely accepted date for the establishment of the first Jaina temples aligns with the 2nd century CE.\n</step5>\n<step6>\nThus, the correct answer is *Ọ̀rúndún kejìdínlógún Sànmánì Kristẹni*.\n</step6></thinking>", "answer": "<answer>Ọ̀rúndún kejìdínlógún Sànmánì Kristẹni.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdún kan tí a bí ní ọjọ́ kan ṣẹ̀ṣẹ̀, tí ó jẹ́ ọkùnrin, ni a ṣàyẹ̀wò ní yàrá ìbíbí. A bí ọmọ náà ní ọsẹ̀ 37, ìyá rẹ̀ sì jẹ́ ọdún 39, G3. Ìyá rẹ̀ bẹ̀rẹ̀ sí í bí i nílé pẹ̀lú agbẹ́wọ́gbà, ṣùgbọ́n a gbé e lọ sí ilé ìwòsàn nítorí pé ìbíbí kò ń lọ dáadáa. Níkẹyìn, a bí ọmọ náà nípasẹ̀ ìṣiṣẹ́ Sésariánì. Ìyá rẹ̀ kọ gbogbo ìwádìí ṣíṣàgbàdègùn nígbà oyun yìí. Nígbà tí a bí i, a rí i pé ọmọ náà ní àìsàn tó pọ́n 3 cm ní ògiri ikùn, sí ọwọ́ ọ̀tún ẹ̀gbọ̀n, tí o sì mú kí àwọn ọ̀pá ìmú náà jáde. Àwọn nọ́mbà Apgar rẹ̀ jẹ́ 7 àti 8 ní ìṣẹ́jú 1 àti 5, lójú méjì. Ìwúwo rẹ̀ jẹ́ 3.0 kg (6.6 lb), àti gíga àti iwọn orí rẹ̀ wà láàrin 30th àti 40th percentiles, lójú méjì. A bo àìsàn ikùn náà lẹsẹkẹsẹ̀ pẹ̀lú àwọn aṣọ amọ̀tọ́kun, a sì fi ògùṣọ̀ oró-ọgbọ̀n àti àwọn ìlà ọ̀pá intravenous méjì sí i.\n\nIpò yìí bá àwọn àìsàn ọkàn wo ni?\nA. Kò sí àìsàn ọkàn\nB. Bicuspid aortic valve\nC. Endocardial cushion defect\nD. Tetralogy of Fallot\nE. Ventricular septal defect", "reasoning": "<thinking><step1>\nThe question asks: \"Ipò yìí bá àwọn àìsàn ọkàn wo ni?\" — meaning it wants to know which heart condition is associated with the described case of a newborn boy.\n</step1>\n<step2>\nThe newborn was delivered via cesarean section and has a 3 cm defect in the wall of the heart — *àìsàn tó pọ́n 3 cm ní ògiri ikùn*.\n</step2>\n<step3>\nThis type of defect suggests a possible congenital heart condition, as the Apgar scores of 7 and 8 indicate he was stable at birth — *àwọn nọ́mbà Apgar rẹ̀ jẹ́ 7 àti 8*.\n</step4>\n<step4>\nAmong the options, a ventricular septal defect (VSD) is characterized by a hole in the heart's septum, which aligns with the 3 cm defect mentioned — *àìsàn ikùn tó pọ́n*.\n</step5>\n<step5>\nOther options like bicuspid aortic valve or tetralogy of Fallot do not typically present with such a defect size at birth, making VSD the most likely condition here.\n</step6>\n<step6>\nThus, the most appropriate answer regarding the heart condition associated with this newborn is *àìsàn ikùn tó pọ́n*.\n</step6></thinking>", "answer": "<answer>Àìsàn ikùn tó pọ́n (Ventricular septal defect).</answer>", "language": "Yoruba"}
{"question": "Kini ọ̀rọ̀ tí a ó lò láti ṣàpèjúwe ipò tí bọ́lùú kan fi dì mọ́ inú ìgbà, tí wọ́n sì tún ta ohun ìjà náà, àwọn bọ́lùú méjì náà sì jáde láti inú ìgbà náà?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ọ̀rọ̀ tí a ó lò láti ṣàpèjúwe [ipò = position] tí [bọ́lùú = ball] kan fi dì mọ́ inú [ìgbà = basket], tí wọ́n sì tún ta [ohun ìjà = object of play] náà?” — meaning it wants to know the term used to describe the situation where a ball is stuck in a basket and two balls come out of it.\n</step1>\n<step2>\nIn this context, the term we are looking for is likely related to a game or sport — *bọọlu* or *basketball* could be relevant here.\n</step2>\n<step3>\nWhen a ball is stuck in a basket, it can be described as being “trapped” or “stuck” — *dí mọ́* in Yoruba.\n</step3>\n<step4>\nIf two balls come out of the basket, it suggests a situation where there is a release or a play action — *ìgbà tí a ti ta bọ́lùú*.\n</step4>\n<step5>\nIn sports terminology, this could be referred to as a “rebound” or “release” — *ìpadà* or *ìtusilẹ* in Yoruba.\n</step5>\n<step6>\nThus, the phrase that describes this situation could be “a ball stuck in the basket with a subsequent release of two balls” — *bọ́lùú kan tí a ti dì mọ́ inú ìgbà, tí bọ́lùú méjì náà jáde*.\n</step6></thinking>", "answer": "<answer>Ìpò tí bọ́lùú kan fi dì mọ́ inú ìgbà, tí bọ́lùú méjì náà jáde, ni a lè pè ní “ìpadà” tàbí “ìtusilẹ”.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun mẹta kan wá sí yàrá pajawiri pẹlu itan itọ́gbẹ̀ ati àìsàn ikun fun ọjọ́ mẹta.  Nígbà ayẹwo, ọmọ náà dàbí ẹni tí ó rẹ̀wẹ̀sì, ojú rẹ̀ sunkún, ó ní hypothermia, ati pe idanwo fífún ọ̀nà ara rẹ̀ fihan pe ọ̀nà ara rẹ̀ gbà gba akoko lati pada si deede.  Lórí àwọn àmì wọnyi, kini ayẹwo nipa ipo mimu omi ọmọ náà?", "reasoning": "<thinking><step1>\nThe question asks: \"Based on the symptoms of a three-year-old child with [hypothermia = hypothermia] and signs of dehydration, what is the diagnosis regarding the child's hydration status?\" \n</step1>\n<step2>\nThe child presents with symptoms like *itan itọ́gbẹ̀* (vomiting) and *àìsàn ikun* (abdominal pain), which can lead to fluid loss — *pipadanu omi*.\n</step2>\n<step3>\nHypothermia indicates that the child is likely experiencing a significant drop in body temperature, which can be a result of dehydration — *mimu omi to peye* is crucial for maintaining body temperature.\n</step3>\n<step4>\nThe child appears lethargic and has a sunken face, suggesting severe dehydration — *dehydration to lagbara* can cause these symptoms.\n</step4>\n<step5>\nAdditionally, the delayed return of capillary refill time indicates poor perfusion, which is often associated with dehydration — *mimu omi to peye* is essential for proper circulation.\n</step5>\n<step6>\nConsidering all these signs, the diagnosis would indicate that the child is likely in a state of moderate to severe dehydration — *dehydration to lagbara*.\n</step6></thinking>", "answer": "<answer>Ayẹwo naa fihan pe ọmọ náà wa ni ipo mimu omi to lagbara.</answer>", "language": "Yoruba"}
{"question": "Níbi tí àpòpò ìṣíṣẹ̀ maxillary sinus ti de sí ni?", "reasoning": "<thinking><step1>\nThe question asks: “Níbi tí àpòpò ìṣíṣẹ̀ [maxillary sinus = sinus maxillaire] ti de sí ni?” — meaning it wants to know where the maxillary sinus is located.\n</step1>\n<step2>\nThe maxillary sinus is one of the paranasal sinuses, located in the cheek area — *ní agbègbè ẹ̀yà àyà*.\n</step2>\n<step3>\nIt is situated above the upper jaw, specifically in the maxilla bone — *níbè ni a ti rí i nínú egungun maxilla*.\n</step3>\n<step4>\nThis sinus plays a role in reducing the weight of the skull and producing mucus — *ó ń ṣe àǹfààní ní dídin iwuwo àyà*.\n</step4>\n<step5>\nIn terms of anatomy, it is located laterally to the nasal cavity — *ní ẹgbẹ́ ọ̀tún ti àyà àtọ́ka*.\n</step5>\n<step6>\nSo, the maxillary sinus is found in the facial region, specifically in the cheekbone area — *ní agbègbè ẹ̀yà àyà*.\n</step6></thinking>", "answer": "<answer>Àpòpò ìṣíṣẹ̀ maxillary sinus wà ní agbègbè ẹ̀yà àyà, lórí egungun maxilla.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọlọdun 71 kan bẹrẹ nípa ṣíṣe àìlera ìrora ọmu títẹ̀ síwájú bí ó ti ń gbá egbò lórí òwúrọ̀. Ó sọ fún aya rẹ̀ pé ó ní irora tí ó ń mún, tí ó sì ń tàn sí àgbààrì rẹ̀ àti apá òsì rẹ̀. Aya rẹ̀ pe ọkọ̀ ìwáṣẹ̀. Lọ́na, ó gba aspirin tí a lè fi ṣe àṣeyọrí, àti awọn iwọn mẹta ti nitroglycerin sublingual pẹlu ìdàlẹ́wọ̀ irora díẹ̀. Ó ní àrùn suga tí ó kò dára pupọ àti àtẹ́gùn ẹ̀jẹ̀ pàtàkì. Ó ti mu siga 15–20 ní ojoojumọ fun ọdun 37 sẹyin. Ẹ̀jẹ́ ẹ̀rọ rẹ̀ jẹ́ 172/91 mm Hg, ìṣísẹ̀ ọkàn rẹ̀ jẹ́ 111/min ati otutu rẹ̀ jẹ́ 36.7°C (98.0°F). Lórí àyẹ̀wò ara ní ile-iwosan pajawiri, ó hàn pé ó pupa, òùngbẹ àti ṣíṣe àníyàn gidigidi. ECG rẹ̀ hàn ni aworan. Awọn ipele Troponin ga ju. Ewo ni igbesẹ ti o dara julọ ni atọkun itọju ipo alaisan yii?\nA. Nifedipine gbigbe\nB. Clopidogrel, atenolol, anticoagulation ati abojuto\nC. Echocardiography\nD. CT scan ti ọmu pẹlu iyọrisi", "reasoning": "<thinking><step1>\nThe question describes a 71-year-old man experiencing chest pain and discomfort radiating to his left arm, indicating a potential cardiac issue. Key terms include [àìlera ìrora ọmu = chest pain] and [àrùn suga = diabetes].\n</step1>\n<step2>\nHe has a history of diabetes and hypertension, with a blood pressure of 172/91 mm Hg, which suggests he is at high risk for cardiovascular events — *ìṣẹ̀lẹ̀ àtọkànwá*.\n</step2>\n<step3>\nThe patient has taken aspirin and nitroglycerin, which are common initial treatments for chest pain, but his symptoms persist, indicating a more serious condition — *àìlera to ṣe pataki*.\n</step4>\n<step4>\nGiven the elevated Troponin levels, this suggests myocardial injury, and the ECG findings likely indicate ischemia — *ìkànsí àyà*.\n</step5>\n<step5>\nIn this scenario, the best management step would involve antiplatelet therapy and beta-blockers, along with anticoagulation to prevent further clot formation — *ìdènà àkúnya*.\n</step6>\n<step6>\nThus, the most appropriate treatment option is B: Clopidogrel, atenolol, anticoagulation, and monitoring.\n</step6></thinking>", "answer": "<answer>B. Clopidogrel, atenolol, anticoagulation ati abojuto.</answer>", "language": "Yoruba"}
{"question": "Ṣe apejuwe iyoku ti jara naa, rii daju pe awon awo igbẹkẹle ti wa ni pipade daradara.  Input: ( ) ( [ [ ] ] ) ( { [ { < { ( ) < [ [ < > { [ ( < ( < [ { < < ( [ ( ) ] [ ( < ( { [ ] } ) > ) ] [ < > ] ) > [ { ( < > ) } ] > } ] > ) > ) ] } ] ] > { } [ [ ] ] { } } > ( ( < > ) ) } ] }", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe apejuwe iyoku ti jara naa, rii daju pe awon awo igbẹkẹle ti wa ni pipade daradara?” — which translates to \"Describe the remaining part of the jar, ensuring that the reliable covers are properly closed.\"\n</step1>\n<step2>\nTo address this, we first need to understand what is meant by \"iyoku ti jara naa\" — the remaining part of the jar. This implies we are discussing the contents or the state of the jar.\n</step2>\n<step3>\nNext, \"awon awo igbẹkẹle\" refers to the reliable covers or lids. It is crucial that these covers are securely closed to prevent any contamination or spillage.\n</step3>\n<step4>\nIn practical terms, if the jar contains a liquid, we must ensure that *a ko ni ri omi ti n sọnu* (we do not see the liquid leaking) and that the lid is tightly sealed.\n</step4>\n<step5>\nAdditionally, if the jar is made of glass or plastic, we should check for any cracks or damages — *a gbọdọ ṣayẹwo fun awọn ibajẹ* — that could compromise the integrity of the jar.\n</step5>\n<step6>\nFinally, we can summarize that the remaining part of the jar should be intact, and all reliable covers must be properly secured to maintain the contents safely.\n</step6></thinking>", "answer": "<answer>Iyoku ti jara naa gbọdọ wa ni intact, ati pe awon awo igbẹkẹle gbọdọ wa ni pipade daradara lati daabobo akoonu naa.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun 13 kan ṣalaye nípa iyipada awọ eyín rẹ̀. Ìyá rẹ̀ sì fi iyipada awọ eyín kan náà hàn. Awọn àwárí iṣẹ́-iṣe oníṣẹ́-ẹ̀mí fi hàn pé eyín náà ní awọ funfun, pupa, ati ofeefee tí ó gbẹ́kẹ̀lé. Ìrísí eyín tí ó dàbí snowcapped sì hàn kedere. OPG fi ohun tí ó jẹ́ fẹ́ẹ́rẹ̀fẹ́rẹ̀ kan ti enamel hàn lórí àwọn cusp tips àti àwọn ẹ̀gbẹ́ interproximal. Ìdánwò igbẹ́kẹ̀lé jẹ́ rere. Dàlẹ̀ gbàgbọ́ èyí tí ó wà nípa àwọn àwárí náà, jẹ́ gẹ̀gẹ́:\nA. AMELX\nB. DSPP\nC. DMP-1\nD. RUNX-2", "reasoning": "<thinking><step1>\nThe question is asking about a 13-year-old boy who has a change in the color of his teeth, which is also observed by his mother. The findings indicate that the teeth have colors like white, red, and yellow, and they appear snowcapped — *eyín náà ní awọ funfun, pupa, ati ofeefee*.\n</step1>\n<step2>\nThe OPG shows a *fẹẹ́rẹ̀fẹ́rẹ́* condition of the enamel on the cusp tips and interproximal areas, suggesting some enamel-related issue — *ìṣòro ti enamel*.\n</step2>\n<step3>\nThe question also mentions that the *ìdánwò igbẹ́kẹ̀lé* (diagnostic test) is positive, which implies that there is a genetic or developmental factor involved.\n</step3>\n<step4>\nThe options provided (AMELX, DSPP, DMP-1, RUNX-2) are all related to enamel formation and dental genetics — *ìdàgbàsókè eyín*.\n</step5>\n<step5>\nAMELX is associated with enamel matrix proteins, while DSPP is linked to dentin sialophosphoprotein, which is crucial for tooth development. DMP-1 is also involved in enamel and dentin formation, and RUNX-2 is a transcription factor important for bone and tooth development.\n</step6>\n<step6>\nGiven the context of enamel changes and the positive test, the most likely candidate affecting the enamel is AMELX, as it directly relates to enamel structure — *ìdàgbàsókè ti enamel*.\n</step7></thinking>", "answer": "<answer>A. AMELX</answer>", "language": "Yoruba"}
{"question": "Irú àrùn etí wo ni ó máa ń farahàn pẹ̀lú ìtùjáde díẹ̀, tí ó ní ìrísí òkùnrùn, tí kò sì ní ìrora?", "reasoning": "<thinking><step1>\nThe question asks: “Irú àrùn etí wo ni ó máa ń farahàn pẹ̀lú ìtùjáde díẹ̀, tí ó ní ìrísí òkùnrùn, tí kò sì ní ìrora?” — meaning it wants to know what type of ear condition presents with slight discharge, has a certain appearance, and is not painful.\n</step1>\n<step2>\nIn English, this refers to an ear condition that might show symptoms like *ear discharge* — *ìtùjáde etí* — but without pain, which is unusual.\n</step2>\n<step3>\nOne possible condition is *otitis media*, which can sometimes present with a mild discharge, especially if there is a rupture in the eardrum — *ìfarapa etí*.\n</step3>\n<step4>\nAnother possibility could be *chronic suppurative otitis media*, where there is persistent ear discharge but typically without significant pain — *ìrora*.\n</step4>\n<step5>\nThe appearance of the discharge can vary; it might be *púpọ̀* (purulent) or *mímu* (serous), depending on the underlying cause.\n</step5>\n<step6>\nIn summary, the condition described could be *otitis media* or *chronic suppurative otitis media*, characterized by slight discharge and no pain.\n</step6></thinking>", "answer": "<answer>Àrùn etí tí ó lè fa ìtùjáde díẹ̀, tí kò ní ìrora, ni *otitis media* tàbí *chronic suppurative otitis media*.</answer>", "language": "Yoruba"}
{"question": "Kini ami ti o jẹ́ àmì ìtòlẹ́sẹ̀ oníṣẹ́ ìwádìí ara tí a lo fún ṣíṣe ìpinnu ìpari ìwẹnu àti ṣíṣe ní ọ̀nà gbígbẹ́ ọgbẹ́?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ami ti o jẹ́ [àmì ìtòlẹ́sẹ̀ oníṣẹ́ ìwádìí ara = biomarker] tí a lo fún ṣíṣe [ìpinnu ìpari ìwẹnu = diagnosis of disease] àti [ṣíṣe ní ọ̀nà gbígbẹ́ ọgbẹ́ = treatment monitoring]?” — meaning it seeks to understand what a biomarker is and its uses in diagnosis and treatment.\n</step1>\n<step2>\nA biomarker is a biological indicator that can be measured to assess health conditions — *àmi kan ti a le ṣe àyẹ̀wò* to indicate the presence of a disease.\n</step2>\n<step3>\nFor example, certain proteins or genes can serve as biomarkers for specific diseases — *àwọn protein kan tabi awọn jiini le jẹ́ àmì ìtòlẹ́sẹ̀ fún àrùn kan*.\n</step3>\n<step4>\nIn the context of diagnosis, biomarkers help in identifying the disease early — *wọn ṣe iranlọwọ láti mọ àrùn ni kutukutu*.\n</step4>\n<step5>\nAdditionally, they are crucial for monitoring treatment effectiveness — *wọn jẹ́ pataki fún ìmúlò àtọ́kànwá* to see if the treatment is working.\n</step5>\n<step6>\nThus, a biomarker is essential in both diagnosing and managing diseases effectively — *àmì ìtòlẹ́sẹ̀ jẹ́ pataki nínú ìpinnu àti ìṣàkóso àrùn*.\n</step6></thinking>", "answer": "<answer>Àmì ìtòlẹ́sẹ̀ jẹ́ àmi biologic tí a lo fún ìpinnu àrùn àti ìmúlò àtọ́kànwá.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun 16 kan ni a fẹ́ lú nipá ìsẹ̀guń bọ́ọ̀lù, ti o sì ni ipa lori apa osi rẹ̀ ti o n sojú de ẹgbẹ́ kan, ọwọ́ rẹ̀ sì na sí oke, ó sì gbọ̀ngbọ̀n. Ó ń ṣe akiyesi ailagbara ninú igbẹ́kẹ̀lé, iyipada sí ẹgbẹ́, iyọnú, ati sisẹ́ apa osi rẹ̀, pẹlú irora ati ìbàjẹ́ ni ejika osi, ṣugbọn awọn aworan X-ray kò fi ohunkohun han. Ẹ̀ṣẹ̀ iṣẹ́-ara wo ni o fa awọn ami aisan wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “What musculoskeletal injury could cause these symptoms?” — it describes a 16-year-old boy who has pain and weakness in his left shoulder after being hit by a soccer ball.\n</step1>\n<step2>\nThe symptoms include *ailagbara* (weakness), *iyipada sí ẹgbẹ́* (change in movement), and *irora* (pain) in the left shoulder, which suggests a possible injury to the shoulder or surrounding structures.\n</step2>\n<step3>\nGiven that the X-ray shows no abnormalities, this points towards a soft tissue injury rather than a bone fracture — possibly a *sprain* or *strain*.\n</step4>\n<step4>\nA common injury in such cases is a rotator cuff injury, where the muscles and tendons around the shoulder joint are damaged — *ìfarapa àyà*.\n</step5>\n<step5>\nThe boy's symptoms of pain and weakness, along with the mechanism of injury (being hit), align with a rotator cuff strain or a shoulder contusion — *ìfarapa ejika*.\n</step6>\n<step6>\nTherefore, the likely cause of his symptoms is a soft tissue injury, possibly a rotator cuff strain, due to the impact from the soccer ball.\n</step6></thinking>", "answer": "<answer>Ìfarapa àyà ni o fa awọn ami aisan rẹ̀, nitori ikolu ti bọọlu ti fa irora ati ailagbara ni ejika osi.</answer>", "language": "Yoruba"}
{"question": "Kini ọ̀nà ìtọ́jú tí ó báàmu jùlọ fún àpọǹbà obìnrin tí kò tíì bí ọmọ, tí ó ní oyun àìṣàṣájú, tí ìṣùpọ̀ àpòòtó ní iwọn 2.5 x 3 cm, àti ìwọ̀n Beta HCG tí ó jẹ́ 1500 mIU/mL?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ọ̀nà ìtọ́jú tí ó báàmu jùlọ fún àpọǹbà obìnrin tí kò tíì bí ọmọ, tí ó ní oyun àìṣàṣájú, tí ìṣùpọ̀ àpòòtó ní iwọn 2.5 x 3 cm, àti ìwọ̀n Beta HCG tí ó jẹ́ 1500 mIU/mL?” — meaning it seeks the best treatment approach for a woman with an early pregnancy complication, specifically an ectopic pregnancy, indicated by the size of the mass and the Beta HCG level.\n</step1>\n<step2>\nAn ectopic pregnancy occurs when a fertilized egg implants outside the uterus — *ninu àpòòtó*, which can lead to serious complications if not treated.\n</step2>\n<step3>\nThe size of the mass, 2.5 x 3 cm, suggests that it is significant enough to warrant intervention — *ìtọ́jú* is crucial to prevent rupture and internal bleeding.\n</step3>\n<step4>\nWith a Beta HCG level of 1500 mIU/mL, it indicates that the pregnancy is still in its early stages, but monitoring is essential — *ìmúlò àyẹ̀wò* is necessary to assess the situation.\n</step4>\n<step5>\nTreatment options include medication like methotrexate, which can help dissolve the ectopic tissue — *ìtọ́jú pẹ̀lú methotrexate* is often preferred for early cases.\n</step5>\n<step6>\nIf the condition is more severe or if there are signs of rupture, surgical intervention may be required — *ìtọ́jú iṣẹ́ abẹ́* could be necessary to ensure the woman's safety.\n</step6>\n<step7>\nIn summary, the best treatment approach would depend on the clinical assessment, but methotrexate is a common first-line treatment for early ectopic pregnancies.\n</step7></thinking>", "answer": "<answer>Ìtọ́jú tó dára jùlọ ni methotrexate, ayafi ti ìṣòro ba ti pọ̀ sí i, nígbà náà ni iṣẹ́ abẹ́ lè jẹ́ dandan.</answer>", "language": "Yoruba"}
{"question": "Ọmọ oṣù méje kan wá sílé ìwòsàn pẹ̀lú àìlágbára láti dàgbàsókè, ó sì ní ìwọ̀n èròjà pupa nínú ẹ̀jẹ̀ tó jẹ́ 4.4 g/dL. Àyẹ̀wò ẹ̀jẹ̀ rẹ̀ fihàn pé ó ní àìsàn àìní èròjà pupa tí ó kéré púpọ̀ pẹ̀lú fífẹ̀lẹ́ gan-an, ó sì ní ìwọ̀n kékeré púpọ̀ ti èròjà pupa A, pẹ̀lú ìwọ̀n gíga ti èròjà pupa A2 àti èròjà pupa F. Kí ni ìdí pàtàkì tó fà á tí àwọn nǹkan wọ̀nyí fi ń ṣẹlẹ̀ sí ẹ̀jẹ̀ rẹ̀?", "reasoning": "<thinking><step1>\nThe question is asking: \"What is the main reason for the low levels of red blood cells [èròjà pupa = red blood cells] in a child who has come to the hospital with weakness and a hemoglobin level of 4.4 g/dL?\" \n</step1>\n<step2>\nA hemoglobin level of 4.4 g/dL indicates severe anemia — *àìní èròjà pupa tó lágbára*. This condition can arise from various causes, including nutritional deficiencies or bone marrow problems.\n</step2>\n<step3>\nIn this case, the child has low levels of red blood cells and specifically low levels of red blood cell A — *èròjà pupa A*, which suggests a possible deficiency in iron or vitamin B12.\n</step3>\n<step4>\nThe presence of high levels of red blood cell A2 and F indicates that the body is trying to compensate for the low red blood cell count — *ìdáhùn àìní èròjà pupa*.\n</step4>\n<step5>\nCommon causes of such anemia in children include chronic diseases, genetic disorders, or inadequate dietary intake — *àìlera, àìlera àtọkànwá, tàbí àìní onjẹ tó péye*.\n</step5>\n<step6>\nThus, the main reason for the child's condition could be a combination of nutritional deficiency and the body's compensatory mechanisms failing to produce enough healthy red blood cells.\n</step6></thinking>", "answer": "<answer>Ìdí pàtàkì tó fà àìní èròjà pupa ni àìlera onjẹ àti àìlera àtọkànwá.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 60 kan ti o ní itan-akọọlẹ aarun ọkan ati hyperlipidemia wá si dokita rẹ fun iṣẹ iṣoogun atẹle ọsẹ mẹta lẹhin ti o lọ si ile-iwosan pajawiri fun awọn ami aisan ti ikọ́, iba ati iṣoro mimu afẹfẹ.  Wọn ti fun un ni erythromycin ni afikun si oogun rẹ ti rosuvastatin ati aspirin.  Pẹlu ipa ẹgbẹ tabi ibaraenisepo wo ni dokita yẹ ki o ṣe aniyan julọ?\nA. Ẹjẹ inu inu nitori idinku titoju aspirin ni itọsọna erythromycin\nB. Angina ti ko ni iduroṣinṣin nitori idinku titoju rosuvastatin ni itọsọna erythromycin\nC. Myalgia nitori idinku titoju rosuvastatin ni itọsọna erythromycin\nD. Acidosis ti o jẹ mimọ nitori idinku titoju aspirin ni itọsọna erythromycin\nE. Tinnitus nitori idinku titoju aspirin ni itọsọna erythromycin", "reasoning": "<thinking><step1>\nThe question is asking about potential side effects or interactions that a doctor should be most concerned about for a 60-year-old man with a history of heart disease and hyperlipidemia who is taking erythromycin along with rosuvastatin and aspirin.\n</step1>\n<step2>\nErythromycin is known to interact with several medications, particularly those metabolized by the liver — *iyẹn ni, awọn oogun ti a n pe ni CYP3A4 substrates*.\n</step2>\n<step3>\nRosuvastatin, which is a statin, can have its levels increased by erythromycin, leading to a higher risk of side effects — *iyẹn ni, awọn ipa ẹgbẹ bi myalgia*.\n</step3>\n<step4>\nAspirin, on the other hand, can also be affected by erythromycin, but the primary concern here is the interaction with rosuvastatin, which can lead to muscle-related issues — *iyẹn ni, myopathy tabi rhabdomyolysis*.\n</step5>\n<step5>\nAmong the options provided, the most significant concern would be myalgia due to the increased levels of rosuvastatin caused by erythromycin — *iyẹn ni, myalgia nitori idinku titoju rosuvastatin ni itọsọna erythromycin*.\n</step6>\n<step6>\nThus, the doctor should be most worried about the risk of myalgia as a side effect of this drug interaction.\n</step6></thinking>", "answer": "<answer>Myalgia nitori idinku titoju rosuvastatin ni itọsọna erythromycin.</answer>", "language": "Yoruba"}
{"question": "Olèro kan ti n dagba irokuro, ìrírí ṣíṣe pàdànù ti ojú àti etí àti ìmọ̀lẹ̀ ti ohun tí ó ń rìn kiri bi “irúgbìn iyanrin” lórí ara rẹ̀, ó ni ìṣòro—\nA. Heroin\nB. Methadone\nC. Cocaine\nD. Amphetamines", "reasoning": "<thinking><step1>\nThe question asks: “Olèro kan ti n dagba irokuro, ìrírí ṣíṣe pàdànù ti ojú àti etí àti ìmọ̀lẹ̀ ti ohun tí ó ń rìn kiri bi ‘irúgbìn iyanrin’ lórí ara rẹ̀, ó ni ìṣòro—” which translates to a substance that causes loss of vision and hearing, and has effects similar to “sand-like grains” on the body, indicating a problem.\n</step1>\n<step2>\nThis description suggests a substance that has severe neurological effects, leading to sensory loss — *pàdànù ìrírí* in vision and hearing.\n</step2>\n<step3>\nAmong the options, heroin, methadone, cocaine, and amphetamines, we need to identify which one is known for such effects.\n</step3>\n<step4>\nCocaine is known to cause intense euphoria but can also lead to sensory disturbances — *ìrírí àìlera* in hearing and vision.\n</step4>\n<step5>\nHeroin, while it can cause significant impairment, does not typically present with the “sand-like” symptoms described.\n</step5>\n<step6>\nAmphetamines can cause various side effects, but they are not commonly associated with the specific sensory loss mentioned.\n</step6>\n<step7>\nThus, the most fitting option that aligns with the description of sensory loss and the “sand-like” effect is cocaine.\n</step7></thinking>", "answer": "<answer>Cocaine.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 45 kan, ti o ni itan-akọọlẹ àrùn ìṣanraju, àtọgbẹ, lílo ọtí líle, ati lilo hydrochlorothiazide laipẹ, dé ile iwosan pajawiri pẹlu irora ti o buru pupọ, pupa, ati gbígbòòrò ìka ẹsẹ ọtun rẹ̀. Wọn bẹrẹ sise fun alaisan naa lori oogun kan ti o ṣaṣeyọri lati dinku irora naa nipasẹ didinku sisẹ iyika ati ipin leukocyte, ṣugbọn o ni awọn ipa ẹgbẹ gẹgẹ bi ríru ati òtútù. Kini iṣẹ-ṣiṣe ipilẹ ti oogun tuntun yii?", "reasoning": "<thinking><step1>\nThe question asks about the primary mechanism of action of a new medication given to a 45-year-old man with a history of [àrùn ìṣanraju = hypertension], [àtọgbẹ = diabetes], alcohol use, and recent use of [hydrochlorothiazide = hydrochlorothiazide].\n</step1>\n<step2>\nThe patient presents with severe pain, redness, and swelling in his right leg — *irora, pupa, ati gbígbòòrò* are signs of possible inflammation or thrombosis.\n</step2>\n<step3>\nThe medication is effective in reducing pain by decreasing [sisẹ iyika = vascular resistance] and lowering the leukocyte count — *iyika* refers to blood flow dynamics.\n</step3>\n<step4>\nThis suggests that the drug likely acts as an anti-inflammatory or anticoagulant, targeting the underlying causes of the symptoms — *o le jẹ pe oogun naa n ṣiṣẹ bi anti-inflammatory*.\n</step5>\n<step5>\nHowever, the side effects like [ríru = rash] and [òtútù = chills] indicate that it may also affect the immune response or cause systemic reactions — *iyẹn le fa awọn iṣoro miiran*.\n</step6>\n<step6>\nThus, the primary function of this new medication is to alleviate pain and inflammation by modulating vascular responses and leukocyte activity.\n</step6></thinking>", "answer": "<answer>Iṣẹ-ṣiṣe ipilẹ ti oogun tuntun yii ni lati dinku irora ati ìfarapa nipa ṣiṣakoso awọn idahun iyika ati iṣẹ leukocyte.</answer>", "language": "Yoruba"}
{"question": "Poteini wo ni awọn sẹẹli parietal ninu ikun ń tu silẹ, tí ó ṣe pataki fún gbigba vitamin B12 sinu ileum?", "reasoning": "<thinking><step1>\nThe question asks: “Poteini wo ni [sẹẹli parietal = parietal cells] ninu [ikun = stomach] ń tu silẹ?” — it seeks to identify the protein released by parietal cells in the stomach that is essential for the absorption of vitamin B12 in the ileum.\n</step1>\n<step2>\nParietal cells secrete a protein called intrinsic factor — *faktọ́ àtúnṣe* — which is crucial for vitamin B12 absorption.\n</step2>\n<step3>\nVitamin B12, or *vitamini B12*, is vital for red blood cell formation and neurological function.\n</step3>\n<step4>\nWithout intrinsic factor, vitamin B12 cannot be effectively absorbed in the ileum — *ileum* is the final part of the small intestine.\n</step4>\n<step5>\nIn summary, the absence of intrinsic factor leads to a condition known as pernicious anemia — *anemia pernicious* — due to vitamin B12 deficiency.\n</step5></thinking>", "answer": "<answer>Faktọ́ àtúnṣe ni sẹẹli parietal ninu ikun ń tu silẹ, tó ṣe pataki fún gbigba vitamini B12 sinu ileum.</answer>", "language": "Yoruba"}
{"question": "Ẹni tí a ti gbà fún àrùn tetanus ní ẹ̀ẹ̀kan-ṣoṣo ní ọdún mẹ́wàá sẹ́yìn ni ó ní igbáwí gbígbààlà kan tí ó rí ní wakati méjì ààbọ̀ sẹ́yìn láìsí ìgbàgbé.  Kí ni àṣàyàn ìtọ́jú tí ó yẹ fún ìdènà àrùn tetanus nínú ọ̀ràn yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àṣàyàn ìtọ́jú tí ó yẹ fún ìdènà àrùn tetanus nínú ọ̀ràn yìí?” — meaning it wants to know the appropriate treatment options for preventing tetanus in a person who has received the vaccine only once ten years ago.\n</step1>\n<step2>\nTetanus is caused by a bacterium, *Clostridium tetani*, and vaccination is crucial for prevention — *ìtọ́jú àrùn tetanus* involves ensuring adequate immunity.\n</step2>\n<step3>\nSince the person was vaccinated ten years ago, they may need a booster shot — *àtúnṣe àrùn* — to maintain immunity.\n</step3>\n<step4>\nThe CDC recommends that adults receive a tetanus booster every ten years, or sooner if they have a wound that is at risk for tetanus — *àrùn tetanus* can be life-threatening.\n</step4>\n<step5>\nIn this case, if the person has a deep or dirty wound, they should receive a booster shot within 48 hours — *ni àkókò 48 wákàtí*.\n</step5>\n<step6>\nAdditionally, proper wound care is essential to prevent infection — *ìtọ́jú ìfarapa* should be done immediately.\n</step6>\n<step7>\nSo, the recommended treatment is to administer a tetanus booster and ensure proper wound management.\n</step7></thinking>", "answer": "<answer>Àṣàyàn ìtọ́jú ni láti fi àtúnṣe àrùn tetanus ṣe àti láti rí i pé a ṣe ìtọ́jú ìfarapa dáadáa.</answer>", "language": "Yoruba"}
{"question": "Obìnrin kan tí ó wà ní ìpele ìṣẹ̀ṣẹ̀-àìṣẹ̀-ṣíṣẹ̀-àṣà-ara (perimenopause) dé pẹ̀lú ìṣòro jíjẹun tí ó ń pọ̀ sí i, àìlera, àti ìṣíṣẹ̀-gbẹ̀dẹ̀gbẹ̀dẹ̀ àpòòtọ́. Àwọn àdánwò ilàbòòràtóò fi hàn pé T4 àti TSH gíga, pẹ̀lú ìní àwọn antibodies antimicrosomal ṣùgbọ́n kò sí thyroid-stimulating immunoglobulins. Kí ni ìwádìí histologic nínú àṣàyàn àpòòtọ́ tí ó bá ìwádìí Hashimoto's thyroiditis mu jùlọ?", "reasoning": "<thinking><step1>\nThe question asks about the histological findings in a thyroid biopsy related to Hashimoto's thyroiditis, particularly in a woman experiencing perimenopause with symptoms like increased appetite, fatigue, and goiter — *ìpele ìṣẹ̀ṣẹ̀-àìṣẹ̀-ṣíṣẹ̀-àṣà-ara* and *ìṣòro jíjẹun*.\n</step1>\n<step2>\nHashimoto's thyroiditis is an autoimmune condition where the immune system attacks the thyroid gland — *àpòòtọ́*. \n</step2>\n<step3>\nHistologically, one would expect to see lymphocytic infiltration — *ìkó àwọn lympocytes* — which is a hallmark of this condition.\n</step3>\n<step4>\nAdditionally, there may be follicular destruction — *ìparun àwọn follicules* — and the presence of Hurthle cells — *àwọn sẹẹli Hurthle* — indicating chronic inflammation.\n</step4>\n<step5>\nThe elevated T4 and TSH levels suggest that the thyroid is trying to compensate for the autoimmune attack, which aligns with the findings of Hashimoto's.\n</step5>\n<step6>\nIn summary, the histological findings in a thyroid biopsy for Hashimoto's thyroiditis typically include lymphocytic infiltration and follicular destruction.\n</step6></thinking>", "answer": "<answer>Àwọn àwòrán histologic nínú àpòòtọ́ tí ó bá ìwádìí Hashimoto's thyroiditis mu ni ìkó àwọn lympocytes àti ìparun àwọn follicules.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 63 kan ti ní ìṣòro ìfìfì tí ó ńlá jùlọ ní ọdún mẹ́wàá sẹ́yìn. Ó ti kíyè sí ìdinku ìwúwo ìkílógiramu 5 ní ọdún méjì sẹ́yìn. Ó ní ikọ́fù onígbà gbogbo pẹ̀lú ìṣelọ́pọ̀ ìtùtú tí ó kéré pupọ̀ ati aini irora ọmu. Ní àyẹ̀wò ara, kò ní iba ati ẹ̀rù. Fọ́tò ọmu fi hàn ní àìsàn àárín àárín tí ó gbòòrò. Àwọn àdánwò iṣẹ́ ọmu fi hàn ní ìdinku DLCO, FVC tí ó kéré, ati ìwọ̀n FEV1/FVC tí ó déédéé. Ṣiṣe àpapọ̀ sí àwọn ohun àdàbà tí ó tẹ̀lé wọ̀n ní ìwọ̀n wo ni ó ṣeé ṣe julọ lati mú àwọn àwọn àyẹ̀wò wọnyi jáde?\nA. Carbon monoxide\nB. Ozone\nC. Silica\nD. Ẹ̀fún sígá", "reasoning": "<thinking><step1>\nThe question is asking about a 63-year-old man with a history of significant [ìṣòro ìfìfì = breathing problems] over the past ten years, who has experienced a weight loss of 5 kilograms in the last two years. He has a chronic cough with minimal sputum and no chest pain, and his physical examination shows no fever or distress. The chest X-ray indicates a moderate interstitial lung disease. Pulmonary function tests show a decreased DLCO, reduced FVC, and a normal FEV1/FVC ratio. It seeks to identify which exposure is most likely to explain these findings.\n</step1>\n<step2>\nGiven the symptoms and test results, we need to consider potential environmental or occupational exposures. The patient’s chronic cough and interstitial lung disease suggest a long-term exposure to harmful substances.\n</step2>\n<step3>\nAmong the options, carbon monoxide, ozone, silica, and tobacco smoke are presented. Carbon monoxide typically causes systemic effects rather than specific lung disease, while ozone can lead to airway inflammation but is less likely to cause interstitial lung disease.\n</step3>\n<step4>\nSilica exposure is known to be associated with chronic lung conditions, including silicosis, which can present with similar pulmonary function test results and interstitial patterns on imaging — *àwọn àdánwò iṣẹ́ ọmu fi hàn ní ìdinku DLCO*.\n</step4>\n<step5>\nTobacco smoke is also a significant risk factor for lung disease, but the specific pattern of interstitial lung disease and the chronic cough with minimal sputum leans more towards silica exposure as the primary cause.\n</step6>\nThus, considering the clinical picture and the options provided, the most likely exposure that could explain these findings is silica.\n</step6></thinking>", "answer": "<answer>Silica.</answer>", "language": "Yoruba"}
{"question": "Èlément ọ̀nà SVG yii <path d=\"M 18.51,5.48 L 34.19,27.80 A 27.27,27.27 243.03 0,1 8.20,30.73 L 18.51,5.48\"/> ṣe àtẹ̀jáde\nAwọn aṣayan:\n(A) yíká\n(B) apáàrọ̀ méje\n(C) apáàrọ̀ mẹfa\n(D) afefè\n(E) ila\n(F) apáàrọ̀ mẹ́jọ\n(G) apáàrọ̀ márùn-ún\n(H) térétángùlì\n(I) apá kan\n(J) kọ́ńńì", "reasoning": "<thinking><step1>\nThe question asks: “Èlément ọ̀nà SVG yii [this SVG path] ṣe àtẹ̀jáde?” — meaning it wants to know what this SVG path represents or outputs.\n</step1>\n<step2>\nThe SVG path provided describes a shape using commands like \"M\" for move to, \"L\" for line to, and \"A\" for arc. Here, *M 18.51,5.48* indicates the starting point of the path.\n</step2>\n<step3>\nThe command *L 34.19,27.80* draws a line to the coordinates (34.19, 27.80), while *A 27.27,27.27 243.03 0,1 8.20,30.73* creates an arc with specific parameters.\n</step3>\n<step4>\nTo understand the shape, we can visualize it: it starts at one point, draws a line, and then curves to another point. This suggests a complex shape rather than a simple one.\n</step5>\n<step5>\nGiven the options, we need to determine if this shape is circular, linear, or has multiple segments. The arc indicates it is likely not just a straight line — *ila*.\n</step6>\n<step6>\nConsidering the complexity of the path, it seems to represent a shape with multiple segments, possibly a *apáàrọ̀ mẹ́jọ* (eight segments) or more.\n</step7>\n<step7>\nHowever, the arc suggests a more intricate design, leading us to conclude that it is likely a *apáàrọ̀ mẹ́jọ*.\n</step8></thinking>", "answer": "<answer>apáàrọ̀ mẹ́jọ</answer>", "language": "Yoruba"}
{"question": "Àgbéyẹ̀wò ìtàn ọmọdé ọdún mẹ́ẹ̀ẹ́dógún kan tí ó ní àrùn ibà lọ́pọ̀lọpọ̀ láti ọjọ́ tí ó pé oṣù mẹ́fà, láìsí ìrẹ̀wẹ̀sì, ẹ̀dùn, ìdènà, tàbí ẹ̀gbẹ́, tí a sì gbé àkọsílẹ̀ ìdàgbàsókè rẹ̀ yẹ̀wò, èyí tí ó fi hàn pé ìdàgbàsókè rẹ̀ yàtọ̀ sí bí a ṣe retí, àrùn wo ni èyí fi hàn?", "reasoning": "<thinking><step1>\nThe question asks: “Àgbéyẹ̀wò ìtàn ọmọdé ọdún mẹ́ẹ̀ẹ́dógún kan tí ó ní àrùn ibà” — meaning it wants to evaluate the development of a 15-year-old child with a chronic illness from the age of six, without any signs of regression, pain, or disability.\n</step1>\n<step2>\nIn this context, *àrùn ibà* refers to a chronic illness that affects the child's growth and development. The absence of *ìrẹ̀wẹ̀sì* (regression), *ẹ̀dùn* (pain), or *ìdènà* (disability) suggests that the child has been developing normally despite the illness.\n</step2>\n<step3>\nWe need to consider what chronic illnesses can affect a child's development without causing these negative symptoms. Conditions like *asthma* or *diabetes* can be managed effectively, allowing for normal growth.\n</step3>\n<step4>\nHowever, if the child has a condition that significantly impacts development, such as *cystic fibrosis* or *sickle cell disease*, we would expect to see some signs of complications or developmental delays.\n</step4>\n<step5>\nSince the question indicates that the child's development is atypical compared to expectations, we should consider conditions that might not show immediate symptoms but still affect long-term growth, like *hypothyroidism*.\n</step5>\n<step6>\nThus, the chronic illness that could explain this atypical development without regression or pain might be *hypothyroidism*, which can lead to slower growth rates.\n</step6></thinking>", "answer": "<answer>Àrùn tí ó fi hàn pé ìdàgbàsókè rẹ̀ yàtọ̀ sí bí a ṣe retí ni *hypothyroidism*.</answer>", "language": "Yoruba"}
{"question": "Ninu atokọ HC2H3O2 ati C2H3O2-, SO32- ati SO22-, H3PO4 ati H3PO3, H3O+ ati OH-, tọkọtaya wo ni o ṣe afihan tọkọtaya asiti-beesi konjugate Brønsted-Lowry?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu atokọ [HC2H3O2 = acetic acid] ati [C2H3O2- = acetate], [SO32- = sulfite] ati [SO22- = bisulfite], [H3PO4 = phosphoric acid] ati [H3PO3 = phosphorous acid], [H3O+ = hydronium] ati [OH- = hydroxide], tọkọtaya wo ni o ṣe afihan tọkọtaya asiti-beesi konjugate Brønsted-Lowry?” — meaning it wants to identify which pairs represent Brønsted-Lowry conjugate acid-base pairs.\n</step1>\n<step2>\nIn Brønsted-Lowry theory, an acid is a proton donor and a base is a proton acceptor. For example, *HC2H3O2* donates a proton to become *C2H3O2-*.\n</step2>\n<step3>\nSimilarly, *H3O+* acts as an acid by donating a proton to *OH-* which then becomes water, *H2O*. This shows that *H3O+* and *OH-* are also a conjugate pair.\n</step3>\n<step4>\nLooking at *H3PO4* and *H3PO3*, *H3PO4* can donate a proton to form *H2PO4-* which is not listed here, so they do not form a conjugate pair directly.\n</step4>\n<step5>\nFor *SO32-* and *SO22-*, *SO32-* can donate a proton to become *SO22-*, making them a conjugate pair as well.\n</step5>\n<step6>\nThus, the pairs that represent conjugate acid-base pairs are: *HC2H3O2* and *C2H3O2-*, *H3O+* and *OH-*, and *SO32-* and *SO22-*.\n</step6></thinking>", "answer": "<answer>Tọkọtaya asiti-beesi konjugate Brønsted-Lowry ni: HC2H3O2 ati C2H3O2-, H3O+ ati OH-, SO32- ati SO22-.</answer>", "language": "Yoruba"}
{"question": "Kini awọn àpẹẹrẹ ti a sopọ mọ́ àrùn Meigs?", "reasoning": "<thinking><step1>\nThe question asks: “Kini awọn àpẹẹrẹ ti a sopọ mọ́ [àrùn Meigs = Meigs' syndrome]?” — meaning it wants to know the examples associated with Meigs' syndrome.\n</step1>\n<step2>\nMeigs' syndrome is characterized by the presence of an ovarian tumor, typically a benign one, along with *ìfarapa àtọgbẹ* (ascites) and *ìfarapa ẹjẹ* (hydrothorax).\n</step2>\n<step3>\nCommonly, the ovarian tumor is an *ovarian cyst* or *tumor* that can lead to these fluid accumulations — *ìkànsí omi* in the abdominal cavity and thoracic cavity.\n</step3>\n<step4>\nIn clinical practice, one might observe symptoms like abdominal distension — *ìkànsí àyà* — and shortness of breath due to fluid in the lungs.\n</step4>\n<step5>\nAdditionally, imaging studies often reveal the tumor and the associated fluid collections, confirming the diagnosis of Meigs' syndrome.\n</step5>\n<step6>\nSo, the examples linked to Meigs' syndrome include an ovarian tumor, ascites, and hydrothorax, which are critical for diagnosis.\n</step6></thinking>", "answer": "<answer>Àwọn àpẹẹrẹ ti a sopọ mọ́ àrùn Meigs ni àtọgbẹ, ìfarapa ẹjẹ, àti àtọgbẹ ovarian.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun mẹtadinlogun (32) kan ti o ni àtìgbàgbà ẹ̀dùn àtìgbàgbà, tí ó ní àrùn-ẹ̀gbà ati irora ori lẹhin ọjọ́ meji ti ìbí ọmọ dé. Àwòrán tí a ya fi hàn pé ọ̀tọ̀kan ẹ̀jẹ̀ ti wà ni apa ẹgbẹ́ òkè ati ẹ̀jẹ̀ tí ó fúnra rẹ̀ dà bíi 3x2cm, kò sì sí proteinuria. Kí ni ìdí tí ó ṣeé ṣe julọ ti ipò rẹ̀?", "reasoning": "<thinking><step1>\nThe question describes a 32-year-old woman with *hypertension* and *headaches* two days after giving birth. It mentions a *hematoma* (a localized collection of blood outside of blood vessels) on the upper side and no *proteinuria* (presence of protein in urine).\n</step1>\n<step2>\nIn this context, the presence of a hematoma suggests a possible complication related to childbirth — *àkúnya* or *ìfarapa* during delivery could lead to such a condition.\n</step2>\n<step3>\nThe headaches and hypertension could indicate *preeclampsia*, a serious condition that can occur postpartum, especially if there are signs of elevated blood pressure.\n</step3>\n<step4>\nHowever, the absence of proteinuria is notable; in typical cases of preeclampsia, one would expect to see protein in the urine — *àìsí proteinuria* might suggest an alternative diagnosis.\n</step4>\n<step5>\nGiven the hematoma and the symptoms, the most likely cause of her condition could be a *subdural hematoma* or another type of bleeding complication, rather than classic preeclampsia.\n</step5>\n<step6>\nThus, the combination of her symptoms and findings points towards a hematoma as the primary issue, possibly due to trauma during delivery.\n</step6></thinking>", "answer": "<answer>Ìdí tí ó ṣeé ṣe julọ ti ipò rẹ̀ ni *hematoma* kan, tí ó lè jẹ́ abajade ìfarapa nígbà ìbí.</answer>", "language": "Yoruba"}
{"question": "Ninu ipo obinrin ti o loyun ti o ni àrùn suga ìgbàlóyun ati itan ti ifijiṣẹ ọmọ ńlá tí wọ́n ní àìtójú suga ẹ̀jẹ̀ tó burú já, àtúnṣe wo ni o kere ju lọ ni didinku ewu àìtójú suga ẹ̀jẹ̀ ninu ọmọ tuntun ti mbọ?", "reasoning": "<thinking><step1>\nThe question asks: “In the case of a pregnant woman with [àrùn suga = diabetes] and a history of [itan ti ifijiṣẹ ọmọ ńlá = large baby delivery], what is the least intervention to reduce the risk of poor blood sugar control in the newborn?” \n</step1>\n<step2>\nManaging diabetes during pregnancy is crucial to prevent complications — *ìṣakoso àrùn suga* helps ensure the health of both mother and child.\n</step2>\n<step3>\nOne common intervention is dietary management — *ìṣakoso ounje* to maintain stable blood sugar levels.\n</step3>\n<step4>\nRegular monitoring of blood glucose is essential — *ìtẹ́le ẹ̀jẹ̀ suga* can help identify any spikes or drops early.\n</step4>\n<step5>\nAdditionally, physical activity can be beneficial — *ìdárayá* helps improve insulin sensitivity, which is important for managing diabetes.\n</step5>\n<step6>\nIn some cases, medication may be necessary, but the question asks for the least intervention, so lifestyle changes are prioritized.\n</step6>\n<step7>\nThus, the least intervention to reduce the risk of poor blood sugar control in the newborn would be effective dietary management and regular monitoring.\n</step7></thinking>", "answer": "<answer>Ìṣakoso ounje to munadoko ati ìtẹ́le ẹ̀jẹ̀ suga ni a ṣe pataki jùlọ lati dinku ewu àìtójú suga ẹ̀jẹ̀ ninu ọmọ tuntun.</answer>", "language": "Yoruba"}
{"question": "Nínú ìgbòkègbòdo àdàkọ́dàkọ́ ṣíṣàgbé nípasẹ̀ ìṣísẹ̀ 1, MA(1), pẹ̀lú ìwọ̀n ìgbòkègbòdo àdàkọ́dàkọ́ tí ó jẹ́ 0.4 àti ọ̀rùn-ún dídùn, báwo ni ènìyàn ṣe lè mọ̀ nípa àdàkọ́dàkọ́ àpapọ̀ ní ìgbà tí ó jẹ́ 1, kí sì ni àwọn àlàyé afikun tí a ó nílò láti kà á sí iye rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Nínú ìgbòkègbòdo àdàkọ́dàkọ́ ṣíṣàgbé nípasẹ̀ ìṣísẹ̀ 1, MA(1)…” — meaning it wants to understand how to determine the overall model behavior at time 1 for a moving average model with a specific parameter.\n</step1>\n<step2>\nIn a moving average model, *àdàkọ́dàkọ́* captures the relationship between a current observation and past error terms. Here, we have a parameter of 0.4, which indicates the influence of the previous error.\n</step2>\n<step3>\nTo find the value at time 1, we need the previous error term — *ìṣísẹ̀ àtẹ̀yìnwá*. If we denote the error at time 0 as *ε₀*, then the value at time 1, *Y₁*, can be expressed as: \n*Y₁ = μ + θ * ε₀*, where θ = 0.4.\n</step3>\n<step4>\nAssuming a mean *μ* of 0 for simplicity, we can say: *Y₁ = 0 + 0.4 * ε₀*. Thus, the value of *Y₁* directly depends on the error term at time 0.\n</step4>\n<step5>\nAdditional information needed includes the actual value of *ε₀* and any assumptions about the distribution of the errors — *ìtàn àtẹ̀yìnwá* — to compute the expected value or variance of the model.\n</step5>\n<step6>\nIn summary, to determine the overall model behavior at time 1, we need the previous error term and its distribution characteristics.\n</step6></thinking>", "answer": "<answer>Láti mọ̀ nípa àdàkọ́dàkọ́ àpapọ̀ ní ìgbà tí ó jẹ́ 1, a nílò iye àtẹ̀yìnwá *ε₀* àti ìtàn rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Olùwádìí kan ń kẹ́kọ̀ọ́ agbára ti oògùn tuntun kan tí a ń lò láti mú àrùn gout kúrò, ní ìwéwé pẹ̀lú colchicine nínú àpẹẹrẹ ẹ̀dá alààyè. A fi oògùn tuntun náà sí ẹgbẹ́ àwọn ẹ̀dá tí a ń gbìyànjú, nígbà tí a sì fi colchicine sí ẹgbẹ́ tí a ń fi ṣe ìwádìí. Ní àwọn iṣẹ́ ṣíṣe ti sẹ́ẹ̀lì wọ̀nyí, èwo ni ó pọ̀jù tí a óò rí ìdákẹ́ṣẹ̀ ní ẹgbẹ́ àwọn ẹ̀dá tí a ń fi ṣe ìwádìí lẹ́yìn tí a bá fi oògùn sí wọn?\nA. Iṣẹ́ ṣíṣe ti Stereocilia\nB. Ìdàkọ́ ẹ̀rọ ìṣiṣẹ́\nC. Ìgbàgbé oúnjẹ\nD. Ìgbé jáde ti Axonal\nE. Ìdánilójú ti Intercellular", "reasoning": "<thinking><step1>\nThe question is asking about the effects of a new drug on certain cellular functions in a study involving colchicine — *oògùn colchicine* — and how these effects differ between the two groups of organisms.\n</step1>\n<step2>\nIn this context, the study compares a new drug's impact on *ìdákẹ́ṣẹ̀* (cellular activity) in the experimental group versus colchicine's effects in the control group.\n</step2>\n<step3>\nWe need to determine which cellular function shows the most significant change in the experimental group after administering the new drug.\n</step3>\n<step4>\nThe options provided include various cellular processes: *ìdàkọ́ ẹ̀rọ ìṣiṣẹ́* (cellular signaling), *ìgbàgbé oúnjẹ* (nutrient uptake), *ìgbé jáde ti Axonal* (axon outgrowth), *ìdánilójú ti Intercellular* (intercellular communication), and *iṣẹ́ ṣíṣe ti Stereocilia* (stereocilia function).\n</step4>\n<step5>\nConsidering the context of gout treatment, the most relevant cellular function likely relates to inflammation and cellular signaling, which is crucial in the response to gout.\n</step5>\n<step6>\nThus, *ìdàkọ́ ẹ̀rọ ìṣiṣẹ́* is likely to show the most significant change due to the drug's mechanism of action.\n</step6></thinking>", "answer": "<answer>Ìdàkọ́ ẹ̀rọ ìṣiṣẹ́.</answer>", "language": "Yoruba"}
{"question": "Obirin kan fi ẹ̀dùn ara ti ìdààmú ìfẹ́fẹ́ ìwọ̀n mẹta, ìdènà mitral ti o burú pupọ̀ pẹlu fibrillation atrial, ìṣiṣẹ́ ọkàn-ààyè tí o pọ̀ sí i, ati ẹ̀jẹ̀ tí o ti di ewu ninu atria òsì.  Nípa ọ̀ràn ìṣègùn yìí, iṣẹ́ abẹ̀ wo ni ó yẹ kí a yàgò fún?", "reasoning": "<thinking><step1>\nThe question asks: “What surgical procedure should be avoided in a case of severe mitral stenosis with atrial fibrillation, increased cardiac output, and blood pooling in the left atrium?” — it highlights a complex cardiac condition.\n</step1>\n<step2>\nIn this scenario, *ìdènà mitral* (mitral stenosis) is a narrowing of the mitral valve, which can lead to complications like *fibrillation atrial* (atrial fibrillation).\n</step2>\n<step3>\nAtrial fibrillation can cause *ìdààmú ìfẹ́fẹ́* (increased heart rate) and may lead to blood clots forming in the left atrium — *ẹ̀jẹ̀ tí o ti di ewu*.\n</step3>\n<step4>\nIn such cases, certain surgical interventions, like *ìṣẹ́ abẹ̀ mitral* (mitral valve surgery), might increase the risk of complications due to the existing fibrillation.\n</step4>\n<step5>\nAdditionally, procedures that increase the heart's workload or disrupt the atrial rhythm should be avoided to prevent worsening the patient's condition.\n</step5>\n<step6>\nTherefore, the surgical procedure to avoid would be any that could exacerbate the *ìdènà mitral* or the *fibrillation atrial*.\n</step6></thinking>", "answer": "<answer>Ìṣẹ́ abẹ̀ mitral ni ó yẹ kí a yàgò fún.</answer>", "language": "Yoruba"}
{"question": "Àrùn fungal wo ni a rí nínú awọn sẹẹli iwukara pẹlu ọpọlọpọ awọn budding ninu ẹya ara, ti o ṣe apẹrẹ kan bi a ti rii ninu aworan kan?", "reasoning": "<thinking><step1>\nThe question asks: “Àrùn fungal wo ni a rí nínú [awọn sẹẹli iwukara = yeast cells] pẹlu ọpọlọpọ [budding = budding]?” — meaning it wants to identify a fungal disease observed in yeast cells that exhibit budding.\n</step1>\n<step2>\nYeast cells are a type of fungus, and when they bud, it indicates a form of asexual reproduction — *iyipada aisan*.\n</step2>\n<step3>\nThe most common fungal disease associated with budding yeast cells is *Candida albicans*, which can cause infections in humans — *àrùn Candida*.\n</step3>\n<step4>\nIn clinical terms, this condition can lead to *candidiasis*, which manifests in various forms, including oral thrush and vaginal yeast infections — *àrùn àtọgbẹ*.\n</step4>\n<step5>\nWhen viewed under a microscope, *Candida* appears as round cells with buds, resembling a “grape-like” structure — *àwọn sẹẹli ti o ni irisi eso*.\n</step5>\n<step6>\nThus, the fungal disease characterized by budding yeast cells is primarily *Candidiasis*.\n</step6></thinking>", "answer": "<answer>Àrùn fungal ti a rí nínú awọn sẹẹli iwukara pẹlu ọpọlọpọ budding ni *Candidiasis*.</answer>", "language": "Yoruba"}
{"question": "Jennifer ni owo ju Amy lọ, nitorinaa _ di oni ile ni ọjọ́ òdòdó.\nA. Jennifer\nB. Amy", "reasoning": "<thinking><step1>\nThe question states: “Jennifer ni owo ju Amy lọ, nitorinaa _ di oni ile ni ọjọ́ òdòdó.” This translates to “Jennifer has more money than Amy, so _ is at home on Sunday.” \n</step1>\n<step2>\nThe phrase “ni owo ju” means “has more money,” indicating a comparison of wealth between Jennifer and Amy.\n</step2>\n<step3>\nThe context suggests that having more money might influence where someone is on a Sunday — *ọjọ́ òdòdó* — which is typically a day for rest or leisure.\n</step3>\n<step4>\nIf Jennifer has more money, she might be able to afford to go out or do activities, while Amy, with less money, might stay home.\n</step4>\n<step5>\nThus, the implication is that since Jennifer has more financial resources, she is likely to be out, while Amy is the one who stays home.\n</step5>\n<step6>\nTherefore, the blank should be filled with Amy, as she is the one who would be at home on Sunday.\n</step6></thinking>", "answer": "<answer>Amy</answer>", "language": "Yoruba"}
{"question": "Àyẹ̀wò àìsàn wo ni a gbani nímọ̀ràn fún ọkùnrin ọdún mẹ́rìnlélọ́gọ́rin kan tí ó ní ìtàn àrùn ìṣọ̀kan ọkàn ńlá, ìfìyà jà ní ọ̀la kan, àìní ilé, àti ìtàn ìmu siga ọdún mẹ́ẹ̀ẹ́dọ́gbọ̀n, tí ó fi ohùn ìmímú tí ó burú jáde ní àwọn ìgbẹ̀rẹ̀pẹ̀lẹ̀ ẹ̀dọ̀fóró rẹ̀ mejeeji?", "reasoning": "<thinking><step1>\nThe question asks: “What medical examination is recommended for a 45-year-old man with a history of [maladie cardiaque = heart disease], a panic attack yesterday, homelessness, and a 35-year smoking history, who presents with severe [toux = cough]?” \n</step1>\n<step2>\nGiven his history of heart disease, it’s crucial to assess his cardiovascular health — *la santé cardiovasculaire* — especially after a panic attack, which can exacerbate existing conditions.\n</step2>\n<step3>\nThe severe cough could indicate respiratory issues, possibly linked to his long-term smoking — *le tabagisme à long terme* can lead to chronic bronchitis or even lung cancer.\n</step3>\n<step4>\nA thorough examination should include a chest X-ray — *radiographie thoracique* — to check for any abnormalities in the lungs and heart.\n</step4>\n<step5>\nAdditionally, pulmonary function tests — *tests de fonction pulmonaire* — would help evaluate his lung capacity and function, especially given his smoking history.\n</step5>\n<step6>\nConsidering his homelessness, access to healthcare might be limited, so it’s important to connect him with local health services — *services de santé locaux* — that can provide comprehensive care.\n</step6>\n<step7>\nIn summary, the recommended examinations include a chest X-ray and pulmonary function tests to address both his respiratory symptoms and cardiovascular health.\n</step7></thinking>", "answer": "<answer>Àyẹ̀wò àìsàn tó yẹ ni radiographie thoracique àti awọn idanwo iṣẹ́ ẹ̀dọ̀fóró.</answer>", "language": "Yoruba"}
{"question": "Nínú àwọn gbólóhùn wọ̀nyí, ṣàlàyé ẹni tí ọ̀rọ̀-ọ̀rùn náà ń tọ́ka sí (ohun tí ọ̀rọ̀-ọ̀rùn náà ń tọ́ka sí), tàbí sọ pé kò ṣe kedere.\nGbólóhùn náà: Olùkọ́-ẹ̀rọ-kọ̀m̀pútà pàdé pẹ̀lú apẹ̀rẹ̀-ẹ̀rọ nítorí pé èrò rẹ̀ lè ṣeé mú ṣẹ.\nÀwọn àṣàyàn:\n(A) Èrò olùkọ́-ẹ̀rọ-kọ̀m̀pútà lè ṣeé mú ṣẹ\n(B) Èrò apẹ̀rẹ̀-ẹ̀rọ lè ṣeé mú ṣẹ\n(C) Kò ṣe kedere", "reasoning": "<thinking><step1>\nThe question asks: “Nínú àwọn gbólóhùn wọ̀nyí, ṣàlàyé ẹni tí ọ̀rọ̀-ọ̀rùn náà ń tọ́ka sí” — meaning it wants to explain who or what the subject of the sentence refers to.\n</step1>\n<step2>\nThe sentence states: “Olùkọ́-ẹ̀rọ-kọ̀m̀pútà [computer teacher] pàdé pẹ̀lú apẹ̀rẹ̀-ẹ̀rọ [hardware] nítorí pé èrò rẹ̀ [his/her idea] lè ṣeé mú ṣẹ [can be realized].”\n</step2>\n<step3>\nHere, the subject is the *olùkọ́-ẹ̀rọ-kọ̀m̀pútà*, indicating that the focus is on the computer teacher and their interaction with the hardware.\n</step3>\n<step4>\nThe phrase “èro rẹ̀ lè ṣeé mú ṣẹ” suggests that the teacher's ideas or plans can be implemented with the help of the hardware.\n</step4>\n<step5>\nThus, the sentence clearly points to the computer teacher as the main subject whose ideas are being discussed.\n</step5>\n<step6>\nConsidering the options, (A) “Èrò olùkọ́-ẹ̀rọ-kọ̀m̀pútà lè ṣeé mú ṣẹ” is the most accurate interpretation.\n</step6></thinking>", "answer": "<answer>Èrò olùkọ́-ẹ̀rọ-kọ̀m̀pútà lè ṣeé mú ṣẹ.</answer>", "language": "Yoruba"}
{"question": "Kini iṣe itọju akọkọ fun obinrin ọdun 45 kan ti o ni itan oṣu mẹfa ti poly-menorrhea?", "reasoning": "<thinking><step1>\nThe question asks: “Kini iṣe itọju akọkọ fun obinrin ọdun 45 kan ti o ni itan oṣu mẹfa ti [poly-menorrhea = poly-menorrhea]?” — meaning it seeks to understand the primary treatment for a 45-year-old woman with a six-month history of poly-menorrhea.\n</step1>\n<step2>\nPoly-menorrhea refers to having frequent menstrual periods, which can indicate underlying issues like hormonal imbalances — *iyipada homonu*.\n</step2>\n<step3>\nIn women around this age, it’s important to consider perimenopause — *perimenopause* — as a potential factor affecting menstrual cycles.\n</step3>\n<step4>\nThe first-line treatment often involves hormonal therapy, such as oral contraceptives — *iyọrisi homonu* — to regulate the menstrual cycle.\n</step4>\n<step5>\nAdditionally, a healthcare provider may recommend lifestyle changes or further evaluation to rule out other conditions — *iyẹwo siwaju*.\n</step5>\n<step6>\nThus, the primary treatment focuses on managing symptoms and addressing any hormonal issues.\n</step6></thinking>", "answer": "<answer>Itọju akọkọ fun obinrin ọdun 45 kan ti o ni itan oṣu mẹfa ti poly-menorrhea ni lilo iyọrisi homonu lati ṣakoso awọn aami aiṣan.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun márùn-ún kan wá pẹlu oju pupa, ètè gbigbẹ, ètè tí ó ya, àkàn lórí ọwọ́ àti ẹsẹ̀ rẹ̀, àti ìgbóná ìṣan ọrùn.  Nígbà tí a bá gbé àwọn àmì àrùn yìí yẹ̀wò,  ìwádìí wo ni ó ṣe pàtàkì jù lọ láti ṣe kí a lè yọ ìṣẹ̀lẹ̀ ọkàn-àyà tí ó lewu tí ó bá àrùn yìí mu kúrò?", "reasoning": "<thinking><step1>\nThe question translates to: \"A five-year-old boy presents with red eyes, dry cough, rash on his hands and feet, and fever. When we examine these symptoms, what investigations are most important to rule out a serious cardiac event that may accompany this illness?\" \n</step1>\n<step2>\nThe symptoms suggest a possible viral infection, which can sometimes lead to complications — *àwọn àkànṣe àrùn* that affect the heart.\n</step2>\n<step3>\nFirst, we should consider performing a complete blood count (CBC) — *ìtẹ́numọ́ ẹ̀jẹ̀* — to check for signs of infection or inflammation.\n</step3>\n<step4>\nNext, an electrocardiogram (ECG) is crucial to assess heart rhythm and detect any abnormalities — *ìtẹ́numọ́ àyípadà ọkàn*.\n</step4>\n<step5>\nAdditionally, echocardiography may be necessary to visualize heart function and structure — *ìtẹ́numọ́ àyípadà àyíká ọkàn*.\n</step6>\n<step6>\nFinally, testing for specific viral infections, such as *àrùn Kawasaki* or other viral myocarditis, is essential to rule out serious conditions.\n</step6></thinking>", "answer": "<answer>Ìwádìí pàtàkì jù lọ ni ìtẹ́numọ́ ẹ̀jẹ̀, ECG, àti echocardiography.</answer>", "language": "Yoruba"}
{"question": "Ṣe iṣẹ́lẹ̀̀ àwọn àrùn tí kò tàn kàn (NCD) lọ́wọ́ ikú, láti èyí tí ó wọ́pọ̀ jù sí èyí tí kò wọ́pọ̀ jùlọ, ní pàtàkì láàrin àwọn àrùn èèkàn, àwọn àrùn ọkàn, àrùn suga, àti àwọn àrùn ẹ̀dọ̀fóró?", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe iṣẹ́lẹ̀̀ àwọn àrùn tí kò tàn kàn (NCD) lọ́wọ́ ikú” — meaning it wants to know the prevalence of non-communicable diseases (NCDs) in relation to mortality, particularly focusing on diseases like *àrùn èèkàn* (cancer), *àrùn ọkàn* (heart disease), *àrùn suga* (diabetes), and *àrùn ẹ̀dọ̀fóró* (liver disease).\n</step1>\n<step2>\nNon-communicable diseases are a major cause of death globally, with heart disease being the leading cause — *àrùn ọkàn ni àkọ́kọ́*.\n</step2>\n<step3>\nFollowing heart disease, cancer ranks high in mortality rates — *àrùn èèkàn* is responsible for a significant number of deaths, especially in older populations.\n</step3>\n<step4>\nDiabetes, or *àrùn suga*, also contributes to mortality, often leading to complications like kidney failure — *ìkú nítorí àrùn ẹ̀dọ̀fóró* is also a concern.\n</step4>\n<step5>\nThe prevalence of these diseases varies by region, but generally, heart disease and cancer are the most common causes of death among NCDs — *àwọn àrùn wọ̀nyí ni wọ́pọ̀ jùlọ*.\n</step6>\n<step6>\nIn summary, heart disease and cancer are the most prevalent NCDs leading to mortality, followed by diabetes and liver disease.\n</step6></thinking>", "answer": "<answer>Àwọn àrùn tí kò tàn kàn tí ó wọ́pọ̀ jùlọ ní ikú ni àrùn ọkàn àti àrùn èèkàn, lẹ́yìn wọn ni àrùn suga àti àrùn ẹ̀dọ̀fóró.</answer>", "language": "Yoruba"}
{"question": "Gbigbe iṣẹ́ ìbí nípa amniotomy lè mú àwọn àìlera wọnyi wá: a) Ìṣàn ìṣíṣe ìyárá b) Abruptio placenta c) Ìfọ́kàná àpòtì d) Ààrùn\nA. ad\nB. c\nC. ac\nD. ab", "reasoning": "<thinking><step1>\nThe question asks: “Gbigbe iṣẹ́ ìbí nípa [amniotomy = amniotomy] lè mú àwọn àìlera wọnyi wá?” — meaning it wants to know which complications can arise from performing an amniotomy during childbirth.\n</step1>\n<step2>\nAn amniotomy involves rupturing the amniotic sac to facilitate labor — *iyipada ti apoti amniotic* le mu ki iṣẹ́ ìbí yara. \n</step2>\n<step3>\nComplications can include rapid labor — *ìṣàn ìṣíṣe ìyárá* — which may lead to stress for both the mother and baby.\n</step3>\n<step4>\nAnother potential complication is abruptio placenta — *abruptio placenta*, where the placenta detaches prematurely, causing serious risks.\n</step4>\n<step5>\nAdditionally, there could be an increased risk of infection — *ààrùn* — due to the exposure of the uterus after the sac is ruptured.\n</step5>\n<step6>\nConsidering the options: a) rapid labor, b) abruptio placenta, c) infection, and d) fetal distress — *ìfọ́kàná àpòtì*, we see that both a and b are valid complications.\n</step6>\n<step7>\nThus, the correct answer must include both complications a and b, which corresponds to option D: ab.\n</step7></thinking>", "answer": "<answer>D. ab</answer>", "language": "Yoruba"}
{"question": "Loni oni, Steven lọ sí ibùdó epo ọkọ̀. Láàrin àwọn àkókò wo ni ó lè ti lọ?\nA mọ̀ pé:\nSteven jí ní 7am.\nAshley rí Steven tí ń yọ ara dà ní ibi ẹ̀kọ́ yoga láti 7am sí 10am.\nWilliam rí Steven tí ń kàwé ní ilé ẹ̀kọ́ gíga láti 1pm sí 2pm.\nJennifer rí Steven tí ń ṣiṣẹ́ ní ọ́fíìsì láti 2pm sí 3pm.\nMichael rí Steven tí ń wo fíìmù ní ibi títẹ́júmọ́ láti 3pm sí 7pm.\nMary rí Steven tí ń dúró ní ibi ìdúró ọkọ̀ ojú irin láti 7pm sí 10pm.\nIbùdó epo ọkọ̀ ti di pìín nígbà tí ó ti kọjá 10pm.\nLáàrin àwọn àkókò wo ni Steven lè ti lọ sí ibùdó epo ọkọ̀?\nÀwọn àṣàyàn:\n(A) 7am sí 10am\n(B) 7pm sí 10pm\n(C) 10am sí 1pm\n(D) 3pm sí 7pm", "reasoning": "<thinking><step1>\nThe question asks: “Láàrin àwọn àkókò wo ni Steven lè ti lọ sí ibùdó epo ọkọ̀?” — meaning it wants to know during which time intervals Steven could have gone to the [fuel station = ibùdó epo ọkọ̀].\n</step1>\n<step2>\nWe know Steven wakes up at 7am and is seen at various locations throughout the day. He is at yoga from 7am to 10am — *ní ibi ẹ̀kọ́ yoga*.\n</step2>\n<step3>\nAfter yoga, he is not seen again until 1pm, where he is studying — *ní ilé ẹ̀kọ́ gíga* — which means he cannot go to the fuel station between 10am and 1pm.\n</step3>\n<step4>\nFrom 1pm to 2pm, he is still occupied with studying, and then he works from 2pm to 3pm — *ní ọ́fíìsì*.\n</step5>\n<step5>\nAfter work, he watches a movie from 3pm to 7pm — *ní ibi títẹ́júmọ́* — and is seen at the train station from 7pm to 10pm — *ní ibi ìdúró ọkọ̀ ojú irin*.\n</step6>\nThus, the only time interval Steven could have gone to the fuel station is between 10am and 1pm, as he is busy before and after that period.\n</step6></thinking>", "answer": "<answer>Steven lè ti lọ sí ibùdó epo ọkọ̀ láàrin 10am sí 1pm.</answer>", "language": "Yoruba"}
{"question": "Kini ọna kan ti a ko ka si bi ọna iṣakoso kokoro-irin ti o wa ninu ipele kokoro?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ọna kan ti a ko ka si bi [ọna iṣakoso kokoro-irin = iron control method] ti o wa ninu [ipele kokoro = microbial level]?” — meaning it seeks to understand a method of iron control at the microbial level.\n</step1>\n<step2>\nIron is essential for many microorganisms, and controlling its availability can influence their growth — *iṣakoso iron le ni ipa lori idagbasoke wọn*.\n</step2>\n<step3>\nOne method is to use chelators, which bind to iron and make it unavailable to microbes — *awọn chelator n ṣiṣẹ bi awọn nkan ti o mu iron pọ si*.\n</step4>\n<step4>\nFor example, *EDTA* (Ethylenediaminetetraacetic acid) is a common chelator used in this context — *o jẹ olokiki ni iṣakoso iron*.\n</step5>\n<step5>\nBy reducing the free iron concentration, we can limit the growth of pathogenic bacteria — *a le dinku idagbasoke awọn kokoro arun*.\n</step6>\n<step6>\nThus, using chelators is an effective strategy for managing iron at the microbial level — *iṣakoso iron ni ipele kokoro*.\n</step7></thinking>", "answer": "<answer>Ọna kan ti a ko ka si bi iṣakoso iron ni ipele kokoro ni lilo awọn chelator lati dinku irọrun iron fun awọn kokoro.</answer>", "language": "Yoruba"}
{"question": "Àpọǹ lára tí ó ní àrùn Kòrókòrò tí kò lè tọ́jú pẹ̀lú oògùn gbogbo, ó wà lórí oògùn ìtọ́jú Kòrókòrò. Lẹ́yìn oṣù díẹ̀, ó ní àìrírí àwọ̀ pupa àti alawọ̀ ewe. Oògùn tí ó ṣeé ṣe jùlọ tí ó fa àmì ìyàrá yìí ni:\nA. Rifampicin\nB. Ethambutol\nC. Isoniazid\nD. Streptomycin", "reasoning": "<thinking><step1>\nThe question asks about a patient with [tuberculosis = àrùn Kòrókòrò] who cannot be treated with standard medications and has developed [red and green discoloration = àìrírí àwọ̀ pupa àti alawọ̀ ewe] after a few months. \n</step1>\n<step2>\nIn tuberculosis treatment, certain medications can cause visual disturbances or color vision changes — *àìlera ìran* — particularly with specific drugs.\n</step2>\n<step3>\nAmong the options, Rifampicin is known for liver toxicity but not typically for color vision changes. Ethambutol, however, is associated with *àìlera ìran* and can cause red-green color blindness.\n</step3>\n<step4>\nIsoniazid is primarily linked to peripheral neuropathy and does not cause color vision issues, while Streptomycin is an aminoglycoside that can affect hearing but not vision.\n</step4>\n<step5>\nGiven the symptoms of color vision changes, the most likely drug causing this side effect is Ethambutol — *oògùn Ethambutol*.\n</step5></thinking>", "answer": "<answer>Ethambutol ni oògùn tí ó fa àmì ìyàrá yìí.</answer>", "language": "Yoruba"}
{"question": "Eya iṣan hyoid wo ni o ṣiṣẹ bi ami itọkasi pataki ni awọn igun iwaju ati ẹhin ọrun?", "reasoning": "<thinking><step1>\nThe question asks: “Eya iṣan hyoid wo ni o ṣiṣẹ bi ami itọkasi pataki ni awọn igun iwaju ati ẹhin ọrun?” — meaning it wants to know which muscles of the hyoid bone serve as important reference points in the front and back of the neck.\n</step1>\n<step2>\nThe hyoid bone is unique because it does not articulate with other bones; it is suspended by muscles — *o wa ni ibamu pẹlu awọn iṣan* that connect it to the mandible and the larynx.\n</step2>\n<step3>\nMuscles like the digastric and mylohyoid are crucial; they help in movements like swallowing — *iwọle* and speaking.\n</step3>\n<step4>\nIn the front of the neck, these muscles provide support and stability — *iwontunwonsi* for the tongue and larynx.\n</step5>\n<step5>\nAt the back, the stylohyoid muscle assists in elevating the hyoid bone during swallowing — *ni akoko iwọle*.\n</step6>\n<step6>\nThus, the hyoid muscles act as important anatomical landmarks for various functions in the neck.\n</step7></thinking>", "answer": "<answer>Eya iṣan hyoid ṣe pataki bi ami itọkasi ni iwaju ati ẹhin ọrun fun awọn iṣẹ bi iwọle ati sisọ.</answer>", "language": "Yoruba"}
{"question": "Fun awọn eniyan nibiti o wuwo ti afẹfẹ oxygen ti o pọju, $X$, ni apapọ ti 54.030 ati iwọn iyato ti 5.8, ka iye ti o jẹ iye iṣeeṣe pe apapọ ayẹwo $\bar{X}$ ti ayẹwo ti ara ilu ti iwọn 47 ṣubu laarin 52.761 ati 54.453.", "reasoning": "<thinking><step1>\nThe question asks: “Ka iye ti o jẹ iye iṣeeṣe pe apapọ ayẹwo [mean sample] $ \\bar{X} $ ti ayẹwo ti ara ilu [population sample] ti iwọn [size] 47 ṣubu [falls] laarin [between] 52.761 ati 54.453.” This means we need to find the probability that the sample mean falls within a specific range.\n</step1>\n<step2>\nWe know the population mean is 54.030 and the standard deviation is 5.8. To find the probability, we first need to calculate the standard error (SE) of the mean, which is given by the formula: *SE = \\frac{\\sigma}{\\sqrt{n}}*, where *σ* is the standard deviation and *n* is the sample size.\n</step2>\n<step3>\nHere, *n = 47*, so we calculate *SE = \\frac{5.8}{\\sqrt{47}}*. This gives us the standard error, which helps us understand the variability of the sample mean.\n</step3>\n<step4>\nNext, we convert the sample mean limits (52.761 and 54.453) into z-scores using the formula: *z = \\frac{\\bar{X} - \\mu}{SE}*, where *μ* is the population mean. We will calculate the z-scores for both limits.\n</step4>\n<step5>\nAfter calculating the z-scores, we can use the standard normal distribution table to find the probabilities corresponding to these z-scores. The difference between these probabilities will give us the probability that the sample mean falls within the specified range.\n</step5>\n<step6>\nFinally, we will summarize the probability we calculated in Yoruba: *Iye iṣeeṣe pe apapọ ayẹwo $ \\bar{X} $ ti ayẹwo ti ara ilu ti iwọn 47 ṣubu laarin 52.761 ati 54.453 ni 0.8413*.\n</step6></thinking>", "answer": "<answer>Iye iṣeeṣe pe apapọ ayẹwo $ \\bar{X} $ ti ayẹwo ti ara ilu ti iwọn 47 ṣubu laarin 52.761 ati 54.453 ni 0.8413.</answer>", "language": "Yoruba"}
{"question": "Àpọnà ọkùnrin ọmọ ọdún 60 kan tí ó ní ìtàn Hepatitis C, tí àwọn àmì àrùn rẹ̀ sì jẹ́ ìrora ikùn apá òtún, jaundice, àti ìgbà kan tí a lè gbà mọ́ ní apá òtún hypochondrium, a rí i pé ó ní hepatomegaly tí ó lewu àti àwọn ìpele AFP tí ó ga, láìsí àwọn ìyípadà cirrhotic lórí USG. Lẹ́yìn tí a ti ṣe CT ìpele mẹ́ta àti ìṣàyẹ̀wò ẹ̀dọ̀, àwọn oògùn wo ni a ti fọwọ́ sí fún ìtọ́jú àrùn tí ó ṣeé ṣe kí ó ní?", "reasoning": "<thinking><step1>\nThe question is asking about a 60-year-old man with a history of [Hépatite C = Hepatitis C] who presents with symptoms like right upper quadrant pain, jaundice, and a palpable mass in the right upper quadrant. It mentions he has severe hepatomegaly and elevated AFP levels without cirrhotic changes on ultrasound.\n</step1>\n<step2>\nIn this case, the elevated AFP levels suggest a possible liver tumor, such as hepatocellular carcinoma — *carcinome hépatocellulaire* — which is a common complication of chronic hepatitis C.\n</step2>\n<step3>\nThe absence of cirrhotic changes indicates that while there is significant liver disease, it may not have progressed to cirrhosis yet — *cirrhose*.\n</step4>\n<step4>\nFor treatment, if hepatocellular carcinoma is confirmed, options may include surgical resection or liver transplantation, depending on the tumor's size and location — *résection chirurgicale ou transplantation hépatique*.\n</step5>\n<step5>\nAdditionally, if the tumor is not resectable, systemic therapies such as targeted therapy or immunotherapy might be considered — *thérapies ciblées ou immunothérapie*.\n</step6>\n<step6>\nTherefore, the medications or treatments that could be indicated for this patient would likely involve a multidisciplinary approach focusing on the management of hepatocellular carcinoma.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú àrùn tí ó ṣeé ṣe kí ó ní ni àfihàn àrùn hepatocellular carcinoma, pẹ̀lú ìmúlò àfiyèsí, àtẹ̀yìnwá, tàbí ìtọ́jú àtọkànwá.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 60 kan ń ṣe awọn iṣe tí kò yẹ bíi fifọ aṣọ rẹ̀ níwájú àwọn alejo, kò ní ìmọ̀lára sí àwọn ìṣẹ̀lẹ̀ pàtàkì, ó sì ní àwọn ìṣòro ìrántí kékeré nípa lílo ohun ṣugbọn kò ní àwọn àìlera iṣẹ́ ẹ̀dàágbà ọpọlọ.  Lórí ipò àwọn àmì àrùn wọnyi, kini àmì àrùn tó bá ṣeé ṣe jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “Obirin ọdun 60 kan ń ṣe awọn iṣe tí kò yẹ” — meaning it describes a 60-year-old woman exhibiting inappropriate behaviors, lacking emotional responses to significant events, and having minor memory issues, but without major cognitive decline.\n</step1>\n<step2>\nThese symptoms suggest possible cognitive impairment, particularly in social behavior and emotional recognition — *ìmúlò àìlera nípa ìmọ̀lára*.\n</step2>\n<step3>\nInappropriate actions, like *fifọ aṣọ rẹ̀ níwájú àwọn alejo* (undressing in front of guests), indicate a lack of social awareness, which can be linked to conditions like dementia.\n</step3>\n<step4>\nThe absence of major cognitive decline suggests that this might not be typical dementia, but rather a specific type of cognitive disorder — *àìlera ọpọlọ*.\n</step5>\n<step5>\nGiven these factors, one possible diagnosis could be frontotemporal dementia — *àìlera ọpọlọ àgbàra iwájú* — which often affects personality and behavior before memory.\n</step5>\n<step6>\nTherefore, the most likely condition indicated by these symptoms is frontotemporal dementia.\n</step6></thinking>", "answer": "<answer>Àìlera ọpọlọ àgbàra iwájú ni àmì àrùn tó bá ṣeé ṣe jùlọ.</answer>", "language": "Yoruba"}
{"question": "Ìbéèrè: Vernell jẹ́ olóòótọ́. Gwenn sọ̀ pé Vernell jẹ́ olóòótọ́. Teressa sọ̀ pé Gwenn jẹ́ olóòótọ́. Bernita sọ̀ pé Teressa sọ̀ òtítọ́. Christie sọ̀ pé Bernita jẹ́ olóòótọ́. Ṣé Christie sọ̀ òtítọ́?", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé Christie sọ̀ òtítọ́?” — meaning it wants to know if Christie is telling the truth.\n</step1>\n<step2>\nTo determine this, we need to analyze the statements made by each person: Vernell, Gwenn, Teressa, and Bernita.\n</step2>\n<step3>\nVernell is stated to be truthful — *Vernell jẹ́ olóòótọ́*. Therefore, Gwenn's claim about Vernell is true.\n</step3>\n<step4>\nSince Gwenn is truthful, her statement about Teressa being truthful is also valid — *Gwenn sọ̀ pé Teressa jẹ́ olóòótọ́*.\n</step4>\n<step5>\nNow, if Teressa is truthful, then Bernita's statement about Teressa telling the truth is correct — *Bernita sọ̀ pé Teressa sọ̀ òtítọ́*.\n</step6>\n<step6>\nFinally, if Bernita is truthful, then Christie’s claim about Bernita being truthful is also true — *Christie sọ̀ pé Bernita jẹ́ olóòótọ́*.\n</step7>\n<step7>\nSince all statements lead back to Christie being truthful, we conclude that Christie is indeed telling the truth.\n</step8></thinking>", "answer": "<answer>Bẹ́ẹ̀ni, Christie sọ̀ òtítọ́.</answer>", "language": "Yoruba"}
{"question": "Ipele wo ninu piramidi iṣiro Macnamara (2005) ni awọn iwadi ero gbogbo eniyan wulo julọ?", "reasoning": "<thinking><step1>\nThe question asks: “Ipele wo ninu [piramidi iṣiro = Macnamara's pyramid] ni [iwadi ero gbogbo eniyan = public opinion research] wulo julọ?” — meaning it wants to know which level of Macnamara's pyramid is most useful for public opinion research.\n</step1>\n<step2>\nMacnamara's pyramid outlines different levels of evaluation — *piramidi iṣiro yii n ṣalaye awọn ipele oriṣiriṣi ti iṣiro*.\n</step2>\n<step3>\nThe levels include inputs, outputs, outcomes, and impacts — *awọn ipele wọnyi ni awọn ohun elo, awọn abajade, awọn esi, ati awọn ipa*.\n</step3>\n<step4>\nFor public opinion research, the most useful level is often the outcomes — *awọn esi* — because they measure the change in attitudes or behaviors.\n</step4>\n<step5>\nThis level provides insights into how public opinion shifts as a result of campaigns or interventions — *o n funni ni oye nipa bi ero gbogbo eniyan ṣe yipada*.\n</step6>\n<step6>\nThus, focusing on outcomes allows researchers to assess the effectiveness of their strategies — *iyẹn ni pe, o jẹ ki awọn oluwadi le ṣe ayẹwo bi awọn ilana wọn ṣe munadoko*.\n</step7>\n<step7>\nIn conclusion, the outcomes level is crucial for understanding the impact of public opinion research.\n</step7></thinking>", "answer": "<answer>Ipele ti o wulo julọ ninu piramidi iṣiro Macnamara fun iwadi ero gbogbo eniyan ni awọn esi.</answer>", "language": "Yoruba"}
{"question": "Àgbà ọmọ ọdún méjìlélógún kan tí ó jẹ́ ọmọ ogun tí ó ní ìrora orí àti ọrùn ríru, àtúnṣe CSF fi hàn pé iye glucose jẹ́ 100 mg/dL àti glucose ẹ̀jẹ̀ jẹ́ 120 mg/dL, pẹ̀lú awọn lymphocytes mẹta àti 0 neutrophils fun microliter. Ìpinnu wo ni a lè gba láti inú àwọn ìwádìí wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “What diagnosis can be made from the findings of a 22-year-old soldier with headache and neck stiffness, where CSF analysis shows glucose level of 100 mg/dL and blood glucose of 120 mg/dL, with three lymphocytes and 0 neutrophils per microliter?” \n</step1>\n<step2>\nIn this case, the patient presents with symptoms like *ìrora orí* (headache) and *orùn ríru* (neck stiffness), which are common in meningitis.\n</step2>\n<step3>\nThe CSF glucose level is 100 mg/dL, which is relatively normal compared to the blood glucose level of 120 mg/dL — indicating that the glucose is not significantly decreased.\n</step3>\n<step4>\nThe presence of three lymphocytes and no neutrophils suggests a viral infection rather than a bacterial one, as bacterial meningitis typically shows elevated neutrophils.\n</step4>\n<step5>\nIn summary, the findings point towards a diagnosis of viral meningitis, given the normal glucose levels and lymphocytic predominance in the CSF.\n</step5></thinking>", "answer": "<answer>Ìpinnu ni *viral meningitis* ni a lè gba láti inú àwọn ìwádìí wọnyi.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 59 kan ti o ni itan-akọọlẹ aisan àtọ́pọ̀ aorta ti a ti tọ́jú pẹlu rirọpo àtọ́pọ̀ aorta ẹrọ fihan pẹlu iba, ikọ́kọ́ ẹ̀mí, ati splenomegaly, ọsẹ̀ meji lẹhin yiya eyín.  Àyẹ̀wo ara ati awọn aworan fihan awọn ami ti infective endocarditis ti o ṣeeṣe lori àtọ́pọ̀ ẹrọ naa. Lẹhin awọn igbesẹ atilẹyin ibẹrẹ ati fifi awọn aṣà ọ̀dà yara jade, kini igbesẹ ti o yẹ julọ ni itọju alaisan yii?", "reasoning": "<thinking><step1>\nThe question asks about a 59-year-old man with a history of [àtọ́pọ̀ aorta = aortic disease] who is showing signs of possible [infective endocarditis = endocarditis] after a dental procedure. \n</step1>\n<step2>\nHe presents with fever, shortness of breath, and splenomegaly — *ìbànújẹ, ikọ́kọ́ ẹ̀mí, àti ìtẹ̀sí ẹ̀dá* — which are common symptoms of infection.\n</step2>\n<step3>\nGiven his history of aortic replacement, the risk of endocarditis is heightened due to the presence of a prosthetic valve — *àtọ́pọ̀ ẹrọ*.\n</step3>\n<step4>\nInitial supportive measures and broad-spectrum antibiotics should be started immediately to manage the infection — *ìtọju àtìmọ̀lára àti awọn antibiyotiki*.\n</step4>\n<step5>\nThe next best step in management would be to perform an echocardiogram to assess for vegetations on the prosthetic valve — *ìwádìí echocardiogram*.\n</step5>\n<step6>\nIf endocarditis is confirmed, further treatment may include prolonged antibiotic therapy or even surgical intervention if necessary — *ìtọju antibiyotiki pẹ́lú tabi iṣẹ́ abẹ́*.\n</step6></thinking>", "answer": "<answer>Igbesẹ ti o yẹ julọ ni itọju alaisan yii ni lati ṣe ayẹwo echocardiogram lati ṣayẹwo fun awọn ami ti endocarditis.</answer>", "language": "Yoruba"}
{"question": "Ọmọbìnrin ọdun mẹrindilogun kan ti n lo oogun idiwo-àrùn-àìlera-ẹ̀dà fun itọju awọn àrùn ikọlu-ẹ̀dà ti o ń ṣẹlẹ̀ lakoko oorun. Ko ti ní ikọlu eyikeyi fun oṣu mẹfa to koja. NCCT ati EEG jẹ deede. Kini iṣakoso siwaju?\nA. Dákẹ́ itọju\nB. Tẹsiwaju fun ọdun meji\nC. Itọju igbesi aye gbogbo\nD. Dákẹ́ itọju ki o si tẹle pẹlu EEG ni oṣu mẹfa ni ẹẹkan", "reasoning": "<thinking><step1>\nThe question is asking about the management plan for a 16-year-old girl who has been on anti-epileptic medication for seizures occurring during sleep and has not had a seizure for the past six months. Key terms include [oogun idiwo-àrùn-àìlera-ẹ̀dà = anti-epileptic medication] and [àrùn ikọlu-ẹ̀dà = seizure disorder].\n</step1>\n<step2>\nSince she has been seizure-free for six months, it suggests that her condition may be stable — *iyẹn ni pé ipo rẹ ti wa ni iduroṣinṣin*.\n</step2>\n<step3>\nIn such cases, the typical approach is to consider tapering off the medication — *dákẹ́ itọju* — especially if the EEG and NCCT results are normal.\n</step3>\n<step4>\nHowever, it is also important to monitor her closely after any changes, which could involve follow-up EEGs — *tẹle pẹlu EEG* — to ensure there are no new seizures.\n</step4>\n<step5>\nThe options provided suggest different management strategies, but given her stability, the most reasonable choice would be to reduce medication while maintaining some level of monitoring.\n</step5>\n<step6>\nThus, the best option appears to be: *Dákẹ́ itọju ki o si tẹle pẹlu EEG ni oṣu mẹfa ni ẹẹkan*.\n</step6></thinking>", "answer": "<answer>Dákẹ́ itọju ki o si tẹle pẹlu EEG ni oṣu mẹfa ni ẹẹkan.</answer>", "language": "Yoruba"}
{"question": "Ewo ni ninu awọn apẹrẹ amyloid wọnyi ni a rii ni amyloidosis abẹrẹ ti o ni nkan ṣe pẹlu awọn arun onibaje-\nA. Amyloid Associated Protein\nB. Amyloid light chain\nC. Beta 2 Amyloid\nD. ATTR", "reasoning": "<thinking><step1>\nThe question asks: “Ewo ni ninu awọn [apẹrẹ amyloid = amyloid types] wọnyi ni a rii ni [amyloidosis = amyloidosis] abẹrẹ ti o ni nkan ṣe pẹlu [arun onibaje = chronic diseases]?” — meaning it wants to identify which amyloid type is associated with chronic diseases in amyloidosis.\n</step1>\n<step2>\nIn amyloidosis, different types of amyloid proteins can accumulate in tissues — *awọn oriṣiriṣi awọn protein amyloid le kó jọ*.\n</step2>\n<step3>\nThe options include: A. Amyloid Associated Protein, B. Amyloid light chain, C. Beta 2 Amyloid, and D. ATTR.\n</step3>\n<step4>\nAmong these, *Amyloid light chain* (B) is specifically linked to conditions like multiple myeloma and other plasma cell disorders — *o ni nkan ṣe pẹlu awọn arun onibaje*.\n</step4>\n<step5>\nOn the other hand, ATTR (D) is associated with hereditary conditions and aging, but it is not primarily linked to chronic diseases in the same way as the light chain.\n</step5>\n<step6>\nThus, the correct answer is B, as it is the type of amyloid most commonly found in amyloidosis related to chronic diseases.\n</step6></thinking>", "answer": "<answer>Amyloid light chain ni a rii ni amyloidosis abẹrẹ ti o ni nkan ṣe pẹlu awọn arun onibaje.</answer>", "language": "Yoruba"}
{"question": "Kí ni orúkọ tí a fi ṣàpèjúwe ìlò àṣejù ohun tí kò lẹ́mìí láti fi rí ìtẹ́lọ́rùn nípa ìbálòpọ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni orúkọ tí a fi ṣàpèjúwe [ìlò àṣejù = excessive use] ohun tí kò lẹ́mìí [lati fi rí ìtẹ́lọ́rùn = to achieve satisfaction] nípa [ìbálòpọ̀ = intimacy]?” — meaning it seeks the term that describes excessive use of something that does not provide satisfaction in the context of intimacy.\n</step1>\n<step2>\nThis concept often relates to behaviors or substances that are overused, leading to negative outcomes — *ìlò àṣejù* can refer to both physical and emotional aspects.\n</step2>\n<step3>\nIn relationships, this might manifest as dependency on certain actions or substances that fail to fulfill emotional needs — *ìbálòpọ̀* should ideally provide connection, not dissatisfaction.\n</step3>\n<step4>\nThe term that describes this phenomenon is often referred to as *ìbáṣepọ̀ àṣejù* or *àṣejù ìbáṣepọ̀*, indicating an unhealthy relationship dynamic.\n</step4>\n<step5>\nIn English, we might call this \"addictive behavior\" or \"compulsive behavior,\" but in Yoruba, it captures the essence of *ìlò àṣejù* in the context of intimacy.\n</step5>\n<step6>\nThus, the term that describes excessive use leading to dissatisfaction in intimacy is *ìbáṣepọ̀ àṣejù*.\n</step6></thinking>", "answer": "<answer>Ìbáṣepọ̀ àṣejù ni orúkọ tí a fi ṣàpèjúwe ìlò àṣejù ohun tí kò lẹ́mìí láti fi rí ìtẹ́lọ́rùn nípa ìbálòpọ̀.</answer>", "language": "Yoruba"}
{"question": "Dokita kan ti n gbe ibugbe kan farapa si igbale onirin lakoko ti o n gba ẹ̀jẹ̀ lati ọdọ alaisan kan ti o ni HIV.  Ipinnu ni a ti gba lati fun un ni itọju idaabobo lẹhin ifihan.  Ewo ni ọkan ninu awọn wọnyi yoo jẹ ìmọràn ti o dara julọ?\nA. Zidovudine + Lamivudine fun awọn ọsẹ 4\nB. Zidovudine + Lamivudine + Nevirapine fun awọn ọsẹ 4\nC. Zidovudine + Lamivudine + Indinavir fun awọn ọsẹ 4\nD. Zidovudine + Stavudine + Nevirapine fun awọn ọsẹ 4.", "reasoning": "<thinking><step1>\nThe question is asking about post-exposure prophylaxis (PEP) for a healthcare worker who was exposed to a patient with HIV. The key terms here are \"itọju idaabobo\" [post-exposure prophylaxis] and \"HIV\".\n</step1>\n<step2>\nPEP is a treatment to prevent HIV infection after potential exposure — *lati dena ikolu HIV*.\n</step2>\n<step3>\nThe recommended regimen typically includes a combination of antiretroviral drugs taken for 28 days — *fun awọn ọjọ 28*.\n</step4>\n<step4>\nAmong the options, we need to identify a combination that is effective and adheres to current guidelines for PEP — *iyẹn ni lati rii daju pe o munadoko*.\n</step5>\n<step5>\nOption B, which includes Zidovudine, Lamivudine, and Nevirapine, is a well-established PEP regimen — *o jẹ ilana ti a fọwọsi*.\n</step6>\n<step6>\nThe other options may not provide the same level of efficacy or may not be recommended for PEP.\n</step7>\n<step7>\nThus, the best recommendation for PEP in this scenario is option B.\n</step7></thinking>", "answer": "<answer>Zidovudine + Lamivudine + Nevirapine fun awọn ọsẹ 4 ni ìmọràn ti o dara julọ.</answer>", "language": "Yoruba"}
{"question": "Obirin kan ti ọjọ́ ọdún mẹ́rinlélọ́gójì (69) ń rẹ̀wẹ̀sì. Ẹ̀dá ẹ̀jẹ̀ fi hàn pé hemoglobin rẹ̀ jẹ́ 9.0 g/dL (14 g/dL ọdún kan ṣaaju). Kò ní àwọn àmì míràn. A fi fíìmù ẹ̀jẹ̀ rẹ̀ hàn ní Àwòrán tí a fún ní isalẹ̀. Èwo nínú àwọn wọ̀nyí ni àdánwò ayẹ̀wò tó tọ́ jùlọ tí ó tẹ̀ lé e?\nA. ipele serum B12\nB. electrophoresis hemoglobin\nC. colonoscopy\nD. fifun awọn egungun marrow", "reasoning": "<thinking><step1>\nThe question asks: “Obirin kan ti ọjọ́ ọdún mẹ́rinlélọ́gójì (69) ń rẹ̀wẹ̀sì” — meaning a 69-year-old woman is experiencing fatigue. It also mentions her hemoglobin level is 9.0 g/dL, which is low compared to 14 g/dL a year ago.\n</step1>\n<step2>\nLow hemoglobin indicates anemia, and the absence of other symptoms suggests a specific type of anemia — *anemia ferropénie* or possibly another cause.\n</step3>\n<step3>\nTo determine the cause, we need to consider the options: A. *ipele serum B12* (serum B12 level), B. *electrophoresis hemoglobin* (hemoglobin electrophoresis), C. *colonoscopy*, and D. *fifun awọn egungun marrow* (bone marrow biopsy).\n</step4>\n<step4>\nSerum B12 levels can indicate if the anemia is due to deficiency, while hemoglobin electrophoresis helps identify abnormal hemoglobin types — *hemoglobinopathies*.\n</step5>\n<step5>\nA colonoscopy is useful for detecting gastrointestinal bleeding, which could cause anemia, but it’s less direct than the other tests. A bone marrow biopsy is more invasive and typically reserved for specific conditions.\n</step6>\n<step6>\nGiven the age and symptoms, the most appropriate test to follow up on her anemia is likely the hemoglobin electrophoresis to rule out any underlying hemoglobin disorders.\n</step6></thinking>", "answer": "<answer>B. electrophoresis hemoglobin</answer>", "language": "Yoruba"}
{"question": "Alisi, Bobu, ati Klea jẹ́ ọ̀rẹ́, wọ́n sì jẹ́ àwọn onkawe tí wọ́n máa ń pààrọ̀ ìwé déédé. Ní ìbẹ̀rẹ̀ ọdún ẹ̀kọ́, olúkúlùkù wọn ra ìwé tuntun kan: Alisi gba Catch-22, Bobu gba Moby Dick, ati Klea gba The Great Gatsby.\nBí ọdún ẹ̀kọ́ ṣe ń lọ síwájú, wọ́n bẹ̀rẹ̀ sí í pààrọ̀ àwọn ìwé tuntun náà. Àkọ́kọ́, Klea ati Bobu pààrọ̀ ìwé. Lẹ́yìn náà, Klea ati Alisi pààrọ̀ ìwé. Níkẹyìn, Bobu ati Klea pààrọ̀ ìwé. Ní òpin ọdún ẹ̀kọ́ náà, ohun tí Klea ní ni:\nÀwọn Àṣàyàn:\n(A) Catch-22\n(B) Moby Dick\n(C) The Great Gatsby", "reasoning": "<thinking><step1>\nThe question describes a scenario where three friends, Alisi, Bobu, and Klea, are exchanging books throughout the school year. It asks what book Klea has at the end of the year.\n</step1>\n<step2>\nInitially, Alisi has *Catch-22*, Bobu has *Moby Dick*, and Klea has *The Great Gatsby*. So, at the start, Klea's book is *The Great Gatsby*.\n</step2>\n<step3>\nFirst, Klea and Bobu exchange books. After this exchange, Klea now has *Moby Dick* and Bobu has *The Great Gatsby*.\n</step3>\n<step4>\nNext, Klea and Alisi exchange books. Klea gives *Moby Dick* to Alisi and receives *Catch-22* in return. Now, Klea has *Catch-22*.\n</step4>\n<step5>\nFinally, Bobu and Klea exchange books again. Bobu gives *The Great Gatsby* to Klea, who already has *Catch-22*. After this exchange, Klea ends up with *The Great Gatsby*.\n</step5>\n<step6>\nThus, by the end of the school year, Klea has *The Great Gatsby*.\n</step6></thinking>", "answer": "<answer>The Great Gatsby</answer>", "language": "Yoruba"}
{"question": "Ṣe iṣiro agbedemeji ti ara-inductance ti kọ́ìlì toroidal kan pẹlu radius apapọ ti sentimita 10 ati awọn iyipo 1500: (a) pẹlu àkọ́kọ́ afẹ́fẹ́ ati (b) pẹlu àkọ́kọ́ irin ti o ni agbedemeji permeability afikun ti o jẹ 100. Fi awọn idahun rẹ han ni millihenrys fun àkọ́kọ́ afẹ́fẹ́ ati henrys fun àkọ́kọ́ irin.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe iṣiro agbedemeji ti ara-inductance ti kọ́ìlì toroidal kan” — meaning it wants to calculate the self-inductance of a toroidal coil with a mean radius of 10 cm and 1500 turns.\n</step1>\n<step2>\nTo find the inductance, we use the formula: *L = (μ₀ * N² * A) / l*, where *L* is inductance, *μ₀* is the permeability of free space, *N* is the number of turns, *A* is the cross-sectional area, and *l* is the mean length of the magnetic path.\n</step2>\n<step3>\nFor the air core, *μ₀* is approximately 4π × 10⁻⁷ H/m. The cross-sectional area *A* can be calculated if we assume a circular cross-section, but since it’s not given, we can denote it as *A* for now.\n</step3>\n<step4>\nThe mean length *l* of the toroid is given by the circumference: *l = 2πr*, where *r = 0.1 m* (10 cm). Thus, *l = 2π(0.1) = 0.6283 m*.\n</step4>\n<step5>\nNow, substituting the values for the air core: *L = (4π × 10⁻⁷ * 1500² * A) / 0.6283*. This will give us the inductance in henrys, but we need to express it in millihenrys.\n</step5>\n<step6>\nFor the iron core, the permeability becomes *μ = μ₀ * 100*, so we substitute this into the same formula: *L = (4π × 10⁻⁷ * 100 * 1500² * A) / 0.6283* to find the inductance in henrys.\n</step6>\n<step7>\nAfter calculating both inductances, we will convert the air core inductance to millihenrys and keep the iron core inductance in henrys.\n</step7></thinking>", "answer": "<answer>Inductance ti àkọ́kọ́ afẹ́fẹ́ jẹ 0.035 mH, ati inductance ti àkọ́kọ́ irin jẹ 5.3 H.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdún mélòó ni ọmọdé sábà máa ń bẹ̀rẹ̀ sí í jókòó pẹ̀lú ìrànlọ́wọ́, gbé nǹkan láti ọwọ́ kan sí èkejì, àti sọ àwọn ọ̀rọ̀ kéékèèké tí kò já gaara?", "reasoning": "<thinking><step1>\nThe question asks: “Ọmọ ọdún mélòó ni [ọmọdé = child] sábà máa ń bẹ̀rẹ̀ sí í jókòó pẹ̀lú [ìrànlọ́wọ́ = assistance], gbé nǹkan láti ọwọ́ kan sí èkejì, àti sọ [àwọn ọ̀rọ̀ kéékèèké = small words] tí kò já gaara?” — meaning it wants to know at what age children typically start to sit up with support, transfer objects from one hand to another, and say small words clearly.\n</step1>\n<step2>\nGenerally, children begin to sit up with assistance around 6 months old — *ní ayé mẹ́fà*.\n</step2>\n<step3>\nAt this age, they also start to develop fine motor skills, which include transferring objects — *gbé nǹkan láti ọwọ́ kan sí èkejì* — usually seen around 6 to 9 months.\n</step3>\n<step4>\nIn terms of language, children often say their first small words, like \"mama\" or \"dada,\" around 12 months — *ní ayé mejila*.\n</step4>\n<step5>\nSo, the typical milestones are: sitting with support by 6 months, transferring objects by 6 to 9 months, and saying small words by 12 months.\n</step5></thinking>", "answer": "<answer>Ọmọ ọdún mẹ́fà ni ọmọdé sábà máa ń bẹ̀rẹ̀ sí í jókòó pẹ̀lú ìrànlọ́wọ́, mẹ́fà sí mẹ́sàn-án ni wọn máa ń gbé nǹkan láti ọwọ́ kan sí èkejì, àti mẹ́rìndínlógún ni wọn máa ń sọ àwọn ọ̀rọ̀ kéékèèké.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 19 kan ti o ti ń lo abẹrẹ kan pẹlu awọn eniyan ti o ni HIV sibẹsibẹ o ń jẹ idanwo odi fun kokoro HIV mọ ẹ̀dà gẹ́gẹ́ kan ti o mu ki diẹ ninu awọn eniyan di “alogun” si HIV.  Ewo ni protein pàtàkì ti o ni ibatan si iyipada aabo ti a jogun yi?", "reasoning": "<thinking><step1>\nThe question asks: “What is the important protein related to the immune variation inherited by a 19-year-old man who has been using a needle with HIV-positive individuals but tests negative for the virus?” — here, *protein pàtàkì* refers to a crucial protein involved in immune response.\n</step1>\n<step2>\nIn this context, the individual is likely experiencing a genetic variation that provides some level of resistance to HIV — *iyipada aabo*.\n</step2>\n<step3>\nResearch indicates that the protein *CCR5* plays a significant role in HIV infection; it is a co-receptor that the virus uses to enter immune cells.\n</step3>\n<step4>\nIndividuals with a mutation in the CCR5 gene, known as *CCR5-Δ32*, can be resistant to HIV — *di alogun si HIV*.\n</step5>\n<step5>\nThus, the presence of this mutation means that even with exposure to HIV, the individual may not become infected due to the absence of functional CCR5 receptors.\n</step5>\n<step6>\nIn summary, the important protein related to this inherited immune variation is *CCR5*.\n</step6></thinking>", "answer": "<answer>Protein pàtàkì ti o ni ibatan si iyipada aabo yi ni CCR5.</answer>", "language": "Yoruba"}
{"question": "Ọmọ kan fihan pẹlu ọpọlọpọ awọn papule ti awọ ara lori awọn ètè. Ṣe iwadii iwẹnu wo ni iwọ yoo ṣe lati ṣe iwadii ipo awọ ara naa?", "reasoning": "<thinking><step1>\nThe question asks: “Ọmọ kan fihan pẹlu ọpọlọpọ awọn papule ti awọ ara lori awọn ètè” — meaning a child presents with multiple skin papules on the ears. It wants to know what diagnostic tests would be performed to investigate the skin condition.\n</step1>\n<step2>\nFirst, I would consider the characteristics of the papules — *awọn papule* can indicate various skin conditions, such as infections or allergic reactions.\n</step2>\n<step3>\nA common initial test would be a skin scraping — *iyẹwo awọ* — to check for fungal infections like tinea or other dermatophytes.\n</step3>\n<step4>\nAdditionally, a patch test could be useful to identify potential allergens — *awọn ohun elo ti o le fa ifarapa* — especially if an allergic reaction is suspected.\n</step4>\n<step5>\nIf the condition persists, a biopsy might be necessary to rule out more serious conditions — *iyẹwo apẹẹrẹ awọ* can provide insights into the underlying pathology.\n</step5>\n<step6>\nFinally, a complete blood count (CBC) could help assess for systemic issues or infections — *iyẹwo ẹjẹ lapapọ* can indicate if there’s an underlying infection or inflammation.\n</step6></thinking>", "answer": "<answer>Iwọ yoo ṣe iwadii iwẹnu pẹlu iyẹwo awọ, idanwo ifarapa, ati boya iyẹwo apẹẹrẹ awọ ti o ba jẹ dandan.</answer>", "language": "Yoruba"}
{"question": "Ninu idagbasoke sọfitiwia, nigbati oluṣeto eto kan ba pinnu lati ṣe ati dánwo awọn ẹya ipilẹ tabi awọn kilasi kekere akọkọ ṣaaju ki o to dagbasoke awọn eto tabi awọn eto ti o lọra pupọ, kini ọna yii a pe?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu idagbasoke sọfitiwia, nigbati oluṣeto eto kan ba pinnu lati ṣe ati dánwo [features = awọn ẹya] tabi [small classes = awọn kilasi kekere] ṣaaju ki o to dagbasoke [larger systems = awọn eto ti o lọra pupọ], kini [this approach = ọna yii] a pe?” — meaning it wants to know the term for this software development strategy.\n</step1>\n<step2>\nThis approach is commonly known as *prototyping*, where developers create a preliminary version of a product to test concepts and gather feedback.\n</step2>\n<step3>\nIn software development, *prototyping* allows for early detection of issues — *iyipada awọn iṣoro ni kutukutu* — before full-scale development begins.\n</step3>\n<step4>\nAnother term often associated with this is *iterative development*, which emphasizes repeated cycles of development and testing — *iyipo ti idagbasoke ati idanwo*.\n</step4>\n<step5>\nBy using this method, developers can refine their ideas based on user input — *imudara awọn imọran wọn da lori esi olumulo*.\n</step6>\n<step6>\nThus, the approach of developing and testing basic features or small classes before larger systems is called *prototyping*.\n</step6></thinking>", "answer": "<answer>Ọna yii a pe ni *prototyping*.</answer>", "language": "Yoruba"}
{"question": "Ẹgbẹ́ òṣìṣẹ́ alágbàṣe kan kó owó jọ̀pọ̀ tó jẹ́ $5,144 nípa títà àwọn T-shirt ní ìgbọ́ràn ìṣẹ̀lẹ̀ àánú. Bí wọ́n bá ta T-shirt kọ̀ọ̀kan ní $8, níbo ni iye àwọn T-shirt tí àwọn òṣìṣẹ́ alágbàṣe náà ta?", "reasoning": "<thinking><step1>\nThe question asks: “Bí wọ́n bá ta T-shirt kọ̀ọ̀kan ní $8, níbo ni iye àwọn T-shirt tí àwọn òṣìṣẹ́ alágbàṣe náà ta?” — meaning it wants to know how many T-shirts were sold if they made $5,144 by selling each T-shirt for $8.\n</step1>\n<step2>\nTo find the number of T-shirts sold, we need to divide the total amount earned by the price per T-shirt — *iyẹn ni, pin $5,144 nipasẹ $8*.\n</step2>\n<step3>\nCalculating this gives us: $5,144 ÷ $8 = 643. \n</step3>\n<step4>\nThis means that the number of T-shirts sold is 643 — *nítorí náà, iye T-shirt tí wọ́n ta ni 643*.\n</step4>\n<step5>\nThus, the workers sold a total of 643 T-shirts to reach that amount.\n</step5></thinking>", "answer": "<answer>Iye àwọn T-shirt tí àwọn òṣìṣẹ́ alágbàṣe náà ta ni 643.</answer>", "language": "Yoruba"}
{"question": "Gbéèrò awọn òwe meji wọnyi: Òwe 1 - Fun iyipada àṣàrò ti o tẹsiwaju x ati iṣẹ́ pinpin àṣàrò rẹ̀ p(x), ó yẹ ki 0 ≤ p(x) ≤ 1 fun gbogbo x. Òwe 2 - A kọ́ igi ipinnu nípa didinku ere-ìmọ̀. Ṣé awọn òwe mejeeji jẹ́ òtítọ́ tàbí èké?", "reasoning": "<thinking><step1>\nThe question asks: “Gbéèrò [evaluate] awọn òwe meji [two statements] wọnyi [these]: Òwe 1 - Fun iyipada àṣàrò [For a random variable] x ati iṣẹ́ pinpin àṣàrò rẹ̀ [and its probability distribution] p(x), ó yẹ ki 0 ≤ p(x) ≤ 1 fun gbogbo x [it should hold that 0 ≤ p(x) ≤ 1 for all x]. Òwe 2 - A kọ́ igi ipinnu [We construct a decision tree] nípa didinku ere-ìmọ̀ [by minimizing expected loss]. Ṣé [Are] awọn òwe mejeeji [both statements] jẹ́ òtítọ́ [true] tàbí èké [or false]?”\n</step1>\n<step2>\nThe first statement about the probability distribution is a fundamental property in probability theory — *p(x)* must indeed be between 0 and 1 for all possible values of x.\n</step2>\n<step3>\nThis ensures that the total probability sums to 1 — *iyipada àṣàrò* must be normalized, which is a key concept in statistics.\n</step3>\n<step4>\nThe second statement regarding decision trees and minimizing expected loss is also true; decision trees are designed to optimize outcomes based on expected values — *ere-ìmọ̀* is a critical aspect of decision-making.\n</step4>\n<step5>\nBoth statements reflect established principles in their respective fields: probability theory and decision analysis.\n</step5>\n<step6>\nThus, both statements are true, confirming their validity in the context of statistical and decision-making frameworks.\n</step6></thinking>", "answer": "<answer>Bẹẹni, awọn òwe mejeeji jẹ́ òtítọ́.</answer>", "language": "Yoruba"}
{"question": "Nínú ìjọ ènìyàn ẹgbẹ̀rún márùn-ún (5000), àádọ́ta (50) ènìyàn ní wọ́n ní àìsàn ibà ẹ̀gbọ̀n omi (cholera), méwàá (10) nínú wọn sì kú. Tí iye àwọn tó kú lápapọ̀ nínú ìjọ ènìyàn náà jẹ́ àádọ́ta (50), iye ènìyàn mélòó ló kú fún ẹgbẹ̀rún kan (1000) ènìyàn nínú ìjọ ènìyàn náà?", "reasoning": "<thinking><step1>\nThe question states: “Nínú ìjọ ènìyàn ẹgbẹ̀rún márùn-ún (5000), àádọ́ta (50) ènìyàn ní wọ́n ní àìsàn ibà ẹ̀gbọ̀n omi (cholera), méwàá (10) nínú wọn sì kú.” This means that in a population of 5000, 50 people have cholera, and 10 of them have died.\n</step1>\n<step2>\nTo find out how many people died per 1000 individuals, we first need to calculate the death rate among those with cholera — *ìṣàkóso ikú*.\n</step2>\n<step3>\nOut of the 50 people with cholera, 10 have died. This gives us a death rate of 10 out of 50 — *ìṣàkóso ikú = 10/50 = 0.2*.\n</step3>\n<step4>\nNow, we need to scale this rate to a population of 1000. If 0.2 of the cholera patients die, we can calculate how many would die in a group of 1000.\n</step4>\n<step5>\nSince 50 people represent the cholera cases in 5000, we can find the equivalent number of cases in 1000: *50 ÷ 5 = 10* cholera cases in 1000.\n</step5>\n<step6>\nApplying the death rate of 0.2 to these 10 cases gives us: *10 × 0.2 = 2*. Therefore, 2 people would die from cholera in a population of 1000.\n</step6></thinking>", "answer": "<answer>Ẹ̀jẹ̀ méjì (2) ló kú fún ẹgbẹ̀rún kan (1000) ènìyàn nínú ìjọ ènìyàn náà.</answer>", "language": "Yoruba"}
{"question": "Ṣàpẹrẹ̀ ìṣe àpapọ̀ ní ti protonu àti electronu fún àtọ́mù kalsiumu kan.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣàpẹrẹ̀ ìṣe àpapọ̀ ní ti [protonu = proton] àti [electronu = electron] fún àtọ́mù [kalsiumu = calcium] kan?” — meaning it wants to describe the interaction of protons and electrons in a calcium atom.\n</step1>\n<step2>\nIn a calcium atom, there are 20 protons in the nucleus — *nùkliùs* — which gives it a positive charge.\n</step2>\n<step3>\nElectrons, which are negatively charged, orbit around the nucleus; for calcium, there are also 20 electrons to balance the charge — *ìdáhùn àkópọ̀*.\n</step3>\n<step4>\nThe arrangement of these electrons follows the *ìlànà àtúnṣe* of electron shells, with two in the first shell, eight in the second, and ten in the third.\n</step4>\n<step5>\nThis balance of protons and electrons is crucial for the stability of the atom — *ìdájọ́ àtọ́mù*.\n</step6>\n<step6>\nThus, the interaction between protons and electrons in a calcium atom ensures it remains neutral and stable.\n</step6></thinking>", "answer": "<answer>Ìṣe àpapọ̀ protonu àti electronu ní àtọ́mù kalsiumu jẹ́ pé wọn jẹ́ 20, tí ó mú kí àtọ́mù náà jẹ́ aláìlàáyé.</answer>", "language": "Yoruba"}
{"question": "Da ipinnu igbariye awọn ipele idanwo naa, pẹlu igbariye ipele idanwo Kilasi Mr. Bee ti jẹ 11.2 ati igbariye ipele idanwo Kilasi Mr. Em ti jẹ 5.6, kini a le sọ nipa iṣọkan awọn iṣẹ idanwo awọn kilasi mejeeji?", "reasoning": "<thinking><step1>\nThe question asks: “Da ipinnu igbariye awọn ipele idanwo naa” — meaning it wants to determine the relationship between the test scores of Mr. Bee's class and Mr. Em's class, which are 11.2 and 5.6 respectively.\n</step1>\n<step2>\nTo analyze the scores, we first note that Mr. Bee's class has a higher average score — *igbariye* — than Mr. Em's class.\n</step2>\n<step3>\nThis difference suggests that the performance of Mr. Bee's students is generally better, indicating *iṣẹ́-idanwo* that may reflect different teaching methods or student engagement levels.\n</step3>\n<step4>\nWe can also consider the standard deviation of the scores to assess *iṣọkan* — the consistency of performance within each class.\n</step4>\n<step5>\nIf Mr. Bee's class has a low standard deviation, it means most students scored similarly, while a high standard deviation in Mr. Em's class would indicate varied performance levels.\n</step5>\n<step6>\nThus, we can conclude that the test scores show a significant difference in performance, with Mr. Bee's class performing better overall.\n</step6></thinking>", "answer": "<answer>Igbariye awọn ipele idanwo fihan pe Kilasi Mr. Bee ni iṣẹ to dara ju Kilasi Mr. Em lọ.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun 60 kan wà pẹ̀lú ìtìjú ẹ̀jẹ̀ tí ó ń jáde láti nípìlì rẹ̀, ó sì ní ìtàn ìdílé àìsàn kànṣẹ̀rì oyún.  Kí ni ìgbésẹ̀ ayẹwo aworan tí ó tọ́ jùlọ tókàn fún ṣíṣàyẹ̀wò síwájú sí i ní ọ̀ràn rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ìgbésẹ̀ ayẹwo aworan tí ó tọ́ jùlọ?” — meaning it wants to know the most appropriate imaging step for a 60-year-old woman with abnormal vaginal bleeding and a family history of gynecological cancer.\n</step1>\n<step2>\nIn cases of abnormal vaginal bleeding, especially in older women, *ayẹwo àwòrán* (imaging studies) are crucial for diagnosis.\n</step2>\n<step3>\nGiven her age and symptoms, a transvaginal ultrasound is often the first step — *ultrasound àyà* helps visualize the uterus and ovaries.\n</step3>\n<step4>\nThis imaging can identify abnormalities like fibroids or polyps — *fibroids* and *polyps* can cause bleeding.\n</step4>\n<step5>\nIf the ultrasound shows concerning findings, further evaluation with a hysteroscopy or MRI may be necessary — *hysteroscopy* allows direct visualization of the uterine cavity.\n</step5>\n<step6>\nConsidering her family history of gynecological cancer, it’s important to rule out malignancy — *ìfarapa* (cancer) must be considered.\n</step6>\n<step7>\nThus, the most appropriate initial imaging step is a transvaginal ultrasound to assess the cause of her bleeding.\n</step7></thinking>", "answer": "<answer>Ìgbésẹ̀ ayẹwo àwòrán tó tọ́ jùlọ ni *ultrasound àyà* láti ṣàyẹ̀wò ìtìjú ẹ̀jẹ̀ rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ṣààlà gbogbo àwọn nọ́mbà àpapọ̀ tí ó tóbi ju 0 lọ tí ó kéré sí \\(2^{250}\\) tí \\(n\\) bá pín \\(2^n\\), \\(n-1\\) bá pín \\(2^{n-1}\\), àti \\(n-2\\) bá pín \\(2^{n-2}\\). Kọ àwọn nọ́mbà wọ̀nyí sílẹ̀ ní ìtẹ̀lé ìgbàgbọ́.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣààlà gbogbo àwọn nọ́mbà àpapọ̀ tí ó tóbi ju 0 lọ tí ó kéré sí \\(2^{250}\\)” — meaning it wants to find all composite numbers greater than 0 and less than \\(2^{250}\\) that satisfy certain divisibility conditions.\n</step1>\n<step2>\nThe conditions state that \\(n\\) must divide \\(2^n\\), \\(n-1\\) must divide \\(2^{n-1}\\), and \\(n-2\\) must divide \\(2^{n-2}\\). This implies that these numbers are related to powers of 2.\n</step2>\n<step3>\nFor a number \\(n\\) to divide \\(2^n\\), it must be a composite number — *n gbọdọ jẹ́ nọ́mbà àpapọ̀* — and typically, this means \\(n\\) should be even, as odd numbers do not divide powers of 2.\n</step3>\n<step4>\nNext, we need to check the range: *n* must be less than \\(2^{250}\\). The largest composite number less than \\(2^{250}\\) is \\(2^{250} - 1\\), but we need to find all composites in this range.\n</step4>\n<step5>\nWe can start listing composite numbers from 4 (the smallest composite) up to \\(2^{250} - 1\\) while ensuring they meet the divisibility conditions. This involves checking each composite number sequentially.\n</step5>\n<step6>\nIn summary, we will compile a list of composite numbers that fit these criteria, ensuring they are all less than \\(2^{250}\\) and greater than 0.\n</step6></thinking>", "answer": "<answer>Àwọn nọ́mbà àpapọ̀ tí ó tóbi ju 0 lọ tí ó kéré sí \\(2^{250}\\) ni: 4, 6, 8, 9, 10, 12, 14, 15, 16, ... , \\(2^{250}-1\\).</answer>", "language": "Yoruba"}
{"question": "Ninu ọkunrin ọlọdun 64 kan ti o ni irora ori ati ailera apa ọwọ apa osi, awoṣe aworan wo ni a rii lori MRI ọpọlọ rẹ pẹlu iyọkuro inu iṣan?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu ọkunrin ọlọdun 64 kan ti o ni irora ori ati ailera apa ọwọ apa osi, awoṣe aworan wo ni a rii lori MRI ọpọlọ rẹ pẹlu iyọkuro inu iṣan?” — meaning it inquires about the MRI findings in a 64-year-old man with headaches and left arm weakness, specifically looking for signs of [iyọkuro inu iṣan = edema].\n</step1>\n<step2>\nIn cases like this, the symptoms suggest possible neurological issues — *awọn iṣoro neurology* — that could be due to various conditions such as stroke or tumors.\n</step2>\n<step3>\nMRI scans are crucial for identifying abnormalities in the brain — *awọn abawọn ninu ọpọlọ* — and can show areas of edema, which is the swelling caused by fluid accumulation.\n</step4>\n<step4>\nIf there is edema, it might indicate an underlying problem like a stroke — *ikọlu* — or a mass effect from a tumor, which could explain the headaches and weakness.\n</step5>\n<step5>\nThe MRI findings could reveal hyperintense areas on T2-weighted images, indicating the presence of edema — *iyọkuro inu iṣan* — in specific regions of the brain.\n</step6>\n<step6>\nThus, the MRI might show signs of edema in the left hemisphere, correlating with the left arm weakness and headaches.\n</step6></thinking>", "answer": "<answer>MRI yoo fihan iyọkuro inu iṣan ni apakan osi ti ọpọlọ, ti o le jẹ nitori ikọlu tabi abawọn miiran.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìpínrọ̀ tó tẹ̀lé yìí kọ̀ọ̀kan ṣàpèjúwe ṣeto àwọn ohun márùn-ún tí a gbé karí ìtòlétò kan tí kò yí pa dà. Àwọn àsọdùn náà bá ara wọn mu nípa ọgbọ́n nínú ìpínrọ̀ kọ̀ọ̀kan. Nínú ìdíje gọ́ọ̀fu kan, àwọn oníṣeré gọ́ọ̀fu márùn-ún wà: Amy, Eve, Mel, Mya, àti Rob. Eve ni ẹni tó pari kẹhin. Rob pari ṣáájú Mel. Amy pari ṣáájú Rob. Mya pari kẹta.\nÀwọn àṣàyàn:\n(A) Amy pari kejì-kẹhin\n(B) Eve pari kejì-kẹhin\n(C) Mel pari kejì-kẹhin\n(D) Mya pari kejì-kẹhin\n(E) Rob pari kejì-kẹhin", "reasoning": "<thinking><step1>\nThe question asks about the finishing positions of five golfers: Amy, Eve, Mel, Mya, and Rob, with specific conditions regarding their placements.\n</step1>\n<step2>\nEve finished last, which means she is in the fifth position — *Eve ni ẹni tó pari kẹhin*.\n</step2>\n<step3>\nRob finished before Mel, indicating Rob is not last and must be in a higher position than Mel — *Rob pari ṣáájú Mel*.\n</step3>\n<step4>\nAmy finished before Rob, so she must also be in a higher position than Rob — *Amy pari ṣáájú Rob*.\n</step4>\n<step5>\nMya finished third, which gives us a clear position for her — *Mya pari kẹta*.\n</step5>\n<step6>\nNow, we can summarize the positions: Mya is third, Eve is fifth, and since Rob must be before Mel and after Amy, we can deduce the order.\n</step6>\n<step7>\nThe only arrangement that fits all these conditions is: Amy (1st), Rob (2nd), Mya (3rd), Mel (4th), and Eve (5th).\n</step7>\n<step8>\nThus, since Amy is in the first position, she cannot be second to last — *Amy pari kejì-kẹhin* is false.\n</step8>\n<step9>\nThe only option that fits is that Eve is indeed the last — *Eve pari kejì-kẹhin* is true.\n</step9></thinking>", "answer": "<answer>Eve pari kejì-kẹhin.</answer>", "language": "Yoruba"}
{"question": "Oògùn kan ní ìwọ̀n ìgbàgbọ́ 80% àti ìwọ̀n ìgbàgbọ́ ẹdọ̀ jẹ́ 0.4.  Ka ìwọ̀n ìṣiṣẹ́ oògùn náà?\nA. 12%\nB. 32%\nC. 48%\nD. 64%", "reasoning": "<thinking><step1>\nThe question asks: “Oògùn kan ní ìwọ̀n ìgbàgbọ́ 80% àti ìwọ̀n ìgbàgbọ́ ẹdọ̀ jẹ́ 0.4” — meaning it provides the efficacy of a drug and the probability of an event, asking for the drug's overall effectiveness.\n</step1>\n<step2>\nTo find the overall effectiveness, we need to use the formula: *ìwọ̀n ìgbàgbọ́ oògùn = ìwọ̀n ìgbàgbọ́ × ìwọ̀n ìgbàgbọ́ ẹdọ̀*.\n</step2>\n<step3>\nHere, the efficacy is 80%, which can be expressed as 0.8, and the probability of the event is 0.4.\n</step3>\n<step4>\nNow, we calculate: *0.8 × 0.4 = 0.32*.\n</step4>\n<step5>\nTo express this as a percentage, we multiply by 100: *0.32 × 100 = 32%*.\n</step5>\n<step6>\nThus, the overall effectiveness of the drug is 32%, which corresponds to option B.\n</step6></thinking>", "answer": "<answer>Ìwọ̀n ìṣiṣẹ́ oògùn náà ni 32%.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mẹtadinlogun kan wá pẹlu ìṣòro ní ọrùn àti ohùn tí ó gbò.  Àyẹ̀wò fi hàn pé ọgbà 2.5-cm kan tí kò yí padà, tí kò sì ní ìṣọkan, wà ní gbùngbùn àìsàn thyroid rẹ̀ pẹlu ìṣòro ọ̀pọ̀lọpọ̀ calcitonin ninu ẹ̀jẹ̀.  Nínú ẹ̀dá ènìyàn tí ó ṣẹ̀dá,  ibi wo ni sẹẹli tí ó ṣe apákan ọgbà náà ti wá julọ?", "reasoning": "<thinking><step1>\nThe question is asking about a 17-year-old male with a thyroid issue, specifically mentioning a 2.5-cm nodule that is stable and non-functional, along with elevated calcitonin levels in his blood. It seeks to identify where the cells that make up this nodule originate from.\n</step1>\n<step2>\nIn humans, thyroid nodules can arise from various types of cells, primarily *sẹẹli follicular* and *sẹẹli C* (C cells). The presence of elevated calcitonin suggests involvement of C cells, which are responsible for producing this hormone.\n</step2>\n<step3>\nC cells, or *sẹẹli C*, are located in the thyroid gland, specifically in the *parafollicular* region. This is crucial because calcitonin is involved in calcium homeostasis.\n</step3>\n<step4>\nGiven that the nodule is stable and non-functional, it likely indicates that it is not actively producing hormones, which aligns with the characteristics of certain types of thyroid nodules.\n</step4>\n<step5>\nThus, the cells that constitute this nodule are most likely derived from the *sẹẹli C* in the thyroid gland, as they are the ones that produce calcitonin.\n</step5>\n<step6>\nIn summary, the origin of the cells in this nodule is the *sẹẹli C* of the thyroid gland.\n</step6></thinking>", "answer": "<answer>Sẹẹli C ti àyà jẹ́ ibi tí sẹẹli tí ó ṣe apákan ọgbà náà ti wá julọ.</answer>", "language": "Yoruba"}
{"question": "Kini a kà sí ìṣẹ̀lẹ̀ tí kò lágbára pupọ̀ nígbà tí a bá ń ṣàyẹ̀wò ìyípadà nínú iye àwọn àrùn àkóbá kan ní ìbámu pẹ̀lú àwọn ìwé kíkọ̀ọ̀kan ti ọjọ́ pípẹ̀ gẹ́gẹ́ bí a ti rí nínú ìwé ìṣẹ̀lẹ̀ oṣù?", "reasoning": "<thinking><step1>\nThe question asks: “Kini a kà sí [ìṣẹ̀lẹ̀ tí kò lágbára pupọ̀ = a minor event] nígbà tí a bá ń ṣàyẹ̀wò [ìyípadà = change] nínú iye [àwọn àrùn àkóbá kan = certain diseases]?” — meaning it seeks to understand what constitutes a minor event when examining changes in disease rates over time.\n</step1>\n<step2>\nIn epidemiology, a minor event might refer to fluctuations that are not statistically significant — *àwọn iyipada ti ko ni itumọ̀ pataki*.\n</step2>\n<step3>\nFor example, if the rate of a disease like [àrùn àkóbá = malaria] shows a slight increase in one month but returns to normal the next, this could be considered a minor event.\n</step3>\n<step4>\nSuch changes may arise from temporary factors like seasonal variations — *àwọn ayipada akoko* — rather than indicating a true rise in incidence.\n</step4>\n<step5>\nIn analyzing long-term data, researchers look for consistent trends rather than isolated spikes — *àwọn aṣa ti o ni iduroṣinṣin*.\n</step5>\n<step6>\nThus, a minor event in this context is a temporary fluctuation that does not reflect a significant change in disease patterns.\n</step6></thinking>", "answer": "<answer>Ìṣẹ̀lẹ̀ tí kò lágbára pupọ̀ ni iyipada igba diẹ ti ko ni itumọ̀ pataki nínú iye àwọn àrùn àkóbá kan.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 58 kan wá sí ẹka pajawiri nitori irora ikun oke ti o ti buru si fun ọjọ meji. O sọ pe ó ríru ati ẹ̀gbẹ́, ati pe kò le gba ohun mimu lọ́nu. Ó dà bí ẹni pe kò ni irọrun. Igbona rẹ̀ jẹ́ 38.1°C (100.6°F), iṣẹ́ ọkàn rẹ̀ jẹ́ 92/min, ìmì rẹ̀ jẹ́ 18/min, ati titẹ ẹ̀jẹ̀ rẹ̀ jẹ́ 132/85 mm Hg. Ẹ̀yẹ̀wò fi hàn pe awọ ofeefee ti wa lórí sclera rẹ̀. Ikùn rẹ̀ ní irora ni apa ọtun oke. Ko si ìfàájì ikùn tabi organomegaly. Awọn ẹkọ ile-iwosan fihan:\nHemoglobin 13 g/dL\nIye leukocyte 16,000/mm3\nSerum\nUrea nitrogen\n25 mg/dL\nCreatinine 2 mg/dL\nAlkaline phosphatase 432 U/L\nAlanine aminotransferase 196 U/L\nAspartate transaminase 207 U/L\nBilirubin\nGbogbo rẹ̀ 3.8 mg/dL\nTaara 2.7 mg/dL\nLipase 82 U/L (N = 14–280)\nAwọn aworan ultrasound ti apa ọtun oke fihan awọn iṣọn bile intrahepatic ati extrahepatic ti a fẹ̀, ati ọpọlọpọ awọn spheres hyperechoic ninu gallbladder. A ko le rii pancreas daradara. A bẹrẹ mimu omi sinu ara ati itọju oogun atẹgun pẹlu ceftriaxone ati metronidazole. Lẹhin wakati mejila, alaisan naa dabi ẹni ti o ṣaisan gidigidi ati pe kò mọ akoko. Igbona rẹ̀ jẹ́ 39.1°C (102.4°F), iṣẹ́ ọkàn rẹ̀ jẹ́ 105/min, ìmì rẹ̀ jẹ́ 22/min, ati titẹ ẹ̀jẹ̀ rẹ̀ jẹ́ 112/82 mm Hg. Ewo ni ọna atọkun ti o yẹ julọ ninu iṣakoso?\"\nA. Awọn aworan CT ikùn\nB. Laparoscopic cholecystectomy\nC. Percutaneous cholecystostomy\nD. Extracorporeal shock wave lithotripsy\nE. Endoscopic retrograde cholangiopancreatography\n\"", "reasoning": "<thinking><step1>\nThe question presents a clinical scenario involving a 58-year-old woman with worsening upper abdominal pain for two days, indicating a potential serious condition. Key terms include [irora ikun = abdominal pain], [ẹ̀gbẹ́ = nausea], and [irọrun = comfort].\n</step1>\n<step2>\nShe has fever, tachycardia, and elevated liver enzymes, suggesting possible liver or biliary pathology — *iyẹn le jẹ́ àkúnya biliary* or *ìfarapa ikùn*.\n</step2>\n<step3>\nThe ultrasound findings show intrahepatic and extrahepatic bile duct dilation and multiple hyperechoic spheres in the gallbladder, indicating possible gallstones — *àkúnya ikùn*.\n</step4>\n<step4>\nGiven her deteriorating condition after treatment initiation, with increased fever and tachycardia, this suggests a potential complication like cholangitis or acute cholecystitis — *ìfarapa ikùn àtọka*.\n</step5>\n<step5>\nIn this case, the most appropriate management option would be to relieve the obstruction and drain the bile, which points towards percutaneous cholecystostomy — *ìtọ́jú percutaneous cholecystostomy*.\n</step6>\n<step6>\nOther options like laparoscopic cholecystectomy may not be suitable due to her unstable condition, and CT imaging would not provide immediate relief.\n</step6></thinking>", "answer": "<answer>C. Percutaneous cholecystostomy</answer>", "language": "Yoruba"}
{"question": "Okùnrin ọdun 53 kan tí ó ní ìtàn àrùn àtẹ́gùn tí ó ṣòro láti ṣakoso, ti wá pẹ̀lú ìrora orí, ìṣòro ìrònú, tí ó sì mọ ara rẹ̀ nìkan. Àtẹ́gùn ẹ̀jẹ̀ rẹ̀ jẹ́ 206/132 mm Hg, àti CT scan ọ̀kan rẹ̀ tí kò ní ìṣàn-àìmọ́ kò fi ohunkóhun hàn. Nígbà tí a bá ronú nípa àwọn àmì wọnyi, ìwádìí àyẹ̀wò wo ni ó ṣeé ṣe jùlọ láti jẹ́risi ipò àrùn tí ó fa àwọn àmì wọnyi?", "reasoning": "<thinking><step1>\nThe question is asking about a 53-year-old man with a history of hypertension who is experiencing headaches, cognitive issues, and self-awareness problems. It also mentions his blood pressure reading of 206/132 mm Hg and a CT scan that shows no abnormalities. The inquiry is about which diagnostic tests would be most appropriate to confirm the condition causing these symptoms.\n</step1>\n<step2>\nGiven the high blood pressure reading, *ìtàn àrùn àtẹ́gùn* (hypertension) could be a significant factor. The symptoms of headache and cognitive difficulties may suggest complications related to hypertension, such as *ìfarapa ọpọlọ* (cerebral damage).\n</step2>\n<step3>\nConsidering the CT scan is normal, we might suspect conditions like *ìfarapa àtọ́kànwá* (intracranial hemorrhage) or *ìṣòro àtọ́kànwá* (intracranial pressure issues) that might not be visible on a standard CT scan.\n</step3>\n<step4>\nA more sensitive test could be an MRI of the brain — *MRI ti ọpọlọ* — which can detect subtle changes in brain tissue that a CT scan might miss.\n</step4>\n<step5>\nAdditionally, checking for *ìfarapa àtọ́kànwá* (intracranial hypertension) through a lumbar puncture could provide valuable information about cerebrospinal fluid pressure.\n</step5>\n<step6>\nIn summary, the most appropriate diagnostic tests to confirm the condition causing these symptoms would likely be an MRI of the brain and possibly a lumbar puncture.\n</step6></thinking>", "answer": "<answer>Àwọn ìwádìí àyẹ̀wò tó yẹ jùlọ ni MRI ti ọpọlọ àti àyẹ̀wò àtọ́kànwá.</answer>", "language": "Yoruba"}
{"question": "Ṣiṣẹ́to ti orílẹ̀-èdè wo ni ó ń pèsè ìṣirò tí ó gbẹ́kẹ̀lé ní ìpele orílẹ̀-èdè àti ìpínlẹ̀ lójúọdún fún ṣíṣàṣàyàn?", "reasoning": "<thinking><step1>\nThe question asks: “Ṣiṣẹ́to ti orílẹ̀-èdè wo ni ó ń pèsè ìṣirò tí ó gbẹ́kẹ̀lé ní ìpele orílẹ̀-èdè àti ìpínlẹ̀ lójúọdún fún ṣíṣàṣàyàn?” — meaning it wants to know which countries provide statistics that rely on national and state levels annually for decision-making.\n</step1>\n<step2>\nCountries often use statistical systems to gather data — *sistemu ìṣirò* — that inform policy and governance.\n</step2>\n<step3>\nFor example, the United States has the Census Bureau, which conducts a comprehensive survey every ten years — *ìṣirò àkópọ̀* — and provides annual estimates.\n</step3>\n<step4>\nSimilarly, countries like Nigeria have the National Bureau of Statistics — *Igbimọ̀ Ìṣirò Orílẹ̀-èdè Nàìjíríà* — that collects data at both national and state levels.\n</step4>\n<step5>\nThese organizations ensure that data is reliable and up-to-date, which is crucial for effective decision-making — *ìpinnu*.\n</step5>\n<step6>\nIn summary, countries with robust statistical systems, like the US and Nigeria, provide essential data for annual decision-making processes.\n</step6></thinking>", "answer": "<answer>Orílẹ̀-èdè tí ó ní sistemu ìṣirò to dára, gẹ́gẹ́ bíi Amẹrika àti Nàìjíríà, ni ń pèsè ìṣirò fún ṣíṣàṣàyàn lójúọdún.</answer>", "language": "Yoruba"}
{"question": "Àwọn àsọtélé wo ni kòṣe òtítọ̀ nípa àrùn toxoplasmosis: pé àwọn oocysts tí ó wà nínú ìgbẹ̀rùn ọgbọ̀ màkírí tuntun jẹ́ ọlọ́gbààárùn àti pé àrùn ìgbẹ̀rùn apá, ìgbẹ̀rùn ọrùn, àti ìgbẹ̀rùn oyún ni àwọn àmì àrùn tí ó wọ́pọ̀ jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn àsọtélé wo ni kòṣe òtítọ̀ nípa àrùn [toxoplasmosis]?” — meaning it wants to know which statements about toxoplasmosis are false.\n</step1>\n<step2>\nToxoplasmosis is caused by a parasite, *Toxoplasma gondii*, which is often found in cat feces — *oocysts* in cat litter can be infectious.\n</step2>\n<step3>\nA common misconception is that all oocysts are highly infectious; however, they require time to become infectious after being shed — *oocysts ko ni ọlọ́gbààárùn lẹ́sẹkẹsẹ*.\n</step3>\n<step4>\nSymptoms of toxoplasmosis can include flu-like signs, but it is not limited to respiratory issues — *àrùn ìgbẹ̀rùn apá* and *ìgbẹ̀rùn ọrùn* are not the most common symptoms.\n</step4>\n<step5>\nIn fact, many people are asymptomatic, and severe symptoms are rare in healthy individuals — *àwọn eniyan to ni ilera le ma ni àkúnya kankan*.\n</step5>\n<step6>\nThus, the statement that respiratory infections are the most common symptoms of toxoplasmosis is false — *ìgbẹ̀rùn oyún* is also not a typical symptom.\n</step6></thinking>", "answer": "<answer>Àwọn àsọtélé ti kòṣe òtítọ̀ ni pé àrùn ìgbẹ̀rùn apá, ìgbẹ̀rùn ọrùn, àti ìgbẹ̀rùn oyún ni àwọn àmì àrùn tó wọ́pọ̀ jùlọ.</answer>", "language": "Yoruba"}
{"question": "Kini idanwo ayẹwo to yẹ julọ fun agbẹ ọdun 45 kan ti o ní awọn àpòòtọ papular erythematous ti o fà kí ara máa korò lori oju, ọrùn, agbegbe ‘V’ ti àyà, apa ọwọ̀, ati awọn apá ọwọ̀ fun ọdun 3, eyiti o buru si ni Igba ooru ati mu dara pupọ ni Igba otutu?", "reasoning": "<thinking><step1>\nThe question asks: “Kini idanwo ayẹwo to yẹ julọ fun agbẹ [farmer] ọdun 45 kan ti o ní [papular erythematous] ti o fà kí ara máa korò [causing skin irritation]?” — meaning it seeks the most appropriate diagnostic test for a 45-year-old farmer with specific skin symptoms.\n</step1>\n<step2>\nThe symptoms described include papular erythematous lesions that worsen in summer and improve in winter — *awọn àpòòtọ ti o buru si ni Igba ooru* suggests a possible seasonal trigger.\n</step2>\n<step3>\nGiven the chronicity of 3 years, one should consider conditions like eczema or contact dermatitis — *dermatitis* could be a key factor here.\n</step3>\n<step4>\nA skin biopsy might be necessary to rule out other conditions — *idanwo ayẹwo awọ* can help confirm the diagnosis.\n</step4>\n<step5>\nAdditionally, patch testing could identify allergens if contact dermatitis is suspected — *idanwo àyẹwo àfiyèsí* would be useful in this context.\n</step5>\n<step6>\nConsidering the symptoms and their pattern, the most appropriate test would likely be a skin biopsy to assess the nature of the lesions.\n</step6></thinking>", "answer": "<answer>Idanwo ayẹwo to yẹ julọ ni idanwo ayẹwo awọ lati ṣe ayẹwo iru awọn àpòòtọ naa.</answer>", "language": "Yoruba"}
{"question": "Nipọn wo ni CPK-MB fi jẹ́ ohun ti o yẹ̀ julọ ju Troponin-T lọ fuń ìwádìí àrùn ọkàn-àìsàn tí ó léwu, kí sì ni idi tí ó fi rí bẹ́ẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Nipọn wo ni [CPK-MB = Creatine Phosphokinase-MB] fi jẹ́ ohun ti o yẹ̀ julọ ju [Troponin-T] lọ fuń ìwádìí [àrùn ọkàn-àìsàn tí ó léwu = acute coronary syndrome]?” — meaning it wants to know why CPK-MB is considered more suitable than Troponin-T for diagnosing acute coronary syndrome.\n</step1>\n<step2>\nCPK-MB is an enzyme that is released when there is damage to the heart muscle — *o jẹ́ àfihàn ti ibajẹ́ sí ẹ̀dá ọkàn*.\n</step2>\n<step3>\nIn acute coronary syndrome, the levels of CPK-MB rise quickly after a heart attack, making it a useful marker — *o ń pọ̀ si lẹ́sẹkẹsẹ*.\n</step3>\n<step4>\nTroponin-T, while also a marker for heart damage, has a slower rise and longer duration in the bloodstream — *o ń gba àkókò diẹ̀ láti pọ̀ si*.\n</step4>\n<step5>\nThis means that in the early hours of a heart attack, CPK-MB can provide quicker results for diagnosis — *iyẹn túmọ̀ sí pé CPK-MB le jẹ́ kí a mọ̀ pé àrùn ọkàn ti ṣẹlẹ̀ ni kiakia*.\n</step6>\n<step6>\nAdditionally, CPK-MB can help differentiate between cardiac and non-cardiac causes of chest pain — *o le ṣe iranlọwọ láti yàtọ̀ sí àwọn ìdí míì ti irora àyà*.\n</step7>\n<step7>\nThus, CPK-MB is often preferred in emergency settings for rapid assessment of heart damage — *nítorí náà, a máa fẹ́ CPK-MB nígbà àkókò pajawiri*.\n</step8></thinking>", "answer": "<answer>CPK-MB jẹ́ ohun ti o yẹ̀ julọ ju Troponin-T lọ fún ìwádìí àrùn ọkàn-àìsàn tí ó léwu nítorí pé o ń pọ̀ si lẹ́sẹkẹsẹ lẹ́yìn ibajẹ́ sí ẹ̀dá ọkàn, tó sì jẹ́ kí a mọ̀ pé àrùn ọkàn ti ṣẹlẹ̀ ni kiakia.</answer>", "language": "Yoruba"}
{"question": "Ni Ile-iwe Alabosi Gusu, awọn ọmọbirin ju awọn ọmọkunrin lọ ni iye 20. Ti awọn ọmọbirin jẹ 180, bawo ni iwọ o ṣe le ṣe iṣiro iye awọn ọmọkunrin ni ile-iwe naa?", "reasoning": "<thinking><step1>\nThe question asks: “Ni Ile-iwe Alabosi Gusu, awọn ọmọbirin ju awọn ọmọkunrin lọ ni iye 20” — meaning there are 20 more girls than boys in the school.\n</step1>\n<step2>\nWe know that the number of girls is 180 — *nọ́mbà àwọn ọmọbirin ni 180*.\n</step2>\n<step3>\nLet’s denote the number of boys as *x*. According to the information, we can express the relationship as: *180 = x + 20*.\n</step3>\n<step4>\nTo find the number of boys, we rearrange the equation: *x = 180 - 20*.\n</step4>\n<step5>\nCalculating this gives us: *x = 160*. Therefore, there are 160 boys in the school.\n</step5></thinking>", "answer": "<answer>Iye awọn ọmọkunrin ni ile-iwe naa ni 160.</answer>", "language": "Yoruba"}
{"question": "Ninu àkànṣe ìdáhùn àṣejù, ìpele wo ni a ṣàpẹrẹ̀ sí fífì àwọn ọkùnrin àti ìgbàgbé àgbàlá fún àwọn obìnrin?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu àkànṣe ìdáhùn àṣejù, ìpele wo ni a ṣàpẹrẹ̀ sí fífì àwọn ọkùnrin àti ìgbàgbé àgbàlá fún àwọn obìnrin?” — meaning it wants to know what level of discrimination exists against men and the societal expectations for women in the context of gender inequality.\n</step1>\n<step2>\nIn discussions of gender inequality, *ìdáhùn àṣejù* refers to the responses or attitudes towards gender roles — *àkànṣe* indicates a framework or model.\n</step2>\n<step3>\nResearch shows that men often face different societal pressures, such as expectations to be providers — *àwọn ìlànà àkóso* that dictate their roles.\n</step3>\n<step4>\nConversely, women frequently encounter *ìgbàgbé àgbàlá*, which refers to societal norms that limit their opportunities and reinforce traditional roles.\n</step4>\n<step5>\nIn many cultures, this leads to a disparity where men are expected to succeed in the public sphere while women are often relegated to domestic responsibilities — *àwọn ojúṣe ile*.\n</step5>\n<step6>\nThus, the level of discrimination can be seen as systemic, affecting both genders but manifesting differently — *ìpele àìlera* varies based on societal expectations.\n</step6>\n<step7>\nIn summary, while men may face pressure to conform to certain roles, women often deal with more restrictive societal norms that limit their freedom and opportunities.\n</step7></thinking>", "answer": "<answer>Ìpele àìlera jẹ́ àfihàn ti ìdáhùn àṣejù, níbi tí àwọn ọkùnrin ti ní ìlànà àkóso, ṣùgbọ́n àwọn obìnrin ní ìgbàgbé àgbàlá tó pọ̀ sí i.</answer>", "language": "Yoruba"}
{"question": "Àṣẹ̀rí wo ni ó ní ẹ̀dùn-ọ̀rọ̀?\nÀwọn àṣàyàn:\n(A) Ṣíṣe àṣàrò nípa ààbò àwọn obìnrin, àti bí wọ́n ṣe lè máa ronú fún ara wọn, yóo mú kí o gba àyàfi láti ọ̀dọ̀ àwọn obìnrin.\n(B) Ṣíṣe àṣàrò nípa ààbò àwọn obìnrin, àti bí wọ́n ṣe lè máa ronú fún ara wọn, yóo mú kí o padà sẹ́yìn láti ọ̀dọ̀ àwọn obìnrin.", "reasoning": "<thinking><step1>\nThe question asks: “Àṣẹ̀rí wo ni ó ní ẹ̀dùn-ọ̀rọ̀?” — which translates to \"What is the implication of the statement?\" It seems to be about the impact of discussing women's safety and self-reflection.\n</step1>\n<step2>\nThe options provided suggest two different outcomes of discussing women's safety — *ààbò àwọn obìnrin* — and how they can think for themselves.\n</step2>\n<step3>\nOption (A) states that this discussion will lead to empowerment, allowing women to think for themselves — *yóo mú kí o gba àyàfi láti ọ̀dọ̀ àwọn obìnrin*.\n</step3>\n<step4>\nIn contrast, option (B) implies that the discussion might cause regression, suggesting a return to dependence — *yóo mú kí o padà sẹ́yìn láti ọ̀dọ̀ àwọn obìnrin*.\n</step4>\n<step5>\nTo analyze, empowerment is generally seen as a positive outcome, promoting independence and self-agency, while regression indicates a negative impact on women's autonomy.\n</step5>\n<step6>\nThus, the implication of discussing women's safety should ideally lead to empowerment rather than regression.\n</step6></thinking>", "answer": "<answer>(A) Ṣíṣe àṣàrò nípa ààbò àwọn obìnrin, àti bí wọ́n ṣe lè máa ronú fún ara wọn, yóo mú kí o gba àyàfi láti ọ̀dọ̀ àwọn obìnrin.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 40 kan wá sí Ẹ̀rùgbà Ìṣẹ̀gun lẹ́yìn tí ó ṣẹ̀ṣẹ̀ jìyà ìṣẹ̀lẹ̀ kékeré kan níbi tí ó ti ṣubú láti lórí bàìkì rẹ̀, ó sì ń kùn ọgbẹ́ ní agbègbè ìgbá ọwọ́ ọ̀tún rẹ̀.  Lórí ìbáwí àwòrán X-ray ti agbègbè yìí, ẹ̀yà ṣíṣe irú ẹ̀yà wo ni kò ní nípa lórí ipò yìí?", "reasoning": "<thinking><step1>\nThe question translates to: \"A 40-year-old man comes to the Emergency Room after recently experiencing a minor incident where he fell from his bike, and he is complaining of pain in the area of his right wrist. Based on the X-ray findings of this area, what type of injury would not affect this position?\" \n</step1>\n<step2>\nThe key terms here include \"ìṣẹ̀lẹ̀ kékeré\" [minor incident], \"agbègbè\" [area], and \"ipò\" [position]. The focus is on understanding the X-ray findings related to the wrist injury.\n</step2>\n<step3>\nInjuries to the wrist can include fractures, sprains, or soft tissue injuries. A common type of fracture is a *fracture du radius* [radius fracture], which would typically affect the wrist's position.\n</step3>\n<step4>\nHowever, if we consider a *contusion* [bruise] or a *tendinopathy* [tendon injury], these might not significantly alter the wrist's position on an X-ray.\n</step4>\n<step5>\nThus, a soft tissue injury like a contusion would not show up on an X-ray and would not affect the bone structure or position.\n</step5>\n<step6>\nIn conclusion, the type of injury that would not affect the position seen on the X-ray is a *contusion* or soft tissue injury.\n</step6></thinking>", "answer": "<answer>Ìfarapa tí kò ní nípa lórí ipò yìí ni *ìfarapa àyà* tàbí *ìfarapa àyà àtọkànwá*.</answer>", "language": "Yoruba"}
{"question": "Èwo nínú àwọn òògùn atọ́jú warápá ni ó máa ń ṣiṣẹ́ lórí ètò GABAergic nípa dídín gbígbà GABA sínú àwọn sẹ́ẹ̀lì iṣan inú ọpọlọ (neurons) àti àwọn sẹ́ẹ̀lì glial (glial cells) kù?", "reasoning": "<thinking><step1>\nThe question asks: “Èwo nínú àwọn òògùn atọ́jú warápá ni ó máa ń ṣiṣẹ́ lórí ètò [GABAergic = GABAergic system]?” — meaning it wants to know which medications affect the GABAergic system by inhibiting GABA uptake in neurons and glial cells.\n</step1>\n<step2>\nThe GABAergic system is crucial for regulating neuronal excitability — *o ṣe pataki fun iṣakoso iṣan-ara* in the brain.\n</step2>\n<step3>\nMedications that influence this system often include *antidepressants* and *anxiolytics*, which can enhance GABA activity.\n</step3>\n<step4>\nFor instance, *benzodiazepines* are known to increase the effect of GABA by binding to its receptors — *wọn n ṣiṣẹ́ lórí àwọn olugba GABA*.\n</step4>\n<step5>\nAdditionally, *barbiturates* also potentiate GABA effects, leading to increased inhibition in the central nervous system — *nítorí náà, wọn fa idinwo ninu eto aifọkanbalẹ*.\n</step6>\n<step6>\nThus, medications like benzodiazepines and barbiturates are key in modulating the GABAergic system by reducing GABA uptake in neurons and glial cells.\n</step6></thinking>", "answer": "<answer>Àwọn òògùn bíi benzodiazepines àti barbiturates ni ó máa ń ṣiṣẹ́ lórí ètò GABAergic nípa dídín gbígbà GABA sínú àwọn sẹ́ẹ̀lì iṣan àti sẹ́ẹ̀lì glial.</answer>", "language": "Yoruba"}
{"question": "Aláìsàn kan fi ahọ́n tí ó yà sí apá ọ̀tún hàn pẹ̀lú ìsọdẹ̀rùn ní apá kan náà. Ìṣàn ara wo pàtó ni ó ní ipa nínú ọ̀ràn yìí?", "reasoning": "<thinking><step1>\nThe question translates to: \"Which specific artery is affected when there is a stroke that shows symptoms on the right side of the body?\" This indicates a focus on understanding the vascular implications of a stroke.\n</step1>\n<step2>\nA stroke occurs when blood flow to a part of the brain is interrupted — *ìkó ẹ̀jẹ̀ sí apá kan ti ọpọlọ* — leading to neurological deficits.\n</step2>\n<step3>\nSymptoms on the right side suggest that the left hemisphere of the brain is affected, as motor control is contralateral — *ìṣàkóso ara ni apá keji*.\n</step3>\n<step4>\nThe artery most commonly involved in such strokes is the middle cerebral artery — *ìṣàn àárín ọpọlọ* — which supplies blood to significant areas of the brain.\n</step5>\n<step5>\nWhen this artery is occluded, it can lead to weakness or paralysis on the right side, along with other cognitive deficits — *ìṣoro ìmọ̀ ọpọlọ*.\n</step6>\n<step6>\nThus, the specific artery implicated in this scenario is the middle cerebral artery, which plays a crucial role in the blood supply to the left hemisphere.\n</step6></thinking>", "answer": "<answer>Ìṣàn àárín ọpọlọ ni ó ní ipa nínú ọ̀ràn yìí.</answer>", "language": "Yoruba"}
{"question": "Ní ọ̀ràn ìyàwó tí ó wà ní ìgbà ìgbàlóyè àṣàájú ní ọ̀sẹ̀ mẹ́rìnlélógún (40) ti àìní ìgbàlóyè, pẹ̀lú ọmọ kan tí ó wà ní ipò ìgbàlóyè ìdákọ̀rọ̀, tí a kò sì rí ìlù ọmọ, tí àpò ìyá sì ti ṣí dáadáa, tí ejìká sì ń jáde, kí ni ọ̀nà ìṣàkóso tó yẹ jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “Ní ọ̀ràn ìyàwó tí ó wà ní ìgbà ìgbàlóyè àṣàájú ní ọ̀sẹ̀ mẹ́rìnlélógún (40) ti àìní ìgbàlóyè…” — meaning it is about a pregnant woman at 40 weeks who is experiencing a lack of labor signs.\n</step1>\n<step2>\nAt 40 weeks, a woman is considered full-term, and *àìní ìgbàlóyè* indicates she has not gone into labor yet, which can be concerning.\n</step2>\n<step3>\nIn such cases, monitoring is crucial; *ìtọ́jú* should include checking the fetal heart rate and ensuring the baby is still active — *ìlù ọmọ*.\n</step3>\n<step4>\nIf there are no signs of labor, healthcare providers may discuss options like *ìmúra* or inducing labor to ensure the safety of both mother and child.\n</step4>\n<step5>\nIt’s also important to assess the mother’s health; *àpò ìyá* being open is a good sign, but further evaluation is necessary if *ejìká* is present.\n</step5>\n<step6>\nUltimately, the best management approach would be to consult with a healthcare professional for personalized advice and possible interventions.\n</step6></thinking>", "answer": "<answer>Ọ̀nà ìṣàkóso tó yẹ jùlọ ni láti bá dókita sọrọ fún ìtọ́jú tó péye àti ìmúra àìlera.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun meji kan, ti o wọn kìlọọgìramu 6.4, ti o si n jiya nínú àìtó ẹ̀mí Vitamin A, ni a ń ṣe ayẹ̀wò fún àìtọ́jú.  Irú ìwọ̀n àìtọ́jú wo ni ọmọ yìí ní?", "reasoning": "<thinking><step1>\nThe question asks: “What type of [àìtọ́jú = deficiency] does a two-year-old child weighing 6.4 kg, who is suffering from a Vitamin A deficiency, have?” \n</step1>\n<step2>\nVitamin A deficiency can lead to several health issues, particularly affecting vision — *àìlera oju* — and immune function.\n</step2>\n<step3>\nIn children, this deficiency often results in *xerophthalmia*, which is a condition characterized by dry eyes and potential blindness.\n</step3>\n<step4>\nAdditionally, the child may experience increased susceptibility to infections due to a weakened immune system — *àìlera àtọ́jú*.\n</step4>\n<step5>\nGiven the child's age and weight, the severity of the deficiency can be classified as moderate to severe, depending on clinical signs observed during examination.\n</step5>\n<step6>\nThus, the child is likely experiencing a significant Vitamin A deficiency, which can lead to serious health complications if not addressed.\n</step6></thinking>", "answer": "<answer>Ọmọ yìí ní àìtọ́jú Vitamin A to ṣe pataki, ti o le fa àìlera oju ati àìlera àtọ́jú.</answer>", "language": "Yoruba"}
{"question": "Da iye awọn iwadii ile-iwosan ti a pese fun obinrin ọdọ kan ti o ni aini ẹjẹ microcytic (MCV-70, Hb 10 gm%, irin ẹjẹ 60, ferritin ẹjẹ 100), kini aisan ti o ṣeeṣe julọ?", "reasoning": "<thinking><step1>\nThe question asks: “Da iye awọn iwadii ile-iwosan ti a pese fun obinrin ọdọ kan ti o ni aini ẹjẹ microcytic” — meaning it wants to know the possible diagnosis for a young woman with microcytic anemia.\n</step1>\n<step2>\nMicrocytic anemia is characterized by low mean corpuscular volume (MCV) and hemoglobin (Hb) levels — *MCV-70* and *Hb 10 gm%* indicate this condition.\n</step2>\n<step3>\nThe iron studies show low serum iron — *irin ẹjẹ 60* — and a ferritin level of 100, which suggests that iron stores are not completely depleted.\n</step3>\n<step4>\nIn young women, the most common cause of microcytic anemia is often related to iron deficiency due to menstrual blood loss — *iyẹn ni, pipadanu ẹjẹ*.\n</step4>\n<step5>\nHowever, given the ferritin level is not very low, we should also consider other causes like thalassemia or chronic disease — *thalassemia* le jẹ aṣayan miiran.\n</step6>\n<step7>\nConsidering the age and gender of the patient, the most likely diagnosis remains iron deficiency anemia — *aini ẹjẹ irin* — due to menstrual loss.\n</step7></thinking>", "answer": "<answer>Aisan ti o ṣeeṣe julọ ni aini ẹjẹ irin nitori pipadanu ẹjẹ oṣooṣu.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin ọmọ ọdún mẹ́rìndínlọ́gbọ̀n kan wá pẹ̀lú àárẹ̀ gbogbo ara tó ń pọ̀ sí i, inú rírun tó máa ń mú ni gbà mú ní ìsàlẹ̀ ikùn, àti ìgbẹ́ ẹlẹ́jẹ̀ lẹ́ẹ̀kọ̀ọ̀kan fún ọ̀sẹ̀ mélòó kan sẹ́yìn. Ní fífi àwọn àmì àìsàn rẹ̀ wò àti ìtàn àrùn jẹjẹrẹ ìfun nínú ìdílé rẹ̀, kí ni ìgbésẹ̀ tó tọ́ jùlọ láti ṣe nínú ìtọ́jú láti ṣe àyẹ̀wò ipò rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What is the best course of action for a 35-year-old man with general body pain, abdominal discomfort, and intermittent bleeding for several weeks?” — it highlights symptoms like *àárẹ̀ gbogbo ara* (general body pain) and *ìgbẹ́ ẹlẹ́jẹ̀* (intermittent bleeding).\n</step1>\n<step2>\nFirst, it’s crucial to understand that these symptoms could indicate a serious underlying condition — *àìlera to ṣe pataki* — such as gastrointestinal issues or a bleeding disorder.\n</step2>\n<step3>\nGiven the abdominal discomfort — *inú rírun* — and bleeding, a medical evaluation is necessary to rule out conditions like ulcers or tumors.\n</step3>\n<step4>\nThe best initial step would be to seek medical attention — *lọ sí ilé-iwosan* — where a healthcare professional can conduct a thorough examination and possibly order tests.\n</step4>\n<step5>\nTests might include blood work to check for anemia — *àìlera ẹjẹ* — and imaging studies like an ultrasound or CT scan to visualize the abdomen.\n</step5>\n<step6>\nIn summary, the most appropriate action is to consult a doctor for a comprehensive assessment of his symptoms and medical history.\n</step6></thinking>", "answer": "<answer>Kí ni ìgbésẹ̀ tó tọ́ jùlọ ni láti lọ sí ilé-iwosan fún àyẹ̀wò àìlera rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Àwọ̀ ṣe ni apo tí kò ṣeé lo fún idìgbò nkan àìsàn nítorí pípèsè èéfín majele tí ó lewu nígbà tí a ba sun, nítorí pé cadmium wà nínú rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọ̀ ṣe ni apo tí kò ṣeé lo fún idìgbò nkan àìsàn nítorí pípèsè èéfín majele tí ó lewu nígbà tí a ba sun, nítorí pé cadmium wà nínú rẹ̀?” — meaning it inquires about the color of a bag that should not be used for carrying items due to the presence of hazardous cadmium when heated.\n</step1>\n<step2>\nCadmium is a toxic metal that can release harmful fumes when heated — *èéfín majele* that can cause serious health issues.\n</step2>\n<step3>\nThe color of bags that typically indicate they are unsafe for such use is often black or dark-colored — *àwọ̀ dudu* — as these materials may contain cadmium.\n</step3>\n<step4>\nIn many cases, manufacturers use dark colors to hide imperfections, which can also mean they use cheaper, potentially toxic materials.\n</step4>\n<step5>\nTherefore, it is crucial to avoid using bags that are dark-colored for carrying food or items that will be heated — *nítorí pé pípèsè èéfín lewu*.\n</step5>\n<step6>\nIn summary, the color that signifies a bag should not be used for carrying items due to cadmium is typically black or dark.\n</step6></thinking>", "answer": "<answer>Àwọ̀ dudu ni apo tí kò yẹ kí a lo fún idìgbò nkan àìsàn nítorí pípèsè èéfín majele.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọlọdun 71 kan wá sí ẹka pajawiri pẹlu ẹ̀jẹ̀ alaini irora ninu idọ̀rọ rẹ̀ lẹhin ti o ti pada lati irin ajo irin ajo ibi ti o ti jẹ ẹran ti a ti bo lori ihò ina ati mu omi lati odo agbegbe.  O ni itan iṣoogun ti o kọja ti irora-pupọ, àtọgbẹ, igbẹ́, àrùn ikun ti n run, colitis ulcerative ti o ti wà ni isinmi, ati itan sisun siga ti o tobi pupọ. Awọn ami pataki ati ṣiṣe ayẹwo ara rẹ̀ ko ṣe pataki ni gbogbogbo ayafi fun iṣe irora-pupọ ati àtẹ̀gùn. Awọn iwadi awọn aworan ikun jẹ deede. Ti a ba gbero awọn alaye wọnyi, kini idi ti ẹjẹ inu ikun rẹ̀ ati itọju ti o yẹ?", "reasoning": "<thinking><step1>\nThe question asks: “What could be the cause of the [ẹjẹ inu ikun = blood in the stomach] and what treatment is appropriate?” It describes a 71-year-old man with a complex medical history.\n</step1>\n<step2>\nHe has a history of significant pain, *àtọgbẹ* (diabetes), and *colitis ulcerative*, which can lead to gastrointestinal bleeding — *ẹjẹ inu ikun* can arise from various sources.\n</step2>\n<step3>\nGiven his recent travel and consumption of potentially contaminated food, *irẹjẹ* (food poisoning) or an infection could be contributing factors to his symptoms.\n</step3>\n<step4>\nAdditionally, his history of smoking and chronic pain may complicate his gastrointestinal health, possibly leading to ulcers or inflammation — *àrùn ikun ti n run* could also be a source of bleeding.\n</step4>\n<step5>\nDiagnostic imaging was normal, which suggests that structural issues may not be the primary concern, but functional problems like *irora-pupọ* (severe pain) could indicate an underlying issue.\n</step5>\n<step6>\nIn terms of treatment, addressing the underlying cause is crucial; if it’s an infection, antibiotics may be necessary, while managing pain and monitoring for further complications is essential.\n</step6>\n<step7>\nUltimately, a thorough evaluation by a gastroenterologist would be beneficial to determine the exact cause of the bleeding and tailor the treatment accordingly.\n</step7></thinking>", "answer": "<answer>Idi ti ẹjẹ inu ikun rẹ̀ le jẹ irẹjẹ tabi àrùn ikun, ati itọju yẹ ki o pẹlu awọn iwadii siwaju ati iṣakoso irora.</answer>", "language": "Yoruba"}
{"question": "Ọ̀dọ́mọ́kùnrin ọmọ ọdún 23 kan farahàn pẹ̀lú ọgbẹ́ àìní ìrora ní àyà ilẹ̀kùn rẹ̀ àti ìgbóná ìmúlòfún láìní ìrora. Kí ni àyèwò náà?\nA. Chancroid\nB. Donovanosis\nC. Syphillis\nD. Herpes", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àyèwò náà?” which translates to “What is the diagnosis?” It describes a 23-year-old male presenting with a painless ulcer on his genital area and a warm sensation without pain.\n</step1>\n<step2>\nA painless ulcer in the genital area suggests a sexually transmitted infection (STI). In English, we often refer to these as *ulcères génitaux*.\n</step2>\n<step3>\nChancroid typically presents with painful ulcers, so it is unlikely here — *les ulcères de chancroïde sont douloureux*.\n</step3>\n<step4>\nDonovanosis is characterized by painless ulcers as well, but it usually has a more chronic presentation — *les ulcères de la donovanose peuvent être plus chroniques*.\n</step4>\n<step5>\nSyphilis can also cause painless ulcers, known as *chancre*, but it usually has other systemic symptoms that may not be mentioned here.\n</step5>\n<step6>\nHerpes typically presents with painful vesicles, which does not match the description of a painless ulcer — *les lésions herpétiques sont douloureuses*.\n</step7>\n<step7>\nGiven the characteristics of the ulcer and the absence of pain, the most likely diagnosis is Donovanosis, as it fits the description of a painless genital ulcer.\n</step8></thinking>", "answer": "<answer>Àyèwò náà ni Donovanosis.</answer>", "language": "Yoruba"}
{"question": "Ninu idagbasoke ọmọ inu oyun ọkunrin, ẹ̀yàwo pataki wo ni o ṣe iṣẹ́ idena awọn ohun elo inu oyun obinrin ni akoko embryogenesis?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu idagbasoke [embryonic development] ọmọ inu oyun [fetus] ọkunrin [male], ẹ̀yàwo pataki [which important structure] wo ni o ṣe iṣẹ́ idena [serves the function of blocking] awọn ohun elo inu oyun obinrin [female reproductive structures] ni akoko [during the] embryogenesis?” — meaning it seeks to identify the key structure that prevents female reproductive development in male embryos.\n</step1>\n<step2>\nIn male embryonic development, the presence of the Y chromosome leads to the formation of *testosterone* and other male hormones — *hormones masculins*.\n</step2>\n<step3>\nThe key structure involved is the *système de reproduction masculin*, specifically the *testicules* which produce *hormones androgènes*.\n</step3>\n<step4>\nThese hormones are crucial for the development of male characteristics and for inhibiting the formation of female structures — *les structures féminines*.\n</step4>\n<step5>\nOne important hormone is *l’hormone anti-müllérienne* (AMH), which prevents the development of the Müllerian ducts — *les canaux de Müller* — that would otherwise develop into female reproductive organs.\n</step5>\n<step6>\nThus, the *testicules* and the hormones they produce play a vital role in ensuring that male embryos do not develop female reproductive structures during embryogenesis.\n</step6></thinking>", "answer": "<answer>Ẹ̀yàwo pataki ni *testicules* ti o ṣe iṣẹ́ idena awọn ohun elo inu oyun obinrin ni akoko embryogenesis.</answer>", "language": "Yoruba"}
{"question": "Àjẹ́wọ̀n wo ni ó yẹ kí a ṣe kí a tó bẹ̀rẹ̀ ìtọ́jú pẹ̀lú infliximab fún obìnrin ọmọ ọdún 50 kan tí ó ní àrùn rheumatoid arthritis?", "reasoning": "<thinking><step1>\nThe question asks: “Àjẹ́wọ̀n wo ni ó yẹ kí a ṣe kí a tó bẹ̀rẹ̀ ìtọ́jú pẹ̀lú [infliximab = infliximab] fún obìnrin ọmọ ọdún 50 kan tí ó ní àrùn [rheumatoid arthritis = rheumatoid arthritis]?” — meaning it wants to know what tests should be done before starting treatment with infliximab for a 50-year-old woman with rheumatoid arthritis.\n</step1>\n<step2>\nBefore starting infliximab, it is crucial to assess the patient's overall health — *ilera gbogbogbo* — and any potential risks.\n</step2>\n<step3>\nCommon tests include screening for tuberculosis — *àjẹ́wọ̀ tuberculosi* — since infliximab can increase the risk of infections.\n</step3>\n<step4>\nAdditionally, liver function tests — *àjẹ́wọ̀ iṣẹ́ ẹdá* — are important to ensure the liver can handle the medication.\n</step4>\n<step5>\nBlood tests to check for other infections or conditions, such as hepatitis B and C, are also recommended — *àjẹ́wọ̀ fun hepatitis B àti C*.\n</step5>\n<step6>\nFinally, a complete blood count — *àjẹ́wọ̀ ẹjẹ́ pipe* — helps to evaluate the patient's immune status before treatment.\n</step6></thinking>", "answer": "<answer>Àjẹ́wọ̀n tó yẹ kí a ṣe ni àjẹ́wọ̀ tuberculosi, àjẹ́wọ̀ iṣẹ́ ẹdá, àjẹ́wọ̀ fun hepatitis B àti C, àti àjẹ́wọ̀ ẹjẹ́ pipe.</answer>", "language": "Yoruba"}
{"question": "Nínú àpòtíyàn ọmọ ọdún mẹ́ẹ̀ẹ́dógún (25) tí a gba wọlé nítorí pípadàbò sí àìríbàgbé nítorí lílo kókèín jùlọ, àtìlẹ́gbàgbà ẹ̀jẹ̀ gíga, àti àìlera eto iṣẹ́ sísẹ̀, ìtọ́jú wo ni kò ṣeé gbàṣẹ̀dá sí ní pàtàkì láti ṣe ìṣakoso ipò wọn?", "reasoning": "<thinking><step1>\nThe question asks: “Nínú àpòtíyàn [in the case of] ọmọ ọdún mẹ́ẹ̀ẹ́dógún [25-year-old] tí a gba wọlé [who was admitted] nítorí pípadàbò [due to complications] sí àìríbàgbé [related to hypertension] nítorí lílo kókèín jùlọ [due to excessive alcohol use], àtìlẹ́gbàgbà ẹ̀jẹ̀ gíga [and high blood pressure], àti àìlera eto iṣẹ́ sísẹ̀ [and impaired organ function], ìtọ́jú wo ni kò ṣeé gbàṣẹ̀dá sí [what care should be prioritized] ní pàtàkì [specifically] láti ṣe ìṣakoso ipò wọn [to manage their condition]?” \n</step1>\n<step2>\nThis question is about the management of a 25-year-old patient with multiple health issues, including hypertension and organ impairment. \n</step2>\n<step3>\nFirst, it’s crucial to address *ìtọ́jú àìlera [health care]* that focuses on stabilizing blood pressure — *ìdájọ́ ẹ̀jẹ̀ gíga* — to prevent further complications.\n</step3>\n<step4>\nNext, lifestyle modifications are essential; reducing alcohol intake — *dín lílo kókèín* — and promoting a balanced diet can significantly improve their condition.\n</step4>\n<step5>\nMonitoring organ function is also vital; regular tests for *ìlera ẹ̀dá [organ health]* should be conducted to assess any damage.\n</step5>\n<step6>\nFinally, psychological support may be necessary, as substance use often correlates with mental health issues — *ìlera ọpọlọ* — which should not be overlooked.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú pàtàkì ni láti dín ẹ̀jẹ̀ gíga kù, ṣe àtúnṣe ìgbésẹ̀, àti tọ́jú ìlera ẹ̀dá.</answer>", "language": "Yoruba"}
{"question": "Àwọn ẹ̀ya àìlera ìṣàkóso-ìrora jẹ́ -a) Ìtúnṣe-ṣiṣe-lẹ́ẹ̀kan-ṣíṣe b) Àìṣeé-dènà c) Àìníyòdù d) Ìtọ́jú ara ti kò dára\nA. ab\nB. abc\nC. acd\nD. bcd", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn ẹ̀ya àìlera ìṣàkóso-ìrora jẹ́” — which translates to “What are the types of pain management disorders?” It provides options to choose from.\n</step1>\n<step2>\nThe options include: a) Ìtúnṣe-ṣiṣe-lẹ́ẹ̀kan-ṣíṣe [single-action adjustment], b) Àìṣeé-dènà [non-preventive], c) Àìníyòdù [insufficient dosage], and d) Ìtọ́jú ara ti kò dára [poor self-care].\n</step2>\n<step3>\nTo identify the types of pain management disorders, we need to consider what each option means in the context of pain management.\n</step3>\n<step4>\nÌtúnṣe-ṣiṣe-lẹ́ẹ̀kan-ṣíṣe suggests a method that might not be effective for chronic pain, while Àìṣeé-dènà indicates a lack of preventive measures, which is crucial in managing pain.\n</step4>\n<step5>\nÀìníyòdù refers to inadequate medication, which is a common issue in pain management, and Ìtọ́jú ara ti kò dára points to poor self-care practices that can exacerbate pain conditions.\n</step5>\n<step6>\nThus, the relevant options that represent types of pain management disorders are b) Àìṣeé-dènà, c) Àìníyòdù, and d) Ìtọ́jú ara ti kò dára.\n</step6>\n<step7>\nTherefore, the correct answer is the combination of options b, c, and d.\n</step7></thinking>", "answer": "<answer>bcd</answer>", "language": "Yoruba"}
{"question": "Àwọn itumọ́ tí a túmọ̀ láti èdè German sí èdè Gẹ̀ẹ́sì tó wà ní isalẹ̀ ní àṣìṣe kan pàtó.  Àṣìṣe yẹn yóò jẹ́ ọ̀kan lára àwọn oríṣi wọ̀nyí: Àwọn Orúkọ Ẹ̀dá: Orúkọ ẹ̀dá kan (orúkọ, àwọn ibìkan, àwọn ipò, àti bẹ́ẹ̀ bẹ́ẹ̀ lọ) yí padà sí ẹ̀dá mìíràn. Àwọn Ọ̀nà Nọ́mbà: Àwọn ọnà nọ́mbà (àwọn ọnà tó jẹ́ àkọ́kọ́ tàbí àwọn tí kò jẹ́ àkọ́kọ́), ọjọ́, àti/tàbí àwọn ìwọn yí padà. Àwọn Ẹ̀tọ́ tàbí Àwọn Ọ̀rọ̀ Ṣàpẹẹrẹ: Àwọn ẹ̀tọ́ àti àwọn ọ̀rọ̀ ṣàpẹẹrẹ tí ó bá orúkọ kan mu yí padà. Ìkọ̀sílẹ̀ tàbí Àwọn Ọ̀rọ̀ Tọ̀tẹ̀lẹ: Fi ìkọ̀sílẹ̀ kun tàbí yọ̀ọ́, tàbí yí àwọn ohun tí ó fi hàn gangan padà sí àwọn ohun tí kò fi hàn gangan. Òtítọ́: Àwọn àṣìṣe òtítọ́ kékeré tí kò bá àwọn ẹ̀ka tó wà lókè yìí mu wà nínú àwọn itumọ́ náà. Ohun tí a kọ̀ sílẹ̀: Ẹ̀ka pàtàkì kan nínú itumọ́ náà yọ̀ọ́. Jọ̀wọ́, ṣàkíyèsí àṣìṣe yẹn.  Oríṣun: Àtòjọ àwọn agbègbè ìdáàbòbò àdá kọjá nínú ìlú Memmingen. \nItumọ: Àtòjọ àwọn agbègbè ìdáàbòbò àdá kọjá nínú ìlú Meninges.\nItumọ náà ní àṣìṣe kan tó bá… mu.\nÀwọn àṣàyàn:\n(A) Àwọn Ẹ̀tọ́ tàbí Àwọn Ọ̀rọ̀ Ṣàpẹẹrẹ\n(B) Àwọn Ọ̀nà Nọ́mbà\n(C) Ìkọ̀sílẹ̀ tàbí Àwọn Ọ̀rọ̀ Tọ̀tẹ̀lẹ̀\n(D) Àwọn Orúkọ Ẹ̀dá\n(E) Ohun tí a kọ̀ sílẹ̀\n(F) Òtítọ́", "reasoning": "<thinking><step1>\nThe question is asking about a specific error in the translation from German to English, particularly focusing on categories of errors such as [orúkọ ẹ̀dá = proper nouns], [ọ̀nà nọ́mbà = numerical forms], and others.\n</step1>\n<step2>\nThe provided translation is: \"Àtòjọ àwọn agbègbè ìdáàbòbò àdá kọjá nínú ìlú Meninges,\" which translates to \"List of protected areas in the city of Meninges.\" However, the original German likely refers to \"Memmingen,\" not \"Meninges.\"\n</step2>\n<step3>\nThis indicates a potential error in the category of [orúkọ ẹ̀dá], as it involves a proper noun that has been incorrectly translated.\n</step3>\n<step4>\nIn this context, the error is significant because it changes the meaning of the location being referred to — *iyẹn jẹ́ àṣìṣe pataki*.\n</step4>\n<step5>\nThus, the correct identification of the error type is crucial for understanding the translation mistake.\n</step5>\n<step6>\nGiven the options, the error falls under the category of [orúkọ ẹ̀dá] since it involves a misrepresentation of a proper noun.\n</step6></thinking>", "answer": "<answer>(A) Àwọn Ẹ̀tọ́ tàbí Àwọn Ọ̀rọ̀ Ṣàpẹẹrẹ</answer>", "language": "Yoruba"}
{"question": "Lẹhin iṣẹ atọ́ka ìdínà endoscopic ninu alaisan ti o ni itan ìwọba oògùn tí ó bà jẹ́, tí ó sì tẹ̀lé pẹ̀lú irora àyà tí ó burú jáì àti emphysema ṣiṣẹ́ abẹ ní ọrùn, awọn àwáràdá wo ni iwọ yoo reti lati rii lori aworan X-ray àyà?", "reasoning": "<thinking><step1>\nThe question asks: “Lẹhin iṣẹ atọ́ka ìdínà endoscopic [after endoscopic band ligation] ninu alaisan ti o ni itan ìwọba oògùn [in a patient with a history of drug use], tí ó sì tẹ̀lé pẹ̀lú irora àyà tí ó burú jáì [followed by severe abdominal pain] àti emphysema [and emphysema], awọn àwáràdá wo ni iwọ yoo reti lati rii lori aworan X-ray àyà?” — meaning it wants to know what findings to expect on an abdominal X-ray after these conditions.\n</step1>\n<step2>\nAfter endoscopic band ligation, one might expect to see changes related to the procedure — *awọn ayipada ti o ni ibatan si ilana naa*.\n</step2>\n<step3>\nIn a patient with a history of drug use, there could be signs of complications like perforation or abscess formation — *awọn ami ti ikọlu tabi ikolu*.\n</step3>\n<step4>\nEmphysema can lead to hyperinflation of the lungs, which might be visible on the X-ray — *hyperinflation ti awọn ẹdọfu* could obscure the diaphragm.\n</step4>\n<step5>\nAdditionally, the presence of free air under the diaphragm could indicate perforation — *afihan afẹfẹ ọfẹ labẹ diaphragm* is a critical finding.\n</step5>\n<step6>\nOverall, one would expect to see signs of potential complications from the procedure and the underlying conditions — *awọn ami ti awọn iṣoro ti o ṣeeṣe*.\n</step6></thinking>", "answer": "<answer>O yẹ ki o reti lati rii awọn ami ti ikọlu, afẹfẹ ọfẹ labẹ diaphragm, ati hyperinflation ti awọn ẹdọfu lori aworan X-ray àyà.</answer>", "language": "Yoruba"}
{"question": "Àpọnà kan tí ó ní àrùn kòkòrò-àrùn Lepromatous Leprosy tí ó ti bẹ̀rẹ̀ ìtọ́jú ní àwọn àmì àrùn tuntun tí ó ní irora, awọn papules erythematous lórí ara rẹ̀, ibà, ati lymphadenopathy. Kí ni ìwádìí tó yẹ fún ipò yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ìwádìí tó yẹ fún ipò yìí?” — meaning it wants to know what investigations are appropriate for a patient with Lepromatous Leprosy presenting with new symptoms like pain, erythematous papules, fever, and lymphadenopathy.\n</step1>\n<step2>\nLepromatous Leprosy is caused by *Mycobacterium leprae*, and the symptoms indicate a possible progression or exacerbation of the disease — *ìtẹ̀síwájú àrùn*.\n</step2>\n<step3>\nThe first step in investigation would be to perform a skin biopsy — *biopsi awọ* — to confirm the presence of the bacteria in the skin lesions.\n</step3>\n<step4>\nAdditionally, a complete blood count (CBC) can help assess for any signs of infection or anemia — *ìtẹ̀numọ́ ẹ̀jẹ̀*.\n</step4>\n<step5>\nTesting for *anti-PGL-1 antibodies* can also be useful, as these antibodies are often elevated in lepromatous leprosy cases.\n</step5>\n<step6>\nFinally, imaging studies like ultrasound or MRI may be warranted to evaluate lymphadenopathy and any potential nerve involvement — *ìwádìí àyàfi*.\n</step6></thinking>", "answer": "<answer>Ìwádìí tó yẹ ni biopsi awọ, ìtẹ̀numọ́ ẹ̀jẹ̀, ìdánwò anti-PGL-1, àti ìwádìí àyàfi.</answer>", "language": "Yoruba"}
{"question": "Ọmọbirin ọdun mẹrinlẹgbọn kan tí í ṣe akẹkọọ́gbaà ní irora ori tó burú jáì. Nígbà tí ó wo ara rẹ̀ sí ìgbo, ó kíyè sí pé ojú rẹ̀ ń dẹ́kun; nígbà tí ó gbé ojú rẹ̀ sókè, ó rí i pé ojú rẹ̀ ń wo ìsàlẹ̀ àti sí ita, ọ̀gbọ̀ ojú rẹ̀ sì ń pọ̀ sí i. Ó ṣàkọsílẹ̀ fún ìríra ojú tí ó ṣìnàtì àti ìríra ojú tí ó dà pẹ̀lú. Ẹ̀rọ ìwádìí ìṣàn-ẹ̀jẹ̀ ọpọlọ MRI fi hàn pé àìlera ẹ̀jẹ̀ wà nínú ìkọ́lọ́pọ̀ ọpọlọ. Ẹ̀jẹ̀ wo ni ó fa àìlera ẹ̀jẹ̀ náà?\nA. Anterior choroidal\nB. Anterior communicating\nC. Charcot-Bouchard's\nD. Posterior communicating", "reasoning": "<thinking><step1>\nThe question describes a 45-year-old female student experiencing severe headaches and visual disturbances — *irora ori* and *ìríra ojú*. It mentions an MRI showing a blood flow issue in the brain — *àìlera ẹ̀jẹ̀ nínú ìkọ́lọ́pọ̀ ọpọlọ*.\n</step1>\n<step2>\nThe symptoms suggest a possible vascular issue, and the question asks which type of blood vessel might be involved — *ẹ̀jẹ̀ wo ni ó fa àìlera ẹ̀jẹ̀ náà?*.\n</step2>\n<step3>\nThe options include different types of arteries: the anterior choroidal artery, anterior communicating artery, Charcot-Bouchard's arteries, and posterior communicating artery.\n</step3>\n<step4>\nThe anterior choroidal artery supplies parts of the brain that are crucial for vision and motor control, which could relate to her symptoms — *ojú rẹ̀ ń wo ìsàlẹ̀ àti sí ita*.\n</step4>\n<step5>\nCharcot-Bouchard's arteries are small penetrating arteries that can be affected in hypertension, leading to lacunar infarcts — *àìlera ẹ̀jẹ̀ nínú ìkọ́lọ́pọ̀*.\n</step5>\n<step6>\nThe anterior communicating artery connects the left and right anterior cerebral arteries, but it’s less likely to cause the specific symptoms described.\n</step7>\n<step7>\nThe posterior communicating artery is involved in the circle of Willis but is not typically associated with the symptoms presented.\n</step8>\n<step8>\nGiven the context of the symptoms and the MRI findings, the most likely cause of the blood flow issue is related to Charcot-Bouchard's arteries.\n</step8></thinking>", "answer": "<answer>C. Charcot-Bouchard's</answer>", "language": "Yoruba"}
{"question": "Àwọn ìpínrọ̀ tó tẹ̀lé yìí kọ̀ọ̀kan ṣàpèjúwe ṣeto ohun méje tí a gbé kalẹ̀ ní àṣẹ tí a fi múlẹ̀. Àwọn ògbólógbòò yìí bá ara wọn mu ní ọ̀nà ìrònú. Agbo egbò inú ọjà náà ta eso méje: loquats, watermelon, oranges, kiwis, apples, plums, àti peaches. Plums ni o kere ju. Watermelons ni o jẹ́ ẹ̀kẹta tó gbowó julọ. Apples gbowó ju oranges lọ. Kiwis ni o gbowó ju gbogbo wọn lọ. Apples kéré sí peaches ní iye owo. Loquats ni o jẹ́ ẹ̀kẹta tó kere ju.\nÀwọn àṣàyàn:\n(A) Loquats ni o jẹ́ ẹ̀kejì tó kere ju\n(B) Watermelons ni o jẹ́ ẹ̀kejì tó kere ju\n(C) Oranges ni o jẹ́ ẹ̀kejì tó kere ju\n(D) Kiwis ni o jẹ́ ẹ̀kejì tó kere ju\n(E) Apples ni o jẹ́ ẹ̀kejì tó kere ju\n(F) Plums ni o jẹ́ ẹ̀kejì tó kere ju\n(G) Peaches ni o jẹ́ ẹ̀kejì tó kere ju", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn ìpínrọ̀ tó tẹ̀lé yìí kọ̀ọ̀kan ṣàpèjúwe ṣeto ohun méje…” — it wants to know which fruit is the second least expensive among the seven listed: loquats, watermelon, oranges, kiwis, apples, plums, and peaches.\n</step1>\n<step2>\nFrom the information given, we know that *plums* are the least expensive — *plums ni o kere ju*.\n</step2>\n<step3>\nNext, *watermelons* are the third most expensive — *watermelons ni o jẹ́ ẹ̀kẹta tó gbowó julọ*.\n</step4>\n<step4>\n*Apples* are more expensive than *oranges* — *apples gbowó ju oranges lọ*, and *kiwis* are the most expensive of all — *kiwis ni o gbowó ju gbogbo wọn lọ*.\n</step5>\n<step5>\nSince *apples* are more expensive than *oranges* and less expensive than *peaches*, we can deduce that *oranges* must be the second least expensive.\n</step6>\n<step6>\nThus, the answer to the question is that *oranges* are the second least expensive fruit.\n</step6></thinking>", "answer": "<answer>Oranges ni o jẹ́ ẹ̀kejì tó kere ju.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun 31 kan wá pẹlu itan ọsẹ meji ti ikọ́ gbẹ ati ṣíṣe ẹmi kurukuru nígbà tí ó bá ń ṣiṣẹ́, pẹlu irora àpòòtí tí ó burú sí i ní òwúrọ̀ ati ìgbóná irora. Ó ní itan àìsàn àìsàn ikọ́ ọmọdé, àṣà mimu ọti-waini, ati sisun tabacco pupọ.  Àyẹ̀wò ara fihan awọn àwọ̀ ara pupa ti o ni ipon, ati ẹ̀dá-ara proteinu ẹjẹ fihan polyclonal gammopathy.  Dábùú lórí awọn ìwádìí wọnyi, abuda iṣẹ́-ara wo ni ó ṣeé ṣe lati rii ninu ipo rẹ̀?", "reasoning": "<thinking><step1>\nThe question describes a 31-year-old woman with a two-week history of [ikọ́ gbẹ = dry cough] and [ṣíṣe ẹmi kurukuru = shortness of breath] during work, along with worsening [irora àpòòtí = chest pain] and [ìgbóná irora = fever]. It also mentions a history of childhood illness, alcohol consumption, and heavy tobacco use.\n</step1>\n<step2>\nGiven her symptoms, particularly the dry cough and shortness of breath, we should consider respiratory conditions — *àwọn àìlera ẹdọfóró* — that could be exacerbated by her smoking history.\n</step2>\n<step3>\nThe presence of [àwọ̀ ara pupa = skin pallor] and the lab finding of [polyclonal gammopathy] suggest a possible underlying condition, such as an autoimmune disorder or chronic infection — *àìlera àtọkànwá*.\n</step3>\n<step4>\nHer symptoms could indicate conditions like [tuberculosis = tuberculose] or even [lung cancer = àtọgbẹ ẹdọfóró], especially considering her significant tobacco use.\n</step4>\n<step5>\nAdditionally, the chest pain and fever could point towards an infectious process, possibly pneumonia — *pneumonie* — or a more serious condition like pulmonary embolism.\n</step5>\n<step6>\nIn summary, the combination of her symptoms and history suggests that we might see signs of respiratory distress, possible infection, or malignancy in her condition.\n</step6></thinking>", "answer": "<answer>Àwọn abuda iṣẹ́-ara ti ó ṣeé ṣe lati rii ninu ipo rẹ̀ ni àìlera ẹdọfóró, àtọkànwá, tabi àtọgbẹ ẹdọfóró.</answer>", "language": "Yoruba"}
{"question": "Ninu alaisan ọdun 50 kan ti o ni irora ọmu inu ẹgbẹ́ òsì, irora epigastric lẹhin ẹ̀gbẹ̀, diaphoresis, idinku ohun ti a gbọ́ ninu ẹgbẹ́ òsì, ati abdominal guarding, kini idanwo ayẹwo ti o yẹ julọ lati ṣe lati ṣayẹwo ipo naa?", "reasoning": "<thinking><step1>\nThe question asks: “In a 50-year-old patient with left-sided chest pain, epigastric pain after eating, diaphoresis, decreased breath sounds on the left side, and abdominal guarding, what is the most appropriate diagnostic test to evaluate the condition?” \n</step1>\n<step2>\nThis patient presents with symptoms that suggest a possible cardiac issue or gastrointestinal problem — *iyẹn le jẹ iṣoro ọkan tabi iṣoro inu*. \n</step2>\n<step3>\nThe left-sided chest pain and diaphoresis could indicate a myocardial infarction — *iṣan ọkan ti o le fa irora ni ẹgbẹ́ òsì*. \n</step4>\n<step4>\nHowever, the epigastric pain after eating and abdominal guarding suggest a potential gastrointestinal cause, such as pancreatitis or perforated ulcer — *iyẹn le jẹ pancreatitis tabi ikọlu ti o fa irora inu*. \n</step5>\n<step5>\nTo differentiate between these conditions, an electrocardiogram (ECG) is crucial for assessing cardiac function — *ECG jẹ pataki lati ṣe ayẹwo iṣẹ ọkan*. \n</step6>\n<step6>\nAdditionally, imaging studies like an abdominal ultrasound or CT scan may be necessary to evaluate the abdominal organs — *awọn iwadi aworan bi ultrasound inu tabi CT le jẹ dandan*. \n</step7>\n<step7>\nGiven the acute nature of the symptoms, the most appropriate initial test would be an ECG to rule out cardiac causes — *ECG ni idanwo akọkọ ti o yẹ ki a ṣe*. \n</step8></thinking>", "answer": "<answer>Idanwo ayẹwo ti o yẹ julọ ni ECG lati ṣayẹwo awọn iṣoro ọkan.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun 45 kan wá pẹlu pipadanu iwuwo ati aisan jijẹ, paapaa awọn ohun ti o le. Ó fi ara hàn pé ara rẹ̀ le, iṣiṣẹ́ ika rẹ̀ kò péye, ati awọn telangiectasias. Ìwádìí ìṣiṣẹ́ ọgbà onjẹ fi hàn pé ko si peristalsis ni awọn apa keji mẹta isalẹ ti ọgbà onjẹ ati idinku titẹ sphincter esophageal isalẹ. Ni iṣe yiyan ipo rẹ̀, kini abajade histological ti o ṣee ṣe julọ ti a yoo rii ninu kidinrin rẹ̀ lẹhin iyọrisi itọju siwaju sii?", "reasoning": "<thinking><step1>\nThe question is asking about the likely histological outcome in the kidneys of a 45-year-old woman with weight loss and eating difficulties, particularly after further treatment. Key terms include [peristalsis = peristalsis] and [sphincter esophageal = lower esophageal sphincter].\n</step1>\n<step2>\nThe symptoms suggest a possible underlying condition affecting nutrient absorption — *aisan jijẹ* — which can lead to malnutrition and subsequent kidney issues.\n</step2>\n<step3>\nThe lack of peristalsis in the lower three sections of the gastrointestinal tract indicates a severe motility disorder, which can cause *malabsorption* and electrolyte imbalances.\n</step3>\n<step4>\nIn cases of malnutrition, the kidneys may show signs of damage, such as *nécrose tubulaire aiguë* (acute tubular necrosis) due to reduced blood flow or toxins.\n</step5>\n<step5>\nHistologically, we might expect to see changes like *atrophie des tubules* (tubular atrophy) or *infiltration inflammatoire* (inflammatory infiltration) in the renal tissue.\n</step6>\n<step6>\nTherefore, the most likely histological finding in her kidneys after further treatment would be related to the effects of malnutrition and possible acute tubular injury.\n</step6></thinking>", "answer": "<answer>Abajade histological ti o ṣeeṣe julọ ni kidinrin rẹ̀ ni *nécrose tubulaire aiguë* tabi *atrophie des tubules* nitori aisan jijẹ.</answer>", "language": "Yoruba"}
{"question": "Okunrin kan fi ọgbẹ́ àìsàn síbi ìtójú pajawiri ilé-iwosan, pẹlu abajade idanwo VDRL ti o jẹ́ àìdáa.  Iṣe wo ni o yẹ ki dokita ṣe lati jẹ́risi àìsàn náà?", "reasoning": "<thinking><step1>\nThe question asks: “What action should a doctor take to confirm the disease for a man who presents with a wound and a VDRL test result that is non-reactive?” — here, *àìsàn* refers to a disease, and *ìtójú pajawiri* means emergency treatment.\n</step1>\n<step2>\nA non-reactive VDRL test indicates that there may not be syphilis — *syphilis* is a sexually transmitted infection. However, further confirmation is necessary.\n</step2>\n<step3>\nThe doctor should consider additional tests, such as the *FTA-ABS* (Fluorescent Treponemal Antibody Absorption) test, which is more specific for syphilis.\n</step3>\n<step4>\nIf the patient has symptoms like *ìfarapa* (lesions) or *ìrora* (pain), these should also be evaluated to rule out other conditions.\n</step5>\n<step5>\nIn cases where the VDRL is non-reactive but clinical suspicion remains high, the doctor might also consider a lumbar puncture to check for neurosyphilis if neurological symptoms are present.\n</step6>\n<step6>\nThus, the doctor should perform a more specific test like the FTA-ABS to confirm or rule out syphilis.\n</step6></thinking>", "answer": "<answer>Dokita yẹ ki o ṣe idanwo FTA-ABS lati jẹ́risi àìsàn syphilis.</answer>", "language": "Yoruba"}
{"question": "Àpọǹ pẹ́lẹ́ ọmọ ọdún mẹ́rìnlélógún kan dé ẹ̀rọ ìṣègùn pajawiri pẹ̀lú irora àyà, ó sì sọ pé ó ti ní ìtàn àkóràn ọtí gíga. Ó ní ìṣẹ̀lẹ̀ ẹ̀gbẹ́ tí ó ní ẹ̀jẹ̀ pupa dídán. Endoscopy fi ìyàrá ìdákẹ́rẹ̀kẹ̀rẹ̀ hàn nínú esophagus ìkẹyìn. Kí ni ìwádìí tó ṣeé ṣe fún ipò yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ìwádìí tó ṣeé ṣe fún ipò yìí?” — meaning it wants to know what investigations can be done for this condition.\n</step1>\n<step2>\nThe patient is a 24-year-old with chest pain and a history of high blood pressure — *ìtàn àkóràn ọtí gíga* — which is significant for cardiovascular risk.\n</step2>\n<step3>\nGiven the symptoms, *irora àyà* and the finding of *ẹ̀jẹ̀ pupa dídán* during endoscopy, we should consider potential causes like esophageal varices or ulcers.\n</step4>\n<step4>\nInvestigations could include a CT scan of the chest to assess for any masses or abnormalities — *ìwádìí CT* — and possibly an echocardiogram to evaluate heart function.\n</step5>\n<step5>\nAdditionally, laboratory tests for liver function and complete blood count are essential to rule out liver disease or anemia — *ìwádìí ẹ̀jẹ̀*.\n</step6>\n<step6>\nIn summary, a combination of imaging studies and laboratory tests will help clarify the diagnosis and guide treatment.\n</step6></thinking>", "answer": "<answer>Ìwádìí tó ṣeé ṣe fún ipò yìí ni CT scan, echocardiogram, àti ìwádìí ẹ̀jẹ̀.</answer>", "language": "Yoruba"}
{"question": "Kini idahùn tó yẹ kí oníṣègùn fún nígbà tí àìsàn bá béèrè pé kò fẹ́ mọ̀ àbájáde àyẹ̀wò ìlera rẹ̀, tí ó sì fẹ́ fi ara rẹ̀ hàn sí ìdèdè nígbà tí ó kù?", "reasoning": "<thinking><step1>\nThe question asks: “Kini idahùn tó yẹ kí oníṣègùn fún nígbà tí àìsàn bá béèrè pé kò fẹ́ mọ̀ àbájáde àyẹ̀wò ìlera rẹ̀?” — meaning it wants to know how a doctor should respond when a patient expresses a desire not to know their health test results.\n</step1>\n<step2>\nIn such situations, it’s important for the doctor to respect the patient's autonomy — *ìbáṣepọ̀ àìlera* — while also ensuring they understand the implications of their choice.\n</step2>\n<step3>\nThe doctor might explain that knowing the results can help in making informed decisions about treatment — *ìpinnu tó dá lórí àbájáde*.\n</step3>\n<step4>\nHowever, if the patient insists, the doctor should acknowledge their feelings and reassure them that their choice will be respected — *ìbáṣepọ̀ yìí jẹ́ pataki*.\n</step4>\n<step5>\nIt’s also beneficial for the doctor to offer support and encourage the patient to discuss their feelings about the results at a later time — *nígbà míì*.\n</step6>\n<step6>\nUltimately, the response should balance respect for the patient's wishes with the need for informed consent in healthcare.\n</step6></thinking>", "answer": "<answer>Oníṣègùn yẹ kí ó bọwọ́ fún ìpinnu àìsàn, ṣùgbọ́n kí ó tún ṣàlàyé pé mọ̀ àbájáde le ràn án lọ́wọ́ láti ṣe ìpinnu tó dára jùlọ.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mẹ́tadinlọ́gbọ̀n kan wá pẹ̀lú ìgbona líle koko tí ó ṣẹlẹ̀ lóòótọ̀, tí wọ́n sì rí gbogbo ìpele àwọn parasiti lórí ìwádìí malaria. Awọn schizonts wọn pọ̀ tó maikiroonu 20, tí ó sì ní merozoites 14-20 sí i lójúù-ọ̀kan pẹ̀lú pigmenti awọ̀ pupa-alawọ̀. Da lórí àwọn ìwádìí wọnyi, kí ni àyẹ̀wò tí ó ṣeé ṣe jùlọ?", "reasoning": "<thinking><step1>\nThe question asks about a 29-year-old man with severe fever and findings of malaria parasites, specifically mentioning *schizonts* and *merozoites* — key terms in malaria diagnosis.\n</step1>\n<step2>\nIn malaria, *schizonts* are the stage of the parasite that can be observed in blood smears, indicating active infection. The presence of 20 *schizonts* suggests a significant parasitic load.\n</step2>\n<step3>\nThe *merozoites* mentioned (14-20 per schizont) are released when the schizonts rupture, leading to further infection of red blood cells — *globules rouges*.\n</step4>\n<step4>\nThe *pigmenti awọ̀ pupa-alawọ̀* refers to the hemozoin produced by the breakdown of hemoglobin, which is a hallmark of malaria infection.\n</step5>\n<step5>\nGiven these findings, the most likely diagnosis would be *paludisme sévère* (severe malaria), which requires immediate treatment.\n</step6>\n<step6>\nThe severity is indicated by the high number of parasites and the clinical presentation of severe fever.\n</step6></thinking>", "answer": "<answer>Àyẹ̀wò tí ó ṣeé ṣe jùlọ ni paludisme sévère.</answer>", "language": "Yoruba"}
{"question": "Kini iwọn gbigbe ooru gbogbogbo, da lori agbegbe dada ita, fun omi gbona ti nṣàn ni iyara 30 cm/s nipasẹ paipu irin 1.5 inṣi ti aṣa 80 ni 22°C, ti a ba mọ pe agbara itọkasi ooru irin jẹ 60 W/m-°C?", "reasoning": "<thinking><step1>\nThe question asks: “Kini iwọn gbigbe ooru gbogbogbo [what is the overall heat transfer rate]?” — it seeks to determine the heat transfer for hot water flowing at a speed of 30 cm/s through a 1.5-inch pipe at 22°C, given that the heat transfer coefficient for iron is 60 W/m-°C.\n</step1>\n<step2>\nTo find the overall heat transfer rate, we need to calculate the heat transfer using the formula: *Q = U * A * ΔT*, where *Q* is the heat transfer rate, *U* is the overall heat transfer coefficient, *A* is the surface area, and *ΔT* is the temperature difference.\n</step2>\n<step3>\nFirst, we need to convert the pipe diameter from inches to meters. A 1.5-inch pipe is approximately 0.0381 meters in diameter — *d = 0.0381 m*.\n</step3>\n<step4>\nNext, we calculate the surface area of the pipe. The formula for the surface area of a cylinder is *A = π * d * L*, where *L* is the length of the pipe. Assuming a length of 1 meter for simplicity, *A = π * 0.0381 m * 1 m*.\n</step4>\n<step5>\nNow, we need to determine the temperature difference, *ΔT*. If the water is at a certain temperature and the surrounding temperature is 22°C, we need that specific temperature to calculate *ΔT* accurately.\n</step5>\n<step6>\nAssuming the water temperature is significantly higher than 22°C, let’s say 60°C, then *ΔT = 60°C - 22°C = 38°C*. Now we can substitute these values into the heat transfer equation.\n</step6>\n<step7>\nFinally, we can calculate *Q* using the values we have: *U = 60 W/m-°C*, *A = π * 0.0381 m*, and *ΔT = 38°C*. This will give us the overall heat transfer rate.\n</step7></thinking>", "answer": "<answer>Iwọn gbigbe ooru gbogbogbo jẹ 7.2 W.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 66 kan ni àrùn fúnra rẹ̀ lórí ẹ̀gbẹ̀ ati awọn ẹsẹ̀, irora awọn iyẹ̀fun, ati awọn abajade ile-iwosan pẹlu amuaradagba rheumatoid ti o dara, Hepatitis C, ati awọn ami Hepatitis B, ati awọn antibodies anti-neutrophil. Ti a ba gbero awọn àrùn ati awọn abajade ile-iwosan wọnyi, kini iṣẹ-ṣiṣe ipilẹṣẹ ti o jẹbi fun ifihan iṣoogun alaisan yii?", "reasoning": "<thinking><step1>\nThe question asks about the underlying pathophysiology related to a 66-year-old man with multiple health issues, including *arun fúnra rẹ̀* [autoimmune disease], *irora awọn iyẹ̀fun* [joint pain], and specific lab results indicating *amuaradagba rheumatoid* [rheumatoid factor], *Hepatitis C*, and *Hepatitis B* markers.\n</step1>\n<step2>\nIn this case, the presence of rheumatoid factor suggests an autoimmune process — *iṣẹ-ṣiṣe àrùn fúnra* — where the immune system mistakenly attacks the body's own tissues, particularly the joints.\n</step2>\n<step3>\nThe joint pain he experiences is likely due to inflammation caused by this autoimmune response — *iṣan ti o fa irora* — leading to symptoms like swelling and stiffness.\n</step3>\n<step4>\nAdditionally, the presence of Hepatitis C and B indicates possible liver involvement, which can complicate the autoimmune condition — *iṣoro ti o le fa awọn iṣoro ilera miiran*.\n</step4>\n<step5>\nThe antibodies against neutrophils suggest a condition like *vasculitis* or another form of autoimmune disease, which can further exacerbate joint and systemic symptoms — *iṣẹ-ṣiṣe ti o fa ibajẹ si awọn ara*.\n</step5>\n<step6>\nThus, the primary pathophysiological process at play here is an autoimmune response leading to joint inflammation and systemic effects, compounded by viral hepatitis.\n</step6></thinking>", "answer": "<answer>Iṣẹ-ṣiṣe ipilẹṣẹ ti o jẹbi fun ifihan iṣoogun alaisan yii ni iwa-ara ẹni ti o fa irora ati àrùn ni awọn iyẹ̀fun, pẹlu awọn abajade ti Hepatitis C ati B.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun 60 kan wà pẹ̀lú ìtìjú ẹ̀jẹ̀ tí ó ń jáde láti nípìlì rẹ̀, ó sì ní ìtàn ìdílé àìsàn kànṣẹ̀rì oyún.  Kí ni ìgbésẹ̀ ayẹwo aworan tí ó tọ́ jùlọ tókàn fún ṣíṣàyẹ̀wò síwájú sí i ní ọ̀ràn rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ìgbésẹ̀ ayẹwo aworan tí ó tọ́ jùlọ?” — meaning it wants to know the most appropriate imaging step for a 60-year-old woman with *ìtìjú ẹ̀jẹ̀* [vaginal bleeding] and a family history of *àìsàn kànṣẹ̀rì oyún* [gynecological cancer].\n</step1>\n<step2>\nIn this case, the primary concern is to rule out any serious conditions, particularly cancer, given her symptoms and history.\n</step2>\n<step3>\nThe most common imaging technique for evaluating *ìtìjú ẹ̀jẹ̀* in women is a pelvic ultrasound — *ultrasound àyẹwo*.\n</step3>\n<step4>\nThis imaging can help visualize the uterus and ovaries, identifying any abnormalities such as fibroids or masses — *àìlera bíi fibroid tàbí àkúnya*.\n</step5>\n<step5>\nIf the ultrasound shows concerning findings, further evaluation with a CT scan or MRI may be warranted — *ayẹwo CT tàbí MRI*.\n</step6>\n<step6>\nThus, the most appropriate initial imaging step for her condition is a pelvic ultrasound to assess the cause of the bleeding.\n</step6></thinking>", "answer": "<answer>Ìgbésẹ̀ ayẹwo aworan tó tọ́ jùlọ ni *ultrasound àyẹwo* pelvic láti ṣàyẹ̀wò ìtìjú ẹ̀jẹ̀ rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun mẹta kan fi ìrora ori tó burú jáde, ó ń bẹ̀rù, ó ní papilledema bilateral, ati ìdinku ìmọ̀.  Àyẹ̀wò CT scan pẹ̀lú ìfúnṣọ́ pàjáwìrì fi ìṣòro ọ̀pọ̀lọpọ̀ hàn nínú cerebellum pẹ̀lú àwọn ìgbàlóró funfun tó mọ́ títóbi ní ayika àwọn àárín dudu tí kò mọ́ títóbi.  Ipò wo ni ìṣòro cerebellum yìí ṣeé ṣe jù lọ láti so mọ́?", "reasoning": "<thinking><step1>\nThe question describes a three-year-old child with severe headache, fear, bilateral papilledema, and decreased consciousness. It mentions a CT scan showing multiple issues in the cerebellum with large white matter lesions surrounding small dark areas. The question asks what condition this cerebellar issue is most likely related to.\n</step1>\n<step2>\nIn this context, *ìrora ori* (headache) and *papilledema* indicate increased intracranial pressure, which can be caused by various conditions affecting the brain.\n</step2>\n<step3>\nThe presence of *ìdinku ìmọ̀* (decreased consciousness) suggests a significant neurological impact, possibly from a mass effect or inflammation in the cerebellum.\n</step3>\n<step4>\nThe CT findings of *ìṣòro ọ̀pọ̀lọpọ̀* (multiple lesions) in the cerebellum could indicate a demyelinating disease, such as multiple sclerosis, or an infectious process like encephalitis.\n</step5>\n<step5>\nHowever, given the age of the child and the specific findings, one must consider *àkúnya* (tumor) as a potential cause, particularly a cerebellar tumor like medulloblastoma, which is common in children.\n</step6>\n<step6>\nThus, the cerebellar issue is most likely related to a *àkúnya* in the cerebellum, given the symptoms and imaging findings.\n</step6></thinking>", "answer": "<answer>Ìṣòro cerebellum yìí ṣeé ṣe jù lọ láti so mọ́ àkúnya nínú cerebellum.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 44 kan wá si ile-iwosan fun ṣiṣayẹwo iṣoro jijẹun ti o ti ní fun ọjọ diẹ sẹhin. Ó sọ pé ó ti ṣakiyesi irora ọmu ti o burú si nigbati ó gbìyànjú lati jẹ ohun ti o le tabi omi. Ó ṣiṣẹ lati ile, kò ní ibaraẹnisọrọ aisan eyikeyi laipẹ, ati pe kò ṣe ibalopọ lọwọlọwọ. Itan-iṣoogun rẹ pẹlu AIDS. Awọn oogun rẹ lọwọlọwọ pẹlu emtricitabine, rilpivirine, ati tenofovir. Igbona rẹ jẹ 38.1°C (100.6°F),  àwọn ìlọ́pọ̀ jẹ 72/min, ìmímú afẹ́fẹ́ jẹ 18/min, ati titẹ ẹjẹ jẹ 136/84 mm Hg. Ṣiṣayẹwo ara jẹ ṣee ṣe fun ẹnu gbẹ pẹlu mucosa pupa ati awọn aami tabi awọn patches ko han kedere, ati ọrùn rirọ pẹlu awọn iṣọn tabi cervical lymphadenopathy ko si. Esophagogastroduodenoscopy fihan awọn patches funfun kekere laarin lumen esophageal. A ṣe biopsy ti ọkan ninu awọn iṣọn naa ati irisi microscopic ti awọn abajade ti han ni isalẹ. Ewo ni o jẹ ayẹwo ti o ṣeeṣe julọ?\nA. Cytomegalovirus esophagitis\nB. Esophageal candidiasis\nC. Herpes esophagitis\nD. Medication-induced esophagitis", "reasoning": "<thinking><step1>\nThe question presents a clinical scenario involving a 44-year-old man with eating difficulties and chest pain when trying to eat or drink. The key terms include [irora ọmu = chest pain], [AIDS], and [esophagogastroduodenoscopy = endoscopy].\n</step1>\n<step2>\nHe has a history of AIDS and is on antiretroviral therapy, which makes him susceptible to opportunistic infections — *awọn àkóràn to n ṣẹlẹ̀ nígbà tí àìlera ba wà*.\n</step2>\n<step3>\nThe symptoms of dry mouth and red mucosa suggest possible infection or irritation — *àkúnya àìlera tabi ìfarapa* in the esophagus.\n</step4>\n<step4>\nThe endoscopy findings of small white patches in the esophagus are particularly indicative of a fungal infection, commonly seen in patients with immunocompromised states — *àwọn àkóràn fungal*.\n</step5>\n<step5>\nAmong the options, esophageal candidiasis is a common complication in patients with AIDS, characterized by white patches and difficulty swallowing — *ìṣoro jijẹun*.\n</step6>\n<step6>\nOther options like cytomegalovirus and herpes esophagitis are also possible but less likely given the presentation and findings.\n</step7>\n<step7>\nThus, the most likely diagnosis based on the symptoms and endoscopic findings is esophageal candidiasis.\n</step7></thinking>", "answer": "<answer>Esophageal candidiasis ni ayẹwo ti o ṣeeṣe julọ.</answer>", "language": "Yoruba"}
{"question": "Fun awọn ipo wo ni a fi Automatic Implantable Cardioverter Defibrillator (AICD) sí?", "reasoning": "<thinking><step1>\nThe question asks: “Fun awọn ipo wo ni a fi [Automatic Implantable Cardioverter Defibrillator (AICD) = AICD] sí?” — meaning it wants to know in which conditions an AICD is implanted.\n</step1>\n<step2>\nAn AICD is typically used for patients at high risk of sudden cardiac arrest — *iṣoro ọkan to le fa ikú ni kiakia*.\n</step2>\n<step3>\nConditions like *arrhythmias* or a history of heart failure are common reasons for implantation — *iṣoro ti o ni ibatan si aifọwọyi ọkan*.\n</step3>\n<step4>\nPatients who have experienced *ventricular fibrillation* or *ventricular tachycardia* are also candidates for an AICD — *iṣoro ti o le fa aisan ọkan to lewu*.\n</step4>\n<step5>\nAdditionally, those with certain genetic conditions that predispose them to arrhythmias may require an AICD — *awọn ipo ajẹsara ti o le fa aifọwọyi*.\n</step5>\n<step6>\nIn summary, an AICD is implanted in patients with serious heart rhythm disorders or those at risk of sudden cardiac events — *iṣoro ọkan to lewu*.\n</step6></thinking>", "answer": "<answer>AICD ni a fi sí fun awọn alaisan ti o ni iṣoro aifọwọyi ọkan to lewu, gẹgẹ bi ventricular fibrillation ati awọn ipo ajẹsara.</answer>", "language": "Yoruba"}
{"question": "Ipò wo ni a mọ̀ sí nípa ìrísí kọlọ́n bíi pàipa amọ̀ lórí barium enema?", "reasoning": "<thinking><step1>\nThe question asks: “Ipò wo ni a mọ̀ sí nípa ìrísí kọlọ́n bíi pàipa amọ̀ lórí barium enema?” — meaning it wants to know what we understand about the appearance of the colon during a barium enema.\n</step1>\n<step2>\nA barium enema is a radiological procedure used to visualize the colon — *àtúnṣe àwòrán kọlọ́n* — by introducing barium sulfate into the rectum.\n</step2>\n<step3>\nThis procedure helps identify abnormalities such as polyps, tumors, or inflammation — *ìyàtọ̀ bíi polypu, àkúnya, tàbí ìfarapa*.\n</step3>\n<step4>\nDuring the barium enema, the barium coats the lining of the colon, making it visible on X-rays — *barium naa n ṣe àfihàn àyíká kọlọ́n*.\n</step4>\n<step5>\nThe appearance can vary; for instance, a normal colon shows smooth contours, while abnormalities may present as irregular shapes — *àwòrán àìlera le jẹ́ àfihàn àìtọ́*.\n</step6>\n<step6>\nIn summary, the barium enema provides critical insights into the colon's health and structure — *ìmọ̀ nípa ilera kọlọ́n*.\n</step6></thinking>", "answer": "<answer>A barium enema n fi hàn ìrísí kọlọ́n, tó lè jẹ́ àfihàn àìlera bíi polypu tàbí àkúnya.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 61 kan wá sí ER pẹlu irora ikun ati aisan gbogbogbo fun ọsẹ meji sẹyin. O sọ pe ó ti gbeyawo ati pe ó jẹ́ ẹni tí kò bá obìnrin mìíràn sùn. Ó ní iwọn otutu ara ti 39.4°C (102.9°F) ó sì ń kùn pe òun ní irora ṣíṣàn ní alẹ́ pẹ̀lú. Nínú àyẹ̀wò ara, ó ní ṣíṣan ẹ̀dọ̀fóró pẹ̀lú irora díẹ̀ ati awọn ika ẹsẹ̀ pupa. Ọ̀gbẹ̀dẹ̀dẹ̀ tó pọn dín-dín wà nibẹ̀, ati àyẹ̀wò àìsàn ẹ̀dọ̀fóró fi hàn pe ó ní ìdánilẹ́kọ̀ọ́ sí gbogbo ibi. Ìgbàdọgbọ́ ẹ̀jẹ̀ pípé ṣe afihan ẹ̀jẹ̀-àìtẹ́lẹ̀, ìdinku ẹjẹ̀-pẹpẹrẹ, ati ìpọ̀sí ìwọ̀n ẹ̀jẹ̀-funfun pẹ̀lú ipò tí ó pọ̀ jùlọ ni lymphocyte. A gbero lati ya ẹjẹ lati inu egungun ni owurọ̀ keji lori awọn abajade iwadi ẹjẹ, ṣugbọn ko ṣe afihan nkan rara nitori pe ko pọ̀ to. A gbà á wọ́lé si ile-iwosan nitori ẹ̀jẹ̀-àìtẹ́lẹ̀ náà, a sì fun un ni ẹjẹ pupa tí a ti kó jọ ati awọn oògùn onibaje gbogbo. Wọ́n tú ù sílé ni ọjọ́ keji pẹ̀lu awọn itọnisọna fun atẹle itọju ni ile-iṣẹ ilera akọkọ. Nibo ni iwadi ile-ẹjẹ wo ni o ṣe deede julọ fun idi akọkọ ti aisan yi?\nA. Àyẹ̀wò iyara fun streptococcal antigen\nB. Quantiferon Gold\nC. Monospot\nD. Tartrate-resistant acid phosphatase (TRAP)\nE. CD 25", "reasoning": "<thinking><step1>\nThe question asks: “Nibo ni iwadi ile-ẹjẹ wo ni o ṣe deede julọ fun idi akọkọ ti aisan yi?” — meaning it wants to know which blood test is most appropriate for the primary cause of the patient's illness.\n</step1>\n<step2>\nThe patient is a 61-year-old man with symptoms like abdominal pain and fever — *irora ikun ati iwọn otutu ara ti 39.4°C* — indicating a possible infection or inflammatory process.\n</step3>\n<step3>\nGiven the symptoms and the lab results showing *ẹ̀jẹ̀-àìtẹ́lẹ̀* and elevated lymphocytes, we should consider infections like viral or bacterial causes.\n</step4>\n<step4>\nThe options include tests for specific infections: A rapid test for streptococcal antigen could indicate a bacterial infection, while Monospot tests for *mononucleosis*.\n</step5>\n<step5>\nHowever, the presence of elevated lymphocytes suggests a viral infection, making the Monospot test a strong candidate for this scenario.\n</step6>\n<step6>\nIn conclusion, the most appropriate blood test for this patient's symptoms and findings is the Monospot test.\n</step6></thinking>", "answer": "<answer>Monospot ni iwadi ile-ẹjẹ ti o ṣe deede julọ fun idi akọkọ ti aisan yi.</answer>", "language": "Yoruba"}
{"question": "Fun awọn obirin tó wà ní ọjọ́ ìṣúgbà, tí ó ní àrùn ìṣàn ṣíṣàkí (JME) tí wọ́n sì ń lò valproate lójú, èyíkéyìí ni wọ́n lè lò láti rọ́pò valproate, tí wọ́n sì lè fún wọn ní ìṣègùn kan ṣoṣo?", "reasoning": "<thinking><step1>\nThe question asks: “Fun awọn obirin tó wà ní ọjọ́ ìṣúgbà, tí ó ní àrùn ìṣàn ṣíṣàkí (JME) tí wọ́n sì ń lò valproate lójú, èyíkéyìí ni wọ́n lè lò láti rọ́pò valproate, tí wọ́n sì lè fún wọn ní ìṣègùn kan ṣoṣo?” — meaning it seeks alternatives to valproate for women of childbearing age with juvenile myoclonic epilepsy (JME).\n</step1>\n<step2>\nValproate is often used for JME, but it poses risks during pregnancy — *o ni ewu fun ìyá àtọkànwá* and can affect fetal development.\n</step2>\n<step3>\nAlternatives include lamotrigine, which is considered safer — *lamotrigine ni a mọ̀ pé ó dára ju* for women in this situation.\n</step3>\n<step4>\nIt’s important to monitor the dosage closely, as *ìṣègùn yìí lè ní àkúnya* when taken during pregnancy.\n</step4>\n<step5>\nAnother option could be levetiracetam, which has a favorable safety profile — *levetiracetam ni a mọ̀ pé ó ní ààbò to dára* for pregnant women.\n</step5>\n<step6>\nIn summary, lamotrigine or levetiracetam can be used as alternatives to valproate for women with JME — *lamotrigine tàbí levetiracetam ni wọ́n lè lò*.\n</step6></thinking>", "answer": "<answer>Lamotrigine tàbí levetiracetam ni wọ́n lè lò gẹ́gẹ́ bí àtúnṣe sí valproate fún àwọn obirin tó wà ní ọjọ́ ìṣúgbà tí ó ní àrùn ìṣàn ṣíṣàkí.</answer>", "language": "Yoruba"}
{"question": "Àwọn àyẹ̀wò ìwádìí ẹ̀jẹ̀ kan fún ọmọbìnrin ọdún méjìlá kan tí ó fi hàn pé 56% HbA, 43% HbS, àti 1% HbF, àti ìwọ̀n osmolality ti ito ti 130 mOsmol/kg H2O, kini àìlera tó pọ̀jùlọ tí ó lè dojú kọ?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn àyẹ̀wò ìwádìí ẹ̀jẹ̀ kan fún ọmọbìnrin ọdún méjìlá kan tí ó fi hàn pé 56% HbA, 43% HbS, àti 1% HbF” — meaning it presents lab results for a 12-year-old girl showing 56% HbA, 43% HbS, and 1% HbF. \n</step1>\n<step2>\nThese results indicate a high level of HbS, which is associated with *sickle cell disease* — *arun ẹ̀jẹ̀ àtọ́ka*.\n</step2>\n<step3>\nThe presence of 43% HbS suggests that she likely has *sickle cell anemia* — *arun ẹ̀jẹ̀ àtọ́ka* rather than just being a carrier.\n</step3>\n<step4>\nAdditionally, the osmolality of her urine is 130 mOsmol/kg H2O, which is relatively low, indicating possible *dehydration* or *inadequate kidney concentration* ability.\n</step4>\n<step5>\nGiven these factors, the most significant health challenge she may face is *crises douloureuses* — painful crises due to sickle cell disease, which can lead to severe complications.\n</step5>\n<step6>\nThus, the primary health issue she may encounter is related to the complications of sickle cell disease, including pain episodes and potential organ damage.\n</step6></thinking>", "answer": "<answer>Àìlera tó pọ̀jùlọ tí ó lè dojú kọ ni arun ẹ̀jẹ̀ àtọ́ka, pẹ̀lú ìṣòro ìrora àti ìfarapa àwọn organ.</answer>", "language": "Yoruba"}
{"question": "Ewo ni o yẹ julọ ninu awọn atọju wọnyi fun atunṣe alaisan ti o ní igbọrọ-gbọrọ gbọn-gbọn mejeeji lẹhin abẹrẹ fun acoustic schwannoma mejeeji:\nA. Ẹrọ gbọ́ tí ó ní agbara mejeeji\nB. Awọn atọju cochlear mejeeji\nC. Atọju cochlear ṣoṣo kan\nD. Atọju ọpọlọ-ara", "reasoning": "<thinking><step1>\nThe question asks: “Ewo ni o yẹ julọ ninu awọn atọju wọnyi fun atunṣe alaisan ti o ní igbọrọ-gbọrọ gbọn-gbọn mejeeji lẹhin abẹrẹ fun [acoustic schwannoma = acoustic neuroma]?” — meaning it seeks the best treatment option for a patient with bilateral tinnitus after surgery for acoustic neuroma.\n</step1>\n<step2>\nBilateral tinnitus refers to ringing in both ears — *igbọrọ-gbọrọ ni awọn etí mejeeji*. This condition can significantly affect a patient's quality of life.\n</step2>\n<step3>\nThe treatment options listed include: A. *Ẹrọ gbọ́ tí ó ní agbara mejeeji* (a hearing aid for both ears), B. *Awọn atọju cochlear mejeeji* (bilateral cochlear implants), C. *Atọju cochlear ṣoṣo kan* (a single cochlear implant), and D. *Atọju ọpọlọ-ara* (brain therapy).\n</step3>\n<step4>\nConsidering the nature of bilateral tinnitus, *atọju cochlear mejeeji* is often the most effective as it addresses hearing loss in both ears simultaneously, potentially improving auditory perception.\n</step4>\n<step5>\nA single cochlear implant may not provide adequate relief for bilateral symptoms, while a hearing aid may not be sufficient for severe cases. *Atọju ọpọlọ-ara* typically focuses on managing symptoms rather than addressing the underlying hearing loss.\n</step5>\n<step6>\nThus, the best option for a patient with bilateral tinnitus after surgery for acoustic schwannoma would be *Awọn atọju cochlear mejeeji*.\n</step6></thinking>", "answer": "<answer>Awọn atọju cochlear mejeeji ni o yẹ julọ fun atunṣe alaisan ti o ní igbọrọ-gbọrọ gbọn-gbọn mejeeji.</answer>", "language": "Yoruba"}
{"question": "Obirin ọlọ́jọ́ ọdún 85 kan ni ọmọ rẹ̀ mú wá sọ́dọ̀ oníṣègùn tó ń tọ́jú rẹ̀ fún ṣiṣayẹ̀wò. Ó ń rí ara rẹ̀ dáadáa láìsí àìsàn ńlá kan. Ọmọ rẹ̀ ń ṣàníyàn pé ẹ̀jẹ̀ ti ń tú lórí ara rẹ̀ púpọ̀ sí i ní ọ̀sẹ̀ méjì tàbí mẹ́ta tó kọjá. Ìtàn àìsàn tó ti ní rí ni àtìgbàgbà ẹ̀jẹ̀ gíga, ìṣòro ìṣẹ́ ẹ̀jẹ̀ gíga, àti àrùn ọ̀nà ìṣàn-yòò tí wọ́n ti mú sàn pẹ̀lu ìlò cephalexin ní ẹnu fún ọ̀sẹ̀ mẹ́ta sẹ́yìn. Ìtàn ìdílé kò ní ohun kan. Lónìí, ìwọ̀n ọkàn rẹ̀ jẹ́ 90/min, ìwọ̀n ìmímú afẹ́fẹ́ jẹ́ 17/min, ẹ̀jẹ̀ ńtẹ́ jẹ́ 125/85 mm Hg, ati otutu jẹ́ 36.7°C (98.1°F). Nínú ṣíṣayẹ̀wò ara, ọkàn rẹ̀ ní ìwọ̀n àti ìgbòkègbodò tó dára, àti ẹ̀dọ̀fóró rẹ̀ mọ́ gbọ̀n ní gbogbo ibi. Ó ní àwọn àmì dídára láìdábò bò ti àwọn àmì ẹ̀jẹ̀ pupa-àfàfà àti àwọn àmì ẹ̀jẹ̀ pupa dudu. Ìwádìí síwájú fi hàn pé PT tó gùn, tí ó dára sí i nígbà tí a bá dá pò pẹ̀lu ẹ̀jẹ̀ déédéé, àwọn ìwádìí iṣẹ́ ẹ̀dọ̀fóró déédéé, àti àbájáde ìdánwò ìgbẹ̀rùn tí ó jẹ́ guaiac rere. Oníṣègùn náà fún un ní oògùn kan tó yẹ kí ó mú ipò rẹ̀ sàn, ó sì gba pé kí a ṣe àwọn ìdánwò síwájú àti ṣiṣayẹ̀wò tókàn. Kí ni ọ̀nà ìṣiṣẹ́ oògùn tí àwọn náà fún aláìsàn náà?\nA. γ-carboxylation ti enzyme pankrisi\nB. Àìsí Protein C\nC. Ìmúṣẹ̀ 7-dehydrocholesterol nípasẹ̀ ìmọ́lẹ̀ UV\nD. γ-carboxylation ti enzyme ẹ̀dọ̀fóró\nE. Ìpìnyọ̀ hormone parathyroid", "reasoning": "<thinking><step1>\nThe question is asking about the mechanism of action of a medication given to a patient with a history of high blood pressure and recent bleeding issues. Key terms include [àìsàn = illness], [ẹ̀jẹ̀ gíga = high blood pressure], and [ìmúṣẹ̀ = activation].\n</step1>\n<step2>\nThe patient has a history of elevated blood pressure and has been experiencing increased bleeding over the past few weeks. This suggests a potential issue with blood coagulation — *ìṣòro ìdàgbàsókè ẹ̀jẹ̀*.\n</step2>\n<step3>\nThe doctor has prescribed a medication to improve the patient's condition and has recommended further tests. The options provided relate to different biochemical processes that could affect coagulation.\n</step4>\n<step4>\nOption A, γ-carboxylation of the pancreatic enzyme, is not directly related to coagulation. However, option D, γ-carboxylation of liver enzymes, is crucial for the synthesis of clotting factors like prothrombin — *àwọn àfààlà ẹ̀jẹ̀*.\n</step5>\n<step5>\nThe absence of Protein C, mentioned in option B, can lead to increased clotting risk, but it does not directly address the mechanism of the prescribed medication. Option C, the activation of 7-dehydrocholesterol via UV light, is unrelated to blood coagulation.\n</step6>\n<step6>\nFinally, option E, parathyroid hormone regulation, is more related to calcium metabolism than coagulation. Therefore, the most relevant mechanism for improving the patient's bleeding issue is the γ-carboxylation of liver enzymes.\n</step7></thinking>", "answer": "<answer>γ-carboxylation ti enzyme ẹ̀dọ̀fóró.</answer>", "language": "Yoruba"}
{"question": "Ninu àyípadà ìgbàgbọ́ apendisaikiisì, ipo wo ni a kà sí ewu jùlọ nígbà tí a bá rí i nípa ìfarajọpọ̀ ti taenia coli?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu àyípadà ìgbàgbọ́ apendisaikiisì, ipo wo ni a kà sí ewu jùlọ nígbà tí a bá rí i nípa ìfarajọpọ̀ ti taenia coli?” — meaning it wants to know what the most dangerous condition is regarding the presence of *taenia coli* in appendicitis.\n</step1>\n<step2>\nIn appendicitis, the inflammation of the appendix can lead to serious complications — *ìfarapa* ti a le ni, such as perforation or abscess formation.\n</step2>\n<step3>\nWhen *taenia coli* is involved, it indicates a parasitic infection that can complicate the situation further — *ìfarapa ti o le fa* *ìkúnà* ti appendicitis.\n</step3>\n<step4>\nThe most dangerous condition in this context is likely *ìfarapa* ti a npe ni *perforation*, which can lead to peritonitis — *ìfarapa ti peritoneum*.\n</step4>\n<step5>\nIf the appendix perforates, it allows bacteria to spread into the abdominal cavity, causing severe infection — *ìfarapa to lagbara*.\n</step5>\n<step6>\nThus, the presence of *taenia coli* can exacerbate the risks associated with appendicitis, particularly leading to perforation.\n</step6></thinking>", "answer": "<answer>Ipo ewu jùlọ ni *ìfarapa* ti a npe ni *perforation* nígbà tí a bá rí *taenia coli* nínú àyípadà ìgbàgbọ́ apendisaikiisì.</answer>", "language": "Yoruba"}
{"question": "Àgbàlagbà obìnrin ọdún mẹ́tadinlọ́gọ́ta (63) kan tí ó ní àkọ́kọ́ àrùn àtọ́jú-ẹ̀jẹ̀ (type 2 diabetes mellitus), àtọ́jú ẹ̀jẹ̀ gíga (arterial hypertension) tí a ń tọ́jú pẹ̀lú torsemide, ìṣúgbò ilẹ̀kùn (increased adiposity), ìgbóná ẹsẹ̀ tí ó ń fà (pitting pedal edema), àti ohùn ọkàn S3 pẹ̀lú ìwọ̀n ìgbàgbé ọkàn òsì (left ventricular ejection fraction) tí ó jẹ́ 51%, àwọn ìṣàpẹẹrẹ oògùn wo ni ó yẹ kí a fi kún ìtọ́jú rẹ̀ láti bójú tó ìṣòro ìmímú tí ó ń ní tuntun (dyspnea on exertion) àti ìkòkòrò (fatigue)?", "reasoning": "<thinking><step1>\nThe question is asking: \"What medications should be added to the treatment of a 63-year-old woman with type 2 diabetes, hypertension treated with torsemide, increased adiposity, pitting pedal edema, and an S3 heart sound with a left ventricular ejection fraction of 51%, to address her new issues of dyspnea on exertion and fatigue?\"\n</step1>\n<step2>\nFirst, we need to consider her existing conditions: *àtọ́jú-ẹ̀jẹ̀* (type 2 diabetes) and *àtọ́jú ẹ̀jẹ̀ gíga* (hypertension) are significant risk factors for cardiovascular issues.\n</step2>\n<step3>\nThe presence of *ìṣúgbò ilẹ̀kùn* (increased adiposity) and *ìgbóná ẹsẹ̀ tí ó ń fà* (pitting pedal edema) suggests fluid retention and possible heart failure, which can contribute to her dyspnea.\n</step3>\n<step4>\nGiven her S3 heart sound, this indicates potential heart failure — *ìṣòro ọkàn*. We might consider adding a diuretic or adjusting her current torsemide dosage to manage fluid overload.\n</step4>\n<step5>\nAdditionally, medications like ACE inhibitors or ARBs could help improve her heart function and manage hypertension, especially since her ejection fraction is low.\n</step5>\n<step6>\nFor her fatigue and dyspnea, optimizing her diabetes management with medications like SGLT2 inhibitors could also be beneficial, as they have been shown to improve heart outcomes.\n</step6>\n<step7>\nIn summary, a combination of diuretics, ACE inhibitors or ARBs, and possibly SGLT2 inhibitors should be considered to address her symptoms effectively.\n</step7></thinking>", "answer": "<answer>Kí a fi diuretics, ACE inhibitors tàbí ARBs, àti SGLT2 inhibitors kún ìtọ́jú rẹ̀ láti bójú tó ìṣòro ìmímú àti ìkòkòrò.</answer>", "language": "Yoruba"}
{"question": "Igba melo ni iye didígí 5 ninu nọmba 24,513 ju iye rẹ̀ lọ ninu nọmba 357?", "reasoning": "<thinking><step1>\nThe question asks: “Igba melo ni iye didígí 5 ninu nọmba 24,513 ju iye rẹ̀ lọ ninu nọmba 357?” — meaning it wants to know how many times the digit 5 in the number 24,513 is greater than its value in the number 357.\n</step1>\n<step2>\nFirst, we identify the value of the digit 5 in both numbers. In 24,513, the 5 is in the hundreds place, so its value is 500 — *iye rẹ̀ ni 500*.\n</step2>\n<step3>\nIn the number 357, the digit 5 is in the tens place, giving it a value of 50 — *iye rẹ̀ ni 50*.\n</step3>\n<step4>\nNext, we compare these two values: 500 and 50. To find how many times 500 is greater than 50, we divide 500 by 50.\n</step4>\n<step5>\nCalculating this gives us: 500 ÷ 50 = 10. Therefore, the digit 5 in 24,513 is 10 times greater than in 357.\n</step5></thinking>", "answer": "<answer>Iye didígí 5 ninu nọmba 24,513 ju iye rẹ̀ lọ ninu nọmba 357 jẹ́ igba mẹ́wàá.</answer>", "language": "Yoruba"}
{"question": "Kini awọn solusan si egboogi mẹrin-ìwọn 6x^2 - 7x - 20 = 0 nipa lilo ọna ègboogi mẹrin-ìwọn?", "reasoning": "<thinking><step1>\nThe question asks: “Kini awọn solusan si [egboogi mẹrin-ìwọn = quadratic equation] 6x^2 - 7x - 20 = 0?” — meaning it wants to find the solutions to the quadratic equation using the quadratic formula.\n</step1>\n<step2>\nThe quadratic formula is given by: *x = (-b ± √(b² - 4ac)) / 2a*, where *a*, *b*, and *c* are coefficients from the equation *ax² + bx + c = 0*.\n</step2>\n<step3>\nIn this case, *a = 6*, *b = -7*, and *c = -20*. We need to calculate the discriminant: *b² - 4ac*.\n</step3>\n<step4>\nCalculating this gives: *(-7)² - 4(6)(-20) = 49 + 480 = 529*. Since the discriminant is positive, there will be two real solutions.\n</step4>\n<step5>\nNow, we substitute back into the quadratic formula: *x = (7 ± √529) / (2 * 6)*.\n</step5>\n<step6>\nCalculating further, we find: *√529 = 23*, so *x = (7 ± 23) / 12*.\n</step6>\n<step7>\nThis results in two solutions: *x = (30 / 12) = 2.5* and *x = (-16 / 12) = -1.33*.\n</step7></thinking>", "answer": "<answer>Awọn solusan si egboogi mẹrin-ìwọn 6x^2 - 7x - 20 = 0 ni x = 2.5 ati x = -1.33.</answer>", "language": "Yoruba"}
{"question": "Steroid wo ni a kà sí aìbá̀mù fún ìtọ́jú ọjọ́ yíyà sí ọjọ́ miíràn láti yàgò fún ìdínkù iṣẹ́ ẹ̀ya hypothalamic-pituitary-adrenal nítorí lílò corticosteroid fún ìgbà gígùn?", "reasoning": "<thinking><step1>\nThe question asks: “Steroid wo ni a kà sí aìbá̀mù fún ìtọ́jú [day-to-day management] sí [other days] láti yàgò fún [reduction] iṣẹ́ [hypothalamic-pituitary-adrenal] nítorí [long-term use] corticosteroid?” — meaning it seeks to understand which steroids are considered safe for managing daily treatment to avoid reducing HPA axis function due to long-term corticosteroid use.\n</step1>\n<step2>\nCorticosteroids can suppress the hypothalamic-pituitary-adrenal (HPA) axis, leading to *iṣoro ilera* if used for extended periods — *lilo corticosteroid fun igba pipẹ*.\n</step2>\n<step3>\nIn managing conditions like asthma or autoimmune diseases, doctors often prescribe lower doses of steroids — *doses kekere ti corticosteroids* — to minimize side effects.\n</step3>\n<step4>\nAlternatives like *hydrocortisone* or *prednisone* may be used, but they still require careful monitoring — *iwadii pẹ̀lú* to prevent HPA suppression.\n</step4>\n<step5>\nAdditionally, using steroid-sparing agents, such as *immunosuppressants*, can help reduce the need for corticosteroids — thereby protecting the HPA axis.\n</step5>\n<step6>\nUltimately, the goal is to find a balance that manages the condition effectively while minimizing the impact on the HPA axis — *lati dinku ipa lori iṣẹ́ HPA*.\n</step6></thinking>", "answer": "<answer>Corticosteroids ti a kà sí aìbá̀mù ni hydrocortisone àti prednisone, ṣugbọn a gbọdọ ṣe abojuto wọn pẹ̀lú.</answer>", "language": "Yoruba"}
{"question": "Ọmọ kan ni ìgbóná kan tí ó wà ní ààrin ọrùn rẹ̀, lábẹ́ egungun hyoid. Kí ni ìgbóná yìí ṣeé ṣe kí ó jẹ́ àmì rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Ọmọ kan ni ìgbóná kan tí ó wà ní ààrin ọrùn rẹ̀, lábẹ́ egungun hyoid” — meaning it describes a child with a lump in the neck, under the hyoid bone. It seeks to understand what this lump could signify.\n</step1>\n<step2>\nA lump in the neck, especially in children, can be due to various causes — *àwọn ìdí mẹta ni ó wà* such as infections, cysts, or tumors.\n</step2>\n<step3>\nInfections like *ìfarapa* or viral illnesses can lead to swollen lymph nodes — *àwọn àyà-ara ti o ni ìfarapa* that may present as a lump.\n</step3>\n<step4>\nAnother possibility is a thyroglossal duct cyst, which is a common congenital condition — *àwọn àyà-ara ti a bí pẹ̀lú* that can appear as a midline neck mass.\n</step4>\n<step5>\nLastly, while less common, tumors — *àwọn àkúnya* — could also be a concern, necessitating further evaluation.\n</step5>\n<step6>\nTherefore, the lump could indicate an infection, a cyst, or potentially a tumor, and medical evaluation is essential for accurate diagnosis.\n</step6></thinking>", "answer": "<answer>Ìgbóná yìí lè jẹ́ àmì ìfarapa, cyst, tàbí àkúnya, tó yẹ kí a ṣe àyẹ̀wò ìlera.</answer>", "language": "Yoruba"}
{"question": "Okùnrin ọmọ ọdún 67 kan tí ó ní àrùn ẹ̀dọ̀fọ́rọ̀ ṣàkíyèsí àwọn àmì àìlera ní apá àti ẹsẹ̀ rẹ̀. Ó ṣàlàyé nípa ìṣòro tí ó ní nínú dìde láti orí àga tàbí nílùú, ṣùgbọ́n kò sí irora tàbí àìdáàrùn. Nígbà àyẹ̀wò, agbára ẹ̀ṣẹ̀ ìpìlẹ̀ jẹ́ mẹrin nínú márùn-ún ní àwọn ẹ̀yà apá àti ẹsẹ̀, ṣùgbọ́n àwọn reflexes, tone, àti ìmọ̀lẹ̀ jẹ́ déédéé. Ó ní àmì àrùn tí ó ní àwọ̀n lórí ojú rẹ̀, àti àwọn papules tí ó gbé gbé lórí ìka rẹ̀. Fún aláìsàn tí ó wà lóríṣìírí yìí pẹ̀lú àìlera ẹ̀ṣẹ̀, yan ibi tí ó ṣeé ṣe jùlọ fún àrùn náà\nA. sẹ́ẹ̀li iho iwájú\nB. iṣan agbedemeji\nC. ìsopọ̀ ẹ̀ṣẹ̀-iṣan\nD. ẹ̀ṣẹ̀", "reasoning": "<thinking><step1>\nThe question describes a 67-year-old man with [àrùn ẹ̀dọ̀fọ́rọ̀ = peripheral artery disease] who notices weakness in his arms and legs, particularly when getting up from a chair or standing, but without pain or discomfort.\n</step1>\n<step2>\nThis condition suggests a possible issue with blood flow or muscle strength — *ìṣòro pẹ̀lú ṣiṣan ẹ̀jẹ̀* or *agbara iṣan*.\n</step2>\n<step3>\nDuring the examination, the baseline strength is noted to be four out of five in the arms and legs, indicating some weakness but not complete loss — *agbara ẹ̀ṣẹ̀ jẹ́ mẹrin nínú márùn-ún*.\n</step3>\n<step4>\nReflexes, tone, and light sensation are normal, which suggests that the nervous system is functioning properly — *ìmọ̀lẹ̀ àti tone jẹ́ déédéé*.\n</step5>\n<step5>\nThe presence of skin lesions, such as [àmì àrùn = skin lesions] and [papules = papules], indicates a possible dermatological issue that could be related to his overall health condition.\n</step6>\n<step6>\nGiven the symptoms and the diagnosis of peripheral artery disease, the most likely site for the disease would be *ìsopọ̀ ẹ̀ṣẹ̀-iṣan* as it relates to blood flow issues in the limbs.\n</step7>\n<step7>\nThus, the best choice for the location of the disease is *ìsopọ̀ ẹ̀ṣẹ̀-iṣan*.\n</step7></thinking>", "answer": "<answer>Ìsopọ̀ ẹ̀ṣẹ̀-iṣan.</answer>", "language": "Yoruba"}
{"question": "Kini idi ti o ṣeé ṣe julọ ti irẹwẹsi oju ti o wà, rirẹ ni ọjọ, ati iṣoro lati ṣe akiyesi ni obinrin ọdun 42 kan ti o ni titẹ ẹjẹ giga, BMI ti 30 kg/m2, ati iwọn glucose ẹjẹ ti 120 mg/dL, ti o ni awọn ami aisan wọnyi botilẹjẹpe o ngba lisinopril?", "reasoning": "<thinking><step1>\nThe question asks: “Kini idi ti o ṣeé ṣe julọ ti irẹwẹsi oju ti o wà, rirẹ ni ọjọ, ati iṣoro lati ṣe akiyesi ni obinrin ọdun 42 kan ti o ni titẹ ẹjẹ giga, BMI ti 30 kg/m2, ati iwọn glucose ẹjẹ ti 120 mg/dL, ti o ni awọn ami aisan wọnyi botilẹjẹpe o ngba lisinopril?” — meaning it seeks to understand the most likely cause of the symptoms in a 42-year-old woman with high blood pressure, obesity, and elevated blood glucose, despite taking lisinopril.\n</step1>\n<step2>\nThe symptoms described include *irẹwẹsi oju* (visual disturbances), *rirẹ ni ọjọ* (daytime fatigue), and *iṣoro lati ṣe akiyesi* (difficulty concentrating). These can be linked to several factors.\n</step2>\n<step3>\nGiven her high blood pressure and obesity, she may be experiencing *iṣoro ti o ni ibatan si ẹjẹ* (blood-related issues) that could affect her vision and energy levels.\n</step3>\n<step4>\nAdditionally, the elevated blood glucose level suggests possible *iṣoro ti o ni ibatan si suga* (sugar-related issues), which can lead to complications like *diabetes-related retinopathy* affecting vision.\n</step4>\n<step5>\nLisinopril is effective for hypertension, but it does not address other underlying conditions such as *iṣoro ti o ni ibatan si suga* or potential sleep apnea, which could contribute to her fatigue and cognitive difficulties.\n</step5>\n<step6>\nIn summary, the combination of high blood pressure, obesity, and elevated glucose levels, along with the side effects of medications, could explain her symptoms.\n</step6></thinking>", "answer": "<answer>Iru awọn aami aisan wọnyi le jẹ nitori iṣoro ti o ni ibatan si suga, hypertension, ati BMI giga, pẹlu awọn ipa ẹgbẹ ti lisinopril.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìpínrọ̀ tó tẹ̀lé e yìí ṣàpèjúwe ṣeto àwọn nǹkan márùn-ún tí a gbé kalẹ̀ ní àṣẹ kan. Àwọn òǹrọ̀ náà bá ara wọn mu ní ọgbọ́n ní gbogbo ìpínrọ̀.  Ilé títà oògùn kan ta àwọn èso márùn-ún: òrànjì, kantaluupu, píṣì, lókùwàtù, àti kìwì.  Píṣì gbowó ju òrànjì lọ.  Kantalupu gbowó ju píṣì lọ.  Kìwì ni ẹ̀kẹta tí ó gbowó jùlọ.  Lókùwàtù ni ẹ̀kejì tí kò gbowó jùlọ.\nÀwọn àṣàyàn:\n(A) Òrànjì ni oògùn tí ó gbààrà jùlọ.\n(B) Kantalupu ni oògùn tí ó gbààrà jùlọ.\n(C) Píṣì ni oògùn tí ó gbààrà jùlọ.\n(D) Lókùwàtù ni oògùn tí ó gbààrà jùlọ.\n(E) Kìwì ni oògùn tí ó gbààrà jùlọ.", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn ìpínrọ̀ tó tẹ̀lé e yìí ṣàpèjúwe ṣeto àwọn nǹkan márùn-ún tí a gbé kalẹ̀ ní àṣẹ kan” — meaning it describes the arrangement of five items based on their prices.\n</step1>\n<step2>\nThe items are: òrànjì [orange], kantaluupu [canteloupe], píṣì [peach], lókùwàtù [watermelon], and kìwì [kiwi]. \n</step2>\n<step3>\nFrom the information given, we know that píṣì is more expensive than òrànjì, which means *píṣì > òrànjì*.\n</step3>\n<step4>\nNext, kantalupu is more expensive than píṣì, so we have *kantalupu > píṣì*. This implies that kantalupu is the most expensive so far.\n</step4>\n<step5>\nKìwì is stated to be the third most expensive, which means it is less expensive than kantalupu and píṣì but more than òrànjì and lókùwàtù.\n</step5>\n<step6>\nFinally, lókùwàtù is the second least expensive, indicating it is cheaper than kìwì but more expensive than òrànjì.\n</step6>\n<step7>\nArranging them based on the prices, we get: kantalupu > píṣì > kìwì > òrànjì > lókùwàtù.\n</step7>\n<step8>\nThus, the item that is the least expensive is òrànjì, making option (A) incorrect, while (B), (C), and (D) are also incorrect based on the order.\n</step8>\n<step9>\nThe correct answer is (E) because kìwì is the third most expensive, confirming it is not the least expensive.\n</step9></thinking>", "answer": "<answer>Kìwì ni oògùn tí ó gbààrà jùlọ.</answer>", "language": "Yoruba"}
{"question": "Àpọnà ọmọ ọdún méjìdínlọ́gbọ̀n kan wà pẹ̀lú ìgbóná ìyẹ̀fun ara àti irora ikùn, pàápàá lẹ́yìn jíjẹ ẹ̀rọ̀ wàrà, èyí tí ó fi hàn pé kò lè mú wàrà.  Èyíkéyìí ni oogun tí ó ní ọ̀nà iṣẹ́ tí ó dàbí ti ọ̀nà ìṣiṣẹ́ ara fún ṣíṣe àṣàkóso ipò yìí?", "reasoning": "<thinking><step1>\nThe question asks: “What medication has a mechanism of action similar to the body's natural processes for managing this condition?” It describes a 29-year-old with abdominal pain and fever after consuming dairy, indicating a possible intolerance or allergy.\n</step1>\n<step2>\nIn this case, the symptoms suggest a reaction to lactose — *lactose intolerance* — where the body cannot properly digest dairy products.\n</step2>\n<step3>\nThe medication that mimics the body's natural processes is likely an enzyme replacement therapy — *ìtọ́jú àfiyèsí* — that helps break down lactose.\n</step4>\n<step4>\nLactase supplements are commonly used for this purpose, allowing individuals to consume dairy without discomfort — *lactase jẹ́ àfiyèsí tó wúlò*.\n</step5>\n<step5>\nThus, the medication that fits this description is lactase, as it aids in digestion by providing the enzyme that the body lacks.\n</step6></thinking>", "answer": "<answer>Lactase ni oogun tí ó ní ọ̀nà iṣẹ́ tí ó dàbí ti ọ̀nà ìṣiṣẹ́ ara fún ṣíṣe àṣàkóso ipò yìí.</answer>", "language": "Yoruba"}
{"question": "Ọmọ alaisan ọdun mẹ́tadinlọ́gún kan wá pẹ̀lú ìṣoro ìwòye òsì, tí ojú ọ̀tún rẹ̀ sì dára, ojú rẹ̀ ríran 6/6 pẹ̀lú ìlera ìṣiṣẹ́ ojú rẹ̀ dára. Ṣugbọn ojú òsì rẹ̀ kò ríran daradara, ó lè rí ìgbòkègbòdò ọwọ́ ti ojú sunmọ, pẹ̀lú àwọn ohun tí ó dàbí òwú àwọ̀ pupa lábẹ́ irúgbìn ojú, ìyapa irúgbìn ojú, àti àwọn ohun tí ó dàbí ẹ̀jẹ̀ tí ó gbòò.  Kí ni àìsàn tí ó ṣeé ṣe jùlọ fún àwọn àmì àrùn wọnyi ní ojú òsì rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks about a 16-year-old patient with left eye vision problems, while the right eye is normal, and it describes symptoms like *redness* and *discharge* from the left eye. \n</step1>\n<step2>\nGiven that the right eye has a vision of 6/6, we can conclude that the right eye is functioning well — *la santé de l'œil droit est bonne*.\n</step2>\n<step3>\nThe left eye's symptoms, such as *écoulement* (discharge) and *rougeur* (redness), suggest an inflammatory condition — possibly *conjonctivite* (conjunctivitis).\n</step3>\n<step4>\nAdditionally, the mention of *des taches rouges* (red spots) and *écoulement sanguin* (bloody discharge) indicates a more serious issue, potentially an infection or a *lésion* (lesion).\n</step4>\n<step5>\nConsidering the age and symptoms, a common diagnosis could be *conjonctivite bactérienne* (bacterial conjunctivitis) or even *ulcère cornéen* (corneal ulcer) if the symptoms are severe.\n</step5>\n<step6>\nThus, the most likely condition affecting the left eye is an infection or inflammation, possibly *conjonctivite* or *ulcère cornéen*.\n</step6></thinking>", "answer": "<answer>Àwọn àmì àrùn wọnyi ní ojú òsì rẹ̀ lè jẹ́ *conjonctivite* tàbí *ulcère cornéen*.</answer>", "language": "Yoruba"}
{"question": "Gẹgẹ́ bí Shapiro ṣe sọ, ìpinnu wo ni àwọn ìwádìí ìgbà pípẹ̀ àti àṣàwákiri jẹ́rìí sí nípa àṣà ìlò oògùn ará?", "reasoning": "<thinking><step1>\nThe question translates to: \"According to Shapiro, what conclusions do long-term studies and explorations provide regarding the use of traditional medicine?\" This indicates a focus on the findings from research on traditional medicine.\n</step1>\n<step2>\nLong-term studies often reveal patterns in how traditional medicine is utilized — *àṣà ìlò oògùn ará* can show effectiveness in treating certain conditions.\n</step2>\n<step3>\nShapiro might highlight that these studies provide evidence of *ìmúlò* (usage) and *àbájáde* (outcomes) that support the integration of traditional practices into modern healthcare.\n</step3>\n<step4>\nExplorations into traditional medicine often uncover cultural significance — *ìtàn àṣà* that influences patient choices and treatment adherence.\n</step4>\n<step5>\nMoreover, findings may indicate that traditional medicine can complement conventional treatments, leading to *ìlera to dára ju* (better health outcomes).\n</step5>\n<step6>\nIn summary, Shapiro's conclusions likely emphasize the importance of recognizing the value of traditional medicine through rigorous research and cultural understanding.\n</step6></thinking>", "answer": "<answer>Ìpinnu Shapiro ni pé, ìwádìí ìgbà pípẹ̀ àti àṣàwákiri fi hàn pé àṣà ìlò oògùn ará ní àkópọ̀ pẹ̀lú ìlera to dára ju.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun mẹrin kan fi edema gbogbo ara ati ascites hàn. Ko siipa haipatenison tabi hematuria. Awọn idanwo iṣẹ ṣiṣe kidinrin jẹ deede. Urinalysis fihan proteinuria pupọ. Okunfa ti o ṣeeṣe julọ ni:\nA. Membranous glomerulonephritis\nB. Arun iyipada kere\nC. Post streptococcal glomerulonephritis\nD. IgA nephropathy", "reasoning": "<thinking><step1>\nThe question presents a case of a four-year-old child with generalized edema and ascites, asking for the most likely cause. Key terms include *edema* (swelling) and *ascites* (fluid accumulation in the abdomen).\n</step1>\n<step2>\nIn this scenario, the absence of hypertension (*haipatenison*) and hematuria (blood in urine) is significant. These factors help narrow down the potential causes of the child's symptoms.\n</step2>\n<step3>\nThe normal kidney function tests indicate that the kidneys are functioning properly, which suggests that the issue may not be due to acute kidney injury or severe kidney disease.\n</step3>\n<step4>\nThe presence of significant proteinuria (*proteinuria pupọ*) points towards a glomerular issue, as this condition typically indicates damage to the kidney's filtering units.\n</step4>\n<step5>\nAmong the options, *membranous glomerulonephritis* is known for causing nephrotic syndrome in children, characterized by edema and heavy proteinuria, making it a strong candidate.\n</step6>\n<step6>\n*Arun iyipada kere* and *post streptococcal glomerulonephritis* usually present with different symptoms, while *IgA nephropathy* often does not cause significant edema or ascites in this age group.\n</step7>\n<step7>\nThus, the most likely cause of the child's condition, given the symptoms and test results, is *membranous glomerulonephritis*.\n</step7></thinking>", "answer": "<answer>Membranous glomerulonephritis ni okunfa ti o ṣeeṣe julọ.</answer>", "language": "Yoruba"}
{"question": "Okùnrin ará Àmẹ́ríkà tó jẹ́ ọmọ Nàìjíríà ọdún méjìlélógójì kan wá pẹ̀lú ìgbóná ojú ati ìṣòro ìmímú afẹ́fẹ́ lẹ́yìn tí ó bẹ̀rẹ̀ sí í lo lisinopril ati atorvastatin àwọn ọ̀sẹ̀ díẹ̀ sẹ́yìn. Ìtàn ìṣègùn rẹ̀ pẹlu àtìgbàgbọ́ ẹ̀jẹ̀ gíga ati dyslipidemia, ati pé òun ní ipele C1 esterase inhibitor tó dára. Nígbà tí a bá gbé àwọn nǹkan wọnyi yẹ̀ wò, kí ni àlàyé tí ó bá gbọ́dọ̀ jùlọ fún ipo rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: \"What is the most important explanation for a 32-year-old American man of Nigerian descent who has high blood pressure and dyslipidemia, and has recently started taking lisinopril and atorvastatin?\" \n</step1>\n<step2>\nThis patient has a history of hypertension — *ìtàn àtìgbàgbọ́ ẹ̀jẹ̀ gíga* — and dyslipidemia, which means he has abnormal lipid levels in his blood.\n</step2>\n<step3>\nLisinopril is an ACE inhibitor used to manage high blood pressure, while atorvastatin is a statin that helps lower cholesterol levels — *ìdílé cholesterol*.\n</step3>\n<step4>\nGiven his recent symptoms of facial swelling and difficulty breathing, these could indicate an allergic reaction or angioedema, which is a known side effect of lisinopril — *ìfọwọ́ra àtọ́ka*.\n</step4>\n<step5>\nAdditionally, the presence of a C1 esterase inhibitor deficiency could complicate his condition, as it relates to hereditary angioedema — *ìfọwọ́ra àtọ́ka àtọkànwá*.\n</step6>\n<step6>\nTherefore, the most critical explanation for his symptoms is likely an adverse reaction to lisinopril, potentially exacerbated by his underlying condition.\n</step6></thinking>", "answer": "<answer>Ìtàn àlàyé tó ṣe pàtàkì jùlọ ni ìfọwọ́ra àtọ́ka àtọkànwá tí ó le fa ìṣòro ìmímú afẹ́fẹ́ àti ìgbóná ojú lẹ́yìn lísinopril.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 45 kan wá si ọfiisi oníṣẹ́gun pẹ̀lú ṣiṣẹ́lẹ̀ àìlera. Ó rò bí ẹni pé ó ń ṣubú lórí ẹsẹ̀ rẹ̀ lọ́pọ̀lọpọ̀, ó sì ṣubú nígbà àìpẹ́ yìí tí ó sì bà ọwọ́ rẹ̀ jẹ́. Itan ìṣẹ̀ṣegun rẹ̀ ṣe pataki fún àrùn suga tí a ṣàkóso dáadáa. Ó ti jẹ́ akọ́ṣẹ́ṣẹ́ vegan ju ọdún 20 lọ. Ó gbé ní ilé pẹ̀lú ọkọ rẹ̀ àti àwọn ọmọ rẹ̀ méjì. Nígbà ayẹwo, ó farahàn bí ẹni tí ounjẹ tó. Ó ní ìdinku proprioception àti imọ̀rírí ìṣẹ̀lẹ̀ ní àwọn ẹsẹ̀ rẹ̀ méjì. Ó ní àmì Romberg tó gbàdúrà. Ó ní ìdinku àwọn àbájáde Achilles ní ìha méjì. Ewo ni ninu àwọn ọ̀nà wọnyi tí ó ṣee ṣe kí ó bàjẹ́ jùlọ ní àpẹẹrẹ alaisan yii?\nA. Fasciculus gracilis\nB. Fasciculus cuneatus\nC. Vestibulospinal\nD. Rubrospinal\nE. Anterior spinothalamic tract", "reasoning": "<thinking><step1>\nThe question is asking which pathway might be most affected in a 45-year-old patient with a history of diabetes and proprioceptive deficits, particularly given their symptoms of falling and reduced sensation in the feet.\n</step1>\n<step2>\nThe patient has a significant history of *àrùn suga* (diabetes) and presents with *ìdinku proprioception* (reduced proprioception), which suggests issues with sensory pathways.\n</step2>\n<step3>\nThe *amí Romberg* (Romberg sign) indicates problems with balance and proprioception, often linked to the dorsal columns of the spinal cord, which are responsible for fine touch and proprioception.\n</step3>\n<step4>\nThe *Fasciculus gracilis* and *Fasciculus cuneatus* are part of the dorsal columns, but the patient’s symptoms suggest a more widespread issue affecting balance, which could involve the vestibular system.\n</step4>\n<step5>\nThe *Vestibulospinal tract* plays a crucial role in maintaining balance and posture, especially when proprioceptive input is compromised, making it a likely candidate for being affected in this patient.\n</step6>\n<step6>\nIn contrast, the *Rubrospinal* and *Anterior spinothalamic tract* are less likely to be directly involved in proprioceptive deficits and balance issues.\n</step6>\n<step7>\nThus, considering the patient's symptoms and the role of the vestibular system in balance, the most affected pathway is likely the *Vestibulospinal tract*.\n</step7></thinking>", "answer": "<answer>Ọ̀nà ti o ṣee ṣe kí ó bàjẹ́ jùlọ ni *Vestibulospinal tract*.</answer>", "language": "Yoruba"}
{"question": "Àpọnà kan fi ìgbàgbọ́ gbígbóná 3.5 cm ní ìgbàgbọ́ lymph node tí ó wà ní apá ìsàlẹ̀ ẹnu, láìsí àwọn àṣìṣe tí a rí nígbà tí a ṣayẹwo orí àti ọrùn rẹ̀.  Àyẹ̀wò wo ni ó yẹ kí a ṣe tókàn láti mọ̀ ìdí tí ó ṣeé ṣe?", "reasoning": "<thinking><step1>\nThe question asks: “Àpọnà kan fi ìgbàgbọ́ gbígbóná 3.5 cm ní ìgbàgbọ́ lymph node tí ó wà ní apá ìsàlẹ̀ ẹnu” — meaning it describes a 3.5 cm lymph node in the submandibular area without any abnormalities found during examination of the head and neck.\n</step1>\n<step2>\nA lymph node of this size can indicate various conditions, including infections or malignancies — *àwọn àkópọ̀ àìlera tàbí àìlera àtọkànwá*.\n</step2>\n<step3>\nTo determine the cause, a healthcare provider might consider imaging studies — *àwọn ìwádìí àwòrán* like ultrasound or CT scan to assess the lymph node further.\n</step3>\n<step4>\nAdditionally, a biopsy may be necessary to rule out cancer — *àyẹ̀wò àyàfi* can provide definitive information about the nature of the lymph node.\n</step4>\n<step5>\nIn this context, it’s crucial to evaluate for any systemic symptoms — *àwọn àfihàn àìlera* such as fever or weight loss that could suggest a more serious underlying condition.\n</step5>\n<step6>\nThus, the appropriate next step would be to perform imaging studies and possibly a biopsy to clarify the diagnosis.\n</step6></thinking>", "answer": "<answer>Àyẹ̀wò tó yẹ ni àwòrán àti àyẹ̀wò àyàfi láti mọ̀ ìdí tí lymph node náà fi gbígbóná.</answer>", "language": "Yoruba"}
{"question": "Ọmọ kan fihan pẹlu ọpọlọpọ awọn papule ti awọ ara lori awọn ètè. Ṣe iwadii iwẹnu wo ni iwọ yoo ṣe lati ṣe iwadii ipo awọ ara naa?", "reasoning": "<thinking><step1>\nThe question asks: “Ọmọ kan fihan pẹlu ọpọlọpọ awọn papule ti awọ ara lori awọn ètè” — meaning a child presents with multiple skin papules on the ears. It wants to know what diagnostic tests would be conducted to investigate this skin condition.\n</step1>\n<step2>\nPapules can indicate various skin conditions, such as *ekiri* (eczema) or *pẹtẹlẹ* (psoriasis). The first step is to perform a thorough clinical examination.\n</step2>\n<step3>\nNext, one might consider a skin scraping to check for fungal infections — *iwadi fun awọn ikọlu fungal* — especially if there are signs of scaling or itching.\n</step3>\n<step4>\nA patch test could also be useful to identify any allergic reactions — *iwadi ifamọra* — particularly if the child has a history of allergies.\n</step4>\n<step5>\nIn some cases, a biopsy may be necessary to rule out more serious conditions — *iwadi biopsi* — especially if the papules are persistent or changing.\n</step5>\n<step6>\nFinally, laboratory tests for blood counts or specific allergens might be conducted to gather more information about the child’s overall health and potential triggers.\n</step6></thinking>", "answer": "<answer>Iwọ yoo ṣe iwadi iwẹnu pẹlu ayẹwo awọ, iwadi fun awọn ikọlu fungal, iwadi ifamọra, ati boya biopsi.</answer>", "language": "Yoruba"}
{"question": "Èlément ọ̀nà SVG yii <path d=\"M 64.51,89.70 A 26.04,26.04 46.27 1,0 28.52,52.07 A 26.04,26.04 46.27 1,0 64.51,89.70\"/> ṣe àkọ́kọ́\nAwọn aṣayan:\n(A) yíká\n(B) apáàrọ̀ méje\n(C) apáàrọ̀ mẹ́fà\n(D) afefè\n(E) ila\n(F) apáàrọ̀ mẹ́jọ\n(G) apáàrọ̀ márùn-ún\n(H) tétrágóń\n(I) apá kan\n(J) àwòjì\n(K) ẹ̀lípìsì", "reasoning": "<thinking><step1>\nThe question asks: “Èlément ọ̀nà SVG yii [this SVG path] ṣe àkọ́kọ́?” — meaning it wants to identify the shape represented by the given SVG path data.\n</step1>\n<step2>\nThe path data describes a series of arcs and lines — *àwọn àkópọ̀ àtàwọn ila* — which suggests a circular or elliptical shape.\n</step2>\n<step3>\nThe command \"A\" in the path indicates an arc, specifically: *àkópọ̀* with a radius of 26.04, which is a significant clue.\n</step3>\n<step4>\nGiven the parameters, this path likely forms a circle or an ellipse, as it uses arcs to create a rounded shape — *àwòjì*.\n</step5>\n<step5>\nAmong the options provided, the term that best describes a circular shape is *àwòjì*, which translates to \"circle\" in English.\n</step6>\nThus, the SVG path represents a circular element.\n</step6></thinking>", "answer": "<answer>àwòjì</answer>", "language": "Yoruba"}
{"question": "Ninu eto kapitalisimu mimọ́, ipa wo ni ijọba ń kó ninu ọrọ̀-aje?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu eto kapitalisimu mimọ́, ipa wo ni ijọba ń kó ninu ọrọ̀-aje?” — meaning it wants to know the role of government in a pure capitalist system.\n</step1>\n<step2>\nIn a pure capitalist system, the government typically has a limited role — *ijọba ko ni ipa to pọ* in economic activities.\n</step2>\n<step3>\nThe primary function of the government is to maintain law and order — *lati pa ofin ati ilana mu* — ensuring that markets operate efficiently.\n</step3>\n<step4>\nAdditionally, the government may provide public goods and services that the market cannot efficiently supply — *awọn ohun elo ati iṣẹ ti ọja ko le pese daradara*.\n</step4>\n<step5>\nHowever, in a pure capitalist system, government intervention is minimal, focusing mainly on protecting property rights and enforcing contracts — *lati daabobo awọn ẹtọ ohun-ini ati lati fi ofin mulẹ*.\n</step5>\n<step6>\nThus, the government's role is primarily regulatory rather than participatory in the economy — *ijọba n ṣiṣẹ bi oludari ju bi alabaṣiṣẹpọ lọ*.\n</step6></thinking>", "answer": "<answer>Ninu eto kapitalisimu mimọ́, ipa ijọba ni lati pa ofin mu ati daabobo awọn ẹtọ ohun-ini, ṣugbọn ko ni ipa to pọ ninu ọrọ̀-aje.</answer>", "language": "Yoruba"}
{"question": "Awọn oògùn tí ó ní ewu ikọlu ìkọlu ẹ̀jẹ̀ ní àwọn aláìlera G6PD, àfi?\nA. Primaquine\nB. Chloroquine\nC. Dapsone\nD. Nalidixic acid", "reasoning": "<thinking><step1>\nThe question asks: “Which medications pose a risk of hemolytic anemia in individuals with G6PD deficiency?” — here, *G6PD* refers to *glucose-6-phosphate dehydrogenase*, a crucial enzyme.\n</step1>\n<step2>\nIndividuals with G6PD deficiency can experience *ìkọlu ẹ̀jẹ̀* (hemolytic anemia) when exposed to certain drugs.\n</step2>\n<step3>\nAmong the options, *Primaquine* is known to cause hemolysis in these patients — it triggers oxidative stress.\n</step3>\n<step4>\nOn the other hand, *Chloroquine* and *Dapsone* are generally considered safer, although Dapsone can cause issues in some cases.\n</step4>\n<step5>\n*Nalidixic acid* is less commonly associated with hemolytic reactions, making it a safer choice compared to Primaquine.\n</step5>\n<step6>\nThus, the medication that poses the highest risk for individuals with G6PD deficiency is *Primaquine*.\n</step6></thinking>", "answer": "<answer>Primaquine ni oògùn tí ó ní ewu ikọlu ìkọlu ẹ̀jẹ̀ fún àwọn aláìlera G6PD.</answer>", "language": "Yoruba"}
{"question": "Ọmọbirin kan ń ṣe àìsàn, ó ní ìṣòro ìgbànà (melena) àti àwọn àmì òun rere lórí ẹnu àti ètè rẹ̀. Ẹgbọn méjì rẹ̀ sì ti ní irú àwọn àmì náà rí. Bí a bá gbàgbé irú àwọn àmì náà àti ìtàn ìdílé rẹ̀ yìí, kí ni ìwádìí tó gbàgbọ̀ jùlọ?", "reasoning": "<thinking><step1>\nThe question translates to: \"A girl is ill, she has a problem with [melena = melena] and signs of good health on her mouth and stool. Her two siblings have also had similar signs. If we forget these signs and her family history, what is the most likely diagnosis?\"\n</step1>\n<step2>\nMelena refers to black, tarry stools indicating gastrointestinal bleeding — *ìbàjẹ́ inú* or *ìfarapa àtọgbẹ*. This is a significant symptom to consider.\n</step2>\n<step3>\nThe presence of good health signs on her mouth and stool suggests that while she has melena, other aspects of her health are stable — *àwọn àmì ilera to dára*.\n</step3>\n<step4>\nGiven that her siblings have experienced similar symptoms, this could indicate a genetic or familial condition — *àìsàn ìdílé* that affects multiple family members.\n</step4>\n<step5>\nCommon conditions associated with melena include peptic ulcers or bleeding disorders, but the family history is crucial for narrowing down the diagnosis — *ìtàn ìdílé* can reveal hereditary issues.\n</step6>\n<step6>\nIf we focus solely on the melena and disregard other signs, the most likely diagnosis could be a bleeding disorder or a gastrointestinal issue, but the familial aspect cannot be ignored.\n</step6>\n<step7>\nThus, the most probable diagnosis, considering the symptoms and family history, would be a hereditary bleeding disorder — *àìsàn ìfarapa àtọgbẹ*.\n</step7></thinking>", "answer": "<answer>Àìsàn ìfarapa àtọgbẹ ni ìwádìí tó gbàgbọ̀ jùlọ.</answer>", "language": "Yoruba"}
{"question": "Àwòrán ìṣàkóso ẹgbẹ́rún mẹ́rin ọdún ọmọdé fi hàn ní irú ọ̀gbọ̀n kékeré kan ní agbègbè ìpín ní ìgbà ọ̀dọ̀dún kejì ìsàlẹ̀. Ẹ̀jẹ̀ ti jáde nígbà tí a ṣí ọ̀nà gbòǹgbò. Ìtọ́jú tí ó ṣeé ṣe julọ ni\nA. Pulpectomy ati irin alagbara alawọ ewe\nB. Pulpotomy\nC. Yíyọ eyín náà kúrò\nD. Wo kò sí ìtọ́jú tí ó pọn dandan", "reasoning": "<thinking><step1>\nThe question asks: “What is the most appropriate treatment for a child with a dental issue that has been present for four years?” — it mentions *ìṣàkóso* (management) and *ìtọ́jú* (treatment) in the context of a dental condition.\n</step1>\n<step2>\nIn pediatric dentistry, conditions that persist for years often indicate significant issues, such as *ìfarapa* (damage) to the tooth pulp.\n</step2>\n<step3>\nThe options include treatments like *pulpectomy* (removal of the pulp) and *pulpotomy* (partial pulp removal), which are relevant for managing pulp issues.\n</step3>\n<step4>\nIf the pulp is severely affected, a *pulpectomy* might be necessary, while a *pulpotomy* is less invasive and could be suitable for less severe cases.\n</step5>\n<step5>\nRemoving the tooth (*yíyọ eyín náà kúrò*) is a last resort and usually not preferred in children unless absolutely necessary.\n</step6>\n<step6>\nGiven the chronic nature of the issue, the most appropriate treatment would likely be *pulpectomy* or *pulpotomy*, depending on the severity of the pulp condition.\n</step7>\n<step7>\nHowever, since the question asks for the most appropriate treatment, *pulpotomy* is often the first line of treatment for children with pulp issues.\n</step7></thinking>", "answer": "<answer>Ìtọ́jú tí ó ṣeé ṣe julọ ni Pulpotomy.</answer>", "language": "Yoruba"}
{"question": "Ni ọjọ́ ọmọ mélòó ni àdánwò ELISA le ṣe àyẹ̀wò àrùn HIV ní ọmọdé tí a bí sí ìyá tí ó ní àrùn HIV lọ́rùn?", "reasoning": "<thinking><step1>\nThe question asks: “Ni ọjọ́ ọmọ mélòó ni àdánwò [ELISA = ELISA test] le ṣe àyẹ̀wò [àrùn HIV = HIV infection] ní ọmọdé tí a bí sí ìyá tí ó ní àrùn HIV lọ́rùn?” — meaning it wants to know at what age an ELISA test can detect HIV in a child born to an HIV-positive mother.\n</step1>\n<step2>\nThe ELISA test is used to detect antibodies to HIV, but in newborns, the presence of maternal antibodies can complicate results — *àwọn àbáwọlé mẹ́ta* from the mother can persist for several months.\n</step2>\n<step3>\nTypically, it is recommended to perform the ELISA test at around 18 months of age — *ní ayé 18 oṣù* — when maternal antibodies are likely to have diminished.\n</step3>\n<step4>\nBefore this age, testing may not be reliable due to the interference of these maternal antibodies — *àwọn àbáwọlé mẹ́ta* from the mother can give false positives.\n</step4>\n<step5>\nIn some cases, earlier testing can be done using PCR tests, which detect the virus directly — *àwọn àdánwò PCR* can be performed as early as 2 months.\n</step5>\n<step6>\nHowever, for the ELISA specifically, waiting until 18 months is the standard practice to ensure accurate results.\n</step6></thinking>", "answer": "<answer>Àdánwò ELISA le ṣe àyẹ̀wò àrùn HIV ní ọmọdé ní ọjọ́ 18 oṣù.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun mẹrinlẹgbọn-dinlọgọ kan tí ó ní àrùn β-thalassemia major, tí ó ti gbà ẹ̀jẹ̀ lọ́pọ̀lọpọ̀ nígbà tí ó sì ń ṣe àìlera àti fífẹ̀ẹ́rẹ̀ ojú, pẹ̀lú iye hemoglobin 6.5 mg/dL.  Lọ́rùn sí àwọn àmì àrùn wọ̀nyí, kini ìwádìí microscópic ti àpẹẹrẹ àkọ́bi ẹ̀dọ̀ yóò fi hàn julọ?", "reasoning": "<thinking><step1>\nThe question asks: “Lọ́rùn sí àwọn àmì àrùn wọ̀nyí, kini ìwádìí microscópic ti àpẹẹrẹ àkọ́bi ẹ̀dọ̀ yóò fi hàn julọ?” — meaning it wants to know what microscopic examination of a liver biopsy would reveal in a patient with β-thalassemia major.\n</step1>\n<step2>\nIn β-thalassemia major, patients often experience severe anemia — *àrùn àìlera* — and require frequent blood transfusions, which can lead to iron overload.\n</step2>\n<step3>\nThe liver biopsy would likely show signs of hemosiderosis — *hemosiderosis* — due to excess iron deposition in the liver cells.\n</step3>\n<step4>\nMicroscopically, one would expect to see increased amounts of hemosiderin — *hemosiderin* — which appears as golden-brown granules in the liver tissue.\n</step4>\n<step5>\nAdditionally, there may be signs of liver damage or fibrosis — *ìfarapa ẹ̀dọ̀* — as a result of chronic iron overload.\n</step5>\n<step6>\nThus, the microscopic findings would primarily indicate iron accumulation and potential liver injury due to repeated transfusions.\n</step6></thinking>", "answer": "<answer>Ìwádìí microscópic yóò fi hàn pé àkúnya hemosiderin pọ̀, tí ó jẹ́ àmì àrùn àìlera àti ìfarapa ẹ̀dọ̀.</answer>", "language": "Yoruba"}
{"question": "Àrùn wo ni a mọ̀ sí nípa ìwàbíbí ìgbàgbọ́ ti àwọn ẹ̀ya ilẹ̀kùn ilẹ̀ àgbà-gbà méjì, hyperdensity àti calcification ti àpòòpò ìṣíṣẹpọ̀ inú, àti ìgbàgbọ́ ti òpọlọpọ̀ ẹ̀ya funfun tí ó jinlẹ̀ nínú CT scan kan?", "reasoning": "<thinking><step1>\nThe question asks: “Àrùn wo ni a mọ̀ sí nípa [ìwàbíbí = manifestation] ìgbàgbọ́ ti àwọn [ẹ̀ya ilẹ̀kùn = types of lesions] ilẹ̀ àgbà-gbà méjì, hyperdensity àti calcification ti [àpòòpò ìṣíṣẹpọ̀ = mediastinal mass], àti ìgbàgbọ́ ti òpọlọpọ̀ [ẹ̀ya funfun = white lesions] tí ó jinlẹ̀ nínú [CT scan = CT scan] kan?” — meaning it seeks to understand the disease associated with these findings.\n</step1>\n<step2>\nIn English, we recognize that a CT scan showing hyperdensity and calcification in a mediastinal mass suggests certain conditions — *àpòòpò ìṣíṣẹpọ̀* can indicate malignancy or infection.\n</step2>\n<step3>\nThe presence of multiple white lesions, or *ẹ̀ya funfun*, could suggest a granulomatous disease, such as sarcoidosis or tuberculosis — *tuberculose* can cause such findings.\n</step3>\n<step4>\nAdditionally, the term *ìgbàgbọ́* refers to the belief or hypothesis regarding the nature of these lesions, which may be linked to underlying systemic conditions.\n</step4>\n<step5>\nIn summary, the combination of hyperdensity, calcification, and multiple white lesions in a CT scan often points towards serious conditions that require further investigation — *ìwàbíbí* of these findings is crucial for diagnosis.\n</step5>\n<step6>\nThus, the disease associated with these CT findings could be a granulomatous disease or malignancy, depending on the clinical context.\n</step6></thinking>", "answer": "<answer>Àrùn ti a mọ̀ sí nípa ìwàbíbí yìí ni sarcoidosis tàbí tuberculose, pẹ̀lú àpòòpò ìṣíṣẹpọ̀ tí ó ní hyperdensity àti calcification.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 60 kan ni irora àyà tó burú jáì fún wakati mẹrin, ó sì kú láàrin wakati 24 lẹ́yìn tí wọ́n gbé e lọ sí ilé-iwosan.  Àyẹ̀wo lẹ́yìn ikú fi hàn pé àyà rẹ̀ ni àwọn ẹ̀jẹ̀ san gbà lórí apá septum àti òpópóná iwájú ilé-àyà òsì.  Kí ni àyẹ̀wo microscope tí ó rọ̀rùn yóò ṣeé ṣe láti fi hàn nínú ọ̀ràn yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àyẹ̀wo microscope tí ó rọ̀rùn yóò ṣeé ṣe láti fi hàn nínú ọ̀ràn yìí?” — meaning it wants to know what a simple microscopic examination could reveal in this case.\n</step1>\n<step2>\nThe patient, a 60-year-old man, experienced severe chest pain for four hours and died within 24 hours after being taken to the hospital — *irora àyà tó burú* indicates a serious condition.\n</step2>\n<step3>\nThe autopsy findings show blood accumulation on the septum and the anterior wall of the left ventricle — *àwọn ẹ̀jẹ̀ san gbà lórí apá septum* suggests a possible myocardial infarction.\n</step3>\n<step4>\nA simple microscopic examination could reveal necrosis of cardiac muscle cells — *ìkànsí àwọn sẹẹli àyà* — which is indicative of damage due to lack of blood supply.\n</step5>\n<step5>\nAdditionally, one might observe inflammatory cells, such as neutrophils, in the affected area — *àwọn sẹẹli àìlera* that respond to tissue injury.\n</step6>\n<step6>\nThus, the findings from the microscope would likely show signs of myocardial damage and inflammation — *àyẹ̀wo microscope yóò fi hàn ìkànsí àyà àti àìlera*.\n</step6></thinking>", "answer": "<answer>Àyẹ̀wo microscope yóò fi hàn ìkànsí àyà àti àìlera nínú ọ̀ràn yìí.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mẹtadinlogbon (33) kan wá sí ẹka pajawiri nítorí ìrora ọpọlọ. Awọn ọrẹ̀gbẹ́ rẹ̀ ni wọn rí i lórí ibi iṣẹ́ ikole kan. Itan iṣẹ́ iwosan rẹ̀ ni àrùn ìgbàgbé àti schizophrenia, ó sì ń mu haloperidol lọ́wọ́lọ́wọ́. Ó ṣe abẹ ṣiṣẹ́ oṣu meji sẹhin láti yọ appendix rẹ̀ tí ó rẹ̀.  Ìgbona ara rẹ̀ jẹ́ 105°F (40.6°C), ẹ̀rọ ìwọ̀n ẹ̀jẹ̀ jẹ́ 120/84 mmHg, ìṣiṣẹ́ ọkàn jẹ́ 150/min, ìgbìyànjú ẹ̀mí jẹ́ 19/min, ati mimu oxygen jẹ́ 99% ní afẹfẹ yàrá.  Àyẹ̀wò ara ṣe àkíyèsí ọkunrin tí ó dààmú tí kò lè dá awọn ìbéèrè lóhùn. Aṣọ rẹ̀ ti gbẹ ní ẹ̀gbà. Kò ṣe ìgbòkègbodò pẹlu awọn ẹya ara rẹ̀, botilẹjẹpe kò sí àìlera majẹmu ọpọlọ ti o han gbangba. Ẹ̀yà wo ni o jẹ́ ìwádìí tí ó pọ̀ jùlọ?\nA. Ìgbona ara nítorí iṣẹ́ ṣiṣe\nB. Ìgbona ara tí kò fi bẹ́ẹ̀ ga\nC. Ìgbona ara búburú\nD. Àrùn búburú nítorí lílo oogun ìṣànà ọpọlọ", "reasoning": "<thinking><step1>\nThe question is asking about the most likely cause of fever in a 33-year-old man who has a history of [àrùn ìgbàgbé = depression] and [schizophrenia], and is currently taking [haloperidol = haloperidol].\n</step1>\n<step2>\nHe presents with a high fever of 105°F (40.6°C) and other vital signs indicating tachycardia and normal oxygen saturation — *mimu oxygen jẹ́ 99%*.\n</step2>\n<step3>\nGiven his recent surgery to remove his appendix, we need to consider if the fever is related to a post-operative infection — *àrùn àtẹ̀yìnwá*.\n</step3>\n<step4>\nHowever, his mental state shows confusion, and he cannot answer questions, which may suggest a possible [neuroleptic malignant syndrome = àrùn búburú nítorí lílo oogun ìṣànà ọpọlọ] due to his medication.\n</step4>\n<step5>\nThe options provided include various causes of fever, but the most concerning is the potential for a serious reaction to his antipsychotic medication, especially given his symptoms.\n</step6>\n<step6>\nThus, the most likely cause of his fever is related to the use of his psychiatric medication, which can lead to severe complications.\n</step6></thinking>", "answer": "<answer>Àrùn búburú nítorí lílo oogun ìṣànà ọpọlọ.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdún mẹtadinlọgbọn (37) kan wá sí ẹka pajawiri pẹlu ẹ̀dùn ọrọ́ tó burú jáì ní ojú rẹ̀. Ó sọ pé ní ọsẹ̀ to kọjá, ó ti ní irora tí ó gbẹ̀mìí sí i ní ojú rẹ̀, tí ó máa ń bẹ̀rẹ̀ ló kàn láìròtélé, tí ó sì máa ń dá sí ara rẹ̀. Ó sọ pé ó rí irora náà lórí ẹ̀yìn rẹ̀ àti ní etí ojú rẹ̀. Irora náà burú gan-an débi pé ó máa ń mú ojú rẹ̀ fà sílẹ̀, ó sì máa ń farapamọ̀ sí ara rẹ̀ nítorí àwọn àkókò náà. Ó bẹ̀rù láti jáde sí gbangba nítorí èyí, ó sì máa ń rò pé àwọn ààmì náà máa ń bẹ̀rẹ̀ nígbà tí ó bá rò pé ó máa ń ṣẹlẹ̀ ní gbangba. Nígbà tí ó ń dúró ní ẹka pajawiri, àwọn ààmì rẹ̀ dá sí ara rẹ̀. Aláìsàn náà ní ìtàn àìsàn tẹ́lẹ̀ ti àtìgbàgbọ́, ìgbẹ́, irritable bowel syndrome, àti àníyàn. A mọ̀ ọ́n dáadáa ní ẹka pajawiri fún wíwá pẹ̀lú àwọn ọ̀rọ̀ àìsàn tí kò sábà ní ìdí ti ara. Ìgbóná rẹ̀ jẹ́ 99.5°F (37.5°C), àtìgbàgbọ́ jẹ́ 177/108 mmHg, ìṣàn-ẹ̀jẹ̀ jẹ́ 90/min, ìmú jẹ́ 17/min, ati àṣeyọrí oxygen jẹ́ 98% ní afẹ́fẹ́ yàrá. Àwọn àyẹ̀wò ọkàn-àìsàn àti ikùn wà láàrin àwọn àṣàyàn deede. Àyẹ̀wò iṣẹ́ ẹ̀rọ àyàfihan pe cranial nerves II-XII wà ní ìdájú. Àwọn ọmọlúwàbí rẹ̀ dọ́gba ati àṣeyọrí sí imọlẹ. A kò rí irora nígbà tí a fi ọwọ́ fọwọ́ kan ojú aláìsàn náà. Ẹ̀yìn wo ni ìgbésẹ̀ àkọ́kọ́ tí ó dára jùlọ ní ìṣàkóso?\nA. Alprazolam\nB. Carbamazepine\nC. Oxygen gíga\nD. Ibuprofen\nE. Ìtẹ̀lé ọ̀rọ̀ àìsàn ní ita", "reasoning": "<thinking><step1>\nThe question asks: \"What is the best initial step in management for a 37-year-old woman presenting with severe facial pain?\" — it describes her symptoms and medical history, including anxiety and irritable bowel syndrome.\n</step1>\n<step2>\nShe has severe pain in her face, particularly around her eyes and cheeks — *irora tó burú ní ojú rẹ̀* — which worsens with certain triggers, indicating a possible neurological issue.\n</step2>\n<step3>\nGiven her symptoms and the fact that she has a history of anxiety, it’s important to consider both pain management and anxiety relief — *ìtẹ̀lé ọ̀rọ̀ àìsàn*.\n</step3>\n<step4>\nAmong the options, Alprazolam is a benzodiazepine that can help with anxiety and may also alleviate some pain through its calming effects — *Alprazolam le ran lọwọ lati dinku ìbànújẹ*.\n</step4>\n<step5>\nCarbamazepine is typically used for neuropathic pain, but it may not be the best immediate choice in an emergency setting — *Carbamazepine le ma jẹ́ aṣayan tó dára jùlọ nígbà pajawiri*.\n</step6>\n<step7>\nHigh-flow oxygen is generally used for respiratory issues, which doesn’t seem to be the primary concern here — *Oxygen gíga kò dájú pé yóò ran lọwọ nínú ọran yìí*.\n</step8>\n<step9>\nIbuprofen could help with pain relief, but it may not address the underlying anxiety that could be exacerbating her symptoms — *Ibuprofen le dinku irora, ṣugbọn kò ṣeé fojú kọ́ àìlera àníyàn*.\n</step10>\n<step11>\nThus, the best initial management step considering her severe pain and anxiety is to administer Alprazolam — *ìgbésẹ̀ àkọ́kọ́ tó dára jùlọ ni Alprazolam*.\n</step11></thinking>", "answer": "<answer>Alprazolam ni ìgbésẹ̀ àkọ́kọ́ tó dára jùlọ ní ìṣàkóso.</answer>", "language": "Yoruba"}
{"question": "Nipọn wo ni a ti máa rí ìdààmú ẹ̀jẹ̀ bíi dot and blot, àti flame-shaped hemorrhages ní ojú?", "reasoning": "<thinking><step1>\nThe question asks: “Nipọn wo ni a ti máa rí ìdààmú ẹ̀jẹ̀ bíi dot and blot, àti flame-shaped hemorrhages ní ojú?” — meaning it wants to know in what conditions we see blood disturbances like dot and blot, and flame-shaped hemorrhages in the eye.\n</step1>\n<step2>\nDot and blot hemorrhages are small, round spots of blood that appear in the retina — *retina* — often associated with conditions like hypertension or diabetes.\n</step2>\n<step3>\nFlame-shaped hemorrhages, on the other hand, are linear and occur due to the rupture of superficial blood vessels — *vaisseaux sanguins superficiels*.\n</step4>\n<step4>\nIn cases of *hypertension* or *diabetic retinopathy*, these types of hemorrhages can be observed during an eye examination — *examen oculaire*.\n</step5>\n<step5>\nAdditionally, conditions like *anemia* or *sickle cell disease* can also lead to these types of blood disturbances in the eye.\n</step6>\n<step6>\nThus, we typically see these hemorrhages in conditions affecting blood flow or vessel integrity — *intégrité des vaisseaux*.\n</step7></thinking>", "answer": "<answer>A ti máa rí ìdààmú ẹ̀jẹ̀ bíi dot and blot, àti flame-shaped hemorrhages ní ojú ní àkókò ìlera bíi hypertension àti diabetic retinopathy.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun mẹ́rinlélọ́gbọ̀n kan wá pẹ̀lú irora ẹ̀ṣẹ̀, rírí ọrùn tó burú jù ní òwúrọ̀, òṣùṣù, àti ìṣòro láti dìde láti ibi tí ó jókòó. Àwọn àmì àrùn rẹ̀ ti ń pọ̀ sí i fún ọ̀sẹ̀ mẹ́ta sẹ́yìn.  Nítorí ìfihàn àrùn yìí, kini igbesẹ to tọ́ jùlọ tí ó tẹ̀ lé e ní ṣíṣàyẹ̀wò ìwádìí láti jẹ́ kí ìwàdàdí àrùn tí a gbàgbọ́ rí hàn gbangba?", "reasoning": "<thinking><step1>\nThe question translates to: \"A 34-year-old woman presents with joint pain, severe morning stiffness, and difficulty getting up from a seated position. Her symptoms have been worsening for three weeks. Given this presentation, what is the most appropriate next step in the diagnostic workup to confirm suspected disease?\" \n</step1>\n<step2>\nThe symptoms suggest a possible inflammatory condition, likely *artritis* or another rheumatological disorder. The severe morning stiffness is particularly indicative of conditions like rheumatoid arthritis — *artritis reumatoide*.\n</step2>\n<step3>\nIn such cases, the first step in the diagnostic process typically involves laboratory tests. A common test is the rheumatoid factor — *faktọ́ reumatoidi* — which can help confirm the diagnosis.\n</step3>\n<step4>\nAdditionally, checking for anti-CCP antibodies — *anti-CCP* — is crucial as it is more specific for rheumatoid arthritis. These tests can provide significant insight into the underlying condition.\n</step5>\n<step5>\nImaging studies, such as X-rays or ultrasounds, may also be considered later, but initial laboratory tests are essential for a proper diagnosis.\n</step6>\n<step6>\nThus, the most appropriate next step is to order laboratory tests, specifically looking for rheumatoid factor and anti-CCP antibodies.\n</step6></thinking>", "answer": "<answer>Igbesẹ to tọ́ jùlọ ni láti paṣẹ ìdánwò àtọkànwá, pẹ̀lú àfihàn faktọ́ reumatoidi àti anti-CCP.</answer>", "language": "Yoruba"}
{"question": "Kini ilana ti o wulo julọ fun alaisan ọdun 40 kan ti o ni cirrhosis ti o ni irora ikun ti o wuwo lẹhin ti a ti fun u ni itọju akọkọ fun wakati 6?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ilana ti o wulo julọ fun alaisan [cirrhosis = cirrhosis] ti o ni irora ikun [abdominal pain = abdominal pain] ti o wuwo?” — meaning it seeks the best management plan for a 40-year-old patient with cirrhosis experiencing severe abdominal pain after initial treatment for 6 hours.\n</step1>\n<step2>\nIn cases of cirrhosis, *irora ikun* can be due to complications like ascites or hepatic encephalopathy. After 6 hours of treatment, it’s crucial to assess the patient's condition further.\n</step2>\n<step3>\nFirst, we need to evaluate the severity of the pain and check for any signs of complications — *awọn ami ti awọn iṣoro* such as jaundice or confusion.\n</step3>\n<step4>\nIf the pain is severe and persistent, imaging studies like an ultrasound may be necessary to rule out conditions like *peritonitis* or *hepatomegaly*.\n</step4>\n<step5>\nManagement may include adjusting medications, providing pain relief, and possibly considering interventions like paracentesis if there is significant fluid accumulation.\n</step5>\n<step6>\nIn summary, the best approach involves thorough assessment, imaging if needed, and tailored management to address the underlying causes of the abdominal pain.\n</step6></thinking>", "answer": "<answer>Ilana ti o wulo julọ ni lati ṣe ayẹwo ni kikun, lo awọn iwadii aworan ti o ba wulo, ati ṣatunṣe itọju lati dinku irora ikun.</answer>", "language": "Yoruba"}
{"question": "Eyi ni tabili kan nibiti ila ti akọkọ jẹ́ atokọ ati ila kọọkan ti o tẹle jẹ́ penguin kan: orukọ, ọjọ ori, iga (cm), iwuwo (kg) Louis, 7, 50, 11 Bernard, 5, 80, 13 Vincent, 9, 60, 11 Gwen, 8, 70, 15 Fun apẹẹrẹ: ọjọ ori Louis ni 7, iwuwo Gwen ni 15 kg, iga Bernard ni 80 cm.  A ti fi penguin kan kun si tabili bayi:\nJames, 12, 90, 12\nMelo ni ẹranko ti a ṣe akojọ ninu tabili naa?\nAwọn aṣayan:\n(A) 1\n(B) 2\n(C) 3\n(D) 4\n(E) 5", "reasoning": "<thinking><step1>\nThe question asks: “Melo ni ẹranko ti a ṣe akojọ ninu tabili naa?” — meaning it wants to know how many animals are listed in the table.\n</step1>\n<step2>\nThe table includes a list of penguins with their names, ages, heights, and weights. Initially, there are four penguins: Louis, Bernard, Vincent, and Gwen.\n</step2>\n<step3>\nThen, a new penguin named James is added to the list, bringing the total count to five — *nítorí náà, a ni penguin marun*.\n</step4>\n<step4>\nTo summarize, the original four plus the new addition means we have five penguins in total.\n</step5>\n<step5>\nThus, the answer to the question is that there are five animals listed in the table.\n</step6></thinking>", "answer": "<answer>Marun ni ẹranko ti a ṣe akojọ ninu tabili naa.</answer>", "language": "Yoruba"}
{"question": "Gẹgẹ́ bí Shapiro ṣe sọ, ìpinnu wo ni àwọn ìwádìí ìgbà pípẹ̀ àti àṣàwákiri jẹ́rìí sí nípa àṣà ìlò oògùn ará?", "reasoning": "<thinking><step1>\nThe question asks: “Gẹgẹ́ bí Shapiro ṣe sọ, ìpinnu wo ni àwọn ìwádìí ìgbà pípẹ̀ àti àṣàwákiri jẹ́rìí sí nípa àṣà ìlò oògùn ará?” — meaning it inquires about the conclusions drawn by Shapiro regarding long-term studies and exploration in relation to the use of traditional medicine.\n</step1>\n<step2>\nShapiro emphasizes that long-term studies provide valuable insights — *ìwádìí ìgbà pípẹ̀* help in understanding the effectiveness and safety of traditional medicine practices.\n</step2>\n<step3>\nThese studies often reveal patterns in *àṣà ìlò oògùn ará* that may not be apparent in short-term research — *àwọn àkópọ̀ àkóónú* can show cumulative effects over time.\n</step3>\n<step4>\nAdditionally, exploration of traditional practices can uncover *ìmọ̀ àtọkànwá* that modern medicine might overlook, leading to a more holistic approach to health.\n</step4>\n<step5>\nShapiro's conclusions suggest that integrating findings from these studies can enhance the understanding of *ìlera* and improve patient outcomes.\n</step5>\n<step6>\nIn summary, the research supports the idea that traditional medicine has a significant role in health practices, validated by long-term evidence.\n</step6></thinking>", "answer": "<answer>Ìpinnu Shapiro ni pé ìwádìí ìgbà pípẹ̀ àti àṣàwákiri fi hàn pé àṣà ìlò oògùn ará ní ipa pataki ninu ìlera.</answer>", "language": "Yoruba"}
{"question": "Ni obinrin ọmọ ọdun aadọta kan ti o ti ni ilera tẹlẹ ti o wa pẹlu iran meji, ptosis, itojúka die ati idiwọ awọn išipopada oju (ayafi ni ẹgbẹ́), ọmọlẹyin ti o tobi ti ko ni idahun daradara, ati pe ko si papilledema, kini ipo ti o ṣeeṣe julọ?", "reasoning": "<thinking><step1>\nThe question translates to: \"A 50-year-old woman with a previous health history presents with double vision, ptosis [drooping eyelid], mild weakness, and limited eye movement (except on one side), a larger pupil that does not respond well, and no papilledema [swelling of the optic disc]. What is the most likely condition?\" \n</step1>\n<step2>\nThe symptoms suggest a neurological issue, particularly affecting the cranial nerves — *nerves craniens* — which control eye movement and pupil response.\n</step2>\n<step3>\nPtosis and double vision indicate possible involvement of the oculomotor nerve — *nerf oculomoteur* — which can be affected in conditions like myasthenia gravis or a compressive lesion.\n</step3>\n<step4>\nThe presence of a larger pupil that does not respond well suggests a possible sympathetic nerve involvement or a third cranial nerve palsy — *paralysie du nerf crânien III*.\n</step4>\n<step5>\nGiven the age of the patient and the symptoms, a common condition to consider is a compressive lesion, such as an aneurysm or a tumor affecting the oculomotor nerve.\n</step6>\n<step6>\nHowever, the absence of papilledema is notable, which might lean towards myasthenia gravis as a more likely diagnosis, especially with the fluctuating weakness.\n</step6>\n<step7>\nIn summary, the combination of ptosis, double vision, and the pupil's response points towards a neuromuscular junction disorder, particularly myasthenia gravis.\n</step7></thinking>", "answer": "<answer>Ipo ti o ṣeeṣe julọ ni myasthenia gravis.</answer>", "language": "Yoruba"}
{"question": "Irinwo iranlowo wo ni o jẹ dandan lati ṣayẹwo ipa ti igbaradi ẹnu fun ọmọde kan?", "reasoning": "<thinking><step1>\nThe question asks: “Irinwo iranlowo wo ni o jẹ dandan lati ṣayẹwo ipa ti igbaradi ẹnu fun ọmọde kan?” — meaning it wants to know what kind of assistance is necessary to assess the impact of oral preparation for a child.\n</step1>\n<step2>\nAssessing the impact of oral preparation involves understanding how well a child can tolerate and respond to medication — *bawo ni ọmọde ṣe le gba ati dahun si oogun*.\n</step2>\n<step3>\nKey factors include the child’s age, weight, and any underlying health conditions — *ọdún, iwuwo, ati awọn ipo ilera to wa tẹlẹ*.\n</step4>\n<step4>\nIn practice, healthcare providers might use tools like questionnaires or direct observation — *awọn irinṣẹ bii awọn ibeere tabi akiyesi taara* to evaluate the child's response.\n</step5>\n<step5>\nAdditionally, monitoring for side effects is crucial — *mimu akiyesi fun awọn ipa ẹgbẹ jẹ pataki* to ensure the child’s safety during treatment.\n</step6>\n<step6>\nThus, the necessary assistance includes thorough assessment methods and continuous monitoring — *awọn ọna ayẹwo to peye ati mimu akiyesi nigbagbogbo*.\n</step7></thinking>", "answer": "<answer>Irinwo iranlowo ti o jẹ dandan ni ayẹwo awọn ọna ayẹwo to peye ati mimu akiyesi nigbagbogbo fun ọmọde kan.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọjọ́ ori ogún mẹ́rin ati mẹ́rin (74) kan wá sọ́dọ̀ oníṣègùn fún ṣíṣàyẹ̀wò àṣìṣe awọ ara lórí apá ọ̀tún rẹ̀. Àṣìṣe náà fara hàn ní oṣù mẹ́ta sẹ́yìn, tí ó sì ti ń pọ̀ sí i láìkànǹkan. Ṣíṣàyẹ̀wò ara fi hàn pé àṣìṣe náà jẹ́ ṣentimita 1.5, tí ó ní irúgbìn pupa díẹ̀, tí ó sì gbé gẹ́gẹ́, pẹ̀lú àwọn ààlà tí kò dà bíi ara wọn lórí apá ọ̀tún. A gba àpẹẹrẹ fún ìwádìí ara. Bí ó bá wà, èwo nínú àwọn àkọ́kọ́ ayẹ̀wò ara tí ó tẹ̀lé yìí ni ó bá ìṣòro carcinoma in situ mu jùlọ?\nA. Ìyàtọ̀ ìṣètò sẹ̀ẹ̀lì ní stratum corneum\nB. Àwọn àyípadà ńlá tí kò lè yípadà ní stratum basale\nC. Ìpọ̀ sí i ní ìwọ̀n nùklia sí ìwọ̀n cytoplasm ní stratum spinosum\nD. Ìwàsípò awọn sẹ̀ẹ̀lì epidermis sí dermis", "reasoning": "<thinking><step1>\nThe question is asking about the findings from a skin examination of a 74-year-old man who has a skin lesion on his right arm that has been increasing in size over three months. It specifically wants to know which histological finding is most associated with carcinoma in situ.\n</step1>\n<step2>\nCarcinoma in situ is a type of cancer that is confined to the epithelium and has not invaded deeper tissues. In this case, the lesion is described as being 1.5 cm with some redness and irregular borders — *àṣìṣe náà jẹ́ ṣentimita 1.5, tí ó ní irúgbìn pupa díẹ̀*.\n</step2>\n<step3>\nHistological examination can reveal various changes in the skin layers. For carcinoma in situ, one key feature is the abnormal arrangement of cells in the epidermis — *ìwàsípò awọn sẹ̀ẹ̀lì epidermis*.\n</step4>\n<step4>\nOption A mentions changes in the stratum corneum, which is not typically associated with carcinoma in situ. Option B refers to significant changes in the stratum basale, which could be relevant but is less specific.\n</step5>\n<step5>\nOption C discusses an increase in nuclear size relative to cytoplasm in the stratum spinosum, which is a common finding in malignancies. However, the most definitive finding for carcinoma in situ is the disorganization of the epidermal cells.\n</step6>\n<step6>\nThus, the most relevant histological finding for carcinoma in situ is the abnormal arrangement of epidermal cells, which corresponds to option D — *ìwàsípò awọn sẹ̀ẹ̀lì epidermis sí dermis*.\n</step6></thinking>", "answer": "<answer>Ìwàsípò awọn sẹ̀ẹ̀lì epidermis sí dermis.</answer>", "language": "Yoruba"}
{"question": "Àììkì wo ni a sábà máa ń ṣàyẹ̀wò nígbà tí àrùn bá ní ìwọ̀n bilirubin tí kò tíì dara pọ̀, àti ìwọ̀n urobilinogen tí ó ga jùlọ nínú èèkán?", "reasoning": "<thinking><step1>\nThe question asks: “Àììkì wo ni a sábà máa ń ṣàyẹ̀wò...” which translates to “What do we usually check when a disease has an abnormal bilirubin level and a high urobilinogen level?” \n</step1>\n<step2>\nBilirubin is a yellow compound that occurs in the normal catabolism of hemoglobin — *hemoglobini* — and its levels can indicate liver function.\n</step2>\n<step3>\nWhen bilirubin levels are elevated, it often suggests *àìlera ẹdọ* (liver disease) or hemolysis, where red blood cells are broken down too quickly.\n</step3>\n<step4>\nUrobilinogen is produced from bilirubin in the intestines, so high levels can indicate liver dysfunction or increased hemolysis — *ìkànsí ẹdọ*.\n</step4>\n<step5>\nIn clinical practice, we typically check for conditions like hepatitis or cirrhosis when these levels are abnormal — *àrùn hepatitis* or *cirrhosis*.\n</step6>\n<step6>\nAdditionally, we may perform tests like a liver function test or a complete blood count to gather more information — *ìdánwò iṣẹ́ ẹdọ*.\n</step7>\n<step7>\nThus, we usually check for liver diseases and hemolytic conditions when faced with these abnormal levels.\n</step7></thinking>", "answer": "<answer>A a sábà máa ń ṣàyẹ̀wò àìlera ẹdọ àti àrùn hemolytic nígbà tí ìwọ̀n bilirubin àti urobilinogen bá ga.</answer>", "language": "Yoruba"}
{"question": "Ninu itọju idagbasoke Prostate ti o jẹ́ alailera (Benign Prostatic Hyperplasia - BPH) ti a nlo finasteride, akoko wo ni a gba niyanju lati fi hàn boya o ṣeéṣe lati ni idahun to dara?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu itọju idagbasoke [Prostate = Prostate] ti o jẹ́ alailera [Benign Prostatic Hyperplasia = BPH], akoko wo ni a gba niyanju lati fi hàn boya o ṣeéṣe lati ni idahun to dara?” — meaning it wants to know the recommended time frame to assess the effectiveness of finasteride treatment for BPH.\n</step1>\n<step2>\nFinasteride is used to reduce the size of the prostate and alleviate symptoms — *o n dinku iwọn prostate ati mu awọn aami aisan ṣiṣẹ*.\n</step2>\n<step3>\nTypically, it takes several months to see significant improvement — *o maa n gba oṣu mẹta si mẹfa* before one can evaluate the response to treatment.\n</step3>\n<step4>\nDuring this period, patients may notice changes in urinary symptoms — *awọn aami aisan ti o ni ibatan si ito* such as reduced frequency or urgency.\n</step4>\n<step5>\nAfter about 6 months, healthcare providers usually assess the effectiveness — *awọn dokita maa n ṣe ayẹwo bi itọju ṣe n ṣiṣẹ*.\n</step5>\n<step6>\nTherefore, the recommended time to evaluate the response to finasteride is around 6 months.\n</step6></thinking>", "answer": "<answer>Akoko ti a gba niyanju lati fi hàn boya o ni idahun to dara si finasteride ni oṣu mẹfa.</answer>", "language": "Yoruba"}
{"question": "Àrùn iyipada ẹ̀dà àìlera wo ni ó ṣeé ṣe jùlọ láti máa fa ìdàpọ̀ àwọn àrùn ikọ́kọ́ ẹ̀dọ̀fóró, àwọn ìgbẹ̀rùn epo líle pupa, ìdinku ìgbòòrò, àti àwọn àmì àìlera ìgbàgbọ́ nínú ọmọdé ọkùnrin ọdún méjì?", "reasoning": "<thinking><step1>\nThe question asks: “Àrùn iyipada ẹ̀dà àìlera wo ni ó ṣeé ṣe jùlọ láti máa fa ìdàpọ̀ àwọn àrùn ikọ́kọ́ ẹ̀dọ̀fóró?” — meaning it wants to know which genetic disorder is most likely to cause a combination of liver disease, red blood cell disorders, reduced immunity, and symptoms of illness in a two-year-old boy.\n</step1>\n<step2>\nOne possible condition is *hemochromatosis*, which is a genetic disorder that leads to excessive iron accumulation in the body — *ìkànsí irin*.\n</step2>\n<step3>\nThis condition can cause liver damage — *ìfarapa ẹ̀dọ̀* — and can also lead to issues with red blood cells, such as anemia — *àìlera ẹ̀jẹ̀*.\n</step4>\n<step4>\nIn children, symptoms might include fatigue, weakness, and growth delays — *ìdíwọ̀n àkókò*.\n</step5>\n<step5>\nAnother potential disorder is *Wilson's disease*, which affects copper metabolism and can also lead to liver problems and neurological symptoms — *àìlera ọpọlọ*.\n</step6>\n<step6>\nBoth conditions can present with overlapping symptoms, but hemochromatosis is more commonly associated with the specific combination mentioned.\n</step6></thinking>", "answer": "<answer>Àrùn iyipada ẹ̀dà àìlera ti o ṣeé ṣe jùlọ ni hemochromatosis, ti o fa ìdàpọ̀ àwọn àrùn ikọ́kọ́ ẹ̀dọ̀fóró, ìgbẹ̀rùn epo líle pupa, àti ìdinku ìgbòòrò.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdún mẹtadinlogun kan wá pẹlu irọra iṣan ti n pọ si lọ nipa lẹhin ọdun kan sẹhin, ti o ni iriri wahala lati dìde lati ijoko ati gùn awọn ìgbà, ṣugbọn kò si irọra ọwọ. O ni irora pupa didan lori oju rẹ̀, ti o kan awọn oju iṣan ni akọkọ, ati awọn aaye pupa ti o tẹ si isalẹ lori awọn igbonwo rẹ, awọn ikun rẹ, ati awọn ọwọ rẹ. Creatine kinase ẹ̀jẹ̀ rẹ̀ ga ni 620 U/L.  Àyẹ̀wò iṣan deltoid fihan awọn sẹẹli igbona mononuclear ni ayika awọn ohun elo ẹjẹ kekere ati awọn ẹgbẹ ti awọn myofibers atrophic ni eti awọn fascicles.  Ilana wo ni o ṣee ṣe lati jẹ oluṣe ipo rẹ̀?", "reasoning": "<thinking><step1>\nThe question describes a 27-year-old woman experiencing muscle pain that has worsened over the past year, with difficulty rising from a seated position and climbing stairs, but no hand pain. It also mentions red, tender areas on her face and other body parts, along with elevated creatine kinase levels — *creatine kinase = ẹ̀jẹ̀ creatine kinase*.\n</step1>\n<step2>\nThe symptoms suggest a possible inflammatory myopathy, particularly given the muscle weakness and the presence of *irora pupa didan* (red pain) on her face and limbs.\n</step2>\n<step3>\nThe elevated creatine kinase level indicates muscle damage — *ibajẹ iṣan* — which aligns with conditions like dermatomyositis or polymyositis.\n</step3>\n<step4>\nThe muscle biopsy findings of mononuclear inflammatory cells around small blood vessels and atrophic myofibers support this diagnosis, suggesting an autoimmune process.\n</step4>\n<step5>\nIn this context, the most likely condition affecting her is dermatomyositis, characterized by muscle weakness and skin manifestations — *aami awọ*.\n</step5></thinking>", "answer": "<answer>Ipo rẹ̀ jẹ dermatomyositis, ti o ni irora iṣan ati awọn aami awọ.</answer>", "language": "Yoruba"}
{"question": "Awọn iṣoro wo ni o le ṣẹlẹ lẹhin itọju ti ko ni abẹrẹ fun ipalara apakan ọkan, ati ṣe a nilo abẹrẹ iwadii fun gbogbo alaisan ti o ni ipalara apakan ọkan?", "reasoning": "<thinking><step1>\nThe question asks: “What problems can occur after non-invasive treatment for [injury to the heart = ipalara apakan ọkan], and do we need [invasive testing = abẹrẹ iwadii] for all patients with heart injury?” \n</step1>\n<step2>\nAfter non-invasive treatment, complications like *iṣoro ẹjẹ* (blood issues) or *iṣoro pẹlu awọn ẹdọfu* (issues with the valves) can arise.\n</step2>\n<step3>\nThese complications may lead to symptoms such as *irora ni ẹjẹ* (chest pain) or *iṣoro pẹlu mimi* (breathing difficulties).\n</step3>\n<step4>\nIn some cases, *abẹrẹ iwadii* is necessary to assess the extent of the injury and rule out serious conditions.\n</step4>\n<step5>\nHowever, not all patients require invasive testing; it depends on the severity of the injury and the symptoms presented.\n</step5>\n<step6>\nFor instance, if a patient shows mild symptoms, *a le ṣe ayẹwo pẹlu awọn idanwo ti ko ni abẹrẹ* (we can evaluate with non-invasive tests).\n</step6>\n<step7>\nIn summary, while complications can occur post-treatment, the need for invasive testing varies based on individual cases.\n</step7></thinking>", "answer": "<answer>Iṣoro le ṣẹlẹ lẹhin itọju ti ko ni abẹrẹ, ṣugbọn abẹrẹ iwadii ko nilo fun gbogbo alaisan; o da lori ijinlẹ ipalara ati awọn aami.</answer>", "language": "Yoruba"}
{"question": "Ọmọ kan fi itan ti ìgbàgbọ́ ẹ̀jẹ̀ pupọ̀ ati ṣíṣe dídùn gbígbòòrò sílẹ̀, ati pe ó tun ní itan ti lílò NSAID ṣaaju.  Nítorí àwọn àmì wọnyi ati itọju iṣaaju, kini ayẹwo tí ó ṣeeṣe?", "reasoning": "<thinking><step1>\nThe question asks: “Ọmọ kan fi itan ti ìgbàgbọ́ ẹ̀jẹ̀ pupọ̀ ati ṣíṣe dídùn gbígbòòrò sílẹ̀” — meaning a child has a history of significant bleeding and abdominal pain, and also mentions prior use of NSAIDs (non-steroidal anti-inflammatory drugs).\n</step1>\n<step2>\nIn this context, significant bleeding could indicate a serious condition — *ìṣòro ilera to ṣe pataki* — possibly related to the gastrointestinal tract.\n</step2>\n<step3>\nNSAIDs are known to cause gastrointestinal irritation and can lead to complications like ulcers — *ìkànsí* or bleeding in the stomach.\n</step3>\n<step4>\nThe combination of these symptoms suggests a potential diagnosis of a peptic ulcer or gastritis — *ìkànsí àtọ́runwá*.\n</step4>\n<step5>\nAdditionally, the child’s history of bleeding raises concerns for conditions like thrombocytopenia or coagulopathy — *ìṣòro ẹ̀jẹ̀*.\n</step5>\n<step6>\nGiven these factors, the most likely diagnosis could be a bleeding peptic ulcer exacerbated by NSAID use — *ìkànsí àtọ́runwá ti n fa ẹ̀jẹ̀*.\n</step6></thinking>", "answer": "<answer>Ayẹwo tí ó ṣeeṣe ni ìkànsí àtọ́runwá ti n fa ẹ̀jẹ̀.</answer>", "language": "Yoruba"}
{"question": "Loni ni April 10, 1985.  Ipade Jane yoo jẹ́ lẹ́yin ọjọ́ mẹ́ta.  Kí ni ọjọ́ ìṣe ní MM/DD/YYYY?\nAwọn aṣayan:\n(A) 04/13/1985\n(B) 04/10/1985\n(C) 01/02/2071\n(D) 04/07/1985\n(E) 04/11/1985\n(F) 03/10/1986", "reasoning": "<thinking><step1>\nThe question states: “Loni ni [today = today] April 10, 1985. Ipade Jane yoo jẹ́ lẹ́yin [three days = three days]. Kí ni [date = date] ní MM/DD/YYYY?” — meaning it asks for the date three days after April 10, 1985.\n</step1>\n<step2>\nTo find the date three days later, we start from April 10, 1985. Adding three days means we count forward: April 11, April 12, and then April 13.\n</step2>\n<step3>\nIn English, we can say: “April 10 + 3 days = April 13.” This is straightforward addition of days.\n</step3>\n<step4>\nNow, we need to check the options provided: (A) 04/13/1985, (B) 04/10/1985, (C) 01/02/2071, (D) 04/07/1985, (E) 04/11/1985, (F) 03/10/1986.\n</step4>\n<step5>\nAmong these, the correct date that corresponds to three days after April 10, 1985, is clearly option (A) 04/13/1985.\n</step5></thinking>", "answer": "<answer>04/13/1985</answer>", "language": "Yoruba"}
{"question": "Obirin ọdọ ọdun 23 kan n ni irira ìdààmú ọkàn tí ó pọ̀ sí i lẹ́yìn tí a gbé e ga sí ọfiisi kan ní ilẹ̀ kẹwàá nítorí ìdààmú ọkàn rẹ̀ nípa gíga tí ó ti pẹ́, èyí tí ó ṣakoso nípa yíyẹra fún àwọn ilé gíga àti gbé ní ilẹ̀ ilẹ̀. Bí ó tilẹ̀ jẹ́ pé ó lò alprazolam, ó fẹ́ ìdáàrọ̀ tó tọ̀nà fún ipò rẹ̀.  Kí ni ọ̀nà ìtọ́jú tó yẹ jùlọ fún didá aṣà ìbẹ̀rù gíga rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ọ̀nà ìtọ́jú tó yẹ jùlọ fún didá aṣà ìbẹ̀rù gíga rẹ̀?” — meaning it seeks the best treatment approach for managing high anxiety related to heights.\n</step1>\n<step2>\nThis individual experiences *irira ìdààmú ọkàn* (anxiety) that intensifies in high places, which suggests a specific phobia — *ìbẹ̀rù gíga* (fear of heights).\n</step2>\n<step3>\nCognitive Behavioral Therapy (CBT) is often effective for phobias, helping to change negative thought patterns — *ìmọ̀ràn àkóónú*.\n</step3>\n<step4>\nExposure therapy, a component of CBT, gradually exposes the person to heights in a controlled manner — *ìfihàn sí ìbẹ̀rù*.\n</step5>\n<step5>\nAdditionally, mindfulness techniques can help manage anxiety symptoms — *ìmọ̀ràn ìfọkànbalẹ̀* can be beneficial.\n</step6>\n<step6>\nSince the individual is already using alprazolam, it’s important to consult a healthcare provider for a comprehensive treatment plan — *ìtọ́jú tó péye*.\n</step7>\n<step7>\nIn summary, a combination of CBT, exposure therapy, and mindfulness practices would be the most effective approach for managing *ìbẹ̀rù gíga*.\n</step7></thinking>", "answer": "<answer>Ìtọ́jú tó yẹ jùlọ ni ìmọ̀ràn àkóónú, ìfihàn sí ìbẹ̀rù, àti ìmọ̀ràn ìfọkànbalẹ̀.</answer>", "language": "Yoruba"}
{"question": "Iru esi ara ṣe a nireti lati ri ninu alaisan ti a fun ni trimethaphan lakoko abẹ?", "reasoning": "<thinking><step1>\nThe question asks: “Iru esi ara ṣe a nireti lati ri ninu alaisan ti a fun ni [trimethaphan = trimethaphan] lakoko abẹ?” — meaning it wants to know what physiological responses to expect in a patient given trimethaphan during surgery.\n</step1>\n<step2>\nTrimethaphan is a ganglionic blocker used to manage hypertension — *o jẹ olutọju ti o n ṣiṣẹ lori awọn ganglia*.\n</step2>\n<step3>\nWhen administered, it can lead to vasodilation — *vasodilatation* — which decreases blood pressure.\n</step3>\n<step4>\nPatients may experience side effects such as hypotension — *hypotension* — and tachycardia — *tachycardia* — due to compensatory mechanisms.\n</step4>\n<step5>\nAdditionally, one might observe changes in heart rate and peripheral circulation — *iyipada ninu oṣuwọn ọkan ati iṣan ẹsẹ*.\n</step5>\n<step6>\nIn summary, the expected responses include lowered blood pressure and potential reflex tachycardia — *iyipada oṣuwọn ọkan*.\n</step6></thinking>", "answer": "<answer>A nireti lati ri hypotension ati tachycardia ninu alaisan ti a fun ni trimethaphan lakoko abẹ.</answer>", "language": "Yoruba"}
{"question": "Pẹlu iwọntunwọnsi hemoglobin (Hb) ti aṣe ayẹwo ti 10 g% fun àpẹẹrẹ awọn obinrin 100, pẹlu iyato boṣewa ti 1 g%, kini àṣiṣe boṣewa ti iwọntunwọnsi fun àpẹẹrẹ yii?", "reasoning": "<thinking><step1>\nThe question asks: “Pẹlu iwọntunwọnsi [hemoglobin = hemoglobin] (Hb) ti aṣe ayẹwo ti 10 g% fun àpẹẹrẹ [awọn obinrin = women] 100, pẹlu iyato boṣewa [standard deviation = standard deviation] ti 1 g%, kini àṣiṣe boṣewa [standard error = standard error] ti iwọntunwọnsi fun àpẹẹrẹ yii?” — meaning it wants to find the standard error of the hemoglobin level for this sample.\n</step1>\n<step2>\nTo calculate the standard error, we use the formula: *SE = σ / √n*, where σ is the standard deviation and n is the sample size.\n</step2>\n<step3>\nHere, σ = 1 g% and n = 100. So, we need to find the square root of 100, which is 10.\n</step3>\n<step4>\nNow, we divide the standard deviation by the square root of the sample size: *SE = 1 g% / 10 = 0.1 g%*.\n</step4>\n<step5>\nThis means the standard error of the hemoglobin level for this sample of women is 0.1 g%.\n</step5></thinking>", "answer": "<answer>Àṣiṣe boṣewa ti iwọntunwọnsi hemoglobin fun àpẹẹrẹ yii ni 0.1 g%.</answer>", "language": "Yoruba"}
{"question": "Kini ipin iwọntunwọnsi owo sisan ọjọ̀ kan ṣe san bi owo sisan owo gbangba ni igba diẹ labẹ anfani aisan ti Òfin ESI?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ipin iwọntunwọnsi owo sisan ọjọ̀ kan ṣe san bi owo sisan owo gbangba ni igba diẹ labẹ anfani aisan ti Òfin ESI?” — meaning it wants to know how the daily benefit amount is calculated under the ESI Act for sickness benefits.\n</step1>\n<step2>\nUnder the ESI Act, *anfani aisan* refers to the sickness benefit provided to insured individuals. The calculation is based on the average daily wages.\n</step2>\n<step3>\nTypically, the daily benefit is a percentage of the average daily wage — *ipin owo sisan* le jẹ 50% ti owo oya ojoojumọ.\n</step3>\n<step4>\nThis benefit is payable for a specific duration, usually up to 91 days for a single spell of sickness — *fun igba to to ọjọ 91*.\n</step4>\n<step5>\nTo determine the exact amount, one must first calculate the average wage over a defined period, often the last 3 months — *awọn oṣu mẹta to kọja*.\n</step6>\n<step6>\nThus, the daily benefit amount is crucial for supporting individuals during their period of illness under the ESI framework.\n</step6></thinking>", "answer": "<answer>Ipin iwọntunwọnsi owo sisan ọjọ̀ kan jẹ 50% ti owo oya ojoojumọ, ti a san fun igba to to ọjọ 91 labẹ Òfin ESI.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 55 kan ni irora lẹhin igbaya rẹ̀ tí kò ní ṣiṣẹ́pọ̀ pẹ̀lú iṣẹ́ ṣiṣe ara, ó sì burú sí i lẹ́yìn tí ó bá dùbúlẹ̀, àti pé awọn oògùn antacid ṣe iranlọwọ́ díẹ̀.  Tí a bá gbé àwọn àmì ìṣẹ̀lẹ̀ wọnyi yẹ̀ wò, kini àìsàn tí ó ṣeé ṣe jùlọ?", "reasoning": "<thinking><step1>\nThe question is asking about a 55-year-old man who experiences pain after eating, which worsens after he lies down, and finds some relief with antacids. This suggests a possible condition related to digestion — *àìsàn ti o ni ibatan si jijẹ*.\n</step1>\n<step2>\nThe symptoms described, particularly the pain after eating and the worsening when lying down, indicate potential issues with the esophagus or stomach — *esophagus* and *ìkànsí*.\n</step2>\n<step3>\nThe fact that antacids provide some relief suggests that the pain may be due to excess stomach acid — *acidité gastrique* — or gastroesophageal reflux disease (GERD).\n</step3>\n<step4>\nIn GERD, stomach acid flows back into the esophagus, causing pain and discomfort, especially when lying down — *nítorí náà, irora le pọ si*.\n</step4>\n<step5>\nConsidering the age of the patient and the symptoms, it is also important to rule out other conditions like peptic ulcers — *ìkànsí àtọ́ka* — but the antacid relief strongly points towards GERD.\n</step5>\n<step6>\nThus, the most likely diagnosis for this patient, given the symptoms and their nature, is gastroesophageal reflux disease.\n</step6></thinking>", "answer": "<answer>Àìsàn tí ó ṣeé ṣe jùlọ ni àìlera àtọ́ka àtọ́ka (GERD).</answer>", "language": "Yoruba"}
{"question": "Ègbògi wo ni ó lè tọju iye rẹ̀ ninu ẹ̀jẹ̀ fún wakati 24 lẹ́yìn ìgbà kan ṣoṣo tí a fi gbà, ṣùgbọ́n àwọn ipa rẹ̀ tí ó ń dá arun ọkàn balẹ̀ kò ju wakati 10 lọ?", "reasoning": "<thinking><step1>\nThe question asks: “Ègbògi wo ni ó lè tọju iye rẹ̀ ninu ẹ̀jẹ̀ fún wakati 24 lẹ́yìn ìgbà kan ṣoṣo tí a fi gbà, ṣùgbọ́n àwọn ipa rẹ̀ tí ó ń dá arun ọkàn balẹ̀ kò ju wakati 10 lọ?” — meaning it wants to know which medication can maintain its level in the blood for 24 hours after a single dose, but its effects on heart disease last no more than 10 hours.\n</step1>\n<step2>\nTo answer this, we need to consider medications that have a long half-life — *àkókò ìdáhùn* — allowing them to remain effective in the bloodstream for an extended period.\n</step2>\n<step3>\nCommon examples include certain antihypertensives or anticoagulants, but we must focus on those specifically for heart conditions — *àwọn egboogi fun arun ọkàn*.\n</step3>\n<step4>\nOne such medication is *metoprolol*, which can control heart rate and blood pressure, but its effects may not last beyond 10 hours.\n</step4>\n<step5>\nHowever, *amlodipine* is another option that can maintain its level in the blood for 24 hours, making it suitable for long-term management.\n</step5>\n<step6>\nThus, we are looking for a medication that balances these properties: long-lasting in the bloodstream but with limited acute effects on heart disease.\n</step6>\n<step7>\nIn conclusion, *amlodipine* fits this description well, as it can be taken once daily while managing blood pressure effectively.\n</step7></thinking>", "answer": "<answer>Amlodipine ni egboogi ti ó lè tọju iye rẹ̀ ninu ẹ̀jẹ̀ fún wakati 24, ṣùgbọ́n ipa rẹ̀ lori arun ọkàn kò ju wakati 10 lọ.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun 62 kan ṣe àkíyèsí pẹ̀lú ìwọ̀n ìrísí ọpọlọ ti ó ń burú sí i, ìgbàgbé, àti ìgbàgbé èrò, àti àlàyé omi ara inu ọpọlọ ti ó fi hàn pé ọ̀pọ̀ protein 14-3-3.  O kú lẹ́yìn oṣù mẹrin.  Nígbà ṣíṣayẹ̀wò ara lẹ́yìn ikú rẹ̀, ṣe àwọn àyípadà arun wo ni ó ṣeé ṣe julọ láti rí ní ọpọlọ rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks about a 62-year-old woman who experienced worsening cognitive function, memory loss, and elevated levels of 14-3-3 protein in her cerebrospinal fluid before passing away after four months. It seeks to identify the most likely pathological changes in her brain.\n</step1>\n<step2>\nThe presence of 14-3-3 protein is often associated with neurodegenerative diseases — *àwọn arun ti ń fa ìparun ọpọlọ*. This protein can indicate conditions like Creutzfeldt-Jakob disease or other forms of prion diseases.\n</step2>\n<step3>\nGiven her symptoms of cognitive decline and memory issues, one might consider *àkúnya* (atrophy) of the brain, particularly in areas like the cortex and hippocampus, which are crucial for memory and cognition.\n</step3>\n<step4>\nAdditionally, the rapid progression of her symptoms suggests a possible *ìfarapa* (lesion) or degeneration that could be linked to a prion disease, which typically leads to spongiform changes in the brain tissue.\n</step5>\n<step5>\nIn summary, the most likely pathological changes would include *ìparun* (atrophy) of the cerebral cortex and hippocampus, along with spongiform degeneration, consistent with a prion disease.\n</step6></thinking>", "answer": "<answer>Àwọn àyípadà arun ti ó ṣeé ṣe julọ ni ìparun ọpọlọ, pàápàá jùlọ ni cortex àti hippocampus, àti ìfarapa spongiform.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìpínrọ̀ tó wà nínú àwọn ìpínrọ̀ tó tẹ̀lé e yìí ṣàpèjúwe ṣeto ohun méje tí a gbé ka nípasẹ̀ ìtòlẹ́sẹ̀ kan. Àwọn ọ̀rọ̀ náà bá ara wọn mu nínú ìpínrọ̀ kọ̀ọ̀kan. Nínú àfihàn ọkọ̀ ayọkẹ́lẹ́ àtijọ́ kan, ọkọ̀ ayọkẹ́lẹ́ méje wà: ọkọ̀ ayọkẹ́lẹ́ ṣíṣe ẹgbẹ́, ọkọ̀ ayọkẹ́lẹ́ ńlá, ọkọ̀ nínú, ọkọ̀ ayọkẹ́lẹ́ kékeré, bàsìkì, ọkọ̀ ayọkẹ́lẹ́ kékeré, àti ọkọ̀ ìrìnàjò. Bàsìkì náà ju ọkọ̀ nínú lọ́jọ́ oríṣìíríṣìí. Ọkọ̀ ayọkẹ́lẹ́ ṣíṣe ẹgbẹ́ náà ju ọkọ̀ ayọkẹ́lẹ́ kékeré lọ́jọ́ oríṣìíríṣìí. Bàsìkì náà jẹ́ tuntun ju ọkọ̀ ayọkẹ́lẹ́ kékeré lọ. Ọkọ̀ ìrìnàjò náà ni èkejì tó ti pẹ́ jùlọ. Ọkọ̀ ayọkẹ́lẹ́ kékeré ni ó ti pẹ́ jùlọ. Ọkọ̀ ayọkẹ́lẹ́ ńlá náà ju ọkọ̀ ayọkẹ́lẹ́ ṣíṣe ẹgbẹ́ lọ́jọ́ oríṣìíríṣìí.\nÀwọn àṣàyàn:\n(A) Ọkọ̀ ayọkẹ́lẹ́ ṣíṣe ẹgbẹ́ ni ó ti pẹ́ jùlọ\n(B) Ọkọ̀ ayọkẹ́lẹ́ ńlá ni ó ti pẹ́ jùlọ\n(C) Ọkọ̀ nínú ni ó ti pẹ́ jùlọ\n(D) Ọkọ̀ ayọkẹ́lẹ́ kékeré ni ó ti pẹ́ jùlọ\n(E) Bàsìkì ni ó ti pẹ́ jùlọ\n(F) Ọkọ̀ ayọkẹ́lẹ́ kékeré ni ó ti pẹ́ jùlọ\n(G) Ọkọ̀ ìrìnàjò ni ó ti pẹ́ jùlọ", "reasoning": "<thinking><step1>\nThe question asks: \"Àwọn ìpínrọ̀ tó wà nínú àwọn ìpínrọ̀ tó tẹ̀lé e yìí ṣàpèjúwe ṣeto ohun méje...\" — it is inquiring about the characteristics and age of seven types of vehicles mentioned.\n</step1>\n<step2>\nThe vehicles include: *ọkọ̀ ayọkẹ́lẹ́ ṣíṣe ẹgbẹ́* (sports car), *ọkọ̀ ayọkẹ́lẹ́ ńlá* (large vehicle), *ọkọ̀ nínú* (sedan), *ọkọ̀ ayọkẹ́lẹ́ kékeré* (small car), *bàsìkì* (bicycle), *ọkọ̀ ayọkẹ́lẹ́ kékeré* (small car again), and *ọkọ̀ ìrìnàjò* (bus).\n</step2>\n<step3>\nFrom the information, the *bàsìkì* is newer than the *ọkọ̀ ayọkẹ́lẹ́ kékeré*, and the *ọkọ̀ ayọkẹ́lẹ́ ṣíṣe ẹgbẹ́* is older than the *ọkọ̀ ayọkẹ́lẹ́ kékeré*.\n</step3>\n<step4>\nThe *ọkọ̀ ìrìnàjò* is the oldest vehicle, while the *ọkọ̀ ayọkẹ́lẹ́ kékeré* has been around the longest.\n</step4>\n<step5>\nAdditionally, the *ọkọ̀ ayọkẹ́lẹ́ ńlá* is older than the *ọkọ̀ ayọkẹ́lẹ́ ṣíṣe ẹgbẹ́*.\n</step5>\n<step6>\nConsidering all these comparisons, we need to determine which vehicle is the oldest based on the given relationships.\n</step6>\n<step7>\nSince the *ọkọ̀ ìrìnàjò* is stated to be the oldest, it is the correct answer.\n</step7></thinking>", "answer": "<answer>Ọkọ̀ ìrìnàjò ni ó ti pẹ́ jùlọ.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 52 kan ti o ni arun ọkan ischemic cardiomyopathy ti lọ si dokita ọkan rẹ̀ nítorí ìrora ìgbàgbé tí ó burú sí i nígbà tí ó bá ń ṣiṣẹ́. Ó sẹ́ gẹ́gẹ́ bí ìṣẹ̀lẹ̀ ìgbàgbé ọmu tìtorí ìgbà àìpẹ́ yìí, tí ó sì ti ń gbàáwẹ̀rẹ̀ awọn oogun rẹ̀, èyí tí ó ní metoprolol, lisinopril, spironolactone, ati furosemide. Àwọn àmì àrùn aláìsàn náà gẹ́gẹ́ bí atẹle: Ìgbóná jẹ́ 98.7 deg F (37.1 deg C), titẹ ẹjẹ jẹ́ 163/78 mmHg, ìṣàn jẹ́ 92/min, ìmímú jẹ́ 14/min, ati itẹriba oxygen jẹ́ 98% lórí afẹ́fẹ́ yàrá. Ẹ̀rọ echocardiogram tuntun fi hàn pé LVEF ti ṣe deede ti 25-35%. Dokita pinnu lati bẹrẹ hydralazine ati isosorbide dinitrate. Ewo ni o tọ́ ninu awọn atẹle nipa apapọ oogun yii?\nA. Ni awọn ohun-ini anti-iredodo lati dinku ewu ti thrombosis artery coronary\nB. Npo iwọn didun ẹjẹ ti o wọ inu ọkan lati mu iṣẹ ṣiṣe ventricular dara si\nC. Nmu awọn ami aisan dara si ṣugbọn ko ni anfani iku gbogbogbo ninu awọn alaisan ti o ni ikuna ọkan\nD. Ndinku iwọn didun ati iṣẹ ti a gbe sori ventricle osi\nE. Ni awọn ipa rere lori atunṣe ọkan", "reasoning": "<thinking><step1>\nThe question is asking about the effects of a combination of medications prescribed for a 52-year-old man with ischemic cardiomyopathy — *arun ọkan ischemic* — who experiences worsening chest pain during exertion.\n</step1>\n<step2>\nThe patient is on medications like metoprolol, lisinopril, spironolactone, and furosemide, which are commonly used for heart failure management — *itọju ikuna ọkan*.\n</step2>\n<step3>\nThe new echocardiogram shows a left ventricular ejection fraction (LVEF) of 25-35%, indicating significant heart dysfunction — *iṣẹ́ ọkan ti ko dara*.\n</step4>\n<step4>\nThe doctor plans to add hydralazine and isosorbide dinitrate, which are vasodilators — *awọn vasodilators* — that help reduce the workload on the heart.\n</step4>\n<step5>\nAmong the options, we need to identify which statement accurately describes the effects of this medication combination.\n</step5>\n<step6>\nOption B states that it increases blood volume entering the heart to improve ventricular function, which is incorrect since these medications actually decrease preload — *dinku preload*.\n</step6>\n<step7>\nOption D, which mentions reducing volume and workload on the left ventricle, aligns with the action of hydralazine and isosorbide dinitrate, making it the most accurate choice.\n</step7></thinking>", "answer": "<answer>D. Ndinku iwọn didun ati iṣẹ ti a gbe sori ventricle osi.</answer>", "language": "Yoruba"}
{"question": "Da ilana idiwọ àrùn kànṣẹ̀ fún obìnrin ọmọ ọdún 61 kan tí kò tíì lọ sí ọ̀dọ̀ oníṣègùn fún ọdún 20, tí ó sì mu ọtí oyinbo lọ́nà tó dára, tí iṣẹ́ rẹ̀ sì le koko, tí ó sì ní ìwọ̀ ara tó dára, àwọn koko àkànṣe wo ni a gbọdọ̀ fi kọ́ ènìyàn náà láti borí ewu àrùn kànṣẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What preventive measures should be taken for a 61-year-old woman who hasn't seen a doctor in 20 years, consumes alcohol moderately, has a good job, and is in good health to avoid the risk of [àrùn kànṣẹ̀ = cancer]?” \n</step1>\n<step2>\nFirst, it's important to understand that regular medical check-ups are crucial — *ìwádìí ilera àkókò* can help detect any potential issues early.\n</step2>\n<step3>\nFor someone who drinks alcohol, moderation is key; excessive consumption can increase cancer risk — *ìmú ọtí oyinbo ju* le fa ewu àrùn kànṣẹ̀.\n</step3>\n<step4>\nAdditionally, maintaining a balanced diet rich in fruits and vegetables — *ounje to ni ẹfọ́ àti eso* — can provide essential nutrients that help in cancer prevention.\n</step4>\n<step5>\nPhysical activity is also vital; regular exercise — *iṣẹ́-ara* — can lower the risk of various cancers and improve overall health.\n</step5>\n<step6>\nLastly, avoiding tobacco in any form is critical, as it is a major risk factor for many types of cancer — *ìfọwọ́si tabac* le mu ewu àrùn kànṣẹ̀ pọ si.\n</step6>\n<step7>\nIn summary, the key preventive measures include regular health check-ups, moderation in alcohol consumption, a healthy diet, regular exercise, and avoiding tobacco.\n</step7></thinking>", "answer": "<answer>Àwọn koko àkànṣe ni: ìwádìí ilera àkókò, ìmú ọtí oyinbo ni ìwọn, ounje to ni ẹfọ́ àti eso, iṣẹ́-ara, àti yago fun tabac.</answer>", "language": "Yoruba"}
{"question": "Lóòótọ́ ìwọ̀n òtútù tí a óò nílò láti ṣe àpótí tini tí ó ti sùn mọ́, tó ní àdánù 8 cm, gíga 12 cm, àti ìwọ̀n òtútù tini 0.04 cm.", "reasoning": "<thinking><step1>\nThe question asks: “Lóòótọ́ ìwọ̀n òtútù tí a óò nílò láti ṣe àpótí tini tí ó ti sùn mọ́” — meaning it wants to know the temperature needed to create a box with specific dimensions.\n</step1>\n<step2>\nThe dimensions given are: *àdánù* (length) of 8 cm, *gíga* (height) of 12 cm, and *ìwọ̀n òtútù* (thickness) of 0.04 cm.\n</step2>\n<step3>\nTo find the temperature, we need to consider the material properties — for example, if it’s a metal or plastic, the melting point will vary.\n</step3>\n<step4>\nAssuming we are working with a common material like plastic, we typically need a temperature above its melting point, which is usually around 100°C for many plastics.\n</step4>\n<step5>\nHowever, the specific temperature can also depend on the method of shaping the box — whether it’s molding or extrusion.\n</step5>\n<step6>\nIn conclusion, for a box with these dimensions, we would generally require a temperature of at least 100°C to ensure proper shaping and integrity.\n</step6></thinking>", "answer": "<answer>Ìwọ̀n òtútù tí a óò nílò láti ṣe àpótí tini yìí ni 100°C.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun 8.5 kan ti o sọnu irunu 11 wá si ile-iwosan rẹ. 21 ya ni ọdun 6.5. Ọmọ naa ni ipalara si 21, oṣu 4 sẹhin o si ni itọju endodontic fun eyi. Kini itọju rẹ si awọn eyin ti o sọnu?\nA. Mu aworan X-ray ki o yọ eyin afikun kuro\nB. Ṣe eto RPD\nC. Ṣe imọran FPD\nD. Ṣe itọju orthodontic, ṣe aaye ki o ṣe eto FPD", "reasoning": "<thinking><step1>\nThe question asks: “What is the treatment for the lost teeth of an 8.5-year-old child who had an endodontic treatment for a tooth injury 4 months ago?” — here, *irunu* means [tooth] and *eyin* means [teeth].\n</step1>\n<step2>\nIn pediatric dentistry, when a child loses teeth, especially after trauma, it’s crucial to assess the situation — *a ṣe ayẹwo ipo naa* to determine the best course of action.\n</step2>\n<step3>\nConsidering the child is still young, options like *RPD* (Removable Partial Denture) may not be ideal due to growth — *a ko le lo RPD nitori idagbasoke*.\n</step4>\n<step4>\nAn *FPD* (Fixed Partial Denture) could be a solution, but it requires healthy adjacent teeth — *eyin to wa ni ayika* to support it.\n</step5>\n<step5>\nOrthodontic treatment might be necessary to create space for an FPD, especially if the child’s teeth are still developing — *itọju orthodontic le jẹ dandan*.\n</step6>\n<step6>\nThus, the most comprehensive approach would be to do orthodontic treatment first, then plan for an FPD — *ṣe itọju orthodontic, ṣe aaye ki o ṣe eto FPD*.\n</step7></thinking>", "answer": "<answer>D. Ṣe itọju orthodontic, ṣe aaye ki o ṣe eto FPD.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 62 kan ti ó ti ní ìṣòro gbọ́ fún ọdún mẹta ṣe àwọn idanwo gbọ́ràn meji.  Nínú idanwo àkọ́kọ́, a gbá fúnki tí a fi ṣe ìdánwò sí egungun mastoid rẹ̀, lẹ́yìn náà sí etí rẹ̀, ó sì sọ pé ó gbọ́ ohùn náà dáadáa sí etí rẹ̀ ní ẹgbẹ́ méjèèjì. Nínú idanwo kejì, nígbà tí a gbá fúnki tí a fi ṣe ìdánwò sí iwájú orí rẹ̀, ó sọ pé ó gbọ́ ohùn náà dáadáa ní ẹgbẹ́ ọ̀tún.  Kí ni ìwádìí tí ó bá àwọn abajade idanwo gbọ́ràn wọnyi mu pọ̀ jùlọ?", "reasoning": "<thinking><step1>\nThe question asks about the findings from hearing tests conducted on a 62-year-old woman who has had hearing problems for three years. It mentions two tests: one involving the mastoid bone and the other the front of the head.\n</step1>\n<step2>\nIn the first test, the patient reported hearing sounds well in both ears — *ó gbọ́ ohùn náà dáadáa sí etí rẹ̀ ní ẹgbẹ́ méjèèjì*. This suggests that the issue may not be with the outer or middle ear.\n</step2>\n<step3>\nThe second test indicated that she heard sounds better in the right ear — *ó sọ pé ó gbọ́ ohùn náà dáadáa ní ẹgbẹ́ ọ̀tún*. This could imply a possible conductive hearing loss on the left side.\n</step3>\n<step4>\nGiven these results, the most likely diagnosis could be *ìṣòro gbọ́ràn ti a fi n pe ni conductive hearing loss* on the left side, as the right ear shows better hearing.\n</step4>\n<step5>\nThe tests suggest that the problem may be related to the structures of the ear, particularly affecting the left side — *iwájú etí* or *egungun mastoid*.\n</step5>\n<step6>\nTherefore, the findings from these hearing tests indicate a potential conductive hearing loss, particularly affecting the left ear.\n</step6></thinking>", "answer": "<answer>Ìwádìí náà fi hàn pé ó ṣee ṣe pé ìṣòro gbọ́ràn ti a fi n pe ni conductive hearing loss ni etí osi.</answer>", "language": "Yoruba"}
{"question": "Àpẹẹrẹ ọmọ alaisan ọdun 70 kan tí ó ti ní àrùn àtọ́rùn-ọ̀sìn ìru 2 fún ìgbà pípẹ̀ dé pẹ̀lú irora ní etí òsì ati ìtànṣán pùrúlẹ̀ntì.  Ní àyẹ̀wò, àpẹẹrẹ náà kò ní ibà, etí òsì rẹ̀ ni ìrora, ati ọ̀nà etí ìta rẹ̀ gbòòrò sí i ati kí ìgbóná, pẹ̀lú iye ẹ̀jẹ̀ funfun tí ó wọ́pọ̀.  Àwọn ìṣẹ̀dá èyíkéyìí ni ó ṣeé ṣe jùlọ láti máa dá ara rẹ̀ lórí fún àrùn náà nínú ọ̀ràn yìí?", "reasoning": "<thinking><step1>\nThe question is asking: “What are the most likely conditions for a 70-year-old patient with type 2 diabetes experiencing pain in the left ear and persistent drainage?” — it highlights symptoms like *irora* (pain) and *ìtànṣán pùrúlẹ̀ntì* (persistent drainage).\n</step1>\n<step2>\nIn this case, the patient has a history of *àrùn àtọ́rùn-ọ̀sìn* (type 2 diabetes), which can complicate infections and healing processes.\n</step2>\n<step3>\nThe symptoms suggest possible *ìfarapa* (infection) in the ear, possibly *otitis media* or *otitis externa*, especially since there is drainage.\n</step3>\n<step4>\nAdditionally, the patient’s age and diabetes increase the risk of complications, making *ìbà* (fever) less likely but still possible.\n</step4>\n<step5>\nThe drainage could indicate a bacterial infection, which might require antibiotics — *antibiotiques* — for treatment.\n</step5>\n<step6>\nGiven these factors, the most likely conditions include *ìfarapa etí* (ear infection) or complications related to diabetes affecting the ear.\n</step6></thinking>", "answer": "<answer>Ìfarapa etí ni àpẹẹrẹ ọmọ alaisan yìí lè ní, pẹ̀lú àkúnya àtọ́rùn-ọ̀sìn tó le fa ìṣòro.</answer>", "language": "Yoruba"}
{"question": "Ọjọ kan lẹhin ti a ti ṣe abẹrẹ carotid endarterectomy osi fun ọkunrin ọdun 63 kan, ori rẹ ti ń bà ṣe kedere. Ó ṣàpèjúwe rẹ̀ gẹ́gẹ́ bí 9 nínú 10 ní agbára. Ó ní ìrírí ìgbóná. Ó ní 80% stenosis ni àtẹ̀gùn carotid osi, ó sì gba heparin ṣáájú abẹrẹ náà. Òun ní itan-àkọọlẹ ti awọn ikọlu ischemic ti ko gun, meji ati oṣu mẹrin sẹyin. Ó ní àtẹ̀gùn gíga, àrùn suga iru 2, ati hypercholesterolemia. Ó ti mu siga pakẹ̀ẹ̀ kan lójoojú fún ọdún 40. Ó mu 1–2 biari ní ọ̀sẹ̀. Àwọn oogun lọ́wọ́lọ́wọ́ pẹlu lisinopril, metformin, sitagliptin, ati aspirin.  Igbona rẹ̀ jẹ́ 37.3°C (99.1°F), ìṣísẹ̀ rẹ̀ jẹ́ 111/min, ati àtẹ̀gùn ẹ̀jẹ̀ rẹ̀ jẹ́ 180/110 mm Hg. Ó dàbí ẹni tí ó rú, tí ó sì mọ̀ ara rẹ̀ nìkan.  Àyẹ̀wò fi hàn pé àwọn ọmọ-aláìdáà fi hàn pé àwọn ọmọ-aláìdáà fi hàn pé àwọn akọ́kọ́ ṣe àyípadà ní ṣọwọ́n sí ìmọ́lẹ̀. Àgbàlà ojú ọtun wà níbẹ̀. Agbára èso jẹ́ dinni ní apá ọtun oke ati isalẹ. Awọn reflexes tendon jinlẹ jẹ 3+ ni apa ọtun.  Àgbàlà abẹrẹ ọrùn òsì wà tí kò fi hàn kedere tabi tu silẹ. Àyẹ̀wò ọkàn kò fi hàn kedere. Iye ẹjẹ gbogbo ati iye serum ti creatinine, electrolytes, ati glucose wa laarin ibiti o yẹ.  A ṣe ayẹwo CT ti ori.  Ewo ni ọkan ninu awọn wọnyi ti o jẹ okunfa ti o lagbara julọ fun ipo alaisan yii?\nA. Iye ti carotid stenosis\nB. Itọju Aspirin\nC. Heparin perioperative\nD. Àtẹ̀gùn gíga\nE. Sisigẹ", "reasoning": "<thinking><step1>\nThe question asks: \"Ewo ni ọkan ninu awọn wọnyi ti o jẹ okunfa ti o lagbara julọ fun ipo alaisan yii?\" — meaning it wants to identify the strongest contributing factor to the patient's condition after carotid endarterectomy.\n</step1>\n<step2>\nThe patient is a 63-year-old man who has undergone a carotid endarterectomy and is experiencing significant headache pain rated 9 out of 10 — *ìrírí ìgbóná*.\n</step2>\n<step3>\nHe has a history of 80% carotid stenosis and has experienced ischemic attacks previously, which indicates a high risk for further complications — *ìtàn-àkọọlẹ ti awọn ikọlu ischemic*.\n</step3>\n<step4>\nHis current medications include aspirin, which is used for stroke prevention, but the presence of high blood pressure — *àtẹ̀gùn gíga* — could exacerbate his condition.\n</step4>\n<step5>\nConsidering the factors, the carotid stenosis level is critical because it directly relates to the risk of ischemic events and the patient's current symptoms.\n</step5>\n<step6>\nWhile aspirin and heparin are important for management, the underlying stenosis is a more significant risk factor for the patient's current state.\n</step6></thinking>", "answer": "<answer>Iye ti carotid stenosis.</answer>", "language": "Yoruba"}
{"question": "Kini àyèwò fún ọmọbìnrin ọdún márùn-ún kan tí ó ní àtìgbàgbà ẹ̀jẹ̀ gíga, virilization, àti hypokalemia?", "reasoning": "<thinking><step1>\nThe question asks: “Kini àyèwò fún [omobìnrin = girl] [ọdún = years] [márùn-ún = five] kan tí ó ní [àtìgbàgbà ẹ̀jẹ̀ gíga = high blood pressure], [virilization], àti [hypokalemia]?” — meaning it wants to know what tests are appropriate for a five-year-old girl with high blood pressure, virilization, and hypokalemia.\n</step1>\n<step2>\nIn this case, the symptoms suggest a possible endocrine disorder — *àìlera endocrine* — that could be causing these issues.\n</step2>\n<step3>\nFirst, a comprehensive hormonal evaluation is necessary, including tests for adrenal hormones — *hormones adrenal* — such as cortisol and aldosterone.\n</step3>\n<step4>\nAdditionally, measuring serum electrolytes is crucial to assess the hypokalemia — *hypokaliémie* — and understand its cause.\n</step4>\n<step5>\nA renal ultrasound might also be indicated to check for any anatomical abnormalities — *àìlera anatomi* — that could contribute to hypertension.\n</step5>\n<step6>\nFinally, a review of the patient's history and physical examination will help in determining if there are any signs of *tumọ̀ endocrine* disorders, such as tumors.\n</step6></thinking>", "answer": "<answer>Àyèwò tó yẹ ni ìdánwò hormonal, ìdánwò electrolytes, àti àyẹ̀wò ultrasound ti kidinrin.</answer>", "language": "Yoruba"}
{"question": "Àsọyẹ̀yẹ́ 1| Àwọn ẹ̀rọ́ àtìlẹ̀yìn-àbò, bíi àwọn àṣàrò ìṣàkóso ìṣe-àgbékalẹ̀, fún ìpín àṣepọ̀ ìṣeeṣe lórí àwọn àmì kan tí a fún ní àpẹẹrẹ ìwọ̀n. Àsọyẹ̀yẹ́ 2| A óò retí pé àwọn àtìlẹ̀yìn-àbò yóò wà ní ọ̀nà kan náà ní gbogbo rẹ̀ bí a ti ń lọ láti ìṣe-àgbékalẹ̀ ṣíṣe-látòkànwá sí àwọn ìṣe-àgbékalẹ̀ apólónìṣiṣẹ́ gíga.\nA. Òtítọ́, Ẹ̀ké\nB. Ẹ̀ké, Kò bá a mu\nC. Kò bá a mu, Ẹ̀ké\nD. Ẹ̀ké, Ẹ̀ké\nE. Òtítọ́, Òtítọ́\nF. Ẹ̀ké, Òtítọ́\nG. Kò bá a mu, Kò bá a mu\nH. Kò bá a mu, Òtítọ́\nI. Ẹ̀ké, Kò sọ\nJ. Òtítọ́, Kò bá a mu", "reasoning": "<thinking><step1>\nThe question is asking about the reliability of certain support systems, specifically in the context of governance and operational frameworks — *àwọn ẹ̀rọ́ àtìlẹ̀yìn-àbò* and *ìṣe-àgbékalẹ̀*.\n</step1>\n<step2>\nIt suggests that we expect these support systems to function consistently as we transition from traditional governance to high-performance operational frameworks — *ìṣe-àgbékalẹ̀ apólónìṣiṣẹ́ gíga*.\n</step2>\n<step3>\nTo evaluate this, we need to consider whether the systems will maintain their effectiveness — *àṣepọ̀ ìṣeeṣe* — across different scenarios.\n</step3>\n<step4>\nThe options provided include various combinations of truthfulness and reliability, such as *Òtítọ́* (true) and *Ẹ̀ké* (false).\n</step4>\n<step5>\nIf we assume that the support systems will indeed function reliably, the correct choice would be *Òtítọ́, Òtítọ́*.\n</step5>\n<step6>\nHowever, if we believe there might be inconsistencies, we would choose *Ẹ̀ké, Kò bá a mu* (false, not applicable).\n</step6>\n<step7>\nGiven the context of transitioning to high-performance frameworks, it seems reasonable to conclude that the systems should be reliable.\n</step7>\n<step8>\nThus, the most logical answer is that both statements about the support systems are true.\n</step8></thinking>", "answer": "<answer>Òtítọ́, Òtítọ́</answer>", "language": "Yoruba"}
{"question": "Kini aisan ti o ṣeeṣe julọ fun ọmọkunrin ọdun mẹjọ kan ti o ni iba, irora awọn eegun ọrùn mejeeji, itan ti irora ọfun, kò sí hepatomegaly, ati iṣẹ́ ẹ̀jẹ̀ iwaju ti o fihan diẹ sii ju 20% ti sẹẹli lympho-plasmacytoid?", "reasoning": "<thinking><step1>\nThe question asks: “Kini aisan ti o ṣeeṣe julọ fun ọmọkunrin ọdun mẹjọ kan ti o ni iba [fever], irora awọn eegun [throat pain] mejeeji, itan ti irora ọfun [history of sore throat], kò sí hepatomegaly [no hepatomegaly], ati iṣẹ́ ẹ̀jẹ̀ iwaju ti o fihan diẹ sii ju 20% ti sẹẹli lympho-plasmacytoid [more than 20% lympho-plasmacytoid cells]?” — meaning it seeks to identify the most likely disease for this 8-year-old boy with these symptoms.\n</step1>\n<step2>\nThe symptoms include fever and throat pain, which are common in infections — *awọn aisan ti o wọpọ ni awọn ikolu*. \n</step2>\n<step3>\nThe presence of lympho-plasmacytoid cells in the blood suggests a possible viral infection — *ikolu viral* could be a strong contender.\n</step3>\n<step4>\nGiven the age of the child and the symptoms, one might consider infectious mononucleosis — *mononucleosis* — often caused by the Epstein-Barr virus.\n</step4>\n<step5>\nThe absence of hepatomegaly is notable, as it can sometimes be present in other conditions, but not always in mononucleosis.\n</step5>\n<step6>\nThus, the combination of fever, throat pain, and the specific blood findings points towards this diagnosis.\n</step6></thinking>", "answer": "<answer>Aisan ti o ṣeeṣe julọ ni mononucleosis.</answer>", "language": "Yoruba"}
{"question": "Ṣé gbólóhùn ọ̀rọ̀ tó tẹ̀ lé e yìí ṣeé gbà gbọ́ bí? \"Francisco Lindor rìn lórí bọ́ọ̀lù kẹrin.\"", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé gbólóhùn ọ̀rọ̀ tó tẹ̀ lé e yìí ṣeé gbà gbọ́ bí?” — meaning it wants to know if the statement \"Francisco Lindor rìn lórí bọ́ọ̀lù kẹrin\" is believable or makes sense.\n</step1>\n<step2>\nThe statement translates to \"Francisco Lindor walks on a four-ball\" — *rìn lórí bọ́ọ̀lù kẹrin* suggests an unusual scenario.\n</step2>\n<step3>\nIn baseball, a four-ball typically refers to a situation where a batter receives four balls and walks to first base — *batteri n gba bọ́ọ̀lù mẹ́rin*.\n</step3>\n<step4>\nHowever, the phrase \"walks on a four-ball\" is not a literal action; it’s more about the result of a play — *iyẹn ni, o n lọ si ibè nitori bọ́ọ̀lù mẹ́rin*.\n</step4>\n<step5>\nThus, while the statement can be interpreted in a baseball context, it doesn't imply that he literally walks on a ball; rather, it reflects a game situation.\n</step5>\n<step6>\nSo, the statement is somewhat metaphorical and can be understood within the context of baseball rules.\n</step6></thinking>", "answer": "<answer>Bẹẹni, gbolohun naa le jẹ́ otitọ ni àkóónú bọọlu, ṣugbọn kò túmọ̀ sí pé ó rìn lórí bọ́ọ̀lù gangan.</answer>", "language": "Yoruba"}
{"question": "Ìbéèrè: Jerry jẹ́ òpà. Gwenn wí pé Jerry jẹ́ òpà. Fidel wí pé Gwenn jẹ́ òpà. Millicent wí pé Fidel sọ́ òtítọ́. Lorine wí pé Millicent sọ́ òtítọ́. Ṣé Lorine sọ́ òtítọ́?", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé Lorine sọ́ òtítọ́?” — meaning it wants to know if Lorine is telling the truth.\n</step1>\n<step2>\nTo analyze this, we start with Jerry being a liar — *Jerry jẹ́ òpà*. Gwenn claims that Jerry is a liar, which means Gwenn could be telling the truth or lying.\n</step2>\n<step3>\nNext, Fidel states that Gwenn is a liar. If Fidel is telling the truth, then Gwenn is indeed a liar, which contradicts Gwenn's statement about Jerry.\n</step3>\n<step4>\nMillicent claims that Fidel is telling the truth. If Millicent is truthful, then Fidel's statement about Gwenn being a liar is valid.\n</step4>\n<step5>\nFinally, Lorine asserts that Millicent is telling the truth. If Lorine is truthful, then all previous statements align, confirming that Jerry is a liar, Gwenn is a liar, and Fidel is truthful.\n</step6>\n<step6>\nHowever, if any of these assumptions about truthfulness are incorrect, it creates a contradiction. Therefore, we need to determine if Lorine's claim holds under scrutiny.\n</step7>\n<step7>\nSince Millicent's truthfulness hinges on Fidel's claim, and if Fidel is indeed truthful, then Lorine must also be telling the truth.\n</step8>\n<step8>\nThus, based on the chain of statements, we conclude that Lorine is indeed telling the truth.\n</step8></thinking>", "answer": "<answer>Bẹẹni, Lorine sọ́ òtítọ́.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 24 kan, ti a ti ṣe ayẹwo fun aisan schizophrenia ati pe o n mu aripiprazole, paroxetine, ati trazodone lọwọlọwọ, fi ilọsiwaju ti o ṣe akiyesi han ninu awọn ariwo ati awọn iro, ṣugbọn o di ariwo ati alafia sii, pẹlu awọn ami aisan ti ko le jókòó lọdu ati iṣipopada awọn ọwọ ati ẹsẹ nigbagbogbo.  Niwọn igba ti awọn ami aisan wọnyi ati iwadii oogun ti ko dara ninu ito, kini igbesẹ atẹle ti o yẹ julọ ninu iṣakoso rẹ?", "reasoning": "<thinking><step1>\nThe question is asking about the next best step in managing a 24-year-old man diagnosed with schizophrenia who is currently on aripiprazole, paroxetine, and trazodone. It notes improvements in auditory hallucinations but mentions increased agitation and restlessness — *iṣoro aifọkanbalẹ* and *iṣipopada* of hands and feet.\n</step1>\n<step2>\nGiven that he is experiencing these side effects, it is important to consider the possibility of akathisia, which is a common side effect of antipsychotics like aripiprazole — *iṣoro ti o ni ibatan si awọn oogun antipsychotic*.\n</step2>\n<step3>\nThe presence of restlessness and agitation suggests that his current medication regimen may need adjustment. One option could be to add a beta-blocker or benzodiazepine to help manage these symptoms — *lati dinku aifọkanbalẹ*.\n</step3>\n<step4>\nAdditionally, it might be beneficial to reassess the dosage of aripiprazole or consider switching to another antipsychotic that has a lower risk of causing akathisia — *iyipada si antipsychotic miiran*.\n</step5>\n<step5>\nMonitoring his renal function is also crucial due to the mention of poor medication adherence and potential side effects, especially since he has issues with *ito* — *urine*.\n</step6>\n<step6>\nIn summary, the next best step would be to address the akathisia by adjusting his medication, possibly adding a beta-blocker, and ensuring proper monitoring of his overall health.\n</step6></thinking>", "answer": "<answer>Igbesẹ ti o tẹle ti o yẹ julọ ni lati ṣe atunṣe iṣakoso oogun rẹ nipa fifi beta-blocker kun tabi iyipada si antipsychotic miiran, ati lati ṣe atẹle iṣẹ renal rẹ.</answer>", "language": "Yoruba"}
{"question": "Ṣe àwọn ọ̀rọ̀ wọ̀nyí ní ìtẹ̀lẹ̀wọ̀: Àkọ́kọ́: mckinley pesticide school radiometer marque prig relish trianon inspiration artful cancelled castrate glaucous ear croon tioga rothschild excite endpoint citadel", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe àwọn ọ̀rọ̀ wọ̀nyí ní ìtẹ̀lẹ̀wọ̀?” — meaning it wants to know if these words have any connections or relationships.\n</step1>\n<step2>\nTo analyze this, I will look for common themes or categories among the words: *mckinley*, *pesticide*, *school*, *radiometer*, *marque*, *prig*, *relish*, *trianon*, *inspiration*, *artful*, *cancelled*, *castrate*, *glaucous*, *ear*, *croon*, *tioga*, *rothschild*, *excite*, *endpoint*, and *citadel*.\n</step2>\n<step3>\nSome words like *pesticide* and *school* can relate to education and agriculture, while others like *radiometer* and *citadel* might connect to science and architecture.\n</step3>\n<step4>\nAdditionally, words such as *inspiration* and *artful* suggest a creative or artistic theme, indicating a possible overlap in the realm of art and expression.\n</step4>\n<step5>\nHowever, there are also unique terms like *rothschild* which refers to a prominent family, and *glaucous*, which describes a color, showing diversity in the meanings.\n</step5>\n<step6>\nIn conclusion, while some words share themes, others stand alone, indicating a mix of categories without a singular connection.\n</step6></thinking>", "answer": "<answer>Bẹ́ẹ̀ni, àwọn ọ̀rọ̀ wọ̀nyí ní ìtẹ̀lẹ̀wọ̀, ṣùgbọ́n wọn ní àkópọ̀ àtọkànwá.</answer>", "language": "Yoruba"}
{"question": "Níwọ̀n ìgbà tí gbèsè àwọn ohun ìní ní ìlú Smithville jẹ́ $52,384,600 gbogbo, tí wọ́n sì nílò láti gba owó orí tó jẹ́ $123,475 fún iṣẹ́ tuntun ní ìlú, $931,442.75 fún ẹ̀kọ́, àti $319,878 fún ìlera àti àbò, ka iye owó orí ìlú náà jáde ní àwọn ọ̀nà wọ̀nyí: (a) gẹ́gẹ́ bí ìpínnísẹ̀ ní ààyè mẹ́ta, (b) ní míìlì sí $1 ti gbèsè àwọn ohun ìní, (c) ní sẹ̀ǹtì sí $100 ti gbèsè àwọn ohun ìní, àti (d) ní míìlì sí $1,000 ti gbèsè àwọn ohun ìní.", "reasoning": "<thinking><step1>\nThe question is asking for the total amount of property tax in Smithville, which is $52,384,600, and how this amount can be allocated for various expenses: $123,475 for new projects, $931,442.75 for education, and $319,878 for health and safety.\n</step1>\n<step2>\nFirst, we need to calculate the total expenses: *$123,475 + $931,442.75 + $319,878* gives us a total of *$1,374,795.75*.\n</step2>\n<step3>\nNext, we will find the remaining amount after expenses: *$52,384,600 - $1,374,795.75* results in *$51,009,804.25*.\n</step3>\n<step4>\nNow, we will calculate the tax rates based on the remaining amount in different formats: (a) as a percentage, (b) in mills per $1 of property value, (c) in cents per $100 of property value, and (d) in mills per $1,000 of property value.\n</step4>\n<step5>\nFor (a), the tax rate as a percentage is calculated by dividing the remaining amount by the total property value: *($51,009,804.25 / $52,384,600) * 100* which gives approximately *97.4%*.\n</step5>\n<step6>\nFor (b), in mills per $1, we multiply the percentage by 10: *97.4% * 10 = 974 mills*.\n</step6>\n<step7>\nFor (c), in cents per $100, we take the percentage and multiply by 1: *97.4 cents*.\n</step7>\n<step8>\nFor (d), in mills per $1,000, we multiply the percentage by 1: *97.4 mills*.\n</step8></thinking>", "answer": "<answer>Iye owó orí ìlú náà jẹ́ 97.4%, 974 mills, 97.4 cents, àti 97.4 mills.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọlọ́gẹ́ mẹ́tadinlọ́gọ́rin ọdún kan tí ó ní ìṣọǹkẹ́mààjì ati àṣìṣe awọ ara tí ó ní ìgbẹ́ lórí ọrùn rẹ̀, ọwọ́ ati ẹsẹ̀ rẹ̀.  Yóò sàn bí a bá tọ́jú rẹ̀ pẹ̀lú èyíkéyìí nínú àwọn wọ̀nyí?\nA. Vitamin A\nB. Thiamine\nC. Folic acid\nD. Nicotinic acid", "reasoning": "<thinking><step1>\nThe question translates to: \"A 37-year-old man with [ìṣọǹkẹ́mààjì = eczema] and [àṣìṣe awọ ara = skin lesions] on his neck, hands, and legs. Will he improve if treated with any of the following?\" \n</step1>\n<step2>\nThe options provided are various vitamins and nutrients, which can affect skin health — *ilera awọ ara*.\n</step2>\n<step3>\nVitamin A is known for its role in skin repair and maintenance — *àtúnṣe awọ*. It helps in cell production and can improve conditions like eczema.\n</step3>\n<step4>\nThiamine, while important for overall health, is not specifically linked to skin conditions — *àìlera awọ ara*.\n</step4>\n<step5>\nFolic acid is crucial for cell division and can support skin health, but it’s not the primary treatment for eczema.\n</step5>\n<step6>\nNicotinic acid, or niacin, can improve skin conditions and is known for its anti-inflammatory properties — *ìmúlò àtọ́kànwá*.\n</step6>\n<step7>\nConsidering the symptoms of eczema and skin lesions, Vitamin A and Nicotinic acid are the most relevant options for treatment.\n</step7>\n<step8>\nHowever, Vitamin A is particularly effective for skin repair, making it a strong candidate for treatment.\n</step8></thinking>", "answer": "<answer>Vitamin A ni yóò sàn fún un.</answer>", "language": "Yoruba"}
{"question": "Oògùn wo ni ó ní ipa kan lórí dilator pupillae tí ó dàbí ipa tí pilocarpine ní lórí sphincter pupillae?", "reasoning": "<thinking><step1>\nThe question asks: “Oògùn wo ni ó ní ipa kan lórí [dilator pupillae = pupillary dilator] tí ó dàbí ipa tí [pilocarpine = pilocarpine] ní lórí [sphincter pupillae = pupillary sphincter]?” — meaning it wants to know which drug affects the pupillary dilator similarly to how pilocarpine affects the pupillary sphincter.\n</step1>\n<step2>\nPilocarpine is a cholinergic agent that causes contraction of the sphincter pupillae, leading to miosis — *réduction de la taille de la pupille*.\n</step2>\n<step3>\nTo find a drug that affects the dilator pupillae, we look for an agent that induces mydriasis — *dilatation de la pupille*.\n</step4>\n<step4>\nOne such drug is atropine, which is an anticholinergic that blocks the action of acetylcholine — *bloque l'action de l'acétylcholine* on the dilator muscles.\n</step5>\n<step5>\nAtropine causes relaxation of the dilator pupillae, resulting in pupil dilation, similar to how pilocarpine causes constriction of the sphincter.\n</step6>\n<step6>\nThus, the drug that has a similar effect on the dilator pupillae as pilocarpine does on the sphincter pupillae is atropine.\n</step6></thinking>", "answer": "<answer>Oògùn tí ó ní ipa kan lórí dilator pupillae bíi ipa tí pilocarpine ní lórí sphincter pupillae ni atropine.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mẹtadinlogun kan ti o ní ìdààmú ẹ̀jẹ̀ ńlá ní ọgbẹ́ inu, a rí ààrùn ọgbẹ́ lórí ẹ̀yìn apá akọkọ́ ti duodenum nígbà tí a ṣe ayẹwo endoscopy inu GI oke, pẹ̀lú àṣeyọrí tí kò ṣeé ṣe láti mú ẹ̀jẹ̀ naa dún. A fi ẹ̀jẹ̀ sí i, a sì gbero láti ṣe abẹ. Ṣe o le sọ ọ̀nà ìṣọ́ṣẹ̀ abẹ tí ó dára jùlọ lati mú ẹ̀jẹ̀ naa dún ati ṣiṣẹ́ ṣe lórí ọrọ̀ tí ó fa ìṣòro náà nínú ọ̀ràn yìí?", "reasoning": "<thinking><step1>\nThe question is asking about the best surgical approach to manage a patient with a significant gastrointestinal bleed due to a duodenal ulcer — *ààrùn ọgbẹ́ lórí ẹ̀yìn apá akọkọ́ ti duodenum*.\n</step1>\n<step2>\nIn cases of severe bleeding, the first step is to stabilize the patient — *lati mu alaisan naa ni iduroṣinṣin* — and ensure adequate blood transfusion.\n</step2>\n<step3>\nNext, during the endoscopy, if the bleeding site is identified, techniques like cauterization or clipping may be attempted — *lati dènà ẹ̀jẹ̀ naa*.\n</step3>\n<step4>\nHowever, if these methods fail, surgical intervention is necessary. The most common procedure is a partial gastrectomy or duodenal resection — *abẹ́ apakan ti àpò-èso tabi àpò-èso duodenal*.\n</step5>\n<step5>\nAdditionally, performing a vagotomy may help reduce acid secretion, which can prevent further ulcer formation — *lati dinku iṣelọpọ acid*.\n</step6>\n<step6>\nUltimately, the choice of surgery depends on the patient's overall condition and the extent of the ulcer — *ipinnu abẹ́ naa da lori ipo gbogbogbo alaisan*.\n</step7>\n<step7>\nIn summary, a combination of surgical resection and vagotomy is often the best approach to manage the bleeding and address the underlying issue.\n</step7></thinking>", "answer": "<answer>Ọ̀nà ìṣọ́ṣẹ̀ abẹ tí ó dára jùlọ ni abẹ́ apakan ti àpò-èso pẹ̀lú vagotomy lati dinku iṣelọpọ acid.</answer>", "language": "Yoruba"}
{"question": "Gẹgẹ́ bí Howe ṣe sọ, iye ìpín ààyè mélòó ni iwọn fífẹ̀ ìgbàgbọ́ ẹnu ní àgbègbè premolar yẹ kí ó jẹ́, láti ọ̀dọ̀ apapọ̀ iwọn mesiodistal gbogbo eyín tí ó wà ní ẹ̀gbẹ́ mesial sí eyín molar kejì, kí a lè rí ìṣe pàtàkì deede gbà pẹ̀lú ọ̀pọ̀lọpọ̀ eyín?", "reasoning": "<thinking><step1>\nThe question translates to: \"According to Howe, what should be the proportion of the length of the premolar arch to the total mesiodistal width of all teeth from the mesial side to the second molar, in order to achieve proper alignment with multiple teeth?\" \n</step1>\n<step2>\nHowe's guidelines suggest that the proportion is crucial for dental alignment — *ìpín ààyè* is essential for ensuring that the teeth fit well together.\n</step2>\n<step3>\nTypically, the length of the premolar arch should be a specific ratio of the total mesiodistal width — *ìwọn fífẹ̀* is often expressed as a percentage.\n</step3>\n<step4>\nIn orthodontics, maintaining this ratio helps in achieving *ìṣe pàtàkì deede* for proper occlusion and aesthetics.\n</step4>\n<step5>\nFor example, if the total mesiodistal width is measured, the premolar arch length should ideally be around 40-45% of that width.\n</step5>\n<step6>\nThis ensures that the alignment of the teeth is not only functional but also visually appealing — *gbà pẹ̀lú ọ̀pọ̀lọpọ̀ eyín*.\n</step6></thinking>", "answer": "<answer>Iwọn fífẹ̀ ìgbàgbọ́ ẹnu ní àgbègbè premolar yẹ kí ó jẹ́ 40-45% ti apapọ̀ iwọn mesiodistal gbogbo eyín tí ó wà ní ẹ̀gbẹ́ mesial sí eyín molar kejì.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdọọdun 18 kan wá sí OPD pẹlu irora ni agbegbe eyín isalẹ ọtun rẹ̀ láìsí itan ara ṣiṣe akiyesi.  Lórí ṣiṣayẹwo inu ẹnu, awọn eyín kì í ṣe caries ati pe wọn dahùn deede si idanwo agbara.  Ṣiṣayẹwo onirọrọ fihan radiolucency multilocular ti a ṣe daradara pẹlu scalloping ni ayika gbongbo 43.  Kini ayẹwo ti o ṣeeṣe julọ?\nA.  Cyst Dentigerous\nB.  Cyst Egún Stafne\nC.  Cyst Egún Rọrùn\nD.  Cyst Ku", "reasoning": "<thinking><step1>\nThe question is asking about a diagnosis for an 18-year-old male who presents to the OPD with pain in the lower right jaw area, specifically mentioning that there is no history of trauma. The examination shows no caries in the teeth and normal responses to vitality tests.\n</step1>\n<step2>\nThe key finding is the presence of multilocular radiolucency with scalloping around the root of tooth 43 — *gbongbo 43*. This suggests a pathological process that is likely cystic in nature.\n</step3>\n<step3>\nIn dental terms, a *cyst* is a fluid-filled sac that can occur in the jaw. The multilocular aspect indicates that it has multiple compartments, which is significant for diagnosis.\n</step4>\n<step4>\nAmong the options provided, a *Cyst Dentigerous* is commonly associated with the crown of an unerupted tooth, while a *Cyst Egún Stafne* is typically found in the mandible and is not usually multilocular.\n</step5>\n<step5>\nThe *Cyst Egún Rọrùn* (simple cyst) is usually unilocular, which does not match the multilocular description. Therefore, the most likely diagnosis given the scalloping and multilocular radiolucency is a *Cyst Dentigerous*.\n</step6>\nThus, the most probable diagnosis based on the findings is a *Cyst Dentigerous*.</thinking>", "answer": "<answer>Cyst Dentigerous</answer>", "language": "Yoruba"}
{"question": "((−4 + −7 − 3 + 3) − (−3 + −2 − −3 ∗ −3)) =", "reasoning": "<thinking><step1>\nThe question asks to solve the expression: “((−4 + −7 − 3 + 3) − (−3 + −2 − −3 ∗ −3))” — we need to simplify both parts of the equation.\n</step1>\n<step2>\nFirst, let's simplify the left side: *−4 + −7 − 3 + 3*. Adding these numbers, we have *−4 − 7 = −11*, then *−11 − 3 = −14*, and finally *−14 + 3 = −11*.\n</step2>\n<step3>\nNow, we move to the right side: *−3 + −2 − −3 ∗ −3*. First, calculate *−3 ∗ −3*, which equals *9*. So, we rewrite it as *−3 + −2 − 9*.\n</step3>\n<step4>\nNow, simplifying this: *−3 + −2 = −5*, and then *−5 − 9 = −14*.\n</step4>\n<step5>\nNow we have the simplified expression: *−11 − (−14)*. Subtracting a negative is the same as adding, so this becomes *−11 + 14*.\n</step5>\n<step6>\nFinally, *−11 + 14 = 3*. Thus, the final result of the expression is *3*.\n</step6></thinking>", "answer": "<answer>3</answer>", "language": "Yoruba"}
{"question": "Kini ànímọ́ ọkàn tí ó máa gbéga nígbà tí ènìyàn bá wà ní ìpele ìwà ìfẹ̀rígbàgbọ́ àrùn bipolar?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ànímọ́ ọkàn tí ó máa gbéga nígbà tí ènìyàn bá wà ní ìpele ìwà ìfẹ̀rígbàgbọ́ àrùn bipolar?” — which translates to \"What are the symptoms of mania when a person is in the manic phase of bipolar disorder?\"\n</step1>\n<step2>\nDuring the manic phase, individuals experience heightened mood — *ìmọ̀lára gíga* — which can lead to increased energy and activity levels.\n</step2>\n<step3>\nCommon symptoms include *ìbànújẹ́* (euphoria), decreased need for sleep — *kò ní fẹ́ sùn*, and racing thoughts — *ìmọ̀lára àkúnya*.\n</step3>\n<step4>\nPeople may also exhibit impulsive behavior, such as spending sprees — *ìtẹ́wọ́gbà owó* — and engaging in risky activities.\n</step4>\n<step5>\nAdditionally, they might have inflated self-esteem — *ìmọ̀lára àtàárọ̀* — feeling invincible or overly confident.\n</step5>\n<step6>\nIn summary, the manic phase of bipolar disorder is characterized by extreme mood elevation, increased energy, and impulsivity — *ìwà àìlera*.\n</step6></thinking>", "answer": "<answer>Ànímọ́ ọkàn tí ó máa gbéga ní ìpele ìwà ìfẹ̀rígbàgbọ́ àrùn bipolar ni ìmọ̀lára gíga, àìní sùn, àti ìbànújẹ́.</answer>", "language": "Yoruba"}
{"question": "Wa film kan ti o dà bi Pretty Woman, Schindler's List, The Shawshank Redemption, Apollo 13:\nAwọn aṣayan:\n(A) Ni Oṣù Keje\n(B) Black Snake Moan\n(C) Dances with Wolves\n(D) Heartbreaker", "reasoning": "<thinking><step1>\nThe question asks: \"Wa film kan ti o dà bi [similar to] Pretty Woman, Schindler's List, The Shawshank Redemption, Apollo 13?\" — meaning it wants to identify a film that shares similarities with these well-known movies.\n</step1>\n<step2>\nPretty Woman is a romantic comedy, while Schindler's List is a historical drama. The Shawshank Redemption is a prison drama, and Apollo 13 is a space film based on true events — *fiimu ti o da lori otitọ*.\n</step2>\n<step3>\nTo find a film that fits, we should consider the themes and genres of the listed films. For instance, *Dances with Wolves* is an epic Western, which might not align closely with the others.\n</step3>\n<step4>\nOn the other hand, *Black Snake Moan* is a drama that explores themes of redemption and personal struggle, which could resonate with the emotional depth found in The Shawshank Redemption.\n</step4>\n<step5>\n*Heartbreaker* is a romantic comedy, similar to Pretty Woman, but it lacks the dramatic weight of the other films. *Ni Oṣù Keje* is not a film title that matches any of the themes.\n</step5>\n<step6>\nConsidering all these factors, *Black Snake Moan* stands out as it shares thematic elements of struggle and redemption, akin to the emotional journeys in the other films.\n</step6></thinking>", "answer": "<answer>Black Snake Moan ni fiimu ti o dà bi Pretty Woman, Schindler's List, The Shawshank Redemption, Apollo 13.</answer>", "language": "Yoruba"}
{"question": "Nígbà tí a bá ti ṣe àkọ́kọ́ọ̀rọ̀ ìsọfúnni kan ní ibi tí ó ti wá, níbo ni wọ́n gbọ́dọ̀ tú u kà ki a bàa lè rí ìjọ̀dún tó tọ́  ti ohun tí a kọ́kọ́ kọ?", "reasoning": "<thinking><step1>\nThe question asks: “Nígbà tí a bá ti ṣe àkọ́kọ́ọ̀rọ̀ [introduction] ìsọfúnni [presentation] kan ní ibi tí ó ti wá, níbo ni wọ́n gbọ́dọ̀ tú u kà ki a bàa lè rí ìjọ̀dún [conclusion] tó tọ́ ti ohun tí a kọ́kọ́ kọ?” — meaning it wants to know where to place the conclusion after making an introduction in a presentation.\n</step1>\n<step2>\nIn a presentation, the introduction sets the stage for the topic — *àkọ́kọ́ọ̀rọ̀ náà* introduces the main ideas.\n</step2>\n<step3>\nTypically, the conclusion should summarize the key points discussed — *ìjọ̀dún náà* wraps up the presentation effectively.\n</step3>\n<step4>\nIt is important to place the conclusion at the end of the presentation — *ní ipari àkọ́ọ̀rọ̀ náà* — to reinforce the main messages.\n</step4>\n<step5>\nThis structure helps the audience remember the key takeaways — *kí àwọn olùgbọ́ le rántí àwọn àkópọ̀ àkọ́kọ́*.\n</step5>\n<step6>\nThus, the conclusion should be the last part of the presentation, ensuring clarity and impact.\n</step6></thinking>", "answer": "<answer>Ìjọ̀dún yẹ kí ó wà ní ipari àkọ́ọ̀rọ̀ ìsọfúnni kan.</answer>", "language": "Yoruba"}
{"question": "Ní ìwádìí ẹ̀dọ̀fún àpòòtí tí ó ní ìgbóná àrùn ẹ̀dọ̀fún gbígbóná nítorí àrùn ẹ̀dọ̀fún B, àwọn àmì àyẹ̀wò oníṣẹ̀dá ara tí a sábà máa ń rí nínú àrùn ẹ̀dọ̀fún B tí ó péye kò sí?", "reasoning": "<thinking><step1>\nThe question translates to: \"In the diagnosis of [liver disease = àrùn ẹ̀dọ̀fún], what are the typical clinical signs that are usually not present in [liver disease B = àrùn ẹ̀dọ̀fún B]?\" This indicates a focus on distinguishing features of liver disease B.\n</step1>\n<step2>\nLiver disease B may present with specific symptoms, but the question asks for signs that are absent — *àmì àyẹ̀wò oníṣẹ̀dá ara tí kò sí*.\n</step2>\n<step3>\nCommon signs in liver diseases include jaundice, ascites, and hepatomegaly — *ìfarapa ẹ̀dọ̀fún, ìkó àdánidá, àti ìtẹ̀sí ẹ̀dọ̀fún*.\n</step3>\n<step4>\nHowever, in liver disease B, one might not see symptoms like *ìfarapa awọ* (skin jaundice) or *ìkó àdánidá* (fluid accumulation) as prominently.\n</step4>\n<step5>\nAdditionally, liver disease B may not exhibit signs of liver failure, such as *ìdààmú àyà* (abdominal discomfort) or *ìdààmú ẹ̀dọ̀fún* (liver tenderness).\n</step5>\n<step6>\nThus, the absence of these signs can help differentiate liver disease B from other liver conditions.\n</step6></thinking>", "answer": "<answer>Àwọn àmì àyẹ̀wò oníṣẹ̀dá ara tí kò sí nínú àrùn ẹ̀dọ̀fún B ni ìfarapa awọ àti ìkó àdánidá.</answer>", "language": "Yoruba"}
{"question": "Loni ni 3/5, ati pe eyi ni igba keji ti Jane ti ri iṣẹlẹ ìṣàn meteorite ni ọdun 1973. Kini ọjọ kan oṣu kan ṣaaju ni MM/DD/YYYY?\nAwọn aṣayan:\n(A) 02/05/1973\n(B) 03/08/1983\n(C) 01/02/1973\n(D) 03/05/2007\n(E) 03/05/1973\n(F) 04/05/1973", "reasoning": "<thinking><step1>\nThe question asks: “Kini ọjọ kan oṣu kan ṣaaju ni MM/DD/YYYY?” — meaning it wants to know the date one month before a specific event in 1973.\n</step1>\n<step2>\nThe event mentioned is the second time Jane saw a meteorite event in 1973. Since the question states \"igba keji\" (second time), we need to identify the date of that event.\n</step2>\n<step3>\nAssuming the event occurred on a specific date in 1973, we need to determine that date first. The options provided suggest various dates in 1973 and beyond.\n</step3>\n<step4>\nIf we take the date of the meteorite event as 03/05/1973, then one month prior would be 02/05/1973 — *ọjọ keji oṣu keji ni ọdun 1973*.\n</step4>\n<step5>\nNow, we check the options: (A) 02/05/1973 is one month before 03/05/1973, while the other options do not fit this timeline.\n</step5>\n<step6>\nThus, the correct answer to the question is the date one month before the assumed event date.\n</step6></thinking>", "answer": "<answer>02/05/1973</answer>", "language": "Yoruba"}
{"question": "Nigbati a ba fi borane ninu tetrahydrofuran (THF) ṣe itọju N-ethyl-N,2,2-trimethylbutanamide ati ethyl 1-isopropyl-5-oxopyrrolidine-3-carboxylate lọtọ, kini awọn ọja akọkọ ti a gba lati iṣẹ kọọkan, ni ṣiṣe?", "reasoning": "<thinking><step1>\nThe question asks: “Nigbati a ba fi [borane = borane] ninu [tetrahydrofuran = THF] ṣe itọju [N-ethyl-N,2,2-trimethylbutanamide] ati [ethyl 1-isopropyl-5-oxopyrrolidine-3-carboxylate] lọtọ, kini [awọn ọja = products] akọkọ ti a gba?” — meaning it wants to know the main products obtained from treating these compounds with borane in THF.\n</step1>\n<step2>\nBorane acts as a reducing agent, so when it reacts with N-ethyl-N,2,2-trimethylbutanamide, it typically reduces the amide group — *iyipada amide* — to an amine.\n</step2>\n<step3>\nIn this case, the product would be N-ethyl-N,2,2-trimethylbutylamine, which is an amine derived from the original amide.\n</step3>\n<step4>\nFor the second compound, ethyl 1-isopropyl-5-oxopyrrolidine-3-carboxylate, borane can reduce the carbonyl group — *iyipada carbonyl* — to an alcohol.\n</step4>\n<step5>\nThus, the main product from this reaction would be ethyl 1-isopropyl-5-hydroxypyrrolidine-3-carboxylate, which is an alcohol.\n</step5>\n<step6>\nIn summary, the main products from these reactions are an amine from the first compound and an alcohol from the second compound.\n</step6></thinking>", "answer": "<answer>Awọn ọja akọkọ ti a gba ni N-ethyl-N,2,2-trimethylbutylamine ati ethyl 1-isopropyl-5-hydroxypyrrolidine-3-carboxylate.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 50 kan ti a mọ̀ ní àrùn emphysema wá sí OPD pẹ̀lú ẹ̀gún ìkùkù sí afẹ́fẹ́ fún ọ̀sẹ̀ mẹ́ta.  Èwo ni ọ̀nà ìtọ́jú tó yẹ fún aláìsàn náà?\nA. Gbígbẹ́ àwọn afẹ́fẹ́ lóríṣìíríṣìí bí wíwọ́ ìgbàárọ̀ sí àyà bá jẹ́ ewu bí bullae bá wà.\nB. Òfúrufú afẹ́fẹ́ gíga ati kí a ṣọ́ aláìsàn náà tọkàntọkàn.\nC. Wíwọ́ ìgbàárọ̀ àyà Seldinger intercostal láti mú kí pneumothorax parẹ̀.\nD. Wíwọ́ ìgbàárọ̀ àyà tó tóbi gan-an nítorí pé ó lè jẹ́ pé ìtànṣẹ́ afẹ́fẹ́ tó pọ̀ gan-an ló wà.", "reasoning": "<thinking><step1>\nThe question is asking about the appropriate treatment for a 50-year-old man with emphysema who has experienced shortness of breath for three weeks. Key terms include [àrùn emphysema = emphysema] and [ẹ̀gún ìkùkù sí afẹ́fẹ́ = shortness of breath].\n</step1>\n<step2>\nEmphysema is a chronic lung condition that leads to difficulty breathing due to damaged alveoli — *àwọn alveoli ti bajẹ́* — which can cause *ìkùkù sí afẹ́fẹ́*.\n</step2>\n<step3>\nIn this case, the treatment options presented include various interventions, such as managing airflow and addressing potential complications like pneumothorax — *pneumothorax*.\n</step3>\n<step4>\nOption A suggests managing airflow with different methods, which is crucial if there are bullae present — *bullae* can lead to serious complications.\n</step4>\n<step5>\nOption B emphasizes high-flow oxygen therapy, which is important for patients with emphysema to ensure adequate oxygenation — *ìmúra afẹ́fẹ́ tó péye*.\n</step5>\n<step6>\nOption C involves a Seldinger intercostal approach to treat pneumothorax, which is a specific procedure that may be necessary if there is a significant air leak.\n</step6>\n<step7>\nOption D suggests a large bore chest tube, which might be needed if there is a large accumulation of air — *ìtànṣẹ́ afẹ́fẹ́ tó pọ̀* — indicating a more severe condition.\n</step7>\n<step8>\nConsidering the patient's history and symptoms, the best approach would be to ensure proper oxygenation while monitoring for complications, making option B a strong candidate.\n</step8></thinking>", "answer": "<answer>Òfúrufú afẹ́fẹ́ gíga ati kí a ṣọ́ aláìsàn náà tọkàntọkàn ni ọ̀nà ìtọ́jú tó yẹ fún aláìsàn náà.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun mẹ́tadinlọ́gbọ̀n (5-lb 8-oz) ọmọkunrin kan tí a bí ní ọsẹ̀ 34 ti oyun rẹ̀, tí ó ń fi cyanosis, ìmí tí kò dára, etí tí kò ga, àwọn àìṣàn ojú, àti ẹsẹ̀ ẹ̀yìn hàn, nígbà tí ìyá rẹ̀ kò gba ìtọ́jú oyun. Kí ni okùnrùn tó ṣeé ṣe jùlọ tí ó fa ipo ọmọ yìí, tí ó ní àìsàn ìbí tí ó nípa lórí sisan ito?", "reasoning": "<thinking><step1>\nThe question asks about a 5-lb 8-oz [ọmọkunrin = baby boy] born at 34 weeks of gestation, presenting with cyanosis, poor breathing, low tone, ocular symptoms, and clubfoot, particularly when the mother did not receive prenatal care. It seeks to identify the most likely condition affecting the baby related to urinary flow issues.\n</step1>\n<step2>\nGiven the symptoms, *cyanosis* indicates a lack of oxygen, which can be due to respiratory distress — *ìmí tí kò dára* suggests the baby is struggling to breathe properly.\n</step2>\n<step3>\nThe low muscle tone — *etí tí kò ga* — and ocular symptoms could indicate a broader systemic issue, possibly linked to prematurity and lack of prenatal care.\n</step3>\n<step4>\nIn this context, one must consider conditions like *syndrome de détresse respiratoire* (respiratory distress syndrome), which is common in preterm infants due to underdeveloped lungs.\n</step4>\n<step5>\nAdditionally, the presence of clubfoot — *ẹsẹ̀ ẹ̀yìn hàn* — may suggest a congenital condition, but the immediate concern is the respiratory issues and cyanosis.\n</step5>\n<step6>\nThe lack of prenatal care could have led to inadequate management of maternal health, contributing to the baby's condition, possibly leading to *malformation* or *hypoxia*.\n</step6>\n<step7>\nThus, the most likely diagnosis here is *syndrome de détresse respiratoire* due to prematurity and lack of prenatal care, affecting the baby's ability to breathe and maintain oxygen levels.\n</step7></thinking>", "answer": "<answer>Okùnrùn tó ṣeé ṣe jùlọ ni syndrome de détresse respiratoire nitori àìlera àkókò àti àìní ìtọ́jú oyun.</answer>", "language": "Yoruba"}
{"question": "Ọpá idẹ̀ kan tí apá ìkọ́rì rẹ̀ jẹ́ yíká, tí radius rẹ̀ jẹ́ 2.1 cm, ń gbé ṣiṣan sinusoidal kan ní iye tí í ṣe 1590 àwọn àyíká lọ́ṣọ̀ọ́kán. Ìwọ̀n ìṣàn ìgbòòrò àwọn axis J jẹ́ J = 0.01e^\\pir sin (\\omegat+\\pir) ampere/cm^2 níbi tí \\omega = 10^4 ti wà, ati r ń tọ́ka sí ìtòsí ní centimeters láti àárín waya náà. Wá agbára tí a ti sọ di ẹ̀gún ní iye centimeters kan ti iye gigùn. Ìwọ̀n itọ́kasi idẹ̀ náà jẹ́ 1.57 × 10^5 mhos/cm.\nA. 6.28 maikiro wati/cm\nB. 2.44 maikiro wati/cm\nC. 31.8 maikiro wati/cm\nD. 12.2 maikiro wati/cm\nE. 4.15 maikiro wati/cm\nF. 8.75 maikiro wati/cm\nG. 5.06 maikiro wati/cm\nH. 3.31 maikiro wati/cm\nI. 9.67 maikiro wati/cm\nJ. 1.59 maikiro wati/cm", "reasoning": "<thinking><step1>\nThe question asks about the power transmitted through a cylindrical conductor with a radius of 2.1 cm, carrying a sinusoidal current density described by J = 0.01e^(πr) sin(ωt + π) ampere/cm², where ω = 10^4. It also provides the conductivity of the copper as 1.57 × 10^5 mhos/cm.\n</step1>\n<step2>\nTo find the power, we first need to calculate the current (I) flowing through the conductor. The current density J is given, and we can find the total current by integrating J over the cross-sectional area of the cylinder — *àgbègbè àyíká*.\n</step2>\n<step3>\nThe cross-sectional area A of the cylinder is A = πr², where r = 2.1 cm. Thus, A = π(2.1 cm)² = 13.85 cm².\n</step3>\n<step4>\nNow, we can calculate the total current I by integrating J over this area: I = ∫J dA. Given J = 0.01e^(πr) sin(ωt + π), we can substitute and integrate to find I.\n</step4>\n<step5>\nNext, we use the formula for power P in terms of current and resistance: P = I²R. The resistance R can be calculated using the conductivity σ: R = 1/(σA). With σ = 1.57 × 10^5 mhos/cm, we can find R and subsequently P.\n</step5>\n<step6>\nFinally, we will compute the numerical values to find the power in micro watts per centimeter — *maikiro wati/cm* — and compare it with the provided options.\n</step6></thinking>", "answer": "<answer>31.8 maikiro wati/cm</answer>", "language": "Yoruba"}
{"question": "Lẹhin ti igbàgbé ejika ti o wa ni iwaju, alaisan ṣe iriri ailera ninu igbọgbẹ́ ọwọ́ ati pipadanu imọlara lori apa ẹgbẹ́ ita ti apa ọwọ́. Ẹ̀yà ẹ̀mí wo ni o ṣee ṣe ki o bajẹ?", "reasoning": "<thinking><step1>\nThe question asks: “Lẹhin ti igbàgbé ejika ti o wa ni iwaju, alaisan ṣe iriri ailera ninu igbọgbẹ́ ọwọ́ ati pipadanu imọlara lori apa ẹgbẹ́ ita ti apa ọwọ́” — meaning it describes a patient experiencing pain in the shoulder and loss of sensation on the outer side of the arm after an anterior shoulder dislocation.\n</step1>\n<step2>\nThis scenario suggests possible nerve damage, specifically to the *nerf axillaire* (axillary nerve), which innervates the deltoid muscle and provides sensation to the skin over the lateral shoulder.\n</step2>\n<step3>\nThe symptoms of pain and sensory loss indicate that the nerve may have been stretched or compressed during the dislocation — *lors de la luxation*.\n</step3>\n<step4>\nIn such cases, one might also consider the involvement of the *plexus brachial* (brachial plexus), which could lead to broader symptoms if affected.\n</step4>\n<step5>\nTo confirm the diagnosis, a physical examination and possibly imaging studies like an MRI or ultrasound would be necessary to assess nerve integrity — *intégrité nerveuse*.\n</step5>\n<step6>\nThus, the likely affected nerve in this case is the axillary nerve, leading to the observed symptoms.\n</step6></thinking>", "answer": "<answer>Nerve axillaire ni o ṣee ṣe ki o bajẹ, ti o fa ailera ati pipadanu imọlara lori apa ẹgbẹ́ ita ti apa ọwọ́.</answer>", "language": "Yoruba"}
{"question": "Kini ewu aisan ti o ṣeeṣe fun ọmọbirin kan ti o ni awọn ami idagbasoke deede ṣugbọn o lo akoko rẹ lati wo ọwọ ara rẹ ati pe ko ba awọn miiran sọrọ?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ewu aisan ti o ṣeeṣe fun ọmọbirin kan ti o ni awọn ami idagbasoke deede ṣugbọn o lo akoko rẹ lati wo ọwọ ara rẹ ati pe ko ba awọn miiran sọrọ?” — meaning it wants to know what potential disorders might affect a girl who has normal developmental signs but spends time looking at her hands and does not communicate with others.\n</step1>\n<step2>\nThis behavior could indicate a condition like autism spectrum disorder (ASD) — *aisan ti o ni ibatan si autism* — where individuals may show restricted interests and social communication challenges.\n</step2>\n<step3>\nThe girl’s focus on her hands might suggest *iṣoro ibaraẹnisọrọ* or repetitive behaviors, which are common in ASD.\n</step3>\n<step4>\nAdditionally, it’s important to consider sensory processing issues — *iṣoro ilana imọlara* — where children may engage in self-stimulatory behaviors to cope with sensory overload.\n</step4>\n<step5>\nOther possibilities could include developmental coordination disorder (DCD) — *aisan iṣakoso idagbasoke* — which affects motor skills and may lead to unusual behaviors as a coping mechanism.\n</step5>\n<step6>\nIn summary, the girl’s behavior could be linked to autism or sensory processing issues, indicating a need for further evaluation.\n</step6></thinking>", "answer": "<answer>Ewu aisan ti o ṣeeṣe fun ọmọbirin yii ni aisan ti o ni ibatan si autism tabi iṣoro ilana imọlara.</answer>", "language": "Yoruba"}
{"question": "Èdèdìí wo ni a tò lórí fún pípàá irúgbìn ọmọdé lẹ́yìn ìṣiṣẹ́ pulpectomy?", "reasoning": "<thinking><step1>\nThe question asks: “Èdèdìí wo ni a tò lórí fún pípàá irúgbìn ọmọdé lẹ́yìn ìṣiṣẹ́ pulpectomy?” — meaning it wants to know what precautions should be taken for a child after a pulpectomy procedure.\n</step1>\n<step2>\nAfter a pulpectomy, it’s crucial to monitor the child for any signs of discomfort — *ìfarapa* or *ìrora* in the mouth.\n</step2>\n<step3>\nThe child should avoid hard or sticky foods — *ounjẹ to nira tabi to n'ibè* — to prevent any damage to the treated tooth.\n</step3>\n<step4>\nAdditionally, maintaining good oral hygiene is essential; brushing gently around the area is important — *fifọ ẹnu ni pẹlẹpẹlẹ*.\n</step4>\n<step5>\nParents should also watch for any unusual swelling or bleeding — *ìkó àtọ́ka tabi ẹ̀jẹ̀* — which could indicate complications.\n</step6>\n<step6>\nFinally, follow-up visits to the dentist are necessary to ensure proper healing — *ìbẹwo lẹ́yìn* is key to a successful recovery.\n</step6></thinking>", "answer": "<answer>A gbọdọ̀ tọ́jú ọmọ náà, ki o má ba jẹ́ ounjẹ to nira, ki o si fọ ẹnu rẹ pẹlẹpẹlẹ lẹ́yìn ìṣiṣẹ́ pulpectomy.</answer>", "language": "Yoruba"}
{"question": "Obirin kan ti ọjọ́-orí rẹ̀ jẹ́ ọdun 26, orukọ rẹ̀ ni Mamta, ní ìtàn ìṣòro ìmímú afẹ́fẹ́ tí ó ń gbòòrò lẹ́yìn ọ̀sẹ̀ méjì ti ìmú afẹ́fẹ́ ìmúlẹ̀ nípa lílo orotracheal intubation.  Wọ́n ti ṣàyẹ̀wò rẹ̀ nísinsìnyí pé ó ní ìdákọ́ṣe trachea tí ó lewu jùlọ.  Nítorí àyẹ̀wò yìí àti ìtàn ìṣègùn rẹ̀, kí ni ìgbésẹ̀ tó yẹ jùlọ tó tẹ̀lé ní ọ̀nà ìṣègùn rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks about a 26-year-old woman named Mamta who has a history of respiratory issues following two weeks of intubation — *ìmú afẹ́fẹ́ ìmúlẹ̀*. It mentions a severe tracheal injury — *ìdákọ́ṣe trachea* — and seeks the most appropriate next step in her medical management.\n</step1>\n<step2>\nGiven her severe tracheal injury, the primary concern is to ensure her airway is secure and functioning properly. This may involve assessing the extent of the injury — *ìtẹ̀numọ̀ ìpọnjú* — and determining if surgical intervention is necessary.\n</step2>\n<step3>\nIn cases of significant tracheal damage, options include surgical repair or possibly a tracheostomy — *tracheostomi* — to bypass the damaged area and secure the airway.\n</step3>\n<step4>\nAdditionally, one must consider her overall respiratory status and any signs of respiratory distress — *ìbànújẹ́ afẹ́fẹ́*. Monitoring her oxygen levels and ensuring she is stable is crucial.\n</step5>\n<step5>\nConsulting with a specialist, such as a thoracic surgeon, would be essential to evaluate the best course of action — *ìmúlò àyẹ̀wò amọ̀ja*.\n</step6>\n<step6>\nThus, the most appropriate next step in her management would likely be to prepare for surgical evaluation and potential intervention.\n</step6></thinking>", "answer": "<answer>Ìgbésẹ̀ tó yẹ jùlọ ni láti ṣàyẹ̀wò Mamta fún ìmúlò àyẹ̀wò amọ̀ja àti ìtẹ̀numọ̀ ìpọnjú trachea rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ṣe iṣiro agbara enthalpy ti iṣelọpọ ti (CH3)2C=CH-CH2-CH(CH3)-CH2-CH=C(CH3)2. A ti fihan pe, \nAgbara atomization ti kaboni = 1000 kJ/mol.\nAgbara isopọ ti H-H = 100 kJ/mol\nAgbara isopọ ti C-C = 200 kJ/mol\nAgbara isopọ ti C=C = 300 kJ/mol\nAgbara isopọ ti C-H = 400 kJ/mol\n\n\n\nA. 11.44 kJ/g\nB. 1900 kJ/g\nC. 67.4 kJ/mol\nD. 11200 kJ/mol", "reasoning": "<thinking><step1>\nThe question asks for the calculation of the enthalpy of formation for the compound (CH3)2C=CH-CH2-CH(CH3)-CH2-CH=C(CH3)2, which is a complex hydrocarbon. We need to understand the bond energies provided: *Agbara atomization ti kaboni* = 1000 kJ/mol, *Agbara isopọ ti H-H* = 100 kJ/mol, *Agbara isopọ ti C-C* = 200 kJ/mol, *Agbara isopọ ti C=C* = 300 kJ/mol, and *Agbara isopọ ti C-H* = 400 kJ/mol.\n</step1>\n<step2>\nTo find the enthalpy of formation, we first need to identify the bonds present in the molecule. The structure contains multiple carbon and hydrogen atoms, so we will count the number of each type of bond.\n</step2>\n<step3>\nNext, we calculate the total energy required to break all the bonds in the reactants and the energy released when forming the bonds in the products. This involves using the bond energies: for example, if there are 10 C-H bonds, the energy contribution from these bonds would be 10 * 400 kJ/mol.\n</step3>\n<step4>\nWe also need to consider the *Agbara atomization ti kaboni* for the carbon atoms involved. If there are 8 carbon atoms, the total energy from carbon atomization would be 8 * 1000 kJ/mol.\n</step4>\n<step5>\nAfter calculating the total energy for breaking and forming bonds, we can find the enthalpy of formation by subtracting the energy of the products from the energy of the reactants. This will give us the final value in kJ/mol.\n</step5>\n<step6>\nFinally, we convert the enthalpy value to kJ/g if needed, but since the options are in kJ/mol, we will focus on that. After performing the calculations, we will compare our result with the provided options.\n</step6></thinking>", "answer": "<answer>11200 kJ/mol</answer>", "language": "Yoruba"}
{"question": "Báwo ni a ṣe ṣe ìpínlẹ̀ àwọn ìsun àti ibi tí ó bo 50% ti gbogbo agbegbe ara, pẹ̀lú ìbajẹ́ sí dermis àti subcutaneous tissue?", "reasoning": "<thinking><step1>\nThe question asks: “Báwo ni a ṣe ṣe ìpínlẹ̀ [assessment] àwọn ìsun [burns] àti ibi tí ó bo 50% ti gbogbo agbegbe ara [body area]?” — meaning it wants to know how to assess burns covering 50% of the total body area, with damage to the dermis and subcutaneous tissue.\n</step1>\n<step2>\nIn assessing burns, we first categorize them by depth: *ìsun kékèké* (first-degree), *ìsun àárín* (second-degree), and *ìsun jinlẹ̀* (third-degree).\n</step2>\n<step3>\nWhen a burn covers 50% of the body, it is classified as a major burn — *ìsun pataki* — which requires immediate medical attention.\n</step3>\n<step4>\nDamage to the dermis and subcutaneous tissue indicates a deeper burn, leading to complications like *àìlera* (infection) and fluid loss — *ìpadanu omi*.\n</step4>\n<step5>\nThe assessment involves evaluating the burn's size, depth, and the patient's overall condition — *ipasẹ̀ àyẹ̀wò* (clinical evaluation).\n</step5>\n<step6>\nIn practice, we use the \"Rule of Nines\" to estimate the total body surface area affected — *ilana mẹsan*.\n</step6>\n<step7>\nFor a burn covering 50%, this is critical for determining treatment options, including fluid resuscitation — *ìtúnṣe omi*.\n</step7>\n<step8>\nThus, assessing such burns involves a systematic approach to evaluate severity and necessary interventions.\n</step8></thinking>", "answer": "<answer>Ìpínlẹ̀ àwọn ìsun tí ó bo 50% ti gbogbo agbegbe ara ni a ṣe pẹlu ìtẹ́numọ̀ si jinlẹ̀, àìlera, àti ìpadanu omi.</answer>", "language": "Yoruba"}
{"question": "Ti o ba ra iwe iṣura 91-ọjọ kan ti o ni iye owo $500,000 fun $485,000, ti o si pa a mọ titi di igba ti o ba de opin rẹ̀, kini oṣuwọn iwuri to sunmọ ti o gba lori idoko-owo yii?", "reasoning": "<thinking><step1>\nThe question asks: “Ti o ba ra iwe iṣura [stock] 91-ọjọ [91-day] kan ti o ni iye owo [face value] $500,000 fun $485,000, ti o si pa a mọ titi di igba ti o ba de opin rẹ̀, kini oṣuwọn iwuri [yield rate] to sunmọ ti o gba lori idoko-owo [investment] yii?” — meaning it wants to know the approximate yield rate on this investment.\n</step1>\n<step2>\nTo find the yield rate, we first calculate the profit made from the investment. The face value is $500,000, and the purchase price is $485,000.\n</step2>\n<step3>\nThe profit can be calculated as: *$500,000 - $485,000 = $15,000*.\n</step3>\n<step4>\nNext, we need to determine the yield based on the investment period, which is 91 days. The yield formula is: *Yield = (Profit / Investment) * (365 / Days)*.\n</step4>\n<step5>\nSubstituting the values, we have: *Yield = ($15,000 / $485,000) * (365 / 91)*.\n</step5>\n<step6>\nCalculating this gives us a yield rate of approximately *0.0930* or *9.30%* when expressed as a percentage.\n</step6></thinking>", "answer": "<answer>Oṣuwọn iwuri to sunmọ ti o gba lori idoko-owo yii jẹ 9.30%.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdún mẹ́ta ọkùnrin kan ti ń ṣe àìfarabalẹ̀, ń gbé egbò irúgbìn jáde, àti ìgbòòrò ikùn. Àwòrán X-ray ikùn pẹ̀lú ìṣe afihan fi hàn àwọn ìkún ilẹ̀kùn kékeré tí ó ṣe déédé, àwọn microcolon, àti adalu gaasi àti meconium tí ó wà ní apá ọ̀tún isalẹ̀. Nítorí àwọn ìwàdíí wọ̀nyí, kini igbesẹ tó tọ́ julọ tókàn nínú ìṣàkóso aláìsàn náà?", "reasoning": "<thinking><step1>\nThe question is asking about the best management step for a three-year-old boy who is exhibiting signs of [àìfarabalẹ̀ = lethargy], has a distended abdomen, and shows specific findings on an X-ray indicating small bowel obstruction with [microcolon = microcolon] and gas and meconium in the right lower quadrant.\n</step1>\n<step2>\nIn cases of small bowel obstruction, especially in young children, the first step is often to assess the severity of the condition — *ìtẹ́numọ̀ àìlera* is crucial.\n</step2>\n<step3>\nThe presence of a distended abdomen and lethargy suggests that the child may be experiencing significant discomfort or complications — *ìfarapa* could be a concern.\n</step3>\n<step4>\nTypically, the management would involve stabilizing the patient, which includes ensuring proper hydration and possibly decompressing the abdomen — *ìmúra omi* and *ìdíwọ̀n àbáyọ* are key components.\n</step5>\n<step5>\nIf the obstruction is confirmed and the child is unstable, surgical intervention may be necessary — *ìtẹ́síwájú iṣẹ́ abẹ́* could be the definitive treatment.\n</step6>\n<step6>\nThus, the most appropriate step in managing this patient would be to stabilize him and prepare for possible surgical intervention if his condition does not improve.\n</step6></thinking>", "answer": "<answer>Igbesẹ tó tọ́ jùlọ ni láti mú un dáradára kí o sì mura sí iṣẹ́ abẹ́ bí àìlera rẹ̀ kò bá yá.</answer>", "language": "Yoruba"}
{"question": "Gbolohun wo ni o ni ilana orukọ-orin to tọ́:\nAwọn aṣayan:\n(A) big ancient square red American cardboard eating shoe\n(B) red ancient big cardboard American square eating shoe", "reasoning": "<thinking><step1>\nThe question asks: “Gbolohun wo ni o ni ilana orukọ-orin to tọ́?” — meaning it wants to know which sentence has the correct order of adjectives in English.\n</step1>\n<step2>\nIn English, adjectives typically follow a specific order: opinion, size, age, shape, color, origin, material, and purpose — *ilana orukọ-orin*.\n</step2>\n<step3>\nLooking at option (A): \"big ancient square red American cardboard eating shoe,\" we see the order is: size (big), age (ancient), shape (square), color (red), origin (American), material (cardboard), and purpose (eating).\n</step3>\n<step4>\nNow, for option (B): \"red ancient big cardboard American square eating shoe,\" the order is incorrect because it places color (red) before size (big) and age (ancient) before shape (square).\n</step4>\n<step5>\nThus, option (A) follows the correct adjective order according to English grammar rules — *ilana to tọ́*.\n</step5></thinking>", "answer": "<answer>(A) big ancient square red American cardboard eating shoe.</answer>", "language": "Yoruba"}
{"question": "Bí ète àdánwò àwọn ẹ̀kúnrẹ́rẹ́ ti olùṣayẹ̀wò bá jẹ́ láti rí i dájú pé kò sí ìpọ̀kùtù sílé tita, olùṣayẹ̀wò náà gbọ́dọ̀ tẹ̀lé àwọn iṣẹ́-ṣiṣe láti\nA. Àṣẹ-ríra àwọn oníbàárà sí iwe ìròyìn títà.\nB. Ìwé ṣíṣe ìrìpodù sí iwe ìròyìn owó tí a gbà.\nC. Iwe ìròyìn owó tí a gbà sí ìwé ṣíṣe ìrìpodù.\nD. Iwe ìròyìn títà sí iwe ìròyìn owó tí a gbà.\nE. Iwe ìròyìn títà sí ìwé ṣíṣe ìrìpodù.\nF. Ìwé ṣíṣe ìrìpodù sí iwe ìròyìn títà.\nG. Àṣẹ-ríra àwọn oníbàárà sí iwe ìròyìn owó tí a gbà.\nH. Iwe ìròyìn owó tí a gbà sí àṣẹ-ríra àwọn oníbàárà.\nI. Ìwé ṣíṣe ìrìpodù sí àṣẹ-ríra àwọn oníbàárà.\nJ. Àṣẹ-ríra àwọn oníbàárà sí ìwé ṣíṣe ìrìpodù.", "reasoning": "<thinking><step1>\nThe question asks: \"Bí ète àdánwò àwọn ẹ̀kúnrẹ́rẹ́ ti olùṣayẹ̀wò bá jẹ́ láti rí i dájú pé kò sí ìpọ̀kùtù sílé tita?\" — meaning it wants to know the steps a reviewer must take to ensure there are no discrepancies in sales reporting.\n</step1>\n<step2>\nTo ensure accuracy in sales reporting, the reviewer must first verify the sales orders — *àṣẹ-ríra* — against the sales report.\n</step2>\n<step3>\nNext, they should check the revenue records — *iwe ìròyìn owó* — to confirm that all sales are accounted for.\n</step3>\n<step4>\nIt is also important to reconcile any discrepancies found in the sales report with the revenue records — *ìwé ṣíṣe ìrìpodù*.\n</step4>\n<step5>\nThe reviewer might need to cross-reference customer orders — *àṣẹ-ríra àwọn oníbàárà* — with the sales report to ensure completeness.\n</step5>\n<step6>\nFinally, they should document all findings and adjustments made during the review process — *iwe ìròyìn títà* — to maintain transparency.\n</step6></thinking>", "answer": "<answer>Olùṣayẹ̀wò gbọ́dọ̀ tẹ̀lé àṣẹ-ríra àwọn oníbàárà sí iwe ìròyìn títà.</answer>", "language": "Yoruba"}
{"question": "Ta ni o jẹ́ olùbẹ̀wò sí ikú Tony ní ìkẹyìn eré 'West Side Story'?", "reasoning": "<thinking><step1>\nThe question asks: “Who is the character that dies at the end of 'West Side Story'?” — specifically referring to Tony, who is a central character in the musical.\n</step1>\n<step2>\nIn 'West Side Story', Tony is a member of the Jets, and his love interest is Maria — *Maria ni ifẹ́ rẹ*.\n</step2>\n<step3>\nThe story culminates in tragedy when Tony is mistakenly shot, leading to his death — *Tony ni a pa ni aṣiṣe*.\n</step3>\n<step4>\nThis moment is pivotal, as it highlights the consequences of gang violence and the impact on love — *ìfarapa ti ìjà àtàwọn ìbáṣepọ*.\n</step4>\n<step5>\nTony's death is a heartbreaking conclusion, emphasizing the themes of love and loss — *ìfẹ́ àti ìpadà*.\n</step5>\n<step6>\nThus, the character who dies at the end of 'West Side Story' is Tony, marking a tragic end to his story.\n</step6></thinking>", "answer": "<answer>Tony ni olùbẹ̀wò sí ikú ní ìkẹyìn eré 'West Side Story'.</answer>", "language": "Yoruba"}
{"question": "Iye apawo wo ni Oṣuwọn Idaabobo Tọkọtaya gbọdọ kọja fun Oṣuwọn Atọrọda Net lati jẹ dogba si ọkan?", "reasoning": "<thinking><step1>\nThe question asks: “Iye apawo wo ni [Oṣuwọn Idaabobo Tọkọtaya = Required Rate of Return] gbọdọ kọja fun [Oṣuwọn Atọrọda Net = Net Present Value] lati jẹ dogba si ọkan?” — meaning it wants to know what the required rate of return must exceed for the net present value to equal one.\n</step1>\n<step2>\nIn finance, the net present value (NPV) is a method used to evaluate the profitability of an investment — *NPV jẹ ọna ti a lo lati ṣe ayẹwo èrè idoko-owo*.\n</step2>\n<step3>\nFor NPV to equal one, the present value of cash inflows must equal the present value of cash outflows — *iye ti awọn owó ti n wọle gbọdọ jẹ dogba si iye ti awọn owó ti n jade*.\n</step3>\n<step4>\nThis means that the required rate of return must be set such that the discounted cash flows yield an NPV of one — *o gbọdọ jẹ pe oṣuwọn idaabobo ti a beere gbọdọ jẹ ki awọn owó ti a ṣe ayẹwo fun NPV jẹ ọkan*.\n</step4>\n<step5>\nTypically, if the required rate of return is lower than the internal rate of return, the NPV will be positive — *ti oṣuwọn idaabobo ba kere ju oṣuwọn inu lọ, NPV yoo jẹ rere*.\n</step5>\n<step6>\nThus, the required rate of return must exceed the internal rate of return for the NPV to equal one — *nitorinaa, oṣuwọn idaabobo gbọdọ kọja oṣuwọn inu fun NPV lati jẹ dogba si ọkan*.\n</step6></thinking>", "answer": "<answer>Oṣuwọn Idaabobo Tọkọtaya gbọdọ kọja Oṣuwọn Inu lati jẹ ki Oṣuwọn Atọrọda Net jẹ dogba si ọkan.</answer>", "language": "Yoruba"}
{"question": "Kini ipo ti kì í ṣe ìdí ìkọ̀lẹ̀ fún ìbí ọmọ nípa àpòòtọ́ lẹ́yìn ìbí ọmọ nípa ìṣẹ̀ abẹ́ ṣáájú?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ipo ti kì í ṣe [ìdí ìkọ̀lẹ̀ = cause of miscarriage] fún [ìbí ọmọ = childbirth] nípa [àpòòtọ́ lẹ́yìn ìbí = postpartum complications] nípa [ìṣẹ̀ abẹ́ = cesarean section] ṣáájú?” — meaning it wants to know what conditions are not causes of miscarriage related to postpartum complications after a cesarean section.\n</step1>\n<step2>\nMiscarriage can occur due to various factors, but certain conditions are not typically linked to it — *àwọn ipo kan kì í ṣe ìdí ìkọ̀lẹ̀*.\n</step2>\n<step3>\nFor instance, postpartum complications like *ìfarapa* or infection after a cesarean do not directly cause miscarriage in subsequent pregnancies.\n</step3>\n<step4>\nAdditionally, maternal age or pre-existing health conditions may influence miscarriage risk, but they are not directly related to complications from a previous cesarean — *ìṣẹ̀ abẹ́*.\n</step5>\n<step5>\nIt's important to note that while postpartum issues can affect future pregnancies, they do not inherently lead to miscarriage — *kò ní fa ìkọ̀lẹ̀*.\n</step6>\n<step6>\nThus, conditions like postpartum hemorrhage or infection are not causes of miscarriage in the context of childbirth after a cesarean section.\n</step6></thinking>", "answer": "<answer>Àwọn ipo bíi ìfarapa lẹ́yìn ìbí kì í ṣe ìdí ìkọ̀lẹ̀ fún ìbí ọmọ nípa àpòòtọ́ lẹ́yìn ìṣẹ̀ abẹ́.</answer>", "language": "Yoruba"}
{"question": "Kini àwọn àpẹẹrẹ àìlera ọrùn-ọmọ yàtọ̀ sí ìgbàgbé ọmọ ní ìgbà kìíní?", "reasoning": "<thinking><step1>\nThe question asks: “Kini àwọn àpẹẹrẹ àìlera [orun-ọmọ = childhood diseases] yàtọ̀ sí [ìgbàgbé ọmọ = child development] ní ìgbà kìíní?” — meaning it wants to know the examples of childhood diseases that differ from child development in early stages.\n</step1>\n<step2>\nChildhood diseases can include conditions like *àìlera àkúnya* (pneumonia) and *àìlera àtọ́kànwá* (measles), which are significant health issues during early childhood.\n</step2>\n<step3>\nIn contrast, child development refers to the physical, cognitive, and emotional growth — *ìdàgbàsókè ọmọ* — that occurs as a child matures.\n</step3>\n<step4>\nFor instance, while *àìlera àkúnya* affects a child's health, *ìdàgbàsókè* involves milestones like walking and talking.\n</step4>\n<step5>\nMoreover, diseases can hinder development; for example, *àìlera àtọ́kànwá* can lead to complications that affect learning abilities.\n</step5>\n<step6>\nThus, while both are crucial, *àìlera* focuses on health issues, whereas *ìdàgbàsókè* emphasizes growth and skills acquisition.\n</step6></thinking>", "answer": "<answer>Àwọn àpẹẹrẹ àìlera ọrùn-ọmọ ni àìlera àkúnya àti àìlera àtọ́kànwá, tí yàtọ̀ sí ìdàgbàsókè ọmọ ní ìgbà kìíní.</answer>", "language": "Yoruba"}
{"question": "Láti ọdún 1970, irú ẹgbẹ́ àwọn alàgbà-ìfẹ́ wo ni ó ti ṣe iṣẹ́ ìṣẹ̀dá àwọn ẹgbẹ́ ìṣiṣẹ́ òṣèlú (PACs) tó pọ̀ jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “Láti ọdún 1970, irú ẹgbẹ́ [alàgbà-ìfẹ́ = interest groups] wo ni ó ti ṣe iṣẹ́ [ìṣẹ̀dá = formation] àwọn ẹgbẹ́ [ìṣiṣẹ́ òṣèlú = political action committees (PACs)] tó pọ̀ jùlọ?” — meaning it wants to know which types of interest groups have been most influential in forming PACs since 1970.\n</step1>\n<step2>\nSince 1970, various interest groups have emerged, particularly in areas like *ilana eto-ọrọ* (economic policy) and *ilana awujọ* (social policy).\n</step2>\n<step3>\nGroups focused on *ilana ayika* (environmental policy) have also gained prominence, advocating for legislation and funding through PACs.\n</step3>\n<step4>\nAdditionally, *egbé́ oloselu* (political organizations) representing business interests, such as the Chamber of Commerce, have been significant in shaping PAC activities.\n</step4>\n<step5>\nMoreover, *egbé́ alágbà-ìfẹ́* (interest groups) related to healthcare and education have mobilized resources to influence political outcomes via PACs.\n</step5>\n<step6>\nIn summary, the most active interest groups in forming PACs since 1970 include those focused on economic, environmental, and social issues, as well as business and healthcare interests.\n</step6></thinking>", "answer": "<answer>Irú ẹgbẹ́ alàgbà-ìfẹ́ tó pọ̀ jùlọ ni àwọn tó ní í ṣe pẹ̀lú ilana eto-ọrọ, ayika, àti ilera.</answer>", "language": "Yoruba"}
{"question": "Èlémenti ọ̀nà SVG yii <path d=\"M 2.00,80.00 L 51.00,59.00 L 86.00,84.00 L 53.00,15.00 L 28.00,48.00 L 41.00,50.00 L 2.00,80.00\"/> ṣe àkàwé kan\nAwọn aṣayan:\n(A) yíká\n(B) ọ̀pọ̀lọpọ̀-àgbọn mẹje\n(C) ọ̀pọ̀lọpọ̀-àgbọn mẹfa\n(D) afefe\n(E) ila\n(F) ọ̀pọ̀lọpọ̀-àgbọn mẹjọ\n(G) ọ̀pọ̀lọpọ̀-àgbọn marun\n(H) àyàká\n(I) apakan\n(J) kókó mẹta", "reasoning": "<thinking><step1>\nThe question asks: “Èlémenti ọ̀nà SVG yii [this SVG path] ṣe àkàwé kan?” — meaning it wants to describe the shape represented by the SVG path data provided.\n</step1>\n<step2>\nThe SVG path data \"M 2.00,80.00 L 51.00,59.00 L 86.00,84.00 L 53.00,15.00 L 28.00,48.00 L 41.00,50.00 L 2.00,80.00\" indicates a series of points connected by lines — *aṣa mẹta ti a so pọ*.\n</step2>\n<step3>\nStarting at (2, 80), the path moves to (51, 59), then to (86, 84), and so on, creating a closed shape — *aṣa ti o ni ipari*.\n</step4>\n<step4>\nThis shape can be analyzed as having multiple angles and sides, suggesting it is a polygon — *aṣa mẹta*.\n</step5>\n<step5>\nCounting the vertices, we see there are seven points, which means it is a heptagon — *aṣa mẹje*.\n</step6>\n<step6>\nThus, the SVG path represents a heptagon, which corresponds to option (F) — *ọ̀pọ̀lọpọ̀-àgbọn mẹje*.\n</step6></thinking>", "answer": "<answer>Ọ̀pọ̀lọpọ̀-àgbọn mẹje.</answer>", "language": "Yoruba"}
{"question": "Ní àwọn àrùn wo ni a sábà máa ń rí àwọn ìlòrí Kerley, pẹ̀lú ìtọ́ka wọn sí àwọn ìṣẹ̀lẹ̀ àárín àwọn sẹ́ẹ̀lì ní ẹ̀dọ̀fóró?", "reasoning": "<thinking><step1>\nThe question asks: “Ní àwọn àrùn wo ni a sábà máa ń rí àwọn [ìlòrí Kerley = Kerley lines]?” — meaning it wants to know which diseases are associated with Kerley lines and their relation to pulmonary conditions.\n</step1>\n<step2>\nKerley lines are indicative of pulmonary edema — *ìkó ẹ̀dọ̀fóró* — which often occurs in heart failure.\n</step2>\n<step3>\nIn heart failure, increased pressure in the pulmonary circulation leads to fluid accumulation — *ìkó omi* in the lungs, causing these lines to appear on imaging.\n</step4>\n<step4>\nOther conditions like pneumonia or interstitial lung disease can also show Kerley lines, as they involve fluid or inflammation in the lung interstitium — *àárín ẹ̀dọ̀fóró*.\n</step5>\n<step5>\nIn summary, diseases like heart failure, pneumonia, and interstitial lung disease are commonly associated with the presence of Kerley lines.\n</step6></thinking>", "answer": "<answer>Àwọn àrùn tí a sábà máa ń rí àwọn ìlòrí Kerley ni àrùn ọkàn, pneumonia, àti àrùn àárín ẹ̀dọ̀fóró.</answer>", "language": "Yoruba"}
{"question": "Lẹ́yìn tí ọmọdékùnrin kan bá ní ibà ṣánṣán àti irúgbìn lymph node tí ó tẹ́lẹ̀ mọ́ lẹ́yìn tí eṣùṣù kan bá fẹ́ ẹ́ nígbà tí ó ń ṣiṣẹ́ nínú ibi ìgbàlógbòló àlìkámà, a rán ìgbẹ́rìgbẹ́rẹ̀ sí ilé ìṣèwádìí fún ìfínní pàtó. Ọ̀nà ìfínní wo ni ó yẹ kí a lo láti mọ̀ àrùn tó ṣeé ṣe pé ó fa ìṣẹ̀lẹ̀ yìí?", "reasoning": "<thinking><step1>\nThe question asks: “What method of testing should be used to identify the disease that may have caused the symptoms after a boy experiences fever and swollen lymph nodes following a tick bite?” — here, *ìbà ṣánṣán* means fever and *irúgbìn lymph node* refers to swollen lymph nodes.\n</step1>\n<step2>\nIn this context, the symptoms suggest a possible infection, often associated with tick bites — *eṣùṣù* can transmit various diseases like Lyme disease or Rocky Mountain spotted fever.\n</step2>\n<step3>\nTo diagnose these conditions, specific tests are required; for instance, serological tests can detect antibodies — *àyẹ̀wò ẹ̀jẹ̀* is crucial for identifying infections.\n</step4>\n<step4>\nIn cases of Lyme disease, a common test is the ELISA (Enzyme-Linked Immunosorbent Assay) followed by a Western blot for confirmation — *àyẹ̀wò ELISA* jẹ́ àyẹ̀wò tó wọ́pọ̀.\n</step5>\n<step5>\nAdditionally, PCR (Polymerase Chain Reaction) can be used to detect the presence of the bacteria directly — *PCR* jẹ́ ọ̀nà míì tó dájú.\n</step6>\n<step6>\nThus, the appropriate testing method to identify the disease linked to the symptoms is a combination of serological tests and possibly PCR.\n</step6></thinking>", "answer": "<answer>Ọ̀nà ìfínní tó yẹ ni àyẹ̀wò ẹ̀jẹ̀ àti PCR láti mọ̀ àrùn tó fa ìṣẹ̀lẹ̀ yìí.</answer>", "language": "Yoruba"}
{"question": "Àwọn àrùn wo ni ó wọ́pọ̀ láti rí àwọn àkóbáà tó gbòòrò káàkiri ní ṣàyẹ̀wò ìwẹ̀rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn àrùn wo ni ó wọ́pọ̀ láti rí àwọn àkóbáà tó gbòòrò káàkiri ní ṣàyẹ̀wò ìwẹ̀rẹ̀?” — meaning it wants to know which diseases are commonly associated with widespread symptoms during a medical examination.\n</step1>\n<step2>\nCommon diseases that present with widespread symptoms include infections like influenza — *ìkànsí* — and conditions such as rheumatoid arthritis, which can cause *ìrora* and *ìfọwọ́ra* in multiple joints.\n</step2>\n<step3>\nAnother example is systemic lupus erythematosus, where patients may experience fatigue and skin rashes — *ìfarapa* — that are widespread.\n</step3>\n<step4>\nIn addition, viral infections like COVID-19 can lead to symptoms such as fever, cough, and body aches — *ìrora ara* — affecting the entire body.\n</step4>\n<step5>\nMoreover, conditions like fibromyalgia are characterized by widespread pain and fatigue, making diagnosis challenging — *ìṣòro àyẹ̀wò*.\n</step5>\n<step6>\nThus, diseases that show widespread symptoms during examination often include infections, autoimmune disorders, and chronic pain syndromes.\n</step6></thinking>", "answer": "<answer>Àwọn àrùn tó wọ́pọ̀ ni ìkànsí, rheumatoid arthritis, lupus, COVID-19, àti fibromyalgia.</answer>", "language": "Yoruba"}
{"question": "Nípa ọ̀ràn ọkùnrin ọmọ ọdún méjìdínlọ́gbọ̀n kan tí ó ní ìṣẹ̀lẹ̀ ọkọ̀ ayọ́kẹ́lẹ́, tí ó sì ní ìrora ikùn tí ó ga julọ, irora tí ó padà, àti àìlera ikùn, àti àyẹ̀wò FAST tí ó dára ní Morrison's pouch, ṣàpèjúwe àwọn àmì tí a retí lára fọ́tò ikùn.", "reasoning": "<thinking><step1>\nThe question asks about a 29-year-old man who has been in a car accident and is experiencing severe abdominal pain, recurrent pain, and abdominal weakness, with a good FAST exam in Morrison's pouch. It wants to describe the expected signs in an abdominal ultrasound.\n</step1>\n<step2>\nIn this case, *irora ikùn* (abdominal pain) can indicate internal injuries, especially if the pain is severe and recurrent — *irora tí ó padà*.\n</step2>\n<step3>\nA good FAST exam suggests that there might not be significant free fluid, but we should still consider potential injuries — *àwọn ìfarapa* — to organs like the spleen or liver.\n</step4>\n<step4>\nIn an ultrasound, we might expect to see *àkúnya* (hematoma) or fluid collections if there are injuries, especially in the *Morrison's pouch* area, which is a common site for fluid accumulation.\n</step5>\n<step5>\nAdditionally, signs of *ìfarapa* could include thickening of the organ walls or irregularities in the liver or spleen, indicating possible lacerations or contusions.\n</step6>\n<step6>\nOverall, the expected findings in the ultrasound would focus on identifying any *àkúnya* or fluid that could suggest internal bleeding or organ damage.\n</step6></thinking>", "answer": "<answer>Àwọn àmì tí a retí lára fọ́tò ikùn ni àkúnya, àtàwọn àfihàn ìfarapa lórí ẹ̀dá àtàwọn òrgan bíi ẹ̀dá àtàwọn àkúnya.</answer>", "language": "Yoruba"}
{"question": "Ninu obinrin ọdun 80 kan ti o ni iṣọn-alọ ọgbẹ́ ti o ṣafihan pẹlu iba, awọn ewu titẹ, ibajẹ-irẹlẹ, ati purpura ti o tan kaakiri, ẹniti ẹ̀dà ìwádìí ẹ̀jẹ̀ rẹ̀ fihan àjàkálẹ̀ àrùn Gram-odi, cytokine wo ni o jẹ́ ẹni ti o ṣe ipalara awọn ohun elo ẹjẹ taara ti a rii ninu ipo rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “In an 80-year-old woman with [iṣọn-alọ ọgbẹ́ = septic shock] presenting with fever, hypotension, skin lesions, and widespread purpura, which cytokine is responsible for directly damaging blood vessels in her condition?” \n</step1>\n<step2>\nSeptic shock is often associated with a severe inflammatory response, where the body releases various cytokines — *cytokines* are signaling proteins that mediate immune responses.\n</step2>\n<step3>\nIn this case, the presence of *àjàkálẹ̀ àrùn Gram-odi* indicates a Gram-negative bacterial infection, which typically triggers the release of pro-inflammatory cytokines.\n</step3>\n<step4>\nOne key cytokine involved in vascular permeability and damage to blood vessels is *tumor necrosis factor-alpha (TNF-α)* — it plays a significant role in the pathophysiology of septic shock.\n</step4>\n<step5>\nIn the context of her symptoms, TNF-α contributes to *ibajẹ-irẹlẹ* and the development of *purpura*, as it increases vascular permeability and promotes inflammation.\n</step5>\n<step6>\nThus, the cytokine that is primarily responsible for the direct damage to blood vessels in this patient's condition is TNF-α.\n</step6></thinking>", "answer": "<answer>Cytokine ti o jẹ́ ẹni ti o ṣe ipalara awọn ohun elo ẹjẹ ni ipo rẹ̀ ni TNF-α.</answer>", "language": "Yoruba"}
{"question": "Ọmọbirin ọdọ́ ọmọ ọdún mejilelọgún kan tí í ṣe akẹ́kọ̀ọ́ ile-ẹ̀kọ́ gíga wá sí ile-iṣẹ́ ìtójú rẹ̀ láti bẹ̀rẹ̀ ìtójú.  Kò ní itàn àrùn tó ṣe pàtàkì rí, ìṣòro kan ṣoṣo tó ní lónìí ni pé ó ti ní ìṣòro ní mímú ìwúwo rẹ̀ dún déédéé.  Àyẹ̀wò otutu rẹ̀ jẹ́ 98.6°F (37.0°C), ṣíṣe ẹ̀jẹ̀ jẹ́ 100/65 mmHg, ìṣiṣẹ́ ọkàn jẹ́ 62/min, àti ìfìfì jẹ́ 12/min.  Ìwúwo ara rẹ̀ jẹ́ 19.5.  Àyẹ̀wò ara rẹ̀ fi hàn pé ó ní àwọn ìka ọwọ́ tí ó le, àti ìbajẹ́ enamel ẹ̀gún.  Àwọn àìṣàn wo ni a lè rí nínú ẹ̀dá ìwádìí tó gbàdúrà fún aláìsàn yìí?\nA.  Dinku klọ́ráìdì, dinku pọtásíùmu, dinku bàìkàbọ́néìtì\nB.  Dinku klọ́ráìdì, dinku pọtásíùmu, pọ̀ sí i bàìkàbọ́néìtì\nC.  Dinku klọ́ráìdì, pọ̀ sí i pọtásíùmu, pọ̀ sí i bàìkàbọ́néìtì\nD.  Pọ̀ sí i klọ́ráìdì, dinku pọtásíùmu, dinku bàìkàbọ́néìtì", "reasoning": "<thinking><step1>\nThe question describes a 16-year-old female student who is seeking medical care, with no significant medical history but a current issue of weight loss. Her vital signs are stable, and her weight is noted as 19.5, which suggests a possible concern regarding her nutritional status.\n</step1>\n<step2>\nThe vital signs indicate a normal temperature of 98.6°F (37.0°C), blood pressure of 100/65 mmHg, heart rate of 62/min, and respiratory rate of 12/min. These values suggest that she is not in acute distress, but her weight may indicate malnutrition or an underlying condition — *àìlera*.\n</step2>\n<step3>\nThe physical examination reveals *ìka ọwọ́ tí ó le* (weakness in the limbs) and *ìbajẹ́ enamel ẹ̀gún* (enamel erosion), which could be linked to dietary deficiencies or metabolic issues.\n</step3>\n<step4>\nIn this context, the options provided relate to electrolyte management, particularly concerning chloride, potassium, and bicarbonate levels. Given her symptoms, we need to consider how these electrolytes might be affected by her condition.\n</step5>\n<step5>\nFor a patient with weight loss and potential malnutrition, it is crucial to assess whether she needs to decrease chloride and potassium while managing bicarbonate levels appropriately. This could indicate an underlying metabolic acidosis or alkalosis.\n</step6>\nBased on the symptoms and examination findings, the most appropriate choice would be to decrease chloride and potassium while managing bicarbonate levels, which aligns with option A.\n</step6></thinking>", "answer": "<answer>Dinku klọ́ráìdì, dinku pọtásíùmu, dinku bàìkàbọ́néìtì.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹta kan ti o ní àwọn ìṣe ìdàgbàsókè déédéé, ṣùgbọ́n ó ní ìwọ̀nba sísọ̀rọ̀ àti ìṣòro nínú ì báṣepò àti ìṣàṣeéṣe. Kò ń ṣe ọ̀rẹ̀. Àìsàn tí ó ṣeé ṣe jùlọ ni\nA. Àìsàn àwọn ọmọdé (Autism)\nB. ADHD\nC. Ìdènà ọgbọ́n (Mental retardation)\nD. Ìṣòro ìmọ̀ kọ́ pàtó (Specific learning disability)", "reasoning": "<thinking><step1>\nThe question describes a three-year-old boy with developmental delays but has good motor skills, while facing challenges in communication and social interaction — *ìwọ̀nba sísọ̀rọ̀* and *ì báṣepò*.\n</step1>\n<step2>\nGiven these symptoms, we need to consider conditions that affect social skills and communication more than physical abilities.\n</step2>\n<step3>\nAutism, or *àìsàn àwọn ọmọdé*, is characterized by difficulties in social interaction and communication, which aligns with the child's profile.\n</step3>\n<step4>\nADHD, while it can affect behavior and attention, typically does not primarily impact communication skills or social interaction in the same way.\n</step4>\n<step5>\nMental retardation, or *ìdènà ọgbọ́n*, involves broader cognitive impairments, which may not specifically match the described situation.\n</step5>\n<step6>\nSpecific learning disabilities, or *ìṣòro ìmọ̀ kọ́ pàtó*, usually manifest later in academic settings and are less likely to be diagnosed at such a young age.\n</step6>\n<step7>\nThus, the most fitting diagnosis for this child, considering his age and symptoms, is likely *àìsàn àwọn ọmọdé*.\n</step7></thinking>", "answer": "<answer>Àìsàn àwọn ọmọdé (Autism).</answer>", "language": "Yoruba"}
{"question": "Nígbà tí a bá ń ṣàyẹ̀wò ohun tó fa ẹ̀dùn ẹ̀jẹ̀ ṣíṣàn jẹ̀jẹ̀rẹ̀ ní ọ̀rọ̀ ìgbàgbọ́ nínú àwọn ẹ̀jẹ̀ tí ó jinlẹ̀ ní ara àpọn, láìsí àìsàn ìlera tí ó bá a mu, àyẹ̀wò pàtó wo ni kò pọn dandan láti ṣe?", "reasoning": "<thinking><step1>\nThe question asks: “What specific examination is not necessary when investigating the causes of [bleeding = ẹ̀dùn ẹ̀jẹ̀] in the context of [faith = ìgbàgbọ́] in the deep [veins = ẹ̀jẹ̀ tí ó jinlẹ̀] of the body, without any underlying health issues?”\n</step1>\n<step2>\nWhen assessing bleeding, one typically considers various tests to identify the source — *àwọn ìdánwò* like blood tests or imaging studies.\n</step2>\n<step3>\nHowever, if there are no health issues, certain invasive procedures may be unnecessary — for instance, *ìdánwò àyẹ̀wò àtọkànwá* (endoscopy) might not be required.\n</step3>\n<step4>\nIn this context, *àyẹ̀wò àtọkànwá* is often used to examine internal bleeding sources, but if the patient is healthy, it may be excessive.\n</step4>\n<step5>\nAdditionally, tests like *ìdánwò ẹ̀jẹ̀* (blood tests) can provide sufficient information without needing invasive methods.\n</step5>\n<step6>\nThus, the examination that is not necessary in this scenario would be an invasive procedure like endoscopy, given the absence of health issues.\n</step6></thinking>", "answer": "<answer>Ìdánwò àtọkànwá (endoscopy) kò pọn dandan láti ṣe nígbà tí kò sí àìsàn ìlera.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọmọ ọdún mẹ́tádínlógún kan wá sí ẹ̀ka ìtọ́jú pajawiri pẹ̀lú irora ikùn àti agbada, pẹ̀lú irora ìgbẹ́ àti ìtùjáde láti inu àgbàdà.  Nítorí ọjọ́ orí rẹ̀, ìwàhàlá irora ikùn, àti itan rẹ̀ nípa ọ̀pọ̀lọpọ̀ ọkọ̀ rẹ̀, èwo ni àdánwò ìwádìí àkọ́kọ́ tó bá ṣe pàtàkì jùlọ láti ṣe láti yanjú àdánùdíẹ̀ tí ó lè jẹ́ ewu ní ọ̀ràn yìí?", "reasoning": "<thinking><step1>\nThe question asks about a 17-year-old girl who presents to the emergency department with abdominal pain and vomiting, along with a history of multiple partners. It seeks to identify the most important initial diagnostic test to address potential risks.\n</step1>\n<step2>\nGiven her age and symptoms, one must consider sexually transmitted infections (STIs) — *àkóràn àtọ́kànwá* — as a possible cause of her abdominal pain and vomiting.\n</step2>\n<step3>\nIn this context, a pelvic examination is crucial, but the most important initial test would be a pregnancy test — *àdánwò ìyàwó* — to rule out ectopic pregnancy, which can be life-threatening.\n</step3>\n<step4>\nThe presence of abdominal pain and a history of multiple partners raises the suspicion for conditions like pelvic inflammatory disease (PID) — *àkóràn àtọ́kànwá àgbàdo* — which can also cause similar symptoms.\n</step4>\n<step5>\nTherefore, while other tests may follow, the pregnancy test is essential to ensure the patient's safety and guide further management.\n</step5></thinking>", "answer": "<answer>Àdánwò ìyàwó ni àdánwò ìwádìí àkọ́kọ́ tó ṣe pàtàkì jùlọ láti ṣe.</answer>", "language": "Yoruba"}
{"question": "Kini ọ̀rọ̀ tí a máa n lò láti ṣàpèjúwe ẹgbẹ́ àwọn ènìyàn tí a ń tẹ̀lé fún àwọn àyẹ̀wò tí ó tẹ̀lé ara wọn láti ṣàyẹ̀wò ipa àwọn eto ìdènà àpòòtọ́?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ọ̀rọ̀ tí a máa n lò láti ṣàpèjúwe [egbe = group] àwọn ènìyàn tí a ń tẹ̀lé [ayẹwo = follow-up examinations]?” — meaning it seeks to identify the term used to describe a group of people monitored for follow-up examinations to assess the impact of preventive measures.\n</step1>\n<step2>\nIn research, this group is often referred to as a *cohorte* — a cohort of individuals who are observed over time.\n</step2>\n<step3>\nThese individuals are typically selected based on certain criteria, such as *àwọn àfihàn ilera* (health indicators) or risk factors relevant to the study.\n</step3>\n<step4>\nThe purpose of monitoring this cohort is to evaluate the effectiveness of *eto ìdènà àpòòtọ́* (preventive measures) in reducing health risks.\n</step4>\n<step5>\nIn English, we might say: “This cohort is crucial for understanding long-term outcomes and the impact of interventions.”\n</step5>\n<step6>\nThus, the term used to describe this group is *cohorte* — a systematic way to track health outcomes over time.\n</step6></thinking>", "answer": "<answer>Ọ̀rọ̀ tí a máa n lò láti ṣàpèjúwe ẹgbẹ́ àwọn ènìyàn yìí ni *cohorte*.</answer>", "language": "Yoruba"}
{"question": "Mo ní fitila mẹrin, firiji kan, ibusun kan, ọkọ ayọkẹlẹ kan, tosta kan, ati irinṣẹ kan. Nọmba ohun ti mo ní melo?", "reasoning": "<thinking><step1>\nThe question asks: “Mo ní fitila mẹrin, firiji kan, ibusun kan, ọkọ ayọkẹlẹ kan, tosta kan, ati irinṣẹ kan” — meaning it wants to know the total number of items listed.\n</step1>\n<step2>\nFirst, let's identify the items: *fitila mẹrin* (four lamps), *firiji kan* (one refrigerator), *ibusun kan* (one bed), *ọkọ ayọkẹlẹ kan* (one car), *tosta kan* (one toaster), and *irinṣẹ kan* (one tool).\n</step2>\n<step3>\nNow, we count each item: 4 (fitila) + 1 (firiji) + 1 (ibusun) + 1 (ọkọ ayọkẹlẹ) + 1 (tosta) + 1 (irinṣẹ).\n</step3>\n<step4>\nCalculating this gives us: 4 + 1 + 1 + 1 + 1 + 1 = 9.\n</step4>\n<step5>\nThus, the total number of items is nine — *nọmba ohun ti mo ní melo ni mẹsan*.\n</step5></thinking>", "answer": "<answer>Mo ní mẹsan.</answer>", "language": "Yoruba"}
{"question": "Kini iwadi pataki ti o yẹ ki a ṣe ṣaaju ki a to tú ọ̀rọ̀ alaisan kan ti o ni H. influenza meningitis silẹ?", "reasoning": "<thinking><step1>\nThe question asks: “Kini iwadi pataki ti o yẹ ki a ṣe ṣaaju ki a to tú [ọ̀rọ̀ alaisan = patient information] kan ti o ni [H. influenza meningitis = Haemophilus influenzae meningitis] silẹ?” — meaning it wants to know what important investigations should be done before discharging a patient with H. influenza meningitis.\n</step1>\n<step2>\nBefore discharge, it is crucial to assess the patient's clinical stability — *iduroṣinṣin alaisan* — ensuring they are free from complications.\n</step2>\n<step3>\nWe should perform a neurological examination to check for any residual effects — *awọn ipa to ku* — of the meningitis.\n</step3>\n<step4>\nAdditionally, laboratory tests like blood cultures and a lumbar puncture may be necessary to confirm the infection has resolved — *lati jẹrisi pe àkóràn ti parí*.\n</step4>\n<step5>\nMonitoring for signs of complications such as seizures or hearing loss is also essential — *awọn aami ti awọn iṣoro*.\n</step6>\n<step6>\nFinally, ensuring the patient has appropriate follow-up care arranged is vital — *pẹlu itọju atẹle to yẹ*.\n</step6></thinking>", "answer": "<answer>Iwadi pataki ti o yẹ ki a ṣe ni idanwo iṣoogun, ayẹwo neurology, ati idanwo lab lati jẹrisi pe àkóràn ti parí.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin ọdun 27 kan ti ó ní ìyàtọ̀ gẹ́gẹ́ bí a ti mọ̀ ninu gẹ́ẹ́nì kan tí ó ṣe àṣàrò fún erò protein L-type calcium, ń ṣe àrùn ọkàn tí kò sábàà ṣẹlẹ̀.  Nígbà ayẹwo ọdún rẹ̀, ó bi nípa ‘agbara ṣiṣẹ́ ventricle’ rẹ̀.  Nítorí ìyàtọ̀ gẹ́gẹ́ bí a ti mọ̀ ninu gẹ́ẹ́nì rẹ̀, ìpele wo ninu agbara ṣiṣẹ́ ventricle ni ó ṣeé ṣe kí ó jẹ́ kí ó nípa lórí jùlọ?", "reasoning": "<thinking><step1>\nThe question is asking about a 27-year-old man with a genetic variation affecting L-type calcium channel function, and how this might impact his ventricular contractility — *agbara ṣiṣẹ́ ventricle*.\n</step1>\n<step2>\nVentricular contractility refers to the heart's ability to contract and pump blood effectively. In this case, the genetic variation could lead to altered calcium handling in cardiac cells — *ìṣàkóso calcium*.\n</step2>\n<step3>\nL-type calcium channels are crucial for calcium influx during the cardiac action potential, which is essential for muscle contraction — *ìdàgbàsókè iṣan*.\n</step4>\n<step4>\nIf the genetic variation reduces calcium entry, it could impair contractility, leading to decreased force of contraction — *agbara dinku*.\n</step5>\n<step5>\nConversely, if the variation enhances calcium influx, it might increase contractility, but this is less common in pathological conditions — *àìlera*.\n</step6>\n<step6>\nThus, the most likely impact on his ventricular contractility would be a decrease due to impaired calcium handling from the genetic variation.\n</step6></thinking>", "answer": "<answer>Ìpele ti ó ṣeé ṣe kí ó nípa lórí jùlọ ni dinku agbara ṣiṣẹ́ ventricle rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 70 kan wá pẹlu irora àyà tí ó burú jáì ní abẹ́ ìyàrá àyà, ati electrocardiogram tí ó fi hàn pé ST elevations wà ní awọn leads inferior II, III, ati avF, ati bẹ̃ẹ̀ ni ní awọn leads V5 ati V6. Da lori awọn abajade wọnyi, ẹyawo ọkan wo ni ó ṣeé ṣe julọ lati ni ipa?", "reasoning": "<thinking><step1>\nThe question asks: “Based on the results of a 70-year-old man with severe chest pain and an electrocardiogram showing ST elevations in inferior leads II, III, and avF, as well as in leads V5 and V6, what type of heart condition is most likely affected?” \n</step1>\n<step2>\nThe presence of ST elevations indicates a possible myocardial infarction — *àìlera ọkan* — particularly in the inferior wall of the heart.\n</step2>\n<step3>\nThe inferior leads (II, III, avF) suggest that the *àyà* (heart) is experiencing ischemia in the lower part, which is often due to blockage in the right coronary artery — *àtẹ́gun ọpọlọ ọtun*.\n</step3>\n<step4>\nAdditionally, the ST elevations in V5 and V6 indicate that there may also be involvement of the lateral wall, which could suggest a more extensive area of damage.\n</step4>\n<step5>\nIn this case, the most likely condition is an inferior ST-elevation myocardial infarction (STEMI) — *àìlera ọkan STEMI* — which can lead to serious complications if not treated promptly.\n</step5>\n<step6>\nThus, the patient is likely experiencing an inferior STEMI due to the observed ST elevations in the specified leads.\n</step6></thinking>", "answer": "<answer>Ọkunrin náà ní àìlera ọkan STEMI ti o ni ipa ni àyà ìsàlẹ̀.</answer>", "language": "Yoruba"}
{"question": "Àpọǹ rẹ́rẹ́ ọmọ ọdún mẹ́rin-dín-lógún kan ti ní ìgbà mẹ́ta tí àrùn ìkùǹgbàá rẹ̀ ti sọ̀kalẹ̀ lọ́nà tí kò ní ìrànlọ́wọ́ ní ìbẹ̀rẹ̀ ìlọ́gbàá rẹ̀. Gẹ́gẹ́ bí apá kan ti ṣíṣàyẹ̀wò fún ìṣòro yìí, àwọn àdánwò tí kò ṣe pàtàkì jùlọ ni:  Hysterosalpinogram, ṣíṣàyẹ̀wò àwọn ohun-àmì àrùn nípa ìrísí ìgbàgbọ́ ẹ̀gbọ̀ngbọ̀ngbọ̀n àwọn tọkọtaya náà, ṣíṣàyẹ̀wò fún àwọn àrùn TORCH, ṣíṣàdánwò endometrial ní ìgbà luteal, àdánwò Postcoital\nA. Àṣàyàn 1,3,5\nB. Àṣàyàn 1,3\nC. Àṣàyàn 3,5\nD. Àṣàyàn 5 nìkan", "reasoning": "<thinking><step1>\nThe question is asking about a four-year-old child who has experienced three episodes of infertility without assistance during their reproductive period. It lists various tests that are considered less critical, including: Hysterosalpingogram, evaluation of symptoms through the couple's reproductive history, TORCH infections screening, endometrial testing during the luteal phase, and postcoital testing.\n</step1>\n<step2>\nIn this context, *àwọn àdánwò tí kò ṣe pàtàkì jùlọ* refers to tests that may not be essential for diagnosing the infertility issue. The question implies that we need to identify which tests are the least important.\n</step2>\n<step3>\nThe tests mentioned include *Hysterosalpinogram* (to check the fallopian tubes), which is often crucial, and *endometrial testing* during the luteal phase, which can provide insights into the uterine lining.\n</step3>\n<step4>\nHowever, *ṣíṣàyẹ̀wò àwọn ohun-àmì àrùn* through the couple's history and *àdánwò Postcoital* (which assesses sperm and cervical mucus interaction) might be less critical in this specific case.\n</step5>\n<step6>\nConsidering the options, we need to select the combination that includes the least important tests. Options A, B, C, and D present different combinations of these tests.\n</step7>\n<step8>\nAfter analyzing the importance of each test, it seems that options including the postcoital test and the couple's history evaluation are less critical compared to the others.\n</step9>\n<step10>\nThus, the best choice that reflects the least important tests would be option C, which includes tests 3 and 5.\n</step10></thinking>", "answer": "<answer>Àṣàyàn 3,5</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 50 kan ti ní irora ọmu lẹhin ẹgbẹ́ ọkan tó ń tàn sí ẹhin, ikọ́rọ̀, ìmúlẹ̀, àti ìgbóná ọkàn. Ó ní ìtàn àwọn ìṣẹ̀lẹ̀ tó dàbí èyí, ati ECG rẹ̀ dára.  Ìwádìí barium swallow àti esophageal manometry fihan aperistalsis ni ju 30% lọ ninu awọn mimu omi pẹlu 20% ti o jẹ nigbakannaa, ati awọn contractions ni awọn ipin mẹta ikẹhin ti esophagus pẹlu awọn amplitudes ti o ju 30 mm Hg lọ.  Oògùn wo ni a le lo lati dinku awọn aami aisan rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What medication can be used to reduce the symptoms of a 50-year-old man who has chest pain radiating to the back, dysphagia, and heartburn, with a history of similar events and a normal ECG?” — it highlights symptoms like *irora ọmu* [chest pain], *ikọ́rọ̀* [dysphagia], and *ìmúlẹ̀* [heartburn].\n</step1>\n<step2>\nThe symptoms suggest a possible esophageal motility disorder, particularly given the findings of *aperistalsis* and abnormal contractions in the esophagus. This indicates that the esophagus is not functioning properly, leading to difficulty swallowing.\n</step2>\n<step3>\nIn such cases, medications like proton pump inhibitors (PPIs) can help manage *ìmúlẹ̀* by reducing stomach acid production, which may alleviate heartburn symptoms.\n</step3>\n<step4>\nAdditionally, medications that promote esophageal motility, such as *metoclopramide*, could be beneficial. This drug enhances the contractions of the esophagus, potentially improving *ikọ́rọ̀*.\n</step4>\n<step5>\nIt's also important to consider lifestyle modifications alongside medication, such as dietary changes and avoiding triggers that worsen symptoms.\n</step5>\n<step6>\nIn summary, a combination of PPIs and prokinetic agents like *metoclopramide* may effectively reduce the patient's symptoms.\n</step6></thinking>", "answer": "<answer>A le lo awọn proton pump inhibitors ati metoclopramide lati dinku awọn aami aisan rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọ̀dọ́ kan wà pẹ̀lú irora àyà tí kò ní í ṣe pẹ̀lú ṣiṣe eré ìdárayà.  Títẹ́tí sí ọkàn rẹ̀ fi hàn pé ọ̀pọ̀lọpọ̀ ìkọlu ìtìjáde wà pẹ̀lú ṣíṣe ìró.  Ìwádìí tí ó ṣe pàtàkì jùlọ fún àyẹ̀wò ni:\nA. ECG\nB. Àyẹ̀wò Thallium 201\nC. Àyẹ̀wò Tc pyrophosphate\nD. Echocardiography", "reasoning": "<thinking><step1>\nThe question translates to: \"A young woman is experiencing chest pain that is not related to physical activity. An examination of her heart shows that there are multiple stress test abnormalities.\" It asks which test is most important for evaluation.\n</step1>\n<step2>\nIn this context, the symptoms suggest a potential cardiac issue — *ìṣòro ọkàn*. The fact that the pain is not related to exercise indicates it could be more serious than typical angina.\n</step2>\n<step3>\nThe options provided include various cardiac tests. An ECG — *ECG* — is useful for initial assessment but may not provide detailed information about ischemia.\n</step3>\n<step4>\nThallium 201 test — *Àyẹ̀wò Thallium 201* — is a nuclear stress test that can show blood flow to the heart muscle, but it is less commonly used now.\n</step4>\n<step5>\nEchocardiography — *Echocardiography* — provides real-time images of the heart and can assess its function, but it may not specifically identify ischemic changes.\n</step5>\n<step6>\nThe Tc pyrophosphate test — *Àyẹ̀wò Tc pyrophosphate* — is typically used for detecting myocardial infarction but is not the first-line test for stress abnormalities.\n</step6>\n<step7>\nGiven the context of multiple stress test abnormalities, the most critical test for evaluating cardiac function and ischemia would be an echocardiogram, as it provides comprehensive information about the heart's structure and function.\n</step7></thinking>", "answer": "<answer>Echocardiography ni àyẹ̀wò pàtàkì jùlọ fún àyẹ̀wò àyà àìlera.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹ́tádinlọ́gọ́rin kan, ní ìyàgbàgbà ẹ̀gbẹ́ ìtá ilẹ̀kùn ẹsẹ̀. Ó ní ìṣòro ìdásílẹ̀ nítorí pé a kò tọ́jú ìyàgbàgbà náà dáadáa.  Ìṣòro ìdásílẹ̀ yìí yóò mú kí:\nA. Ẹsẹ̀ ṣe genu valgum\nB. Ẹsẹ̀ ṣe genu varum\nC. Ẹsẹ̀ ṣe genu recurvatum\nD. Ẹsẹ̀ já", "reasoning": "<thinking><step1>\nThe question is asking about a 13-year-old boy with a knee deformity, specifically regarding the consequences of poor management of this condition. The key terms include \"ìyàgbàgbà\" [deformity] and \"ìṣòro ìdásílẹ̀\" [knee problem].\n</step1>\n<step2>\nIn this context, \"ìyàgbàgbà\" refers to a deformity that can affect the alignment of the legs. Poor management can lead to various types of knee deformities.\n</step2>\n<step3>\nThe options provided are different types of knee deformities: \n- \"genu valgum\" [knock-knees], \n- \"genu varum\" [bow legs], \n- \"genu recurvatum\" [back-knee], \n- and \"já\" [normal].\n</step3>\n<step4>\nIf the knee is not properly managed, it is likely to develop into either \"genu valgum\" or \"genu varum,\" depending on the specific alignment issues.\n</step5>\n<step5>\nConsidering the age and the description of the problem, \"genu valgum\" is a common outcome when there is poor alignment, leading to the knees bending inward.\n</step6>\n<step6>\nThus, the most likely consequence of this poorly managed knee deformity is \"genu valgum.\"\n</step6></thinking>", "answer": "<answer>Ẹsẹ̀ yóò ṣe genu valgum.</answer>", "language": "Yoruba"}
{"question": "Báwo ni a ṣe yẹ ki a tọ́jú obìnrin kan tí ó lóyún nígbà kejì (gravida 3) tí ó ní ìtàn abẹ́rù mẹ́rin ní ìgbà ọ̀sù kejì ìlóyún, tí ó sì ní ìṣòro ìgbà ṣíṣí ọ̀fun (cervical funneling) ní ọ̀sù 22 ti ìlóyún rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Báwo ni a ṣe yẹ ki a tọ́jú obìnrin kan tí ó lóyún nígbà kejì (gravida 3)?” — meaning it seeks guidance on how to manage a pregnant woman with a history of four previous miscarriages and cervical funneling at 22 weeks of pregnancy.\n</step1>\n<step2>\nFirst, it’s important to understand that *ìtàn abẹ́rù* (history of miscarriages) increases the risk of complications in subsequent pregnancies — *ìṣòro àkúnya*.\n</step2>\n<step3>\nCervical funneling, or *ìṣòro ìgbà ṣíṣí ọ̀fun*, indicates that the cervix is shortening or dilating prematurely, which can lead to preterm labor — *ìbí àkúnya*.\n</step3>\n<step4>\nManagement should include close monitoring through regular ultrasounds to assess cervical length — *ìtẹ́le àyẹ̀wò* — and possibly progesterone supplementation to support the pregnancy.\n</step4>\n<step5>\nAdditionally, advising the patient to avoid strenuous activities and to rest as much as possible is crucial — *ìsinmi* le jẹ́ pataki.\n</step5>\n<step6>\nIn cases of significant cervical changes, a cervical cerclage may be considered to provide additional support — *àtúnṣe ọ̀fun*.\n</step6>\n<step7>\nOverall, a multidisciplinary approach involving obstetricians and possibly maternal-fetal medicine specialists is essential for optimal care.\n</step7></thinking>", "answer": "<answer>A yẹ ki a tọ́jú obìnrin náà pẹ̀lú ìtẹ́le àyẹ̀wò, ìsinmi, àti ìmúlò progesterone, pẹ̀lú àtúnṣe ọ̀fun bí ó bá jẹ́ dandan.</answer>", "language": "Yoruba"}
{"question": "Iru iwadi aarun ọgbẹ̀gbẹ̀wo ni a ṣe lati dán igbẹ́kẹ̀lé ìmọ̀ran nípa idi àrùn kan?", "reasoning": "<thinking><step1>\nThe question asks: “Iru iwadi aarun [disease study] ọgbẹ̀gbẹ̀wo [clinical trial] ni a ṣe lati dán igbẹ́kẹ̀lé [to test the reliability] ìmọ̀ran [information] nípa idi àrùn kan [about a disease]?” — meaning it seeks to understand what type of clinical trials are conducted to test the reliability of information regarding a disease.\n</step1>\n<step2>\nClinical trials are research studies that test new treatments or interventions — *iwadi tuntun* — to determine their efficacy and safety.\n</step2>\n<step3>\nThere are different phases of clinical trials: Phase I tests safety, Phase II tests efficacy, and Phase III compares the new treatment to standard care — *iwadi ti a ṣe ni ipele*.\n</step3>\n<step4>\nIn these trials, participants are monitored closely for side effects and outcomes — *awọn alabaṣiṣẹpọ ni a n ṣakiyesi* to gather data on the treatment's effectiveness.\n</step4>\n<step5>\nThe results from these trials help inform medical guidelines and practices — *awọn abajade iwadi yi n ṣe iranlọwọ lati ṣe alaye awọn ilana iṣoogun*.\n</step6>\n<step6>\nThus, the type of study conducted is a clinical trial, which is essential for validating treatment approaches for a specific disease.\n</step6></thinking>", "answer": "<answer>Iwadi aarun ọgbẹ̀gbẹ̀wo ni a ṣe lati dán igbẹ́kẹ̀lé ìmọ̀ran nípa idi àrùn kan ni iwadi tuntun ti a n ṣe lati ṣayẹwo aabo ati ṣiṣe.</answer>", "language": "Yoruba"}
{"question": "Agbẹ́dẹ́wọ̀n obìnrin ọmọ ọdún 55 kan ti wọ́n tọ́jú ní ẹ̀ka ìṣègùn pajawiri lẹ́yìn tí ó ṣubú láti ibi ìtàgé sí inú ihò òrùlé. Àwòrán X-ray fi ìyàtọ̀ ní ọ̀nà ìtẹ̀sílẹ̀ ti ulna hàn. A rò pé ìdààmú ní àwọn ẹ̀yà cartilage triangular fibrocartilage wa. Pẹ̀lú eyikeyi ninu awọn egungun wọnyi ni ulna maa n sopọ mọ ẹgbẹ́ ẹ̀gbà?\nA. Triquetrum\nB. Hamate\nC. Radius ati lunate\nD. Radius", "reasoning": "<thinking><step1>\nThe question is asking about the connection of the ulna bone in a 55-year-old woman who fell and has an X-ray showing an abnormality in the ulna's alignment — specifically, it mentions a potential issue with the triangular fibrocartilage [cartilage triangulaire fibrocartilage].\n</step1>\n<step2>\nIn the wrist anatomy, the ulna connects to several bones. The key bones to consider are the radius and the carpal bones — *les os du carpe*.\n</step2>\n<step3>\nThe ulna primarily articulates with the radius and the carpal bones, particularly the lunate and triquetrum — *le triquetrum* and *le lunatum*.\n</step4>\n<step4>\nThe triangular fibrocartilage complex [complexe fibrocartilagineux triangulaire] is crucial for stability between the ulna and the carpal bones.\n</step5>\n<step5>\nGiven the options, the ulna directly connects with the radius and lunate, making option C the most relevant — *le radius et le lunatum*.\n</step6>\n<step6>\nThus, the ulna is most commonly associated with the radius and lunate in this context.\n</step6></thinking>", "answer": "<answer>Ulna maa n sopọ mọ Radius ati lunate.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹ́tádinlógún kan tí ọkọ̀ ayọkẹ́lẹ́ bá lu, ó ní irora inu ni apá òsì, àti ìṣòro ẹ̀dọ̀fóró ìpele III, tí a rí ìdààmú ẹ̀jẹ̀ lára rẹ̀ ní CT scan. Ara rẹ̀ dáradára síi. Ṣe àlàyé ọ̀nà ìtọ́jú tí a gbọ́dọ̀ tẹ̀ lé láti tọ́jú ìṣòro ẹ̀dọ̀fóró náà.", "reasoning": "<thinking><step1>\nThe question asks: “What treatment approach should be followed for a 17-year-old boy who was hit by a car, has left-sided abdominal pain, and shows signs of grade III liver injury on a CT scan?” — here, *ìṣòro ẹ̀dọ̀fóró = liver injury*.\n</step1>\n<step2>\nIn cases of grade III liver injury, the first step is to assess the severity of the injury — *ìtẹ́numọ̀ àìlera* is crucial.\n</step2>\n<step3>\nMonitoring vital signs is essential; we need to check for *ìfarapa ẹ̀jẹ̀* or internal bleeding, which can be life-threatening.\n</step3>\n<step4>\nIf the patient is stable, *ìtọ́jú àìlera* may involve bed rest and pain management — using medications like acetaminophen.\n</step4>\n<step5>\nHowever, if there are signs of significant bleeding or the patient’s condition worsens, surgical intervention may be necessary — *ìtẹ̀síwájú iṣẹ́ abẹ́* could be required.\n</step6>\n<step6>\nIn summary, the treatment plan should focus on careful monitoring, supportive care, and readiness for possible surgery if complications arise.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú ìṣòro ẹ̀dọ̀fóró yẹ kí o ní ìtẹ́numọ̀ àìlera, ìtọ́jú àìlera, àti ìtẹ̀síwájú iṣẹ́ abẹ́ bí a bá rí i pé ó ṣe pàtàkì.</answer>", "language": "Yoruba"}
{"question": "Ninu ipo wo ni dida okuta kidinirin ti o ni kalsiamu ko ṣeeṣe?\nA. Adenoma parathyroid.\nB. Myeloma pupọ.\nC. Sarcoidosis.\nD. Àrùn Lesch-Nyhan.", "reasoning": "<thinking><step1>\nThe question asks: “Ninu ipo wo ni dida okuta kidinirin ti o ni kalsiamu ko ṣeeṣe?” — meaning it wants to know in which condition the formation of kidney stones containing calcium is unlikely.\n</step1>\n<step2>\nKidney stones, or *okuta kidinirin*, often form due to high levels of calcium in the urine — *kalsiamu ninu urine*.\n</step2>\n<step3>\nConditions like *adenoma parathyroid* can increase calcium levels, leading to stone formation.\n</step3>\n<step4>\nIn contrast, *myeloma pupọ* can cause hypercalcemia, which also promotes stone development.\n</step4>\n<step5>\n*Sarcoidosis* can lead to increased calcium absorption, making stones more likely as well.\n</step5>\n<step6>\nHowever, *àrùn Lesch-Nyhan* is primarily associated with uric acid stones rather than calcium stones, making it less likely for calcium stones to form.\n</step6>\n<step7>\nThus, the condition where calcium stone formation is unlikely is *àrùn Lesch-Nyhan*.\n</step7></thinking>", "answer": "<answer>Àrùn Lesch-Nyhan ni ipo ti dida okuta kidinirin ti o ni kalsiamu ko ṣeeṣe.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 25 kan wá sí Ẹ̀ka Ìtọ́jú Ìpàdàbọ̀ Àkànṣe pẹ̀lú àìlera ìgbàgbọ́, ìgbóná ara tí ó tàn káàkiri, ríru, ẹ̀gbọ̀n, àti ìgbóná ara fún ọjọ́ méjì. Ìwádìí ara fi hàn pé ọ̀pọ́n àbẹ́rẹ̀ tí ó gbẹ́ wà nínú àpò-ẹ̀yìn rẹ̀, àti ẹ̀jẹ̀ tí a mú fún ìwádìí kò ní ààrùn, èyí tí ó fi hàn pé àrùn ìgbóná ara tí ó gbóná gan-an. Àyọ̀kà tí ó yàtọ̀ sí i lórí sẹ́ẹ̀li T ni majẹ̀mu náà ṣe pàtàkì jù lọ láti so mọ́?", "reasoning": "<thinking><step1>\nThe question asks about a 25-year-old woman who presents to the Emergency Department with symptoms like fever, chills, and body aches — *àìlera ìgbàgbọ́* and *ìgbóná ara* for two days. \n</step1>\n<step2>\nThe findings show that she has multiple abscesses in her back — *àbẹ́rẹ̀* — and the blood tests indicate no infection, suggesting a severe fever without a clear infectious cause.\n</step2>\n<step3>\nIn this context, the mention of *àyọ̀kà* related to T cells is crucial because it indicates a potential immune response issue — *ìṣòro àbáyọ́*.\n</step3>\n<step4>\nThe importance of T cell involvement could suggest an autoimmune condition or a severe systemic reaction, which is critical for diagnosis — *pàtàkì fún ìdánilójú*.\n</step5>\n<step5>\nThus, understanding the T cell response helps in determining the underlying cause of her symptoms and guiding treatment — *ìtọ́jú*.\n</step6>\n<step6>\nIn summary, the T cell profile is essential to clarify the nature of her illness and to rule out serious conditions.\n</step6></thinking>", "answer": "<answer>Àyọ̀kà T jẹ́ pàtàkì láti mọ́ ìdí àìlera rẹ̀ àti láti ṣe àyẹ̀wò àrùn tó lè jẹ́ àìlera àbáyọ́.</answer>", "language": "Yoruba"}
{"question": "Alisi, Bobu, Klea, Deifu, Ifi, Feredi, ati Geriturudu jẹ́ awọn agbaṣe ni iṣẹ́ ìrìn-àjò yìí.  Ní ìbẹ̀rẹ̀ orin náà, olúkúlùkù wọn ní ọ̀rẹ́: Alisi ń jọṣe pẹlu Samu, Bobu ń jọṣe pẹlu Izzi, Klea ń jọṣe pẹlu Melisa, Deifu ń jọṣe pẹlu Lola, Ifi ń jọṣe pẹlu Helga, Feredi ń jọṣe pẹlu Ophelia, ati Geriturudu ń jọṣe pẹlu Karl.\nLáàrin orin náà, awọn agbaṣe sábà máa ń yí ọ̀rẹ́ pada.  Àkọ́kọ́, Bobu ati Alisi yí ọ̀rẹ́ pada.  Lẹ́yìn náà, Ifi ati Alisi yí ọ̀rẹ́ pada.  Lẹ́yìn náà, Deifu ati Feredi yí ọ̀rẹ́ pada.  Lẹ́yìn náà, Geriturudu ati Ifi yí ọ̀rẹ́ pada.  Lẹ́yìn náà, Ifi ati Deifu yí ọ̀rẹ́ pada.  Lẹ́yìn náà, Geriturudu ati Deifu yí ọ̀rẹ́ pada.  Níkẹyìn, Bobu ati Klea yí ọ̀rẹ́ pada. Nígbà tí ìrìn-àjò náà bá parí, Feredi ń jọṣe pẹlu\nAwọn aṣayan:\n(A) Samu\n(B) Izzi\n(C) Melisa\n(D) Lola\n(E) Helga\n(F) Ophelia\n(G) Karl", "reasoning": "<thinking><step1>\nThe question describes a scenario where several characters, Alisi, Bobu, Klea, Deifu, Ifi, Feredi, and Geriturudu, are paired with friends at the beginning of a song. It asks who Feredi ends up with at the end of the journey after several friend swaps.\n</step1>\n<step2>\nInitially, the pairs are: Alisi with Samu, Bobu with Izzi, Klea with Melisa, Deifu with Lola, Ifi with Helga, Feredi with Ophelia, and Geriturudu with Karl. \n</step2>\n<step3>\nThe first swap is between Bobu and Alisi, so now Bobu is with Samu and Alisi with Izzi. \n</step3>\n<step4>\nNext, Ifi swaps with Alisi, resulting in Ifi with Izzi and Alisi with Helga. \n</step4>\n<step5>\nThen, Deifu swaps with Feredi, leading to Deifu with Ophelia and Feredi with Lola. \n</step5>\n<step6>\nAfter that, Geriturudu swaps with Ifi, so Geriturudu is now with Izzi and Ifi with Karl. \n</step6>\n<step7>\nThen, Ifi swaps with Deifu, resulting in Ifi with Ophelia and Deifu with Karl. \n</step7>\n<step8>\nNext, Geriturudu swaps with Deifu, leading to Geriturudu with Karl and Deifu with Izzi. \n</step8>\n<step9>\nFinally, Bobu and Klea swap, so Bobu is now with Melisa and Klea with Izzi. \n</step9>\n<step10>\nAt the end of all these swaps, we need to determine who Feredi is with. After analyzing the swaps, Feredi ends up with Lola.\n</step10></thinking>", "answer": "<answer>Lola</answer>", "language": "Yoruba"}
{"question": "Lẹ́yìn tí aláìsàn kan fúnra rẹ̀ ṣe ìdánimọ̀ pé òun ní àrùn ẹsẹ̀ tóńjẹni (athlete's foot) tí ìtọ́jú àkọ́kọ́ sì mú àmì àrùn náà sàn díẹ̀ ṣùgbọ́n kò mú un lọ pátápátá, àbájáde àyẹ̀wò ègé àwọ ẹsẹ̀ tí wọ́n fi ránṣẹ́ sílé àyẹ̀wò fi hàn pé kòkòrò olú tó ń dàgbà láìyára wà níbẹ̀ pẹ̀lú àwọn microconidia kéékèèké díẹ̀. Dá orúkọ ìran (genus) dermatophyte tí wọ́n yà sọ́tọ̀ nínú ọ̀ràn yìí.", "reasoning": "<thinking><step1>\nThe question asks: “Dá orúkọ ìran (genus) dermatophyte tí wọ́n yà sọ́tọ̀ nínú ọ̀ràn yìí” — meaning it wants to identify the genus of the dermatophyte responsible for athlete's foot.\n</step1>\n<step2>\nAthlete's foot is caused by fungi that thrive in warm, moist environments — *àwọn kokoro arun* ti o n gbe ni agbegbe gbigbona ati tutu.\n</step2>\n<step3>\nThe most common dermatophyte associated with this condition is *Trichophyton rubrum* — a species that often leads to persistent infections.\n</step3>\n<step4>\nIn cases where initial treatment is insufficient, *ìtọ́jú àkọ́kọ́* may not eliminate the infection completely, indicating the need for further intervention.\n</step4>\n<step5>\nThe presence of *microconidia* suggests that the fungus is actively reproducing, which is typical for *Trichophyton* species.\n</step5>\n<step6>\nThus, the genus of the dermatophyte in this case is *Trichophyton*.\n</step6></thinking>", "answer": "<answer>Ìran dermatophyte tí wọ́n yà sọ́tọ̀ nínú ọ̀ràn yìí ni *Trichophyton*.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun mẹ́tadinlọ́gọ́ta (35) kan wọ́lé sí ilé ìwòsàn pẹ̀lú ìṣòro ìṣàn tí ó ń tàn jáde láti ara rẹ̀ ní apá òtún isalẹ̀. Àyẹ̀wò ara fi hàn pé ó ní ìṣàn ìwọ̀n inu. Da lórí ibi tí ó wà àti àwọn ànímọ́ rẹ̀, kí ni àlàyé tó bá dara jùlọ fún ìṣàn ìwọ̀n yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àlàyé tó bá dara jùlọ fún [ìṣàn ìwọ̀n = internal bleeding]?” — meaning it seeks the best explanation for internal bleeding in a 35-year-old woman who has presented with this issue.\n</step1>\n<step2>\nInternal bleeding occurs when blood leaks from blood vessels into the body — *ìṣàn náà lè ṣẹlẹ̀ nítorí ìfarapa tàbí àìlera*.\n</step2>\n<step3>\nIn this case, the bleeding is noted in the lower right abdomen — *apá òtún isalẹ̀*, which could indicate issues with organs like the appendix or ovaries.\n</step4>\n<step4>\nSymptoms may include pain, dizziness, or weakness — *ìrora, ìrora tó pọ̀, àti àìlera* are common signs of internal bleeding.\n</step5>\n<step5>\nDiagnosis typically involves imaging tests like ultrasound or CT scan — *àyẹ̀wò àwòrán* helps to identify the source of the bleeding.\n</step6>\n<step6>\nTherefore, the best explanation for this internal bleeding could be a ruptured cyst or an appendicitis — *ìfarapa àtọ́ka tàbí ìṣòro appendicitis*.\n</step6></thinking>", "answer": "<answer>Àlàyé tó dára jùlọ fún ìṣàn ìwọ̀n yìí ni pé ó lè jẹ́ ìfarapa àtọ́ka tàbí ìṣòro appendicitis.</answer>", "language": "Yoruba"}
{"question": "Nigbati igbimo ile-iwosan kan bá fẹ́ ṣe idiwọ́ iṣẹ́ abẹ̀ tí a kò bá ṣe ní ibi tó yẹ́ ṣáájú kí àkọ̀nàkọ̀nà kan tó ṣẹlẹ̀ nípa ṣíṣàgbéyẹ̀wò àwọn ọ̀ràn eto, àpẹrẹ̀, ilana, àti iṣẹ́, ẹ̀ka pàtó wo ni wọ́n máa gbé yọ sínú àgbéyẹ̀wò wọn tí ó dojú kọ́ ìdánilójú àwọn àìṣẹ́lẹ̀ tí ó ṣeeṣe nínú eto náà?", "reasoning": "<thinking><step1>\nThe question asks: “When a hospital committee wants to prevent a surgical procedure that should not be performed without prior review of the system issues, which specific department will they include in their review to address potential adverse events in the system?” This involves understanding the roles of various departments in a hospital setting.\n</step1>\n<step2>\nIn a hospital, *ẹka iṣoogun* (the medical department) plays a crucial role in evaluating surgical procedures. They assess patient safety and the appropriateness of the procedure.\n</step2>\n<step3>\nAdditionally, *ẹka iṣakoso didara* (the quality management department) is essential for reviewing protocols and ensuring compliance with safety standards — they help identify potential risks.\n</step4>\n<step4>\nThe *ẹka imulo* (policy department) may also be involved, as they establish guidelines that govern surgical practices and ensure that all procedures align with best practices.\n</step5>\n<step5>\nFinally, *ẹka imọ-ẹrọ* (the engineering department) could be consulted to evaluate the technical aspects of surgical equipment and facilities, ensuring they meet safety requirements.\n</step6>\n<step6>\nThus, the committee would likely include the medical, quality management, policy, and engineering departments in their review to comprehensively address potential adverse events.\n</step6></thinking>", "answer": "<answer>Wọ́n máa gbé ẹka iṣoogun, ẹka iṣakoso didara, ẹka imulo, àti ẹka imọ-ẹrọ sínú àgbéyẹ̀wò wọn.</answer>", "language": "Yoruba"}
{"question": "Ṣé àwọn ènìyàn tó nífẹ̀ẹ́ sí mímú ohun ṣe àtòkọ́ ní àrùn ọkàn?\nA. Rárá, mímú ohun ṣe àtòkọ́ kì í ṣe àmì àrùn ọkàn nígbà gbogbo.\nB. Bẹ́ẹ̀ni, àwọn ènìyàn tó nífẹ̀ẹ́ sí mímú ohun ṣe àtòkọ́ ní àrùn OCD.\nC. Bẹ́ẹ̀ni, àwọn tó ní àrùn OCD nìkan ló nífẹ̀ẹ́ sí mímú ohun ṣe àtòkọ́.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé àwọn ènìyàn tó nífẹ̀ẹ́ sí mímú ohun ṣe àtòkọ́ ní àrùn ọkàn?” — which translates to “Do people who enjoy compulsive behaviors have a mental illness?”\n</step1>\n<step2>\nTo understand this, we need to clarify what *mímú ohun ṣe àtòkọ́* means — it refers to compulsive behaviors, often associated with conditions like OCD (Obsessive-Compulsive Disorder).\n</step2>\n<step3>\nPeople with OCD often engage in compulsive actions to alleviate anxiety — *nípa dènà ìbànújẹ* — but not everyone who enjoys these behaviors has a mental illness.\n</step3>\n<step4>\nOption A states that compulsive behaviors are not always a sign of mental illness, which is true; many people may have habits without having a disorder.\n</step4>\n<step5>\nOption B suggests that those who enjoy compulsive behaviors may have OCD, which is partially correct, but it’s not exclusive to them.\n</step5>\n<step6>\nOption C claims that only those with OCD enjoy compulsive behaviors, which is misleading since many can engage in similar behaviors without having OCD.\n</step6>\n<step7>\nThus, the most accurate answer is that while some people with OCD may enjoy compulsive behaviors, it does not mean all who do have a mental illness.\n</step7></thinking>", "answer": "<answer>Rárá, mímú ohun ṣe àtòkọ́ kì í ṣe àmì àrùn ọkàn nígbà gbogbo.</answer>", "language": "Yoruba"}
{"question": "Iru isesi ara-alagbara wo ni a fi awọn ami aisan bii iba, urticaria, nyún, ati wiwu lẹhin abẹrẹ Penicillin han, ti o si kan aporo IgG?", "reasoning": "<thinking><step1>\nThe question asks: “Iru [isesi ara-alagbara = allergic reaction] wo ni a fi awọn ami aisan bii [iba = fever], [urticaria = hives], [nyún = itching], ati [wiwu = swelling] lẹhin abẹrẹ [Penicillin = Penicillin injection] han, ti o si kan [aporo IgG = IgG antibody]?” — meaning it wants to know what type of allergic reaction is indicated by these symptoms after a Penicillin injection related to IgG.\n</step1>\n<step2>\nAn allergic reaction occurs when the immune system responds to a substance as if it were harmful — *nigbati eto ajẹsara ba fesi si nkan bi ẹni pe o jẹ ipalara*.\n</step2>\n<step3>\nIn this case, Penicillin can trigger an IgE-mediated response, leading to symptoms like fever, hives, itching, and swelling — *awọn ami aisan wọnyi le jẹ abajade ti fesi ajẹsara*.\n</step4>\n<step4>\nIgG antibodies are typically involved in secondary immune responses, but in this context, they may indicate a delayed hypersensitivity reaction — *fesi ti o pẹ*.\n</step5>\n<step5>\nThe symptoms suggest a possible allergic reaction, which could be classified as an anaphylactic reaction if severe — *fesi anaphylactic*.\n</step6>\n<step6>\nThus, the type of allergic reaction indicated here is likely a hypersensitivity reaction to Penicillin, possibly mediated by IgE.\n</step6></thinking>", "answer": "<answer>Iru isesi ara-alagbara ti a fi awọn ami aisan wọnyi han ni fesi ajẹsara ti o pẹ si Penicillin, ti o le jẹ ti IgE.</answer>", "language": "Yoruba"}
{"question": "Labẹ apawo ni Ìgbéwọ́ Ẹ̀ṣẹ̀ India ni iṣẹ́ tí ó jẹ́ pé a máa pa ẹnikan mọ́ lábẹ́ agbára ẹni, tí a sì máa ṣe ìṣẹ̀lẹ̀kùn sí i láìní ìpinnu láti pa á ni a ti gbékalẹ̀?", "reasoning": "<thinking><step1>\nThe question translates to: \"What is the [law = ofin] in India regarding the [death penalty = ẹ̀ṣẹ̀ ikú] that allows for someone to be executed without a decision to kill them?\" This indicates a focus on the legal framework surrounding capital punishment in India.\n</step1>\n<step2>\nIn India, the death penalty is governed by the Indian Penal Code and other laws — *kódà, àwọn òfin yìí ni a fi n ṣakoso ẹ̀ṣẹ̀ ikú*.\n</step2>\n<step3>\nThe law allows for the death penalty in certain serious crimes, such as murder — *àwọn ẹ̀ṣẹ̀ tó ṣe pàtàkì, bí i ikú*.\n</step3>\n<step4>\nHowever, the execution must follow a legal process, including trials and appeals — *ṣùgbọ́n, a ní láti tẹle ilana ofin, pẹ̀lú ìdájọ́ àti ìpè*.\n</step4>\n<step5>\nThe concept of \"rarest of rare\" is crucial; the Supreme Court of India states that the death penalty should only be applied in the most heinous cases — *ìtàn àìmọ̀, a ní láti fi ẹ̀ṣẹ̀ ikú ṣe àfihàn nínú àwọn ọran tó burú jùlọ*.\n</step6>\n<step6>\nThus, executing someone without a proper legal decision contradicts the principles of justice in India — *nítorí náà, pa ẹnikan mọ́ lábẹ́ agbára ẹni láìní ìpinnu jẹ́ àìtẹ́lọ́run*.\n</step7>\n<step7>\nIn summary, the law requires a thorough judicial process before any execution can take place — *òfin náà ní àìmọ̀ pé a ní láti ní ilana kíkankíkan ṣáájú kí a tó pa ẹnikan*.\n</step7></thinking>", "answer": "<answer>Ìgbéwọ́ ẹ̀ṣẹ̀ ikú ni India ní àìmọ̀ pé a ní láti tẹle ilana ofin kíkankíkan ṣáájú kí a tó pa ẹnikan.</answer>", "language": "Yoruba"}
{"question": "Da ipele idagbasoke ọmọ ọwẹ ti o wa ni ẹda 80th fun gigun ati iwuwo, ti bẹrẹ sisun, nwa awọn ohun ti o ti sọkalẹ, sọ 'mama' ati 'dada' lai ṣe pataki, ati pe o le ṣe agbara pincer, kini ọgbọ́n ẹ̀rọ afikun ti a nireti ni ọjọ-ori yii?", "reasoning": "<thinking><step1>\nThe question asks: “What additional cognitive skills are expected at this age?” — referring to a child who is 80th percentile for height and weight, has started crawling, says 'mama' and 'dada' indiscriminately, and can perform a pincer grasp.\n</step1>\n<step2>\nAt this developmental stage, children typically show increased curiosity and exploration — *iwariiri* and *iṣawari* are key behaviors as they crawl and interact with their environment.\n</step2>\n<step3>\nCognitive skills include problem-solving abilities, such as figuring out how to reach a toy — *bawo ni a ṣe le de ohun kan* — and understanding cause and effect.\n</step3>\n<step4>\nThey may also begin to recognize familiar faces and objects, showing signs of memory development — *iranti* is crucial at this stage.\n</step4>\n<step5>\nAdditionally, social skills are emerging; they might engage in simple games like peek-a-boo — *ere-ibè* — which helps with social interaction and bonding.\n</step5>\n<step6>\nOverall, we expect advancements in language comprehension, as they start to associate words with meanings, even if they are still babbling.\n</step6></thinking>", "answer": "<answer>Ni ọjọ-ori yii, a nireti ilọsiwaju ninu awọn ọgbọn iṣaro, iranti, ati awọn ọgbọn awujọ, pẹlu ibaraenisepo pẹlu awọn nkan ati awọn eniyan.</answer>", "language": "Yoruba"}
{"question": "Pẹlu awọn iye iwọn didun ito ti Na+ = 137 mmol/L, K+ = 4 mmol/L, Cl- = 110 mmol/L, ati HCO3- = 15 mmol/L, ka ipin anion naa.", "reasoning": "<thinking><step1>\nThe question asks: “Pẹlu awọn iye iwọn didun ito ti [Na+ = sodium], [K+ = potassium], [Cl- = chloride], ati [HCO3- = bicarbonate], ka ipin anion naa?” — meaning it wants to calculate the anion gap using the provided electrolyte values.\n</step1>\n<step2>\nThe anion gap is calculated using the formula: *anion gap = [Na+] - ([Cl-] + [HCO3-])*.\n</step2>\n<step3>\nSubstituting the values: *Na+ = 137 mmol/L*, *Cl- = 110 mmol/L*, and *HCO3- = 15 mmol/L*.\n</step3>\n<step4>\nSo, we compute: *anion gap = 137 - (110 + 15)*, which simplifies to *137 - 125*.\n</step4>\n<step5>\nThis results in an anion gap of *12 mmol/L*.\n</step5></thinking>", "answer": "<answer>Ipin anion naa jẹ 12 mmol/L.</answer>", "language": "Yoruba"}
{"question": "Olùwadiwọn kan ń kẹ́kọ̀ọ́ oògùn kan tí ó nípa lórí ọ̀nà homonu taị́róídì, ó sì ṣàkíyèsí pé lẹ́yìn tí ó fún àwọn ọ̀tọ̀dọ̀mọ̀tọ̀dọ̀mọ̀ ní oògùn náà, ìwọ̀n T3 tí ó kún fún ẹ̀jẹ̀ ṣísẹ̀ dínkùù, nígbà tí ìwọ̀n T4 tí ó kún fún ẹ̀jẹ̀ ṣísẹ̀ sì pọ̀ sí i, ní ìwéwé sí ìwọ̀n àkọ́kọ́. Èwo ni ọ̀nà ṣiṣẹ́ oògùn yìí lè jẹ́?", "reasoning": "<thinking><step1>\nThe question asks: “What mechanism of action might a drug have that affects thyroid hormones, specifically T3 and T4 levels?” — here, T3 and T4 refer to thyroid hormones that regulate metabolism.\n</step1>\n<step2>\nThe observation indicates that after administering the drug, T3 levels decreased while T4 levels increased — *nígbà tí T3 dínkù, T4 pọ̀ sí i*.\n</step2>\n<step3>\nThis suggests that the drug may inhibit the conversion of T4 to T3, which is a common pathway in thyroid hormone metabolism — *ìyẹn ni pé oògùn náà lè dènà ìyípadà T4 sí T3*.\n</step3>\n<step4>\nIn addition, the increase in T4 could imply that the drug stimulates the thyroid gland or enhances T4 production — *oògùn náà lè mu ki àtọ́ka T4 pọ̀ si*.\n</step4>\n<step5>\nAnother possibility is that the drug affects the binding proteins or receptors for these hormones, altering their availability in the bloodstream — *oògùn náà lè ní ipa lórí àwọn àtọ́ka tàbí àwọn olùdáhùn*.\n</step5>\n<step6>\nThus, the mechanism could involve inhibition of T3 synthesis or increased T4 secretion, leading to the observed hormonal changes — *ìdènà T3 tàbí ìmúra T4*.\n</step6></thinking>", "answer": "<answer>Oògùn yìí lè ní ipa lórí ìyípadà T4 sí T3 tàbí mu àtọ́ka T4 pọ̀ sí i.</answer>", "language": "Yoruba"}
{"question": "Mo ní fitila mẹrin, firiji kan, ibusun kan, ọkọ ayọkẹlẹ kan, tosta kan, ati irinṣẹ kan. Nọmba ohun ti mo ní melo?", "reasoning": "<thinking><step1>\nThe question asks: “Mo ní fitila mẹrin, firiji kan, ibusun kan, ọkọ ayọkẹlẹ kan, tosta kan, ati irinṣẹ kan” — meaning it wants to know the total number of items listed.\n</step1>\n<step2>\nFirst, let's identify the items: *fitila mẹrin* (four lamps), *firiji kan* (one refrigerator), *ibusun kan* (one bed), *ọkọ ayọkẹlẹ kan* (one car), *tosta kan* (one toaster), and *irinṣẹ kan* (one tool).\n</step2>\n<step3>\nNow, we count each item: 4 (fitila) + 1 (firiji) + 1 (ibusun) + 1 (ọkọ ayọkẹlẹ) + 1 (tosta) + 1 (irinṣẹ).\n</step3>\n<step4>\nCalculating this gives us: 4 + 1 + 1 + 1 + 1 + 1 = 9.\n</step4>\n<step5>\nThus, the total number of items is nine — *nọmba ohun ti mo ní melo ni mẹsan*.\n</step5></thinking>", "answer": "<answer>Mo ní mẹsan ohun.</answer>", "language": "Yoruba"}
{"question": "Èéṣe tí ẹ̀rí tí onílé ilé náà fi wí nípa ohun tí olùṣọ́ ilé náà sọ̀rọ̀ sí ṣe máa jẹ́ pé a kò gbà á gbọ́ ní kọ́ọ̀tì ní ọ̀ràn tí ọmọ akẹ́kọ̀ọ́ ere ìṣeré ìdánúṣù kan fi ẹjọ́ onílé ilé náà lẹ́yìn tí ó ṣubú nítorí ọ̀nà ilé tí ó gbòòrò?", "reasoning": "<thinking><step1>\nThe question asks: “What evidence does the homeowner have regarding what the caretaker said that might not be accepted in court in a case where a student fell due to a wide pathway?” — it seeks to understand the legal implications of the caretaker's statements.\n</step1>\n<step2>\nIn legal terms, *ẹ̀rí* (evidence) must be credible and relevant to the case — *ẹ̀rí tí ó yẹ* to support the homeowner's claims.\n</step2>\n<step3>\nIf the caretaker made statements that are considered hearsay — *ìtàn àìmọ̀* — they may not be admissible in court.\n</step3>\n<step4>\nFor instance, if the caretaker said, “I told the student to be careful,” this might not hold weight without direct evidence — *ẹ̀rí taara*.\n</step4>\n<step5>\nAdditionally, the condition of the pathway — *ipò ọ̀nà* — must be evaluated; if it was indeed wide and hazardous, it could shift liability to the homeowner.\n</step5>\n<step6>\nThus, the homeowner needs strong evidence, like photographs or witness statements, to substantiate their claims against the caretaker's statements.\n</step6></thinking>", "answer": "<answer>Onílé ilé náà ní láti fi ẹ̀rí tó dájú hàn pé ọ̀nà ilé náà jẹ́ àìlera, kí ìtàn àìmọ̀ olùṣọ́ ilé náà má bà a jẹ́ pé a kò gbà á gbọ́ ní kọ́ọ̀tì.</answer>", "language": "Yoruba"}
{"question": "Awọn ohun elo wo ni a maa n lò ninu iṣẹ ìgbàgbọ́ ṣíṣàn sí ìṣàn-ẹ̀jẹ̀ tó gbòòrò?", "reasoning": "<thinking><step1>\nThe question asks: “Awọn ohun elo wo ni a maa n lò ninu iṣẹ ìgbàgbọ́ ṣíṣàn sí ìṣàn-ẹ̀jẹ̀ tó gbòòrò?” — meaning it wants to know what materials are used in the process of blood transfusion.\n</step1>\n<step2>\nIn blood transfusion, *ìṣàn-ẹ̀jẹ̀* refers to the transfer of blood from one person to another, typically to treat conditions like anemia or trauma.\n</step2>\n<step3>\nKey materials include sterile blood bags — *àpò ẹ̀jẹ̀ tó mọ́* — which are essential for safely collecting and storing blood.\n</step3>\n<step4>\nAdditionally, there are blood filters — *àfihàn ẹ̀jẹ̀* — used to remove any clots or impurities before the blood enters the recipient's bloodstream.\n</step4>\n<step5>\nMedical professionals also use intravenous (IV) lines — *ìlà ẹ̀jẹ̀* — to facilitate the actual transfusion process.\n</step5>\n<step6>\nFinally, proper labeling and documentation materials are crucial for tracking blood type compatibility — *ìbáṣepọ̀ ẹ̀jẹ̀* — to prevent transfusion reactions.\n</step6></thinking>", "answer": "<answer>Àwọn ohun elo ti a maa n lò ninu iṣẹ ìgbàgbọ́ ṣíṣàn ni àpò ẹ̀jẹ̀, àfihàn ẹ̀jẹ̀, ìlà ẹ̀jẹ̀, àti awọn ohun elo ìkọkọ.</answer>", "language": "Yoruba"}
{"question": "Àgbàlàgbàlàwo ni àwọn Maya gba ọ̀nà kíkọ̀ àti ètò ìṣirò wọn lọ́wọ́?", "reasoning": "<thinking><step1>\nThe question asks: “Àgbàlàgbàlàwo ni àwọn Maya gba ọ̀nà kíkọ̀ àti ètò ìṣirò wọn lọ́wọ́?” — meaning it wants to know how the Maya developed their writing and numerical systems.\n</step1>\n<step2>\nThe Maya civilization created a complex writing system known as *hieroglyphics* — *àkóónú Maya* — which combined logograms and syllabic symbols.\n</step2>\n<step3>\nTheir writing was used for various purposes, including recording historical events and religious texts — *ìtàn àtijọ́* and *ìwé àṣẹ*.\n</step3>\n<step4>\nIn terms of their numerical system, the Maya utilized a vigesimal (base-20) system, which is quite different from the decimal system we commonly use — *eto ìṣirò vigesimal*.\n</step4>\n<step5>\nThey also invented the concept of zero, which was revolutionary for mathematics — *ìmọ̀ zero* was crucial for their calculations.\n</step5>\n<step6>\nThe combination of these systems allowed the Maya to keep detailed records and perform complex calculations, showcasing their advanced understanding of mathematics and writing.\n</step6></thinking>", "answer": "<answer>Àwọn Maya gba ọ̀nà kíkọ̀ wọn nípasẹ̀ àkóónú Maya àti eto ìṣirò vigesimal, pẹ̀lú ìmọ̀ zero.</answer>", "language": "Yoruba"}
{"question": "Ìwọ̀n ọ̀rọ̀ ìmọ̀ nípa ọkùnrin ọmọ ọdún méje-dín-lógún kan tí ó ní igbẹ́ tí kò ní irora lórí ìsàlẹ̀ ẹsẹ̀ òsì rẹ̀, ìtàn irora ẹsẹ̀ tí ó sàn nígbà tí a bá fà ẹsẹ̀ náà sísàlẹ̀, àti àwọn ìwádìí Doppler ultrasound tí ó fi hàn pé ìṣàn ẹ̀jẹ̀ ti dín kù nínú àtẹ̀gùn tibial ẹ̀yìn òsì pẹ̀lú kò sí ìṣàn rárá nínú àtẹ̀gùn dorsalis pedis, kí ni ìdí pàtàkì tí ó ṣeé ṣe jùlọ tí ó fà á?", "reasoning": "<thinking><step1>\nThe question is asking about a 17-year-old male with a condition characterized by *no pain* in the left lower leg, but with a history of pain that improves when the leg is lowered. It also mentions Doppler ultrasound findings showing reduced blood flow in the *tibial artery* but no flow in the *dorsalis pedis artery*.\n</step1>\n<step2>\nThis scenario suggests a possible vascular issue, likely related to *maladie artérielle périphérique* (peripheral artery disease). The absence of pain when the leg is lowered indicates that gravity may be aiding blood flow to the affected area.\n</step2>\n<step3>\nThe Doppler ultrasound results are crucial; they show that there is a significant reduction in blood flow in the tibial artery, which could indicate *sténose* (narrowing) or blockage.\n</step3>\n<step4>\nIn this case, the most likely cause of the symptoms could be *thrombose* (thrombosis) or an embolism affecting the tibial artery, leading to ischemia in the lower leg.\n</step5>\n<step5>\nThe lack of blood flow in the dorsalis pedis artery further supports the idea of a significant vascular obstruction, which could lead to complications if not addressed.\n</step6>\n<step6>\nThus, the primary reason for these findings is likely a vascular obstruction, possibly due to a thrombus affecting blood supply to the lower leg.\n</step6></thinking>", "answer": "<answer>Ìdí pàtàkì tí ó fà á ni *ìṣàn ẹ̀jẹ̀ dín kù* nínú àtẹ̀gùn tibial, tí ó lè jẹ́ *thrombose* tàbí *embolism* tó fa *ishemia* nínú ẹsẹ̀ òsì.</answer>", "language": "Yoruba"}
{"question": "Ṣeto awọn iṣan wọnyi ni ibamu si iṣẹlẹ ti ipa wọn ninu ibajẹ supra-condylar ti humerus a. Iṣan Median b. Iṣan Radial c. Iṣan Anterior interosseous d. Iṣan Ulnar\nA. c,a,d,b\nB. c,a,b,d\nC. a,c,b,d\nD. d,a,b,c", "reasoning": "<thinking><step1>\nThe question asks: “Ṣeto awọn iṣan wọnyi ni ibamu si iṣẹlẹ ti ipa wọn ninu ibajẹ supra-condylar ti humerus” — meaning it wants to arrange the muscles according to their role in a supracondylar humerus fracture.\n</step1>\n<step2>\nIn a supracondylar fracture, the median nerve is often affected first — *iṣan Median* is crucial because it innervates the flexor muscles of the forearm.\n</step2>\n<step3>\nNext, the anterior interosseous nerve, a branch of the median nerve, is also impacted — *iṣan Anterior interosseous* affects the deep flexors.\n</step3>\n<step4>\nThe ulnar nerve, while important, is typically less affected in this type of injury — *iṣan Ulnar* is involved in hand movements but is not the primary concern initially.\n</step4>\n<step5>\nFinally, the radial nerve is usually the least affected in supracondylar fractures — *iṣan Radial* primarily affects wrist extension and is often spared.\n</step5>\n<step6>\nThus, the order based on their involvement in the injury would be: anterior interosseous, median, ulnar, and radial — which corresponds to option B: c, a, b, d.\n</step6></thinking>", "answer": "<answer>c,a,b,d</answer>", "language": "Yoruba"}
{"question": "Kí ni okunfa àkọ́kọ́ ti àwọn àmì bí ìrírí ojú méjì, àìlòye sọ̀rọ̀, àti ìgbẹ́mìí ìgbìyẹn ní àrùn oúnjẹ C. botulinum?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni okunfa àkọ́kọ́ ti àwọn àmì bí ìrírí ojú méjì, àìlòye sọ̀rọ̀, àti ìgbẹ́mìí ìgbìyẹn ní àrùn oúnjẹ [C. botulinum = Clostridium botulinum food poisoning]?” — meaning it wants to know the primary cause of symptoms like double vision, speech difficulties, and muscle weakness in C. botulinum poisoning.\n</step1>\n<step2>\nC. botulinum produces a potent toxin that affects the nervous system — *toxin yii n fa iparun si eto aifọkanbalẹ*.\n</step2>\n<step3>\nThe symptoms mentioned, such as double vision (*ìrírí ojú méjì*) and speech difficulties (*àìlòye sọ̀rọ̀*), are due to the toxin's effect on the neuromuscular junctions — *ibèèrè àfiyèsí*.\n</step3>\n<step4>\nMuscle weakness (*ìgbẹ́mìí ìgbìyẹn*) occurs because the toxin prevents the release of acetylcholine, which is essential for muscle contraction — *ìdí niyi ti a fi n ri àìlera*.\n</step4>\n<step5>\nIngestion of improperly canned or preserved foods is a common source of this toxin — *oúnjẹ ti a ko pa dáadáa*.\n</step5>\n<step6>\nThus, the primary cause of these symptoms is the neurotoxic effects of the C. botulinum toxin on the body.\n</step6></thinking>", "answer": "<answer>Okunfa àkọ́kọ́ ti àwọn àmì yìí ni ipa tó n fa nipasẹ toxin C. botulinum lórí eto aifọkanbalẹ.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mẹtadinlogun kan ti bẹ̀rù pé aya rẹ̀ ń bá olori rẹ̀ ṣe àṣejù. Ó rò pé ọrẹ́ rẹ̀ kan tí ó wà ní òkèèrè náà sì wà nínú rẹ̀ nípa ṣíṣe àtilẹ̀yin. Awọn ọrẹ́ rẹ̀ ti gbìyànjú láti fi hàn án, ṣùgbọ́n wọn kò lè ṣe bẹ́ẹ̀. Ẹ̀dà ti àpẹẹrẹ náà dára, kò ní ìrírí èrò inú, tàbí ìṣe míràn tí kò bá àṣà. Àyẹ̀wò tó bá dara jùlọ ni\nA. Ṣikiṣironia\nB. Àrùn inú tí ó lékè\nC. Àrùn ìrò tí ó gbàgbọ́\nD. Àrùn ìṣètò.", "reasoning": "<thinking><step1>\nThe question presents a scenario about a 19-year-old man who fears that his wife is being unfaithful. He thinks a friend abroad is involved in this situation, and his friends have tried to show him otherwise but cannot. The question asks for the best psychological evaluation method for this case.\n</step1>\n<step2>\nIn psychology, when someone has irrational fears or beliefs, it often relates to *àrùn ìrò* — which translates to delusional disorder. This disorder involves persistent false beliefs despite evidence to the contrary.\n</step2>\n<step3>\nThe mention of his friends trying to convince him suggests that he is not open to alternative explanations, which is a key characteristic of *àrùn ìrò*.\n</step3>\n<step4>\nOptions like *ṣikiṣironia* (which refers to a type of irony) or *àrùn inú tí ó lékè* (which means a minor internal disorder) do not fit the context of his strong, unfounded beliefs.\n</step5>\n<step5>\n*Àrùn ìṣètò* (which refers to a personality disorder) might also be relevant, but the focus here is on his delusions rather than personality traits.\n</step6>\n<step6>\nThus, the most appropriate evaluation for his situation is *àrùn ìrò* — as it directly addresses his unfounded fears about his wife's fidelity.\n</step6></thinking>", "answer": "<answer>Àrùn ìrò tí ó gbàgbọ́.</answer>", "language": "Yoruba"}
{"question": "Kini ayẹ́gbẹ́ àìsàn tó ṣeé ṣe jùlọ fún agbẹ̀ ọmọ ọdún mẹ́rìnlágbọn kan tó ní irora ìfẹ́rọ̀gbà ati àìsàn ara tí ó dàbí àmọ̀ lórí àwọn apá ara tó yẹ̀lẹ̀mọ̀ oòrùn, pẹ̀lú àwọn àmì àìsàn tó burú sí i nígbà ìgbà ooru, tí a bá gbé ìtàn àwọn ikọlu porphyria tó máa ń ṣẹlẹ̀ lẹ́ẹ̀kan sílẹ̀ rẹ̀ yẹ̀wò?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ayẹ́gbẹ́ àìsàn tó ṣeé ṣe jùlọ fún agbẹ̀ ọmọ ọdún mẹ́rìnlágbọn kan…” which translates to “What is the most likely diagnosis for a 14-year-old child…” It mentions symptoms like *irora ìfẹ́rọ̀gbà* [abdominal pain] and *àìsàn ara* [systemic illness] affecting the lower body, especially during *ìgbà ooru* [summer].\n</step1>\n<step2>\nGiven the age and symptoms, one must consider common conditions in adolescents. The abdominal pain could indicate several issues, but the systemic nature suggests something more widespread.\n</step2>\n<step3>\nThe mention of *àìsàn ara* and worsening symptoms in summer points towards conditions that are exacerbated by heat or dehydration. One possible condition is *sickle cell disease* — *àìsàn ẹjẹ́ àtọ́ka* — which can cause severe pain crises.\n</step4>\n<step5>\nAdditionally, *porphyria* is mentioned, which is a group of disorders that can cause abdominal pain and skin symptoms. However, it is less common than sickle cell disease in this demographic.\n</step6>\n<step6>\nConsidering all these factors, the most likely diagnosis for this 14-year-old with abdominal pain and systemic symptoms, particularly in the summer, is *àìsàn ẹjẹ́ àtọ́ka*.\n</step6></thinking>", "answer": "<answer>Àìsàn ẹjẹ́ àtọ́ka ni ayẹ́gbẹ́ àìsàn tó ṣeé ṣe jùlọ fún agbẹ̀ ọmọ ọdún mẹ́rìnlágbọn kan tó ní irora ìfẹ́rọ̀gbà.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹfa kan ni iya rẹ̀ mú wá sí iwaju fún ìbẹ̀wò ìlera. Ó sọ pé òun yóò bẹ̀rẹ̀ ilé-iwe ọmọ kékeré laipẹ. Ó dààmú pé kò fẹ́ràn láti lọ ṣeré ní ita pẹ̀lú àwọn ọmọdé mìíràn lórí ilẹ̀. Nígbà tí a bi í, aláìsàn náà sọ pé “Mo fẹ́ràn awọn ere fidio ju sísí lọ. Àbúrò mi tó dàgbà máa ṣeré pẹ̀lú mi.” Ìyá rẹ̀ sọ pé àwọn olùkọ́ rẹ̀ jẹ́ ká mọ̀ pé ó ṣe dáradára ní ilé-iwe kíkékèèké tí ó sì kópa nínú àwọn eré ẹgbẹ́. Aláìsàn náà jẹ́ olùgbọ́ rere déédéé ṣùgbọ́n ó ti di aláìgbọràn sí fífẹ́ “láti ṣe àwọn nǹkan fún ara rẹ̀,” bíi bíbò wọ̀ ní òwúrọ̀. Aláìsàn náà kò ní àwọn àrùn onígbà gbogbo. Ó ní àlárùn pẹpẹ. Kò mu oògùn èyíkéyìí ṣùgbọ́n ó ní ohun ìgbàlà epinephrine fún àlárùn rẹ̀. Àbúrò rẹ̀ ní àrùn àìrígbàdùn, bàbá bàbá rẹ̀ sì kú ní ọjọ́ orí 56 nítorí àìsàn ọkàn. Ẹ̀rọ àtẹ̀jáde ẹ̀jẹ̀ ọmọ náà jẹ́ 110/70 mmHg àti ìṣísẹ̀ jẹ́ 105/min. Ó wà ní ìpínlẹ̀ 50th fún gíga àti wúwo. Ní àyẹ̀wò ara, a gbọ́ ìró ẹ̀jẹ̀ systolic ìdá II. Nígbà tí aláìsàn náà dìde dúró, ìró náà dín kù. Ìgbà tí ẹ̀jẹ̀ yí padà sí irun jẹ́ kéré ju aaya 2 lọ. Ẹ̀yí wo nínú àwọn wọ̀nyí ni igbesẹ̀ tó tọ́ jùlọ ní ìṣàkóso?\nA. Àtẹ̀jáde fọ́tò X-ray àyà\nB. Ìpín àwọn ẹ̀jẹ̀ lápapọ̀\nC. Echocardiogram\nD. Electrocardiogram\nE. Ìdánilójú", "reasoning": "<thinking><step1>\nThe question asks: \"Which of the following is the most appropriate step in management?\" It presents a case of a six-year-old boy with various health concerns, including a history of asthma and a family history of heart disease.\n</step1>\n<step2>\nThe child has a history of asthma — *àlárùn pẹpẹ* — and carries an epinephrine auto-injector for emergencies. This indicates a significant respiratory condition that needs monitoring.\n</step2>\n<step3>\nGiven the family history of heart disease — *àìsàn ọkàn* — and the child's vital signs, including a blood pressure of 110/70 mmHg and a heart rate of 105/min, we need to assess cardiac function.\n</step3>\n<step4>\nThe options include various diagnostic tests: an X-ray, blood tests, echocardiogram, electrocardiogram, and reassurance. The child's symptoms and family history suggest a cardiac evaluation is necessary.\n</step5>\n<step5>\nAn echocardiogram — *echocardiogram* — would provide detailed information about the heart's structure and function, which is crucial given the family history of heart disease.\n</step6>\n<step6>\nWhile an electrocardiogram — *electrocardiogram* — is also important, the echocardiogram offers more comprehensive insights into potential structural issues.\n</step7>\n<step7>\nThus, the most appropriate step in management, considering the child's background and symptoms, is to perform an echocardiogram.\n</step7></thinking>", "answer": "<answer>Echocardiogram ni igbesẹ̀ tó tọ́ jùlọ ní ìṣàkóso.</answer>", "language": "Yoruba"}
{"question": "Kini iṣe-iṣe abẹrẹ ti o yẹ fun ọmọ ọdun mẹfa kan ti o ni àrùn ikọ́ òfun lórí lọ́pọ̀lọpọ̀, ìmimi ní ẹnu, àìdàgbàsókè, ẹnu-ìrì bálu, àti ìgbọ́ tí kò dára?", "reasoning": "<thinking><step1>\nThe question asks: “Kini iṣe-iṣe abẹrẹ ti o yẹ fun ọmọ ọdun mẹfa kan ti o ni àrùn ikọ́ òfun lórí lọ́pọ̀lọpọ̀?” — meaning it wants to know the appropriate treatment for a six-year-old child with multiple symptoms like *ìmimi ní ẹnu* (mouth breathing), *àìdàgbàsókè* (stunted growth), *ẹnu-ìrì bálu* (nasal congestion), and *ìgbọ́ tí kò dára* (poor hearing).\n</step1>\n<step2>\nIn children, *àrùn ikọ́ òfun* (upper respiratory infection) can lead to complications like *ìmimi ní ẹnu*, which indicates that the child is struggling to breathe through the nose.\n</step2>\n<step3>\nThe presence of *ẹnu-ìrì bálu* suggests nasal obstruction, possibly due to enlarged adenoids or chronic sinusitis — *sinusitis àkókò*.\n</step3>\n<step4>\nFor a child with these symptoms, a common treatment approach includes nasal corticosteroids — *corticosteroids àtọ́ka* — to reduce inflammation and improve nasal airflow.\n</step4>\n<step5>\nAdditionally, if the child has *àìdàgbàsókè*, it’s crucial to monitor their growth and possibly refer them to a specialist for further evaluation — *iwadii si amọ̀ja*.\n</step6>\n<step6>\nIn some cases, surgery may be necessary to remove obstructive tissues, especially if *ìgbọ́ tí kò dára* is linked to chronic ear infections — *àkúnya etí*.\n</step7>\n<step7>\nThus, the treatment plan should be comprehensive, addressing both the respiratory symptoms and any underlying issues affecting growth and hearing.\n</step7></thinking>", "answer": "<answer>Iṣe-iṣe abẹrẹ ti o yẹ ni lilo corticosteroids àtọ́ka, iwadii si amọ̀ja, ati, ti o ba jẹ dandan, iṣẹ abẹ lati yọ awọn ohun ti o fa idena.</answer>", "language": "Yoruba"}
{"question": "Obirin ti o ni kokoro arun HIV, ti o sunmo si akoko ibimọ, ìmọràn ti a fun ni a) Ọgbẹni naa yẹ ki o bẹrẹ ṣiṣe itọju ṣaaju ki o to bí ọmọ b) Yẹra fun idapọ ẹjẹ lakoko ibimọ c) Ibi ipọnju funfun ni a fẹ d) Iṣẹ abẹ Caesarean yoo dinku gbigbe kokoro arun HIV si ọmọ\nA. acd\nB. bcd\nC. abc\nD. abd", "reasoning": "<thinking><step1>\nThe question is asking about the recommendations for a woman with HIV [kokoro arun HIV] who is close to giving birth [akoko ibimọ]. \n</step1>\n<step2>\nFirst, it is crucial for the mother to start treatment [itọju] before giving birth to reduce the risk of transmission to the baby. \n</step2>\n<step3>\nNext, avoiding blood mixing [idapọ ẹjẹ] during childbirth is essential to prevent the virus from spreading. \n</step4>\nAdditionally, a white blood cell count [ibi ipọnju funfun] is important to monitor the mother's health and the effectiveness of the treatment. \n</step5>\nFinally, a Caesarean section [Iṣẹ abẹ Caesarean] is often recommended as it can significantly lower the chances of transmitting HIV to the child during delivery. \n</step6>\nConsidering these points, the correct recommendations include starting treatment, avoiding blood mixing, and opting for a Caesarean section. \n</step7>\nThus, the correct answer is B, which includes options b, c, and d. \n</step8>\nHowever, option a is also valid since starting treatment is crucial, so the answer could also include a. \n</step9>\nUltimately, the best choice that encompasses the most critical recommendations is D, which includes a, b, and d. \n</step10>\nTherefore, the answer is D. \n</step10></thinking>", "answer": "<answer>abd</answer>", "language": "Yoruba"}
{"question": "Jẹ́ kí n jẹ́ ẹ̀dá ìṣe àwọn nọ́mbà àkọ́kọ́ kékeré méjì tó ní nọ́mbà mẹ́ta. Kí ni ìṣe àpapọ̀ àwọn nọ́mbà tí ó wà nínú n?", "reasoning": "<thinking><step1>\nThe question asks: “Jẹ́ kí n jẹ́ ẹ̀dá ìṣe àwọn [nọ́mbà àkọ́kọ́ = prime numbers] kékeré méjì tó ní [nọ́mbà mẹ́ta = three digits]?” — meaning it wants to know the product of two small prime numbers that have three digits.\n</step1>\n<step2>\nFirst, we identify the smallest three-digit prime numbers. The smallest three-digit prime is 101, followed by 103.\n</step2>\n<step3>\nNext, we need to calculate the product of these two prime numbers: 101 and 103.\n</step3>\n<step4>\nTo find the product, we can use multiplication: 101 × 103. This can be calculated as follows: 101 × 100 + 101 × 3.\n</step4>\n<step5>\nCalculating this gives us: 10100 + 303 = 10403.\n</step5>\n<step6>\nThus, the product of the two smallest three-digit prime numbers is 10403.\n</step6></thinking>", "answer": "<answer>Ìṣe àpapọ̀ àwọn nọ́mbà àkọ́kọ́ kékeré méjì tó ní nọ́mbà mẹ́ta ni 10403.</answer>", "language": "Yoruba"}
{"question": "Ipò ẹ̀jẹ̀ wo ni a lè rí lára ẹni tí ọ̀pọ̀lọpọ̀ neutrophils, basophils, eosinophils, àti platelets bá wà nínú ẹ̀jẹ̀ rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Ipò ẹ̀jẹ̀ wo ni a lè rí lára ẹni tí [neutrophils, basophils, eosinophils, àti platelets = neutrophils, basophils, eosinophils, and platelets] bá wà nínú ẹ̀jẹ̀ rẹ̀?” — meaning it wants to know what condition can be identified when there are high levels of these blood components.\n</step1>\n<step2>\nHigh levels of neutrophils, known as *neutrophilia*, often indicate an infection or inflammation — *ìfarapa* kan le fa eyi.\n</step2>\n<step3>\nBasophils can increase in response to allergies or certain infections — *ìfarapa àtọkànwá* le fa *basophilia*.\n</step3>\n<step4>\nEosinophils are typically elevated in allergic reactions or parasitic infections — *ìfarapa àtọkànwá* tabi *àkóràn parasitic* le fa *eosinophilia*.\n</step4>\n<step5>\nLastly, high platelet counts, or *thrombocytosis*, can occur due to various reasons, including inflammation or bone marrow disorders — *ìfarapa* tabi *àìlera ẹ̀jẹ̀* le fa eyi.\n</step5>\n<step6>\nIn summary, the presence of high levels of these cells can indicate conditions like infections, allergies, or inflammatory diseases — *àìlera* kan le jẹ́ abajade.\n</step6></thinking>", "answer": "<answer>Ipò ẹ̀jẹ̀ tí a lè rí ni àìlera, ìfarapa, tàbí àkóràn parasitic.</answer>", "language": "Yoruba"}
{"question": "Iye ijinna to sunmọ̀ ti o wà laarin isalẹ̀ calculus ati apẹrẹ̀ alveolar ni apo periodontal eniyan?", "reasoning": "<thinking><step1>\nThe question asks: “Iye ijinna to sunmọ̀ ti o wà laarin isalẹ̀ [calculus = calculus] ati [apẹrẹ̀ alveolar = alveolar bone] ni [apo periodontal = periodontal pocket] eniyan?” — meaning it wants to know the distance between calculus and alveolar bone in the human periodontal pocket.\n</step1>\n<step2>\nIn periodontal health, calculus can form on the tooth surface and may lead to inflammation — *inflammation* of the surrounding tissues.\n</step2>\n<step3>\nThe distance between calculus and alveolar bone is crucial because it indicates the severity of periodontal disease — *a ṣe ayẹwo ipo ilera periodontal*.\n</step3>\n<step4>\nTypically, this distance can vary, but in healthy individuals, it should be minimal — *ijinna to kere ju*.\n</step5>\n<step5>\nIn cases of periodontal disease, this distance increases due to bone loss — *pipadanu egungun* around the teeth.\n</step6>\n<step6>\nThus, the distance is measured in millimeters, and a greater distance suggests more severe disease — *ijinna to pọ si*.\n</step7>\n<step7>\nIn summary, the distance between calculus and alveolar bone in a periodontal pocket is a key indicator of periodontal health.\n</step7></thinking>", "answer": "<answer>Iye ijinna to sunmọ̀ laarin isalẹ̀ calculus ati apẹrẹ̀ alveolar ni apo periodontal eniyan jẹ́ àmì pataki ti ilera periodontal.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 28 kan ti ó ní àrùn ìrìrì ọkàn méjì tí ó ti ń mu lithium carbonate fún ọdún márùn-ún, ó ní ìdọ́gba omi tí ó pọ̀ tóbi àti ìgbàgbé omi, pẹ̀lú nocturia.  Àwọn ìdánwò ilé ìwòsàn rẹ̀ fi hàn ní iwọn pataki ti ito ti 1.003 àti iwọn osmolality ito ti 150 mOsm/kg H2O.  Bawo ni ipo ọkunrin yìí àti àwọn ìṣẹ̀dá ilé ìwòsàn ṣe nípa lórí iwọn àti osmolality omi ara rẹ̀, gẹ́gẹ́ bí a ti fi hàn nínú àwòrán Darrow-Yannet?", "reasoning": "<thinking><step1>\nThe question asks about a 28-year-old man with a history of bipolar disorder who has been taking lithium carbonate for five years. He presents with polyuria (excessive urination) and nocturia (nighttime urination), and his lab results show a specific gravity of 1.003 and an osmolality of 150 mOsm/kg H2O.\n</step1>\n<step2>\nPolyuria can occur due to the effects of lithium on the kidneys — *lithium le fa awọn iṣoro ni awọn kidinrin* that can lead to a condition known as nephrogenic diabetes insipidus.\n</step2>\n<step3>\nThe specific gravity of 1.003 indicates dilute urine, suggesting that the kidneys are not concentrating urine effectively — *kidinrin ko le ṣe idapọ omi daradara*.\n</step3>\n<step4>\nThe osmolality of 150 mOsm/kg H2O is also low, which aligns with the findings of polyuria and indicates a lack of proper water reabsorption — *a ko ni imudara omi to peye*.\n</step4>\n<step5>\nAccording to the Darrow-Yannet diagram, this situation reflects a state of low effective circulating volume, which can lead to compensatory mechanisms that further affect renal function — *iyipada ninu iṣẹ kidinrin*.\n</step5>\n<step6>\nIn summary, the man's condition is characterized by impaired water reabsorption due to lithium's effects, leading to low urine concentration and high urine output.\n</step6></thinking>", "answer": "<answer>Ipo ọkunrin yìí jẹ́ pé àìlera omi ni a fa nipasẹ lithium, tí ó yọrí sí ìdọ́gba omi tó kéré àti osmolality omi tó kéré, pẹ̀lú polyuria.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọmọ ọdún 24 kan wá sí ọ̀dọ̀ oníṣègùn fún ṣíṣàyẹ̀wò àìgbàgbé àkókò ìgbà àìṣẹ̀ àti irora ikùn isalẹ̀ tí ó ń bẹ láìdàpọ̀ fún ọjọ́ méjì. Àkókò ìgbà àìṣẹ̀ àkọ́kọ́ rẹ̀ bẹ̀rẹ̀ ní ọjọ́-orí ọdún 12, àti ìgbà àìṣẹ̀ ti wà ní àkókò ìgbà tí ó dára ti ọjọ́ 28. Àkókò ìgbà àìṣẹ̀ tó kẹhin rẹ̀ jẹ́ ọsẹ̀ méje sẹ́yìn. Ọdún méjì sẹ́yìn, a tọ́jú rẹ̀ fún àrùn chlamydia. Ṣíṣàyẹ̀wò ìṣẹ̀gbẹ́ ṣe àfihàn àpò, ilà tí ó pọ̀ díẹ̀. Ṣíṣàyẹ̀wò endometrial fi hàn ìṣàtupadà decidual ti endometrium láìsí chorionic villi. Ṣíṣàyẹ̀wò síwájú sí i ti aláìsàn yìí ṣeé ṣe jù lọ láti fi hàn èyíkéyí nínú àwọn abajade wọ̀nyí?\nA. Ìṣàtupadà rere ti isan ti oúnjẹ myometrium\nB. Ẹyin tí ó ní irúgbìn ní ita àpò\nC. Ìgbàgbọ́ endometrial nípa sẹ́ẹ̀li plasma\nD. Ẹyin òfo tí ó ní irúgbìn nípa irúgbìn méjì", "reasoning": "<thinking><step1>\nThe question is asking about the possible findings in a patient who has a history of irregular menstruation and lower abdominal pain, with specific details about her menstrual cycle and previous chlamydia infection. Key terms include [ìgbà àìṣẹ̀ = menstrual period], [irora ikùn isalẹ̀ = lower abdominal pain], and [àpò = pouch].\n</step1>\n<step2>\nThe patient has had irregular periods since age 12, with her last period being seven weeks ago. This suggests a potential hormonal imbalance or other underlying issues — *àìlera homonu*.\n</step2>\n<step3>\nThe endometrial examination shows decidual changes without chorionic villi, indicating a possible early pregnancy or a recent miscarriage — *ìṣàtupadà decidual*.\n</step4>\n<step5>\nGiven the history of chlamydia, there could be complications like pelvic inflammatory disease, which might affect the findings — *àrùn ikọ̀sẹ̀ àyà*.\n</step6>\n<step6>\nNow, considering the options: A suggests a normal myometrial response, B refers to an ectopic pregnancy, C indicates endometrial changes due to plasma cells, and D suggests an empty ovum with two types of cells.\n</step7>\n<step7>\nThe most likely finding in this context, given the endometrial changes and the absence of chorionic villi, would be related to the decidual changes, which aligns with option C — *ìgbàgbọ́ endometrial nípa sẹ́ẹ̀li plasma*.\n</step8>\n<step8>\nThus, the findings are consistent with endometrial changes that could indicate a response to a recent pregnancy or hormonal changes.\n</step8></thinking>", "answer": "<answer>Ìgbàgbọ́ endometrial nípa sẹ́ẹ̀li plasma.</answer>", "language": "Yoruba"}
{"question": "Àpọǹràn kan tí ó ní ìṣẹ̀ṣẹ̀gùn gbogbo-ìṣẹ̀lẹ̀ ní ìrora àti ìṣòro ní ìmímú afẹ́fẹ́ ló bá lojiji. Bí a bá ń wo àwọn oríṣìí ìṣẹ̀ṣẹ̀gùn àìlera àyà, èwo ni ó ṣeé ṣe jùlọ láti mú àwọn ìṣòro bẹ́ẹ̀ ṣẹlẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Which types of [asthma medications = ìṣẹ̀ṣẹ̀gùn àìlera àyà] are most likely to cause [breathing problems = ìṣòro ní ìmímú afẹ́fẹ́]?” — indicating a focus on the side effects of asthma treatments.\n</step1>\n<step2>\nAsthma medications can be divided into two main categories: *les médicaments de contrôle* and *les médicaments de secours*.\n</step2>\n<step3>\nControl medications, like inhaled corticosteroids, are generally safe but can cause side effects such as *une irritation de la gorge* or *une candidose buccale*.\n</step3>\n<step4>\nOn the other hand, rescue medications, particularly short-acting beta-agonists, can lead to increased heart rate — *une tachycardie* — which might indirectly affect breathing.\n</step4>\n<step5>\nIn some cases, overuse of rescue inhalers can lead to paradoxical bronchospasm — *un spasme bronchique paradoxal* — worsening breathing issues instead of alleviating them.\n</step5>\n<step6>\nTherefore, while both types of medications are essential, *les médicaments de secours* are more likely to cause immediate breathing problems if misused.\n</step6></thinking>", "answer": "<answer>Àwọn ìṣẹ̀ṣẹ̀gùn àìlera àyà tí ó ṣeé ṣe jùlọ láti mú ìṣòro ní ìmímú afẹ́fẹ́ ṣẹlẹ̀ ni àwọn ìṣẹ̀ṣẹ̀gùn àìlera àyà àtẹ́yìnwá, pàápàá jùlọ bí a bá lo wọn ju.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọlọdún mẹ́rinlá kan tí ó jẹ́ ọ̀mùtí paramọ́ sí ilé ìwòsàn pẹ̀lú àìsàn pankirẹ́ásì tí ó léwu. Ó ń bì, ó sì ń rí bí ẹní máa dákú nígbà tí ó bá dìde dúró. Nígbà tí wọ́n ṣe àyẹ̀wò rẹ̀, ó ní ìrora líle ní ìhà ọ̀tún òkè ikùn rẹ̀, àti pé ìró ìfun rẹ̀ ti dínkù. Àwọ̀ búlúù kan yí igbẹ́ rẹ̀ ká. Kí ni ìtumọ̀ ohun tí wọ́n rí yìí?\nA. Àwòrán CT ti ikùn yóò fi hàn pé àìsàn pankirẹ́ásì líle tí ń pa èrò ara run ló ní.\nB. Àwòrán X-ray ti ikùn yóò fi hàn pé kalisíọ́mù ti kó jọ sínú pankirẹ́ásì rẹ̀.\nC. Ó yẹ kí wọ́n ṣe ìwádìí láti mọ̀ bóyá àìsàn apẹ́ńdíìsì kò bá wà pẹ̀lú rẹ̀.\nD. Ó ṣe é ṣe kí ó ní ihò láàrín pankirẹ́ásì àti àwọn ẹ̀jẹ̀ ńlá ní ikùn.", "reasoning": "<thinking><step1>\nThe question describes a 14-year-old boy who is admitted to the hospital with a serious pancreatitis condition. It mentions symptoms like pain in the upper right abdomen and a blue discoloration around his belly — *àìsàn pankirẹ́ásì* and *àwọ̀ búlúù*.\n</step1>\n<step2>\nIn cases of pancreatitis, the pain can be severe, and the blue discoloration indicates possible internal bleeding — *ìjìyà tó lágbára* and *ìjìyà inú*.\n</step2>\n<step3>\nThe options provided suggest different diagnostic imaging results. A CT scan could reveal severe pancreatitis causing damage to surrounding organs — *àwòrán CT*.\n</step3>\n<step4>\nAn X-ray might show calcium deposits in the pancreas, but this is less common — *àwòrán X-ray*.\n</step5>\n<step5>\nThe mention of appendicitis suggests that further investigation is needed to rule it out, which is a common concern in abdominal pain cases — *àìsàn apẹ́ńdíìsì*.\n</step6>\n<step6>\nLastly, the possibility of a hole between the pancreas and major blood vessels indicates a severe complication that could arise from pancreatitis — *ihò láàrín pankirẹ́ásì àti àwọn ẹ̀jẹ̀ ńlá*.\n</step7>\n<step7>\nConsidering the symptoms and the severity of the condition, the most likely interpretation is that the CT scan would show severe pancreatitis causing significant damage.\n</step7></thinking>", "answer": "<answer>Àwòrán CT ti ikùn yóò fi hàn pé àìsàn pankirẹ́ásì líle tí ń pa èrò ara run ló ní.</answer>", "language": "Yoruba"}
{"question": "Ní ìbámu pẹ̀lú àwọn àmì àrùn tó ń fara hàn lára ọkùnrin ọlọ́dún márùndínlógójì tí ìṣòro èémí rẹ̀ ń le sí i, ẹ̀gbẹ̀ gbígbẹ, àárẹ̀, ìṣòro nígbà mímu, àmì àrùn Raynaud, àti lílọ́ rọ̀ọ̀ awọ ara, kí ni a lè rí nípa iṣẹ́ ẹ̀dọ̀fóró aláìsàn yìí?", "reasoning": "<thinking><step1>\nThe question translates to: \"In relation to the symptoms of a 35-year-old man whose breathing issues include shortness of breath, fatigue, difficulty during exertion, Raynaud's phenomenon, and skin changes, what can we observe about the function of this patient's lungs?\" \n</step1>\n<step2>\nThe symptoms suggest a possible respiratory condition — *àìlera ẹ̀dọ̀fóró* — affecting lung function. \n</step2>\n<step3>\nShortness of breath, or *ìṣòro èémí*, indicates that the lungs may not be effectively exchanging oxygen, which could be due to *àkúnya* or inflammation.\n</step3>\n<step4>\nFatigue and difficulty during exertion suggest that the body is not getting enough oxygen, leading to *ìfarapa* in physical activities.\n</step4>\n<step5>\nRaynaud's phenomenon, which involves reduced blood flow to extremities, could indicate an underlying vascular issue affecting overall oxygen delivery — *ìṣòro àkúnya*.\n</step5>\n<step6>\nSkin changes might reflect poor circulation or oxygenation, further supporting the idea of compromised lung function.\n</step6>\n<step7>\nIn summary, the combination of these symptoms points to a significant impairment in lung function, possibly due to a chronic respiratory condition or vascular issues.\n</step7></thinking>", "answer": "<answer>Iṣẹ́ ẹ̀dọ̀fóró aláìsàn yìí fihan pé àìlera tó lágbára ni, pẹ̀lú ìṣòro èémí, àkúnya, àti ìfarapa.</answer>", "language": "Yoruba"}
{"question": "Ka a ka iye iwosan ounjẹ jẹ́ nígbà tí 55 ninu awọn ènìyàn 200 tí wà ní àṣeyọrí ọjọ́ìbí kan ṣẹ̀ṣẹ̀ bà jẹ́ ounjẹ.", "reasoning": "<thinking><step1>\nThe question asks: “Ka a ka iye iwosan ounjẹ jẹ́ nígbà tí 55 ninu awọn ènìyàn 200 tí wà ní àṣeyọrí ọjọ́ìbí kan ṣẹ̀ṣẹ̀ bà jẹ́ ounjẹ?” — meaning it wants to know the percentage of people who experienced food poisoning during a birthday celebration.\n</step1>\n<step2>\nTo find the percentage, we need to divide the number of people who got sick, which is 55, by the total number of people, 200.\n</step2>\n<step3>\nThis can be expressed mathematically as: *(55 / 200) × 100* to convert it into a percentage.\n</step3>\n<step4>\nCalculating this gives us: *55 ÷ 200 = 0.275*, and then multiplying by 100 results in *27.5%*.\n</step4>\n<step5>\nThus, we can conclude that *27.5%* of the people at the birthday party experienced food poisoning.\n</step5></thinking>", "answer": "<answer>Iye iwosan ounjẹ jẹ́ 27.5% ninu awọn ènìyàn 200.</answer>", "language": "Yoruba"}
{"question": "Níbo lórí ilẹ̀ ayé tí oòrùn kò tíì tàn rí?\nA. Kò sí ibi kan lórí ilẹ̀ ayé tí oòrùn kò tíì tàn rí.\nB. Oòrùn kò tíì tàn ní Àríwá Pọ́ọ̀lù.\nC. Oòrùn kò tíì tàn ní Gúúsù Pọ́ọ̀lù.\nD. Oòrùn kò tíì tàn ní Àntáktíkà.\nE. Oòrùn kò tíì tàn ní Aláskà.\nF. Oòrùn kò tíì tàn ní United Kingdom.\nG. Oòrùn kò tíì tàn ní Síìtíì.\nH. Oòrùn kò tíì tàn ní Rọ́ṣíà.", "reasoning": "<thinking><step1>\nThe question asks: “Níbo lórí ilẹ̀ ayé tí oòrùn kò tíì tàn rí?” — which translates to “Where on Earth has the sun not yet set?”.\n</step1>\n<step2>\nIn general, the sun is always shining on some part of the Earth due to its rotation — *ilẹ̀ ayé n yí ká*.\n</step2>\n<step3>\nHowever, there are specific regions, especially near the poles, where the sun can remain above the horizon for extended periods — *ní àgbègbè àríwá àti gúúsù*.\n</step4>\n<step4>\nFor instance, during summer in the Arctic, the sun does not set at all — *oòrùn kò tíì tàn ní Àríwá Pọ́ọ̀lù*.\n</step5>\n<step5>\nConversely, in Antarctica, the sun also does not set during its summer months — *oòrùn kò tíì tàn ní Àntáktíkà*.\n</step6>\n<step6>\nThus, the correct answer would be that there are places where the sun has not set, particularly in the polar regions.\n</step6></thinking>", "answer": "<answer>Oòrùn kò tíì tàn ní Àríwá Pọ́ọ̀lù àti Àntáktíkà.</answer>", "language": "Yoruba"}
{"question": "Lẹhin ìfọ́pa ìṣígun wo ni àyè sínivíàálì ti ìdákọ́rò glenohumeral ń bá àyè subdeltoid bursa sọ̀rọ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Lẹhin ìfọ́pa ìṣígun wo ni àyè sínivíàálì ti ìdákọ́rò glenohumeral ń bá àyè subdeltoid bursa sọ̀rọ̀?” — meaning it wants to know about the relationship between the synovial cavity of the glenohumeral joint and the subdeltoid bursa after an injury.\n</step1>\n<step2>\nThe glenohumeral joint, or *ìdákọ́rò glenohumeral*, is a ball-and-socket joint that allows for a wide range of motion in the shoulder.\n</step2>\n<step3>\nAfter an injury, the synovial cavity — *àyè sínivíàálì* — can become inflamed, leading to conditions like bursitis, which affects the subdeltoid bursa.\n</step3>\n<step4>\nThe subdeltoid bursa, or *àyè subdeltoid*, acts as a cushion to reduce friction between the shoulder joint and the deltoid muscle.\n</step4>\n<step5>\nWhen there is inflammation in the glenohumeral joint, it can cause pain and swelling that affects the subdeltoid bursa, leading to *ìrora* and limited movement.\n</step5>\n<step6>\nIn summary, the relationship is that inflammation in the glenohumeral joint's synovial cavity can directly impact the subdeltoid bursa, causing discomfort and dysfunction.\n</step6></thinking>", "answer": "<answer>Ìfọ́pa ìṣígun le fa ìdákọ́rò glenohumeral láti ní ìfọ́kànsí, tó ń nípa lórí àyè subdeltoid bursa, tó ń fa ìrora àti ìdíwọ̀n ìmúṣiṣẹ́.</answer>", "language": "Yoruba"}
{"question": "Ipò ìṣàìmọ̀tẹ̀lẹ̀ wo ni a ṣàpẹẹrẹ̀ pẹ̀lú àìlera lati ranti alaye pataki ti ara ẹni, nigbagbogbo nitori iṣẹlẹ ibanujẹ, gẹgẹ bi a ti rii ninu ọmọbirin ọdun 16 kan ti a ṣe iwa ibalopọ pẹlu, ti ko si le ranti iṣẹlẹ naa botilẹjẹpe awọn igbiyanju rẹ?", "reasoning": "<thinking><step1>\nThe question asks: “Ipò ìṣàìmọ̀tẹ̀lẹ̀ wo ni a ṣàpẹẹrẹ̀ pẹ̀lú àìlera lati ranti alaye pataki ti ara ẹni?” — meaning it seeks to identify a type of amnesia related to personal information recall, often due to a distressing event.\n</step1>\n<step2>\nThis situation describes a case of *dissociative amnesia*, where the individual cannot remember important personal information — *alaye pataki ti ara ẹni* — typically linked to trauma.\n</step2>\n<step3>\nIn this context, the 16-year-old girl experiences memory loss after a distressing event, which is a classic symptom of this condition — *aami aisan ti a mọ̀*.\n</step3>\n<step4>\nDissociative amnesia can occur as a defense mechanism, where the mind blocks out memories to protect the individual from emotional pain — *lati daabobo ẹni kọọkan lati irora ẹdun*.\n</step4>\n<step5>\nIt’s important to note that this type of amnesia is different from other memory disorders, as it is specifically tied to psychological trauma rather than physical brain injury.\n</step5>\n<step6>\nThus, the condition exemplified here is *ìṣàìmọ̀tẹ̀lẹ̀ àìlera*, which is characterized by the inability to recall significant personal experiences due to a traumatic event.\n</step6></thinking>", "answer": "<answer>Ìṣàìmọ̀tẹ̀lẹ̀ àìlera ni a ṣàpẹẹrẹ̀ pẹ̀lú àìlera lati ranti alaye pataki ti ara ẹni nitori iṣẹlẹ ibanujẹ.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin kan ọmọ ọdun 27, ti o jẹ́ ògbóńgbò, wọ́n gbé e lọ sí ilé ìwòsàn lẹ́yìn tí ó ṣubú láti orí òpópó. Ìwádìí ara rẹ̀ fi hàn pé aláìsàn náà kò lè gbé apá rẹ̀ sókè ju ìwọ̀n 15° lọ, bẹ́ẹ̀ ni kò sì lè yí apá rẹ̀ padà sí ẹ̀gbẹ́. Ìwádìí X-ray fi hàn pé apá rẹ̀ fọ́ ní ọ̀nà tí kò tọ́. Ó ní ìdákọ̀rọ̀ rírí ní àgbègbè ejíka rẹ̀. Ní àwọn ìpalára wọ̀n-ọn-ní yí, èwo ni ó ṣeé ṣe jùlọ láti bá àwọn àmì àrùn ìwádìí ara hàn?\nA. Ìfọ́ apá ọwọ́ ìsàlẹ̀\nB. Ìfọ́ apá ọwọ́ glẹnọ́ìdì\nC. Ìfọ́ apá ọwọ́ ọrùn abẹ́\nD. Ìfọ́ apá ọwọ́ ọrùn adá", "reasoning": "<thinking><step1>\nThe question is asking about the most likely injury type for a 27-year-old man who has a shoulder injury after a fall, with limited arm movement and an X-ray showing a fracture — *fọ́* — in an abnormal position.\n</step1>\n<step2>\nGiven the symptoms, he cannot raise his arm beyond 15° and has *ìdákọ̀rọ̀ rírí* in the shoulder area, indicating a significant injury.\n</step2>\n<step3>\nThe options provided are different types of shoulder injuries: \nA. *Ìfọ́ apá ọwọ́ ìsàlẹ̀* (lower arm fracture)\nB. *Ìfọ́ apá ọwọ́ glẹnọ́ìdì* (glenoid fracture)\nC. *Ìfọ́ apá ọwọ́ ọrùn abẹ́* (subscapularis fracture)\nD. *Ìfọ́ apá ọwọ́ ọrùn adá* (acromion fracture).\n</step3>\n<step4>\nConsidering the mechanism of injury and the inability to move the arm, a glenoid fracture — *ìfọ́ apá ọwọ́ glẹnọ́ìdì* — is likely, as it directly affects shoulder stability.\n</step5>\n<step5>\nThe glenoid is part of the shoulder joint, and fractures here can severely limit movement, which aligns with the patient's symptoms.\n</step6>\nThus, the most probable injury type is a glenoid fracture.\n</step6></thinking>", "answer": "<answer>Ìfọ́ apá ọwọ́ glẹnọ́ìdì.</answer>", "language": "Yoruba"}
{"question": "Lẹhin tí wọ́n gba àpọǹdẹ̀ kan tí ó ní ipalara orí sí ilé-iwosan, wọ́n sì tọ́jú rẹ̀ ní ICU nítorí àtọ́pẹ̀ àtẹ́gun inu ọpọlọ, wọ́n sì fi ẹ̀rọ atẹgun sí i, pẹ̀lú omi onísun ati awọn oògùn tí ń mú kí ọṣẹ̀ dà, ó ní ọ̀pọ̀lọpọ̀ ọṣẹ̀ tó pọ̀ sí i, tó jẹ́ líta 3.5, ìwọ̀n sódíọ̀mu ẹ̀jẹ̀ rẹ̀ sì jẹ́ 156 mEq/L, ati ìwọ̀n osmolarity ẹ̀jẹ̀ rẹ̀ sì jẹ́ 316 mOsm/kg nígbà tí ọjọ́ kan kọjá.  Kí ni okunfa tí ó ṣeé ṣe julọ ti ọ̀pọ̀lọpọ̀ ọṣẹ̀ yìí nínú ọ̀ràn yìí?", "reasoning": "<thinking><step1>\nThe question asks about the possible cause of high levels of [ọṣẹ̀ = sodium] in a patient who has suffered a head injury and is being treated in the ICU for [àtọ́pẹ̀ àtẹ́gun inu ọpọlọ = cerebral edema].\n</step1>\n<step2>\nIn cases of cerebral edema, the body may retain sodium due to various factors — *àwọn ifosiwewe bii àìlera àtọ́pẹ̀* can lead to increased sodium levels.\n</step2>\n<step3>\nThe use of intravenous fluids, especially those containing sodium, can also contribute to elevated sodium levels — *omi onísun* may have a high sodium concentration.\n</step3>\n<step4>\nAdditionally, the stress response from the injury can cause hormonal changes that promote sodium retention — *ìdáhùn àìlera* can lead to increased aldosterone secretion.\n</step4>\n<step5>\nGiven the patient's sodium level of 3.5 liters and the osmolarity of 316 mOsm/kg, it suggests a state of hypernatremia — *ìpamọ́ ọṣẹ̀ tó pọ̀* could be a result of these factors.\n</step6>\n<step6>\nTherefore, the most likely cause of the elevated sodium levels in this case is related to the body's response to the head injury and the treatment administered.\n</step6></thinking>", "answer": "<answer>Okunfa tí ó ṣeé ṣe julọ ti ọ̀pọ̀lọpọ̀ ọṣẹ̀ yìí ni ìdáhùn àìlera àti lilo omi onísun tó ní ọṣẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ninu ipo wiwo oyun oyun inu ikun pẹlu ọmọ ọdun 18 ati igbẹ́ ti o so mọ́ omentum nigba abẹrẹ lati yọkuro apendisiti, kini iṣe abẹrẹ to tọ lati ṣe nipa ọmọ naa ati igbẹ́?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu ipo wiwo [oyun = pregnancy] [inu ikun = abdominal cavity] pẹlu [omo ọdun 18 = 18-year-old child] ati [igbẹ́ = hernia] ti o so mọ́ [omentum = omentum] nigba [abẹrẹ = surgery] lati yọkuro [apendisiti = appendicitis], kini [iṣe abẹrẹ to tọ = appropriate surgical procedure] lati ṣe nipa ọmọ naa ati igbẹ́?” — meaning it seeks to understand the appropriate surgical approach for a pregnant 18-year-old with a hernia connected to the omentum during an appendectomy.\n</step1>\n<step2>\nIn this scenario, the presence of pregnancy complicates the surgical procedure — *iyipada ninu anatomii* due to the growing uterus.\n</step2>\n<step3>\nThe surgeon must consider the risks to both the mother and the fetus — *iṣoro ti o le fa fun iya ati ọmọ* during the appendectomy.\n</step3>\n<step4>\nA careful evaluation of the hernia is crucial; if it poses a significant risk, it may need to be addressed simultaneously — *iyẹn ni, a le ṣe abẹrẹ fun apendisiti ati igbẹ́ ni akoko kan*.\n</step4>\n<step5>\nThe use of minimally invasive techniques, like laparoscopic surgery, could be beneficial — *surgery laparoscopic* reduces recovery time and minimizes trauma.\n</step6>\n<step6>\nUltimately, the decision should involve a multidisciplinary team to ensure the best outcome for both the mother and the child — *iṣeduro ti o dara julọ fun iya ati ọmọ*.\n</step7></thinking>", "answer": "<answer>Iṣe abẹrẹ to tọ ni lati ṣe abẹrẹ laparoscopic fun apendisiti ati igbẹ́, pẹlu akiyesi pataki si aabo iya ati ọmọ.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdọọdun 24 kan ṣafihan ara rẹ̀ pẹlu irora igbonwo ọwọ́ ọtun lẹhin ti o ṣubu lórí ọwọ́ rẹ̀ tí ó na silẹ̀ nígbà ìjìṣẹ̀ bọ́ọ̀lù bà́sìkẹ̀tì. Ní àyẹ̀wo, ìrora wà nínú àpótí snuffbox anatomical. Ẹ̀yà wo nínú igbonwo ọwọ́ ni ó ṣeé ṣe kí ó bàjẹ́ jùlọ, nígbà tí a bá gbé àwọn àmì àrùn kan tí ó fi hàn gbangba hàn?", "reasoning": "<thinking><step1>\nThe question asks: \"Which part of the wrist is most likely to be injured when there is pain in the anatomical snuffbox after a fall during a basketball game?\" — it focuses on wrist injuries related to a specific area.\n</step1>\n<step2>\nThe anatomical snuffbox is a triangular depression on the lateral aspect of the wrist — *apá ọtun ti igbonwo*. Pain in this area often indicates issues with the scaphoid bone.\n</step2>\n<step3>\nWhen someone falls on an outstretched hand, the scaphoid is particularly vulnerable to fractures — *ìfarapa scaphoid* can occur due to the impact.\n</step3>\n<step4>\nSymptoms like tenderness in the snuffbox and pain during wrist movement suggest a possible fracture — *ìfarapa* can lead to complications if not treated properly.\n</step4>\n<step5>\nIn this case, imaging studies like X-rays or MRIs are crucial to confirm the diagnosis — *ìwádìí àwòrán* helps visualize the injury.\n</step5>\n<step6>\nThus, the scaphoid bone is the most likely structure to be injured in this scenario, especially given the mechanism of injury described.\n</step6></thinking>", "answer": "<answer>Ẹ̀yà ti igbonwo ọwọ́ tí ó ṣeé ṣe kí ó bàjẹ́ jùlọ ni scaphoid bone.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 52 kan ti o ni itan-akọọlẹ aarun suga, titẹ ẹjẹ giga, ati GERD wá si ile-iwosan pajawiri pẹlu irora ọmu ati pe a gbe e si ile-iwosan fun ikọlu ọkan ti o buru.  Ọjọ kan lẹhin ti a bẹrẹ itọju rẹ, o ni iṣọn-ori ati wiwo òfo.  Titẹ ẹjẹ tuntun jẹ 90/60 mm Hg, ati awọn abajade ile-iwosan fihan ipele creatinine ti 2.3 mg/dL.  Ni akiyesi ilosoke ninu creatinine ati iyipada titẹ ẹjẹ, oogun wo ninu itọju rẹ ni o fa awọn aiṣedeede ile-iwosan wọnyi?", "reasoning": "<thinking><step1>\nThe question is asking about a 52-year-old man with a history of diabetes [aarun suga], hypertension [titẹ ẹjẹ giga], and GERD who experienced complications after treatment for a heart attack. It wants to identify which medication caused the hospital abnormalities, particularly the rise in creatinine [ilevelu creatinine] and the drop in blood pressure [titẹ ẹjẹ].\n</step1>\n<step2>\nIn such cases, medications like ACE inhibitors or diuretics are commonly used for heart conditions. However, these can lead to renal impairment — *iṣoro kidinrin* — especially in patients with pre-existing kidney issues.\n</step2>\n<step3>\nThe rise in creatinine indicates possible acute kidney injury [iṣoro kidinrin aigbọran], which can occur due to reduced renal perfusion from low blood pressure.\n</step3>\n<step4>\nIf the patient was started on a diuretic, it could cause dehydration and further decrease blood volume, leading to hypotension — *titẹ ẹjẹ kekere* — and increased creatinine levels.\n</step4>\n<step5>\nAdditionally, if an ACE inhibitor was introduced, it could also contribute to renal dysfunction, particularly if the patient is already at risk due to his medical history.\n</step5>\n<step6>\nThus, the most likely culprit for the observed abnormalities in this patient is a diuretic, which can exacerbate kidney issues and cause hypotension.\n</step6></thinking>", "answer": "<answer>Oògùn ti o fa awọn aiṣedeede ile-iwosan wọnyi ni diuretic.</answer>", "language": "Yoruba"}
{"question": "Ọmọ tuntun kan bẹrẹ sí tú irùgbìn àti omi tí bile ti ba jẹ́ ní wákàtí mẹ́fà lẹ́yìn ìbí, lẹ́yìn ìbí tí a ṣàkíyèsí ọ̀pọ̀lọpọ̀ omi amniotic.  Àyẹ̀wò ara jẹ́ déédéé, àti awòrán X-ray inu ikun fi àmì kan tí ó jẹ́ pàtàkì hàn.  Lórí ìsọfúnni yìí, kí ni àlàyé tí ó ṣeé ṣe jùlọ?", "reasoning": "<thinking><step1>\nThe question is asking: “A newborn starts to pass urine and meconium six hours after birth, following a significant amount of amniotic fluid observed. A physical examination is normal, and an abdominal X-ray shows a significant finding. Based on this information, what is the most likely explanation?” \n</step1>\n<step2>\nIn this context, the newborn passing urine and meconium indicates normal physiological function — *iṣẹ́ ara to peye* — which is expected shortly after birth.\n</step2>\n<step3>\nThe significant amount of amniotic fluid could suggest a condition like polyhydramnios, but since the physical examination is normal, we need to consider other factors.\n</step4>\n<step4>\nThe abdominal X-ray showing a significant finding could indicate an obstruction or a condition like *atresia intestinale* (intestinal atresia), which is a blockage in the intestines.\n</step5>\n<step5>\nGiven that the newborn is passing meconium, it suggests that the obstruction is not complete, but the presence of meconium could also indicate that the intestines are functioning to some extent.\n</step6>\n<step6>\nThus, the most likely explanation is that the newborn may have a mild intestinal obstruction, possibly due to *atresia* or another similar condition, which is consistent with the X-ray findings.\n</step6></thinking>", "answer": "<answer>Àlàyé tí ó ṣeé ṣe jùlọ ni pé ọmọ tuntun náà le ní ìdí àtẹ̀gùn inú, gẹ́gẹ́ bí àpẹẹrẹ, *atresia intestinale*.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 50 kan ti a mọ̀ pe ó ní àrùn sùùgbà fún ọdún pípẹ́ ti wá pẹ̀lú ìṣàn-ìgbàgbọ́ tí kò dára, ìdùn-àdùn, ìṣòro nínú ìgbàgbọ́, àti àìlọ́gbọ́n láti gbàgbọ́ pátápátá. Kí ni ó ṣeé ṣe kí ó ń jìyà nípa rẹ̀?\nA. BPH\nB. UTI\nC. Àpòòṣì atonic\nD. Àrùn ìṣan ara", "reasoning": "<thinking><step1>\nThe question is asking: \"What could a 50-year-old man with a long-standing illness experience regarding his symptoms of poor faith, discomfort, and difficulty in believing?\" The key terms include \"àrùn sùùgbà\" [chronic illness], \"ìṣàn-ìgbàgbọ́\" [faith issues], and \"àìlọ́gbọ́n\" [difficulty in believing].\n</step1>\n<step2>\nGiven the symptoms described, it seems the man is experiencing significant psychological distress, which can be linked to chronic conditions. Chronic illnesses often lead to *ìbànújẹ* [depression] and *ìṣòro nínú ìgbàgbọ́* [issues with faith].\n</step2>\n<step3>\nAmong the options provided, we need to consider which condition could lead to such psychological symptoms. BPH [Benign Prostatic Hyperplasia] typically causes urinary issues but not directly related to faith or belief.\n</step3>\n<step4>\nA UTI [Urinary Tract Infection] can cause discomfort but is less likely to lead to long-term faith issues. However, *àpòòṣì atonic* [atonic bladder] could lead to chronic urinary problems, which might contribute to distress.\n</step5>\n<step6>\nThe most relevant option seems to be \"Àrùn ìṣan ara\" [chronic illness], as it encompasses a range of conditions that could lead to both physical and psychological symptoms, including the ones described.\n</step6>\n<step7>\nThus, the man’s experience of discomfort and faith issues could be a result of living with a chronic illness, which affects both his physical health and mental state.\n</step7></thinking>", "answer": "<answer>Àrùn ìṣan ara ni ó ṣeé ṣe kí ó ń jìyà nípa rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 62 kan ti ó ti ní ìṣòro gbọ́ fún ọdún mẹta ṣe àwọn idanwo gbọ́ràn meji.  Nínú idanwo àkọ́kọ́, a gbá fúnki tí a fi ṣe ìdánwò sí egungun mastoid rẹ̀, lẹ́yìn náà sí etí rẹ̀, ó sì sọ pé ó gbọ́ ohùn náà dáadáa sí etí rẹ̀ ní ẹgbẹ́ méjèèjì. Nínú idanwo kejì, nígbà tí a gbá fúnki tí a fi ṣe ìdánwò sí iwájú orí rẹ̀, ó sọ pé ó gbọ́ ohùn náà dáadáa ní ẹgbẹ́ ọ̀tún.  Kí ni ìwádìí tí ó bá àwọn abajade idanwo gbọ́ràn wọnyi mu pọ̀ jùlọ?", "reasoning": "<thinking><step1>\nThe question asks about the findings from hearing tests conducted on a 62-year-old woman who has had hearing problems for three years. It mentions two tests: one involving the mastoid bone and the other the front of the head.\n</step1>\n<step2>\nIn the first test, the patient reported hearing sounds well in both ears after the mastoid bone test — *egungun mastoid* — indicating that her hearing might be relatively normal in that context.\n</step2>\n<step3>\nHowever, in the second test, which involved the front of her head, she only heard sounds well in her right ear — *etí ọ̀tún* — suggesting a possible issue with the left ear.\n</step3>\n<step4>\nThis pattern indicates a potential conductive hearing loss on the left side, as the right ear seems to function better during the second test — *ìṣòro gbọ́ àtẹ́gùn*.\n</step4>\n<step5>\nThe results imply that the patient may have a blockage or damage affecting her left ear, while the right ear remains relatively unaffected.\n</step5>\n<step6>\nThus, the most likely conclusion from these hearing test results is that there is a unilateral conductive hearing loss on the left side.\n</step6></thinking>", "answer": "<answer>Ìwádìí náà fi hàn pé ó ní ìṣòro gbọ́ àtẹ́gùn ni etí ọ̀tún, pẹ̀lú ìṣòro kan lórí etí òsì.</answer>", "language": "Yoruba"}
{"question": "Gẹgẹ́ bí àwọn ìtọ́ni ọdún 2010 láti ọ̀dọ̀ Ìjọba Ìlera àti Ìdílé, iye ìbẹ̀wò ìtọ́jú ṣíṣàkọ́ṣàkọ́ tí ó kéré jùlọ ni?", "reasoning": "<thinking><step1>\nThe question translates to: \"According to the 2010 guidelines from the Ministry of Health and Family, what is the minimum amount of outpatient treatment?\" This indicates a focus on healthcare guidelines.\n</step1>\n<step2>\nIn healthcare, *ìtọ́jú ṣíṣàkọ́ṣàkọ́* refers to outpatient treatment, which is care provided without admission to a hospital.\n</step2>\n<step3>\nThe 2010 guidelines likely specify a minimum number of visits or sessions for effective outpatient care — *ìbẹ̀wò* is crucial for monitoring patient progress.\n</step3>\n<step4>\nTypically, these guidelines are based on best practices to ensure patients receive adequate care while minimizing costs — *ìdílé* plays a role in family health management.\n</step4>\n<step5>\nTo find the exact figure, one would refer to the specific document from the Ministry, as it outlines the standards for healthcare delivery.\n</step5>\n<step6>\nThus, the minimum amount of outpatient treatment is defined in those guidelines, ensuring that patients receive necessary follow-ups.\n</step6></thinking>", "answer": "<answer>Iye ìbẹ̀wò ìtọ́jú ṣíṣàkọ́ṣàkọ́ tí ó kéré jùlọ ni a ṣe àfihàn nínú ìtọ́ni ọdún 2010 láti ọ̀dọ̀ Ìjọba Ìlera àti Ìdílé.</answer>", "language": "Yoruba"}
{"question": "Da irisi iṣẹlẹ ọkunrin agbalagba kan ti o ni irora ikun oke ati ẹjẹ ninu ògìrì, nibiti endoscopy fihan idagbasoke kan ni pyloric antrum inu ikun ati CT scan fihan idagbasoke naa ti o kan pyloric antrum lai si igbẹkẹle sinu awọn ohun elo ti o yika tabi metastasis jijìn, ati laparotomy fihan idagbasoke neoplastic ti o kan ogiri ẹhin inu ikun ati ipari pancreas, kini ọna iṣẹ abẹ ti o yẹ julọ yoo jẹ?", "reasoning": "<thinking><step1>\nThe question asks: “What is the most appropriate surgical approach for an elderly man with upper abdominal pain and blood in the stool, where endoscopy shows a growth in the pyloric antrum and CT scan indicates the growth affects the pyloric antrum without local invasion or distant metastasis, and laparotomy reveals a neoplastic growth affecting the posterior wall of the stomach and the tail of the pancreas?” \n</step1>\n<step2>\nThis situation describes a patient with a neoplasm — *neoplasma* — in the pyloric region, which is critical for gastric outflow.\n</step2>\n<step3>\nGiven that there is no evidence of local invasion or metastasis, the surgical approach should aim for complete resection — *résection complète* — of the tumor.\n</step3>\n<step4>\nTypically, for such cases, a distal gastrectomy is performed, which involves removing the distal part of the stomach along with the pylorus — *gastrectomie distale*.\n</step4>\n<step5>\nAdditionally, since the growth affects the tail of the pancreas, a splenectomy may also be necessary if the tumor is close to the spleen — *splénectomie*.\n</step5>\n<step6>\nIn summary, the most appropriate surgical procedure would be a distal gastrectomy with possible splenectomy, ensuring clear margins are achieved.\n</step6></thinking>", "answer": "<answer>Iṣẹ abẹ ti o yẹ julọ ni gastrectomy distale pẹlu splénectomie ti o ba jẹ dandan.</answer>", "language": "Yoruba"}
{"question": "Kini orukọ ilana naa ti o waye lakoko idagbasoke embryonic ti o mu ki awọn ipele germ mẹta naa ṣe?", "reasoning": "<thinking><step1>\nThe question asks: “Kini orukọ ilana naa ti o waye lakoko [idagbasoke embryonic = embryonic development] ti o mu ki [awọn ipele germ mẹta = the three germ layers] ṣe?” — meaning it wants to know the name of the process during embryonic development that leads to the formation of the three germ layers.\n</step1>\n<step2>\nThis process is crucial because it establishes the basic body plan — *ilana yii ṣe pataki nitori o da ipilẹ ara*. \n</step2>\n<step3>\nThe three germ layers are *ectoderm, mesoderm,* and *endoderm*, which differentiate into various tissues and organs.\n</step3>\n<step4>\nThe name of this process is *gastrulation*, where the single-layered blastula reorganizes into these three layers — *gastrulation ni ilana ti o n yipada blastula kan si awọn ipele mẹta*.\n</step4>\n<step5>\nDuring gastrulation, cells migrate and change shape, which is essential for proper development — *iyipada awọn sẹẹli ati gbigbe wọn jẹ pataki fun idagbasoke to pe*.\n</step6>\n<step6>\nThus, the process that leads to the formation of the three germ layers during embryonic development is called gastrulation.\n</step6></thinking>", "answer": "<answer>Ilana ti o mu ki awọn ipele germ mẹta ṣe ni a npe ni gastrulation.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 42 kan ni a ti ṣe akiyesi pe o ni àrùn suga iru keji fun ọdun 20. A ti ṣe akiyesi pe o ni àtọgbẹ ẹ̀jẹ̀ pẹlu titẹ ẹjẹ ni iwọn 150/94.  Idanwo ito fihan proteinuria to kere. Awọn oògùn wo ni yoo dara julọ lati tọju àtọgbẹ ẹjẹ ninu eniyan yii?\nA. Enalapril\nB. Hydrochlorothiazide\nC. Propranolol\nD. Nifedipine", "reasoning": "<thinking><step1>\nThe question asks: “What medications would be best to treat [àtọgbẹ ẹ̀jẹ̀ = hypertension] in a 42-year-old woman who has had [àrùn suga iru keji = type 2 diabetes] for 20 years and shows signs of [proteinuria = protein in urine]?” \n</step1>\n<step2>\nIn patients with type 2 diabetes, managing hypertension is crucial to prevent complications — *lati yago fun awọn iṣoro ilera*.\n</step2>\n<step3>\nThe blood pressure reading of 150/94 indicates stage 1 hypertension, which requires treatment — *itọju pataki*.\n</step3>\n<step4>\nEnalapril, an ACE inhibitor, is often recommended for diabetic patients because it helps protect kidney function — *o n ṣe iranlọwọ lati daabobo iṣẹ́ kidinrin*.\n</step4>\n<step5>\nHydrochlorothiazide is a diuretic that can lower blood pressure but may not provide the same renal protection as Enalapril — *o le ma fun ni aabo kidinrin to peye*.\n</step6>\n<step6>\nPropranolol is a beta-blocker, which is less preferred in this scenario due to its side effects and lack of renal benefits — *o ni awọn ipa ẹgbẹ ti o le fa iṣoro*.\n</step7>\n<step7>\nNifedipine is a calcium channel blocker that can lower blood pressure but is not the first choice for diabetic patients — *ko jẹ aṣayan akọkọ fun awọn alaisan ti o ni àtọgbẹ*.\n</step8>\n<step8>\nThus, the best choice for treating hypertension in this patient with diabetes and proteinuria would be Enalapril.\n</step8></thinking>", "answer": "<answer>Enalapril ni oògùn ti o dara julọ lati tọju àtọgbẹ ẹ̀jẹ̀ ninu eniyan yii.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mejila kan tí ó ní ibajẹ́ egungun femur lẹ́yìn ìṣòro ọkọ̀ ayọ́kẹ́lẹ́, a ṣe ìtọ́jú abẹ́ fún un. Lẹ́yìn tí a ti fi oògùn ìsunwọ̀n rẹ̀, ó ní iba gbígbóná tó jẹ́ 40 degC (104 degF), ríru ara, àti ito tí ó ní ẹ̀jẹ̀. Ní àwọn wọ̀nyí, èwo ni ọ̀nà ìtọ́jú tí ó dára jùlọ?\nA. Ṣíṣe ito rẹ̀ di alagbẹ̀rẹ̀, fifun ni mannitol, àti títẹ̀síwájú pẹ̀lú iṣẹ́ abẹ́ náà\nB. Fifun ni dantrolene sodium àti títẹ̀síwájú pẹ̀lú iṣẹ́ abẹ́ náà\nC. Fifun ni dantrolene sodium àti dádúró iṣẹ́ abẹ́ náà\nD. Fifun ni oògùn steroid tí a fi sí inu ẹ̀jẹ̀ àti oògùn antihistamine pẹ̀lú títẹ̀síwájú pẹ̀lú iṣẹ́ abẹ́ náà", "reasoning": "<thinking><step1>\nThe question is asking about the best treatment approach for a 12-year-old boy who has a [ibajẹ́ egungun femur = femur fracture] after a car accident and is experiencing a high fever of 40 degrees Celsius (104 degrees Fahrenheit), body stiffness, and bloody urine.\n</step1>\n<step2>\nIn this case, the symptoms suggest a possible complication like *rhabdomyolysis* or an infection, which can occur after trauma — *ìfarapa*.\n</step2>\n<step3>\nThe treatment options include administering medications like dantrolene sodium, which is used for *malignant hyperthermia*, and considering the need for surgical intervention.\n</step3>\n<step4>\nOption A suggests making the urine alkaline, giving mannitol, and continuing with surgery — this could help with kidney protection but may not address the fever and stiffness effectively.\n</step4>\n<step5>\nOption B proposes giving dantrolene sodium and continuing with surgery, which is crucial if there is a risk of *hyperthermia*.\n</step5>\n<step6>\nOption C also suggests dantrolene sodium but halting the surgery, which might not be advisable if the fracture needs immediate attention.\n</step6>\n<step7>\nOption D recommends giving steroids and antihistamines along with continuing surgery, which could help with inflammation but may not directly address the fever and bloody urine.\n</step7>\n<step8>\nConsidering the symptoms and the need for urgent care, the best option seems to be B, as it addresses the potential for *malignant hyperthermia* while allowing for necessary surgical intervention.\n</step8></thinking>", "answer": "<answer>Fifun ni dantrolene sodium àti títẹ̀síwájú pẹ̀lú iṣẹ́ abẹ́ náà ni ọ̀nà ìtọ́jú tí ó dára jùlọ.</answer>", "language": "Yoruba"}
{"question": "Gẹgẹ bi itọsọna Ẹgbẹ́ Àwọn Ọgbẹ́ni Àgbà Àwọn Ọmọ-iṣẹ́ Ìlera Àgbáyé, àìtó ṣiṣẹ́ ti iodine jẹ́ arun tí ó gbòòrò sí gbogbo agbegbe kan bí ìwọ̀n ìṣẹ̀lẹ̀ goiter ninu àwọn ọmọdé tí wọ́n wà nílé-ìwé bá ju -\nA. 1%\nB. 5%\nC. 10%\nD. 15%", "reasoning": "<thinking><step1>\nThe question translates to: \"According to the guidelines of the World Health Organization, iodine deficiency is a widespread disease in a region when the prevalence of goiter in school-aged children exceeds what percentage?\" \n</step1>\n<step2>\nIodine deficiency can lead to *goitre*, which is an enlargement of the thyroid gland — *ìtẹ̀sí àyà*.\n</step2>\n<step3>\nThe World Health Organization (WHO) sets specific thresholds for iodine deficiency — *àìtó iodine* — to assess public health.\n</step3>\n<step4>\nFor school-aged children, if the prevalence of goiter exceeds a certain percentage, it indicates a significant public health issue.\n</step4>\n<step5>\nResearch shows that a prevalence of goiter above 5% is considered a public health concern — *àìlera àgbáyé*.\n</step5>\n<step6>\nThus, the correct answer to the question regarding the percentage threshold is 5%.\n</step6></thinking>", "answer": "<answer>5%</answer>", "language": "Yoruba"}
{"question": "Kini ipa ti fifẹ́rẹ̀sí awọn ọja gypsum kíá ati fún igba pipẹ̀ lórí akoko didìrẹ̀, bí ó bá wà láàrin àwọn àṣàyàn tó yẹ?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ipa ti [fifẹ́rẹ̀sí = exposure] awọn [ọja gypsum = gypsum products] kíá ati fún igba pipẹ̀ = short-term and long-term effects on [akoko didìrẹ̀ = setting time], bí ó bá wà láàrin [àṣàyàn tó yẹ = appropriate options]?” — meaning it wants to know the effects of gypsum product exposure on setting time.\n</step1>\n<step2>\nGypsum products are commonly used in construction and art, and their setting time is crucial for proper application — *akoko didìrẹ̀ jẹ́ pataki*.\n</step2>\n<step3>\nShort-term exposure to gypsum can lead to rapid setting, which might be beneficial in some cases — *fifẹ́rẹ̀sí kíá le fa didìrẹ̀ yarayara*.\n</step3>\n<step4>\nHowever, prolonged exposure can cause issues like premature hardening, making it difficult to work with — *fifẹ́rẹ̀sí fún igba pipẹ̀ le fa iṣoro*.\n</step4>\n<step5>\nIn terms of appropriate options, one might consider additives that can modify the setting time — *àwọn afikun le ṣe atunṣe akoko didìrẹ̀*.\n</step6>\n<step6>\nUltimately, the balance between short-term and long-term effects is essential for optimal use of gypsum products in various applications.\n</step6></thinking>", "answer": "<answer>Fifẹ́rẹ̀sí awọn ọja gypsum kíá le fa didìrẹ̀ yarayara, ṣugbọn fún igba pipẹ̀, ó lè fa iṣoro bi didìrẹ̀ tó péye.</answer>", "language": "Yoruba"}
{"question": "Awọn ọ̀nà wo ni a sábà máa ń lò láti tọ́jú àwọn òkúta ìṣàn èso ẹ̀dọ̀, ati ọ̀nà wo ni a kò sábà máa ń lò?", "reasoning": "<thinking><step1>\nThe question asks: “What methods are commonly used to manage [òkúta ìṣàn èso ẹ̀dọ̀ = kidney stones], and what methods are not commonly used?” — indicating a need to explore both common and uncommon treatment options.\n</step1>\n<step2>\nCommonly, *ìtọju* for kidney stones includes hydration — *mimu omi pupọ* — to help flush out the stones.\n</step2>\n<step3>\nAnother common method is medication, such as pain relievers — *ìyàtọ̀ àìlera* — to manage discomfort during the passing of stones.\n</step3>\n<step4>\nIn some cases, procedures like lithotripsy — *lithotripsy* — are used to break down larger stones into smaller pieces for easier passage.\n</step4>\n<step5>\nOn the other hand, methods that are not commonly used include invasive surgeries unless absolutely necessary — *ìtọju àìlera tó nira*.\n</step5>\n<step6>\nAdditionally, some alternative treatments, like herbal remedies, lack sufficient scientific backing and are not widely recommended.\n</step6>\n<step7>\nThus, the focus remains on hydration, medication, and lithotripsy as effective methods, while invasive surgery and unproven alternatives are less favored.\n</step7></thinking>", "answer": "<answer>Àwọn ọ̀nà tó wọpọ̀ ni mimu omi, ìyàtọ̀ àìlera, àti lithotripsy, nigba tí ìtọju àìlera tó nira àti àwọn ìtọju àìlera àìmọ̀ ni a kò sábà máa ń lò.</answer>", "language": "Yoruba"}
{"question": "Obinrin ọdún mẹ́ẹ̀dógún (25) kan wá pẹ̀lú irora ikùn tí ń ṣẹlẹ̀ lọ́pọ̀lọpọ̀ àti àrùn ẹ̀jẹ̀ òṣùwọ̀n. Ìwádìí ẹ̀jẹ̀ ẹ̀gbẹ̀ rẹ̀ fi hàn pé àwọn sẹ̀ẹ̀lì pupa ẹ̀jẹ̀ rẹ̀ ní àmì bàsọfílíkì. Kí ni àkóràn tí ó ṣeé ṣe jùlọ fún ìṣọpọ̀ àwọn àmì àti àwọn ìwádìí ẹ̀jẹ̀ yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àkóràn tí ó ṣeé ṣe jùlọ fún ìṣọpọ̀ àwọn àmì àti àwọn ìwádìí ẹ̀jẹ̀ yìí?” — meaning it wants to know the most likely diagnosis for a 25-year-old woman with abdominal pain and low blood count, indicated by the presence of *bàsọfílíkì* (basophils) in her blood test.\n</step1>\n<step2>\nThe symptoms include *irora ikùn* (abdominal pain) and *àrùn ẹ̀jẹ̀ òṣùwọ̀n* (low blood count), which can suggest several conditions.\n</step2>\n<step3>\nThe presence of basophils, which are often elevated in certain conditions, points towards possible allergic reactions or hematological disorders — *àwọn àrùn ẹ̀jẹ̀*.\n</step3>\n<step4>\nIn this context, one must consider conditions like *leukemia* or *myeloproliferative disorders*, where basophils can be increased.\n</step4>\n<step5>\nAdditionally, *àrùn àtọgbẹ* (infections) or *àrùn autoimmune* (autoimmune diseases) could also lead to similar symptoms and blood findings.\n</step5>\n<step6>\nGiven the combination of abdominal pain and the specific blood findings, the most likely diagnosis could be *chronic myeloid leukemia* (CML), which is associated with elevated basophils.\n</step6></thinking>", "answer": "<answer>Àkóràn tí ó ṣeé ṣe jùlọ ni *chronic myeloid leukemia* (CML).</answer>", "language": "Yoruba"}
{"question": "Nínú àwọn àrùn wọ̀n-ọnìí, èwo ni ó ní ẹ̀rí mẹ́ta yìí:  telangiectasia,  ìgbàgbé ẹ̀jẹ̀ ìmú, àti ìtàn ìdílé tí ó dára fún àrùn náà:\nA. Àrùn Hodgkin.\nB. Osler-Weber-Rendu.\nC. Àrùn Sturge-Weber.\nD. Kò sí èyíkéyìí", "reasoning": "<thinking><step1>\nThe question asks: “Nínú àwọn àrùn wọ̀n-ọnìí, èwo ni ó ní ẹ̀rí mẹ́ta yìí: telangiectasia, ìgbàgbé ẹ̀jẹ̀ ìmú, àti ìtàn ìdílé tí ó dára fún àrùn náà?” — meaning it wants to identify which disease is associated with telangiectasia, recurrent nosebleeds, and a positive family history.\n</step1>\n<step2>\nTelangiectasia refers to small dilated blood vessels on the skin or mucous membranes — *àwọn ẹ̀jẹ̀ tó ti fa àfiyèsí*.\n</step2>\n<step3>\nRecurrent nosebleeds, or *ìgbàgbé ẹ̀jẹ̀ ìmú*, are a common symptom in certain vascular disorders.\n</step3>\n<step4>\nA positive family history indicates a genetic component, which is significant in conditions like Osler-Weber-Rendu syndrome — *àrùn Osler-Weber-Rendu*.\n</step4>\n<step5>\nHodgkin's lymphoma and Sturge-Weber syndrome do not typically present with these symptoms; they have different clinical features.\n</step5>\n<step6>\nThus, the combination of telangiectasia, recurrent nosebleeds, and a family history strongly points to Osler-Weber-Rendu syndrome.\n</step6></thinking>", "answer": "<answer>Àrùn Osler-Weber-Rendu ni ó ní ẹ̀rí mẹ́ta yìí: telangiectasia, ìgbàgbé ẹ̀jẹ̀ ìmú, àti ìtàn ìdílé tí ó dára.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìpínrọ̀ tó tẹ̀lé e yìí ṣàpèjúwe ṣeto àwọn ohun méje tí a pín sí ipò kan pato. Àwọn ọ̀rọ̀ náà bá ara wọn mu nígbà gbogbo. Lórí ẹ̀ka igi kan, àwọn ẹyẹ méje wà: ẹyẹ buluu, òwú, akìnkàn, fàlkọ̀n, ẹyẹ oníṣùgbò, rọ́bì̀nì, àti kwàìlì. Ẹyẹ oníṣùgbò wà ní òsì fàlkọ̀n. Òwú wà ní ẹ̀kẹ́ta láti òsì. Rọ́bì̀nì wà ní òsì ẹyẹ oníṣùgbò. Kwàìlì wà ní ọ̀nà ọwọ́ ọ̀tún fàlkọ̀n. Rọ́bì̀nì wà ní ọ̀nà ọwọ́ ọ̀tún òwú. Ẹyẹ buluu wà ní ẹ̀kẹ́ta láti ọ̀nà ọwọ́ ọ̀tún.\nÀwọn àṣàyàn:\n(A) Ẹyẹ buluu ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ\n(B) Òwú ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ\n(C) Akìnkàn ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ\n(D) Fàlkọ̀n ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ\n(E) Ẹyẹ oníṣùgbò ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ\n(F) Rọ́bì̀nì ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ\n(G) Kwàìlì ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn ìpínrọ̀ tó tẹ̀lé e yìí ṣàpèjúwe ṣeto àwọn ohun méje tí a pín sí ipò kan pato” — meaning it describes the arrangement of seven birds in specific positions.\n</step1>\n<step2>\nWe have seven birds: *ẹyẹ buluu* (blue bird), *òwú* (white bird), *akìnkàn* (sparrow), *fàlkọ̀n* (falcon), *ẹyẹ oníṣùgbò* (woodpecker), *rọ́bì̀nì* (robin), and *kwàìlì* (quail).\n</step2>\n<step3>\nThe *ẹyẹ oníṣùgbò* is located to the left of the *fàlkọ̀n*, and the *òwú* is in the third position from the left.\n</step3>\n<step4>\nThe *rọ́bì̀nì* is to the left of the *ẹyẹ oníṣùgbò*, while the *kwàìlì* is on the right side of the *fàlkọ̀n*.\n</step4>\n<step5>\nThe *rọ́bì̀nì* is also to the right of the *òwú*, and the *ẹyẹ buluu* is in the third position from the right.\n</step5>\n<step6>\nNow, we need to determine which bird is furthest to the right — *ni ọ̀nà ọwọ́ ọ̀tún jùlọ*.\n</step6>\n<step7>\nBased on the arrangement, the *kwàìlì* is positioned to the right of the *fàlkọ̀n*, and since the *ẹyẹ buluu* is in the third position from the right, it is not the furthest.\n</step7>\n<step8>\nThus, the *rọ́bì̀nì* is the one that is furthest to the right, as it is positioned after the *òwú* and *ẹyẹ oníṣùgbò*.\n</step8></thinking>", "answer": "<answer>Rọ́bì̀nì ni ẹni tí ó wà ní ọ̀nà ọwọ́ ọ̀tún jùlọ.</answer>", "language": "Yoruba"}
{"question": "Oníṣẹ́gun kan fi ohun ìfọwọ́gbà sí inú ikùn ọ̀tẹ̀lẹ̀mọ́ṣẹ̀ nígbà ìṣiṣẹ́ abẹ.  Ní abẹ́ ìgbìmọ̀ wo ni a ó fi ẹjọ́ sí i?\nA. Ìwà ibi tí ó jẹ́ ẹ̀bi\nB. Ìwà ibi tí ó jẹ́ ẹ̀bi (ìlànà àṣàmúlò)\nC. Res ispa loquitor\nD. Ẹ̀bi tí ó jẹ́ ti ẹlòmíràn", "reasoning": "<thinking><step1>\nThe question translates to: \"A doctor placed a foreign object in the patient's body during surgery. Under which legal principle will the case be judged?\" The key terms here are [ìfọwọ́gbà = foreign object] and [ìṣiṣẹ́ abẹ = surgical procedure].\n</step1>\n<step2>\nThis situation involves medical malpractice, specifically when a foreign object is left inside a patient — *ìfọwọ́gbà kan ti a fi sí inú ikùn*.\n</step2>\n<step3>\nIn legal terms, the principle of *res ipsa loquitur* applies here, meaning \"the thing speaks for itself.\" This principle suggests that the mere occurrence of the event implies negligence.\n</step3>\n<step4>\nOptions A and D refer to negligence related to others' actions, while option B mentions *ìlànà àṣàmúlò*, which is about the misuse of a procedure.\n</step4>\n<step5>\nGiven that the foreign object was unintentionally left inside, the most relevant legal principle is *res ipsa loquitur*, as it directly addresses the negligence inherent in such a situation.\n</step5>\n<step6>\nThus, the case will likely be judged under the principle of *res ipsa loquitur*.\n</step6></thinking>", "answer": "<answer>C. Res ispa loquitor</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹta kan tí a ti fún ní àwọn oògùn ìgbàárọ̀, a mú un wá sí ipò ìtójú àwọn ọmọdé nígbà tí ó ní irora ọfun, ibà, àti ìgbìyànjú ìmímú afẹ́fẹ́ pẹ̀lú àìlọ́wọ́ láti gbé oúnjẹ̀ sílẹ̀ fún wakati mẹrin sẹ́yìn. Ìwádìí fi hàn pé ọmọ náà ńṣe bí ẹni tí ó ṣàìsàn gidigidi, ó sì ń mí afẹ́fẹ́ lọ́pọ̀lọpọ̀. Ó ní ìṣàn ní suprasternal, supraclavicular àti intercostal nígbà tí ó bá ń gbà afẹ́fẹ́. Èwo nínú èyí tó tọ́ jùlọ:\nA. Acute Laryngotracheobronchitis\nB. Acute Epiglottitis\nC. Diphtheria\nD. Bronchopneumonia", "reasoning": "<thinking><step1>\nThe question describes a three-year-old boy who has been given medication for a respiratory issue and presents with symptoms like throat pain, fever, and difficulty breathing — *irora ọfun, ibà, àti ìgbìyànjú ìmímú afẹ́fẹ́*.\n</step1>\n<step2>\nThe child has been experiencing significant illness, indicated by *àìsàn gidigidi*, and shows signs of respiratory distress, which is critical to note.\n</step2>\n<step3>\nThe presence of retractions in the suprasternal, supraclavicular, and intercostal areas suggests a severe respiratory condition — *ìṣàn ní suprasternal, supraclavicular àti intercostal*.\n</step3>\n<step4>\nAmong the options, *Acute Laryngotracheobronchitis* typically presents with a barking cough and stridor, while *Acute Epiglottitis* often involves severe throat pain and difficulty swallowing.\n</step4>\n<step5>\n*Diphtheria* can cause a sore throat and respiratory distress but is less common with the current vaccination protocols. *Bronchopneumonia* usually presents with fever and cough but may not specifically cause the retractions noted.\n</step5>\n<step6>\nGiven the symptoms and the child's age, *Acute Epiglottitis* is the most concerning due to the risk of airway obstruction and the acute nature of the symptoms.\n</step6></thinking>", "answer": "<answer>Ìtòsí tó tọ́ jùlọ ni *Acute Epiglottitis*.</answer>", "language": "Yoruba"}
{"question": "Nígbà tí obìnrin ọmọ ọdún mẹ́ẹ́dógún (25) bá ní irú ìgbóná tí ó gbòde gbòde, tí kò sì ń tànká, tí kò sì ní ìrora, ní apá ọ̀tún rẹ̀, tó sì to bíi sẹ̀ǹtìmítà 2 sí 1.5, tí a sì rí ní x-ray pé ó dà bíi gilasi ilẹ̀, tí ó sì tàn kálẹ̀ láti inú eyín ajá sí àgbègbè eyín àkọ́kọ́, ìtọ́jú abẹ̀ wo ni ó yẹ?", "reasoning": "<thinking><step1>\nThe question asks about the appropriate surgical treatment for a 25-year-old woman with a specific type of swelling — *ìgbóná* — that is firm, non-tender, and located on her right side, measuring approximately 2 by 1.5 cm, with an X-ray showing a glass-like appearance — *dà bíi gilasi ilẹ̀*.\n</step1>\n<step2>\nIn this case, the firm swelling could indicate a benign condition, possibly a cyst or a tumor — *àpẹẹrẹ àtọ́ka* that requires careful evaluation.\n</step2>\n<step3>\nThe fact that it is non-tender and has a specific size suggests it might not be an acute issue, but the X-ray findings are crucial — *ìwádìí x-ray* indicates further investigation is necessary.\n</step3>\n<step4>\nSurgical intervention might be indicated if the lesion is suspected to be problematic or if it causes cosmetic concerns — *ìtọ́jú abẹ̀ le jẹ́ dandan*.\n</step4>\n<step5>\nThe surgical approach could involve excision of the lesion, especially if it is confirmed to be benign — *yiyọ́ àpẹẹrẹ àtọ́ka* to prevent any potential complications.\n</step5>\n<step6>\nIn summary, the recommended surgical treatment would likely be excision of the lesion, considering its characteristics and imaging results.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú abẹ̀ tó yẹ ni yíyọ́ àpẹẹrẹ àtọ́ka.</answer>", "language": "Yoruba"}
{"question": "Ṣe àpòtúnlé ènìyàn lè dàgbà padà lẹ́yìn iṣẹ́ abẹ́ gbogbo àpòtúnlé?\nA. Rárá, àpòtúnlé ènìyàn kò lè dàgbà padà lẹ́yìn iṣẹ́ abẹ́ gbogbo àpòtúnlé.\nB. Bẹ́ẹ̀ni, àpòtúnlé ènìyàn lè dàgbà padà lẹ́yìn iṣẹ́ abẹ́ gbogbo àpòtúnlé.\nC. Bẹ́ẹ̀ni, àpòtúnlé ènìyàn máa ń túmọ̀ ní oṣù kọ̀ọ̀kan.\nD. Bẹ́ẹ̀ni, ẹ̀rí tí ó ṣeé gbẹ́kẹ̀ lé wà pé àpòtúnlé ènìyàn dàgbà padà lẹ́yìn iṣẹ́ abẹ́ gbogbo àpòtúnlé.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe àpòtúnlé ènìyàn lè dàgbà padà lẹ́yìn iṣẹ́ abẹ́ gbogbo àpòtúnlé?” — meaning it is inquiring whether a person can recover after undergoing all types of surgery.\n</step1>\n<step2>\nRecovery after surgery, or *àpòtúnlé*, depends on various factors including the type of surgery and the individual's health — *ilera ènìyàn*.\n</step2>\n<step3>\nIn many cases, patients can indeed recover fully, but this is not guaranteed for every type of surgery — *kò sí ìdánilójú fún gbogbo iṣẹ́ abẹ́*.\n</step3>\n<step4>\nFor example, some surgeries may have complications that affect recovery — *àwọn iṣoro le dide*.\n</step5>\n<step5>\nHowever, there is evidence suggesting that many individuals do regain their health after surgery — *ẹ̀rí tí ó ṣeé gbẹ́kẹ̀ lé wà pé*.\n</step6>\n<step6>\nThus, the answer leans towards the possibility of recovery, especially with proper care and rehabilitation.\n</step6></thinking>", "answer": "<answer>Bẹ́ẹ̀ni, ẹ̀rí tí ó ṣeé gbẹ́kẹ̀ lé wà pé àpòtúnlé ènìyàn dàgbà padà lẹ́yìn iṣẹ́ abẹ́ gbogbo àpòtúnlé.</answer>", "language": "Yoruba"}
{"question": "Kini ẹ̀dùnàṣẹ òfin tí ó ní agbára julọ tí ó fi hàn pé Bea kò jẹ́bi sí Ann nípa ọ̀rọ̀ adehun tí wọ́n kọ sílẹ̀, nígbà tí a bá ronú nípa iṣẹ́ àti ìlérí tí ẹnìkọ̀ọ̀kan wọn ṣe nígbà tí wọ́n ṣe adehun náà?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ẹ̀dùnàṣẹ òfin tí ó ní agbára julọ tí ó fi hàn pé Bea kò jẹ́bi sí Ann nípa ọ̀rọ̀ adehun tí wọ́n kọ sílẹ̀?” — meaning it seeks to identify the strongest legal defense that shows Bea is not liable to Ann regarding the contract they entered into.\n</step1>\n<step2>\nIn contract law, a key principle is *ìlérí* (promise) and whether it was fulfilled — *báwo ni ìlérí náà ṣe jẹ́?* This involves examining the obligations of both parties.\n</step2>\n<step3>\nIf Bea can prove that there was a lack of *ìmọ̀lára* (consideration) or that the contract was void due to misrepresentation, she may not be held liable.\n</step3>\n<step4>\nAdditionally, if Bea can show that Ann did not fulfill her part of the agreement, it could serve as a defense — *ti Ann kò bá ṣe ohun tí ó yẹ kó ṣe*.\n</step5>\n<step5>\nAnother possible defense is the concept of *àìlera* (capacity); if Bea lacked the legal capacity to enter into the contract, it could invalidate her obligations.\n</step6>\n<step6>\nThus, the strongest legal defense for Bea would likely be demonstrating that the contract was not valid due to lack of consideration or Ann's failure to perform her obligations.\n</step6></thinking>", "answer": "<answer>Ẹ̀dùnàṣẹ òfin tó lágbára jùlọ fún Bea ni láti fi hàn pé adehun náà kò pé nitori àìmọ̀lára tàbí pé Ann kò ṣe ohun tí ó yẹ kó ṣe.</answer>", "language": "Yoruba"}
{"question": "Nítorí àrùn kànṣà ìdàpọ̀ ẹ̀dọ̀ (hepatocellular carcinoma) tí ọ̀rọ̀ àrùn àtọ́jú ṣúgà ẹ̀jẹ̀ ìru kejì (type 2 diabetes mellitus), àrùn ẹ̀dọ̀ hepatitis C tí ó lè wà fún ìgbà pípẹ̀, àti ìwà àìṣàkóso ọtí, tí ó sì ń lò Metalimus 100 mg nísinsìnyí fún ìtọ́jú àrùn kànṣà náà, èéṣe tí àwọn oníṣègùn kò lè yí i padà sí Noxbinle nítorí àǹfààní ìgbàlà rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Why can't doctors switch from Metalimus 100 mg to Noxbinle for treating [àrùn kànṣà ìdàpọ̀ ẹ̀dọ̀ = hepatocellular carcinoma] considering the benefits of [ìgbàlà = survival]?” \n</step1>\n<step2>\nHepatocellular carcinoma is often linked with chronic conditions like [àrùn ẹ̀dọ̀ hepatitis C = hepatitis C] and [àtọ́jú ṣúgà ẹ̀jẹ̀ ìru kejì = type 2 diabetes mellitus], which complicate treatment options.\n</step2>\n<step3>\nMetalimus is currently being used, and it may have specific mechanisms that target the cancer effectively — *ó lè ní ànfààní kan tó dára jùlọ*.\n</step3>\n<step4>\nSwitching to Noxbinle could be risky if it doesn't provide the same level of efficacy or if it interacts negatively with the patient's existing conditions — *àwọn àkópọ̀ àrùn lè fa ìṣòro*.\n</step4>\n<step5>\nMoreover, the decision to change medication often considers the patient's overall health status and response to current treatment — *ìdáhùn àrùn àti ìlera gbogbogbo*.\n</step5>\n<step6>\nIf Metalimus is providing a significant benefit, doctors may prefer to continue with it rather than risk a switch that could jeopardize the patient's survival — *ànfààní ìgbàlà* is paramount.\n</step6></thinking>", "answer": "<answer>Àwọn oníṣègùn kò lè yí Metalimus padà sí Noxbinle nítorí ànfààní ìgbàlà rẹ̀ àti ìṣòro tó lè dide pẹ̀lú àrùn àtọ́jú.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun marun kan fi ìgbóná ikùn hàn, tí a fi ṣe kedere pé ó jẹ́ nítorí ìmúgbòòjì ẹdọ, pẹ̀lú àwọn ìṣẹ̀lẹ̀ àìṣakoso hypoglycemia àti ketosis. Kí ni àyẹ̀wò tí ó ṣeé ṣe jùlọ tí a fi àwọn àmì àrùn wọ̀nyí ṣe?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni àyẹ̀wò tí ó ṣeé ṣe jùlọ tí a fi àwọn àmì àrùn wọ̀nyí ṣe?” — meaning it wants to know what the most likely test is for a five-year-old showing signs of [ìmúgbòòjì ẹdọ = liver dysfunction], along with episodes of [hypoglycemia = low blood sugar] and [ketosis = ketone production].\n</step1>\n<step2>\nIn this case, the symptoms suggest a metabolic issue, possibly related to the liver's ability to process glucose — *ìmúgbòòjì ẹdọ* can lead to hypoglycemia.\n</step2>\n<step3>\nThe most relevant test would be a blood glucose test — *àyẹ̀wò ẹ̀jẹ̀ glucose* — to measure the sugar levels in the child’s blood.\n</step3>\n<step4>\nAdditionally, checking for ketones in the urine — *àyẹ̀wò ketone ninu ẹ̀jẹ̀* — can help confirm ketosis, which is often a response to low glucose levels.\n</step4>\n<step5>\nConsidering the age of the child and the symptoms, a comprehensive metabolic panel — *àyẹ̀wò àkópọ̀ metabolic* — might also be necessary to assess liver function and overall metabolic status.\n</step5>\n<step6>\nThus, the most likely test to perform first would be the blood glucose test, as it directly addresses the hypoglycemia and its potential causes.\n</step6></thinking>", "answer": "<answer>Àyẹ̀wò ẹ̀jẹ̀ glucose ni àyẹ̀wò tí ó ṣeé ṣe jùlọ fún ọmọ ọdún marun yìí.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 50 kan ti ní irora ọmu lẹhin ẹgbẹ́ ọkan tó ń tàn sí ẹhin, ikọ́rọ̀, ìmúlẹ̀, àti ìgbóná ọkàn. Ó ní ìtàn àwọn ìṣẹ̀lẹ̀ tó dàbí èyí, ati ECG rẹ̀ dára.  Ìwádìí barium swallow àti esophageal manometry fihan aperistalsis ni ju 30% lọ ninu awọn mimu omi pẹlu 20% ti o jẹ nigbakannaa, ati awọn contractions ni awọn ipin mẹta ikẹhin ti esophagus pẹlu awọn amplitudes ti o ju 30 mm Hg lọ.  Oògùn wo ni a le lo lati dinku awọn aami aisan rẹ̀?", "reasoning": "<thinking><step1>\nThe question is asking: \"What medication can be used to reduce the symptoms of a 50-year-old man who has chest pain radiating to the back, dysphagia, and heartburn?\" — key terms include *irora ọmu* [chest pain], *ikọ́rọ̀* [dysphagia], and *ìmúlẹ̀* [heartburn].\n</step1>\n<step2>\nThe symptoms suggest a possible esophageal disorder, especially since the patient has a history of similar events and a normal ECG — *ECG rẹ̀ dára* indicates no immediate cardiac issues.\n</step2>\n<step3>\nThe barium swallow and esophageal manometry results show aperistalsis, which means the esophagus is not contracting properly — *aperistalsis ni ju 30% lọ* indicates significant dysfunction.\n</step3>\n<step4>\nIn cases like this, medications such as proton pump inhibitors (PPIs) can help reduce heartburn — *oògùn bi PPIs* can decrease stomach acid production.\n</step5>\n<step5>\nAdditionally, muscle relaxants may be considered to alleviate dysphagia and chest pain — *oògùn ti o le dinku ikọ́rọ̀* and improve esophageal motility.\n</step6>\n<step6>\nTherefore, a combination of PPIs and muscle relaxants could be effective in managing his symptoms.\n</step6></thinking>", "answer": "<answer>A le lo PPIs ati awọn relaxants iṣan lati dinku awọn aami aisan rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Kini jara awọn ohun kikọ ti a tẹjade nigbati eto FORTRAN ti a fun ni ba ṣiṣẹ, nipa lilo awọn eto data ti a ṣalaye ati iṣeto loopu?", "reasoning": "<thinking><step1>\nThe question asks: “Kini jara [sequence] awọn ohun kikọ [characters] ti a tẹjade [printed] nigbati eto [program] FORTRAN ti a fun ni ba ṣiṣẹ?” — meaning it wants to know what characters are printed when a given FORTRAN program runs.\n</step1>\n<step2>\nIn FORTRAN, a program typically defines data types and uses loops — *eto data* and *iṣeto loopu* — to control the flow of execution.\n</step2>\n<step3>\nWhen the program runs, it processes the defined data types, which could be integers, real numbers, or characters — *nọmba, awọn nọmba gidi, tabi awọn ohun kikọ*.\n</step3>\n<step4>\nThe loop structure, such as a *DO loop*, iterates over a range of values, printing each character or value as specified — *tẹjade kọọkan ohun kikọ tabi iye*.\n</step4>\n<step5>\nFor example, if the program is set to print characters from an array, it will output each character in sequence until the loop completes — *jade kọọkan ohun kikọ ni jara*.\n</step5>\n<step6>\nThus, the output will depend on the specific data and loop conditions defined in the program — *jade yoo dale lori data pato ati awọn ipo loop ti a ṣalaye*.\n</step6></thinking>", "answer": "<answer>Jara awọn ohun kikọ ti a tẹjade yoo dale lori awọn eto data ati iṣeto loopu ti a ṣalaye ninu eto FORTRAN.</answer>", "language": "Yoruba"}
{"question": "Ní orílẹ̀-èdè kan tí ìwọ̀n ìbí ọmọ jẹ́ 25 nínú ẹgbẹ̀rún, àti ìwọ̀n ikú jẹ́ 10 nínú ẹgbẹ̀rún, kí ni ìwọ̀n ìdàgbàsókè àpapọ̀ àwọn ènìyàn orílẹ̀-èdè náà, tí a fi ìpín yẹ̀ wò?", "reasoning": "<thinking><step1>\nThe question asks: “Ní orílẹ̀-èdè kan tí ìwọ̀n ìbí ọmọ jẹ́ 25 nínú ẹgbẹ̀rún, àti ìwọ̀n ikú jẹ́ 10 nínú ẹgbẹ̀rún” — meaning it provides birth and death rates and wants to know the overall growth rate of the population.\n</step1>\n<step2>\nTo find the overall growth rate, we subtract the death rate from the birth rate — *ìwọ̀n ìbí ọmọ* minus *ìwọ̀n ikú*.\n</step2>\n<step3>\nHere, the birth rate is 25 per thousand and the death rate is 10 per thousand — so we calculate: 25 - 10.\n</step3>\n<step4>\nThis gives us a net growth rate of 15 per thousand — *ìdàgbàsókè àpapọ̀*.\n</step4>\n<step5>\nIn percentage terms, we can express this growth rate as 1.5% — since 15 per thousand is equivalent to 1.5 per hundred.\n</step5>\n<step6>\nThus, the overall growth rate indicates how the population is increasing or decreasing over time.\n</step6></thinking>", "answer": "<answer>Ìwọ̀n ìdàgbàsókè àpapọ̀ àwọn ènìyàn orílẹ̀-èdè náà ni 1.5%.</answer>", "language": "Yoruba"}
{"question": "Ní Amẹ́ríkà, Ọjọ́ Ìdúpẹ̀ wà ní Ọjọ́ Ẹ̀kẹrin Ọjọ́bọ́ oṣù Kọkànlá. Lónìí ni Ọjọ́ Ìdúpẹ̀ Amẹ́ríkà ọdún 2001. Kí ni ọjọ́ kan oṣù kan ṣáájú rẹ̀ ní MM/DD/YYYY?\nÀwọn Àṣàyàn:\n(A) 11/22/2001\n(B) 10/21/2002\n(C) 07/21/2002\n(D) 10/22/1923\n(E) 10/15/2002\n(F) 10/22/2002", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ọjọ́ kan oṣù kan ṣáájú rẹ̀ ní MM/DD/YYYY?” — meaning it wants to know the date one month before Thanksgiving in the United States, which is on the fourth Thursday of November.\n</step1>\n<step2>\nIn 2001, Thanksgiving was on November 22nd. To find the date one month earlier, we need to go back to October.\n</step2>\n<step3>\nOne month before November 22nd is October 22nd — *Ọjọ́ 22 oṣù Kẹwa*.\n</step3>\n<step4>\nNow, we need to check the options provided to see if October 22nd, 2001 is listed.\n</step4>\n<step5>\nLooking at the choices, (F) 10/22/2002 is close, but it’s actually a year later. The correct date is 10/22/2001, which is not listed.\n</step5>\n<step6>\nHowever, since the question specifies one month before, we can confirm that the answer is indeed October 22nd, 2001.\n</step6></thinking>", "answer": "<answer>10/22/2001</answer>", "language": "Yoruba"}
{"question": "Bí a bá yí ohun tí ó wọn kìlògìráàmù kan padà sí agbara pátápátá nípa lílo ìlànà ìwọ̀n agbara-ìwọ̀n ìwọ̀n, báwo ni ó ṣe lè tan imọlẹ fún bọ́lùbù 100-W?", "reasoning": "<thinking><step1>\nThe question asks: “Bí a bá yí ohun tí ó wọn kìlògìráàmù kan padà sí agbara pátápátá” — meaning it wants to know how to convert a certain energy source into a total power output, specifically for a 100-W [watts] bulb.\n</step1>\n<step2>\nTo convert energy into power, we use the formula: *Agbara = Ìkànsí ÷ Àkókò* — where power is energy divided by time.\n</step2>\n<step3>\nFor a 100-W bulb, it means it consumes 100 joules of energy per second — *100 joules ni gbogbo ìsẹ́jú kan*.\n</step3>\n<step4>\nIf we want to power this bulb, we need to ensure that the energy source can provide at least 100 joules every second — *a nilo orisun agbara ti o le pese 100 joules ni gbogbo ìsẹ́jú kan*.\n</step4>\n<step5>\nUsing a renewable energy source, like solar panels, can be effective — *panẹli oorun le jẹ́ ọna to munadoko* to achieve this energy conversion.\n</step5>\n<step6>\nIn summary, to power a 100-W bulb, we must ensure our energy source can consistently deliver the required energy output — *orukọ agbara wa gbọdọ jẹ́ ki o le pese agbara to peye*.\n</step6></thinking>", "answer": "<answer>Lati tan imọlẹ bọ́lùbù 100-W, a nilo orisun agbara ti o le pese 100 joules ni gbogbo ìsẹ́jú kan.</answer>", "language": "Yoruba"}
{"question": "Obirin ọjọ́ ọdún 66 kan wá sí ẹ̀ka pajawiri pẹ̀lú ìtàn ọjọ́ kan ti irora ikun ti o burú jáì, ríru, ati ẹ̀gàn, pẹ̀lú àìgbọ́ràn omi líle pẹ̀lú awọn streaks ẹjẹ fun ọjọ́ 5 to kọja, lẹhin itọju pẹlu ciprofloxacin fun arun ọna ito. Ó ní iwọn otutu ti 39.3°C, ìṣiṣẹ́ ọkàn ti 110/min, ati titẹ ẹjẹ ti 100/60 mm Hg. Iwadii fihan ikun ti o fẹ̀, irora ninu awọn quadrants isalẹ, awọn ohun inu ikun ti ko ni agbara, ati idanwo ẹjẹ iṣẹkun rere. Awọn abajade ile-iwosan fihan leukocytosis ati awọn aisan iwọntunwọnsi. Kini X-ray ikun yoo ṣe afihan julọ ninu alaisan yii, ni ibamu si itan rẹ ati awọn ami aisan?", "reasoning": "<thinking><step1>\nThe question asks: “Kini X-ray ikun [abdominal X-ray] yoo ṣe afihan julọ ninu alaisan yii?” — meaning it wants to know what the abdominal X-ray will most likely show in this patient.\n</step1>\n<step2>\nThe patient is a 66-year-old woman with severe abdominal pain, *irora ikun*, and has been experiencing symptoms like *àìgbọ́ràn omi líle* and blood streaks for 5 days.\n</step2>\n<step3>\nGiven her symptoms and the fact that she has leukocytosis, this suggests an inflammatory process — possibly *arun apọju* or an infection.\n</step3>\n<step4>\nThe abdominal X-ray may reveal signs of *ìfarapa* or *ìkó* (obstruction), especially if there is any free air indicating perforation.\n</step4>\n<step5>\nAdditionally, if there are any masses or fluid levels, they could indicate complications like *ìfarapa abẹ́* or abscess formation.\n</step5>\n<step6>\nConsidering her fever and tachycardia, the X-ray might show *ìfarapa* in the abdominal area, which aligns with her clinical presentation.\n</step6></thinking>", "answer": "<answer>X-ray ikun yoo ṣe afihan ìfarapa tabi ìkó, pẹlu awọn ami ti arun apọju tabi abẹ́.</answer>", "language": "Yoruba"}
{"question": "Eyawo membranu sẹẹli wo ni o ṣiṣẹ bi agbààlà fun awọn amuaradagba pataki lori dada sẹẹli, gẹgẹ bi alkaline phosphatase ati lipoprotein lipase, nipasẹ asopọ covalent pẹlu afowopaawa oligosaccharide kan?", "reasoning": "<thinking><step1>\nThe question asks: “Eyawo membranu sẹẹli wo ni o ṣiṣẹ bi agbààlà fun awọn amuaradagba pataki [which membrane works as a scaffold for important proteins]?” — specifically mentioning alkaline phosphatase and lipoprotein lipase.\n</step1>\n<step2>\nIn English, we understand that the question is about cell membranes that facilitate the attachment of proteins — *membranes that act as scaffolds* for proteins through covalent bonding.\n</step2>\n<step3>\nThe proteins mentioned, alkaline phosphatase and lipoprotein lipase, are often associated with specific types of membranes — *membran pataki* that support their functions.\n</step3>\n<step4>\nCovalent attachment to an oligosaccharide — *asopọ covalent pẹlu afowopaawa oligosaccharide* — suggests a glycosylation process that stabilizes these proteins on the membrane.\n</step4>\n<step5>\nIn this context, the endoplasmic reticulum (ER) and the plasma membrane are key players — *membran sẹẹli* that provide the necessary environment for these proteins to function effectively.\n</step5>\n<step6>\nThus, the membrane that serves as a scaffold for these proteins is likely the plasma membrane, which allows for the proper orientation and activity of alkaline phosphatase and lipoprotein lipase.\n</step6></thinking>", "answer": "<answer>Membranu sẹẹli ti o ṣiṣẹ bi agbààlà fun alkaline phosphatase ati lipoprotein lipase ni membranu plasma.</answer>", "language": "Yoruba"}
{"question": "Poteini wo ni awọn sẹẹli parietal ninu ikun ń tu silẹ, tí ó ṣe pataki fún gbigba vitamin B12 sinu ileum?", "reasoning": "<thinking><step1>\nThe question asks: “What do the parietal cells in the stomach secrete that is important for the absorption of vitamin B12 in the ileum?” — here, *poteini* refers to proteins and *sẹẹli parietal* means parietal cells.\n</step1>\n<step2>\nParietal cells secrete hydrochloric acid — *asidrokloriki* — which creates an acidic environment in the stomach.\n</step2>\n<step3>\nThis acidic environment is crucial for the conversion of pepsinogen to pepsin, aiding in protein digestion — *iyipada pepsinogen si pepsin*.\n</step3>\n<step4>\nAdditionally, parietal cells produce intrinsic factor — *ifactor inu* — which is essential for the absorption of vitamin B12.\n</step4>\n<step5>\nWithout intrinsic factor, vitamin B12 cannot be effectively absorbed in the ileum — *ileum* is the final part of the small intestine.\n</step5>\n<step6>\nThus, the secretion of intrinsic factor by parietal cells is vital for preventing vitamin B12 deficiency — *aijẹ vitamin B12*.\n</step6></thinking>", "answer": "<answer>Sẹẹli parietal ninu ikun ń tu ifactor inu silẹ, tó ṣe pataki fún gbigba vitamin B12 sinu ileum.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdún mẹ́rinlélógún kan tí ó bí ọmọ nílé oṣù méjì sẹ́yìn ńwá pẹ̀lú ìyà ara ìṣàn ìgbà ìbí kikún. Ṣé ìgbà wo ni a gba nímọ̀ràn fún atunṣe abẹ ní ọ̀ràn yìí?", "reasoning": "<thinking><step1>\nThe question asks: “At what time should a [abẹ = surgery] be considered for a woman who is 41 years old and has given birth two months ago, experiencing severe abdominal pain?” \n</step1>\n<step2>\nIn this case, the woman is likely dealing with complications post-delivery — *àìlera lẹ́yìn ìbí* can lead to serious conditions.\n</step2>\n<step3>\nSevere abdominal pain could indicate issues like *ìfarapa* or infection, which may require surgical intervention.\n</step3>\n<step4>\nTypically, if the pain is persistent and worsening, it’s crucial to seek medical advice — *ìmọ̀ràn ilera* should be sought immediately.\n</step5>\n<step5>\nIn general, surgery is considered if conservative treatments fail or if there are signs of serious complications — *àkúnya àìlera*.\n</step6>\n<step6>\nTherefore, if the pain is severe and ongoing, it is advisable to consult a doctor for possible surgery within a few days of the onset of symptoms.\n</step7></thinking>", "answer": "<answer>A gba nímọ̀ràn fún atunṣe abẹ ní ọ̀sẹ̀ mẹta lẹ́yìn ìbí, bí ìyà ara bá ti pọ̀ síi.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 60 kan wa pẹlu awọn aami aisan ti o pẹlu irora ọmu ti o gbọn, ti o buru si nigbati o ba gbẹnu jinlẹ, ati ti o dara si nigbati o ba tẹsiwaju siwaju, ikọ́kọ́ ti ko gbinja, iba, ohun orin giga ti o fọ́n kiri lori idanwo ọkan, ati awọn abajade X-ray ọmu ti awọn fọto ọkan ti o tobi ati itọ́ni pleural. Ṣe o ṣe iyapa ST-elevation myocardial infarction ọsẹ mẹta sẹyin, ti a tọju pẹlu fifi stent sii. Da lori ifihan iṣoogun yii, kini idi ti o ṣeeṣe julọ ti ipo alaisan lọwọlọwọ?", "reasoning": "<thinking><step1>\nThe question describes a 60-year-old man with symptoms including chest pain that worsens with deep breaths and improves with leaning forward, cough, fever, and high-pitched sounds on heart examination, along with chest X-ray results showing enlarged heart and pleural effusion. It asks for the most likely cause of his current condition.\n</step1>\n<step2>\nGiven the recent history of ST-elevation myocardial infarction (STEMI) treated with stenting, we need to consider complications that can arise post-myocardial infarction — *iṣẹlẹ lẹhin ifasilẹ ọkan*.\n</step2>\n<step3>\nThe symptoms of chest pain that improves with leaning forward suggest *pericarditis*, which is inflammation of the pericardium — *iṣan ti o wa ni ayika ọkan*.\n</step3>\n<step4>\nAdditionally, the presence of fever and cough could indicate an infection or inflammation, possibly leading to *pleuritis* or *pleural effusion* — *iṣan ti o wa ni ayika ẹdọfóró*.\n</step4>\n<step5>\nThe enlarged heart on the X-ray may suggest heart failure or complications from the recent myocardial infarction, such as *cardiac tamponade* if there is significant fluid accumulation.\n</step5>\n<step6>\nConsidering all these factors, the most likely diagnosis for this patient is *pericarditis* secondary to his recent myocardial infarction.\n</step6></thinking>", "answer": "<answer>Iṣan ti o wa ni ayika ọkan (pericarditis) ni idi ti o ṣeeṣe julọ ti ipo alaisan lọwọlọwọ.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 65 kan ń ṣe afihan sisẹ̀ ẹ̀jẹ̀ láti inu ẹ̀dọ̀fóró ati ìṣẹ̀lẹ̀ ìgbẹ́ ẹ̀gbàá mẹta. Kini ayẹ̀wò tó ṣeé ṣe jùlọ nípa àwọn àmì wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “Ọkunrin ọdun 65 kan ń ṣe afihan sisẹ̀ ẹ̀jẹ̀ láti inu ẹ̀dọ̀fóró ati ìṣẹ̀lẹ̀ ìgbẹ́ ẹ̀gbàá mẹta” — meaning a 65-year-old man is showing signs of [liver failure] and [three episodes of fainting]. It wants to know what examination is most appropriate for these symptoms.\n</step1>\n<step2>\nIn cases of liver failure, *àwọn àmì* like jaundice or ascites may be present, indicating serious liver dysfunction — *iṣẹ́ ẹ̀dọ̀* ti bajẹ́.\n</step2>\n<step3>\nFainting episodes can be linked to various causes, including low blood pressure or arrhythmias — *àìlera ẹ̀jẹ̀* le fa ìgbẹ́ ẹ̀gbàá.\n</step3>\n<step4>\nA comprehensive evaluation is necessary, which may include blood tests to assess liver function — *àyẹ̀wò ẹ̀jẹ̀* lati wo iṣẹ́ ẹ̀dọ̀.\n</step4>\n<step5>\nImaging studies like an ultrasound can help visualize the liver and check for abnormalities — *àyẹ̀wò àwòrán* le jẹ́ iranlọwọ.\n</step5>\n<step6>\nGiven the combination of liver symptoms and fainting, a liver function test is crucial — *ayẹwo iṣẹ́ ẹ̀dọ̀* ni a ṣe pataki.\n</step6>\n<step7>\nAdditionally, checking for potential complications like portal hypertension is also important — *ìṣòro àtẹ̀gùn ẹ̀jẹ̀* le jẹ́ àbáyọ.\n</step7></thinking>", "answer": "<answer>Ayẹwo iṣẹ́ ẹ̀dọ̀ ni a ṣe pataki jùlọ fún ọkunrin yìí.</answer>", "language": "Yoruba"}
{"question": "Oníṣègun kan tú sílídíìdìi lẹ́dà (PbS) sínú omi. Níwíwí pé ìwọ̀n ọjà tí ó lè yọ (K_sp) jẹ́ 1 × 10^-28, kini ìwọ̀n mọ́lààrì kọ̀ọ̀kan àyọ̀nà (Pb^2+ àti S^2-) nínú ojúṣe naa?", "reasoning": "<thinking><step1>\nThe question asks: “Oníṣègun kan tú sílídíìdìi lẹ́dà (PbS) sínú omi” — meaning it is about the solubility of lead sulfide in water. The given solubility product constant (K_sp) is 1 × 10^-28.\n</step1>\n<step2>\nTo find the molar concentrations of the ions, we start with the dissociation of lead sulfide: *PbS(s) ⇌ Pb^2+(aq) + S^2-(aq)*.\n</step2>\n<step3>\nFrom the dissociation, we see that for every mole of PbS that dissolves, one mole of Pb^2+ and one mole of S^2- are produced — *nítorí náà, [Pb^2+] = [S^2-]*.\n</step3>\n<step4>\nLet’s denote the molar concentration of Pb^2+ and S^2- as *s*. Therefore, we can express K_sp as: *K_sp = [Pb^2+][S^2-] = s * s = s^2*.\n</step4>\n<step5>\nSubstituting the value of K_sp into the equation gives us: *s^2 = 1 × 10^-28*.\n</step5>\n<step6>\nTo find *s*, we take the square root: *s = √(1 × 10^-28) = 1 × 10^-14*.\n</step6>\n<step7>\nThus, the molar concentrations of both ions in the solution are equal: *[Pb^2+] = [S^2-] = 1 × 10^-14 M*.\n</step7></thinking>", "answer": "<answer>Ìwọ̀n mọ́lààrì kọ̀ọ̀kan àyọ̀nà (Pb^2+ àti S^2-) nínú ojúṣe naa jẹ́ 1 × 10^-14 M.</answer>", "language": "Yoruba"}
{"question": "Nigbati ìbúlé ìmọ́lẹ̀ monochromatic kan bá wọ́ inú fère irin-ajo kan láti afẹ́fẹ́, àwọn ànímọ́ ìmọ́lẹ̀ wo ni a yí pada?", "reasoning": "<thinking><step1>\nThe question asks: “Nigbati ìbúlé ìmọ́lẹ̀ monochromatic kan bá wọ́ inú fère irin-ajo kan láti afẹ́fẹ́” — meaning it wants to know what happens to monochromatic light when it enters a prism from air.\n</step1>\n<step2>\nWhen monochromatic light, or *ìmọ́lẹ̀ monochromatic*, enters a prism, it changes speed due to the different optical density of the prism material — *ìdàgbàsókè àfihàn*.\n</step2>\n<step3>\nThis change in speed causes the light to bend, or *yí padà*, at the interface between air and the prism.\n</step3>\n<step4>\nThe bending of light is described by Snell's Law, which states that the angle of incidence and refraction are related — *ìtàn àfihàn*.\n</step4>\n<step5>\nSince the light is monochromatic, it maintains its color but changes direction, resulting in a phenomenon known as refraction — *ìfihàn*.\n</step6>\n<step6>\nIn summary, when monochromatic light enters a prism, it bends due to the change in speed, leading to refraction without a change in color.\n</step6></thinking>", "answer": "<answer>Nigbati ìbúlé ìmọ́lẹ̀ monochromatic bá wọ́ inú fère irin-ajo kan, ìmọ́lẹ̀ náà yí padà sí i, ṣùgbọ́n kò yipada àwọ̀ rẹ.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 30 kan ti o ti lo ọti-lile fun ọdun 15 ti n ṣafihan awọn ami aisan ti iberu, ailagbara lati mọ, sọrọ fun ara rẹ̀, ihuwasi agbere, awọn iwariri, ati awọn iwariri oju ti ejò ati awọn ẹda ẹlẹgbẹ lẹhin ti o da mimu ọti-lile duro ọjọ meji sẹhin.  Kini ipo ti o ṣee ṣe julọ ti o ni iriri?", "reasoning": "<thinking><step1>\nThe question asks about a 30-year-old man who has been consuming alcohol for 15 years and is now showing symptoms like anxiety, inability to recognize or speak for himself, aggressive behavior, tremors, and visual hallucinations after stopping alcohol for two days. This suggests a possible condition related to alcohol withdrawal.\n</step1>\n<step2>\nThe symptoms described, such as *ihuwasi agbere* (aggressive behavior) and *iwariri* (tremors), are common in individuals who have been heavy drinkers and suddenly stop drinking — *da mimu duro*.\n</step2>\n<step3>\nThe presence of *awọn iwariri oju* (visual hallucinations) indicates a severe withdrawal syndrome, which can lead to a condition known as delirium tremens — *delirium tremens*.\n</step3>\n<step4>\nDelirium tremens typically occurs 48 to 72 hours after the last drink and is characterized by confusion, agitation, and severe autonomic instability — *aifọkanbalẹ ara*.\n</step4>\n<step5>\nGiven the timeline and symptoms, it is likely that this individual is experiencing alcohol withdrawal delirium, which is a medical emergency requiring immediate intervention.\n</step5>\n<step6>\nIn summary, the most probable condition he is experiencing is *delirium tremens* due to alcohol withdrawal.\n</step6></thinking>", "answer": "<answer>Ipo ti o ṣee ṣe julọ ti o ni iriri ni *delirium tremens* nitori aisan iberu ati aito ọti-lile.</answer>", "language": "Yoruba"}
{"question": "Ti a ba mọ pe idaamu kolesiterolu gbogbo eniyan kan jẹ 300 mg/dl, idaamu kolesiterolu HDL jẹ 25 mg/dl, ati idaamu triglycerides (TG) jẹ 150 mg/dl, ka iye idaamu kolesiterolu LDL.", "reasoning": "<thinking><step1>\nThe question asks: “If total cholesterol [idaamu kolesiterolu = total cholesterol] is 300 mg/dl, HDL cholesterol [idaamu kolesiterolu HDL = HDL cholesterol] is 25 mg/dl, and triglycerides [idaamu triglycerides = triglycerides] are 150 mg/dl, what is the LDL cholesterol [idaamu kolesiterolu LDL = LDL cholesterol] level?” \n</step1>\n<step2>\nTo find LDL cholesterol, we can use the Friedewald formula: LDL = Total Cholesterol - HDL - (Triglycerides/5).\n</step2>\n<step3>\nFirst, we substitute the values: LDL = 300 mg/dl - 25 mg/dl - (150 mg/dl / 5).\n</step3>\n<step4>\nCalculating the triglycerides part: 150 mg/dl divided by 5 equals 30 mg/dl.\n</step4>\n<step5>\nNow, we can continue: LDL = 300 mg/dl - 25 mg/dl - 30 mg/dl, which simplifies to LDL = 245 mg/dl.\n</step5></thinking>", "answer": "<answer>Iye idaamu kolesiterolu LDL jẹ 245 mg/dl.</answer>", "language": "Yoruba"}
{"question": "Ooru, ẹni kan ṣoṣo ni, ni pipadanu iṣẹ ṣiṣe ti $20,000 ọdun mẹta sẹyin. Pipadanu iṣura Ẹ̀ka 1244 ṣe idaji mẹta ninu mẹrin ti pipadanu yẹn. Ooru kò ní owo-wiwọle ti o san owo-ori lati ọdun yẹn titi di ọdun yii. Ni ọdun yii, Ooru ni owo-wiwọle gbogbogbo ti $80,000 ati pe o ni pipadanu miiran ti $50,000 lori iṣura Ẹ̀ka 1244. Ti a ba gba pe Ooru le gbe pipadanu iṣẹ ṣiṣe gbogbo $20,000 lọ si ọdun yii, kini iye ati iru pipadanu Ẹ̀ka 1244 ti Ooru le dinku fun ọdun yii?\nA. Pipadanu olu-ilu $20,000.\nB. Pipadanu deede $30,000.\nC. Pipadanu olu-ilu $40,000.\nD. Pipadanu deede $40,000.\nE. Pipadanu olu-ilu $30,000.\nF. Pipadanu deede $35,000.\nG. Pipadanu olu-ilu $50,000.\nH. Pipadanu deede $20,000.\nI. Pipadanu deede $50,000.\nJ. Pipadanu olu-ilu $35,000.", "reasoning": "<thinking><step1>\nThe question asks about the tax implications for Ooru, who has a [pipadanu iṣẹ ṣiṣe = operating loss] of $20,000 from three years ago and a [pipadanu iṣura = stock loss] related to Section 1244 that accounts for three-quarters of that loss.\n</step1>\n<step2>\nOoru has not had any taxable income to offset this loss until this year, when he reports a total income of $80,000 and an additional stock loss of $50,000 under Section 1244.\n</step2>\n<step3>\nThe key point is that Ooru can carry forward the entire operating loss of $20,000 to this year, which can be used to offset his income.\n</step3>\n<step4>\nNow, the stock loss under Section 1244 allows for a different treatment; it can be treated as an ordinary loss rather than a capital loss, which is beneficial for tax purposes.\n</step4>\n<step5>\nGiven that Ooru can apply the $20,000 operating loss against his income, he can also utilize the stock loss of $50,000, but he needs to determine how much of that can be deducted this year.\n</step5>\n<step6>\nSince the total stock loss is $50,000, and he can deduct the full amount as an ordinary loss, he can choose to deduct $30,000 of the Section 1244 loss, which is the maximum allowed after applying the operating loss.\n</step6>\n<step7>\nThus, the total deduction for this year would be the combination of the operating loss and the Section 1244 loss, leading to a total ordinary loss deduction of $50,000.\n</step7></thinking>", "answer": "<answer>Pipadanu deede $50,000.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìpínrọ̀ tó wà nínú àwọn ìpínrọ̀ tó tẹ̀lé e yìí ṣàpèjúwe ṣeto ohun méje tí a gbé ka nípasẹ̀ ìtòlẹ́sẹ̀ kan. Àwọn ọ̀rọ̀ náà bá ara wọn mu nínú ìpínrọ̀ kọ̀ọ̀kan. Nínú àfihàn ọkọ̀ ayọkẹ́lẹ́ àtijọ́ kan, ọkọ̀ ayọkẹ́lẹ́ méje wà: ọkọ̀ ayọkẹ́lẹ́ ṣíṣe ẹgbẹ́, ọkọ̀ ayọkẹ́lẹ́ ńlá, ọkọ̀ nínú, ọkọ̀ ayọkẹ́lẹ́ kékeré, bàsìkì, ọkọ̀ ayọkẹ́lẹ́ kékeré, àti ọkọ̀ ìrìnàjò. Bàsìkì náà ju ọkọ̀ nínú lọ́jọ́ oríṣìíríṣìí. Ọkọ̀ ayọkẹ́lẹ́ ṣíṣe ẹgbẹ́ náà ju ọkọ̀ ayọkẹ́lẹ́ kékeré lọ́jọ́ oríṣìíríṣìí. Bàsìkì náà jẹ́ tuntun ju ọkọ̀ ayọkẹ́lẹ́ kékeré lọ. Ọkọ̀ ìrìnàjò náà ni èkejì tó ti pẹ́ jùlọ. Ọkọ̀ ayọkẹ́lẹ́ kékeré ni ó ti pẹ́ jùlọ. Ọkọ̀ ayọkẹ́lẹ́ ńlá náà ju ọkọ̀ ayọkẹ́lẹ́ ṣíṣe ẹgbẹ́ lọ́jọ́ oríṣìíríṣìí.\nÀwọn àṣàyàn:\n(A) Ọkọ̀ ayọkẹ́lẹ́ ṣíṣe ẹgbẹ́ ni ó ti pẹ́ jùlọ\n(B) Ọkọ̀ ayọkẹ́lẹ́ ńlá ni ó ti pẹ́ jùlọ\n(C) Ọkọ̀ nínú ni ó ti pẹ́ jùlọ\n(D) Ọkọ̀ ayọkẹ́lẹ́ kékeré ni ó ti pẹ́ jùlọ\n(E) Bàsìkì ni ó ti pẹ́ jùlọ\n(F) Ọkọ̀ ayọkẹ́lẹ́ kékeré ni ó ti pẹ́ jùlọ\n(G) Ọkọ̀ ìrìnàjò ni ó ti pẹ́ jùlọ", "reasoning": "<thinking><step1>\nThe question asks: \"Which vehicle has been around the longest?\" — it provides a list of seven vehicles: *ọkọ̀ ayọkẹ́lẹ́ ṣíṣe ẹgbẹ́* (sports car), *ọkọ̀ ayọkẹ́lẹ́ ńlá* (large car), *ọkọ̀ nínú* (sedan), *ọkọ̀ ayọkẹ́lẹ́ kékeré* (small car), *bàsìkì* (bicycle), *ọkọ̀ ayọkẹ́lẹ́ kékeré* (small car again), and *ọkọ̀ ìrìnàjò* (bus).\n</step1>\n<step2>\nFrom the information given, we know that the *bàsìkì* is newer than the *ọkọ̀ ayọkẹ́lẹ́ kékeré*, indicating that the bicycle is not the oldest.\n</step2>\n<step3>\nThe *ọkọ̀ ayọkẹ́lẹ́ ṣíṣe ẹgbẹ́* is older than the *ọkọ̀ ayọkẹ́lẹ́ kékeré*, which suggests that the sports car is not the oldest either.\n</step3>\n<step4>\nThe *ọkọ̀ ayọkẹ́lẹ́ ńlá* is older than the *ọkọ̀ ayọkẹ́lẹ́ ṣíṣe ẹgbẹ́*, meaning it could potentially be one of the oldest.\n</step4>\n<step5>\nThe *ọkọ̀ ìrìnàjò* is noted as the second oldest, which means it is not the oldest vehicle.\n</step5>\n<step6>\nSince the *ọkọ̀ ayọkẹ́lẹ́ kékeré* is mentioned to be the oldest, we can conclude that it is the vehicle that has been around the longest.\n</step6></thinking>", "answer": "<answer>Ọkọ̀ ayọkẹ́lẹ́ kékeré ni ó ti pẹ́ jùlọ.</answer>", "language": "Yoruba"}
{"question": "Ohun elo mimu iyọ̀n kan ní iyara yípo ìṣáájú ti awọn iyipada 240 ni iṣẹju kan. Lẹhin aaya 10, iyara rẹ dinku si awọn iyipada 180 ni iṣẹju kan nitori idinku angular ti o gbẹkẹle.  Ka iye awọn iyipada afikun gbogbo ti ohun elo mimu iyọ̀n naa pari ṣaaju ki o to de opin pipe.", "reasoning": "<thinking><step1>\nThe question asks: “Ka iye awọn iyipada afikun gbogbo ti ohun elo mimu iyọ̀n naa pari ṣaaju ki o to de opin pipe?” — meaning it wants to calculate the total number of changes made by the device before it stops completely.\n</step1>\n<step2>\nInitially, the device operates at a speed of 240 changes per minute — *iyara 240 ni iṣẹju kan*. After 10 seconds, this speed decreases to 180 changes per minute — *iyara dinku si 180 ni iṣẹju kan*.\n</step2>\n<step3>\nFirst, we need to determine how many changes occur in the first 10 seconds. Since there are 60 seconds in a minute, we can calculate the changes in that time frame.\n</step3>\n<step4>\nIn 10 seconds, the number of changes at 240 changes per minute is: \n240 changes/minute * (10 seconds / 60 seconds) = 40 changes.\n</step4>\n<step5>\nAfter 10 seconds, the speed is now 180 changes per minute. We need to find out how long it takes for the device to stop completely — *de opin pipe*.\n</step5>\n<step6>\nAssuming the device stops after a linear decrease, we can calculate the time it takes to go from 180 to 0 changes per minute. The decrease is 60 changes per minute over a certain time period.\n</step6>\n<step7>\nIf we assume a constant rate of decrease, we can find the total changes made during this period until it stops. The average speed during this time is (180 + 0) / 2 = 90 changes per minute.\n</step7>\n<step8>\nNow, we need to determine how long it takes to go from 180 to 0. If it decreases at a rate of 6 changes per minute (from 240 to 180 in 10 seconds), it will take 30 seconds to stop completely.\n</step8>\n<step9>\nIn those 30 seconds, the total changes would be: 90 changes/minute * 30 seconds / 60 seconds = 45 changes.\n</step9>\n<step10>\nAdding the initial 40 changes to the 45 changes gives us a total of 85 changes before the device stops.\n</step10></thinking>", "answer": "<answer>Iye awọn iyipada afikun gbogbo ti ohun elo mimu iyọ̀n naa pari ṣaaju ki o to de opin pipe ni 85.</answer>", "language": "Yoruba"}
{"question": "Ṣe ìṣiro àyè ìjìnlẹ̀ tí ó pọ̀ jùlọ láti inú àtẹ́lẹwọ̀n sí orísun ìmọ́lẹ̀ ọ̀nà kan tí agbára rẹ̀ jẹ́ 50 kandẹ́lì, nígbà tí àtẹ́lẹwọ̀n náà bá ń wọn 15 mm nípa 40 mm, tí ó sì gbọ́dọ̀ jẹ́ pé oṣuwọn 0.2 lúmẹ̀ǹsì ni kó fi wá sí fótósẹ́lì kí ó tó ṣiṣẹ́.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe ìṣiro àyè ìjìnlẹ̀ tí ó pọ̀ jùlọ láti inú àtẹ́lẹwọ̀n sí orísun ìmọ́lẹ̀ ọ̀nà kan tí agbára rẹ̀ jẹ́ 50 kandẹ́lì?” — meaning it wants to calculate the area of illumination from a light source with a power of 50 candela.\n</step1>\n<step2>\nTo find the area of illumination, we use the formula for luminous intensity and the distance from the source — *ìmọ́lẹ̀ = I / d²*, where *I* is the intensity and *d* is the distance.\n</step2>\n<step3>\nHere, the distance can be calculated from the dimensions given: 15 mm by 40 mm. We need to convert these measurements into meters for consistency — *15 mm = 0.015 m* and *40 mm = 0.04 m*.\n</step3>\n<step4>\nNext, we find the distance from the light source to the area being illuminated. Assuming the light spreads uniformly, we can use the average distance — *d = √(0.015² + 0.04²)*.\n</step4>\n<step5>\nCalculating this gives us a distance of approximately 0.043 m. Now, we can substitute this value into our illumination formula: *ìmọ́lẹ̀ = 50 / (0.043)²*.\n</step5>\n<step6>\nAfter calculating, we find the illumination level, and to find the area, we need to consider the efficiency factor of 0.2 lumens per candela — *àyè = I * 0.2*.\n</step6>\n<step7>\nFinally, we can conclude the area of illumination based on the calculations performed.\n</step7></thinking>", "answer": "<answer>Àyè ìjìnlẹ̀ tí ó pọ̀ jùlọ láti inú àtẹ́lẹ̀wọ̀n náà jẹ́ 0.2 m².</answer>", "language": "Yoruba"}
{"question": "Ninu eto ipele TNM fun aarun eénu, bawo ni a ṣe ṣe ipinnu lori iṣọn-ọgbẹ́ kan ṣoṣo ti o wa ni ẹgbẹ kanna ti o to sentimita 2, pẹlu kikọlu inu ìpín?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu eto ipele [TNM = Tumor, Node, Metastasis] fun aarun [eénu = cancer], bawo ni a ṣe ṣe ipinnu lori iṣọn-ọgbẹ́ kan ṣoṣo ti o wa ni ẹgbẹ kanna ti o to sentimita 2, pẹlu kikọlu inu [ìpín = region]?” — meaning it wants to know how to determine the classification of a single tumor in the same region that is 2 centimeters, with involvement of the region.\n</step1>\n<step2>\nIn the TNM staging system, the size of the tumor is crucial — *iwọn iṣọn-ọgbẹ́* determines the T classification. A tumor that is 2 centimeters would typically be classified as T1.\n</step2>\n<step3>\nNext, we consider the lymph nodes — *awọn iṣọn lymph* — to see if there is any involvement. If there is no lymph node involvement, it remains N0; if there is involvement, it could be N1 depending on the number of nodes affected.\n</step3>\n<step4>\nThe presence of regional involvement, or *kikọlu inu ìpín*, suggests that the cancer may have spread locally, which could affect the overall staging.\n</step4>\n<step5>\nThus, if the tumor is 2 cm and there is regional involvement, we might classify it as T1, and if there is lymph node involvement, it could be N1, leading to a combined classification of T1N1.\n</step5>\n<step6>\nIn summary, the classification would depend on the specific details of lymph node involvement and regional spread, but a single tumor of 2 cm with regional involvement suggests a T1 stage.\n</step6></thinking>", "answer": "<answer>Iṣọn-ọgbẹ́ kan ṣoṣo ti o to sentimita 2 pẹlu kikọlu inu ìpín le jẹ T1, ati pe ti iṣọn lymph ba ni ipa, o le jẹ N1.</answer>", "language": "Yoruba"}
{"question": "Ọmọdé kan tó ní pyoderma ń fi àwọn àmì bí ìṣòro tó léwu, ìṣòro ìmí, àti fọ́tò ìṣiṣẹ́ ọmu àyà tó ń fi ìgbẹ́kẹ̀lé tí kò péye àti ọ̀pọ̀lọpọ̀ àwọn àpò ìfúùfù afẹ́fẹ́ tí ògiri wọn kò tóbi hàn. Ẹ̀dá ìmọ̀ tó ṣeé ṣe jùlọ tó fa àìsàn yìí kọ́?", "reasoning": "<thinking><step1>\nThe question asks: “What is the most likely cause of pyoderma in a child who shows symptoms like severe skin issues, respiratory problems, and multiple small air sacs with inadequate development?” — here, *pyoderma* refers to a bacterial skin infection.\n</step1>\n<step2>\nPyoderma often occurs due to bacterial infections, particularly *Staphylococcus aureus*, which can lead to skin lesions — *àpò àìlera*.\n</step2>\n<step3>\nIn children, underlying conditions like *immunosuppression* can exacerbate these infections, making them more severe — *àìlera àtọkànwá*.\n</step3>\n<step4>\nRespiratory issues may arise if the infection spreads or if the child has a compromised immune system, leading to *ìṣòro ìmí*.\n</step4>\n<step5>\nAdditionally, the presence of multiple small air sacs suggests possible lung involvement, which could be linked to the severity of the skin condition — *ìgbẹ́kẹ̀lé tí kò péye*.\n</step6>\n<step6>\nThus, the most likely cause of this child's pyoderma is a bacterial infection, potentially exacerbated by an underlying immune deficiency.\n</step6></thinking>", "answer": "<answer>Ìdí tó ṣeé ṣe jùlọ fún pyoderma ọmọ yìí ni àìlera àtọkànwá tí ó fa àìlera àpò àìlera.</answer>", "language": "Yoruba"}
{"question": "Ní ọ̀ràn ìgbà tí ọkàn bá ṣe àìsàn ní kíákíá (acute myocardial infarction) tí àyẹ̀wò ìṣísẹ̀ àwọn ọ̀pá ẹ̀jẹ̀ ọkàn (coronary artery angiography) kò sì fi hàn pé ẹ̀jẹ̀ ti dán mọ́lẹ̀ (thrombosis), àwọn ohun tí ń mú ìgbóná gbóná (mediator of inflammation) wo ni ó ń mú kí àwọn sẹ́ẹ̀lì ìṣísẹ̀ tí ó lágbára (vascular smooth muscle cells) balẹ̀, tí ó sì mú kí àwọn ìṣísẹ̀ kékeré (arterioles) gbòòrò sí i?", "reasoning": "<thinking><step1>\nThe question asks about the mediators of inflammation that cause vascular smooth muscle cells to relax and lead to the dilation of arterioles during an acute myocardial infarction, even when coronary artery angiography does not show thrombosis.\n</step1>\n<step2>\nIn an acute myocardial infarction, inflammation plays a crucial role — *ìgbà tí ọkàn bá ṣe àìsàn* can trigger various inflammatory mediators.\n</step2>\n<step3>\nKey mediators include nitric oxide (NO), which is produced by endothelial cells — *àwọn sẹ́ẹ̀lì àtọ́ka* — and causes vasodilation by relaxing smooth muscle cells.\n</step3>\n<step4>\nAdditionally, prostaglandins are released during inflammation, contributing to the relaxation of vascular smooth muscle — *ìṣísẹ̀ tí ó lágbára*.\n</step4>\n<step5>\nHistamine also plays a role by increasing blood flow and promoting vasodilation, which can lead to the widening of arterioles — *gbòòrò sí i*.\n</step5>\n<step6>\nThese mediators work together to ensure adequate blood flow and oxygen delivery to the heart muscle, even in the absence of thrombosis.\n</step6></thinking>", "answer": "<answer>Àwọn ohun tí ń mú ìgbóná gbóná ni nitric oxide, prostaglandins, àti histamine, tí ń fa kí àwọn sẹ́ẹ̀lì ìṣísẹ̀ balẹ̀, tí ó sì mú kí àwọn ìṣísẹ̀ kékeré gbòòrò sí i.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun marun kan wà pẹlu ìṣẹlẹ ìgbàgbọ́ kòtọ̀ ati àtọ́pàdà ẹ̀jẹ̀ giga pẹlu iwọn ẹjẹ ti 130/80 mm Hg.  Àyẹ̀wò homonu wo ni yoo jẹ́ ìdánilẹ́kọ̀ọ́ julọ ninu ọ̀ràn yìí?", "reasoning": "<thinking><step1>\nThe question asks: “What hormone test would be most informative in a case of a five-year-old boy with [hypertension = àtọ́pàdà ẹ̀jẹ̀] and [cushing syndrome = ìṣẹlẹ ìgbàgbọ́ kòtọ̀]?” \n</step1>\n<step2>\nIn this context, hypertension in a young child can be indicative of underlying conditions, such as *ìṣẹlẹ ìgbàgbọ́ kòtọ̀*, which is characterized by excess cortisol production.\n</step2>\n<step3>\nTo diagnose Cushing's syndrome, one would typically measure cortisol levels — *iwọn cortisol* — in the blood or urine.\n</step3>\n<step4>\nA common test is the 24-hour urinary free cortisol test, which assesses how much cortisol is excreted in urine over a day — *àyẹ̀wò àtọ́pàdà cortisol ni àkókò 24-wakati*.\n</step4>\n<step5>\nAdditionally, a late-night salivary cortisol test can also be useful, as cortisol levels should be low at night — *iwọn cortisol yẹ ki o jẹ́ kekere ni alẹ́*.\n</step6>\n<step6>\nThus, the most informative hormone test in this case would be the 24-hour urinary free cortisol test to evaluate for Cushing's syndrome.\n</step6></thinking>", "answer": "<answer>Àyẹ̀wò àtọ́pàdà cortisol ni àkókò 24-wakati ni yoo jẹ́ ìdánilẹ́kọ̀ọ́ julọ ninu ọ̀ràn yìí.</answer>", "language": "Yoruba"}
{"question": "Ọmọbirin ọdun 15 oṣu kan ni a mu wá sọ́dọ́ oníṣègùn nítorí ìgbóná tí kò ga pupọ̀ fún ọjọ́ méjì àti ìgbóná tí ó ní irora lórí ika ọwọ́ ọ̀tún rẹ̀.  A bí i nígbà tí ó yẹ, ó sì ti ní ìlera dáadáa, ayafi fún àìsàn ara tí ó wà lórí ètè rẹ̀ ní ọ̀sẹ̀ méjì sẹ́yìn, èyí tí ó sàn láìní ìtọ́jú. Ó ń gbé nílé pẹ̀lú àwọn òbí rẹ̀, àbúrò rẹ̀ ọmọ ọdún márùn-ún, àti àwọn ọmọ ẹlẹ́dẹ̀ méjì.  Ìgbóná ara rẹ̀ jẹ́ 38.5°C (101.3°F), ìṣẹ́ ọkàn rẹ̀ jẹ́ 110/min, ìmímú rẹ̀ jẹ́ 30/min, àti ṣíṣe ẹ̀jẹ̀ rẹ̀ jẹ́ 100/70 mm Hg.  Àwòrán ika ọwọ́ ọ̀tún ni a fi hàn.  Àyẹ̀wò ara fi hàn pé ìgbóná gbogbo epo igbóná.  Níwọ̀n ìgbà tí èyí tó tẹ̀lé jẹ́ ọlọ́run ìṣẹ̀lẹ̀ tí ó ṣeé ṣe jùlọ?\nA. Sporothrix schenckii\nB. Human papillomavirus type 1\nC. Herpes simplex virus type 1\nD. Trichophyton rubrum", "reasoning": "<thinking><step1>\nThe question describes a 15-year-old girl with a fever of 38.5°C (101.3°F) and pain in her right arm, asking for the most likely cause of her symptoms — *àwọn àkóónú àìlera*.\n</step1>\n<step2>\nGiven her recent history of a skin condition that improved without treatment, this suggests a possible infectious etiology — *àìlera àkóónú*.\n</step3>\n<step3>\nThe fever and arm pain could indicate a systemic infection or localized infection, possibly related to a skin condition — *àìlera ara*.\n</step4>\n<step4>\nAmong the options, Sporothrix schenckii is known for causing skin infections that can lead to systemic symptoms, especially in young individuals — *àìlera àkóónú ti o ni ibatan si Sporothrix*.\n</step5>\n<step5>\nHuman papillomavirus type 1 typically causes warts, while Herpes simplex virus type 1 is more associated with oral lesions — *àìlera ti o ni ibatan si herpes*.\n</step6>\n<step6>\nTrichophyton rubrum is a fungus that causes tinea infections, which may not explain the systemic fever and arm pain as well as Sporothrix would — *àìlera ti o ni ibatan si Trichophyton*.\n</step7>\n<step7>\nThus, considering the symptoms and the context, the most likely cause of her condition is Sporothrix schenckii — *àìlera ti o ni ibatan si Sporothrix*.\n</step8></thinking>", "answer": "<answer>Sporothrix schenckii.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹta ni a mú wá fun ṣiṣayẹwo idagbasoke gbogbogbo. Gẹgẹ bi awọn obi rẹ̀, ó ń ṣeré pẹlu awọn ọmọ miiran, ṣugbọn kii ṣe ni ọ̀nà ti ìmọ̀ṣọ̀kan. Ó sì ti bẹrẹ sí í gun kẹkẹ́ mẹta-kẹkẹ́ laipẹ. Nipa ibeere, iwọ yoo rí i pe a ti kọ́ ọ lati lo ile igbọ̀nwọ́, ó sì le gbé 9 bulọ́kì sókè. Nipa ṣiṣayẹwo, iwọ yoo rí i pe ó le ṣe afọwọ́yà kan, biotilẹjẹpe kò tíì le ṣe afọwọ́yà kan tàbí kí ó fa awọn fígbà. Pẹlupẹlu, ó ń sọrọ̀ ni awọn ọ̀rọ̀ meji, ṣugbọn kò tíì le lo awọn gbolohun ọ̀rọ̀ ti o rọrùn. Da lori awọn abajade wọnyi, o sọ fun awọn obi pe idagbasoke ọmọ wọn ni ibamu pẹlu eyikeyi ninu awọn wọnyi?\nA. Awujọ deede, moto deede, ede deede\nB. Awujọ ti ṣé, moto deede, ede deede\nC. Awujọ deede, moto ti ṣé, ede ti ṣé\nD. Awujọ deede, moto deede, ede ti ṣé\nE. Awujọ ti ṣé, moto deede, ede ti ṣé", "reasoning": "<thinking><step1>\nThe question is asking about the developmental milestones of a three-year-old boy, specifically in terms of social, motor, and language skills — *awujọ* [social], *moto* [motor], and *ede* [language].\n</step1>\n<step2>\nHe plays with other children, which indicates *awujọ deede* [normal social development], but he does not exhibit *ìmọ̀ṣọ̀kan* [cooperative play], suggesting some delay.\n</step2>\n<step3>\nHe has started riding a tricycle, showing *moto deede* [normal motor skills] for his age, as this is a typical milestone.\n</step3>\n<step4>\nHe can stack 9 blocks, which is also a sign of appropriate motor development, but he struggles with more complex tasks like drawing or pulling toys — indicating some limitations.\n</step4>\n<step5>\nIn terms of language, he speaks in two-word phrases but cannot form simple sentences yet, which suggests a delay in *ede* [language development].\n</step5>\n<step6>\nBased on these observations, the child shows normal social and motor skills but delayed language skills, leading to the conclusion that his development aligns with option D: *Awujọ deede, moto deede, ede ti ṣé* [Normal social, normal motor, delayed language].\n</step6></thinking>", "answer": "<answer>Awujọ deede, moto deede, ede ti ṣé.</answer>", "language": "Yoruba"}
{"question": "Awọn iwọn wo ni a lo lati ṣe iwọn sisẹ̀dààmú data?", "reasoning": "<thinking><step1>\nThe question asks: “Awọn iwọn wo ni a lo lati ṣe iwọn sisẹ̀dààmú data?” — meaning it wants to know what metrics are used to measure data processing performance.\n</step1>\n<step2>\nIn data processing, we often look at metrics like throughput — *iṣan data* — which indicates how much data is processed in a given time.\n</step2>\n<step3>\nAnother important metric is latency — *akoko idaduro* — which measures the time it takes for a data request to be completed.\n</step3>\n<step4>\nWe also consider efficiency, often expressed as a ratio of useful work done to the total resources used — *iṣeduro*.\n</step4>\n<step5>\nAdditionally, error rate — *iṣeduro aṣiṣe* — is crucial, as it shows how often errors occur during data processing.\n</step5>\n<step6>\nFinally, scalability — *iṣeduro iwọn* — is important to assess how well a system can handle increased loads.\n</step6></thinking>", "answer": "<answer>Awọn iwọn ti a lo lati ṣe iwọn sisẹ̀dààmú data ni iṣan data, akoko idaduro, iṣeduro, iṣeduro aṣiṣe, ati iṣeduro iwọn.</answer>", "language": "Yoruba"}
{"question": "Fun awọn alaisan ọdun 50 kan ti a ṣe abẹrẹ mastectomy fun aarun oyinbo inu ọmu ti o ni ọpọlọpọ awọn ibi ati awọn lymph nodes axillary mẹta ti o dara, kini ibi ti o wọpọ julọ fun metastasis latọna jijin ninu iru awọn ọran bẹẹ?", "reasoning": "<thinking><step1>\nThe question asks: “Fun awọn alaisan [patients] ọdun 50 kan ti a ṣe abẹrẹ [mastectomy] fun [breast cancer] ti o ni ọpọlọpọ awọn ibi [lesions] ati awọn [lymph nodes] axillary mẹta ti o dara, kini ibi ti o wọpọ julọ fun [metastasis] latọna jijin [distant metastasis] ninu iru awọn ọran bẹẹ?” — meaning it wants to know the most common site for distant metastasis in such cases.\n</step1>\n<step2>\nIn breast cancer, especially with multiple lesions and involvement of axillary lymph nodes, the risk of metastasis increases significantly — *iṣeeṣe ti metastasis n pọ si*.\n</step2>\n<step3>\nCommon sites for distant metastasis include the bones, liver, and lungs — *ẹsẹ, ẹdọ, ati awọn ẹdọfóró* are particularly notable.\n</step3>\n<step4>\nAmong these, the bones are often the most frequent site for metastasis — *ẹsẹ ni a maa n ri metastasis julọ* in breast cancer patients.\n</step4>\n<step5>\nThis is due to the bone's rich vascular supply and the tendency of cancer cells to migrate there — *iṣan ẹjẹ ọlọrọ ti awọn ẹsẹ* makes it a favorable environment for cancer cells.\n</step6>\n<step6>\nTherefore, in patients with advanced breast cancer, the most common site for distant metastasis is the bones.\n</step6></thinking>", "answer": "<answer>Ibi ti o wọpọ julọ fun metastasis latọna jijin ninu iru awọn ọran bẹẹ ni ẹsẹ.</answer>", "language": "Yoruba"}
{"question": "Àpẹẹrẹ ọmọ alaisan ọdun 72 kan wá sí Yàrá Ipajáde pẹlu ìgbẹ̀rùn ẹ̀jẹ̀ àti ìgbóná apá òsì. Ó ní itan ìmu siga kan ti pakiti kan ti siga fun ọjọ kan fun ọdun 30.  Nítorí àwọn ààmì wọnyi àti ìwádìí afikun ti àwọn àìṣe deede ti ojú ti o tọka si iṣẹ́ ìtẹ́rù, kini idi ti o ṣeé ṣe julọ ti ifihan rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What is the most likely cause of the patient's presentation?” — referring to a 72-year-old patient with [ìgbẹ̀rùn ẹ̀jẹ̀ = blood pressure] and [ìgbóná apá òsì = left arm pain].\n</step1>\n<step2>\nGiven the patient's age and symptoms, we should consider common cardiovascular issues — *àwọn iṣoro ọkan* — especially since he has a history of smoking for 30 years.\n</step2>\n<step3>\nThe left arm pain could indicate a heart-related issue, often associated with *ìfarapa ọkan* or myocardial infarction — commonly known as a heart attack.\n</step3>\n<step4>\nAdditionally, the presence of high blood pressure — *ìgbẹ̀rùn ẹ̀jẹ̀* — is a significant risk factor for heart disease, which further supports this possibility.\n</step4>\n<step5>\nConsidering these factors, the most likely cause of his symptoms is an acute coronary syndrome — *ìṣòro àkúnya ọkan* — which includes conditions like a heart attack.\n</step5></thinking>", "answer": "<answer>Ìdí ti o ṣeé ṣe julọ ti ifihan rẹ̀ ni àkúnya ọkan.</answer>", "language": "Yoruba"}
{"question": "Ọmọbìnrin ọdun mẹsan kan wá pẹlu ẹjẹ inu iṣọn-ẹ̀, ẹ̀gàn, ìṣò, ati irora ti nṣàn ni agbegbe lumbar ọtun, pẹlu àwọn àmì ti kò hàn kedere lori ẹdọ, ati pe o wa ni ipo iṣẹku.  Igbese itọju wo ni a gbọdọ ṣe ninu itọju rẹ?", "reasoning": "<thinking><step1>\nThe question asks: “What treatment steps should be taken for a 9-year-old girl presenting with [ẹjẹ inu iṣọn-ẹ̀ = blood in urine], [ẹ̀gàn = vomiting], [ìṣò = diarrhea], and pain in the right lumbar region, with unclear signs on the liver, and in a state of shock?” \n</step1>\n<step2>\nFirst, we need to assess the severity of her condition — *a ṣe ayẹwo ipo rẹ* to determine if she is stable or in critical condition.\n</step2>\n<step3>\nGiven the symptoms, especially the blood in urine and shock, this could indicate a serious underlying issue like a urinary tract infection or kidney problem — *iyọnu ti iṣọn-ẹ̀ tabi iṣoro ẹdọ*.\n</step4>\n<step4>\nImmediate actions include establishing IV access for fluid resuscitation — *a nilo lati fi omi kun* to address her shock and dehydration.\n</step5>\n<step5>\nNext, laboratory tests should be ordered, including a complete blood count and urinalysis — *a gbọdọ ṣe ayẹwo ẹjẹ ati iṣọn-ẹ̀* to identify any infections or abnormalities.\n</step6>\n<step6>\nIf her condition worsens or if there are signs of internal bleeding, surgical consultation may be necessary — *a le nilo ijumọsọrọ pẹlu awọn oniwosan* for further evaluation.\n</step7>\n<step7>\nIn summary, the immediate treatment steps involve stabilization, fluid resuscitation, and diagnostic testing to guide further management.\n</step7></thinking>", "answer": "<answer>Igbese itọju akọkọ ni lati fi omi kun, ṣe ayẹwo ẹjẹ, ati ṣe ayẹwo iṣọn-ẹ̀ lati pinnu itọju to yẹ.</answer>", "language": "Yoruba"}
{"question": "Àpọnà tí ó bá ara rẹ̀ jà ní ìṣẹ̀lẹ̀ ọ̀nà gbé àìníjàánu ọmu ati ikùn wá.  Lórí àwọn ìwádìí X-ray ọmu rẹ̀, kini àyẹ̀wò tí ó ṣeé ṣe jùlọ fún ipò ọmu tí a rí?", "reasoning": "<thinking><step1>\nThe question translates to: \"What is the most likely diagnosis for the lung condition observed in the X-ray findings?\" It refers to a situation where the patient has respiratory distress and chest pain — *ìṣẹ̀lẹ̀ ọ̀nà gbé àìníjàánu ọmu*.\n</step1>\n<step2>\nIn cases of respiratory distress, common conditions include pneumonia, pulmonary embolism, or even a pneumothorax — *pneumothorax* being a collapsed lung.\n</step2>\n<step3>\nThe X-ray findings can show signs of fluid accumulation, which indicates pneumonia — *ìfarapa ọmu* — or air in the pleural space for pneumothorax.\n</step3>\n<step4>\nIf the patient presents with fever and cough, pneumonia is more likely; however, if there is sudden sharp chest pain, pneumothorax should be considered — *ìfarapa ọmu* versus *pneumothorax*.\n</step5>\n<step5>\nAdditionally, the patient's history and symptoms are crucial; for instance, a history of smoking could increase the risk of chronic obstructive pulmonary disease (COPD) — *arun àìlera ọmu*.\n</step6>\n<step6>\nThus, based on the X-ray findings and symptoms, the most likely diagnosis could be pneumonia or pneumothorax, depending on the specific details observed.\n</step6></thinking>", "answer": "<answer>Àyẹ̀wò tí ó ṣeé ṣe jùlọ fún ipò ọmu tí a rí ni pneumonia tàbí pneumothorax, gẹ́gẹ́ bí ìfarapa àti àwòrán X-ray ṣe fi hàn.</answer>", "language": "Yoruba"}
{"question": "Kini awọn ami aisan pataki ti Arun oju Vernal ti a ṣe akiyesi ni awọn alaisan ti o ni ipo yii?", "reasoning": "<thinking><step1>\nThe question asks: “Kini awọn ami aisan pataki ti [Arun oju Vernal = Vernal Keratoconjunctivitis] ti a ṣe akiyesi ni awọn alaisan ti o ni ipo yii?” — meaning it wants to know the key symptoms of Vernal Keratoconjunctivitis in affected patients.\n</step1>\n<step2>\nVernal Keratoconjunctivitis is an allergic condition affecting the eyes, often seen in children — *o maa n waye ni awọn ọmọde*.\n</step2>\n<step3>\nKey symptoms include intense itching — *irora to lagbara*, redness of the eyes — *pupa oju*, and tearing — *iyọ oju*.\n</step3>\n<step4>\nPatients may also experience photophobia, which is sensitivity to light — *iṣoro si imọlẹ*.\n</step4>\n<step5>\nAnother common symptom is the presence of mucus discharge — *iyọ ti o ni mucus* from the eyes, especially during allergy seasons.\n</step5>\n<step6>\nIn summary, the main symptoms of Vernal Keratoconjunctivitis are severe itching, redness, tearing, light sensitivity, and mucus discharge.\n</step6></thinking>", "answer": "<answer>Awọn ami aisan pataki ti Arun oju Vernal ni irora to lagbara, pupa oju, iyọ oju, iṣoro si imọlẹ, ati iyọ ti o ni mucus.</answer>", "language": "Yoruba"}
{"question": "Ṣiṣe iṣiro agbara to wa ni MeV fun jijẹ alpha ti Polonium-210.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣiṣe iṣiro agbara to wa ni [MeV = mega electron volts] fun [jijẹ alpha = alpha decay] ti [Polonium-210 = Polonium-210]?” — meaning it wants to calculate the energy released in MeV during the alpha decay of Polonium-210.\n</step1>\n<step2>\nAlpha decay involves the emission of an alpha particle, which consists of 2 protons and 2 neutrons — *iyẹn ni, helium nucleus*.\n</step2>\n<step3>\nFor Polonium-210, the decay can be represented as: *Polonium-210 → Lead-206 + alpha particle*.\n</step3>\n<step4>\nThe energy released during this process can be calculated using the mass defect and Einstein's equation, E=mc² — *nítorí náà, a nilo lati mọ iyatọ ninu awọn masi*.\n</step4>\n<step5>\nThe mass of Polonium-210 is approximately 210.001, and Lead-206 is about 205.974 — *iyẹn ni, a le ṣe iṣiro iyatọ naa*.\n</step6>\n<step6>\nAfter calculating the mass defect and converting it to energy, we find that the energy released is around 5.4 MeV — *nítorí náà, agbara ti a gba ni MeV jẹ 5.4*.\n</step7></thinking>", "answer": "<answer>Agbara to wa ni MeV fun jijẹ alpha ti Polonium-210 jẹ 5.4 MeV.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun mejilelọgbọta (32) kan ti n ṣe bọ́ọ̀lù ẹsẹ̀ ni o ni ibajẹ́ púpọ̀ ninu awọn iṣan ẹsẹ̀ rẹ̀, gẹ́gẹ́ bí ayẹwo MRI ti fi hàn. Ṣe àkíyèsí egungun tí ó ní í ṣe pẹ̀lú awọn ibajẹ́ iṣan wọnyi.", "reasoning": "<thinking><step1>\nThe question asks: “What are the bones related to the muscle injuries of a 32-year-old man who plays football?” — it seeks to identify the bones that might be affected by muscle damage.\n</step1>\n<step2>\nMuscle injuries in the legs can involve various bones, particularly in the lower limb — *ẹsẹ̀ isalẹ* which includes the femur, tibia, and fibula.\n</step2>\n<step3>\nThe femur, or *egungun ọfọn*, is the thigh bone and is crucial for movement; injuries here can affect the surrounding muscles.\n</step3>\n<step4>\nThe tibia, known as *egungun tibia*, is the larger bone in the lower leg and bears weight, while the fibula, or *egungun fibula*, is smaller and provides stability.\n</step4>\n<step5>\nInjuries to the muscles can lead to stress on these bones, potentially causing conditions like stress fractures — *ibajẹ́ egungun*.\n</step5>\n<step6>\nAdditionally, the patella, or *egungun àyà*, is important as it protects the knee joint and can be involved in muscle injuries related to the quadriceps.\n</step6>\n<step7>\nOverall, the bones most likely affected by muscle injuries in this context are the femur, tibia, fibula, and patella.\n</step7></thinking>", "answer": "<answer>Egungun mẹrin pataki ni femur, tibia, fibula, ati patella ni wọn ni ibatan pẹ̀lú awọn ibajẹ́ iṣan ẹsẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ìgbòkànṣe ẹ̀sìn títóbi wo ni a rí nínú èkìkì Phillis Wheatley tó pè ní ‘On Being Brought from Africa to America,’ pàápàá jùlọ nípa àwọn koko ìmọ̀ràn ọkàn àti èrò náà pé gbogbo ènìyàn, láìka orílẹ̀-èdè sí, lè di mímọ́ àti ìgbàlà?", "reasoning": "<thinking><step1>\nThe question asks about the major religious themes found in Phillis Wheatley's poem \"On Being Brought from Africa to America,\" particularly regarding the ideas of salvation and the notion that all people, regardless of their origin, can attain grace — *ìgbàlà*.\n</step1>\n<step2>\nIn the poem, Wheatley reflects on her journey from Africa to America, which she interprets as a divine plan — *èdá Ọlọ́run* — suggesting that her enslavement was part of a larger purpose.\n</step2>\n<step3>\nShe emphasizes the concept of redemption, stating that through Christianity, even those who were once seen as \"pagan\" can find *ìmọ̀ràn ọkàn* and salvation.\n</step3>\n<step4>\nWheatley’s use of the term \"mercy\" highlights the idea that God's grace is available to everyone, regardless of their background — *orílẹ̀-èdè* or status.\n</step4>\n<step5>\nMoreover, she challenges the prejudices of her time by asserting that all humans are equal in the eyes of God, promoting a universal message of hope and faith — *ìgbàlà*.\n</step5>\n<step6>\nThus, the poem serves as a powerful reminder that through faith, anyone can achieve spiritual enlightenment and redemption, transcending their earthly circumstances.\n</step6></thinking>", "answer": "<answer>Nínú èkìkì rẹ, Wheatley fi hàn pé gbogbo ènìyàn, láìka orílẹ̀-èdè sí, lè di mímọ́ àti ìgbàlà nípasẹ̀ ìgbàgbọ́.</answer>", "language": "Yoruba"}
{"question": "Ti agba omi ṣanṣan ọkọ ayọkẹlẹ kan bá le gba galonu 15 nigbati o ba kun, ti galonu 7 si wa ninu agba naa lọwọlọwọ, iṣẹ mathimatiki wo ni iwọ yoo lo lati pinnu iye galonu ti o ṣi nilo lati kun agba naa?", "reasoning": "<thinking><step1>\nThe question asks: “Ti agba omi ṣanṣan ọkọ ayọkẹlẹ kan bá le gba galonu 15…” — meaning it wants to know how much more water is needed to fill a tank that can hold 15 gallons.\n</step1>\n<step2>\nCurrently, there are 7 gallons in the tank — *galonu 7 si wa ninu agba naa lọwọlọwọ*.\n</step2>\n<step3>\nTo find out how much more is needed, we need to subtract the current amount from the total capacity — *a nilo lati yọ iye ti o wa lọwọlọwọ kuro ninu agbara lapapọ*.\n</step3>\n<step4>\nThe mathematical operation here is simple subtraction: 15 gallons (total capacity) minus 7 gallons (current amount).\n</step4>\n<step5>\nSo, the equation would be: 15 - 7 = ? — *iyẹn ni 15 - 7 = ?*.\n</step5>\n<step6>\nThis calculation will give us the number of gallons still needed to fill the tank completely.\n</step6></thinking>", "answer": "<answer>Iye galonu ti o ṣi nilo lati kun agba naa ni 8.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹ́rìndínlógún kan wà pẹlu ipo ọpọlọ ti yipada ati acidosis ṣíṣe pàtàkì. Lẹhin ti a ti fi i sinu tube ati gbe si ẹrọ atẹgun pẹlu awọn eto iranlọwọ iṣakoso iwọn didun, a gba afẹfẹ ẹjẹ artery kan ti o fi pH 7.05 han, pCO2 ti 40 mmHg, ti o tọka si acidosis ṣíṣe pàtàkì ti ko ni igbẹhin. Ti a ba gbe awọn iwari wọnyi ati awọn eto ẹrọ atẹgun lọwọlọwọ ti oṣuwọn ẹmi ti 14/min ati iwọn didun tidal ti 350 mL, pẹlu awọn ipele PEEP ati FiO2 boṣewa, kini atunṣe ti o dara julọ si awọn eto ẹrọ atẹgun lati yanju ipo acid-base rẹ dara julọ?", "reasoning": "<thinking><step1>\nThe question is asking about a 17-year-old boy with altered mental status and acute respiratory acidosis. It provides specific blood gas values: pH 7.05 and pCO2 40 mmHg, indicating significant respiratory acidosis without compensation.\n</step1>\n<step2>\nIn this case, *acidosis ṣíṣe pàtàkì* means that the body is unable to compensate for the high levels of carbon dioxide, which is causing the low pH. The patient is on a ventilator with a respiratory rate of 14/min and a tidal volume of 350 mL.\n</step2>\n<step3>\nTo correct the acid-base status, we need to increase the minute ventilation. This can be achieved by either increasing the respiratory rate or the tidal volume — *iyipada ninu iwọn didun tabi oṣuwọn ẹmi*.\n</step3>\n<step4>\nGiven the current settings, increasing the tidal volume might be more effective since the patient is already at a moderate respiratory rate. A higher tidal volume will help eliminate more CO2 — *iyipada ti o ga julọ yoo mu ki CO2 dinku*.\n</step4>\n<step5>\nAdditionally, we should monitor the patient's response to these changes closely, ensuring that the pH moves towards normal levels. If necessary, we might also consider adjusting the PEEP or FiO2 settings, but the primary focus should be on ventilation.\n</step5>\n<step6>\nThus, the best adjustment to the ventilator settings would be to increase the tidal volume to improve the patient's acid-base status effectively.\n</step6></thinking>", "answer": "<answer>Atunṣe ti o dara julọ si awọn eto ẹrọ atẹgun ni lati pọ si iwọn didun tidal lati mu ipo acid-base rẹ dara si.</answer>", "language": "Yoruba"}
{"question": "Pẹlu àwọn àmì àrùn bí: ríru tó gbà jìgì, ògòrò, orírí, ìrora orí, ìgbàgbé, ríru, ara gbígbẹ̀ àti fífò ara pẹ̀lú ìyẹ̀fun díẹ̀, àti ìyípadà tuntun ninu oúnjẹ tí ó ní àfikún ati èwebe, kini ọ̀rọ̀ tí ó ṣeé ṣe jùlọ tí ó fa ipo alaisan yii?", "reasoning": "<thinking><step1>\nThe question asks: “Pẹlu àwọn àmì àrùn bí: ríru tó gbà jìgì, ògòrò, orírí, ìrora orí, ìgbàgbé, ríru, ara gbígbẹ̀ àti fífò ara pẹ̀lú ìyẹ̀fun díẹ̀, àti ìyípadà tuntun ninu oúnjẹ tí ó ní àfikún ati èwebe, kini ọ̀rọ̀ tí ó ṣeé ṣe jùlọ tí ó fa ipo alaisan yii?” — meaning it wants to identify the most likely cause of a condition with symptoms like dizziness, headache, fatigue, and changes in diet.\n</step1>\n<step2>\nThe symptoms listed suggest a possible health issue — *àrùn kan* — that could be related to various factors, including dietary changes or stress.\n</step2>\n<step3>\nDizziness (*ríru tó gbà jìgì*) and headache (*ìrora orí*) can often be linked to dehydration or nutritional deficiencies — *aìní àwọn àkópọ̀ onjẹ*.\n</step3>\n<step4>\nAdditionally, fatigue (*ìgbàgbé*) and changes in appetite (*ìyípadà ninu oúnjẹ*) may indicate an underlying condition like anemia or thyroid issues — *àìlera àtọgbẹ*.\n</step5>\n<step6>\nConsidering the symptoms and potential causes, one might conclude that a common issue could be related to poor nutrition or dehydration — *aìlera onjẹ*.\n</step7>\n<step8>\nIn summary, the most likely cause of these symptoms could be a combination of inadequate nutrition and dehydration.\n</step8></thinking>", "answer": "<answer>Ìdí tí ó ṣeé ṣe jùlọ fún ipo alaisan yii ni aìlera onjẹ àti aìní omi.</answer>", "language": "Yoruba"}
{"question": "Nínú ọmọdé tí ó ní retinoblastoma, èwo nínú àwọn wọ̀nyí kì í ṣe ohun tí a sábà rí nínú X-ray: Oṣù Kẹsán 2012\nA. Ẹ̀fún iṣan inu ojú\nB. Ẹ̀fún iṣan inu ọpọlọ\nC. Ọ̀pọ̀lọpọ̀ ẹ̀fún iṣan tí ó ní iwúrí nínú àgbàṣe ori\nD. Ṣíṣí àfonífọ́n òpó òrìṣìríṣì", "reasoning": "<thinking><step1>\nThe question is asking: “In a child with [retinoblastoma = retinoblastoma], which of the following is not typically seen in an X-ray?” \n</step1>\n<step2>\nRetinoblastoma is a type of eye cancer that primarily affects children, and it usually presents with specific signs on imaging. \n</step2>\n<step3>\nOptions include: A. *Ẹ̀fún iṣan inu ojú* (tumor in the eye), B. *Ẹ̀fún iṣan inu ọpọlọ* (tumor in the brain), C. *Ọ̀pọ̀lọpọ̀ ẹ̀fún iṣan tí ó ní iwúrí nínú àgbàṣe ori* (multiple tumors with calcification in the skull), and D. *Ṣíṣí àfonífọ́n òpó òrìṣìríṣì* (opening of various channels).\n</step3>\n<step4>\nTypically, X-rays can show calcifications associated with retinoblastoma, especially in the eye and sometimes in the skull. \n</step4>\n<step5>\nHowever, *ṣíṣí àfonífọ́n òpó òrìṣìríṣì* is not a finding that would be visible on an X-ray related to retinoblastoma, as it pertains more to vascular structures rather than tumors.\n</step5>\n<step6>\nThus, the correct answer is the option that does not relate to typical findings in retinoblastoma on X-ray.\n</step6></thinking>", "answer": "<answer>D. Ṣíṣí àfonífọ́n òpó òrìṣìríṣì</answer>", "language": "Yoruba"}
{"question": "Eleyi SVG ipa ona  <path d=\"M 59.64,77.72 L 75.18,56.50 M 75.18,56.50 L 6.90,59.13 M 6.90,59.13 L 22.09,77.44 M 22.09,77.44 L 2.73,94.57 M 2.73,94.57 L 91.78,91.66 M 91.78,91.66 L 59.64,77.72\"/> ya aworan\nAwọn aṣayan:\n(A) iyika\n(B) heptagon\n(C) hexagon\n(D) kite\n(E) ila\n(F) octagon\n(G) pentagon\n(H) onigun mẹrin\n(I) apakan\n(J) onigun mẹta", "reasoning": "<thinking><step1>\nThe question asks: “Eleyi SVG ipa ona [SVG path] ya aworan [draws a shape]” — meaning it wants to identify the shape represented by the given SVG path data.\n</step1>\n<step2>\nThe SVG path describes a series of lines connecting various points — *iyika* (circle) or *onigun* (polygon) could be possibilities.\n</step2>\n<step3>\nTo analyze the path, we note the coordinates: it starts at (59.64, 77.72) and connects to (75.18, 56.50), then to (6.90, 59.13), and so on.\n</step3>\n<step4>\nCounting the distinct points and the connections, we see that there are multiple line segments, suggesting a polygonal shape.\n</step4>\n<step5>\nThe final connection returns to the starting point, indicating a closed shape. Given the number of sides, we can determine the specific polygon.\n</step6>\n<step6>\nAfter analyzing the connections, it appears to form a *onigun mẹta* (triangle) based on the number of vertices.\n</step6></thinking>", "answer": "<answer>Onigun mẹta ni aworan yii.</answer>", "language": "Yoruba"}
{"question": "Kini otitọ meji nipa ọna mimu oògùn wọ inu ara nípa ti sisọ oògùn sinu iṣan (I.M.) ati sisọ oògùn labẹ awọ ara (I.D.)?", "reasoning": "<thinking><step1>\nThe question asks: “Kini otitọ meji nipa [mimu oògùn = drug administration] wọ inu ara nípa ti [sisọ oògùn sinu iṣan = intramuscular injection] ati [sisọ oògùn labẹ awọ ara = intradermal injection]?” — meaning it wants to know two truths about drug administration methods.\n</step1>\n<step2>\nFirst, an intramuscular injection delivers medication deep into the muscle — *oògùn naa n wọ inu iṣan* for faster absorption into the bloodstream.\n</step2>\n<step3>\nIn contrast, an intradermal injection places the drug just beneath the skin — *oògùn naa n wa labẹ awọ ara*, which is often used for allergy tests or vaccinations.\n</step3>\n<step4>\nThe absorption rate for intramuscular injections is generally quicker than for intradermal injections — *iyara mimu oògùn naa yara ju*.\n</step4>\n<step5>\nAdditionally, the volume of medication that can be administered is larger in intramuscular injections compared to intradermal injections — *iṣan le gba iwọn oògùn tobi ju*.\n</step5></thinking>", "answer": "<answer>Ojúṣe meji ni: 1) Mimu oògùn sinu iṣan n mu ki oògùn naa yara wọ inu ẹjẹ, 2) Mimu oògùn labẹ awọ ara n jẹ ki oògùn naa wa ni isalẹ awọ fun idanwo ati ajesara.</answer>", "language": "Yoruba"}
{"question": "Ọmọbirin ọdun mẹrindilogun kan ni awọn obi rẹ̀ mú wá sọ́dọ̀ onísègùn ọmọdé rẹ̀ pẹ̀lú àníyàn pé ọmọbirin wọn kò tíì ní ìgbà ìṣẹ̀ṣẹ̀ àkọ́kọ́ rẹ̀. Awọn obi sọ pé ọmọ náà kò ní àìsàn èyíkéyìí nígbà ìgbàlódé rẹ̀. A bí i nígbà tí ó pé, nípasẹ̀ ìbí ara, tí ó sì ti dé àwọn ìpele ìdàgbàsókè mìíràn gbogbo. Gẹ́gẹ́ bí àtúnyẹ̀wò àkọsílẹ̀, ọmọ náà fi hàn pé ọmú rẹ̀ bẹ̀rẹ̀ sí dàgbà ní ọdún mẹ́wàá. Ọmọ náà kò ní ìdààmú nípa bí ó ṣe rí, ṣùgbọ́n ó ń ṣàníyàn pé ohun kan lè ṣẹlẹ̀ nítorí pé kò tíì ní ìgbà ìṣẹ̀ṣẹ̀.  Ìgbóná ara ọmọ náà jẹ́ 97.9°F (36.6°C), ṣíṣe ẹ̀jẹ̀ jẹ́ 116/70 mmHg, ìṣe ọkàn jẹ́ 66/min, àti ìgbà mímu afẹ́fẹ́ jẹ́ 12/min. Nígbà àyẹ̀wò, ọmọ náà dà bí ọjọ́ orí rẹ̀, ó sì ní ìdàgbàsókè déédéé. Ó ní ìdàgbàsókè ọmú Tanner 5 ṣùgbọ́n irun ìdí Tanner 2. Ní àyẹ̀wò àgbàyanu, àwọn ẹ̀yà ìbímọ rẹ̀ hàn gbangba, ṣùgbọ́n àgbàyanu náà pari sí àpòtọ́.  Àwọn ìwádìí ilàbòlò fi hàn pé ọmọ náà ní iye tí ó ga ju ti testositeroni, estrogen, àti luteinizing hormone.  Èwo nínú àwọn wọ̀nyí ni karyotype tí ó ṣeé ṣe julọ fún ọmọ náà?\nA. 45, XO\nB. 46, XY\nC. 47, XXY\nD. 47, XYY", "reasoning": "<thinking><step1>\nThe question is asking about the most likely karyotype for a 16-year-old girl who has not yet started her [première menstruation = first menstruation]. \n</step1>\n<step2>\nThe girl shows normal development for her age, with a Tanner stage of 5 for breast development but only stage 2 for pubic hair — indicating some delay in sexual maturation.\n</step2>\n<step3>\nHer hormone levels are elevated for testosterone, estrogen, and luteinizing hormone, which could suggest a condition affecting her sexual development — *développement sexuel*.\n</step4>\n<step4>\nThe options provided include karyotypes that are typically associated with different conditions: Turner syndrome (45, XO), Klinefelter syndrome (47, XXY), and others.\n</step5>\n<step5>\nGiven her female phenotype and the hormonal profile, the most likely karyotype is 47, XXY, which is associated with Klinefelter syndrome, but this is typically male. However, the presence of elevated hormones suggests a possible intersex condition.\n</step6>\n<step6>\nThus, the most fitting karyotype for her situation, considering the options, would be 45, XO, which is Turner syndrome, as it aligns with her lack of menstruation and developmental delays.\n</step6></thinking>", "answer": "<answer>45, XO</answer>", "language": "Yoruba"}
{"question": "Ní ìjìròrò ẹ̀kọ́ kan tí ó nípa pẹ̀lú àwọn ẹ̀dá ẹlẹ́gẹ̀rẹ̀ tí wọ́n ní àwọn àìlọ́wọ́-tẹ́lẹ̀ pàtó nínú àwọn apá kan ti hypothalamus, ẹ̀yà kan ti àwọn ẹlẹ́gẹ̀rẹ̀ fi hàn pé wọ́n ní ìwọ̀n ìwúwo ara (BMI) tí ó kéré pupọ̀ àti ìdinku 40% nínú oúnjẹ tí wọ́n jẹ, ní ìwéjé àwọn ẹlẹ́gẹ̀rẹ̀ àkóyẹ̀yẹ̀.  Lórí ipò ìwádìí wọ̀nyí, ní àpà kan pàtó wo nínú hypothalamus ni àwọn ìṣẹ́lẹ̀ ìbajẹ́ náà ṣee ṣe kí wọ́n wà?", "reasoning": "<thinking><step1>\nThe question asks about a study related to certain [hormones = ẹ̀dá ẹlẹ́gẹ̀rẹ̀] in specific parts of the hypothalamus and their effects on body mass index (BMI) and food intake.\n</step1>\n<step2>\nIn this context, the hypothalamus plays a crucial role in regulating appetite and energy balance — *ìṣàkóso àkúnya àti ìdájọ́ agbara*.\n</step2>\n<step3>\nThe study indicates that these hormones can lead to a significantly low BMI and a 40% reduction in food intake — *ìdinku 40% nínú oúnjẹ*.\n</step3>\n<step4>\nThis suggests that specific areas of the hypothalamus, such as the arcuate nucleus, might be involved in these processes — *àwọn apá kan ti hypothalamus*.\n</step4>\n<step5>\nDysfunction in these regions could disrupt normal hunger signals, leading to decreased food consumption — *ìbajẹ́ nínú àwọn apá yìí lè fa ìdinku nínú àkúnya*.\n</step6>\n<step6>\nThus, the events of dysfunction might occur in the arcuate nucleus or the paraventricular nucleus of the hypothalamus.\n</step6></thinking>", "answer": "<answer>Ìṣẹ́lẹ̀ ìbajẹ́ náà lè wà nínú arcuate nucleus tàbí paraventricular nucleus ti hypothalamus.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun méje-dín-lẹ́gbọ̀n-dín-mẹ́rin kan wà ni ile-iwosan fun itọju ikọ́ àìsàn ẹ̀dùn-àìlera ti o ti ń jiya fun ọjọ́ mẹta sẹ́yìn. Ọsẹ kan ṣaaju, ó ti ń rẹ̀wẹ̀sì dáadáa titi di ìgbà tí ó fi bẹ̀rẹ̀ sí ní ohun tí ó ṣàpèjúwe gẹgẹ bi àìlera tutu. Lọ́jọ́ díẹ̀ lẹ́yìn náà, ó bẹ̀rẹ̀ sí ní ìṣòro ní ìmímú afẹ́fẹ́, ó sì ní ikọ́ tí ó ń tu àti iba. Bi ipo rẹ̀ ṣe burú si pelu itọju oogun apakokoro ni ile, a gbe e wọle fun awọn oogun apakokoro intravenous ati ṣayẹwo. O ní itan-akọọlẹ igba ti o mu siga ti ọdun mẹ́ẹdọgbọn, ati pe a ti ṣe ayẹwo rẹ̀ fun àìlera ti o gbàgbà ti ẹ̀dùn-àìlera (COPD). Ṣaaju ki o to wọle si ile-iwosan, ọkunrin naa n mu formoterol, budesonide, ati oxygen ni ile. O ti ń mu oti oyinbo mẹta lojoojumọ fun ọdun 60 sẹhin, o si mu ewe igbẹ ni ọdun 20 rẹ. Awọn abajade idanwo iṣẹ́ ẹ̀jẹ̀ rẹ lati ọsẹ kan sẹyin ati lati ọjọ́ tí ó wọ ile-iwosan wa ni bi atẹle:\nỌjọ́ mẹ́ta sẹ́yìn\nNi ọjọ́ tí ó wọ ile-iwosan\nOògùn ẹjẹ (ṣẹṣẹ)  130 mg/dL\nAwọn ẹ̀ka ẹ̀jẹ̀\nSodium 142 mEq/L\nPotassium 3.9 mEq/L\nChloride 101 mEq/L\nSerum creatinine 0.8 mg/dL\nBlood urea nitrogen 9 mg/dL\nCholesterol, gbogbo rẹ̀ 170 mg/dL\nHDL-cholesterol 42 mg/dL\nLDL-cholesterol 110 mg/dL\nTriglycerides 130 mg/dL\nOògùn ẹjẹ (ṣẹṣẹ)  100 mg/dL\nAwọn ẹ̀ka ẹ̀jẹ̀\nSodium 140 mEq/L\nPotassium 4.0 mEq/L\nChloride 100 mEq/L\nSerum creatinine 0.9 mg/dL\nBlood urea nitrogen 11 mg/dL\nCholesterol, gbogbo rẹ̀ 130 mg/dL\nHDL-cholesterol 30 mg/dL\nLDL-cholesterol 80 mg/dL\nTriglycerides 180 mg/dL\nKini o ṣalaye daradara iyipada ninu profaili lipid alaisan yii lakoko akoko yii?\nA. Ikọlu COPD ti o buru si\nB. Ọna ẹ̀gbà oogun\nC. Idahun ti ara\nD. Àìlera Pneumonia\nE. Àìlera dyslipidemia ti a ko mọ", "reasoning": "<thinking><step1>\nThe question asks: \"Kini o ṣalaye daradara iyipada ninu profaili lipid alaisan yii lakoko akoko yii?\" — meaning it wants to explain the changes in the patient's lipid profile during this time.\n</step1>\n<step2>\nThe lipid profile shows a decrease in total cholesterol from 170 mg/dL to 130 mg/dL, and HDL-cholesterol dropped significantly from 42 mg/dL to 30 mg/dL — indicating a potential health issue.\n</step2>\n<step3>\nThe patient has a history of COPD [àìlera ti o gbàgbà ti ẹ̀dùn-àìlera], which can worsen due to inflammation and stress on the body, leading to changes in lipid metabolism.\n</step3>\n<step4>\nAdditionally, the increase in triglycerides from 130 mg/dL to 180 mg/dL suggests a possible response to illness or medication effects — *idahun ti ara* to the patient's condition.\n</step4>\n<step5>\nConsidering these factors, the most likely explanation for the lipid profile changes is related to the worsening of COPD, as the patient's overall health has declined.\n</step5>\n<step6>\nThus, the answer aligns with option A: Ikọlu COPD ti o buru si.\n</step6></thinking>", "answer": "<answer>Ikọlu COPD ti o buru si.</answer>", "language": "Yoruba"}
{"question": "Bakteria wo ni o maa n fa arun ọkan ti o ni ibatan si valve ti a fi sii ni igba diẹ lẹhin abẹrẹ (laarin osu meji)?", "reasoning": "<thinking><step1>\nThe question asks: “Bakteria wo ni o maa n fa arun ọkan ti o ni ibatan si valve ti a fi sii ni igba diẹ lẹhin abẹrẹ (laarin osu meji)?” — meaning it wants to know which bacteria can cause heart infections related to a valve placed shortly after a procedure (within two months).\n</step1>\n<step2>\nInfections related to heart valves are often due to *endocarditis*, which can be caused by bacteria entering the bloodstream — *bakteria ti o wọ inu ẹjẹ*.\n</step2>\n<step3>\nCommon bacteria responsible for this include *Staphylococcus aureus* and *Streptococcus viridans* — these are often found in the mouth and skin.\n</step3>\n<step4>\nWhen a valve is placed, especially after a procedure, there is a risk of these bacteria causing an infection — *arun* that can lead to serious complications.\n</step5>\n<step5>\nSymptoms may include fever, heart murmurs, and fatigue — *aami arun* ti o le fa iṣoro to ṣe pataki.\n</step6>\n<step6>\nTherefore, the bacteria that can cause heart infections after valve placement include *Staphylococcus aureus* and *Streptococcus viridans*.\n</step6></thinking>", "answer": "<answer>Bakteria ti o maa n fa arun ọkan ni *Staphylococcus aureus* ati *Streptococcus viridans*.</answer>", "language": "Yoruba"}
{"question": "Ewo ninu awọn amọ̀na àfihàn àdàmọ́ ìṣọ̀kan oníṣẹ́-ẹ̀yà tó jẹ́ mọ́ oníṣẹ́ ara kan pato tí a ń pè ní immunoglobulin?\nA. Ẹ̀wọ̀n L\nB. Ẹ̀wọ̀n H\nC. Ẹ̀wọ̀n J\nD. Agbegbe iyipada", "reasoning": "<thinking><step1>\nThe question asks: “Ewo ninu awọn amọ̀na àfihàn àdàmọ́ ìṣọ̀kan oníṣẹ́-ẹ̀yà tó jẹ́ mọ́ oníṣẹ́ ara kan pato tí a ń pè ní immunoglobulin?” — meaning it is inquiring about which of the options is a specific type of immunoglobulin.\n</step1>\n<step2>\nImmunoglobulins are antibodies produced by the immune system — *àwọn àdàmọ́ ìṣọ̀kan* — that help fight infections.\n</step2>\n<step3>\nThere are different classes of immunoglobulins, such as IgA, IgM, IgG, and IgE, each with distinct functions — *kọọkan ni iṣẹ́ àtọkànwá*.\n</step3>\n<step4>\nThe question provides options: Ẹ̀wọ̀n L, Ẹ̀wọ̀n H, Ẹ̀wọ̀n J, and Agbegbe iyipada. We need to identify which one corresponds to a known immunoglobulin.\n</step4>\n<step5>\nAmong these, *Ẹ̀wọ̀n H* is commonly recognized as IgH, which refers to heavy chains in immunoglobulins — *àwọn ẹ̀yà to wuwo*.\n</step5>\n<step6>\nThe other options do not correspond to standard immunoglobulin classifications, making *Ẹ̀wọ̀n H* the correct answer.\n</step6></thinking>", "answer": "<answer>Ẹ̀wọ̀n H.</answer>", "language": "Yoruba"}
{"question": "Pari gbogbo ẹgbẹ́ àkọ́kọ́ yìí, rii daju pe àwọn àmì ìṣíṣẹ́ ṣiṣẹ́ sí gbogbo rẹ̀ dáadáa.  Àkọ́kọ́: < ( < { [ { } < ( { ( < < < { [ ( [ ( [ { { < [ { } < ( ) > ] > } } ] ) ] ) ] } > < > > ( ( < { } > ) ) > ) } ) > ] } > )", "reasoning": "<thinking><step1>\nThe question asks: “Pari gbogbo ẹgbẹ́ àkọ́kọ́ yìí, rii daju pe àwọn àmì ìṣíṣẹ́ ṣiṣẹ́ sí gbogbo rẹ̀ dáadáa” — which translates to \"Complete this initial sequence, ensuring that all operational symbols work correctly.\"\n</step1>\n<step2>\nTo solve this, I need to analyze the sequence of symbols provided: *< ( < { [ { } < ( { ( < < < { [ ( [ ( [ { { < [ { } < ( ) > ] > } } ] ) ] ) ] } > < > > ( ( < { } > ) ) > ) } ) > ] } >)*.\n</step2>\n<step3>\nThe goal is to ensure that every opening symbol has a corresponding closing symbol — *àwọn àmì ìṣíṣẹ́* must match correctly.\n</step3>\n<step4>\nStarting from the left, I will track each symbol: for every *<*, I need a *>*; for every *{*, I need a *}*, and so on. This is a common problem in programming and mathematics.\n</step4>\n<step5>\nAs I go through the sequence, I will count the occurrences of each type of symbol to confirm they balance out — *ìṣirò àtẹ̀jáde*.\n</step5>\n<step6>\nAfter checking, if all symbols are balanced and correctly nested, I can conclude that the sequence is valid.\n</step6>\n<step7>\nIf any symbols are unmatched, I will need to adjust the sequence accordingly to ensure it is correct.\n</step7></thinking>", "answer": "<answer>Gbogbo àmì ìṣíṣẹ́ nínú àkọ́kọ́ yìí dáadáa, kò sí àìpẹ̀.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọmọ ọdún mẹ́ẹ̀ẹ́dọ́gbọ̀n kan ṣàkọ́kọ́ pé fífẹ́rẹ̀ẹ́ ẹnu rẹ̀ lọ́rọ̀ọ̀rọ̀, nígbà gbogbo, ń ṣe é ní ìrora, yàtọ̀ sí fífúnni ní ẹ̀jẹ̀ púpọ̀.  Àyẹ̀wò ẹnu fi hàn pé èrò ohun tí ó gbàgbé lórí igi ehin àwọn méjèèjì.  Níní ìṣòro ara ìdààmú wo ni àìsàn yìí ṣeé ṣe jù lọ́wọ́ àwọn ọmọlẹ́yìn yìí?\nA.  Pemphigiod mucous membrane tí kò lewu\nB.  Lupus erythematosus discoid tí ó gbòkè gbòkè\nC. Pemphigus\nD. Psoriasis", "reasoning": "<thinking><step1>\nThe question is asking about a 35-year-old woman who experiences painful oral lesions and excessive bleeding, with examination revealing lesions on both gums. It seeks to identify the underlying condition causing these symptoms.\n</step1>\n<step2>\nThe symptoms described, such as *ìrora* (pain) and *fífúnni ní ẹ̀jẹ̀ púpọ̀* (excessive bleeding), suggest a serious oral condition. \n</step2>\n<step3>\nAmong the options, Pemphigus is an autoimmune disorder that leads to painful blisters in the mouth — *àìsàn pemphigus* can cause significant discomfort and bleeding.\n</step3>\n<step4>\nOn the other hand, *lupus erythematosus discoid* typically presents with skin lesions rather than oral symptoms, making it less likely in this case.\n</step5>\n<step5>\n*Pemphigoid mucous membrane* is less severe and usually does not cause the same level of pain or bleeding as Pemphigus, which is more aggressive.\n</step6>\n<step6>\nTherefore, the most likely condition causing these symptoms is Pemphigus, which aligns with the painful oral lesions and bleeding.\n</step6></thinking>", "answer": "<answer>Pemphigus.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 66 kan wá sí ẹka pajawiri nitori irora àyà ti ó ti pé ọjọ́ kan, ìṣẹlẹ̀ ọkàn, àti ìkùkùgbà nígbà tí ó bá ń fi agbára ṣiṣẹ́. Ó ní ìṣẹlẹ̀ kan náà ní ọjọ́ mẹta sẹ́yìn, a sì tọ́ka sí i pé ó ní ìkọlu ọkàn-àgbà ní ògiri isalẹ̀. Wọ́n gbà á wọlé, a sì ṣe ìṣe atọ́ka-ọkàn-àgbà tí ó ṣeé gbà nípasẹ̀ ìgbàgbọ́ ní ọjọ́ yẹn. Ẹ̀ẹ́rọ ayẹwo ìgbà tí ńṣiṣẹ́ nígbà ìṣe náà fi hàn pé ìdènà náà ti parẹ̀ pátápátá. Àwọn àdánwò ilé-ẹ̀kọ́, pẹlu glucose ẹ̀jẹ̀, lípídí, àti ìṣirò ẹ̀jẹ̀, wà láàrin àwọn ìlò tí ó gbọ́dọ̀ wà. Wọ́n tú u sílẹ̀ ní ọjọ́ lẹ́yìn ìṣe náà lórí ìtọ́jú oògùn ti aspirin, simvastatin, ati isosorbide dinitrate. Nígbà tí wọ́n tú u sílẹ̀, kò ní irora àyà tàbí ìkùkùgbà. Lọ́wọ́lọ́wọ́, àwọn àwọn àyèèwò rẹ̀ dàgbà, àti ECG ní ìsinmi fi ìdálékè T tuntun hàn. Ẹ̀yà wo nínú àwọn wọnyi ni àdánwò tí ó gbẹ́kẹ̀lé jùlọ fún fifi ìtọ́ka náà mulẹ̀ kíákíá ní ọkùnrin yìí?\nA. Lactate dehydrogenase\nB. Creatine kinase MB\nC. Cardiac troponin T\nD. Copeptin\nE. Aspartate aminotransferase", "reasoning": "<thinking><step1>\nThe question is asking which test is most reliable for confirming a diagnosis of a heart attack in a 66-year-old man who presented with chest pain and other symptoms — *irora àyà* and *ìkùkùgbà*.\n</step1>\n<step2>\nIn cases of suspected myocardial infarction, *ìkọlu ọkàn* is a critical concern, and certain biomarkers are more indicative than others.\n</step2>\n<step3>\nAmong the options provided, *Cardiac troponin T* is known to be the most specific and sensitive marker for heart muscle damage — *ìfarapa ọkàn*.\n</step3>\n<step4>\nWhile *Creatine kinase MB* is also used, it is less specific compared to troponin, as it can be elevated in other conditions.\n</step4>\n<step5>\nTests like *lactate dehydrogenase* and *aspartate aminotransferase* are not specific for cardiac events, making them less reliable for this purpose.\n</step6>\n<step6>\nTherefore, the best choice for confirming the diagnosis quickly in this patient is *Cardiac troponin T*.\n</step6></thinking>", "answer": "<answer>Cardiac troponin T</answer>", "language": "Yoruba"}
{"question": "Àpọnà ọmọ ọdún méjìlélọ́gún kan wà níwájú pẹ̀lú irora ikun ẹgbẹ́ òsì, ó wà ní ìlera, tí ìwádìí FAST sì fi hàn pé ó ní ẹ̀gbà. Àyẹ̀wò CT pẹ̀lú ìṣòro ìṣàn ń tọ́ka sí ìṣàn ẹ̀jẹ̀ àti ìṣòro ìgbàgbọ́ ẹ̀dọ̀fúnfún ìpele IV.  Kí ni ọ̀nà ìtọ́jú tó yẹ jùlọ fún àpọnà yìí?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ọ̀nà ìtọ́jú tó yẹ jùlọ fún àpọnà yìí?” — meaning it wants to know the best treatment approach for a 16-year-old with abdominal pain and a diagnosis of appendicitis.\n</step1>\n<step2>\nThe patient has symptoms indicating *ìkànsí* (appendicitis) and has been diagnosed with *ìṣòro ìṣàn* (vascular issues) and *ìṣòro ìgbàgbọ́ ẹ̀dọ̀fúnfún* (IV stage liver problems) based on CT findings.\n</step2>\n<step3>\nIn cases of appendicitis, the standard treatment is usually *ìtọ́jú àtẹ́gùn* (surgical intervention), specifically an appendectomy.\n</step3>\n<step4>\nHowever, given the patient's additional complications, such as *ìṣòro ìṣàn*, careful consideration is needed for surgery timing and approach.\n</step4>\n<step5>\nIf the vascular issues are significant, it may be necessary to stabilize the patient first — *ìmúdàgba ilera* — before proceeding with surgery.\n</step5>\n<step6>\nIn summary, the best treatment approach would involve addressing the appendicitis while managing the vascular complications, possibly requiring a multidisciplinary team.\n</step6></thinking>", "answer": "<answer>Ọ̀nà ìtọ́jú tó yẹ jùlọ ni àtẹ́gùn, pẹ̀lú ìmúdàgba ilera ṣáájú, nípa ti ìṣòro ìṣàn.</answer>", "language": "Yoruba"}
{"question": "Kini idi ti ko gbọdọ lo awọn oogun thrombolytic ni ọrọ ikọlu ọkan to nira ni apa iwaju?", "reasoning": "<thinking><step1>\nThe question asks: “Kini idi ti ko gbọdọ lo awọn [oogun thrombolytic = thrombolytic drugs] ni [ọrọ ikọlu ọkan to nira = severe heart attack] ni apa iwaju?” — meaning it wants to know why thrombolytic drugs should not be used in a severe heart attack in the front part of the heart.\n</step1>\n<step2>\nThrombolytic drugs are designed to dissolve blood clots — *wọn jẹ́ àwòrán àtọ́ka* ti o n ṣiṣẹ́ lati pa awọn àtọka ẹjẹ run.\n</step2>\n<step3>\nIn cases of a severe heart attack, particularly in the anterior wall, there is a risk of complications — *ìṣòro* le dide ti o ba lo wọn ni ọna ti ko tọ.\n</step3>\n<step4>\nFor example, if the blockage is due to a rupture of plaque, thrombolytics may not be effective — *wọn le ma ṣiṣẹ́ daradara* nitori pe wọn ko le pa àtọka ẹjẹ ti o fa ikọlu naa run.\n</step4>\n<step5>\nAdditionally, using thrombolytics can lead to bleeding complications — *ìfarapa ẹjẹ* le ṣẹlẹ, eyi ti o le jẹ́ ewu fun alaisan.\n</step5>\n<step6>\nTherefore, in severe anterior myocardial infarction, other treatments like angioplasty are preferred — *ìtọ́jú mìíràn gẹgẹ bí angioplasty ni a fẹ́ràn* ju.\n</step6></thinking>", "answer": "<answer>Ko yẹ ki a lo awọn oogun thrombolytic ni ọrọ ikọlu ọkan to nira ni apa iwaju nitori ewu ti ìfarapa ẹjẹ ati aini iṣẹ́ wọn ni awọn ọran kan.</answer>", "language": "Yoruba"}
{"question": "Eya iṣan hyoid wo ni o ṣiṣẹ bi ami itọkasi pataki ni awọn igun iwaju ati ẹhin ọrun?", "reasoning": "<thinking><step1>\nThe question asks: “Eya iṣan hyoid wo ni o ṣiṣẹ bi ami itọkasi pataki ni awọn igun iwaju ati ẹhin ọrun?” — meaning it wants to know which muscles associated with the hyoid bone act as important reference points in the front and back of the neck.\n</step1>\n<step2>\nThe hyoid bone is unique because it does not articulate with other bones; it serves as an attachment point for several muscles — *o jẹ aaye asopọ fun ọpọlọpọ awọn iṣan*.\n</step2>\n<step3>\nMuscles like the digastric and mylohyoid are crucial for movements of the jaw and swallowing — *iṣan digastric ati mylohyoid* n ṣiṣẹ lati mu ki ẹnu ṣi ati pa.\n</step3>\n<step4>\nIn the back of the neck, the stylohyoid muscle helps elevate the hyoid bone during swallowing — *iṣan stylohyoid* n ṣe iranlọwọ lati gbe eya iṣan hyoid soke.\n</step4>\n<step5>\nThese muscles provide structural support and assist in the movement of the larynx, which is essential for phonation — *iṣan wọnyi n pese atilẹyin ati iranlọwọ ninu gbigbe larynx*.\n</step6>\n<step6>\nThus, the hyoid muscle group plays a vital role in both the anterior and posterior aspects of the neck — *iṣan hyoid jẹ pataki ni awọn igun iwaju ati ẹhin ọrun*.\n</step7></thinking>", "answer": "<answer>Iṣan hyoid ṣiṣẹ bi ami itọkasi pataki ni awọn igun iwaju ati ẹhin ọrun nipasẹ atilẹyin ati gbigbe larynx.</answer>", "language": "Yoruba"}
{"question": "Orúkọ wo ni wọ́n fi ń ṣàpèjúwe àpẹẹrẹ ìṣesí nípa mímu ọtí tí ó ní àwọn àmì bíi ìgbẹ́kẹ̀lé ara àti ọpọlọ lórí ọtí, ìbálára mu ọtí, àwọn àmì ìyọkúrò tí ó máa ń yọjú tí ènìyàn bá dẹ́kun mímu ọtí, àti àìlè kó ara ẹni níjàánu nípa mímu ọtí?", "reasoning": "<thinking><step1>\nThe question asks: “Orúkọ wo ni wọ́n fi ń ṣàpèjúwe àpẹẹrẹ ìṣesí nípa mímu ọtí?” — meaning it seeks to identify the term used to describe the effects of alcohol consumption, particularly regarding physical and mental health.\n</step1>\n<step2>\nWhen discussing the effects of alcohol, we refer to *ìṣesí* which includes both physical and psychological symptoms — *àmì bíi ìgbẹ́kẹ̀lé ara* (physical dependence) and *ìbálára mu ọtí* (alcohol use disorder).\n</step2>\n<step3>\nCommon signs of alcohol withdrawal — *àmì ìyọkúrò* — can include anxiety, tremors, and sweating when one stops drinking suddenly.\n</step3>\n<step4>\nAdditionally, *àìlè kó ara ẹni níjàánu* refers to the inability to control drinking, which is a hallmark of alcohol dependence.\n</step4>\n<step5>\nIn summary, the term that encapsulates these effects is *ìṣesí mímu ọtí* — the overall impact of alcohol on an individual’s health and behavior.\n</step5></thinking>", "answer": "<answer>Ìṣesí mímu ọtí ni wọ́n fi ń ṣàpèjúwe àpẹẹrẹ ìṣesí nípa mímu ọtí, tó ní àwọn àmì bíi ìgbẹ́kẹ̀lé ara, ìbálára mu ọtí, àti àìlè kó ara ẹni níjàánu.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun mẹrinlelogun kan wà pẹlu ailera ti n tẹsiwaju ati irora iṣan isalẹ, pẹlu irira ninu sisọ mimọ. Iwoye CT fihan iṣẹku ti o n mu didan ti o wa laarin dura ni aarin-ẹhin. Kini ayẹwo ti o ṣeeṣe julọ fun ipo yii?", "reasoning": "<thinking><step1>\nThe question translates to: \"A 24-year-old woman has persistent pain and lower abdominal discomfort, with difficulty in urination. A CT scan shows a mass causing obstruction in the midline of the abdomen. What is the most likely diagnosis for this condition?\" \n</step1>\n<step2>\nThe symptoms include *irora iṣan isalẹ* (lower abdominal pain) and *irira ninu sisọ mimọ* (difficulty in urination), which suggests a possible obstruction in the urinary tract.\n</step2>\n<step3>\nThe CT scan reveals a *iṣẹku* (mass) causing obstruction, indicating that it could be a tumor or cyst affecting the surrounding structures.\n</step3>\n<step4>\nIn young women, common causes of such masses include *fibroïdes* (fibroids) or *cysts* (cysts), but given the age and symptoms, a more serious condition should be considered.\n</step4>\n<step5>\nConsidering the age and the nature of the mass, one potential diagnosis could be *teratoma* or another type of germ cell tumor, which can present with similar symptoms.\n</step6>\n<step6>\nThus, the most likely diagnosis for this condition is a *teratoma* or a similar germ cell tumor causing the obstruction and associated symptoms.\n</step6></thinking>", "answer": "<answer>Ayẹwo ti o ṣeeṣe julọ fun ipo yii ni teratoma tabi iru iṣan-ara miiran ti n fa idena.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 65 kan wá sí OPD pẹlu ẹ̀dùn ikun lẹhin jijẹun, ìgbà ìtùjáde ati ẹ̀gbẹ́. Ó sọ̀rọ̀ nípa àrùn ọkàn-àrùn tí ó ti ní fún ọdún 20 sẹyin. Ẹ̀rù ẹ̀jẹ̀ rẹ̀ - 160/100 mm Hg, ìṣan-ẹjẹ̀ rẹ̀ - 80/min. Nígbà tí a ṣe àyẹ̀wò ikun rẹ̀, kò sí irora tàbí rígiditi. Kí ni àkóràn tí ó ṣeé ṣe julọ:\nA. Ẹ̀gbà ikun\nB. Àrùn Wilkie\nC. Ẹ̀gbà ikun ti ko ni iwosan\nD. Ìgbẹ̀rùn ìṣan-ẹjẹ̀ ti ko ni iwosan", "reasoning": "<thinking><step1>\nThe question presents a case of a 65-year-old woman who comes to the OPD with abdominal pain after eating, nausea, and vomiting. It mentions her history of heart disease for 20 years, which is crucial for understanding her current symptoms.\n</step1>\n<step2>\nThe symptoms of abdominal pain after eating — *ẹ̀dùn ikun lẹ́yìn jijẹun* — could indicate several gastrointestinal issues. Given her age and medical history, we need to consider serious conditions.\n</step2>\n<step3>\nHer blood pressure is elevated at 160/100 mm Hg, indicating *ìkànsí ẹ̀jẹ̀* (hypertension), which can complicate her condition. The heart disease history suggests potential cardiovascular involvement.\n</step3>\n<step4>\nThe absence of tenderness or rigidity during the abdominal examination — *kò sí irora tàbí rígiditi* — makes acute surgical conditions less likely, such as appendicitis or perforation.\n</step4>\n<step5>\nConsidering the options, *àrùn Wilkie* (Wilkie's syndrome) is a possibility due to her symptoms of postprandial pain and nausea, which can occur when the duodenum is compressed.\n</step5>\n<step6>\nHowever, *ẹ̀gbà ikun* (gastric outlet obstruction) is also a strong contender, especially in the context of her chronic heart disease and potential for complications like gastric cancer.\n</step6>\n<step7>\nUltimately, the most likely diagnosis, given her symptoms and history, points towards *ẹ̀gbà ikun ti ko ni iwosan* (non-healing gastric outlet obstruction), as it aligns with her chronic condition and current presentation.\n</step7></thinking>", "answer": "<answer>Ẹ̀gbà ikun ti ko ni iwosan ni àkóràn tí ó ṣeé ṣe julọ.</answer>", "language": "Yoruba"}
{"question": "Ẹ̀ka ìtànṣán wo ni àwọn ohun tí ó bà jẹ́ ìṣẹ̀dá microtubules nínú àwọn sẹ́ẹ̀li ẹ̀dọ̀fóró yóò kàn jùlọ?\nA. Àwọn oníṣẹ́-ìtànṣán amínó-ààsidì\nB. Àwọn oníṣẹ́-ìtànṣán kátékólámínì\nC. Àwọn oníṣẹ́-ìtànṣán tí ó gbòòrò lára mèmùbàráń\nD. Àwọn oníṣẹ́-ìtànṣán pépítídì", "reasoning": "<thinking><step1>\nThe question asks: “Ẹ̀ka ìtànṣán wo ni àwọn ohun tí ó bà jẹ́ ìṣẹ̀dá [microtubules = microtubules] nínú àwọn sẹ́ẹ̀li [ẹ̀dọ̀fóró = kidney cells] yóò kàn jùlọ?” — meaning it wants to know which category of proteins is most involved in the formation of microtubules in kidney cells.\n</step1>\n<step2>\nMicrotubules are structural components of the cytoskeleton, and they are primarily made from tubulin proteins — *àwọn amínó-ààsidì tubulin*.\n</step2>\n<step3>\nIn kidney cells, the assembly of microtubules is crucial for maintaining cell shape and function — *ìtànṣán sẹ́ẹ̀li*.\n</step3>\n<step4>\nThe options provided include different types of proteins: A. *Àwọn oníṣẹ́-ìtànṣán amínó-ààsidì* (amino acid proteins), B. *Àwọn oníṣẹ́-ìtànṣán kátékólámínì* (kinectin proteins), C. *Àwọn oníṣẹ́-ìtànṣán tí ó gbòòrò lára mèmùbàráń* (proteins that are abundant in membranes), and D. *Àwọn oníṣẹ́-ìtànṣán pépítídì* (peptide proteins).\n</step4>\n<step5>\nAmong these, the most relevant to microtubule formation are the tubulin proteins, which are specifically categorized under option A — *àwọn oníṣẹ́-ìtànṣán amínó-ààsidì*.\n</step5>\n<step6>\nThus, the category of proteins that most directly relates to the formation of microtubules in kidney cells is the amino acid proteins.\n</step6></thinking>", "answer": "<answer>Àwọn oníṣẹ́-ìtànṣán amínó-ààsidì ni wọ́n kàn jùlọ nínú ìṣẹ̀dá microtubules nínú àwọn sẹ́ẹ̀li ẹ̀dọ̀fóró.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 63 kan ti a fi itanna fifẹ́ sí ẹnu lẹhin ijamba ọkọ ayọkẹlẹ ti o lọra pupọ n fi ami aisan mimi ati awọn ohun ti ko gbọ́ daradara jade lori ẹgbẹ́ òsì ti ẹ̀dọ̀fóró lẹhin ọjọ́ kẹta ti a fi itanna fifẹ́ sí ẹnu rẹ̀ hàn. Ṣiṣayẹwo afẹfẹ ẹ̀jẹ̀ atẹ́gùn fi ami aisan mimi gbígbẹ́ hàn, ati aworan X-ray fi ìjinlẹ si igun costophrenic ni ẹgbẹ́ òsì hàn, pẹlu ilosoke ninu titẹ afẹfẹ ìbúgbà.  Kini igbesẹ ti o yẹ julọ ti o tẹle lati ṣe itoju fun alaisan yii?", "reasoning": "<thinking><step1>\nThe question asks: \"What is the most appropriate next step in managing a 63-year-old man who has respiratory symptoms and hearing issues after a car accident?\" — it highlights key terms like [itanna fifẹ́ = intubation], [ijamba ọkọ ayọkẹlẹ = car accident], and [afẹfẹ ẹ̀jẹ̀ = blood gas].\n</step1>\n<step2>\nThe patient shows signs of respiratory distress — *aami aisan mimi* — and has a history of intubation, which suggests a serious condition.\n</step2>\n<step3>\nThe blood gas analysis indicates respiratory acidosis — *afẹfẹ ẹ̀jẹ̀ atẹ́gùn fi ami aisan mimi gbígbẹ́ hàn* — meaning the patient is not adequately ventilating.\n</step3>\n<step4>\nThe X-ray shows a costophrenic angle blunting — *ilana igun costophrenic* — which could indicate pleural effusion or other complications.\n</step5>\n<step5>\nGiven these findings, the most appropriate next step would be to perform a thoracentesis — *iyẹwo ẹ̀dọ̀fóró* — to relieve any potential pleural effusion and improve breathing.\n</step6>\n<step6>\nThis procedure will help in both diagnosis and treatment, addressing the immediate respiratory distress.\n</step6></thinking>", "answer": "<answer>Igbesẹ ti o yẹ julọ ni lati ṣe iyẹwo ẹ̀dọ̀fóró lati dinku ẹ̀dọ̀fóró ti o ṣeeṣe ati mu ilọsiwaju mimi.</answer>", "language": "Yoruba"}
{"question": "Nínú ọ̀rọ̀ àrùn sífílísì ọmọdékùnrin ọdún méjìdínlógún kan tí ó ti ní sífílísì àkọ́kọ́, tí ó sì ti ní sífílísì ọpọlọ, tí a sì ti bẹ̀rẹ̀ ìtọ́jú tó yẹ fún un, àyẹ̀wò wo ni a lò láti ṣàkíyèsí bí ìtọ́jú náà ṣe ń ṣiṣẹ́?", "reasoning": "<thinking><step1>\nThe question asks: “What examination is used to monitor the treatment of a 17-year-old boy who has had primary syphilis and now has neurosyphilis?” — here, *àyẹ̀wò* means examination and *ìtọ́jú* means treatment.\n</step1>\n<step2>\nIn cases of neurosyphilis, it is crucial to assess the effectiveness of treatment — *ìtọ́jú* — through specific tests.\n</step2>\n<step3>\nOne common examination is the *test CSF* (cerebrospinal fluid) analysis, which checks for the presence of *Treponema pallidum* antibodies.\n</step3>\n<step4>\nAdditionally, a *VDRL* (Venereal Disease Research Laboratory) test can be performed on the CSF to evaluate the response to treatment.\n</step4>\n<step5>\nMonitoring symptoms such as *àìlera* (weakness) or changes in neurological function is also essential during treatment.\n</step5>\n<step6>\nThus, the examination to monitor treatment effectiveness in this case would primarily involve CSF analysis and possibly a VDRL test.\n</step6></thinking>", "answer": "<answer>Àyẹ̀wò tó yẹ ni àyẹ̀wò CSF àti VDRL láti ṣàkíyèsí bí ìtọ́jú ṣe ń ṣiṣẹ́.</answer>", "language": "Yoruba"}
{"question": "Kini ewu ilera kan ti ko pọ si nipasẹ itọju rirọpo homonu ni awọn obinrin ti o ti kọja akoko oyún?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ewu ilera kan ti ko pọ si nipasẹ itọju rirọpo homonu ni awọn obinrin ti o ti kọja akoko oyún?” — meaning it wants to know what health risks are not increased by hormone replacement therapy (HRT) in women who have gone through menopause.\n</step1>\n<step2>\nHormone replacement therapy is often used to alleviate symptoms of menopause — *a ṣe itọju yii lati dinku awọn aami aiṣan ti menopause*.\n</step2>\n<step3>\nCommon concerns with HRT include risks like breast cancer and cardiovascular issues — *awọn ewu bii àtọgbẹ àtọgbẹ ati awọn iṣoro ọkan*.\n</step3>\n<step4>\nHowever, studies suggest that certain conditions, such as osteoporosis, may actually benefit from HRT — *itọju rirọpo homonu le mu ilọsiwaju wa si osteoporosis*.\n</step4>\n<step5>\nAdditionally, HRT does not significantly increase the risk of developing colorectal cancer — *iwuwo ti aisan colorectal ko pọ si*.\n</step5>\n<step6>\nIn summary, while there are risks associated with HRT, some health issues, like osteoporosis and colorectal cancer, are not exacerbated by this treatment.\n</step6></thinking>", "answer": "<answer>Ewu ilera kan ti ko pọ si nipasẹ itọju rirọpo homonu ni osteoporosis ati aisan colorectal.</answer>", "language": "Yoruba"}
{"question": "Àwọn àyẹ̀wò ìwádìí ẹ̀jẹ̀ kan fún ọmọbìnrin ọdún méjìlá kan tí ó fi hàn pé 56% HbA, 43% HbS, àti 1% HbF, àti ìwọ̀n osmolality ti ito ti 130 mOsmol/kg H2O, kini àìlera tó pọ̀jùlọ tí ó lè dojú kọ?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn àyẹ̀wò ìwádìí ẹ̀jẹ̀ kan fún ọmọbìnrin ọdún méjìlá kan tí ó fi hàn pé 56% HbA, 43% HbS, àti 1% HbF” — meaning it presents lab results for a 12-year-old girl showing 56% HbA, 43% HbS, and 1% HbF, and asks about the most likely complication.\n</step1>\n<step2>\nThe high percentage of HbS (hemoglobin S) indicates that this girl likely has sickle cell disease — *arun ẹ̀jẹ̀ àtọ́ka*.\n</step2>\n<step3>\nSickle cell disease can lead to various complications, including vaso-occlusive crises — *ìṣòro ikọ̀sílẹ̀* — due to the sickle-shaped cells blocking blood flow.\n</step4>\n<step4>\nAdditionally, the osmolality of her urine is low at 130 mOsmol/kg H2O, which suggests possible renal concentrating ability issues — *ìṣòro ni iṣẹ́ àyẹ̀wò ẹ̀jẹ̀*.\n</step5>\n<step5>\nCommon complications in sickle cell disease include acute chest syndrome — *ìṣòro àyà àkúnya* — and increased risk of infections due to spleen dysfunction — *ìṣòro àìlera àyà*.\n</step6>\n<step6>\nGiven these factors, the most significant complication she may face is likely related to vaso-occlusive crises or acute chest syndrome.\n</step6></thinking>", "answer": "<answer>Àìlera tó pọ̀jùlọ tí ó lè dojú kọ ni ìṣòro ikọ̀sílẹ̀ tàbí ìṣòro àyà àkúnya.</answer>", "language": "Yoruba"}
{"question": "Ninu itọju ọmọbirin ọdun 17 kan ti o gbiyanju lati pa ara rẹ̀ pẹlu lilo acetaminophen pupọ, a fun u ni oogun kan ti o jẹ́ ipilẹ̀ṣẹ̀ glutathione ati atunṣe fun didaniloju majele acetaminophen. Yàtọ̀ sí ipa rẹ̀ ninu mimu majele kuro, kini ọ̀nà míì ti oogun yìí ṣe ń mú ipò alaisan náà sunwọ̀n sí?", "reasoning": "<thinking><step1>\nThe question asks about the treatment of a 17-year-old girl who attempted suicide using excessive acetaminophen — *acetaminophen* is a common pain reliever that can be toxic in high doses. It also inquires about the role of a glutathione-based drug in her recovery.\n</step1>\n<step2>\nGlutathione is a powerful antioxidant that helps detoxify the liver — *o n ṣe iranlọwọ lati yọ majele kuro ni ẹdọ*. In cases of acetaminophen overdose, it replenishes glutathione levels that are depleted.\n</step2>\n<step3>\nBy restoring glutathione, the drug aids in the conjugation process, which is crucial for detoxifying harmful metabolites — *o n ṣe iranlọwọ lati mu awọn ọja majele ti o lewu kuro*.\n</step3>\n<step4>\nAdditionally, glutathione can reduce oxidative stress in the liver — *o le dinku aapọn oxidative ni ẹdọ*, which is beneficial for overall liver function and recovery.\n</step4>\n<step5>\nThis means that beyond just removing the toxin, the drug supports cellular health and promotes healing — *o n ṣe atilẹyin ilera sẹẹli ati mu imularada ṣiṣẹ*.\n</step6>\n<step6>\nThus, the glutathione-based medication not only detoxifies but also enhances liver recovery and function.\n</step6></thinking>", "answer": "<answer>Oògùn ti o da lori glutathione n ṣe iranlọwọ lati mu ilera ẹdọ pọ si ati imularada, ni afikun si mimu majele kuro.</answer>", "language": "Yoruba"}
{"question": "Àfikún àwọn àṣà ilẹ̀̀ kẹ́míkà tí a ṣàpèjúwe, ṣe ìpinnu ẹgbẹ́ ìṣọ̀kan mọlikulu ti ọjà E tí ó léwu gidigidi tí ó ṣe nígbà tí ọjà C bá bá pẹlu àwọn ìwọ̀n méjì ti gaasi D.", "reasoning": "<thinking><step1>\nThe question asks: “Àfikún àwọn àṣà ilẹ̀̀ kẹ́míkà tí a ṣàpèjúwe” — meaning it wants to know about the chemical properties described and how they relate to the stability of a dangerous product E when mixed with gas D in the presence of compound C.\n</step1>\n<step2>\nTo analyze this, we first consider the properties of the compounds involved — *àwọn àṣà ilẹ̀̀ kẹ́míkà* — particularly focusing on their reactivity and stability.\n</step2>\n<step3>\nProduct E is described as highly dangerous, which suggests it may be reactive or unstable under certain conditions — *ìpinnu ẹgbẹ́ ìṣọ̀kan* indicates the need to assess its molecular stability.\n</step3>\n<step4>\nWhen product C interacts with gas D, we must evaluate the potential for a reaction that could lead to hazardous outcomes — *ìbáṣepọ̀ tó le fa ewu*.\n</step4>\n<step5>\nFor example, if gas D is flammable or reactive, mixing it with product E could create a volatile situation — *àwọn ipo tó le fa ìfarapa*.\n</step5>\n<step6>\nThus, understanding the molecular interactions and the conditions under which they occur is crucial for determining the safety of this mixture — *àwọn ipo ààbò*.\n</step7>\n<step8>\nIn conclusion, the stability of product E in the presence of gas D and compound C must be carefully assessed to prevent dangerous reactions.\n</step8></thinking>", "answer": "<answer>Ìpinnu ẹgbẹ́ ìṣọ̀kan mọlikulu ti ọjà E jẹ́ pataki lati yago fun ìbáṣepọ̀ tó le fa ewu pẹ̀lú gaasi D àti ọjà C.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 25 kan tí ó ti ní ìdààmú ọkàn nípa ọ̀pọ̀lọpọ̀ nǹkan tó jẹ́mọ́ ìlera rẹ̀ fún ọdún kan, pẹ̀lú ìbẹ̀rù àìsàn kansa, àìdánilójú iṣẹ́, ìṣẹ̀ṣe ìmọ̀lẹ̀, àti ìbáṣepọ̀ ìdílé rẹ̀, tí àyẹ̀wo ọpọlọ rẹ̀ sì dára, kò sì ní ìgbóná orí nígbà tí a ṣe àyẹ̀wo rẹ̀, kini ìtọ́jú oníṣẹ́-àwọn-òògùn tó yẹ julọ ní àkọ́kọ́ fún ṣíṣe ìtọ́jú àwọn ààmì àrùn rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What is the best initial pharmacological treatment for a 25-year-old man who has experienced anxiety symptoms related to health concerns for a year, including fear of cancer, job insecurity, insomnia, and family relationship issues, with a normal mental status exam and no fever?” \n</step1>\n<step2>\nThis situation describes a case of generalized anxiety disorder (GAD) — *àìlera àníyàn gbogbogbo* — where the patient has persistent anxiety without significant physical illness.\n</step2>\n<step3>\nIn such cases, first-line treatments often include selective serotonin reuptake inhibitors (SSRIs) — *awọn olutọju serotonin ti o yan* — which help to regulate mood and reduce anxiety.\n</step3>\n<step4>\nCommon SSRIs like fluoxetine or sertraline can be effective; they work by increasing serotonin levels in the brain — *nipa imudara ipele serotonin ninu ọpọlọ*.\n</step4>\n<step5>\nAdditionally, cognitive-behavioral therapy (CBT) is recommended alongside medication — *ìtọ́jú ìmọ̀ràn-ìṣe* — to address the underlying thought patterns contributing to anxiety.\n</step5>\n<step6>\nThus, the best initial treatment would be to start an SSRI while also considering CBT for comprehensive management of his symptoms.\n</step6></thinking>", "answer": "<answer>Ìtọ́jú tó dára jùlọ ni láti bẹ̀rẹ̀ pẹ̀lú SSRI gẹ́gẹ́ bí fluoxetine tàbí sertraline, pẹ̀lú ìmọ̀ràn-ìṣe.</answer>", "language": "Yoruba"}
{"question": "Ọdọmọkunrin ọdun mẹẹdogun kan kù sí iwọn giga àwọn ọmọ ogun rẹ̀, láìsí ìtàn àìsàn tó ṣe pàtàkì tàbí àwọn àmì bí ìyípadà ìwọn àdánù, ìdènà ẹ̀gbẹ̀, tàbí òrùn.  Ó wà ní ìpele Tanner kejì ti idagbasoke ìbálòpọ̀, àti àwọn àkọsílẹ̀ idagbasoke rẹ̀ fi ìwọn àgbàyanu ìbí hàn, pẹ̀lú gíga àti ìwọn àdánù tí ó sọ̀kalẹ̀ sí ìpín 5th lati ọ̀dún mẹfa.  Ìwo X-ray ọwọ́ òsì rẹ̀ fi ìdènà ọjọ́ egungun hàn. Nígbà tí a bá gbé èdè yìí yẹ̀ wò, kí ni ìdí tí ó ṣeé ṣe jùlọ tí ó fa gíga rẹ̀ tí kò tó?", "reasoning": "<thinking><step1>\nThe question asks: \"What is the most likely reason for a 15-year-old boy's height being below average?\" — it mentions factors like *ìtàn àìsàn* [medical history], *ìyípadà ìwọn àdánù* [weight changes], and *ìdènà ẹ̀gbẹ̀* [bone growth issues].\n</step1>\n<step2>\nAt 15 years old, boys are typically in a growth spurt, so being below average height could indicate a growth delay — *ìdí tí ó fa ìdènà ìdagbasoke*.\n</step2>\n<step3>\nThe mention of *ìpele Tanner kejì* [Tanner stage II] suggests he is in the early stages of puberty, which is crucial for growth — *ìbálòpọ̀* and height increase.\n</step3>\n<step4>\nThe X-ray showing *ìdènà ọjọ́ egungun* [bone age delay] indicates that his bones are not maturing at the expected rate, which can affect height.\n</step5>\n<step5>\nCommon causes for this could include genetic factors, nutritional deficiencies, or hormonal imbalances — *àìlera àtọkànwá* [endocrine disorders] could also play a role.\n</step6>\n<step6>\nIn summary, the most likely reason for his below-average height is a delay in bone maturation, possibly due to hormonal or nutritional factors.\n</step7></thinking>", "answer": "<answer>Ìdí tí ó ṣeé ṣe jùlọ fún gíga rẹ̀ tí kò tó ni ìdènà ìdagbasoke egungun, tí ó lè jẹ́ nítorí àìlera àtọkànwá tàbí àìlera onjẹ.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun mẹtadinlogun kan wá pẹlu awọn ami aisan ọpọlọ ti o ti buru si lọna ti o gbamu, gẹgẹ bi ẹtan pe wọn fẹ pa a, fifi ara sẹyin kuro ninu awujọ, ati idinku ninu itọju ara fun ọdun meji. O ti gba lati bẹrẹ itọju oogun bayi. Da lori ifihan aisan yii, oogun atọpa atọpa wo ni yoo yẹ julọ lati bẹrẹ gẹgẹ bi itọju akọkọ?", "reasoning": "<thinking><step1>\nThe question asks: “Obirin ọdun mẹtadinlogun kan wá pẹlu awọn ami aisan ọpọlọ ti o ti buru si lọna ti o gbamu” — meaning a 19-year-old woman presents with severe psychiatric symptoms, including suicidal ideation, social withdrawal, and decreased self-care for two years. It also mentions she has started medication treatment now.\n</step1>\n<step2>\nGiven the symptoms, this woman likely suffers from a serious mental health condition, possibly *depression* or *bipolar disorder* — *aisan ọpọlọ* ti o le fa awọn iṣoro wọnyi.\n</step2>\n<step3>\nThe presence of suicidal thoughts indicates a need for urgent intervention — *itọju pajawiri* — to ensure her safety and well-being.\n</step3>\n<step4>\nFirst-line treatments for such conditions often include *antidepressants* or *mood stabilizers*. For severe depression, *SSRIs* (Selective Serotonin Reuptake Inhibitors) are commonly prescribed.\n</step4>\n<step5>\nIn this case, starting with an SSRI like *fluoxetine* or *sertraline* would be appropriate, as they are effective and generally well-tolerated.\n</step5>\n<step6>\nAdditionally, considering her severe symptoms, close monitoring and possibly combining medication with therapy — *itọju pẹlu iwa-ara* — would be beneficial.\n</step6></thinking>", "answer": "<answer>Oogun atọpa ti o yẹ julọ lati bẹrẹ ni *fluoxetine* tabi *sertraline* gẹgẹ bi itọju akọkọ.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdún 23 kan wá sí ọ̀dọ̀ oníṣègùn tó ń tọ́jú rẹ̀ nígbà gbogbo nítorí imú rẹ̀ tí ń sún, ìmú rẹ̀ tí ń fẹ́, àti ikọ́ tí ó ti wà fún oṣù díẹ̀. Ó sẹ́ pé òun kò gbọ̀n tàbí pé òun kò nílò láàárín, ṣùgbọ́n ó sọ pé àwọn àrùn rẹ̀ ti dààmú sí ìgbésí ayé rẹ̀ ojoojumọ. Ẹni náà kò ní ìtàn ìṣòro ìlera tí ó ṣe pàtàkì rí. Ó ń mu ọtí wáìnì nígbà míì ní ọ̀sẹ̀. Ìgbóná ara rẹ̀ jẹ́ 98.6°F (37.0°C), ẹ̀dùn ọ̀fun jẹ́ 124/88 mmHg, ìṣẹ̀lẹ̀ ọkàn jẹ́ 80/min, ìmí jẹ́ 13/min, àti ìgbóògùn oxygen jẹ́ 98% ní afẹ́fẹ́ yàrá. Ìwádìí ara fi hàn pé ọ̀dọ́mọkùnrin kan tí ó lè dára tí ó ń fún imú rẹ̀ ní ṣíkọ̀. Ìgbá imú rẹ̀ kò fà àrùn kan jáde. Ìwòye oropharynx ẹni náà kò ṣe kedere. Nínú àwọn wọ̀nyí, èwo ni ìgbésẹ̀ tó tọ́ jùlọ tó kàn ní ọ̀nà ìṣègùn?\nA. Amoxicillin\nB. Intranasal saline\nC. Intranasal steroid\nD. Loratadine", "reasoning": "<thinking><step1>\nThe question is asking about the best medical step for a 23-year-old man with nasal congestion, runny nose, and a cough lasting for a few months. He has no significant health history and occasionally drinks alcohol. His vital signs are stable, and the physical exam suggests a possible allergic condition.\n</step1>\n<step2>\nGiven the symptoms, *imú tí ń sún* and *imú tí ń fẹ́*, it seems likely that he is experiencing allergic rhinitis or a similar condition. The absence of fever and stable vital signs suggest that this is not an acute infection.\n</step2>\n<step3>\nIn cases of allergic rhinitis, treatment often includes *stéroïdes intranasaux* to reduce inflammation in the nasal passages. This is particularly effective for long-term management.\n</step3>\n<step4>\nWhile options like *amoxicillin* are antibiotics and would not be appropriate here, *loratadine* is an antihistamine that could help with symptoms but may not address the underlying inflammation as effectively as steroids.\n</step5>\n<step5>\n*Intranasal saline* can provide some relief but is more of a supportive measure rather than a primary treatment. Therefore, the best choice for this patient would be *stéroïdes intranasaux*.\n</step6>\n<step6>\nThus, the most appropriate medical step for this patient is to prescribe intranasal steroids to manage his symptoms effectively.\n</step6></thinking>", "answer": "<answer>Ìgbésẹ̀ tó tọ́ jùlọ ni *stéroïdes intranasaux*.</answer>", "language": "Yoruba"}
{"question": "Gẹgẹ́ bí Hobbes ṣe sọ, báwo ni ìmọ̀ràn àìṣòdodo ṣe ní ìtumọ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Gẹgẹ́ bí Hobbes ṣe sọ, báwo ni [ìmọ̀ràn àìṣòdodo = the concept of injustice] ṣe ní ìtumọ̀?” — meaning it wants to understand how Hobbes defines the concept of injustice.\n</step1>\n<step2>\nHobbes argues that injustice arises when there is a violation of a social contract — *àdéhùn awujọ* that individuals agree upon for mutual benefit.\n</step2>\n<step3>\nIn his view, *ìmọ̀ràn àìṣòdodo* is linked to the absence of a common power to enforce laws — *a ko ni agbara kan ti yóò fi mú un ṣiṣẹ́*.\n</step3>\n<step4>\nHe believes that without a strong authority, people may act in self-interest, leading to chaos — *ìjàngbọn* and conflict.\n</step4>\n<step5>\nThus, injustice is not just a moral failing but a breakdown of societal order — *ìdàpọ̀ awujọ* that relies on agreed-upon rules.\n</step5>\n<step6>\nIn summary, Hobbes sees injustice as a failure to uphold the social contract, resulting in disorder and conflict among individuals.\n</step6></thinking>", "answer": "<answer>Ìmọ̀ràn àìṣòdodo ni Hobbes sọ pé ó jẹ́ àìlera ti àdéhùn awujọ, tó ń fa ìjàngbọn àti àìlera awujọ.</answer>", "language": "Yoruba"}
{"question": "Kini ayẹ̀wo ti o ṣeé ṣe julọ fun ọmọ ọdun marun kan ti o ni awọn àmì àrùn ti ko ṣeé fò, awọn àmì àrùn ti o ga soke, ẹ̀jẹ̀ kekere lori awọn ẹsẹ isalẹ, irora ikun díẹ̀, ati pe a rii IgA ni ẹ̀yà ara rẹ̀ lori awọn ohun elo ẹjẹ ati awọn sẹẹli fúnfun ẹjẹ ti o wa ni ayika awọn ohun elo ẹjẹ?", "reasoning": "<thinking><step1>\nThe question asks: “Kini ayẹ̀wo ti o ṣeé ṣe julọ fun ọmọ ọdun marun kan ti o ni awọn àmì àrùn ti ko ṣeé fò?” — meaning it wants to know the most likely examination for a five-year-old child with specific symptoms.\n</step1>\n<step2>\nThe symptoms include *àwọn àmì àrùn ti ko ṣeé fò* (non-specific symptoms), *ẹ̀jẹ̀ kekere lori awọn ẹsẹ isalẹ* (low blood on the lower limbs), and *irora ikun díẹ̀* (slight abdominal pain).\n</step2>\n<step3>\nGiven these symptoms, one might suspect a condition related to *IgA* (Immunoglobulin A) levels, especially since it is mentioned that *a rii IgA ni ẹ̀yà ara rẹ̀* (IgA is found in their body).\n</step3>\n<step4>\nIn children, elevated IgA can indicate conditions like *àrùn àtọgbẹ* (autoimmune diseases) or *àrùn àtọgbẹ ti ara* (systemic diseases).\n</step4>\n<step5>\nThe most appropriate examination would likely be a blood test to assess IgA levels and possibly a *biopsy* if necessary to evaluate for underlying conditions.\n</step5>\n<step6>\nThus, the examination should focus on *ayẹwo ẹ̀jẹ̀* (blood examination) and possibly further tests based on the findings.\n</step6></thinking>", "answer": "<answer>Ayẹwo ẹ̀jẹ̀ ni ayẹ̀wo ti o ṣeé ṣe julọ fun ọmọ ọdun marun kan pẹlu awọn àmì àrùn wọnyi.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun mẹrinlẹgbẹta (40) kan ti ń gba itọju fun aarun ẹ̀jẹ̀ lymphatic chronic (CLL) ń ní ìgbóná àti ìdinku ìwọn ara rẹ̀, pẹ̀lú ìgbóná ara àti ìṣòro ìwọn ara rẹ̀ ni awọn oṣù diẹ sẹyin.  Àìsàn wo ni ó ṣeé ṣe julọ lati fa awọn ààmì wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “What disease is most likely causing the symptoms of fever and weight loss in a 40-year-old woman receiving treatment for chronic lymphocytic leukemia (CLL)?” \n</step1>\n<step2>\nIn patients with CLL, *àìlera* can lead to various complications, including infections due to immunosuppression — *immunosuppression* is a common issue in these cases.\n</step2>\n<step3>\nFever (*ìgbóná*) and weight loss (*ìdinku ìwọn ara*) can indicate an underlying infection, which is a frequent complication in CLL patients.\n</step3>\n<step4>\nCommon infections include bacterial infections, but viral infections like *HIV* or *hepatitis* can also occur, especially if the immune system is compromised.\n</step4>\n<step5>\nAdditionally, *leukemia* itself can cause systemic symptoms like fever due to the disease's progression or complications such as *sepsis*.\n</step5>\n<step6>\nThus, the most likely cause of these symptoms in this context is an infection, possibly due to the immunocompromised state from CLL treatment.\n</step6></thinking>", "answer": "<answer>Àìsàn ti o ṣee ṣe julọ ni ikolu, nitori ipo àìlera ti o fa ìgbóná ati ìdinku ìwọn ara.</answer>", "language": "Yoruba"}
{"question": "Kí ni orúkọ tí a fi ṣàpèjúwe ìlò àṣejù ohun tí kò lẹ́mìí láti fi rí ìtẹ́lọ́rùn nípa ìbálòpọ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni orúkọ tí a fi ṣàpèjúwe [ìlò àṣejù = excessive use] ohun tí kò lẹ́mìí [lati fi rí ìtẹ́lọ́rùn = to achieve satisfaction] nípa [ìbálòpọ̀ = intimacy]?” — meaning it seeks the term that describes excessive use of something to find satisfaction in intimacy.\n</step1>\n<step2>\nIn English, this concept is often referred to as \"addiction\" or \"dependency\" — *ìfarapa* on certain behaviors or substances.\n</step2>\n<step3>\nWhen someone relies excessively on something for intimacy, it can lead to negative consequences — *àkúnya* on personal relationships and emotional health.\n</step3>\n<step4>\nIn Yoruba, this could be described as *ìlò àṣejù ti ohun kan* to seek *ìtẹ́lọ́rùn* in *ìbálòpọ̀*.\n</step4>\n<step5>\nCommon examples include dependency on pornography or substances to enhance intimate experiences — *ìfarapa sí àwòrán àìmọ̀* or *ìmúra*.\n</step5>\n<step6>\nThus, the term that describes this excessive use is often referred to as *ìfarapa* in the context of intimacy.\n</step6></thinking>", "answer": "<answer>Ìfarapa ni orúkọ tí a fi ṣàpèjúwe ìlò àṣejù ohun tí kò lẹ́mìí láti fi rí ìtẹ́lọ́rùn nípa ìbálòpọ̀.</answer>", "language": "Yoruba"}
{"question": "Ìbéèrè: Jerry jẹ́ òpà. Gwenn wí pé Jerry jẹ́ òpà. Fidel wí pé Gwenn jẹ́ òpà. Millicent wí pé Fidel sọ́ òtítọ́. Lorine wí pé Millicent sọ́ òtítọ́. Ṣé Lorine sọ́ òtítọ́?", "reasoning": "<thinking><step1>\nThe question asks: “Does Lorine tell the truth?” — it involves a chain of statements about who is a liar or telling the truth.\n</step1>\n<step2>\nJerry is said to be a liar — *Jerry jẹ́ òpà*, which means he does not tell the truth.\n</step2>\n<step3>\nGwenn claims that Jerry is a liar, which means Gwenn is stating a fact about Jerry's honesty — *Gwenn wí pé Jerry jẹ́ òpà*.\n</step3>\n<step4>\nFidel then claims that Gwenn is a liar — *Fidel wí pé Gwenn jẹ́ òpà*, suggesting that if Fidel is truthful, then Gwenn is not.\n</step4>\n<step5>\nMillicent asserts that Fidel is telling the truth — *Millicent wí pé Fidel sọ́ òtítọ́*, which means she believes Fidel's statement about Gwenn.\n</step6>\n<step6>\nLorine supports Millicent's claim, stating that Millicent is also telling the truth — *Lorine wí pé Millicent sọ́ òtítọ́*.\n</step7>\n<step7>\nTo determine if Lorine is telling the truth, we need to analyze the chain: if Millicent is truthful, then Fidel must be truthful, which means Gwenn is a liar, confirming Jerry's status as a liar.\n</step8>\n<step8>\nSince all statements align, Lorine is indeed telling the truth — *Lorine sọ́ òtítọ́*.\n</step9></thinking>", "answer": "<answer>Bẹẹni, Lorine sọ́ òtítọ́.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun 50 kan ni awọ ara pupa lori irun ẹrẹkẹ, ẹnu, ati iwaju, ti o fi ara hàn pẹlu awọn iṣan ẹjẹ ti o gbòòrò, awọn nodules, ati awọn pustules, ṣugbọn o ṣe akiyesi pe ko si awọn comedones. Kini ayẹwo ti o ṣeeṣe julọ da lori awọn abuda iṣoogun wọnyi?", "reasoning": "<thinking><step1>\nThe question asks: “Obirin ọdun 50 kan ni [awọ ara pupa = red skin] lori [irun ẹrẹkẹ = scalp], [ẹnu = face], ati [iwaju = forehead], ti o fi ara hàn pẹlu [iṣan ẹjẹ ti o gbòòrò = enlarged blood vessels], [nodules], ati [pustules], ṣugbọn o ṣe akiyesi pe ko si [comedones = comedones].” This means it is inquiring about the most likely diagnosis based on these symptoms.\n</step1>\n<step2>\nThe symptoms described suggest a skin condition characterized by redness and inflammation — *iyẹn ni, awọ pupa ati irora*. The presence of pustules and nodules indicates an inflammatory process.\n</step2>\n<step3>\nThe absence of comedones is significant because it helps differentiate between conditions like acne and other dermatoses. In this case, *ko si comedones* suggests that acne is less likely.\n</step3>\n<step4>\nConsidering the age of the patient and the symptoms, one possible diagnosis could be *rosacea*, which often presents with facial redness, pustules, and visible blood vessels — *iṣan ẹjẹ ti o gbòòrò*.\n</step4>\n<step5>\nAdditionally, *rosacea* can affect the scalp and face, aligning with the areas mentioned in the question. The pustules are also typical of this condition.\n</step5>\n<step6>\nTherefore, based on the clinical features provided, the most likely diagnosis is *rosacea*.\n</step6></thinking>", "answer": "<answer>Ayẹwo ti o ṣeeṣe julọ ni rosacea.</answer>", "language": "Yoruba"}
{"question": "Kini a npe ni ìṣẹ̀lẹ̀ náà nígbà tí awọn etchant gel tó jẹ́ alápòòpòò gbàgbé àwọn agbègbè kan láìṣe ìtọ́jú wọn nítorí iṣẹ́ ìgbòòrì wọn tó ga jù lọ tí ó ṣèdíwò ìṣàn wọn?", "reasoning": "<thinking><step1>\nThe question asks: “Kini a npe ni [ìṣẹ̀lẹ̀ = incident] náà nígbà tí [etchant gel = etchant gel] tó jẹ́ alápòòpòò gbàgbé [agbègbè = areas] kan láìṣe [ìtọ́jú = treatment] wọn nítorí [iṣẹ́ ìgbòòrì = high activity] wọn tó ga jù lọ tí ó ṣèdíwò [ìṣàn = flow] wọn?” — meaning it wants to know what happens when etchant gel neglects certain areas due to high activity affecting their flow.\n</step1>\n<step2>\nIn this context, the incident refers to a situation where the etchant gel fails to properly etch certain areas — *nítorí pé etchant gel naa ko ni agbara to lati ṣiṣẹ́ ni gbogbo agbègbè*.\n</step2>\n<step3>\nThis can lead to uneven etching, which is problematic in processes like semiconductor manufacturing — *ninu iṣelọpọ semiconductor*.\n</step3>\n<step4>\nWhen the gel is too active, it may react too quickly, causing *ìṣàn àìlera* in the areas that are not adequately treated.\n</step4>\n<step5>\nThe result is that some regions remain unetched or poorly etched, leading to defects — *àìlera* in the final product.\n</step5>\n<step6>\nThus, this incident can be termed as *ìṣẹ̀lẹ̀ àìlera etching* due to the neglect of certain areas by the etchant gel.\n</step6></thinking>", "answer": "<answer>Ìṣẹ̀lẹ̀ àìlera etching ni a npe ni nígbà tí etchant gel gbàgbé agbègbè kan nítorí iṣẹ́ ìgbòòrì rẹ tó ga jù lọ.</answer>", "language": "Yoruba"}
{"question": "Oríṣìí ina kan wà lórí ọ̀rùn lẹnisi kan tí ó kọ́ ìrìnrìn, ó sì dá àwòrán kan sílẹ̀ ní 25 cm kúrò ní lẹnisi náà ní apá kejì. A gbé lẹnisi kejì kan sí àpapọ̀ pẹ̀lú èkìní, àti ẹgbẹ́ ẹ̀rọ náà dá àwòrán kan sílẹ̀ ní 40 cm ní apá tí ó yàtọ̀ sí orísun náà. Kí ni iṣẹ́ ṣíṣàgbéde ti lẹnisi kejì, níwọ̀n ìgbà tí iṣẹ́ ṣíṣàgbéde ti lẹnisi àkọ́kọ́ jẹ́ dandan láti tọ́jú ipo ti àwòrán tí a dá sílẹ̀?", "reasoning": "<thinking><step1>\nThe question is asking about the focal length of a second lens in a system where the first lens has a specific focal length and produces an image at a certain distance. The key terms here are \"ìrìnrìn\" [focal length], \"àwòrán\" [image], and \"orísun\" [source].\n</step1>\n<step2>\nThe first lens creates an image at 25 cm from itself. This means that the object distance for the first lens is related to its focal length — *f = (1/u + 1/v)*, where *u* is the object distance and *v* is the image distance.\n</step2>\n<step3>\nFor the second lens, it produces an image at 40 cm from the source. The total distance between the two lenses must be considered, as the image from the first lens acts as the object for the second lens.\n</step3>\n<step4>\nIf the distance between the two lenses is the sum of the image distance from the first lens and the object distance for the second lens, we can set up the equation: *d = 25 cm + x*, where *x* is the distance from the second lens to the image.\n</step4>\n<step5>\nTo find the focal length of the second lens, we need to ensure that the image produced by it is at the correct position, which is 40 cm from the source. Thus, we can use the lens formula again for the second lens: *1/f2 = (1/u2 + 1/v2)*, where *u2* is the object distance for the second lens.\n</step5>\n<step6>\nBy substituting the known values and solving for *f2*, we can determine the focal length of the second lens, ensuring that the overall system maintains the desired image position.\n</step6></thinking>", "answer": "<answer>Iṣẹ́ ṣíṣàgbéde ti lẹnisi kejì jẹ́ 10 cm.</answer>", "language": "Yoruba"}
{"question": "Ninu ọmọkunrin ọdun mẹjọ kan ti o ni awọn àmì àrùn bíi awọn àmì òfúrufú tí kò gbòòrò lórí awọn ẹsẹ̀, ìgbóná àwọn ilẹ̀kùn ẹsẹ̀, hematuria, ati proteinuria, kini itupalẹ microscopic ti apẹrẹ biopsy ti kidirin rẹ̀ yio fi hàn julọ?", "reasoning": "<thinking><step1>\nThe question asks: “In an eight-year-old boy with symptoms like [òfúrufú = edema] in the legs, [ìgbóná = heat] in the feet, hematuria, and proteinuria, what would the microscopic analysis of his kidney biopsy most likely show?” \n</step1>\n<step2>\nThese symptoms suggest a possible kidney condition, particularly involving inflammation or damage — *àìlera* to the kidney structures.\n</step2>\n<step3>\nHematuria indicates blood in the urine, while proteinuria suggests excess protein, which points to *glomerular damage*.\n</step3>\n<step4>\nIn cases like this, one might expect to see *lesions* in the glomeruli, such as *proliferation of mesangial cells* or *deposits* in the kidney tissue.\n</step4>\n<step5>\nThe presence of edema and heat in the feet could indicate fluid retention due to kidney dysfunction — *ìṣòro omi*.\n</step5>\n<step6>\nThus, the biopsy would likely reveal changes consistent with *glomerulonephritis*, characterized by inflammation and possible scarring.\n</step6></thinking>", "answer": "<answer>Itupalẹ microscopic ti kidirin rẹ̀ yio fi hàn pé àìlera glomeruli, pẹlu ìmúlò àtọka ati àìlera.</answer>", "language": "Yoruba"}
{"question": "\"Èyí tó wá jẹ́ ẹ̀rí tó dára gan-an: Ní àkọ́kọ́, Kámín jẹ́ ọmọbìnrin Hátí. Síwájú sí i, jẹ́jẹ́ ọmọbìnrin Shónà tó péye fún kíkọ́ jẹ́ ọmọbìnrin Hátí. Èyí tó ṣeé gba lóye ni pé: Kámín kì í ṣe ọmọbìnrin Shónà.\"\nṢé ẹ̀rí náà, gẹ́gẹ́ bí àwọn ẹ̀rí tó hàn gbangba, ó dára tàbí kò dára?\nÀwọn àṣàyàn:\n- ó dára\n- kò dára", "reasoning": "<thinking><step1>\nThe question translates to: \"This evidence is very strong: First, Kámín is the daughter of Hátí. Furthermore, she is the daughter of Shónà, which is necessary for being Hátí's daughter. The conclusion drawn is that Kámín cannot be Shónà's daughter.\" It asks whether this evidence is strong or not.\n</step1>\n<step2>\nTo evaluate the strength of the evidence, we need to analyze the relationships stated. Kámín being the daughter of Hátí means she is directly linked to Hátí — *Kámín jẹ́ ọmọ Hátí*.\n</step2>\n<step3>\nHowever, the claim that Kámín is also the daughter of Shónà contradicts the conclusion that she cannot be Shónà's daughter. This creates a logical inconsistency — *ìdípọ̀ àkópọ̀*.\n</step3>\n<step4>\nIf Kámín is indeed the daughter of both Hátí and Shónà, then the conclusion that she cannot be Shónà's daughter is flawed — *ìpinnu yìí kò dára*.\n</step4>\n<step5>\nThus, the evidence presented does not hold up under scrutiny, as it contradicts itself. Therefore, we can conclude that the evidence is not strong — *kò dára*.\n</step5></thinking>", "answer": "<answer>Kò dára.</answer>", "language": "Yoruba"}
{"question": "Ninu àwọn àtúnṣe ti Ẹgbẹ́ Àgbáyé fún Àwọn Òṣìṣẹ́ Àwọn Àṣàyàn (ISO) sí eto FDI, kini koodu 05 ṣe tọ́ka sí gan-an?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu àwọn àtúnṣe ti Ẹgbẹ́ Àgbáyé fún Àwọn Òṣìṣẹ́ Àwọn Àṣàyàn (ISO) sí eto FDI, kini koodu 05 ṣe tọ́ka sí gan-an?” — meaning it wants to know what code 05 refers to in the context of ISO amendments related to FDI.\n</step1>\n<step2>\nISO, or the International Organization for Standardization, sets standards that can impact foreign direct investment — *ìdoko-owo taara láti òkèèrè*.\n</step2>\n<step3>\nCode 05 typically refers to a specific classification or standard within the ISO framework — *ìtòsọna kan pato*.\n</step4>\n<step4>\nIn this context, it might relate to guidelines for investment practices or operational standards — *àwọn ilana fun ìdoko-owo*.\n</step5>\n<step5>\nTo clarify, ISO codes help in categorizing different sectors or practices, and code 05 could indicate a focus on a particular industry or operational guideline.\n</step6>\n<step6>\nThus, code 05 in the ISO amendments for FDI likely pertains to a specific standard or guideline relevant to investment practices.\n</step6></thinking>", "answer": "<answer>Koodu 05 tọ́ka sí àtúnṣe kan pato ti o ni ibatan si awọn ilana ìdoko-owo ni ISO.</answer>", "language": "Yoruba"}
{"question": "Kini abuda oogun ti o ṣe iranlọwọ lati dinku ipa ẹgbẹ rẹ nipasẹ sisọpọ pẹlu awọn eroja afojusun nikan ati kii ṣe awọn miiran?", "reasoning": "<thinking><step1>\nThe question asks: “Kini abuda oogun ti o ṣe iranlọwọ lati dinku ipa ẹgbẹ rẹ?” — meaning it wants to know what property of a drug helps reduce its side effects by interacting only with target elements.\n</step1>\n<step2>\nThis property is known as *selectivity* — it allows the drug to bind to specific receptors or enzymes, minimizing interactions with non-target sites.\n</step2>\n<step3>\nWhen a drug is selective, it reduces the likelihood of *ipa ẹgbẹ* (side effects) because it avoids affecting other biological pathways.\n</step3>\n<step4>\nFor example, a selective drug might target *receptors* in the brain without influencing those in the heart, thus preventing unwanted cardiovascular effects.\n</step4>\n<step5>\nIn pharmacology, this is crucial for developing medications that are effective yet have fewer adverse effects — *awọn ipa odi*.\n</step5>\n<step6>\nTherefore, the key property is selectivity, which ensures that the drug interacts primarily with its intended targets.\n</step6></thinking>", "answer": "<answer>Abuda oogun ti o ṣe iranlọwọ lati dinku ipa ẹgbẹ rẹ ni *selectivity*, ti o n ṣiṣẹ pẹlu awọn eroja afojusun nikan.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 60 kan wá sí ẹka pajawiri pẹlu irora ọmu inu, ṣíṣe ẹmi kuru, ati itan iṣẹ abẹ ekan ọsẹ mẹta sẹhin ti o fa idinku ni iṣiṣe.  Àyẹ̀wò rẹ̀ fihan ẹsẹ isalẹ ti o gbona ati ti o dùn. Bí oníṣẹ́ abẹ ti ṣe iye enu pẹlu irora ọmu inu ṣugbọn o nilo lati pinnu boya CT angiogram jẹ dandan, kini ìwádìí àyẹ̀wò ti yoo fihan pupọ julọ pe a nilo iṣẹ́ ṣiṣe afikun pẹlu CT angiogram?", "reasoning": "<thinking><step1>\nThe question asks: \"What diagnostic findings would most indicate the need for a CT angiogram?\" — it describes a 60-year-old man with chest pain, shortness of breath, and a history of surgery three weeks ago, along with warm and tender lower extremities.\n</step1>\n<step2>\nIn this case, the symptoms suggest possible complications like *thrombosis* or *embolism* — *ìfarapa ẹjẹ* could be a concern given the recent surgery.\n</step2>\n<step3>\nA CT angiogram is particularly useful for visualizing blood vessels and identifying blockages — *ìṣeduro ẹjẹ* or abnormalities in the vascular system.\n</step3>\n<step4>\nKey findings that would support the need for a CT angiogram include: *ìkànsí ti ẹjẹ*, significant leg swelling, or signs of *ìfarapa àtọgbẹ*.\n</step4>\n<step5>\nAdditionally, if the patient exhibits *ìfarapa ti ẹjẹ* in the lower extremities, this could indicate a serious condition like deep vein thrombosis (DVT).\n</step6>\n<step6>\nUltimately, if the clinical examination reveals these signs, a CT angiogram would be warranted to assess for any vascular issues.\n</step6></thinking>", "answer": "<answer>Ìwádìí àyẹ̀wò ti yoo fihan pe CT angiogram jẹ dandan ni: ìkànsí ti ẹjẹ, ìfarapa àtọgbẹ, ati ìfarapa ti ẹjẹ ni ẹsẹ isalẹ.</answer>", "language": "Yoruba"}
{"question": "Kini itọju to yẹ julọ fun ọkunrin ọdun 59 kan ti kò ní àrùn ṣùgbọ́n ní ìṣàn mitral myxomatous tí ó lewu, ìwọn idasilẹ ventricle òsì ti 45%, ati ìwọn ila opin systolic ti 2.9 cm/m²?", "reasoning": "<thinking><step1>\nThe question asks: “Kini itọju to yẹ julọ fun [ọkunrin = man] ọdun 59 kan ti kò ní àrùn ṣùgbọ́n ní [ìṣàn mitral myxomatous = myxomatous mitral regurgitation] tí ó lewu?” — meaning it seeks the best treatment for a 59-year-old man without other diseases but with severe myxomatous mitral regurgitation.\n</step1>\n<step2>\nIn this case, the patient has a left ventricular ejection fraction of 45% — *ìwọn idasilẹ ventricle òsì* — indicating significant heart dysfunction.\n</step2>\n<step3>\nThe systolic area of 2.9 cm/m² suggests that the heart is under stress, which can lead to heart failure — *ìfarapa ọkan*.\n</step3>\n<step4>\nFor patients with severe mitral regurgitation and reduced ejection fraction, surgical intervention is often recommended — *ìtẹ́wọ́gba abẹ́*.\n</step4>\n<step5>\nThe most common surgical option is mitral valve repair or replacement, depending on the severity and anatomy of the valve — *ìtúnṣe tabi rọ́pò àtẹ́gùn mitral*.\n</step5>\n<step6>\nAdditionally, medical management may include diuretics to manage symptoms of heart failure — *ìṣègùn diuretics*.\n</step6>\n<step7>\nUltimately, the best treatment approach should be individualized based on the patient's overall health and preferences — *ìtọ́sọ́nà to dá lórí ilera gbogbogbo*.\n</step7></thinking>", "answer": "<answer>Itọju to yẹ julọ ni ìtẹ́wọ́gba abẹ́ fun àtẹ́gùn mitral, pẹlú ìṣègùn diuretics láti ṣakoso àìlera ọkan.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹtala kan ní ìtàn ẹ̀jẹ̀ ìmú tí ń bọ̀lẹ̀ déédéé, àti wíwádìí fi hàn pé ọ̀pọ̀lọpọ̀, àwọn ìṣan ẹ̀jẹ̀ kékeré tí wọ́n gbòòrò sí i wà lórí ètè rẹ̀, ìmú rẹ̀, àti àwọn ìka rẹ̀. Pẹ̀lú àwọn àmì àrùn wọ̀nyí àti ìtàn ìdílé tó jọra nínú baba rẹ̀, àrùn wo ni àrùn yìí pọ̀ sí i fún?", "reasoning": "<thinking><step1>\nThe question asks: “What disease is likely indicated by a 13-year-old boy with a history of recurrent nosebleeds [ìtàn ẹ̀jẹ̀ ìmú = history of nosebleeds], and findings of multiple enlarged small blood vessels [ìṣan ẹ̀jẹ̀ kékeré = small blood vessels] on his nose, face, and limbs?” \n</step1>\n<step2>\nRecurrent nosebleeds can be a sign of various conditions, but in this case, the presence of enlarged blood vessels suggests a vascular issue — *ìṣoro ẹ̀jẹ̀*.\n</step2>\n<step3>\nGiven the family history [ìtàn ìdílé] of similar symptoms in his father, we should consider hereditary conditions — *àwọn àrùn àtọkànwá*.\n</step3>\n<step4>\nOne possible condition is Osler-Weber-Rendu syndrome, also known as hereditary hemorrhagic telangiectasia [àrùn àtọkànwá ẹ̀jẹ̀]. This condition leads to abnormal blood vessel formation.\n</step4>\n<step5>\nSymptoms include frequent nosebleeds, and the presence of telangiectasias [ìṣan ẹ̀jẹ̀] on the skin and mucous membranes, which aligns with the boy's symptoms.\n</step5>\n<step6>\nThus, considering the recurrent nosebleeds, enlarged blood vessels, and family history, the most likely diagnosis is Osler-Weber-Rendu syndrome.\n</step6></thinking>", "answer": "<answer>Àrùn Osler-Weber-Rendu ni àrùn yìí pọ̀ sí i fún.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹsan kan wà pẹlu ríru, òtútù, ìfẹ́ omi tí ó pọ̀ sí i, ìṣàn ní òru, irora ikùn díẹ̀, ìdinku ìwọn ara, àti ibà díẹ̀. Bí a bá gbé àwọn àmì wọ̀nyí yẹ̀wò, tí a sì gbé àrùn ìpìlẹ̀ kan tí ó ní í ṣe pẹlu àwọn àmì ìdílé yẹ̀wò, ìfarajọ HLA wo ni ó ṣeé ṣe jùlọ láti ṣe ìdáhùn sí ipò rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks about a nine-year-old boy presenting with symptoms like fever, chills, increased thirst, night sweats, abdominal pain, weight loss, and mild fever. It seeks to identify the most likely HLA haplotype associated with these symptoms, which may indicate an underlying condition.\n</step1>\n<step2>\nThese symptoms could suggest a chronic condition, possibly an autoimmune disease or a malignancy. In Yoruba, one might say: *àìlera àtọkànwá* (chronic illness) could be a concern here.\n</step2>\n<step3>\nThe presence of night sweats and weight loss is particularly concerning for conditions like lymphoma or other hematological disorders — *àrùn ẹjẹ* (blood disease).\n</step3>\n<step4>\nIn terms of HLA haplotypes, certain types are associated with autoimmune diseases. For example, HLA-B27 is linked to ankylosing spondylitis, while HLA-DR4 is associated with rheumatoid arthritis — *àrùn àtọkànwá*.\n</step4>\n<step5>\nGiven the symptoms, one might consider HLA-DR2, which is often associated with systemic lupus erythematosus (SLE) — *àrùn lupus* — especially in children.\n</step6>\n<step6>\nThus, the most likely HLA haplotype to consider in this case is HLA-DR2, given the combination of symptoms presented.\n</step6></thinking>", "answer": "<answer>HLA-DR2 ni àfarawọ́ HLA tó ṣeé ṣe jùlọ fún ipò ọmọkunrin yìí.</answer>", "language": "Yoruba"}
{"question": "Ẹni tí ó ní ìṣòro ìdènà oúnjẹ jẹun ọ̀jọ̀ owúrọ̀ tí a fi ẹran ṣe, kini ó gbàdùn?\nA. ìrora ọkàn\nB. jijẹ jùlọ\nC. ayọ̀\nD. ìtẹ́lọ́rùn\nE. rí agbára gbà", "reasoning": "<thinking><step1>\nThe question translates to: \"What does a person with a food intolerance enjoy when they eat meat in the morning?\" — focusing on the experience of someone with a food intolerance, specifically in the context of eating meat.\n</step1>\n<step2>\nFood intolerance can lead to discomfort or adverse reactions — *ìṣòro ìdènà oúnjẹ* can cause various symptoms after eating certain foods.\n</step2>\n<step3>\nIn this case, the options provided include feelings or experiences: *ìrora ọkàn* (chest pain), *jijẹ jùlọ* (overeating), *ayọ̀* (joy), *ìtẹ́lọ́rùn* (satisfaction), and *rí agbára gbà* (feeling energized).\n</step3>\n<step4>\nTypically, someone with food intolerance may not enjoy the meal due to potential discomfort — they might experience *ìrora* rather than *ayọ̀*.\n</step4>\n<step5>\nTherefore, the most likely answer is that they do not find satisfaction or joy in the meal, but rather discomfort or pain.\n</step5>\n<step6>\nThus, the correct answer relates to the negative experience rather than a positive one.\n</step6></thinking>", "answer": "<answer>ìrora ọkàn</answer>", "language": "Yoruba"}
{"question": "Ṣe iṣiro iyipada ninu enthalpy (ΔH) nigbati a ba gbona 2 moli ti kòpá (Cu) lati 50°C si 200°C, nipa lilo ọna asopọ agbara ooru C = a + bT nibiti a = 5.41 cal mol^-1 K^-1 ati b = 1.50 cal mol^-1 K^-2.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe iṣiro iyipada ninu [enthalpy = enthalpy] (ΔH) nigbati a ba gbona 2 moli ti [kòpá = copper] (Cu) lati 50°C si 200°C?” — meaning it wants to calculate the change in enthalpy when heating copper.\n</step1>\n<step2>\nTo find ΔH, we need to use the heat capacity formula: C = a + bT, where a = 5.41 cal mol^-1 K^-1 and b = 1.50 cal mol^-1 K^-2.\n</step2>\n<step3>\nFirst, we calculate the heat capacity at the initial temperature (T1 = 50°C = 323 K) and the final temperature (T2 = 200°C = 473 K).\n</step3>\n<step4>\nAt T1, C(T1) = 5.41 + 1.50 * 323 = 5.41 + 484.5 = 489.91 cal mol^-1 K^-1.\n</step4>\n<step5>\nAt T2, C(T2) = 5.41 + 1.50 * 473 = 5.41 + 709.5 = 714.91 cal mol^-1 K^-1.\n</step5>\n<step6>\nNow, we calculate the average heat capacity (C_avg) over the temperature range: C_avg = (C(T1) + C(T2)) / 2 = (489.91 + 714.91) / 2 = 602.41 cal mol^-1 K^-1.\n</step6>\n<step7>\nNext, we find the temperature change: ΔT = T2 - T1 = 473 K - 323 K = 150 K.\n</step7>\n<step8>\nFinally, we calculate ΔH using the formula: ΔH = n * C_avg * ΔT, where n = 2 mol. Thus, ΔH = 2 * 602.41 * 150 = 180723 cal.\n</step8></thinking>", "answer": "<answer>Iyipada ninu enthalpy (ΔH) jẹ 180723 cal fun 2 moli ti kòpá lati 50°C si 200°C.</answer>", "language": "Yoruba"}
{"question": "Àpòòtọ́ ẹ̀dọ̀fóró wo ni ó jẹ́ olùṣiṣẹ́ pàtàkì fún ìrísì ìgbàgbé tí ó ń wá sí ara ọmọdékùnrin ọmọ ọdún mẹ́ẹ̀ẹ́dógún kan tí ó ń gbàgbé, pàápàá lẹ́yìn eré ẹ̀rọ̀ kékeré?", "reasoning": "<thinking><step1>\nThe question asks: “Àpòòtọ́ ẹ̀dọ̀fóró wo ni ó jẹ́ olùṣiṣẹ́ pàtàkì fún ìrísì ìgbàgbé?” — meaning it wants to know which neurotransmitter is crucial for the development of a 17-year-old boy who is experiencing memory issues, especially after playing video games.\n</step1>\n<step2>\nIn English, neurotransmitters are chemical messengers in the brain that affect mood and memory — *àwọn olùṣiṣẹ́ ẹ̀dọ̀fóró*.\n</step2>\n<step3>\nFor memory and learning, *dopamine* is particularly important; it plays a role in reward and motivation, which can be influenced by video game play.\n</step3>\n<step4>\nWhen a teenager plays video games, *dopamine* levels can spike, leading to changes in how they process information — *bá a ṣe ń ṣiṣẹ́ pẹ̀lú ìmọ̀*.\n</step4>\n<step5>\nAdditionally, *serotonin* is another key neurotransmitter that helps regulate mood and can affect cognitive functions — *ìmọ̀ràn àyíká*.\n</step5>\n<step6>\nIn summary, both *dopamine* and *serotonin* are crucial for a 17-year-old's cognitive development, especially when considering the impact of gaming on memory.\n</step6></thinking>", "answer": "<answer>Dopamine àti serotonin ni àwọn ẹ̀dọ̀fóró pàtàkì fún ìrísì ìgbàgbé ọmọ ọdún mẹ́ẹ̀ẹ́dógún kan.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ọdun 45 kan ń ṣe ẹ̀dùn ilà-isàlẹ̀ ati ìtùjáde àgbàdà.  Nígbà àyẹ̀wo, cervicitis wà pẹ̀lú ìtùjáde àgbàdà mucopurulent.  Àyẹ̀wo Gram ti ìtùjáde náà fihan  ìwọ̀n sélì pus tí ó pọ̀, ṣugbọn kò sí àkójọpọ̀ kokoro.  Ọ̀nà tí ó dára jù lọ láti yà kọ́kọ̀rọ̀ tí ó ṣeé ṣe kí ó jẹ́ olùfaṣẹ́hìn ni:\nA. Ìgbẹ́kẹ̀lé lórí agar chocolate tí a fi hemin kún un\nB. Ìgbẹ́kẹ̀lé lórí sẹ́lì McCoy\nC. Ìgbẹ́kẹ̀lé lórí agar ẹ̀jẹ̀ ènìyàn bilayer kan\nD. Ìgbẹ́kẹ̀lé lórí àwọn ìlà sẹ́lì Vero", "reasoning": "<thinking><step1>\nThe question is asking about the best culture medium for a 45-year-old woman experiencing *cervicitis* with *mucopurulent discharge* and a Gram stain showing a high number of *pus cells* but no bacterial growth.\n</step1>\n<step2>\nIn cases like this, where there is a mucopurulent discharge, it suggests a possible infection that may not be easily cultured using standard methods — *àwọn ọna àyẹ̀wò àtọkànwá*.\n</step2>\n<step3>\nThe options provided include different types of culture media, and we need to determine which one is most suitable for isolating potential pathogens in this context.\n</step3>\n<step4>\nOption A mentions *agar chocolate* with hemin, which is good for fastidious organisms but may not be the best first choice here.\n</step4>\n<step5>\nOption B, *McCoy cells*, are used for viral cultures, which is not relevant for this case.\n</step5>\n<step6>\nOption C, a *bilayer human blood agar*, could support a wide range of bacteria but might not be optimal for the specific discharge observed.\n</step6>\n<step7>\nOption D, *Vero cell line*, is typically used for viral isolation, which again does not apply here.\n</step7>\n<step8>\nConsidering the need for a medium that can support the growth of potential pathogens from a mucopurulent discharge, the best choice would be a medium that can handle a variety of bacteria, which leads us to option C.\n</step8></thinking>", "answer": "<answer>Ìgbẹ́kẹ̀lé lórí agar ẹ̀jẹ̀ ènìyàn bilayer kan.</answer>", "language": "Yoruba"}
{"question": "Àwọn ìpínrọ̀ tó tẹ̀lé yìí kọ̀ọ̀kan ṣàpèjúwe ṣeto ohun mẹta tí a gbé kalẹ̀ ní ìtẹ̀lé kan tí kò yí pa dà. Àwọn ọǹrọ̀ náà bá ara wọn mu ní ìpínrọ̀ kọ̀ọ̀kan. Agbẹ̀tẹ̀rẹ̀ ẹ̀dá èso kan ta èso mẹta: ẹ̀gúsí, ẹ̀fọ́, àti mango. Mango ni o kere ju. Ẹ̀gúsí ni ìkejì gbowó julọ.\nÀwọn àṣàyàn:\n(A) Ẹ̀gúsí ni o gbowó julọ\n(B) Ẹ̀fọ́ ni o gbowó julọ\n(C) Mango ni o gbowó julọ", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn ìpínrọ̀ tó tẹ̀lé yìí kọ̀ọ̀kan ṣàpèjúwe ṣeto ohun mẹta…” — meaning it wants to describe a set of three items based on given statements.\n</step1>\n<step2>\nThe items mentioned are *ẹ̀gúsí* (melon seed), *ẹ̀fọ́* (vegetable), and *mango* (mango). The question states that *mango* is the least expensive.\n</step2>\n<step3>\nNext, it mentions that *ẹ̀gúsí* is the second most expensive item — *ìkejì gbowó julọ* — which implies that *ẹ̀fọ́* must be the most expensive.\n</step3>\n<step4>\nThus, we can deduce the order of prices: *ẹ̀fọ́* > *ẹ̀gúsí* > *mango*.\n</step4>\n<step5>\nThe options provided are: (A) *ẹ̀gúsí* ni o gbowó julọ, (B) *ẹ̀fọ́* ni o gbowó julọ, and (C) *mango* ni o gbowó julọ.\n</step5>\n<step6>\nSince *ẹ̀fọ́* is the most expensive, the correct answer is option (B).\n</step6></thinking>", "answer": "<answer>Ẹ̀fọ́ ni o gbowó julọ.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin kan tí kò tíì dàgbà pẹ̀lú àwọn èéfín tó rọ̀ bíi wàrà tí ó wà ní oríṣiríṣi ibi ní ara rẹ̀ pẹ̀lú àwọn èéfín kan nínú ẹnu rẹ̀. Kí ni pàtó ohun tí o rò pé a ó rí nígbà tí a bá ṣe àyẹ̀wò \"immunofluorescence\" lára èyí tí a mú láti ara ọmọ náà?", "reasoning": "<thinking><step1>\nThe question asks: “What specific findings might we see during an immunofluorescence examination of a young boy with skin lesions resembling [wàrà = eczema] and oral lesions?” \n</step1>\n<step2>\nImmunofluorescence is a technique used to detect specific antibodies or antigens in tissues — *a n lo o lati wa awọn antibody tabi antigen ni awọn tissue*.\n</step2>\n<step3>\nIn cases like this, we might expect to see *immunoglobulin* deposits in the skin, indicating an autoimmune response — *idahun autoimmune*.\n</step4>\n<step4>\nFor example, if the lesions are due to conditions like pemphigus vulgaris, we would see IgG and C3 deposits at the *basement membrane* — *ni ipele ipilẹ*.\n</step5>\n<step5>\nAdditionally, if the lesions are related to lupus erythematosus, we might find a \"butterfly rash\" pattern with specific antibody staining — *a le ri àpẹẹrẹ \"butterfly rash\"*.\n</step6>\n<step6>\nThus, the findings during the immunofluorescence examination could reveal various patterns of antibody deposition, which help in diagnosing the underlying condition.\n</step6></thinking>", "answer": "<answer>A ó rí àpẹẹrẹ ti awọn antibody ti a fi ọwọ́ ṣe ni àyẹ̀wò immunofluorescence, ti o le jẹ IgG ati C3 ni ipele ipilẹ, ti o ba jẹ pemphigus vulgaris, tabi àpẹẹrẹ \"butterfly rash\" ti o ba jẹ lupus erythematosus.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdọ ọdun 23 kan n ni irira ìdààmú ọkàn tí ó pọ̀ sí i lẹ́yìn tí a gbé e ga sí ọfiisi kan ní ilẹ̀ kẹwàá nítorí ìdààmú ọkàn rẹ̀ nípa gíga tí ó ti pẹ́, èyí tí ó ṣakoso nípa yíyẹra fún àwọn ilé gíga àti gbé ní ilẹ̀ ilẹ̀. Bí ó tilẹ̀ jẹ́ pé ó lò alprazolam, ó fẹ́ ìdáàrọ̀ tó tọ̀nà fún ipò rẹ̀.  Kí ni ọ̀nà ìtọ́jú tó yẹ jùlọ fún didá aṣà ìbẹ̀rù gíga rẹ̀?", "reasoning": "<thinking><step1>\nThe question is asking: \"Kí ni ọ̀nà ìtọ́jú tó yẹ jùlọ fún didá aṣà ìbẹ̀rù gíga rẹ̀?\" — which translates to \"What is the best treatment approach for managing her severe anxiety?\" \n</step1>\n<step2>\nThe individual is experiencing heightened anxiety, particularly related to heights — *ìbẹ̀rù gíga* — and has a history of this condition. \n</step2>\n<step3>\nCognitive Behavioral Therapy (CBT) is often effective for anxiety disorders — *ìtọ́jú ìmọ̀ràn àkópọ̀* — as it helps patients understand and change their thought patterns.\n</step3>\n<step4>\nExposure therapy, a component of CBT, gradually exposes the patient to heights in a controlled manner — *ìfarapa sí gíga* — to reduce fear over time.\n</step4>\n<step5>\nAdditionally, lifestyle changes such as regular exercise and mindfulness practices can support anxiety management — *ìmúrasílẹ̀* and *ìdánilójú* are beneficial.\n</step5>\n<step6>\nSince she is already using alprazolam, it’s important to consult a healthcare professional to adjust her medication if necessary — *ìmúlò àpò-ìwòsàn* should be monitored.\n</step6>\n<step7>\nIn summary, a combination of CBT, exposure therapy, and lifestyle modifications would be the most effective approach for her severe anxiety related to heights.\n</step7></thinking>", "answer": "<answer>Ìtọ́jú tó yẹ jùlọ ni ìmọ̀ràn àkópọ̀, ìfarapa sí gíga, àti ìmúrasílẹ̀.</answer>", "language": "Yoruba"}
{"question": "Fún ọ̀pọ̀lọpọ̀ àwọn nọ́mbà gidi kan níbi tí ọ̀pọ̀lọpọ̀ àwọn iye iye déédéé rẹ̀ ti yàrá, tí ìṣùpọ̀ ọ̀pọ̀lọpọ̀ náà sì jẹ́ 2, ṣàlàyé bí ó ṣe ṣeé ṣe láti ṣe àtúnṣe sí àwọn ẹ̀ka kí ìṣùpọ̀ náà lè jẹ́ 4. Pẹ̀lú, ṣé o lè fún wa ní àpẹẹrẹ àwọn aaye metric X àti Y, níbi tí X ti di pípẹ̀ àti ìdàpọ̀, àti iṣẹ́ tí ó bá a mu láti X sí Y tí àwòrán X lábẹ́ iṣẹ́ yìí kì í ṣe pípẹ̀ àti ìdàpọ̀?", "reasoning": "<thinking><step1>\nThe question asks: \"Fún ọ̀pọ̀lọpọ̀ àwọn nọ́mbà gidi kan...\" which translates to \"For many real numbers...\" and it discusses how to adjust categories so that the sum becomes 4 instead of 2.\n</step1>\n<step2>\nTo achieve this, we need to consider how to redistribute the values — *pín àwọn iye* — across the categories to increase the total sum.\n</step2>\n<step3>\nIf the current sum is 2, we can add values to certain categories or adjust existing ones — *yípadà àwọn ẹ̀ka* — to reach the desired sum of 4.\n</step3>\n<step4>\nFor example, if we have two categories with values 1 and 1, we could change one to 2 and the other to 2 — *yípadà 1 sí 2* — to achieve the new sum.\n</step4>\n<step5>\nNow, regarding the metric points X and Y, if X represents a length and Y represents a volume, we can say that as X increases, the relationship to Y might not be linear — *ìbáṣepọ̀ X àti Y kì í ṣe pípẹ̀*.\n</step6>\n<step6>\nFor instance, if X is the radius of a cylinder and Y is its volume, increasing X does not mean Y will increase proportionally — *ìdàpọ̀ Y kì í ṣe pípẹ̀*.\n</step7>\n<step7>\nThus, we can summarize that adjusting the categories involves careful redistribution of values, and the relationship between X and Y can be complex.\n</step8></thinking>", "answer": "<answer>Láti ṣe àtúnṣe sí àwọn ẹ̀ka kí ìṣùpọ̀ náà lè jẹ́ 4, a lè pín àwọn iye gidi, gẹgẹ bí àpẹẹrẹ, yípadà 1 sí 2. Àwọn aaye metric X àti Y lè ní ìbáṣepọ̀ tó nira, bí X ṣe ń pọ̀ sí i, Y kì í ṣe pípẹ̀.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 26 kan ti ń ṣe atunṣe abẹrẹ ti septum rẹ̀ ti o yipada ni iriri ẹ̀jẹ̀ pupọ̀ lórí tábìlì yàrá abẹrẹ. Àkókò prothrombin ati iye platelet ṣaaju abẹrẹ jẹ́ deede. Itan iṣoogun ti o ti kọja ti alaisan naa ṣe pataki fun awọn ami bulu igbagbogbo lori awọ ara rẹ̀ pẹlu irọrun sisun lati igba ti o jẹ ọmọde. O sọ pe o ni iru aisan ẹjẹ iru-ẹ̀ya kan ti nṣiṣẹ ninu ebi rẹ̀ ṣugbọn ko le ranti awọn alaye eyikeyi. Ewo ni o tọ julọ fun ipo ti o ṣeeṣe julọ fun alaisan yii?\nA. Desmopressin ati tranexamic acid\nB. Cryoprecipitate\nC. Plasma tuntun ti a fi tutu\nD. Recombinant factor IX\nE. Gbigbe ẹjẹ pupa", "reasoning": "<thinking><step1>\nThe question is asking about a 26-year-old man who is experiencing significant bleeding after a septum repair. It mentions that his prothrombin time and platelet count were normal, which suggests that common coagulation issues are not present.\n</step1>\n<step2>\nThe patient has a history of frequent blue spots on his skin and easy bruising since childhood — *irọrun sisun* indicates a possible bleeding disorder. He mentions a hereditary blood condition in his family but cannot recall details.\n</step2>\n<step3>\nGiven the symptoms and family history, this could suggest a condition like von Willebrand disease, which is characterized by easy bruising and bleeding — *aisan ẹ̀jẹ̀ iru-ẹ̀ya*.\n</step3>\n<step4>\nIn such cases, treatment often involves desmopressin, which helps increase levels of von Willebrand factor — *desmopressin* is commonly used for this purpose.\n</step5>\n<step5>\nThe options provided include various treatments for bleeding disorders. Since the patient's symptoms align with von Willebrand disease, the most appropriate choice would be A: Desmopressin and tranexamic acid, as they are effective in managing bleeding in such conditions.\n</step6>\nThus, the most likely treatment for this patient’s condition is desmopressin combined with tranexamic acid.</thinking>", "answer": "<answer>Desmopressin ati tranexamic acid ni o tọ julọ fun ipo alaisan yii.</answer>", "language": "Yoruba"}
{"question": "Àpọnà ọlọ́rùn ọdún mẹ́tadinlógún kan tí ó ń mu oti lile tí wọ́n ń tọ́jú fún àrùn àgbàgede, ní ìwọ̀n irin tí ó pọ̀ sí i nínú ẹ̀jẹ̀ àti ìwọ̀n transferrin tí ó pọ̀ sí i.  Lórí àwọn ìwádìí ilé-ìwòsàn wọ̀nyí, kí ni ìwádìí tí ó ṣeé ṣe jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “Àpọnà ọlọ́rùn ọdún mẹ́tadinlógún kan tí ó ń mu oti lile tí wọ́n ń tọ́jú fún àrùn àgbàgede” — referring to a 17-year-old patient with heavy drinking habits being treated for chronic liver disease.\n</step1>\n<step2>\nIn chronic liver disease, *àrùn àgbàgede* can lead to various complications, including changes in blood parameters — specifically, elevated iron levels and transferrin.\n</step2>\n<step3>\nThe question implies a need for research studies that focus on the relationship between heavy alcohol consumption and these blood changes — *ìwádìí lórí ìbáṣepọ̀*.\n</step3>\n<step4>\nCommon studies might investigate the effects of alcohol on liver function tests and iron metabolism — *ìwádìí lórí iṣẹ́ àyẹ̀wò ẹ̀jẹ̀*.\n</step4>\n<step5>\nAdditionally, studies could explore the prevalence of iron overload in patients with liver disease due to alcohol — *ìwádìí lórí àkúnya irin nínú àwọn aláìlera*.\n</step5>\n<step6>\nThus, the most relevant research would likely focus on the correlation between heavy drinking and increased iron and transferrin levels in chronic liver disease patients.\n</step6></thinking>", "answer": "<answer>Ìwádìí tí ó ṣeé ṣe jùlọ ni lórí ìbáṣepọ̀ àtàwọn ìyípadà irin àti transferrin nínú àrùn àgbàgede tó ní ìtàn mu oti lile.</answer>", "language": "Yoruba"}
{"question": "Yara ìṣúra kan bẹrẹ pẹlu awọn apo ẹ̀ka ẹyẹ mẹ́san. Ni gbogbo ọsẹ̀, awọn ẹ̀bun afikun ni a ṣe: Ọjọ́ Ajẹ́ ṣe ẹ̀bun mẹ́rìndínlọ́gbọ̀n, Ọjọ́ Ẹtì ṣe ẹ̀bun mejilelọ́gbọ̀n, Ọjọ́rú ṣe ẹ̀bun mẹta, Ọjọ́bọ́ ṣe ẹ̀bun mẹ́ẹ̀ẹ̀kan, ati Ọjọ́ Jimọ́ ṣe ẹ̀bun mẹ́rìndínlọ́gbọ̀n. Ǹwọ̀n awọn apo ẹ̀ka ẹyẹ wo ni yoo wà ninu yara ìṣúra ni ipari ọsẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: \"Yara ìṣúra kan bẹrẹ pẹlu awọn apo ẹ̀ka ẹyẹ mẹ́san\" — meaning a storage room starts with nine boxes of birds. \n</step1>\n<step2>\nEvery week, additional gifts are given: on Monday (*Ọjọ́ Ajẹ́*), 25 gifts are added; on Friday (*Ọjọ́ Ẹtì*), 15 gifts; on Tuesday (*Ọjọ́rú*), 3 gifts; on Thursday (*Ọjọ́bọ́*), 1 gift; and on Saturday (*Ọjọ́ Jimọ́*), 25 gifts.\n</step2>\n<step3>\nTo find the total number of boxes at the end of the week, we need to sum the initial boxes and the additional gifts: 9 boxes plus the gifts from each day.\n</step3>\n<step4>\nCalculating the total gifts: 25 + 15 + 3 + 1 + 25 = 69 gifts added throughout the week.\n</step4>\n<step5>\nNow, adding the initial 9 boxes to the 69 gifts gives us: 9 + 69 = 78 boxes in total.\n</step5>\n<step6>\nThus, at the end of the week, the storage room will contain 78 boxes of birds.\n</step6></thinking>", "answer": "<answer>Yara ìṣúra naa yoo ni apo ẹ̀ka ẹyẹ mẹ́jọ [78] ni ipari ọsẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ṣàbẹ̀wò bí àwọn ọ̀rọ̀-ìṣirò tí ó wà nínú Z[x] ṣe ń mú ìwòye Eisenstein ṣẹ̀ fún àìlọ́ṣẹ̀ lórí Q. x^2 - 12\nA. Bẹ́ẹ̀ni, pẹ̀lú p=4.\nB. Rárá, nítorí pé àwọn ọ̀rọ̀-ìṣirò náà ṣẹ̀ṣẹ̀ jáde.\nC. Bẹ́ẹ̀ni, pẹ̀lú p=1.\nD. Rárá, nítorí pé àwọn ọ̀rọ̀-ìṣirò náà kò mú ìwòye Eisenstein ṣẹ̀.\nE. Rárá.\nF. Bẹ́ẹ̀ni, pẹ̀lú p=12.\nG. Bẹ́ẹ̀ni, pẹ̀lú p=3.\nH. Bẹ́ẹ̀ni, pẹ̀lú p=5.\nI. Bẹ́ẹ̀ni, pẹ̀lú p=6.\nJ. Bẹ́ẹ̀ni, pẹ̀lú p=2.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣàbẹ̀wò bí àwọn ọ̀rọ̀-ìṣirò tí ó wà nínú Z[x] ṣe ń mú ìwòye Eisenstein ṣẹ̀ fún àìlọ́ṣẹ̀ lórí Q. x^2 - 12” — meaning it wants to know if the polynomial x^2 - 12 satisfies Eisenstein's criterion over the rationals [Q].\n</step1>\n<step2>\nEisenstein's criterion states that a polynomial is irreducible over the rationals if there exists a prime number p such that the coefficients satisfy specific conditions — *p* must divide all coefficients except the leading one, and *p²* must not divide the constant term.\n</step2>\n<step3>\nFor the polynomial x^2 - 12, the coefficients are 1 (leading) and -12 (constant). We need to check various primes to see if any satisfy the criterion.\n</step3>\n<step4>\nIf we take p = 2, it divides -12 but not 1, and since 2² = 4 does not divide -12, this works. However, we must check other primes as well.\n</step4>\n<step5>\nNext, if we try p = 3, it divides -12 but not 1, and 3² = 9 does not divide -12 either. This also satisfies Eisenstein's criterion.\n</step5>\n<step6>\nWe can also check p = 4, but since 4 is not a prime, it doesn't apply. Continuing this way, we find that p = 2 and p = 3 both work, but we need to confirm if any other primes do as well.\n</step7>\n<step7>\nUltimately, since we found valid primes, we conclude that the polynomial x^2 - 12 does satisfy Eisenstein's criterion for p = 2 and p = 3.\n</step8></thinking>", "answer": "<answer>Bẹ́ẹ̀ni, pẹ̀lú p=2 àti p=3.</answer>", "language": "Yoruba"}
{"question": "Kini o ṣee ṣe ki o fa ipadanu iran lojiji laisi irora ninu ọdọmọkunrin agbalagba ti o pada wa laisi iranlọwọ laarin oṣu mẹta?", "reasoning": "<thinking><step1>\nThe question asks: “Kini o ṣee ṣe ki o fa [ipadanu iran lojiji = sudden vision loss] laisi irora [irora = pain] ninu [ọdọmọkunrin agbalagba = adult male] ti o pada wa [pada wa = recovered] laisi [iranlọwọ = assistance] laarin [oṣu mẹta = three months]?” — meaning it seeks to understand potential causes of sudden vision loss without pain in a recovering adult male within three months.\n</step1>\n<step2>\nSudden vision loss can occur due to various factors, even without pain. For instance, *retinal detachment* can happen, where the retina separates from the back of the eye — *eyin ti o ya*.\n</step2>\n<step3>\nAnother possibility is *vitreous hemorrhage*, which is bleeding into the vitreous humor, leading to vision changes — *iyipada ninu iran*.\n</step3>\n<step4>\nAdditionally, *amaurosis fugax* is a temporary loss of vision that can occur without pain, often due to transient ischemia — *isẹlẹ ti o ni ibatan si ẹjẹ*.\n</step4>\n<step5>\nIn some cases, *diabetic retinopathy* can also lead to vision loss without immediate pain, especially in individuals with a history of diabetes — *itan itan ti àtọgbẹ*.\n</step5>\n<step6>\nFinally, *glaucoma* can cause vision loss gradually, sometimes without pain, particularly in its early stages — *ni ipele ibẹrẹ*.\n</step6>\n<step7>\nThus, the causes of sudden vision loss without pain in this context could include retinal detachment, vitreous hemorrhage, amaurosis fugax, diabetic retinopathy, or glaucoma.\n</step7></thinking>", "answer": "<answer>Ipadanu iran lojiji laisi irora le fa nipasẹ iyapa retina, ikọlu vitreous, amaurosis fugax, retinopathy àtọgbẹ, tabi glaucoma.</answer>", "language": "Yoruba"}
{"question": "Nigbati a ba n gbero ipa eto imulo didiṣẹgun ọrọ-aje, iru awọn igbakugba akoko wo ni a maa n ṣe akiyesi deede?", "reasoning": "<thinking><step1>\nThe question asks: “Nigbati a ba n gbero [ipa eto imulo didiṣẹgun ọrọ-aje = economic policy intervention], iru awọn igbakugba akoko wo ni a maa n ṣe akiyesi deede?” — meaning it wants to know what time frames are typically considered when planning economic policy interventions.\n</step1>\n<step2>\nWhen planning economic policies, we often look at both short-term and long-term effects — *a maa n wo awọn ipa igba kukuru ati igba pipẹ*.\n</step2>\n<step3>\nShort-term considerations might include immediate impacts on employment and inflation — *ipa lẹsẹkẹsẹ lori iṣẹ ati idiyele*.\n</step3>\n<step4>\nLong-term considerations involve sustainable growth and structural changes in the economy — *idagbasoke to ni itẹsiwaju ati awọn ayipada ilana*.\n</step4>\n<step5>\nAdditionally, policymakers often analyze historical data to predict future trends — *a tun n wo data itan lati ṣe asọtẹlẹ awọn aṣa iwaju*.\n</step5>\n<step6>\nIn summary, both short-term and long-term time frames are crucial for effective economic policy planning — *igba kukuru ati igba pipẹ jẹ pataki fun eto imulo ọrọ-aje to munadoko*.\n</step6></thinking>", "answer": "<answer>Nigbati a ba n gbero ipa eto imulo didiṣẹgun ọrọ-aje, a maa n ṣe akiyesi awọn igbakugba akoko igba kukuru ati igba pipẹ.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdọọdun 21 kan wá pẹlu èso 3 cm kan ninu ẹ̀ka ọlọ́gẹ̀ẹ́rẹ̀ẹ́ apá òsì. Àyẹ̀wò èso naa fihan pe ọ̀pọ̀lọpọ̀ ti àyàfi ara wa ninu iṣan. Da lori ohun ti a rii yii, kini àyẹ̀wò ti o ṣeeṣe julọ?", "reasoning": "<thinking><step1>\nThe question asks: “Obirin ọdọọdun 21 kan wá pẹlu èso 3 cm kan ninu ẹ̀ka ọlọ́gẹ̀ẹ́rẹ̀ẹ́ apá òsì” — meaning a 21-year-old woman presents with a 3 cm mass in the left breast. \n</step1>\n<step2>\nThe examination shows that there are multiple [àyàfi ara = lymph nodes] involved, which suggests a possible underlying condition.\n</step2>\n<step3>\nIn young women, a breast mass can often be benign, such as a [fibroadenoma = fibroadenoma], but the presence of multiple lymph nodes raises suspicion for malignancy.\n</step3>\n<step4>\nWe must consider differential diagnoses, including [cancer = ikọ̀sẹ̀] of the breast, especially given the age and presentation.\n</step4>\n<step5>\nA common next step in this scenario would be to perform imaging studies, such as a [mammogram = mamogramu] or ultrasound, to further evaluate the mass.\n</step5>\n<step6>\nBased on the findings, the most likely diagnosis could be [breast cancer = ikọ̀sẹ̀ ọmú], especially if the lymph nodes are involved.\n</step6></thinking>", "answer": "<answer>Àyẹ̀wò ti o ṣeeṣe julọ ni ikọ̀sẹ̀ ọmú.</answer>", "language": "Yoruba"}
{"question": "Ninu iṣẹ abẹ ti ilokulo ẹkun ọtun ẹdọ, ẹya wo ni a le lo lati tẹriba ẹgbẹ ẹdọ ti a ge?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu iṣẹ abẹ ti ilokulo [ẹkun = lobe] ẹdọ [ẹdọ = liver], ẹya wo ni a le lo lati tẹriba [tẹriba = to replace] ẹgbẹ [egbe = segment] ẹdọ ti a ge?” — meaning it wants to know which part can be used to replace a segment of the liver that has been removed.\n</step1>\n<step2>\nIn liver surgery, particularly for conditions like cirrhosis or tumors, a segment of the liver may be resected — *a le ge ẹya kan ti ẹdọ*.\n</step2>\n<step3>\nThe liver has a remarkable ability to regenerate, so often, a portion of the liver from a healthy donor can be used — *a le lo ẹya ẹdọ lati ọdọ oluranlowo*.\n</step3>\n<step4>\nThis donor liver segment can be from the left lobe or right lobe, depending on the specific needs of the patient — *iyẹn ni, a le lo ẹkun osi tabi ẹkun otun*.\n</step4>\n<step5>\nIn some cases, living donor liver transplantation is performed, where a part of the liver is taken from a living person — *iyẹn ni, a le gba ẹya ẹdọ lati ọdọ eniyan ti o wa laaye*.\n</step5>\n<step6>\nUltimately, the goal is to ensure that the remaining liver can regenerate and function properly — *lati rii daju pe ẹdọ to ku le tun dagba*.\n</step6></thinking>", "answer": "<answer>A le lo ẹya ẹdọ lati ọdọ oluranlowo lati tẹriba ẹgbẹ ẹdọ ti a ge.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun mẹrin kan tí ó ní àrùn àìrírẹ̀ ń ṣe àìlera, kò lè sọ̀rọ̀, ń gbìdàà run run, pẹlu pulsus paradoxus, àti ìwádìí ẹ̀jẹ̀ lára tí ó fi hàn pé respiratory acidosis ni. Ṣé kí a ṣe kini tó tọ́ jù lọ láti tọ́jú ọmọ yìí?", "reasoning": "<thinking><step1>\nThe question asks: “What is the best way to treat a four-year-old child with respiratory distress, who cannot speak, is breathing rapidly, has pulsus paradoxus, and shows blood tests indicating respiratory acidosis?” \n</step1>\n<step2>\nRespiratory distress in children can be serious, especially with symptoms like *pulsus paradoxus* — which indicates significant respiratory compromise.\n</step2>\n<step3>\nFirst, we need to ensure the child has adequate oxygenation — *oxygénation adéquate* — possibly using supplemental oxygen.\n</step3>\n<step4>\nNext, addressing the underlying cause of respiratory acidosis is crucial; this may involve bronchodilators — *bronchodilatateurs* — if there is an asthma component.\n</step4>\n<step5>\nAdditionally, monitoring the child’s vital signs and providing supportive care is essential; *les soins de soutien* can help stabilize the child.\n</step5>\n<step6>\nIn severe cases, intubation may be necessary to secure the airway and ensure proper ventilation — *ventilation appropriée*.\n</step6>\n<step7>\nThus, the best approach involves immediate oxygen support, addressing the cause of acidosis, and possibly advanced airway management.\n</step7></thinking>", "answer": "<answer>Tó tọ́ jù lọ ni láti fi oxygen ranṣẹ́, tọ́jú àrùn tó fa respiratory acidosis, àti ṣe àyẹ̀wò àìlera ọmọ náà.</answer>", "language": "Yoruba"}
{"question": "Wọ́n mú ọkùnrin ọdún mẹ́rinlélógún kan wá sí ẹ̀ka ìtọ́jú pajawiri lẹ́yìn tí iná tí ó lágbára gan-an fi sun ọwọ́ òsì rẹ̀. Nígbà tí wọ́n ṣayẹ̀wò rẹ̀, òtòṣì ìka ààrin òsì rẹ̀ di pupa, àti ìsun ẹ̀gbà kejì tó bo gbogbo ọwọ́ òsì rẹ̀. Ẹ̀jẹ̀ ńṣàn lọ́dọ̀ọ̀dọ̀ ní apá ìta àti apá inú, kò sì sí àmì ìṣòro ìwògbà. Ẹ̀gbà jáde wà ní ìsàlẹ̀ ẹsẹ̀ ọ̀tún rẹ̀. Ọ̀rọ̀ ooru rẹ̀ jẹ́ 37.7°C (99.8°F), ẹ̀rọ ìwọ̀n ẹ̀jẹ̀ rẹ̀ jẹ́ 110/70 mm Hg, ìṣàn ọkàn rẹ̀ jẹ́ 105/min, ìgbà tí ó ń gbìyànjú lati mí jẹ́ 26/min. Ìṣàn-yòò rẹ̀ jẹ́ pupa-brown, ìṣàn-yòò sì jẹ́ 0.3 mL/kg/h. Ìwádìí ilé-ìwòsàn fi hàn pé:\nHemoglobin 19.9 g/dL\nHematocrit 33%\nNọ́mbà ẹ̀jẹ̀ funfun 11,111/mm3\nSerum\nCreatinine 4.6 mg/dL\nCreatine phosphokinase 123 U/L\nK+ 7.7 mEq/L\nNa+ 143 mEq/L\nKini ọ̀nà tí ó ṣeé ṣe jùlọ fún àìṣẹ́-ṣiṣẹ́ kídínì rẹ̀ yìí?\nA. Ìpadánù omi ati epo-ara àti hypovolemia\nB. Rhabdomyolysis, myoglobinuria, ati ìpalára kídínì\nC. Ìpalára iná tí ó taara sí kídínì\nD. Septicemia tí ó yọrí sí acute pyelonephritis", "reasoning": "<thinking><step1>\nThe question asks: \"Kini ọ̀nà tí ó ṣeé ṣe jùlọ fún àìṣẹ́-ṣiṣẹ́ kídínì rẹ̀ yìí?\" — meaning it wants to identify the most likely cause of kidney dysfunction in a 24-year-old man who suffered severe burns.\n</step1>\n<step2>\nThe patient has significant lab findings: elevated creatinine at 4.6 mg/dL and high potassium levels at 7.7 mEq/L, indicating possible kidney injury — *ìpalára kídínì*.\n</step2>\n<step3>\nGiven the context of severe burns, one must consider rhabdomyolysis, which can occur due to muscle damage from burns — *ìpalára iṣan* leading to myoglobinuria.\n</step4>\n<step5>\nThe presence of brown urine and elevated creatine phosphokinase (CPK) supports this diagnosis, as myoglobin can cause acute kidney injury — *ìṣẹ́-ṣiṣẹ́ kídínì*.\n</step6>\n<step6>\nOptions A and C are less likely because while hypovolemia can occur, the specific lab findings point more towards rhabdomyolysis rather than direct thermal injury to the kidneys.\n</step7>\n<step7>\nTherefore, the most plausible cause of the kidney dysfunction in this case is rhabdomyolysis, which is consistent with the clinical presentation and lab results.\n</step8></thinking>", "answer": "<answer>Ìpalára kídínì rẹ̀ jẹ́ nitori rhabdomyolysis, myoglobinuria, àti ìpalára kídínì.</answer>", "language": "Yoruba"}
{"question": "Oníṣẹ́-tábàkì ọjọ́ogun kan ọmọ ọdún 56, a ti ge ìṣòro kan tí ó wà ní bronchus kúrò. Àmì ìṣèdáradá immunohistochemical tí ó ṣe é yẹ̀ jùlọ láti ṣe àyẹ̀wò tó tọ́ jẹ́:\nA. Cytokeratin\nB. Vimentin\nC. Epithelial membrane cadherin\nD. Leucocyte common antigen", "reasoning": "<thinking><step1>\nThe question is asking about the most appropriate immunohistochemical marker to examine a problem in the bronchus of a 56-year-old patient. The key terms here are \"immunohistochemical marker\" and \"bronchus\" — *ìṣèdáradá immunohistochemical* and *bronchus*.\n</step1>\n<step2>\nIn this context, we need to identify which marker is most relevant for bronchial tissue. *Cytokeratin* is typically used to identify epithelial cells, which are abundant in the bronchus.\n</step2>\n<step3>\n*Vimentin* is more associated with mesenchymal cells, so it may not be the best choice for bronchial issues. It’s important to focus on markers that highlight epithelial characteristics.\n</step3>\n<step4>\n*Epithelial membrane cadherin* (also known as E-cadherin) is crucial for cell adhesion in epithelial tissues, making it a strong candidate for bronchial examination.\n</step4>\n<step5>\n*Leucocyte common antigen* is generally used for identifying leukocytes, which are not the primary focus when examining bronchial epithelial problems.\n</step5>\n<step6>\nConsidering the options, *Epithelial membrane cadherin* is the most suitable marker for assessing bronchial tissue integrity and pathology.\n</step6></thinking>", "answer": "<answer>Epithelial membrane cadherin ni àmì ìṣèdáradá immunohistochemical tó yẹ jùlọ láti ṣe àyẹ̀wò bronchus.</answer>", "language": "Yoruba"}
{"question": "Ẹ̀gbọ̀n-ẹ̀dá wo ni ó ṣe iṣẹ́ bí ìpilẹ̀ṣẹ̀ kan tí a ti ṣe àtúnṣe neurotransmitter acetylcholine?", "reasoning": "<thinking><step1>\nThe question asks: “Ẹ̀gbọ̀n-ẹ̀dá wo ni ó ṣe iṣẹ́ bí ìpilẹ̀ṣẹ̀ kan tí a ti ṣe àtúnṣe [neurotransmitter = neurotransmitter] acetylcholine?” — meaning it wants to know what type of receptor functions like a modified acetylcholine neurotransmitter.\n</step1>\n<step2>\nAcetylcholine acts on two main types of receptors: *les récepteurs nicotiniques* and *les récepteurs muscariniques*.\n</step2>\n<step3>\nNicotinic receptors are ionotropic, meaning they directly control ion channels — *ils permettent le passage des ions* when acetylcholine binds.\n</step3>\n<step4>\nOn the other hand, muscarinic receptors are metabotropic, which means they activate intracellular signaling pathways — *ils modifient l'activité cellulaire* through G-proteins.\n</step4>\n<step5>\nIf we consider a modified acetylcholine, it might interact with either type of receptor, but the effects would depend on the specific modification — *la modification pourrait influencer la sélectivité du récepteur*.\n</step6>\n<step6>\nIn summary, both types of receptors can be influenced by acetylcholine, but the nature of the modification will determine the specific receptor interaction.\n</step6></thinking>", "answer": "<answer>Ìpilẹ̀ṣẹ̀ kan tí a ti ṣe àtúnṣe acetylcholine lè ṣiṣẹ́ pẹ̀lú èyí tí a mọ̀ sí *récepteurs nicotiniques* tàbí *récepteurs muscariniques*.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 62 ni aya rẹ̀ mú wá sí ẹ̀ka ijẹ̀rìí pajawiri nítorí ìwọn pípòpò tí ó ga jùlọ ní ilé. Kò ní àrùn kankan. Ó ní ìtàn àrùn pípòpò gíga àti hyperlipidemia tí ó fi ń mu atenolol àti atorvastatin, ṣùgbọ́n aya rẹ̀ sọ pé ó ṣẹ́ atenolol rẹ̀ nígbà àìpẹ́ yìí, ó sì kò le ṣe àtúnṣe rẹ̀ nítorí pé kò ní iṣẹ́ àbò ilera. Òṣùwọ̀n otutu rẹ̀ jẹ́ 36.8°C (98.2°F), ìṣiṣẹ́ ọkàn rẹ̀ jẹ́ 65/min, ìṣiṣẹ́ ìmímú rẹ̀ jẹ́ 22/min, àti pípòpò rẹ̀ jẹ́ 201/139 mm Hg. Kò ní papilledema ní ìwádìí fundoscopic. CT scan kò fi àmì ìbàjẹ́ ẹ̀jẹ̀ tàbí ischemia hàn nínú ọpọlọ. Nínú àwọn wọ̀nyí, kí ni ìgbésẹ̀ tó tọ́ jùlọ tó tẹ̀ lé e?\nA. Bẹ̀rẹ̀ tàbí bẹ̀rẹ̀ sí í lo oògùn ìwọn kéré láti dín pípòpò kérékérè sí ní ọjọ́ 24–48 tó ń bọ̀.\nB. Bẹ̀rẹ̀ tàbí bẹ̀rẹ̀ sí í lo oògùn ìwọn kéré láti dín pípòpò lọ́wọ́lọ́wọ́ sí ní ọjọ́ 24–48 tó ń bọ̀.\nC. Bẹ̀rẹ̀ sí í lo oògùn ìwọn gíga láti mú pípòpò rẹ̀ wá sí isalẹ̀ 140/90 lákọ̀ọ́kan ọjọ́ 24.\nD. Mú un wọ ICU kí o sì bẹ̀rẹ̀ sí í lo oògùn in intravenous láti dín pípòpò rẹ̀ kù sí 10% nínú wákàtí àkọ́kọ́.\nE. Mú un wọ ICU kí o sì bẹ̀rẹ̀ sí í lo oògùn in intravenous láti dín pípòpò rẹ̀ kù sí 25% nínú wákàtí 4 àkọ́kọ́.", "reasoning": "<thinking><step1>\nThe question presents a case of a 62-year-old man with high blood pressure [pípòpò = hypertension] and a history of high blood pressure and hyperlipidemia. His wife reports he recently missed his atenolol dose.\n</step1>\n<step2>\nHis vital signs show a blood pressure of 201/139 mm Hg, which is significantly elevated — *pípòpò rẹ̀ ga ju* the normal range.\n</step2>\n<step3>\nThe absence of papilledema on fundoscopic examination suggests there is no acute end-organ damage, but his blood pressure is still dangerously high.\n</step4>\n<step4>\nIn this situation, the goal is to reduce his blood pressure safely and effectively — *dín pípòpò rẹ̀ kù* without causing harm.\n</step5>\n<step5>\nOptions A and B suggest starting oral medications to lower blood pressure over 24-48 hours, which may not be aggressive enough given his current levels.\n</step6>\n<step6>\nOptions C, D, and E involve intravenous medications, with D and E suggesting ICU admission for more intensive management — *mú un wọ ICU*.\n</step7>\n<step7>\nConsidering the severity of his hypertension, option D proposes a 10% reduction in the first hour, which is a more cautious approach, while option E suggests a 25% reduction over 4 hours, which is more aggressive.\n</step8>\n<step8>\nThe best choice would be to ensure rapid but safe management of his hypertension, thus option E is the most appropriate.\n</step9></thinking>", "answer": "<answer>Mú un wọ ICU kí o sì bẹ̀rẹ̀ sí í lo oògùn in intravenous láti dín pípòpò rẹ̀ kù sí 25% nínú wákàtí 4 àkọ́kọ́.</answer>", "language": "Yoruba"}
{"question": "Ọdọmọkunrin kan wá pẹlu rírí tí ó ṣòfò ní ojú ọtun, lẹ́yìn oṣù mẹta, ojú òsì sì bẹ̀rẹ̀ sí í ṣòfò pẹlu, pẹlu àwọn àmì àrùn tí ó jẹ́ ìgbóná àti ìgbóná disiki, edema, telangiectasia ti o yika papillary, idahùn pupillary déédéé, ati centrocecal scotoma lórí perimetry. Kí ni ìwádìí tí ó ṣeé ṣe julọ?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni ìwádìí tí ó ṣeé ṣe julọ?” — meaning it wants to know what the most likely investigation is for a patient with specific symptoms.\n</step1>\n<step2>\nThe patient presents with symptoms like *rírí tí ó ṣòfò* (visual disturbances) and *edema* (swelling), which suggest a possible underlying condition affecting the eyes.\n</step2>\n<step3>\nThe presence of *telangiectasia* (dilated blood vessels) and *idahùn pupillary déédéé* (fixed dilated pupils) indicates potential damage to the optic nerve or retina.\n</step4>\n<step4>\nGiven the symptoms, especially *centrocecal scotoma* (a type of visual field defect), one might suspect conditions like *glaucoma* or *optic neuritis*.\n</step5>\n<step5>\nThe most appropriate investigation to assess these symptoms would be *perimetry* (visual field testing) to evaluate the extent of visual field loss.\n</step6>\n<step6>\nAdditionally, an *MRI* (Magnetic Resonance Imaging) could be useful to rule out any structural abnormalities in the brain or optic nerve.\n</step7>\n<step7>\nThus, the most likely investigation is *perimetry* to assess the visual field defects.\n</step7></thinking>", "answer": "<answer>Ìwádìí tí ó ṣeé ṣe julọ ni perimetry láti ṣe àyẹ̀wò àìlera àwòrán.</answer>", "language": "Yoruba"}
{"question": "Aminosidi wo ni Vitamin K fi carboxylation ṣe lati mu awọn ohun elo coagulation di ti ara ṣiṣẹ?", "reasoning": "<thinking><step1>\nThe question asks: “Aminosidi wo ni [Vitamin K = Vitamin K] fi [carboxylation = carboxylation] ṣe lati mu [awọn ohun elo coagulation = coagulation factors] di ti ara ṣiṣẹ?” — meaning it wants to know which amino acids Vitamin K uses for carboxylation to activate coagulation factors.\n</step1>\n<step2>\nVitamin K is essential for the carboxylation process, which modifies certain amino acids in proteins — specifically, it acts on *glutamic acid*.\n</step2>\n<step3>\nThis modification allows coagulation factors like prothrombin to bind calcium ions — *ion kalsiyumu* — which is crucial for their function in blood clotting.\n</step3>\n<step4>\nIn this context, the amino acid that Vitamin K primarily acts on is *glutamate*, which is converted to *gamma-carboxyglutamate*.\n</step4>\n<step5>\nWithout sufficient Vitamin K, the carboxylation of these amino acids is impaired, leading to issues with blood coagulation — *iṣoro pẹlu iṣan ẹjẹ*.\n</step5>\n<step6>\nThus, Vitamin K is vital for the activation of coagulation factors through the carboxylation of specific amino acids, particularly glutamic acid.\n</step6></thinking>", "answer": "<answer>Vitamin K fi carboxylation ṣe lati mu glutamic acid ṣiṣẹ lati mu awọn ohun elo coagulation di ti ara ṣiṣẹ.</answer>", "language": "Yoruba"}
{"question": "Jiroro awọn abuda ti awọn iyokù ti a ṣe deede lati awoṣe GARCH ti a ṣe iṣiro, ni pataki nipa fifihan pinpin ti a gba wọn laaye ati eyikeyi awọn awoṣe iriri gbogbogbo ti awọn iyokù wọnyi le fihan.", "reasoning": "<thinking><step1>\nThe question asks: “Jiroro awọn abuda ti awọn iyokù ti a ṣe deede lati awoṣe [GARCH = Generalized Autoregressive Conditional Heteroskedasticity] ti a ṣe iṣiro” — meaning it wants to discuss the characteristics of residuals estimated from a GARCH model.\n</step1>\n<step2>\nResiduals from a GARCH model are crucial for understanding volatility — *iyipada* in financial time series. They should ideally be *iṣeduro* (normally distributed).\n</step2>\n<step3>\nOne key characteristic is that they often exhibit *autokorrelasi* (autocorrelation), indicating that past values influence future values, which is a common feature in financial data.\n</step3>\n<step4>\nAdditionally, these residuals may show *leptokurtosis*, meaning they have heavier tails than a normal distribution — *iyipada ti o ni awọn irọra tobi ju*.\n</step4>\n<step5>\nIn practice, one might use statistical tests like the Jarque-Bera test to assess normality — *idanwo Jarque-Bera* — and check for autocorrelation using the Ljung-Box test.\n</step5>\n<step6>\nOverall, the residuals from a GARCH model should reflect the underlying volatility dynamics and can be used to forecast future volatility — *iyipada iwaju*.\n</step6></thinking>", "answer": "<answer>Awọn abuda ti awọn iyokù lati awoṣe GARCH ni pe wọn yẹ ki o jẹ iṣeduro, ni autokorrelasi, ati pe wọn le ni leptokurtosis, ti o fihan iyipada ti o ni awọn irọra tobi ju.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun mẹ́ta kan ni a ti ṣe ayẹwo fun àrùn ìṣù àdánù kan tí a rí ìṣọ̀kan glomeruloid Schiller-Duval ninu.  Lẹ́yìn orchiectomy, àmì ẹ̀jẹ̀ wo ni a gbọ́dọ̀ ṣàyẹwo lati ṣayẹwo boya àrùn náà padà sí i?", "reasoning": "<thinking><step1>\nThe question asks: “After an orchiectomy, what blood markers should be checked to monitor for recurrence of a [tumor = àrùn]?” — specifically referring to a case involving a glomeruloid Schiller-Duval pattern.\n</step1>\n<step2>\nIn cases of testicular tumors, particularly those with a Schiller-Duval pattern, *hormones* and *tumor markers* are crucial for monitoring.\n</step2>\n<step3>\nThe primary markers to check include *alpha-fetoprotein (AFP)* and *human chorionic gonadotropin (hCG)* — both are significant in assessing tumor activity.\n</step3>\n<step4>\nElevated levels of these markers post-surgery may indicate that the tumor has returned — *àrùn náà ti padà*.\n</step4>\n<step5>\nAdditionally, regular imaging studies may be recommended to complement blood tests — *àwọn ìwádìí àwòrán* can help visualize any recurrence.\n</step5>\n<step6>\nThus, monitoring AFP and hCG levels is essential after orchiectomy for detecting any potential recurrence of the tumor.\n</step6></thinking>", "answer": "<answer>A gbọ́dọ̀ ṣàyẹwo àkópọ̀ AFP àti hCG lẹ́yìn orchiectomy láti rí bóyá àrùn náà padà sí i.</answer>", "language": "Yoruba"}
{"question": "Ọmọbinrin kan mú ọmọ rẹ̀ lọ sí ọdọ onísègùn ọmọdé nítorí pé ó ń ṣàníyàn nípa ìlera rẹ̀. Ó sọ pé gbogbo ìgbà ayé ọmọ rẹ̀, ó ti máa ń hùwà ìkà. Sibẹsibẹ, ó ti bẹ̀rẹ̀ sí í gbẹ́ ara rẹ̀ ní àìpẹ́ yìí, tí ó sì fa ìpalára àti ẹ̀jẹ̀. Ọmọ náà ní ìtàn ìṣòro ìlera ti ìwọ̀n ọgbọ́n tí ó kéré jùlọ àti àwọn àkókò ìrora abẹ́rẹ̀ tí ó le koko. Ìgbóná ara rẹ̀ jẹ́ 99.5°F (37.5°C), ẹ̀rọ ìwọ̀n ẹ̀jẹ̀ jẹ́ 87/48 mmHg, ìṣẹ́ ọkàn jẹ́ 90/min, ìmímú afẹ́fẹ́ jẹ́ 17/min, àti ìwọ̀n òògùn afẹ́fẹ́ jẹ́ 98% ní afẹ́fẹ́ yàrá. Ìwádìí ara fi hàn pé ọmọ náà ń gbìyànjú láti gbẹ́ apá rẹ̀. Nínú àwọn wọ̀nyí, èwo ni àṣà ìní ogún àrùn tí aláìsàn yìí ń fi hàn?\nA. Autosomal recessive\nB. Maternal\nC. X-linked dominant\nD. X-linked recessive", "reasoning": "<thinking><step1>\nThe question is asking about the inheritance pattern of a disease in a child who has shown signs of illness, specifically mentioning behaviors like *hùwà ìkà* (acting out) and recent *ìpalára* (injury).\n</step1>\n<step2>\nThe child has a history of health issues and presents with symptoms that suggest a genetic condition. The key terms here are *ìṣòro ìlera* (health problems) and *àṣà ìní ogún àrùn* (inheritance pattern of the disease).\n</step2>\n<step3>\nGiven the symptoms and the fact that the child is female, we need to consider how genetic conditions are passed down. For instance, *àrùn X-linked* (X-linked diseases) can affect females differently than males.\n</step3>\n<step4>\nIf the condition were *X-linked recessive*, it would typically manifest in males more severely, while females can be carriers. However, if it were *X-linked dominant*, it would affect females more directly.\n</step4>\n<step5>\nThe child's vital signs indicate some distress, but the specific mention of *ìgbóná ara* (fever) and low blood pressure suggests a serious condition that could be linked to a genetic disorder.\n</step5>\n<step6>\nConsidering all this, the most likely inheritance pattern for a female child with these symptoms is *X-linked recessive*, as it aligns with the typical presentation of such conditions.\n</step6></thinking>", "answer": "<answer>D. X-linked recessive</answer>", "language": "Yoruba"}
{"question": "A múyìnrin ọmọ ọdún mẹ́ẹ̀ẹ́rìndínlógún kan ni awọn òbí rẹ̀ mú wá sí ilé ìwòsàn àwọn aláìsàn níta pẹ̀lú ẹ̀gùn ti ìgbàgbé ìdákún ìka rẹ̀ fún àwọn oṣù díẹ̀ sẹ́yìn. Nígbà tí a fi béèrè sí i síwájú sí i, ìyá rẹ̀ ṣàkíyèsí pé ọmọbirin náà kò ti ṣe dáadáa ní ilé ẹ̀kọ́. Ó tún gbàgbọ́ pé ọmọbirin náà kúrú ju àwọn ọmọdé mìíràn lọ ní ìpínlẹ̀ rẹ̀. Nígbà àyẹ̀wò, ìṣẹ̀lẹ̀ ọkàn rẹ̀ jẹ́ 72/min, òṣùpá jẹ́ 37.6°C (99.7°F), ìwọ̀n ìgbìyẹn jẹ́ 16/min, àti ẹ̀rù ẹ̀jẹ̀ jẹ́ 120/88 mm Hg. Ọmọbirin náà ní ìka ẹ̀gbà mẹ́rin àti márùn-ún kukúrú lórí ọwọ́ méjèèjì rẹ̀, ojú yíká, àti eyín tí wọ́n yípa. Ìgàá rẹ̀ jẹ́ 135 cm (4 ft 5 in) ó sì wọn 60 kg (132 lb). Àwọn ìròyìn ìwádìí fi àwọn iye wọ̀n-ọn-nì hàn:\nHemoglobin (Hb%) 12.5 g/dL\nÌwọ̀n gbogbo ẹ̀jẹ̀ funfun 10,000/mm3\nPlatelets 260,000/mm3\nKalsíyò, ẹ̀jẹ̀ (Ca2+) 4.0 mg/dL\nÁlúbùmínu ẹ̀jẹ̀ 4.0 g/dL\nAlanine aminotransferase (ALT), ẹ̀jẹ̀ 15 U/L\nAspartate aminotransferase (AST), ẹ̀jẹ̀ 8 U/L\nKreatinínu ẹ̀jẹ̀ 0.5 mg/dL\nYúríà 27 mg/dL\nSódíyò 137 mEq/L\nPótásíyò 4.5 mEq/L\nMágínésíyò 2.5 mEq/L\nHọ́ọ̀mù parathyroid, ẹ̀jẹ̀, N-terminal 930 pg/mL (déédé: 230-630 pg/mL)\nVitaminu D ẹ̀jẹ̀ 45 ng/dL\nNíwọ̀n ìṣe ìgbàgbọ́ wo ni ọ̀nà ìní àìsàn tí aláìsàn yìí ní?\nA. X-linked recessive\nB. Autosomal dominant\nC. Mitochondrial inheritance\nD. Autosomal recessive", "reasoning": "<thinking><step1>\nThe question is asking about the type of inheritance pattern for a patient who is a 16-year-old girl with certain health issues, including a history of short stature and specific laboratory findings. The key terms to note are \"àìsàn\" [disease] and \"ìní\" [inheritance].\n</step1>\n<step2>\nGiven her short stature and the family history, we need to consider genetic conditions that could lead to these symptoms. *Kúrú* [short stature] can be associated with various genetic disorders.\n</step2>\n<step3>\nThe laboratory results show normal hemoglobin and platelet counts, but the elevated parathyroid hormone level suggests a possible issue with calcium metabolism. This could indicate a genetic condition affecting bone growth or metabolism.\n</step4>\n<step5>\nAmong the options, X-linked recessive conditions typically affect males more severely, while autosomal dominant conditions would likely show symptoms in every generation. Autosomal recessive conditions could fit if both parents are carriers.\n</step6>\n<step6>\nConsidering the girl's symptoms and the elevated parathyroid hormone, *ìní àìsàn* [inheritance pattern] is likely to be autosomal recessive, as this could explain the combination of short stature and metabolic issues.\n</step7>\n<step7>\nThus, the most fitting inheritance pattern for this case is *ìní àìsàn autosomal recessive*.\n</step7></thinking>", "answer": "<answer>Ìní àìsàn yìí jẹ́ autosomal recessive.</answer>", "language": "Yoruba"}
{"question": "Nigba ti a ba n gbero awọn aṣayan iṣakoso oyun fun obinrin ọdun 23 kan, kini itan-iṣe iṣoogun pàtó wo ni yoo mú kí alamọja ilera ṣe iṣeduro ohun miiran dipo awọn oogun iṣakoso oyun ti o ní homonu?", "reasoning": "<thinking><step1>\nThe question asks: “Nigba ti a ba n gbero [aṣayan iṣakoso oyun = contraceptive options] fun obinrin [ọdún = year] 23 kan, kini [itan-iṣe iṣoogun = medical history] pàtó wo ni yoo mú kí alamọja ilera [health professional] ṣe iṣeduro [recommend] ohun miiran dipo [instead of] awọn [oogun iṣakoso oyun = hormonal contraceptives]?” — meaning it seeks to understand what specific medical history might lead a health professional to recommend alternatives to hormonal contraceptives for a 23-year-old woman.\n</step1>\n<step2>\nA health professional will consider the patient's medical history, including any conditions like *hypertension* or *migraine* that could be exacerbated by hormonal methods — *awọn ọna iṣakoso oyun ti o ni homonu*.\n</step2>\n<step3>\nIf the woman has a history of *thromboembolism* or *cancer*, these factors are critical — *itan-iṣe iṣoogun rẹ* could indicate a higher risk with hormonal options.\n</step3>\n<step4>\nAdditionally, lifestyle factors such as smoking or being over a certain age can influence the recommendation — *ti o ba n mu siga*, for example, it may lead to a preference for non-hormonal methods.\n</step4>\n<step5>\nIn such cases, alternatives like *iṣakoso oyun ti ko ni homonu* (non-hormonal contraceptives) such as copper IUDs or barrier methods might be suggested.\n</step5>\n<step6>\nUltimately, the decision will depend on a comprehensive assessment of her health status and personal preferences — *a gbọdọ ṣe ayẹwo gbogbo awọn ifosiwewe wọnyi*.\n</step6></thinking>", "answer": "<answer>Alamọja ilera yoo ṣe iṣeduro awọn aṣayan iṣakoso oyun ti ko ni homonu ti obinrin naa ba ni itan-iṣe iṣoogun ti o ni ipa lori lilo awọn oogun iṣakoso oyun ti o ni homonu.</answer>", "language": "Yoruba"}
{"question": "Nígbà tí a bá ń wo àwọn ìṣọ̀kan kemikali wọn, èéṣe tí oògùn ‘X’, èyí tí í ṣe tertiary amine anticholinesterase, fi yẹ̀ sílẹ̀ fún lílò gẹ́gẹ́ bí miotic ju oògùn ‘Y’, èyí tí í ṣe èròjà ammonium quaternary?", "reasoning": "<thinking><step1>\nThe question asks: “Why is drug ‘X’, a [tertiary amine anticholinesterase], preferred for use as a miotic compared to drug ‘Y’, which is a [quaternary ammonium compound]?” \n</step1>\n<step2>\nDrug ‘X’ works by inhibiting the enzyme acetylcholinesterase, leading to increased levels of acetylcholine — *iyẹn ni pe, o mu ki acetylcholine pọ si* at the neuromuscular junction.\n</step2>\n<step3>\nThis increase causes *àkúnya* of the iris sphincter muscle, resulting in pupil constriction — *ìkànsí*.\n</step3>\n<step4>\nOn the other hand, drug ‘Y’, being a quaternary ammonium compound, has a more limited ability to penetrate biological membranes — *o ni ihamọra to lopin*.\n</step4>\n<step5>\nThis limited penetration means that drug ‘Y’ is less effective in reaching the target sites in the eye compared to drug ‘X’.\n</step5>\n<step6>\nAdditionally, drug ‘X’ has a longer duration of action due to its ability to remain active in the system — *o ni àkókò pipẹ*.\n</step6>\n<step7>\nThus, for miotic purposes, drug ‘X’ is more effective and preferred over drug ‘Y’ because of its mechanism and pharmacokinetics.\n</step7></thinking>", "answer": "<answer>Oògùn ‘X’ ni a fẹ́ràn fún lílò gẹ́gẹ́ bí miotic ju oògùn ‘Y’ lọ nítorí pé o ni agbara to pọ̀ síi láti mu ki ìkànsí ṣẹlẹ̀.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ile-iwe kan ṣe àṣìṣe ninu idanwo rẹ̀, wọ́n mú un, wọ́n sì lù ú ní ibi ìpàdé àsọtẹ̀lẹ̀, ó sì ní ìfẹ́ láti má ṣe èyí mọ́, irú iṣakoso wo ni èyí jẹ́?\nA. ìyà\nB. ìdènà odi\nC. kíkọ̀sílẹ̀\nD. ìdènà rere", "reasoning": "<thinking><step1>\nThe question translates to: \"A student made a mistake in their exam, they were caught, and they were punished at a disciplinary meeting, and they want to avoid this in the future. What type of control is this?\" The key terms here are [ìyà = punishment], [ìdènà odi = negative reinforcement], [kíkọ̀sílẹ̀ = reprimanding], and [ìdènà rere = positive reinforcement].\n</step1>\n<step2>\nThe scenario describes a situation where a student faces consequences for their actions — *l'élément de punition* is evident here.\n</step2>\n<step3>\nIn this context, the punishment serves as a deterrent, aiming to prevent the student from repeating the mistake — *pour éviter la répétition de l'erreur*.\n</step4>\n<step4>\nThe options provided include various forms of behavioral control: *ìyà* (punishment) is direct, while *ìdènà odi* (negative reinforcement) implies removing something unpleasant to encourage a behavior.\n</step5>\n<step5>\nSince the student is being punished, this aligns most closely with *ìyà*, which is a form of control that aims to discourage undesirable behavior through consequences.\n</step6>\n<step6>\nThus, the type of control being described here is clearly *ìyà*.\n</step6></thinking>", "answer": "<answer>Ìyà.</answer>", "language": "Yoruba"}
{"question": "Fi ẹ́kún ọ̀nà tí ó ku sílẹ̀, dáàrúdààrú kí ìwọ̀n àwọn ìwọ̀n ìṣirò tókàn náà wà ní ọ̀nà tó tọ́.  Ohun tí a fún ọ̀ ní: [ ( ) { [ ] } [ ] [ ] { < { ( ( { } ) ) { [ { } ] } } > [ ] }", "reasoning": "<thinking><step1>\nThe question asks: “Fi ẹ́kún ọ̀nà tí ó ku sílẹ̀, dáàrúdààrú kí ìwọ̀n àwọn ìwọ̀n ìṣirò tókàn náà wà ní ọ̀nà tó tọ́” — meaning it wants to know how to arrange the given brackets correctly.\n</step1>\n<step2>\nTo solve this, we need to ensure that every opening bracket has a corresponding closing bracket — *kí gbogbo ẹ̀kún tó ṣí ní ìbáṣepọ̀ pẹ̀lú ẹ̀kún tó pa*.\n</step2>\n<step3>\nThe provided sequence is: [ ( ) { [ ] } [ ] [ ] { < { ( ( { } ) ) { [ { } ] } } > [ ] }.\n</step3>\n<step4>\nWe start by identifying the types of brackets: parentheses ( ), curly braces { }, square brackets [ ], and angle brackets < > — *a ṣe àyẹ̀wò gbogbo ẹ̀kún wọ̀nyí*.\n</step4>\n<step5>\nNext, we check for balance: every time we open a bracket, we must close it in the correct order — *kí a má ba a ṣe àtúnṣe àtúnṣe*.\n</step5>\n<step6>\nAfter analyzing the sequence, we can rearrange it to ensure proper nesting and closure — *a lè ṣe àtúnṣe rẹ̀ láti jẹ́ pé gbogbo ẹ̀kún wà ní àtúnṣe tó pé*.\n</step6>\n<step7>\nThe correct arrangement of the brackets would be: { [ ( ) ] { [ ] } } — *yìí ni àtúnṣe tó tọ́*.\n</step7></thinking>", "answer": "<answer>{ [ ( ) ] { [ ] } }</answer>", "language": "Yoruba"}
{"question": "Àìkúnàgbà wo ni a ṣàpẹẹrẹ pẹlu àwọn ìṣẹlẹ àìlera tí ó máa ń pada lẹ́ẹ̀kan sígbà mìíràn ti eczema flexural, contact urticaria, àwọn àkóràn ara tí ó máa ń pada lẹ́ẹ̀kan sígbà mìíràn, àti ìrora ikun tí ó léwu àti àìlera ikun lẹ́yìn jíjẹ ẹja òkun lọ́wọ́ ọkùnrin ọdún méjìdínlọ́gbọ̀n kan?", "reasoning": "<thinking><step1>\nThe question asks: “Àìkúnàgbà wo ni a ṣàpẹẹrẹ...” which translates to “What are the examples of conditions that tend to recur like flexural eczema, contact urticaria, recurrent skin disorders, and severe abdominal pain after eating seafood in a 25-year-old man?”\n</step1>\n<step2>\nFlexural eczema, known as *eczéma flexural*, is a chronic skin condition that often flares up due to allergens or irritants — *awọn ohun amí àìlera*.\n</step2>\n<step3>\nContact urticaria occurs when the skin reacts to a specific substance, leading to hives — *àkóràn ara* that can reappear with repeated exposure.\n</step3>\n<step4>\nRecurrent skin disorders can include conditions like psoriasis or dermatitis, which are often triggered by environmental factors — *àwọn ifosiwewe ayika*.\n</step4>\n<step5>\nSevere abdominal pain after eating seafood could indicate a food allergy or intolerance, which can also recur — *ìrora ikun* that happens consistently with certain foods.\n</step5>\n<step6>\nIn summary, these conditions are characterized by their tendency to recur, often due to specific triggers or underlying sensitivities — *àìlera tí ó máa ń pada lẹ́ẹ̀kan sígbà mìíràn*.\n</step6></thinking>", "answer": "<answer>Àwọn àpẹẹrẹ ni eczema flexural, contact urticaria, àti ìrora ikun lẹ́yìn jíjẹ ẹja òkun.</answer>", "language": "Yoruba"}
{"question": "Àpọǹ lára kan, nígbà tí a ń lò ẹ̀rọ ìmúṣẹ̀ mímu, àtúnṣe ẹ̀jẹ̀ ìṣàn ara rẹ̀ ni pH 7.48, PaCO<sub>2</sub> 25mmHg, PaO<sub>2</sub> 76mmHg, BE -6mmol/L, [img=~/QImg/2014-02-20-16-47-10/image008.jpg]18.5mmol/L,  àwa gbọ́dọ̀ rò pé ó jẹ́\nA. Ìṣàn ẹ̀jẹ̀ bàsìkì ìmúṣẹ̀ mímu\nB. Ìṣàn ẹ̀jẹ̀ àṣídí ìmúṣẹ̀ mímu\nC. Ìṣàn ẹ̀jẹ̀ àṣídí àṣà\nD. Ìṣàn ẹ̀jẹ̀ bàsìkì àṣà\nE. Ìṣàn ẹ̀jẹ̀ àṣídí ìmúṣẹ̀ mímu + Ìṣàn ẹ̀jẹ̀ bàsìkì àṣà", "reasoning": "<thinking><step1>\nThe question is asking about a specific condition related to blood gas values during mechanical ventilation — *àtúnṣe ẹ̀jẹ̀ ìṣàn ara* refers to blood gas analysis.\n</step1>\n<step2>\nThe pH of 7.48 indicates alkalosis, which means the blood is more basic than normal — *ìṣàn ẹ̀jẹ̀ bàsìkì* suggests a basic blood condition.\n</step2>\n<step3>\nThe low PaCO<sub>2</sub> of 25 mmHg shows that there is hyperventilation, which is consistent with respiratory alkalosis — *ìmúṣẹ̀ mímu* implies mechanical ventilation is involved.\n</step3>\n<step4>\nThe PaO<sub>2</sub> of 76 mmHg indicates hypoxemia, meaning there is insufficient oxygen in the blood — *ìṣàn ẹ̀jẹ̀ àṣídí* could be a consideration here.\n</step4>\n<step5>\nThe base excess (BE) of -6 mmol/L suggests a metabolic component, indicating a possible metabolic acidosis — *ìṣàn ẹ̀jẹ̀ àṣídí àṣà* could also be relevant.\n</step5>\n<step6>\nConsidering all these factors, the most fitting option would be a combination of respiratory alkalosis due to mechanical ventilation and a metabolic acidosis — *Ìṣàn ẹ̀jẹ̀ àṣídí ìmúṣẹ̀ mímu + Ìṣàn ẹ̀jẹ̀ bàsìkì àṣà*.\n</step6></thinking>", "answer": "<answer>Ìṣàn ẹ̀jẹ̀ àṣídí ìmúṣẹ̀ mímu + Ìṣàn ẹ̀jẹ̀ bàsìkì àṣà.</answer>", "language": "Yoruba"}
{"question": "Ní àyẹ̀wò ọmú tó jẹ́ ìṣe déédéé, nígbà tí awọ ara bá ń gbé lọ pẹ̀lú pẹpẹ̀ ọmú tí ó wà lábẹ́ rẹ̀, ìpìlẹ̀ ara wo ni ó sábà máa ń so pẹpẹ̀ ọmú náà mọ́ awọ ara tí ó bo o lórí?", "reasoning": "<thinking><step1>\nThe question translates to: \"In a breast examination, when the skin is lifted with the breast tissue underneath, which anatomical structure typically connects the breast tissue to the overlying skin?\" This is asking about the anatomical connections in the breast.\n</step1>\n<step2>\nIn the breast, the connection between the breast tissue and the skin is primarily due to *les ligaments de Cooper* — known as Cooper's ligaments in English.\n</step2>\n<step3>\nThese ligaments provide structural support and help maintain the shape of the breast — *ils aident à maintenir la forme du sein*.\n</step3>\n<step4>\nDuring a breast examination, when the skin is lifted, these ligaments can be seen as the tissue moves — *les tissus se déplacent*.\n</step4>\n<step5>\nAdditionally, the breast is composed of glandular tissue and adipose tissue, but the ligaments are crucial for the connection to the skin — *les tissus adipeux et glandulaires*.\n</step5>\n<step6>\nThus, the anatomical structure that connects the breast tissue to the skin is primarily Cooper's ligaments — *les ligaments de Cooper*.\n</step6></thinking>", "answer": "<answer>Ìpìlẹ̀ ara tó sábà máa ń so pẹpẹ̀ ọmú náà mọ́ awọ ara ni *les ligaments de Cooper*.</answer>", "language": "Yoruba"}
{"question": "Ninu obinrin ti o loyun ti ọmọ rẹ̀ ti ṣaju ti wọn ṣe ayẹwo fun arun adrenal hyperplasia ti a bi pẹlu rẹ̀, oogun wo ni a gbọdọ fun ni lakoko oyun yii lati dènà arun naa lati dagba ninu ọmọ lọwọlọwọ yii?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu obinrin ti o loyun ti ọmọ rẹ̀ ti ṣaju ti wọn ṣe ayẹwo fun [arun adrenal hyperplasia = congenital adrenal hyperplasia] ti a bi pẹlu rẹ̀, oogun wo ni a gbọdọ fun ni lakoko oyun yii?” — meaning it wants to know what medication should be given to a pregnant woman whose previous child was diagnosed with congenital adrenal hyperplasia.\n</step1>\n<step2>\nCongenital adrenal hyperplasia is a genetic disorder affecting adrenal gland function — *arun yii n fa iṣoro ninu iṣelọpọ awọn homonu*.\n</step2>\n<step3>\nIn such cases, the primary concern is to prevent the fetus from developing the condition — *lati dènà ọmọ naa lati ni arun naa*.\n</step4>\n<step4>\nThe standard treatment involves administering glucocorticoids, such as hydrocortisone — *hydrocortisone ni a maa n lo* — to the mother during pregnancy.\n</step5>\n<step5>\nThis medication helps to suppress the overproduction of adrenal hormones in the fetus — *o n dènà iṣelọpọ awọn homonu adrenal ti o pọ ju*.\n</step6>\n<step6>\nThus, the appropriate medication to give during pregnancy is hydrocortisone to manage the risk of congenital adrenal hyperplasia in the current child.\n</step6></thinking>", "answer": "<answer>Oògùn ti a gbọdọ fun ni lakoko oyun ni hydrocortisone lati dènà arun adrenal hyperplasia ninu ọmọ lọwọlọwọ yii.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 48 kan wá sí ile-iṣẹ iṣẹ-iwosan pajawiri pẹlu irora inu ikun lẹhin jijẹun ati ikọ́ gbẹ ti o maa n buru ju ni owurọ, eyiti mejeeji ti pọ si ni iye ni awọn oṣu diẹ sẹyin.  Oun ni ilera ni ọ̀nà míràn, kò sì ní ẹ̀dùn ọ̀rọ̀ mìíràn. Itan ilera ti o ti kọja ṣe pataki fun aisan ibanujẹ ńlá, àníyàn, ati hypothyroidism.  Àyẹ̀wo ara kò ní àbùkù.  Pẹlu awọn aṣayan wọnyi, kini igbesẹ ti o tọ julọ ni itọju alaisan?\nA. Ẹ̀rọ itọ́ka ọkàn\nB. Awọn iyipada ọna igbesi aye\nC. Bẹrẹ itọju Omeprazole\nD.  Imu fluoroscopic barium", "reasoning": "<thinking><step1>\nThe question describes a 48-year-old man who presents to the emergency department with abdominal pain after eating and worsening constipation, which has increased over the past few months. It also mentions his past medical history of major depression, anxiety, and hypothyroidism, but his physical examination shows no abnormalities.\n</step1>\n<step2>\nGiven his symptoms, *irora inu ikun* (abdominal pain) and *ikọ́ gbẹ* (constipation), we need to consider the most appropriate treatment option. His history of *hypothyroidism* can contribute to constipation, as it often slows down metabolism.\n</step2>\n<step3>\nThe options provided include various interventions. Option A, *ẹ̀rọ itọ́ka ọkàn* (cardiac monitoring), seems irrelevant since there are no cardiac symptoms. \n</step3>\n<step4>\nOption B, *awọn iyipada ọna igbesi aye* (lifestyle changes), could be beneficial, especially dietary modifications to improve bowel movements. However, it may not address the immediate symptoms effectively.\n</step4>\n<step5>\nOption C, starting *itọju Omeprazole* (Omeprazole treatment), is aimed at reducing stomach acid, which might help if the pain is related to acid reflux, but it doesn't directly address constipation.\n</step5>\n<step6>\nLastly, option D, *imu fluoroscopic barium* (fluoroscopic barium swallow), is a diagnostic procedure rather than a treatment and is not necessary at this stage.\n</step6>\n<step7>\nConsidering the patient's symptoms and history, the best initial approach would be to address the constipation and possibly the hypothyroidism. Therefore, lifestyle changes that include increased fiber intake and hydration could be the most appropriate first step.\n</step7></thinking>", "answer": "<answer>Awọn iyipada ọna igbesi aye ni igbesẹ ti o tọ julọ ni itọju alaisan.</answer>", "language": "Yoruba"}
{"question": "Àjọ̀ṣepọ̀ àwọn ìgbẹ́rẹpọ̀ abẹ́ wo ni a gba nímọ̀ràn fún atúnkọ́ àti àtúnṣe ìparun gbígbòòrò fún ìdábòbò tí ó kún fún ẹ̀gbẹ̀rún mẹ́ta ọ̀kan láàrin ẹnu òkè?", "reasoning": "<thinking><step1>\nThe question asks: “Àjọ̀ṣepọ̀ àwọn ìgbẹ́rẹpọ̀ abẹ́ wo ni a gba nímọ̀ràn fún atúnkọ́ àti àtúnṣe ìparun gbígbòòrò fún ìdábòbò tí ó kún fún ẹ̀gbẹ̀rún mẹ́ta ọ̀kan láàrin ẹnu òkè?” — which translates to asking about the recommended combinations of underlying factors for the reconstruction and modification of extensive damage for a structure that is filled with over three thousand units between the upper mouth.\n</step1>\n<step2>\nIn English, this refers to structural engineering principles, particularly in the context of *atúnkọ́* (reconstruction) and *àtúnṣe* (modification) of a building or structure.\n</step2>\n<step3>\nKey factors to consider include the *ìgbẹ́rẹpọ̀ abẹ́* (underlying factors) such as the load-bearing capacity, material strength, and environmental conditions — *àwọn ipo ayika* that could affect the integrity of the structure.\n</step3>\n<step4>\nFor extensive damage, it’s crucial to assess the *ìparun gbígbòòrò* (extensive damage) and determine if the foundation is stable — *báwo ni ipilẹṣẹ ṣe dára*.\n</step4>\n<step5>\nAdditionally, using advanced materials and techniques, such as *àwọn ohun elo to ti ni ilọsiwaju* (advanced materials), can enhance the durability and safety of the reconstruction.\n</step5>\n<step6>\nFinally, consulting with structural engineers who specialize in large-scale projects is essential for ensuring that all factors are adequately addressed — *ìmọ̀ràn àwọn onímọ̀-èrọ* is invaluable.\n</step6></thinking>", "answer": "<answer>Àjọ̀ṣepọ̀ àwọn ìgbẹ́rẹpọ̀ abẹ́ ti a gba nímọ̀ràn fún atúnkọ́ àti àtúnṣe ìparun gbígbòòrò ni: ìmúdàgba ohun elo, ayẹwo ipilẹṣẹ, àti ìmọ̀ràn onímọ̀-èrọ.</answer>", "language": "Yoruba"}
{"question": "Da ipele idagbasoke ọmọ ọwẹ ti o wa ni ẹda 80th fun gigun ati iwuwo, ti bẹrẹ sisun, nwa awọn ohun ti o ti sọkalẹ, sọ 'mama' ati 'dada' lai ṣe pataki, ati pe o le ṣe agbara pincer, kini ọgbọ́n ẹ̀rọ afikun ti a nireti ni ọjọ-ori yii?", "reasoning": "<thinking><step1>\nThe question asks: “What additional cognitive skills are expected at this age?” — referring to a child who is in the 80th percentile for height and weight, has started to walk, says 'mama' and 'dada' indiscriminately, and can perform a pincer grasp.\n</step1>\n<step2>\nAt this age, typically around 12 months, children show significant cognitive development — *iṣeduro ọpọlọ* is becoming more evident.\n</step2>\n<step3>\nThey begin to understand simple commands and may respond to their name — *wọn le fesi si orukọ wọn*.\n</step3>\n<step4>\nAdditionally, they engage in more complex play, such as stacking blocks or exploring objects — *iṣere ti o ni idiju diẹ sii* is a sign of cognitive growth.\n</step4>\n<step5>\nSocially, they may exhibit attachment to caregivers and show preferences for certain toys — *wọn le ni ifẹ si awọn ohun elo kan*.\n</step6>\n<step6>\nOverall, we expect skills like problem-solving, memory recall, and basic understanding of cause and effect — *iṣeduro ti iṣoro, iranti, ati oye ipilẹ ti idi ati abajade*.\n</step7></thinking>", "answer": "<answer>Ni ọjọ-ori yii, a nireti awọn ọgbọn ẹ̀rọ afikun bi iṣeduro iṣoro, iranti, ati oye ti idi ati abajade.</answer>", "language": "Yoruba"}
{"question": "Obìnrin ti ó lóyún ọmọ, ọdún mẹ́tádínlógún (29) tí ó wà ní ọ̀sẹ̀ kejìdínlógún (24) ti ìlóyún rẹ̀, ti ń forígbàgbé ojú, ati orí òrùn, tí ńwá ibùgbé ẹ̀jẹ̀ gíga sí 159/90 mm Hg àti 154/96 mm Hg. Ṣe àyẹ̀wò ìwádìí wo ni a gbọdọ̀ ṣe tókàn láti jẹ́risi síwájú sí i nípa ìwàdíí àrùn ìgbàlóyún ìgbàgbé (preeclampsia)?", "reasoning": "<thinking><step1>\nThe question asks: “What tests should be conducted to confirm the diagnosis of [àrùn ìgbàlóyún ìgbàgbé = preeclampsia]?” It provides details about a pregnant woman who is 29 years old and 24 weeks into her pregnancy, experiencing symptoms like headaches and elevated blood pressure readings of 159/90 mm Hg and 154/96 mm Hg.\n</step1>\n<step2>\nPreeclampsia is characterized by high blood pressure and often protein in the urine — *ìkànsí ẹ̀jẹ̀ gíga* àti *ìkànsí àkúnya*.\n</step2>\n<step3>\nTo confirm preeclampsia, a doctor would typically order a urinalysis to check for protein — *àyẹ̀wò àkúnya*.\n</step3>\n<step4>\nAdditionally, blood tests are crucial to assess liver and kidney function — *àyẹ̀wò ẹ̀jẹ̀* fún ìmúlò ẹ̀dá àti ìmúlò àyà.\n</step4>\n<step5>\nMonitoring the patient's symptoms and blood pressure regularly is also essential — *ìmúlò àkúnya àtàwọn àkíyèsí*.\n</step5>\n<step6>\nIf the tests indicate significant proteinuria or abnormal liver/kidney function, it would support the diagnosis of preeclampsia — *ìjápọ̀ àrùn ìgbàlóyún ìgbàgbé*.\n</step6></thinking>", "answer": "<answer>Àyẹ̀wò àkúnya àti àyẹ̀wò ẹ̀jẹ̀ ni a gbọdọ̀ ṣe láti jẹ́risi àrùn ìgbàlóyún ìgbàgbé.</answer>", "language": "Yoruba"}
{"question": "Wa inverse Laplace transform L^-1[1 / {s(s^2 + 4)}], nipa lilo convolution.\nA. (1 / 2)(e^(2t) - 1)\nB. (1 / 2)(1 + cos2t)\nC. (1 / 4)(1 - cos2t)\nD. (1 / 4)(sin(2t) - cos(2t))\nE. (1 / 2)sin(2t)\nF. e^(-2t) * sin(2t)\nG. (1 / 2)(1 - cos2t)\nH. t * sin(2t)\nI. (1 / 4)(1 + cos2t)\nJ. sin(2t)", "reasoning": "<thinking><step1>\nThe question asks for the inverse Laplace transform, denoted as L^-1, of the function 1 / {s(s^2 + 4)} using convolution — *lilo convolution*.\n</step1>\n<step2>\nTo solve this, we first recognize that we can decompose the function into simpler parts. The term s(s^2 + 4) suggests we can use partial fraction decomposition.\n</step2>\n<step3>\nWe can express 1 / {s(s^2 + 4)} as A/s + (Bs + C)/(s^2 + 4) for some constants A, B, and C — *nitorinaa, a le wa A, B, ati C*.\n</step3>\n<step4>\nAfter finding these constants, we can take the inverse Laplace transform of each term separately. The inverse transform of 1/s is 1, and for (Bs + C)/(s^2 + 4), we can use known transforms for sine and cosine functions.\n</step4>\n<step5>\nUsing convolution, we can combine the results of the transforms. The convolution theorem states that the inverse transform of a product is the convolution of the individual transforms.\n</step5>\n<step6>\nAfter performing the calculations, we find that the result corresponds to one of the options provided. The correct answer simplifies to (1 / 2)(1 - cos(2t)).\n</step6></thinking>", "answer": "<answer>(1 / 4)(1 - cos(2t))</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 26 kan ti o ni ipalara apa ọwọ́ arinrin de pẹlu isubu ọwọ́, isubu ika, pipadanu imọlara lori apa ẹhin ọwọ́, ṣugbọn o tun le fa agba pada. Kini ayẹwo naa?", "reasoning": "<thinking><step1>\nThe question asks: “Okunrin ọdun 26 kan ti o ni ipalara apa ọwọ́ arinrin de pẹlu isubu ọwọ́, isubu ika, pipadanu imọlara lori apa ẹhin ọwọ́, ṣugbọn o tun le fa agba pada. Kini ayẹwo naa?” — meaning it describes a 26-year-old man with an arm injury involving *isubu* (fall), *pipadanu imọlara* (loss of sensation), but he can still *fa agba* (move his arm). It seeks to identify the diagnosis.\n</step1>\n<step2>\nThe symptoms suggest a possible nerve injury, particularly affecting the *nerves* in the arm — *nervi* that control sensation and movement.\n</step2>\n<step3>\nThe loss of sensation in the back of the arm indicates potential damage to the radial nerve — *nervi radialis* — which is responsible for extending the wrist and fingers.\n</step3>\n<step4>\nThe fact that he can still move his arm suggests that there might be partial function remaining, indicating a possible *neuropraxia* (temporary nerve injury) rather than a complete transection.\n</step4>\n<step5>\nIn such cases, a thorough physical examination and possibly imaging studies like an MRI or ultrasound would be necessary to confirm the diagnosis and assess the extent of the injury.\n</step5>\n<step6>\nThus, the likely diagnosis for this patient is a radial nerve injury due to the fall, characterized by sensory loss and weakness in extension.\n</step6></thinking>", "answer": "<answer>Ayẹwo naa ni ipalara si *nervi radialis* nitori isubu, pẹlu pipadanu imọlara ati ailagbara ni itẹsiwaju.</answer>", "language": "Yoruba"}
{"question": "Eyi ni tabili kan nibiti ila keji akọkọ jẹ́ ori ati ila kọọkan ti o tẹle jẹ́ penguin kan: orukọ, ọjọ ori, iga (cm), iwuwo (kg) Louis, 7, 50, 11 Bernard, 5, 80, 13 Vincent, 9, 60, 11 Gwen, 8, 70, 15  Fun apẹẹrẹ: ọjọ ori Louis ni 7, iwuwo Gwen ni 15 kg, iga Bernard ni 80 cm.  A ti fi penguin kan kun si tabili naa:\nJames, 12, 90, 12\nKini iga apapọ awọn penguin?\nAwọn aṣayan:\n(A) 60\n(B) 65\n(C) 70\n(D) 75\n(E) 80", "reasoning": "<thinking><step1>\nThe question asks: “Kini iga apapọ [average height] awọn penguin?” — meaning it wants to find the average height of the listed penguins.\n</step1>\n<step2>\nFirst, we need to identify the heights of all the penguins: Louis is 50 cm, Bernard is 80 cm, Vincent is 60 cm, Gwen is 70 cm, and James is 90 cm.\n</step2>\n<step3>\nNow, we add these heights together: 50 + 80 + 60 + 70 + 90 = 350 cm.\n</step3>\n<step4>\nNext, we count the number of penguins: there are 5 penguins in total.\n</step4>\n<step5>\nTo find the average height, we divide the total height by the number of penguins: 350 cm ÷ 5 = 70 cm.\n</step5></thinking>", "answer": "<answer>Iga apapọ awọn penguin ni 70 cm.</answer>", "language": "Yoruba"}
{"question": "Da ibeere ti o wa ni iwaju ara ẹni ti ọmọbirin ọdun mẹrin yii ti o ni iṣoro nipa ede, iṣoro ni ibaraẹnisọrọ awujọ, ati awọn ihuwasi ti o tun ṣe leralera, kini abuda onímọ̀-ara-ẹni ti a mọ̀ ti ipo naa ti o ṣeeṣe ki o ni?", "reasoning": "<thinking><step1>\nThe question asks: “What is the likely self-regulatory characteristic associated with a four-year-old girl who has language issues, social communication problems, and repetitive behaviors?” — here, *iṣoro nipa ede* means language issues, *iṣoro ni ibaraẹnisọrọ awujọ* refers to social communication problems, and *ihuwasi ti o tun ṣe leralera* indicates repetitive behaviors.\n</step1>\n<step2>\nThese symptoms suggest a developmental disorder, particularly *autism spectrum disorder (ASD)*, which is characterized by challenges in communication and social interaction.\n</step2>\n<step3>\nChildren with ASD often exhibit *ihuwasi ti o tun ṣe leralera*, such as repeating phrases or engaging in specific routines — this is a common trait.\n</step3>\n<step4>\nAdditionally, they may struggle with understanding social cues, leading to *iṣoro ni ibaraẹnisọrọ awujọ* — difficulties in making friends or engaging in typical play.\n</step4>\n<step5>\nThe self-regulatory characteristic that is often observed in such cases is *iṣakoso ara ẹni*, which refers to the ability to manage one's emotions and behaviors in social contexts.\n</step6>\n<step6>\nIn summary, the likely self-regulatory characteristic for this girl could be a challenge in *iṣakoso ara ẹni*, impacting her social interactions and communication.\n</step6></thinking>", "answer": "<answer>Abuda onímọ̀-ara-ẹni ti o ṣeeṣe ki o ni ni iṣakoso ara ẹni ti o nira, ti o ni ipa lori ibaraẹnisọrọ awujọ rẹ.</answer>", "language": "Yoruba"}
{"question": "Èdè iṣẹ́ wo ni a gbọdọ̀ lo lati dènà àṣìṣe ninu idanimọ́ ibi abẹ̀ tabi iṣẹ́ abẹ̀ ninu yàrá abẹ̀, pàápàá nípa awọn igbese idena ṣaaju abẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “Èdè iṣẹ́ wo ni a gbọdọ̀ lo lati dènà àṣìṣe ninu idanimọ́ ibi abẹ̀ tabi iṣẹ́ abẹ̀?” — meaning it wants to know what procedures or practices should be used to prevent errors in identifying surgical sites or during surgery.\n</step1>\n<step2>\nPreventing errors in surgical site identification involves several key practices — *awọn iṣe pataki* that ensure the correct site is operated on.\n</step2>\n<step3>\nFirst, a thorough preoperative verification process is essential — *ilana ayẹwo ṣaaju iṣẹ́ abẹ̀* that includes confirming the patient's identity and the surgical site.\n</step3>\n<step4>\nUsing surgical checklists can significantly reduce errors — *lilo atokọ iṣẹ́ abẹ̀* helps to ensure that all necessary steps are followed before the procedure begins.\n</step4>\n<step5>\nAdditionally, marking the surgical site clearly — *fifi ami si ibi abẹ̀* — is crucial to avoid any confusion during the operation.\n</step5>\n<step6>\nFinally, effective communication among the surgical team members — *ibaraẹnisọrọ to munadoko* — is vital to confirm details and prevent misunderstandings.\n</step6></thinking>", "answer": "<answer>Lati dènà àṣìṣe ninu idanimọ́ ibi abẹ̀, a gbọdọ̀ lo ilana ayẹwo ṣaaju iṣẹ́ abẹ̀, atokọ iṣẹ́ abẹ̀, fifi ami si ibi abẹ̀, ati ibaraẹnisọrọ to munadoko.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdun mẹrinlelogun (36) kan, G2 P1, ti lo ọsẹ mẹwa (10) loyun. Ọmọ rẹ̀ akọkọ jẹ́ obinrin, ti a bí pẹlu awọn ara ìbímọ̀ tí kò dára, tí o sì kú ní oṣù mẹfa nitori àìsàn iyipada.  Pẹlu itan yii, bawo ni iwọ yoo ṣe ṣalaye ewu jiini ti nini ọmọ miiran pẹlu awọn ara ìbímọ̀ tí kò dára ninu oyun yii?", "reasoning": "<thinking><step1>\nThe question asks: “Bawo ni iwọ yoo ṣe ṣalaye ewu jiini ti nini ọmọ miiran pẹlu awọn ara ìbímọ̀ tí kò dára?” — meaning it wants to know how to explain the genetic risk of having another child with congenital anomalies.\n</step1>\n<step2>\nThe woman is 36 years old and has a history of having a child with *ara ìbímọ̀ tí kò dára* (congenital anomalies), which raises concerns about genetic risks in future pregnancies.\n</step2>\n<step3>\nGenetic anomalies can be influenced by various factors, including maternal age — *ọdún iya* — which increases the risk of chromosomal abnormalities.\n</step3>\n<step4>\nIn her case, since the first child had serious issues and died at six months due to *àìsàn iyipada* (metabolic disease), this history suggests a potential genetic predisposition.\n</step4>\n<step5>\nIt is important to consider genetic counseling — *iṣeduro jiini* — to assess risks and possibly conduct tests during the current pregnancy.\n</step5>\n<step6>\nAdditionally, the presence of congenital anomalies in the first child may indicate a higher likelihood of recurrence, which can be explained to the mother as *ewu jiini ti o pọ si*.\n</step6>\n<step7>\nTherefore, the risk of having another child with similar issues is significant and should be discussed thoroughly with healthcare providers.\n</step7></thinking>", "answer": "<answer>Ewu jiini ti nini ọmọ miiran pẹlu awọn ara ìbímọ̀ tí kò dára jẹ́ pataki, nitori itan iṣaaju ati ọjọ-ori iya.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdún 21 kan ṣe àyẹ̀wò pẹ̀lú ìgbàárò àti àìgbọ̀ràn ẹ̀fẹ̀, àìrígbọ̀n, tí ó ní ìrùn burúkú lẹ́yìn tí ó padà láti irin-ajo ibi idì tí ó mu omi odò tí a kò tọ́jú. Ìwádìí ẹ̀fẹ̀ fi hàn àwọn protozoans tí ó ń gbé.  Ewúrà wo ni a gbọdọ̀ fi hàn láti tọ́jú ipo rẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What treatment should be shown to manage the condition of a 21-year-old man who has symptoms like [ìgbàárò = abdominal pain], [àìgbọ̀ràn ẹ̀fẹ̀ = shortness of breath], and [àìrígbọ̀n = diarrhea] after returning from a trip where he drank untreated river water?” \n</step1>\n<step2>\nThe symptoms suggest a possible infection, likely due to protozoans, which can cause gastrointestinal issues and respiratory symptoms — *àìlera ti eto àtọ́runwa*.\n</step2>\n<step3>\nIn such cases, hydration is crucial — *mú omi tó peye* — to prevent dehydration from diarrhea.\n</step3>\n<step4>\nAntimicrobial treatment may be necessary, particularly if the protozoan infection is confirmed — *ìtọju pẹlu awọn oogun antimicrobial*.\n</step4>\n<step5>\nAdditionally, monitoring for any worsening symptoms is important, as complications can arise from untreated infections — *ìmúlò àkíyèsí*.\n</step5>\n<step6>\nIn summary, the treatment should include hydration, possible antimicrobial therapy, and careful observation of symptoms.\n</step6></thinking>", "answer": "<answer>Ìtọju rẹ̀ yẹ kí o ní mímu omi tó peye, ìtọju antimicrobial, àti ìmúlò àkíyèsí.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọkunrin ọjọ́ mẹta, ti ó ní ìwàṣẹ̀ṣẹ̀gbà tí ó dára, ni a mú wá sí ẹ̀ka ìṣègùn pajawiri, ó sì ń fi àwọn àmì àrùn gbígbẹ, hyperkalemia, àti hyponatremia hàn. Láti wádìí àìsàn tí ó lè fa àwọn àmì wọnyi, ìwádìí ẹ̀jẹ̀ wo ni yóò ṣe kedere?", "reasoning": "<thinking><step1>\nThe question asks: “What blood tests should be done to investigate the condition causing the symptoms of hyperkalemia and hyponatremia in a three-year-old boy?” — it highlights the need to understand the underlying causes of these electrolyte imbalances.\n</step1>\n<step2>\nHyperkalemia means high potassium levels, while hyponatremia indicates low sodium levels — *ìwọn potassium tó ga* and *ìwọn sodium tó kéré* can suggest various medical issues.\n</step2>\n<step3>\nIn children, these conditions can arise from dehydration, kidney dysfunction, or hormonal imbalances — *a le ni àìlera nínú iṣẹ́ kidinrin* or *àìlera hormonal* like adrenal insufficiency.\n</step3>\n<step4>\nTo investigate, a basic metabolic panel (BMP) is essential — *ìtẹ́wọ́gba àtẹ̀jáde àtọka* that measures electrolytes, kidney function, and glucose levels.\n</step4>\n<step5>\nAdditionally, checking for adrenal function through tests like ACTH stimulation test could be necessary — *ìwádìí iṣẹ́ adrenal* to rule out conditions like Addison's disease.\n</step5>\n<step6>\nA complete blood count (CBC) might also be useful to assess for any underlying infections or anemia — *ìwádìí ẹ̀jẹ̀ pẹ̀lú àkópọ̀* to provide a broader picture of the child's health.\n</step6>\n<step7>\nThus, the key tests to perform include BMP, adrenal function tests, and CBC to clarify the cause of the symptoms.\n</step7></thinking>", "answer": "<answer>Ìwádìí ẹ̀jẹ̀ tó yẹ kí a ṣe ni BMP, ìwádìí iṣẹ́ adrenal, àti CBC.</answer>", "language": "Yoruba"}
{"question": "Ọmọkunrin ọdun mẹwa kan fi ìgbóná àti ìṣàn ojú pupa tí ó ń ru lórí, ọ̀pọ̀lọpọ̀ ìṣàn pẹ̀lú ìtùjáde purulent, irun tí ó rọrùn láti fà jáde, àti àwọn ìṣan lymph tí ó ń dàgbà ní agbègbè occipital wá, èwo ni yóò ṣe iranlọwọ jùlọ fún ṣíṣàyẹ̀wò àlàyé?\nA. Biopsy àti ìfẹ́ràn Giemsa\nB. Ìgbẹ́kẹ̀lé àwọn kokoro arun\nC. Ìgbòògì KOH\nD. Ìdánwò Patch, ìfẹ́ràn Gram àti Tzank smear", "reasoning": "<thinking><step1>\nThe question is asking which diagnostic method would be most helpful for examining a 10-year-old boy with symptoms like fever, red eyes, purulent discharge, and enlarged lymph nodes in the occipital area.\n</step1>\n<step2>\nThese symptoms suggest a possible infection or inflammatory condition — *àkóràn* or *ìfarapa*. The presence of purulent discharge indicates a bacterial infection, which is crucial to consider.\n</step2>\n<step3>\nAmong the options, a biopsy and Giemsa stain — *ìfẹ́ràn Giemsa* — can help identify specific cellular changes and infections, particularly in cases of suspected malignancy or chronic infection.\n</step3>\n<step4>\nHowever, the option that focuses on identifying pathogens — *ìgbẹ́kẹ̀lé àwọn kokoro arun* — is essential for diagnosing infections, especially in a child with these symptoms.\n</step4>\n<step5>\nKOH treatment is typically used for fungal infections, while patch tests and Gram stains are more for skin conditions and bacterial identification, respectively.\n</step6>\n<step6>\nThus, the most relevant choice for examining the underlying cause of the symptoms is the one that focuses on identifying pathogens.\n</step6></thinking>", "answer": "<answer>Ìgbẹ́kẹ̀lé àwọn kokoro arun ni yóò ṣe iranlọwọ jùlọ fún ṣíṣàyẹ̀wò àlàyé.</answer>", "language": "Yoruba"}
{"question": "Lallo, ọkunrin ọdun 25, fi irora, pupa ati omi ti o ti n jade kuro ni oju osi rẹ̀ han fun ọjọ́ kan sẹ́yìn.  A kò sì fẹ́ràn imọlẹ̀ sí.  Àyẹ̀wò tó gbọ́dọ̀ jẹ́ ni-\nA. Keratitis\nB.  Igbona ti iwaju uveitis\nC. Igbona ti ẹhin uveitis\nD. Glaucoma ti kò lágbára", "reasoning": "<thinking><step1>\nThe question describes a 25-year-old man, Lallo, who has symptoms of pain, redness, and discharge from his left eye for one day, and he is sensitive to light — *a sensitivity to light* indicates a potential eye condition.\n</step1>\n<step2>\nThe symptoms suggest an inflammatory process in the eye, which could be related to conditions like *keratitis* or *uveitis*.\n</step2>\n<step3>\nKeratitis involves inflammation of the cornea, often causing pain and redness, but the discharge is a key symptom that might not fit this condition perfectly.\n</step3>\n<step4>\nUveitis can be anterior or posterior; *anterior uveitis* typically presents with pain, redness, and photophobia — *sensibilité à la lumière* — which aligns with Lallo's symptoms.\n</step4>\n<step5>\nThe options include anterior uveitis (B) and posterior uveitis (C), but given the acute nature and the symptoms, anterior uveitis is more likely.\n</step6>\n<step6>\nGlaucoma (D) usually presents with different symptoms, such as severe headache and vision changes, which are not mentioned here.\n</step7>\n<step7>\nThus, the most fitting diagnosis for Lallo's symptoms is *igbona ti iwaju uveitis*.\n</step7></thinking>", "answer": "<answer>Igbona ti iwaju uveitis.</answer>", "language": "Yoruba"}
{"question": "Kini idi ti ko gbọdọ lo awọn oogun thrombolytic ni ọrọ ikọlu ọkan to nira ni apa iwaju?", "reasoning": "<thinking><step1>\nThe question asks: “Kini idi ti ko gbọdọ lo awọn [oogun thrombolytic = thrombolytic drugs] ni [ọrọ ikọlu ọkan to nira = severe heart attack] ni apa iwaju?” — meaning it wants to know why thrombolytic drugs should not be used in a severe heart attack in the front part of the heart.\n</step1>\n<step2>\nThrombolytic drugs are designed to dissolve blood clots — *wọn jẹ́ àpẹẹrẹ ti awọn oogun ti a lo lati fọ́ àkúnya ẹjẹ*.\n</step2>\n<step3>\nIn cases of a severe heart attack, especially in the anterior wall, there may be a risk of complications — *ìṣòro le dide* if the blood flow is not properly restored.\n</step3>\n<step4>\nUsing thrombolytics can lead to bleeding complications, particularly in the brain — *ìjẹ̀pàtàkì ni ọpọlọ* — which is a serious risk.\n</step4>\n<step5>\nAdditionally, if the heart muscle is already significantly damaged, thrombolytics may not be effective — *o le ma ṣiṣẹ́* as intended.\n</step5>\n<step6>\nTherefore, in severe anterior myocardial infarction, the risks outweigh the benefits of using thrombolytic therapy — *ìdí ni pé awọn ewu ju awọn anfani lọ*.\n</step6></thinking>", "answer": "<answer>Ko gbọdọ lo awọn oogun thrombolytic ni ọrọ ikọlu ọkan to nira ni apa iwaju nitori ewu ti ìjẹ̀pàtàkì ati aito ti iṣẹ́ wọn.</answer>", "language": "Yoruba"}
{"question": "Èwo nínú àwọn apá inú ètò ìdágìrì gbogboogbò ni àwọn oògùn afẹ́fẹ́ ìsúnrú tí ó máa ń rọ̀ kò pèsè?", "reasoning": "<thinking><step1>\nThe question asks: “Èwo nínú àwọn apá inú ètò ìdágìrì gbogboogbò ni àwọn oògùn afẹ́fẹ́ ìsúnrú tí ó máa ń rọ̀ kò pèsè?” — meaning it wants to know which parts of the overall respiratory system are affected by inhaled corticosteroids.\n</step1>\n<step2>\nInhaled corticosteroids are primarily used to reduce inflammation in the airways — *àwọn àtọ́ka afẹ́fẹ́* — which is crucial for managing conditions like asthma and COPD.\n</step2>\n<step3>\nThese medications work by targeting the bronchial tubes — *àwọn tube bronkial* — to decrease swelling and mucus production.\n</step3>\n<step4>\nWhen the airways are inflamed, it leads to symptoms such as wheezing and shortness of breath — *ìkànsí àti ìṣòro nípa afẹ́fẹ́*.\n</step4>\n<step5>\nInhaled corticosteroids help to restore normal airflow by reducing this inflammation, thus improving breathing — *ìmúra afẹ́fẹ́*.\n</step6>\n<step6>\nSo, the main parts affected are the bronchial tubes and the surrounding tissues in the lungs — *àwọn àyà*.\n</step7>\n<step8>\nIn summary, inhaled corticosteroids primarily target the airways to alleviate respiratory symptoms.\n</step8></thinking>", "answer": "<answer>Àwọn oògùn afẹ́fẹ́ ìsúnrú máa ń rọ̀ kò pèsè nípa dínkù ìkànsí nínú àwọn tube bronkial àti àwọn àyà.</answer>", "language": "Yoruba"}
{"question": "Ninu ayẹwo egungun kan ti o fihan awọn egungun trabeculae ti ko deede ati awọn sẹẹli apẹrẹ irawọ pẹlu awọn ilana cytoplasmic gigun ti o wa laarin lacunae, nipasẹ awọn ẹda wo ni paṣipaṣọ ounjẹ ati awọn ohun elo idoti laarin awọn osteocytes wọnyi ṣee ṣe julọ?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu ayẹwo egungun kan ti o fihan [trabecular bones = egungun trabeculae] ti ko deede ati [star-shaped cells = awọn sẹẹli apẹrẹ irawọ] pẹlu [long cytoplasmic processes = awọn ilana cytoplasmic gigun] ti o wa laarin [lacunae = lacunae], through which [nutrient exchange = paṣipaṣọ ounjẹ] and [waste removal = ohun elo idoti] among these [osteocytes = osteocytes] is most likely facilitated?” \n</step1>\n<step2>\nIn bone tissue, osteocytes are crucial for maintaining bone health — *wọn jẹ pataki fun itọju ilera egungun*. They reside in lacunae and have long processes that extend through tiny channels called canaliculi.\n</step2>\n<step3>\nThese processes allow for communication and nutrient exchange between osteocytes and the surrounding bone matrix — *paṣipaṣọ laarin awọn osteocytes ati matrix egungun*. \n</step4>\n<step4>\nThe trabecular bone structure provides a large surface area, enhancing the efficiency of nutrient and waste exchange — *iyẹn mu ki paṣipaṣọ ounjẹ ati idoti jẹ irọrun*.\n</step5>\n<step5>\nThus, the long cytoplasmic processes of osteocytes facilitate the transport of nutrients and waste products, ensuring that these cells remain healthy and functional — *nitorinaa, awọn ilana cytoplasmic gigun n ṣe iranlọwọ fun gbigbe awọn ounjẹ ati awọn ohun elo idoti*.\n</step6>\n<step6>\nIn summary, the trabecular bone structure and the star-shaped osteocytes with their long processes are essential for effective nutrient and waste exchange.\n</step6></thinking>", "answer": "<answer>Awọn ilana cytoplasmic gigun ti awọn osteocytes n ṣe iranlọwọ fun paṣipaṣọ ounjẹ ati idoti laarin wọn.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọjọ́ méjì tí a mú wá sí ọfiisi dokita ọmọdé pẹ̀lú ìtàn ìmí ti o ni oorun, ìgbàgbé ikùn, ati iya rẹ̀ ni a tọ́ka si polyhydramnios ṣaaju ìbí. A ṣe X-RAY, a fi han ni isalẹ, kini àìṣàn tí ó wọpọ̀ julọ tí ó ni nkan ṣe pẹlu rẹ̀?\nA. TRISOMY 13\nB. TRISOMY 15\nC. TRISOMY 18\nD. TRISOMY 21", "reasoning": "<thinking><step1>\nThe question translates to: \"A two-day-old baby brought to the pediatrician's office with a history of *ìmí ti o ni oorun* [breathing difficulties], *ìgbàgbé ikùn* [abdominal distension], and a reference to *polyhydramnios* [excess amniotic fluid] before birth. An X-ray shows findings below; what is the most common condition associated with this?\" \n</step1>\n<step2>\nIn this context, *polyhydramnios* can indicate potential congenital anomalies, which are often linked to chromosomal abnormalities — *awọn aipe chromosomal*.\n</step2>\n<step3>\nThe symptoms presented, such as breathing difficulties and abdominal distension, suggest possible serious conditions, including trisomy syndromes — *awọn ajẹsara trisomy*.\n</step4>\n<step4>\nAmong the options, Trisomy 21, also known as Down syndrome, is the most common chromosomal abnormality associated with such presentations — *Trisomy 21 ni aipe chromosomal ti o wọpọ jùlọ*.\n</step5>\n<step5>\nWhile Trisomy 13 and Trisomy 18 are also serious conditions, they are less common compared to Trisomy 21, especially in newborns with these symptoms — *Trisomy 13 ati Trisomy 18 jẹ́ aipe ti o nira, ṣugbọn wọn ko wọpọ bi Trisomy 21*.\n</step6>\n<step6>\nThus, considering the commonality and the symptoms, the most likely diagnosis is Trisomy 21.\n</step6></thinking>", "answer": "<answer>Trisomy 21 ni àìṣàn tí ó wọpọ̀ julọ tí ó ni nkan ṣe pẹlu rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Kini àwọn àpẹẹrẹ gidi ti àrùn quinsy nípa ìtọ́jú rẹ̀ àti bí ó ṣe máa ń hàn?", "reasoning": "<thinking><step1>\nThe question asks: “Kini àwọn àpẹẹrẹ gidi ti àrùn [quinsy = quinsy] nípa ìtọ́jú rẹ̀ àti bí ó ṣe máa ń hàn?” — meaning it wants to know real examples of quinsy in terms of its treatment and how it manifests.\n</step1>\n<step2>\nQuinsy, or *abscessus tonsillaris*, is a complication of tonsillitis where pus forms around the tonsils — *pusu ti wa ni ayika awọn tonsils*.\n</step2>\n<step3>\nSymptoms include severe throat pain, difficulty swallowing — *ìṣòro ni mimu*, and fever — *ìgbàgbọ́*.\n</step3>\n<step4>\nIn treatment, antibiotics are crucial — *antibiotics jẹ́ pataki* to fight the infection, and sometimes drainage of the abscess is necessary — *ìtọ́jú pusu*.\n</step5>\n<step5>\nPatients may also receive pain relief — *ìtura fun irora* and hydration — *mimu omi* to help with symptoms.\n</step6>\n<step6>\nSo, quinsy presents with intense throat pain and may require both medical and surgical interventions — *ìtọ́jú ilera àti iṣẹ́ abẹ́*.\n</step6></thinking>", "answer": "<answer>Àrùn quinsy hàn ní irora gíga ní ẹnu, àti ìtọ́jú rẹ̀ ni antibiotics, ìtọ́jú pusu, àti ìtura fun irora.</answer>", "language": "Yoruba"}
{"question": "Ọkùnrin ọmọ ọdún mẹ́ẹ̀ẹ́dógún kan wà, tí ara rẹ̀ ń fà á níbi kan, àti àwọn àṣìṣe oníyàrá pupa ní orí ikùn rẹ̀, àyà rẹ̀, àwọn ọwọ́ rẹ̀, àti isalẹ̀ ẹsẹ̀ rẹ̀, pẹ̀lú ìgbóná irúgbìn, àti àwọn àṣìṣe irun tí ó ga sókè, tí ó dà bí ewé ẹ̀gbà ní ayika agbó.  Nítorí àwọn àmì wọ̀nyí, ṣé ìwádìí ilé-iwosan wo ni ó gbọ́dọ̀ ṣe láti jẹ́ kí a mọ̀ pé kí a lè mọ̀ ohun tí àrùn náà jẹ́?", "reasoning": "<thinking><step1>\nThe question asks: \"What medical investigations should be conducted to determine the illness of a 14-year-old boy with symptoms like [ìgbóná irúgbìn = fever], [àṣìṣe oníyàrá pupa = red rashes], and other signs?\" \n</step1>\n<step2>\nFirst, we need to consider the symptoms: fever, rashes on the body, and possibly other systemic signs — *àwọn àmì àìlera* that could indicate an infection or allergic reaction.\n</step2>\n<step3>\nA complete blood count (CBC) would be essential to check for signs of infection — *àwọn àkópọ̀ ẹ̀jẹ̀* le fi hàn pé àrùn kan wà.\n</step3>\n<step4>\nAdditionally, skin tests or allergy tests might be necessary to rule out allergic reactions — *ìwádìí àrùn àìlera*.\n</step4>\n<step5>\nIf the rashes resemble *ewé ẹ̀gbà* (a type of plant), it could suggest a specific type of dermatitis, so a skin biopsy might be useful — *ìwádìí àyẹ̀wò irun*.\n</step6>\n<step7>\nFinally, imaging studies like a chest X-ray could help assess any underlying respiratory issues, especially if there are respiratory symptoms — *ìwádìí àyẹ̀wò àyà*.\n</step7></thinking>", "answer": "<answer>Ìwádìí ilé-iwosan tó yẹ kí a ṣe ni: àkópọ̀ ẹ̀jẹ̀, ìwádìí àrùn àìlera, àyẹ̀wò irun, àti àyẹ̀wò àyà.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 25 kan ni a mu wa si ẹka pajawiri iṣẹgun iṣẹgun ni iṣẹju 30 lẹhin ti o ti jamba pẹlu kẹkẹ ẹlẹṣin.  Kò fi àṣọ àbò orí sí.  Àyẹ̀wò ara rẹ̀ fi hàn pé ó ní ìgbẹ́ru lórí oju òsì rẹ̀.  Àyẹ̀wò CT ti ori rẹ̀ fi hàn pé egungun sphenoid òsì rẹ̀ ti fọ, tí ó sì n tẹ́ lorí àwọn iho òsì ti ó ga jùlọ.  Àyẹ̀wò ara ẹni náà yóò ṣeé ṣe kí ó fi hàn irú àwọn abajade wo ni ninu àwọn atẹle wọnyi?\nA. Ìdinku imọlara oorùn\nB. Ìgbona lórí ẹ̀yìn òsì\nC. Ìwòye òsì ẹgbẹ́ ti ó dára\nD. Ìkùnà ìgbona oju òsì", "reasoning": "<thinking><step1>\nThe question describes a 25-year-old man who was brought to the emergency department after a bicycle accident, without wearing a helmet. It mentions that he has tenderness on the left side of his face and a CT scan shows a fracture of the left sphenoid bone, which is pressing on the superior orbital fissure.\n</step1>\n<step2>\nGiven the injury, we need to consider the potential neurological effects due to the fracture. The sphenoid bone is crucial as it houses important structures, including cranial nerves and blood vessels — *àwọn nǹkan pataki*.\n</step2>\n<step3>\nThe left sphenoid fracture could lead to complications such as *ìkùnà ìgbona oju* (ocular dysfunction) because it affects the area around the eye, potentially impacting vision and eye movement.\n</step3>\n<step4>\nAdditionally, the pressure on the superior orbital fissure might cause symptoms like *ìdinku imọlara oorùn* (decreased sensation) in the distribution of the affected cranial nerves, particularly the trigeminal nerve.\n</step4>\n<step5>\nConsidering the options provided, *ìgbona lórí ẹ̀yìn òsì* (pain on the left side) could also be a symptom, but it is less specific to the fracture's direct effects compared to the other options.\n</step5>\n<step6>\nUltimately, the most likely outcomes from the CT findings would be *ìkùnà ìgbona oju* and *ìdinku imọlara oorùn*, but the most direct consequence of the fracture pressing on the fissure is likely to be ocular dysfunction.\n</step6></thinking>", "answer": "<answer>Ìkùnà ìgbona oju òsì.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 61 kan wá pẹlu ọ̀rọ̀ tí ó ṣòro láti gbọ́ àti ìṣòro sísọ gbólóhùn pípé, ṣugbọn ó lè lóye ohun gbogbo tí a sọ fún un, ó sì lè tun gbólóhùn sọ láìṣòro.  Itan ìṣòro ìlera rẹ̀ pẹlu àtìgbàgbọ́ ẹ̀jẹ̀ gíga, ìwọ̀n òróró ẹ̀jẹ̀ gíga, itan ìmu siga ọdún 25, àti lílo ọtí líle déédéé. Nígbà àyẹ̀wò, ó dúró nígbà tí ó ń sọ̀rọ̀ fúnra rẹ̀, ó sì fi hàn pé irú aphasia kan ni.  Nígbà tí a bá gbé àwọn ìwàdíí yìí yẹ̀wò, ní ipin irú ẹ̀jẹ̀ wo ni ó ṣeé ṣe kí infarct ṣẹlẹ̀ sí i jùlọ?", "reasoning": "<thinking><step1>\nThe question is asking about the type of blood vessel condition that could lead to an infarct in a 61-year-old man with hearing difficulties and speech issues, specifically mentioning *aphasia*.\n</step1>\n<step2>\nGiven his medical history of *hypertension* (àtìgbàgbọ́ ẹ̀jẹ̀ gíga) and *hyperlipidemia* (ìwọ̀n òróró ẹ̀jẹ̀ gíga), these are significant risk factors for vascular problems.\n</step2>\n<step3>\nInfarcts typically occur due to blockages in blood vessels, often from *thrombosis* or *embolism* — *ìdípa ẹ̀jẹ̀* or *ìkó ẹ̀jẹ̀*.\n</step3>\n<step4>\nConsidering his history of smoking (*imu siga*) and heavy alcohol use (*lilo ọtí líle*), these habits can exacerbate vascular issues, increasing the likelihood of an infarct.\n</step4>\n<step5>\nThe type of blood vessel most likely affected would be the *arteries* (àwọn àtọ́run) supplying the brain, leading to a *cerebral infarct* (infarct ọpọlọ).\n</step5>\n<step6>\nThus, the combination of his medical history and lifestyle factors suggests that a *cerebral infarct* is the most probable type of infarct he could experience.\n</step6></thinking>", "answer": "<answer>Infarct ọpọlọ ni irú ẹ̀jẹ̀ tí ó ṣeé ṣe kí ó ṣẹlẹ̀ sí i jùlọ.</answer>", "language": "Yoruba"}
{"question": "Ọmọbìnrin ọdun mẹrindilogun kan ti n lo oogun idiwo-àrùn-àìlera-ẹ̀dà fun itọju awọn àrùn ikọlu-ẹ̀dà ti o ń ṣẹlẹ̀ lakoko oorun. Ko ti ní ikọlu eyikeyi fun oṣu mẹfa to koja. NCCT ati EEG jẹ deede. Kini iṣakoso siwaju?\nA. Dákẹ́ itọju\nB. Tẹsiwaju fun ọdun meji\nC. Itọju igbesi aye gbogbo\nD. Dákẹ́ itọju ki o si tẹle pẹlu EEG ni oṣu mẹfa ni ẹẹkan", "reasoning": "<thinking><step1>\nThe question is asking about the management plan for a 16-year-old girl who has been on antiepileptic medication for seizures occurring during sleep and has not had a seizure for the past six months. Key terms include [oogun idiwo-àrùn-àìlera-ẹ̀dà = antiepileptic medication] and [àrùn ikọlu-ẹ̀dà = seizure disorder].\n</step1>\n<step2>\nSince she has been seizure-free for six months, it raises the question of whether to continue treatment or consider tapering off the medication — *dákẹ́ itọju*.\n</step2>\n<step3>\nThe standard practice often involves evaluating the patient's history and EEG results, which are normal in this case — *NCCT ati EEG jẹ deede*.\n</step4>\n<step4>\nIn many cases, if a patient has been seizure-free for a significant period, a gradual reduction of medication may be appropriate — *tẹsiwaju fun ọdun meji* could be an option, but it depends on individual circumstances.\n</step5>\n<step5>\nHowever, lifelong treatment may be recommended for some patients, especially if there are risk factors for recurrence — *itọju igbesi aye gbogbo* might be considered if there are concerns about future seizures.\n</step6>\n<step6>\nGiven the context, the most reasonable approach would be to taper the medication and follow up with EEG in six months — *dákẹ́ itọju ki o si tẹle pẹlu EEG ni oṣu mẹfa ni ẹẹkan*.\n</step7></thinking>", "answer": "<answer>Dákẹ́ itọju ki o si tẹle pẹlu EEG ni oṣu mẹfa ni ẹẹkan.</answer>", "language": "Yoruba"}
{"question": "Kí ni orukọ tí a fi npè àìlera ìkún ọgbẹ́ tí ó fa kí àìsàn náà ṣe atúnṣe ọgbẹ́ rẹ̀ sí ìbàṣepọ̀ àìlóòótọ́ ti maxilla sí mandible kí ó lè ní iṣẹ́ ṣíṣe mastication tí ó dára?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni orukọ tí a fi npè àìlera ìkún ọgbẹ́ tí ó fa kí àìsàn náà ṣe atúnṣe ọgbẹ́ rẹ̀ sí ìbàṣepọ̀ àìlóòótọ́ ti maxilla sí mandible?” — meaning it wants to know the name of a condition that affects the relationship between the maxilla and mandible, impacting mastication.\n</step1>\n<step2>\nThis condition is often referred to as *malocclusion*, which occurs when the upper jaw (maxilla) and lower jaw (mandible) do not align properly.\n</step2>\n<step3>\nMalocclusion can lead to difficulties in chewing — *ìṣòro ní mímu onjẹ* — and can cause pain or discomfort in the jaw.\n</step3>\n<step4>\nIn dental terms, this misalignment can result from various factors, including genetics or developmental issues — *ìdí tí a fi le ní àìlera yìí*.\n</step4>\n<step5>\nTreatment options may include orthodontics — *ìtọ́jú ẹ̀dá-èdá* — to correct the alignment and improve mastication function.\n</step5>\n<step6>\nSo, the name of the condition affecting the relationship between the maxilla and mandible is *malocclusion*.\n</step6></thinking>", "answer": "<answer>Orukọ àìlera yìí ni *malocclusion*.</answer>", "language": "Yoruba"}
{"question": "Okunrin ọdun 30 kan ní cholesteatoma attics ti eti osi pẹlu thrombophlebitis sinus ẹgbẹ.  Ewo ninu awọn wọnyi yoo jẹ iṣẹ abẹ ti a yan\nA. Mastoidectomy odi ikan\nB. Mastoidectomy pẹlu obliteration agbegbe\nC. Mastoidectomy ti o rọrun pẹlu Tympanoplasty\nD. Mastoidectomy odi isalẹ", "reasoning": "<thinking><step1>\nThe question asks: “Okunrin ọdun 30 kan ní [cholesteatoma = cholesteatoma] attics ti eti osi pẹlu [thrombophlebitis = thrombophlebitis] sinus ẹgbẹ” — meaning it describes a 30-year-old man with a cholesteatoma in the attic of the left ear and associated thrombophlebitis of the lateral sinus.\n</step1>\n<step2>\nIn cases of cholesteatoma, surgical intervention is often necessary to remove the growth and prevent complications — *iyẹwo abẹ jẹ pataki lati yago fun awọn iṣoro*.\n</step2>\n<step3>\nThe options provided include different types of mastoidectomy, which is a common procedure for addressing cholesteatoma — *mastoidectomy ni a lo lati mu cholesteatoma ṣiṣẹ*.\n</step3>\n<step4>\nConsidering the presence of thrombophlebitis, a more extensive approach may be required to ensure complete removal and manage any potential complications — *iyẹwo abẹ ti o ni ilọsiwaju le jẹ dandan*.\n</step4>\n<step5>\nOption A, *Mastoidectomy odi ikan*, is less comprehensive, while option B, *Mastoidectomy pẹlu obliteration agbegbe*, suggests a more thorough approach that could address the cholesteatoma effectively.\n</step5>\n<step6>\nOption C, *Mastoidectomy ti o rọrun pẹlu Tympanoplasty*, may not adequately address the thrombophlebitis, and option D, *Mastoidectomy odi isalẹ*, might not be sufficient either.\n</step6>\n<step7>\nThus, the most appropriate choice considering the complexity of the case is option B, which allows for both removal of the cholesteatoma and management of the sinus condition — *iyẹwo abẹ yii ni a yan fun itọju to peye*.\n</step7></thinking>", "answer": "<answer>Mastoidectomy pẹlu obliteration agbegbe ni a yan fun itọju cholesteatoma ati thrombophlebitis sinus.</answer>", "language": "Yoruba"}
{"question": "Iye iwọn apapọ ìwọn àwọn ọmọkunrin mẹwa kan ni a ti kà sí 18.2 kg ní àkọ́kọ́.  Ṣùgbọ́n, a rí i lẹ́yìn náà pé ìwọn ọmọkunrin kan ni a kọ̀wé sí ní 2.0 kg dípò ìwọn gidi rẹ̀ tí í ṣe 20 kg.  Ka ìwọn apapọ̀ gidi àwọn ènìyàn náà.", "reasoning": "<thinking><step1>\nThe question asks: \"Iye iwọn apapọ ìwọn [average weight] àwọn ọmọkunrin mẹwa kan ni a ti kà sí 18.2 kg\" — meaning it wants to find the true average weight after correcting one boy's weight.\n</step1>\n<step2>\nInitially, the average weight of ten boys is calculated as 18.2 kg, which means the total weight is 10 times 18.2 kg — *iyẹn jẹ́ 182 kg*.\n</step2>\n<step3>\nHowever, one boy's weight was recorded incorrectly as 2.0 kg instead of his actual weight of 20 kg — *iyẹn túmọ̀ sí pé a ti kà 18 kg kéré ju*.\n</step3>\n<step4>\nTo find the correct total weight, we need to adjust the total by adding the difference: 20 kg - 2.0 kg = 18 kg — *nítorí náà, a máa fi 18 kg kun*.\n</step4>\n<step5>\nNow, the corrected total weight becomes 182 kg + 18 kg = 200 kg — *iyẹn ni 200 kg gidi*.\n</step6>\n<step6>\nFinally, to find the new average weight, we divide the corrected total weight by the number of boys: 200 kg ÷ 10 = 20 kg — *nítorí náà, iwọn apapọ̀ gidi ni 20 kg*.\n</step6></thinking>", "answer": "<answer>Iwọn apapọ̀ gidi àwọn ọmọkunrin mẹwa náà ni 20 kg.</answer>", "language": "Yoruba"}
{"question": "Loretta Gould ń ṣe àṣàyàn láàrin àwọn ọ̀nà ìsanwó meji fún ipò amòye títà ní Houston Oil Company. Nínú àṣàyàn àkọ́kọ́, ó gbà ẹ̀sanwó ẹgbẹ̀rún mẹ́jọ ($8,000) àti iye owó tí ó jẹ́ ìdá ọgọ́rùn-ún kan (1%) ti àwọn ohun tí ó ta, tí a ṣe ìṣiro pé ó jẹ́ ẹgbẹ̀rún mẹ́jọ (80,000) ní ọdún àkọ́kọ́. Nínú àṣàyàn keji, ó gbà ẹ̀sanwó ẹgbẹ̀rún márùn-ún àti ẹgbẹ̀ta ọgọ́rùn-ún mẹ́jọ ($5,800) àti iye owó tí ó jẹ́ ìdá ọgọ́rùn-ún márùn-ún (5%) lórí àwọn ohun tí ó ta tí ó ju ẹgbẹ̀rún mẹ́tadinlọ́gọ́rin ($30,000) lọ. Àṣàyàn ìsanwó wo ni ó dára jù, tí ó sì ju èkejì lọ ní bí?", "reasoning": "<thinking><step1>\nThe question asks: \"Loretta Gould is choosing between two payment options for a sales manager position at Houston Oil Company.\" It provides two options with specific salaries and commission structures.\n</step1>\n<step2>\nIn the first option, she receives a salary of $8,000 and a commission of 1% on sales, which is projected to be $80,000 in the first year. So, the commission would be *0.01 × 80,000 = $800*.\n</step2>\n<step3>\nAdding the salary and commission for the first option gives: *$8,000 + $800 = $8,800*.\n</step3>\n<step4>\nIn the second option, she has a salary of $5,800 and a commission of 5% on sales exceeding $30,000. If we assume sales are $80,000 again, the commission would be calculated on the amount over $30,000, which is $50,000.\n</step4>\n<step5>\nThus, the commission for the second option is *0.05 × 50,000 = $2,500*. Adding this to her salary gives: *$5,800 + $2,500 = $8,300*.\n</step5>\n<step6>\nComparing both options, $8,800 from the first option is greater than $8,300 from the second option, making the first option more favorable.\n</step6></thinking>", "answer": "<answer>Àṣàyàn ìsanwó àkọ́kọ́ ni ó dára jù, pẹ̀lú $8,800.</answer>", "language": "Yoruba"}
{"question": "Ṣe àtúnṣe Laplace ti fúnṣọ̀n F(s) = [(2s^2 - 4) / {(s - 2)(s + 1)(s - 3)}] kọ́?", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe àtúnṣe Laplace ti fúnṣọ̀n F(s) = [(2s^2 - 4) / {(s - 2)(s + 1)(s - 3)}] kọ́?” — meaning it wants to know if the Laplace transform of the function F(s) is correct.\n</step1>\n<step2>\nTo determine this, we first need to analyze the function F(s) — *fúnṣọ̀n* means function in Yoruba.\n</step2>\n<step3>\nThe expression consists of a polynomial in the numerator, *2s^2 - 4*, and a product of linear factors in the denominator, *{(s - 2)(s + 1)(s - 3)}*.\n</step3>\n<step4>\nWe can simplify the numerator: *2s^2 - 4* can be factored as *2(s^2 - 2)*, which is useful for partial fraction decomposition.\n</step4>\n<step5>\nNext, we apply the method of partial fractions to express F(s) in a form suitable for inverse transformation — *àtúnṣe àkópọ̀*.\n</step5>\n<step6>\nAfter decomposition, we can find the inverse Laplace transform of each term separately, which will give us the time-domain function.\n</step6>\n<step7>\nThus, the Laplace transform is valid, and we can proceed with the calculations to find the time-domain representation.\n</step7></thinking>", "answer": "<answer>Bẹẹni, àtúnṣe Laplace ti fúnṣọ̀n F(s) jẹ́ tọ́.</answer>", "language": "Yoruba"}
{"question": "Ọmọbirin kan ń ṣe àìsàn, ó ní ìṣòro ìgbànà (melena) àti àwọn àmì òun rere lórí ẹnu àti ètè rẹ̀. Ẹgbọn méjì rẹ̀ sì ti ní irú àwọn àmì náà rí. Bí a bá gbàgbé irú àwọn àmì náà àti ìtàn ìdílé rẹ̀ yìí, kí ni ìwádìí tó gbàgbọ̀ jùlọ?", "reasoning": "<thinking><step1>\nThe question translates to: \"A girl is ill, she has a problem with [melena = melena] and signs of good health on her mouth and her stool. Her two siblings have also had similar signs. If we forget these signs and her family history, what is the most likely diagnosis?\" \n</step1>\n<step2>\nMelena refers to black, tarry stools indicating gastrointestinal bleeding — *ìkó ẹjẹ nínú etí* or upper GI issues. \n</step2>\n<step3>\nGiven that her siblings have experienced similar symptoms, this suggests a possible genetic or familial condition — *àìsàn ìdílé* that could predispose them to gastrointestinal issues.\n</step3>\n<step4>\nThe presence of good health signs in her mouth and stool indicates that while she has melena, she may not be in acute distress — *kò ní ìṣòro tó lágbára* at the moment.\n</step5>\n<step5>\nConsidering these factors, the most likely diagnosis could be a condition like *peptic ulcer disease* or *gastrointestinal bleeding* from a less severe source, rather than something immediately life-threatening.\n</step6>\nThus, the diagnosis should focus on the gastrointestinal tract, particularly conditions that cause melena without severe systemic symptoms.\n</step6></thinking>", "answer": "<answer>Ìwádìí tó gbàgbọ̀ jùlọ ni àìsàn àtọgbẹ́ tàbí ìkó ẹjẹ nínú etí.</answer>", "language": "Yoruba"}
{"question": "Kí ni a ń pè nígbà tí ènìyàn bá dá ìmọ̀ràn lóòótọ́, ṣùgbọ́n ó fi ọ̀pọ̀lọpọ̀ àti àwọn àlàyé tí kò ṣe pàtàkì kún un kí ó tó dé ọ̀rọ̀ pàtàkì náà?", "reasoning": "<thinking><step1>\nThe question asks: “Kí ni a ń pè nígbà tí ènìyàn bá dá ìmọ̀ràn lóòótọ́, ṣùgbọ́n ó fi ọ̀pọ̀lọpọ̀ àti àwọn àlàyé tí kò ṣe pàtàkì kún un kí ó tó dé ọ̀rọ̀ pàtàkì náà?” — meaning it wants to know what we call a situation where someone gives true advice but includes a lot of unnecessary details before getting to the main point.\n</step1>\n<step2>\nThis situation can be described as *tẹ́lẹ̀ àlàyé* or *over-explaining*, where the speaker provides excessive information — *ìmọ̀ràn tó pọ̀ ju* — that distracts from the core message.\n</step2>\n<step3>\nIn English, we might refer to this as “beating around the bush” — *kí a má ba àdúrà mu* — which means avoiding the main topic by talking about irrelevant details.\n</step3>\n<step4>\nIn Yoruba, one might say: “Ó ń fi *ìtàn àlàyé* kún un, tó fi jẹ́ pé a kò rí i dájú pé a ti mọ̀ ohun tó ṣe pàtàkì.”\n</step4>\n<step5>\nThis can lead to confusion or frustration for the listener, as they may struggle to identify the key point — *ọ̀rọ̀ pàtàkì* — amidst all the extra information.\n</step6>\n<step6>\nThus, we can conclude that this phenomenon is often referred to as *ìtàn àlàyé tó pọ̀* or simply *over-explaining*.\n</step6></thinking>", "answer": "<answer>A ń pè é ní ìtàn àlàyé tó pọ̀.</answer>", "language": "Yoruba"}
{"question": "Ní ìbámu pẹ̀lú àyẹ̀wò histological àti àbàwọ́n immunohistochemical fún CD117 tí a fihàn nínú àwọn àwòrán, kí ni ìdámọ̀ àìsàn (pathological diagnosis) tí ó ṣeéṣe jùlọ?", "reasoning": "<thinking><step1>\nThe question asks: “Ní ìbámu pẹ̀lú àyẹ̀wò histological àti àbàwọ́n immunohistochemical fún CD117” — meaning it is inquiring about the pathological diagnosis most likely indicated by histological examination and immunohistochemical staining for CD117.\n</step1>\n<step2>\nCD117, also known as c-KIT, is a receptor tyrosine kinase that is often expressed in certain tumors — *àwọn àkóónú kan* like gastrointestinal stromal tumors (GISTs).\n</step2>\n<step3>\nIn histological analysis, the presence of CD117 can indicate the proliferation of neoplastic cells — *ìdàgbàsókè àwọn sẹẹli neoplastic*.\n</step3>\n<step4>\nWhen evaluating tissue samples, a positive CD117 staining suggests a diagnosis of GIST, which is characterized by *ìfarapa ti awọn sẹẹli interstitial ti Cajal*.\n</step4>\n<step5>\nOther conditions may express CD117, but GIST is the most common association — *ìbáṣepọ̀ tó wọpọ jùlọ* with this marker.\n</step5>\n<step6>\nThus, the pathological diagnosis most likely indicated by positive CD117 staining is GIST — *àìsàn GIST*.\n</step6></thinking>", "answer": "<answer>Àìsàn GIST ni ìdámọ̀ àìsàn tí ó ṣeéṣe jùlọ pẹ̀lú àbàwọ́n immunohistochemical fún CD117.</answer>", "language": "Yoruba"}
{"question": "Gẹgẹ́ bí ọ̀rọ̀ Sókrátéèsì, èéṣe ti ó fi ṣe pàtàkì láti mọ ohun tó mú iṣẹ́ kan ṣe pàtàkì, gẹ́gẹ́ bí iṣẹ́ àánú tàbí iṣẹ́ òdodo, irú iṣẹ́ tí ó jẹ́?", "reasoning": "<thinking><step1>\nThe question asks: “Gẹgẹ́ bí ọ̀rọ̀ Sókrátéèsì, èéṣe ti ó fi ṣe pàtàkì láti mọ ohun tó mú iṣẹ́ kan ṣe pàtàkì?” — meaning it wants to understand why it is important to know what makes a certain action significant, such as a noble act or a just act.\n</step1>\n<step2>\nIn philosophy, particularly in the context of Sókrátéèsì (Socratic thought), understanding the essence of an action is crucial for ethical reasoning — *ìmọ̀ nípa ìtàn iṣẹ́ kan* helps in discerning its moral value.\n</step2>\n<step3>\nFor instance, an act of kindness — *iṣẹ́ àánú* — is significant because it promotes well-being and fosters community, while a just act — *iṣẹ́ òdodo* — upholds fairness and equality.\n</step3>\n<step4>\nSókrátéèsì emphasized that knowledge leads to virtue; thus, knowing the importance of actions helps individuals make better choices — *yíyàn iṣẹ́ tó dára*.\n</step4>\n<step5>\nMoreover, understanding the motivations behind actions allows for deeper reflection on one's character and intentions — *ìtàn àtinúdá*.\n</step5>\n<step6>\nIn summary, knowing what makes an action significant is essential for ethical living and personal growth — *ìdàgbàsókè ẹni*.\n</step6></thinking>", "answer": "<answer>Ó ṣe pàtàkì láti mọ ohun tó mú iṣẹ́ kan ṣe pàtàkì nítorí pé ó ràn wa lọ́wọ́ láti ṣe àṣeyọrí ìwà rere àti ìdàgbàsókè ẹni.</answer>", "language": "Yoruba"}
{"question": "Ninu ọ̀rọ̀ ìgbọ̀ràn-etí tí kò dára nítorí àrùn àìsàn, nínú àwọn ọmọdé tí wọ́n ní àrùn meningitis tí àkójọpọ̀ bàkitéríà fa, báwo ni àkókò tí a fi bẹ̀rẹ̀ sí í lo oògùn gbígbẹ̀mí ṣe nípa lórí bí ìgbọ̀ràn-etí kò dára ṣe máa ń pọ̀ sí i?", "reasoning": "<thinking><step1>\nThe question asks: “In cases of poor hearing due to bacterial meningitis in children, how does the timing of starting treatment with corticosteroids affect the worsening of hearing?” — it focuses on the relationship between treatment timing and hearing impairment.\n</step1>\n<step2>\nBacterial meningitis can lead to complications like hearing loss — *ìgbọ̀ràn-etí kò dára* — due to inflammation and damage to the auditory pathways.\n</step2>\n<step3>\nStarting corticosteroids early can reduce inflammation — *ìdinku ìfarapa* — which may help preserve hearing function.\n</step4>\n<step4>\nResearch indicates that the sooner treatment begins, the better the outcomes; delayed treatment can lead to more severe hearing loss — *ìgbọ̀ràn-etí ti o buru jù*.\n</step5>\n<step5>\nIn summary, timely administration of corticosteroids is crucial; it can mitigate the risk of worsening hearing impairment in children with meningitis.\n</step6></thinking>", "answer": "<answer>Àkókò tí a fi bẹ̀rẹ̀ sí í lo oògùn gbígbẹ̀mí ṣe pàtàkì, nítorí pé ó lè dinku ìfarapa àti ìbáṣepọ̀ rẹ̀ pẹ̀lú ìgbọ̀ràn-etí kò dára.</answer>", "language": "Yoruba"}
{"question": "Ninì ṣiṣe-ọ̀rọ̀ alkylation benzene pẹ̀lù ethylene, èéṣe ti kataliti MFI-irú fi ń fi hàn sí ọ̀nà tí ó ga jù sí hydrocarbon C8 ju awọn kataliti asiti homogeni lọ?", "reasoning": "<thinking><step1>\nThe question asks: “Ninì ṣiṣe-ọ̀rọ̀ [alkylation = alkylation] benzene pẹ̀lù [ethylene = ethylene], èéṣe ti [kataliti = catalyst] MFI-irú fi ń fi hàn sí ọ̀nà tí ó ga jù sí [hydrocarbon = hydrocarbon] C8 ju [kataliti asiti homogeni = homogeneous acid catalysts] lọ?” — meaning it wants to know why MFI-type catalysts show higher selectivity for C8 hydrocarbons in the alkylation of benzene with ethylene compared to homogeneous acid catalysts.\n</step1>\n<step2>\nAlkylation of benzene with ethylene involves the formation of larger hydrocarbons — *hydrocarbures plus grands* — through a reaction that can be influenced by the type of catalyst used.\n</step2>\n<step3>\nMFI-type catalysts, which are zeolite-based, provide a unique pore structure that favors the formation of specific products — *produits spécifiques* — like C8 hydrocarbons.\n</step3>\n<step4>\nIn contrast, homogeneous acid catalysts tend to produce a broader range of products, leading to less selectivity — *moins de sélectivité* — for the desired C8 hydrocarbons.\n</step4>\n<step5>\nThe shape-selective nature of MFI catalysts allows for better control over the reaction pathways, thus enhancing the yield of C8 hydrocarbons — *rendement des hydrocarbures C8*.\n</step5>\n<step6>\nTherefore, the higher selectivity of MFI-type catalysts in this reaction can be attributed to their unique structural properties and the ability to direct the reaction towards specific products.\n</step6></thinking>", "answer": "<answer>Kataliti MFI-irú ni ànfààní àtọkànwá ti o mu ki wọn ni àṣeyọrí to ga jùlọ ni iṣelọpọ hydrocarbon C8 nigba ṣiṣe-ọ̀rọ̀ alkylation benzene pẹ̀lù ethylene.</answer>", "language": "Yoruba"}
{"question": "Kini awọn ẹya pataki ti a ṣakiyesi ninu ikọlu AV ipele keji nipa apẹrẹ adaṣe ventricular, iyara atrial ti a fi wé iyara ventricular, ati akoko itọsọna AV?", "reasoning": "<thinking><step1>\nThe question asks: “Kini awọn ẹya pataki ti a ṣakiyesi ninu ikọlu AV ipele keji?” — meaning it wants to know the key features observed in second-degree AV block.\n</step1>\n<step2>\nIn a second-degree AV block, there are two main types: *Mobitz type I* and *Mobitz type II*. The distinction is crucial for understanding the condition.\n</step2>\n<step3>\nOne key feature is the *apẹrẹ adaṣe ventricular* — the pattern of ventricular contraction. In Mobitz type I, the ventricular rate may vary, while in Mobitz type II, it remains more consistent.\n</step3>\n<step4>\nAnother important aspect is the *iyara atrial ti a fi wé iyara ventricular* — the relationship between atrial and ventricular rates. In type I, the atrial rate is usually faster than the ventricular rate, leading to dropped beats.\n</step4>\n<step5>\nFinally, the *akoko itọsọna AV* — the AV conduction time — is significant. In type I, this interval progressively lengthens before a dropped beat, while in type II, it remains constant until a beat is dropped.\n</step5>\n<step6>\nThus, the key features include the pattern of ventricular contraction, the relationship between atrial and ventricular rates, and the AV conduction time.\n</step6></thinking>", "answer": "<answer>Awọn ẹya pataki ti ikọlu AV ipele keji ni apẹrẹ adaṣe ventricular, iyara atrial ti a fi wé iyara ventricular, ati akoko itọsọna AV.</answer>", "language": "Yoruba"}
{"question": "Salli duro ni ila. Ila naa lọra gidigidi. Kini o n riri?\nA. ibanujẹ\nB. idaduro\nC. ibinu\nD. tite siwaju\nE. ilọsiwaju", "reasoning": "<thinking><step1>\nThe question translates to: \"Salli is feeling very [ila = sad]. What is she experiencing?\" — indicating that we need to identify the emotion associated with feeling sad.\n</step1>\n<step2>\nFeeling sad often relates to emotional distress — *ibanujẹ* — which can manifest in various ways.\n</step2>\n<step3>\nIn this context, *ila* suggests a deep sense of sorrow, which aligns closely with *ibanujẹ*.\n</step3>\n<step4>\nOther options like *idaduro* (stagnation) or *ibinu* (anger) do not fit the emotional state of sadness.\n</step4>\n<step5>\nThe remaining options, *tite siwaju* (moving forward) and *ilọsiwaju* (progress), imply positive feelings, which contradict the notion of being sad.\n</step5>\n<step6>\nThus, the most appropriate answer that corresponds to Salli's feeling of sadness is *ibanujẹ*.\n</step6></thinking>", "answer": "<answer>Ibanujẹ</answer>", "language": "Yoruba"}
{"question": "Iṣẹ abẹrẹ wo ni a kò ka si ẹ̀rí-ìdásílẹ̀ fún iṣakoso àrùn ìgbìgbẹ́ òfúrufú tó lewu?", "reasoning": "<thinking><step1>\nThe question asks: “Iṣẹ abẹrẹ wo ni a kò ka si ẹ̀rí-ìdásílẹ̀ fún iṣakoso àrùn ìgbìgbẹ́ òfúrufú tó lewu?” — meaning it wants to know which vaccine is not considered evidence-based for managing severe asthma.\n</step1>\n<step2>\nIn the context of asthma management, vaccines can play a role, but not all are effective — *kò gbogbo abẹrẹ ni a ṣe àfihàn pé wọn jẹ́ doko*.\n</step2>\n<step3>\nFor severe asthma, the focus is often on treatments like corticosteroids and bronchodilators, rather than vaccines — *àwọn itọju bíi corticosteroids ni a máa n lo*.\n</step3>\n<step4>\nOne vaccine that is sometimes discussed is the influenza vaccine, but it is not specifically for asthma management — *abẹrẹ influenza kò jẹ́ àfihàn doko fún iṣakoso àrùn ìgbìgbẹ́*.\n</step5>\n<step5>\nIn fact, the primary concern is that some vaccines may not provide direct benefits for asthma control — *àwọn abẹrẹ kan lè ma ni anfani taara fún iṣakoso àrùn*.\n</step6>\n<step6>\nThus, the vaccine that is not considered evidence-based for managing severe asthma is the influenza vaccine.\n</step6></thinking>", "answer": "<answer>Abẹrẹ influenza ni a kò ka si ẹ̀rí-ìdásílẹ̀ fún iṣakoso àrùn ìgbìgbẹ́ òfúrufú tó lewu.</answer>", "language": "Yoruba"}
{"question": "Kini idi ti o ṣeé ṣe julọ ti àìsàn ọgbẹ̀ tó wà ní ẹsẹ̀ òsì ọkùnrin ọdún mẹ́tálélógún kan tí ó ṣẹ̀ṣẹ̀ lọ sí etíkun òkun?", "reasoning": "<thinking><step1>\nThe question asks: “Kini idi ti o ṣeé ṣe julọ ti àìsàn ọgbẹ̀ [wound infection] tó wà ní ẹsẹ̀ òsì [left leg] ọkùnrin [man] ọdún mẹ́tálélógún [thirteen years] kan tí ó ṣẹ̀ṣẹ̀ lọ sí etíkun òkun [recently went to the beach]?” — meaning it wants to know the most likely cause of a wound infection in this context.\n</step1>\n<step2>\nA wound infection can occur due to exposure to bacteria, especially in environments like the beach — *etíkun* where sand and water may harbor pathogens.\n</step2>\n<step3>\nIn this case, the man might have sustained a cut or scrape on his left leg while playing or walking on the beach — *nígbà tí ó nṣeré tabi rìn*.\n</step3>\n<step4>\nIf the wound was not properly cleaned, *ti a kò bá fọ́ ọ́ dáadáa*, bacteria can enter and cause an infection.\n</step4>\n<step5>\nCommon symptoms of a wound infection include redness, swelling, and pus — *ìfarapa, ìkó, àti ìkópa*.\n</step5>\n<step6>\nAdditionally, the warm and humid environment of the beach can promote bacterial growth — *àwọn àyíká gbona àti ìkó*.\n</step6>\n<step7>\nThus, the most likely cause of the wound infection is a combination of exposure to bacteria from the beach and inadequate wound care.\n</step7></thinking>", "answer": "<answer>Idi ti àìsàn ọgbẹ̀ náà jẹ́ àkúnya ti àkúnya àtọkànwá àti àìfọ́ àìlera tó péye.</answer>", "language": "Yoruba"}
{"question": "Kini yoo tẹle fun Angelina Jolie?\nA. Emi kò ní ìmọ̀.\nB. Angelina Jolie yoo ṣere ninu \"The Tourist\".\nC. Angelina Jolie yoo fẹ Brad Pitt.\nD. Angelina Jolie yoo ṣere ninu \"Tomb Raider\".\nE. Angelina Jolie yoo ṣere ninu \"Salt\".", "reasoning": "<thinking><step1>\nThe question asks: “Kini yoo tẹle fun Angelina Jolie?” which translates to \"What will happen next for Angelina Jolie?\".\n</step1>\n<step2>\nTo answer this, we need to consider her recent projects and public appearances — *awọn iṣẹ́ rẹ̀ tuntun*.\n</step2>\n<step3>\nAngelina Jolie is known for her roles in various films, including *Tomb Raider* and *Salt*, which are significant in her career.\n</step3>\n<step4>\nAmong the options provided, \"The Tourist\" is a film she starred in, but it was released earlier, so it may not be the next project.\n</step4>\n<step5>\nThe option mentioning her relationship with Brad Pitt is more about her personal life, which may not directly relate to her upcoming projects.\n</step5>\n<step6>\nConsidering her filmography, *Salt* is a notable film, but it was released in 2010, so it’s not a current project either.\n</step7>\n<step7>\nThus, the most relevant option that aligns with her recent work is that she will star in \"The Tourist,\" as it is a film she has already been associated with.\n</step8></thinking>", "answer": "<answer>Angelina Jolie yoo ṣere ninu \"The Tourist\".</answer>", "language": "Yoruba"}
{"question": "Ọmọbirin ọdun mẹrindilogun kan ti o ti n mu oogun fun irora fún ọdun meji sẹhin ni a ti rí pẹlu awọ bulu-dudu lori awọn eekanna rẹ.  Oogun wo ni o ṣeese jẹ́  ẹ̀bi fún awọ yii?", "reasoning": "<thinking><step1>\nThe question asks: “What medication is likely responsible for the blue-black discoloration on the fingers of a 16-year-old girl who has been taking pain medication for the past two years?” — here, *awọ bulu-dudu = blue-black discoloration* and *oogun fun irora = pain medication*.\n</step1>\n<step2>\nCertain medications can cause skin discoloration as a side effect — *awọn oogun kan le fa iyipada awọ bi abajade*.\n</step3>\n<step3>\nFor instance, drugs like *minocycline* are known to cause a blue-black pigmentation — *pigmenta bulu-dudu* on the skin, especially in long-term use.\n</step4>\n<step4>\nAdditionally, *antimalarials* such as *chloroquine* can also lead to similar skin changes — *iyipada awọ ti o jọra*.\n</step5>\n<step5>\nGiven that she has been on pain medication, it’s essential to consider if she has been prescribed any of these drugs for chronic pain management.\n</step6>\n<step6>\nThus, the likely culprit for the blue-black discoloration could be *minocycline* or *chloroquine*, depending on her specific medication history.\n</step6></thinking>", "answer": "<answer>Oogun ti o ṣeese jẹ́ ẹ̀bi fún awọ bulu-dudu yii ni *minocycline* tabi *chloroquine*.</answer>", "language": "Yoruba"}
{"question": "Àgbàlagbà ọmọ ọdún mẹtadinlogun kan tí ó jẹ́ olùṣọ́gbààlù láti Bangladesh ni wọ́n ṣe ayẹ̀wò fún àrùn ẹ̀gbà, lẹ́yìn tí ó fi àkùkọ̀ tí ó ti pẹ́ tí ó sì ní ìṣòro ní àyèwò X-ray ọmú rẹ̀ tí ó fi hàn pé ọ̀gbẹ̀ àrùn ẹ̀gbà ti wà ní apá ọ̀dọ̀ òkè. Wọ́n bẹ̀rẹ̀ sí ní fún un ní oògùn ìtọ́jú àrùn ẹ̀gbà tí ó ní oògùn kan tí ó dènà ìṣiṣẹ́pọ̀ epo-ṣuga ti ògiri sẹẹli mycobacterium. Ṣàlàyé ọ̀nà tí ó gbọ́dọ̀ jẹ́ jùlọ tí Mycobacterium tuberculosis gbà fi ara rẹ̀ dá sí oògùn yìí.", "reasoning": "<thinking><step1>\nThe question asks: “Àgbàlagbà ọmọ ọdún mẹtadinlogun kan tí ó jẹ́ olùṣọ́gbààlù láti Bangladesh ni wọ́n ṣe ayẹ̀wò fún àrùn ẹ̀gbà” — meaning it refers to a 17-year-old patient from Bangladesh who was tested for tuberculosis.\n</step1>\n<step2>\nThe patient has a history of chronic cough and the X-ray shows *ọ̀gbẹ̀ àrùn ẹ̀gbà* in the upper lobe of the lung, indicating a possible case of tuberculosis — *tuberculose*.\n</step2>\n<step3>\nThe treatment involves medication that targets the bacteria, specifically *Mycobacterium tuberculosis*, which is known to be resistant to certain drugs.\n</step3>\n<step4>\nThis resistance occurs because *Mycobacterium tuberculosis* can develop mechanisms to evade the effects of the drugs, such as altering its cell wall or using efflux pumps — *pumps ti ń yọ̀ epo-ṣuga*.\n</step5>\n<step5>\nAdditionally, the bacteria can enter a dormant state, making them less susceptible to antibiotics — *oògùn* that target actively dividing cells.\n</step6>\n<step6>\nTherefore, the primary way *Mycobacterium tuberculosis* can resist the treatment is through genetic mutations that confer drug resistance.\n</step6></thinking>", "answer": "<answer>Mycobacterium tuberculosis le dènà oògùn nípasẹ̀ àtúnṣe jènétìkì tí ń fa ìfarapa sí ìdílé oògùn.</answer>", "language": "Yoruba"}
{"question": "Ṣàpẹrẹ ṣiṣe awọn iṣẹlẹ ti o tọ ni iṣẹlẹ ati ibimọ, bẹrẹ lati ibamu.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣàpẹrẹ ṣiṣe awọn iṣẹlẹ ti o tọ ni [iṣẹlẹ = event] ati [ibimọ = birth], bẹrẹ lati [ibamu = compatibility].” — meaning it wants to outline the correct processes in events and births, starting from compatibility.\n</step1>\n<step2>\nIn any event planning, *ibamu* is crucial; it ensures that all elements align well — for example, the venue must suit the number of guests.\n</step2>\n<step3>\nNext, consider the *iṣẹlẹ* itself: the theme, schedule, and activities must be coherent and engaging for attendees — *awọn iṣẹlẹ gbọdọ jẹ iwunilori*.\n</step3>\n<step4>\nFor births, compatibility refers to the health of both the mother and the baby; prenatal care is essential — *itoju prenatal* helps monitor this.\n</step4>\n<step5>\nIn both contexts, communication is key; for events, clear instructions are needed, while for births, *ibaraẹnisọrọ* between healthcare providers and parents is vital.\n</step5>\n<step6>\nFinally, evaluating feedback after an event or monitoring the health of the newborn post-birth ensures continuous improvement — *imudara* is necessary for future success.\n</step6></thinking>", "answer": "<answer>Lati ṣe awọn iṣẹlẹ ti o tọ ni iṣẹlẹ ati ibimọ, bẹrẹ lati ibamu, o nilo ibamu, iṣakoso, ibaraẹnisọrọ, ati imudara.</answer>", "language": "Yoruba"}
{"question": "Onímọ̀ ọgbọ́n fìlàsófì wo ni ó sọ pé òfin adayeba dá lórí ìwà ènìyàn àti àìní rẹ̀ láti gbé ní àárín àwọn ènìyàn?", "reasoning": "<thinking><step1>\nThe question asks: “Onímọ̀ ọgbọ́n fìlàsófì wo ni ó sọ pé òfin adayeba dá lórí ìwà ènìyàn àti àìní rẹ̀ láti gbé ní àárín àwọn ènìyàn?” — which translates to “Which philosopher stated that natural law is based on human behavior and needs to coexist among people?”\n</step1>\n<step2>\nThis refers to the concept of natural law, or *òfin adayeba*, which suggests that laws are derived from moral principles inherent in human nature.\n</step2>\n<step3>\nA key philosopher associated with this idea is Thomas Aquinas, who argued that *òfin adayeba* is rooted in human reason and the common good.\n</step3>\n<step4>\nHe believed that human beings have certain needs and behaviors that must be respected for a society to function well — *ìwà ènìyàn* and *àìní* are essential for harmony.\n</step4>\n<step5>\nAquinas posited that laws should reflect these natural inclinations, ensuring that they promote justice and the welfare of the community.\n</step5>\n<step6>\nThus, the philosopher who articulated this view is Thomas Aquinas, emphasizing the connection between natural law and human behavior.\n</step6></thinking>", "answer": "<answer>Onímọ̀ ọgbọ́n fìlàsófì tí ó sọ pé òfin adayeba dá lórí ìwà ènìyàn ni Thomas Aquinas.</answer>", "language": "Yoruba"}
{"question": "Ta ni Leonardo DiCaprio n fẹ?\nA. Emi kò ní ẹ̀sùn.\nB. Blake Lively ni Leonardo DiCaprio n fẹ.\nC. Naomi Campbell ni Leonardo DiCaprio n fẹ.\nD. Demi Moore ni Leonardo DiCaprio n fẹ.\nE. Paris Hilton ni Leonardo DiCaprio n fẹ.", "reasoning": "<thinking><step1>\nThe question asks: “Ta ni [Leonardo DiCaprio = Leonardo DiCaprio] n fẹ?” — meaning it wants to know who Leonardo DiCaprio is currently dating.\n</step1>\n<step2>\nLeonardo DiCaprio is known for his high-profile relationships — *o ti ni ibasepo pẹlu ọpọlọpọ awọn obinrin olokiki*.\n</step2>\n<step3>\nAmong the options, we have several celebrities: *Blake Lively, Naomi Campbell, Demi Moore,* and *Paris Hilton*.\n</step3>\n<step4>\nHistorically, DiCaprio has been linked to models and actresses, but as of recent news, he has been seen with *Camila Morrone*.\n</step4>\n<step5>\nHowever, looking at the options provided, *Blake Lively* is not a recent partner, and the others are also not current.\n</step5>\n<step6>\nThus, the correct answer is that none of the options reflect his current relationship status accurately.\n</step6></thinking>", "answer": "<answer>Emi kò ní ẹ̀sùn.</answer>", "language": "Yoruba"}
{"question": "Ọkunrin ọdun 70 kan wá sí ọdọ oníṣẹ́-ìlera rẹ̀ fún ṣiṣayẹwo gbogbogbòò. Ó sọ pé ó ti wà ní ilera daradara, ó sì ti ń mu oogun rẹ̀ gẹ́gẹ́ bí a ti kọ́ wí. Ó ṣẹṣẹ bẹ̀rẹ̀ oúnjẹ tuntun kan àti afikun lati mú ilera rẹ̀ sunwọ̀n sí i, ó sì ti bẹ̀rẹ̀ sí ṣiṣẹ́ ṣiṣe. Àìlera tó ní nígbà àtijọ́ ni àrùn-ṣuga, ìdààmú ọkàn-àìlera, àti ẹ̀dùn-àìlera. Ó kò gbàgbé ìkùkù àìlera ní ìsinmi tàbí nígbà tí ó bá ń fi ara rẹ̀ síṣẹ́. A ṣe ECG, ó sì wà láàrin àwọn àdàkọdá deede. Àwọn iye ìṣàyẹwò ni a paṣẹ gẹ́gẹ́ bí a ti rí ní isalẹ.\n\nÈròjà Ẹ̀jẹ̀:\nNa+: 139 mEq/L\nCl-: 100 mEq/L\nK+: 6.7 mEq/L\nHCO3-: 25 mEq/L\nGlucose: 133 mg/dL\nCa2+: 10.2 mg/dL\n\nEwo ni oṣuwọn ti o ṣeé ṣe julọ fun ṣiṣiṣe alaisan yii?\nA. Ikuna kidirin kan ti o yara\nB. Awọn iyipada ounjẹ\nC. Hemolysis\nD. Oogun\nE. Rhabdomyolysis", "reasoning": "<thinking><step1>\nThe question asks: \"Ewo ni oṣuwọn ti o ṣeé ṣe julọ fun ṣiṣiṣe alaisan yii?\" — meaning it wants to know the most likely cause of the patient's condition.\n</step1>\n<step2>\nThe patient is a 70-year-old man with a history of diabetes and heart issues — *àrùn-ṣuga* àti *ìdààmú ọkàn-àìlera*. His potassium level is notably high at 6.7 mEq/L, which indicates potential complications.\n</step2>\n<step3>\nHigh potassium levels can lead to serious conditions like *ikuna kidirin* (kidney failure) or *rhabdomyolysis*, especially if there is muscle breakdown.\n</step4>\n<step4>\nConsidering the patient's recent dietary changes and supplements, *àwọn iyipada ounjẹ* could also contribute to his elevated potassium levels.\n</step5>\n<step5>\nHowever, the most immediate concern with such a high potassium level is the risk of cardiac issues, which aligns with the patient's history of heart problems.\n</step6>\n<step6>\nThus, the most likely cause of his condition, given the context and lab results, is *ikuna kidirin kan ti o yara* (acute kidney failure).\n</step6></thinking>", "answer": "<answer>Ikuna kidirin kan ti o yara.</answer>", "language": "Yoruba"}
{"question": "((-3 - 9 - 3 - 1) + (-4 * -9 * -7 - -6)) =", "reasoning": "<thinking><step1>\nThe question asks to solve the expression: “((-3 - 9 - 3 - 1) + (-4 * -9 * -7 - -6))” — we need to evaluate this step by step.\n</step1>\n<step2>\nFirst, simplify the expression inside the first parentheses: *-3 - 9 - 3 - 1* equals *-16*.\n</step2>\n<step3>\nNext, we look at the second part: *-4 * -9 * -7*. Multiplying these gives us a positive result because multiplying two negatives results in a positive: *-4 * -9 = 36*, then *36 * -7 = -252*.\n</step3>\n<step4>\nNow, we need to simplify *-4 * -9 * -7 - -6*. This becomes *-252 + 6*, which equals *-246*.\n</step4>\n<step5>\nNow we combine the results: *-16 + -246* equals *-262*.\n</step5></thinking>", "answer": "<answer>La réponse est -262.</answer>", "language": "Yoruba"}
{"question": "Nínú ìwádìí kan níbi tí ẹgbẹ́ ẹ̀kọ́ ìwòsàn kan ń dánwò ìdinku àrùn èèkánní nínú àwọn àlùfáà nípa lílo oògùn èèkánní tí a ń dánwò pẹ̀lú àwọn iwọ̀n ìgbàṣẹ̀ wàhálà, báwo ni ìwọ yóò ṣe ṣàpèjúwe ìsopọ̀ láàrin àwọn iwọ̀n ìgbàṣẹ̀ náà àti ìdinku àrùn èèkánní ní ti àwọn ohun tí a ń ṣàlàyé àti àwọn ohun tí a ń dáhùn sí?", "reasoning": "<thinking><step1>\nThe question asks: \"Nínú ìwádìí kan níbi tí ẹgbẹ́ ẹ̀kọ́ ìwòsàn kan ń dánwò [ìdinku àrùn èèkánní = reduction of chronic disease] nínú àwọn àlùfáà [in clergy]...\" — meaning it wants to explore the relationship between certain variables in a medical study.\n</step1>\n<step2>\nIn this context, the study likely examines how *ìwọ̀n ìgbàṣẹ̀ wàhálà* [levels of stress] affect the *ìdinku àrùn èèkánní* among the clergy.\n</step2>\n<step3>\nWe can hypothesize that higher stress levels may lead to poorer health outcomes — *àwọn àbájáde ilera to buru* — thus increasing the prevalence of chronic diseases.\n</step3>\n<step4>\nConversely, effective stress management techniques could potentially lead to a reduction in chronic disease symptoms — *ìdinku àrùn èèkánní*.\n</step4>\n<step5>\nTo describe this relationship, one might say that as *ìwọ̀n ìgbàṣẹ̀ wàhálà* decreases, the incidence of chronic diseases also decreases, indicating a negative correlation.\n</step5>\n<step6>\nIn summary, the connection between stress levels and chronic disease reduction is crucial for understanding health outcomes in this population.\n</step6></thinking>", "answer": "<answer>Ìsopọ̀ láàrin àwọn ìwọ̀n ìgbàṣẹ̀ wàhálà àti ìdinku àrùn èèkánní jẹ́ pé bí ìwọ̀n ìgbàṣẹ̀ wàhálà ṣe ń dín kù, bẹ́ẹ̀ ni àrùn èèkánní ṣe ń dín kù.</answer>", "language": "Yoruba"}
{"question": "Oníṣegun kan ti o jẹ́ ọ̀mọ̀wé ìmọ̀ ìṣègùn ń wá ọ̀nà tí ó dára jù lọ láti tọ́jú àrùn HIV. Àwọn àrùn náà tí àrùn HIV ti bà jẹ́ ń gbé ìdáàbòbò ara wọn kalẹ̀ nípa ṣiṣe àwọn antibody sí àwọn protein tí ó bojúmọ̀ HIV. Àwọn antibody wọ̀nyí ni àwọn kan náà tí a ń rí nípa lílo ELISA àti western blot assays tí a fi ń wádìí àrùn náà. Oníṣegun náà ń gbiyanjú láti ṣe àgbékalẹ̀ antibody tuntun tí ó lágbára jù lọ sí àwọn protein tí ó bojúmọ̀ HIV kan náà tí ìdáàbòbò ara tí ó wà ládúùrọ̀ ń gbà. Láàrin àwọn protein tó wà nísàlẹ̀ yìí, èwo ni ó ṣeé ṣe jù lọ láti jẹ́ ohun tí antibody tí ó ń ṣe ń fojú tó?\nA. gp120\nB. CXCR4\nC. p24\nD. p17", "reasoning": "<thinking><step1>\nThe question is asking which protein is most likely to be targeted by a new, stronger antibody against HIV — specifically, it mentions the role of antibodies in recognizing HIV proteins.\n</step1>\n<step2>\nIn the context of HIV, *àwọn protein* like gp120, CXCR4, p24, and p17 are crucial for the virus's ability to infect cells. \n</step2>\n<step3>\nGp120 is known for its role in binding to CD4 receptors on T cells, which is essential for HIV entry — *ìbáṣepọ̀ rẹ̀ pẹ̀lú CD4* is a key step in the infection process.\n</step3>\n<step4>\nP24 is a core protein that forms part of the viral capsid, and it is often used in diagnostics — *p24 ni a máa n rí nínú àwọn ìdánwò HIV*.\n</step4>\n<step5>\nCXCR4 is a co-receptor that HIV uses to enter cells, but it is not a direct target for antibodies like gp120 or p24 — *CXCR4 jẹ́ olùfúnni àṣẹ, ṣùgbọ́n kò jẹ́ protein tí antibody máa fojú tó*.\n</step5>\n<step6>\nP17 is a matrix protein, but it is less exposed to the immune system compared to gp120 and p24 — *p17 kò ní àfihàn tó dára jù lọ*.\n</step7>\n<step8>\nConsidering the need for a strong antibody response, targeting gp120 would likely be the most effective strategy due to its prominent role in the infection process.\n</step8></thinking>", "answer": "<answer>gp120</answer>", "language": "Yoruba"}
{"question": "Obirin ọmọ ọdun mẹrinlelogun kan ni a ṣe ayẹwo gẹgẹbi ọran ti àkóràn inu ọpọlọ ti pneumococcal. A rán apẹẹrẹ ẹ̀jẹ̀ rẹ̀ lọ fun idanwo ìgbàlà. Ní àkókò yìí, oògùn tí ó dára jù lọ láti bẹ̀rẹ̀ pẹlu gẹgẹbi itọju ìdánilójú ni -\nA. Penicillin G\nB. Doxycycline\nC. Streptomycin\nD. Vancomyin + Ceftriaxone", "reasoning": "<thinking><step1>\nThe question is asking about the best initial treatment for a 16-year-old diagnosed with a case of [àkóràn inu ọpọlọ = meningitis] caused by pneumococcus. \n</step1>\n<step2>\nIn cases of pneumococcal meningitis, the recommended treatment typically involves antibiotics that are effective against the bacteria — *bakteria* responsible for the infection.\n</step2>\n<step3>\nAmong the options provided, Penicillin G is a classic choice for treating pneumococcal infections, but resistance can be an issue — *ìfarapa* ti a fi ń ṣe àkóràn yìí.\n</step3>\n<step4>\nDoxycycline and Streptomycin are not first-line treatments for pneumococcal meningitis; they are used for other types of infections — *àkóràn mìíràn*.\n</step5>\n<step5>\nThe combination of Vancomycin and Ceftriaxone is often recommended for severe cases, especially when there is a risk of resistant strains — *ìfarapa ti o le fa* àkóràn.\n</step6>\n<step6>\nThus, the best initial treatment option for this case is Vancomycin + Ceftriaxone, as it covers a broader range of potential resistant pneumococci.\n</step6></thinking>", "answer": "<answer>Vancomycin + Ceftriaxone ni oògùn tí ó dára jù lọ láti bẹ̀rẹ̀ pẹlu gẹgẹbi itọju ìdánilójú.</answer>", "language": "Yoruba"}
{"question": "Ninu ọràn kan tí alejo kan kú nítorí àrùn ọkàn nígbà tí wọ́n dè é nígbà ìjàrá ní ilé rẹ̀, ẹ̀sùn wo ni olè náà yẹ kí wọ́n dá lẹ́jọ́, nígbà tí ìjàrá náà bẹ̀rẹ̀ pẹ̀lú ìfòkànbalẹ̀ pẹ̀lú ohun ìjà, àti ikú alejo náà sì ṣẹlẹ̀ gẹ́gẹ́ bí abajade taara ti iṣẹ́ ẹ̀ṣẹ̀ náà?", "reasoning": "<thinking><step1>\nThe question asks: “Ninu ọràn kan tí alejo kan kú nítorí àrùn ọkàn nígbà tí wọ́n dè é nígbà ìjàrá” — meaning it wants to know what charge should be brought against a thief when a guest dies from a heart condition during a robbery.\n</step1>\n<step2>\nIn this scenario, the key issue is whether the thief's actions directly caused the guest's death — *ikú alejo náà*.\n</step2>\n<step3>\nIf the robbery involved *ìfòkànbalẹ̀ pẹ̀lú ohun ìjà* (use of a weapon), it could be classified as a violent crime.\n</step3>\n<step4>\nThe legal principle of causation is crucial here; if the heart condition was exacerbated by the stress of the robbery, it may lead to a charge of *ìkà* (manslaughter).\n</step4>\n<step5>\nHowever, if the heart condition was pre-existing and unrelated to the robbery, the thief might face lesser charges, such as *jija* (theft) without the homicide implication.\n</step5>\n<step6>\nUltimately, the charge would depend on the evidence showing the direct link between the robbery and the death — *ìbáṣepọ̀ tó dájú*.\n</step6></thinking>", "answer": "<answer>Olè náà yẹ kí wọ́n dá lẹ́jọ́ fún ìkà, bí ikú alejo náà ṣe jẹ́ abajade taara ti ìjàrá.</answer>", "language": "Yoruba"}
{"question": "Àpọǹdá kan tí ó ní àrùn AIDS tí ó sì ń gbàdúrà pẹ̀lú Zidovudine, Lamivudine, àti Indinavir ń ní àrùn ìgbẹ̀rùn ẹ̀dọ̀fóró.  Òògùn wo ni a gbọdọ̀ yà kúrò fún àpọǹdá yìí nítorí ìdàpọ̀ òògùn tí ó lè ṣẹlẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What medication should be avoided for a patient with AIDS who is taking Zidovudine, Lamivudine, and Indinavir due to potential drug interactions?” — here, *àpọǹdá* means patient, and *àrùn AIDS* refers to AIDS disease.\n</step1>\n<step2>\nZidovudine, Lamivudine, and Indinavir are antiretroviral drugs used to manage HIV/AIDS — *òògùn antiretroviral*.\n</step2>\n<step3>\nWhen considering drug interactions, it’s crucial to identify medications that can adversely affect the metabolism of these antiretrovirals — *ìdàpọ̀ òògùn* can lead to increased toxicity or reduced efficacy.\n</step3>\n<step4>\nFor instance, certain medications like *rifampicin* can induce liver enzymes, which may lower the effectiveness of Indinavir — this is a significant concern.\n</step4>\n<step5>\nAdditionally, drugs that also affect the liver, such as *ketoconazole*, could increase Indinavir levels, leading to toxicity — *ìfarapa*.\n</step5>\n<step6>\nTherefore, it is essential to avoid medications that can either induce or inhibit liver enzymes affecting these antiretrovirals.\n</step6>\n<step7>\nIn summary, one must be cautious with drugs like *rifampicin* and *ketoconazole* when treating a patient on this regimen.\n</step7></thinking>", "answer": "<answer>A gbọdọ̀ yà kúrò nínú àpọǹdá yìí pẹ̀lú rifampicin àti ketoconazole.</answer>", "language": "Yoruba"}
{"question": "Alaisan kan wa pelu awon aisan inu, wiwu inu, ati irora inu.  MRI fihan pe awon eegun inu obinrin mejeeji ni kokoro pelu titan kaakiri si egungun inu ibadi ati egbo inu. Lati inu awon nnkan ti a ri yii, kini ipo ti kokoro inu obinrin yii wa?", "reasoning": "<thinking><step1>\nThe question translates to: \"What is the condition of the woman's internal organs based on the MRI findings showing inflammation and pain?\" It mentions *awọn aisan inu* [internal diseases], *wiwu inu* [abdominal pain], and *irora inu* [internal pain].\n</step1>\n<step2>\nThe MRI indicates that there is *kokoro* [inflammation] affecting both internal organs and extending to the *egungun inu ibadi* [pelvic bones] and *egbo inu* [abdominal wall].\n</step2>\n<step3>\nThis suggests a significant level of *titan kaakiri* [widespread inflammation], which could indicate a serious underlying condition, possibly an infection or an autoimmune disorder.\n</step3>\n<step4>\nIn medical terms, this could be described as *inflammation généralisée* [generalized inflammation], which often leads to complications if not addressed promptly.\n</step4>\n<step5>\nThe presence of pain and inflammation in the internal organs typically points to a condition that requires immediate medical attention, such as *apandẹ* [appendicitis] or *irora inu* [internal pain] due to other causes.\n</step5>\n<step6>\nThus, the condition of the woman's internal organs appears to be serious, with *kokoro* affecting multiple areas, indicating a need for further evaluation and treatment.\n</step6></thinking>", "answer": "<answer>Ipo ti kokoro inu obinrin yii wa ni ipo to lewu, pẹlu wiwu ati irora inu ti o nilo itọju lẹsẹkẹsẹ.</answer>", "language": "Yoruba"}
{"question": "Àpọǹ lára ń yọ̀ọ́ sọ́rọ̀, ìrora, àti ìgbọ́nrín tí ń gbòòrò sí i. Nígbà tí a ṣe àyẹ̀wò rẹ̀, ìgbóná pupa kan wà lẹ́yìn ìdí tí ó dára, tí ó sì yí padà sí funfun nígbà tí a fi ohun èlò tí a ń pè ní pneumatic speculum tẹ̀ sí i. Ìtọ́jú rẹ̀ pẹ̀lú gbogbo àwọn wọ̀nyí yàtọ̀ sí:\nA. Irègbédídì\nB. Ìṣirò\nC. Interferons\nD. Ìtẹ́lẹ̀ṣẹ̀ níṣàájú ṣíṣirò", "reasoning": "<thinking><step1>\nThe question describes a medical condition involving symptoms like *ìrora* [pain] and *ìgbọ́nrín* [swelling], with a notable *ìgbóná pupa* [redness] that changes to *funfun* [white] when a *pneumatic speculum* is applied.\n</step1>\n<step2>\nThis suggests an inflammatory response, possibly indicating an infection or irritation. The presence of *ìrora* and *ìgbọ́nrín* points towards a condition that requires specific treatment.\n</step2>\n<step3>\nThe options provided include various treatment methods: *Irègbédídì* [antibiotics], *Ìṣirò* [surgery], *Interferons*, and *Ìtẹ́lẹ̀ṣẹ̀ níṣàájú ṣíṣirò* [pre-surgical intervention].\n</step3>\n<step4>\nGiven the symptoms and the examination findings, the most appropriate treatment would likely be *Irègbédídì*, as it targets infections effectively.\n</step5>\n<step5>\n*Ìṣirò* might be considered if there were complications, but the initial approach should focus on addressing the infection with antibiotics.\n</step6>\n<step6>\nThus, the best choice for treatment in this scenario is *Irègbédídì*.\n</step6></thinking>", "answer": "<answer>Irègbédídì ni ìtọ́jú tó dára jùlọ fún àpọǹ lára yìí.</answer>", "language": "Yoruba"}
{"question": "Ṣe iṣakoso abẹrẹ ti o dara julọ fun ọkunrin ọdun 18 kan ti o ni irora ati igbona ni ẹnu-atẹgun apa ọtun rẹ̀, iṣoro díẹ̀ ninu ṣiṣi ẹnu, iba, ati iṣiṣẹ̀ ọkàn ti o pọ̀ sí i, lẹhin ti awọn ami ati awọn aami aisan wọnyi ba ti dinku?", "reasoning": "<thinking><step1>\nThe question asks: “Ṣe iṣakoso abẹrẹ ti o dara julọ fun ọkunrin ọdun 18 kan ti o ni irora ati igbona ni ẹnu-atẹgun apa ọtun rẹ̀?” — meaning it seeks the best management for an 18-year-old man with pain and fever in his right tonsil area.\n</step1>\n<step2>\nThe symptoms include *irora* (pain), *igbona* (fever), and difficulty opening the mouth — *iṣoro díẹ̀ ninu ṣiṣi ẹnu*.\n</step2>\n<step3>\nThese signs suggest a possible infection, such as *tonsillitis* or *pharyngitis*, which may require antibiotics if bacterial.\n</step3>\n<step4>\nAfter the symptoms have decreased, it’s important to monitor for any recurrence — *iwadii fun eyikeyi atunṣe* of the symptoms.\n</step4>\n<step5>\nManagement may include pain relief with analgesics — *irinṣẹ́ irora* — and hydration to soothe the throat.\n</step5>\n<step6>\nIn summary, the best management involves monitoring, symptomatic treatment, and possibly antibiotics if a bacterial infection is confirmed.\n</step6></thinking>", "answer": "<answer>Iṣakoso abẹrẹ ti o dara julọ ni atẹle awọn ami, itọju irora, ati awọn antibiotics ti o ba jẹ pe ikolu ba jẹ ti bacterial.</answer>", "language": "Yoruba"}
{"question": "Nítorí pé 60% àwọn ẹ̀yà ẹ̀rọ amóhùnmáwòrán kan wà láààyè ju ọdún mẹ́ta lọ, àti 70% wà láààyè kéré sí ọdún mẹ́fà, tí a sì gbà pé igba ìgbé ayé wọn tẹ̀lé ìpín àkọ́kọ́ gbogbo, kí ni ìwọ̀n àpapọ̀ àti ìyàtọ̀ ìwọ̀n ibùgbé ayé àwọn ẹ̀yà wọ̀nyí?", "reasoning": "<thinking><step1>\nThe question translates to: \"Since 60% of certain species of [amóhùnmáwòrán = mammals] live longer than three years, and 70% live less than six years, what is the average lifespan and the variance of the lifespan of these species?\" \n</step1>\n<step2>\nTo find the average lifespan, we need to consider the two groups: those living more than three years and those living less than six years. \n</step2>\n<step3>\nAssuming a simple model, we can estimate the average lifespan of the first group as greater than three years, possibly around 4.5 years, while the second group could average around 5 years.\n</step3>\n<step4>\nNext, we calculate the weighted average: *àpapọ̀ = average* = (0.6 * 4.5) + (0.7 * 5) / (0.6 + 0.7).\n</step4>\n<step5>\nFor variance, we need to consider the spread of the lifespans around the average — *ìyàtọ̀ = variance* — which requires more detailed data on the actual lifespans.\n</step5>\n<step6>\nHowever, without specific lifespan data, we can only estimate that the variance will be influenced by the distribution of lifespans in both groups.\n</step6></thinking>", "answer": "<answer>Ìwọ̀n àpapọ̀ jẹ́ 4.5 ọdún, ṣùgbọ́n ìyàtọ̀ ìwọ̀n ibùgbé ayé kò le dájú láìní àlàyé tó péye.</answer>", "language": "Yoruba"}
{"question": "Obìnrin Afirika Amerika ọdun 42 kan ṣe afihan irora ọmu inu lójijì tí ó sàn nígbà tí ó bá jókòó sókè tí ó sì tẹ̀ síwájú, pẹ̀lú ọwọ́ àti ọgbọ̀n tí ó gbẹ̀. Ó ń lo hydralazine fún àtìgbàgbà àtìgbàgbà àtìgbàgbà, ó sì ní àdánwò àtìgbàgbà antinuclear tó yẹ̀, ṣùgbọ́n ó gbàdúrà fún àtìgbàgbà ST elevations lórí ECG.  Àyọkà antibody pàtó wo ni a nìyànjú láti rí ninu ẹ̀jẹ̀ rẹ̀ tí ó fi hàn pé lupus erythematosus tí oògùn fa nitori lílò hydralazine?", "reasoning": "<thinking><step1>\nThe question asks about a 42-year-old African American woman who experiences sudden chest pain when sitting forward, and she has been using hydralazine for hypertension. It also mentions a positive antinuclear antibody test and ST elevations on the ECG. The focus is on identifying a specific antibody related to drug-induced lupus erythematosus caused by hydralazine.\n</step1>\n<step2>\nHydralazine is known to potentially induce lupus-like symptoms, particularly in certain populations. In this case, we need to consider the antibodies associated with drug-induced lupus — *lupus erythematosus induit par les médicaments*.\n</step2>\n<step3>\nThe most common antibody associated with hydralazine-induced lupus is anti-histone antibodies — *anticorps anti-histones*. These antibodies are often present in patients with drug-induced lupus.\n</step3>\n<step4>\nIn addition to anti-histone antibodies, one might also check for other autoantibodies, but anti-histone is the key marker for this condition.\n</step4>\n<step5>\nGiven her symptoms and the use of hydralazine, it is crucial to confirm the presence of these antibodies to establish the diagnosis of drug-induced lupus.\n</step5>\n<step6>\nThus, the specific antibody we are looking for in her blood is the anti-histone antibody.\n</step6></thinking>", "answer": "<answer>Anticorps anti-histones.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọjọ́ ogún (2) ti ń ṣe àìlera ẹ̀dọ̀fọ́, aṣọ̀dà, àti ìdànì bílátíràlì.  Ìṣiṣẹ̀ ọkàn ọmọ náà jẹ́ 180/min, ìṣiṣẹ̀ ẹ̀dọ̀fọ́ sì jẹ́ 56/min, ìwọn ẹ̀dọ̀ jẹ́ 7.5 cm. Ọmọ náà ní ìtàn àwọn ìṣẹ̀lẹ̀ ìgbàgbọ́, ikọ́, àti àìlera ẹ̀dọ̀fọ́ láti ìgbà tí a bí i.  Nínú àyẹ̀wò ọkàn, a gbọ́ ìró ọkàn ìdá III ìdènà sístòliki ní agbègbè pàrástẹ̀nàlì òsì.  Èrò X-ray àyà fi hàn pé ọkàn ńlá pẹ̀lú ipilẹ̀ kòkòrò àti àgbàlà àyà tí ó kún fún ẹ̀jẹ̀.  Lórí àwọn ìṣẹ̀dá àyẹ̀wò wọ̀nyí, kí ni àìsàn tí ó pọ̀jù gbogbo rẹ̀ fún ọmọ kékeré yìí?", "reasoning": "<thinking><step1>\nThe question is asking about the most likely disease affecting a 2-year-old child with specific symptoms: *àìlera ẹ̀dọ̀fọ́* (heart failure), *aṣọ̀dà* (edema), and *ìdànì bílátíràlì* (bilateral lung issues).\n</step1>\n<step2>\nThe child's heart rate is 180/min, which is quite high — *ìṣiṣẹ̀ ọkàn* (heart rate) is elevated, indicating possible stress on the heart.\n</step2>\n<step3>\nThe respiratory rate is 56/min, suggesting *ìdààmú ẹ̀dọ̀fọ́* (respiratory distress), which aligns with the presence of *ìdànì bílátíràlì*.\n</step3>\n<step4>\nThe examination reveals a *ìró ọkàn ìdá III* (grade III heart murmur) in the left parasternal area, indicating significant heart dysfunction.\n</step5>\n<step5>\nThe X-ray shows cardiomegaly (enlarged heart) with pulmonary congestion — *àgbàlà àyà tí ó kún fún ẹ̀jẹ̀* (lung fields filled with blood), which is common in heart failure.\n</step6>\n<step6>\nConsidering all these findings, the most likely diagnosis for this child is *àìlera ẹ̀dọ̀fọ́* (heart failure) due to congenital heart disease or cardiomyopathy.\n</step6></thinking>", "answer": "<answer>Àìlera ẹ̀dọ̀fọ́ ni àìsàn tí ó pọ̀jù fún ọmọ kékeré yìí.</answer>", "language": "Yoruba"}
{"question": "Fún ọmọkunrin ọdún mẹfa kan tí ó ní àìlera ẹsẹ̀ méjèèjì tí ó ń pọ̀ sí i, àti itan ìdílé nípa arákùnrin rẹ̀ tí ó kú ní ọdún mẹrinlẹ́gbẹ̀rin, èyíkéyìí ni oògùn tí ó yẹ kí a yàgò fún nígbà ìṣe ẹ̀gbà láti dènà àwọn àṣìṣe tí ó lè ṣẹlẹ̀?", "reasoning": "<thinking><step1>\nThe question asks: “What medication should be avoided for a six-year-old boy with bilateral leg weakness and a family history of a brother who died at age fourteen?” — it seeks to identify potential risks in medication due to the child's condition and family history.\n</step1>\n<step2>\nIn children, especially those with *àìlera ẹsẹ̀ méjèèjì* (bilateral leg weakness), certain medications can exacerbate their condition or lead to serious side effects.\n</step2>\n<step3>\nGiven the family history of a brother who died young, it’s crucial to consider genetic factors — *àwọn ifosiwewe jiini* — that might affect medication metabolism or response.\n</step3>\n<step4>\nFor instance, medications like *non-steroidal anti-inflammatory drugs (NSAIDs)* can sometimes lead to complications in children with underlying conditions.\n</step4>\n<step5>\nAdditionally, if the child has any neuromuscular disorders, certain muscle relaxants or sedatives could pose risks — *oògùn ti o le fa ìdààmú*.\n</step5>\n<step6>\nTherefore, it’s essential to consult a healthcare professional to determine the safest options and avoid any medications that could trigger adverse effects.\n</step6></thinking>", "answer": "<answer>Oògùn ti a yẹ kí a yàgò fún ni *non-steroidal anti-inflammatory drugs (NSAIDs)* àti *muscle relaxants* nitori àìlera ẹsẹ̀ méjèèjì àti itan ìdílé.</answer>", "language": "Yoruba"}
{"question": "Bittu, ọmọkunrin ọdun mẹfa, ni awọn àmì kekere ti ko ní pigment ati awọn macules scaly lori irun.  Diẹ ninu awọn ọrẹ rẹ̀ tun ni awọn ipalara bẹẹ.  Ayẹwo ti o ṣeeṣe julọ ni kini?\nA. Pityriasis rosea\nB. Pityriasis versicolor\nC. Ààrùn àwọn ara alaimọ\nD. Pityriasis alba", "reasoning": "<thinking><step1>\nThe question asks: “Bittu, a six-year-old boy, has small spots without pigment and scaly macules on his skin. Some of his friends also have similar lesions. What is the most likely diagnosis?” This indicates a skin condition, and we need to identify it among the options provided.\n</step1>\n<step2>\nThe symptoms described, such as *àmì kekere ti ko ní pigment* (small spots without pigment) and *macules scaly* (scaly macules), suggest a dermatological issue. \n</step2>\n<step3>\nConsidering the age of the child and the fact that friends have similar lesions, we should think about common skin conditions in children — *àwọn ààrùn awọ* (skin diseases).\n</step3>\n<step4>\nPityriasis alba is characterized by hypopigmented patches, often seen in children, and can appear scaly — *pityriasis alba ni a mọ̀ gẹ́gẹ́ bí àyẹ̀wò àìlera awọ*.\n</step4>\n<step5>\nPityriasis rosea typically presents with a herald patch and is less common in this scenario, while pityriasis versicolor usually involves discolored patches due to fungal infection — *pityriasis versicolor jẹ́ ààrùn ti o ni ibatan pẹ̀lú àkóràn*.\n</step6>\n<step7>\nGiven the description and the context, the most fitting diagnosis is likely pityriasis alba, as it aligns with the symptoms and is common among children.\n</step7></thinking>", "answer": "<answer>Àyẹwo ti o ṣeeṣe julọ ni pityriasis alba.</answer>", "language": "Yoruba"}
{"question": "Ọdọmọdún mẹ́ẹ́ẹ́dógún kan wà pẹ̀lú irọ́rùn tí ń pọ̀ sí i, àti àìlera nígbà tí ó bá ń ṣiṣẹ́, wíwádìí ara rẹ̀ sì fi hàn pé ìyàtọ̀ ńlá kan wà láàrin ohùn ọkàn rẹ̀ kejì, pẹ̀lú ohùn ọkàn tí ó jẹ́ nígbà ìdènà àti àkókò ìgbà tí ọkàn ń lu.  Ṣé kí èrò ṣíṣàyẹ̀wò ohun tí ó wà nínú ọkàn rẹ̀ yóò rí bí?", "reasoning": "<thinking><step1>\nThe question asks: “What will an examination of the heart reveal?” — it mentions symptoms like *irọ́rùn* [discomfort] and *àìlera* [weakness] during activity, indicating potential heart issues.\n</step1>\n<step2>\nThe heart's function can be assessed through various tests, such as an *ekg* [electrocardiogram] or *echocardiogram* to visualize heart function and structure.\n</step2>\n<step3>\nGiven the symptoms, there may be signs of *ìdènà* [blockage] or irregular heartbeats, which can be detected during these examinations.\n</step3>\n<step4>\nThe examination might also reveal *àkókò* [timing] issues in the heartbeat, indicating arrhythmias or other cardiac conditions.\n</step4>\n<step5>\nAdditionally, blood tests could show levels of certain markers that indicate heart stress or damage, such as *troponin*.\n</step5>\n<step6>\nIn summary, the examination will likely show abnormalities in heart rhythm and structure, which are critical for diagnosing the underlying issues.\n</step6></thinking>", "answer": "<answer>Ìwádìí ohun tí ó wà nínú ọkàn rẹ̀ yóò fi hàn pé ó lè ní àìlera, ìdènà, tàbí àkókò àìtọ́ nínú ìdáhùn rẹ̀.</answer>", "language": "Yoruba"}
{"question": "Alisi, Bobu, Klea, Deifu, ati Ifi n ṣe ayẹyẹ ṣíṣe àyẹ̀wò ẹ̀bùn funfun ẹlẹ́rìn. Ni ibẹ̀rẹ̀ ìṣẹ̀lẹ̀ náà, wọ́n gbà ẹ̀bùn kan ti awọ̀ ọ̀tòọ̀tọ̀: Alisi ní ẹ̀bùn awọ̀ pupa, Bobu ní bọ́ọ̀lù awọ̀ ọ̀pọ̀tọ́, Klea ní ẹ̀bùn awọ̀ pupa, Deifu ní ẹ̀bùn awọ̀ alẹ́wà, ati Ifi ní ẹ̀bùn awọ̀ alawọ̀.\nGẹ́gẹ́ bí ìṣẹ̀lẹ̀ náà ti nlọ siwaju, awọn tọkọtaya eniyan ṣe ayẹ̀wò ẹ̀bùn. Akọkọ, Alisi ati Ifi ṣe ayẹ̀wò awọn ẹ̀bùn wọn. Lẹ́yìn náà, Bobu ati Deifu ṣe ayẹ̀wò awọn ẹ̀bùn wọn. Lẹ́yìn náà, Bobu ati Ifi ṣe ayẹ̀wò awọn ẹ̀bùn wọn. Lẹ́yìn náà, Klea ati Ifi ṣe ayẹ̀wò awọn ẹ̀bùn wọn. Nikẹhin, Deifu ati Alisi ṣe ayẹ̀wò awọn ẹ̀bùn wọn. Ni opin ìṣẹ̀lẹ̀ náà, Ifi ní\nAwọn aṣayan:\n(A) ẹ̀bùn awọ̀ pupa\n(B) bọ́ọ̀lù awọ̀ ọ̀pọ̀tọ́\n(C) ẹ̀bùn awọ̀ pupa\n(D) ẹ̀bùn awọ̀ alẹ́wà\n(E) ẹ̀bùn awọ̀ alawọ̀", "reasoning": "<thinking><step1>\nThe question describes a scenario where Alisi, Bobu, Klea, Deifu, and Ifi are celebrating by examining gifts of different colors. It asks what gift Ifi ends up with at the end of the event.\n</step1>\n<step2>\nInitially, the gifts are: Alisi has a red gift [ẹ̀bùn awọ̀ pupa], Bobu has a multicolored ball [bọ́ọ̀lù awọ̀ ọ̀pọ̀tọ́], Klea also has a red gift, Deifu has a beautiful gift [ẹ̀bùn awọ̀ alẹ́wà], and Ifi has a green gift [ẹ̀bùn awọ̀ alawọ̀].\n</step2>\n<step3>\nAs the event progresses, pairs of people examine their gifts. First, Alisi and Ifi check their gifts, which means Ifi still has the green gift at this point.\n</step3>\n<step4>\nNext, Bobu and Deifu examine their gifts. This does not affect Ifi's gift either, as they are not involved in this pair.\n</step4>\n<step5>\nThen, Bobu and Ifi check their gifts. Ifi still has the green gift, and Bobu has the multicolored ball.\n</step5>\n<step6>\nAfter that, Klea and Ifi examine their gifts. Ifi's gift remains unchanged, still being the green gift.\n</step6>\n<step7>\nFinally, Deifu and Alisi check their gifts. This also does not change Ifi's gift, which has consistently been the green gift throughout the event.\n</step7>\n<step8>\nAt the end of the event, since Ifi has not exchanged or changed gifts with anyone, Ifi still has the green gift.\n</step8></thinking>", "answer": "<answer>ẹ̀bùn awọ̀ alawọ̀</answer>", "language": "Yoruba"}
{"question": "Ṣé dídinku agbọǹdù ati didinku insulin ni ọ̀nà ti a ti fi ìmọ̀ sáyẹ́nsì jẹ́rìí sí jùlọ lati dinku ìwúwo?\nA. Rárá, ọ̀pọ̀lọpọ̀ oúnjẹ oníṣòwò tí a ti fi ìmọ̀ sáyẹ́nsì jẹ́rìí sí pé ó ń mú kí ìwúwo dinku wà.\nB. Bẹ́ẹ̀ni, dídinku agbọǹdù ati didinku insulin ni ọ̀nà ti a ti fi ìmọ̀ sáyẹ́nsì jẹ́rìí sí jùlọ lati dinku ìwúwo.\nC. Bẹ́ẹ̀ni, oúnjẹ tí kò ní agbọǹdù pupọ̀ ni ọ̀nà tí ó dára jùlọ lati dinku ìwúwo.\nD. Bẹ́ẹ̀ni, nítorí pé agbọǹdù ń mú kí o ṣe ìwúwo pọ̀ sí i.", "reasoning": "<thinking><step1>\nThe question asks: “Ṣé dídinku agbọǹdù ati didinku insulin ni ọ̀nà ti a ti fi ìmọ̀ sáyẹ́nsì jẹ́rìí sí jùlọ lati dinku ìwúwo?” — which translates to “Is reducing carbohydrates and reducing insulin the scientifically proven way to lose weight?”\n</step1>\n<step2>\nTo answer this, we need to consider the role of carbohydrates — *agbọǹdù* — in weight management. High carbohydrate intake can lead to increased insulin levels, which may promote fat storage.\n</step2>\n<step3>\nResearch indicates that lower carbohydrate diets can lead to weight loss by reducing insulin levels — *didinku insulin* — and promoting fat utilization for energy.\n</step3>\n<step4>\nHowever, it’s important to note that not all weight loss strategies are the same; some may focus on overall caloric intake rather than just carbohydrate reduction.\n</step4>\n<step5>\nIn this context, option B states that reducing carbohydrates and insulin is the most scientifically proven method for weight loss, which aligns with current dietary research.\n</step5>\n<step6>\nThus, while there are multiple approaches to weight loss, the evidence supports that managing carbohydrate intake and insulin levels can be effective.\n</step6></thinking>", "answer": "<answer>Bẹ́ẹ̀ni, dídinku agbọǹdù ati didinku insulin ni ọ̀nà ti a ti fi ìmọ̀ sáyẹ́nsì jẹ́rìí sí jùlọ lati dinku ìwúwo.</answer>", "language": "Yoruba"}
{"question": "Ninu ọkunrin ọdun 49 kan ti o ni àìsàn lílo ọtí, tí ó ní àwọn àmì àrùn tí ó fi hàn pé ẹ̀jẹ̀ ń ṣàn láti inu ikun, tí ó sì nilo oògùn kan láti dín titẹ inu iṣan ẹjẹ̀ portal kù, iṣẹ́ oògùn náà ni láti dènà ìtùjáde awọn homonu tí ń fa kí iṣan ẹjẹ̀ gbèrè ní agbegbe splanchnic, ati láti dènà ìtùjáde glucagon ati insulin.  Oògùn yìí jẹ́ apẹẹrẹ ṣiṣẹ́da ti ohun kan tí àwọn irú ṣẹ́ẹ̀lì pàtó wo ni ó máa ń ṣe?", "reasoning": "<thinking><step1>\nThe question asks about a 49-year-old man with a history of alcohol use disorder who has symptoms indicating internal bleeding from the stomach — *àìsàn lílo ọtí* and *àmì àrùn* suggestive of *ìtùjáde ẹ̀jẹ̀*.\n</step1>\n<step2>\nHe needs a medication to reduce portal hypertension — *titẹ inu iṣan ẹjẹ̀ portal* — which is often caused by increased blood flow in the splanchnic area.\n</step2>\n<step3>\nThe medication should inhibit the release of hormones that cause vasodilation in the splanchnic circulation — *ìtùjáde awọn homonu*.\n</step4>\n<step4>\nAdditionally, it must prevent the secretion of glucagon and insulin, which can exacerbate the condition — *dènà ìtùjáde glucagon ati insulin*.\n</step5>\n<step5>\nThis type of medication is typically a non-selective beta-blocker, which reduces blood flow and pressure in the portal system — *apẹẹrẹ ti oògùn yìí ni beta-blocker*.\n</step6>\n<step6>\nIn summary, the drug works by blocking certain receptors to manage blood flow and pressure effectively.\n</step6></thinking>", "answer": "<answer>Oògùn yìí jẹ́ beta-blocker ti a lo láti dín titẹ inu iṣan ẹjẹ̀ portal kù.</answer>", "language": "Yoruba"}
{"question": "Ọmọ ọdun mẹta kan ṣe afihan awọn ami aiṣan ti iṣọn-ara, petechiae gbogbo ara, itan-ara aisan kokoro arun ọsẹ meji sẹyin, hemoglobin deede, hematocrit, iye WBC ati iyatọ, ṣugbọn iye platelet ti 19,000/iL. Ni akiyesi awọn ami aisan ati awọn abajade ile-iwosan wọnyi, arun kokoro eyi ni o kere julọ lati ni asopọ pẹlu ipo ọmọ yii?", "reasoning": "<thinking><step1>\nThe question asks about a three-year-old child showing symptoms of [iṣọn-ara = bleeding disorder], with petechiae all over the body, a history of [aisan kokoro = viral illness] two weeks ago, normal hemoglobin, hematocrit, and WBC count, but a platelet count of 19,000/iL. It seeks to identify the least likely viral condition associated with this child's situation.\n</step1>\n<step2>\nIn this case, the low platelet count — *iyẹnumọ platelet* — is significant. Conditions like *thrombocytopenic purpura* can cause petechiae due to low platelets.\n</step2>\n<step3>\nCommon viral infections that lead to low platelets include *arun dengue* and *arun rubella*, but we need to find the least likely connection.\n</step3>\n<step4>\nConsidering the child's recent viral illness, *arun kokoro* could be linked to conditions like *arun Epstein-Barr* or *arun cytomegalovirus*, but these typically do not cause such low platelet counts.\n</step4>\n<step5>\nAmong the options, *arun measles* is less commonly associated with thrombocytopenia compared to others like dengue or rubella, making it a candidate for the least likely connection.\n</step5>\n<step6>\nThus, the least likely viral illness to be associated with this child's condition, given the symptoms and lab results, is *arun measles*.\n</step6></thinking>", "answer": "<answer>Arun measles ni arun kokoro ti o kere julọ lati ni asopọ pẹlu ipo ọmọ yii.</answer>", "language": "Yoruba"}
{"question": "Obirin ọdọ, ọdun 24, ti o gbé iwuwo lọ́wọ́, wá pẹlu irora inu, eyiti o bẹ̀rẹ̀ nigba ti o n gbé iwuwo, pẹlu awọn ami aisan bi irora ninu apa ọtun oke, àkàn, ati idagba egbòogi. Awọn aworan fihan iṣura kan ti o yatọ si ara rẹ̀ ni apa ọtun oke. Ti a ba gbé awọn ami aisan wọnyi, kini abajade ile-iwosan miiran ti o ni ibatan si profaili lipid rẹ ti o ṣee ṣe julọ lati rii?", "reasoning": "<thinking><step1>\nThe question is asking about a 24-year-old woman who experiences abdominal pain when lifting weights, with symptoms like pain in the upper right quadrant, nausea, and vomiting. It also mentions imaging showing a mass in the upper right quadrant. The inquiry is about potential hospital outcomes related to her lipid profile.\n</step1>\n<step2>\nGiven her symptoms, particularly the pain in the upper right quadrant — *irora ninu apa ọtun oke* — this could suggest a gallbladder issue, such as *kòkòrò* or gallstones, especially since she is experiencing nausea and vomiting.\n</step2>\n<step3>\nIn cases of gallbladder disease, one might expect to see elevated lipid levels, particularly triglycerides — *triglycerides* — which can be associated with gallstone formation.\n</step3>\n<step4>\nAdditionally, if there is a mass present, it could indicate complications like cholecystitis or even pancreatitis, which can also affect lipid metabolism — *iṣeduro lipid*.\n</step4>\n<step5>\nTherefore, the most likely hospital outcome related to her lipid profile would be an increase in triglycerides and possibly cholesterol levels — *ipele cholesterol* — due to the underlying gallbladder pathology.\n</step5>\n<step6>\nIn summary, the expected result would be an abnormal lipid profile, particularly with elevated triglycerides.\n</step6></thinking>", "answer": "<answer>Abajade ile-iwosan ti o ṣee ṣe julọ ni pe profaili lipid rẹ yoo ni awọn ipele triglycerides ti o ga.</answer>", "language": "Yoruba"}
{"question": "Àwọn ọ̀nà ìtọ́jú wo ni ó yẹ fún ọkùnrin ọmọ ọdún 60 kan tí ó ní àrùn kọ́lónì apá òsì, tí ó sì ń ṣe àìṣẹ́ ṣiṣẹ́ kọ́lónì apá òsì tó le?", "reasoning": "<thinking><step1>\nThe question asks: “Àwọn ọ̀nà ìtọ́jú wo ni ó yẹ fún ọkùnrin ọmọ ọdún 60 kan tí ó ní àrùn [kòlonì apá òsì = left colon disease], tí ó sì ń ṣe àìṣẹ́ [ṣiṣẹ́ = functioning] kọ́lónì apá òsì tó le?” — meaning it wants to know the treatment options for a 60-year-old man with left colon disease who is experiencing impaired left colon function.\n</step1>\n<step2>\nFor a patient with left colon disease, *ìtọ́jú* often includes dietary changes — *àtúnṣe onjẹ* — to manage symptoms and improve bowel health.\n</step2>\n<step3>\nIncorporating more fiber into the diet can help — *fibre* aids in digestion and can alleviate constipation, which is common in such conditions.\n</step3>\n<step4>\nAdditionally, medications may be prescribed to manage inflammation or pain — *ìfarapa* and *ìrora* are key concerns in this context.\n</step4>\n<step5>\nRegular monitoring by a healthcare professional is crucial — *ìtọ́jú ilera* ensures that any complications are addressed promptly.\n</step6>\n<step6>\nIn severe cases, surgical options might be considered if the condition worsens — *ìṣẹ́ abẹ́* could be necessary to remove affected sections of the colon.\n</step7>\n<step7>\nOverall, a combination of lifestyle changes, medication, and regular check-ups is essential for managing left colon disease effectively.\n</step8></thinking>", "answer": "<answer>Àwọn ọ̀nà ìtọ́jú fún ọkùnrin yìí ni àtúnṣe onjẹ, ìmúra àkópọ̀, àti ìtọ́jú ilera pẹ̀lú ìṣẹ́ abẹ́ bí ó bá jẹ́ pé àrùn náà ti pọ̀ sí i.</answer>", "language": "Yoruba"}
